0001171843-15-001465.txt : 20150317 0001171843-15-001465.hdr.sgml : 20150317 20150317160823 ACCESSION NUMBER: 0001171843-15-001465 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150317 DATE AS OF CHANGE: 20150317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AKORN INC CENTRAL INDEX KEY: 0000003116 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 720717400 STATE OF INCORPORATION: LA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32360 FILM NUMBER: 15706436 BUSINESS ADDRESS: STREET 1: 1925 W. FIELD COURT, SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 847-279-6100 MAIL ADDRESS: STREET 1: 1925 W. FIELD COURT, SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 10-K 1 f10k_030215.htm FORM 10-K f10k_030215.htm
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

Form 10-K

þ
Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
   
 
For the fiscal year ended December 31, 2014
   
o
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 001-32360

AKORN, INC.
(Exact name of registrant as specified in its charter)

LOUISIANA
72-0717400
(State or other jurisdiction of
(I.R.S. Employer Identification No.)
incorporation or organization)
  

1925 W. Field Court, Suite 300, Lake Forest, Illinois 60045
(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (847) 279-6100


SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

Title of each class 
  
Name of each exchange on which registered 
Common Stock, No Par Value
  
The NASDAQ Stock Market LLC

SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
(None)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No þ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes þ No o

Indicate by check mark if disclosure of delinquent filers in response to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):
Large accelerated filer: þ
Accelerated filer: o
Non-accelerated filer: o
Smaller reporting company: o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No þ

The aggregate market value of the voting stock of the registrant held by non-affiliates (affiliates being, for these purposes only, directors, executive officers and holders of more than 5% of the registrant’s common stock) of the registrant as of June 30, 2014 was approximately $1,701,738,000 based on the closing market price of $33.25 reported on the Nasdaq Stock Market LLC.

The number of shares of the registrant’s common stock, no par value per share, outstanding as of February 27, 2015 was 113,924,711.

Documents incorporated by reference: Definitive Proxy Statement for the 2015 Annual Meeting incorporated by reference into Part I and Park III, Items 10-14 of this Form 10-K.

 
 
 
Forward-Looking Statements and Factors Affecting Future Results

Unless otherwise indicated or except where the context otherwise requires, the terms “we,” “us” and “our” or other similar terms in this Annual Report on Form 10-K refer to Akorn, Inc. and its wholly owned subsidiaries.

Certain statements in this Form 10-K constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act. When used in this document, the words “anticipate,” “believe,” “estimate” and “expect” and similar expressions are generally intended to identify forward-looking statements. Any forward-looking statements, including statements regarding our intent, beliefs or expectations are not guarantees of future performance. These statements are subject to risks and uncertainties and actual results may differ materially from those in the forward-looking statements as a result of various factors, including but not limited to:

 
•
Our ability to continue to comply with all of the requirements of the U.S. Food and Drug Administration, including current Good Manufacturing Practices regulations;

 
•
Our ability to obtain additional funding or financing to operate and grow our business;

 
•
The effects of federal, state and other governmental regulation on our business;

 
•
Our ability to obtain and maintain regulatory approvals for our products;

 
•
Our success in developing, manufacturing, acquiring and marketing new products;
 
 
•
Our ability to generate cash from operations sufficient to meet our working capital, term loan, and revolving debt servicing requirements;
 
 
•
Our ability to bring new products to market and the effects of sales of such products on our financial results;

 
•
Our ability to successfully integrate acquired businesses and products;

 
•
Our ability to satisfy all of our obligations under the agreements and instruments governing our debt obligations;

 
•
The effects of competition from other generic pharmaceuticals and from other pharmaceutical companies;

 
•
Availability of raw materials needed to produce our products; and

 
•
Other factors referred to in this Form 10-K and our other Securities and Exchange Commission filings.

See “Item 1A - Risk Factors”. As a result, you should not place undue reliance on any forward-looking statements. You should read this report completely with the understanding that our actual results may differ materially from what we expect. Unless required by law, we undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
 

 
 
2
 
FORM 10-K TABLE OF CONTENTS

 
 
Page 
PART I
PART II
PART III
PART IV
 
 
 
3
 
PART I
 

Akorn, Inc. together with its wholly owned subsidiaries (“Akorn” or the “Company”) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and over-the-counter (“OTC”) consumer health products. We specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.

Akorn is a Louisiana corporation founded in 1971 in Abita Springs, Louisiana. In 1997, we relocated our corporate headquarters to the Chicago, Illinois area and currently maintain our principal corporate offices in Lake Forest, Illinois.  We operate pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York; and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York. Our research and development (“R&D”) centers are located in Vernon Hills, Illinois, Copiague, New York, and Warminster, Pennsylvania, and we have other corporate offices in Ann Arbor, Michigan; Amityville, New York; and Gurgaon, India.
 
In this annual report, we have reported results for two operating segments:  Prescription Pharmaceuticals and Consumer Health.  These two segments are described in greater detail below. For information regarding revenues and gross profit for each of our segments, see Item 7 “Results of Operations” and Note 12 — “Segment Information” in the Notes to our Consolidated Financial Statements.
 
Prescription Pharmaceuticals Segment. The Company’s Prescription Pharmaceutical segment represented approximately 91.5% of the Company’s net sales in the year ended December 31, 2014 generated from the sale of branded and generic prescription pharmaceuticals. The segment consists of pharmaceutical products in a variety of dosage forms including sterile ophthalmics, injectables and inhalants, and non-sterile oral liquids, topicals, nasal sprays and otics. The Company markets a number of pain management drugs including various controlled substances. In addition, the Company, through Akorn India Private Limited (“AIPL”), manufactures pharmaceuticals for various markets outside the US.

The Company’s suite of marketed generic products includes Clobetasol Propionate, a corticosteroid used to treat various skin conditions; Fluticasone Propionate, which is a corticosteroid used for nasal symptoms of allergic and non-allergic rhinitis conditions; Lidocaine/Prilocaine, a topical anesthetic; Progesterone, which is used to prevent endometrial hyperplasia; and Vancomycin, an antibiotic used to treat bacterial infections, among others. Branded marketed products include, among others, Akten®, a topical ocular anesthetic gel, AzaSite®, an antibiotic used to treat bacterial conjunctivitis, Cosopt®, Cosopt® PF, Betimol® and Zioptan®, which are used in the treatment of glaucoma, Nembutal®, which is a sedative, and Xopenex® Inhalation Solution, which is used in the treatment or prevention of bronchospasm.

Consumer Health Segment.  The Company’s Consumer Health segment represented approximately 8.5% of the Company’s net sales in the year ended December 31, 2014 which was generated through the sale of branded and private label consumer and animal health products. The segment principally consists of OTC products focused on ophthalmics including dry eye treatment under the TheraTears® brand name as well as a portfolio of private label OTC ophthalmic products. Additionally, the Company markets other OTC consumer health products including Mag-Ox®, a diabetes magnesium supplement, and the Zostrix® brand of capsaicin products for pain management of conditions including arthritis or foot pain, among others. The segment also includes animal health branded and generic products such as Anased®, Tolazine®, Yobine®, Butorphic® and VetaKet®.

Manufacturing. We operate U.S. manufacturing facilities in Decatur, Illinois, Somerset, New Jersey, and Amityville, New York, and a manufacturing facility in Paonta Sahib, Himachal Pradesh, India (see Item 2 - Properties, for more information). Through these manufacturing facilities, we manufacture a diverse assortment of sterile pharmaceutical products, including liquid injectables, lyophilized injectables, gels, and ophthalmic solutions and ointments for our Prescription Pharmaceutical and Consumer Health segments. Our Somerset facility manufactures ophthalmic solutions, ointment products and gels, our Decatur manufacturing facility manufactures liquid injectables, lyophilized injectables and ophthalmic solutions, while our Amityville, New York facility manufactures sterile ophthalmic solutions, sterile ointments and gels, and non-sterile nasal sprays, topical ointments and creams, oral syrups and solutions, and liquid unit dose cups.  The manufacturing facility in Paonta Sahib, Himachal Pradesh, India manufactures sterile liquid injectables including cephalosporins, carbapenems, hormones and general injectables, as well as oral cephalosporins.  We are diligently working towards obtaining approval from the U.S. Food and Drug Administration (“FDA”) to manufacture various products from the Paonta Sahib facility for export to the U.S. as well as approvals to supply other regulated markets.

Sales and Marketing. We rely on our sales and marketing teams to help us maintain and, where possible, increase our market share in our predominantly non-proprietary product offering.  Our sales organization consists of multiple teams, including: (1) regional outside sales teams focused on prescription pharmaceutical product sales; (2) an inside sales team focused on customers in smaller markets; (3) a national accounts sales team focused on wholesale, retail pharmacy chain and group purchasing organization (“GPO”) markets; and (4) a branded drug sales team focused on those branded prescription products. Our outside sales representatives sell ophthalmic products directly to retinal surgeons and ophthalmologists, and sell other pharmaceutical products directly to local hospitals in order to support compliance and pull-through against GPO contracts. The inside sales team augments our outside sales teams efforts to sell products in markets where outside sales would not be cost effective. Our national accounts sales team seeks to establish and maintain contracts with wholesalers, retail pharmacy chains and GPOs that represent hospitals in the United States as well as insurance companies and pharmacy benefit management organizations (“PBM”).  Our branded drug team supports the sale of branded pharmaceutical drugs to wholesalers and other purchasing organizations. We also utilize contracted salespeople to maintain and expand the presence of our products within retail pharmacy and national supermarket chains in the U.S. and other countries. To support our sales efforts, we have a customer service team, as well as a marketing department focused on promoting and raising awareness about our product offerings.

 
4
 
 Research and Development.  We seek to continually grow our business by developing new products, either internally or through strategic partnerships.  Internal R&D projects are carried out at our primary R&D facility located in Vernon Hills, Illinois, and our other R&D facilities in Copiague, New York and Warminster, Pennsylvania.  The majority of product development activity takes place at our R&D facilities, while our manufacturing facilities provide support for the latter phases of product development and exhibit batch production.  We believe that having our own dedicated R&D facilities allows us to significantly increase the size of our product pipeline as well as shorten the time between project launch and filing with the FDA. We also utilize outside vendors for portions of R&D projects to take advantage of external capabilities and cost-efficiencies.  As of December 31, 2014, we had 107 full-time employees directly involved in product R&D activities.

We strategically partner with drug development and manufacturing companies throughout the world for the development of drug products that we believe will be complementary to our existing product offerings, but for which we may lack the expertise to develop or the capability, capacity, or cost-efficiencies to manufacture.  We may owe payments to these partners from time to time based on their achievement of milestones, up to and including launch of the product.  Our development partner is typically responsible for manufacturing or sourcing of the finished product, and receives a royalty or a profit split from the sales of the product.

R&D costs are expensed as incurred. Such costs amounted to $29.2 million, $19.9 million and $15.9 million for the years ended December 31, 2014, 2013 and 2012, respectively, and include both internal R&D expenses and milestone fees paid to our strategic partners.

We received 14 Abbreviated New Drug Application (“ANDA”) product approvals, one New Drug Application (“NDA”) product approval and two tentative ANDA approvals from the FDA in 2014; 2 approvals and 1 tentative approval in 2013 and 5 approvals in 2012.  During 2014, we submitted 23 new ANDA filings to the FDA, increasing the number of our ANDA filings currently under review by the FDA Office of Generic Drugs to 87 as of December 31, 2014, compared to 63 under review as of December 31, 2013 and 55 under review as of December 31, 2012. We plan to continue to regularly submit additional ANDA filings based on perceived market opportunities. For more information, see “Government Regulation.”

See “Government Regulation” and Item 1A. Risk Factors – “Our growth depends on our ability to timely develop and successfully market new pharmaceutical products.”

Mergers and Acquisitions. We actively seek to expand and enhance our business through strategic acquisitions.  We seek to acquire businesses assets and products that we believe complement our existing business and provide us opportunities for growth and synergies.  Below is a summary of our recent strategic acquisitions of companies and businesses. See Item 1A – “Risk Factors” for a description of risks that accompany our acquisition strategy.

Excelvision AG:

On July 22, 2014, our Luxembourg subsidiary, Akorn International S.à r.l., entered into a share purchase agreement with Fareva SA, to acquire all of the issued and outstanding shares of capital stock of Excelvision AG, a Swiss Company (“Excelvision”) for 21.7 million Swiss Francs (“CHF”), net of certain working capital amounts. Excelvision is a contract manufacturer located in Hettlingen, Switzerland specializing in ophthalmic products.

The acquisition was completed on January 2, 2015 upon payment of the previously-agreed to consideration, which equated to $25.9 million U.S. dollars, and was funded through available cash on hand. The consideration remains subject to a net working capital adjustment payable by the Company. The acquisition is intended to expand the Company’s manufacturing capacity.
 
VPI Holdings Corp. Inc. Acquisition:

On August 12, 2014, the Company completed an acquisition of VersaPharm Incorporated, a Georgia corporation (“VersaPharm”) for a total purchase price of approximately $433.0 million (the “VersaPharm Acquisition”), subject to net working capital adjustment. On May 9, 2014, the Company had entered into an Agreement and Plan of Merger (the “VP Merger Agreement”) to acquire VPI Holdings Corp. (“VPI”), the parent company of VersaPharm.

 
5
 
In connection with Federal Trade Commission (“FTC”) approval of the VersaPharm Acquisition, the Company entered into an agreement (the “Rifampin Divestment Agreement”) with Watson Laboratories, Inc. (“Watson”), a wholly owned subsidiary of Actavis plc, to divest certain rights and assets to the Company’s Rifampin injectable product, as further described below in Note 16 – “Business Combinations, Dispositions and Other Strategic Investments.” Under the terms of the disposition the Company received $1.0 million for the pending product rights and recorded a gain of $0.8 million in Other non-operating income, net in the year ended December 31, 2014 related to the divestment.

VersaPharm is a developer and marketer of multi-source prescription pharmaceuticals. VersaPharm markets its products to drug wholesalers, retail drug chains, pharmaceutical distributors, GPOs, hospitals, clinics and government agencies.

The VersaPharm Acquisition complements and expands the Company’s product portfolio by diversifying its offering to niche dermatology markets.  VersaPharm’s product portfolio, pipeline and development capabilities are complimentary to the Hi-Tech Pharmacal Co., Inc. (“HiTech”) acquisition, described below. Through which the Company acquired manufacturing capabilities needed for many of VersaPharm’s current and pipeline products. The VersaPharm Acquisition also enhances the Company’s new product pipeline as VersaPharm has significant R&D experience and knowledge and numerous in-process research and development (“IPR&D”) products are under active development.

The VersaPharm Acquisition was principally funded through a $445.0 million term loan with certain other lenders with JPMorgan Chase Bank, N.A. acting as the administrative agent (the “Incremental Term Loan”) entered into concurrent with completing the acquisition, and through available Company cash.

Hi-Tech Pharmacal Co., Inc., Acquisition:

On April 17, 2014, the Company completed its acquisition of Hi-Tech for a total purchase price of approximately $650.0 million (the “Hi-Tech Acquisition”). The acquisition was approved by the shareholders of Hi-Tech on December 19, 2013, and was approved by the FTC on April 11, 2014 following review pursuant to provisions of Hart-Scott Rodino Act (“HSR”).

In connection with the Hi-Tech Acquisition, the Company entered into an agreement (the “Divestment Agreement”) with Watson Laboratories, Inc., a wholly owned subsidiary of Actavis plc, to divest certain rights and assets, as further described below in Note 16, Business Combinations, Dispositions and Other Strategic Investments.

Hi-Tech is a specialty pharmaceutical company which develops, manufactures and markets generic and branded prescription and OTC products. Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gel products. Hi-Tech’s Health Care Products division is a developer and marketer of OTC products, and their ECR Pharmaceuticals subsidiary (“ECR”) markets branded prescription products, which was divested during the year ended December 31, 2014. Hi-Tech operates a manufacturing facility and corporate offices in Amityville, New York, and ECR maintains its corporate offices in Richmond, Virginia.

The Hi-Tech Acquisition complements and expands the Company’s product portfolio by diversifying its offerings to its retail customers beyond ophthalmics to other niche dosage forms such as oral liquids, topical creams and ointments, nasal sprays and otics. The Hi-Tech Acquisition is also expected to enhance the Company’s new product pipeline. Further, the Hi-Tech Acquisition adds branded OTC products in the categories of cough and cold, nasals, and topicals to the Company’s TheraTears® brand of eye care products, and provides additional domestic manufacturing capacity for the Company.

The Hi-Tech Acquisition was principally funded through a $600.0 million term loan entered into concurrent with the completion of the acquisition, and through Hi-Tech cash assumed through the acquisition.

Kilitch Acquisition:

On February 28, 2012, we acquired selected assets of Kilitch Drugs (India) Limited (“Kilitch”) pursuant to a Business Transfer Agreement (“BTA”) between our subsidiary, Akorn India Private Limited and Kilitch signed on October 6, 2011 (the “Kilitch Acquisition”).  We paid approximately $60.1 million in cash at closing, which included consideration of $55.2 million and acquisition-related costs of $4.9 million.  The primary assets acquired were Kilitch’s pharmaceutical manufacturing facility in Paonta Sahib, Himachal Pradesh, India and its ongoing contract manufacturing business.  We also acquired pursuant to the BTA selected assets of NBZ Pharma Limited, a company affiliated with Kilitch, from which we acquired the rights to manufacture and distribute certain pharmaceuticals products.  The Paonta Sahib facility currently manufactures pharmaceutical products primarily for contract customers in India and for export to unregulated markets.  Pursuant to the BTA we are working actively toward gaining FDA approval to manufacture certain of our product at the Paonta Sahib facility for export to the U.S.  See Item 1A. Risk Factors — “Failure to obtain regulatory certification of our manufacturing facility in India for production of pharmaceutical products for export to the United States, as well as other regulated world markets, could impair our ability to grow and adversely affect our business, financial condition and results of operations” and “Risk Factor - Failure to comply with the U.S. Foreign Corrupt Practices Act could subject us to, among other things, penalties and legal expenses that could harm our reputation and have a material adverse effect on our business, financial condition and operating results” for more information.

 
6
 
Business Development.  In addition to our acquisitions of companies, we also maintain a business development program that identifies potential product acquisition or product licensing opportunities. We have strategically focused our business development efforts on products that complement our existing product lines and which are expected to have few competitors. Below is a summary of our recent product acquisition or licensing transactions. See Item 1A—“Risk  Factors” for a description of risks that accompany our business development strategy.

Lloyd Products Acquisition:

On October 2, 2014, Akorn Animal Health, Inc., a wholly owned subsidiary of the Company, entered into a definitive product acquisition agreement with Lloyd, Inc., to acquire certain rights and inventory related to a suite of animal health injectable products (the “Lloyd Products”) used in pain management and anesthesia. The Company acquired the products for $16.1 million, funded through available cash paid at closing, and a contingent payment of $2.0 million, which becomes payable upon FDA approval of a supplement related to one of the acquired products. The purpose of the Lloyd Products acquisition is to expand the Company’s animal health product portfolio.

Xopenex Product Acquisition:

On October 1, 2014, the Company entered into a definitive product acquisition agreement with Sunovion Pharmaceuticals Inc., to acquire certain rights and inventory related to the branded product, Xopenex® Inhalation Solution (levalbuterol hydrochloride) (the “Xopenex Product”). The purchase price for the acquisition was $45.0 million, funded through available cash paid at closing, net of certain liabilities for product return reserves, rebates, and chargeback reserves, which were assumed by Oak Pharmaceuticals, Inc. (“Oak”), a subsidiary of Akorn, subject to a cap. The total cash paid at closing was $41.5 million

Xopenex® is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. The purpose of the Xopenex Acquisition is to expand the Company’s product portfolio of prescription pharmaceuticals.

Zioptan Product Acquisition:

On April 1, 2014, the Company acquired from Merck, Sharp and Dohme Corp. (“Merck”) the U.S. NDA rights to Zioptan®, a prescription ophthalmic eye drop indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, from Merck, Sharp and Dohme Corp. (“Merck”). The total consideration at closing was $11.2 million. The purpose of the acquisition is to expand the Company’s product portfolio of branded prescription pharmaceuticals indicated for ophthalmology.

In connection with the acquisition, the Company entered into a master supply agreement with Merck whereby Merck will continue manufacturing Zioptan® for a transitional period.

Betimol Product Acquisition:

On January 2, 2014, the Company acquired the NDA rights to Betimol®, a prescription ophthalmic eye drop for the reduction of eye pressure in glaucoma patients, from Santen Pharmaceutical Co., Ltd., (“Santen”). The purpose of the Betimol Acquisition is to expand the Company’s product portfolio of branded prescription pharmaceuticals indicated for ophthalmology. The total consideration will be equal to 1.5 times the Company’s net sales of Betimol® in the first year following the acquisition. The Company paid a non-refundable amount of $7.5 million upon completing the acquisition and will pay any remaining amount 60 days following the first year post-acquisition. There is also a provision for a $2.0 million increase to the total consideration should net sales of Betimol® exceed a sizable threshold in any one of the first five years following the acquisition.

Upon completing the Betimol Acquisition, the Company entered into a supply agreement with Santen whereby Santen will continue manufacturing Betimol® for a transitional period.

 
7
 
Merck Products Acquisition:

On November 15, 2013, we acquired three ophthalmic products from Merck for $52.8 million in cash (the “Merck Products Acquisition”).  The products acquired were:
 
·
AzaSite® – (azithromycin ophthalmic solution), a prescription sterile eye drop solution used to treat bacterial conjunctivitis,
 
·
Cosopt® – (dorzolamide hydrochloride and timolol maleate ophthalmic solution), a prescription sterile eye drop solution that is used to lower the pressure in the eye (intraocular pressure) in patients with open-angle glaucoma or ocular hypertension; and
 
·
Cosopt® PF – a preservative-free prescription version of Cosopt®, supplied in sterile, single-use containers.

This acquisition expanded our line of prescription ophthalmic products to include additional branded products, and is expected to provide a platform to support future acquisitions and in-licensing of branded pharmaceuticals.  Upon entering into the product acquisition agreement, we entered into supply agreements with Merck and a third party to ensure continued supply of the three products.  The Merck Products Acquisition included our acquisition of a Merck subsidiary corporation, Inspire Pharmaceuticals, Inc. (“Inspire”), which was and continues to be the holder of the product rights to AzaSite®.

Lundbeck Products Acquisition:

On December 22, 2011, we acquired three NDAs from H. Lundbeck A/S (“Lundbeck”), a Denmark Corporation. On the date of closing of this acquisition (the “Lundbeck Acquisition”), we made an initial payment of $45.0 million and owed a subsequent milestone payment of $15.0 million in cash on the third anniversary of the closing date, which was paid in 2014.  The acquired portfolio consists of Nembutal®, a Schedule II controlled drug, Diuril® and Cogentin®. In addition, we paid approximately $4.6 million for Lundbeck’s existing inventory of the three acquired products.  This acquisition provided us with three branded, hospital injectables to add to our portfolio.
 
Patents, Trademarks and Proprietary Rights.  We consider the protection of our patents, trademarks and proprietary rights important to maintaining and growing our business.  Through our acquisitions, we have increased the number and importance of trademarks related to our products and product lines.  Through acquisitions, we also acquired rights to the trade names for the branded, prescription ophthalmic products AzaSite®, Betimol®, Cosopt® PF, and Zioptan®, respiratory product Xopenex®, as well as OTC eye care product TheraTears®. We are committed to maintaining and defending these trade names as they are important in supporting the success and growth of this business. In addition, we maintain and defend trademarks related to a number of internally-developed products, as well as others licensed from third parties.

We have sought, and intend to continue to seek, patent protection in the United States and selected foreign countries where deemed appropriate and advantageous to us.  The importance of these patents does not vary among our business segments.  We currently have eleven patents, none of which expire within the next three years.

We also rely upon trade secrets, unpatented proprietary know-how and continuing technological innovation to maintain and develop our competitive position. We enter into confidentiality agreements with certain of our employees pursuant to which such employees agree to assign to us any inventions relating to our business made by them while in our employ. However, there can be no assurance that others may not acquire or independently develop similar technology or, if patents are not issued with respect to products arising from research, that we will be able to maintain information pertinent to such research as proprietary technology or trade secrets. See Item 1A. “Risk Factors —Our patents and proprietary rights may not adequately protect our products and processes” and “Third parties may claim that we infringe their proprietary rights and may prevent or delay us from manufacturing and selling some of our new products” for more information.

Employee Relations. As of December 31, 2014, we had 1,277 permanent, full-time employees and 21 part-time or temporary employees in the United States and 367 permanent and 216 contract or temporary employees working for our subsidiary in India.  Of our full-time employees working in the U.S., 427 worked at our manufacturing facilities in Decatur, Illinois, 167 worked at our manufacturing facility in Somerset, New Jersey, 346 worked at our manufacturing facility in Amityville, New York, 55 were field-based salespersons, 13 were inside salespersons, 52 worked at our R&D facility in Vernon Hills, Illinois, 26 worked at our R&D facility in Warminster, Pennsylvania, 29 worked at R&D facilities acquired through the Hi-Tech acquisition, principally in Copiague, New York, and the remaining 162 worked in corporate support functions, including 124 at our principal corporate office in Lake Forest, Illinois, 13 in our other corporate office at Ann Arbor, Michigan, and 25 at our distribution facility in Gurnee, Illinois. We believe we have good relations with our employees.  None of our employees are represented by a collective bargaining agreement.

 
8
 
Competition. The marketing and manufacturing of pharmaceutical products is highly competitive, with many established manufacturers, suppliers and distributors actively engaged in all phases of the business. Many of our competitors have substantially greater financial and other resources, including greater sales volume, larger sales forces and greater manufacturing capacity. See Item 1A. Risk Factors — “Our industry is very competitive. Additionally, changes in technology could render our products obsolete” for more information.

The companies that compete with our Prescription Pharmaceuticals segment include Actavis plc., Apotex Inc., Boehringer Ingelheim GmbH, Fresenius Kabi AG, Hikma Pharmaceuticals plc., Hospira Inc., Novartis International AG, Perrigo Company plc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical industries Ltd., and Valeant Pharmaceuticals International, Inc., among others.  The Prescription Pharmaceuticals segment competes primarily on the basis of price and service.

The companies that compete with our Consumer Health segment include both generic and name brand companies such as Actavis plc., Johnson & Johnson, Perrigo Company plc., Pfizer Inc., and Valeant Pharmaceuticals International, Inc., among others. The Consumer Health segment competes primarily on the basis of price and service.

Suppliers and Customers. We require a supply of quality raw materials and components to manufacture and package pharmaceutical products for ourselves and for the third parties with which we have contracted. The principal components of our products are active and inactive pharmaceutical ingredients and certain packaging materials. Many of these components are available from only a single source and, in the case of many of our ANDAs and NDAs, only one supplier of raw materials has been identified. Because FDA approval of drugs requires manufacturers to specify their proposed suppliers of active ingredients and certain packaging materials in their applications, FDA approval of any new supplier would be required if active ingredients or such packaging materials were no longer available from the specified supplier. The qualification of a new supplier could delay our development and marketing efforts. If for any reason we are unable to obtain sufficient quantities of any of the raw materials or components required to produce and package our products, we may not be able to manufacture our products as planned. In addition, certain of the pharmaceutical products that we market are manufactured by third parties that serve as our only supplier of those products.  Any delays or failure of a contract manufacturing partner to supply finished goods timely or in adequate volume could impede our marketing of those products.

No supplier represented 10% or more of our purchases in 2014, 2013 or 2012.  See Item 1A. Risk Factors – “Many of the raw materials and components used in our products come from a single source” for more information.

In 2014, 2013 and 2012, a high percentage of our sales were to the three large wholesale drug distributors noted below.  These three wholesale drug distributors account for a large portion of our gross sales, net revenues and accounts receivable in both of our segments. The three large wholesale drug distributors are:

•
AmerisourceBergen Corporation (“Amerisource”);
•
Cardinal Health, Inc. (“Cardinal”); and
•
McKesson Corporation (“McKesson”).

On a combined basis, these three wholesale drug distributors accounted for approximately 77% of our total gross sales and 61% of our net revenue in the year ended December 31, 2014, and 86% of our gross accounts receivable as of December 31, 2014. The difference between gross sales and net revenue is that gross sales is calculated before allowances for chargebacks, rebates, promotions and product returns (See “Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations — “Critical Accounting Policies” for more information).

The table below presents the percentages of our total gross sales, net revenue and gross trade accounts receivable attributed to each of these three wholesale drug distributors as of and for the years ended December 31, 2014, 2013 and 2012, respectively:

   
2014
    
2013
    
2012
  
 
 
  
 
Gross
Sales
    
 
Net
Revenue
    
Gross
Accounts
Receivable
    
 
Gross
Sales
    
 
Net
Revenue
    
Gross
Accounts
Receivable
    
 
Gross
Sales
    
 
Net
Revenue
    
Gross
Accounts
Receivable
  
Amerisource
     38 %     28 %     46 %     19 %     14 %     25 %     19 %     14 %     29 %
Cardinal
     16 %     14 %     17 %     23 %     16 %     26 %     23 %     17 %     30 %
McKesson
     23 %     19 %     23 %     16 %     11 %     12 %     16 %     11 %     14 %
Combined Total
     77 %     61 %     86 %     58 %     41 %     63 %     58 %     42 %     73 %

Amerisource, Cardinal and McKesson are key distributors of our products, as well as a broad range of health care products for many other companies. None of these distributors is an end user of our products. Generally speaking, if sales to any one of these distributors were to diminish or cease, we believe that the end users of our products would likely find little difficulty obtaining our products either directly from us or from another distributor. However, the loss of one or more of these distributors, together with a delay or inability to secure an alternative distribution source for end users, could have a material negative impact on our revenue, business, financial condition and results of operations. Furthermore, Amerisouce, Cardinal and McKesson have recently entered into strategic alliances with Walgreens Company (now Walgreens Boots Alliance, Inc.), CVS Health Corporation and Rite Aid Corporation, respectively.  Since Walgreens, CVS Health and Rite-Aid are customers for several of our products, the loss of our distributor relationship with any of the three large wholesalers could result in a reduction to our revenues.

 
9
 
We consider our business relationships with Amerisource, Cardinal and McKesson to be in good standing and we currently have fee for services contracts with each of them. However, a change in purchasing patterns, a decrease in inventory levels, an increase in returns of our products, delays in purchasing products and delays in payment for products by one or more of these distributors could have a material negative impact on our revenue, business, financial condition and results of operations. See Item 1A “Risk Factors –We depend on a small number of distributors, the loss of any of which could have a material adverse effect” for more information.

Backorders. As of December 31, 2014, we had approximately $19.2 million of products on backorder as compared to approximately $3.9 million of backorders as of December 31, 2013. We anticipate filling all open backorders during 2015.

Government Regulation. Pharmaceutical manufacturers and distributors are subject to extensive regulation by government agencies, including the FDA, the Drug Enforcement Administration (“DEA”), the FTC and other federal, state and local agencies. The Federal Food, Drug and Cosmetic Act (the “FDC Act”), the Controlled Substance Act and other federal statutes and regulations govern or influence the development, testing, manufacture, labeling, storage and promotion of products that we manufacture and market. The FDA inspects drug manufacturers and storage facilities to determine compliance with its current Good Manufacturing Practices (“cGMP”) regulations, non-compliance with which can result in fines, recall and seizure of products, total or partial suspension of production, refusal to approve NDAs and ANDAs and criminal prosecution. The FDA also has the authority to revoke approval of drug products.

FDA approval is required before any application drug product can be manufactured and marketed. New drugs require the application filing of an NDA, including clinical studies demonstrating the safety and efficacy of the drug. Generic drugs, which are equivalents of existing, off-patent brand name drugs, require the application filing of an ANDA. An ANDA does not, for the most part, require clinical studies since safety and efficacy have already been demonstrated by the product originator. However, the ANDA must, for example, provide data demonstrating the equivalency of the generic formulation in terms of bioavailability. The time required by the FDA to review and approve NDAs and ANDAs is variable and, to a large extent, beyond our control.

        We are subject to periodic inspections by the FDA and the DEA.  Throughout the five year period ended December 31, 2014, there have been no product interruptions associated with regulatory inspection or related review activities.  The most recent inspections conducted during April and May of 2014 at our Somerset, New Jersey facility and May and June of 2014 at our Decatur, Illinois facility resulted in no regulatory actions.   The June 2014 FDA inspection of the Akorn India operation also resulted in no regulatory actions, and site status is pending confirmation from FDA.

DEA Regulation. We also manufacture and distribute several controlled-drug substances, the distribution and handling of which are regulated by the DEA. Failure to comply with DEA regulations can result in fines or seizure of product.  There were no DEA citations issued to us in 2014, 2013, or 2012.

Environment. We do not anticipate any material adverse effect from compliance with federal, state and local provisions that have been enacted or adopted regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment.

Foreign Sales. During 2014, 2013 and 2012, approximately $16.6 million, $27.3 million, and $29.4 million of our net revenue, respectively, was related to sales to customers in foreign countries.  The decline in foreign revenues in comparison to 2013 is primarily the result of reduced sales generated by AIPL, our subsidiary in India. Of our total foreign sales in 2014, 2013 and 2012, $7.2 million, $15.8 million and $16.7 million, respectively, were generated by AIPL, which exclusively sells product to customers in India and other unregulated world markets. The declining revenue generated by AIPL through the respective periods is principally the result of the Company’s decision to reduce revenues associated with comparatively low-margin contract manufacturing to focus on achieving U.S. FDA site approval. The Company’s worldwide business is subject to risks of currency fluctuations, governmental actions and other governmental proceedings abroad. The Company does not regard these risks as a deterrent to further expansion of its operations abroad. However, the Company closely reviews its methods of operations and seeks to adopt strategies responsive to changing economic and political conditions.

Seasonality and other Cyclical Sales Fluctuations. The majority of our products do not experience significant seasonality.  We do market certain prescription pharmaceutical and consumer health products for the treatment of allergies that typically generate higher sales volume in the warmer months as well as cough and cold products which typically generate higher sales volume in the colder months, but these products do not materially impact our overall sales trends. Additionally, we market various antidote products through our Prescription Pharmaceuticals segment, the sales of which are largely timed to the expiration of existing stock held by our ongoing customers.  In addition, since the fourth quarter of 2012 we have been a distributor of Tetanus and Diphtheria (“Td”) vaccines, which tends to generate higher sales in spring through fall.

 
10
 
Government Contracts. We maintain distribution contracts with the U.S. Federal Government (“Government”), including Veteran’s Administration among others. A number of these contracts allow the Government to terminate upon written notice. We do not believe that any single termination is likely or would be material to our operations.

Available Information. We file annual, quarterly and special reports, proxy statements and other information with the Securities and Exchange Commission (“SEC”). Materials filed with the SEC can be read and copied at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549.  Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330.  The SEC maintains an Internet web site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. Our filings are available to the public at the website maintained by the SEC, http://www.sec.gov. We also make available, free of charge, through our web site at www.akorn.com, our reports on Forms 10-K, 10-Q, and 8-K, and amendments to those reports, as soon as reasonably practicable after they are filed with or furnished to the SEC.  The information contained on our web site is not a part of this document.
 
 
 
 
 
 
 
 
 
 
 
 
 
11
 

An investment in our common stock involves a high degree of risk. In addition to the other information included in this Annual Report on Form 10-K, you should carefully consider each of the risks described below before purchasing shares of our common stock. The risk factors set forth below are not the only risks that may affect our business. Our business could also be affected by additional risks not currently known to us or that we currently deem to be immaterial. If any of the following risks actually occur, our business, financial condition and results of operations could materially suffer. As a result, the trading price of our common stock could decline, and you may lose all or part of your investment.

Our growth and profitability is dependent on our ability to complete strategic acquisitions or to identify, acquire or develop, new products to market and distribute.

We continue to seek growth opportunities, either by completing strategic acquisitions or by developing and introducing new pharmaceutical products. Continued improvement in our financial performance is dependent on our ability to introduce new products on an ongoing basis, whether developed internally or by third party partners, or acquired from other companies. Any delays or an inability to successfully identify suitable acquisition targets, or acquire or develop, and market and distribute new products, or acquisition or development of new products that do not yield sufficient margins, may result in adverse financial consequences to our business.

We may not achieve the anticipated benefits from our acquisitions and we may face difficulties in integrating them, which could adversely affect our operating results, increase costs and place a significant strain on our management.
      
If we fail to manage the integration of our domestic and international acquisitions and achieve expected synergies and revenue growth, our business could be disrupted and our operating results could be negatively impacted. The operating success of both our domestic and international acquisitions involves the integration of products, processes and personnel into our existing model. In addition, the integration of international acquisitions requires both establishing and training a local management team and overseeing the operations remotely, and can involve cultural, monetary and systems challenges. Our personnel, systems, procedures, or controls may not be adequate to support both our ongoing business and the acquired businesses. If any newly-acquired businesses or assets require a disproportionate share of our resources and management’s attention, our overall financial results may suffer.

Failure to obtain regulatory certification of our manufacturing facility in India for production of pharmaceutical products for export to the United States, as well as other regulated world markets, could impair our ability to grow and adversely affect our business, financial condition and results of operations.
 
We operate a manufacturing campus in Paonta Sahib, India, which we acquired through a business combination in 2012. The manufacturing units within this campus were built to the standards of regulated markets, including the United States, but they are not currently approved by the FDA to manufacture products for export to the United States. It is our intention to obtain certification from the FDA and other regulatory authorities to allow this facility to manufacture products for export to the United States and other regulated world markets. Obtaining such certification in a timely manner is critical to our sustaining our growth. An inability to obtain or maintain such certification could restrict our ability to achieve our growth objectives, which would adversely affect our business, financial condition and results of operations.

Further, our operations in India may be adversely affected by general economic conditions and economic and fiscal policy in India, including changes in exchange rates and controls, interest rates and taxation policies; any reversal of India’s recent economic liberalization and deregulation policies; as well as social stability and political, economic or diplomatic developments affecting India in the future. In addition, India is known to have experienced governmental corruption to some degree and, in some circumstances, anti-bribery laws may conflict with some local customs and practices. As a result of our internal policies aimed at full compliance with the U.S. Foreign Corrupt Practices Act (“FCPA”) and similar anti-bribery laws, we may be at a competitive disadvantage to competitors that are not subject to, or do not comply with, such laws.

Our indebtedness reduces our financial and operating flexibility.

We have entered into various credit arrangements to fund certain of our operations and activities, principally business combinations. During the year ended December 31, 2014 we significantly increased our debt obligations through new term loans. As of December 31, 2014, our debt includes a $600.0 million Existing Term Loan Facility, a $445.0 million Incremental Term Loan Facility, and $87.5 million principal balance in our Convertible Senior Notes due 2016 (the “Notes”) and we also have available borrowing  capacity under our credit facilities (See “Item 7 - Management’s Discussion and Analysis of Financial Condition and  Results of Operations – Financial Condition and Liquidity” for definitions and descriptions of our Existing Term Loan  Facility, Incremental Term Loan Facility and Notes and our credit facilities).. A high level of indebtedness subjects us to a number of adverse risks. In particular, a significant portion of our current indebtedness has variable interest terms meaning we are subject to the risks associated with higher interest rates, and moreover, a high level of indebtedness may impair our ability to obtain additional financing in the future and increases the risk that we may default on our debt obligations. In addition, our current debt arrangements require that we devote a significant portion of our cash flows to service amounts outstanding under those debt arrangements. We also are subject to various covenants with respect to our indebtedness, including the obligation to meet certain defined financial ratios and our ability to pay distributions to our shareholders is restricted. Further, our indebtedness may restrict or otherwise impair our ability to raise additional capital through other debt financing, which could restrict our ability to grow our business. Our ability to meet our debt obligations, to comply with all required covenants, and to reduce our level of indebtedness depends on our future performance. General economic conditions and financial, business and other factors affect our operations and our future performance. Many of these factors are beyond our control. If we do not have sufficient funds on hand to pay our debt when due, we may be required to seek a waiver or amendment from our lenders, refinance our indebtedness, incur additional indebtedness, sell assets or sell additional shares of securities. We may not be able to complete such transactions on terms acceptable to us, or at all. Our failure to generate sufficient funds to pay our debts or to undertake any of these actions successfully could result in a default on our debt obligations, which would materially adversely affect our business, results of operations and financial condition.

 
12
 
We may not generate cash flow sufficient to pay interest and make required principal repayments on our Term Loans.

On April 17, 2014, upon completing the Hi-Tech Acquisition, we entered into a $600.0 million term loan with certain other lenders with JPMorgan Chase Bank, N.A. acting as the administrative agent (the “Existing Term Loan”) and on August 12, 2014, upon completing the VersaPharm Acquisition, we entered into a $445.0 million term loan with certain other lenders with JPMorgan Chase Bank, N.A. acting as the administrative agent (the “Incremental Term Loan”). These term loans significantly increased our debt obligations. The Existing Term Loan and Incremental Term Loan each bear interest at a variable rate at a margin above prime or LIBOR, at our election. In addition to our interest obligation, we are required to repay 0.25% of the principal balance quarterly, beginning with the second and first full quarter, respectively after entering into the loan agreements. The remaining outstanding balance under each of the Existing Term Loan and the Incremental Term Loan will be due and payable on April 17, 2021. If we do not generate sufficient operating cash flows to fund these payments or obtain additional funding from external sources at acceptable terms, we may not have sufficient funds to satisfy our principal and interest payment obligations when those obligations are due, which would place us into default under the terms of the Existing Term Loan and the Incremental Term Loan. Such default would have a material adverse effect on our business, financial condition and results of operations. Further, our borrowings are secured by all or substantially all of the Company’s assets. If the Company defaults on its obligations under the Existing Term Loan or the Incremental Term Loans, the lenders may be able to foreclose upon its security interest and otherwise be entitled to obtain or control Company assets.

Our growth depends on our ability to timely develop and successfully market new pharmaceutical products.

Our strategy for growth is dependent upon our ability to develop products that can be promoted through current marketing and distributions channels and, when appropriate, the enhancement of such marketing and distribution channels. We may fail to meet our anticipated time schedule for the filing of ANDAs and NDAs or may decide not to pursue ANDAs or NDAs that we have already submitted or anticipate submitting. Our internal development of new pharmaceutical products is dependent upon the research and development capabilities of our personnel and our strategic business alliance infrastructure. There can be no assurance that we or our strategic business alliance partners will successfully develop new pharmaceutical products or, if developed, that we will successfully commercialize these new pharmaceutical products. In addition, there can be no assurance that we will receive all necessary FDA approvals or that such approvals will not involve delays, which may adversely affect the commercial success of our products. Our failure to develop new products or to receive FDA approval of ANDAs or NDAs could have a material adverse effect on our business, financial condition and results of operations. Even if successfully developed and launched, no assurance can be given as to the actual size of the market for any product or the level of profitability and sales of the product.

Generic and off-patent pharmaceutical products are particularly susceptible to competition, substitution policies and reimbursement policies.

Our success depends, in part, on our ability to identify suitable branded pharmaceutical products to target for development of generic equivalents, determine or anticipate the dates when these branded pharmaceuticals are expected to come off patent, and time our product development activities accordingly so that we will be ready to manufacture and market our generic equivalent products at the most advantageous times. Generic pharmaceuticals must meet the same quality standards as branded pharmaceuticals, even though these equivalent pharmaceuticals are sold at prices that are significantly lower than branded pharmaceuticals. Generic substitution is regulated by the federal and state governments, as is reimbursement for generic drug dispensing. There can be no assurance that substitution will be permitted for newly approved generic drugs or that such products will be subject to government reimbursement. In addition, generic products developed by competing drug companies may render our generic products noncompetitive or obsolete, or may glut the market with competing products resulting in a reduction in sale price or market share for the generic products we sell. There can be no assurance that we will be able to consistently bring generic pharmaceutical products to market quickly and efficiently in the future. An increase in competition in the sale of generic pharmaceutical products or our failure to bring such products to market before our competitors could have a material adverse effect on our business, financial condition and results of operations.

 
13
 
Further, there is no proprietary protection for most of the branded pharmaceutical products that either we or other pharmaceutical companies sell. In addition, governmental and cost-containment pressures regarding the dispensing of generic equivalents will likely result in generic substitution and competition generally for our branded pharmaceutical products. We attempt to mitigate the effect of this substitution through, among other things, creation of strong brand-name recognition and product-line extensions for our branded pharmaceutical products, but there can be no assurance that we will be successful in these efforts.

We are subject to extensive government regulations that increase our costs, subject us to various obligations and could subject us to fines, prevent us from selling our products or prevent us from operating our facilities.

Various federal and state government agencies regulate virtually all aspects of our business. The development, testing, manufacturing, processing, quality, safety, efficacy, packaging, labeling, record keeping, distribution, storage and advertising of our products, and disposal of waste products arising from such activities, are subject to regulation by the FDA, DEA, FTC, the Consumer Product Safety Commission, the Occupational Safety and Health Administration and the Environmental Protection Agency. Similar state and local agencies also have jurisdiction over these activities. Noncompliance with applicable United States and/or state or local regulatory requirements can result in fines, injunctions, penalties, mandatory recalls or seizures, suspensions of production, recommendations by the FDA against governmental contracts and criminal prosecution. Any of these could have a material adverse effect on our business, financial condition and results of operations. New, modified and additional regulations, statutes or legal interpretation, if any, could, among other things, require changes to manufacturing methods, expanded or different labeling, recall, replacement or discontinuation of certain products, additional record keeping procedures and expanded documentation of the properties of certain products and additional scientific substantiation. Such changes or new legislation could have a material adverse effect on our business, financial condition and results of operations.  Certain of the regulatory risks that we are subject to are outlined below.

We are subject to regulation by the FDA. All pharmaceutical manufacturers, including us, are subject to regulation by the FDA under the authority of the FDC Act. Under the FDC Act, the federal government has extensive administrative and judicial enforcement authority over the activities of finished drug product manufacturers to ensure compliance with FDA regulations. This authority includes, but is not limited to, the authority to initiate judicial action to seize unapproved or non-complying products, to enjoin non-complying activities, to halt manufacturing operations that are not in compliance with cGMP, to recall products, to seek civil and monetary penalties and to criminally prosecute violators. Other enforcement activities include refusal to approve product applications, withdrawal of previously approved applications or prohibition on marketing of certain grandfathered products. Any such enforcement activities, especially the restriction or prohibition on sales of products we market or the halting of our manufacturing operations, could have a material adverse effect on our business, financial condition and results of operations. In addition, the FDA or other government agencies having regulatory authority over pharmaceutical products may request us to voluntarily or involuntarily conduct product recalls due to disputed labeling claims, manufacturing issues, quality defects or for other reasons. Restriction or prohibition on sales, halting of manufacturing operations, recalls of our pharmaceutical products or other enforcement actions could have a material adverse effect on our business, financial condition and results of operations. Further, such actions, in certain circumstances, may constitute an event of default under the terms of our various financing arrangements.

We must obtain approval from the FDA for each pharmaceutical product that we market. The FDA approval process is typically lengthy, and approval is never certain. Our new products could take a significantly longer time than we expect to gain regulatory approval and may never gain approval. Even if the FDA or another regulatory agency approves a product, the approval may limit the indicated uses for a product, may otherwise limit our ability to promote, sell and distribute a product or may require post-marketing studies or impose other post-marketing obligations, which could have a material adverse effect on marketability and profitability of the new products.

We and our third-party manufacturers are subject to periodic inspection by the FDA to assure regulatory compliance regarding the manufacturing, distribution, and promotion of pharmaceutical products. The FDA imposes stringent mandatory requirements on the manufacture and distribution of pharmaceutical products to ensure their safety and efficacy. The FDA also regulates drug labeling and the advertising of prescription drugs. A finding by a governmental agency or court that we are not in compliance with FDA requirements could have a material adverse effect on our business, financial condition and results of operations.

If the FDA changes its regulatory position, it could force us to delay or suspend our manufacturing, distribution or sales of certain products. FDA interpretations of existing or pending regulations and standards may change over time with the advancement of associated technologies, industry trends, and/or prevailing scientific rationale. If the FDA changes its regulatory position due to such factors, it could result in delay or suspension of the manufacturing, distribution or sales of certain of our products. In addition, modifications or enhancements of approved products are in many circumstances subject to additional FDA approvals which may or may not be granted and which may be subject to a lengthy application process. Any change in the FDA’s enforcement policy or any decision by the FDA to require an approved NDA or ANDA for one of our products not currently subject to the approved NDA or ANDA requirements or any delay in the FDA approving an NDA or ANDA for one of our products could have a material adverse effect on our business, financial condition and results of operations.

 
14
 
We are subject to extensive DEA regulation, which could result in our being fined or otherwise penalized. We also manufacture and sell drugs which are “controlled substances” as defined in the Federal Controlled Substances Act and similar state laws, which impose, among other things, certain licensing, security and record keeping requirements administered by the DEA and similar state agencies, as well as quotas for the manufacture, purchase and sale of controlled substances. The DEA could limit or reduce the amount of controlled substances which we are permitted to manufacture and market or issue fines and penalties against us for purported non-compliance with DEA regulations, which could have a material adverse effect on our business, financial condition and results of operations.

We may be subject to governmental demands to continue production and marketing of certain products which we would otherwise not continue. We manufacture and sell drugs which include those identified as life-saving, essential or critical by the World Health Organization and other generic and branded drugs whose production or sale by the Company could be required by various governments or governmental agencies irrespective of the financial effects. Required production or sale of these products which we would otherwise not continue could affect our financial and operating flexibility.

We are subject to the Federal Drug Supply Chain Security Act ("DSCSA") that requires development of an electronic pedigree to track and trace each prescription drug at the salable unit level through the distribution system, which will be effective incrementally over a 10-year period. Compliance with DSCSA and future U.S. federal or state electronic pedigree requirements may increase the Company's operational expenses and impose significant administrative burdens.

We depend on a small number of distributors, the loss of any of which could have a material adverse effect.

A small number of large wholesale drug distributors account for a significant portion of our gross sales, net revenues and accounts receivable. The following three wholesalers – Amerisource, Cardinal and McKesson – accounted for approximately 77% of total gross sales and 61% of total net revenues in 2014, and 86% of gross trade receivables as of December 31, 2014. In addition to acting as distributors of our products, these three companies also distribute a broad range of health care products on behalf of many other companies. The loss of our relationship with one or more of these wholesalers, together with a delay or inability to secure an alternative distribution source for end users, could have a material adverse impact on our revenue and results of operations. In particular, Amerisource, Cardinal and McKesson have entered into strategic drug purchasing alliances with Walgreens Company (now Walgreens Boots Alliance, Inc.), CVS Health Corporation and Rite Aid Corporation, respectively.  The chain drugstores are customers for a number of our products.  Therefore, the loss of our relationship with any of the three large wholesalers would likely result in the loss of revenue from sales to these drugstore chains.  A change in purchasing patterns or inventory levels, an increase in returns of our products, penalties assessed against us for failure to supply or failure to maintain service levels, delays in purchasing products and delays in payment for products by one or more of these distributors also could have a material adverse impact on our revenue, results of operations and cash flows.

Sales of our products may be adversely affected by the continuing consolidation of our customer base.

In addition to our sales to wholesale drug distributors detailed above, a significant proportion of our sales are made to relatively few retail drug chains and managed care purchasing organizations. These customers are continuing to undergo significant consolidation. Such consolidation has provided and may continue to provide them with additional purchasing leverage, and consequently may increase the pricing pressures that we face. Additionally, the emergence of large buying groups representing independent retail pharmacies, and the prevalence and influence of managed care organizations and similar institutions, enable those groups to extract price discounts on our products.

Our net sales and quarterly growth comparisons may also be affected by fluctuations in the buying patterns of retail chains, major distributors and other trade buyers, whether resulting from seasonality, pricing, wholesaler buying decisions or other factors. In addition, since such a significant portion of our revenues is derived from relatively few customers, any financial difficulties experienced by a single customer, or any delay in receiving payments from a single customer, could have a material adverse effect on our business, results of operations and financial condition.
 
 
15
 
We may not generate cash flow sufficient to pay interest on our outstanding convertible senior notes or repurchase the notes upon a fundamental change.
 
In June 2011, we issued $120.0 million aggregate principal amount of 3.50% Convertible Senior Notes. As of December 31, 2014, $87.5 million principal balance of the Notes remains outstanding. The Notes require us to make semi-annual coupon interest payments of $2.1 million on June 1 and December 1 of each year until the Notes mature on June 1, 2016. If we do not generate sufficient operating cash flows to fund these payments or obtain additional funding from external sources at acceptable terms, we may not have sufficient funds to satisfy our interest payment obligations when those obligations are due which would place us in default under the Indenture (as defined below). If a fundamental change (as defined in the Indenture) occurs, holders of the Notes may require us to repurchase their Notes. If we fail to repurchase the Notes when required, we will be in default under the Indenture.

We may need to obtain additional capital to continue to grow our business.

We may require additional funds in order to materially grow our business. We require substantial liquidity to implement long-term cost savings and productivity improvement plans, continue capital spending to improve our manufacturing facilities to increase capacity and support product development programs, meet scheduled term debt and lease maturities, to effect acquisitions and to run our normal business operations. We may seek additional funds through public and private financing, including equity and debt offerings. However, adequate funds through the financial markets or from other sources may not be available to us when needed or on favorable terms. Without sufficient additional capital funding, we may be required to delay, scale back or abandon some or all of our product development, manufacturing, acquisition, licensing and marketing initiatives, or operations. Further, such additional financing, if obtained, may require the granting of rights, preferences or privileges senior to those of the common stock and result in substantial dilution of the existing ownership interests of the common stockholders and could include covenants and restrictions that limit our ability to operate or expand our business in a manner that we deem to be in our best interest.

Our industry is very competitive. Additionally, changes in technology could render our products obsolete.

We face significant competition from other pharmaceutical companies, including major pharmaceutical companies with financial resources substantially greater than ours, in developing, acquiring, manufacturing and marketing pharmaceutical products. The selling prices of pharmaceutical products typically decline as competition increases. Further, other products now in use, under development or acquired by other pharmaceutical companies, may be more effective or offered at lower prices than our current or future products. The industry is characterized by rapid technological change that may render our products obsolete, and competitors may develop their products more rapidly than we can. Competitors may also be able to complete the regulatory process sooner, and therefore, may begin to market their products in advance of ours. We believe that competition in sales of our products is based primarily on price, service and technical capabilities. There can be no assurance that: (i) we will be able to develop or acquire commercially attractive pharmaceutical products; (ii) additional competitors will not enter the market; (iii) our existing products will not be rendered obsolete by the introduction or switch to generic of competing products; or (iv) competition from other pharmaceutical companies will not have a material adverse effect on our business, financial condition and results of operations.

Unstable market and economic conditions may have serious adverse consequences on our business. 

Our general business strategy may be adversely affected by volatile general economic conditions and, or, business environment. If equity and credit market conditions prove unfavorable, we may have difficulty obtaining desired debt or equity financing, or obtaining such financing may be more difficult, more costly, and more dilutive. A prolonged or profound economic downturn could result in adverse changes to product reimbursement, pricing or sales levels, which would harm our operating results. There is a risk that one or more of our current service providers, manufacturers and other partners may not survive difficult economic times, which would directly affect our ability to attain our operating goals on schedule and on budget. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon development plans. Moreover, our stock price may decline due to the volatility of the stock market and general economic conditions.

We have identified material weaknesses in our internal control over financial reporting. If our remedial measures are insufficient to address the material weaknesses, or if we otherwise fail to establish and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results, timely file our periodic reports, maintain our reporting status or prevent fraud.

In connection with our assessment of the effectiveness of our internal control over financial reporting as of December 31, 2014, we concluded there were certain material weaknesses in internal control over financial reporting related to identified control deficiencies in respect of completeness and accuracy of data used in the determination of significant estimates and accounting transactions and the process in place to support the accurate and timely reporting of financial results and disclosures.  We also concluded that, as of December 31, 2014, we had inadequate controls in place to prevent or detect material errors in the financial statements of acquired subsidiaries, and an error was identified related to the chargeback reserve of Hi-Tech recognized at the acquisition date which requires the restatement of our condensed consolidated financial statements for the quarter and six-months ended June 30, 2014 and the nine months ended September 30, 2014. Note that we excluded from our assessment of the effectiveness of our internal control over financial reporting as of December 31, 2014, Hi-Tech’s and VersaPharm’s internal control over financial reporting. Under standards established by the Public Company Accounting Oversight Board, a material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected or corrected on a timely basis.

 
16
 
We are working to remediate the material weaknesses.  With respect to validation of the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions, management intends to:

 
·
Conduct manual data validation procedures on certain reports related to gross to net adjustments and inventory.
 
·
Enhance the design of management review controls to increase the level of precision.
 
·
Establish a dedicated revenue accounting team focused primarily on significant gross to net revenue adjustments.
 
·
Ensure all systems relied upon in the financial reporting process are subject to Information Technology General Controls (ITGCs) which are intended to prevent system changes that could affect the completeness and accuracy of the data used.

With respect to timely and accurate filing of our financial results, management intends to:
 
 
·
Undertake a financial close process improvement project utilizing external consultants to identify efficiencies and enhance reporting capabilities as well as opportunities to reduce the incidence of errors.
 
·
Implement more robust accounting policies and work with consultants to streamline close activities and implement best practices.
 
·
Enhance communications between the accounting and tax groups to ensure timely and accurate tax considerations.
 
·
Deploy additional internal and/or external tax resources to allow for additional levels of management review controls.
 
 With respect to the financial statement of acquired subsidiaries, management intends to:
 
 
·
Evaluate the control environment of target acquisitions and acquired entities in a timely fashion to facilitate improvements in the subsidiary’s control environment within the year of acquisition.
 
·
Develop controls specifically designed to identify material errors within subsidiary financial statements.
 
·
Drive consistency in internal controls across all Akorn entities.
 
·
Deploy appropriate personnel with public company accounting experience at the subsidiary level, as needed.
 
Additionally, we plan on creating a new position to oversee accounting systems, administer and monitor ITGCs, coordinate between the Company’s accounting and information technology departments, identify opportunities to streamline and improve processes through greater automation, and plan to add personnel with internal controls and process improvement capabilities within the accounting function. Responsibilities will include designing internal controls and ensuring compliance, implementing global accounting policies and procedures, and implementing process improvements.
 
The actions that we are taking are subject to ongoing senior management review, as well as audit committee oversight.
 
Although we plan to complete this remediation as quickly as possible, we cannot at this time estimate how long it will take, and our initiatives may not prove to be successful in remediating this material weakness.  If our remedial measures are insufficient to address the material weaknesses, or if additional material weaknesses or in our internal control over financial reporting are discovered or occur in the future, our consolidated financial statements may contain material misstatements and we could be required to further restate our financial results.

Our management or our independent registered public accounting firm may identify other material weaknesses in our internal control over financial reporting in the future. The existence of internal control material weaknesses may result in current and potential stockholders losing confidence in our financial reporting, which could harm our business, the market price of our common stock, and our ability to retain our current, or obtain new, alliance and collaboration agreements’ partners.

In addition, the existence of material weaknesses in our internal control over financial reporting may affect our ability to timely file periodic reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The inability to timely file periodic reports could result in the SEC revoking the registration of our common stock, which would prohibit us from listing or having our stock quoted on the NASDAQ Global Market or any other stock exchange. This would have an adverse effect on our business and stock price by limiting the publicly available information regarding us and greatly reducing the ability of our stockholders to sell or trade our common stock.

Our revenues depend on sale of products manufactured by third parties, which we cannot control.

       We rely in part on external third parties to manufacture certain of the products we sell. Currently, this risk is limited to several of our products. However, we expect this risk to become more significant as we receive approvals for new products to be manufactured through our strategic partnerships and as we seek additional growth opportunities beyond the capacity and capabilities of our current manufacturing facilities. If we are unable to obtain or retain third-party manufacturers for these products on commercially acceptable terms, we may not be able to distribute such products as planned. Further, no assurance can be given that the manufacturers we use will be able to provide us with sufficient quantities of our products to meet our needs or that the products supplied to us will meet our specifications. Any delays or difficulties with third-party manufacturers could adversely affect the marketing and distribution of certain of our products, which could have a material adverse effect on our business, financial condition and results of operations.

Many of the raw materials and components used in our products come from a single source.

We require a supply of quality raw materials and components to manufacture and package pharmaceutical products for ourselves and for third parties with which we have contracted. Many of the raw materials and components used in our products come from a single source and interruptions in the supply of these raw materials and components could disrupt our manufacturing of specific products and cause our sales and profitability to decline. Further, in the case of many of our ANDAs and NDAs, only one supplier of raw materials has been identified. Because FDA approval of drugs requires manufacturers to specify their proposed suppliers of active pharmaceutical ingredients and certain packaging materials in their applications, FDA approval of any new supplier would be required if active ingredients or such packaging materials were no longer available from the specified supplier. The qualification of a new supplier could delay our development and marketing efforts. If for any reason we are unable to obtain sufficient quantities of any of the raw materials or components required to produce and package our products, we may not be able to manufacture our products as planned, which could have a material adverse effect on our business, financial condition and results of operations.
 
 
17
 
Any failure to comply with the complex reporting and payment obligations under Medicare, Medicaid and other government programs may result in litigation or sanctions.
 
We are subject to various federal and state laws pertaining to healthcare fraud and abuse, including anti-kickback, false claims, marketing and pricing laws. We are also subject to Medicaid and other government reporting and payment obligations that are highly complex and somewhat ambiguous. Violations of these laws and reporting obligations are punishable by criminal and/or civil sanctions and exclusion from participation in federal and state healthcare programs such as Medicare and Medicaid. The recent healthcare reform legislation made several changes to the federal anti-kickback statute, false claims laws, and health care fraud statute such as increasing penalties and making it easier for the government to bring sanctions against pharmaceutical companies. If our past, present or future operations are found to be in violation of any of the laws described above or other similar governmental regulations, we may be subject to the applicable penalty associated with the violation which could adversely affect our ability to operate our business and negatively impact our financial results. Further, if there is a change in laws, regulations or administrative or judicial interpretations, we may have to change our business practices or our existing business practices could be challenged as unlawful, which could materially adversely affect our business, financial position and results of operations.
 
Exercise of options, granting of restricted shares, or issuance of shares pursuant to our convertible debt, may have a substantial dilutive effect on our common stock.

If the price per share of our common stock at the time of exercise of any stock options is in excess of the various exercise prices of such options, exercise of such options would have a dilutive effect on our common stock. As of December 31, 2014, holders of our outstanding options would receive 6.4 million shares of our common stock at a weighted average exercise price of $11.44 per share.

Our earnings per share will also be diluted if the average closing price of our common stock exceeds the conversion price (currently $8.76 per share) on our convertible Notes. The Notes became convertible for the quarter ending on June 30, 2012 as a result of the Company’s stock trading at or above the required price of $11.39 per share for 20 of the last 30 trading days in the quarter ended March 31, 2012 and have remained convertible for each successive quarter as a result of meeting the trading price requirement at the end of each prior quarter.  During the year ended December 31, 2014, approximately $32.5 million of the Notes were converted by the holders while $87.5 million remain available for conversion.  If the Notes are surrendered for conversion, we have the option of satisfying all or a portion of our obligation in shares of our common stock, which could result in substantial dilution of the existing ownership interests of our common shareholders.

We have grown at a very rapid pace. Our inability to effectively manage or support this growth may have a material adverse effect on our business, financial position, results of operations and cash and could cause the market value of our common stock to decline.

We have grown very rapidly over the past year as a result of several acquisitions and increasing sales, and additional growth through acquisitions is possible in the future. This growth has put significant demands on our processes, systems, and people. We have made and expect to make further investments in additional personnel, systems, and internal control processes to help manage our growth. Attracting, retaining and motivating key employees in various departments and locations to support our growth are critical to our business, and competition for these people can be significant. If we are unable to hire and/or retain qualified employees and/or if we do not effectively invest in systems and processes to manage and support our rapid growth and the challenges and difficulties associated with managing a larger, more complex business, and/or if we cannot effectively manage and integrate our increasingly diverse and global platform, there could be a material adverse effect on our business, financial position, results of operations and/or cash flow, and the market value of our common stock could decline.

Changes in healthcare law and policy changes may adversely affect our business.
 
In March 2010, the U.S. Congress enacted the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act (collectively, the “Healthcare Act”). This health care reform legislation is intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. As examples, the current legislation include measures that would (i) significantly increase Medicaid rebates through both the expansion of the program and significant increases in rebates; (ii) substantially expand the Public Health System (340B) program to allow other entities to purchase prescription drugs at substantial discounts; (iii)  extend the Medicaid rebate rate to a significant portion of Managed Medicaid enrollees; (iv) assess a 50% rebate on Medicaid Part D spending in the coverage gap for branded and authorized generic prescription drugs; and (v) levy an excise tax on certain drug and device manufacturers.

While the aforementioned healthcare reform legislation may increase the number of patients who have insurance coverage for our products, such insurance mandate did not commence until January 2014, and the healthcare reform legislation also restructured and reduced payments to Medicare managed care plans and reduces reimbursements to many third-party payers. Accordingly, the timing on the insurance mandate, the change in the Medicaid rebate levels, the additional fees imposed on us to the extent we market branded drugs, other compliance obligations, and the reduced reimbursement levels to institutional customers may result in a loss of revenue and could adversely affect our business. While we will not know the full effects of this health care reform legislation until applicable federal and state agencies issue regulations or guidance under the new law and the new law has been fully implemented, it appears likely to continue the pressure on pharmaceutical pricing, especially under the Medicare program, and to increase our regulatory burdens and operating costs.

In addition, other legislative changes have been proposed and adopted since the Healthcare Act was enacted. Congress passed the Budget Control Act of 2011 which, among other things, created measures for spending reductions by Congress, including a committee tasked with proposing legislation to reduce the federal deficit. The committee did not act, which triggered the legislation's automatic reduction to government programs.  Because of this legislation, Medicare reimbursement to providers was reduced overall by 2% beginning April 1, 2013.  This, and other new laws, may result in additional reductions in Medicare and other health care funding, which could have a material adverse effect on our customers and accordingly, our financial operations.

 
18
 
The sales of our products depend in part on the availability of reimbursement from third-party payers such as government health administration authorities, private health insurers, health maintenance organizations including PBMs and other health care-related organizations. We expect both federal and state governments in the U.S. and foreign governments to continue to propose and pass new legislation, rules and regulations designed to contain or reduce the cost of healthcare while expanding individual healthcare benefits. Existing regulations that affect the price of pharmaceutical and other medical products may also change before any of our products are approved for marketing. Cost control initiatives could decrease the price that we receive for any product we develop in the future. In addition, PBMs and other third-party payers are increasingly challenging the price and cost-effectiveness of medical products and services. Significant uncertainty exists as to the reimbursement status of newly approved pharmaceutical products. Our products may not be considered cost effective, or adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize a return on our investments. All of these may harm our ability to market our products and generate profits.

We have entered into several strategic business alliances that may not result in marketable products.

We have entered into several strategic business alliances that have been formed to supply us with low cost finished dosage form products. We have entered into various purchase and supply agreements and license agreements that are all designed to provide finished dosage form products that can be marketed through our distribution pipeline. There can be no assurance that these agreements will result in additional FDA-approved ANDAs or NDAs, or that we will be able to market any such additional products at a profit. In addition, any clinical trial expenses that we may incur in connection with these strategic business alliances may negatively impact our financial results.

We may become involved in legal proceedings from time to time which may result in losses, damage to our business and reputation and place a strain on our internal resources.

In the ordinary course of our business, we may be involved in legal proceedings with both private parties and certain government agencies, including FDA. Litigation may result in verdicts against us, which may include significant monetary awards, judgments that certain of our intellectual property rights are invalid or unenforceable and injunctions preventing the manufacture, marketing and sale of our products. If disputes are resolved unfavorably, our business, financial condition and results of operations may be adversely affected.

Any litigation, whether or not successful, may damage our reputation. Furthermore, we are likely to incur substantial expense in defending these lawsuits and the time demands of such lawsuits could divert management’s attention from ongoing business concerns and interfere with our normal operations.

In the normal course of business, we periodically enter into employment agreements, legal settlements, and other agreements which incorporate indemnification provisions. We maintain insurance coverage which we believe will effectively mitigate our obligations under these indemnification provisions. However, should our obligation under an indemnification provision exceed our coverage or should coverage be denied, it could have a material adverse effect on our business, financial position and results of operations.

Third parties may claim that we infringe their proprietary rights and may prevent or delay us from manufacturing and selling some of our new products.

The manufacture, use and sale of new products that are the subject of conflicting patent rights have been the subject of substantial litigation in the pharmaceutical industry. Pharmaceutical companies with patented brand products frequently sue companies that file applications to produce generic equivalents of their patented brand products for alleged patent infringement or other violations of intellectual property rights, which may delay or prevent the entry of such generic products into the market. Generally, a generic drug may not be marketed until the applicable patent(s) on the brand name drug expire or are held to be not infringed, invalid, or unenforceable. When we or our development partners submit an ANDA to the FDA for approval of a generic drug, we and/or our development partners must certify either (i) that there is no patent listed by the FDA as covering the relevant brand product, (ii) that any patent listed as covering the brand product has expired, (iii) that the patent listed as covering the brand product will expire prior to the marketing of the generic product, in which case the ANDA will not be finally approved by the FDA until the expiration of such patent, or (iv) that any patent listed as covering the brand drug is invalid or will not be infringed by the manufacture, sale or use of the generic product for which the ANDA is submitted.

 
19
 
Under any circumstance in which an act of infringement is alleged to occur, there is a risk that a brand pharmaceutical company may sue us for alleged patent infringement or other violations of intellectual property rights. Also, competing pharmaceutical companies may file lawsuits against us or our strategic partners alleging patent infringement or may file declaratory judgment actions of non-infringement, invalidity, or unenforceability against us relating to our own patents. We have been sued for patent infringement related to several of our current ANDA filings and we anticipate that we will be sued once we file ANDAs for other products in our pipeline. Such litigation is often costly and time-consuming and could result in a substantial delay in, or prevent, the introduction and/or marketing of our products, which could have a material adverse effect on our business, financial condition and results of operations.

Although the parties to patent and intellectual property disputes in the pharmaceutical industry have often settled their disputes through licensing or similar arrangements, the costs associated with these arrangements may be substantial and could include ongoing royalties. Furthermore, we cannot be certain that the necessary licenses would be available to us on terms we believe to be acceptable.

Our patents and proprietary rights may not adequately protect our products and processes.

The patent and proprietary rights position of competitors in the pharmaceutical industry generally is highly uncertain, involves complex legal and factual questions, and is the subject of much litigation. There can be no assurance that any patent applications or other proprietary rights, including licensed rights, relating to our potential products or processes will result in patents being issued or other proprietary rights secured, or that the resulting patents or proprietary rights, if any, will provide protection against competitors who: (i) successfully challenge our patents or proprietary rights; (ii) obtain patents or proprietary rights that may have an adverse effect on our ability to conduct business; or (iii) are able to circumvent our patent or proprietary rights position. It is possible that other parties have conducted or are conducting research and could make discoveries of pharmaceutical formulations or processes that would precede any discoveries made by us, which could prevent us from obtaining patent or other protection for these discoveries or marketing products developed therefrom. Consequently, there can be no assurance that others will not independently develop pharmaceutical products similar to or rendering obsolete those that we are planning to develop, or duplicate any of our products. Our inability to obtain patents for, or other proprietary rights in, our products and processes or the ability of competitors to circumvent or obsolete our patents or proprietary rights could have a material adverse effect on our business, financial condition and results of operations.  Additionally, our inability to successfully defend our existing patents against Paragraph IV challenges by competing drug companies could have a material adverse effect on our business, financial condition and results of operations.

Further, the majority of the drug products that we market are generics, with essentially no patent or proprietary rights attached. While this fact allowed us the opportunity to develop or to purchase and obtain FDA approval to market our generic products, it also allows competing drug companies to do the same. Should multiple additional drug companies choose to develop and market the same generic products that we actively market, our profit margins could decline, which would have a material adverse effect on our business, financial condition and results of operations.

The Chairman of our Board of Directors is subject to conflicts of interest, and through his stock ownership and position as Chairman has substantial influence over our business strategies and policies.

John N. Kapoor, Ph.D., the Chairman of our Board of Directors and a principal shareholder, is the President of EJ Financial Enterprises, Inc. (“EJ Financial”), a health care consulting investment company. EJ Financial is involved in the management of health care companies in various fields, and Dr. Kapoor is involved in various capacities with the management and operation of these companies. The John N. Kapoor Trust dated 9/20/89 (the “Kapoor Trust”), the beneficiary and sole trustee of which is Dr. Kapoor, is a principal shareholder of each of these companies. As a result, Dr. Kapoor does not devote his full time to our business. Although such companies do not currently compete directly with us, certain companies with which EJ Financial is involved are in the pharmaceutical business. Discoveries made by one or more of these companies could render our products less competitive or obsolete. Potential conflicts of interest could have a material adverse effect on our business, financial condition and results of operations.

As of December 31, 2014, Dr. Kapoor beneficially owns approximately 30% of our common stock. As a result, Dr. Kapoor can strongly influence, and potentially control, the outcome of our corporate actions, including the election of our directors and transactions involving a change of control. This concentrated control limits other shareholders’ ability to influence corporate matters and, as a result, the Company may take actions that other shareholders do not view as beneficial. Further, decisions made by Dr. Kapoor with respect to his and his related parties’ ownership or trading of our common stock could have an adverse effect on the market value of our common stock and an adverse effect on our business.

We depend on key executive officers and must continue to attract and retain key personnel in order to compete successfully.
 
20
 

Our success depends, in part, on our ability to attract and retain key executive officers. The loss of one or more of our key executive officers could have a material adverse effect on our business, financial condition and results of operations.

Further, our performance depends, to a large extent, on the continued service of our key research and development personnel, other technical employees, managers and sales personnel and our ability to continue to attract and retain such personnel. Competition for such personnel is intense, particularly for highly motivated and experienced research and development and other technical personnel. We are facing increasing competition from companies with greater financial resources for such personnel. There can be no assurance that we will be able to attract and retain sufficient numbers of highly skilled personnel in the future, and the inability to do so could have a material adverse effect on our business, and on our results of operations and financial condition.

We may implement product recalls and could be exposed to significant product liability claims; we may have to pay significant amounts to those harmed and may suffer from adverse publicity as a result.

The manufacturing and marketing of pharmaceuticals involves an inherent risk that our products, or items within our products, may prove to be defective and cause a health risk. In that event, we may voluntarily implement a recall or market withdrawal or may be required to do so by a regulatory authority. We have recalled products in the past and, based on this experience, believe that the occurrence of a recall could result in significant costs to us, potential disruptions in the supply of our products to our customers and adverse publicity, all of which could harm our ability to market our products.

Although we are not currently subject to any material product liability proceedings, we may incur material liabilities relating to product liability claims in the future. Even meritless claims could subject us to adverse publicity, hinder us from securing insurance coverage in the future and require us to incur significant legal fees and divert the attention of the key employees from running our business. Successful product liability claims brought against us could have a material adverse effect on our business, financial condition and results of operations.

        We currently have product liability insurance in the amount of $20,000,000 for aggregate annual claims with a $250,000 deductible per incident and a $1,250,000 aggregate annual deductible. However, there can be no assurance that such insurance coverage will be sufficient to fully cover potential claims. Additionally, there can be no assurance that adequate insurance coverage will be available in the future at acceptable costs, if at all, or that a product liability claim would not have a material adverse effect on our business, financial condition and results of operations.

The FDA may require us to stop marketing certain grandfathered drugs.

We market several generic prescription products which do not have formal FDA approvals because these products have been grandfathered into the provisions of the 1938 Federal FDC Act or the 1962 amendments to the Act. These products are non-application drugs that are manufactured and marketed without FDA-issued ANDAs or NDAs on the basis of their having been marketed by industry prior to the 1962 Amendments of the FDC Act.  We marketed nine such products during 2014, generating net sales revenue of $43.4 million. Of the nine products during 2014, two were approved through either an ANDA or an NDA prior to the filing of this Form 10-K.  Following enactment of the FDC Act in 1938, drugs on the market prior to that time were exempted or “grandfathered” and manufacturers were not required to file an NDA. Recently, FDA has increased its efforts to force companies to file and seek FDA approval for grandfathered products. Efforts have included issuing notices to companies currently manufacturing these products to cease its distribution of said products.

On October 2, 2012, we received a Warning Letter from the FDA citing that we were manufacturing Pilocarpine Hydrochloride Ophthalmic Solution (“PHOS”), a grandfathered drug, without an approved NDA. We fully cooperated with the FDA and discontinued selling PHOS. No enforcement action was initiated and no fines were assessed by the FDA against us and the loss of revenue associated with the discontinuation of PHOS was immaterial.  Further, in the second quarter of 2012, we filed an ANDA for PHOS, which is currently under review by the FDA.

If the FDA issues additional Warning Letters with respect one or more of our grandfathered products, we may be forced to discontinue marketing the affected products, which could have an adverse effect on our revenues and results of operations.

The FDA may authorize sales of some prescription pharmaceuticals on a non-prescription basis, which would reduce the profitability of our prescription products.

From time to time, the FDA elects to permit sales of some pharmaceuticals currently sold on a prescription basis without a prescription. FDA approval of the sale of our products without a prescription would reduce demand for our competing prescription products and, accordingly, reduce our profits.

 
21
 
We could experience business interruptions at our manufacturing facilities, which may have a material adverse effect on our business, financial position and results of operations.

We manufacture drug products at one international and three domestic manufacturing facilities. Any one or more of these facilities may be forced to shut down or may be unable to operate at full capacity as a result of hurricanes, tornadoes, earthquakes, storms and other extreme weather events as well as strikes, war, violent upheavals, terrorist acts and other force majeure events. For example, our manufacturing facility in Somerset, New Jersey was shut down for approximately two weeks in October and November 2012 as a result of power outages and related business disruptions caused by Superstorm Sandy. A significant disruption at any of these facilities, even on a short-term basis, could impair our ability to produce and ship drug products to the market on a timely basis, which may have a material adverse effect on our business, financial position and results of operations.

The testing required for the regulatory approval of our products is conducted by independent third parties. Any failure by any of these third parties to perform this testing properly and in a timely manner may have an adverse effect upon our ability to obtain regulatory approvals.

Our applications for the regulatory approval of our products incorporate the results of testing and other information that is conducted or gathered by independent third parties (including, for example, manufacturers of raw materials, testing laboratories, contract research organizations or independent research facilities). Our ability to obtain regulatory approval of the products being tested is dependent upon the quality of the work performed by these third parties, the quality of the third parties’ facilities, and the accuracy of the information provided by third parties. We have little or no control over any of these factors. If this testing is not performed properly, our ability to obtain regulatory approvals could be restricted or delayed.

We may be subject to disruptions or failures in our information technology systems and network infrastructures that could have a material adverse effect on our business.

We rely on the efficient and uninterrupted operation of complex information technology systems and network infrastructures to operate our business. We also hold data in various data center facilities upon which our business depends. A disruption, infiltration or failure of our information technology systems or any of our data centers as a result of software or hardware malfunctions, system implementations or upgrades, computer viruses, third-party security breaches, employee error, theft or misuse, malfeasance, power disruptions, natural disasters or accidents could cause breaches of data security, loss of intellectual property and critical data and the release and misappropriation of sensitive competitive information. Any of these events could result in the loss of key information, impair our production and supply chain processes, harm our competitive position, cause us to incur significant costs to remedy any damages and ultimately materially and adversely affect our business, results of operations and financial condition. While we have implemented a number of protective measures, such measures may not be adequate or implemented properly to prevent or fully address the adverse effect of such events.

Failure to comply with the U.S. Foreign Corrupt Practices Act could subject us to, among other things, penalties and legal expenses that could harm our reputation and have a material adverse effect on our business, financial condition and operating results. 

Our U.S. operations are currently subject to the FCPA. We are required to comply with the FCPA, which generally prohibits covered entities and their intermediaries from engaging in bribery or making other prohibited payments to foreign officials for the purpose of obtaining or retaining business or other benefits. In addition, the FCPA imposes accounting standards and requirements on publicly traded U.S. corporations and their foreign affiliates, which are intended to prevent the diversion of corporate funds to the payment of bribes and other improper payments, and to prevent the establishment of “off books” slush funds from which such improper payments can be made. While we believe we have effective compliance programs in place to prevent violations of these laws, if our employees, third-party sales representatives or other agents are found to have engaged in such practices, we could suffer severe penalties, including criminal and civil penalties, disgorgement and other remedial measures, including further changes or enhancements to our procedures, policies and controls, as well as potential personnel changes and disciplinary actions.

The requirements of being a public company may strain our resources and distract management.

As a public company, we are subject to the reporting requirements of the Exchange Act and the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”). These requirements are extensive. The Exchange Act requires that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal control over financial reporting. In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting, significant resources and management oversight is required. This may divert management’s attention from other business concerns, which could have a material adverse effect on our business, financial condition and results of operations.

 
22
 
We may issue preferred stock and the terms of such preferred stock may reduce the market value of our common stock.

We are authorized to issue up to a total of 5,000,000 shares of preferred stock in one or more series. Subject to certain limitations, our board of directors may authorize issuance of shares of preferred stock and the terms of such preferred stock without further action by holders of our common stock. If we issue shares of preferred stock, it could affect the rights or reduce the market value of our common stock. In particular, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with or sell our assets to a third party. These terms may include voting rights, preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions. We continue to seek capital for the growth of our business, and this additional capital may be raised through the issuance of preferred stock.

We experience significant quarterly fluctuation of our results of operations, which may increase the volatility of our stock price.

Our results of operations may vary from quarter to quarter due to a variety of factors including, but not limited to, the timing of the development and marketing of new pharmaceutical products, the failure to develop such products, delays in obtaining government approvals, including FDA approval of NDAs or ANDAs for our products, expenditures to comply with governmental requirements for manufacturing facilities, expenditures incurred to acquire and promote pharmaceutical products, changes in our customer base, a customer’s termination of a substantial account, the availability and cost of raw materials, interruptions in supply by third-party manufacturers, seasonal or cyclical fluctuations in the sales of certain of our products, the introduction of new products or technological innovations by our competitors, loss of key personnel, changes in the mix of products sold by us, changes in sales and marketing expenditures, competitive pricing pressures, expenditures incurred to pursue or contest pending or threatened legal action and our ability to meet our financial covenants. There can be no assurance that we will be successful in avoiding losses in any future period. Such fluctuations may result in volatility in the price of our common stock.

Charges to earnings resulting from acquisitions could have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

Under generally accepted accounting principles (“GAAP”) business acquisition accounting standards, we recognize the identifiable assets acquired, the liabilities assumed, and any noncontrolling interests in acquired companies generally at their acquisition date fair values and, in each case, separately from goodwill. Goodwill as of the acquisition date is measured as the excess amount of consideration transferred, which is also generally measured at fair value, and the net of the acquisition date amounts of the identifiable assets acquired and the liabilities assumed. Our estimates of fair value are based upon assumptions believed to be reasonable but which are inherently uncertain. After we complete an acquisition, the following factors could result in material charges and adversely affect our operating results and may adversely affect our cash flow:
 
·
costs incurred to combine the operations of companies we acquire, such as transitional employee expenses and employee retention, redeployment or relocation expenses;
 
·
impairment of goodwill or intangible assets, including acquired IPR&D;
 
·
amortization of intangible assets acquired;
 
·
a reduction in the useful lives of intangible assets acquired;
 
·
identification of or changes to assumed contingent liabilities, including, but not limited to, contingent purchase price consideration, income tax contingencies and other non-income tax contingencies, after our final determination of the amounts for these contingencies or the conclusion of the measurement period (generally up to one year from the acquisition date), whichever comes first;
 
·
charges to our operating results to eliminate certain duplicative pre-acquisition activities, to restructure our operations or to reduce our cost structure;
 
·
charges to our operating results resulting from expenses incurred to effect the acquisition;
 
·
changes to contingent consideration liabilities, including accretion and fair value adjustments. A significant portion of these adjustments could be accounted for as expenses that will decrease our net income and earnings per share for the periods in which those costs are incurred. Such charges could cause a material adverse effect on our business, financial position, results of operations and/or cash flow, and could cause the market value of the common stock to decline.
 
As of December 31, 2014, we had recorded $278.8 million of goodwill on our consolidated balance sheet.

 
23
 
Item 1B. Unresolved Staff Comments.

None.

Item 2. Properties.

We have two company-owned facilities in Decatur, Illinois.  The Wyckles Road facility, which consists of 76,000 square feet of building space located on 15 acres of land, is used for packaging, warehousing, distribution, and office space.  The Grand Avenue facility is a 65,000 square-foot manufacturing facility. We recently acquired less than one acre of land adjacent to the Grand Avenue facility which may be used for expansion.  Our Decatur facilities support our Prescription Pharmaceuticals and Consumer Health segments.

Through the merger with Hi-Tech during the year, we acquired seven buildings which support our Prescription Pharmaceuticals and Consumer Health segments with approximately 225,000 square feet which includes:
 
·
42,000 square foot facility dedicated to liquid and semi-solid production
 
·
28,000 square foot facility housing a sterile manufacturing facility, DEA manufacturing, chemistry and microbiology laboratories
 
·
72,000 square foot facility used for the warehousing of finished goods which also houses our Health Care Products division
 
·
22,000 square foot facility with 4,000 square feet of office space and 18,000 square feet of warehouse space
 
·
8,000 square foot office building which is utilized for administrative functions
 
·
35,000 square foot facility with mixed office, laboratory and manufacturing space
 
·
18,000 square foot building located in Copiague, New York, which is used for research and development activities
 
Our wholly owned subsidiary, AIPL, owns and operates approximately 245,000 square feet of pharmaceutical manufacturing, warehousing and distribution facilities situated on approximately 14 acres of land in Paonta Sahib, Himachal Pradesh, India.  This facility manufactures drugs primarily for contract customers in India and for export to various unregulated world markets.

Our wholly owned subsidiary, Akorn (New Jersey) Inc. leases a 50,000 square-foot facility in Somerset, New Jersey pursuant to a seven-year lease agreement that began on August 1, 2010. This lease allows us the option to renew for up to four additional five-year periods beyond the initial expiration date of July 31, 2017.  The Somerset facility is used for drug manufacturing, research and development and administrative activities related to our Prescription Pharmaceuticals segment. Akorn (New Jersey) Inc. also leases a 6,600 square foot on-site warehouse which is subject to annual renewal at our option.

In connection with the acquisition of VersaPharm during the year, our wholly owned subsidiary, Clover Pharmaceuticals Corp, leased a research and development facility in Warminster, Pennsylvania for an initial term ending December 31, 2017 , with option to renew for an additional three years.  The Warminster facility is approximately 12,000 square feet and is used for drug R&D and administrative activities related to our Prescription Pharmaceuticals segment. As part of the VersaPharm acquisition, we also took over a lease of a warehouse and office space in Marietta, Georgia consisting of approximately 20,000 square feet and expiring May 31, 2016. All other leases maintained by VersaPharm and its subsidiaries prior to the acquisition have been terminated.

Our manufacturing facilities in Decatur, Illinois, Somerset, New Jersey and Amityville, New York are expected to be adequate to accommodate our current manufacturing needs.  We will gain additional capacity to support continued growth if our manufacturing facility in Paonta Sahib, India receives FDA approval to manufacture products for shipment to the U.S. market.

Our corporate headquarters and administrative offices consist of 34,000 square feet of leased space in an office building in Lake Forest, Illinois.  We maintain a leased space in Gurnee, Illinois, which was recently expanded by 38,000 square feet to a total of approximately 112,000 square feet, in order to accommodate our product warehousing and distribution needs.  Both the Lake Forest lease and the Gurnee lease extend through March 2018.  Our leased R&D facility located in Vernon Hills, Illinois was recently expanded by 4,000 square feet to a total of 23,000 square feet and is maintained pursuant to a seven-year lease expiring August 31, 2020.  Our subsidiary, AVR, maintains their corporate offices in a 3,200-square foot leased facility in Ann Arbor, Michigan.

Item 3. Legal Proceedings.

We are party to various legal proceedings and potential claims arising in the ordinary course of our business. Such legal proceedings include our Paragraph IV challenges to other drug manufacturers’ proprietary rights, and any counter-suits filed by such drug manufacturers in response.  The amount, if any, of ultimate liability with respect to legal proceedings involving the Company cannot reasonably be determined.  Despite the inherent uncertainties of litigation, at this time the Company does not believe that any such proceedings will have a material adverse impact on its financial condition, results of operations, or cash flows. Set forth below is a listing of potentially material legal proceedings of the Company, including its Hi-Tech, and VersaPharm subsidiaries in existence as of the date of filing this Form 10-K.
 
24
 
On September 11, 2013, the Attorney General of the State of Louisiana filed a lawsuit in Louisiana state court against Hi-Tech, and numerous other pharmaceutical companies, under various state laws, alleging that each defendant caused the state’s Medicaid agency to provide reimbursement for drug products that allegedly were not approved by the FDA and therefore allegedly not reimbursable under the federal Medicaid program. The state seeks unspecified damages, statutory fines, penalties, attorney’s fees and costs. On October 15, 2013, the defendants removed the lawsuit to the U.S. District Court for the Middle District of Louisiana. Subsequently, the case was remanded to state court, where the case is in the initial discovery stage. The Company intends to vigorously defend against all claims in the lawsuit.

In May 2013, Inspire, a wholly owned subsidiary, received a Notice Letter that Mylan Pharmaceuticals, Inc (“Mylan”) filed an ANDA with the FDA seeking marketing approval for a 1% azithromycin ophthalmic solution prior to the expiration of the five U.S. patents licensed to us and listed in the Orange Book for Azasite®.  On June 14, 2013, Insite, Merck, Inspire and Pfizer filed a complaint against Mylan and a related entity alleging that their proposed product infringes the listed patents.  The parties agreed to settle the matter and the case was dismissed by court order on March 4, 2015.

On September 12, 2012, Fera Pharmaceuticals, LLC (“Fera”) filed a civil complaint against the Company and certain individual defendants in the Supreme Court of New York. On October 15, 2012, the case was removed to the Federal District Court for the Southern District of New York, and subsequently, Fera filed an amended complaint. The complaint alleges, among other things, breach of manufacturing and confidentiality agreements, fraud in the inducement and misappropriation of the plaintiff’s trade secrets.  The Company intends to vigorously defend these allegations.  On January  13, 2015, the Company filed a counterclaim against Fera and certain affiliates  (Alfera  Pharmaceuticals,  LLC;  Feranda,  LLC;  Baci   007,   LLC;   and    Fera Holdings, LLC), as well as Perrigo Company of Tennessee and Perrigo Company plc, asserting violations of Sections 1 and 2 of the Sherman Act and tortious interference with business relations.  The case is in the discovery phase, and no trial date has been scheduled.

On June 8, 2012, plaintiff Mathew Harrison filed  a class action lawsuit, Civil Action No. 12-2897, in the U.S. District Court for the Eastern District of New York, against Wayne Perry, Dynova Laboratories, Inc., Sicap Industries, LLC, Walgreens Co. and Hi-Tech. On May 16, 2012, plaintiff David Delre filed a class action lawsuit, Civil Action No. 12-2429, in the U.S. District Court for the Eastern District of New York, against Wayne Perry, Dynova Laboratories, Inc., Sicap Industries, LLC, and Hi-Tech. Each complaint alleges, among other things, that their Sinus Buster ® products are improperly marketed, labeled and sold as homeopathic products, and that these allegations support claims of fraud, unjust enrichment, breach of express and implied warranties and alleged violations of various state and federal statutes. Hi-Tech answered the complaints and asserted cross-claims against the other defendants. The Court consolidated these two cases into one action entitled Sinus Buster Products Consumer Litigation. Dynova has filed for bankruptcy. The case has now been settled by Hi-Tech with plaintiffs by Agreement dated December 16, 2013 and the Court approved the settlement by an Order dated November 10, 2014.

In April 2011, Inspire Pharmaceuticals, Inc., a wholly owned subsidiary of the Company, acquired through a business combination on November 15, 2013, received a Notice letter from Sandoz, Inc. (“Sandoz”) providing notice that Sandoz filed an ANDA with the FDA seeking marketing approval for a 1% azithromycin ophthalmic solution prior to the expiration of the five U.S. patents licensed to us and listed in the Orange Book for Azasite®.  On May 26, 2011, Merck, Insite Vision Incorporated and Pfizer filed a complaint against Sandoz and related entities in the district court of New Jersey alleging that their proposed product infringes the listed patents.  On October 4, 2013, the court issued judgment in favor of Inspire and the other plaintiffs finding all the asserted claims of the patents in the litigation valid and infringed by Sandoz and related entities.  Sandoz has appealed this decision.  The Company intends to vigorously contest any Sandoz assertions that these patents should have been found not infringed, invalid or unenforceable.

In August 2014, former Hi-Tech director and employee Reuben Seltzer delivered to the Company a demand letter in August 2014 alleging that the Company breached his employment agreement and improperly terminated Mr. Seltzer’s employment.  Mr. Seltzer further alleges that he is entitled to compensation in the approximate amount of $5.2 million.  The Company disputes these claims and intends to vigorously defend these allegations.
 
On March 4, 2015, putative class action plaintiff Solomon Yeung filed suit in the Federal District Court Northern District Illinois against Akorn, Inc., Rajat Rai, Timothy Dick and Bruce Kutinsky, alleging defendants violated Rules 10b-5 and 20(a) of the 1934 Exchange Act.  According to the complaint, certain financial and other related data related to certain Akorn subsidiaries could not be timely collected and compiled and Akorn would be unable to timely complete its assessment of the effectiveness of its internal control over financial reporting as of December 31, 2014. The complaint also alleges that Akorn’s internal control over financial reporting was ineffective and material weaknesses existed relating to the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions and accurate and timely reporting of its financial results and disclosures in its Form 10-K. Plaintiff alleges that as a consequence, when Akorn announced on March 2, 2015 that it would need an extension to file an annual report for the year ending December 31, 2014, its stock dropped.  The Company and individual defendants dispute these claims and intend to vigorously defend these allegations.
 
 
 
25
 
Item 4. Mine Safety Disclosures.

Not applicable.
 
Executive Officers  of the Company

The following table identifies our current executive officers, the positions they hold, and the year in which they became an officer, as of March 17, 2015.  Our officers are appointed by the Board to hold office until their successors are elected and qualified.
 
Name
Position
Age
Year Became
Officer
       
Raj Rai
Chief Executive Officer (“CEO”)
48
2009
Timothy A. Dick
Chief Financial Officer (“CFO”)
45
2009
Joseph Bonaccorsi
Senior Vice President, General Counsel, and Secretary (“General Counsel”)
50
2009
Bruce Kutinsky
Chief Operating Officer (“COO”)
49
2010
Steve Lichter
Executive Vice President, Pharmaceutical Operations
56
2015

Raj Rai.  Mr. Rai was appointed Interim Chief Executive Officer in June 2009, and appointed Chief Executive Officer in May 2010.  He had been appointed Strategic Consultant to the Special Committee of the Board in February 2009, following the departure of our former President and Chief Executive Officer.  Prior to joining Akorn, Mr. Rai was the President and CEO of Option Care, Inc., a leading provider of home infusion pharmacy and specialty pharmacy services, which was acquired by Walgreen Co. in August 2007.  Mr. Rai previously served on the board of directors of SeQual Technologies Inc.
 
Timothy A. Dick.   Mr. Dick was appointed Chief Financial Officer in June 2009. Most recently, he was Vice President, Operations Improvement & Analysis of Option Care, Inc., a division of Walgreen Co. Mr. Dick has previously held various leadership positions in the areas of financial planning, analysis, and acquisitions at Option Care, Inc.  Prior to joining Option Care, Inc. in September 2001, Mr. Dick held various management positions in finance and acquisitions with both Johnson & Johnson and Peace Health, a Seattle-based regional health care system.
 
 Joseph Bonaccorsi.  Mr. Bonaccorsi joined Akorn in 2009 as Senior Vice President, Secretary and General Counsel.  Mr. Bonaccorsi came to Akorn from Walgreen Co., where he served as Senior Vice President Mergers & Acquisition and Counsel for the Walgreens-Option Care Home Care division. Mr. Bonaccorsi joined Option Care, Inc. in 2002, where he served as Senior Vice President, General Counsel, Secretary and Corporate Compliance Officer through 2007. Prior to joining Option Care, Inc., he was in private law practice in Chicago, Illinois.  He received his BS degree from Northwestern University and his Juris Doctorate from Loyola University School of Law, Chicago.

Bruce Kutinsky, Pharm.D. Dr. Kutinsky joined Akorn in late 2009 as Senior Vice President of Corporate Strategy and was named President, Consumer Health Division following the Company’s acquisition of Advanced Vision Research, Inc. in May 2011.  In September 2012, Dr. Kutinsky was appointed to serve as Akorn’s Chief Operating Officer.  Before joining Akorn, Dr. Kutinsky was Vice President – Strategic Solutions for Walgreens.  Prior to that, Dr. Kutinsky served in various roles at Option Care from 1997 to 2007, most recent of which was as Executive Vice President, Specialty Pharmacy.  Dr. Kutinsky holds a Doctor of Pharmacy degree from the University of Michigan.

Steve Lichter, Mr. Lichter joined Akorn in early 2015 as Executive Vice President, Pharmaceutical Operations. Mr. Lichter joins Akorn from Abbott Laboratories, where he served in various leadership roles over 32 years, most recently as Corporate Vice President, Operations, for Abbott’s Established Pharmaceutical Division in Switzerland. In this role, Mr. Lichter was responsible for the division’s global supply chain operations including active and finished drug product manufacturing, procurement, manufacturing, engineering, and commercial operations. Mr. Lichter holds a B.S. in Business Management and an MBA from Northern Illinois University.

 
26
 
PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

The following table sets forth, for the fiscal periods indicated, the high and low sales prices for our common stock for the two most recent fiscal years and through a portion of the first quarter of our current fiscal year.  From February 7, 2007 to the date of this report, our common stock has been listed on the NASDAQ Global Market under the symbol “AKRX”.  Previously, from November 24, 2004 until February 6, 2007, our common stock was listed on the American Stock Exchange (currently known as the NYSE MKT) under the symbol “AKN.”

 
  
High
    
Low
  
Year Ending December 31, 2015
            
1st Quarter (through February 27, 2015)
   $
55.86
    
 
35.45
  
Year Ended December 31, 2014
                
4th Quarter
   $ 45.25     $ 33.16  
3rd Quarter
     39.48       31.34  
2nd Quarter
     33.31       20.52  
1st Quarter
     28.00       20.63  
Year Ended December 31, 2013
                
4th Quarter
   $ 26.16     $ 19.03  
3rd Quarter
     20.22       13.34  
2nd Quarter
     15.49       12.86  
1st Quarter
     14.70       12.44  

As of February 27, 2015, there were 113,924,711 shares of our common stock outstanding, held by approximately 342 stockholders of record. This number does not include stockholders for which shares are held in a “nominee” or “street” name. The closing price of our common stock on February 27, 2015 was $53.81 per share.

We did not pay cash dividends in 2014, 2013 or 2012 and do not expect to pay dividends on our common stock in the foreseeable future. Moreover, we may be restricted or limited from making dividend payments pursuant to the terms of our financing arrangements with certain other financial institutions (see “Note 6 - Financing Arrangements”).

We did not repurchase any shares of our common stock during the years 2014, 2013 or 2012.
 
27
 
PERFORMANCE GRAPH
 
The following Stock Performance Graph and related information shall not be deemed “soliciting material” or “filed” with the Securities and Exchange Commission, nor should such information be incorporated by reference into any future filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, each as amended, except to the extent that we specifically incorporate it by reference in such filing.

The graph below compares the cumulative shareholder return on our common stock with the NASDAQ Stock Market (U.S.) Index, and the Nasdaq Health Care Index (ticker symbol: ^IXHC) over the last five years through December 31, 2014.  The graph assumes $100 was invested in our common stock, as well as the two indices presented, at the end of December 2009 and that all dividends were reinvested during the subsequent five-year period. 



Total Return Chart
  
2009
    
2010
    
2011
    
2012
    
2013
    
2014
  
NASDAQ Stock Market (U.S.) Index
     100       117       115       133       184       209  
NASDAQ Health Care Index (^IXHC)
     100       110       115       147       230       296  
Akorn, Inc. (AKRX)
     100       339       621       746       1,375       2,022  
 
 
28
 
Item 6. Selected Financial Data

The following table sets forth selected summary historical financial data.  We have prepared this table using our consolidated financial statements for the five years ended December 31, 2014, 2013, 2012, 2011 and 2010.  Our consolidated financial statements upon which the selected summary historical financial data is derived were audited by Ernst & Young LLP, independent registered public accounting firm, during each of the three years ended December 31, 2012, 2011 and 2010 and were audited by KPMG LLP, independent registered public accounting firm, during each of the two years ended December 31, 2014 and 2013.  This summary should be read in conjunction with our audited Consolidated Financial Statements and Notes thereto, and "Item 7 -- Management's Discussion and Analysis of Financial Condition and Results of Operations" and other financial information included herein.
 
   
Years Ended December 31,
  
 
 
2014
    
2013
    
2012
    
2011
    
2010
  
(In thousands, except per share data)
                              
Revenues
   $ 593,078     $ 317,711     $ 256,158     $ 136,920     $ 86,409  
Gross profit
     297,590       171,904       148,692       79,689       42,465  
Operating income
     96,715       88,204       68,756       33,266       11,272  
Interest and other non-operating income (expense)
     (37,579 )     (5,309 )     (11,256 )     8,040       10,704  
Pretax income from continuing operations
     59,136       82,895       57,500       41,306       21,976  
Income tax provision (benefit) from continuing operations
     23,288       30,533       22,122       (1,707 )     152  
Income from continuing operations
   $ 35,848     $ 52,362     $ 35,378     $ 43,013     $ 21,824  
Weighted average shares outstanding:
                                        
Basic
     103,480       96,181       95,189       94,549       92,801  
Diluted
     123,110       113,898       110,510       103,912       99,250  
PER SHARE:
                                        
Equity, per diluted share
   $ 3.14     $ 2.28     $ 1.82     $ 1.52     $ 0.87  
Income from continuing operations per share:
                                        
Basic
     0.35       0.54       0.37       0.45       0.24  
Diluted
     0.34       0.46       0.32       0.41       0.22  
                                         
Share Price: High
     45.25       26.16       16.87       11.77       6.50  
  Low
     20.52       12.44       10.52       4.87       1.27  
BALANCE SHEET DATA:
                                        
Current assets
   $ 494,329     $ 168,856     $ 158,707     $ 155,949     $ 73,613  
Net property, plant & equipment
     143,788       82,108       80,679       44,389       32,731  
Total assets
     1,906,901       431,805       369,565       307,145       111,116  
Current liabilities
     134,165       61,245       43,291       28,289       21,940  
Long-term obligations, less current installments
     1,385,985       110,380       125,193       120,648       2,424  
Shareholders’ equity
     386,751       260,180       201,081       158,208       86,752  
CASH FLOW DATA:
                                        
Cash provided by operating activities
   $ 30,918     $ 57,326     $ 26,244     $ 19,657     $ 12,282  
Cash (used in) provided by investing activities
     (966,541 )     (66,874 )     (75,501 )     (95,034 )     31,555  
Cash provided by (used in) financing activities
     972,308       3,118       6,366       117,716       (3,831 )
Effect of changes in exchange rates
     (183 )     (173 )     (290 )  
─
    
─
  
(Decrease)/increase in cash and cash equivalents
     36,502       (6,603 )     (43,181 )     42,339       40,006  
 
 
29
 
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

OVERVIEW

Akorn, Inc. together with its wholly owned subsidiaries is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and OTC consumer health products. We specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.
 
The Company through its Prescription Pharmaceuticals reportable segment manufactures and markets generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topical, inhalants, and nasal sprays which span a broad range of indications.  In addition, through its Consumer Health reportable segment, the Company manufactures and markets animal health and OTC products, both branded and private label.  OTC products include a suite of products for the treatment of dry eye sold under the TheraTears® brand name.

        We have identified two operating segments:

 
Prescription Pharmaceuticals – sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.
 
Consumer Health – sales of animal health and over-the-counter OTC products, both branded and private label.  OTC products include a suite of products for the treatment of dry eye sold under the TheraTears® brand name.

Acquisitions:

In recent periods, we have completed several business, asset and product acquisitions, including the various acquisitions described below. As a result of purchase accounting, we generally only reflect the results of an acquired business from the date of acquisition, which significantly affects the comparability of our financial results from period to period.
 
We have made several recent acquisitions of businesses that we believe complement our existing business and strategy. On January 2, 2015, the Company completed the acquisition of Excelvision AG, a Swiss contract manufacturer specializing in ophthalmic products. The purchase price of this acquisition was 21.7 million CHF, net of certain working capital adjustments. On August 12, 2014, the Company completed the acquisition of VersaPharm Incorporated, a developer and marketer of multi-source prescription pharmaceuticals incorporated in the state of Georgia. The purchase price of this acquisition was approximately $433.0 million, subject to net working capital adjustments. On April 17, 2014, the Company completed the acquisition of Hi-Tech Pharmacal Co., Inc., a specialty pharmaceutical company which develops, manufactures and markets generic and branded prescription and OTC products. The purchase price of this acquisition was approximately $650.0 million.
 
Similarly, we have made several recent acquisitions of products and assets that we believe complement our existing product offerings. On October 2, 2014, the Company acquired certain rights and inventory related to a suite of animal health injectable products formerly owned by Lloyd, Inc. These products have uses in pain management and anesthesia. The purchase price of this product acquisition was $16.1 million. On October 1, 2014, the Company acquired certain rights and inventory related to the branded product Xopenex® Inhalation Solution. This product is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and certain children with reversible obstructive airway disease. The purchase price of this product acquisition was $45.0 million. On April 12, 2012 and January 2, 2014, the Company acquired certain rights to Zioptan® and Betimol® respectively. Both products are prescription ophthalmic eye drops indicated for treatment of intraocular pressure. The purchase price of the Zioptan® product acquisition was $11.2 million. The purchase price of the Betimol® product acquisition will be 1.5 times the Company’s net sales of that product in the first year following its acquisition.
 
For a more detailed description of our recent company and product acquisitions, see “Item 1- Business - Mergers and Acquisitions.”
 
30
 
New Product Development:
 
        We increased the expansion of our product pipeline during 2014, as we submitted 23 new ANDAs to the FDA in the year, increasing to 87 the total number of filings under FDA review.  During 2014, we received FDA approval on 14 ANDAs, one NDA and two tentative ANDA approvals.  During the year, we also acquired two new R&D centers in Warminster, Pennsylvania and Copiague, New York to complement our Vernon Hills, Illinois center.  We continue to develop new products internally, as well as opportunistically partnering with other drug companies for products that we would not intend to manufacture ourselves.  R&D expense in 2014 was $29.2 million compared to $19.9 million in the prior year.

Revenue & Gross Profit:
 
Our revenue increased to $593.1 million in 2014, an increase of 86.7% over revenue of $317.7 million in 2013.  Of this $275.4 million increase, approximately $259.8 million or 94.3% was related to new products released, approved or acquired since the start of 2013.  The Hi-Tech and VersaPharm business combinations combined to account for $198.6 million of the revenue increase.  We also saw a $18.2 million increase in revenue from existing products, with $4.2 million of the change from increased volumes and $14.0 million from competitive pricing actions as we continue to increase our market penetration.  Our gross profit increased by $125.7 million, an increase of 73.1% over gross profit of $171.9 million in 2013. Our overall gross profit margin was 50.2% in 2014 compared to 54.1% in 2013.  The lower margin experienced in 2014, is primarily due to the effect of fees incurred due to competitive pricing actions during the year and inventory step-up amortization resulting from the various mergers and acquisitions of the Company in 2014.

RESULTS OF OPERATIONS

For the years 2014, 2013 and 2012, we have identified and reported operating results for two distinct business segments:  Prescription Pharmaceuticals and Consumer Health. Our reported results by segment are based upon various internal financial reports that disaggregate certain operating information. Our chief operating decision maker, as defined in Accounting Standards Codification (“ASC”) Topic 280, Segment Reporting, is our CEO.  Our CEO oversees operational assessments and resource allocations based upon the results of our reportable segments, all of which have available discrete financial information. During the year ended December 31, 2014, the Company acquired Hi-Tech and as a result, underwent a change in the organizational and reporting structure of the Company's reportable segments, establishing two reporting segments that each report to the Chief Operating Decision Maker (CODM), as defined in ASC Topic 280, Segment Reporting, and Chief Executive Officer (CEO), Raj Rai. Historical results for the years ended December 31, 2013 and 2012 have been restated in accordance with those reporting segments (See Note 12 – “Segment Information” for further discussion).

The following table sets forth amounts and percentages of total revenue for certain items from our Consolidated Statements of Comprehensive Income and our segment reporting information for the year ended December 31, 2014, with restated segment reporting information for the years ended December 31, 2013 and 2012 (dollar amounts in thousands):
 
   
2014
    
2013
    
2012
  
   
Amount
    
% of Revenue
    
Amount
    
% of Revenue
    
Amount
    
% of Revenue
  
Revenues:
                                    
Prescription Pharmaceuticals
   $ 542,846       91.5 %   $ 279,911       88.1 %   $ 223,881       87.4 %
Consumer Health
     50,232       8.5 %     37,800       11.9 %     32,277       12.6 %
Total revenues
     593,078       100.0 %     317,711       100.0 %     256,158       100.0 %
Gross profit and gross margin percentage:
                                                
Prescription Pharmaceuticals
     270,197       49.8 %     151,182       54.0 %     129,884       58.0 %
Consumer Health
     27,393       54.5 %     20,722       54.8 %     18,808       58.3 %
Total gross profit
     297,590       50.2 %     171,904       54.1 %     148,692       58.0 %
Operating expenses:
                                                
Selling, general & administrative expenses
     95,463       16.1 %     53,508       16.8 %     48,053       18.8 %
Research and development expenses
     29,199       4.9 %     19,858       6.3 %     15,858       6.2 %
Amortization of intangibles
     44,066       7.4 %     7,422       2.3 %     6,870       2.7 %
Acquisition-related costs
     32,147       5.4 %     2,912       0.9 %     9,155       3.6 %
Operating income
   $ 96,715       16.3 %   $ 88,204       27.8 %   $ 68,756       26.8 %
                                                 
Income from continuing operations
     35,848       6.0 %     52,362       16.5 %     35,378       13.8 %
Loss from discontinued operations
     (503 )     (0.1 %)     —       —       —       —  
Net income
   $ 35,345       6.0 %   $ 52,362       16.5 %   $ 35,378       13.8 %
 
 
31
 
COMPARISON OF YEARS ENDED DECEMBER 31, 2014 AND 2013
     
Our revenues were $593.1 million in 2014, an increase of $275.4 million, or 86.7%, as compared to 2013.  The increase in revenue was primarily due to the acquisitions completed during the year including two full quarters of Hi-Tech, which generated $176.9 million of revenue in the year, a full quarter of VersaPharm operations, which generated $21.7 million of revenue in the year and other product acquisitions. Of the remaining $76.8 million increase, $55.8 million was related to other acquisitions completed during the year and late in the prior year including AzaSite®, Cosopt® PF, Betimol®, Zioptan®, Xopenex®, and Lloyd’s, a $18.2 million increase related to existing products of which $4.2 million was volume related and $14.0 million was related to pricing increases, $5.4 million related to new or recently re-launched products and a $3.3 million increase in private label products, partially offset by a $5.9 million decline in yearly revenues due to products which were either divested or discontinued during the year. In addition, sales were impacted by fees incurred to effect competitive pricing actions on products such as Clobetasol Propionate of $52.2 million. Excluding the impact of these fees incurred to effect competitive pricing actions, net revenues during the year would have been $645.3 million.

In terms of reportable segments, 2014 revenues from our Prescription Pharmaceuticals segment were $542.8 million, an increase of $262.9 million, or 93.9%, over the prior year.  This increase was primarily related to acquisitions which generated $244.0 million of the change, sales of new and revived products, which accounted for $5.4 million of the increase, and increased sales of existing products which accounted for $19.4 million, principally due to price increases which resulted in $14.0 million of the change, partially offset by declining revenues from divested or discontinued products which reduced revenues by $5.9 million.  The Consumer Health segment revenues were $50.2 million, an increase of $12.4 million, or 32.9%, over the prior year.  Of the increase, $10.4 million was related to Consumer Health revenues generated through the acquisition of Hi-Tech, while $3.3 million of the remainder was due to increased sales of private label products, wholly generated through volume increases during the year, partially offset by a $1.3 million decline in existing business revenues.

Our 2014 revenues of $593.1 million was net of adjustments totaling $849.5 million for chargebacks and rebates, administration fees, returns, discounts and allowances, and coupons and advertising.  Chargeback and rebate expense for 2014 was $739.8 million, or 51.3% of gross revenue, compared to $183.4 million, or 34.7% of gross revenue, in 2013.  The $556.4 million increase in chargeback and rebate expense was due to the acquisitions and mergers completed during the year and the negative costs of costs of competitive pricing action for various products.  The increase in chargeback and rebate expense as a percentage of gross sales was attributable to fees incurred to effect competitive pricing actions taken on various products and higher overall chargeback and rebate expenses as a percent of gross revenues from the acquisitions and mergers consummated throughout the year.  Our products returns provision in 2014 was $20.0 million, or 1.4% of gross sales, compared to $5.0 million, or 0.9% of gross sales, in 2013.  The increase in percentage of returns to gross revenues was due to the product mix as a result of the acquisitions and mergers completed during the year.

Our consolidated gross profit for 2014 was $297.6 million, or 50.2% of revenue, compared to $171.9 million, or 54.1% of revenue, in 2013.  This $125.7 million, or 73.1%, increase in gross profit was principally due to our revenue growth from acquisitions entered into during the year.  The decrease in our overall gross profit margin was primarily due to fees incurred to effect competitive pricing actions on various products taken throughout the year and amortization of acquisition related inventory step-up. Additionally, shifts in product mix were also a contributing factor to the overall decrease in gross profit margin. Excluding the fees incurred to effect competitive pricing actions and inventory step-up amortization of $20.8 million experienced during the year gross profit would have been $368.4 million or 57.1% of adjusted net revenues of $645.3 million. The gross profit margin from sales of prescription pharmaceuticals was 49.8% in 2014 compared to 54.0% in 2013.  The decrease in the gross margin percentage was due to fees incurred to effect competitive pricing actions on various products throughout the year and shifts in the product mix to comparatively lower margin products.  The gross profit margin on consumer health sales was 54.5% in 2014 compared to 54.8% in the prior year.  This slight decrease was due to product mix shifts due to acquisitions and mergers consummated throughout the year.

Total operating expenses were $200.9 million in 2014, an increase of $117.2 million, or 140.0%, over the prior year, which was primarily due to the acquisitions entered into during the year and the additional costs associated with the operations of those businesses.
 
Selling, general and administrative (“SG&A”) expenses were $95.5 million in 2014, an increase of $42.0 million, or 78.4%, over the prior year expense of $53.5 million.  The increase included $28.4 million associated with the legacy business, principally the result of the requirement to accommodate the expanded product offering generated by the acquisitions entered into during the year, an increase of $10.4 million in SG&A expenses at Hi-Tech and a $3.2 million increase in SG&A expenses at VersaPharm.  Significant increases in the legacy business SG&A expenses in comparison to the prior year included a $10.8 million increase in wages and related costs and a $7.2 million increase in other SG&A expenses. As a percentage of sales, SG&A expenses declined to 16.1% compared to 16.8% in the prior year.
 
32
 
R&D expenses were $29.2 million in 2014, an increase of $9.3 million or 47.0% over the R&D expense of $19.9 million recorded in the prior year.  This increase was wholly related to the Hi-Tech and VersaPharm acquisitions and mergers consummated in 2014 which included R&D facilities in Copiague, New York and Warminster, Pennsylvania.  The Hi-Tech acquisition accounted for $8.0 million of the increase while the VersaPharm acquisition accounted for the remaining $1.3 million increase.

Amortization of intangibles consists of the amortization of NDA and ANDA drug acquisition costs over the anticipated market lives of the acquired products, as well as the amortization of other intangible assets acquired through business combinations.  Amortization of intangibles was $44.1 million in 2014, compared to $7.4 million in 2013.  This increase of $36.6 million was wholly related to the acquisitions occurring during the year, principally Hi-Tech and VersaPharm.

We recorded $32.1 million of acquisition-related costs during 2014, compared to $2.9 million in 2013.  Of the current year expenses, $21.3 million was related to the Hi-Tech acquisition, $8.1 million was related to the VersaPharm acquisition, and $1.1 million was aggregated from the acquisitions of Betimol®, Zioptan®, Xopenex®, Lloyd’s, and ExcelVision during the year. In the prior year, acquisition-related expenses were primarily related to the Hi-Tech and Merck acquisitions.
 
Amortization of deferred financing costs totaled approximately $12.1 million in 2014, an increase of $11.3 million as compared to the $0.8 million recognized in 2013.  The increase in deferred financing fees expense in the year was wholly the result of the new debt instruments entered into during the year.

Total interest expense was $35.7 million in 2014, compared to $8.6 million in the prior year.  The increase in the year is primarily due to the addition of the Existing Term and Incremental Term loans entered into upon the consummation of the Hi-Tech and VersaPharm acquisitions, respectively. In 2014, we recorded non-cash interest expense of $4.9 million compared to $4.6 million of non-cash interest expense in the prior year.  Our non-cash interest expense was related to the original issue discount on our convertible notes.

We reported a net income of $35.3 million in 2014, or 6.0% of revenues, compared to net income of $52.4 million in 2013, or 16.5% of revenues. The $17.0 million decline in net income was primarily due to fees incurred to effect competitive pricing actions on Clobetasol Propionate and certain other products, increase in amortization of acquired Hi-Tech and VersaPharm intangible assets acquired, increase in acquisition-related costs, the amortization of Hi-Tech and VersaPharm inventory step-up and debt financing cost amortization, which more than offset the positive operating effect of the various acquisitions and our other business growth in the year and the $9.8 million gain from the product divestiture which occurred in the year ended December 31, 2014.

COMPARISON OF YEARS ENDED DECEMBER 31, 2013 AND 2012
 
        Our revenues were $317.7 million in 2013, an increase of $61.6 million, or 24.0%, compared to 2012.  This increase in revenue was primarily from increased sales of new and revived products, defined as products that we began selling during 2012 or 2013, which accounted for approximately $48.5 million of the increase.  Sales of existing products accounted for $12.0 million of the increase, with a $14.7 million increase related to volume gains being partially offset by a $2.7 million decline due to a slight reduction in average sale prices.  Business and product acquisitions accounted for an increase of $1.1 million, as new revenue from products acquired late in 2013 more than offset lower revenue from our subsidiary in India, in part due to weakening of the Indian rupee against the U.S. dollar.

        In terms of reportable segments, 2013 revenues from our Prescription Pharmaceuticals segment were $279.9 million, an increase of $56.0 million, or 25.0%, over the prior year.  This increase was primarily related to sales of new and revived products, with progesterone capsules and Td vaccine accounting for $28.5 million of the increase and the addition of the Merck products increasing revenues by an additional $1.6 million. The remaining fluctuation was related to increased sales of new and revived products which were wholly due to volume increases with overall prices in the segment decreasing slightly in relation to 2012. The Consumer Health segment revenues were $37.8 million, an increase of $5.5 million or 17.1%, over the prior year. The increase was principally the result of increases in OTC product sales of TheraTears® branded products and private label products, which accounted for $4.3 million of the increase, with the remainder resulting from increased sales of vet related products.

        Our 2013 revenues of $317.7 million was net of adjustments totaling $210.9 million for chargebacks and  rebates, administration fees, returns, discounts and allowances, and coupons and advertising.  Chargeback and rebate expense for 2013 was $183.4 million, or 34.7% of gross revenue, compared to $112.2 million, or 29.0% of gross revenue, in 2012.  The $71.2 million increase in chargeback and rebate expense was due to higher gross sales volume and increases in WAC for various products in 2013.  The increase in chargeback and rebate expense as a percentage of gross sales was attributable to an overall increase in the gap between WAC and contract price.  Our products returns provision in 2013 was $5.0 million, or 0.9% of gross sales, compared to $3.8 million, or 1.0% of gross sales, in 2012.  The slight decrease in percentage was due to favorable historical product return trends.
 
33
 
        Our consolidated gross profit for 2013 was $171.9 million, or 54.1% of revenue, compared to $148.7 million, or 58.0% of revenue, in 2012.  This $23.2 million, or 15.6%, increase in gross profit was principally due to our revenue growth from new and revived products.  The decrease in our overall gross profit margin was primarily due to the fact that a significant percentage of our revenue growth was in products that are contract manufactured and which may also involve margin sharing arrangements with development partners.  Pricing pressure for various products was also a contributing factor to the overall decrease in gross profit margin.

        The gross profit from sales of the Prescription Pharmaceuticals segment was $151.2 million or 54.0% in 2013 compared to $129.9 million or 58.0% in 2012.  Our sales growth in this segment was heavily weighted toward products that are manufactured by third parties and have profit sharing arrangements, resulting in a decrease in the overall gross profit margin of the segment.  Pricing pressures on certain existing products also contributed to the margin contraction.  The gross profit on Consumer Health segment sales was $20.7 million or 54.8% in 2013 compared to $18.8 million or 58.3% in the prior year.  This decrease in the gross profit margin was principally due to pricing pressure on certain products.

        Total operating expenses were $83.7 million in 2013, an increase of $3.8 million, or 4.7%, over the prior year.  Increases in SG&A expenses, R&D expenses and amortization of intangibles were partially offset by a decline in acquisition-related expenses.

SG&A expenses were $53.5 million in 2013, an increase of $5.4 million, or 11.4%, over the prior year expense of $48.1 million.  The $5.4 million increase included a $1.5 million increase related to expanding our sales force, an increase of $1.0 million in FDA fees and a $1.0 million increase in legal costs, including settlements.  As a percentage of sales, SG&A expenses declined to 16.8% compared to 18.8%, evidence of an improved leveraging of sales.

        R&D expenses were $19.9 million in 2013, an increase of $4.0 million over the R&D expense of $15.9 million recorded in the prior year.  This increase was related to the continued growth in our investment in R&D.  Among the largest components of the increase in expenses were a $1.0 million increase in R&D exhibit batch expenses and a $0.7 million increase in FDA fees.

        Amortization of intangibles consists of the amortization of NDA and ANDA drug acquisition costs over the anticipated market lives of the acquired products, as well as the amortization of other intangible assets acquired through business combinations.  Amortization of intangibles was $7.4 million in 2013 compared to $6.9 million in 2012.  This increase of $0.5 million was primarily related to the fourth quarter acquisition of three ophthalmic products from Merck.

We recorded $2.9 million of acquisition-related costs during 2013, compared to $9.2 million in 2012.  Of the current year expenses, $1.7 million was related to the Hi-Tech acquisition, $0.5 million was related to milestone achievement payments to the former owners of the business we acquired from Kilitch Drugs (India) Limited, and $0.7 million was related to the Merck Product Acquisition and other acquisition activities.  In the prior year, acquisition-related expenses were exclusively related to the Kilitch acquisition.
 
Amortization of deferred financing costs totaled approximately $0.8 million in both 2013 and 2012.  The expense in each year was related to amortizing the deferred financing costs related to our Notes and our BoA Facility.

        Total interest expense was $8.6 million in 2013, compared to $10.4 million in the prior year.  In 2013, we recorded non-cash interest expense of $4.6 million compared to $6.4 million of non-cash interest in the prior year.  Our non-cash interest expense was related to the debt discount on our Notes and to the change in fair value of our additional consideration of $15 million payable to Lundbeck A/S in December 2014 related to our acquisition of various injectable products in December 2011.  The year to year decline was primarily related to a decrease in interest accrued on the Lundbeck additional consideration.  Our net cash interest expense in each year principally consisted of interest payable on the Notes.

        In the fourth quarter of 2013, we recorded a $3.7 million gain from our “bargain purchase” of three ophthalmic products from Merck.  The bargain purchase was largely derived from the excess of the fair value of acquired net deferred tax assets over their economic value as calculated by discounting their future cash flows.  We also recognized income of $0.2 million in relation to foreign currency forward contracts designed to hedge future capital expenditures at AIPL against strengthening of the Indian rupee against the U.S. dollar.
 
FINANCIAL CONDITION AND LIQUIDITY

Cash Flow
 
34
 
As of December 31, 2014, we had cash and cash equivalents of $70.7 million, which is $36.5 million higher than our cash and cash equivalents balance of $34.2 million as of December 31, 2013.  This increase in cash and cash equivalents was primarily related to positive operating cash flows for the year of $30.9 million and positive financing cash flows of $972.3 million resulting from the loans entered into during the year to finance the Hi-Tech and VersaPharm acquisitions, partially offset by investing cash outflows of $966.5 million relating to payments for the Hi-Tech and VersaPharm acquisitions, and other smaller acquisitions completed during the year and the effect of exchange rates on cash and cash equivalents of $0.2 million.  Our net working capital was $360.2 million at December 31, 2014, compared to $107.6 million at December 31, 2013, an increase of $252.6 million.

During 2014, we generated $30.9 million in cash flow from operations.  This positive operating cash flow was primarily the result of depreciation and amortization add-backs of $58.5 million, our net income of $35.3 million, a $25.3 million increase related to deferred tax assets, net, an increase in accrued expenses and other liabilities of $26.3 million, an add-back of amortization of inventory step-up acquired throughout the year of $20.8 million, an add-back of deferred financing costs of $12.1 million, and other aggregating operating cash inflows of $25.0 million,  partially offset by a $95.5 million increase in accounts receivable primarily due to a steep increase in revenues in the fourth quarter of 2014, $38.7 million related to excess tax benefits from stock compensation, a $15.3 million increase in ending inventories, and other aggregating operating cash outflows of $23.0 million.  In 2013, we generated $57.3 million in cash flow from operations.  This positive operating cash flow was primarily the result of our net income of $52.4 million and non-cash expenses of $19.2 million, partially offset by a $14.3 million increase in accounts receivable and a $3.8 million increase in inventory.
 
In 2014, we used $966.5 million of cash in investing activities.  Of this total, $910.6 million was used for the acquisition of Hi-Tech and VersaPharm, while $85.7 million was used for other product acquisitions, including $41.5 million used to acquire the Xopenex® products, and $44.3 million used to acquire other products including Zioptan®, Betimol® Lloyd’s products and others. Additionally, $29.6 million was used to acquire property, plant and equipment.  These uses of cash were partially offset by $59.4 million received in proceeds related to the disposition of assets sold during the year. In the prior year, we used $66.9 million cash in investing activities.  Of this total, $55.5 million was used for product acquisitions, including $52.8 million used to acquire three branded ophthalmic products from Merck, and $11.6 million was used to acquire property, plant and equipment.  These uses of cash were partially offset by $0.2 million received in distribution from our non-consolidated Akorn-Strides, LLC (the “Joint Venture Company”).

Financing activities generated $972.3 million in cash during 2014, which included $1,045.0 million generated from proceeds under borrowing arrangements related to the Hi-Tech and VersaPharm acquisitions and $55.7 million generated from stock option and warrant exercises, participation in the employee stock purchase plan (“ESPP”) and excess tax benefits from stock compensation, partially offset by $85.0 million in debt repayment related to existing VersaPharm debt acquired, $28.4 million in deferred financing costs paid during the year and $15.0 million related to the payment of contingent liabilities.   During 2013, we generated $3.1 million in cash, which included $6.1 million generated from stock option exercises and participation in the ESPP, partially offset by $3.0 million in debt financing costs.
 
Liquidity and Capital Needs
 
We require certain capital resources in order to maintain and expand our business.  Our future capital expenditures may include substantial projects undertaken to upgrade, expand and improve our manufacturing facilities, both in the U.S. and India.  Our cash obligations include the principal and interest payments due on our Existing Term Loan and Incremental Term Loans (as defined below and described throughout this report) and $87.5 million of the Notes due 2016, plus any amount we may borrow under the JPMorgan Facility. We believe that our cash reserves, operating cash flows, and availability under our credit facilities will be sufficient to finance any future expansions and meet our cash needs for the foreseeable future.
 
We continue to evaluate opportunities to grow and expand our business through the acquisition of new businesses, manufacturing facilities, or pharmaceutical product rights.  Such acquisitions may require us to obtain additional sources of capital.  We cannot predict the amount of capital that may be required to complete such acquisitions, and there is no assurance that sufficient financing for these activities would be available on terms acceptable to us, if at all.

Incremental Term Loan

Concurrent with the closing of its acquisition of VersaPharm, Akorn, Inc. and its wholly owned domestic subsidiaries (the “Akorn Loan Parties”) entered into a $445.0 million Incremental Facility Joinder Agreement (the “Incremental Term Loan Facility”) pursuant to a Loan Agreement (the “Incremental Term Loan Agreement”) dated August 12, 2014 between the Akorn Loan Parties as borrowers, certain other lenders, with JPMorgan Chase Bank, N.A. (“JPMorgan”), acting as administrative agent. The proceeds received pursuant to the Incremental Term Loan Agreement were used to finance the VersaPharm Acquisition, as further described below in Note 16, Business Combinations, Dispositions and Other Strategic Investments.
 
35
 
The Incremental Term Loan Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement.

The Incremental Term Loan Facility requires quarterly principal repayment equal to 0.25% of the initial loan amount of $445.0 million beginning with the first full quarter following the closing date of the Incremental Term Loan Agreement, with a final payment of the remaining principal balance due at maturity seven (7) years from the date of closing of the Existing Term Loan Agreement. The Company may prepay all or a portion of the remaining outstanding principal amount under the Incremental Term Loan Agreement at any time, or from time to time, subject to prior notice requirement to the lenders and payment of applicable fees. Prepayment of principal will be required should the Company incur any indebtedness not permitted under the Incremental Term Loan Agreement, or effect the sale, transfer or disposition of any property or asset, other than in the ordinary course of business. To the extent the Incremental Term Loan Facility is refinanced within the first six (6) months of closing, a 1.00% prepayment fee will be due. As of December 31, 2014 outstanding debt under the Incremental Term Loan Facility was $443.9 million and the Company was in full compliance with all applicable covenants which included customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities.

Interest accrues based, at the Company’s election, on an adjusted prime/federal funds rate (“ABR Loan”) or an adjusted LIBOR (“Eurodollar Loan”) rate, plus a margin of 2.50% for ABR Loans, and 3.50% for Eurodollar Loans. Each such margin will decrease by 0.25% in the event the Company’s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. During an event of default, as defined in the Existing Term Loan Agreement, any interest rate will be increased by 2.00% per annum. Per the Existing Term Loan Agreement, the interest rate on LIBOR loans cannot fall below 4.50%.

Existing Term Loan

Concurrent with the closing of its acquisition of Hi-Tech the Akorn Loan Parties entered into a $600.0 million Term Facility (the “Existing Term Facility”) pursuant to a Loan Agreement dated April 17, 2014 (the “Existing Term Loan Agreement”) between the Akorn Loan Parties as borrowers, certain other lenders, with JPMorgan, acting as administrative agent. The Company may increase the loan amount up to an additional $150.0 million, or more, provided certain financial covenants and other conditions are satisfied. The proceeds received pursuant to the Existing Term Loan Agreement were used to finance the Hi-Tech Acquisition, as further described below in “Note 16 - Business Combinations, Dispositions and Other Strategic Investments.”

The Existing Term Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement.

The Existing Term Loan Agreement requires quarterly principal repayment equal to 0.25% of the initial loan amount of $600.0 million beginning with the second full quarter following the closing date of the Existing Term Loan Agreement, with a final payment of the remaining principal balance due at maturity seven (7) years from the date of closing of the Existing Term Loan Agreement. The Company may prepay all or a portion of the remaining outstanding principal amount under the Existing Term Loan Agreement at any time, or from time to time, subject to prior notice requirement to the lenders and payment of applicable fees. Prepayment of principal will be required should the Company incur any indebtedness not permitted under the Existing Term Loan Agreement, or effect the sale, transfer or disposition of any property or asset, other than in the ordinary course of business. As of December 31, 2014, outstanding debt under the term loan facility was $598.5 million and the Company was in full compliance with all applicable covenants which included customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities.

Interest accrues based, at the Company’s election, on an adjusted prime/federal funds rate or an adjusted LIBOR rate, plus a margin of 2.50% for ABR Loans, and 3.50% for Eurodollar Loans. Each such margin will decrease by 0.25% in the event Akorn’s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. During an event of default, as defined in the Existing Term Loan Agreement, any interest rate will be increased by 2.00% per annum. Per the Existing Term Loan Agreement, the interest rate on LIBOR loans cannot fall below 4.50%.

Convertible Notes
 
On June 1, 2011, the Company completed an offering of $120.0 million aggregate principal amount of 3.50% Convertible Senior Notes due 2016, which includes $20.0 million of Notes issued in connection with the full exercise by the initial purchasers of their over-allotment option. The Notes are governed by our indenture (the “Indenture”) with Wells Fargo Bank, National Association serving as trustee.  The Notes were offered and sold only to qualified institutional buyers.  The net proceeds from the sale of the Notes were approximately $115.3 million, after deducting underwriting fees and other related expenses.
 
 
36
 
The Notes have a maturity date of June 1, 2016 and pay interest at an annual rate of 3.50% semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2011.  The Notes are convertible into our common stock, cash or a combination thereof at an initial conversion price of $8.76 per share, which is equivalent to an initial conversion rate of approximately 114.1553 shares per $1,000 principal amount of Notes.  The conversion price is subject to adjustment for certain events described in the Indenture, including certain corporate transactions which will increase the conversion rate and decrease the conversion price for a holder that elects to convert its Notes in connection with such corporate transaction. The conversion price has not been adjusted as of the date of this Form 10-K.
 
The Notes may be converted at any time prior to the close of business on the business day immediately preceding December 1, 2015 only  under the following circumstances:  (1) during any calendar quarter commencing after September 30, 2011, if the closing sale price of our common stock, for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the calendar quarter immediately preceding the calendar quarter in which the conversion occurs, is more than 130% of the conversion price in effect on each applicable trading day; (2) during the five consecutive trading-day period following any five consecutive trading-day period in which the trading price for the Notes per $1,000 principal amount of Notes for each such trading day was less than 98% of the closing sale price of our common stock on such date multiplied by the then-current conversion rate; or (3) upon the occurrence of specified corporate events.  On or after December 1, 2015 until the close of business on the business day immediately preceding the stated maturity date, holders may surrender all or any portion of their Notes for conversion at any time, regardless of the foregoing circumstances. Upon conversion, we will pay or deliver, at our option, cash, shares of our common stock, or a combination thereof.  We may not redeem the Notes prior to the maturity date.  If a fundamental change (as defined in the Indenture) occurs prior to the stated maturity date, holders may require us to purchase for cash all or a portion of their Notes. The Notes became convertible for the second quarter of 2012 as a result of the Company’s stock trading at or above the required price of $11.39 per share for 20 of the last 30 trading days in the quarter ended March 31, 2012.  The Notes have remained convertible for each successive quarter as a result of meeting the trading price requirement at the end of each prior quarter. During the year ended December 31, 2014, approximately $32.5 million of this convertible debt was converted at the holder’s request which resulted in an additional $1.0 million of expense recognized due to the conversions.

The Company recorded the following expenses in relation to the Notes during the years ended December 31, 2014, 2013 and 2012 (in thousands):

   
2014
    
2013
    
2012
  
Interest expense at 3.50% coupon rate
   $
4,105
     $ 4,200     $ 4,200  
Debt discount amortization
     4,317       4,113       3,828  
Deferred financing cost amortization
     780       744       692  
Loss on conversion
     990       —       —  
    $
10,192
     $ 9,057     $ 8,720  

Credit Facilities:

JPMorgan Credit Facility

On April 17, 2014, the Akorn Loan Parties entered into a Credit Agreement (the “JPM Credit Agreement”) with JPMorgan acting as administrative agent, and Bank of America, N.A., as syndication agent for certain other lenders (at closing, Bank of America, N.A. and Wells Fargo Bank, N. A.) for a $150.0 million revolving credit facility (the “JPM Revolving Facility”). Upon entering into the JPM Credit Agreement, the Company terminated its prior $60.0 million revolving credit facility with Bank of America, N.A., as further described below.

Subject to other conditions in the JPM Credit Agreement, advances under the JPM Revolving Facility will be made in accordance with a borrowing base consisting of the sum of the following:
(a)
85% of eligible accounts receivable;
(b)
The lesser of:

 
a.
65% of the lower of cost or market value of eligible raw materials and work in process inventory, valued on a first in first out basis, and
 
b.
85% of the orderly liquidation value of eligible raw materials and work in process inventory, valued on a first in first out basis;

(c)
The lesser of:
 
a.
75% of the lower of cost or market value of eligible finished goods inventory, valued on a first in first out basis, and

 
b.
85% of the orderly liquidation value of eligible finished goods inventory, valued on a first in first out basis up to 85% of the liquidation value of eligible inventory (or 75% of market value finished goods inventory); and
(d)
Less any reserves deemed necessary by the administrative agent, and allowed in its permitted discretion.
 
 
37
 
The total amount available under the JPM Revolving Facility includes a $10.0 million letter of credit facility.

Under the terms of the JPM Credit Agreement, if availability under the JPM Revolving Facility falls below 12.5% of commitments or $15.0 million for more than 30 consecutive days, the Company may be subject to cash dominion, additional reporting requirements, and additional covenants and restrictions. The Company may seek additional commitments to increase the maximum amount of the JPM Revolving Facility to $200.0 million.

Unless cash dominion is exercised by the lenders in connection with the JPM Revolving Facility, the Company will be required to repay the JPM Revolving Facility upon its expiration five years from issuance, subject to permitted extension, and will pay monthly interest on the outstanding balance based, at the Company’s election, on an adjusted prime/federal funds rate (“ABR”) or an adjusted LIBOR (“Eurodollar”), plus a margin determined in accordance with the Company’s consolidated fixed charge coverage ratio (EBITDA to fixed charges) as follows:

Fixed Charge Coverage Ratio
Revolver ABR Spread
Revolver Eurodollar Spread
Category 1 > 1.50 to 1.0
0.50%
1.50%
Category 2 > 1.25 to 1.00 but < 1.50 to 1.00
0.75%
1.75%
Category 3 < 1.25 to 1.00
1.00%
2.00%

In addition to interest on borrowings, the Company will pay an unused line fee of 0.25% per annum on the unused portion of the JPM Revolving Facility.

During an event of default, as defined in the JPM Credit Agreement, any interest rate will be increased by 2.0% per annum.

The JPM Revolving Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement. The financial covenants require the Akorn Loan Parties to maintain the following on a consolidated basis:

 
(a)
Minimum Liquidity, as defined in the JPM Credit Agreement, of not less than (a) $120.0 million plus (b) 25% of the JPM Revolving Facility commitments during the three month period preceding the June 1, 2016 maturity date of the Company’s $120.0 million of senior convertible notes; and
 

 
(b)
Ratio of EBITDA to fixed charges of no less than 1.00 to 1.00 (measured quarterly for the trailing 4 quarters).
 
The Company may use any proceeds from borrowings under the JPM Revolving Facility for working capital needs and for the general corporate purposes of the Company and its subsidiaries, and to otherwise replace letters of credit that were outstanding upon the termination of the Company’s prior revolving credit facility with Bank of America, N.A. At December 31, 2014, there were no outstanding borrowings and one outstanding letter of credit in the amount of approximately $1.2 million under the JPM Revolving Facility. Availability under the facility as of December 31, 2014 was approximately $148.8 million.

The JPM Credit Agreement places customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities of the Akorn Loan Parties in a manner designed to protect the collateral while providing flexibility for growth and the continuation of the historic business activities of the Company and its subsidiaries. The Company was in full compliance with these financial covenants as of December 31, 2014.

Bank of America Credit Facility

On October 7, 2011, the Company and its domestic subsidiaries (the “Borrowers”) entered into a Loan and Security Agreement (the “BoA Credit Agreement”) with Bank of America, N.A. (the “Agent”) and other financial institutions (collectively with the Agent, the “BoA Lenders”) through which we obtained a $20.0 million revolving line of credit (the “BoA Facility”), which included a $2.0 million letter of credit facility.  On October 4, 2013, the parties entered into an amendment increasing the total loan commitment under the revolving credit agreement to $60.0 million.  The BoA Facility was scheduled to mature in March 2016.  We were permitted to early terminate the BoA Lenders’ commitments under the BoA Facility upon 90 days’ notice to the Agent at any time after the first year.
   
On April 17, 2014, concurrent with the Company entering into the JPM Credit Agreement, the Company and the Agent agreed to early terminate the BoA Credit Agreement, without penalty.
 
38
 
Warrants

Kapoor Warrants

During 2009, we granted various warrants to acquire our common stock (the “Kapoor Warrants”) to EJ Funds, LP (“EJ Funds”) and the Kapoor Trust, companies controlled by the Chairman of our Board of Directors, Dr. John N. Kapoor.  These warrants were issued in relation to the modification to various financing and other agreements, including the GE/EJ Credit Agreement, whereby our Chairman, through entities he controls, provided financing to the Company in its time of need.  Each of the Kapoor Warrants was scheduled to expire five years after its grant date.

On June 28, 2010, we entered into an Amended and Restated Registration Rights Agreement (the “Amended Agreement”) with Dr. Kapoor which modified certain terms related to our obligation to obtain and maintain registration of any shares issued pursuant to exercise of the Kapoor Warrants.  The Amended Agreement still requires us to use “commercially reasonable efforts” to file a registration statement pursuant to Rule 415 of the Securities Act of 1933 (“Registration Statement”) for any shares of common stock that may be issued under the applicable warrant agreements, and to maintain the continuous effectiveness of such Registration Statement.  However, the Registration Rights Agreement was amended to explicitly provide that in the event that we, after using good faith commercially reasonable efforts, are not able to obtain or maintain registration of the common stock, delivery of unregistered shares upon exercise of the Kapoor Warrants will be deemed acceptable and a net cash settlement will not be required.

On June 28, 2010, upon entering into the Amended Agreement, we completed a final Black-Scholes calculation of the fair value of the Kapoor Warrants and adjusted their book value accordingly, then reclassified the Kapoor Warrants from a current liability to a component of shareholders’ equity.  After reclassifying the Kapoor Warrants to shareholders’ equity, no subsequent fair value adjustments were required.
 
The following table provides summarized information about the Kapoor Warrants as of December 31, 2013:

 
Granted To:
 
Grant Date
  
Warrants Granted
    
Exercise Price
    
Book Value ($000s)
  
                     
EJ Funds
Apr.13, 2009
     1,939,639     $ 1.11     $ 4,829  
Kapoor Trust
Apr.13, 2009
     1,501,933     $ 1.11       3,740  
EJ Funds
Aug.17, 2009
     1,650,806     $ 1.16       4,127  
Kapoor Trust
Aug.17, 2009
     2,099,935     $ 1.16       5,250  
        7,192,313             $ 17,946  
 
On April 10, 2014, the holder exercised all of his 7.2 million outstanding stock warrants. The Company received cash proceeds of approximately $8.2 million from the warrant exercise during the year ended December 31, 2014.

CONTRACTUAL OBLIGATIONS

     In order to support the continued increase in the number of relevant and marketable pharmaceutical products that we market and sell, we will from time to time partner with outside firms for the development of selected products.  These development agreements frequently call for the payment of “milestone payments” as various steps in the process are completed in relation to product development and submission to the FDA for approval.  The dollar amount of these payments is generally fixed contractually, assuming that the required milestones are achieved.  However, the timing of such payments is contingent based on a variety of factors and is therefore subject to change.  The amounts disclosed in the below table under the caption “Strategic Partners – Contingent Payments” represents our best estimate of the amount and expected timing of the “milestone payments” and other fees we expect to pay to outside development partners based on our current contractual agreements with them.  These milestone payments are accrued as liabilities on our balance sheets once the milestones have been achieved.

On January 2, 2014 the Company acquired the U.S. NDA rights to Betimol® from Santen. The total consideration payable will equal 1.5 times the Company’s net sales of Betimol® in the first year following acquisition. The Company paid consideration of $7.5 million upon closing this transaction and expects to owe additional contingent consideration to Santen in the quarter ended March 31, 2015. This liability was initially recorded on our books at the discounted value of $4.0 million, which considers both the time value of money and the slight possibility that less than the full amount will ultimately become due. At December 31, 2014 the liability was $4.3 million.

As more fully described under “Item 2 – Properties”, we lease the facilities that we occupy in Marietta, Georgia; Gurnee, Illinois, Lake Forest, Illinois and Vernon Hills, Illinois, as well as in Ann Arbor, Michigan, Somerset, New Jersey, and Warminster, Pennsylvania.  We also lease various pieces of office equipment at these facilities, as well as at our manufacturing facilities in Decatur, Illinois and Amityville, New York.  Our remaining obligations under these leases are summarized in the table below.
 
39
 
As of December 31, 2014, our principal outstanding debt obligation was related to our Existing and Incremental term loans and our convertible notes.  We had no outstanding loans under our JPM Credit Agreement at December 31, 2014, or any time since we entered into this agreement on April 17, 2014.

The following table details our future contractual obligations as of December 31, 2014 (in thousands):

Description 
  
Total
    
2015
    
2016
    
2017
    
2018
    
2019
    
2020 and
beyond
  
4.5% Existing term loan due 2021
   $ 598,500     $ 6,000     $ 6,000     $ 6,000     $ 6,000     $ 6,000     $ 568,500  
Interest Payable – 4.5% existing term loan 2
     166,709       27,203       27,004       26,656       26,382       26,108       33,356  
4.5% Incremental term loan due 2021
     443,888       4,450       4,450       4,450       4,450       4,450       421,638  
Interest Payable – 4.5% Incremental term loan 2
     123,644       20,176       20,028       19,770       19,567       19,364       24,739  
3.5% convertible senior notes due 2016
     87,525       —       87,525       —       —       —       —  
Interest payable – 3.5% convertible notes
     4,595       3,063       1,532       —       —       —       —  
Contingent consideration – acquisitions
     7,613       7,481       132       —       —       —       —  
Inventory purchase commitments
     6,664       6,664       —       —       —       —       —  
Leases
    
11,140
      
2,806
      
2,836
      
2,579
      
873
      
494
      
1,553
  
Strategic partners – contingent payments 1
     19,389       12,916       3,250       3,202       21       —       —  
Total:
   $
1,469,667
     $
90,759
     $
152,757
     $
62,657
     $
57,293
     $
56,416
     $
1,049,786
  
 
1  
Note the strategic partner payments include our best estimates regarding if and when various contingencies and market opportunities will occur in 2015 and beyond
 
2  
Interest on borrowings under these facilities are variable as calculated at our election, on an ABR rate or an adjusted LIBOR rate, plus a margin of 2.50% for ABR loans, and 3.50% for LIBOR loans with a minimum rate of 4.5%. The calculated interest payable amounts above assume the minimum rate of 4.5% across the term of the associated loan.

OFF BALANCE SHEET ARRANGEMENTS

        We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our shareholders.

CRITICAL ACCOUNTING POLICIES
 
Our significant accounting policies are described in Note 2 to Consolidated Financial Statements and are in accordance with U.S. GAAP.

Revenue Recognition

Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. Revenue from product sales are recognized when title and risk of loss have passed to the customer.

Provision for estimated chargebacks, rebates, discounts, managed care rebates, product returns and doubtful accounts is made at the time of sale and is analyzed and adjusted, if necessary, at each balance sheet date.

Allowance for Chargebacks and Rebates

We enter into contractual agreements with certain third parties such as hospitals, group-purchasing and managed care organizations to sell certain products at predetermined prices. The parties have elected to have these contracts administered through wholesalers that buy the product from the Company and subsequently sell it to these third parties. When a wholesaler sells products to one of these third parties that are subject to a contractual price agreement, the difference between the price paid to the Company by the wholesaler and the price under the specific contract is charged back to the Company by the wholesaler. The Company tracks sales and submitted chargebacks by product number and contract for each wholesaler. Utilizing this information, the Company estimates a chargeback percentage for each product and records an allowance as a reduction to gross sales when the Company records its sale of the products. The Company reduces the chargeback allowance when a chargeback request from a wholesaler is processed. Actual chargebacks processed by the Company can vary materially from period to period based upon actual sales volume through the wholesalers. However, the Company’s provision for chargebacks is fully reserved for at the time when sales revenues are recognized.

Management obtains certain wholesaler inventory reports to aid in analyzing the reasonableness of the chargeback allowance. The Company assesses the reasonableness of its chargeback allowance by applying the product chargeback percentage based on historical activity to the quantities of inventory on hand at the wholesaler per the wholesaler inventory reports. In accordance with its accounting policy, the Company estimates the percentage amount of wholesaler inventory that will ultimately be sold to third parties that are subject to contractual price agreements based on a trend of such sales through wholesalers. The Company uses this percentage estimate until historical trends indicate that a revision should be made. On an ongoing basis, the Company evaluates its actual chargeback rate experience, and new trends are factored into its estimates each quarter as market conditions change.
 
40
 
Similarly, we maintain an allowance for rebates related to fee for service contracts and other programs with certain customers. Rebate percentages vary by product and by volume purchased by each eligible customer. We track sales by product number for each eligible customer and then apply the applicable rebate percentage, using both historical trends and actual experience to estimate our rebate allowance. We reduce gross sales and increase the rebate allowance by the estimated rebate amount when we sell our products to our rebate-eligible customers. We reduce the rebate allowance when we process a customer request for a rebate. At each balance sheet date, we analyze the allowance for rebates against actual rebates processed and make necessary adjustments as appropriate. Actual rebates processed can vary materially from period to period. However, our provision for rebates is fully reserved for at the time when sales revenues are recognized.

The recorded allowances reflect our current estimate of the future chargeback and rebate liability to be paid or credited to our wholesaler and other customers under the various contracts and programs. For the years ended December 31, 2014, 2013 and 2012, we recorded chargeback and rebate expense of $739.8 million, $183.4 million and $112.2 million, respectively. The allowances for chargebacks and rebates were $155.3 million and $12.9 million as of December 31, 2014 and 2013, respectively.  The current year increase in our allowance for chargebacks and rebates was primarily due to the merger and acquisitions and the effects of significant pricing increases on certain products occurring throughout the year ended December 31, 2014.

Allowance for Product Returns

Certain of the Company’s products are sold with the customer having the right to return the product within specified periods and guidelines for a variety of reasons, including but not limited to, pending expiration dates. Provisions are made at the time of sale based upon tracked historical experience. Historical factors such as one-time events as well as pending new developments that would impact the expected level of returns are taken into account to determine the appropriate reserve estimate at each balance sheet date. As part of the evaluation of the balance required, the Company considers actual returns to date that are in process, the expected impact of any product recalls and the wholesaler’s inventory information to assess the magnitude of unconsumed product that may result in sales returns to the Company in the future. The sales returns level can be impacted by factors such as overall market demand and market competition and availability for substitute products which can increase or decrease the end-user pull through for sales of the Company’s products and ultimately impact the level of sales returns. Actual returns experience and trends are factored into the Company’s estimates each quarter as market conditions change. Actual returns processed can vary materially from period to period.

For the years ended December 31, 2014, 2013 and 2012, we recorded a net provision for product returns of $20.0 million, $5.0 million and $3.8 million, respectively.  The year-over-year increases in the product returns provision was related to our increase in sales in the applicable periods, principally as a result of the Hi-Tech and VersaPharm acquisitions during the year ended December 31, 2014.  As of December 31, 2014 and 2013, our allowances for product returns were $44.6 million and $8.2 million, respectively.

Allowance for Coupons, Promotions and Co-Pay discount cards:

        We issue coupons from time to time that are redeemable against certain of our Consumer Health products. Upon release of coupons into the market, the Company records an estimate of the dollar value of coupons expected to be redeemed. This estimate is based on historical experience and is adjusted as needed based on actual redemptions. In addition to couponing, from time to time the Company authorizes various retailers to run in-store promotional sales of its products. Upon receiving confirmation that a promotion was run, the Company accrues an estimate of the dollar amount expected to be owed back to the retailer. This estimate is trued up to actual upon receipt of the invoice from the retailer. Additionally, the Company provides consumer co-pay discount cards for certain of its branded ophthalmic products, administered through outside agents to provide discounted products when redeemed. Upon release of the cards into the market, the Company records an estimate of the dollar value of co-pay discounts expected to be utilized. This estimate is based on historical experience and is adjusted as needed based on actual usage.

        For the years ended December, 31, 2014, 2013 and 2012, we recorded provisions for coupons, promotions and co-pay discount cards totaling $7.7 million, $4.5 million and $3.0 million, respectively.  As of December 31, 2014 and 2013, the balance in our reserve for coupons, promotions and co-pay discount cards was $1.2 million and $0.5 million, respectively.
 
Allowance for Doubtful Accounts

Provisions for doubtful accounts, which reflect trade receivable balances owed to us that are believed to be uncollectible, are recorded as a component of SG&A expenses. In estimating the allowance for doubtful accounts, we consider our historical experience with collections and write-offs, the credit quality of our customers and any recent or anticipated changes thereto, and the outstanding balances and past due amounts from our customers.
 
41
 

On a monthly basis, we perform a detailed analysis of the receivables due from our wholesaler customers and provide a specific reserve against known uncollectible items for each of the wholesaler customers. We also include in the allowance for doubtful accounts an amount that we estimate to be uncollectible for all other customers based on a percentage of the past due receivables. The percentage we reserve increases as the age of the receivables increases.

For the year ended December 31, 2014 our net provision for doubtful accounts was $0.3 million, while in the years ended December 2013 and 2012, our net provisions for doubtful accounts were insignificant, equaling less than $0.1 million in each year.  As of December 31, 2014, we had $62.4 million of gross accounts receivable that was past due as a result of the cyclical timing of payments received from customers, of which $3.7 million was past due for greater than 60 days.

Allowance for Slow-Moving and Obsolete Inventory

Inventories are stated at the lower of cost (average cost method) or market. We maintain an allowance for slow-moving and obsolete inventory as well as inventory where the cost is in excess of its net realizable value (“NRV”).  For finished goods inventory, the Company estimates the amount of inventory that may not be sold prior to its expiration or is slow moving based upon review of recent sales activity and wholesaler inventory information. The Company also analyzes its raw material and component inventory for slow moving items/NRV.  For the years ended December 31, 2014, 2013 and 2012, we recorded a total provision for inventory obsolescence/NRV in cost of sales of $12.3 million, $2.1 million, and $2.4 million, respectively. The total allowance for inventory obsolescence/NRV was $21.2 million and $5.7 million as of December 31, 2014 and 2013, respectively.

We capitalize inventory costs associated with our products prior to regulatory approval when, based on management judgment, future commercialization is considered probable and future economic benefit is expected to be realized. The Company assesses the regulatory approval process and where the product stands in relation to that approval process including any known constraints or impediments to approval. The Company also considers the shelf life of the product in relation to the product timeline for approval.

Business Combinations
 
        Business combinations are accounted for under ASC 805, Business Combinations, using the acquisition method of accounting. The acquisition method of accounting requires an acquirer to recognize the assets acquired and the liabilities assumed at the acquisition date measured at their fair values as of that date.  Fair value determinations are based on discounted cash flow analyses or other valuation techniques.  In determining the fair value of the assets acquired and liabilities assumed in a material acquisition, we may utilize appraisals from third party valuation firms to determine fair values of some or all of the assets acquired and liabilities assumed, or may complete some or all of the valuations internally.  In either case, we take full responsibility for the determination of the fair value of the assets acquired and liabilities assumed.  The value of goodwill will be determined as the excess of the fair value of the consideration conveyed to the seller over the fair value of the net assets received.  Under the acquisition method of accounting, we will identify the acquirer and the closing date and apply applicable recognition principles and conditions.
 
        Acquisition-related costs are costs incurred by us to effect a business combination. We account for acquisition-related costs as expenses in the periods in which the costs are incurred and the services are received.  During the years ended December 31, 2014, 2013 and 2012, we recorded acquisition-related costs of $32.1 million, $2.9 million and $9.2 million, respectively. Acquisition costs in 2014 were primarily related to change-in-control fees, merger and acquisition advisor fees, severance and other costs necessary to realize synergies.
 
Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the tax effects of temporary differences between the financial reporting and tax bases of assets and liabilities, and net operating loss and other tax credit carry-forwards. These items are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce the recognized deferred tax assets to the amount that is more likely than not to be realized.

Intangible Assets

Our intangible assets consist primarily of goodwill, which is carried at initial value and subject to evaluation for impairment, in-process research and development, which is accounted for as an indefinite-lived intangible asset, subject to impairment testing until completion or abandonment of the project, and product licensing costs, trademarks and other such costs, which are capitalized and amortized on a straight-line basis over their useful lives, ranging from one year to thirty years. The Company regularly assesses its intangible assets for impairment based on several factors, including estimated fair value and anticipated cash flows. If the Company incurs additional costs to renew or extend the life of an intangible asset, such costs are added to the remaining unamortized cost of the asset, if any, and the sum is amortized over the extended remaining life of the asset.
 
42
 

We recorded amortization expense of $44.1 million, $7.4 million, and $6.9 million for the years ended December 31, 2014, 2013 and 2012, respectively, in relation to our intangible assets.  Accumulated amortization was $82.2 million and $39.1 million at December 31, 2014 and 2013, respectively.
 
Goodwill is tested for impairment annually or more frequently if changes in circumstances or the occurrence of events suggest that impairment may exist. The Company uses widely accepted valuation techniques to determine the fair value of its reporting units used in its annual goodwill impairment analysis. The Company’s valuation is primarily based on qualitative and quantitative assessments regarding the fair value of the reporting unit relative to its carrying value. We model the fair value of the reporting unit based on actual projected earnings and cash flows of the reporting unit. The goodwill of our Prescription Pharmaceuticals reporting unit and reportable segment relates to the Hi-Tech, VersaPharm and Kilitch Drugs (India) Limited acquisitions.  We performed a qualitative “step-zero” assessment of the goodwill of the Prescription Pharmaceuticals reporting unit goodwill as of October 1, 2014 and determined that the fair value of this operating segment exceeded its carrying value and, therefore, concluded that there was no impairment. The goodwill of our Consumer Health segment relates to our acquisitions of Hi-Tech and Advanced Vision Research, Inc. We conducted a qualitative “step-zero” assessment of the goodwill of our Consumer Health reporting unit on October 1, 2014 and determined that the fair value of this operating segment exceeded its carrying value and, therefore, concluded that there was no impairment.

Stock-Based Compensation

Stock-based compensation cost is estimated at grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions to be used in the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its common stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. treasury securities of similar term in effect during the quarter in which the options were granted. The dividend yield reflects the Company’s historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises the estimate in subsequent periods, if necessary, if actual forfeitures differ from initial estimates.

RECENT ACCOUNTING PRONOUNCEMENTS

       In August 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-15 “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”), to provide guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for us in our fourth quarter of fiscal 2016 with early adoption permitted. The adoption of ASU 2014-15 is not expected to have a material effect on the Company’s consolidated financial statements or disclosures.
 
In May 2014, FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which provides guidance for revenue recognition. ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. This ASU also supersedes some cost guidance included in Subtopic 605-35, “Revenue Recognition-Construction-Type and Production-Type Contracts.” The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which a company expects to be entitled in exchange for those goods or services. In doing so, companies will be required to use more judgment and make more estimates than under previous guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for the Company for the fiscal year beginning January 1, 2017 and, at that time the Company may adopt the new standard under the full retrospective approach or the modified retrospective approach, as permitted under the standard. Early adoption of the standard is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company’s consolidated financial statements and disclosures.
 
In April 2014, the FASB issued ASU No. 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity” (“ASU 2014-08”), which changes the criteria for reporting discontinued operations while enhancing disclosures in this area. Pursuant to ASU 2014-08, only disposals representing a strategic shift, such as a major line of business, a major geographical area or a major equity investment, which were not expected to have continuing cash flows should be presented as a discontinued operation. If the disposal does qualify as a discontinued operation under ASU 2014-08, the entity will be required to provide expanded disclosures. ASU 2014-08 is effective for the Company beginning January 1, 2015. The adoption of ASU 2014-08 is not expected to have a material effect on the Company’s consolidated financial statements or disclosures.
 
43
 
In July 2013, the FASB issued Accounting Standards Update (“ASU”) 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.   ASU 2013-11 was issued to eliminate the diversity in practice in presentation of unrecognized tax benefits, and amends ASC 740, “Income Taxes,” to provide clarification of the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. According to the new guidance, unrecognized tax benefits will be netted against all available same-jurisdiction loss or other tax carryforward that would be utilized, rather than only being netted against carryforwards that are created by the unrecognized tax benefits. The revised guidance is effective for interim and annual periods beginning after December 15, 2013, with early adoption permitted.  Adoption of this guidance did not have a material impact on our financial statements or financial reporting.
 
Item 7A. Quantitative and Qualitative Disclosures about Market Risk

As of December 31, 2014, our principal debt obligations included the $600.0 million Existing Term Loan and a $445.0 million Incremental Term Loan. Interest on borrowings under these facilities are variable as calculated at our election, on an ABR rate or an adjusted LIBOR rate, plus a margin of 2.50% for ABR loans, and 3.50% for LIBOR loans. Each such margin will decrease by 0.25% in the event the Company’s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. As the interest rates on these facilities are variable they may expose the Company to interest rate risk on such borrowings. A 1/8% variance in interest rates would impact net income by approximately $1.3 million throughout the year.

As of December 31, 2014, we were party to the $150.0 million JPM Credit Agreement with JPMorgan providing for a revolving credit facility. Interest on borrowings under the JPM Credit Agreement were to be calculated at a premium above either the current prime rate or current LIBOR rates plus a margin determined in accordance with the Company’s consolidated fixed charge coverage ratio (EBITDA to fixed charges), exposing us to interest rate risk on such borrowings. As of December 31, 2014 and throughout the year ended December 31, 2014, we had no outstanding loans under the JPM Credit Agreement. At December 31, 2014, we had one outstanding letter of credit under the JPM Credit Agreement for $1.2 million.

As of December 31, 2014, debt also included $87.5 million of the Notes due 2016. The Notes bear a fixed interest rate of 3.50%, with semi-annual interest payments due every June 1st and December 1st until maturity. Since the interest rate on this debt is fixed, we have no interest rate risk related to the Convertible Notes. Based on the closing price of our common stock at the end of 2014, the fair value of the Notes was approximately $360.9 million compared to their face value of $87.5 million as of December 31, 2014.  However, this variance is due to the conversion feature in the Notes rather than to changes in market interest rates.  As noted above, the Notes carry a fixed interest rate and therefore do not subject us to interest rate risk.

We acquired the principal manufacturing facility and ongoing business of Kilitch, an Indian pharmaceutical company on February 28, 2012.  Accordingly, we are subject to foreign exchange risk based on changes in the exchange rate between U.S. dollars and Indian rupees.  Additionally, the business we acquired from Kilitch is itself subject to foreign exchange risk related to certain of its export sales to unregulated markets in Africa, Asia and elsewhere, which are typically denominated in U.S. dollars rather than the local currency, Indian rupees. The Company entered into three non-deliverable forward contracts in October 2013 to protect against unfavorable trends with regard to currency translation rates between U.S. dollars (“USD”) and Indian rupees (“INR”) for planned capital expenditures at AIPL, which all three matured and were redeemed during the year ended December 31, 2014.
 
 
44
 
Our financial instruments include cash and cash equivalents, accounts receivable, available for sale securities, accounts payable and the Notes. The fair values of cash and cash equivalents, accounts receivable and accounts payable approximate book value because of the short maturity of these instruments.  Available for sale securities are stated at fair value adjusted for certain lock-up provisions which prevent us from selling until a set period of time has elapsed. As of December 31, 2014, we hold available for sale securities in shares of Nicox S.A. an international Company whose shares are publically traded on the Euronext Paris exchange, with a cost basis of $10.8 million which was initially valued at $12.5 million discounted to reflect certain lockup provisions preventing immediate sale of underlying shares received. The fair value of these securities at December 31, 2014 was $8.4 million and the decline in value is due to declines in the share price of Nicox S.A. shares and $0.6 million of sales of shares not subject to the lockup provision. We monitor these investments for other than temporary declines in market value, and charge impairment losses to income when an other than temporary decline in value occurs.

At December 31, 2014, the bulk of our cash and cash equivalents balance was invested in overnight instruments, the interest rates of which may change daily.  Accordingly, these overnight investments are subject to market risk.
 
 
 
 
 
 
45
 
Item 8. Financial Statements and Supplementary Data

The following financial statements are included in Part II, Item 8 of this Form 10-K.

INDEX:

Reports of Independent Registered Public Accounting Firms
Consolidated Balance Sheets as of December 31, 2014 and 2013
Consolidated Statements of Comprehensive Income for the years ended December 31, 2014, 2013 and 2012
Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2014, 2013 and 2012
Consolidated Statements of Cash Flows for the years ended December 31, 2014, 2013 and 2012
Notes to Consolidated Financial Statements
 
 
46
 
Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders of Akorn, Inc.
 
We have audited the accompanying consolidated balance sheets of Akorn, Inc. and subsidiaries (Akorn, Inc.) as of December 31, 2014 and 2013, and the related consolidated statements of comprehensive income, shareholders’ equity, and cash flows for each of the years then ended. We also have audited Akorn, Inc.’s internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control – Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Akorn, Inc.’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting, included in Item 9A (ii) of Akorn Inc.’s December 31, 2014 annual report on Form 10-K. Our responsibility is to express an opinion on these consolidated financial statements and an opinion on Akorn, Inc.’s internal control over financial reporting based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the consolidated financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
 
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
 
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Material weaknesses related to ineffective controls over (1) the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions, (2) the accurate and timely reporting of the financial results and disclosures, and (3) the financial statements of acquired subsidiaries, have been identified and included in management’s assessment (Item 9A (ii)).  These material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2014 consolidated financial statements.
 
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Akorn, Inc. and subsidiaries as of December 31, 2014 and 2013, and the results of their operations and their cash flows for each of the years then ended, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, because of the effect of the aforementioned material weaknesses on the achievement of the objectives of the control criteria, Akorn, Inc. has not maintained effective internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control—Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
 
Akorn, Inc. acquired Hi Tech Pharmacal Co, Inc. (Hi Tech), and VPI Holdings Corp. Inc. (VersaPharm) during 2014, and management excluded from its assessment of the effectiveness of Akorn, Inc.’s internal control over financial reporting as of December 31, 2014, Hi Tech’s and VersaPharm’s internal control over financial reporting associated with total assets of $254,257,000 and $13,801,000, respectively, and total revenues of $164,825,000 and $9,173,000, respectively, included in the consolidated financial statements of Akorn, Inc. as of and for the year ended December 31, 2014. Our audit of internal control over financial reporting of Akorn, Inc. also excluded an evaluation of the internal control over financial reporting of Hi Tech and VersaPharm.
 
We do not express an opinion or any other form of assurance on management’s statements referring to corrective actions taken or to be taken after December 31, 2014, relative to the aforementioned material weaknesses in internal control over financial reporting.
 

/s/ KPMG LLP
Chicago, Illinois
March 17, 2015
 
 
47
 
Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders of Akorn, Inc.

We have audited the accompanying consolidated statements of comprehensive income, shareholders' equity and cash flows of Akorn, Inc. for the year ended December 31, 2012. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated results of its operations and its cash flows of Akorn, Inc. for the year ended December 31, 2012, in conformity with U.S. generally accepted accounting principles.

/s/Ernst & Young LLP
Chicago, Illinois
March 1, 2013 except for Note 12 – Segment Information, as to which the date is
March 17, 2015
 
 

 
48
 
AKORN, INC.
CONSOLIDATED BALANCE SHEETS
(In Thousands,
 Except Share Data)
 
   
December 31,
  
 
  
2014
    
2013
  
ASSETS
            
CURRENT ASSETS
            
Cash and cash equivalents
   $ 70,680     $ 34,178  
Trade accounts receivable, net
     220,716       64,998  
Inventories, net
     131,310       55,982  
Deferred taxes, current
     33,480       7,945  
Available for sale security, current
     7,268       —  
Prepaid expenses and other current assets
     30,875       5,753  
TOTAL CURRENT ASSETS
     494,329       168,856  
PROPERTY, PLANT AND EQUIPMENT, NET
     143,788       82,108  
OTHER LONG-TERM ASSETS
                
Goodwill
     278,774       29,831  
Product licensing rights, net
     704,218       115,900  
Other intangibles, net
     259,141       14,605  
Deferred financing costs, net
     21,560       5,676  
Deferred taxes, non-current
     3,020       1,643  
Long-term investments
     208       10,006  
Other non-current assets
     1,863       3,180  
TOTAL OTHER LONG-TERM ASSETS
     1,268,784       180,841  
TOTAL ASSETS
   $ 1,906,901     $ 431,805  
LIABILITIES AND SHAREHOLDERS’ EQUITY
                
CURRENT LIABILITIES
                
Trade accounts payable
   $ 44,116     $ 22,999  
Purchase consideration payable, current
     7,481       14,728  
Income taxes payable
     1       1,459  
Accrued royalties
     13,041       6,004  
Accrued compensation
     13,467       7,692  
Current maturities of long-term debt
     10,450       —  
Accrued administrative fees
     27,774       2,544  
Accrued expenses and other liabilities
     17,835       5,819  
TOTAL CURRENT LIABILITIES
     134,165       61,245  
LONG-TERM LIABILITIES
                
   Long-term debt
     1,114,481       108,750  
   Deferred tax liability, non-current
     268,968       —  
 Lease incentive obligations and other long-term liabilities
     2,536       1,630  
TOTAL LONG-TERM LIABILITIES
     1,385,985       110,380  
TOTAL LIABILITIES
     1,520,150       171,625  
SHAREHOLDERS’ EQUITY
                
Common stock, no par value — 150,000,000 shares authorized; 111,734,901 and 96,569,186 shares issued and outstanding at December 31, 2014 and 2013
     351,235       239,235  
 Warrants to acquire common stock
     —       17,946  
 Retained earnings
     50,711       15,366  
 Accumulated other comprehensive loss
     (15,195 )     (12,367 )
TOTAL SHAREHOLDERS’ EQUITY
     386,751       260,180  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
   $ 1,906,901     $ 431,805  

See notes to the consolidated financial statements.

 
49
 
AKORN, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In Thousands, Except Per Share Data)
 
 
   
Year ended December 31,
  
 
  
2014
    
2013
    
2012
  
                   
REVENUES
   $ 593,078     $ 317,711     $ 256,158  
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)
     295,488       145,807       107,466  
GROSS PROFIT
     297,590       171,904       148,692  
                         
Selling, general and administrative expenses
     95,463       53,508       48,053  
Acquisition-related costs
     32,147       2,912       9,155  
Research and development expenses
     29,199       19,858       15,858  
Amortization of intangibles
     44,066       7,422       6,870  
TOTAL OPERATING EXPENSES
     200,875       83,700       79,936  
OPERATING INCOME
     96,715       88,204       68,756  
                         
Amortization of deferred financing costs
     (12,129 )     (842 )     (782 )
Interest expense, net
     (35,657 )     (8,649 )     (10,474 )
Equity in earnings of unconsolidated joint venture
     —       80       —  
Bargain purchase gain
     —       3,707       —  
Gain from product divestiture
     9,807       —       —  
Other non-operating income, net
     400       395       —  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
     59,136       82,895       57,500  
Income tax provision
     23,288       30,533       22,122  
INCOME FROM CONTINUING OPERATIONS
   $ 35,848     $ 52,362     $ 35,378  
Loss from discontinued operations, net of tax
     (503 )     —       —  
CONSOLIDATED NET INCOME
   $ 35,345     $ 52,362     $ 35,378  
CONSOLIDATED NET INCOME PER COMMON SHARE:
                        
Income from continuing operations, basic
   $ 0.35     $ 0.54     $ 0.37  
Loss from discontinued operations, basic
     (0.01 )     —       —  
CONSOLIDATED NET INCOME, BASIC
   $ 0.34     $ 0.54     $ 0.37  
                         
Income from continuing operations, diluted
   $ 0.34     $ 0.46     $ 0.32  
Loss from discontinued operations, diluted
     (0.01 )     —       —  
CONSOLIDATED NET INCOME, DILUTED
   $ 0.33     $ 0.46     $ 0.32  
                         
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME PER COMMON SHARE:
                        
BASIC
     103,480       96,181       95,189  
DILUTED
     123,110       113,898       110,510  
                         
COMPREHENSIVE INCOME:
                        
Consolidated net income
   $ 35,345     $ 52,362     $ 35,378  
Unrealized holding loss on available-for-sale securities, net of tax of $663
     (1,124 )     —       —  
Foreign currency translation loss, net of tax of $877, $3,328 and $3,040 for the years ended December 31, 2014, 2013 and 2012, respectively
     (1,704 )     (6,463 )     (5,904 )
COMPREHENSIVE INCOME
   $ 32,517     $ 45,899     $ 29,474  
 
See notes to the consolidated financial statements.

 
50
 
AKORN, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2012, 2013 AND 2014
(In Thousands)
         
Warrants
    
Retained
              
         
to acquire
    
Earnings
    
Other
        
   
Common Stock
    
Common
    
(Accumulated
    
Comprehensive
        
   
Shares
    
Amount
    
Stock
    
Deficit)
    
Loss
    
Total
  
                                     
BALANCES AT DECEMBER 31, 2011
     94,938     $ 212,636     $ 17,946     $ (72,374 )   $ —     $ 158,208  
Consolidated net income
     —       —       —       35,378       —       35,378  
Exercise of stock options
     806       1,511       —       —       —       1,511  
Employee stock purchase plan issuances
     71       368       —       —       —       368  
Restricted stock awards
     29       351       —       —       —       351  
Stock-based compensation expense
     —       6,681       —       —       —      
6,681
  
Foreign currency translation loss
     —       —       —       —       (5,904 )     (5,904 )
Excess tax benefit – stock compensation
     —       4,488       —       —       —       4,488  
BALANCES AT DECEMBER 31, 2012
     95,844     $ 226,035     $ 17,946     $ (36,996 )   $ (5,904 )   $ 201,081  
Consolidated net income
     —       —       —       52,362       —       52,362  
Exercise of stock options
     630       2,634       —       —       —       2,634  
Employee stock purchase plan issuances
     61       588       —       —       —       588  
Restricted stock awards
     34       579       —       —       —       579  
Stock-based compensation expense
     —       6,471       —       —       —       6,471  
Foreign currency translation loss
     —       —       —       —       (6,463 )     (6,463 )
Excess tax benefit – stock compensation
     —       2,928       —       —       —       2,928  
BALANCES AT DECEMBER 31, 2013
     96,569     $ 239,235     $ 17,946     $ 15,366     $ (12,367 )   $ 260,180  
Consolidated net income
     —       —       —       35,345       —       35,345  
Exercise of stock options
     4,226       8,013       —       —       —       8,013  
Employee stock purchase plan issuances
     73       829       —       —       —       829  
Restricted stock awards
     16       1,188       —       —       —       1,188  
Stock-based compensation expense
     —       6,354       —       —       —       6,354  
Foreign currency translation loss
     —       —       —       —       (1,704 )     (1,704 )
Excess tax benefit – stock compensation
     —       38,710       —       —       —       38,710  
Unrealized holding loss on available-for-sale  securities
     —       —       —       —       (1,124 )     (1,124 )
Convertible note conversions
     3,659       30,789       —       —       —       30,789  
Exercise of warrants
     7,192       26,117       (17,946 )     —       —       8,171  
BALANCES AT DECEMBER 31, 2014
     111,735     $ 351,235     $ —     $ 50,711     $ (15,195 )   $ 386,751  
 
See notes to the consolidated financial statements.
 
 
51
 
AKORN, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands)
   
Year ended December 31,
  
 
  
2014
    
2013
    
2012
  
                   
OPERATING ACTIVITIES:
                  
Consolidated net income
   $ 35,345     $ 52,362     $ 35,378  
Loss from discontinued operations, net of tax
     503       —       —  
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
                        
Depreciation and amortization
     58,538       14,476       11,455  
Amortization of deferred financing fees
     12,129       842       782  
Amortization of favorable (unfavorable) contracts
     72       (1,905 )     (635 )
Amortization of inventory step-up
     20,798       —       —  
Non-cash stock compensation expense
     7,542       7,050       7,032  
Non-cash interest expense
     4,871       4,634       6,436  
Non-cash gain on bargain purchase
     —       (3,707 )     —  
Gain from product divestiture
     (9,807 )     —       —  
Deferred income taxes, net
     25,293       2,091       67  
Excess tax benefit from stock compensation
     (38,710 )     (2,928 )     (4,488 )
Non-cash settlement of product warranty liability
     —       (1,299 )     —  
Equity in earnings of unconsolidated joint venture
     —       ( 80 )     —  
Loss on extinguishment of debt
     990       —       —  
Gain on sale of available for sale security
     (7 )     —       —  
Changes in operating assets and liabilities:
                        
Trade accounts receivable, net
     (95,470 )     (14,277 )     (23,856 )
Inventories, net
     (15,262 )     (3,797 )     (15,447 )
Prepaid expenses and other current assets
     (13,180 )     (648 )     (5,689 )
Trade accounts payable
     11,024       1,975       4,489  
Accrued expenses and other liabilities
     26,249       2,537       10,720  
NET CASH PROVIDED BY OPERATING ACTIVITIES
     30,918       57,326       26,244  
INVESTING ACTIVITIES:
                        
Payments for acquisitions and equity investments, net of cash acquired
     (987,802 )     (55,482 )     (55,047 )
Proceeds from disposal of assets
     59,361       —       —  
Payments for other intangible assets
     (8,532 )     —       —  
Purchases of property, plant and equipment
     (29,568 )     (11,642 )     (20,454 )
Distributions from unconsolidated joint venture
     —       250       —  
NET CASH USED IN INVESTING ACTIVITIES
     (966,541 )     (66,874 )     (75,501 )
FINANCING ACTIVITIES:
                        
Proceeds from issuances of debt
     1,045,000       —       —  
Proceeds under stock option and stock purchase plans
     8,842       3,222       1,878  
Payments of contingent acquisition liabilities
     (15,000 )     —       —  
Debt financing costs
     (28,366 )     (3,032 )     —  
Proceeds from warrant exercises
     8,171       —       —  
Excess tax benefits from stock compensation
     38,710       2,928       4,488  
Debt repayment
     (85,049 )     —       —  
NET CASH PROVIDED BY FINANCING ACTIVITIES
     972,308       3,118       6,366  
Effect of changes in exchange rates on cash and cash equivalents
     (183 )     (173 )     (290 )
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
     36,502       (6,603 )     (43,181 )
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR
     34,178       40,781       83,962  
CASH AND CASH EQUIVALENTS AT END OF YEAR
   $ 70,680     $ 34,178     $ 40,781  
 
See notes to the consolidated financial statements.

 
52
 
AKORN, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 — Business and Basis of Presentation

Business: Akorn, Inc. together with its wholly owned subsidiaries (“Akorn” or “Company”) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and over-the-counter (“OTC”) consumer health products. We specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.

Akorn is a Louisiana corporation founded in 1971 in Abita Springs, Louisiana. In 1997, we relocated our corporate headquarters to the Chicago, Illinois area and currently maintain our principal corporate office in Lake Forest, Illinois.  We operate pharmaceutical manufacturing facilities in Decatur, Illinois, Somerset, New Jersey, Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York. Our research and development (“R&D”) centers are located in Vernon Hills, Illinois, Copiague, New York, and Warminster, Pennsylvania, and we have other corporate offices in Ann Arbor, Michigan; Amityville, New York; and Gurgaon, India.
 
Note 2 — Summary of Significant Accounting Policies

Consolidation: The accompanying consolidated financial statements include the accounts of Akorn, Inc. and its wholly owned domestic and foreign subsidiaries.  All inter-company transactions and balances have been eliminated in consolidation, and the financial statements of Akorn India Private Limited (“AIPL”) have been translated from Indian rupees to U.S. dollars based on the currency translation rates in effect during the period or as of the date of consolidation, as applicable.  The Company has no involvement with variable interest entities.

As of the year ended December 31, 2014 the Company was a 50% owner of a dormant joint venture, Akorn-Strides, LLC (the “Joint Venture Company”) (See Note 17 – Unconsolidated Joint Venture.).  The Company and its strategic partner each had equal voting rights and shared operational control.  Accordingly, the Company accounted for its investment in the Joint Venture Company using the equity method of accounting.  The Company’s proportionate share of the Joint Venture Company’s income had been recorded under the caption “Equity in earnings of unconsolidated joint venture” in the Company’s consolidated statements of operations.  The Joint Venture Company sold all of its abbreviated new drug application (“ANDA”) rights to Pfizer, Inc. in December 2010 and ceased operations during 2011.

Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Significant estimates and assumptions for the Company relate to the allowances for chargebacks, rebates, product returns, coupons, promotions and doubtful accounts, as well as the reserve for slow-moving and obsolete inventories, the carrying value and lives of intangible assets, the useful lives of fixed assets, the carrying value of deferred income tax assets and liabilities, the assumptions underlying share-based compensation, accrued but unreported employee benefit costs and assumptions underlying the accounting for business combinations.

Revenue Recognition: Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. Revenues from product sales are recognized when title and risk of loss have passed to the customer.

Provision for estimated chargebacks, rebates, discounts, managed care rebates, product returns and doubtful accounts is made at the time of sale and is analyzed and adjusted, if necessary, at each balance sheet date.

Freight:  The Company records amounts billed to customers for shipping and handling as revenue, and records shipping and handling expense related to product sales as cost of sales.

Cash and Cash Equivalents: The Company considers all unrestricted, highly liquid investments with maturity of three months or less when purchased to be cash and cash equivalents.  At December 31, 2014 and 2013, approximately $2.9 million and $2.7 million of cash held by our India operations as of those dates was restricted, and was reported within prepaid expenses and other current assets and other non-current assets, respectively.

 
53
 
Accounts Receivable: Trade accounts receivables are stated at their net realizable value.  The nature of the Company’s business involves, in the ordinary course, significant judgments and estimates relating to chargebacks, coupon redemption, product returns, rebates, discounts given to customers and allowances for doubtful accounts.  Depending on the products, the end-user customers, the specific terms of national supply contracts and the particular arrangements with the Company’s wholesaler customers, certain rebates, chargebacks and other credits are recorded as deductions to the Company’s trade accounts receivable.

Unless otherwise noted, the provisions and allowances for the following customer deductions are reflected in the accompanying consolidated financial statements as reductions of revenues and trade accounts receivable, respectively.

Chargebacks and Rebates: The Company enters into contractual agreements with certain third parties such as hospitals, group-purchasing and managed care organizations to sell certain products at predetermined prices. The parties have elected to have these contracts administered through wholesalers that buy the product from the Company and subsequently sell it to these third parties. When a wholesaler sells products to one of these third parties that are subject to a contractual price agreement, the difference between the price paid to the Company by the wholesaler and the price under the specific contract is charged back to the Company by the wholesaler. The Company tracks sales and submitted chargebacks by product number and contract for each wholesaler. Utilizing this information, the Company estimates a chargeback percentage for each product and records an allowance as a reduction to gross sales when the Company records its sale of the products. The Company reduces the chargeback allowance when a chargeback request from a wholesaler is processed. Actual chargebacks processed by the Company can vary materially from period to period based upon actual sales volume through the wholesalers. However, the Company’s provision for chargebacks is fully reserved for at the time when sales revenues are recognized.

Management obtains certain wholesaler inventory reports to aid in analyzing the reasonableness of the chargeback allowance. The Company assesses the reasonableness of its chargeback allowance by applying the product chargeback percentage based on historical activity to the quantities of inventory on hand at the wholesaler per the wholesaler inventory reports. In accordance with its accounting policy, the Company estimates the percentage amount of wholesaler inventory that will ultimately be sold to third parties that are subject to contractual price agreements based on a trend of such sales through wholesalers. The Company uses this percentage estimate until historical trends indicate that a revision should be made. On an ongoing basis, the Company evaluates its actual chargeback rate experience, and new trends are factored into its estimates each quarter as market conditions change.
 
Similarly, the Company maintains an allowance for rebates related to contract and other programs with certain customers. Rebate percentages vary by product and by volume purchased by each eligible customer. The Company tracks sales by product number for each eligible customer and then applies the applicable rebate percentage, using both historical trends and actual experience to estimate its rebate allowance. The Company reduces gross sales and increases the rebate allowance by the estimated rebate amount when the Company sells its products to its rebate-eligible customers. The Company reduces the rebate allowance when it processes a customer request for a rebate. At each balance sheet date, the Company analyzes the allowance for rebates against actual rebates processed and makes necessary adjustments as appropriate. Actual rebates processed can vary materially from period to period.

Sales Returns: Certain of the Company’s products are sold with the customer having the right to return the product within specified periods and guidelines for a variety of reasons, including but not limited to, pending expiration dates. Provisions are made at the time of sale based upon tracked historical experience. Historical factors such as one-time events as well as pending new developments that would impact the expected level of returns are taken into account to determine the appropriate reserve estimate at each balance sheet date. As part of the evaluation of the balance required, the Company considers actual returns to date that are in process, the expected impact of any product recalls and the wholesaler’s inventory information to assess the magnitude of unconsumed product that may result in sales returns to the Company in the future. The sales returns level can be impacted by factors such as overall market demand and market competition and availability for substitute products which can increase or decrease the end-user pull through for sales of the Company’s products and ultimately impact the level of sales returns. Actual returns experience and trends are factored into the Company’s estimates each quarter as market conditions change. Actual returns processed can vary materially from period to period.

Allowance for Coupons, Promotions and Co-Pay discount cards: The Company issues coupons from time to time that are redeemable against certain of our Consumer Health products. Upon release of coupons into the market, the Company records an estimate of the dollar value of coupons expected to be redeemed. This estimate is based on historical experience and is adjusted as needed based on actual redemptions. In addition to couponing, from time to time the Company authorizes various retailers to run in-store promotional sales of its products. Upon receiving confirmation that a promotion was run, the Company accrues an estimate of the dollar amount expected to be owed back to the retailer. This estimate is trued up to actual upon receipt of the invoice from the retailer. Additionally, the Company provides consumer co-pay discount cards, administered through outside agents to provide discounted products when redeemed. Upon release of the cards into the market, the Company records an estimate of the dollar value of co-pay discounts expected to be utilized. This estimate is based on historical experience and is adjusted as needed based on actual usage.

 
54
 
Doubtful Accounts: Provisions for doubtful accounts, which reflect trade receivable balances owed to the Company that are believed to be uncollectible, are recorded as a component of SG&A expenses. In estimating the allowance for doubtful accounts, the Company considers its historical experience with collections and write-offs, the credit quality of its customers and any recent or anticipated changes thereto, and the outstanding balances and past due amounts from its customers.  Accounts are considered past due when they remain uncollected beyond the due date specified in the applicable contract or on the applicable invoice, whichever is deemed to take precedence.

As of December 31, 2014, the Company had a total of $62.4 million of past due gross accounts receivable, of which $3.7 million was more than 60 days past due. The Company performs monthly a detailed analysis of the receivables due from its wholesaler customers and provides a specific reserve against known uncollectible items. The Company also includes in the allowance for doubtful accounts an amount that it estimates to be uncollectible for all other customers, based on a percentage of the past due receivables. The percentage reserved increases as the age of the receivables increases.  Accounts are written off once all reasonable collections efforts have been exhausted and/or when facts or circumstances regarding the customer (i.e. bankruptcy filing) indicate that the chance of collection is remote.
 
Advertising and Promotional Allowances to Customers: The Company routinely sells its consumer health products to major retail drug chains. From time to time, the Company may arrange for these retailers to run in-store promotional sales of the Company’s products. The Company reserves an estimate of the dollar amount owed back to the retailer, recording this amount as a reduction to revenue at the later of the date on which the revenue is recognized or the date the sales incentive is offered. When the actual invoice for the sales promotion is received from the retailer, the Company adjusts its estimate accordingly. Advertising and promotional expenses paid to customers are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 605-50, Customer Payments and Incentives.

Inventories: Inventories are stated at the lower of cost (average cost method) or market (see Note 4 — “Inventories”). The Company maintains an allowance for slow-moving and obsolete inventory as well as inventory where the cost is in excess of its net realizable value (“NRV”). For finished goods inventory, the Company estimates the amount of inventory that may not be sold prior to its expiration or is slow moving based upon recent sales activity by unit and wholesaler inventory information. The Company also analyzes its raw material and component inventory for slow moving items/NRV. For the years ended December 31, 2014, 2013 and 2012, the Company recorded a provision for inventory obsolescence/NRV of $12.3 million, $2.1 million, and $2.4 million, respectively. The allowances for inventory obsolescence were $21.2 million and $5.7 million as of December 31, 2014 and 2013, respectively.

The Company capitalizes inventory costs associated with its products prior to regulatory approval when, based on management judgment, future commercialization is considered probable and future economic benefit is expected to be realized. The Company assesses the regulatory approval process and where the product stands in relation to that approval process including any known constraints or impediments to approval. The Company also considers the shelf life of the product in relation to the product timeline for approval.

At December 31, 2014, the Company established a reserve of $1.9 million related to R&D raw materials that are not expected to be utilized prior to expiration while at December 31, 2013, the Company had approximately $1.0 million in reserves for R&D raw materials. The entire balance of the R&D raw materials has been reserved, as the Company deemed it unlikely that the products would receive U.S. Food and Drug Administration (the “FDA”) approval far enough in advance of expiration to be sellable.

 Intangible Assets: Intangible assets consist primarily of goodwill, which is carried at its initial value, subject to evaluation for impairment, in-process research and development, which is accounted for as an indefinite-lived intangible asset, subject to impairment testing until completion or abandonment of the project, and product licensing costs, trademarks and other such costs, which are capitalized and amortized on a straight-line basis over their useful lives, ranging from one (1) year to thirty (30) years.  Accumulated amortization was $82.2 million and $39.1 million at December 31, 2014 and 2013, respectively.  Amortization expense was $44.1 million, $7.4 million and $6.9 million for the years ended December 31, 2014, 2013 and 2012, respectively. The Company regularly assesses its intangible assets for impairment based on several factors, including estimated fair value and anticipated cash flows.  If the Company incurs additional costs to renew or extend the life of an intangible asset, such costs are added to the remaining unamortized cost of the asset, if any, and the sum is amortized over the extended remaining life of the asset.
 
Goodwill is tested for impairment annually or more frequently if changes in circumstances or the occurrence of events suggest that impairment may exist. The Company uses widely accepted valuation techniques to determine the fair value of its reporting units used in its annual goodwill impairment analysis. The Company’s valuation is primarily based on qualitative and quantitative assessments regarding the fair value of the reporting unit relative to its carrying value. The Company modeled the fair value of the reporting unit based on projected earnings and cash flows of the reporting unit. The Company performed its annual impairment test on October 1, 2014 and determined that the fair value of its reporting units are substantially in excess of its carrying value and, therefore, no impairment charge was necessary.

 
55
 
Changes in goodwill during the two years ended December 31, 2014 were as follows (in thousands):
   
Goodwill
  
December 31, 2012
   $ 32,159  
Acquisitions
  
─
  
Impairments
  
─
  
Foreign currency translation
     (2,328 )
December 31, 2013
   $ 29,831  
Acquisitions
     260,911  
Impairments
  
─
  
Dispositions
     (11,454 )
Foreign currency translation
     (514 )
December 31, 2014
   $ 278,774  
 
The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2014 for those assets that are not already fully amortized (dollar amounts in thousands):

   
Gross
Carrying
Amount
    
Accumulated
Amortization
    
Net
Carrying
Amount
    
Weighted Average
Remaining Amortization Period (years)
  
Product licensing rights
   $ 778,734     $ (74,516 )   $ 704,218       12.4  
In-process research and development (“IPR&D”)
     230,788       —       230,788    
N/A – Indefinite lived
  
Trademarks
     16,000       (1,721 )     14,279       18.6  
Customer relationships
    
6,427
       (3,392 )     3,035       11.0  
Other intangibles
     11,234       (879 )     10,355       7.5  
Non-compete agreements
    
2,409
       (1,725 )     684       1.4  
    $ 1,045,592     $ (82,233 )   $ 963,359          
 
Changes in intangible assets during the two years ended December 31, 2014 were as follows (in thousands):

   
Product licensing rights
    
IPR&D
    
Trademarks
    
Customer relationships
    
Other intangibles
    
Non-compete agreements
  
December 31, 2012
   $ 63,654     $ —     $ 8,972     $ 5,588     $ —     $ 2,171  
Acquisitions
     57,969       —       —       —       —       —  
Amortization
     (5,723 )     —       (316 )     (740 )     —       (643 )
Foreign currency translation
     —       —       —       (210 )     —       (217 )
December 31, 2013
   $ 115,900     $ —     $ 8,656     $ 4,638     $ —     $ 1,311  
Acquisitions
    
668,457
       230,788       6,500       300       11,234       —  
Amortization
     (39,761 )     —       (877 )     (1,934 )     (879 )     (615 )
Dispositions
     (40,378 )     —       —       —       —       —  
Foreign currency translation
     —       —       —       31       —       (12 )
December 31, 2014
   $ 704,218     $ 230,788     $ 14,279     $ 3,035     $ 10,355     $ 684  

The amortization expense of acquired intangible assets for each of the following five years will be as follows (in thousands):

Year ending December 31,
  
Amortization Expense
  
2015
   $ 65,966  
2016
     65,739  
2017
     65,312  
2018
     65,108  
2019
     62,244  

 
56
 
Property, Plant and Equipment: Property, plant and equipment is stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method in amounts considered sufficient to amortize the cost of the assets to operations over their estimated useful lives or lease terms. Depreciation expense was $14.5 million, $7.1 million and $4.6 million for the years ended December 31, 2014, 2013 and 2012, respectively.  The amortization of assets under capital leases is included within depreciation expense. The following table sets forth the average estimated useful lives of the Company’s property, plant and equipment, by asset category:

Asset category
  
Depreciable Life (years)
  
Buildings
     30  
Leasehold improvements
     20  
Furniture and equipment
     7  
Automobiles
     5  
Computer hardware and software
     5  

Net Income Per Common Share: Basic net income per common share is based upon weighted average common shares outstanding. Diluted net income per common share is based upon the weighted average number of common shares outstanding, including the dilutive effect, if any, of stock options and convertible securities using the treasury stock and if converted methods.  Anti-dilutive shares excluded from the computation of diluted net income per share for 2014, 2013 and 2012 include 735,000, 975,000 and 581,000 shares, respectively, related to options, warrants, and convertible securities.

Income Taxes: Income taxes are accounted for under the asset and liability method.  Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and net operating loss and other tax credit carry-forwards. These items are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce the deferred income tax assets to the amount that is more likely than not to be realized.

Fair Value of Financial Instruments: The Company applies ASC Topic 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC Topic 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC Topic 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability, and are to be developed based on the best information available in the circumstances.

The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:

 
-
Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. The carrying value of the Company‘s cash and cash equivalents are considered Level 1 assets.

 
-
Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as directly or indirectly observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. The market value of the Company’s forward contracts to hedge against changes in currency translation rates between U.S. dollars and Indian rupees was a Level 2 asset.

 
-
Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. The additional consideration payable related to the Company’s acquisition of three branded, injectable drug products from the U.S. subsidiary of H. Lundbeck A/S (the “Lundbeck Acquisition”), a Denmark Corporation, on December 22, 2011 was a Level 3 liability, as are the additional consideration payable to Santen Pharmaceutical Co. Ltd. (“Santen”) in relation to the Company’s acquisition of the U.S. New Drug Application (“NDA”) rights to Betimol® on January 2, 2014, and the fair valuation of the available for sale investment held in shares of Nicox S.A.

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):
 
 
57
 
         
Fair Value Measurements at Reporting Date, Using:
  
Description
  
December 31,
2014
    
Quoted Prices
in Active
Markets for
Identical Items
(Level 1)
    
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Unobservable
Inputs
(Level 3)
  
Cash and cash equivalents
   $ 70,680     $ 70,680     $ —     $ —  
Available-for-sale securities
     8,391       —       —       8,391  
   Total assets
   $ 79,071     $ 70,680     $ —     $ 8,391  
                                 
Purchase consideration payable
   $ 7,613     $ —     $ —     $ 7,613  
   Total liabilities
   $ 7,613     $ —     $ —     $ 7,613  
 
Description
  
December 31,
2013
    
Quoted Prices
in Active
Markets for
Identical Items
(Level 1)
    
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Unobservable
Inputs
(Level 3)
  
Cash and cash equivalents
   $ 34,178     $ 34,178     $ —     $ —  
Foreign currency forward contracts
     208       —       208       —  
   Total assets
   $ 34,386     $ 34,178     $ 208     $ —  
                                 
Purchase consideration payable
   $ 14,728     $ —     $ —     $ 14,728  
   Total liabilities
   $ 14,728     $ —     $ —     $ 14,728  
 
The carrying amount at December 31, 2014 of purchase consideration payable includes estimated consideration due to Santen related to the Company’s acquisition of U.S. NDA rights to Betimol® on January 2, 2014. The liability was initially discounted based on the Company’s assumed discount rate and revalued at December 31, 2014 using this same discount rate. The Company identified no events that would cause its calculated assumed discount rate to change between the acquisition date and December 31, 2014. The additional consideration contingently payable to Santen was initially estimated at $4.5 million discounted to $4.0 million based on a discount rate of 12.6%. The Company performed evaluations of the fair value of this liability at December 31, 2014 based on utilizing significant unobservable inputs and determined the fair value of this liability to be $4.3 million. The increase in fair value during the year ended December 31, 2014 of approximately $0.3 million has been recorded as non-cash interest expense within the Company’s consolidated statement of comprehensive income for the year ended December 31, 2014.
 
The remaining purchase consideration payable is principally comprised of net working capital amounts owed relating to the ECR and Watson Laboratories, Inc. (“Watson”) divestitures, at fair value as determined based on the underlying contracts and the Company’s subjective evaluation of the additional consideration.
 
As of December 31, 2014, the Company was carrying available for sale investments in shares of Nicox S.A. initially valued at $12.5 million discounted to reflect certain lockup provisions preventing immediate sale of underlying shares received for the Company’s investment in an available for sale security or an approximately $1.7 million unrealized gain. During the year the Company sold $0.6 million of the available-for-sale security, realizing an immaterial gain, and due to declines in the share price of Nicox S.A. stock from the initial valuation, the Company recognized a $1.8 million unrealized loss as of the year ended December 31, 2014. The remaining $8.4 million of securities are still subject to certain lockup provisions and as such, the fair value of the investments is estimated using observable and unobservable inputs to discount for lack of marketability. (See Note 16 – Business Combinations, Dispositions and Other Strategic Investments)
 
The carrying amount at December 31, 2013 of the purchase consideration payable for the Lundbeck acquisition was initially determined based on the terms of the underlying contracts and the Company’s subjective evaluation of the likelihood of the additional purchase consideration becoming payable related to the Company’s obligation to pay additional consideration for the acquisition of selected assets from H. Lundbeck A/S (“Lundbeck”) on December 22, 2011.  The underlying obligation was long-term in nature, and therefore was discounted to present value based on an assumed discount rate.  The additional consideration of $15.0 million, contingently payable to Lundbeck on December 22, 2014, was initially discounted to $11.3 million based on a discount rate of 10.0%, and subsequently adjusted in final acquisition accounting to $11.6 million based on applying a 9.0% discount rate.  At December 31, 2013, the Company again evaluated the fair value based on utilizing significant unobservable inputs and derived a discount rate of 1.85%, determining that the appropriate discounted value was $14.7 million based upon the likelihood of achieving the underlying revenue targets and a derived cost of debt based on the remaining term. On December 22, 2014 the Company remitted final payment for the contingent purchase consideration due to Lundbeck of $15.0 million.
 
 
58
 
The Company entered into three non-deliverable forward contracts in October 2013 to protect against unfavorable trends with regard to currency translation rates between U.S. dollars (“USD”) and Indian rupees (“INR”) for planned capital expenditures at AIPL, which all three matured and were redeemed during the year ended December 31, 2014. The forward contracts were based on current and future anticipated investment in AIPL, the Company’s subsidiary in India. These forward contracts include projected currency translation rates between INR and USD. Any difference between the actual and projected foreign currency translations rates on the respective settlement dates would result in payment from the counterparty to the Company, or vice versa, as the case may be. As all of the contracts matured during the year ended December 31, 2014, the Company realized a $0.7 million gain in fair value during the year ended December 31, 2014 as Other non-operating income in its consolidated statements of comprehensive income.

Warrants: The Company issued various warrants during 2009 to entities controlled by John N. Kapoor, Ph.D., the Chairman of the Company’s Board of Directors (the “Kapoor Warrants”).  The Company had classified the fair value of these warrants as a current liability in accordance with ASC 815-40-15-3, Derivatives and Hedging, (formerly EITF 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock). This classification was made as a result of the requirement that the shares to be issued upon exercise of the Kapoor Warrants be registered shares, which could not be absolutely assured.  The Kapoor Warrants were adjusted to fair value at the end of each quarter through Black-Scholes calculations which considered changes in the market price of the Company’s common stock, the remaining contractual life of the Kapoor Warrants, and other factors.  Any change in the fair value of the Kapoor Warrants was recorded as income or expense on the Company’s consolidated statements of operations for the applicable period.

On June 28, 2010, the Company and Dr. Kapoor entered into an Amended and Restated Registration Rights Agreement (the “Amended Agreement”) which modified certain terms related to the Company’s obligation to obtain and maintain registration of any shares issued pursuant to exercise of the Kapoor Warrants.  The Amended Agreement still requires the Company to use “commercially reasonable efforts” to file a registration statement pursuant to Rule 415 of the Securities Act of 1933 (“Registration Statement”) for any shares of common stock that may be issued under the applicable warrant agreements, and to maintain the continuous effectiveness of such Registration Statement until the earliest of: (i) the date no shares of the Company’s common stock qualify as registrable securities, (ii) the date on which all of the registrable securities may be sold in a single transaction by the holder to the public pursuant to Rule 144 or a similar rule, or (iii) the date upon which the John N. Kapoor Trust Dated September 20, 1989 (the “Kapoor Trust”) and EJ Funds, LP (“EJ Funds”) have transferred all of the registrable securities.  However, the Registration Rights Agreement was amended to provide that in the event the Company, after using its good faith commercially reasonable efforts, is not able to obtain or maintain registration of the common stock, delivery of unregistered shares upon exercise of the Kapoor Warrants will be deemed acceptable and a net cash settlement will not be required. The Amended Agreement further provides that the term “commercially reasonable efforts” in such instance shall not mean an absolute obligation of the Company to obtain and maintain registration.

As a result of the changes effected through the Amended Agreement, on June 28, 2010 the Company changed its accounting treatment of the Kapoor Warrants, no longer classifying them as a current liability with periodic adjustments to fair value but instead classifying them as a component of shareholders’ equity in accordance with ASC 815-40.   Accordingly, the fair value of the Kapoor Warrants, which was $17.9 million on June 28, 2010, was reclassified from a current liability to a component of shareholders’ equity on that date.  Following this change in classification, no future fair value adjustments are required.

The liability at June 28, 2010 for the Kapoor Warrants was estimated using a Black-Scholes valuation model with the fair value per warrant ranging from $2.49 to $2.50.  The expected volatility of the Kapoor Warrants was based on the historical volatility of the Company’s common stock. The expected life assumption was based on the remaining life of the Kapoor Warrants. The risk-free interest rate for the expected term of the Kapoor Warrants was based on the average market rate on U.S. treasury securities in effect during the applicable quarter. The dividend yield reflected historical experience as well as future expectations over the expected term of the Kapoor Warrants.

The assumptions used in estimating the fair value of the warrants at June 28, 2010 were as follows:

Expected volatility
  
79.7%
 
Expected life (in years)
  3.8 –
4.1
Risk-free interest rate
  
1.8%
  
Dividend yield
  
—
 

 
59
 
The following table provides summarized information about the Kapoor Warrants as of December 31, 2013:

Granted To:
Grant Date
  
Warrants Granted
    
Exercise Price
    
Book Value ($000s)
  
                     
EJ Funds
Apr.13, 2009
     1,939,639     $ 1.11     $ 4,829  
Kapoor Trust
Apr.13, 2009
     1,501,933     $ 1.11       3,740  
EJ Funds
Aug.17, 2009
     1,650,806     $ 1.16       4,127  
Kapoor Trust
Aug.17, 2009
     2,099,935     $ 1.16       5,250  
        7,192,313             $ 17,946  

On April 10, 2014, the holder exercised all of the approximately 7.2 million outstanding stock warrants. The Company received cash proceeds of approximately $8.2 million from the warrant exercise during the year ended December 31, 2014.
 
Stock-Based Compensation: Stock-based compensation cost is estimated at grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions to be used in the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its common stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. Treasury securities of similar term in effect during the quarter in which the options were granted. The dividend yield reflects the Company’s historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises the estimate in subsequent periods, if necessary, if actual forfeitures differ from initial estimates.
 
Note 3 — Accounts Receivable, Sales and Allowances

The nature of the Company’s business inherently involves, in the ordinary course, significant amounts and substantial volumes of transactions and estimates relating to allowances for product returns, chargebacks, rebates, doubtful accounts and discounts given to customers. This is a natural circumstance of the pharmaceutical industry and is not specific to the Company. Depending on the product, the end-user customer, the specific terms of national supply contracts and the particular arrangements with the Company’s wholesaler customers, certain rebates, chargebacks and other credits are deducted from the Company’s accounts receivable. The process of claiming these deductions depends on wholesalers reporting to the Company the amount of deductions that were earned under the terms of the respective agreement with the end-user customer (which in turn depends on the specific end-user customer, each having its own pricing arrangement, which entitles it to a particular deduction). This process can lead to partial payments against outstanding invoices as the wholesalers take the claimed deductions at the time of payment.
 
With the exception of the provision for doubtful accounts, which is reflected as part of selling, general and administrative expense, the provisions for the following customer reserves are reflected as a reduction of revenues in the accompanying consolidated statements of comprehensive income. The ending reserve balances are included in trade accounts receivable, net in the Company’s consolidated balance sheets.
 
Net trade accounts receivable consists of the following (in thousands):
 
   
December 31,
  
 
  
2014
    
2013
  
Gross accounts receivable
   $
445,027
     $ 88,165  
Less reserves for:
                
Chargebacks and rebates
     (155,297 )     (12,882 )
Product returns
     (44,644 )     (8,164 )
Discounts and allowances
     (22,691 )     (1,644 )
Advertising and promotions
     (1,217 )     (452 )
Doubtful accounts
     (462 )     (25 )
Trade accounts receivable, net
   $ 220,716     $ 64,998  

For the years ended December 31, 2014, 2013 and 2012, the Company recorded the following adjustments to gross sales (in thousands):

 
60
 
   
Year ended December 31,
  
   
2014
    
2013
    
2012
  
Gross sales
   $ 1,442,537     $ 528,574     $ 386,582  
Less adjustments for:
                        
Chargebacks and rebates
     (739,760 )     (183,403 )     (112,244 )
Product returns
     (20,006 )     (5,001 )     (3,783 )
Discounts and allowances
     (31,178 )     (8,464 )     (6,074 )
Administrative fees
     (50,786 )     (9,471 )     (5,293 )
Advertising, promotions, and other
     (7,729 )     (4,524 )     (3,030 )
Revenues, net
   $
593,078
     $ 317,711     $ 256,158  
 
The annual activity in the Company’s allowance for customer deductions accounts for the three years ended December 31, 2014 is as follows (in thousands):
 
   
Returns
    
Chargebacks & Rebates
    
Discounts
    
Doubtful Accounts
    
Advert. & Promotions
    
TOTAL
  
Balance at December 31, 2011
     6,846       5,949       743       99       386       14,023  
Provision
     3,783       112,243       6,074       (82 )     2,063       124,081  
Charges processed
     (2,220 )     (104,740 )     (5,455 )     13       (1,864 )     (114,266 )
Balance at December 31, 2012
   $ 8,409     $ 13,452     $ 1,362     $ 30     $ 585     $ 23,838  
Provision
     5,001       183,403       8,464       (5 )     4,524       201,387  
Charges processed
     (5,246 )     (183,973 )     (8,182 )     —       (4,657 )     (202,058 )
Balance at December 31, 2013
   $ 8,164     $ 12,882     $ 1,644     $ 25     $ 452     $ 23,167  
Provision
     20,006      
739,760
       31,178       346       7,729      
799,019
  
Additions from acquisitions
     29,172      
29,593
      
5,161
       88       311      
64,325
  
Charges processed
     (12,698 )     (626,938 )     (15,292 )     3       (7,275 )     (662,200 )
Balance at December 31, 2014
   $ 44,644     $
155,297
     $
22,691
     $ 462     $ 1,217     $
224,311
  
 
Note 4 — Inventories

The components of inventories, net of allowances, are as follows (in thousands):

   
December 31,
  
 
  
2014
    
2013
  
Finished goods
   $
64,442
     $ 22,886  
Work in process
    
4,335
       3,883  
Raw materials and supplies
    
62,533
       29,213  
    $ 131,310     $ 55,982  
 
The Company maintains an allowance for excess and obsolete inventory, as well as inventory where its cost is in excess of its net realizable value.  The activity in the allowance for excess, obsolete, and net realizable value inventory account for the two years ended December 31, 2014 was as follows (in thousands):

   
Years Ended December 31,
  
 
  
2014
    
2013
  
Balance at beginning of year
   $ 5,700     $ 6,819  
Provision
     12,275       2,089  
Additions from acquisitions
     8,220       —  
Charges
     (5,016 )      (3,208 )
Balance at end of year
   $ 21,179     $ 5,700  
 
Note 5 – Property, Plant and Equipment

Property, plant and equipment consist of the following (in thousands):

   
December 31,
  
 
  
2014
    
2013
  
Land
   $ 9,323     $ 2,606  
Buildings and leasehold improvements
     63,846       46,281  
Furniture and equipment
     112,708       76,536  
      185,877       125,423  
Accumulated depreciation
     (68,093 )     (54,470 )
      117,784       70,953  
Construction in progress
    
26,004
       11,155  
    $
143,788
     $ 82,108  
 
 
61
 
At December 31, 2014 and 2013, property plant and equipment carrying a net book value of $25.6 million and $21.1 million, respectively, was located outside the United States.
 
Note 6 — Financing Arrangements

Incremental Term Loan

Concurrent with the closing of its acquisition of VersaPharm Incorporated (“VersaPharm”), Akorn, Inc. and its wholly owned domestic subsidiaries (the “Akorn Loan Parties”) entered into a $445.0 million Incremental Facility Joinder Agreement (the “Incremental Term Loan Facility”) pursuant to a Loan Agreement (the “Incremental Term Loan Agreement”) dated August 12, 2014 between the Akorn Loan Parties as borrowers, certain other lenders, with JPMorgan Chase Bank, N.A. (“JPMorgan”), acting as administrative agent. The proceeds received pursuant to the Incremental Term Loan Agreement were used to finance the acquisition of VersaPharm, a Georgia corporation (“VersaPharm Acquisition”).

The Incremental Term Loan Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement.

The Incremental Term Loan Facility requires quarterly principal repayment equal to 0.25% of the initial loan amount of $445.0 million beginning with the first full quarter following the closing date of the Incremental Term Loan Agreement, with a final payment of the remaining principal balance due at maturity seven (7) years from the date of closing of the Existing Term Loan Agreement. The Company may prepay all or a portion of the remaining outstanding principal amount under the Incremental Term Loan Agreement at any time, or from time to time, subject to prior notice requirement to the lenders and payment of applicable fees. Prepayment of principal will be required should the Company incur any indebtedness not permitted under the Incremental Term Loan Agreement, or effect the sale, transfer or disposition of any property or asset, other than in the ordinary course of business. To the extent the Incremental Term Loan Facility is refinanced within the first six (6) months of closing, a 1.00% prepayment fee will be due. As of December 31, 2014 outstanding debt under the Incremental Term Loan Facility was $443.9 million and the Company was in full compliance with all applicable covenants which included customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities.

Interest accrues based, at the Company’s election, on an adjusted prime/federal funds rate (“ABR Loan”) or an adjusted LIBOR (“Eurodollar Loan”) rate, plus a margin of 2.50% for ABR Loans, and 3.50% for Eurodollar Loans. Each such margin will decrease by 0.25% in the event the Company’s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. During an event of default, as defined in the Existing Term Loan Agreement, any interest rate will be increased by 2.00% per annum. Per the Existing Term Loan Agreement, the interest rate on LIBOR loans cannot fall below 4.50%.

For the year ended December 31, 2014, the Company recorded interest expense of $7.8 million in relation to the Incremental Term Loan Agreement.

As of December 31, 2014, in connection with entering into the $445.0 million Incremental Term Loan Agreement, the Company capitalized $10.9 million in deferred financing fees. Approximately $1.8 million of this total represented loan commitment fees which were amortized to expense during the year ended December 31, 2014. The $1.8 million of loan commitment fees amortized in the year ended December 31, 2014 consisted of $1.7 million in commitment fee amortization and $0.1 million in ticking fees. The Company will amortize the remaining deferred financing fees using the effective interest method over the term of the Incremental Term Loan Agreement.

Existing Term Loan

Concurrent with the closing of its acquisition of Hi-Tech (the “Hi-Tech Acquisition”) Akorn Loan Parties entered into a $600.0 million Term Facility (the “Existing Term Facility”) pursuant to a Loan Agreement dated April 17, 2014 (the “Existing Term Loan Agreement”) between the Akorn Loan Parties as borrowers, certain other lenders, with JPMorgan, acting as administrative agent. The Company may increase the loan amount up to an additional $150.0 million, or more, provided certain financial covenants and other conditions are satisfied. The proceeds received pursuant to the Existing Term Loan Agreement were used to finance the Hi-Tech Acquisition.

 
62
 
The Existing Term Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement.

The Existing Term Loan Agreement requires quarterly principal repayment equal to 0.25% of the initial loan amount of $600.0 million beginning with the second full quarter following the closing date of the Existing Term Loan Agreement, with a final payment of the remaining principal balance due at maturity seven (7) years from the date of closing of the Existing Term Loan Agreement. The Company may prepay all or a portion of the remaining outstanding principal amount under the Existing Term Loan Agreement at any time, or from time to time, subject to prior notice requirement to the lenders and payment of applicable fees. Prepayment of principal will be required should the Company incur any indebtedness not permitted under the Existing Term Loan Agreement, or effect the sale, transfer or disposition of any property or asset, other than in the ordinary course of business. As of December 31, 2014 outstanding debt under the term loan facility was $598.5 million and the Company was in full compliance with all applicable covenants which included customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities.

Interest accrues based, at the Company’s election, on an adjusted prime/federal funds rate or an adjusted LIBOR rate, plus a margin of 2.50% for ABR Loans, and 3.50% for Eurodollar Loans. Each such margin will decrease by 0.25% in the event Akorn’s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. During an event of default, as defined in the Existing Term Loan Agreement, any interest rate will be increased by 2.00% per annum. Per the Existing Term Loan Agreement, the interest rate on LIBOR loans cannot fall below 4.50%.

For the year ended December 31, 2014, the Company recorded interest expense of $19.4 million in relation to the Existing Term Loan.

As of December 31, 2014, in connection with entering into the $600.0 million Existing Term Loan, the Company capitalized $20.3 million in deferred financing fees. Approximately $7.4 million of this total represented loan commitment fees, of which $7.4 million was amortized to expense during the year ended December 31, 2014. The $7.4 million of loan commitment fees amortized in the year ended December 31, 2014 consisted of $5.0 million in ticking fees and $2.4 million in commitment fee amortization. The Company will amortize the remaining deferred financing fees using the effective interest method over the term of the Existing Term Loan Agreement.

JPMorgan Credit Facility

On April 17, 2014, the Akorn Loan Parties entered into a Credit Agreement (the “JPM Credit Agreement”) with JPMorgan acting as administrative agent, and Bank of America, N.A., as syndication agent for certain other lenders (at closing, Bank of America, N.A. and Wells Fargo Bank, N. A.) for a $150.0 million revolving credit facility (the “JPM Revolving Facility”). Upon entering into the JPM Credit Agreement, the Company terminated its prior $60.0 million revolving credit facility with Bank of America, N.A., as further described below.

Subject to other conditions in the JPM Credit Agreement, advances under the JPM Revolving Facility will be made in accordance with a borrowing base consisting of the sum of the following:
  (a)
85% of eligible accounts receivable;
  (b)
The lesser of:
 
a.
65% of the lower of cost or market value of eligible raw materials and work in process inventory, valued on a first in first out basis, and
 
b.
85% of the orderly liquidation value of eligible raw materials and work in process inventory, valued on a first in first out basis;
                              (c)
The lesser of:
 
a.
75% of the lower of cost or market value of eligible finished goods inventory, valued on a first in first out basis, and
 
b.
85% of the orderly liquidation value of eligible finished goods inventory, valued on a first in first out basis up to 85% of the liquidation value of eligible inventory (or 75% of market value finished goods inventory); and
 (d)
Less any reserves deemed necessary by the administrative agent, and allowed in its permitted discretion.

The total amount available under the JPM Revolving Facility includes a $10.0 million letter of credit facility.

 
63
 
Under the terms of the JPM Credit Agreement, if availability under the JPM Revolving Facility falls below 12.5% of commitments or $15.0 million for more than 30 consecutive days, the Company may be subject to cash dominion, additional reporting requirements, and additional covenants and restrictions. The Company may seek additional commitments to increase the maximum amount of the JPM Revolving Facility to $200.0 million.

Unless cash dominion is exercised by the lenders in connection with the JPM Revolving Facility, the Company will be required to repay the JPM Revolving Facility upon its expiration five (5) years from issuance, subject to permitted extension, and will pay interest on the outstanding balance monthly based, at the Company’s election, on an adjusted prime/federal funds rate (“ABR”) or an adjusted LIBOR (“Eurodollar”), plus a margin determined in accordance with the Company’s consolidated fixed charge coverage ratio (EBITDA to fixed charges) as follows:

Fixed Charge
Coverage Ratio
Revolver ABR
Spread
Revolver
Eurodollar
Spread
Category 1
> 1.50 to 1.0
0.50%
1.50%
Category 2
> 1.25 to 1.00 but
< 1.50 to 1.00
0.75%
1.75%
Category 3
< 1.25 to 1.00
1.00%
2.00%

In addition to interest on borrowings, the Company will pay an unused line fee of 0.25% per annum on the unused portion of the JPM Revolving Facility.

During an event of default, as defined in the JPM Credit Agreement, any interest rate will be increased by 2.0% per annum.

The JPM Revolving Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement. The financial covenants require the Akorn Loan Parties to maintain the following on a consolidated basis:
 
(a)
Minimum Liquidity, as defined in the JPM Credit Agreement, of not less than (a) $120.0 million plus (b) 25% of the JPM Revolving Facility commitments during the three month period preceding the June 1, 2016 maturity date of the Company’s senior convertible notes.
 
(b)
Ratio of EBITDA to fixed charges of no less than 1.00 to 1.00 (measured quarterly for the trailing 4 quarters).

As of December 31, 2014 the Company was in full compliance with all covenants applicable to the JPM Revolving Facility.

The Company may use any proceeds from borrowings under the JPM Revolving Facility for working capital needs and for the general corporate purposes of the Company and its subsidiaries, and to otherwise replace letters of credit that were outstanding upon the termination of the Company’s prior revolving credit facility with Bank of America, N.A. At December 31, 2014, there were no outstanding borrowings and one outstanding letter of credit in the amount of approximately $1.2 million under the JPM Revolving Facility. Availability under the facility as of December 31, 2014 was approximately $148.8 million.

The JPM Credit Agreement places customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities of the Akorn Loan Parties in a manner designed to protect the collateral while providing flexibility for growth and the historic business activities of the Company and its subsidiaries.

Convertible Notes

On June 1, 2011, the Company closed on an offering of $120.0 million aggregate principal amount of 3.50% Convertible Senior Notes due 2016 (the “Notes”) which included $20.0 million in aggregate principal amount of the Notes issued in connection with the full exercise by the initial purchasers of their over-allotment option. The Notes are governed by the Company’s indenture with Wells Fargo Bank, National Association, as trustee (the “Indenture”).  The Notes were offered and sold only to qualified institutional buyers.  The net proceeds from the sale of the Notes were approximately $115.3 million, after deducting underwriting fees and other related expenses.
 
 
64
 
The Notes have a maturity date of June 1, 2016 and pay interest at an annual rate of 3.50% semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2011.  The Notes are convertible into the Company’s common stock, cash or a combination thereof at an initial conversion price of $8.76 per share, which is equivalent to an initial conversion rate of approximately 114.1553 shares per $1,000 principal amount of Notes.  The conversion price is subject to adjustment for certain events described in the Indenture, including certain corporate transactions which will increase the conversion rate and decrease the conversion price for a holder that elects to convert its Notes in connection with such corporate transaction.

The Notes may be converted at any time prior to the close of business on the business day immediately preceding December 1, 2015 only under the following circumstances:  (1) during any calendar quarter commencing after September 30, 2011, if the closing sale price of the Company’s common stock, for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the calendar quarter immediately preceding the calendar quarter in which the conversion occurs, is more than 130% of the conversion price in effect on each applicable trading day; (2) during the five consecutive trading-day period following any five consecutive trading-day period in which the trading price for the Notes per $1,000 principal amount of Notes for each such trading day was less than 98% of the closing sale price of the Company’s common stock on such date multiplied by the then-current conversion rate; or (3) upon the occurrence of specified corporate events.  On or after December 1, 2015 until the close of business on the business day immediately preceding the stated maturity date, holders may surrender all or any portion of their Notes for conversion at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, at the Company’s option, cash, shares of the Company’s common stock, or a combination thereof.  If a fundamental change (as defined in the Indenture) occurs prior to the stated maturity date, holders may require the Company to purchase for cash all or a portion of their Notes.
 
The Notes became convertible for the quarter ending on June 30, 2012 as a result of the Company’s stock trading at or above the required price of $11.39 per share for 20 of the last 30 trading days in the quarter ended March 31, 2012.  The Notes have remained convertible for each successive quarter as a result of meeting the trading price requirement at the end of each prior quarter. During the year ended December 31, 2014, approximately $32.5 million of this convertible debt was converted at the holder’s request which resulted in an additional $1.0 million of expense recognized due to the conversions.
 
The Notes are not listed on any securities exchange or on any automated dealer quotation system, but are traded on a secondary market made by the initial purchasers.  The initial purchasers of the Notes advised the Company of their intent to make a market in the Notes following the offering, though they are not obligated to do so and may discontinue any market making at any time.
 
As of December 31, 2014, the Notes were trading at approximately 412.4% of their face value, resulting in a total market value of $360.9 million compared to their face value of $87.5 million.  The actual conversion value of the Notes is based on the product of the conversion rate and the market price of the Company's common stock at conversion, as defined in the Indenture.  As of December 31, 2014, the Company's common stock closed at $36.20 per share, resulting in a pro forma conversion value for the Notes of approximately $361.7 million.  Increases in the market value of the Company’s common stock increase the Company’s obligation accordingly.  There is no upper limit placed on the possible conversion value of the Notes.
 
The Notes are accounted for in accordance with ASC 470-20, Debt with Conversion and Other Options.  Under ASC 470-20, issuers of convertible debt instruments that may be settled in cash upon conversion, including partial cash settlement, are required to separately account for the liability (debt) and equity (conversion option) components.  The application of ASC 470-20 resulted in the recognition of $21.3 million as the value for the equity component.  This amount was offset by $0.8 million of equity issuance costs, as described below, and both were affected by the conversion of $32.5 million notes as documented above.  At the dates indicated, the net carrying amount of the liability component and the remaining unamortized debt discount were as follows (in thousands):
 
   
December 31,
  
   
2014
    
2013
  
Carrying amount of equity component
   $
14,930
     $ 20,470  
Carrying amount of the liability component
     82,543       108,750  
Unamortized discount of the liability component
    
4,982
       11,250  
Unamortized debt financing costs
     901       2,034  
 
The Company incurred debt issuance costs of $4.7 million related to its issuance of the Notes.  In accordance with ASC 470-20, the Company allocated this debt issuance cost ratably between the liability and equity components of the Notes, resulting in $3.9 million of debt issuance costs allocated to the liability component and $0.8 million allocated to the equity component.  The portion allocated to the liability component was classified as deferred financing costs and is being amortized by the effective interest method through the earlier of the maturity date of the Notes or the date of conversion, while the portion allocated to the equity component was recorded as an offset to additional paid-in capital upon issuance of the Notes.

During the years ended December 31, 2014, 2013 and 2012, the Company recorded the following expenses in relation to the Notes (in thousands):
 
 
65
 
   
2014
    
2013
    
2012
  
Interest expense at 3.50% coupon rate
   $
4,105
     $ 4,200     $ 4,200  
Debt discount amortization
     4,317       4,113       3,828  
Deferred financing cost amortization
     780       744       692  
Loss on conversion
     990       —       —  
    $
10,192
     $ 9,057     $ 8,720  
 
Upon issuing the Notes, the Company established a deferred tax liability of $8.6 million related to the debt discount of $21.3 million, with an offsetting debit of $8.6 million to common stock.  The deferred tax liability was established because the amortization of the debt discount generates non-cash interest expense that is not deductible for income tax purposes.  Since the Company’s net deferred tax assets were fully reserved by valuation allowance at the time the Notes were issued, the Company reduced its valuation allowance by $8.6 million upon recording the deferred tax liability related to the debt discount with an offsetting credit of $8.6 million to common stock.  As a result, the net impact of these entries was a debit of $8.6 million to the valuation reserve against the Company’s deferred tax assets and a credit of $8.6 million to deferred tax liability.  The deferred tax liability is being amortized monthly as the Company records non-cash interest from its amortization of the debt discount on the Notes.

Aggregate cumulative maturities of long-term obligations commencing in 2015 are:

(In thousands)
  
2015
    
2016
    
2017
    
2018
    
Thereafter
  
Maturities
   $ 10,450     $
97,975
     $ 10,450     $ 10,450     $ 1,000,588  

Bank of America Credit Facility
 
On October 7, 2011, the Company and its domestic subsidiaries (the “Borrowers”) entered into a Loan and Security Agreement (the “BoA Credit Agreement”) with Bank of America, N.A. (the “Agent”) and other financial institutions (collectively with the Agent, the “BoA Lenders”) through which it obtained a $20.0 million revolving line of credit, which included a $2.0 million letter of credit facility. On April 17, 2014, concurrent with the Company entering into the JPM Credit Agreement, the Company and the Agent agreed to early terminate the BoA Credit Agreement, without penalty.
 
Note 7 — Earnings per Common Share

Basic net income per common share is based upon the weighted average common shares outstanding during the period. Diluted net income per common share is based upon the weighted average number of common shares outstanding, including the dilutive effect, if any, of stock options, warrants and the conversion feature of convertible notes using the treasury stock method.
 
Diluted net income per share assumed the principal amount of the convertible Notes would be cash settled and any conversion spread would be settled using common shares, as the Company has the choice of settling either in cash or shares. The Company had demonstrated a past practice and intent of cash settlement for the principal and stock settlement of the conversion spread. As a result, earnings per share calculations for periods ended prior to and including September 30, 2014 only included the assumption of conversion to common shares for the convertible spread. During the quarter ended December 31, 2014, the Company changed its practice of cash settlement and settled redemptions using common shares for both the principal and conversion spread and accordingly, earnings per share amounts were calculated using the if-converted method. For the year ended December 31, 2014, the earnings per share amounts were calculated using the if-converted method.

The Company’s potentially dilutive shares consist of: (i) vested and unvested stock options that are in-the-money, (ii) unvested RSAs, (iii) warrants that are in-the-money, and (iv) shares potentially issuable upon conversion of the Notes.  
 
A reconciliation of the earnings per share data from a basic to a fully diluted basis is detailed below (amounts in thousands, except per share data):

   
2014
    
2013
    
2012
  
Income from continuing operations used for basic earnings per share
   $
35,848
     $ 52,362     $ 35,378  
Convertible debt income adjustments, net of tax
     5,825       —       —  
Income from continuing operations adjusted for convertible debt as used for diluted earnings per share
   $
41,673
     $ 52,362     $ 35,378  
Income from continuing operations per share:
                        
   Basic
   $
0.35
     $ 0.54     $ 0.37  
   Diluted (1)
   $
0.34
     $ 0.46     $ 0.32  
Loss from discontinued operations, net of tax
   $ (503 )   $ —     $ —  
Loss from discontinued operations, net of tax per share:
                        
   Basic
   $
(0.01
 )   $ —     $ —  
   Diluted
   $
(0.01
 )   $ —     $ —  
                         
Shares used in computing income (loss) per share:
                        
Weighted average basic shares outstanding
     103,480       96,181       95,189  
Dilutive securities:
                        
   Stock options and unvested RSAs
     4,234       4,516       4,289  
   Stock warrants
     1,874       6,702       6,564  
   Shares issuable on conversion of the Notes (2)
     13,522       6,499       4,468  
Total dilutive securities
     19,630       17,717       15,321  
                         
Weighted average diluted shares outstanding
     123,110       113,898       110,510  
 
 
66
 
 
(1)
Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $5.8 million, after-tax for the year ended December 31, 2014.
 
(2)
Shares issuable on conversion of the Notes for the year ended December 31, 2014 have increased in comparison to the fiscal years ended December 31, 2013 and 2012 due to stock appreciation which underlies the shares issuable on conversion of the notes and the Company’s change in practice on October 1, 2014 to more likely than not settle future note conversions solely through shares as we are now utilizing the if-converted method for convertible debt conversion obligations.

Note 8 — Leasing Arrangements

The Company leases real and personal property in the normal course of business under various operating leases, including non-cancelable and month-to-month agreements. Rental expense under these leases was $3.3 million, $2.9 million and $2.3 million for the years ended December 31, 2014, 2013 and 2012, respectively.

Landlord incentives are recorded as deferred rent and amortized on a straight-line basis over the lease term.  Rent escalations are recorded on a straight-line basis over the lease term.  The Company’s main operating leases for its Lake Forest and Gurnee facilities have original terms of ten years.  The Lake Forest facility lease allows for a five-year renewal at the option of the Company.

The following is a schedule, by year, of future minimum rental payments required under non-cancelable operating and capital leases in place as of December 31, 2014 (in thousands):

Year ending December 31,
      
2015
   $
2,569
  
2016
    
2,532
  
2017
    
2,230
  
2018
    
769
  
2019
     466  
2020 and thereafter
    
3,182
  
Total
   $
11,748
  

Through the acquisition of VersaPharm during 2014, our wholly owned subsidiary Clover Pharmaceuticals Corp. leased a research and development facility in Warminster, Pennsylvania for an initial term ending December 31, 2017 , with option to renew for an additional 3 years. Monthly rent at the Warminster facility is approximately $11,000 for 12,000 square feet and is used for drug research and development and administrative activities related to our Prescription Pharmaceuticals segment. As part of the VersaPharm acquisition, the Company also took over a lease of a warehouse and office space in Marietta, Georgia consisting of approximately 20,000 square feet and terminated effective August, 2016 with monthly rent of approximately $10,000. All other leases maintained by VersaPharm and its subsidiaries prior to the acquisition have been terminated.

On December 1, 2012, the Company entered into a lease for a new R&D center in Vernon Hills, Illinois which was expanded during the year ended December 31, 2014.  This lease extends through April 30, 2020, and obligates the Company to pay monthly rent of approximately $15,000, plus proportionate real estate taxes and common area maintenance.  Prior to moving its R&D activities to Vernon Hills, Illinois, the Company had leased space for its R&D activities within the Illinois Science & Technology Park in Skokie, Illinois.  This lease commenced on February 1, 2010, and extended through its early termination date of February 1, 2014.  Upon vacating the Skokie space shortly after moving R&D operations to Vernon Hills, Illinois, the Company accrued to expense its remaining obligations under the Skokie lease.

On July 27, 2010, the Company, through its wholly owned subsidiary, Akorn (New Jersey), Inc., an Illinois corporation, entered into a seven-year building lease agreement (the “Original Somerset Lease”) with Veronica Development Associates, a New Jersey general partnership, extending the Company’s occupancy of its 50,000 square foot manufacturing facility located at 72-6 Veronica Avenue, Somerset, New Jersey. This lease commenced on August 1, 2010 and continues through July 31, 2017. Under terms of the new lease, base rent was initially set at $38,801 per month, subject to periodic cost of living adjustments. In addition to base rent, the Company is obligated to pay its proportionate share of estimated property taxes, assessments and maintenance costs. The lease agreement contains a renewal provision allowing the Company the option to renew for up to four additional five-year periods upon providing written notice of its intention to renew at least six months prior to termination of the original lease or any renewal period. Furthermore, on January 24, 2011 the Company entered into an additional lease in Somerset for approximately 6,600 square feet of warehousing space to store various pharmaceutical products (the “Somerset Warehouse Lease”). The monthly lease was set at $3,300 per month, subject to similar period cost of living adjustments and other proportionate costs as the Original Somerset Lease. The lease agreement is set for annual renewal at the option of the Company and has been renewed until at least January 31, 2016.
 
 
67
 
On March 3, 2010, the Company entered into an eight-year sub-lease agreement with a related party, EJ Financial Enterprises, Inc. (“EJ Financial”), for their sub-lease of a portion of the Company’s corporate offices in Lake Forest, Illinois.  John N. Kapoor, Ph.D., Chairman of the Company’s Board of Directors, is the President of EJ Financial.  This sub-lease commenced on April 1, 2010.  Per the terms of the sub-lease agreement, EJ Financial will pay monthly base rent plus a proportionate share of common area maintenance costs.   The Company and EJ Financial agreed to early terminate this agreement, and the sub-lease was terminated in July 2012 at which time the space was retrofitted for corporate purposes.  EJ Financial paid the Company approximately $240,000 in rent and common area maintenance fees during the shortened term of this sub-lease.
 
Note 9 — Stock Options, Employee Stock Purchase Plan and Restricted Stock

Stock Option Plan

The Company maintains equity compensation plans that allow the Company’s Board of Directors to grant stock options to eligible employees, officers and directors.  Under the 2003 Stock Option Plan, 2,519,000 options were granted, none of which remained outstanding as of December 31, 2011.  On March 29, 2005, the Company’s Board of Directors approved the Amended and Restated Akorn, Inc. 2003 Stock Option Plan (the “Amended 2003 Plan”), effective as of April 1, 2005, and this was subsequently approved by its stockholders on May 27, 2005. The Amended 2003 Plan was an amendment and restatement of the 2003 Stock Option Plan and provides the Company with the ability to grant other types of equity awards to eligible participants besides stock options. Starting on May 27, 2005, all new awards were granted under the Amended 2003 Plan.  The aggregate number of shares of the Company’s common stock initially approved for issuance pursuant to awards granted under the Amended 2003 Plan was 5,000,000.  On August 7, 2009, the Company’s stockholders voted to increase this figure to 11,000,000 at the recommendation of the Company’s Board of Directors, and on December 31, 2011 voted to increase the available shares by another 8,000,000, to a final total of 19,000,000 shares. Under the Amended 2003 Plan, 15,828,000 options have been granted to employees and directors, 6,529,000 options have been exercised, 4,331,000 options have been canceled, and 4,968,000 remain outstanding as of December 31, 2014.  Options granted under the Amended 2003 Plan have exercise prices equivalent to the market value of the Company’s common stock on the date of grant and expire five years from date of issuance.  All options granted during 2013 vest one quarter per year on each of the first four anniversaries of their grant dates.  Options granted in earlier years generally had a three-year vesting schedule.

The Amended 2003 Plan reached its scheduled expiration date on November 6, 2013.  Accordingly, no additional awards may be issued under the Amended 2003 Plan beyond that date.  However, any awards outstanding as of November 6, 2013 issued under the Amended 2003 Plan will remain outstanding in accordance with their terms.

At the Company’s 2014 Annual Meeting of Shareholders, the Company’s shareholders approved the adoption of the Akorn, Inc. 2014 Stock Option Plan (the “2014 Plan”). The 2014 Plan reserves 7.5 million shares for issuance upon the grant of stock options, restricted shares, or various other instruments to directors, employers and consultants.

Under the 2014 Plan, 1,475,000 options have been granted to employees and directors, no options have been exercised, 57,000 options have been canceled, and 1,419,000 remain outstanding as of December 31, 2014.  Options granted under the 2014 Stock Option Plan have exercise prices equivalent to the market value of the Company’s common stock on the date of grant and expire from five to ten years from date of issuance depending on the option grant date.  All options granted to employees during the year ended December 31, 2014 vest one quarter per year on each of the first four anniversaries of their grant dates while all options granted to non-employee directors fully vest on the first anniversary date of their grant.

The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation – Stock Compensation (formerly SFAS No. 123 (revised 2004), Share Based Payment (SFAS 123(R))).  Accordingly, stock-based compensation cost is estimated at the grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions that enter into the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. Treasury securities in effect during the quarter in which the options were granted. The dividend yield reflects historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises in subsequent periods, if necessary, if actual forfeitures differ from those estimates.

 
68
 
The Company recorded stock option compensation expense of approximately $6.0 million, $6.2 million and $6.4 million during the years ended December 31, 2014, 2013 and 2012, respectively.  The Company uses the single-award method for allocating the compensation cost to each period.

The assumptions used in estimating the fair value of the stock options granted during the period, along with the weighted-average grant date fair values, were as follows:
 
 
2014
  
2013
  
2012
           
Expected volatility
46%
 -
71%
   49% -
68%
   77% -
85%
Expected life (in years)
  
5.4
        4.0
  
    
4.0
  
Risk-free interest rate
 0.9% -
2.2%
   0.7% -
1.4%
   0.7% -
0.8%
Dividend yield
  
—
      
—
      
—
  
Fair value per stock option
  
$16.08
 
    
$6.95
 
    
$7.76
  
 
     A summary of stock option activity within the Company’s stock-based compensation plans for the years ended December 31, 2014, 2013 and 2012 is as follows:
 
 
 
 
 
  
 
Number of
Shares
(in thousands)
    
 
Weighted
Average
Exercise Price
    
Weighted Average
Remaining
Contractual Term
(Years)
    
Aggregate
Intrinsic Value
(in thousands)
  
Outstanding at December 31, 2011
     9,399     $ 2.89                  
Granted
     1,221       12.96                  
Exercised
     (806 )     1.87                  
Forfeited or expired
     (87 )     4.42                  
Outstanding at December 31, 2012
     9,727     $ 4.22                  
Granted
     321       15.76                  
Exercised
     (630 )     4.18                  
Forfeited or expired
     (190 )     13.10                  
Outstanding at December 31, 2013
     9,228     $ 4.45                  
Granted
     1,475       28.59                  
Exercised
     (4,226 )     1.91                  
Forfeited or expired
     (91 )     22.56                  
Outstanding at December 31, 2014
     6,386     $
11.44
       2.48     $ 158,097  
Exercisable at December 31, 2014
     4,316     $ 5.43       1.01     $ 132,813  

The aggregate intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company’s common stock at the end of the period and the exercise price of the in-the-money stock options. The total intrinsic value of stock options exercised during the years ended December 31, 2014, 2013 and 2012 was approximately $141.7 million, $8.9 million and $9.1 million, respectively. As a result of the stock options exercised, the Company received cash and recorded additional paid-in-capital of approximately $8.0 million, $2.6 million and $1.5 million during the years ended December 31, 2014, 2013 and 2012, respectively.

As of December 31, 2014, the total amount of unrecognized compensation cost related to non-vested stock options was approximately $20.7 million which is expected to be recognized as expense over a weighted-average period of 3.1 years.

From time to time the Company grants restricted stock awards to certain employees and members of its Board of Directors (“Directors”). Restricted share awards are valued at the closing market price of the Company’s common stock on the day of grant and the total value of the award is recognized as expense ratably over the vesting period of the grants.
 
On May 2, 2014, the Company granted a total of 71,582 restricted shares to senior management which vest at 25% per year on the anniversary date of the grant ending May 2, 2018. Also on May 2, 2014, the Company modified approximately 2.3 million options to extend the option term for grants to certain individuals in Senior Management. On September 5, 2014, the Company granted a total of 257,416 restricted shares to senior management and 8,034 shares to a Director to make the individuals who received extended option terms on May 2, 2014 whole given increased tax liabilities. The shares each vest at 25% per year on the anniversary date of the grant ending September 5, 2018. On May 3, 2013, the Company granted a total of 31,899 restricted shares to its Directors, of which 15,946 shares vested immediately upon issuance and the remaining 15,953 shares vested on May 3, 2014.  During 2012, the Company granted 35,000 shares of restricted shares valued at approximately $0.5 million to members of its Board of Directors, of which half vested immediately and half vested on the one year anniversary of grant.  The Company recognized compensation expense of approximately $1.2 million, $0.6 million and $0.4 million during the years ended December 31, 2014, 2013 and 2012, respectively, related to restricted stock awards.

 
69
 
The following is a summary of non-vested restricted stock activity:
 
   
Number of Shares
(in thousands)
    
Weighted Average
Grant Date Fair Value
  
Nonvested at December 31, 2011
     13     $ 1.34  
Granted
     35       14.63  
Vested
     (30 )     9.09  
Canceled
     —       —  
Nonvested at December 31, 2012
     18     $ 14.63  
Granted
     32       15.36  
Vested
     (34 )     14.98  
Canceled
     —       —  
Nonvested at December 31, 2013
     16     $ 15.36  
Granted
     337       35.31  
Vested
     (16 )     15.36  
Canceled
     —       —  
Nonvested at December 31, 2014
     337     $ 35.31  

As of December 31, 2014, the total amount of unrecognized compensation cost related to restricted stock awards was approximately $10.8 million which is expected to be recognized as expense over a weighted-average period of 3.6 years.

Employee Stock Purchase Plan

     The Akorn, Inc. Employee Stock Purchase Plan (the “ESPP”) permits eligible employees to acquire shares of the Company’s common stock through payroll deductions.  The ESPP has been structured to qualify under Section 423 of the Internal Revenue Code (“IRC”).  Employees who elect to participate in the ESPP may withhold from 1% to 15% of base wages toward the purchase of stock.  Shares are purchased at a 15% discount off the lesser of the market price at the beginning or the ending of the applicable offering period.  The ESPP has two offering periods each year, one running from January 1st to December 31st and the other running from July 1st to December 31st.  In a given year, employees may enroll in either plan, but not both.  Per IRC rules, annual purchases per employee are limited to $25,000 worth of stock, valued as of the beginning of the offering period.  Accordingly, with the 15% discount, employees may withhold no more than $21,250 per year toward the purchase of stock under the ESPP.

     A maximum of 2 million shares of the Company’s common stock may be issued under the ESPP.  Including shares issues in early 2015 related to employee participation in the ESPP during 2014, a total of 1,420,438 shares have been issued thus far under the ESPP, leaving 579,562 shares available for future issuance.  The Company issued approximately 67,000, 73,000 and 61,000 shares of its common stock related to employee participation in the ESPP during 2014, 2013 and 2012, respectively.  For the years ended December 31, 2014, 2013 and 2012, the Company recorded compensation expense of approximately $0.4, $0.2 and $0.2 million, respectively in each period related to the ESPP.
 
Note 10 — Income Taxes from Continuing Operations

The income tax provision (benefit) from continuing operations consisted of the following (in thousands):
 
 
  
Current
    
Deferred
    
Total
  
Year ended December 31, 2014
                  
Federal
   $ 34,799     $ (11,674 )   $ 23,125  
State
     4,991       (2,698 )     2,293  
Foreign
     4       (2,134 )     (2,130 )
    $ 39,794     $ (16,506 )   $ 23,288  
Year ended December 31, 2013
                        
Federal
   $ 27,985     $ (3,050 )   $ 24,935  
State
     4,145       2,051       6,196  
Foreign
     —       (598 )     (598 )
    $ 32,130     $ (1,597 )   $ 30,533  
Year ended December 31, 2012
                        
Federal
   $ 20,843     $ (504 )   $ 20,339  
State
     4,232       (911 )     3,321  
Foreign
     —       (1,538 )      (1,538 )
    $ 25,075     $ (2,953 )   $ 22,122  
 
 
70
 
Income tax expense differs from the “expected” tax expense computed by applying the U.S. Federal corporate income tax rates of 35% to income from continuing operations before income taxes, as follows (in thousands):
 
 
  
Years Ended December 31,
  
 
  
2014
    
2013
    
2012
  
Computed “expected” tax expense
   $ 20,698     $ 29,013     $ 20,125  
Change in income taxes resulting from:
                        
State income taxes, net of Federal income tax
     1,490       4,027       2,159  
Foreign income tax expense (benefit)
     (454 )     622       1,468  
Deduction for domestic production activities
     (1,444 )     (1,361 )     (1,277 )
R&D tax credits
     (447 )     (1,652 )     (508 )
Other expense (benefit), net
     2,329       (116 )     155  
Valuation allowance change
     1,116       —       —  
Income tax expense
   $ 23,288     $ 30,533     $ 22,122  
 
The geographical allocation of the Company’s income from continuing operations before income taxes between U.S. and foreign operations was as follows (in thousands):
 
   
2014
    
2013
    
2012
  
Pre-tax income from continuing U.S. operations
   $
67,114
     $ 86,382     $ 66,087  
Pre-tax loss from continuing foreign operations
     (7,978 )     (3,487 )     (8,587 )
Total pre-tax income from continuing operations
   $
59,136
     $ 82,895     $ 57,500  

Net deferred income taxes at December 31, 2014 and 2013 include (in thousands):

   
December 31, 2014
    
December 31, 2013
  
   
Current
    
Noncurrent
    
Current
    
Noncurrent
  
Deferred tax assets:
                        
   Net operating loss carry-forward
   $ 4,277     $ 16,190     $ 439     $ 14,061  
   Stock-based compensation
     —       6,408       —       6,630  
Chargeback reserves
     5,391       —       —       —  
   Reserve for product returns
     12,255       —       3,189       —  
   Inventory valuation reserve
     5,764       —       2,193       —  
   Other
     8,570      
192
       3,325       1,751  
      Total deferred tax assets
   $ 36,257     $
22,790
     $ 9,146     $ 22,442  
      Valuation allowance
     —       (1,116 )     —       —  
            Net deferred tax assets
   $ 36,257     $
21,674
     $ —     $ —  
                                 
Deferred tax liabilities:
                                
   Prepaid expenses
   $ (1,982 )   $ —     $ (1,120 )   $ —  
   Inventory step-up
     (1,619 )     —                  
   Unamortized discount – convertible notes
     —       (1,776 )     —       (4,223 )
   Depreciation & amortization – tax over book
     —       (285,022 )     —       (16,576 )
   Other
     —       —       (81 )     —  
      Total deferred tax liabilities
   $ (3,601 )   $ (286,798 )   $ (1,201 )   $ (20,799 )
                                 
Net deferred income tax asset (liability)
   $ 32,656     $ (265,124 )   $ 7,945     $ 1,643  
 
The Company records a valuation allowance to reduce net deferred income tax assets to the amount that is more likely than not to be realized. In performing its analysis of whether a valuation allowance to reduce the deferred income tax asset was necessary, the Company evaluated the data and determined that as of December 31, 2014 it could not conclude that it was more likely than not that certain of the net operating losses of its Indian subsidiary would be realized.  Accordingly, the Company established a valuation allowance of $1.1 million against its deferred tax assets as of December 31, 2014.  The Company had concluded that all of its deferred tax assets were more likely than not to be realized as of December 31, 2013; accordingly, no valuation allowance was in place as of that date.

 
71
 
The deferred tax balances have been reflected gross on the balance sheet, and are netted only if they are in the same jurisdiction.
     
The Company’s net operating loss (“NOL”) carry-forwards as of December 31, 2014 consist of three component pieces: (i) U.S. Federal NOL carry-forwards valued at $11.3 million, (ii) Illinois NOL carry-forwards valued at $2.2 million, and (iii) foreign (Indian) NOLs of $7.1 million.  The U.S. Federal NOL carry-forwards were obtained through the Merck Acquisition completed in the fourth quarter of 2013, ($7.5 million) and the acquisition of VersaPharm in the third quarter of 2014 ($3.8 million).  The Illinois NOL carry-forwards relate to the Company’s tax losses in the decade of the 2000s and have not yet been fully utilized due to the State of Illinois’s suspension of the use of NOLs for the years 2011, 2012 and 2013.  These NOLs would be due to expire from 2021 to 2025, and are expected to be utilized well before their expiration dates.  The foreign NOL carry-forwards relate to operating losses by the Company’s subsidiary in India, which was acquired in 2012.  Of the $7.1 million foreign NOL, $1.1 million expire beginning in 2022; the Company has established a valuation allowance against this entire amount.  The remaining $6.0 million of the foreign NOLs can be carried forward indefinitely, and the Company has concluded that they are more likely than not to be utilized and therefore has not established a valuation allowance against them.  The Company previously had valued NOL carry-forwards in the State of New Jersey.  However, due to changes in the tax law, the Company determined that these NOLs would never be utilized and wrote them off during 2013.

In late 2014, the Company was notified that its Federal income tax return for the year ended December 31, 2013 would be examined by the Internal Revenue Service beginning in early 2015.  The Company’s Hi-Tech Pharmacal subsidiary is currently undergoing an examination by the Internal Revenue Service for its tax year ended April 30, 2013.  The Company’s VersaPharm subsidiary has also been notified that its Federal income tax return for the year ended December 31, 2012 will be examined beginning in 2015.  Additionally, the Company is undergoing examinations by Illinois and Massachusetts for various tax years.  The Company’s U.S. Federal income tax returns filed for years 2011 through 2013 are open for examination by the Internal Revenue Service.  The majority of the Company’s state and local income tax returns filed for years 2010 through 2013 remain open for examination as well.

In accordance with ASC 740-10-25, Income Taxes – Recognition, the Company performs reviews of its tax positions to determine whether it is “more likely than not” that its tax positions will be sustained upon examination, and if any tax positions are deemed to fall short of that standard, the Company reserves based on the financial exposure and the likelihood of its tax positions not being sustained.  Based on its review as of December 31, 2014, the Company determined that it would not recognize tax benefits as follows (in thousands):

Balance at December 31, 2011
   $ —  
Additions relating to current year
     1,265  
Additions relating to prior years
     220  
Balance at December 31, 2012
   $ 1,485  
Additions relating to current year
     589  
Terminations of exposures relating to prior years
     (1,229 )
Balance at December 31, 2013
   $ 845  
Additions relating to current year
     408  
Additions relating to acquired entities
     456  
Terminations of exposures relating to prior years
     —  
Balance at December 31, 2014
   $ 1,709  
 
If recognized, $1.2 million of the above positions will impact the Company’s effective rate, while the remaining $0.5 million will result in a reduction of the Company’s goodwill.  Due to the uncertainty of both timing and resolution of potential income tax examinations, the Company is unable to determine whether any amounts included in the December 31, 2014 balance of unrecognized tax benefits represent tax positions that could significantly change during the next twelve months.  The Company accounts for interest and penalties as income tax expense.  There were no uncertain tax positions prior to 2012.

Note 11 — Retirement Plan

All full-time Akorn employees are eligible to participate in the Company’s 401(k) Plan. During the years ended December 31, 2014, 2013 and 2012, plan-related expense totaled approximately $1.3 million, $0.8 million and $0.8 million, respectively. The Company provides a matching contribution based on a percentage of the amount contributed by each employee, which is funded on a current basis.  The Company suspended its match on 401(k) contributions during 2009 and did not match 401(k) contributions through March 31, 2010.  Effective April 1, 2010, the Company reinstituted a matching contribution at a rate of 25% of the first 6% contributed by employees.  On January 1, 2011, the Company increased its matching contribution to 50% of the first 6% contributed, and has maintained this match rate through December 31, 2014.  Company matching contributions vest 50% after two years of credited service and 100% after three years of credited service.
 
 
72
 
Note 12 — Segment Information

During the year ended December 31, 2014, the Company acquired Hi-Tech and as a result, underwent a change in the organizational and reporting structure of the Company's reportable segments, establishing two reporting segments that each report to the Chief Operating Decision Maker (CODM), as defined in ASC Topic 280, Segment Reporting, and Chief Executive Officer (CEO), Raj Rai. Our performance will be assessed and resources will be allocated by the CODM based on the following two reportable segments:

- Prescription Pharmaceuticals
- Consumer Health

Prior to the realignment the Company managed the business as three distinct reporting segments; Ophthalmics, Hospital Drugs and Injectables, and Contract Services.

The changes combine operations that have a similar product type, serve comparable customers and address similar business issues and industry dynamics. The new segment reporting structure provides shareholders and other users of our financial statements with more useful information about our segments.

     
Current Segments
     
Prescription Pharmaceuticals
Consumer Health
Former Segments
Akorn
Ophthalmics
X
X (a)
Hospital Drugs and Injectables
X
  
Contract Services
X
  
Hi-Tech
Generic Pharmaceuticals (“Hi-Tech Generic”)
X
  
OTC Branded Pharmaceuticals (“HCP”)
  
X (b)
Prescription Brands (“ECR”)
     X (c)
  

(a)
Represents the previous acquisition of Advanced Vision Research, Inc./TheraTears®
(b)
Represents the previous Hi-Tech reportable segment HCP (“Health Care Products”)
(c)
Represents the previous Hi-Tech reportable segment ECR which was divested during the year ended December 31, 2014 and whose results have been included within discontinued operations.

The Company’s Prescription Pharmaceutical segment principally consists of generic and branded Prescription Pharmaceuticals products which span a broad range of indications as well as a variety of dosage forms including: sterile ophthalmics, injectables and inhalants, and non-sterile oral liquids, topicals, nasal sprays. In addition, the Company, through Akorn India Private Limited (“AIPL”), manufactures pharmaceuticals for various markets outside the US. The Company’s Consumer Health segment principally consists of animal health and over-the-counter products, both branded and private label.  OTC products includes a suite of products for the treatment of dry eye sold under the TheraTears® brand name.

Financial information about the Company’s reportable segments is based upon internal financial reports that aggregate certain operating information. The Company’s CEO oversees operational assessments and resource allocations based upon the results of the Company’s reportable segments, which have available and discrete financial information.

Selected financial info by reporting segment is presented below (in thousands). The Company has restated prior periods including the years ended December 31, 2013 and 2012 to reflect the strategic realignment described above.
 
 
  
Years ended December 31,
  
 
  
2014
    
2013
    
2012
  
REVENUES
                  
Prescription Pharmaceuticals
   $ 542,846     $ 279,911     $ 223,881  
Consumer Health
     50,232       37,800       32,277  
Total revenues
   $ 593,078     $ 317,711     $ 256,158  
                         
GROSS PROFIT
                        
Prescription Pharmaceuticals
   $ 270,197     $ 151,182     $ 129,884  
Consumer Health
     27,393       20,722       18,808  
Total gross profit
   $ 297,590     $ 171,904     $ 148,692  

The Company manages its business segments to the gross profit level and manages its operating and other costs on a company-wide basis. Inter-segment activity at the gross profit level is minimal. The Company does not have discrete assets by segment, as certain manufacturing and warehouse facilities support more than one segment, and therefore does not report assets by segment.

 
73
 
During 2014, 2013 and 2012, approximately $16.6 million, $27.3 million and $29.4 million of the Company’s net revenue, respectively, was from customers located in foreign countries.  Sales generated by Akorn India Private Limited, the Company’s wholly owned subsidiary in India, accounted for $7.2 million, $15.8 million and $16.7 million of the foreign sales amounts for 2014, 2013 and 2012, respectively.  In these years, AIPL sold product exclusively to contract customers in India and to export customers in unregulated world markets, outside the United States, which has declined in the current year due to a reduction in the customer base.

Goodwill from the Company’s acquisition of Advanced Vision Research, Inc. in May 2011, the acquisition of selected assets of Kilitch Drugs (India) Limited in February 2012, the merger with Hi-Tech and subsequent disposal of the Watson assets on April 17, 2014, the disposal of the ECR component June 20, 2014 and the acquisition of VersaPharm on August 12, 2014 have been allocated to the appropriate reporting segment and reporting unit.  The carrying amounts of goodwill as restated by segment were as follows (in thousands):
 
   
Prescription Pharmaceuticals
    
Consumer Health
    
Total
  
December 31, 2012
   $ 20,296     $ 11,863     $ 32,159  
Acquisitions
  
─
    
─
    
─
  
Impairments
  
─
    
─
    
─
  
Foreign currency Translation
     (2,328 )  
─
       (2,328 )
December 31, 2013
   $ 17,968     $ 11,863     $ 29,831  
Acquisitions
     256,057       4,854       260,911  
Impairments
  
─
    
─
    
─
  
Dispositions
     (11,454 )  
─
       (11,454 )
Foreign currency translations
     (514 )  
─
       (514 )
December 31, 2014
   $ 262,057     $ 16,717     $ 278,774  

Note 13 — Commitments and Contingencies

On January 2, 2014 the Company acquired the U.S. NDA rights to Betimol® from Santen. The total consideration payable will equal 1.5 times the Company’s net sales of Betimol® in the first year following acquisition. The Company paid consideration of $7.5 million upon closing this transaction and expects to owe additional consideration, which will become payable in the first quarter of 2015. The additional consideration contingently payable to Santen was initially estimated at $4.5 million discounted to $4.0 million based on a discount rate of 12.6%. The Company performed evaluations of the fair value of this liability at December 31, 2014 based on utilizing significant unobservable inputs and determined the fair value of this liability to be $4.3 million.

The Company has entered into strategic business agreements for the development and marketing of finished dosage form pharmaceutical products with various pharmaceutical development companies.

Each strategic business agreement includes a future payment schedule for contingent milestone payments and in certain strategic business agreements, minimum royalty payments.  The Company will be responsible for contingent milestone payments and minimum royalty payments to these strategic business partners based upon the occurrence of future events.  Each strategic business agreement defines the triggering event of its future payment schedule, such as meeting product development progress timelines, successful product testing and validation, successful clinical studies, various FDA and other regulatory approvals and other factors as negotiated in each agreement.  None of the contingent milestone payments or minimum royalty payments is individually material to the Company.  

On October 17, 2012, the Company entered into an exclusive distribution agreement with the Massachusetts Biological Laboratory of the University of Massachusetts (“MBL”) for the Company’s marketing of MBL-manufactured tetanus-diphtheria vaccine (“Td vaccine”) over an initial contract term of two (2) years. On July 1, 2014, the Company terminated the agreement and renegotiated a new distribution agreement for an additional contract term of (1) year. The new agreement commits the Company to acquire $4.8 million of Td vaccine in the first six months of the fiscal year ended December 31, 2015.

The Company is party to a supply agreement with a third party for the provision of two of the injectable pharmaceuticals acquired by the Company from Lundbeck on December 21, 2011. This agreement requires the Company to acquire product with an estimated total cost of approximately $1.9 million in 2015.

 
74
 
The table below summarizes contingent potential milestone payments due to strategic partners in the years 2015 and beyond, assuming all such contingencies occur (in thousands):

Year ending December 31,
  
Milestone Payments
  
2015
   $ 12,916  
2016
     3,250  
2017
     3,202  
2018
     21  
Total
   $ 19,389  
 
The Company is a party in legal proceedings and potential claims arising in the ordinary course of its business. The amount, if any, of ultimate liability with respect to such matters cannot be determined. Despite the inherent uncertainties of litigation, management of the Company believes that the ultimate disposition of such proceedings and exposures will not have a material adverse impact on the financial condition, results of operations, or cash flows of the Company.
 
Note 14 — Supplemental Cash Flow Information (in thousands)

   
Year ended December 31,
  
   
2014
    
2013
    
2012
  
Interest and taxes paid:
                  
   Interest paid
    
31,413
       4,320       4,200  
   Income taxes paid
     6,294       27,450       21,455  

Note 15 – Recent Accounting Pronouncements

In August 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-15 “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”), to provide guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for us in our fourth quarter of fiscal 2016 with early adoption permitted. The adoption of ASU 2014-15 is not expected to have a material effect on the Company’s consolidated financial statements or disclosures.
 
In May 2014, FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which provides guidance for revenue recognition. ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. This ASU also supersedes some cost guidance included in Subtopic 605-35, “Revenue Recognition-Construction-Type and Production-Type Contracts.” The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which a company expects to be entitled in exchange for those goods or services. In doing so, companies will be required to use more judgment and make more estimates than under previous guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for the Company for the fiscal year beginning January 1, 2017 and, at that time the Company may adopt the new standard under the full retrospective approach or the modified retrospective approach, as permitted under the standard. Early adoption of the standard is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company’s consolidated financial statements and disclosures.
 
In April 2014, the FASB issued ASU No. 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity” (“ASU 2014-08”), which changes the criteria for reporting discontinued operations while enhancing disclosures in this area. Pursuant to ASU 2014-08, only disposals representing a strategic shift, such as a major line of business, a major geographical area or a major equity investment, which were not expected to have continuing cash flows should be presented as a discontinued operation. If the disposal does qualify as a discontinued operation under ASU 2014-08, the entity will be required to provide expanded disclosures. ASU 2014-08 is effective for the Company beginning January 1, 2015. The adoption of ASU 2014-08 is not expected to have a material effect on the Company’s consolidated financial statements or disclosures.

 
75
 
In July 2013, the FASB issued Accounting Standards Update (“ASU”) 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.   ASU 2013-11 was issued to eliminate the diversity in practice in presentation of unrecognized tax benefits, and amends ASC 740, “Income Taxes,” to provide clarification of the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. According to the new guidance, unrecognized tax benefits will be netted against all available same-jurisdiction loss or other tax carryforward that would be utilized, rather than only being netted against carryforwards that are created by the unrecognized tax benefits. The revised guidance is effective for interim and annual periods beginning after December 15, 2013, with early adoption permitted.  Adoption of this guidance did not have a material impact on our financial statements or financial reporting.
 
Note 16 – Business Combinations, Dispositions and Other Strategic Investments

Excelvision AG

On July 22, 2014, our Luxembourg subsidiary, Akorn International S.à r.l., entered into a share purchase agreement with Fareva SA to acquire all of the issued and outstanding shares of capital stock of its wholly owned subsidiary, Excelvision AG, a Swiss Company (“Excelvision”) for 21.7 million Swiss Francs (“CHF”), net of certain working capital amounts. Excelvision is a contract manufacturer located in Hettlingen, Switzerland specializing in ophthalmic products.

On January 2, 2015, the Company acquired all of the outstanding shares of capital stock of Excelvision for $25.9 million U.S. dollars funded through available cash on hand. The consideration remains subject to a net working capital adjustment payable by the Company. The Company’s acquisition of Excelvision AG is being accounted for as a business combination in accordance with ASC 805 – Business Combinations.  The purpose of the acquisition is to expand the Company’s manufacturing capacity and reduce production costs. The Company will include information about the fair value of acquired assets and assumed liabilities of the Excelvision acquisition in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2015. During the year ended December 31, 2014, the Company recorded approximately $0.3 million in acquisition related expenses in connection with the Excelvision acquisition.

Lloyd Animal Health Products

On October 2, 2014, Akorn Animal Health, Inc., a wholly owned subsidiary of the Company entered into a definitive Product acquisition agreement with Lloyd, Inc., to acquire certain rights and inventory related to a suite of animal health injectable products (the “Lloyd Products”) used in pain management and anesthesia. The Company acquired the products for $16.1 million, funded through available cash paid at closing, and a contingent payment of $2.0 million, discounted to $1.9 million using a 4.5% discount rate and other unobservable inputs, which becomes payable upon FDA approval of a supplement related to one of the acquired products. The Company’s acquisition of the Lloyd Products is being accounted for as a business combination in accordance with ASC 805 – Business Combinations.  The purpose of the acquisition is to expand the Company’s animal health product portfolio.

The following table sets forth the consideration paid for the Lloyd Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with generally accepted accounting principles (“GAAP”).  The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of the Lloyd Products.

 
76
 
Consideration:
      
Amount of cash paid
  
$
16.1
  
Fair value of contingent payment
    
1.9
  
Total consideration at closing
  
$
18.0
  
         
Recognized amounts of identifiable assets acquired:
        
Accounts receivable
    
0.1
  
Inventory
    
2.5
  
Product licensing rights
    
10.0
  
IPR&D
    
5.5
  
Accounts payable assumed
    
(0.1)
  
Fair value of assets acquired
  
$
18.0
  

IPR&D assets represent ongoing in-process research and development projects obtained through the acquisition. Weighted average remaining amortization period of intangible assets acquired through the Lloyd acquisition as of the closing date was 10.7 years. The rights to Lloyd products are included within product licensing rights, net on the Company’s condensed consolidated balance sheet as of December 31, 2014.

The Company has not provided pro forma revenue and earnings of the Company as if the Lloyd Products Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Lloyd Product rights were not managed as a discrete business by the previous owner. Accordingly, determining the pro forma revenue and earnings of the Company including the Lloyd Products Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.

Xopenex Inhalation Solutions

On October 1, 2014, the Company entered into a definitive product acquisition agreement with Sunovion Pharmaceuticals Inc., a Delaware corporation to acquire certain rights and inventory related to the branded product, Xopenex® Inhalation Solution (levalbuterol hydrochloride) (the “Xopenex Product”) for $45 million, funded through available cash paid at closing, net of certain liabilities for product return reserves, rebates, and chargeback reserves, which were assumed by Oak Pharmaceuticals, Inc. (“Oak”), a subsidiary of Akorn, subject to a cap. The total cash paid at closing was $41.5 million, which was net of certain liabilities for product return reserves, rebates, and chargeback reserves assumed by the Company.

Xopenex® is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. The Company’s acquisition of Xopenex® (the “Xopenex Acquisition”) is being accounted for as a business combination in accordance with ASC 805 – Business Combinations.  The purpose of the Xopenex Acquisition is to expand the Company’s product portfolio of prescription pharmaceuticals.

Pursuant to the purchase agreement, certain trademarks and patents related to the Xopenex Product will be licensed to Oak by Sunovion. Further, in connection with closing the Purchase Agreement, the Company and Sunovion entered into a customary transition services agreement. Additionally, the Company assumed a distribution agreement for authorized generic of the product and assumed certain open purchase orders placed in ordinary course for active pharmaceutical ingredients.

The following table sets forth the consideration paid for the Xopenex Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.  The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of the Xopenex Product.

Consideration:
      
Amount of cash paid
  
$
41.5
  
Product returns and reserves assumed
    
3.5
  
Total consideration at closing
  
$
45.0
  
         
Recognized amounts of identifiable assets acquired:
        
Accounts Receivable, net (product returns and reserves assumed)
    
(3.5)
  
Inventory
    
6.3
  
Product licensing rights
    
38.7
  
Fair value of net assets acquired
  
$
41.5
  

 
77
 
Weighted average remaining amortization period of the intangible asset acquired as of the closing date was 10 years. The rights to Xopenex® are included within product licensing rights, net on the Company’s condensed consolidated balance sheet as of December 31, 2014.  During the year ended December 31, 2014, the Company recorded approximately $0.7 million in acquisition related expenses in connection with the Xopenex acquisition.

VPI Holdings Corp. Inc.

On August 12, 2014, the Company completed its acquisition of VersaPharm, a Georgia corporation for a total purchase price of approximately $433.0 million, subject to net working capital adjustments. This purchase price was based on acquiring all outstanding equity interests of VPI Holdings Corp. (“VPI”), the parent company of VersaPharm and was equal to $440.0 million, net of various post-closing adjustments related to working capital, cash, and transaction expenses of approximately $7.0 million.

On May 9, 2014, the Company entered into an Agreement and Plan of Merger (the “VP Merger Agreement”) to acquire VPI. Upon consummation of the merger, each share of VPI’s common stock and preferred stock issued and outstanding immediately prior to such time, other than those shares held in treasury by VersaPharm, owned by Akorn, Akorn Enterprises II, Inc., or VPI or any other subsidiary of VPI (each of which were cancelled) and to which dissenters’ rights have been properly exercised, were cancelled and converted into the right to receive its per share right to the aggregate merger consideration, subject to various post-closing adjustments related to working capital, cash, transaction expenses and funded indebtedness. In addition, all stock options of VPI held immediately prior to the consummation of the merger became fully vested and were cancelled upon consummation of the merger with the right to receive payment on the terms set forth in the VP Merger Agreement.

The acquisition was approved by the Federal Trade Commission (“FTC”) on August 4, 2014 following review pursuant to provisions of Hart-Scott Rodino Act (“HSR”). In connection with the VersaPharm Acquisition, the Company entered into an agreement (the “Rifampin Divestment Agreement”) with Watson, a wholly owned subsidiary of Actavis plc, to divest certain rights and assets to the Company’s Rifampin injectable product. Under the terms of the disposition the Company received $1.0 million for the pending product rights and recorded a gain of $0.8 million in Other non-operating income, net in the year ended December 31, 2014 related to the divestment.

VersaPharm is a developer and marketer of multi-source prescription pharmaceuticals. VersaPharm markets its products to drug wholesalers, retail drug chains, pharmaceutical distributors, group purchasing organizations, hospitals, clinics and government agencies.

The VersaPharm Acquisition complements and expands the Company’s product portfolio by diversifying its offering to niche dermatology markets.  VersaPharm’s product portfolio, pipeline and development capabilities are complementary to our acquisition of Hi-Tech Pharmacal Co, Inc. (“HiTech”) acquisition which brought with it the manufacturing capabilities needed for many of VersaPharm’s current and pipeline products. The VersaPharm Acquisition also enhances the Company’s new product pipeline as VersaPharm has significant research and development experience and knowledge and numerous IPR&D products are under active development.

The VersaPharm Acquisition was principally funded through a $445.0 million Incremental Term Loan Facility entered into concurrent with completing the acquisition, and through available Akorn cash. For further details on the term loan financing, please refer to the description in Note 6 – Financing Arrangements.

During the year ended December 31, 2014, the Company recorded approximately $8.1 million, in acquisition-related expenses in connection with the VersaPharm Acquisition. These expenses principally consisted of various legal fees and other acquisition costs which have been recorded within “acquisition related costs” as part of operating expenses in the Company’s consolidated statement of comprehensive income in the applicable periods.

The following table sets forth the consideration paid for the VersaPharm Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.  The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of VersaPharm.

 
78
 
Consideration:
  
Initial Fair
Valuation
    
Measurement
Period
Adjustments
    
Adjusted
 Fair
Valuation
  
Amount of cash paid to VersaPharm stockholders
   $ 322.7     $ —     $ 322.7  
Amount of cash paid to vested VersaPharm option holders
     14.2       —       14.2  
Amounts paid to escrow accounts
     10.3       —       10.3  
Transaction expenses paid for previous owners of VersaPharm
     3.4       —       3.4  
Total consideration paid at closing
     350.6       —       350.6  
VersaPharm debt paid off through closing cash
     82.4       —       82.4  
Total cash paid at closing
   $ 433.0     $ —     $ 433.0  
                         
Recognized amounts of identifiable assets acquired and liabilities assumed:
                        
Cash and cash equivalents
   $ 0.1     $ —     $ 0.1  
Accounts receivable
     10.0       1.0       11.0  
Inventory
     20.9       (0.2 )     20.7  
Other current assets
     2.8      
4.8
      
7.6
  
Property and equipment
     1.5       —       1.5  
Trademarks
     1.0       —       1.0  
Product licensing rights
     250.8       —       250.8  
Intangibles, other
     5.2       —       5.2  
IPR&D
     215.9       —       215.9  
Goodwill
     90.6       0.8       91.4  
Total assets acquired
   $ 598.8     $
6.4
     $
605.2
  
Assumed current liabilities
     (18.3 )     (0.6 )     (18.9 )
Assumed non-current liabilities
     (76.0 )             (76.0 )
Deferred tax liabilities
     (153.9 )      (5.8 )      (159.7 )
Total liabilities assumed
   $ (248.2 )   $
(6.4
 )   $ (254.6 )
    $ 350.6     $ —     $ 350.6  

The changes in estimates recorded subsequent to the initial accounting estimate was related to refining the calculated fair value of acquired accounts receivable and assumed tax amounts, due to the acquisition.
 
Goodwill represents expected synergies resulting from the combination of the entities and other intangible assets that do not qualify for separate recognition, while IPR&D assets represent ongoing in-process research and development projects obtained through the acquisition. The Company does not anticipate being able to deduct any of the associated incremental value of goodwill and other intangible assets for income tax purposes, but expects to be able to deduct approximately $43.2 million of value associated with pre-existing VersaPharm goodwill and other intangible assets for income tax purposes in future periods.
 
During the year ended December 31, 2014, the Company recorded net revenue of approximately $21.7 million related to sales of the VersaPharm products subsequent to acquisition.
 
Weighted average remaining amortization period of intangible assets acquired other than goodwill and IPR&D through the VersaPharm acquisition as of the closing date was 11.4 years in aggregate, 11.4 years for product licensing rights, 11.0 years for other intangibles, and 3 years for trademarks.

Hi-Tech Pharmacal Co., Inc.

On April 17, 2014, the Company completed its acquisition of Hi-Tech for a total purchase price of approximately $650.0 million. This purchase price was based on acquiring all outstanding shares of Hi-Tech common stock for $43.50 per share, buying out the intrinsic value of Hi-Tech’s stock options, and paying the single-trigger separation payments to various Hi-Tech executives due upon change in control. The total consideration paid is net of Hi-Tech’s cash acquired subsequent to Hi-Tech’s payment of $44.6 million of stock options and single trigger separation payments as of April 17, 2014.

On August 27, 2013, the Company entered into an Agreement and Plan of Merger (the “HT Merger Agreement”) to acquire Hi-Tech. Subject to the terms and conditions of the HT Merger Agreement, upon completion of the merger on April 17, 2014, each share of Hi-Tech’s common stock, par value $0.01 per share, issued and outstanding and held by non-interested parties at the time of the merger (the “Hi-Tech Shares”), was cancelled and converted into the right to receive $43.50 in cash, without interest, less any applicable withholding taxes, upon surrender of the outstanding Hi-Tech Shares.

 
79
 
In connection with the Hi-Tech Acquisition, the Company entered into an agreement (the “Divestment Agreement”) with Watson Laboratories, Inc., a wholly owned subsidiary of Actavis plc, to divest certain rights and assets - see below for further consideration.

Hi-Tech is a specialty pharmaceutical company which develops, manufactures and markets generic and branded prescription and OTC products. Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gel products. Hi-Tech’s Health Care Products division is a developer and marketer of OTC products, and their ECR Pharmaceuticals subsidiary markets branded prescription products. Hi-Tech operates a manufacturing facility and corporate offices in Amityville, New York, and ECR maintains its corporate offices in Richmond, Virginia.

The Hi-Tech Acquisition is expected to complement and expand the Company’s product portfolio by diversifying its offering to its retail customers beyond ophthalmics to other niche dosage forms such as oral liquids, topical creams and ointments, nasal sprays and otics. The Hi-Tech Acquisition is also expected to enhance the Company’s new product pipeline. Further, the Hi-Tech Acquisition will add branded OTC products in the categories of cough and cold, nasals, and topicals to the Company’s existing TheraTears® brand of eye care products, and will provide additional domestic manufacturing capacity for the Company.

The Hi-Tech Acquisition was principally funded through a $600.0 million term loan entered into concurrent with completing the acquisition, and through Hi-Tech cash assumed through the acquisition.

During the year ended December 31, 2014,and 2013 the Company recorded approximately $21.3 million and $1.6 million, respectively, in acquisition-related expenses in connection with the Hi-Tech Acquisition. These expenses principally consisted of various legal fees and other acquisition costs which have been recorded within “acquisition related costs” as part of operating expenses in the Company’s consolidated statement of comprehensive income in the applicable periods.

The following table sets forth the consideration paid for the Hi-Tech Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.  The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of Hi-Tech.

Consideration:
  
Initial Fair
Valuation
    
Measurement
Period
Adjustments
    
Adjusted Fair
Valuation
  
Amount of cash paid to Hi-Tech shareholders
   $ 605.0     $ —     $ 605.0  
Amount of cash paid to vested Hi-Tech option holders
     40.5       —       40.5  
Amount of cash paid to key executives under single-trigger separation payments upon change-in-control
     4.1       —       4.1  
    $ 649.6     $ —     $ 649.6  
 
Recognized amounts of identifiable assets acquired and liabilities assumed:
  
Initial Fair Valuation
    
Measurement Period Adjustments
    
Adjusted Fair Valuation
  
Cash and cash equivalents
   $ 89.7     $ —     $ 89.7  
Accounts receivable
     57.3       (5.7 )     51.6  
Inventory
     53.7       (0.7 )     53.0  
Other current assets
     20.6       13.1       33.7  
Property and equipment
     45.5       (2.0 )     43.5  
Product licensing rights
     343.5       —       343.5  
IPR&D
     9.4       —       9.4  
Customer Relationships
     0.3       —       0.3  
Trademarks
     5.5       —       5.5  
Goodwill
     171.5       (2.0 )     169.5  
Other non-current assets
     0.6       —       0.6  
Total assets acquired
   $ 797.8     $ 2.7     $ 800.5  
Assumed current liabilities
     (23.5 )     1.7       (21.8 )
Assumed non-current liabilities
     (2.8 )     (0.2 )     (3.0 )
Deferred tax liabilities
     (121.9 )     (4.2 )     (126.1 )
Total liabilities assumed
   $ (148.2 )   $ (2.7 )   $ (150.9 )
    $ 649.6     $ —     $ 649.6  
 
 
80
 
The changes in estimates recorded subsequent to the initial accounting estimate was related to refining the calculated fair value of acquired accounts receivable and assumed tax amounts, due to the merger.
 
Goodwill represents expected synergies resulting from the combination of the entities and other intangible assets that do not qualify for separate recognition, while IPR&D assets represent ongoing in-process research and development projects obtained through the acquisition. The Company does not anticipate being able to deduct any of the associated incremental value of goodwill and other intangible assets for income tax purposes, but expects to be able to deduct approximately $18.9 million of value associated with pre-existing Hi-Tech goodwill and other intangible assets for income tax purposes in future periods.
 
During the year ended December 31, 2014, the Company recorded net revenue of approximately $176.9 million related to sales of the Hi-Tech products subsequent to acquisition.
 
Weighted average amortization period of intangible assets acquired other than goodwill and IPR&D through the Hi-Tech acquisitions as of the closing date was 15.6 years in aggregate, 15.7 years for product licensing rights, 1 year for customer relationships and 9 years for trademarks.

Watson Product Disposition

In connection with the Hi-Tech Merger, Akorn entered into an agreement (the “Disposition Agreement”) with Watson to dispose of certain rights and assets related to three Hi-Tech products marketed under Abbreviated New Drug Applications — Ciprofloxacin Hydrochloride Ophthalmic Solution, Levofloxacin Ophthalmic Solution and Lidocaine Hydrochloride Jelly — and one Akorn product marketed under a New Drug Application: Lidocaine/Prilocaine Topical Cream, collectively “the products”. The Divestment Agreement further included one product under development. Net revenues for the Akorn products marketed under a New Drug Application: Lidocaine/Prilocaine Topical Cream were approximately $1.5 million and $6.8 million in the years ended December 31, 2014 and 2013, respectively. This disposition was required pursuant to a proposed consent order accepted by vote of the FTC on April 11, 2014. The closing of the disposition agreement, which was contingent upon the consummation of the Company’s acquisition of 50% or more of the voting securities of Hi-Tech, took place on April 17, 2014. Under the terms of the disposition the Company received $16.8 million for the intangible product rights, associated goodwill, and saleable inventory of the products denoted above. The Company recorded a gain of $9.0 million in Other (expense) income, net in the year ended December 31, 2014, resulting from the difference of the consideration received and assets disposed, see below.

Calculation of gain from Watson product disposition (in millions)
        
Consideration received
   $
16.8
  
Intangible assets disposed
    
(5.9
)
Goodwill disposed
    
(1.1
)
Other assets disposed
    
(0.8
)
Pre-Tax gain recognized
   $
9.0
  

Upon completing the Watson product disposition, the Company entered into a master supply agreement with Watson whereby the Company will continue manufacturing the products for a transitional period not to exceed two years. The parties also entered into a transition services agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to Watson.

ECR Divestiture

On June 20, 2014, the Company divested its subsidiary, ECR Pharmaceuticals, net of three branded products (specifically Cormax®, VoSol® HC, and Zolvit® Oral Solution otherwise known as “Lortab”) to Valeant Pharmaceuticals (“Valeant”) for $41.0 million in cash and assumption of certain liabilities. Through the divestiture, the Company recognized a nominal gain on the sale of the intangible product rights, associated goodwill, saleable inventory and other assets of ECR. ECR, which promotes certain branded pharmaceuticals through its sales force, was acquired through the acquisition of Hi-Tech. As the Company has divested a component of the combined entity and does not expect material continuing cash flows, ECR results which included net revenues of $3.4 million and a net loss from discontinued operations of ($0.5) million for the period from acquisition to disposition (which both occurred during the year ended December 31, 2014) have been included within discontinued operations in the consolidated statements of comprehensive income, see below.

 
81
 
Calculation of gain/from ECR Divestiture (in millions)
      
Consideration received
   $
41.0
  
Intangible assets divested
    
(33.6
)
Goodwill divested
    
(10.4
)
Other assets divested
    
(1.2
)
Assumed liabilities divested
    
5.1
  
Pre-Tax Gain recognized
   $
0.9
  

Zioptan Acquisition

On April 1, 2014, the Company acquired the U.S. NDA rights to Zioptan®, a prescription ophthalmic eye drop indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, from Merck, Sharp and Dohme Corp. (“Merck”). The Company’s acquisition of U.S. NDA rights to Zioptan® (the “Zioptan Acquisition”) is being accounted for as a business combination in accordance with ASC 805 – Business Combinations. The purpose of the Zioptan Acquisition is to expand the Company’s product portfolio of prescription pharmaceuticals. The total consideration at closing was $11.2 million, all of which was recognized as product licensing rights as of the acquisition date and has an amortization period of 10 years.

Upon completing the Zioptan Acquisition, the Company entered into a master supply agreement with Merck whereby Merck will continue manufacturing Zioptan® for a transitional period not to exceed two years, during which time the Company will work to transfer manufacturing. The transfer price, per the terms of the supply agreement, will equal Merck’s historical product cost. The parties also entered into a Transition Services Agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to the Company.

The U.S. NDA rights to Zioptan® are included within product licensing rights, net on the Company’s consolidated balance sheet as of December 31, 2014.

The Company has not provided pro forma revenue and earnings of the Company as if the Zioptan Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Zioptan® rights were not managed as a discrete business by Merck. Accordingly, determining the pro forma revenue and earnings of the Company including the Zioptan Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.

Betimol Acquisition

On January 2, 2014, the Company acquired the NDA rights to Betimol®, a prescription ophthalmic eye drop for the reduction of eye pressure in glaucoma patients, from Santen. The Company’s acquisition of U.S. NDA rights to Betimol® (the “Betimol Acquisition”) is being accounted for as a business combination in accordance with ASC 805 – Business Combinations. The purpose of the Betimol Acquisition is to expand the Company’s product portfolio of prescription pharmaceuticals. The total consideration will be equal to 1.5 times the Company’s net sales of Betimol® in the first year following acquisition, such year starting upon the Company’s first sale of the product. The Company paid $7.5 million upon completing the acquisition and will pay any remaining amount 60 days following the first year post-acquisition. There is also a provision for a $2.0 million increase to the total consideration should net sales of Betimol® exceed $14.0 million in any one of the first five years following acquisition, the Company has valued this at $0. There is no provision for reducing the purchase price below the initial $7.5 million paid.

Upon completing the Betimol Acquisition, the Company entered into a supply agreement with Santen whereby Santen will continue manufacturing Betimol® for a transitional period not to exceed two years, during which time the Company will work to site transfer manufacturing to one of its facilities. The transfer price, per the terms of the supply agreement, will equal Santen’s cost of API plus actual cost of manufacturing the product, making this a favorable contract pursuant to ASC 805. The parties also entered into a transition services agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to the Company.

 
82
 
The following table sets forth the consideration paid for the Betimol Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.

Betimol Acquisition:
      
Consideration paid in cash at closing
   $
7.5
  
Purchase consideration payable
    
4.0
  
    $
11.5
  
         
Fair value of acquired assets:
        
U.S. NDA rights to Betimol®
   $
11.4
  
Favorable supply agreement
    
0.1
  
    $
11.5
  

The U.S. NDA rights to Betimol® are included within product licensing rights, net on the Company’s consolidated balance sheet as of December 31, 2014 and has an amortization period of 15 years. The favorable supply agreement is included within other long-term assets on the Company’s consolidated balance sheet as of December 31, 2014.

The Company estimated that it would owe additional consideration to Santen of approximately $4.5 million. Since this is a performance-based earn-out payment, this additional consideration was discounted to approximately $4.0 million. As of the year ended December 31, 2014, the Company revised the additional consideration calculation to $4.3 million and recorded $0.3 million of other operating expense reflecting a fair value adjustment to increase the estimated additional consideration obligation as a result of revised operating expectations.

The Company has not provided pro forma revenue and earnings of the Company as if the Betimol Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Betimol® rights were not managed as a discrete business by Santen. Accordingly, determining the pro forma revenue and earnings of the Company including the Betimol Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.

Merck Products Acquisition

On November 15, 2013, the Company acquired from Merck the U.S. rights to three branded ophthalmic products for $52.8 million in cash (the “Merck Acquisition”). The acquired assets met the definition of a business, and accordingly, have been accounted for as a business combination in accordance with ASC 805 – Business Combinations. Through the Merck Acquisition, the Company purchased Inspire Pharmaceuticals, Inc. (“Inspire”), a wholly owned subsidiary of Merck. This legal entity owns the U.S. rights to AzaSite®, a prescription eye drop used to treat bacterial conjunctivitis. The U.S. rights to the other two products involved in the acquisition, Cosopt® and Cosopt® PF (preservative free), were purchased directly from Merck. The Cosopt® products are prescription sterile eye drop solutions used to lower the pressure in the eye in people with open-angle glaucoma or ocular hypertension. The acquisition of these products expands the Company’s ophthalmic product portfolio to include branded, prescription eye drops, and is complementary to the Company’s existing portfolio of products. The Company believes that this acquisition leverages its existing sales force and ophthalmic and optometric physician relationships.

The following table sets forth the consideration paid for the Merck Acquisition and the fair values of the assets acquired and the liabilities assumed (in millions):

Product rights:
      
AzaSite®
   $
13.8
  
Cosopt®
    
21.6
  
Cosopt® PF
    
20.3
  
Product rights total
   $
55.7
  
Prepaid expenses
    
0.1
  
Deferred tax assets, net
    
0.7
  
Total fair value of acquired assets
   $
56.5
  
Consideration paid
   $
52.8
  
Gain from bargain purchase
   $
3.7
  

 
83
 
Through its acquisition of Inspire Pharmaceuticals, Inc. the Company assumed that entity’s net operating loss carry-forwards (“NOLs”) and unamortized start-up costs. The “deferred tax assets, net” listed above represents the difference between the acquired deferred tax assets, the NOLs, and unamortized start-up costs, and the acquired deferred tax liabilities, which represent the book versus tax basis differences in the product rights. The bargain purchase amount was largely derived from the difference between the fair value and the economic value, as calculated through discounted cash flow analysis, of the deferred tax assets, net. In particular, due to the long-term nature of the NOLs acquired, the book value of the resulting deferred tax asset significantly exceeded its discounted cash flow value.

The Company anticipates amortizing the acquired products on a straight-line basis from the Merck Acquisition date through December 31, 2019. The Merck Acquisition agreement specified the tax values assigned to each product. The tax value of AzaSite® product rights will not be amortizable for tax purposes, as these rights were obtained through the stock acquisition of Inspire Pharmaceuticals, Inc. That Company anticipates that the assigned tax values of Cosopt® and Cosopt® PF will be amortizable for tax purposes over a 15-year period.

The Company has not provided pro forma revenue and earnings of the Company as if the Merck Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The products acquired from Merck were not managed as a discrete business by Merck. Accordingly, determining the pro forma revenue and earnings of the Company including the Merck Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.

Kilitch Acquisition

On February 28, 2012, Akorn India Private Limited, a wholly owned subsidiary of the Company completed and closed on its acquisition of selected assets of Kilitch Drugs (India) Limited (“KDIL”).  This acquisition (the “Kilitch Acquisition”) was pursuant to the terms of the Business Transfer Agreement (the “BTA”) entered into among the Company, KDIL and the members of the promoter group of KDIL on October 5, 2011.  In accordance with terms contained in the BTA, the Company also closed on a related product transfer agreement between the Company and NBZ Pharma Limited (“NBZ”), a company associated with KDIL.  The primary asset transferred in the Kilitch Acquisition was KDIL’s manufacturing facility in Paonta Sahib, Himachal Pradesh, India, along with its existing contract manufacturing business.  KDIL was engaged in the manufacture and sale of pharmaceutical products for contract customers in India and for export to various unregulated world markets.  While the Paonta Sahib manufacturing facility is not currently certified by the FDA for the exporting of drugs to the U.S., the facility was designed with future FDA certification in mind.  Accordingly, the Kilitch Acquisition provided the Company with the potential for future expansion of its manufacturing capacity for products to be sold in the U.S., as well as the opportunity to expand the Company’s footprint into markets outside the U.S.  The Company has determined that the assets acquired through the Kilitch Acquisition constitute a “business” as defined by Rule 11-01(d) of Regulation S-X and ASC 805, Business Combinations.  Accordingly, the Company has accounted for the Kilitch Acquisition as a business combination.

AIPL paid the equivalent of approximately USD $60.1 million at closing.  Total purchase consideration was approximately $55.2 million which consisted of approximately $51.2 million in base consideration and $4.0 million in reimbursement for capital expenditures made by KDIL from April 1, 2011 to the closing date.  AIPL also paid $7.3 million related to compensation earned from the achievement of acquisition-related milestones, and $1.6 million in stamp duties paid to transfer title to the land and buildings at Paonta Sahib from Kilitch to AIPL.  In addition, the Company expects to pay up to an additional $0.5 million for future services that would be expensed as the services are provided.  The compensation for acquisition-related milestones and other acquisition costs have been recorded within “acquisition related costs” as part of operating expenses in the Company’s consolidated statement of comprehensive income.  The BTA also contains a working capital guarantee that calls for KDIL or AIPL to reimburse the other party for any shortfall or excess, respectively, in the actual acquired working capital compared to the target working capital as established in the BTA.

The following table sets forth the consideration paid for the Kilitch Acquisition, the acquisition-related costs incurred, and the fair values of the assets acquired and the liabilities assumed (U.S. dollar amounts in millions):

 
84
 
Consideration:
Initial Fair
Valuation
    
Measurement Period Adjustments
    
Adjusted Fair
Valuation
  
Cash paid
   $ 55.2     $ —     $ 55.2  
Less working capital shortfall refunded by sellers
     (0.9 )     (0.1 )     (1.0 )
    $ 54.3     $ (0.1 )   $ 54.2  
                         
Acquisition-related costs:
                        
Stamp duties paid for transfer of land and buildings
   $ 1.6     $ —     $ 1.6  
Acquisition-related compensation expense
     6.7       0.5       7.2  
Due diligence, legal, travel and other acquisition-related costs
     0.6       0.1       0.7  
    $ 8.9     $ 0.6     $ 9.5  
                         
Recognized amounts of identifiable assets acquired and liabilities assumed:
                  
Accounts receivable
   $ 2.1     $ —     $ 2.1  
Inventory
     1.8       —       1.8  
Land
     3.7       (1.1 )     2.6  
Buildings, plant and equipment
     8.5       —       8.5  
Construction in progress
     14.2       —       14.2  
Goodwill, deductible
     21.6       1.0       22.6  
Other intangible assets, deductible
     5.8       0.1       5.9  
Other assets
     0.1       —       0.1  
Assumed liabilities
     (2.1 )     (0.8 )     (2.9 )
Deferred tax liabilities
     (1.4 )     0.7       (0.7 )
    $ 54.3     $ (0.1 )   $ 54.2  
 
The Adjusted Fair Valuation presented above is final.  The changes in estimate recorded subsequent to the initial accounting estimate were primarily related to refining the calculated fair value of certain acquired assets, adjustments to the working capital settlement amount due from the sellers to the Company, and final determination regarding the tax-deductibility of the acquired intangible assets.  The acquisition-related compensation expense during 2012 was primarily related to pre-negotiated compensation paid to members of the sellers’ family based on achievement of various operational milestones.
 
Goodwill represents expected synergies and intangible assets that do not qualify for separate recognition.  Based on an Indian Supreme Court ruling in 2012 upholding the deductibility of goodwill for India tax purposes, the Company anticipates being able to deduct the value of goodwill for income tax purposes in India.  A later Indian Supreme Court ruling raised doubt as to the tax deductibility of the cost of the non-compete agreement entered into between AIPL and the sellers.  Accordingly, the Company amended its acquisition accounting to establish a deferred tax liability related to this intangible asset. The Company had initially recorded a deferred tax liability valued at $1.4 million and subsequently adjusted to $0.7 million related to intangible assets and other accrued liabilities that it does not believe will be amortizable for Indian tax purposes.  This remaining deferred tax liability of $0.7 million was reversed against goodwill during 2012.  
 
For book purposes, the other intangible assets acquired are being amortized over lives of four to five years. Goodwill is not amortized for book purposes but is subject to impairment testing.  The tangible assets acquired consist primarily of construction in progress fair valued at $14.2 million, buildings, plant and equipment fair valued at a combined $8.5 million, land fair valued at $2.6 million, accounts receivable fair valued at $2.1 million and inventory fair valued at $1.8 million as of the acquisition date.

During 2014, 2013 and 2012, the Company paid $2.8 million, $2.7 million and $0.8 million, respectively, for the acquisition of drug product licensing rights (NDA and ANDA rights) which were not individually significant. No assets were acquired other than the drug rights, and no liabilities assumed.
 
The unaudited pro forma results presented below reflect the consolidated results of operations inclusive of the Xopenex acquisition, VersaPharm acquisition and Akorn Rifampin product divestiture (“VersaPharm transactions”), and the Hi-Tech acquisition, Watson product disposition and ECR divestiture (“Hi-Tech transactions”) which occurred during the year ended December 31, 2014, as if the transactions had taken place at the beginning of the earliest period presented below. The pro forma results include amortization associated with the acquired tangible and intangible assets, interest on debt incurred for the transactions, amortization of inventory step-up, acquisition related expenses and income tax expense affected for the pro forma results. The unaudited pro forma financial information presented below does not reflect the impact of any actual or anticipated synergies expected to result from the acquisitions. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations as they would have been had the transactions been effected on the assumed date (amounts in thousands, except per share data):

 
85
 
   
For the Year Ended
December 31,
  
   
2014
    
2013
  
Revenue
   $
733,012
     $ 623,922  
Net income from continuing operations
    
71,722
       4,891  
Net income from continuing operations per share
   $
0.58
     $ 0.04  

Other Strategic Investments

On August 1, 2011, the Company entered into a Series A-2 Preferred Stock Purchase Agreement to acquire a minority ownership interest in Aciex Therapeutics Inc. (“Aciex”), a private ophthalmic development pharmaceutical company based in Westborough, MA, for $8.0 million in cash. Subsequently, on September 30, 2011, the Company entered into Amendment No. 1 to Series A-2 Preferred Stock Purchase Agreement to acquire additional shares of Series A-2 Preferred Stock in Aciex for approximately $2.0 million in cash. On April 17, 2014, the Company entered into a secured note and warrant purchase agreement to acquire secured, convertible promissory notes of Aciex for approximately $0.4 million in cash. On June 27, 2014, the Company entered into a second secured note and warrant purchase agreement to acquire additional secured, convertible promissory notes of Aciex for an additional amount of approximately $0.4 million. The Company’s aggregate investment in Aciex was $10.8 million at cost. Aciex was an ophthalmic drug development company focused on developing novel therapeutics to treat ocular diseases. Aciex’s pipeline consisted of both clinical stage assets and pre-Investigational new drug stage assets. The investments detailed above had provided the Company with an ownership interest in Aciex of below 20%. The Aciex Agreement and Aciex Amendment contained certain customary rights and preferences over the common stock of Aciex and further provided that the Company shall have had the right to a seat on the Aciex board of directors.

On July 2, 2014 Nicox S.A., (“Nicox”) an international Company entered into an arrangement to acquire all of the outstanding equity of Aciex (the “Aciex Acquisition”).

On October 22, 2014 Nicox shareholders voted at the Nicox General Meeting, to approve the Aciex Acquisition. The transaction was consummated on October 24, 2014, following the completion of certain legal conditions and formalities. As consideration for its carried investment in Aciex, the Company received from the Aciex Acquisition pro-rata shares of Nicox which are publically traded on the Euronext Paris exchange. Through the closing the Company received approximately 4.3 million shares of Nicox which were subject to certain lockup provisions preventing immediate sale of underlying shares received for the Company’s investment in an available for sale security.

Through the year ended December 31, 2014 the Company sold 0.2 million unrestricted shares for approximately $0.6 million realizing an immaterial gain on the sale of shares.

In accordance with ASC Topic 820, the Company records unrealized holding gains and losses on the remaining available for sale securities in the “Accumulated other comprehensive income” caption in the consolidated Balance Sheet. For the year ended December 31, 2014 the Company recognized an unrealized holding loss, net of tax of $1.1 million as calculated based on the discounted value of the investment given the contractual lockup provisions. The Company has determined that of the remaining $8.4 million of unrealized fair value associated with the investment, $7.2 million is expected to be converted to cash within 1 year from the balance sheet date and has been classified as a current asset, while $1.2 million is expected to be converted beyond one year and has been classified as a non-current asset.
 
 Note 17 — Unconsolidated Joint Venture

The Company was a 50% partner in a joint venture agreement with an Indian drug development company since September 2004.  This joint venture launched its first product in 2008 and generated revenue from 2008 until its business assets were sold and transferred.  While the joint venture still exists legally, it ceased operations upon the completion of the sale and transfer of its operating assets to Pfizer, Inc. in the second quarter of 2011. No operations have occurred since the sale, but the net income recorded in the year ended December 31, 2013 was primarily related to adjustments to the joint venture Company’s reserves for product returns upon expiration of the period for which product returns could be made.

 
86
 
The following tables sets forth condensed statements of income for the three years ended December 31, 2014, 2013 and 2012 and the condensed balance sheets as of December 31, 2014 and 2013 for Akorn-Strides, LLC, along with information regarding the amount of earnings allocated to each member-partner of the LLC (in thousands):
 
CONDENSED STATEMENTS OF INCOME (Unaudited)
  
       
   
Year ended December 31,
  
   
2014
    
2013
    
2012
  
REVENUES
   $ —     $ 163     $ —  
Cost of sales
     —       (1 )     —  
GROSS PROFIT
     —       164       —  
Operating expenses
     —       3       —  
OPERATING INCOME
     —       161       —  
Gain from Pfizer ANDA Sale
     —       —       —  
INCOME BEFORE INCOME TAXES
     —       161       —  
Income tax (benefit) / provision
     —       —       —  
NET INCOME
   $ —     $ 161     $ —  
 
CONDENSED BALANCE SHEETS (Unaudited)
  
       
   
December 31,
  
 
  
2014
    
2013
  
ASSETS
            
Cash
   $ 25     $ 25  
Other current assets
     1       1  
TOTAL ASSETS
   $ 26     $ 26  
                 
LIABILITIES & MEMBERS’ EQUITY
                
Trade accounts payable & other accrued liabilities
   $ —     $ —  
    TOTAL LIABILITIES
     —       —  
                 
Members’ equity
     26       26  
TOTAL LIABILITIES & MEMBERS’ EQUITY
   $ 26     $ 26  
 
As of December 31, 2014, no future product returns are expected.
 
Note 18 — Customer, Supplier and Product Concentration

Customer Concentration

In 2014, 2013 and 2012, a significant portion of the Company’s gross and net sales reported were through three large wholesale drug distributors, and a significant portion of  the Company’s accounts receivable as of December 31, 2014, 2013 and 2012 were due from these wholesale drug distributors as well. AmerisourceBergen Health Corporation (“Amerisource”), Cardinal Health, Inc. (“Cardinal”) and McKesson Drug Company (“McKesson”) are all distributors of the Company’s products, as well as suppliers of a broad range of health care products.  Aside from these three wholesale drug distributors, no other customers accounted for more than 10% of gross sales, net revenues or gross trade receivables for the indicated dates and periods.

The following table sets forth the percentage of the Company’s gross and net sales and gross accounts receivable attributable to these three distributors for the periods indicated:

   
2014
    
2013
    
2012
  
 
 
 
  
 
Gross
Sales
    
 
Net
Revenue
    
Gross
 Accounts
Receivable
    
 
Gross
Sales
    
 
Net
Revenue
    
Gross
 Accounts
Receivable
    
 
Gross
Sales
    
 
Net
Revenue
    
Gross
 Accounts
Receivable
  
Amerisource
     38 %     28 %     46 %     19 %     14 %     25 %     19 %     14 %     29 %
Cardinal
     16 %     14 %     17 %     23 %     16 %     26 %     23 %     17 %     30 %
McKesson
     23 %     19 %     23 %     16 %     11 %     12 %     16 %     11 %     14 %
Total
     77 %     61 %     86 %     58 %     41 %     63 %     58 %     42 %     73 %

 
87
 
If sales to Amerisource, Cardinal or McKesson were to diminish or cease, the Company believes that the end users of its products would find little difficulty obtaining the Company’s products either directly from the Company or from another distributor.

Supplier Concentration

The Company requires a supply of quality raw materials and components to manufacture and package pharmaceutical products for its own use and for third parties with which it has contracted. The principal components of the Company’s products are active and inactive pharmaceutical ingredients and certain packaging materials. Many of these components are available from only a single source and, in the case of many of the Company’s ANDAs and NDAs, only one supplier of raw materials has been identified. Because FDA approval of drugs requires manufacturers to specify their proposed suppliers of active ingredients and certain packaging materials in their applications, FDA approval of any new supplier would be required if active ingredients or such packaging materials were no longer available from the specified supplier. The qualification of a new supplier could delay the Company’s development and marketing efforts. If for any reason the Company is unable to obtain sufficient quantities of any of the raw materials or components required to produce and package its products, it may not be able to manufacture its products as planned, which could have a material adverse effect on the Company’s business, financial condition and results of operations.

No individual supplier represented 10% or more of the Company’s purchases in any of the years ended December 31, 2014, 2013 or 2012.

Product Concentration

During the year ended December 31, 2014 none of the Company’s products represented 10% or more of net revenue, while in the years ended December 31, 2013 and 2012, one of the Company’s prescription pharmaceutical products represented 11.8% and 12.5% of the Company’s total net revenue, respectively while no other products represented 10% or more of the Company’s net revenue.  The Company attempts to minimize the risk associated with product concentrations by continuing to acquire and develop new products to add to its portfolio.
 
Note 19 — Related Party Transactions

In the recent past, the Company engaged in various related party transactions with John N. Kapoor, Ph.D., Chairman of the Company’s Board of Directors and a significant holder of the Company’s common stock.

On March 3, 2010, the Company entered into an 8-year agreement with EJ Financial for their sub-lease of a portion of the Company’s corporate offices in Lake Forest, Illinois.  This sub-lease commenced on April 1, 2010.  Subsequently, the Company and EJ Financial agreed to early terminate this agreement, and accordingly the sub-lease was terminated in July 2012.  EJ Financial paid the Company a total of approximately $240,000 in rent and common area maintenance fees over the shortened term of this sub-lease.

In connection with the various modifications agreed to during 2009 to the EJ Funds credit facility and the Subordinated Note, the Company issued various stock warrants to Dr. Kapoor.  See Note 2, Summary of Significant Accounting Policies, for information about the Kapoor Warrants.

During the years ended December 31, 2014, 2013 and 2012 the Company obtained legal services totaling $1.9 million, $0.7 million and $0.5 million, respectively, of which $0.2 million was payable as of December 31, 2014 and 2013 from Polsinelli PC (formerly Polsinelli Shughart PC), a law firm for which the spouse of the Company’s Senior Vice President, General Counsel and Secretary is an attorney and shareholder.
 
Note 20 — Severance Charges

Subsequent to the closing of the various mergers and acquisitions transacted through the years ended December 31, 2014 and 2013, the Company entered into severance agreements promising associated payments; and as such, severance expense was recognized related to these agreements. As of December 31, 2014 and 2013, the accrued severance balances were insignificant, equaling less than $0.1 million in each year.
 
 
88
 
Note 21 – Selected Quarterly Financial Data (Unaudited)
 
 
  
 
    
 
Income (Loss) From Continuing Operations
    
Net Income (Loss)
  
 
(In thousands, except per share amounts)
  
Revenues
    
Gross
Profit
    
Operating
Income (Loss)
    
Amount
    
Per Basic
Share
    
Per Diluted
Share
    
Amount
    
Per Basic
Share
    
Per Diluted
Share
  
Year Ended December 31, 2014:
                                                      
4th Quarter
   $ 227,828     $ 128,382     $ 71,907     $ 34,232     $ 0.32     $ 0.29     $ 34,232     $ 0.32     $ 0.29  
3rd Quarter
     132,732       51,734       (6,042 )     (11,650 )     (0.11 )     (0.11 )     (11,650 )     (0.11 )     (0.11 )
2nd Quarter (as restated)
    
141,896
      
67,818
      
7,410
      
3,438
      
0.03
      
0.03
      
2,935
      
0.03
      
0.02
  
1st Quarter
     90,622       49,656       23,440       9,828       0.10       0.08       9,828       0.10       0.08  
Year Ended December 31, 2013:
                                                                        
4th Quarter
   $ 84,953     $ 46,970     $ 25,176     $ 16,678     $ 0.17     $ 0.14     $ 16,678     $ 0.17     $ 0.14  
3rd Quarter
     81,892       43,697       22,188       12,205       0.13       0.11       12,205       0.13       0.11  
2nd Quarter
     77,012       42,092       22,251       12,637       0.13       0.11       12,637       0.13       0.11  
1st Quarter
     73,854       39,145       18,589       10,842       0.11       0.10       10,842       0.11       0.10  
 
On March 17, 2015, the Company issued a press release announcing that the Audit Committee of the Company’s Board of Directors, upon the recommendation of management, concluded that the previously issued financial statements contained in the Company’s Quarterly Reports on Form 10-Q for the periods ended June 30, 2014 and September 30, 2014 should not be relied upon because of an error in the financial statements as of and for the three and six month periods ended June 30, 2014 and as of and for the nine month period ended September 30, 2014, and that those financial statements would be restated to make the necessary accounting adjustments.

On April 17, 2014, the Company completed its acquisition of Hi-Tech for a total purchase price of approximately $650.0 million. During the 2014 year-end audit process, an error was identified in the fair value allocation of assets acquired and liabilities assumed in connection with the acquisition of Hi-Tech, which resulted in an overstated chargeback reserve as of April 17, 2014. The error, which was identified on March 11, 2015, resulted from an overstatement of Hi-Tech’s chargeback reserve in connection with applying the acquisition method of accounting at the closing of the Hi-Tech acquisition.

The overstatement in the chargeback reserve was caused by a manual error made in preparing the data whereby there was a duplication of inventory units held by one customer utilized in the calculation of the reserve amount for Hi-Tech products at the acquisition date.  The duplication resulted in an overstatement of chargeback reserves by approximately $8.9 million for the opening balance sheet of Hi-Tech as of April 17, 2014. The chargeback reserve at the end of the quarter ended June 30, 2014 was then calculated correctly, resulting in the earlier overstated reserve amount being included in revenue during the quarter ended June 30, 2014. The correction of the error in the quarter ended June 30, 2014 resulted in a reduction of previously reported revenue by $8.9 million, a reduction of previously reported pre-tax income by $8.9 million and a reduction of previously reported net income, goodwill and retained earnings by $5.6 million, for the Company’s three and six month periods ended June 30, 2014.
 
The error was limited to the Company’s financial results for the three and six months ended June 30, 2014, but the error did impact the Company’s previously filed results for the nine months ended September 30, 2014 (which were filed in connection with the Company’s Form 10-Q for the quarter ended September 30, 2014) because the second quarter results were included within that period. The estimated impact of this error for the restated three and six month periods ended June 30, 2014 is to reduce basic and diluted net income per share by approximately $0.05 per share. The estimated impact of this error for the restated nine month period ended September 30, 2014 is to reduce basic and diluted net income per share by approximately $0.06 and $0.05 per share, respectively.

The error has been corrected in the full year financial statements included elsewhere in this Annual Report.  In addition, the above unaudited selected quarterly financial data has been corrected to eliminate the error.  The Company also expects to file amendments on Form 10-Q/A to its previously filed Form 10-Qs for the second and third quarters of 2014 to reflect the corrections and accordingly, the financial statements in those Form 10-Qs should not be relied upon until such time as the Company has filed its Form 10-Q/As for those periods.
 
 
89
 
Effects of Restatement on Previously Filed Quarterly Results

The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported financial statements as of and for the three and six month periods ended June 30, 2014 and as of and for the nine month period ended September 30, 2014.

The effect of the restatement on the previously filed condensed consolidated balance sheet as of June 30, 2014 is as follows, in thousands:

   
As Reported
    
Adjustments
    
As Restated
  
Prepaid expenses and other current assets
   $ 17,120     $ (107 )   $ 17,013  
TOTAL CURRENT ASSETS
     397,180       (107 )     397,073  
Goodwill
     196,016       (5,568 )     190,448  
TOTAL OTHER LONG-TERM ASSETS
     690,898       (5,568 )     685,330  
TOTAL ASSETS
   $ 1,223,773     $ (5,675 )   $ 1,218,098  
Income taxes payable
     675       (104 )     571  
TOTAL CURRENT LIABILITIES
     103,777       (104 )     103,673  
TOTAL LIABILITIES
     929,304       (104 )     929,200  
Retained earnings
     33,700       (5,571 )     28,129  
TOTAL SHAREHOLDERS’ EQUITY
     294,469       (5,571 )     288,898  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
   $ 1,223,773     $ (5,675 )   $ 1,218,098  

The effect of the restatement on the previously filed condensed consolidated income statement for the three months ended June 30, 2014 is as follows, in thousands except per share amounts:

   
As Reported
    
Adjustments
    
As Restated
  
Revenues
   $ 150,749     $ (8,853 )   $ 141,896  
GROSS PROFIT
     76,671       (8,853 )     67,818  
OPERATING INCOME
     16,263       (8,853 )     7,410  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
     14,312       (8,853 )     5,459  
Income tax provision
     5,303       (3,282 )     2,021  
INCOME FROM CONTINUING OPERATIONS
   $ 9,009     $ (5,571 )   $ 3,438  
NET INCOME
   $ 8,506     $ (5,571 )   $ 2,935  
NET INCOME PER SHARE:
                        
Income from continuing operations, basic
   $ 0.09     $ (0.06 )   $ 0.03  
NET INCOME, BASIC
   $ 0.08     $ (0.05 )   $ 0.03  
Income from continuing operations, diluted
   $ 0.08     $ (0.05 )   $ 0.03  
NET INCOME, DILUTED
   $ 0.07     $ (0.05 )   $ 0.02  
COMPREHENSIVE INCOME:
                        
Consolidated net income
   $ 8,506     $ (5,571 )   $ 2,935  
COMPREHENSIVE INCOME
   $ 8,353     $ (5,571 )   $ 2,782  

The effect of the restatement on the previously filed condensed consolidated income statement for the six months ended June 30, 2014 is as follows, in thousands except per share amounts:

   
As Reported
    
Adjustments
    
As Restated
  
Revenues
   $ 241,371     $ (8,853 )   $ 232,518  
GROSS PROFIT
     126,327       (8,853 )     117,474  
OPERATING INCOME
     39,703       (8,853 )     30,850  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
     30,004       (8,853 )     21,151  
Income tax provision
     11,167       (3,282 )     7,885  
INCOME FROM CONTINUING OPERATIONS
   $ 18,837     $ (5,571 )   $ 13,266  
NET INCOME
   $ 18,334     $ (5,571 )   $ 12,763  
NET INCOME PER SHARE:
                        
Income from continuing operations, basic
   $ 0.19     $ (0.06 )   $ 0.13  
NET INCOME, BASIC
   $ 0.18     $ (0.05 )   $ 0.13  
Income from continuing operations, diluted
   $ 0.16     $ (0.05 )   $ 0.11  
NET INCOME, DILUTED
   $ 0.16     $ (0.05 )   $ 0.11  
COMPREHENSIVE INCOME:
                        
Consolidated net income
   $ 18,334     $ (5,571 )   $ 12,763  
COMPREHENSIVE INCOME
   $ 19,886     $ (5,571 )   $ 14,315  

 
90
 
The effect of the restatement on the previously filed condensed consolidated statement of cash flows for the six months ended June 30, 2014 is as follows, in thousands:

   
As Reported
    
Adjustments
    
As Restated
  
Consolidated net income
   $ 18,334     $ (5,571 )   $ 12,763  
Changes in operating assets and liabilities:
                        
Trade accounts receivable
     (27,991 )     8,853       (19,138 )
Prepaid expenses and other current assets
     4,329       (3,178 )     1,151  
Accrued expenses and other liabilities
     8,799       (104 )     8,695  

Taken together, these adjustments result in no impact on the Company’s net cash provided by operating activities for the six months ended June 30, 2014 or the Company’s cash and cash equivalents balance as of June 30, 2014.

The effect of the restatement on the previously filed condensed consolidated balance sheet as of September 30, 2014 is as follows, in thousands:

   
As Reported
    
Adjustments
    
As Restated
  
Prepaid expenses and other current assets
   $ 33,078     $ (3 )   $ 33,075  
TOTAL CURRENT ASSETS
     494,098       (3 )     494,095  
Goodwill
     290,648       (5,568 )     285,080  
TOTAL OTHER LONG-TERM ASSETS
     1,243,363       (5,568 )     1,237,795  
TOTAL ASSETS
   $ 1,876,833     $ (5,571 )   $ 1,871,262  
Retained earnings
     22,051       (5,571 )     16,480  
TOTAL SHAREHOLDERS’ EQUITY
     320,322       (5,571 )     314,751  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
   $ 1,876,833     $ (5,571 )   $ 1,871,262  

The effect of the restatement on the previously filed condensed consolidated income statement for the nine months ended September 30, 2014 is as follows, in thousands except per share amounts:

   
As Reported
    
Adjustments
    
As Restated
  
Revenues
   $ 374,103     $ (8,853 )   $ 365,250  
GROSS PROFIT
     178,061       (8,853 )     169,208  
OPERATING INCOME
     33,661       (8,853 )     24,808  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
     11,465       (8,853 )     2,612  
Income tax provision
     4,278       (3,282 )     996  
INCOME FROM CONTINUING OPERATIONS
   $ 7,187     $ (5,571 )   $ 1,616  
NET INCOME
   $ 6,684     $ (5,571 )   $ 1,113  
NET INCOME PER SHARE:
                        
Income from continuing operations, basic
   $ 0.07     $ (0.05 )   $ 0.02  
NET INCOME, BASIC
   $ 0.07     $ (0.06 )   $ 0.01  
Income from continuing operations, diluted
   $ 0.06     $ (0.05 )   $ 0.01  
NET INCOME, DILUTED
   $ 0.06     $ (0.05 )   $ 0.01  
COMPREHENSIVE INCOME:
                        
Consolidated net income
   $ 6,684     $ (5,571 )   $ 1,113  
COMPREHENSIVE INCOME
   $ 7,840     $ (5,571 )   $ 2,269  

The effect of the restatement on the previously filed condensed consolidated statement of cash flows for the nine months ended September 30, 2014 is as follows, in thousands:

   
As Reported
    
Adjustments
    
As Restated
  
Consolidated net income
   $ 6,684     $ (5,571 )   $ 1,113  
Changes in operating assets and liabilities:
                        
Trade accounts receivable
     (24,193 )     8,853       (15,340 )
Prepaid expenses and other current assets
     (11,209 )     (3,282 )     (14,491 )
 
Taken together, these adjustments result in no impact on the Company’s net cash provided by operating activities for the nine months ended September 30, 2014 or the Company’s cash and cash equivalents balance as of September 30, 2014.
 
 
91
 
Note 22 – Legal Proceedings.

We are party to legal proceedings and potential claims arising in the ordinary course of our business. Such legal proceedings include Akorn’s Paragraph IV challenges to other drug manufacturers’ proprietary rights, and the counter-suits filed by those drug manufacturers in response.  The amount, if any, of ultimate liability with respect to legal proceedings involving the Company cannot be determined.  Despite the inherent uncertainties of litigation, at this time the Company does not believe that such proceedings will have a material adverse impact on our financial condition, results of operations, or cash flows. Set forth below is a listing of potentially material legal proceedings of the Company, including Akorn, Hi-Tech, and VersaPharm in existence as of the date of filing this Form 10-K.

On September 11, 2013, the Attorney General of the State of Louisiana filed a lawsuit in Louisiana state court against Hi-Tech, and numerous other pharmaceutical companies, under various state laws, alleging that each defendant caused the state’s Medicaid agency to provide reimbursement for drug products that allegedly were not approved by FDA and therefore allegedly not reimbursable under the federal Medicaid program. The state seeks unspecified damages, statutory fines, penalties, attorney’s fees and costs. On October 15, 2013, the defendants removed the lawsuit to the U.S. District Court for the Middle District of Louisiana. Subsequently, the case was remanded to state court, where the case is in the initial discovery stage. The Company intends to vigorously defend against all claims in the lawsuit.

In May 2013, Inspire, a wholly owned subsidiary, received a Notice Letter that Mylan Pharmaceuticals, Inc. (“Mylan”) filed an ANDA with the FDA seeking marketing approval for a 1% azithromycin ophthalmic solution prior to the expiration of the five U.S. patents licensed to us and listed in the Orange Book for Azasite®.  On June 14, 2013, Insite, Merck, Inspire and Pfizer filed a complaint against Mylan and a related entity alleging that their proposed product infringes the listed patents.  The parties agreed to settle the matter and the case was dismissed by court order on March 4, 2015.

On September 12, 2012, Fera Pharmaceuticals, LLC (“Fera”) filed a civil complaint against the Company and certain individual defendants in the Supreme Court of New York. On October 15, 2012, the case was removed to the Federal District Court for the Southern District of New York, and subsequently, Fera filed an amended complaint. The complaint alleges, among other things, breach of manufacturing and confidentiality agreements, fraud in the inducement and misappropriation of the plaintiff’s trade secrets.  The Company intends to vigorously defend these allegations.  On January  13, 2015, the Company filed a counterclaim against Fera and certain affiliates  (Alfera  Pharmaceuticals,  LLC;  Feranda,  LLC;  Baci   007,   LLC;   and    Fera Holdings, LLC), as well as Perrigo Company of Tennessee and Perrigo Company plc, asserting violations of Sections 1 and 2 of the Sherman Act and tortious interference with business relations.  The case is in the discovery phase, and no trial date has been scheduled.

On June 8, 2012, plaintiff Mathew Harrison filed  a class action lawsuit, Civil Action No. 12-2897, in the U.S. District Court for the Eastern District of New York, against Wayne Perry, Dynova Laboratories, Inc., Sicap Industries, LLC, Walgreens Co. and Hi-Tech. On May 16, 2012, plaintiff David Delre filed a class action lawsuit, Civil Action No. 12-2429, in the U.S. District Court for the Eastern District of New York, against Wayne Perry, Dynova Laboratories, Inc., Sicap Industries, LLC, and Hi-Tech. Each complaint alleges, among other things, that their Sinus Buster® products are improperly marketed, labeled and sold as homeopathic products, and that these allegations support claims of fraud, unjust enrichment, breach of express and implied warranties and alleged violations of various state and federal statutes. Hi-Tech answered the complaints and asserted cross-claims against the other defendants. The Court consolidated these two cases into one action entitled Sinus Buster Products Consumer Litigation. Dynova has filed for bankruptcy. The case has now been settled by Hi-Tech with plaintiffs by Agreement dated December 16, 2013 and the Court approved the settlement by an Order dated November 10, 2014.

 
92
 
In April 2011, Inspire Pharmaceuticals, Inc., a wholly owned subsidiary of the Company, acquired through a business combination on November 15, 2013, received a Notice letter from Sandoz, Inc. (“Sandoz”) providing notice that Sandoz filed an ANDA with the FDA seeking marketing approval for a 1% azithromycin ophthalmic solution prior to the expiration of the five U.S. patents licensed to us and listed in the Orange Book for Azasite®.  On May 26, 2011, Merck, Insite Vision Incorporated and Pfizer filed a complaint against Sandoz and related entities in the district court of New Jersey alleging that their proposed product infringes the listed patents.  On October 4, 2013, the court issued judgment in favor of Inspire and the other plaintiffs finding all the asserted claims of the patents in the litigation valid and infringed by Sandoz and related entities.  Sandoz has appealed this decision.  The Company intends to vigorously contest any Sandoz assertions that these patents should have been found not infringed, invalid or unenforceable.

Former Hi-Tech director and employee Reuben Seltzer delivered to the Company a demand letter in August 2014 alleging that the Company breached his employment agreement and improperly terminated Mr. Seltzer’s employment.  Mr. Seltzer further alleges that he is entitled to compensation in the approximate amount of $5.2 million.  The Company disputes these claims and intends to vigorously defend these allegations.
 
On March 4, 2015, putative class action plaintiff Solomon Yeung filed suit in the Federal District Court Northern District Illinois against Akorn, Inc., Rajat Rai, Timothy Dick and Bruce Kutinsky, alleging defendants violated Rules 10b-5 and 20(a) of the 1934 Exchange Act.  According to the complaint, certain financial and other related data related to certain Akorn subsidiaries could not be timely collected and compiled and Akorn would be unable to timely complete its assessment of the effectiveness of its internal control over financial reporting as of December 31, 2014. The complaint also alleges that Akorn’s internal control over financial reporting was ineffective and material weaknesses existed relating to the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions and accurate and timely reporting of its financial results and disclosures in its Form 10-K. Plaintiff alleges that as a consequence, when Akorn announced on March 2, 2015 that it would need an extension to file an annual report for the year ending December 31, 2014, its stock dropped.  The Company and individual defendants dispute these claims and intend to vigorously defend these allegations.
 
 

 
 
93
 
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

(i)      Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2014. The term “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on this evaluation, management concluded as of December 31, 2014 that our disclosure controls and procedures were not effective because of material weaknesses in our internal control over financial reporting, described below in Management’s Report on Internal Control Over Financial Reporting. Notwithstanding the identified material weaknesses, management believes the consolidated financial statements included in this Annual Report on Form 10-K fairly represent in all material respects our financial condition, results of operations and cash flows at and for the periods presented in accordance with U.S. GAAP.
 
(ii)      Management’s Report on Internal Control Over Financial Reporting

Company management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rule 13a-15(f) under the Exchange Act. Under the supervision and with the participation of Company management, including the CEO and the CFO, an evaluation was performed of the effectiveness of the Company’s internal control over financial reporting. The evaluation was based on the framework in Internal Control — Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
 
We completed the acquisitions of Hi Tech Pharmacal Co, Inc. (“Hi-Tech”) and VPI Holdings Corp. Inc. (“VersaPharm”) on April 17, 2014 and August 12, 2014, respectively.  We excluded from our assessment of the effectiveness of our internal control over financial reporting as of December 31, 2014, Hi Tech’s and VersaPharm’s internal control over financial reporting associated with assets of $254,257,000 and $13,801,000, respectively, and revenues of $164,825,000 and $9,173,000, respectively, included in the Consolidated Financial Statements of Akorn, Inc. and subsidiaries as of and for the year ended December 31, 2014.

Based on our evaluation under the criteria set forth in Internal Control — Integrated Framework (1992), our management concluded that, as of December 31, 2014, our internal control over financial reporting was not effective because of the identification of material weaknesses described as follows:
 
●
We did not have controls designed to validate the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions.  As a result, errors were identified in the underlying data used to support significant estimates and accounting transactions, primarily relating to gross to net revenue adjustments and income taxes.  Accordingly, we believe we have a material weakness because there is a reasonable possibility that a material misstatement to the interim or annual financial statements would not be prevented or detected on a timely basis.
 
·
We did not have an adequate process or appropriate controls in place to support the accurate and timely reporting of our financial results and disclosures in our Form 10-K. As a result, errors were identified primarily related to gross to net revenue adjustments and income tax balances at year end. Accordingly, we believe we have a material weakness because there is a reasonable possibility that a material misstatement to the interim or annual financial statements would not be prevented or detected on a timely basis.
 
 
94
 
·
We did not have an adequate process or appropriate controls in place to prevent or detect material errors in the financial statements of acquired subsidiaries.  As a result, errors were identified primarily related to gross to net revenue adjustments, expenses, inventory and accrued liabilities in the financial statements at the acquisition date and at year-end.  One of the aforementioned errors related to the chargeback reserve of Hi-Tech recognized at the acquisition date and required the restatement of our condensed consolidated financial statements for the quarter and six-months ended June 30, 2014 and the nine months ended September 30, 2014, as disclosed in our Form 8-K dated March 17, 2015.
 
The Company’s internal control over financial reporting as of December 31, 2014 was audited by KPMG LLP, an independent registered public accounting firm, as stated in its report included in Item 8 of this Form 10-K.

(iii)           Remediation Plan for Material Weaknesses in Internal Control over Financial Reporting

With the oversight of senior management and our audit committee, the Company has begun taking steps and plans to take additional measures to remediate the underlying causes of the material weaknesses.  With respect to validation of the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions, management intends to:
 
 
·
Conduct manual data validation procedures on certain reports related to gross to net adjustments and inventory.
 
·
Enhance the design of management review controls to increase the level of precision.
 
·
Establish a dedicated revenue accounting team focused primarily on significant gross to net revenue adjustments.
 
·
Ensure all systems relied upon in the financial reporting process are subject to Information Technology General Controls (ITGCs) which are intended to prevent system changes that could affect the completeness and accuracy of the data used.
 
With respect to timely and accurate filing of our financial results, management intends to:
 
 
·
Undertake a financial close process improvement project utilizing external consultants to identify efficiencies and enhance reporting capabilities as well as opportunities to reduce the incidence of errors.
 
·
Implement more robust accounting policies and work with consultants to streamline close activities and implement best practices.
 
·
Enhance communications between the accounting and tax groups to ensure timely and accurate tax considerations.
 
·
 Deploy additional internal and/or external tax resources to allow for additional levels of management review controls.
 
 With respect to the financial statements of acquired subsidiaries, management intends to:
 
 
·
Evaluate the control environment of target acquisitions and acquired entities in a timely fashion to facilitate improvements in the subsidiary’s control environment within the year of acquisition.
 
·
Develop controls specifically designed to identify material errors within subsidiary financial statements.
 
·
Drive consistency in internal controls across all Akorn entities.
 
·
Deploy appropriate personnel with public company accounting experience at the subsidiary level, as needed.
 
Additionally, we plan on creating a new position to oversee accounting systems, administer and monitor ITGCs, coordinate between the Company’s accounting and information technology departments, identify opportunities to streamline and improve processes through greater automation, and plan to add personnel with internal controls and process improvement capabilities within the accounting function. Responsibilities will include designing internal controls and ensuring compliance, implementing global accounting policies and procedures, and implementing process improvements.
 
While senior management and our audit committee are closely monitoring the implementation of these remediation plans, there is no assurance that the aforementioned plans will be sufficient and that additional steps may not be necessary.

(iv)           Changes in Internal Control Over Financial Reporting

As previously disclosed under “Item 9A – Controls and Procedures” in our Annual Report on Form 10-K for the fiscal year ended December 31,2013, we concluded that our internal control over financial reporting was not effective based on the material weaknesses identified. In the fourth quarter ended December 31, 2014, we had sufficient evidence to conclude that we completed remediation of the following material weakness:
 
·
The Company did not have sufficient segregation of duties over information system access such that employees had the ability to inappropriately initiate and record transactions, and there were no compensating, preventative or detective controls.  Although no inappropriate transactions were identified based on our review, we believe we have a material weakness because there is a reasonable possibility that a material misstatement to the interim or annual financial statements would not be prevented or detected on a timely basis.
 
Management had concluded as of December 31, 2013 that the internal control over financial reporting was not effective based on the material weaknesses identified. During the year, management undertook the following steps to improve internal control over financial reporting; however, material weaknesses still exist as described above:
 
·
Enhanced the design of our internal control over financial reporting to include additional quality checks by each control owner and additional levels in the review process.
·
Added additional accounting staff to allow for better distribution of key financial close process activities to improve accuracy and timeliness.
·
Required all hosted software vendors to provide Service Organization Control (SOC) Type 2 reports on the suitability of design and operating effectiveness of controls at the service provider.
·
Added a Director of Financial Reporting to focus exclusively on SEC reporting and technical accounting matters.
·
Enhanced the internal audit function with the addition of three internal audit employees.
 
During the quarter ended December 31, 2014, the Company implemented additional controls and processes, and made enhancements to documentation and support around internal control over financial reporting. There were no other material changes in the internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(f) and 15d-15(f) that occurred during the quarter ended December 31, 2014 that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

 
95
 
Item 9B. Other Information.

     None.
 
 
 
 
96
 
PART III
Item 10. Directors, Executive Officers and Corporate Governance.

    Incorporated by reference to the sections entitled “I. – Proposals – Proposal 1 – Elections of Directors”, “II. – Corporate Governance and Related Matters” and “IV. – Executive Compensation and Other Information – Executive Officers” in the definitive proxy statement for the 2015 annual meeting and the material under the caption “Executive Officers of the Company” in Part I of this Report on Form 10-K.

Item 11. Executive Compensation.

    Incorporated by reference to the sections entitled “IV. – Executive Compensation and Other Information” in the definitive proxy statement for the 2015 annual meeting.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

    Incorporated by reference to the section entitled “III. – Security Ownership of Certain Beneficial Owners and Management” in the definitive proxy statement for the 2015 annual meeting.

Item 13. Certain Relationships and Related Transactions and Director Independence.

    Incorporated by reference to the section entitled “II. – Corporate Governance and Related Matters – Certain Relationships and Related Transactions” in the definitive proxy statement for the 2015 annual meeting.

Item 14. Principal Accounting Fees and Services.

    Incorporated by reference to the section entitled “I. – Proposals – Proposal 2. Ratification of Selection of Independent Registered Public Accounting Firm” in the definitive proxy statement for the 2015 annual meeting.
 
 
 
97
 

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a)
Documents filed as part of this report.

(1)  
 Financial Statements. The consolidated financial statements listed on the index to Item 8 of this Annual Report on Form 10-K are filed as a part of this Annual Report.

(2)  
Financial Statement Schedules. All financial statement schedules have been omitted since the information is either not applicable or required or is included in the financial statements or notes thereof.

(3)  
Exhibits. Those exhibits marked with a (*) refer to exhibits filed herewith. The other exhibits are incorporated herein by reference, as indicated in the following list. Those exhibits marked with a (†) refer to management contracts or compensatory plans or arrangements. Portions of the exhibits marked with a (Ω) are the subject of a Confidential Treatment Request under 17 C.F.R. §§ 200.80(b)(4), 200.83 and 240.24b-2.  Omitted material for which confidential treatment has been requested has been filed separately with the SEC.

Exhibit No.                                             Description                                
2.1 W
Share Purchase Agreement, dated May 3, 2011, by and among Akorn, Inc., AVR Business Trust, Advanced Vision Research, Inc., Advanced Vision Pharmaceuticals, LLC, and the Shareholders of AVR Business Trust, incorporated by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on May 9, 2011.
 
2.2 W
Business Transfer Agreement dated as October 6, 2011 among Akorn, Inc., Akorn India Private Limited, Kilitch Drugs (India) Limited, and members of the promoter group of the Kilitch Drugs (India) Limited, incorporated by reference to Exhibit 2.1 to Akorn Inc.’s report on Form 8-K filed on October 6, 2011.
 
2.3
Asset Sale and Purchase Agreement dated December 22, 2011 between Oak Pharmaceuticals, Inc. and Lundbeck, Inc., incorporated by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on December 30, 2011.
 
2.4
Agreement and Plan of Merger, dated as of August 26, 2013, by and among Akorn, Inc., Akorn Enterprises, Inc., and Hi-Tech Pharmacal Co., Inc., incorporated by reference to Exhibit 2.1 to Akorn’s report on Form 8-K filed on August, 28, 2013.
 
2.5 W
Stock and Asset Purchase and License Agreement dated as of November 15, 2013 by and among Oak Pharmaceuticals, Inc., a wholly owned subsidiary of Akorn, Inc., Merck & Co., Inc., Merck Sharp & Dohme Corp., and Inspire Pharmaceuticals, Inc., incorporated by reference to Exhibit 2.1 to Akorn’s report on Form 8-K filed on November 21, 2013.
 
2.6
Agreement and Plan of Merger dated as of May 9, 2014 by and among Akorn Enterprises II, Inc., a wholly owned subsidiary of Akorn, Inc., VPI Holdings Corp., and Tailwind Management LP, incorporated by reference to Exhibit 2.1 to Akorn’s report on Form 8-K filed on May 12, 2014.
 
2.7 W
Product Acquisition Agreement dated as of September 30, 2014 by and among Oak Pharmaceuticals, Inc., a wholly owned subsidiary of Akron, Inc., and Sunovion Pharmaceuticals, Inc., incorporated by reference to Exhibit 2.1 to Akorn’s report on Form 8-K filed on October 1, 2014.
 
3.1
Restated Articles of Incorporation of Akorn, Inc. dated September 16, 2004, incorporated by reference to Exhibit 3.1 to Akorn, Inc.’s Registration Statement on Form S-1 filed on September 21, 2004(Commission file No. 001-32360).
 
3.2
By-Laws of Akorn, Inc., as amended effective October 4, 2013, incorporated by reference to Exhibit 3.2 to Akorn’s report on Form 8-K filed on October 10, 2013.
 
4.1
Form of Securities Purchase Agreement dated March 1, 2006, between Akorn, Inc. and certain investors incorporated by reference to Exhibit 4.1 to Akorn, Inc.’s report on Form 8-K filed on March 7, 2006 (Commission file No. 001-32360).
 
4.2
Securities Purchase Agreement dated March 10, 2010, between Akorn, Inc. and Serum Institute of India Ltd, incorporated by reference to Exhibit 10.1 to our report on Form 8-K filed on March 16, 2010.
 
4.3
Akorn, Inc. Common Stock Purchase Warrant, dated April 13, 2009, in favor of EJ Funds LP, incorporated by reference to Exhibit 4.1 of Akorn, Inc.’s report on Form 8-K filed on April 17, 2009.
 
4.4
Modification, Warrant and Investor Rights Agreement, dated April 13, 2009, among Akorn, Inc., Akorn (New Jersey), Inc., and EJ Funds LP, incorporated by reference to Exhibit 4.2 to Akorn, Inc.’s report on Form 8-K filed on April 17, 2009.
 
98
 
4.5
Akorn, Inc. Common Stock Purchase Warrant, dated April 15, 2009, in favor of John N. Kapoor Trust dated 9/20/89, incorporated by reference to Exhibit 4.1 to Akorn, Inc.’s report on Form 8-K filed on April 21, 2009.
 
4.6
Common Stock Purchase Warrant dated August 17, 2009, in favor of EJ Funds LP, incorporated by reference to Exhibit 10.2 to Akorn, Inc.’s report on Form 8-K filed on August 21, 2009.
 
4.7
Common Stock Purchase Warrant dated August 17, 2009, in favor of John N. Kapoor Trust Dated 9/20/89, incorporated by reference to Exhibit 10.4 to Akorn, Inc.’s report on Form 8-K filed on August 21, 2009.
 
4.8
Warrant, dated March 10, 2010, granted by Akorn, Inc. to Serum Institute of India Ltd, incorporated by reference to Exhibit 4.1 to Akorn, Inc.’s report on Form 8-K filed on March 16, 2010.
 
4.9
Amended and Restated Registration Rights Agreement dated June 28, 2010, between Akorn, Inc. and The John N. Kapoor Trust Dated September 20, 1989 and EJ Funds LP, incorporated by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on July 2, 2010.
 
4.10
Indenture dated as of June 1, 2011 by and between Akorn, Inc. and Wells Fargo Bank, National Association, as trustee, including the form of 3.50% Convertible Senior Note due 2016 (included as Exhibit A to the Indenture), incorporated by reference to Exhibit 4.1 to Akorn, Inc.’s report on Form 8-K filed on June 2, 2011.
 
10.1†
Form of Akorn, Inc. Non-Qualified Stock Option Agreement, incorporated by reference to Exhibit 10.36 to Akorn, Inc.’s report on Form 10-K for the fiscal year ended December 31, 2003, filed on March 30, 2004 (Commission file No. 001-32360).
 
10.2†
Form of Akorn, Inc. Incentive Stock Option Agreement, incorporated by reference to Exhibit 10.37 to Akorn, Inc.’s report on Form 10-K for the fiscal year ended December 31, 2003, filed on March 30, 2004 (Commission file No. 001-32360).
 
10.3†
Amended and Restated Akorn, Inc. 2003 Stock Option Plan, as amended, incorporated by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on March 8, 2012.
 
10.4†
Amended and Restated Employee Stock Purchase Plan incorporated by reference to Appendix B to the Akorn, Inc. definitive proxy statement on Schedule 14A filed on July 24, 2009.
 
10.5†
Form of Akorn Inc. 2014 Stock Option Plan, incorporated by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on May 8, 2014.
 
10.6†
Form of Amendment to Executive Consulting Agreement between Akorn, Inc. and Raj Rai, dated December 8, 2009, incorporated by reference to Exhibit 10.1 to Akorn, Inc’s report on Form 8-K filed on December 22, 2009.
 
10.7†
Form of Second Amendment to Executive Consulting Agreement between Akorn, Inc. and Raj Rai, its Chief Executive Officer, effective December 8, 2010, incorporated by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on December 28, 2010.
 
10.8†
Form of Employment Agreement, dated December 22, 2010, between Akorn, Inc. and Timothy Dick, its Chief Financial Officer, incorporated by reference to Exhibit 10.2 to Akorn, Inc.’s report on Form 8-K filed on December 28, 2010.
 
10.9†
Form of Employment Agreement, dated December 22, 2010, between Akorn, Inc. and Joe Bonaccorsi, its Secretary, incorporated by reference to Exhibit 10.3 to Akorn, Inc.’s report on Form 8-K filed on December 28, 2010.
 
10.10†
Form of Employment Agreement, dated April 11, 2014, between Akorn, Inc. and Raj Rai, its Chief Executive Officer, effective January 1, 2014, incorporated by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on April 16, 2014.
 
10.11†
Form of Employment Agreement, dated April 11, 2014, between Akorn, Inc. and Bruce Katinsky, its Chief Operating Officer, incorporated by reference to Exhibit 10.2 to Akorn, Inc.’s report on Form 8-K filed on April 16, 2014.
 
10.12
Series A-2 Preferred Stock Purchase Agreement dated as of August 1, 2011 by and between Akorn, Inc. and Aciex Therapeutics, Inc., incorporated by reference to Exhibit 10.1 to Akorn Inc.’s report on Form 10-Q filed on November 9, 2011.
 
10.13
Amendment #1 to Series A-2 Preferred Stock Purchase Agreement dated as of September 30, 2011 by and between Akorn, Inc. and Aciex Therapeutics, Inc., incorporated by reference to Exhibit 10.1 to Akorn Inc.’s report on Form 10-Q filed on November 9, 2011.
 
10.14
Lease Agreement dated July 15, 2010, by and between Veronica Development Associates, a New Jersey general partnership, and Akorn (New Jersey), Inc., an Illinois corporation, for the Company’s 50,000 square foot manufacturing facility at 72-6 Veronica Avenue, Somerset, New Jersey, incorporate by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on July 30, 2010.
 
 
99
 
10.15
Subordinated Promissory Note dated July 28, 2008, issued by Akorn, Inc. to The John N. Kapoor Trust Dated September 20, 1989, in the principal amount of $5,000,000, incorporated by reference to Exhibit 10.1 to Akorn, Inc.’s report on Form 8-K filed on August 1, 2008.
 
10.16
Subordination and Intercreditor Agreement dated July 28, 2008, by and among Akorn, Inc., The John N. Kapoor Trust Dated September 20, 1989, LaSalle Bank National Association, as administrative agent for all senior lenders party to the senior credit agreement, and Akorn (New Jersey), Inc., incorporated by reference to Exhibit 10.2 to Akorn, Inc.’s report on Form 8-K filed on August 1, 2008.
 
10.17
Reimbursement and Warrant Agreement, dated April 15, 2009, among Akorn, Inc. Akorn (New Jersey), Inc., John N. Kapoor Trust dated 09/20/89, and EJ Funds LP, incorporated by reference to Exhibit 10.1 to Akorn Inc.’s report on Form 8-K filed on April 21, 2009.
 
10.18
Amended and Restated Subordinated Note dated August 17, 2009, made by the Company and Akorn (New Jersey), Inc., in favor of John N. Kapoor Trust Dated 9/20/89, incorporated by reference to Exhibit 10.3 of a Form 8-K filed on August 21, 2009.
 
10.19
Loan and Security Agreement dated as of October 7, 2011 among Akorn, Inc., a Louisiana corporation, and its domestic subsidiaries, with certain financial institutions as lenders (Lenders), and Bank of America, N.A. as agent (Agent) for the Lenders, incorporated by reference to Exhibit 10.1 to Akorn Inc.’s report on Form 8-K filed on October 13, 2011.
 
10.20
Joinder and Fourth Amendment to Loan and Security Agreement and Second Amendment to Pledge Agreement dated as of October 4, 2013 among Akorn, Inc., its domestic subsidiaries, and Bank of America, N.A., incorporated by reference to Akorn’s current report on Form 8-K filed on October 10, 2013.
 
10.21
Replacement Note dated as of October 4, 2013 in the principal amount of $60 million by Akorn, Inc. and its domestic subsidiaries in favor of Bank of America, N.A, incorporated by reference to Akorn’s current report on Form 8-K filed on October 10, 2013.
 
10.22
First Amendment to Trademark Security Agreement dated as of October 4, 2013 among Akorn, Inc. and Advanced Vision Research, Inc. in favor of Bank of America, N.A., incorporated by reference to Akorn’s current report on Form 8-K filed on October 10, 2013.
 
10.23
Loan Agreement dated as of April 17, 2014 among Akorn, Inc., with certain financial institutions as lenders (Lenders), and JPMorgan Chase Bank as administrative agent (Agent) for the Lenders, incorporated by reference to Exhibit 10.1 to Akorn Inc.’s report on Form 8-K filed on April 23, 2014.
 
10.24
Credit Agreement dated as of April 17, 2014 among Akorn, Inc., with certain financial institutions as lenders (Lenders), and JPMorgan Chase Bank as administrative agent (Agent) for the Lenders, incorporated by reference to Exhibit 10.2 to Akorn Inc.’s report on Form 8-K filed on April 23, 2014.
 
10.25
Incremental Facility Joinder Agreement dated as of August 12, 2014 among Akorn, Inc., with certain financial institutions as lenders (Lenders) and JPMorgan Chase Bank as administrative agent (Agent) for the Lenders, incorporated by reference to Exhibit 10.1 to Akorn Inc.’s report on Form 8-K filed on August 15, 2014.
 
21.1 *
Listing of Subsidiaries of Akorn, Inc.
 
23.1 *
Consent of KPMG, LLP, Independent Registered Public Accounting Firm
 
23.2 *
Consent of Ernst & Young, LLP, Independent Registered Public Accounting Firm
 
31.1 *
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a).
 
31.2 *
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a).
 
32.1 *
Certification of the Chief Executive Officer pursuant to 18 USC Section 1350.
 
32.2 *
Certification of the Chief Financial Officer pursuant to 18 USC Section 1350.
 
 
100
 
101
The financial statements and footnotes from the Akorn, Inc. Annual Report on Form 10-K for the year ended December 31, 2014, filed on March 17, 2015, formatted in XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statement of Shareholders’ Equity, (iv) Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements.
 
 
 
 
 

 
 
101
 
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
AKORN, INC.
     
  By: /s/ RAJAT RAI
   
Rajat Rai
Chief Executive Officer
 

Date: March 17, 2015

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant, and in the capacities and on the dates indicated.

Signature
  
Title
  
Date
         
/s/ RAJAT RAI
  
Chief Executive Officer
  
March 17, 2015
Rajat Rai
        
         
/s/ TIMOTHY A. DICK
  
Chief Financial Officer (Principal Financial Officer
  
March 17, 2015
Timothy A. Dick
  
and Principal Accounting Officer)
    
         
/s/ JOHN N. KAPOOR, PH.D.
  
Director, Chairman of the Board
  
March 17, 2015
John N. Kapoor, Ph.D.
        
         
/s/ KENNETH S. ABRAMOWITZ
  
Director
  
March 17, 2015
Kenneth S. Abramowitz
        
         
/s/ ADRIENNE L. GRAVES
  
Director
  
March 17, 2015
Adrienne L. Graves
        
         
/s/ RONALD M. JOHNSON
  
Director
  
March 17, 2015
Ronald M. Johnson
        
         
/s/ STEVEN J. MEYER
  
Director
  
March 17, 2015
Steven J. Meyer
        
         
/s/ BRIAN TAMBI
  
Director
  
March 17, 2015
Brian Tambi
        
         
/s/ ALAN WEINSTEIN
  
Director
  
March 17, 2015
Alan Weinstein
        
         
 
 
 
102
EX-21.1 2 exh_211.htm EXHIBIT 21.1 exh_211.htm
 EXHIBIT 21.1

AKORN, INC.
LISTING OF SUBSIDIARIES OF THE REGISTRANT
As of December 31, 2014



Legal Entity Name
  
Incorporation
  
Ownership
         
Registrant / Parent Corporation:
        
     Akorn, Inc.
  
Louisiana
  
Shareholders (NASDAQ: AKRX)
         
U.S. subsidiaries of Akorn, Inc.:
        
     Advanced Vision Research, Inc.
  
Delaware
  
Akorn, Inc. (LA)
     Akorn (New Jersey), Inc.
  
Illinois
  
Akorn, Inc. (LA)
     Akorn Animal Health, Inc.
  
Delaware
  
Akorn, Inc. (LA)
     Akorn Ophthalmics, Inc.
Akorn Sales, Inc.
  
Delaware
Delaware
  
Akorn, Inc. (LA)
Akorn, Inc. (LA)
     Inspire Pharmaceuticals, Inc.
  
Delaware
  
Oak Pharmaceuticals, Inc. (DE)
     Oak Pharmaceuticals, Inc.
Hi-Tech Pharmacal Co., Inc.
10 Edison Street LLC
13 Edison Street LLC
VPI Holdings Corp.
VPI Holdings Sub, LLC.
VersaPharm Incorporated
Covenant Pharma, Inc.
Olta Pharmaceuticals Corp.
Clover Pharmaceuticals Corp.
  
Delaware
Delaware
Delaware
Delaware
Delaware
Delaware
Georgia
Georgia
Delaware
Delaware
  
Akorn, Inc. (LA)
Akorn, Inc. (LA)
Hi-Tech Pharmacal Co., Inc. (DE)
Hi-Tech Pharmacal Co., Inc. (DE)
Akorn, Inc. (LA)
VPI Holdings Corp. (DE)
VPI Holdings Sub, LLC. (DE)
VPI Holdings Sub, LLC. (DE)
VersaPharm Incorporated (GA)
VersaPharm Incorporated (GA)
Akorn-Strides, LLC
  
Delaware
  
Akorn, Inc. (LA) (50% owned)
         
Foreign subsidiaries of Akorn, Inc.:
        
     WorldAkorn Pharma Mauritius
  
Mauritius
  
Akorn, Inc. (LA)
     Akorn India Private Limited
Akorn Canada, Inc.
Akorn International S.à r.l.
  
India
Canada
Luxembourg
  
WorldAkorn Pharma Mauritius
Akorn, Inc. (LA)
Oak Pharmaceuticals, Inc. (DE)
EX-23.1 3 exh_231.htm EXHIBIT 23.1 exh_231.htm
Exhibit 23.1

 
Consent of Independent Registered Public Accounting Firm
 
The Board of Directors
 
Akorn, Inc.:
 
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-124190, 333-167031, 333-179476, 333-161908, 333-195673), of Akorn, Inc. of our report dated March 17, 2015, with respect to the consolidated balance sheets of Akorn, Inc. and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of comprehensive income, shareholders’ equity, and cash flows, for each of the years then ended, and the effectiveness of internal control over financial reporting as of December 31, 2014, which report appears  in the December 31, 2014 annual report on Form 10-K of Akorn, Inc.

Our report dated March 17, 2015, on the effectiveness of internal control over financial reporting as of December 31, 2014, expresses our opinion that Akorn, Inc. did not maintain effective internal control over financial reporting as of December 31, 2014 because of the effect of material weaknesses on the achievement of the objectives of the control criteria and contains an explanatory paragraph that states that material weaknesses exist related to 1) the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions, 2)  the process and controls in place to support the accurate and timely reporting of the financial results and disclosures, and 3) the process and controls in place over the financial statements of acquired subsidiaries, have been identified and included in management’s assessment.

Our report dated March 17, 2015 on effectiveness of internal control over financial reporting as of December 31, 2014, contains an explanatory paragraph that states management excluded from its assessment of the effectiveness of internal control over financial reporting as of December 31, 2014, Hi Tech Pharmacal Co, Inc.’s (Hi Tech) and VPI Holdings Corp. Inc.’s (VersaPharm) internal control over financial reporting associated with total assets of $254,257,000 and $13,801,000, respectively, and total revenues of $164,825,000 and $9,173,000, respectively, included in the consolidated financial statements of Akorn, Inc. and subsidiaries as of and for the year ended December 31, 2014. Our audit of internal control over financial reporting of Akorn, Inc. also excluded an evaluation of the internal control over financial reporting of Hi Tech and VersaPharm.

 
/s/ KPMG LLP

Chicago, Illinois
March 17, 2015
 EX-23.2 4 exh_232.htm EXHIBIT 23.2 exh_232.htm
Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the incorporation by reference in the following Registration Statements:
 
(1)  
Registration Statement (Form S-8 No. 333-124190) pertaining to the Amended and Restated Akorn, Inc. 2003 Stock Option Plan;
(2)  
Registration Statement (Form S-8 No. 333-167031) pertaining to the Amended and Restated Akorn, Inc. Employee Stock Purchase Plan;
(3)  
Registration Statement (Form S-8 No. 333-179476) pertaining to the Amended and Restated Akorn, Inc. 2003 Stock Option Plan;
(4)  
Registration Statement (Form S-8 No. 333-161908) pertaining to the Amended and Restated Akorn, Inc. 2003 Stock Option Plan; and
(5)  
Registration Statement (Form S-8 No. 333-195673) pertaining to the registration of 7,500,000 shares of common stock, no par value, authorized for issuance under the Akorn Inc. 2014 Stock Option Plan;
 
of our report dated March 1, 2013, except for Note 12 – Segment Information, as to which the date is March 17, 2015, with respect to the consolidated statements of comprehensive income, shareholders' equity and cash flows of Akorn, Inc. for the year ended December 31, 2012, included in this Annual Report (Form 10-K) of Akorn, Inc. for its year ended December 31, 2014.

/s/ Ernst & Young LLP

Chicago, Illinois
March 17, 2015
 
 
 EX-31.1 5 exh_311.htm EXHIBIT 31.1 exh_311.htm
EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Rajat Rai, certify that:

1. I have reviewed this report on Form 10-K of Akorn, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 17, 2015

/s/ RAJAT RAI                      
Rajat Rai
Chief Executive Officer
 EX-31.2 6 exh_312.htm EXHIBIT 31.2 exh_312.htm
EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Timothy A. Dick, certify that:

1. I have reviewed this report on Form 10-K of Akorn, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 17, 2015

/s/ TIMOTHY A. DICK            
Timothy A. Dick
Chief Financial Officer
 EX-32.1 7 exh_321.htm EXHIBIT 32.1 exh_321.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. 1350

In connection with the Annual Report of Akorn, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2014, as filed with the Securities and Exchange Commission and to which this Certification is an exhibit (the “Report”), the undersigned officer of Akorn, Inc. does hereby certify, pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) and Rule 13a-14(b) promulgated under the Securities Exchange Act of 1934, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 17, 2015

/s/ RAJAT RAI
Rajat Rai
Chief Executive Officer
 EX-32.2 8 exh_322.htm EXHIBIT 32.2 exh_322.htm
EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. 1350

In connection with the Annual Report of Akorn, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2014, as filed with the Securities and Exchange Commission and to which this Certification is an exhibit (the “Report”), the undersigned officer of Akorn, Inc. does hereby certify, pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) and Rule 13a-14(b) promulgated under the Securities Exchange Act of 1934, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 17, 2015

/s/ TIMOTHY A. DICK
Timothy A. Dick
Chief Financial Officer

 EX-101.INS 9 akrx-20141231.xml XBRL INSTANCE DOCUMENT 0000003116 2014-12-31 0000003116 2013-12-31 0000003116 2014-01-01 2014-12-31 0000003116 2013-01-01 2013-12-31 0000003116 2012-01-01 2012-12-31 0000003116 us-gaap:CommonStockMember 2011-12-31 0000003116 us-gaap:WarrantMember 2011-12-31 0000003116 us-gaap:RetainedEarningsMember 2011-12-31 0000003116 2011-12-31 0000003116 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0000003116 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000003116 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-01-01 2012-12-31 0000003116 us-gaap:CommonStockMember 2012-12-31 0000003116 us-gaap:WarrantMember 2012-12-31 0000003116 us-gaap:RetainedEarningsMember 2012-12-31 0000003116 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0000003116 2012-12-31 0000003116 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0000003116 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0000003116 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000003116 us-gaap:CommonStockMember 2013-12-31 0000003116 us-gaap:WarrantMember 2013-12-31 0000003116 us-gaap:RetainedEarningsMember 2013-12-31 0000003116 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000003116 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000003116 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0000003116 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0000003116 us-gaap:WarrantMember us-gaap:CommonStockMember 2014-01-01 2014-12-31 0000003116 us-gaap:WarrantMember us-gaap:WarrantMember 2014-01-01 2014-12-31 0000003116 us-gaap:WarrantMember 2014-01-01 2014-12-31 0000003116 us-gaap:WarrantMember us-gaap:CommonStockMember 2014-12-31 0000003116 us-gaap:WarrantMember us-gaap:RetainedEarningsMember 2014-12-31 0000003116 us-gaap:WarrantMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000003116 us-gaap:WarrantMember 2014-12-31 0000003116 2015-02-27 0000003116 2014-06-30 0000003116 us-gaap:MinimumMember 2014-01-01 2014-12-31 0000003116 us-gaap:MaximumMember 2014-01-01 2014-12-31 0000003116 akrx:SantenMember 2014-12-31 0000003116 akrx:SantenMember 2014-01-01 2014-12-31 0000003116 akrx:SantenMember us-gaap:FairValueInputsLevel3Member 2014-12-31 0000003116 akrx:SantenMember us-gaap:FairValueInputsLevel3Member us-gaap:InterestExpenseMember 2014-01-01 2014-12-31 0000003116 akrx:InitialValueMember 2014-12-31 0000003116 akrx:HLundbeckASMember 2011-12-22 0000003116 akrx:HLundbeckASMember 2011-12-22 2011-12-22 0000003116 akrx:HLundbeckASMember 2013-01-01 2013-12-31 0000003116 akrx:HLundbeckASMember 2014-01-01 2014-12-31 0000003116 2010-06-28 0000003116 akrx:KapoorWarrantsMember 2014-04-10 0000003116 akrx:KapoorWarrantsMember 2014-04-01 2014-04-10 0000003116 akrx:ProductLicensingRightsMember 2014-12-31 0000003116 akrx:ProductLicensingRightsMember 2014-01-01 2014-12-31 0000003116 akrx:IntellectualPropertyandResearchandDevelopmentMember 2014-12-31 0000003116 akrx:IntellectualPropertyandResearchandDevelopmentMember 2014-01-01 2014-12-31 0000003116 us-gaap:TrademarksMember 2014-12-31 0000003116 us-gaap:TrademarksMember 2014-01-01 2014-12-31 0000003116 us-gaap:CustomerRelationshipsMember 2014-12-31 0000003116 us-gaap:CustomerRelationshipsMember 2014-01-01 2014-12-31 0000003116 us-gaap:OtherIntangibleAssetsMember 2014-12-31 0000003116 us-gaap:OtherIntangibleAssetsMember 2014-01-01 2014-12-31 0000003116 us-gaap:NoncompeteAgreementsMember 2014-12-31 0000003116 us-gaap:NoncompeteAgreementsMember 2014-01-01 2014-12-31 0000003116 akrx:ProductLicensingRightsMember 2012-12-31 0000003116 us-gaap:TrademarksMember 2012-12-31 0000003116 us-gaap:CustomerRelationshipsMember 2012-12-31 0000003116 us-gaap:NoncompeteAgreementsMember 2012-12-31 0000003116 akrx:ProductLicensingRightsMember 2013-01-01 2013-12-31 0000003116 us-gaap:TrademarksMember 2013-01-01 2013-12-31 0000003116 us-gaap:CustomerRelationshipsMember 2013-01-01 2013-12-31 0000003116 us-gaap:NoncompeteAgreementsMember 2013-01-01 2013-12-31 0000003116 akrx:ProductLicensingRightsMember 2013-12-31 0000003116 us-gaap:TrademarksMember 2013-12-31 0000003116 us-gaap:CustomerRelationshipsMember 2013-12-31 0000003116 us-gaap:NoncompeteAgreementsMember 2013-12-31 0000003116 us-gaap:BuildingMember 2014-01-01 2014-12-31 0000003116 us-gaap:LeaseholdImprovementsMember 2014-01-01 2014-12-31 0000003116 us-gaap:FurnitureAndFixturesMember 2014-01-01 2014-12-31 0000003116 us-gaap:AutomobilesMember 2014-01-01 2014-12-31 0000003116 us-gaap:ComputerEquipmentMember 2014-01-01 2014-12-31 0000003116 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0000003116 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0000003116 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000003116 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000003116 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000003116 akrx:ModificationWarrantsMember 2013-01-01 2013-12-31 0000003116 akrx:ModificationWarrantsMember 2013-12-31 0000003116 akrx:ReimbursementsWarrantsMember 2013-01-01 2013-12-31 0000003116 akrx:ReimbursementsWarrantsMember 2013-12-31 0000003116 akrx:CreditFacilityWarrantsMember 2013-01-01 2013-12-31 0000003116 akrx:CreditFacilityWarrantsMember 2013-12-31 0000003116 akrx:SubordinatedNoteWarrantsMember 2013-01-01 2013-12-31 0000003116 akrx:SubordinatedNoteWarrantsMember 2013-12-31 0000003116 us-gaap:AllowanceForSalesReturnsMember 2011-12-31 0000003116 akrx:CharegebacksandRebatesMember 2011-12-31 0000003116 us-gaap:ReserveForCashDiscountMember 2011-12-31 0000003116 us-gaap:AllowanceForDoubtfulAccountsMember 2011-12-31 0000003116 us-gaap:AllowanceForPromotionsMember 2011-12-31 0000003116 us-gaap:AllowanceForSalesReturnsMember 2012-01-01 2012-12-31 0000003116 akrx:CharegebacksandRebatesMember 2012-01-01 2012-12-31 0000003116 us-gaap:ReserveForCashDiscountMember 2012-01-01 2012-12-31 0000003116 us-gaap:AllowanceForDoubtfulAccountsMember 2012-01-01 2012-12-31 0000003116 us-gaap:AllowanceForPromotionsMember 2012-01-01 2012-12-31 0000003116 us-gaap:AllowanceForSalesReturnsMember 2012-12-31 0000003116 akrx:CharegebacksandRebatesMember 2012-12-31 0000003116 us-gaap:ReserveForCashDiscountMember 2012-12-31 0000003116 us-gaap:AllowanceForDoubtfulAccountsMember 2012-12-31 0000003116 us-gaap:AllowanceForPromotionsMember 2012-12-31 0000003116 us-gaap:AllowanceForSalesReturnsMember 2013-01-01 2013-12-31 0000003116 akrx:CharegebacksandRebatesMember 2013-01-01 2013-12-31 0000003116 us-gaap:ReserveForCashDiscountMember 2013-01-01 2013-12-31 0000003116 us-gaap:AllowanceForDoubtfulAccountsMember 2013-01-01 2013-12-31 0000003116 us-gaap:AllowanceForPromotionsMember 2013-01-01 2013-12-31 0000003116 us-gaap:AllowanceForSalesReturnsMember 2013-12-31 0000003116 akrx:CharegebacksandRebatesMember 2013-12-31 0000003116 us-gaap:ReserveForCashDiscountMember 2013-12-31 0000003116 us-gaap:AllowanceForDoubtfulAccountsMember 2013-12-31 0000003116 us-gaap:AllowanceForPromotionsMember 2013-12-31 0000003116 us-gaap:AllowanceForSalesReturnsMember 2014-01-01 2014-12-31 0000003116 akrx:CharegebacksandRebatesMember 2014-01-01 2014-12-31 0000003116 us-gaap:ReserveForCashDiscountMember 2014-01-01 2014-12-31 0000003116 us-gaap:AllowanceForDoubtfulAccountsMember 2014-01-01 2014-12-31 0000003116 us-gaap:AllowanceForPromotionsMember 2014-01-01 2014-12-31 0000003116 us-gaap:AllowanceForSalesReturnsMember 2014-12-31 0000003116 akrx:CharegebacksandRebatesMember 2014-12-31 0000003116 us-gaap:ReserveForCashDiscountMember 2014-12-31 0000003116 us-gaap:AllowanceForDoubtfulAccountsMember 2014-12-31 0000003116 us-gaap:AllowanceForPromotionsMember 2014-12-31 0000003116 akrx:OutsidetheUnitedStatesMember 2014-12-31 0000003116 akrx:OutsidetheUnitedStatesMember 2013-12-31 0000003116 us-gaap:LandMember 2014-12-31 0000003116 us-gaap:LandMember 2013-12-31 0000003116 us-gaap:BuildingAndBuildingImprovementsMember 2014-12-31 0000003116 us-gaap:BuildingAndBuildingImprovementsMember 2013-12-31 0000003116 us-gaap:FurnitureAndFixturesMember 2014-12-31 0000003116 us-gaap:FurnitureAndFixturesMember 2013-12-31 0000003116 akrx:IncrementalTermLoanFacilityMember akrx:JPMorganMember 2014-08-12 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember 2014-04-17 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember 2014-08-01 2014-08-12 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember akrx:PrepaymentTermSixMonthsMember 2014-08-12 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember 2014-12-31 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember us-gaap:BaseRateMember 2014-08-01 2014-08-12 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember us-gaap:LondonInterbankOfferedRateLIBORMember 2014-08-01 2014-08-12 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember 2014-08-12 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember 2014-01-01 2014-12-31 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember akrx:CommitmentFeesMember 2014-01-01 2014-12-31 0000003116 akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember akrx:TicketingFeesMember 2014-01-01 2014-12-31 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember 2014-04-17 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember 2011-06-30 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember 2014-04-01 2014-04-17 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember 2014-12-31 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember us-gaap:BaseRateMember 2014-04-01 2014-04-17 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember us-gaap:EurodollarMember 2014-04-01 2014-04-17 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember us-gaap:MaximumMember 2014-04-17 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember 2014-01-01 2014-12-31 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember akrx:TicketingFeesMember 2014-01-01 2014-09-30 0000003116 akrx:TermLoanFacilityMember akrx:JPMorganMember akrx:CommitmentFeesMember 2014-01-01 2014-09-30 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:BOfARevolvingFacilityMember akrx:BOfAMember akrx:TerminatedMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember akrx:TheLesserOfForScenarioTwoConsiderationAMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember akrx:TheLesserOfForScenarioTwoConsiderationBMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember akrx:TheLesserOfForScenarioThreeConsiderationAMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember akrx:TheLesserOfForScenarioThreeConsiderationBMember 2014-04-17 0000003116 us-gaap:LetterOfCreditMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember 2014-04-01 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember akrx:PotentialMember 2014-04-17 0000003116 akrx:JPMRevolvingFacilityMember akrx:JPMorganMember 2014-04-17 0000003116 akrx:JPMRevolvingFacilityMember akrx:JPMorganMember 2014-04-01 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:JPMorganMember 2014-12-31 0000003116 akrx:JPMRevolvingFacilityMember akrx:JPMorganMember 2014-12-31 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember 2011-06-30 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember us-gaap:OverAllotmentOptionMember 2011-06-30 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember 2011-06-01 2011-06-30 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember 2014-12-31 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember akrx:Per1000PrincipalAmountOfNotesMember 2014-01-01 2014-12-31 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember akrx:Scenario1Member 2014-01-01 2014-12-31 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember 2014-01-01 2014-12-31 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember akrx:Scenario2Member 2014-01-01 2014-12-31 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember us-gaap:MinimumMember akrx:Scenario2Member 2014-01-01 2014-12-31 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember akrx:Scenario2Member 2014-12-31 0000003116 akrx:NotesMember us-gaap:SeniorNotesMember 2012-01-01 2012-03-31 0000003116 2011-06-02 0000003116 2011-06-01 2011-06-02 0000003116 2011-06-01 2011-06-01 0000003116 akrx:BOfARevolvingFacilityMember akrx:BOfAMember 2011-10-07 0000003116 us-gaap:LetterOfCreditMember akrx:BOfAMember 2011-10-07 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:Category1Member us-gaap:BaseRateMember 2014-04-17 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:Category1Member us-gaap:EurodollarMember 2014-04-17 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:Category2Member us-gaap:BaseRateMember 2014-04-17 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:Category2Member us-gaap:EurodollarMember 2014-04-17 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:Category3Member us-gaap:BaseRateMember 2014-04-17 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember akrx:Category3Member us-gaap:EurodollarMember 2014-04-17 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember us-gaap:MinimumMember akrx:Category1Member us-gaap:BaseRateMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember us-gaap:MinimumMember akrx:Category1Member us-gaap:EurodollarMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember us-gaap:MaximumMember akrx:Category2Member us-gaap:BaseRateMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember us-gaap:MaximumMember akrx:Category2Member us-gaap:EurodollarMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember us-gaap:MinimumMember akrx:Category2Member us-gaap:BaseRateMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember us-gaap:MinimumMember akrx:Category2Member us-gaap:EurodollarMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember us-gaap:MaximumMember akrx:Category3Member us-gaap:BaseRateMember 2014-04-17 0000003116 us-gaap:RevolvingCreditFacilityMember akrx:JPMRevolvingFacilityMember us-gaap:MaximumMember akrx:Category3Member us-gaap:EurodollarMember 2014-04-17 0000003116 us-gaap:ConvertibleDebtMember 2014-12-31 0000003116 us-gaap:ConvertibleDebtMember 2013-12-31 0000003116 us-gaap:ConvertibleDebtMember 2014-01-01 2014-12-31 0000003116 us-gaap:ConvertibleDebtMember 2013-01-01 2013-12-31 0000003116 us-gaap:ConvertibleDebtMember 2012-01-01 2012-12-31 0000003116 us-gaap:ConvertibleDebtMember 2012-12-31 0000003116 akrx:LakeForestandGurneeFacilitiesMember 2014-01-01 2014-12-31 0000003116 akrx:WarminsterPennsylvaniaFacilityMember 2014-01-01 2014-12-31 0000003116 akrx:WarminsterPennsylvaniaFacilityMember 2014-12-31 0000003116 akrx:MarriettaGeorgiaFacilityMember 2014-12-31 0000003116 akrx:MarriettaGeorgiaFacilityMember 2014-01-01 2014-12-31 0000003116 akrx:VernonHillsIllinoisFacilityMember 2014-01-01 2014-12-31 0000003116 akrx:SomersetNewJerseyFacilityMember 2014-12-31 0000003116 akrx:SomersetNewJerseyFacilityMember 2014-01-01 2014-12-31 0000003116 akrx:SomersetWarehouseLeaseMember 2014-12-31 0000003116 akrx:SomersetWarehouseLeaseMember 2014-01-01 2014-12-31 0000003116 akrx:EJFinancialEnterprisesIncMember 2010-03-03 2010-03-03 0000003116 akrx:EJFinancialEnterprisesIncMember 2012-07-01 2012-07-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember 2004-07-08 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember 2004-07-08 2004-07-08 0000003116 akrx:Amended2003PlanMember 2005-05-27 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember 2009-08-07 0000003116 akrx:Amended2003PlanMember 2011-01-01 2011-12-31 0000003116 akrx:Amended2003PlanMember 2011-12-31 0000003116 akrx:Amended2003PlanMember 2014-01-01 2014-12-31 0000003116 akrx:Amended2003PlanMember 2014-12-31 0000003116 akrx:The2003PlanAndAmended2003PlanMember 2014-01-01 2014-12-31 0000003116 akrx:OptionsGrantedIn2014Member 2014-01-01 2014-12-31 0000003116 akrx:OptionsGrantedInEarlierYearsMember 2014-01-01 2014-12-31 0000003116 akrx:TwoThousandFourteenPlanMember 2014-05-02 0000003116 akrx:TwoThousandFourteenPlanMember 2014-01-01 2014-12-31 0000003116 akrx:TwoThousandFourteenPlanMember 2014-12-31 0000003116 akrx:TwoThousandFourteenPlanMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0000003116 akrx:TwoThousandFourteenPlanMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0000003116 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2014-05-02 2014-05-02 0000003116 us-gaap:RestrictedStockMember us-gaap:ManagementMember 2014-05-02 2014-05-02 0000003116 akrx:SeniorManagementMember 2014-05-02 2014-05-02 0000003116 us-gaap:RestrictedStockMember akrx:SeniorManagementMember 2014-09-05 2014-09-05 0000003116 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2014-09-05 2014-09-05 0000003116 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2013-05-03 2013-05-03 0000003116 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2014-05-03 0000003116 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2012-01-01 2012-12-31 0000003116 us-gaap:RestrictedStockMember 2014-01-01 2014-12-31 0000003116 us-gaap:RestrictedStockMember 2013-01-01 2013-12-31 0000003116 us-gaap:RestrictedStockMember 2012-01-01 2012-12-31 0000003116 us-gaap:RestrictedStockMember 2014-12-31 0000003116 akrx:EmployeeStockPurchasePlanESPPMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0000003116 akrx:EmployeeStockPurchasePlanESPPMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0000003116 akrx:EmployeeStockPurchasePlanESPPMember 2014-01-01 2014-12-31 0000003116 akrx:EmployeeStockPurchasePlanESPPMember 2014-12-31 0000003116 akrx:EmployeeStockPurchasePlanESPPMember 2013-01-01 2013-12-31 0000003116 akrx:EmployeeStockPurchasePlanESPPMember 2012-01-01 2012-12-31 0000003116 akrx:EmployeeStockPurchasePlanESPPMember 2011-01-01 2011-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember 2014-01-01 2014-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember 2013-01-01 2013-12-31 0000003116 akrx:TwoThousandAndThreeStockOptionPlanMember 2012-01-01 2012-12-31 0000003116 akrx:StockOptionPlan2014And2003Member 2011-12-31 0000003116 akrx:StockOptionPlan2014And2003Member 2012-01-01 2012-12-31 0000003116 akrx:StockOptionPlan2014And2003Member 2012-12-31 0000003116 akrx:StockOptionPlan2014And2003Member 2013-01-01 2013-12-31 0000003116 akrx:StockOptionPlan2014And2003Member 2013-12-31 0000003116 akrx:StockOptionPlan2014And2003Member 2014-01-01 2014-12-31 0000003116 akrx:StockOptionPlan2014And2003Member 2014-12-31 0000003116 us-gaap:RestrictedStockMember 2011-12-31 0000003116 us-gaap:RestrictedStockMember 2012-12-31 0000003116 us-gaap:RestrictedStockMember 2013-12-31 0000003116 us-gaap:DomesticCountryMember 2014-12-31 0000003116 us-gaap:StateAndLocalJurisdictionMember 2014-12-31 0000003116 us-gaap:ForeignCountryMember 2014-12-31 0000003116 akrx:MerckAcquisitionMember us-gaap:DomesticCountryMember 2014-12-31 0000003116 akrx:VersaPharmMember us-gaap:DomesticCountryMember 2014-12-31 0000003116 us-gaap:ForeignCountryMember akrx:NOLExpiringBeginningIn2022Member 2014-12-31 0000003116 us-gaap:ForeignCountryMember akrx:IndefiniteLivedNOLMember 2014-12-31 0000003116 akrx:PriorTo2012Member 2014-12-31 0000003116 2011-01-01 2011-12-31 0000003116 akrx:DeferredTaxesCurrentMember 2014-12-31 0000003116 akrx:DeferredTaxesNoncurrentMember 2014-12-31 0000003116 akrx:DeferredTaxesCurrentMember 2013-12-31 0000003116 akrx:DeferredTaxesNoncurrentMember 2013-12-31 0000003116 2010-04-01 2010-12-31 0000003116 akrx:OutsidetheUnitedStatesMember 2014-01-01 2014-12-31 0000003116 akrx:OutsidetheUnitedStatesMember 2013-01-01 2013-12-31 0000003116 akrx:OutsidetheUnitedStatesMember 2012-01-01 2012-12-31 0000003116 country:IN 2014-01-01 2014-12-31 0000003116 country:IN 2013-01-01 2013-12-31 0000003116 country:IN 2012-01-01 2012-12-31 0000003116 akrx:PrescriptionPharmaceuticalsMember 2014-01-01 2014-12-31 0000003116 akrx:PrescriptionPharmaceuticalsMember 2013-01-01 2013-12-31 0000003116 akrx:PrescriptionPharmaceuticalsMember 2012-01-01 2012-12-31 0000003116 akrx:ConusmerHealthMember 2014-01-01 2014-12-31 0000003116 akrx:ConusmerHealthMember 2013-01-01 2013-12-31 0000003116 akrx:ConusmerHealthMember 2012-01-01 2012-12-31 0000003116 akrx:PrescriptionPharmaceuticalsMember 2012-12-31 0000003116 akrx:ConusmerHealthMember 2012-12-31 0000003116 akrx:PrescriptionPharmaceuticalsMember 2013-12-31 0000003116 akrx:ConusmerHealthMember 2013-12-31 0000003116 akrx:PrescriptionPharmaceuticalsMember 2014-12-31 0000003116 akrx:ConusmerHealthMember 2014-12-31 0000003116 akrx:BetimolAcquisitionMember 2014-01-02 0000003116 akrx:BetimolAcquisitionMember 2014-01-01 2014-01-02 0000003116 akrx:BetimolAcquisitionMember 2014-12-31 0000003116 us-gaap:ScenarioForecastMember 2015-03-31 0000003116 akrx:TdVaccineMember 2012-10-01 2012-10-17 0000003116 akrx:TdVaccineMember 2014-07-01 2014-07-31 0000003116 akrx:TdVaccineMember 2014-07-31 0000003116 akrx:SupplyAgreementWithHospiraMember 2011-12-31 0000003116 akrx:SupplyAgreementWithHospiraMember us-gaap:ScenarioForecastMember 2015-12-31 0000003116 akrx:ExcelvisionMember 2014-07-22 2014-07-22 0000003116 akrx:ExcelvisionMember us-gaap:SubsequentEventMember 2015-01-02 2015-01-02 0000003116 akrx:ExcelvisionMember 2014-01-01 2014-12-31 0000003116 akrx:LloydAnimalHealthProductsMember 2014-10-02 2014-10-02 0000003116 akrx:LloydAnimalHealthProductsMember akrx:BeforeDiscountMember 2014-10-02 0000003116 akrx:LloydAnimalHealthProductsMember akrx:AfterDiscountMember 2014-10-02 0000003116 akrx:LloydAnimalHealthProductsMember 2014-10-02 0000003116 akrx:LloydAnimalHealthProductsMember 2014-01-01 2014-12-31 0000003116 akrx:XopenexInhalationSolutionsMember 2014-01-01 2014-12-31 0000003116 akrx:XopenexInhalationSolutionsMember 2014-10-01 2014-10-01 0000003116 akrx:VersaPharmMember 2014-08-12 2014-08-12 0000003116 akrx:VersaPharmMember akrx:RifampinMember 2014-01-01 2014-12-31 0000003116 akrx:VersaPharmMember akrx:IncrementalTermLoanAgreementMember akrx:JPMorganMember 2014-08-12 0000003116 akrx:VersaPharmMember 2014-01-01 2014-12-31 0000003116 akrx:VersaPharmMember 2014-12-31 0000003116 akrx:VersaPharmMember akrx:VersaPharmProductsMember 2014-01-01 2014-12-31 0000003116 akrx:VersaPharmMember us-gaap:LicensingAgreementsMember 2014-01-01 2014-12-31 0000003116 akrx:VersaPharmMember us-gaap:OtherIntangibleAssetsMember 2014-01-01 2014-12-31 0000003116 akrx:VersaPharmMember us-gaap:TrademarksMember 2014-01-01 2014-12-31 0000003116 akrx:HiTechPharmacalCoIncMember 2014-04-17 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:TermLoanMember akrx:JPMorganMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember 2014-01-01 2014-12-31 0000003116 akrx:HiTechPharmacalCoIncMember 2013-01-01 2013-12-31 0000003116 akrx:HiTechPharmacalCoIncMember 2014-12-31 0000003116 akrx:HiTechPharmacalCoIncMember akrx:HiTechProductsMember 2014-01-01 2014-12-31 0000003116 akrx:HiTechPharmacalCoIncMember us-gaap:LicensingAgreementsMember 2014-01-01 2014-12-31 0000003116 akrx:HiTechPharmacalCoIncMember us-gaap:CustomerRelationshipsMember 2014-01-01 2014-12-31 0000003116 akrx:HiTechPharmacalCoIncMember us-gaap:TrademarksMember 2014-01-01 2014-12-31 0000003116 akrx:MarketedUnderAbbreviatedNewDrugApplicationsMember akrx:WatsonLaboratoriesIncMember 2014-04-17 0000003116 akrx:MarketedUnderANewDrugApplicationMember akrx:WatsonLaboratoriesIncMember 2014-04-17 0000003116 2014-04-17 0000003116 akrx:LidocainePrilocaineTopicalCreamMember akrx:WatsonLaboratoriesIncMember 2014-01-01 2014-12-31 0000003116 akrx:LidocainePrilocaineTopicalCreamMember akrx:WatsonLaboratoriesIncMember 2013-01-01 2013-12-31 0000003116 us-gaap:OtherNonoperatingIncomeExpenseMember akrx:WatsonProductDispositionMember 2014-04-17 2014-04-17 0000003116 2014-04-01 2014-12-31 0000003116 akrx:HiTechPharmacalCoIncMember akrx:WatsonProductDispositionMember 2014-04-01 2014-12-31 0000003116 akrx:ECRPharmaceuticalsDivestitureMember 2014-06-20 0000003116 akrx:ECRPharmaceuticalsDivestitureMember 2014-01-01 2014-12-31 0000003116 us-gaap:LicensingAgreementsMember akrx:ZioptanMember 2014-01-01 2014-12-31 0000003116 akrx:ZioptanMember 2014-01-01 2014-12-31 0000003116 akrx:BetimolAcquisitionMember 2014-01-02 2014-01-02 0000003116 akrx:BetimolAcquisitionMember 2014-01-01 2014-12-31 0000003116 akrx:BetimolAcquisitionMember akrx:BeforeDiscountMember 2014-12-31 0000003116 akrx:BetimolAcquisitionMember akrx:AfterDiscountMember 2014-12-31 0000003116 akrx:MerckAcquisitionMember akrx:InspirePharmaceuticalsMember 2013-11-15 0000003116 akrx:MerckAcquisitionMember 2013-11-01 2013-11-15 0000003116 akrx:MerckAcquisitionMember 2013-11-15 0000003116 akrx:MerckAcquisitionMember 2014-01-01 2014-12-31 0000003116 akrx:KilitchDrugsLimitedMember 2012-02-28 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:BeforeAdjustmentMember 2012-12-31 0000003116 akrx:KilitchDrugsLimitedMember akrx:AfterAdjustmentMember 2012-12-31 0000003116 akrx:KilitchDrugsLimitedMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0000003116 akrx:KilitchDrugsLimitedMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0000003116 akrx:KilitchDrugsLimitedMember 2012-01-01 2012-12-31 0000003116 akrx:KilitchDrugsLimitedMember 2014-01-01 2014-12-31 0000003116 akrx:KilitchDrugsLimitedMember 2013-01-01 2013-12-31 0000003116 akrx:AciexAgreementMember 2011-08-01 2011-08-31 0000003116 akrx:AciexAgreementMember 2011-09-30 2011-09-30 0000003116 akrx:AciexAgreementMember us-gaap:ConvertibleDebtMember 2014-04-17 2014-04-17 0000003116 akrx:AciexAgreementMember us-gaap:ConvertibleDebtMember 2014-06-27 2014-06-27 0000003116 akrx:AciexAgreementMember 2014-06-27 2014-06-27 0000003116 2014-06-27 2014-06-27 0000003116 akrx:AciexAgreementMember 2014-10-22 0000003116 akrx:AciexAgreementMember 2014-01-01 2014-12-31 0000003116 akrx:AciexAgreementMember 2014-12-31 0000003116 akrx:XopenexAcquisitionMember 2014-01-01 2014-12-31 0000003116 akrx:XopenexAcquisitionMember 2014-10-01 2014-10-02 0000003116 akrx:XopenexAcquisitionMember 2014-10-02 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:CashPaidToVersaPharmStockholderMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:CashPaidToVersaPharmStockholderMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:CashPaidToVersaPharmOptionHoldersMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:CashPaidToVersaPharmOptionHoldersMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:CashPaidToEscrowMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:CashPaidToEscrowMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:CashPaidToPaidToPreviousOwnersOfVersaPharmMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:CashPaidToPaidToPreviousOwnersOfVersaPharmMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:EquityConsiderationPaidAtClosingMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:EquityConsiderationPaidAtClosingMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:DebtPayoffMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:DebtPayoffMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember 2014-08-01 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:ChangeInEstimateMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember us-gaap:TrademarksMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember us-gaap:TrademarksMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:ProductLicensingRightsMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:ProductLicensingRightsMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:IntangiblesOtherMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:IntangiblesOtherMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:InitialFairValuationMember akrx:IPR_DMember 2014-08-12 0000003116 akrx:VersaPharmMember akrx:AdjustedFairValuationMember akrx:IPR_DMember 2014-08-12 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember akrx:CashPaidToHiTechStockholderMember 2014-04-01 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember akrx:CashPaidToHiTechStockholderMember 2014-04-01 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember akrx:CashPaidToVestedHiechOptionHoldersMember 2014-04-01 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember akrx:CashPaidToVestedHiechOptionHoldersMember 2014-04-01 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember akrx:CashPaidToKeyExecutivesMember 2014-04-01 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember akrx:CashPaidToKeyExecutivesMember 2014-04-01 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember 2014-04-01 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember 2014-04-01 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:ChangeInEstimateMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember akrx:ProductLicensingRightsMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember akrx:ProductLicensingRightsMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember akrx:IPR_DMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember akrx:IPR_DMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember us-gaap:CustomerRelationshipsMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember us-gaap:CustomerRelationshipsMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:InitialFairValuationMember us-gaap:TrademarksMember 2014-04-17 0000003116 akrx:HiTechPharmacalCoIncMember akrx:AdjustedFairValuationMember us-gaap:TrademarksMember 2014-04-17 0000003116 akrx:KilitchDrugsLimitedMember akrx:InitialFairValuationMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:AdjustedFairValuationMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:InitialFairValuationMember 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:ChangeInEstimateMember 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:AdjustedFairValuationMember 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:ChangeInEstimateMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:InitialFairValuationMember akrx:StampDutiesPaidForTransferOfLandAndBuildingsMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:AdjustedFairValuationMember akrx:StampDutiesPaidForTransferOfLandAndBuildingsMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:InitialFairValuationMember akrx:AcquisitionRelatedCompensationExpenseMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:ChangeInEstimateMember akrx:AcquisitionRelatedCompensationExpenseMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:AdjustedFairValuationMember akrx:AcquisitionRelatedCompensationExpenseMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:InitialFairValuationMember akrx:DueDiligenceLegalTravelAndOtherAcquistionRelatedCostsMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:ChangeInEstimateMember akrx:DueDiligenceLegalTravelAndOtherAcquistionRelatedCostsMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:AdjustedFairValuationMember akrx:DueDiligenceLegalTravelAndOtherAcquistionRelatedCostsMember 2012-02-01 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:InitialFairValuationMember us-gaap:OtherIntangibleAssetsMember 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:ChangeInEstimateMember us-gaap:OtherIntangibleAssetsMember 2012-02-28 0000003116 akrx:KilitchDrugsLimitedMember akrx:AdjustedFairValuationMember us-gaap:OtherIntangibleAssetsMember 2012-02-28 0000003116 akrx:WatsonProductMember 2014-12-31 0000003116 akrx:WatsonProductMember 2014-01-01 2014-12-31 0000003116 akrx:ECRPharmaceuticalsDivestitureMember 2014-12-31 0000003116 akrx:BetimolAcquisitionMember us-gaap:LicensingAgreementsMember 2014-12-31 0000003116 akrx:BetimolAcquisitionMember us-gaap:OtherIntangibleAssetsMember 2014-12-31 0000003116 akrx:MerckAcquisitionMember akrx:AzaSiteMember 2013-12-31 0000003116 akrx:MerckAcquisitionMember akrx:CosoptMember 2013-12-31 0000003116 akrx:MerckAcquisitionMember akrx:CosoptPFMember 2013-12-31 0000003116 akrx:MerckAcquisitionMember 2013-12-31 0000003116 akrx:MerckAcquisitionMember 2013-10-01 2013-12-31 0000003116 akrx:HiTechAcquisitionWatsonProductDispositionAndECRDivestitureMember 2014-01-01 2014-12-31 0000003116 akrx:HiTechAcquisitionWatsonProductDispositionAndECRDivestitureMember 2013-01-01 2013-12-31 0000003116 us-gaap:CorporateJointVentureMember 2014-01-01 2014-12-31 0000003116 akrx:AkornStridesMember 2013-01-01 2013-12-31 0000003116 akrx:AkornStridesMember 2014-12-31 0000003116 akrx:AkornStridesMember 2013-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2013-01-01 2013-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2014-01-01 2014-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2014-01-01 2014-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2014-01-01 2014-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2014-01-01 2014-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2013-01-01 2013-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2013-01-01 2013-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2013-01-01 2013-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2012-01-01 2012-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2012-01-01 2012-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:AmerisourceMember 2012-01-01 2012-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2014-01-01 2014-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2014-01-01 2014-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2014-01-01 2014-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2013-01-01 2013-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2013-01-01 2013-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2013-01-01 2013-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2012-01-01 2012-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2012-01-01 2012-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:CardinalMember 2012-01-01 2012-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2014-01-01 2014-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2014-01-01 2014-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2014-01-01 2014-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2013-01-01 2013-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2013-01-01 2013-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2013-01-01 2013-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2012-01-01 2012-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2012-01-01 2012-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember akrx:McKessonMember 2012-01-01 2012-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember 2014-01-01 2014-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2014-01-01 2014-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2014-01-01 2014-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember 2013-01-01 2013-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2013-01-01 2013-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2013-01-01 2013-12-31 0000003116 akrx:GrossSalesMember us-gaap:CustomerConcentrationRiskMember 2012-01-01 2012-12-31 0000003116 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2012-01-01 2012-12-31 0000003116 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2012-01-01 2012-12-31 0000003116 akrx:EJFinancialEnterprisesIncMember 2010-03-03 2010-03-03 0000003116 akrx:PolsinelliMember 2014-01-01 2014-12-31 0000003116 akrx:PolsinelliMember 2013-01-01 2013-12-31 0000003116 akrx:PolsinelliMember 2012-01-01 2012-12-31 0000003116 akrx:PolsinelliMember 2014-12-31 0000003116 akrx:PolsinelliMember 2013-12-31 0000003116 us-gaap:ScenarioAdjustmentMember 2014-06-30 0000003116 us-gaap:ScenarioAdjustmentMember 2014-01-01 2014-06-30 0000003116 us-gaap:ScenarioAdjustmentMember 2014-04-01 2014-06-30 0000003116 us-gaap:ScenarioAdjustmentMember 2014-01-01 2014-09-30 0000003116 2014-10-01 2014-12-31 0000003116 2014-07-01 2014-09-30 0000003116 2014-04-01 2014-06-30 0000003116 2014-01-01 2014-03-31 0000003116 2013-10-01 2013-12-31 0000003116 2013-07-01 2013-09-30 0000003116 2013-04-01 2013-06-30 0000003116 2013-01-01 2013-03-31 0000003116 us-gaap:ScenarioPreviouslyReportedMember 2014-06-30 0000003116 us-gaap:ScenarioPreviouslyReportedMember 2014-04-01 2014-06-30 0000003116 us-gaap:ScenarioPreviouslyReportedMember 2014-01-01 2014-06-30 0000003116 2014-01-01 2014-06-30 0000003116 us-gaap:ScenarioPreviouslyReportedMember 2014-09-30 0000003116 us-gaap:ScenarioAdjustmentMember 2014-09-30 0000003116 2014-09-30 0000003116 us-gaap:ScenarioPreviouslyReportedMember 2014-01-01 2014-09-30 0000003116 2014-01-01 2014-09-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure utr:sqft Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $5.8 million, after-taxfor the year ended December 31, 2014. Shares issuable on conversion of the Notes for the year ended December 31, 2014 have increased in comparison to the fiscal years ended December 31, 2013 and 2012 due to stock appreciation which underlies the shares issuable on conversion of the notes and the Company's change in practice on October 1, 2014 to more likely than not settle future note conversions solely through shares as we are now utilizing the if-converted method for convertible debt conversion obligations. 70680000 34178000 220716000 64998000 131310000 55982000 33480000 7945000 7268000 30875000 5753000 494329000 168856000 143788000 82108000 278774000 29831000 704218000 115900000 259141000 14605000 21560000 5676000 3020000 1643000 208000 10006000 1863000 3180000 1268784000 180841000 1906901000 431805000 44116000 22999000 7481000 14728000 1000 1459000 13041000 6004000 13467000 7692000 10450000 27774000 2544000 17835000 5819000 134165000 61245000 1114481000 108750000 268968000 2536000 1630000 1385985000 110380000 1520150000 171625000 351235000 239235000 17946000 50711000 15366000 -15195000 -12367000 386751000 260180000 1906901000 431805000 0 0 150000000 150000000 111734901 96569186 111734901 96569186 593078000 317711000 256158000 295488000 145807000 107466000 297590000 171904000 148692000 95463000 53508000 48053000 32147000 2912000 9155000 29199000 19858000 15858000 44066000 7422000 6870000 200875000 83700000 79936000 96715000 88204000 68756000 12129000 842000 782000 -35657000 -8649000 -10474000 80000 3707000 9807000 400000 395000 59136000 82895000 57500000 23288000 30533000 22122000 35848000 52362000 35378000 -503000 35345000 52362000 35378000 0.35 0.54 0.37 -0.01 0.34 0.54 0.37 0.34 0.46 0.32 -0.01 0.33 0.46 0.32 103480000 96181000 95189000 123110000 113898000 110510000 -1124000 -1704000 -6463000 -5904000 32517000 45899000 29474000 877000 3328000 3040000 94938000 212636000 17946000 -72374000 158208000 35378000 806000 1511000 1511000 71000 368000 368000 29000 351000 351000 6681000 6681000 -5904000 -5904000 4488000 4488000 95844000 226035000 17946000 -36996000 -5904000 201081000 52362000 630000 2634000 2634000 61000 588000 588000 34000 579000 579000 6471000 6471000 -6463000 -6463000 2928000 2928000 96569000 239235000 17946000 15366000 -12367000 35345000 4226000 8013000 8013000 73000 829000 829000 16000 1188000 1188000 6354000 6354000 -1704000 -1704000 38710000 38710000 -1124000 -1124000 3659000 30789000 30789000 7192000 26117000 -17946000 8171000 111735000 351235000 50711000 -15195000 386751000 58538000 14476000 11455000 12129000 842000 782000 72000 -1905000 -635000 20798000 7542000 7050000 7032000 4871000 4634000 6436000 -3707000 -25293000 -2091000 -67000 38710000 2928000 4488000 -1299000 -990000 7000 95470000 14277000 23856000 15262000 3797000 15447000 13180000 648000 5689000 11024000 1975000 4489000 26249000 2537000 10720000 30918000 57326000 26244000 987802000 55482000 55047000 59361000 8532000 29568000 11642000 20454000 250000 -966541000 -66874000 -75501000 1045000000 8842000 3222000 1878000 -15000000 28366000 3032000 8171000 38710000 2928000 4488000 85049000 972308000 3118000 6366000 -183000 -173000 -290000 36502000 -6603000 -43181000 40781000 83962000 AKORN INC 10-K --12-31 113924711 1701738000 false 0000003116 Yes No Large Accelerated Filer Yes 2014 FY 2014-12-31 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 1 &#8212; Business and Basis of Presentation</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Business:</font> Akorn, Inc. together with its wholly owned subsidiaries (&#8220;Akorn&#8221; or &#8220;Company&#8221;) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and over-the-counter (&#8220;OTC&#8221;) consumer health products. We specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Akorn is a Louisiana corporation founded in 1971 in Abita Springs, Louisiana. In 1997, we relocated our corporate headquarters to the Chicago, Illinois area and currently maintain our principal corporate office in Lake Forest, Illinois.&#160;&#160;We operate pharmaceutical manufacturing facilities in Decatur, Illinois, Somerset, New Jersey, Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York. Our research and development (&#8220;R&amp;D&#8221;) centers are located in Vernon Hills, Illinois, Copiague, New York, and Warminster, Pennsylvania, and we have other corporate offices in Ann Arbor, Michigan; Amityville, New York; and Gurgaon, India.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 2 &#8212; Summary of Significant Accounting Policies</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Consolidation:</font> The accompanying consolidated financial statements include the accounts of Akorn, Inc. and its wholly owned domestic and foreign subsidiaries.&#160;&#160;All inter-company transactions and balances have been eliminated in consolidation, and the financial statements of Akorn India Private Limited (&#8220;AIPL&#8221;) have been translated from Indian rupees to U.S. dollars based on the currency translation rates in effect during the period or as of the date of consolidation, as applicable.&#160;&#160;The Company has no involvement with variable interest entities.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of the year ended December 31, 2014 the Company was a 50% owner of a dormant joint venture, Akorn-Strides, LLC (the &#8220;Joint Venture Company&#8221;) (See Note 17 <font style="FONT-STYLE: italic; DISPLAY: inline">&#8211;</font> <font style="FONT-STYLE: italic; DISPLAY: inline">Unconsolidated Joint Venture</font>.).&#160;&#160;The Company and its strategic partner each had equal voting rights and shared operational control.&#160;&#160;Accordingly, the Company accounted for its investment in the Joint Venture Company using the equity method of accounting.&#160;&#160;The Company&#8217;s proportionate share of the Joint Venture Company&#8217;s income had been recorded under the caption &#8220;Equity in earnings of unconsolidated joint venture&#8221; in the Company&#8217;s consolidated statements of operations.&#160;&#160;The Joint Venture Company sold all of its abbreviated new drug application (&#8220;ANDA&#8221;) rights to Pfizer, Inc. in December 2010 and ceased operations during 2011.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Use of Estimates:</font> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Significant estimates and assumptions for the Company relate to the allowances for chargebacks, rebates, product returns, coupons, promotions and doubtful accounts, as well as the reserve for slow-moving and obsolete inventories, the carrying value and lives of intangible assets, the useful lives of fixed assets, the carrying value of deferred income tax assets and liabilities, the assumptions underlying share-based compensation, accrued but unreported employee benefit costs and assumptions underlying the accounting for business combinations.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition:</font> Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. Revenues from product sales are recognized when title and risk of loss have passed to the customer.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Provision for estimated chargebacks, rebates, discounts, managed care rebates, product returns and doubtful accounts is made at the time of sale and is analyzed and adjusted, if necessary, at each balance sheet date.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Freight:&#160;&#160;</font>The Company records amounts billed to customers for shipping and handling as revenue, and records shipping and handling expense related to product sales as cost of sales.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Cash and Cash Equivalents:</font> The Company considers all unrestricted, highly liquid investments with maturity of three months or less when purchased to be cash and cash equivalents.&#160;&#160;At December 31, 2014 and 2013, approximately $2.9 million and $2.7 million of cash held by our India operations as of those dates was restricted, and was reported within <font style="FONT-STYLE: italic; DISPLAY: inline">prepaid expenses and other current assets</font> and <font style="FONT-STYLE: italic; DISPLAY: inline">other non-current assets</font>, respectively.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Accounts Receivable:</font> Trade accounts receivables are stated at their net realizable value.&#160;&#160;The nature of the Company&#8217;s business involves, in the ordinary course, significant judgments and estimates relating to chargebacks, coupon redemption, product returns, rebates, discounts given to customers and allowances for doubtful accounts.&#160;&#160;Depending on the products, the end-user customers, the specific terms of national supply contracts and the particular arrangements with the Company&#8217;s wholesaler customers, certain rebates, chargebacks and other credits are recorded as deductions to the Company&#8217;s trade accounts receivable.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Unless otherwise noted, the provisions and allowances for the following customer deductions are reflected in the accompanying consolidated financial statements as reductions of revenues and trade accounts receivable, respectively.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Chargebacks and Rebates:</font> The Company enters into contractual agreements with certain third parties such as hospitals, group-purchasing and managed care organizations to sell certain products at predetermined prices. The parties have elected to have these contracts administered through wholesalers that buy the product from the Company and subsequently sell it to these third parties. When a wholesaler sells products to one of these third parties that are subject to a contractual price agreement, the difference between the price paid to the Company by the wholesaler and the price under the specific contract is charged back to the Company by the wholesaler. The Company tracks sales and submitted chargebacks by product number and contract for each wholesaler. Utilizing this information, the Company estimates a chargeback percentage for each product and records an allowance as a reduction to gross sales when the Company records its sale of the products. The Company reduces the chargeback allowance when a chargeback request from a wholesaler is processed. Actual chargebacks processed by the Company can vary materially from period to period based upon actual sales volume through the wholesalers. However, the Company&#8217;s provision for chargebacks is fully reserved for at the time when sales revenues are recognized.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management&#160;obtains certain wholesaler inventory reports to aid in analyzing the reasonableness of the chargeback allowance. The Company assesses the reasonableness of its chargeback allowance by applying the product chargeback percentage based on historical activity to the quantities of inventory on hand at the wholesaler per the wholesaler inventory reports. In accordance with its accounting policy, the Company estimates the percentage amount of wholesaler inventory that will ultimately be sold to third parties that are subject to contractual price agreements based on a trend of such sales through wholesalers. The Company uses this percentage estimate until historical trends indicate that a revision should be made. On an ongoing basis, the Company evaluates its actual chargeback rate experience, and new trends are factored into its estimates each quarter as market conditions change.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Similarly, the Company maintains an allowance for rebates related to contract and other programs with certain customers. Rebate percentages vary by product and by volume purchased by each eligible customer. The Company tracks sales by product number for each eligible customer and then applies the applicable rebate percentage, using both historical trends and actual experience to estimate its rebate allowance. The Company reduces gross sales and increases the rebate allowance by the estimated rebate amount when the Company sells its products to its rebate-eligible customers. The Company reduces the rebate allowance when it processes a customer request for a rebate. At each balance sheet date, the Company analyzes the allowance for rebates against actual rebates processed and makes necessary adjustments as appropriate. Actual rebates processed can vary materially from period to period.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Sales Returns:</font> Certain of the Company&#8217;s products are sold with the customer having the right to return the product within specified periods and guidelines for a variety of reasons, including but not limited to, pending expiration dates. Provisions are made at the time of sale based upon tracked historical experience. Historical factors such as one-time events as well as pending new developments that would impact the expected level of returns are taken into account to determine the appropriate reserve estimate at each balance sheet date. As part of the evaluation of the balance required, the Company considers actual returns to date that are in process, the expected impact of any product recalls and the wholesaler&#8217;s inventory information to assess the magnitude of unconsumed product that may result in sales returns to the Company in the future. The sales returns level can be impacted by factors such as overall market demand and market competition and availability for substitute products which can increase or decrease the end-user pull through for sales of the Company&#8217;s products and ultimately impact the level of sales returns. Actual returns experience and trends are factored into the Company&#8217;s estimates each quarter as market conditions change. Actual returns processed can vary materially from period to period.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Allowance for Coupons, Promotions and Co-Pay discount cards:</font> The Company issues coupons from time to time that are redeemable against certain of our Consumer Health products. Upon release of coupons into the market, the Company records an estimate of the dollar value of coupons expected to be redeemed. This estimate is based on historical experience and is adjusted as needed based on actual redemptions. In addition to couponing, from time to time the Company authorizes various retailers to run in-store promotional sales of its products. Upon receiving confirmation that a promotion was run, the Company accrues an estimate of the dollar amount expected to be owed back to the retailer. This estimate is trued up to actual upon receipt of the invoice from the retailer. Additionally, the Company provides consumer co-pay discount cards, administered through outside agents to provide discounted products when redeemed. Upon release of the cards into the market, the Company records an estimate of the dollar value of co-pay discounts expected to be utilized. This estimate is based on historical experience and is adjusted as needed based on actual usage.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Doubtful Accounts:</font> Provisions for doubtful accounts, which reflect trade receivable balances owed to the Company that are believed to be uncollectible, are recorded as a component of SG&amp;A expenses. In estimating the allowance for doubtful accounts, the Company considers its historical experience with collections and write-offs, the credit quality of its customers and any recent or anticipated changes thereto, and the outstanding balances and past due amounts from its customers.&#160;&#160;Accounts are considered past due when they remain uncollected beyond the due date specified in the applicable contract or on the applicable invoice, whichever is deemed to take precedence.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, the Company had a total of $62.4 million of past due gross accounts receivable, of which $3.7 million was more than 60 days past due. The Company performs monthly a detailed analysis of the receivables due from its wholesaler customers and provides a specific reserve against known uncollectible items. The Company also includes in the allowance for doubtful accounts an amount that it estimates to be uncollectible for all other customers, based on a percentage of the past due receivables. The percentage reserved increases as the age of the receivables increases.&#160;&#160;Accounts are written off once all reasonable collections efforts have been exhausted and/or when facts or circumstances regarding the customer (i.e. bankruptcy filing) indicate that the chance of collection is remote.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Advertising and Promotional Allowances to Customers:</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>The Company routinely sells its consumer health products to major retail drug chains. From time to time, the Company may arrange for these retailers to run in-store promotional sales of the Company&#8217;s products. The Company reserves an estimate of the dollar amount owed back to the retailer, recording this amount as a reduction to revenue at the later of the date on which the revenue is recognized or the date the sales incentive is offered. When the actual invoice for the sales promotion is received from the retailer, the Company adjusts its estimate accordingly. Advertising and promotional expenses paid to customers are expensed as incurred in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 605-50, <font style="FONT-STYLE: italic; DISPLAY: inline">Customer Payments and Incentives</font>.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Inventories:</font> <font style="FONT-STYLE: normal">Inventories are stated at the lower of cost (average cost method) or market (see Note 4 &#8212; &#8220;Inventories&#8221;). The Company maintains an allowance for slow-moving and obsolete inventory as well as inventory where the cost is in excess of its net realizable value (&#8220;NRV&#8221;). For finished goods inventory, the Company estimates the amount of inventory that may not be sold prior to its expiration or is slow moving based upon recent sales activity by unit and wholesaler inventory information. The Company also analyzes its raw material and component inventory for slow moving items/NRV. For the years ended December 31, 2014, 2013 and 2012, the Company recorded a provision for inventory obsolescence/NRV of $12.3 million, $2.1 million, and $2.4 million, respectively. The allowances for inventory obsolescence were $21.2 million and $5.7 million as of December 31, 2014 and 2013, respectively.</font></font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company capitalizes inventory costs associated with its products prior to regulatory approval when, based on management judgment, future commercialization is considered probable and future economic benefit is expected to be realized. The Company assesses the regulatory approval process and where the product stands in relation to that approval process including any known constraints or impediments to approval. The Company also considers the shelf life of the product in relation to the product timeline for approval.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December 31, 2014, the Company established a reserve of $1.9 million related to R&amp;D raw materials that are not expected to be utilized prior to expiration while at December 31, 2013, the Company had approximately $1.0 million in reserves for R&amp;D raw materials. The entire balance of the R&amp;D raw materials has been reserved, as the Company deemed it unlikely that the products would receive U.S. Food and Drug Administration (the &#8220;FDA&#8221;) approval far enough in advance of expiration to be sellable.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="FONT-STYLE: italic; DISPLAY: inline">Intangible Assets:</font> Intangible assets consist primarily of goodwill, which is carried at its initial value, subject to evaluation for impairment, in-process research and development, which is<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>accounted for as an indefinite-lived intangible asset, subject to impairment testing until completion or abandonment of the project, and product licensing costs, trademarks and other such costs, which are capitalized and amortized on a straight-line basis over their useful lives, ranging from one (1) year to thirty (30) years.&#160;&#160;Accumulated amortization was $82.2 million and $39.1 million at December 31, 2014 and 2013, respectively.&#160;&#160;Amortization expense was $44.1 million, $7.4 million and $6.9 million for the years ended December 31, 2014, 2013 and 2012, respectively. The Company regularly assesses its intangible assets for impairment based on several factors, including estimated fair value and anticipated cash flows.&#160;&#160;If the Company incurs additional costs to renew or extend the life of an intangible asset, such costs are added to the remaining unamortized cost of the asset, if any, and the sum is amortized over the extended remaining life of the asset.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Goodwill is tested for impairment annually or more frequently if changes in circumstances or the occurrence of events suggest that impairment may exist. The Company uses widely accepted valuation techniques to determine the fair value of its reporting units used in its annual goodwill impairment analysis. The Company&#8217;s valuation is primarily based on qualitative and quantitative assessments regarding the fair value of the reporting unit relative to its carrying value. The Company modeled the fair value of the reporting unit based on projected earnings and cash flows of the reporting unit. The Company performed its annual impairment test on October 1, 2014 and determined that the fair value of its reporting units are substantially in excess of its carrying value and, therefore, no impairment charge was necessary.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Changes in goodwill during the two years ended December 31, 2014 were as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,159</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,328</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,831</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260,911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dispositions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,454</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(514</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278,774</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the major categories of the Company&#8217;s intangible assets and the weighted-average remaining amortization period as of December 31, 2014 for those assets that are not already fully amortized (dollar amounts in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted Average</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font> Amortization Period (years)</font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">778,734</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(74,516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">704,218</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In-process research and development (&#8220;IPR&amp;D&#8221;)</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N/A &#8211; Indefinite lived</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,721</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,279</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relationships</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,427</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,392</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,035</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,234</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(879</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,355</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-compete agreements</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,409</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,725</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,045,592</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(82,233</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">963,359</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Changes in intangible assets during the two years ended December 31, 2014 were as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relationships</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-compete agreements</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,654</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,972</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,588</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,171</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 8.1pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,969</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,723</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(316</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(740</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(643</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(210</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(217</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,900</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,656</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,638</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,311</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">668,457</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,500</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">300</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,234</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(39,761</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(877</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,934</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(879</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(615</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dispositions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40,378</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">704,218</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,279</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,035</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,355</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The amortization expense of acquired intangible assets for each of the following five years will be as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization Expense</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,966</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,739</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,312</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2018</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,108</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2019</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,244</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Property, Plant and Equipment:</font> Property, plant and equipment is stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method in amounts considered sufficient to amortize the cost of the assets to operations over their estimated useful lives or lease terms. Depreciation expense was $14.5 million, $7.1 million and $4.6 million for the years ended December 31, 2014, 2013 and 2012, respectively.&#160;&#160;The amortization of assets under capital leases is included within depreciation expense. The following table sets forth the average estimated useful lives of the Company&#8217;s property, plant and equipment, by asset category:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asset category</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciable Life (years)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Buildings</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furniture and equipment</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Automobiles</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computer hardware and software</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Net Income Per Common Share:</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic net income per common share is based upon weighted average common shares outstanding. Diluted net income per common share is based upon the weighted average number of common shares outstanding, including the dilutive effect, if any, of stock options and convertible securities using the treasury stock and if converted methods.&#160;&#160;Anti-dilutive shares excluded from the computation of diluted net income per share for 2014, 2013 and 2012 include 735,000, 975,000 and 581,000 shares, respectively, related to options, warrants, and convertible securities.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Income Taxes:</font> Income taxes are accounted for under the asset and liability method.&#160;&#160;Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and net operating loss and other tax credit carry-forwards. These items are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce the deferred income tax assets to the amount that is more likely than not to be realized.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Fair Value of Financial Instruments:</font> The Company applies ASC Topic 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC Topic 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company&#8217;s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC Topic 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity&#8217;s own assumptions based on market data and the entity&#8217;s judgments about the assumptions that market participants would use in pricing the asset or liability, and are to be developed based on the best information available in the circumstances.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="top" width="76%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 1</font>&#8212;Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. The carrying value of the Company&#8216;s cash and cash equivalents are considered Level 1 assets.</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="top" width="76%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 2</font>&#8212;Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as directly or indirectly observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. The market value of the Company&#8217;s forward contracts to hedge against changes in currency translation rates between U.S. dollars and Indian rupees was a Level 2 asset.</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="top" width="76%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 3</font>&#8212;Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. The additional consideration payable related to the Company&#8217;s acquisition of three branded, injectable drug products from the U.S. subsidiary of H. Lundbeck A/S (the &#8220;Lundbeck Acquisition&#8221;), a Denmark Corporation, on December 22, 2011 was a Level 3 liability, as are the additional consideration payable to Santen Pharmaceutical Co. Ltd. (&#8220;Santen&#8221;) in relation to the Company&#8217;s acquisition of the U.S. New Drug Application (&#8220;NDA&#8221;) rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> on January 2, 2014, and the fair valuation of the available for sale investment held in shares of Nicox S.A.</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes the basis used to measure the fair values of the Company&#8217;s financial instruments (amounts in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Fair&#160;Value&#160;Measurements&#160;at&#160;Reporting&#160;Date,&#160;Using:</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quoted Prices</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">in Active</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Markets for</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Identical Items</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Observable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Unobservable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Available-for-sale securities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Total assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79,071</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase consideration payable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160; Total liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quoted Prices</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">in Active</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Markets for</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Identical Items</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Observable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Unobservable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency forward contracts</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Total assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,386</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase consideration payable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160; Total liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amount at December 31, 2014 of purchase consideration payable includes estimated consideration due to Santen related to the Company&#8217;s acquisition of U.S. NDA rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> on January 2, 2014. The liability was initially discounted based on the Company&#8217;s assumed discount rate and revalued at December 31, 2014 using this same discount rate. The Company identified no events that would cause its calculated assumed discount rate to change between the acquisition date and December 31, 2014. The additional consideration contingently payable to Santen was initially estimated at $4.5 million discounted to $4.0 million based on a discount rate of 12.6%. The Company performed evaluations of the fair value of this liability at December 31, 2014 based on utilizing significant unobservable inputs and determined the fair value of this liability to be $4.3 million. The increase in fair value during the year ended December 31, 2014 of approximately $0.3 million has been recorded as non-cash interest expense within the Company&#8217;s consolidated statement of comprehensive income for the year ended December 31, 2014.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The remaining purchase consideration payable is principally comprised of net working capital amounts owed relating to the ECR and Watson Laboratories, Inc. (&#8220;Watson&#8221;) divestitures, at fair value as determined based on the underlying contracts and the Company&#8217;s subjective evaluation of the additional consideration.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, the Company was carrying available for sale investments in shares of Nicox S.A. initially valued at $12.5 million discounted to reflect certain lockup provisions preventing immediate sale of underlying shares received for the Company&#8217;s investment in an available for sale security or an approximately $1.7 million unrealized gain. During the year the Company sold $0.6 million of the available-for-sale security, realizing an immaterial gain, and due to declines in the share price of Nicox S.A. stock from the initial valuation, the Company recognized a $1.8 million unrealized loss as of the year ended December 31, 2014. The remaining $8.4 million of securities are still subject to certain lockup provisions and as such, the fair value of the investments is estimated using observable and unobservable inputs to discount for lack of marketability. (See Note 16 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations, Dispositions and Other Strategic Investments</font>)</font></font></font></font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amount at December 31, 2013 of the purchase consideration payable for the Lundbeck acquisition was initially determined based on the terms of the underlying contracts and the Company&#8217;s subjective evaluation of the likelihood of the additional purchase consideration becoming payable related to the Company&#8217;s obligation to pay additional consideration for the acquisition of selected assets from H. Lundbeck A/S (&#8220;Lundbeck&#8221;) on December 22, 2011.&#160;&#160;The underlying obligation was long-term in nature, and therefore was discounted to present value based on an assumed discount rate.&#160;&#160;The additional consideration of $15.0 million, contingently payable to Lundbeck on December 22, 2014, was initially discounted to $11.3 million based on a discount rate of 10.0%, and subsequently adjusted in final acquisition accounting to $11.6 million based on applying a 9.0% discount rate.&#160;&#160;At December 31, 2013, the Company again evaluated the fair value based on utilizing significant unobservable inputs and derived a discount rate of 1.85%, determining that the appropriate discounted value was $14.7 million based upon the likelihood of achieving the underlying revenue targets and a derived cost of debt based on the remaining term. On December 22, 2014 the Company remitted final payment for the contingent purchase consideration due to Lundbeck of $15.0 million.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company entered into three non-deliverable forward contracts in October 2013 to protect against unfavorable trends with regard to currency translation rates between U.S. dollars (&#8220;USD&#8221;) and Indian rupees (&#8220;INR&#8221;) for planned capital expenditures at AIPL, which all three matured and were redeemed during the year ended December 31, 2014. The forward contracts were based on current and future anticipated investment in AIPL, the Company&#8217;s subsidiary in India. These forward contracts include projected currency translation rates between INR and USD. Any difference between the actual and projected foreign currency translations rates on the respective settlement dates would result in payment from the counterparty to the Company, or vice versa, as the case may be. As all of the contracts matured during the year ended December 31, 2014, the Company realized a $0.7 million gain in fair value during the year ended December 31, 2014 as <font style="FONT-STYLE: italic; DISPLAY: inline">Other non-operating income</font> in its consolidated statements of comprehensive income.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Warrants:</font> The Company issued various warrants during 2009 to entities controlled by John N. Kapoor, Ph.D., the Chairman of the Company&#8217;s Board of Directors (the &#8220;Kapoor Warrants&#8221;).&#160;&#160;The Company had classified the fair value of these warrants as a current liability in accordance with ASC 815-40-15-3, <font style="FONT-STYLE: italic; DISPLAY: inline">Derivatives and Hedging</font>, (formerly EITF 00-19, <font style="FONT-STYLE: italic; DISPLAY: inline">Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock</font>). This classification was made as a result of the requirement that the shares to be issued upon exercise of the Kapoor Warrants be registered shares, which could not be absolutely assured.&#160;&#160;The Kapoor Warrants were adjusted to fair value at the end of each quarter through Black-Scholes calculations which considered changes in the market price of the Company&#8217;s common stock, the remaining contractual life of the Kapoor Warrants, and other factors.&#160;&#160;Any change in the fair value of the Kapoor Warrants was recorded as income or expense on the Company&#8217;s consolidated statements of operations for the applicable period.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 28, 2010, the Company and Dr. Kapoor entered into an Amended and Restated Registration Rights Agreement (the &#8220;Amended Agreement&#8221;) which modified certain terms related to the Company&#8217;s obligation to obtain and maintain registration of any shares issued pursuant to exercise of the Kapoor Warrants.&#160;&#160;<font style="DISPLAY: inline">The Amended Agreement still requires the Company to use &#8220;commercially reasonable efforts&#8221; to file a registration statement pursuant to Rule 415 of</font> <font style="DISPLAY: inline">the Securities Act of 1933</font> <font style="DISPLAY: inline">(&#8220;Registration Statement&#8221;) for any shares of common stock that may be issued under the</font> applicable warrant agreements<font style="DISPLAY: inline">, and to maintain the continuous effectiveness of such Registration Statement until the earliest of: (i) the date no shares of the Company&#8217;s common stock qualify as registrable securities, (ii) the date on which all of the registrable securities may be sold in a single transaction by the holder to the public pursuant to Rule 144 or a similar rule, or (iii) the date upon which the John N. Kapoor Trust Dated September 20, 1989 (the &#8220;Kapoor Trust&#8221;) and EJ Funds, LP (&#8220;EJ Funds&#8221;) have transferred all of the registrable securities.&#160;&#160;However, the Registration Rights Agreement was amended to provide that in the event the Company, after using its good faith commercially reasonable efforts, is not able to obtain or maintain registration of the common stock, delivery of</font> <font style="DISPLAY: inline">unregistered shares upon exercise of the Kapoor Warrants will be deemed acceptable and a net cash settlement will not be required</font><font style="DISPLAY: inline">. The Amended Agreement further provides that the term &#8220;commercially reasonable efforts&#8221; in such instance shall not mean an absolute obligation of the Company to obtain and maintain registration.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As a result of the changes effected through the Amended Agreement, on June 28, 2010 the Company changed its accounting treatment of the Kapoor Warrants, no longer classifying them as a current liability with periodic adjustments to fair value but instead classifying them as a component of shareholders&#8217; equity in accordance with ASC 815-40.&#160;&#160;&#160;Accordingly, the fair value of the Kapoor Warrants, which was $17.9 million on June 28, 2010, was reclassified from a current liability to a component of shareholders&#8217; equity on that date.&#160;&#160;Following this change in classification, no future fair value adjustments are required.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The liability at June 28, 2010 for the Kapoor Warrants was estimated using a Black-Scholes valuation model with the fair value per warrant ranging from $2.49 to $2.50.&#160;&#160;The expected volatility of the Kapoor Warrants was based on the historical volatility of the Company&#8217;s common stock. The expected life assumption was based on the remaining life of the Kapoor Warrants. The risk-free interest rate for the expected term of the Kapoor Warrants was based on the average market rate on U.S. treasury securities in effect during the applicable quarter. The dividend yield reflected historical experience as well as future expectations over the expected term of the Kapoor Warrants.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The assumptions used in estimating the fair value of the warrants at June 28, 2010 were as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79.7%</font></font> </div> </td> <td valign="bottom" width="29%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected life (in years)</font> </div> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;3.8</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td valign="bottom" width="29%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk-free interest rate</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.8%</font></font> </div> </td> <td valign="bottom" width="29%"> &#160; </td> </tr> <tr> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dividend yield</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="29%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 9.8pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table provides summarized information about the Kapoor Warrants as of December 31, 2013:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="49%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted To:</font> </div> </td> <td valign="bottom" width="21%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant Date</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants Granted</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Book Value ($000s)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="49%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="21%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">EJ Funds</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr.13, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,939,639</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,829</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kapoor Trust</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr.13, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,501,933</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,740</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">EJ Funds</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug.17, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,650,806</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,127</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="49%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kapoor Trust</font> </div> </td> <td valign="bottom" width="21%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug.17, 2009</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2,099,935</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">5,250</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="49%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="21%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">7,192,313</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">17,946</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 10, 2014, the holder exercised all of the approximately 7.2 million outstanding stock warrants. The Company received cash proceeds of approximately $8.2 million from the warrant exercise during the year ended December 31, 2014.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Stock-Based Compensation:</font> Stock-based compensation cost is estimated at grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions to be used in the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its common stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. Treasury securities of similar term in effect during the quarter in which the options were granted. The dividend yield reflects the Company&#8217;s historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises the estimate in subsequent periods, if necessary, if actual forfeitures differ from initial estimates.</font> </div><br/> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Consolidation:</font> The accompanying consolidated financial statements include the accounts of Akorn, Inc. and its wholly owned domestic and foreign subsidiaries.&#160;&#160;All inter-company transactions and balances have been eliminated in consolidation, and the financial statements of Akorn India Private Limited (&#8220;AIPL&#8221;) have been translated from Indian rupees to U.S. dollars based on the currency translation rates in effect during the period or as of the date of consolidation, as applicable.&#160;&#160;The Company has no involvement with variable interest entities.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of the year ended December 31, 2014 the Company was a 50% owner of a dormant joint venture, Akorn-Strides, LLC (the &#8220;Joint Venture Company&#8221;) (See Note 17 <font style="FONT-STYLE: italic; DISPLAY: inline">&#8211;</font> <font style="FONT-STYLE: italic; DISPLAY: inline">Unconsolidated Joint Venture</font>.).&#160;&#160;The Company and its strategic partner each had equal voting rights and shared operational control.&#160;&#160;Accordingly, the Company accounted for its investment in the Joint Venture Company using the equity method of accounting.&#160;&#160;The Company&#8217;s proportionate share of the Joint Venture Company&#8217;s income had been recorded under the caption &#8220;Equity in earnings of unconsolidated joint venture&#8221; in the Company&#8217;s consolidated statements of operations.&#160;&#160;The Joint Venture Company sold all of its abbreviated new drug application (&#8220;ANDA&#8221;) rights to Pfizer, Inc. in December 2010 and ceased operations during 2011.</font></div> 0.50 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Use of Estimates:</font> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Significant estimates and assumptions for the Company relate to the allowances for chargebacks, rebates, product returns, coupons, promotions and doubtful accounts, as well as the reserve for slow-moving and obsolete inventories, the carrying value and lives of intangible assets, the useful lives of fixed assets, the carrying value of deferred income tax assets and liabilities, the assumptions underlying share-based compensation, accrued but unreported employee benefit costs and assumptions underlying the accounting for business combinations.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition:</font> Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. Revenues from product sales are recognized when title and risk of loss have passed to the customer.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Provision for estimated chargebacks, rebates, discounts, managed care rebates, product returns and doubtful accounts is made at the time of sale and is analyzed and adjusted, if necessary, at each balance sheet date.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Freight:&#160;&#160;</font>The Company records amounts billed to customers for shipping and handling as revenue, and records shipping and handling expense related to product sales as cost of sales.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Cash and Cash Equivalents:</font> The Company considers all unrestricted, highly liquid investments with maturity of three months or less when purchased to be cash and cash equivalents.&#160;&#160;At December 31, 2014 and 2013, approximately $2.9 million and $2.7 million of cash held by our India operations as of those dates was restricted, and was reported within <font style="FONT-STYLE: italic; DISPLAY: inline">prepaid expenses and other current assets</font> and <font style="FONT-STYLE: italic; DISPLAY: inline">other non-current assets</font>, respectively.</font></div> 2900000 2700000 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Accounts Receivable:</font> Trade accounts receivables are stated at their net realizable value.&#160;&#160;The nature of the Company&#8217;s business involves, in the ordinary course, significant judgments and estimates relating to chargebacks, coupon redemption, product returns, rebates, discounts given to customers and allowances for doubtful accounts.&#160;&#160;Depending on the products, the end-user customers, the specific terms of national supply contracts and the particular arrangements with the Company&#8217;s wholesaler customers, certain rebates, chargebacks and other credits are recorded as deductions to the Company&#8217;s trade accounts receivable.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Unless otherwise noted, the provisions and allowances for the following customer deductions are reflected in the accompanying consolidated financial statements as reductions of revenues and trade accounts receivable, respectively.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Unless otherwise noted, the provisions and allowances for the following customer deductions are reflected in the accompanying consolidated financial statements as reductions of revenues and trade accounts receivable, respectively.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Chargebacks and Rebates:</font> The Company enters into contractual agreements with certain third parties such as hospitals, group-purchasing and managed care organizations to sell certain products at predetermined prices. The parties have elected to have these contracts administered through wholesalers that buy the product from the Company and subsequently sell it to these third parties. When a wholesaler sells products to one of these third parties that are subject to a contractual price agreement, the difference between the price paid to the Company by the wholesaler and the price under the specific contract is charged back to the Company by the wholesaler. The Company tracks sales and submitted chargebacks by product number and contract for each wholesaler. Utilizing this information, the Company estimates a chargeback percentage for each product and records an allowance as a reduction to gross sales when the Company records its sale of the products. The Company reduces the chargeback allowance when a chargeback request from a wholesaler is processed. Actual chargebacks processed by the Company can vary materially from period to period based upon actual sales volume through the wholesalers. However, the Company&#8217;s provision for chargebacks is fully reserved for at the time when sales revenues are recognized.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management&#160;obtains certain wholesaler inventory reports to aid in analyzing the reasonableness of the chargeback allowance. The Company assesses the reasonableness of its chargeback allowance by applying the product chargeback percentage based on historical activity to the quantities of inventory on hand at the wholesaler per the wholesaler inventory reports. In accordance with its accounting policy, the Company estimates the percentage amount of wholesaler inventory that will ultimately be sold to third parties that are subject to contractual price agreements based on a trend of such sales through wholesalers. The Company uses this percentage estimate until historical trends indicate that a revision should be made. On an ongoing basis, the Company evaluates its actual chargeback rate experience, and new trends are factored into its estimates each quarter as market conditions change.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Similarly, the Company maintains an allowance for rebates related to contract and other programs with certain customers. Rebate percentages vary by product and by volume purchased by each eligible customer. The Company tracks sales by product number for each eligible customer and then applies the applicable rebate percentage, using both historical trends and actual experience to estimate its rebate allowance. The Company reduces gross sales and increases the rebate allowance by the estimated rebate amount when the Company sells its products to its rebate-eligible customers. The Company reduces the rebate allowance when it processes a customer request for a rebate. At each balance sheet date, the Company analyzes the allowance for rebates against actual rebates processed and makes necessary adjustments as appropriate. Actual rebates processed can vary materially from period to period.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Sales Returns:</font> Certain of the Company&#8217;s products are sold with the customer having the right to return the product within specified periods and guidelines for a variety of reasons, including but not limited to, pending expiration dates. Provisions are made at the time of sale based upon tracked historical experience. Historical factors such as one-time events as well as pending new developments that would impact the expected level of returns are taken into account to determine the appropriate reserve estimate at each balance sheet date. As part of the evaluation of the balance required, the Company considers actual returns to date that are in process, the expected impact of any product recalls and the wholesaler&#8217;s inventory information to assess the magnitude of unconsumed product that may result in sales returns to the Company in the future. The sales returns level can be impacted by factors such as overall market demand and market competition and availability for substitute products which can increase or decrease the end-user pull through for sales of the Company&#8217;s products and ultimately impact the level of sales returns. Actual returns experience and trends are factored into the Company&#8217;s estimates each quarter as market conditions change. Actual returns processed can vary materially from period to period.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Allowance for Coupons, Promotions and Co-Pay discount cards:</font> The Company issues coupons from time to time that are redeemable against certain of our Consumer Health products. Upon release of coupons into the market, the Company records an estimate of the dollar value of coupons expected to be redeemed. This estimate is based on historical experience and is adjusted as needed based on actual redemptions. In addition to couponing, from time to time the Company authorizes various retailers to run in-store promotional sales of its products. Upon receiving confirmation that a promotion was run, the Company accrues an estimate of the dollar amount expected to be owed back to the retailer. This estimate is trued up to actual upon receipt of the invoice from the retailer. Additionally, the Company provides consumer co-pay discount cards, administered through outside agents to provide discounted products when redeemed. Upon release of the cards into the market, the Company records an estimate of the dollar value of co-pay discounts expected to be utilized. This estimate is based on historical experience and is adjusted as needed based on actual usage.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Doubtful Accounts:</font> Provisions for doubtful accounts, which reflect trade receivable balances owed to the Company that are believed to be uncollectible, are recorded as a component of SG&amp;A expenses. In estimating the allowance for doubtful accounts, the Company considers its historical experience with collections and write-offs, the credit quality of its customers and any recent or anticipated changes thereto, and the outstanding balances and past due amounts from its customers.&#160;&#160;Accounts are considered past due when they remain uncollected beyond the due date specified in the applicable contract or on the applicable invoice, whichever is deemed to take precedence.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, the Company had a total of $62.4 million of past due gross accounts receivable, of which $3.7 million was more than 60 days past due. The Company performs monthly a detailed analysis of the receivables due from its wholesaler customers and provides a specific reserve against known uncollectible items. The Company also includes in the allowance for doubtful accounts an amount that it estimates to be uncollectible for all other customers, based on a percentage of the past due receivables. The percentage reserved increases as the age of the receivables increases.&#160;&#160;Accounts are written off once all reasonable collections efforts have been exhausted and/or when facts or circumstances regarding the customer (i.e. bankruptcy filing) indicate that the chance of collection is remote.</font></div> 62400000 3700000 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Advertising and Promotional Allowances to Customers:</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>The Company routinely sells its consumer health products to major retail drug chains. From time to time, the Company may arrange for these retailers to run in-store promotional sales of the Company&#8217;s products. The Company reserves an estimate of the dollar amount owed back to the retailer, recording this amount as a reduction to revenue at the later of the date on which the revenue is recognized or the date the sales incentive is offered. When the actual invoice for the sales promotion is received from the retailer, the Company adjusts its estimate accordingly. Advertising and promotional expenses paid to customers are expensed as incurred in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 605-50, <font style="FONT-STYLE: italic; DISPLAY: inline">Customer Payments and Incentives</font>.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Inventories:</font> <font style="FONT-STYLE: normal">Inventories are stated at the lower of cost (average cost method) or market (see Note 4 &#8212; &#8220;Inventories&#8221;). The Company maintains an allowance for slow-moving and obsolete inventory as well as inventory where the cost is in excess of its net realizable value (&#8220;NRV&#8221;). For finished goods inventory, the Company estimates the amount of inventory that may not be sold prior to its expiration or is slow moving based upon recent sales activity by unit and wholesaler inventory information. The Company also analyzes its raw material and component inventory for slow moving items/NRV. For the years ended December 31, 2014, 2013 and 2012, the Company recorded a provision for inventory obsolescence/NRV of $12.3 million, $2.1 million, and $2.4 million, respectively. The allowances for inventory obsolescence were $21.2 million and $5.7 million as of December 31, 2014 and 2013, respectively.</font></font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company capitalizes inventory costs associated with its products prior to regulatory approval when, based on management judgment, future commercialization is considered probable and future economic benefit is expected to be realized. The Company assesses the regulatory approval process and where the product stands in relation to that approval process including any known constraints or impediments to approval. The Company also considers the shelf life of the product in relation to the product timeline for approval.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December 31, 2014, the Company established a reserve of $1.9 million related to R&amp;D raw materials that are not expected to be utilized prior to expiration while at December 31, 2013, the Company had approximately $1.0 million in reserves for R&amp;D raw materials. The entire balance of the R&amp;D raw materials has been reserved, as the Company deemed it unlikely that the products would receive U.S. Food and Drug Administration (the &#8220;FDA&#8221;) approval far enough in advance of expiration to be sellable.</font></font></div> 12300000 2100000 2400000 1900000 1000000 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Intangible Assets:</font> Intangible assets consist primarily of goodwill, which is carried at its initial value, subject to evaluation for impairment, in-process research and development, which is<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>accounted for as an indefinite-lived intangible asset, subject to impairment testing until completion or abandonment of the project, and product licensing costs, trademarks and other such costs, which are capitalized and amortized on a straight-line basis over their useful lives, ranging from one (1) year to thirty (30) years.&#160;&#160;Accumulated amortization was $82.2 million and $39.1 million at December 31, 2014 and 2013, respectively.&#160;&#160;Amortization expense was $44.1 million, $7.4 million and $6.9 million for the years ended December 31, 2014, 2013 and 2012, respectively. The Company regularly assesses its intangible assets for impairment based on several factors, including estimated fair value and anticipated cash flows.&#160;&#160;If the Company incurs additional costs to renew or extend the life of an intangible asset, such costs are added to the remaining unamortized cost of the asset, if any, and the sum is amortized over the extended remaining life of the asset.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Goodwill is tested for impairment annually or more frequently if changes in circumstances or the occurrence of events suggest that impairment may exist. The Company uses widely accepted valuation techniques to determine the fair value of its reporting units used in its annual goodwill impairment analysis. The Company&#8217;s valuation is primarily based on qualitative and quantitative assessments regarding the fair value of the reporting unit relative to its carrying value. The Company modeled the fair value of the reporting unit based on projected earnings and cash flows of the reporting unit. The Company performed its annual impairment test on October 1, 2014 and determined that the fair value of its reporting units are substantially in excess of its carrying value and, therefore, no impairment charge was necessary.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Changes in goodwill during the two years ended December 31, 2014 were as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,159</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,328</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,831</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260,911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dispositions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,454</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(514</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278,774</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the major categories of the Company&#8217;s intangible assets and the weighted-average remaining amortization period as of December 31, 2014 for those assets that are not already fully amortized (dollar amounts in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted Average</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font> Amortization Period (years)</font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">778,734</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(74,516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">704,218</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In-process research and development (&#8220;IPR&amp;D&#8221;)</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N/A &#8211; Indefinite lived</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,721</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,279</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relationships</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,427</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,392</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,035</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,234</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(879</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,355</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-compete agreements</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,409</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,725</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,045,592</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(82,233</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">963,359</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Changes in intangible assets during the two years ended December 31, 2014 were as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relationships</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-compete agreements</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,654</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,972</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,588</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,171</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 8.1pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,969</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,723</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(316</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(740</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(643</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(210</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(217</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,900</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,656</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,638</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,311</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">668,457</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,500</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">300</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,234</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(39,761</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(877</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,934</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(879</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(615</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dispositions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40,378</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">704,218</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,279</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,035</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,355</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The amortization expense of acquired intangible assets for each of the following five years will be as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization Expense</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,966</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,739</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,312</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2018</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,108</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2019</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,244</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> P1Y P30Y 39100000 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Property, Plant and Equipment:</font> Property, plant and equipment is stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method in amounts considered sufficient to amortize the cost of the assets to operations over their estimated useful lives or lease terms. Depreciation expense was $14.5 million, $7.1 million and $4.6 million for the years ended December 31, 2014, 2013 and 2012, respectively.&#160;&#160;The amortization of assets under capital leases is included within depreciation expense. The following table sets forth the average estimated useful lives of the Company&#8217;s property, plant and equipment, by asset category:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asset category</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciable Life (years)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Buildings</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furniture and equipment</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Automobiles</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computer hardware and software</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 14500000 7100000 4600000 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Net Income Per Common Share:</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic net income per common share is based upon weighted average common shares outstanding. Diluted net income per common share is based upon the weighted average number of common shares outstanding, including the dilutive effect, if any, of stock options and convertible securities using the treasury stock and if converted methods.&#160;&#160;Anti-dilutive shares excluded from the computation of diluted net income per share for 2014, 2013 and 2012 include 735,000, 975,000 and 581,000 shares, respectively, related to options, warrants, and convertible securities.</font></font></div> 735000 975000 581000 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Income Taxes:</font> Income taxes are accounted for under the asset and liability method.&#160;&#160;Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and net operating loss and other tax credit carry-forwards. These items are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce the deferred income tax assets to the amount that is more likely than not to be realized.</font></div> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Fair Value of Financial Instruments:</font> The Company applies ASC Topic 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC Topic 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company&#8217;s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC Topic 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity&#8217;s own assumptions based on market data and the entity&#8217;s judgments about the assumptions that market participants would use in pricing the asset or liability, and are to be developed based on the best information available in the circumstances.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="top" width="76%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 1</font>&#8212;Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. The carrying value of the Company&#8216;s cash and cash equivalents are considered Level 1 assets.</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="top" width="76%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 2</font>&#8212;Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as directly or indirectly observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. The market value of the Company&#8217;s forward contracts to hedge against changes in currency translation rates between U.S. dollars and Indian rupees was a Level 2 asset.</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="top" width="76%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 3</font>&#8212;Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. The additional consideration payable related to the Company&#8217;s acquisition of three branded, injectable drug products from the U.S. subsidiary of H. Lundbeck A/S (the &#8220;Lundbeck Acquisition&#8221;), a Denmark Corporation, on December 22, 2011 was a Level 3 liability, as are the additional consideration payable to Santen Pharmaceutical Co. Ltd. (&#8220;Santen&#8221;) in relation to the Company&#8217;s acquisition of the U.S. New Drug Application (&#8220;NDA&#8221;) rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> on January 2, 2014, and the fair valuation of the available for sale investment held in shares of Nicox S.A.</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes the basis used to measure the fair values of the Company&#8217;s financial instruments (amounts in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Fair&#160;Value&#160;Measurements&#160;at&#160;Reporting&#160;Date,&#160;Using:</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quoted Prices</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">in Active</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Markets for</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Identical Items</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Observable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Unobservable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Available-for-sale securities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Total assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79,071</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase consideration payable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160; Total liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quoted Prices</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">in Active</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Markets for</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Identical Items</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Observable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Unobservable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency forward contracts</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Total assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,386</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase consideration payable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160; Total liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amount at December 31, 2014 of purchase consideration payable includes estimated consideration due to Santen related to the Company&#8217;s acquisition of U.S. NDA rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> on January 2, 2014. The liability was initially discounted based on the Company&#8217;s assumed discount rate and revalued at December 31, 2014 using this same discount rate. The Company identified no events that would cause its calculated assumed discount rate to change between the acquisition date and December 31, 2014. The additional consideration contingently payable to Santen was initially estimated at $4.5 million discounted to $4.0 million based on a discount rate of 12.6%. The Company performed evaluations of the fair value of this liability at December 31, 2014 based on utilizing significant unobservable inputs and determined the fair value of this liability to be $4.3 million. The increase in fair value during the year ended December 31, 2014 of approximately $0.3 million has been recorded as non-cash interest expense within the Company&#8217;s consolidated statement of comprehensive income for the year ended December 31, 2014.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The remaining purchase consideration payable is principally comprised of net working capital amounts owed relating to the ECR and Watson Laboratories, Inc. (&#8220;Watson&#8221;) divestitures, at fair value as determined based on the underlying contracts and the Company&#8217;s subjective evaluation of the additional consideration.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, the Company was carrying available for sale investments in shares of Nicox S.A. initially valued at $12.5 million discounted to reflect certain lockup provisions preventing immediate sale of underlying shares received for the Company&#8217;s investment in an available for sale security or an approximately $1.7 million unrealized gain. During the year the Company sold $0.6 million of the available-for-sale security, realizing an immaterial gain, and due to declines in the share price of Nicox S.A. stock from the initial valuation, the Company recognized a $1.8 million unrealized loss as of the year ended December 31, 2014. The remaining $8.4 million of securities are still subject to certain lockup provisions and as such, the fair value of the investments is estimated using observable and unobservable inputs to discount for lack of marketability. (See Note 16 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations, Dispositions and Other Strategic Investments</font>)</font></font></font></font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amount at December 31, 2013 of the purchase consideration payable for the Lundbeck acquisition was initially determined based on the terms of the underlying contracts and the Company&#8217;s subjective evaluation of the likelihood of the additional purchase consideration becoming payable related to the Company&#8217;s obligation to pay additional consideration for the acquisition of selected assets from H. Lundbeck A/S (&#8220;Lundbeck&#8221;) on December 22, 2011.&#160;&#160;The underlying obligation was long-term in nature, and therefore was discounted to present value based on an assumed discount rate.&#160;&#160;The additional consideration of $15.0 million, contingently payable to Lundbeck on December 22, 2014, was initially discounted to $11.3 million based on a discount rate of 10.0%, and subsequently adjusted in final acquisition accounting to $11.6 million based on applying a 9.0% discount rate.&#160;&#160;At December 31, 2013, the Company again evaluated the fair value based on utilizing significant unobservable inputs and derived a discount rate of 1.85%, determining that the appropriate discounted value was $14.7 million based upon the likelihood of achieving the underlying revenue targets and a derived cost of debt based on the remaining term. On December 22, 2014 the Company remitted final payment for the contingent purchase consideration due to Lundbeck of $15.0 million.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company entered into three non-deliverable forward contracts in October 2013 to protect against unfavorable trends with regard to currency translation rates between U.S. dollars (&#8220;USD&#8221;) and Indian rupees (&#8220;INR&#8221;) for planned capital expenditures at AIPL, which all three matured and were redeemed during the year ended December 31, 2014. The forward contracts were based on current and future anticipated investment in AIPL, the Company&#8217;s subsidiary in India. These forward contracts include projected currency translation rates between INR and USD. Any difference between the actual and projected foreign currency translations rates on the respective settlement dates would result in payment from the counterparty to the Company, or vice versa, as the case may be. As all of the contracts matured during the year ended December 31, 2014, the Company realized a $0.7 million gain in fair value during the year ended December 31, 2014 as <font style="FONT-STYLE: italic; DISPLAY: inline">Other non-operating income</font> in its consolidated statements of comprehensive income.</font></div> 4500000 4000000 0.126 4300000 300000 12500000 1700000 600000 1800000 15000000 11300000 0.100 11600000 0.090 0.0185 14700000 15000000 3 700000 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Warrants:</font> The Company issued various warrants during 2009 to entities controlled by John N. Kapoor, Ph.D., the Chairman of the Company&#8217;s Board of Directors (the &#8220;Kapoor Warrants&#8221;).&#160;&#160;The Company had classified the fair value of these warrants as a current liability in accordance with ASC 815-40-15-3, <font style="FONT-STYLE: italic; DISPLAY: inline">Derivatives and Hedging</font>, (formerly EITF 00-19, <font style="FONT-STYLE: italic; DISPLAY: inline">Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock</font>). This classification was made as a result of the requirement that the shares to be issued upon exercise of the Kapoor Warrants be registered shares, which could not be absolutely assured.&#160;&#160;The Kapoor Warrants were adjusted to fair value at the end of each quarter through Black-Scholes calculations which considered changes in the market price of the Company&#8217;s common stock, the remaining contractual life of the Kapoor Warrants, and other factors.&#160;&#160;Any change in the fair value of the Kapoor Warrants was recorded as income or expense on the Company&#8217;s consolidated statements of operations for the applicable period.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 28, 2010, the Company and Dr. Kapoor entered into an Amended and Restated Registration Rights Agreement (the &#8220;Amended Agreement&#8221;) which modified certain terms related to the Company&#8217;s obligation to obtain and maintain registration of any shares issued pursuant to exercise of the Kapoor Warrants.&#160;&#160;<font style="DISPLAY: inline">The Amended Agreement still requires the Company to use &#8220;commercially reasonable efforts&#8221; to file a registration statement pursuant to Rule 415 of</font> <font style="DISPLAY: inline">the Securities Act of 1933</font> <font style="DISPLAY: inline">(&#8220;Registration Statement&#8221;) for any shares of common stock that may be issued under the</font> applicable warrant agreements<font style="DISPLAY: inline">, and to maintain the continuous effectiveness of such Registration Statement until the earliest of: (i) the date no shares of the Company&#8217;s common stock qualify as registrable securities, (ii) the date on which all of the registrable securities may be sold in a single transaction by the holder to the public pursuant to Rule 144 or a similar rule, or (iii) the date upon which the John N. Kapoor Trust Dated September 20, 1989 (the &#8220;Kapoor Trust&#8221;) and EJ Funds, LP (&#8220;EJ Funds&#8221;) have transferred all of the registrable securities.&#160;&#160;However, the Registration Rights Agreement was amended to provide that in the event the Company, after using its good faith commercially reasonable efforts, is not able to obtain or maintain registration of the common stock, delivery of</font> <font style="DISPLAY: inline">unregistered shares upon exercise of the Kapoor Warrants will be deemed acceptable and a net cash settlement will not be required</font><font style="DISPLAY: inline">. The Amended Agreement further provides that the term &#8220;commercially reasonable efforts&#8221; in such instance shall not mean an absolute obligation of the Company to obtain and maintain registration.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As a result of the changes effected through the Amended Agreement, on June 28, 2010 the Company changed its accounting treatment of the Kapoor Warrants, no longer classifying them as a current liability with periodic adjustments to fair value but instead classifying them as a component of shareholders&#8217; equity in accordance with ASC 815-40.&#160;&#160;&#160;Accordingly, the fair value of the Kapoor Warrants, which was $17.9 million on June 28, 2010, was reclassified from a current liability to a component of shareholders&#8217; equity on that date.&#160;&#160;Following this change in classification, no future fair value adjustments are required.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The liability at June 28, 2010 for the Kapoor Warrants was estimated using a Black-Scholes valuation model with the fair value per warrant ranging from $2.49 to $2.50.&#160;&#160;The expected volatility of the Kapoor Warrants was based on the historical volatility of the Company&#8217;s common stock. The expected life assumption was based on the remaining life of the Kapoor Warrants. The risk-free interest rate for the expected term of the Kapoor Warrants was based on the average market rate on U.S. treasury securities in effect during the applicable quarter. The dividend yield reflected historical experience as well as future expectations over the expected term of the Kapoor Warrants.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The assumptions used in estimating the fair value of the warrants at June 28, 2010 were as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79.7%</font></font> </div> </td> <td valign="bottom" width="29%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected life (in years)</font> </div> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;3.8</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td valign="bottom" width="29%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk-free interest rate</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.8%</font></font> </div> </td> <td valign="bottom" width="29%"> &#160; </td> </tr> <tr> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dividend yield</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="29%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 9.8pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table provides summarized information about the Kapoor Warrants as of December 31, 2013:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="49%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted To:</font> </div> </td> <td valign="bottom" width="21%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant Date</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants Granted</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Book Value ($000s)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="49%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="21%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">EJ Funds</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr.13, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,939,639</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,829</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kapoor Trust</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr.13, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,501,933</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,740</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">EJ Funds</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug.17, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,650,806</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,127</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="49%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kapoor Trust</font> </div> </td> <td valign="bottom" width="21%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug.17, 2009</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2,099,935</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">5,250</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="49%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="21%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">7,192,313</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">17,946</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 10, 2014, the holder exercised all of the approximately 7.2 million outstanding stock warrants. The Company received cash proceeds of approximately $8.2 million from the warrant exercise during the year ended December 31, 2014.</font></div> 17900000 2.49 2.50 7200000 8200000 <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Stock-Based Compensation:</font> Stock-based compensation cost is estimated at grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions to be used in the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its common stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. Treasury securities of similar term in effect during the quarter in which the options were granted. The dividend yield reflects the Company&#8217;s historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises the estimate in subsequent periods, if necessary, if actual forfeitures differ from initial estimates.</font></div> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,159</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,328</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,831</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260,911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dispositions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,454</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(514</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278,774</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 32159000 -2328000 260911000 11454000 -514000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted Average</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font> Amortization Period (years)</font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">778,734</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(74,516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">704,218</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In-process research and development (&#8220;IPR&amp;D&#8221;)</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N/A &#8211; Indefinite lived</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,721</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,279</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relationships</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,427</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,392</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,035</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,234</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(879</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,355</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-compete agreements</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,409</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,725</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,045,592</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(82,233</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">963,359</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 778734000 74516000 704218000 P12Y146D 230788000 16000000 1721000 14279000 P18Y219D 6427000 3392000 3035000 P11Y 11234000 879000 10355000 P7Y6M 2409000 1725000 684000 P1Y146D 1045592000 82233000 963359000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relationships</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-compete agreements</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,654</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,972</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,588</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,171</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 8.1pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,969</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,723</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(316</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(740</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(643</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(210</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(217</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,900</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,656</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,638</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,311</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">668,457</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,500</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">300</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,234</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(39,761</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(877</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,934</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(879</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(615</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dispositions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40,378</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">704,218</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230,788</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,279</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,035</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,355</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 63654000 8972000 5588000 2171000 57969000 -5723000 -316000 -740000 -643000 -210000 -217000 115900000 8656000 4638000 1311000 668457000 230788000 6500000 300000 11234000 -39761000 -877000 -1934000 -879000 -615000 40378000 31000 -12000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization Expense</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,966</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,739</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,312</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2018</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65,108</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2019</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,244</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 65966000 65739000 65312000 65108000 62244000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asset category</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciable Life (years)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Buildings</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furniture and equipment</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Automobiles</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computer hardware and software</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> P30Y P20Y P7Y P5Y P5Y <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Fair&#160;Value&#160;Measurements&#160;at&#160;Reporting&#160;Date,&#160;Using:</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quoted Prices</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">in Active</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Markets for</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Identical Items</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Observable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Unobservable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Available-for-sale securities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Total assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79,071</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,680</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase consideration payable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160; Total liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quoted Prices</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">in Active</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Markets for</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Identical Items</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Observable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Significant</font></font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Unobservable</font></font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inputs</font></font> </div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Level&#160;3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency forward contracts</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Total assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,386</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase consideration payable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160; Total liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 70680000 70680000 8391000 8391000 79071000 70680000 8391000 7613000 7613000 7613000 7613000 34178000 34178000 208000 208000 34386000 34178000 208000 14728000 14728000 14728000 14728000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79.7%</font></font> </div> </td> <td valign="bottom" width="29%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected life (in years)</font> </div> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;3.8</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211;</font> </td> <td valign="bottom" width="29%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk-free interest rate</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.8%</font></font> </div> </td> <td valign="bottom" width="29%"> &#160; </td> </tr> <tr> <td align="left" valign="bottom" width="58%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dividend yield</font> </div> </td> <td valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="29%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 9.8pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> </tr> </table> 0.797 P3Y292D P4Y36D 0.018 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="49%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted To:</font> </div> </td> <td valign="bottom" width="21%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant Date</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants Granted</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Book Value ($000s)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="49%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="21%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">EJ Funds</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr.13, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,939,639</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,829</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kapoor Trust</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr.13, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,501,933</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,740</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="49%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">EJ Funds</font> </div> </td> <td valign="bottom" width="21%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug.17, 2009</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,650,806</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,127</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="49%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kapoor Trust</font> </div> </td> <td valign="bottom" width="21%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug.17, 2009</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2,099,935</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">5,250</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="49%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="21%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">7,192,313</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">17,946</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 2009-04-13 1939639000 1.11 4829000 2009-04-13 1501933000 1.11 3740000 2009-08-17 1650806000 1.16 4127000 2009-08-17 2099935000 1.16 5250000 7192313000 17946000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 3 &#8212; Accounts Receivable, Sales and Allowances</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The nature of the Company&#8217;s business inherently involves, in the ordinary course, significant amounts and substantial volumes of transactions and estimates relating to allowances for product returns, chargebacks, rebates, doubtful accounts and discounts given to customers. This is a natural circumstance of the pharmaceutical industry and is not specific to the Company. Depending on the product, the end-user customer, the specific terms of national supply contracts and the particular arrangements with the Company&#8217;s wholesaler customers, certain rebates, chargebacks and other credits are deducted from the Company&#8217;s accounts receivable. The process of claiming these deductions depends on wholesalers reporting to the Company the amount of deductions that were earned under the terms of the respective agreement with the end-user customer (which in turn depends on the specific end-user customer, each having its own pricing arrangement, which entitles it to a particular deduction). This process can lead to partial payments against outstanding invoices as the wholesalers take the claimed deductions at the time of payment.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">With the exception of the provision for doubtful accounts, which is reflected as part of selling, general and administrative expense, the provisions for the following customer reserves are reflected as a reduction of revenues in the accompanying consolidated statements of comprehensive income. The ending reserve balances are included in trade accounts receivable, net in the Company&#8217;s consolidated balance sheets.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net trade accounts receivable consists of the following (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">445,027</font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">88,165</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less reserves for:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chargebacks and rebates</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">155,297</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12,882</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product returns</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(44,644</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,164</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Discounts and allowances</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,691</font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,644</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advertising and promotions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,217</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(452</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Doubtful accounts</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(462</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts receivable, net</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">220,716</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,998</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the years ended December 31, 2014, 2013 and 2012, the Company recorded the following adjustments to gross sales (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross sales</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,442,537</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">528,574</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">386,582</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less adjustments for:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chargebacks and rebates</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">739,760</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(183,403</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(112,244</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product returns</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,006</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,001</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,783</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Discounts and allowances</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(31,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,464</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,074</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Administrative fees</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(50,786</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9,471</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,293</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advertising, promotions, and other</font></font> </div> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7,729</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,524</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,030</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues, net</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">593,078</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">317,711</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">256,158</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The annual activity in the Company&#8217;s allowance for customer deductions accounts for the three years ended December 31, 2014 is as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Returns</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chargebacks <font style="DISPLAY: inline">&amp; Rebates</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Discounts</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Doubtful <font style="DISPLAY: inline">Accounts</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advert. &amp; <font style="DISPLAY: inline">Promotions</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">TOTAL</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2011</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,846</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,949</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">743</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">386</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,023</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,783</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,243</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,074</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(82</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,063</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124,081</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charges processed</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(2,220</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(104,740</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(5,455</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">13</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,864</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(114,266</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,409</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,452</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,362</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">585</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,838</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,001</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">183,403</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,464</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,524</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">201,387</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charges processed</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(5,246</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(183,973</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(8,182</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(4,657</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(202,058</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,164</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,882</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,644</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">452</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,167</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,006</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">739,760</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">346</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,729</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">799,019</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions from acquisitions</font></font> </div> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,172</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,593</font></font></font></font> </div> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,161</font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">88</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">311</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,325</font></font></font></font> </div> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charges processed</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(12,698</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">626,938</font></font></font></font></font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">15,292</font></font></font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">3</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(7,275</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">662,200</font></font></font></font></font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">44,644</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">155,297</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">22,</font><font style="DISPLAY: inline">691</font></font></font></font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">462</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,217</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">224,311</font></font></font></font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">445,027</font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">88,165</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less reserves for:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chargebacks and rebates</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">155,297</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12,882</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product returns</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(44,644</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,164</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Discounts and allowances</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,691</font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,644</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advertising and promotions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,217</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(452</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Doubtful accounts</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(462</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts receivable, net</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">220,716</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,998</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 445027000 88165000 155297000 12882000 44644000 8164000 22691000 1644000 1217000 452000 462000 25000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross sales</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,442,537</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">528,574</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">386,582</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less adjustments for:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chargebacks and rebates</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">739,760</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(183,403</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(112,244</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product returns</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,006</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,001</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,783</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Discounts and allowances</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(31,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,464</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,074</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Administrative fees</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(50,786</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9,471</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,293</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advertising, promotions, and other</font></font> </div> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7,729</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,524</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,030</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues, net</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">593,078</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">317,711</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">256,158</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 1442537000 528574000 386582000 739760000 183403000 112244000 20006000 5001000 3783000 31178000 8464000 6074000 50786000 9471000 5293000 7729000 4524000 3030000 593078000 317711000 256158000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Returns</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chargebacks <font style="DISPLAY: inline">&amp; Rebates</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Discounts</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Doubtful <font style="DISPLAY: inline">Accounts</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advert. &amp; <font style="DISPLAY: inline">Promotions</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">TOTAL</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2011</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,846</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,949</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">743</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">386</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,023</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,783</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,243</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,074</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(82</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,063</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124,081</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charges processed</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(2,220</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(104,740</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(5,455</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">13</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,864</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(114,266</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,409</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,452</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,362</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">585</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,838</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,001</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">183,403</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,464</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,524</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">201,387</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charges processed</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(5,246</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(183,973</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(8,182</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(4,657</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(202,058</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,164</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,882</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,644</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">452</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,167</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,006</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">739,760</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">346</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,729</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">799,019</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions from acquisitions</font></font> </div> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,172</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,593</font></font></font></font> </div> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,161</font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">88</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">311</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,325</font></font></font></font> </div> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charges processed</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(12,698</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">626,938</font></font></font></font></font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">15,292</font></font></font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">3</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(7,275</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">662,200</font></font></font></font></font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="40%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">44,644</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">155,297</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">22,</font><font style="DISPLAY: inline">691</font></font></font></font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">462</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,217</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">224,311</font></font></font></font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 6846000 5949000 743000 99000 386000 14023000 3783000 112243000 6074000 -82000 2063000 124081000 -2220000 -104740000 -5455000 13000 -1864000 -114266000 8409000 13452000 1362000 30000 585000 23838000 5001000 183403000 8464000 -5000 4524000 201387000 -5246000 -183973000 -8182000 -4657000 -202058000 8164000 12882000 1644000 25000 452000 23167000 20006000 739760000 31178000 346000 7729000 799019000 29172000 29593000 5161000 88000 311000 64325000 -12698000 -626938000 -15292000 3000 -7275000 -662200000 44644000 155297000 22691000 462000 1217000 224311000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 4 &#8212; Inventories</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The components of inventories, net of allowances, are as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Finished goods</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,442</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,886</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Work in process</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,335</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,883</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raw materials and supplies</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,533</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,213</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">131,310</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,982</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company maintains an allowance for excess and obsolete inventory, as well as inventory where its cost is in excess of its net realizable value.&#160;&#160;The activity in the allowance for excess, obsolete, and net realizable value inventory account for the two years ended December 31, 2014 was as follows (in thousands):</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Years Ended December 31,</font><font id="TAB2-3" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at beginning of year</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,700</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,819</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,275</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,089</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions from acquisitions</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,220</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charges</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(5,016</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#160;(3,208</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at end of year</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">21,179</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">5,700</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Finished goods</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,442</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,886</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Work in process</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,335</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,883</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raw materials and supplies</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,533</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,213</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">131,310</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,982</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 64442000 22886000 4335000 3883000 62533000 29213000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Years Ended December 31,</font><font id="TAB2-3" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at beginning of year</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,700</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,819</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,275</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,089</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions from acquisitions</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,220</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charges</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(5,016</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#160;(3,208</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at end of year</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">21,179</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">5,700</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 5700000 6819000 12275000 2089000 8220000 -5016000 -3208000 21179000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 5 &#8211; Property, Plant and Equipment</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property, plant and equipment consist of the following (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-70" style="MARGIN-LEFT: 6.2pt"></font><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-71" style="MARGIN-LEFT: 6.2pt"></font><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Land</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,323</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,606</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Buildings and leasehold improvements</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,846</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,281</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furniture and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,708</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">76,536</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">185,877</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125,423</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated depreciation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68,093</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(54,470</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">117,784</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,953</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Construction in progress</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,004</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,155</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">143,788</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,108</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December 31, 2014 and 2013, property plant and equipment carrying a net book value of $25.6 million and $21.1 million, respectively, was located outside the United States.</font></font> </div><br/> 25600000 21100000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-70" style="MARGIN-LEFT: 6.2pt"></font><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-71" style="MARGIN-LEFT: 6.2pt"></font><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Land</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,323</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,606</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Buildings and leasehold improvements</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,846</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,281</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furniture and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,708</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">76,536</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">185,877</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125,423</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated depreciation</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68,093</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(54,470</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">117,784</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,953</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Construction in progress</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,004</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,155</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">143,788</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,108</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 9323000 2606000 63846000 46281000 112708000 76536000 185877000 125423000 68093000 54470000 117784000 70953000 26004000 11155000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 6 &#8212; Financing Arrangements</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Incremental Term Loan</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Concurrent with the closing of its acquisition of VersaPharm Incorporated (&#8220;VersaPharm&#8221;), Akorn, Inc. and its wholly owned domestic subsidiaries (the &#8220;Akorn Loan Parties&#8221;) entered into a $445.0 million Incremental Facility Joinder Agreement (the &#8220;Incremental Term Loan Facility&#8221;) pursuant to a Loan Agreement (the &#8220;Incremental Term Loan Agreement&#8221;) dated August 12, 2014 between the Akorn Loan Parties as borrowers, certain other lenders, with JPMorgan Chase Bank, N.A. (&#8220;JPMorgan&#8221;), acting as administrative agent. The proceeds received pursuant to the Incremental Term Loan Agreement were used to finance the acquisition of VersaPharm, a Georgia corporation (&#8220;VersaPharm Acquisition&#8221;).</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Incremental Term Loan Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company&#8217;s primary deposit account pursuant to a deposit account control agreement.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Incremental Term Loan Facility requires quarterly principal repayment equal to 0.25% of the initial loan amount of $445.0 million beginning with the first full quarter following the closing date of the Incremental Term Loan Agreement, with a final payment of the remaining principal balance due at maturity seven (7) years from the date of closing of the Existing Term Loan Agreement. The Company may prepay all or a portion of the remaining outstanding principal amount under the Incremental Term Loan Agreement at any time, or from time to time, subject to prior notice requirement to the lenders and payment of applicable fees. Prepayment of principal will be required should the Company incur any indebtedness not permitted under the Incremental Term Loan Agreement, or effect the sale, transfer or disposition of any property or asset, other than in the ordinary course of business. To the extent the Incremental Term Loan Facility is refinanced within the first six (6) months of closing, a 1.00% prepayment fee will be due. As of December 31, 2014 outstanding debt under the Incremental Term Loan Facility was $443.9 million and the Company was in full compliance with all applicable covenants which included customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Interest accrues based, at the Company&#8217;s election, on an adjusted prime/federal funds rate (&#8220;ABR Loan&#8221;) or an adjusted LIBOR (&#8220;Eurodollar Loan&#8221;) rate, plus a margin of 2.50% for ABR Loans, and 3.50% for Eurodollar Loans. Each such margin will decrease by 0.25% in the event the Company&#8217;s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. During an event of default, as defined in the Existing Term Loan Agreement, any interest rate will be increased by 2.00% per annum. Per the Existing Term Loan Agreement, the interest rate on LIBOR loans cannot fall below 4.50%.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the year ended December 31, 2014, the Company recorded interest expense of $7.8 million in relation to the Incremental Term Loan Agreement.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, in connection with entering into the $445.0 million Incremental Term Loan Agreement, the Company capitalized $10.9 million in deferred financing fees. Approximately $1.8 million of this total represented loan commitment fees which were amortized to expense during the year ended December 31, 2014. The $1.8 million of loan commitment fees amortized in the year ended December 31, 2014 consisted of $1.7 million in commitment fee amortization and $0.1 million in ticking fees. The Company will amortize the remaining deferred financing fees using the effective interest method over the term of the Incremental Term Loan Agreement.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Existing Term Loan</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Concurrent with the closing of its acquisition of Hi-Tech (the &#8220;Hi-Tech Acquisition&#8221;) Akorn Loan Parties entered into a $600.0 million Term Facility (the &#8220;Existing Term Facility&#8221;) pursuant to a Loan Agreement dated April 17, 2014 (the &#8220;Existing Term Loan Agreement&#8221;) between the Akorn Loan Parties as borrowers, certain other lenders, with JPMorgan, acting as administrative agent. The Company may increase the loan amount up to an additional $150.0 million, or more, provided certain financial covenants and other conditions are satisfied. The proceeds received pursuant to the Existing Term Loan Agreement were used to finance the Hi-Tech Acquisition.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Existing Term Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company&#8217;s primary deposit account pursuant to a deposit account control agreement.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Existing Term Loan Agreement requires quarterly principal repayment equal to 0.25% of the initial loan amount of $600.0 million beginning with the second full quarter following the closing date of the Existing Term Loan Agreement, with a final payment of the remaining principal balance due at maturity seven (7) years from the date of closing of the Existing Term Loan Agreement. The Company may prepay all or a portion of the remaining outstanding principal amount under the Existing Term Loan Agreement at any time, or from time to time, subject to prior notice requirement to the lenders and payment of applicable fees. Prepayment of principal will be required should the Company incur any indebtedness not permitted under the Existing Term Loan Agreement, or effect the sale, transfer or disposition of any property or asset, other than in the ordinary course of business. As of December 31, 2014 outstanding debt under the term loan facility was $598.5 million and the Company was in full compliance with all applicable covenants which included customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Interest accrues based, at the Company&#8217;s election, on an adjusted prime/federal funds rate or an adjusted LIBOR rate, plus a margin of 2.50% for ABR Loans, and 3.50% for Eurodollar Loans. Each such margin will decrease by 0.25% in the event Akorn&#8217;s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. During an event of default, as defined in the Existing Term Loan Agreement, any interest rate will be increased by 2.00% per annum. Per the Existing Term Loan Agreement, the interest rate on LIBOR loans cannot fall below 4.50%.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the year ended December 31, 2014, the Company recorded interest expense of $19.4 million in relation to the Existing Term Loan.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, in connection with entering into the $600.0 million Existing Term Loan, the Company capitalized $20.3 million in deferred financing fees. Approximately $7.4 million of this total represented loan commitment fees, of which $7.4 million was amortized to expense during the year ended December 31, 2014. The $7.4 million of loan commitment fees amortized in the year ended December 31, 2014 consisted of $5.0 million in ticking fees and $2.4 million in commitment fee amortization. The Company will amortize the remaining deferred financing fees using the effective interest method over the term of the Existing Term Loan Agreement.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JPMorgan Credit Facility</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 17, 2014, the Akorn Loan Parties entered into a Credit Agreement (the &#8220;JPM Credit Agreement&#8221;) with JPMorgan acting as administrative agent, and Bank of America, N.A., as syndication agent for certain other lenders (at closing, Bank of America, N.A. and Wells Fargo Bank, N. A.) for a $150.0 million revolving credit facility (the &#8220;JPM Revolving Facility&#8221;). Upon entering into the JPM Credit Agreement, the Company terminated its prior $60.0 million revolving credit facility with Bank of America, N.A., as further described below.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subject to other conditions in the JPM Credit Agreement, advances under the JPM Revolving Facility will be made in accordance with a borrowing base consisting of the sum of the following:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="10%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;(a)</font> </div> </td> <td align="left" valign="top" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85% of eligible accounts receivable;</font> </div> </td> </tr> <tr> <td valign="top" width="10%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; (b)</font> </div> </td> <td align="left" valign="top" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The lesser of:</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font> </div> </td> <td align="left" valign="top" width="86%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65% of the lower of cost or market value of eligible raw materials and work in process inventory, valued on a first in first out basis, and</font> </div> </td> </tr> <tr> <td valign="top" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font> </div> </td> <td align="left" valign="top" width="86%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85% of the orderly liquidation value of eligible raw materials and work in process inventory, valued on a first in first out basis;</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="10%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; (c)</font> </div> </td> <td align="left" colspan="2" valign="top" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The lesser of:</font> </div> </td> </tr> <tr> <td valign="top" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font> </div> </td> <td align="left" valign="top" width="86%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75% of the lower of cost or market value of eligible finished goods inventory, valued on a first in first out basis, and</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font> </div> </td> <td align="left" valign="top" width="86%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85% of the orderly liquidation value of eligible finished goods inventory, valued on a first in first out basis up to 85% of the liquidation value of eligible inventory (or 75% of market value finished goods inventory); and</font> </div> </td> </tr> <tr> <td valign="top" width="10%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;(d)</font> </div> </td> <td align="left" colspan="2" valign="top" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less any reserves deemed necessary by the administrative agent, and allowed in its permitted discretion.</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The total amount available under the JPM Revolving Facility includes a $10.0 million letter of credit facility.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of the JPM Credit Agreement, if availability under the JPM Revolving Facility falls below 12.5% of commitments or $15.0 million for more than 30 consecutive days, the Company may be subject to cash dominion, additional reporting requirements, and additional covenants and restrictions. The Company may seek additional commitments to increase the maximum amount of the JPM Revolving Facility to $200.0 million.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Unless cash dominion is exercised by the lenders in connection with the JPM Revolving Facility, the Company will be required to repay the JPM Revolving Facility upon its expiration five (5) years from issuance, subject to permitted extension, and will pay interest on the outstanding balance monthly based, at the Company&#8217;s election, on an adjusted prime/federal funds rate (&#8220;ABR&#8221;) or an adjusted LIBOR (&#8220;Eurodollar&#8221;), plus a margin determined in accordance with the Company&#8217;s consolidated fixed charge coverage ratio (EBITDA to fixed charges) as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="70%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: lightgrey;"> <td valign="top" width="50%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-TOP: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fixed Charge</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Coverage Ratio</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-TOP: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revolver ABR</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Spread</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-TOP: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revolver</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Eurodollar</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Spread</font> </div> </td> </tr> <tr> <td valign="top" width="50%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Category 1</font></font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&gt; 1.50 to 1.0</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.50%</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.50%</font> </div> </td> </tr> <tr> <td valign="top" width="50%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Category 2</font></font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&gt; 1.25 to 1.00 but</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&lt; 1.50 to 1.00</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.75%</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.75%</font> </div> </td> </tr> <tr> <td valign="top" width="50%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Category 3</font></font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&lt; 1.25 to 1.00</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00%</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.00%</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition to interest on borrowings, the Company will pay an unused line fee of 0.25% per annum on the unused portion of the JPM Revolving Facility.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During an event of default, as defined in the JPM Credit Agreement, any interest rate will be increased by 2.0% per annum.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The JPM Revolving Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company&#8217;s primary deposit account pursuant to a deposit account control agreement. The financial covenants require the Akorn Loan Parties to maintain the following on a consolidated basis:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font> </div> </td> <td align="left" valign="top" width="76%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Minimum Liquidity, as defined in the JPM Credit Agreement, of not less than (a) $120.0 million plus (b) 25% of the JPM Revolving Facility commitments during the three month period preceding the June 1, 2016 maturity date of the Company&#8217;s senior convertible notes.</font> </div> </td> </tr> <tr> <td valign="top" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="top" width="4%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font> </div> </td> <td align="left" valign="top" width="76%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ratio of EBITDA to fixed charges of no less than 1.00 to 1.00 (measured quarterly for the trailing 4 quarters).</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014 the Company was in full compliance with all covenants applicable to the JPM Revolving Facility.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company may use any proceeds from borrowings under the JPM Revolving Facility for working capital needs and for the general corporate purposes of the Company and its subsidiaries, and to otherwise replace letters of credit that were outstanding upon the termination of the Company&#8217;s prior revolving credit facility with Bank of America, N.A. At December 31, 2014, there were no outstanding borrowings and one outstanding letter of credit in the amount of approximately $1.2 million under the JPM Revolving Facility. Availability under the facility as of December 31, 2014 was approximately $148.8 million.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The JPM Credit Agreement places customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities of the Akorn Loan Parties in a manner designed to protect the collateral while providing flexibility for growth and the historic business activities of the Company and its subsidiaries.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Convertible Notes</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 1, 2011, the Company closed on an offering of $120.0 million aggregate principal amount of 3.50% Convertible Senior Notes due 2016 (the &#8220;Notes&#8221;) which included $20.0 million in aggregate principal amount of the Notes issued in connection with the full exercise by the initial purchasers of their over-allotment option. The Notes are governed by the Company&#8217;s indenture with Wells Fargo Bank, National Association, as trustee (the &#8220;Indenture&#8221;).&#160;&#160;The Notes were offered and sold only to qualified institutional buyers.&#160;&#160;The net proceeds from the sale of the Notes were approximately $115.3 million, after deducting underwriting fees and other related expenses.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Notes have a maturity date of June 1, 2016 and pay interest at an annual rate of 3.50% semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2011.&#160;&#160;The Notes are convertible into the Company&#8217;s common stock, cash or a combination thereof at an initial conversion price of $8.76 per share, which is equivalent to an initial conversion rate of approximately 114.1553 shares per $1,000 principal amount of Notes.&#160;&#160;The conversion price is subject to adjustment for certain events described in the Indenture, including certain corporate transactions which will increase the conversion rate and decrease the conversion price for a holder that elects to convert its Notes in connection with such corporate transaction.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Notes may be converted at any time prior to the close of business on the business day immediately preceding December 1, 2015 only under the following circumstances:&#160;&#160;(1) during any calendar quarter commencing after September 30, 2011, if the closing sale price of the Company&#8217;s common stock, for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the calendar quarter immediately preceding the calendar quarter in which the conversion occurs, is more than 130% of the conversion price in effect on each applicable trading day; (2) during the five consecutive trading-day period following any five consecutive trading-day period in which the trading price for the Notes per $1,000 principal amount of Notes for each such trading day was less than 98% of the closing sale price of the Company&#8217;s common stock on such date multiplied by the then-current conversion rate; or (3) upon the occurrence of specified corporate events.&#160;&#160;On or after December 1, 2015 until the close of business on the business day immediately preceding the stated maturity date, holders may surrender all or any portion of their Notes for conversion at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, at the Company&#8217;s option, cash, shares of the Company&#8217;s common stock, or a combination thereof.&#160;&#160;If a fundamental change (as defined in the Indenture) occurs prior to the stated maturity date, holders may require the Company to purchase for cash all or a portion of their Notes.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Notes became convertible for the quarter ending on June 30, 2012 as a result of the Company&#8217;s stock trading at or above the required price of $11.39 per share for 20 of the last 30 trading days in the quarter ended March 31, 2012.&#160;&#160;The Notes have remained convertible for each successive quarter as a result of meeting the trading price requirement at the end of each prior quarter. During the year ended December 31, 2014, approximately $32.5 million of this convertible debt was converted at the holder&#8217;s request which resulted in an additional $1.0 million of expense recognized due to the conversions.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Notes are not listed on any securities exchange or on any automated dealer quotation system, but are traded on a secondary market made by the initial purchasers.&#160;&#160;The initial purchasers of the Notes advised the Company of their intent to make a market in the Notes following the offering, though they are not obligated to do so and may discontinue any market making at any time.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, the Notes were trading at approximately 412.4% of their face value, resulting in a total market value of $360.9 million compared to their face value of $87.5 million.&#160;&#160;The actual conversion value of the Notes is based on the product of the conversion rate and the market price of the Company's common stock at conversion, as defined in the Indenture.&#160;&#160;As of December 31, 2014, the Company's common stock closed at $36.20 per share, resulting in a pro forma conversion value for the Notes of approximately $361.7 million.&#160;&#160;Increases in the market value of the Company&#8217;s common stock increase the Company&#8217;s obligation accordingly.&#160;&#160;There is no upper limit placed on the possible conversion value of the Notes.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Notes are accounted for in accordance with ASC 470-20,<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman">Debt with Conversion and Other Options</font><font style="FONT-STYLE: italic; DISPLAY: inline">.</font>&#160;&#160;Under ASC 470-20, issuers of convertible debt instruments that may be settled in cash upon conversion, including partial cash settlement, are required to separately account for the liability (debt) and equity (conversion option) components.&#160;&#160;The application of ASC 470-20 resulted in the recognition of $21.3 million as the value for the equity component.&#160; This amount was offset by $0.8 million of equity issuance costs, as described below, and both were affected by the conversion of $32.5 million notes as documented above.&#160;&#160;At the dates indicated, the net carrying amount of the liability component and the remaining unamortized debt discount were as follows (in thousands):</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying amount of equity component</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,930</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,470</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying amount of the liability component</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,543</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">108,750</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unamortized discount of the liability component</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,982</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unamortized debt financing costs</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">901</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,034</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company incurred debt issuance costs of $4.7 million related to its issuance of the Notes.&#160;&#160;In accordance with ASC 470-20, the Company allocated this debt issuance cost ratably between the liability and equity components of the Notes, resulting in $3.9 million of debt issuance costs allocated to the liability component and $0.8 million allocated to the equity component.&#160;&#160;The portion allocated to the liability component was classified as deferred financing costs and is being amortized by the effective interest method through the earlier of the maturity date of the Notes or the date of conversion, while the portion allocated to the equity component was recorded as an offset to additional paid-in capital upon issuance of the Notes.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the years ended December 31, 2014, 2013 and 2012, the Company recorded the following expenses in relation to the Notes (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest expense at 3.50% coupon rate</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,105</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Debt discount amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,317</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,113</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,828</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred financing cost amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">780</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">744</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">692</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss&#160;on conversion</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">990</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,192</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,057</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,720</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon issuing the Notes, the Company established a deferred tax liability of $8.6 million related to the debt discount of $21.3 million, with an offsetting debit of $8.6 million to common stock.&#160;&#160;The deferred tax liability was established because the amortization of the debt discount generates non-cash interest expense that is not deductible for income tax purposes.&#160;&#160;Since the Company&#8217;s net deferred tax assets were fully reserved by valuation allowance at the time the Notes were issued, the Company reduced its valuation allowance by $8.6 million upon recording the deferred tax liability related to the debt discount with an offsetting credit of $8.6 million to common stock.&#160;&#160;As a result, the net impact of these entries was a debit of $8.6 million to the valuation reserve against the Company&#8217;s deferred tax assets and a credit of $8.6 million to deferred tax liability.&#160;&#160;The deferred tax liability is being amortized monthly as the Company records non-cash interest from its amortization of the debt discount on the Notes.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Aggregate cumulative maturities of long-term obligations commencing in 2015 are:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In thousands)</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2017</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2018</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Thereafter</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="50%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Maturities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">97,975</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,000,588</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Bank of America Credit Facility</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 7, 2011, the Company and its domestic subsidiaries (the &#8220;Borrowers&#8221;) entered into a Loan and Security Agreement (the &#8220;BoA Credit Agreement&#8221;) with Bank of America, N.A. (the &#8220;Agent&#8221;) and other financial institutions (collectively with the Agent, the &#8220;BoA Lenders&#8221;) through which it obtained a $20.0 million revolving line of credit, which included a $2.0 million letter of credit facility. On April 17, 2014, concurrent with the Company entering into the JPM Credit Agreement, the Company and the Agent agreed to early terminate the BoA Credit Agreement, without penalty.</font> </div><br/> 445000000 0.0025 P7Y 0.0100 443900000 0.0250 0.0350 0.0025 2.25 0.0200 0.0450 7800000 10900000 1800000 1700000 100000 600000000 150000000 0.0025 P7Y 598500000 0.0250 0.0350 0.0025 2.25 0.0200 0.0450 19400000 20300000 7400000 7400000 5000000 2400000 150000000 60000000 0.85 0.65 0.85 0.75 0.85 0.85 0.75 10000000 0.125 15000000 P30D 200000000 P5Y 0.0025 0.020 120000000 0.25 1.00 P12M 0 1 1200000 148800000 120000000 0.0350 20000000 115300000 8.76 114.1553 1000 P20D P30D 1.30 P5D P5D 1000 0.98 11.39 P20D P30D 32500000 1000000 4.124 360900000 87500000 36.20 361700000 21300000 800000 4700000 3900000 8600000 21300000 8600000 8600000 8600000 20000000 2000000 <table cellpadding="0" cellspacing="0" width="70%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: lightgrey;"> <td valign="top" width="50%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-TOP: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fixed Charge</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Coverage Ratio</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-TOP: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revolver ABR</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Spread</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-TOP: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revolver</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Eurodollar</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Spread</font> </div> </td> </tr> <tr> <td valign="top" width="50%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Category 1</font></font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&gt; 1.50 to 1.0</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.50%</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.50%</font> </div> </td> </tr> <tr> <td valign="top" width="50%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Category 2</font></font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&gt; 1.25 to 1.00 but</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&lt; 1.50 to 1.00</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.75%</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.75%</font> </div> </td> </tr> <tr> <td valign="top" width="50%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Category 3</font></font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&lt; 1.25 to 1.00</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00%</font> </div> </td> <td valign="top" width="25%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.00%</font> </div> </td> </tr> </table> 0.0050 0.0150 0.0075 0.0175 0.0100 0.0200 1.50 1.50 1.50 1.50 1.25 1.25 1.25 1.25 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying amount of equity component</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,930</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,470</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying amount of the liability component</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,543</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">108,750</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unamortized discount of the liability component</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,982</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unamortized debt financing costs</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">901</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,034</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 14930000 20470000 82543000 108750000 4982000 11250000 901000 2034000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest expense at 3.50% coupon rate</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,105</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Debt discount amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,317</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,113</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,828</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred financing cost amortization</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">780</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">744</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">692</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss&#160;on conversion</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">990</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,192</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,057</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,720</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 4105000 4200000 4200000 4317000 4113000 3828000 780000 744000 692000 990000 10192000 9057000 8720000 0.0350 0.0350 0.0350 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In thousands)</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2017</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2018</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Thereafter</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="50%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Maturities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">97,975</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,000,588</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 10450000 97975000 10450000 10450000 1000588000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 7 &#8212; Earnings per Common Share</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic net income per common share is based upon the weighted average common shares outstanding during the period. Diluted net income per common share is based upon the weighted average number of common shares outstanding, including the dilutive effect, if any, of stock options, warrants and the conversion feature of convertible notes using the treasury stock method.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Diluted net income per share assumed the principal amount of the convertible Notes would be cash settled and any conversion spread would be settled using common shares, as the Company has the choice of settling either in cash or shares. The Company had demonstrated a past practice and intent of cash settlement for the principal and stock settlement of the conversion spread. As a result, earnings per share calculations for periods ended prior to and including September 30, 2014 only included the assumption of conversion to common shares for the convertible spread. During the quarter ended December 31, 2014, the Company changed its practice of cash settlement and settled redemptions using common shares for both the principal and conversion spread and accordingly, earnings per share amounts were calculated using the if-converted method. For the year ended December 31, 2014, the earnings per share amounts were calculated using the if-converted method.</font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s potentially dilutive shares consist of: (i) vested and unvested stock options that are in-the-money, (ii) unvested RSAs, (iii) warrants that are in-the-money, and (iv) shares potentially issuable upon conversion of the Notes.&#160;&#160;</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A reconciliation of the earnings per share data from a basic to a fully diluted basis is detailed below (amounts in thousands, except per share data):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations used for basic earnings per share</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,848</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52,362</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,378</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Convertible debt income adjustments, net of tax</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,825</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations adjusted for convertible debt as used for diluted earnings per share</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41,673</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52,362</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,378</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations per share:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Basic</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.35</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.54</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Diluted (1)</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.34</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.46</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.32</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss from discontinued operations, net of tax</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(503</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss from discontinued operations, net of tax per share:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Basic</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Diluted</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares used in computing income (loss) per share:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average basic shares outstanding</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,480</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">96,181</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95,189</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dilutive securities:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Stock options and unvested RSAs</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,234</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,289</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Stock warrants</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,874</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,702</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,564</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Shares issuable on conversion of the Notes (2)</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,522</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,499</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,468</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total dilutive securities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,630</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,717</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,321</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average diluted shares outstanding</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">123,110</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">113,898</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">110,510</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-16" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 18pt"> <div> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font> </div> </td> <td> <div align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $5.8 million, after-tax for the year ended December 31, 2014.</font> </div> </td> </tr> </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-17" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 18pt"> <div> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td style="WIDTH: 18pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font> </div> </td> <td> <div align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Shares issuable on conversion of the Notes for the year ended December 31, 2014 have increased in comparison to the fiscal years ended December 31, 2013 and 2012 due to stock appreciation which underlies the shares issuable on conversion of the notes and the Company&#8217;s change in practice on October 1, 2014 to more likely than not settle future note conversions solely through shares as we are now utilizing the if-converted method for convertible debt conversion obligations.</font> </div> </td> </tr> </table><br/> 5800000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations used for basic earnings per share</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,848</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52,362</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,378</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Convertible debt income adjustments, net of tax</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,825</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations adjusted for convertible debt as used for diluted earnings per share</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41,673</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52,362</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,378</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations per share:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Basic</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.35</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.54</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.37</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Diluted (1)</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.34</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.46</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.32</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss from discontinued operations, net of tax</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(503</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss from discontinued operations, net of tax per share:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Basic</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Diluted</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares used in computing income (loss) per share:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average basic shares outstanding</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,480</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">96,181</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95,189</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dilutive securities:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Stock options and unvested RSAs</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,234</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,289</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Stock warrants</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,874</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,702</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,564</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Shares issuable on conversion of the Notes (2)</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,522</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,499</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,468</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total dilutive securities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,630</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,717</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,321</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average diluted shares outstanding</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">123,110</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">113,898</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">110,510</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 5825000 41673000 52362000 35378000 -0.01 -0.01 4234000 4516000 4289000 1874000 6702000 6564000 13522000 6499000 4468000 19630000 17717000 15321000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 8 &#8212; Leasing Arrangements</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company leases real and personal property in the normal course of business under various operating leases, including non-cancelable and month-to-month agreements. Rental expense under these leases was $3.3 million, $2.9 million and $2.3 million for the years ended December 31, 2014, 2013 and 2012, respectively.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Landlord incentives are recorded as deferred rent and amortized on a straight-line basis over the lease term.&#160;&#160;Rent escalations are recorded on a straight-line basis over the lease term.&#160;&#160;The Company&#8217;s main operating leases for its Lake Forest and Gurnee facilities have original terms of ten years.&#160;&#160;The Lake Forest facility lease allows for a five-year renewal at the option of the Company.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following is a schedule, by year, of future minimum rental payments required under non-cancelable operating and capital leases in place as of December 31, 2014 (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending December 31,</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,569</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,532</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,230</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2018</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">769</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2019</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">466</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2020 and thereafter</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">3,182</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-72" style="MARGIN-LEFT: 5.05pt"></font>Total</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">11,748</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through the acquisition of VersaPharm during 2014, our wholly owned subsidiary Clover Pharmaceuticals Corp. leased a research and development facility in Warminster, Pennsylvania for an initial term ending December 31, 2017 , with option to renew for an additional 3 years. Monthly rent at the Warminster facility is approximately $11,000 for 12,000 square feet and is used for drug research and development and administrative activities related to our Prescription Pharmaceuticals segment. As part of the VersaPharm acquisition, the Company also took over a lease of a warehouse and office space in Marietta, Georgia consisting of approximately 20,000 square feet and terminated effective August, 2016 with monthly rent of approximately $10,000. All other leases maintained by VersaPharm and its subsidiaries prior to the acquisition have been terminated.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 1, 2012, the Company entered into a lease for a new R&amp;D center in Vernon Hills, Illinois which was expanded during the year ended December 31, 2014.&#160;&#160;This lease extends through April 30, 2020, and obligates the Company to pay monthly rent of approximately $15,000, plus proportionate real estate taxes and common area maintenance.&#160;&#160;Prior to moving its R&amp;D activities to Vernon Hills, Illinois, the Company had leased space for its R&amp;D activities within the Illinois Science &amp; Technology Park in Skokie, Illinois.&#160;&#160;This lease commenced on February 1, 2010, and extended through its early termination date of February 1, 2014.&#160;&#160;Upon vacating the Skokie space shortly after moving R&amp;D operations to Vernon Hills, Illinois, the Company accrued to expense its remaining obligations under the Skokie lease.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 27, 2010, the Company, through its wholly owned subsidiary, Akorn (New Jersey), Inc., an Illinois corporation, entered into a seven-year building lease agreement (the &#8220;Original Somerset Lease&#8221;) with Veronica Development Associates, a New Jersey general partnership, extending the Company&#8217;s occupancy of its 50,000 square foot manufacturing facility located at 72-6 Veronica Avenue, Somerset, New Jersey. This lease commenced on August 1, 2010 and continues through July 31, 2017. Under terms of the new lease, base rent was initially set at $38,801 per month, subject to periodic cost of living adjustments. In addition to base rent, the Company is obligated to pay its proportionate share of estimated property taxes, assessments and maintenance costs. The lease agreement contains a renewal provision allowing the Company the option to renew for up to four additional five-year periods upon providing written notice of its intention to renew at least six months prior to termination of the original lease or any renewal period. Furthermore, on January 24, 2011 the Company entered into an additional lease in Somerset for approximately 6,600 square feet of warehousing space to store various pharmaceutical products (the &#8220;Somerset Warehouse Lease&#8221;). The monthly lease was set at $3,300 per month, subject to similar period cost of living adjustments and other proportionate costs as the Original Somerset Lease. The lease agreement is set for annual renewal at the option of the Company and has been renewed until at least January 31, 2016.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 3, 2010, the Company entered into an eight-year sub-lease agreement with a related party, EJ Financial Enterprises, Inc. (&#8220;EJ Financial&#8221;), for their sub-lease of a portion of the Company&#8217;s corporate offices in Lake Forest, Illinois.&#160;&#160;John N. Kapoor, Ph.D., Chairman of the Company&#8217;s Board of Directors, is the President of EJ Financial.&#160;&#160;This sub-lease commenced on April 1, 2010.&#160;&#160;Per the terms of the sub-lease agreement, EJ Financial will pay monthly base rent plus a proportionate share of common area maintenance costs.&#160;&#160;&#160;The Company and EJ Financial agreed to early terminate this agreement, and the sub-lease was terminated in July 2012 at which time the space was retrofitted for corporate purposes.&#160;&#160;EJ Financial paid the Company approximately $240,000 in rent and common area maintenance fees during the shortened term of this sub-lease.</font> </div><br/> 3300000 2900000 2300000 P10Y P5Y P3Y 11000 12000 20000 10000 15000 50000 38801 P5Y 6600 3300 P8Y 240000 <table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending December 31,</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,569</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,532</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,230</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2018</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">769</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2019</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">466</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2020 and thereafter</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">3,182</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-72" style="MARGIN-LEFT: 5.05pt"></font>Total</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">11,748</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 2569000 2532000 2230000 769000 466000 3182000 11748000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 9 &#8212; Stock Options, Employee Stock Purchase Plan and Restricted Stock</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock Option Plan</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company maintains equity compensation plans that allow the Company&#8217;s Board of Directors to grant stock options to eligible employees, officers and directors.&#160;&#160;Under the 2003 Stock Option Plan, 2,519,000 options were granted, none of which remained outstanding as of December 31, 2011.&#160;&#160;On March 29, 2005, the Company&#8217;s Board of Directors approved the Amended and Restated Akorn, Inc. 2003 Stock Option Plan (the &#8220;Amended 2003 Plan&#8221;), effective as of April 1, 2005, and this was subsequently approved by its stockholders on May 27, 2005. The Amended 2003 Plan was an amendment and restatement of the 2003 Stock Option Plan and provides the Company with the ability to grant other types of equity awards to eligible participants besides stock options. Starting on May 27, 2005, all new awards were granted under the Amended 2003 Plan.&#160;&#160;The aggregate number of shares of the Company&#8217;s common stock initially approved for issuance pursuant to awards granted under the Amended 2003 Plan was 5,000,000.&#160;&#160;On August 7, 2009, the Company&#8217;s stockholders voted to increase this figure to 11,000,000 at the recommendation of the Company&#8217;s Board of Directors, and on December 31, 2011 voted to increase the available shares by another 8,000,000, to a final total of 19,000,000 shares. Under the Amended 2003 Plan, 15,828,000 options have been granted to employees and directors, 6,529,000 options have been exercised, 4,331,000 options have been canceled, and 4,968,000 remain outstanding as of December 31, 2014.&#160;&#160;Options granted under the Amended 2003 Plan have exercise prices equivalent to the market value of the Company&#8217;s common stock on the date of grant and expire five years from date of issuance.&#160;&#160;All options granted during 2013 vest one quarter per year on each of the first four anniversaries of their grant dates.&#160;&#160;Options granted in earlier years generally had a three-year vesting schedule.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Amended 2003 Plan reached its scheduled expiration date on November 6, 2013.&#160;&#160;Accordingly, no additional awards may be issued under the Amended 2003 Plan beyond that date.&#160;&#160;However, any awards outstanding as of November 6, 2013 issued under the Amended 2003 Plan will remain outstanding in accordance with their terms.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At the Company&#8217;s 2014 Annual Meeting of Shareholders, the Company&#8217;s shareholders approved the adoption of the Akorn, Inc. 2014 Stock Option Plan (the &#8220;2014 Plan&#8221;). The 2014 Plan reserves 7.5 million shares for issuance upon the grant of stock options, restricted shares, or various other instruments to directors, employers and consultants.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the 2014 Plan, 1,475,000 options have been granted to employees and directors, no options have been exercised, 57,000 options have been canceled, and 1,419,000 remain outstanding as of December 31, 2014.&#160;&#160;Options granted under the 2014 Stock Option Plan have exercise prices equivalent to the market value of the Company&#8217;s common stock on the date of grant and expire from five to ten years from date of issuance depending on the option grant date.&#160;&#160;All options granted to employees during the year ended December 31, 2014 vest one quarter per year on each of the first four anniversaries of their grant dates while all options granted to non-employee directors fully vest on the first anniversary date of their grant.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounts for stock-based compensation in accordance with ASC Topic 718, <font style="FONT-STYLE: italic; DISPLAY: inline">Compensation &#8211; Stock Compensation</font> (formerly SFAS No. 123 (revised 2004), <font style="FONT-STYLE: italic; DISPLAY: inline">Share Based Payment</font> (SFAS 123(R))).&#160;&#160;Accordingly, stock-based compensation cost is estimated at the grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions that enter into the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. Treasury securities in effect during the quarter in which the options were granted. The dividend yield reflects historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises in subsequent periods, if necessary, if actual forfeitures differ from those estimates.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded stock option compensation expense of approximately $6.0 million, $6.2 million and $6.4 million during the years ended December 31, 2014, 2013 and 2012, respectively.&#160;&#160;The Company uses the single-award method for allocating the compensation cost to each period.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The assumptions used in estimating the fair value of the stock options granted during the period, along with the weighted-average grant date fair values, were as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="top" width="65%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td colspan="3" valign="middle" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td valign="middle" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="middle" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td valign="middle" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="middle" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font> </div> </td> </tr> <tr> <td valign="bottom" width="65%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="bottom" width="11%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="bottom" width="11%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="bottom" width="11%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46%</font></font> </div> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71%</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68%</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85%</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected life (in years)</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.4</font></font></font> </div> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> &#160; </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;4.0</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.0</font></font> </div> </td> <td valign="bottom" width="4%"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk-free interest rate</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.9%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.2%</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4%</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.8%</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dividend yield</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> &#160; </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> &#160; </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="4%"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value per stock option</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16.08</font></font></font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$6.95</font></font></font> </div> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$7.76</font></font></font> </div> </div> </td> <td valign="bottom" width="4%"> &#160; </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;A summary of stock option activity within the Company&#8217;s stock-based compensation plans for the years ended December 31, 2014, 2013 and 2012 is as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-73" style="MARGIN-LEFT: 10.4pt"></font>Shares</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(in thousands)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-74" style="MARGIN-LEFT: 2.85pt"></font>Weighted</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-75" style="MARGIN-LEFT: 6.6pt"></font>Average</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted Average</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Remaining</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Contractual Term</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Years)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Aggregate</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Intrinsic Value</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(in thousands)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2011</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,399</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.89</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,221</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12.96</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(806</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.87</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(87</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.42</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2012</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,727</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.22</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">321</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.76</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(630</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.18</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(190</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2013</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,228</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.45</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,475</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28.59</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,226</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.91</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(91</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22.56</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2014</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,386</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.44</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.48</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">158,097</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable at December 31, 2014</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,316</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.43</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">132,813</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The aggregate intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company&#8217;s common stock at the end of the period and the exercise price of the in-the-money stock options. The total intrinsic value of stock options exercised during the years ended December 31, 2014, 2013 and 2012 was approximately $141.7 million, $8.9 million and $9.1 million, respectively. As a result of the stock options exercised, the Company received cash and recorded additional paid-in-capital of approximately $8.0 million, $2.6 million and $1.5 million during the years ended December 31, 2014, 2013 and 2012, respectively.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, the total amount of unrecognized compensation cost related to non-vested stock options was approximately $20.7 million which is expected to be recognized as expense over a weighted-average period of 3.1 years.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time the Company grants restricted stock awards to certain employees and members of its Board of Directors (&#8220;Directors&#8221;). Restricted share awards are valued at the closing market price of the Company&#8217;s common stock on the day of grant and the total value of the award is recognized as expense ratably over the vesting period of the grants.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 2, 2014, the Company granted a total of 71,582 restricted shares to senior management which vest at 25% per year on the anniversary date of the grant ending May 2, 2018. Also on May 2, 2014, the Company modified approximately 2.3 million options to extend the option term for grants to certain individuals in Senior Management. On September 5, 2014, the Company granted a total of 257,416 restricted shares to senior management and 8,034 shares to a Director to make the individuals who received extended option terms on May 2, 2014 whole given increased tax liabilities. The shares each vest at 25% per year on the anniversary date of the grant ending September 5, 2018. On May 3, 2013, the Company granted a total of 31,899 restricted shares to its Directors, of which 15,946 shares vested immediately upon issuance and the remaining 15,953 shares vested on May 3, 2014.&#160;&#160;During 2012, the Company granted 35,000 shares of restricted shares valued at approximately $0.5 million to members of its Board of Directors, of which half vested immediately and half vested on the one year anniversary of grant.&#160;&#160;The Company recognized compensation expense of approximately $1.2 million, $0.6 million and $0.4 million during the years ended December 31, 2014, 2013 and 2012, respectively, related to restricted stock awards.</font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following is a summary of non-vested restricted stock activity:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of Shares</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">(in thousands)</font><font id="TAB2-4" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted Average</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Grant Date Fair Value</font><font id="TAB2-5" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2011</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.34</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.63</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.09</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled</font> </div> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.63</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.36</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.98</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled</font> </div> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.36</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">337</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35.31</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.36</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2014</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">337</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35.31</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, the total amount of unrecognized compensation cost related to restricted stock awards was approximately $10.8 million which is expected to be recognized as expense over a weighted-average period of 3.6 years.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Employee Stock Purchase Plan</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Akorn, Inc. Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) permits eligible employees to acquire shares of the Company&#8217;s common stock through payroll deductions.&#160;&#160;The ESPP has been structured to qualify under Section 423 of the Internal Revenue Code (&#8220;IRC&#8221;).&#160;&#160;Employees who elect to participate in the ESPP may withhold from 1% to 15% of base wages toward the purchase of stock.&#160;&#160;Shares are purchased at a 15% discount off the lesser of the market price at the beginning or the ending of the applicable offering period.&#160;&#160;The ESPP has two offering periods each year, one running from January 1<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">st</font> to December 31<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">st</font> and the other running from July 1<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">st</font> to December 31<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">st</font>.&#160;&#160;In a given year, employees may enroll in either plan, but not both.&#160;&#160;Per IRC rules, annual purchases per employee are limited to $25,000 worth of stock, valued as of the beginning of the offering period.&#160;&#160;Accordingly, with the 15% discount, employees may withhold no more than $21,250 per year toward the purchase of stock under the ESPP.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A maximum of 2 million shares of the Company&#8217;s common stock may be issued under the ESPP.&#160;&#160;Including shares issues in early 2015 related to employee participation in the ESPP during 2014, a total of 1,420,438 shares have been issued thus far under the ESPP, leaving 579,562 shares available for future issuance.&#160;&#160;The Company issued approximately 67,000, 73,000 and 61,000 shares of its common stock related to employee participation in the ESPP during 2014, 2013 and 2012, respectively.&#160;&#160;For the years ended December 31, 2014, 2013 and 2012, the Company recorded compensation expense of approximately $0.4, $0.2 and $0.2 million, respectively in each period related to the ESPP.</font></font> </div><br/> 0 2519000 5000000 11000000 8000000 19000000 15828000 6529000 4331000 4968000 P5Y P4Y P3Y 7500000 0 1475000 57000 1419000 P5Y P10Y P4Y 6000000 6200000 6400000 141700000 8900000 9100000 8000000 2600000 1500000 20700000 P3Y36D 71582 0.25 2300000 257416 8034 0.25 31899 15946 15953 35000 500000 1200000 600000 400000 10800000 P3Y219D 0.01 0.15 0.15 25000 21250 2000000 1420438 579562 67000 73000 61000 400000 200000 200000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="top" width="65%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td colspan="3" valign="middle" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td valign="middle" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="middle" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td valign="middle" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="middle" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font> </div> </td> </tr> <tr> <td valign="bottom" width="65%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="bottom" width="11%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="bottom" width="11%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="3" valign="bottom" width="11%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46%</font></font> </div> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71%</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68%</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85%</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected life (in years)</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.4</font></font></font> </div> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> &#160; </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;4.0</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.0</font></font> </div> </td> <td valign="bottom" width="4%"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk-free interest rate</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.9%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.2%</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4%</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7%</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.8%</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dividend yield</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> &#160; </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> &#160; </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></font> </div> </td> <td valign="bottom" width="4%"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value per stock option</font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16.08</font></font></font> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$6.95</font></font></font> </div> </div> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td valign="top" width="1%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="4%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$7.76</font></font></font> </div> </div> </td> <td valign="bottom" width="4%"> &#160; </td> </tr> </table> 0.46 0.71 0.49 0.68 0.77 0.85 P5Y146D P4Y P4Y 0.009 0.022 0.007 0.014 0.007 0.008 0 0 0 16.08 6.95 7.76 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-73" style="MARGIN-LEFT: 10.4pt"></font>Shares</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(in thousands)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-74" style="MARGIN-LEFT: 2.85pt"></font>Weighted</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-75" style="MARGIN-LEFT: 6.6pt"></font>Average</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted Average</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Remaining</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Contractual Term</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Years)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Aggregate</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Intrinsic Value</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(in thousands)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2011</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,399</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.89</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,221</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12.96</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(806</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.87</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(87</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.42</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2012</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,727</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.22</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">321</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.76</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(630</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.18</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(190</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2013</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,228</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.45</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,475</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28.59</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,226</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.91</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(91</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22.56</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2014</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,386</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.44</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.48</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">158,097</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable at December 31, 2014</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,316</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.43</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">132,813</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 9399000 2.89 1221000 12.96 806000 1.87 87000 4.42 9727000 4.22 321000 15.76 630000 4.18 190000 13.10 9228000 4.45 1475000 28.59 4226000 1.91 91000 22.56 6386000 11.44 P2Y175D 158097000 4316000 5.43 P1Y3D 132813000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of Shares</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">(in thousands)</font><font id="TAB2-4" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted Average</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Grant Date Fair Value</font><font id="TAB2-5" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2011</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.34</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.63</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.09</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled</font> </div> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.63</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.36</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.98</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled</font> </div> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.36</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">337</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35.31</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15.36</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nonvested at December 31, 2014</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">337</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35.31</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 13000 1.34 35000 14.63 30000 9.09 18000 14.63 32000 15.36 34000 14.98 16000 15.36 337000 35.31 16000 15.36 337000 35.31 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 10 &#8212; Income Taxes from Continuing Operations</font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The income tax provision (benefit) from continuing operations consisted of the following (in thousands):</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Current</font><font id="TAB2-6" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Deferred</font><font id="TAB2-7" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Total</font><font id="TAB2-8" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year ended December 31, 2014</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,799</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,674</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,125</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,991</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,698</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,293</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">4</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(2,</font><font style="DISPLAY: inline">134</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(2,</font><font style="DISPLAY: inline">130</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">39,</font><font style="DISPLAY: inline">794</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(</font><font style="DISPLAY: inline">16,506</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">23,288</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year ended December 31, 2013</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,985</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,050</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-76" style="MARGIN-LEFT: 0.65pt"></font>24,935</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,145</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-77" style="MARGIN-LEFT: 6.4pt"></font>2,051</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-78" style="MARGIN-LEFT: 0.65pt"></font>6,196</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(598</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(598</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">32,130</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,597</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-79" style="MARGIN-LEFT: 0.65pt"></font><font style="DISPLAY: inline">30,533</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year ended December 31, 2012</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,843</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(504</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-80" style="MARGIN-LEFT: 0.65pt"></font>20,339</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,232</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-81" style="MARGIN-LEFT: 2.65pt"></font>(911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,321</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,538</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#160;(1,538</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">25,075</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(2,953</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-82" style="MARGIN-LEFT: 0.65pt"></font><font style="DISPLAY: inline">22,122</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income tax expense differs from the &#8220;expected&#8221; tax expense computed by applying the U.S. Federal corporate income tax rates of 35% to income from continuing operations before income taxes, as follows (in thousands):</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Years Ended December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2012</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computed &#8220;expected&#8221; tax expense</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,698</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,013</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,125</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in income taxes resulting from:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State income taxes, net of Federal income tax</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,490</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-83" style="MARGIN-LEFT: 7.45pt"></font>4,027</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-84" style="MARGIN-LEFT: 7.45pt"></font>2,159</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign income tax expense (benefit)</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(454</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">622</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,468</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deduction for domestic production activities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,444</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,361</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,277</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">R&amp;D tax credits</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(447</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,652</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(508</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other expense (benefit), net</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,329</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(116</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">155</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation allowance change</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,116</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-85" style="MARGIN-LEFT: 20.75pt"></font><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax expense</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">23,288</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">30,533</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">22,122</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The geographical allocation of the Company&#8217;s income from continuing operations before income taxes between U.S. and foreign operations was as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2012</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-tax income from continuing U.S. operations</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,114</font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,382</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,087</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-tax loss from continuing foreign operations</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,978</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,487</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,587</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total pre-tax income from continuing operations</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,136</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,895</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,500</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net deferred income taxes at December 31, 2014 and 2013 include (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Noncurrent</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Noncurrent</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Net operating loss carry-forward</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,277</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,190</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">439</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,061</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Stock-based compensation</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,408</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,630</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chargeback reserves</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Reserve for product returns</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,255</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,189</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Inventory valuation reserve</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,764</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,193</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">8,570</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">192</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">3,325</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,751</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,257</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,790</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,146</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,442</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Valuation allowance</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,116</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net deferred tax assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">36,257</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">21,674</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Prepaid expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,982</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,120</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Inventory step-up</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,619</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Unamortized discount &#8211; convertible notes</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,776</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,223</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Depreciation &amp; amortization &#8211; tax over book</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">285,022</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,576</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(81</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(3,601</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">286,798</font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,201</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(20,799</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net deferred income tax asset (liability)</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">32,656</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">265,124</font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">7,945</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,643</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company records a valuation allowance to reduce net deferred income tax assets to the amount that is more likely than not to be realized. In performing its analysis of whether a valuation allowance to reduce the deferred income tax asset was necessary, the Company evaluated the data and determined that as of December 31, 2014 it could not conclude that it was more likely than not that certain of the net operating losses of its Indian subsidiary would be realized.&#160;&#160;Accordingly, the Company established a valuation allowance of $1.1 million against its deferred tax assets as of December 31, 2014.&#160;&#160;The Company had concluded that all of its deferred tax assets were more likely than not to be realized as of December 31, 2013; accordingly, no valuation allowance was in place as of that date.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The deferred tax balances have been reflected gross on the balance sheet, and are netted only if they are in the same jurisdiction.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s net operating loss (&#8220;NOL&#8221;) carry-forwards as of December 31, 2014 consist of three component pieces: (i) U.S. Federal NOL carry-forwards valued at $11.3 million, (ii) Illinois NOL carry-forwards valued at $2.2 million, and (iii) foreign (Indian) NOLs of $7.1 million.&#160;&#160;The U.S. Federal NOL carry-forwards were obtained through the Merck Acquisition completed in the fourth quarter of 2013, ($7.5 million) and the acquisition of VersaPharm in the third quarter of 2014 ($3.8 million).&#160;&#160;The Illinois NOL carry-forwards relate to the Company&#8217;s tax losses in the decade of the 2000s and have not yet been fully utilized due to the State of Illinois&#8217;s suspension of the use of NOLs for the years 2011, 2012 and 2013.&#160;&#160;These NOLs would be due to expire from 2021 to 2025, and are expected to be utilized well before their expiration dates.&#160;&#160;The foreign NOL carry-forwards relate to operating losses by the Company&#8217;s subsidiary in India, which was acquired in 2012.&#160;&#160;Of the $7.1 million foreign NOL, $1.1 million expire beginning in 2022; the Company has established a valuation allowance against this entire amount.&#160;&#160;The remaining $6.0 million of the foreign NOLs can be carried forward indefinitely, and the Company has concluded that they are more likely than not to be utilized and therefore has not established a valuation allowance against them.&#160;&#160;The Company previously had valued NOL carry-forwards in the State of New Jersey.&#160;&#160;However, due to changes in the tax law, the Company determined that these NOLs would never be utilized and wrote them off during 2013.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In late 2014, the Company was notified that its Federal income tax return for the year ended December 31, 2013 would be examined by the Internal Revenue Service beginning in early 2015.&#160;&#160;The Company&#8217;s Hi-Tech Pharmacal subsidiary is currently undergoing an examination by the Internal Revenue Service for its tax year ended April 30, 2013.&#160;&#160;The Company&#8217;s VersaPharm subsidiary has also been notified that its Federal income tax return for the year ended December 31, 2012 will be examined beginning in 2015.&#160;&#160;Additionally, the Company is undergoing examinations by Illinois and Massachusetts for various tax years.&#160;&#160;The Company&#8217;s U.S. Federal income tax returns filed for years 2011 through 2013 are open for examination by the Internal Revenue Service.&#160;&#160;The majority of the Company&#8217;s state and local income tax returns filed for years 2010 through 2013 remain open for examination as well.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 740-10-25, <font style="FONT-STYLE: italic; DISPLAY: inline">Income Taxes &#8211; Recognition</font>, the Company performs reviews of its tax positions to determine whether it is &#8220;more likely than not&#8221; that its tax positions will be sustained upon examination, and if any tax positions are deemed to fall short of that standard, the Company reserves based on the financial exposure and the likelihood of its tax positions not being sustained.&#160;&#160;Based on its review as of December 31, 2014, the Company determined that it would not recognize tax benefits as follows (in thousands):</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2011</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to current year</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,265</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to prior years</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">220</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,485</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to current year</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">589</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Terminations of exposures relating to prior years</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,229</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">845</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to current year</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">408</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to acquired entities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">456</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Terminations of exposures relating to prior years</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,709</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If recognized, $1.2 million of the above positions will impact the Company&#8217;s effective rate, while the remaining $0.5 million will result in a reduction of the Company&#8217;s goodwill.&#160;&#160;Due to the uncertainty of both timing and resolution of potential income tax examinations, the Company is unable to determine whether any amounts included in the December 31, 2014 balance of unrecognized tax benefits represent tax positions that could significantly change during the next twelve months.&#160;&#160;The Company accounts for interest and penalties as income tax expense.&#160;&#160;There were no uncertain tax positions prior to 2012.</font></font> </div><br/> 0.35 0 11300000 2200000 7100000 7500000 3800000 1100000 6000000 1200000 500000 0 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Current</font><font id="TAB2-6" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Deferred</font><font id="TAB2-7" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Total</font><font id="TAB2-8" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year ended December 31, 2014</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,799</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,674</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,125</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,991</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,698</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,293</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">4</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(2,</font><font style="DISPLAY: inline">134</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(2,</font><font style="DISPLAY: inline">130</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">39,</font><font style="DISPLAY: inline">794</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(</font><font style="DISPLAY: inline">16,506</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">23,288</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year ended December 31, 2013</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,985</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,050</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-76" style="MARGIN-LEFT: 0.65pt"></font>24,935</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,145</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-77" style="MARGIN-LEFT: 6.4pt"></font>2,051</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-78" style="MARGIN-LEFT: 0.65pt"></font>6,196</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(598</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(598</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">32,130</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,597</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-79" style="MARGIN-LEFT: 0.65pt"></font><font style="DISPLAY: inline">30,533</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year ended December 31, 2012</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,843</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(504</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-80" style="MARGIN-LEFT: 0.65pt"></font>20,339</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,232</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-81" style="MARGIN-LEFT: 2.65pt"></font>(911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,321</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,538</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#160;(1,538</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">25,075</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(2,953</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-82" style="MARGIN-LEFT: 0.65pt"></font><font style="DISPLAY: inline">22,122</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 34799000 -11674000 23125000 4991000 -2698000 2293000 4000 -2134000 -2130000 39794000 -16506000 27985000 -3050000 24935000 4145000 2051000 6196000 -598000 -598000 32130000 -1597000 20843000 -504000 20339000 4232000 -911000 3321000 -1538000 -1538000 25075000 -2953000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Years Ended December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2012</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computed &#8220;expected&#8221; tax expense</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,698</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,013</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,125</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in income taxes resulting from:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State income taxes, net of Federal income tax</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,490</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-83" style="MARGIN-LEFT: 7.45pt"></font>4,027</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-84" style="MARGIN-LEFT: 7.45pt"></font>2,159</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign income tax expense (benefit)</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(454</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">622</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,468</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deduction for domestic production activities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,444</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,361</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,277</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">R&amp;D tax credits</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(447</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,652</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(508</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other expense (benefit), net</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,329</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(116</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">155</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation allowance change</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,116</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-85" style="MARGIN-LEFT: 20.75pt"></font><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax expense</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">23,288</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">30,533</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">22,122</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 20698000 29013000 20125000 1490000 4027000 2159000 -454000 622000 1468000 -1444000 -1361000 -1277000 -447000 -1652000 -508000 2329000 -116000 155000 1116000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2012</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-tax income from continuing U.S. operations</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,114</font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,382</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,087</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-tax loss from continuing foreign operations</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,978</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,487</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,587</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total pre-tax income from continuing operations</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,136</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,895</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,500</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 67114000 86382000 66087000 -7978000 -3487000 -8587000 59136000 82895000 57500000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Noncurrent</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Noncurrent</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Net operating loss carry-forward</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,277</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,190</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">439</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,061</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Stock-based compensation</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,408</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,630</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chargeback reserves</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,391</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Reserve for product returns</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,255</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,189</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Inventory valuation reserve</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,764</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,193</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">8,570</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">192</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">3,325</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,751</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,257</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,790</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,146</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,442</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Valuation allowance</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,116</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net deferred tax assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">36,257</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">21,674</font></font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Prepaid expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,982</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,120</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Inventory step-up</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,619</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Unamortized discount &#8211; convertible notes</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,776</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,223</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Depreciation &amp; amortization &#8211; tax over book</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">285,022</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,576</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(81</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Total deferred tax liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(3,601</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">286,798</font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,201</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(20,799</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net deferred income tax asset (liability)</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">32,656</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">265,124</font></font></font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">7,945</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,643</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 4277000 16190000 439000 14061000 6408000 6630000 5391000 12255000 3189000 5764000 2193000 8570000 192000 3325000 1751000 36257000 22790000 9146000 22442000 1116000 36257000 21674000 1982000 1120000 1619000 1776000 4223000 285022000 16576000 81000 3601000 286798000 1201000 20799000 32656000 -265124000 7945000 1643000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2011</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to current year</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,265</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to prior years</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">220</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,485</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to current year</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">589</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Terminations of exposures relating to prior years</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(1,229</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">845</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to current year</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">408</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions relating to acquired entities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">456</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Terminations of exposures relating to prior years</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">&#8212;</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,709</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 0 1265000 220000 1485000 589000 1229000 845000 408000 456000 1709000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 11 &#8212; Retirement Plan</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All full-time Akorn employees are eligible to participate in the Company&#8217;s 401(k) Plan. During the years ended December 31, 2014, 2013 and 2012, plan-related expense totaled approximately $1.3 million, $0.8 million and $0.8 million, respectively. The Company provides a matching contribution based on a percentage of the amount contributed by each employee, which is funded on a current basis.&#160;&#160;The Company suspended its match on 401(k) contributions during 2009 and did not match 401(k) contributions through March 31, 2010.&#160;&#160;Effective April 1, 2010, the Company reinstituted a matching contribution at a rate of 25% of the first 6% contributed by employees.&#160;&#160;On January 1, 2011, the Company increased its matching contribution to 50% of the first 6% contributed, and has maintained this match rate through December 31, 2014.&#160;&#160;Company matching contributions vest 50% after two years of credited service and 100% after three years of credited service.</font></font> </div><br/> 1300000 800000 800000 0.25 0.06 0.50 0.06 0.50 1.00 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 12 &#8212; Segment Information</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended December 31, 2014, the Company acquired Hi-Tech and as a result, underwent a change in the organizational and reporting structure of the Company's reportable segments, establishing two reporting segments that each report to the Chief Operating Decision Maker (CODM), as defined in ASC Topic 280, <font style="FONT-STYLE: italic; DISPLAY: inline">Segment Reporting</font>, and Chief Executive Officer (CEO), Raj Rai. Our performance will be assessed and resources will be allocated by the CODM based on the following two reportable segments:</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">- Prescription Pharmaceuticals</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">- Consumer Health</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Prior to the realignment the Company managed the business as three distinct reporting segments; Ophthalmics, Hospital Drugs and Injectables, and Contract Services.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The changes combine operations that have a similar product type, serve comparable customers and address similar business issues and industry dynamics. The new segment reporting structure provides shareholders and other users of our financial statements with more useful information about our segments.</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="top" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="40%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="top" width="46%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-TOP: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current Segments</font> </div> </td> </tr> <tr> <td valign="top" width="7%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="7%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="40%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Prescription Pharmaceuticals</font> </div> </td> <td valign="top" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consumer Health</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td rowspan="6" valign="middle" width="7%" style="border-bottom: black 1.1pt solid; text-align: center; border-left: #000000 1pt solid; background-color: transparent;"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Former Segments</font> </div> </td> <td rowspan="3" valign="middle" width="7%" style="border-bottom: black 1.1pt solid; text-align: center; border-left: #000000 1pt solid; background-color: transparent;"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Akorn</font> </div> </td> <td align="left" valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ophthalmics</font> </div> </td> <td valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X</font> </div> </td> <td valign="middle" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X (a)</font> </div> </td> </tr> <tr> <td align="left" valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hospital Drugs and Injectables</font> </div> </td> <td valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X</font> </div> </td> <td valign="middle" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contract Services</font> </div> </td> <td valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X</font> </div> </td> <td valign="middle" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td rowspan="3" valign="middle" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Hi-Tech</font> </div> </td> <td align="left" valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Generic Pharmaceuticals (&#8220;Hi-Tech Generic&#8221;)</font> </div> </td> <td valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X</font> </div> </td> <td valign="middle" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">OTC Branded Pharmaceuticals (&#8220;HCP&#8221;)</font> </div> </td> <td valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="middle" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X (b)</font> </div> </td> </tr> <tr> <td align="left" valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prescription Brands (&#8220;ECR&#8221;)</font> </div> </td> <td valign="middle" width="40%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;X (c)</font> </div> </td> <td valign="middle" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="right" valign="top" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font> </div> </td> <td align="left" valign="top" width="78%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Represents the previous acquisition of Advanced Vision Research, Inc./TheraTears<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font></font> </div> </td> </tr> <tr> <td align="right" valign="top" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font> </div> </td> <td align="left" valign="top" width="78%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Represents the previous Hi-Tech reportable segment HCP (&#8220;Health Care Products&#8221;)</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="right" valign="top" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font> </div> </td> <td align="left" valign="top" width="78%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Represents the previous Hi-Tech reportable segment ECR which was divested during the year ended December 31, 2014 and whose results have been included within discontinued operations.</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s Prescription Pharmaceutical segment principally consists of generic and branded Prescription Pharmaceuticals products which span a broad range of indications as well as a variety of dosage forms including: sterile ophthalmics, injectables and inhalants, and non-sterile oral liquids, topicals, nasal sprays. In addition, the Company, through Akorn India Private Limited (&#8220;AIPL&#8221;), manufactures pharmaceuticals for various markets outside the US. The Company&#8217;s Consumer Health segment principally consists of animal health and over-the-counter products, both branded and private label.&#160;&#160;OTC products includes a suite of products for the treatment of dry eye sold under the TheraTears<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> brand name.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial information about the Company&#8217;s reportable segments is based upon internal financial reports that aggregate certain operating information. The Company&#8217;s CEO oversees operational assessments and resource allocations based upon the results of the Company&#8217;s reportable segments, which have available and discrete financial information.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Selected financial info <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">by reporting segment is presented below (in thousands). The Company has restated prior periods including the years ended December 31, 2013 and 2012 to reflect the strategic realignment described above.</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Years ended December 31,</font><font id="TAB2-9" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-86" style="MARGIN-LEFT: 7.95pt"></font><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-87" style="MARGIN-LEFT: 7.95pt"></font><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-88" style="MARGIN-LEFT: 7.95pt"></font><font style="DISPLAY: inline">2012</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">REVENUES</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prescription Pharmaceuticals</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">542,846</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">279,911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">223,881</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consumer Health</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">50,232</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">37,800</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">32,277</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total revenues</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">593,078</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">317,711</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">256,158</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GROSS PROFIT</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prescription Pharmaceuticals</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">270,197</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,182</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129,884</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consumer Health</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">27,393</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">20,722</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">18,808</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total gross profit</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">297,590</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">171,904</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">148,692</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company manages its business segments to the gross profit level and manages its operating and other costs on a company-wide basis. Inter-segment activity at the gross profit level is minimal. The Company does not have discrete assets by segment, as certain manufacturing and warehouse facilities support more than one segment, and therefore does not report assets by segment.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During 2014, 2013 and 2012, approximately $16.6 million, $27.3 million and $29.4 million of the Company&#8217;s net revenue, respectively, was from customers located in foreign countries.&#160;&#160;Sales generated by Akorn India Private Limited, the Company&#8217;s wholly owned subsidiary in India, accounted for $7.2 million, $15.8 million and $16.7 million of the foreign sales amounts for 2014, 2013 and 2012, respectively.&#160;&#160;In these years, AIPL sold product exclusively to contract customers in India and to export customers in unregulated world markets, outside the United States, which has declined in the current year due to a reduction in the customer base.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Goodwill from the Company&#8217;s acquisition of Advanced Vision Research, Inc. in May 2011, the acquisition of selected assets of Kilitch Drugs (India) Limited in February 2012, the merger with Hi-Tech and subsequent disposal of the Watson assets on April 17, 2014, the disposal of the ECR component June 20, 2014 and the acquisition of VersaPharm on August 12, 2014 have been allocated to the appropriate reporting segment and reporting unit.&#160;&#160;The carrying amounts of goodwill as restated by segment were as follows (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Prescription Pharmaceuticals</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consumer Health</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,296</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,863</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,159</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency Translation</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,328</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,328</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,968</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,863</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,831</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">256,057</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260,911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dispositions</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,454</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,454</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translations</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(514</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(514</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">262,057</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,717</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278,774</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> 2 16600000 27300000 29400000 7200000 15800000 16700000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Years ended December 31,</font><font id="TAB2-9" style="LETTER-SPACING: 3pt; COLOR: black"></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-86" style="MARGIN-LEFT: 7.95pt"></font><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-87" style="MARGIN-LEFT: 7.95pt"></font><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1-88" style="MARGIN-LEFT: 7.95pt"></font><font style="DISPLAY: inline">2012</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">REVENUES</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prescription Pharmaceuticals</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">542,846</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">279,911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">223,881</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consumer Health</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">50,232</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">37,800</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">32,277</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total revenues</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">593,078</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">317,711</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">256,158</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GROSS PROFIT</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prescription Pharmaceuticals</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">270,197</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,182</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129,884</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consumer Health</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">27,393</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">20,722</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">18,808</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total gross profit</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">297,590</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">171,904</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">148,692</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 542846000 279911000 223881000 50232000 37800000 32277000 270197000 151182000 129884000 27393000 20722000 18808000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Prescription Pharmaceuticals</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consumer Health</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,296</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,863</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,159</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency Translation</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,328</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,328</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,968</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,863</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,831</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisitions</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">256,057</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260,911</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairments</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dispositions</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,454</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,454</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translations</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(514</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9472;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(514</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2014</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">262,057</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,717</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278,774</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 20296000 11863000 -2328000 17968000 11863000 256057000 4854000 11454000 -514000 262057000 16717000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 13 &#8212; Commitments and Contingencies</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 2, 2014 the Company acquired the U.S. NDA rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> from Santen. The total consideration payable will equal 1.5 times the Company&#8217;s net sales of Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> in the first year following acquisition. The Company paid consideration of $7.5 million upon closing this transaction and expects to owe additional consideration, which will become payable in the first quarter of 2015. The additional consideration contingently payable to Santen was initially estimated at $4.5 million discounted to $4.0 million based on a discount rate of 12.6%. The Company performed evaluations of the fair value of this liability at December 31, 2014 based on utilizing significant unobservable inputs and determined the fair value of this liability to be $4.3 million.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has entered into strategic business agreements for the development and marketing of finished dosage form pharmaceutical products with various pharmaceutical development companies.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Each strategic business agreement includes a future payment schedule for contingent milestone payments and in certain strategic business agreements, minimum royalty payments.&#160;&#160;The Company will be responsible for contingent milestone payments and minimum royalty payments to these strategic business partners based upon the occurrence of future events.&#160;&#160;Each strategic business agreement defines the triggering event of its future payment schedule, such as meeting product development progress timelines, successful product testing and validation, successful clinical studies, various FDA and other regulatory approvals and other factors as negotiated in each agreement.&#160;&#160;None of the contingent milestone payments or minimum royalty payments is individually material to the Company.&#160;&#160;</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 17, 2012, the Company entered into an exclusive distribution agreement with the Massachusetts Biological Laboratory of the University of Massachusetts (&#8220;MBL&#8221;) for the Company&#8217;s marketing of MBL-manufactured tetanus-diphtheria vaccine (&#8220;Td vaccine&#8221;) over an initial contract term of two (2) years. On July 1, 2014, the Company terminated the agreement and renegotiated a new distribution agreement for an additional contract term of (1) year. The new agreement commits the Company to acquire $4.8 million of Td vaccine in the first six months of the fiscal year ended December 31, 2015.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is party to a supply agreement with a third party for the provision of two of the injectable pharmaceuticals acquired by the Company from Lundbeck on December 21, 2011. This agreement requires the Company to acquire product with an estimated total cost of approximately $1.9 million in 2015.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The table below summarizes contingent potential milestone payments due to strategic partners in the years 2015 and beyond, assuming all such contingencies occur (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending December 31,</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Milestone Payments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,916</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,202</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2018</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,389</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is a party in legal proceedings and potential claims arising in the ordinary course of its business. The amount, if any, of ultimate liability with respect to such matters cannot be determined. Despite the inherent uncertainties of litigation, management of the Company believes that the ultimate disposition of such proceedings and exposures will not have a material adverse impact on the financial condition, results of operations, or cash flows of the Company.</font> </div><br/> 1.5 7500000 4500000 4000000 0.126 4300000 P2Y P1Y 4800000 2 1900000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending December 31,</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Milestone Payments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,916</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,202</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2018</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,389</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 12916000 3250000 3202000 21000 19389000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 14 &#8212; Supplemental Cash Flow Information (in thousands)</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ended December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest and taxes paid:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Interest paid</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,413</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,320</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Income taxes paid</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,294</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,455</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ended December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest and taxes paid:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Interest paid</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,413</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,320</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Income taxes paid</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,294</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,455</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 31413000 4320000 4200000 6294000 27450000 21455000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 15 &#8211; Recent Accounting Pronouncements</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In August 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-15 &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</font>&#8221; (&#8220;ASU 2014-15&#8221;), to provide guidance on management&#8217;s responsibility in evaluating whether there is substantial doubt about a company&#8217;s ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for us in our fourth quarter of fiscal 2016 with early adoption permitted. The adoption of ASU 2014-15 is not expected to have a material effect on the Company&#8217;s consolidated financial statements or disclosures.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In May 2014, FASB issued Accounting Standards Update No. 2014-09, &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Revenue from Contracts with Customers</font>&#8221; (&#8220;ASU 2014-09&#8221;), which provides guidance for revenue recognition. ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, &#8220;Revenue Recognition,&#8221; and most industry-specific guidance. This ASU also supersedes some cost guidance included in Subtopic 605-35, &#8220;Revenue Recognition-Construction-Type and Production-Type Contracts.&#8221; The standard&#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which a company expects to be entitled in exchange for those goods or services. In doing so, companies will be required to use more judgment and make more estimates than under previous guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for the Company for the fiscal year beginning January 1, 2017 and, at that time the Company may adopt the new standard under the full retrospective approach or the modified retrospective approach, as permitted under the standard. Early adoption of the standard is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company&#8217;s consolidated financial statements and disclosures.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In April 2014, the FASB issued ASU No. 2014-08, &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity</font>&#8221; (&#8220;ASU 2014-08&#8221;), which changes the criteria for reporting discontinued operations while enhancing disclosures in this area. Pursuant to ASU 2014-08, only disposals representing a strategic shift, such as a major line of business, a major geographical area or a major equity investment, which were not expected to have continuing cash flows should be presented as a discontinued operation. If the disposal does qualify as a discontinued operation under ASU 2014-08, the entity will be required to provide expanded disclosures. ASU 2014-08 is effective for the Company beginning January 1, 2015. The adoption of ASU 2014-08 is not expected to have a material effect on the Company&#8217;s consolidated financial statements or disclosures.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In July 2013, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2013-11, <font style="FONT-STYLE: italic; DISPLAY: inline">Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.&#160;&#160;</font> ASU 2013-11 was issued to eliminate the diversity in practice in presentation of unrecognized tax benefits, and amends ASC 740, &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Income Taxes,</font>&#8221; to provide clarification of the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. According to the new guidance, unrecognized tax benefits will be netted against all available same-jurisdiction loss or other tax carryforward that would be utilized, rather than only being netted against carryforwards that are created by the unrecognized tax benefits. The revised guidance is effective for interim and annual periods beginning after December&#160;15, 2013, with early adoption permitted.&#160; Adoption of this guidance did not have a material impact on our financial statements or financial reporting.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 16 &#8211; Business Combinations, Dispositions and Other Strategic Investments</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Excelvision AG</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 22, 2014, our Luxembourg subsidiary, Akorn International S.&#224; r.l., entered into a share purchase agreement with Fareva SA to acquire all of the issued and outstanding shares of capital stock of its wholly owned subsidiary, Excelvision AG, a Swiss Company (&#8220;Excelvision&#8221;) for 21.7 million Swiss Francs (&#8220;CHF&#8221;), net of certain working capital amounts. Excelvision is a contract manufacturer located in Hettlingen, Switzerland specializing in ophthalmic products.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 2, 2015, the Company acquired all of the outstanding shares of capital stock of Excelvision for $25.9 million U.S. dollars funded through available cash on hand. The consideration remains subject to a net working capital adjustment payable by the Company. The Company&#8217;s acquisition of Excelvision AG is being accounted for as a business combination in accordance with ASC 805 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations</font>.&#160;&#160;The purpose of the acquisition is to expand the Company&#8217;s manufacturing capacity and reduce production costs. <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The Company will include information about the fair value of acquired assets and assumed liabilities of the Excelvision acquisition in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.</font> During the year ended December 31, 2014, the Company recorded approximately $0.3 million in acquisition related expenses in connection with the Excelvision acquisition.</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Lloyd Animal Health Products</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 2, 2014, Akorn Animal Health, Inc., a wholly owned subsidiary of the Company entered into a definitive Product acquisition agreement with Lloyd, Inc., to acquire certain rights and inventory related to a suite of animal health injectable products (the &#8220;Lloyd Products&#8221;) used in pain management and anesthesia. The Company acquired the products for $16.1 million, funded through available cash paid at closing, and a contingent payment of $2.0 million, discounted to $1.9 million using a 4.5% discount rate and other unobservable inputs, which becomes payable upon FDA approval of a supplement related to one of the acquired products. The Company&#8217;s acquisition of the Lloyd Products is being accounted for as a business combination in accordance with ASC 805 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations</font>.&#160;&#160;The purpose of the acquisition is to expand the Company&#8217;s animal health product portfolio.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the consideration paid for the Lloyd Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;).&#160;&#160;The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of the Lloyd Products.</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Consideration:</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16.1</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of contingent payment</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.9</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consideration at closing</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18.0</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Recognized amounts of identifiable assets acquired:</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.5</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.0</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.5</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable assumed</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1)</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of assets acquired</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18.0</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">IPR&amp;D assets represent ongoing in-process research and development projects obtained through the acquisition. Weighted average remaining amortization period of intangible assets acquired through the Lloyd acquisition as of the closing date was 10.7 years. The rights to Lloyd products are included within product licensing rights, net on the Company&#8217;s condensed consolidated balance sheet as of December 31, 2014.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has not provided pro forma revenue and earnings of the Company as if the Lloyd Products Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Lloyd Product rights were not managed as a discrete business by the previous owner. Accordingly, determining the pro forma revenue and earnings of the Company including the Lloyd Products Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Xopenex Inhalation Solutions</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 1, 2014, the Company entered into a definitive product acquisition agreement with Sunovion Pharmaceuticals Inc., a Delaware corporation to acquire certain rights and inventory related to the branded product, Xopenex<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> Inhalation Solution (levalbuterol hydrochloride) (the &#8220;Xopenex Product&#8221;) for $45 million, funded through available cash paid at closing, net of certain liabilities for product return reserves, rebates, and chargeback reserves, which were assumed by Oak Pharmaceuticals, Inc. (&#8220;Oak&#8221;), a subsidiary of Akorn, subject to a cap. The total cash paid at closing was $41.5 million, which was net of certain liabilities for product return reserves, rebates, and chargeback reserves assumed by the Company.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Xopenex<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. The Company&#8217;s acquisition of Xopenex<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> (the &#8220;Xopenex Acquisition&#8221;) is being accounted for as a business combination in accordance with ASC 805 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations</font>.&#160;&#160;The purpose of the Xopenex Acquisition is to expand the Company&#8217;s product portfolio of prescription pharmaceuticals.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the purchase agreement, certain trademarks and patents related to the Xopenex Product will be licensed to Oak by Sunovion. Further, in connection with closing the Purchase Agreement, the Company and Sunovion entered into a customary transition services agreement. Additionally, the Company assumed a distribution agreement for authorized generic of the product and assumed certain open purchase orders placed in ordinary course for active pharmaceutical ingredients.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the consideration paid for the Xopenex Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.&#160;&#160;The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of the Xopenex Product.</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Consideration:</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41.5</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product returns and reserves assumed</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.5</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consideration at closing</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45.0</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Recognized amounts of identifiable assets acquired:</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts Receivable, net (product returns and reserves assumed)</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3.5)</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.3</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38.7</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of net assets acquired</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41.5</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Weighted average remaining amortization period of the intangible asset acquired as of the closing date was 10 years. The rights to Xopenex<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> are included within product licensing rights, net on the Company&#8217;s condensed consolidated balance sheet as of December 31, 2014.&#160;&#160;During the year ended December 31, 2014, the Company recorded approximately $0.7 million in acquisition related expenses in connection with the Xopenex acquisition.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">VPI Holdings Corp. Inc.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 12, 2014, the Company completed its acquisition of VersaPharm, a Georgia corporation for a total purchase price of approximately $433.0 million, subject to net working capital adjustments. This purchase price was based on acquiring all outstanding equity interests of VPI Holdings Corp. (&#8220;VPI&#8221;), the parent company of VersaPharm and was equal to $440.0 million, net of various post-closing adjustments related to working capital, cash, and transaction expenses of approximately $7.0 million.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 9, 2014, the Company entered into an Agreement and Plan of Merger (the &#8220;VP Merger Agreement&#8221;) to acquire VPI. Upon consummation of the merger, each share of VPI&#8217;s common stock and preferred stock issued and outstanding immediately prior to such time, other than those shares held in treasury by VersaPharm, owned by Akorn, Akorn Enterprises II, Inc., or VPI or any other subsidiary of VPI (each of which were cancelled) and to which dissenters&#8217; rights have been properly exercised, were cancelled and converted into the right to receive its per share right to the aggregate merger consideration, subject to various post-closing adjustments related to working capital, cash, transaction expenses and funded indebtedness. In addition, all stock options of VPI held immediately prior to the consummation of the merger became fully vested and were cancelled upon consummation of the merger with the right to receive payment on the terms set forth in the VP Merger Agreement.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The acquisition was approved by the Federal Trade Commission (&#8220;FTC&#8221;) on August 4, 2014 following review pursuant to provisions of Hart-Scott Rodino Act (&#8220;HSR&#8221;). In connection with the VersaPharm Acquisition, the Company entered into an agreement (the &#8220;Rifampin Divestment Agreement&#8221;) with Watson, a wholly owned subsidiary of Actavis plc, to divest certain rights and assets to the Company&#8217;s Rifampin injectable product. Under the terms of the disposition the Company received $1.0 million for the pending product rights and <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">recorded a gain of $0.8 million in</font> <font style="FONT-STYLE: italic; DISPLAY: inline">Other non-operating income, net</font> <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">in the year ended December 31, 2014 related to the divestment</font>.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">VersaPharm is a developer and marketer of multi-source prescription pharmaceuticals. VersaPharm markets its products to drug wholesalers, retail drug chains, pharmaceutical distributors, group purchasing organizations, hospitals, clinics and government agencies.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The VersaPharm Acquisition complements and expands the Company&#8217;s product portfolio by diversifying its offering to niche dermatology markets.&#160;&#160;VersaPharm&#8217;s product portfolio, pipeline and development capabilities are complementary to our acquisition of Hi-Tech Pharmacal Co, Inc. (&#8220;HiTech&#8221;) acquisition which brought with it the manufacturing capabilities needed for many of VersaPharm&#8217;s current and pipeline products. The VersaPharm Acquisition also enhances the Company&#8217;s new product pipeline as VersaPharm has significant research and development experience and knowledge and numerous IPR&amp;D products are under active development.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The VersaPharm Acquisition was principally funded through a $445.0 million Incremental Term Loan Facility entered into concurrent with completing the acquisition, and through available Akorn cash. For further details on the term loan financing, please refer to the description in Note 6 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Financing Arrangements</font>.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended December 31, 2014, the Company recorded approximately $8.1 million, in acquisition-related expenses in connection with the VersaPharm Acquisition. These expenses principally consisted of various legal fees and other acquisition costs which have been recorded within &#8220;acquisition related costs&#8221; as part of operating expenses in the Company&#8217;s consolidated statement of comprehensive income in the applicable periods.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the consideration paid for the VersaPharm Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.&#160;&#160;The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of VersaPharm.</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consideration:</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Measurement</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Period</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to VersaPharm stockholders</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">322.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">322.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to vested VersaPharm option holders</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts paid to escrow accounts</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transaction expenses paid for previous owners of VersaPharm</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consideration paid at closing</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">VersaPharm debt paid off through closing cash</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total cash paid at closing</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">433.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">433.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recognized amounts of identifiable assets acquired and liabilities assumed:</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.8</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.6</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intangibles, other</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">215.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">215.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">91.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets acquired</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">598.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.4</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">605.2</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed non-current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(76.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(76.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(153.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5.8</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159.7</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total liabilities assumed</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(248.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.4</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">254.6</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The changes in estimates recorded subsequent to the initial accounting estimate was related to refining the calculated fair value of acquired accounts receivable and assumed tax amounts, due to the acquisition.</font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Goodwill represents expected synergies resulting from the combination of the entities and other intangible assets that do not qualify for separate recognition, while IPR&amp;D assets represent ongoing in-process research and development projects obtained through the acquisition. The Company does not anticipate being able to deduct any of the associated incremental value of goodwill and other intangible assets for income tax purposes, but expects to be able to deduct approximately $43.2 million of value associated with pre-existing VersaPharm goodwill and other intangible assets for income tax purposes in future periods.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended December 31, 2014, the Company recorded net revenue of approximately $21.7 million related to sales of the VersaPharm products subsequent to acquisition.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Weighted average remaining amortization period of intangible assets acquired other than goodwill and IPR&amp;D through the VersaPharm acquisition as of the closing date was 11.4 years in aggregate, 11.4 years for product licensing rights, 11.0 years for other intangibles, and 3 years for trademarks.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Hi-Tech Pharmacal Co., Inc.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 17, 2014, the Company completed its acquisition of Hi-Tech for a total purchase price of approximately $650.0 million. This purchase price was based on acquiring all outstanding shares of Hi-Tech common stock for $43.50 per share, buying out the intrinsic value of Hi-Tech&#8217;s stock options, and paying the single-trigger separation payments to various Hi-Tech executives due upon change in control. The total consideration paid is net of Hi-Tech&#8217;s cash acquired subsequent to Hi-Tech&#8217;s payment of $44.6 million of stock options and single trigger separation payments as of April 17, 2014.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 27, 2013, the Company entered into an Agreement and Plan of Merger (the &#8220;HT Merger Agreement&#8221;) to acquire Hi-Tech. Subject to the terms and conditions of the HT Merger Agreement, upon completion of the merger on April 17, 2014, each share of Hi-Tech&#8217;s common stock, par value $0.01 per share, issued and outstanding and held by non-interested parties at the time of the merger (the &#8220;Hi-Tech Shares&#8221;), was cancelled and converted into the right to receive $43.50 in cash, without interest, less any applicable withholding taxes, upon surrender of the outstanding Hi-Tech Shares.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the Hi-Tech Acquisition, the Company entered into an agreement (the &#8220;Divestment Agreement&#8221;) with Watson Laboratories, Inc., a wholly owned subsidiary of Actavis plc, to divest certain rights and assets - see below for further consideration.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Hi-Tech is a specialty pharmaceutical company which develops, manufactures and markets generic and branded prescription and OTC products. Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gel products. Hi-Tech&#8217;s Health Care Products division is a developer and marketer of OTC products, and their ECR Pharmaceuticals subsidiary markets branded prescription products. Hi-Tech operates a manufacturing facility and corporate offices in Amityville, New York, and ECR maintains its corporate offices in Richmond, Virginia.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Hi-Tech Acquisition is expected to complement and expand the Company&#8217;s product portfolio by diversifying its offering to its retail customers beyond ophthalmics to other niche dosage forms such as oral liquids, topical creams and ointments, nasal sprays and otics. The Hi-Tech Acquisition is also expected to enhance the Company&#8217;s new product pipeline. Further, the Hi-Tech Acquisition will add branded OTC products in the categories of cough and cold, nasals, and topicals to the Company&#8217;s existing TheraTears<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> brand of eye care products, and will provide additional domestic manufacturing capacity for the Company.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Hi-Tech Acquisition was principally funded through a $600.0 million term loan entered into concurrent with completing the acquisition, and through Hi-Tech cash assumed through the acquisition.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended December 31, 2014,and 2013 the Company recorded approximately $21.3 million and $1.6 million, respectively, in acquisition-related expenses in connection with the Hi-Tech Acquisition. These expenses principally consisted of various legal fees and other acquisition costs which have been recorded within &#8220;acquisition related costs&#8221; as part of operating expenses in the Company&#8217;s consolidated statement of comprehensive income in the applicable periods.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the consideration paid for the Hi-Tech Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.&#160;&#160;The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of Hi-Tech.</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consideration:</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Measurement</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Period</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to Hi-Tech shareholders</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">605.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">605.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to vested Hi-Tech option holders</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to key executives under <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">single-trigger separation payments upon change-in-control</font></font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recognized amounts of identifiable assets acquired and liabilities assumed:</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial Fair Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Measurement Period Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted Fair Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">343.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">343.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer Relationships</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">171.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">169.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other non-current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets acquired</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">797.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">800.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(23.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed non-current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(121.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(126.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total liabilities assumed</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(148.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(150.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The changes in estimates recorded subsequent to the initial accounting estimate was related to refining the calculated fair value of acquired accounts receivable and assumed tax amounts, due to the merger.</font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Goodwill represents expected synergies resulting from the combination of the entities and other intangible assets that do not qualify for separate recognition, while IPR&amp;D assets represent ongoing in-process research and development projects obtained through the acquisition. The Company does not anticipate being able to deduct any of the associated incremental value of goodwill and other intangible assets for income tax purposes, but expects to be able to deduct approximately $18.9 million of value associated with pre-existing Hi-Tech goodwill and other intangible assets for income tax purposes in future periods.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended December 31, 2014, the Company recorded net revenue of approximately $176.9 million related to sales of the Hi-Tech products subsequent to acquisition.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Weighted average amortization period of intangible assets acquired other than goodwill and IPR&amp;D through the Hi-Tech acquisitions as of the closing date was 15.6 years in aggregate, 15.7 years for product licensing rights, 1 year for customer relationships and 9 years for trademarks.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Watson Product Disposition</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">In connection with the Hi-Tech Merger, Akorn entered into an agreement (the &#8220;Disposition Agreement&#8221;) with Watson to dispose of certain rights and assets related to three Hi-Tech products marketed under Abbreviated New Drug Applications &#8212; Ciprofloxacin Hydrochloride Ophthalmic Solution, Levofloxacin Ophthalmic Solution and Lidocaine Hydrochloride Jelly &#8212; and one Akorn product marketed under a New Drug Application: Lidocaine/Prilocaine Topical Cream, collectively &#8220;the products&#8221;. The Divestment Agreement further included one product under development. Net revenues for the Akorn products marketed under a New Drug Application: Lidocaine/Prilocaine Topical Cream were approximately $1.5 million and $6.8 million in the years ended December 31, 2014 and 2013, respectively. This disposition was required pursuant to a proposed consent order accepted by vote of the FTC on April 11, 2014. The closing of the disposition agreement, which was contingent upon the consummation of the Company&#8217;s acquisition of 50% or more of the voting securities of Hi-Tech, took place on April 17, 2014. Under the terms of the disposition the Company received $16.8 million for the intangible product rights, associated goodwill, and saleable inventory of the products denoted above. The Company recorded a gain of $9.0 million in</font> <font style="BACKGROUND-COLOR: #ffffff; FONT-STYLE: italic; DISPLAY: inline">Other (expense) income, net</font> <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">in the year ended December 31, 2014, resulting from the difference of the consideration received and assets disposed, see below.</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Calculation of gain from Watson product disposition (in millions)</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consideration received</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16.8</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intangible assets disposed</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5.9</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill disposed</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.1</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets disposed</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.8</font> </div> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-Tax gain recognized</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.0</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon completing the Watson product disposition, the Company entered into a master supply agreement with Watson whereby the Company will continue manufacturing the products for a transitional period not to exceed two years. The parties also entered into a transition services agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to Watson.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ECR Divestiture</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 20, 2014, the Company divested its subsidiary, ECR Pharmaceuticals, net of three branded products (specifically Cormax<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, VoSol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> HC, and Zolvit<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> Oral Solution otherwise known as &#8220;Lortab&#8221;) to Valeant Pharmaceuticals (&#8220;Valeant&#8221;) for $41.0 million in cash and assumption of certain liabilities. Through the divestiture, the Company recognized a nominal gain on the sale of the intangible product rights, associated goodwill, saleable inventory and other assets of ECR. ECR, which promotes certain branded pharmaceuticals through its sales force, was acquired through the acquisition of Hi-Tech. As the Company has divested a component of the combined entity and does not expect material continuing cash flows, ECR results which included net revenues of $3.4 million and a net loss from discontinued operations of ($0.5) million for the period from acquisition to disposition (which both occurred during the year ended December 31, 2014) have been included within <font style="FONT-STYLE: italic; DISPLAY: inline">discontinued operations</font> in the consolidated statements of comprehensive income, see below.</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Calculation of gain/from ECR Divestiture (in millions)</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consideration received</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41.0</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intangible assets divested</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(33.6</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill divested</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10.4</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets divested</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.2</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed liabilities divested</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.1</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-Tax Gain recognized</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.9</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Zioptan Acquisition</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 1, 2014, the Company acquired the U.S. NDA rights to Zioptan<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, a prescription ophthalmic eye drop indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, from Merck, Sharp and Dohme Corp. (&#8220;Merck&#8221;). The Company&#8217;s acquisition of U.S. NDA rights to Zioptan<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> (the &#8220;Zioptan Acquisition&#8221;) is being accounted for as a business combination in accordance with ASC 805 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations</font>. The purpose of the Zioptan Acquisition is to expand the Company&#8217;s product portfolio of prescription pharmaceuticals. The total consideration at closing was $11.2 million, all of which was recognized as product licensing rights as of the acquisition date and has an amortization period of 10 years.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon completing the Zioptan Acquisition, the Company entered into a master supply agreement with Merck whereby Merck will continue manufacturing Zioptan<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> for a transitional period not to exceed two years, during which time the Company will work to transfer manufacturing. The transfer price, per the terms of the supply agreement, will equal Merck&#8217;s historical product cost. The parties also entered into a Transition Services Agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to the Company.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The U.S. NDA rights to Zioptan<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> are included within product licensing rights, net on the Company&#8217;s consolidated balance sheet as of December 31, 2014.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has not provided pro forma revenue and earnings of the Company as if the Zioptan Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Zioptan<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> rights were not managed as a discrete business by Merck. Accordingly, determining the pro forma revenue and earnings of the Company including the Zioptan Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Betimol Acquisition</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 2, 2014, the Company acquired the NDA rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, a prescription ophthalmic eye drop for the reduction of eye pressure in glaucoma patients, from Santen. The Company&#8217;s acquisition of U.S. NDA rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> (the &#8220;Betimol Acquisition&#8221;) is being accounted for as a business combination in accordance with ASC 805 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations</font>. The purpose of the Betimol Acquisition is to expand the Company&#8217;s product portfolio of prescription pharmaceuticals. The total consideration will be equal to 1.5 times the Company&#8217;s net sales of Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> in the first year following acquisition, such year starting upon the Company&#8217;s first sale of the product. The Company paid $7.5 million upon completing the acquisition and will pay any remaining amount 60 days following the first year post-acquisition. There is also a provision for a $2.0 million increase to the total consideration should net sales of Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> exceed $14.0 million in any one of the first five years following acquisition, the Company has valued this at $0. There is no provision for reducing the purchase price below the initial $7.5 million paid.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon completing the Betimol Acquisition, the Company entered into a supply agreement with Santen whereby Santen will continue manufacturing Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> for a transitional period not to exceed two years, during which time the Company will work to site transfer manufacturing to one of its facilities. The transfer price, per the terms of the supply agreement, will equal Santen&#8217;s cost of API plus actual cost of manufacturing the product, making this a favorable contract pursuant to ASC 805. The parties also entered into a transition services agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to the Company.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the consideration paid for the Betimol Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Betimol Acquisition:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consideration paid in cash at closing</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.5</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase consideration payable</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.0</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.5</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of acquired assets:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">U.S. NDA rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font></font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.4</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Favorable supply agreement</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.5</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The U.S. NDA rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> are included within product licensing rights, net on the Company&#8217;s consolidated balance sheet as of December 31, 2014 and has an amortization period of 15 years. The favorable supply agreement is included within other long-term assets on the Company&#8217;s consolidated balance sheet as of December 31, 2014.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company estimated that it would owe additional consideration to Santen of approximately $4.5 million. Since this is a performance-based earn-out payment, this additional consideration was discounted to approximately $4.0 million. As of the year ended December 31, 2014, the Company revised the additional consideration calculation to $4.3 million and <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">recorded $0.3 million of other operating expense reflecting a fair value adjustment to increase the estimated additional consideration obligation as a result of revised operating expectations.</font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has not provided pro forma revenue and earnings of the Company as if the Betimol Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> rights were not managed as a discrete business by Santen. Accordingly, determining the pro forma revenue and earnings of the Company including the Betimol Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Merck Products Acquisition</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 15, 2013, the Company acquired from Merck the U.S. rights to three branded ophthalmic products for $52.8 million in cash (the &#8220;Merck Acquisition&#8221;). The acquired assets met the definition of a business, and accordingly, have been accounted for as a business combination in accordance with ASC 805 &#8211; <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations</font>. Through the Merck Acquisition, the Company purchased Inspire Pharmaceuticals, Inc. (&#8220;Inspire&#8221;), a wholly owned subsidiary of Merck. This legal entity owns the U.S. rights to AzaSite<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, a prescription eye drop used to treat bacterial conjunctivitis. The U.S. rights to the other two products involved in the acquisition, Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> and Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> PF (preservative free), were purchased directly from Merck. The Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> products are prescription sterile eye drop solutions used to lower the pressure in the eye in people with open-angle glaucoma or ocular hypertension. The acquisition of these products expands the Company&#8217;s ophthalmic product portfolio to include branded, prescription eye drops, and is complementary to the Company&#8217;s existing portfolio of products. The Company believes that this acquisition leverages its existing sales force and ophthalmic and optometric physician relationships.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the consideration paid for the Merck Acquisition and the fair values of the assets acquired and the liabilities assumed (in millions):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product rights:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">AzaSite<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font></font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13.8</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font></font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21.6</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> PF</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.3</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product rights total</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55.7</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets, net</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total fair value of acquired assets</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56.5</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consideration paid</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.8</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain from bargain purchase</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.7</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through its acquisition of Inspire Pharmaceuticals, Inc. the Company assumed that entity&#8217;s net operating loss carry-forwards (&#8220;NOLs&#8221;) and unamortized start-up costs. The &#8220;deferred tax assets, net&#8221; listed above represents the difference between the acquired deferred tax assets, the NOLs, and unamortized start-up costs, and the acquired deferred tax liabilities, which represent the book versus tax basis differences in the product rights. The bargain purchase amount was largely derived from the difference between the fair value and the economic value, as calculated through discounted cash flow analysis, of the deferred tax assets, net. In particular, due to the long-term nature of the NOLs acquired, the book value of the resulting deferred tax asset significantly exceeded its discounted cash flow value.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company anticipates amortizing the acquired products on a straight-line basis from the Merck Acquisition date through December 31, 2019. The Merck Acquisition agreement specified the tax values assigned to each product. The tax value of AzaSite<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> product rights will not be amortizable for tax purposes, as these rights were obtained through the stock acquisition of Inspire Pharmaceuticals, Inc. That Company anticipates that the assigned tax values of Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> and Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> PF will be amortizable for tax purposes over a 15-year period.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has not provided pro forma revenue and earnings of the Company as if the Merck Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The products acquired from Merck were not managed as a discrete business by Merck. Accordingly, determining the pro forma revenue and earnings of the Company including the Merck Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Kilitch Acquisition</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 28, 2012, Akorn India Private Limited, a wholly owned subsidiary of the Company completed and closed on its acquisition of selected assets of Kilitch Drugs (India) Limited (&#8220;KDIL&#8221;).&#160;&#160;This acquisition (the &#8220;Kilitch Acquisition&#8221;) was pursuant to the terms of the Business Transfer Agreement (the &#8220;BTA&#8221;) entered into among the Company, KDIL and the members of the promoter group of KDIL on October 5, 2011.&#160;&#160;In accordance with terms contained in the BTA, the Company also closed on a related product transfer agreement between the Company and NBZ Pharma Limited (&#8220;NBZ&#8221;), a company associated with KDIL.&#160;&#160;The primary asset transferred in the Kilitch Acquisition was KDIL&#8217;s manufacturing facility in Paonta Sahib, Himachal Pradesh, India, along with its existing contract manufacturing business.&#160;&#160;KDIL was engaged in the manufacture and sale of pharmaceutical products for contract customers in India and for export to various unregulated world markets.&#160;&#160;While the Paonta Sahib manufacturing facility is not currently certified by the FDA for the exporting of drugs to the U.S., the facility was designed with future FDA certification in mind.&#160;&#160;Accordingly, the Kilitch Acquisition provided the Company with the potential for future expansion of its manufacturing capacity for products to be sold in the U.S., as well as the opportunity to expand the Company&#8217;s footprint into markets outside the U.S.&#160;&#160;The Company has determined that the assets acquired through the Kilitch Acquisition constitute a &#8220;business&#8221; as defined by Rule 11-01(d) of Regulation S-X and ASC 805, <font style="FONT-STYLE: italic; DISPLAY: inline">Business Combinations</font>.&#160;&#160;Accordingly, the Company has accounted for the Kilitch Acquisition as a business combination.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AIPL paid the equivalent of approximately USD $60.1 million at closing.&#160;&#160;Total purchase consideration was approximately $55.2 million which consisted of approximately $51.2 million in base consideration and $4.0 million in reimbursement for capital expenditures made by KDIL from April 1, 2011 to the closing date.&#160;&#160;AIPL also paid $7.3 million related to compensation earned from the achievement of acquisition-related milestones, and $1.6 million in stamp duties paid to transfer title to the land and buildings at Paonta Sahib from Kilitch to AIPL.&#160; In addition, the Company expects to pay up to an additional $0.5 million for future services that would be expensed as the services are provided.&#160;&#160;The compensation for acquisition-related milestones and other acquisition costs have been recorded within &#8220;acquisition related costs&#8221; as part of operating expenses in the Company&#8217;s consolidated statement of comprehensive income.&#160;&#160;The BTA also contains a working capital guarantee that calls for KDIL or AIPL to reimburse the other party for any shortfall or excess, respectively, in the actual acquired working capital compared to the target working capital as established in the BTA.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the consideration paid for the Kilitch Acquisition, the acquisition-related costs incurred, and the fair values of the assets acquired and the liabilities assumed (U.S. dollar amounts in millions):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Consideration:</font></font> </div> </td> <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Measurement Period Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less working capital shortfall refunded by sellers</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Acquisition-related costs:</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stamp duties paid for transfer of land and buildings</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisition-related compensation expense</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Due diligence, legal, travel and other acquisition-related costs</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" colspan="4" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Recognized amounts of identifiable assets acquired and liabilities assumed:</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Land</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Buildings, plant and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Construction in progress</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill, deductible</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangible assets, deductible</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Adjusted Fair Valuation presented above is final.&#160;&#160;The changes in estimate recorded subsequent to the initial accounting estimate were primarily related to refining the calculated fair value of certain acquired assets, adjustments to the working capital settlement amount due from the sellers to the Company, and final determination regarding the tax-deductibility of the acquired intangible assets.&#160;&#160;The acquisition-related compensation expense during 2012 was primarily related to pre-negotiated compensation paid to members of the sellers&#8217; family based on achievement of various operational milestones.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Goodwill represents expected synergies and intangible assets that do not qualify for separate recognition.&#160;&#160;Based on an Indian Supreme Court ruling in 2012 upholding the deductibility of goodwill for India tax purposes, the Company anticipates being able to deduct the value of goodwill for income tax purposes in India.&#160;&#160;A later Indian Supreme Court ruling raised doubt as to the tax deductibility of the cost of the non-compete agreement entered into between AIPL and the sellers.&#160;&#160;Accordingly, the Company amended its acquisition accounting to establish a deferred tax liability related to this intangible asset. The Company had initially recorded a deferred tax liability valued at $1.4 million and subsequently adjusted to $0.7 million related to intangible assets and other accrued liabilities that it does not believe will be amortizable for Indian tax purposes.&#160; This remaining deferred tax liability of $0.7 million was reversed against goodwill during 2012.&#160;&#160;</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For book purposes, the other intangible assets acquired are being amortized over lives of four to five years.&#160;Goodwill is not amortized for book purposes but is subject to impairment testing.&#160;&#160;The tangible assets acquired consist primarily of construction in progress fair valued at $14.2 million, buildings, plant and equipment fair valued at a combined $8.5 million, land fair valued at $2.6 million, accounts receivable fair valued at $2.1 million and inventory fair valued at $1.8 million as of the acquisition date.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During 2014, 2013 and 2012, the Company paid $2.8 million, $2.7 million and $0.8 million, respectively, for the acquisition of drug product licensing rights (NDA and ANDA rights) which were not individually significant. No assets were acquired other than the drug rights, and no liabilities assumed.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The unaudited pro forma results presented below reflect the consolidated results of operations inclusive of the Xopenex acquisition, VersaPharm acquisition and Akorn Rifampin product divestiture (&#8220;VersaPharm transactions&#8221;), and the Hi-Tech acquisition, Watson product disposition and ECR divestiture (&#8220;Hi-Tech transactions&#8221;) which occurred during the year ended December 31, 2014, as if the transactions had taken place at the beginning of the earliest period presented below. The pro forma results include amortization associated with the acquired tangible and intangible assets, interest on debt incurred for the transactions, amortization of inventory step-up, acquisition related expenses and income tax expense affected for the pro forma results. The unaudited pro forma financial information presented below does not reflect the impact of any actual or anticipated synergies expected to result from the acquisitions. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations as they would have been had the transactions been effected on the assumed date (amounts in thousands, except per share data):</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Year Ended</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">733,012</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">623,922</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income from continuing operations</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71,722</font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,891</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income from continuing operations per share</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.58</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other Strategic Investments</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">On August 1, 2011, the Company entered into a Series A-2 Preferred Stock Purchase Agreement to acquire a minority ownership interest in Aciex Therapeutics Inc. (&#8220;Aciex&#8221;), a private ophthalmic development pharmaceutical company based in Westborough, MA, for $8.0 million in cash. Subsequently, on September 30, 2011, the Company entered into Amendment No. 1 to Series A-2 Preferred Stock Purchase Agreement to acquire additional shares of Series A-2 Preferred Stock in Aciex for approximately $2.0 million in cash. On April 17, 2014, the Company entered into a secured note and warrant purchase agreement to acquire secured, convertible promissory notes of Aciex for approximately $0.4 million in cash. On June 27, 2014, the Company entered into a second secured note and warrant purchase agreement to acquire additional secured, convertible promissory notes of Aciex for an additional amount of approximately $0.4 million. The Company&#8217;s aggregate investment in Aciex was $10.8 million at cost. Aciex was an ophthalmic drug development company focused on developing novel therapeutics to treat ocular diseases. Aciex&#8217;s pipeline consisted of both clinical stage assets and pre-Investigational new drug stage assets. The investments detailed above had provided the Company with an ownership interest in Aciex of below 20%. The Aciex Agreement and Aciex Amendment contained certain customary rights and preferences over the common stock of Aciex and further provided that the Company shall have had the right to a seat on the Aciex board of directors.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">On July 2, 2014 Nicox S.A., (&#8220;Nicox&#8221;) an international Company entered into an arrangement to acquire all of the outstanding equity of Aciex (the &#8220;Aciex Acquisition&#8221;).</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">On October 22, 2014 Nicox shareholders voted at the Nicox General Meeting, to approve the Aciex Acquisition. The transaction was consummated on October 24, 2014, following the completion of certain legal conditions and formalities. As consideration for its carried investment in Aciex, the Company received from the Aciex Acquisition pro-rata shares of Nicox which are publically traded on the Euronext Paris exchange. Through the closing the Company received approximately 4.3 million shares of Nicox which were subject to</font> certain lockup provisions preventing immediate sale of underlying shares received for the Company&#8217;s investment in an available for sale security.</font></font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">Through the year ended December 31, 2014 the Company sold 0.2 million unrestricted shares for approximately $0.6 million realizing an immaterial gain on the sale of shares.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC Topic 820, t<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">he Company records unrealized holding gains and losses on the remaining</font> available for sale <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">securities in the &#8220;Accumulated other comprehensive income&#8221; caption in the consolidated Balance Sheet. For the year ended December 31, 2014 the Company recognized an unrealized holding loss, net of tax of $1.1 million as calculated based on the discounted value of the investment given the contractual lockup provisions. The Company has determined that of the remaining $8.4 million of unrealized fair value associated with the investment, $7.2 million is expected to be converted to cash within 1 year from the balance sheet date and has been classified as a current asset, while $1.2 million is expected to be converted beyond one year and has been classified as a non-current asset.</font></font> </div><br/> 21700000 25900000 300000 16100000 2000000 1900000 0.045 P10Y255D 45000000 41500000 P10Y 700000 433000000 440000000 7000000 1000000 800000 445000000 8100000 43200000 21700000 P11Y146D P11Y146D P11Y P3Y 650000000 43.50 44600000 0.01 43.50 600000000 21300000 1600000 18900000 176900000 P15Y219D P15Y255D P1Y P9Y 3 1 1 1500000 6800000 0.50 16800000 9000000 P2Y 3 41000000 3400000 -500000 11200000 P10Y P2Y 7500000 P60D 2000000 14000000 P1Y P5Y 0 P2Y P15Y 4500000 4000000 300000 3 52800000 2 P15Y 60100000 55200000 51200000 4000000 7300000 1600000 500000 1400000 700000 700000 P4Y P5Y 14200000 8500000 2600000 2100000 1800000 2800000 2700000 800000 8000000 2000000 400000 400000 10800000 0.20 4300000 200000 600000 1100000 8400000 7200000 P1Y 1200000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Consideration:</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16.1</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of contingent payment</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.9</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consideration at closing</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18.0</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Recognized amounts of identifiable assets acquired:</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.5</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.0</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.5</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable assumed</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1)</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of assets acquired</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18.0</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 1900000 18000000 100000 2500000 10000000 5500000 -100000 18000000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Consideration:</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41.5</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product returns and reserves assumed</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.5</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consideration at closing</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45.0</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Recognized amounts of identifiable assets acquired:</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="top" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts Receivable, net (product returns and reserves assumed)</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3.5)</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.3</font> </div> </td> <td valign="top" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38.7</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of net assets acquired</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </div> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41.5</font> </div> </td> <td valign="top" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 41500000 3500000 45000000 -3500000 6300000 38700000 41500000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consideration:</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Measurement</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Period</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to VersaPharm stockholders</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">322.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">322.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to vested VersaPharm option holders</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts paid to escrow accounts</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transaction expenses paid for previous owners of VersaPharm</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total consideration paid at closing</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">VersaPharm debt paid off through closing cash</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total cash paid at closing</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">433.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">433.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recognized amounts of identifiable assets acquired and liabilities assumed:</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.8</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.6</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intangibles, other</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">215.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">215.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">91.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets acquired</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">598.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.4</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">605.2</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed non-current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(76.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(76.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(153.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5.8</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159.7</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total liabilities assumed</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(248.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.4</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">254.6</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consideration:</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Measurement</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Period</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to Hi-Tech shareholders</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">605.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">605.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to vested Hi-Tech option holders</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount of cash paid to key executives under <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">single-trigger separation payments upon change-in-control</font></font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recognized amounts of identifiable assets acquired and liabilities assumed:</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial Fair Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Measurement Period Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted Fair Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product licensing rights</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">343.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">343.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">IPR&amp;D</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer Relationships</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">171.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">169.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other non-current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets acquired</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">797.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">800.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(23.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed non-current liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(121.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(126.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total liabilities assumed</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(148.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(150.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Consideration:</font></font> </div> </td> <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Measurement Period Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted Fair</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less working capital shortfall refunded by sellers</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Acquisition-related costs:</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stamp duties paid for transfer of land and buildings</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acquisition-related compensation expense</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Due diligence, legal, travel and other acquisition-related costs</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" colspan="4" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Recognized amounts of identifiable assets acquired and liabilities assumed:</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventory</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Land</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Buildings, plant and equipment</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.5</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Construction in progress</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill, deductible</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangible assets, deductible</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.8</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.5pt; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54.3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 322700000 322700000 14200000 14200000 10300000 10300000 3400000 3400000 350600000 350600000 82400000 82400000 433000000 433000000 100000 100000 10000000 1000000 11000000 20900000 -200000 20700000 2800000 4800000 7600000 1500000 1500000 1000000 1000000 250800000 250800000 5200000 5200000 215900000 215900000 90600000 800000 91400000 598800000 6400000 605200000 18300000 600000 18900000 76000000 76000000 153900000 5800000 159700000 248200000 6400000 254600000 350600000 350600000 605000000 605000000 40500000 40500000 4100000 4100000 649600000 649600000 89700000 89700000 57300000 -5700000 51600000 53700000 -700000 53000000 20600000 13100000 33700000 45500000 -2000000 43500000 343500000 343500000 9400000 9400000 300000 300000 5500000 5500000 171500000 -2000000 169500000 600000 600000 797800000 2700000 800500000 23500000 -1700000 21800000 2800000 200000 3000000 121900000 4200000 126100000 148200000 2700000 150900000 649600000 649600000 55200000 55200000 -900000 -100000 -1000000 54300000 -100000 54200000 1600000 1600000 6700000 500000 7200000 600000 100000 700000 8900000 600000 9500000 2100000 2100000 1800000 1800000 3700000 -1100000 2600000 8500000 8500000 14200000 14200000 21600000 1000000 22600000 5800000 100000 5900000 100000 100000 2100000 800000 2900000 1400000 -700000 700000 54300000 -100000 54200000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Calculation of gain from Watson product disposition (in millions)</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consideration received</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16.8</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intangible assets disposed</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5.9</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill disposed</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.1</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1pt"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets disposed</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.8</font> </div> </td> <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-Tax gain recognized</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.0</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Calculation of gain/from ECR Divestiture (in millions)</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consideration received</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41.0</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intangible assets divested</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(33.6</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill divested</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10.4</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets divested</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.2</font> </div> </td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </div> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assumed liabilities divested</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.1</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pre-Tax Gain recognized</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.9</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 16800000 5900000 1100000 800000 9000000 41000000 33600000 10400000 1200000 5100000 900000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Betimol Acquisition:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consideration paid in cash at closing</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.5</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase consideration payable</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.0</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="90%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.5</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of acquired assets:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">U.S. NDA rights to Betimol<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font></font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.4</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Favorable supply agreement</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="90%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.5</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 7500000 4000000 11500000 11400000 100000 11500000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product rights:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">AzaSite<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font></font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13.8</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font></font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21.6</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cosopt<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font> PF</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.3</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product rights total</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55.7</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.1</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 1px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets, net</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 1px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1px solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.7</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total fair value of acquired assets</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56.5</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consideration paid</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.8</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain from bargain purchase</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.7</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 13800000 21600000 20300000 55700000 100000 700000 56500000 52800000 3700000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Year Ended</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">733,012</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">623,922</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income from continuing operations</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71,722</font></font></font> </div> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,891</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net income from continuing operations per share</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.58</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 733012000 623922000 71722000 4891000 0.58 0.04 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 17 &#8212; Unconsolidated Joint Venture</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company was a 50% partner in a joint venture agreement with an Indian drug development company since September 2004.&#160;&#160;This joint venture launched its first product in 2008 and generated revenue from 2008 until its business assets were sold and transferred.&#160;&#160;While the joint venture still exists legally, it ceased operations upon the completion of the sale and transfer of its operating assets to Pfizer, Inc. in the second quarter of 2011. No operations have occurred since the sale, but the net income recorded in the year ended December 31, 2013 was primarily related to adjustments to the joint venture Company&#8217;s reserves for product returns upon expiration of the period for which product returns could be made.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following tables sets forth condensed statements of income for the three years ended December 31, 2014, 2013 and 2012 and the condensed balance sheets as of December 31, 2014 and 2013 for Akorn-Strides, LLC, along with information regarding the amount of earnings allocated to each member-partner of the LLC (in thousands):</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td colspan="12" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED STATEMENTS OF INCOME (Unaudited)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REVENUES</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">163</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cost of sales</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GROSS PROFIT</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">164</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OPERATING INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain from Pfizer ANDA Sale</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INCOME BEFORE INCOME TAXES</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax (benefit) / provision</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NET INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td colspan="8" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED BALANCE SHEETS (Unaudited)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ASSETS</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOTAL ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">LIABILITIES &amp; MEMBERS&#8217; EQUITY</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts payable &amp; other accrued liabilities</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">TOTAL LIABILITIES</font></font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Members&#8217; equity</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOTAL LIABILITIES &amp; MEMBERS&#8217; EQUITY</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2014, no future product returns are expected.</font> </div><br/> 0.50 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td colspan="12" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED STATEMENTS OF INCOME (Unaudited)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REVENUES</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">163</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cost of sales</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GROSS PROFIT</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">164</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OPERATING INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain from Pfizer ANDA Sale</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INCOME BEFORE INCOME TAXES</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax (benefit) / provision</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NET INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 163000 -1000 164000 3000 161000 161000 161000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td colspan="8" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED BALANCE SHEETS (Unaudited)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ASSETS</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOTAL ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">LIABILITIES &amp; MEMBERS&#8217; EQUITY</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts payable &amp; other accrued liabilities</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">TOTAL LIABILITIES</font></font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 0.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Members&#8217; equity</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 1.5pt"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOTAL LIABILITIES &amp; MEMBERS&#8217; EQUITY</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 1.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 25000 25000 1000 1000 26000 26000 26000 26000 26000 26000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 18 &#8212; Customer, Supplier and Product Concentration</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Customer Concentration</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2014, 2013 and 2012, a significant portion of the Company&#8217;s gross and net sales reported were through three large wholesale drug distributors, and a significant portion of&#160;&#160;the Company&#8217;s accounts receivable as of December 31, 2014, 2013 and 2012 were due from these wholesale drug distributors as well. AmerisourceBergen Health Corporation (&#8220;Amerisource&#8221;), Cardinal Health, Inc. (&#8220;Cardinal&#8221;) and McKesson Drug Company (&#8220;McKesson&#8221;) are all distributors of the Company&#8217;s products, as well as suppliers of a broad range of health care products.&#160;&#160;Aside from these three wholesale drug distributors, no other customers accounted for more than 10% of gross sales, net revenues or gross trade receivables for the indicated dates and periods.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the percentage of the Company&#8217;s gross and net sales and gross accounts receivable attributable to these three distributors for the periods indicated:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Sales</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenue</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Accounts</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Receivable</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Sales</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenue</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Accounts</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Receivable</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Sales</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-89" style="MARGIN-LEFT: 3.7pt"></font>Net</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenue</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Accounts</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Receivable</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 2.9pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amerisource</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 2.9pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cardinal</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 2.9pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">McKesson</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">23</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">19</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">23</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">16</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">11</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">12</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">16</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">11</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">14</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 2.9pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If sales to Amerisource, Cardinal or McKesson were to diminish or cease, the Company believes that the end users of its products would find little difficulty obtaining the Company&#8217;s products either directly from the Company or from another distributor.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplier Concentration</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company requires a supply of quality raw materials and components to manufacture and package pharmaceutical products for its own use and for third parties with which it has contracted. The principal components of the Company&#8217;s products are active and inactive pharmaceutical ingredients and certain packaging materials. Many of these components are available from only a single source and, in the case of many of the Company&#8217;s ANDAs and NDAs, only one supplier of raw materials has been identified. Because FDA approval of drugs requires manufacturers to specify their proposed suppliers of active ingredients and certain packaging materials in their applications, FDA approval of any new supplier would be required if active ingredients or such packaging materials were no longer available from the specified supplier. The qualification of a new supplier could delay the Company&#8217;s development and marketing efforts. If for any reason the Company is unable to obtain sufficient quantities of any of the raw materials or components required to produce and package its products, it may not be able to manufacture its products as planned, which could have a material adverse effect on the Company&#8217;s business, financial condition and results of operations.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">No individual supplier represented 10% or more of the Company&#8217;s purchases in any of the years ended December 31, 2014, 2013 or 2012.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Product Concentration</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended December 31, 2014 none of the Company&#8217;s products represented 10% or more of net revenue, while in the years ended December 31, 2013 and 2012, one of the Company&#8217;s prescription pharmaceutical products represented 11.8% and 12.5% of the Company&#8217;s total net revenue, respectively while no other products represented 10% or more of the Company&#8217;s net revenue.&#160;&#160;The Company attempts to minimize the risk associated with product concentrations by continuing to acquire and develop new products to add to its portfolio.</font> </div><br/> 3 3 3 0.118 0.125 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 0.5pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Sales</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenue</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Accounts</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Receivable</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Sales</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenue</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Accounts</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Receivable</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Sales</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-89" style="MARGIN-LEFT: 3.7pt"></font>Net</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenue</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Accounts</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Receivable</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 2.9pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amerisource</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 2.9pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cardinal</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 2.9pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">McKesson</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">23</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">19</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">23</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">16</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">11</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">12</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">16</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">11</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">14</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 2.9pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> </table> 0.38 0.28 0.46 0.19 0.14 0.25 0.19 0.14 0.29 0.16 0.14 0.17 0.23 0.16 0.26 0.23 0.17 0.30 0.23 0.19 0.23 0.16 0.11 0.12 0.16 0.11 0.14 0.77 0.61 0.86 0.58 0.41 0.63 0.58 0.42 0.73 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 19 &#8212; Related Party Transactions</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the recent past, the Company engaged in various related party transactions with John N. Kapoor, Ph.D., Chairman of the Company&#8217;s Board of Directors and a significant holder of the Company&#8217;s common stock.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 3, 2010, the Company entered into an 8-year agreement with EJ Financial for their sub-lease of a portion of the Company&#8217;s corporate offices in Lake Forest, Illinois.&#160;&#160;This sub-lease commenced on April 1, 2010.&#160;&#160;Subsequently, the Company and EJ Financial agreed to early terminate this agreement, and accordingly the sub-lease was terminated in July 2012.&#160;&#160;EJ Financial paid the Company a total of approximately $240,000 in rent and common area maintenance fees over the shortened term of this sub-lease.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the various modifications agreed to during 2009 to the EJ Funds credit facility and the Subordinated Note, the Company issued various stock warrants to Dr. Kapoor.&#160;&#160;See Note 2, <font style="FONT-STYLE: italic; DISPLAY: inline">Summary of Significant Accounting Policies</font>, for information about the Kapoor Warrants.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the years ended December 31, 2014, 2013 and 2012 the Company obtained legal services totaling $1.9 million, $0.7 million and $0.5 million, respectively, of which $0.2 million was payable as of December 31, 2014 and 2013 from Polsinelli PC (formerly Polsinelli Shughart PC), a law firm for which the spouse of the Company&#8217;s Senior Vice President, General Counsel and Secretary is an attorney and shareholder.</font> </div><br/> P8Y 240000 1900000 700000 500000 200000 200000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 20 &#8212; Severance Charges</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subsequent to the closing of the various mergers and acquisitions transacted through the years ended December 31, 2014 and 2013, the Company entered into severance agreements promising associated payments; and as such, severance expense was recognized related to these agreements. As of December 31, 2014 and 2013, the accrued severance balances were insignificant, equaling less than $0.1 million in each year.</font> </div><br/> 100000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 21 &#8211; Selected Quarterly Financial Data (Unaudited)</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" colspan="10" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Income (Loss) From Continuing Operations</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Net Income (Loss)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In thousands, except per share amounts)</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Revenues</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Profit</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Operating</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Income (Loss)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Amount</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Per Basic</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Share</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Per Diluted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Share</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Amount</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Per Basic</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Share</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Per Diluted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Share</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year Ended December 31, 2014:</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4th Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">227,828</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">128,382</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71,907</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,232</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.32</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.29</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,232</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.32</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.29</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3rd Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">132,732</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,734</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,042</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,650</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,650</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="19%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2nd Quarter (as restated)</font></font> </div> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">141,896</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,818</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,410</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,438</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,935</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.02</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1st Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,622</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49,656</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,440</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,828</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,828</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year Ended December 31, 2013:</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4th Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">84,953</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,970</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,176</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,678</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,678</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3rd Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">81,892</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,697</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,188</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,205</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,205</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2nd Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77,012</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,092</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,251</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,637</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,637</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1st Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,145</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,589</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,842</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-90" style="MARGIN-LEFT: 5pt"></font>0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-91" style="MARGIN-LEFT: 5pt"></font>0.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,842</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 17, 2015, the Company issued a press release announcing that the Audit Committee of the Company&#8217;s Board of Directors, upon the recommendation of management, concluded that the previously issued financial statements contained in the Company&#8217;s Quarterly Reports on Form 10-Q for the periods ended June 30, 2014 and September 30, 2014 should not be relied upon because of an error in the financial statements as of and for the three and six month periods ended June 30, 2014 and as of and for the nine month period ended September 30, 2014, and that those financial statements would be restated to make the necessary accounting adjustments.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 17, 2014, the Company completed its acquisition of Hi-Tech for a total purchase price of approximately $650.0 million. During the 2014 year-end audit process, an error was identified in the fair value allocation of assets acquired and liabilities assumed in connection with the acquisition of Hi-Tech, which resulted in an overstated chargeback reserve as of April 17, 2014. The error, which was identified on March 11, 2015, resulted from an overstatement of Hi-Tech&#8217;s chargeback reserve in connection with applying the acquisition method of accounting at the closing of the Hi-Tech acquisition.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The overstatement in the chargeback reserve was caused by a manual error made in preparing the data whereby there was a duplication of inventory units held by one customer utilized in the calculation of the reserve amount for Hi-Tech products at the acquisition date.&#160;&#160;The duplication resulted in an overstatement of chargeback reserves by approximately $8.9 million for the opening balance sheet of Hi-Tech as of April 17, 2014. The chargeback reserve at the end of the quarter ended June 30, 2014 was then calculated correctly, resulting in the earlier overstated reserve amount being included in revenue during the quarter ended June 30, 2014. The correction of the error in the quarter ended June 30, 2014 resulted in a reduction of previously reported revenue by $8.9 million, a reduction of previously reported pre-tax income by $8.9 million and a reduction of previously reported net income, goodwill and retained earnings by $5.6 million, for the Company&#8217;s three and six month periods ended June 30, 2014.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The error was limited to the Company&#8217;s financial results for the three and six months ended June 30, 2014, but the error did impact the Company&#8217;s previously filed results for the nine months ended September 30, 2014 (which were filed in connection with the Company&#8217;s Form 10-Q for the quarter ended September 30, 2014) because the second quarter results were included within that period. The estimated impact of this error for the restated three and six month periods ended June 30, 2014 is to reduce basic and diluted net income per share by approximately $0.05 per share. The estimated impact of this error for the restated nine month period ended September 30, 2014 is to reduce basic and diluted net income per share by approximately $0.06 and $0.05 per share, respectively.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The error has been corrected in the full year financial statements included elsewhere in this Annual Report.&#160;&#160;In addition, the above unaudited selected quarterly financial data has been corrected to eliminate the error.&#160;&#160;The Company also expects to file amendments on Form 10-Q/A to its previously filed Form 10-Qs for the second and third quarters of 2014 to reflect the corrections and accordingly, the financial statements in those Form 10-Qs should not be relied upon until such time as the Company has filed its Form 10-Q/As for those periods.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Effects of Restatement on Previously Filed Quarterly Results</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company&#8217;s previously reported financial statements as of and for the three and six month periods ended June 30, 2014 and as of and for the nine month period ended September 30, 2014.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The effect of the restatement on the previously filed condensed consolidated balance sheet as of June 30, 2014 is as follows, in thousands:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,120</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(107</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,013</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL CURRENT ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">397,180</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(107</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">397,073</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">196,016</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,568</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">190,448</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL OTHER LONG-TERM ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">690,898</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,568</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">685,330</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,223,773</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,675</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,218,098</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income taxes payable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">675</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL CURRENT LIABILITIES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,777</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,673</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL LIABILITIES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">929,304</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">929,200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Retained earnings</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,700</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,129</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL SHAREHOLDERS&#8217; EQUITY</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">294,469</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">288,898</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,223,773</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,675</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,218,098</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The effect of the restatement on the previously filed condensed consolidated income statement for the three months ended June 30, 2014 is as follows, in thousands except per share amounts:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">150,749</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">141,896</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GROSS PROFIT</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">76,671</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,818</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">OPERATING INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,263</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,410</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,312</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,459</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax provision</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,303</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,282</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,021</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,009</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,438</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,506</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,935</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME PER SHARE:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, basic</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, BASIC</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, diluted</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, DILUTED</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.02</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,506</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,935</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,353</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,782</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The effect of the restatement on the previously filed condensed consolidated income statement for the six months ended June 30, 2014 is as follows, in thousands except per share amounts:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">241,371</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">232,518</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GROSS PROFIT</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">126,327</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">117,474</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">OPERATING INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,703</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,850</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,004</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,151</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax provision</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,167</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,282</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,885</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,837</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,266</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,334</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,763</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME PER SHARE:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, basic</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.19</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, BASIC</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.18</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, diluted</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, DILUTED</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,334</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,763</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,886</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,315</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The effect of the restatement on the previously filed condensed consolidated statement of cash flows for the six months ended June 30, 2014 is as follows, in thousands:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,334</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,763</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in operating assets and liabilities:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,991</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,138</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,329</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,151</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses and other liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,799</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,695</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Taken together, these adjustments result in no impact on the Company&#8217;s net cash provided by operating activities for the six months ended June 30, 2014 or the Company&#8217;s cash and cash equivalents balance as of June 30, 2014.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The effect of the restatement on the previously filed condensed consolidated balance sheet as of September 30, 2014 is as follows, in thousands:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,078</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,075</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL CURRENT ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">494,098</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">494,095</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">290,648</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,568</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">285,080</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL OTHER LONG-TERM ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,243,363</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,568</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,237,795</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,876,833</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,871,262</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Retained earnings</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,051</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,480</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL SHAREHOLDERS&#8217; EQUITY</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">320,322</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">314,751</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,876,833</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,871,262</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The effect of the restatement on the previously filed condensed consolidated income statement for the nine months ended September 30, 2014 is as follows, in thousands except per share amounts:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">374,103</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">365,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GROSS PROFIT</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">178,061</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">169,208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">OPERATING INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,661</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,808</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,465</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,612</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax provision</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,278</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,282</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">996</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,187</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,616</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,113</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME PER SHARE:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, basic</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.02</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, BASIC</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, diluted</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, DILUTED</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,113</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,840</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,269</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The effect of the restatement on the previously filed condensed consolidated statement of cash flows for the nine months ended September 30, 2014 is as follows, in thousands:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,113</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in operating assets and liabilities:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24,193</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(15,340</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,209</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,282</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,491</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Taken together, these adjustments result in no impact on the Company&#8217;s net cash provided by operating activities for the nine months ended September 30, 2014 or the Company&#8217;s cash and cash equivalents balance as of September 30, 2014.</font> </div><br/> -8900000 -0.05 -0.05 -0.05 -0.05 -0.06 -0.05 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td align="left" colspan="10" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Income (Loss) From Continuing Operations</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Net Income (Loss)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In thousands, except per share amounts)</font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Revenues</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Profit</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Operating</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Income (Loss)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Amount</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Per Basic</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Share</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Per Diluted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Share</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Amount</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Per Basic</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Share</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Per Diluted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Share</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year Ended December 31, 2014:</font></font> </div> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4th Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">227,828</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">128,382</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71,907</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,232</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.32</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.29</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,232</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.32</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.29</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3rd Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">132,732</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,734</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,042</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,650</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,650</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="19%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2nd Quarter (as restated)</font></font> </div> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">141,896</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,818</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,410</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,438</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,935</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.02</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1st Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,622</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49,656</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,440</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,828</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,828</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Year Ended December 31, 2013:</font></font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4th Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">84,953</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,970</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,176</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,678</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,678</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.14</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3rd Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">81,892</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,697</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,188</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,205</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,205</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2nd Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77,012</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,092</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,251</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,637</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,637</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="19%"> <div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.05pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1st Quarter</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73,854</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,145</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,589</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,842</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-90" style="MARGIN-LEFT: 5pt"></font>0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-91" style="MARGIN-LEFT: 5pt"></font>0.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,842</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 227828000 128382000 71907000 34232000 0.32 0.29 34232000 0.32 0.29 132732000 51734000 -6042000 -11650000 -0.11 -0.11 -11650000 -0.11 -0.11 141896000 67818000 7410000 3438000 0.03 0.03 2935000 0.03 0.02 90622000 49656000 23440000 9828000 0.10 0.08 9828000 0.10 0.08 84953000 46970000 25176000 16678000 0.17 0.14 16678000 0.17 0.14 81892000 43697000 22188000 12205000 0.13 0.11 12205000 0.13 0.11 77012000 42092000 22251000 12637000 0.13 0.11 12637000 0.13 0.11 73854000 39145000 18589000 10842000 0.11 0.10 10842000 0.11 0.10 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,120</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(107</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,013</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL CURRENT ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">397,180</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(107</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">397,073</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">196,016</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,568</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">190,448</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL OTHER LONG-TERM ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">690,898</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,568</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">685,330</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,223,773</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,675</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,218,098</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income taxes payable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">675</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL CURRENT LIABILITIES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,777</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,673</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL LIABILITIES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">929,304</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">929,200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Retained earnings</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,700</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,129</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL SHAREHOLDERS&#8217; EQUITY</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">294,469</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">288,898</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,223,773</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,675</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,218,098</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">150,749</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">141,896</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GROSS PROFIT</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">76,671</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,818</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">OPERATING INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,263</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,410</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,312</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,459</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax provision</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,303</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,282</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,021</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,009</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,438</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,506</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,935</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME PER SHARE:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, basic</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, BASIC</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, diluted</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, DILUTED</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.02</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,506</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,935</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,353</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,782</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">241,371</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">232,518</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GROSS PROFIT</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">126,327</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">117,474</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">OPERATING INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,703</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,850</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,004</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,151</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax provision</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,167</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,282</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,885</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,837</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,266</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,334</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,763</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME PER SHARE:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, basic</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.19</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, BASIC</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.18</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, diluted</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, DILUTED</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,334</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,763</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,886</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,315</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,334</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,763</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in operating assets and liabilities:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,991</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,138</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,329</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,178</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,151</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses and other liabilities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,799</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,695</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,078</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,075</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL CURRENT ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">494,098</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">494,095</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">290,648</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,568</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">285,080</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL OTHER LONG-TERM ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,243,363</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,568</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,237,795</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL ASSETS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,876,833</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,871,262</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Retained earnings</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,051</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,480</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL SHAREHOLDERS&#8217; EQUITY</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">320,322</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">314,751</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,876,833</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,871,262</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">374,103</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">365,250</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GROSS PROFIT</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">178,061</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">169,208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">OPERATING INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,661</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,808</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,465</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,612</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income tax provision</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,278</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,282</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">996</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">INCOME FROM CONTINUING OPERATIONS</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,187</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,616</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,113</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME PER SHARE:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, basic</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.02</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, BASIC</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income from continuing operations, diluted</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET INCOME, DILUTED</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.05</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,113</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMPREHENSIVE INCOME</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,840</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,269</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Reported</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-TOP: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As Restated</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-TOP: black 1.1pt solid; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated net income</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,684</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,571</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,113</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in operating assets and liabilities:</font> </div> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24,193</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,853</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(15,340</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="55%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font> </div> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,209</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,282</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; BORDER-LEFT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,491</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1.1pt solid"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> </table> 17120000 -107000 17013000 397180000 -107000 397073000 196016000 -5568000 190448000 690898000 -5568000 685330000 1223773000 -5675000 1218098000 675000 -104000 571000 103777000 -104000 103673000 929304000 -104000 929200000 33700000 -5571000 28129000 294469000 -5571000 288898000 1223773000 -5675000 1218098000 150749000 -8853000 76671000 -8853000 16263000 -8853000 14312000 -8853000 5459000 5303000 -3282000 2021000 9009000 -5571000 8506000 -5571000 0.09 -0.06 0.08 0.08 -0.05 0.07 8353000 -5571000 2782000 241371000 -8853000 232518000 126327000 -8853000 117474000 39703000 -8853000 30850000 30004000 -8853000 21151000 11167000 -3282000 7885000 18837000 -5571000 13266000 18334000 -5571000 12763000 0.19 -0.06 0.13 0.18 0.13 0.16 -0.05 0.11 0.16 0.11 19886000 -5571000 14315000 27991000 -8853000 19138000 -4329000 3178000 -1151000 8799000 -104000 8695000 33078000 -3000 33075000 494098000 -3000 494095000 290648000 -5568000 285080000 1243363000 -5568000 1237795000 1876833000 -5571000 1871262000 22051000 -5571000 16480000 320322000 -5571000 314751000 1876833000 -5571000 1871262000 374103000 -8853000 365250000 178061000 -8853000 169208000 33661000 -8853000 24808000 11465000 -8853000 2612000 4278000 -3282000 996000 7187000 -5571000 1616000 6684000 -5571000 1113000 0.07 -0.05 0.02 0.07 0.01 0.06 -0.05 0.01 0.06 0.01 7840000 -5571000 2269000 24193000 -8853000 15340000 11209000 3282000 14491000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 22 &#8211; Legal Proceedings.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are party to legal proceedings and potential claims arising in the ordinary course of our business. Such legal proceedings include Akorn&#8217;s Paragraph IV challenges to other drug manufacturers&#8217; proprietary rights, and the counter-suits filed by those drug manufacturers in response.&#160;&#160;The amount, if any, of ultimate liability with respect to legal proceedings involving the Company cannot be determined.&#160;&#160;Despite the inherent uncertainties of litigation, at this time the Company does not believe that such proceedings will have a material adverse impact on our financial condition, results of operations, or cash flows. Set forth below is a listing of potentially material legal proceedings of the Company, including Akorn, Hi-Tech, and VersaPharm in existence as of the date of filing this Form 10-K.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 11, 2013, the Attorney General of the State of Louisiana filed a lawsuit in Louisiana state court against Hi-Tech, and numerous other pharmaceutical companies, under various state laws, alleging that each defendant caused the state&#8217;s Medicaid agency to provide reimbursement for drug products that allegedly were not approved by FDA and therefore allegedly not reimbursable under the federal Medicaid program. The state seeks unspecified damages, statutory fines, penalties, attorney&#8217;s fees and costs. On October 15, 2013, the defendants removed the lawsuit to the U.S. District Court for the Middle District of Louisiana. Subsequently, the case was remanded to state court, where the case is in the initial discovery stage. The Company intends to vigorously defend against all claims in the lawsuit.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In May 2013, Inspire, a wholly owned subsidiary, received a Notice Letter that Mylan Pharmaceuticals, Inc. (&#8220;Mylan&#8221;) filed an ANDA with the FDA seeking marketing approval for a 1% azithromycin ophthalmic solution prior to the expiration of the five U.S. patents licensed to us and listed in the Orange Book for Azasite<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font>.&#160;&#160;On June 14, 2013, Insite, Merck, Inspire and Pfizer filed a complaint against Mylan and a related entity alleging that their proposed product infringes the listed patents.&#160;&#160;The parties agreed to settle the matter and the case was dismissed by court order on March 4, 2015.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 12, 2012, Fera Pharmaceuticals, LLC (&#8220;Fera&#8221;) filed a civil complaint against the Company and certain individual defendants in the Supreme Court of New York. On October 15, 2012, the case was removed to the Federal District Court for the Southern District of New York, and subsequently, Fera filed an amended complaint. The complaint alleges, among other things, breach of manufacturing and confidentiality agreements, fraud in the inducement and misappropriation of the plaintiff&#8217;s trade secrets.&#160;&#160;The Company intends to vigorously defend these allegations.&#160;&#160;On January&#160;&#160;13, 2015, the Company filed a counterclaim against Fera and certain affiliates&#160;&#160;(Alfera&#160;&#160;Pharmaceuticals,&#160;&#160;LLC;&#160;&#160;Feranda,&#160;&#160;LLC;&#160;&#160;Baci&#160;&#160;&#160;007,&#160;&#160;&#160;LLC;&#160;&#160;&#160;and&#160;&#160;&#160;&#160;Fera Holdings, LLC), as well as Perrigo Company of Tennessee and Perrigo Company plc, asserting violations of Sections 1 and 2 of the Sherman Act and tortious interference with business relations.&#160;&#160;The case is in the discovery phase, and no trial date has been scheduled.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 8, 2012, plaintiff Mathew Harrison filed&#160;&#160;a class action lawsuit, Civil Action No. 12-2897, in the U.S. District Court for the Eastern District of New York, against Wayne Perry, Dynova Laboratories, Inc., Sicap Industries, LLC, Walgreens Co. and Hi-Tech. On May 16, 2012, plaintiff David Delre filed a class action lawsuit, Civil Action No. 12-2429, in the U.S. District Court for the Eastern District of New York, against Wayne Perry, Dynova Laboratories, Inc., Sicap Industries, LLC, and Hi-Tech. Each complaint alleges, among other things, that their Sinus Buster<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> products are improperly marketed, labeled and sold as homeopathic products, and that these allegations support claims of fraud, unjust enrichment, breach of express and implied warranties and alleged violations of various state and federal statutes. Hi-Tech answered the complaints and asserted cross-claims against the other defendants. The Court consolidated these two cases into one action entitled Sinus Buster Products Consumer Litigation. Dynova has filed for bankruptcy. The case has now been settled by Hi-Tech with plaintiffs by Agreement dated December 16, 2013 and the Court approved the settlement by an Order dated November 10, 2014.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In April 2011, Inspire Pharmaceuticals, Inc., a wholly owned subsidiary of the Company, acquired through a business combination on November 15, 2013, received a Notice letter from Sandoz, Inc. (&#8220;Sandoz&#8221;) providing notice that Sandoz filed an ANDA with the FDA seeking marketing approval for a 1% azithromycin ophthalmic solution prior to the expiration of the five U.S. patents licensed to us and listed in the Orange Book for Azasite<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-WEIGHT: bold">&#174;</font>.&#160;&#160;On May 26, 2011, Merck, Insite Vision Incorporated and Pfizer filed a complaint against Sandoz and related entities in the district court of New Jersey alleging that their proposed product infringes the listed patents.&#160;&#160;On October 4, 2013, the court issued judgment in favor of Inspire and the other plaintiffs finding all the asserted claims of the patents in the litigation valid and infringed by Sandoz and related entities.&#160;&#160;Sandoz has appealed this decision.&#160;&#160;The Company intends to vigorously contest any Sandoz assertions that these patents should have been found not infringed, invalid or unenforceable.</font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Former Hi-Tech director and employee Reuben Seltzer delivered to the Company a demand letter in August 2014 alleging that the Company breached his employment agreement and improperly terminated Mr. Seltzer&#8217;s employment.&#160;&#160;Mr. Seltzer further alleges that he is entitled to compensation in the approximate amount of $5.2 million.&#160;&#160;The Company disputes these claims and intends to vigorously defend these allegations.</font></font> </div><br/><div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 4, 2015, putative class action plaintiff Solomon Yeung filed suit in the Federal District Court Northern District Illinois against Akorn, Inc., Rajat Rai, Timothy Dick and Bruce Kutinsky, alleging defendants violated Rules 10b-5 and 20(a) of the 1934 Exchange Act.&#160;&#160;According to the complaint, certain financial and other related data related to certain Akorn subsidiaries could not be timely collected and compiled and Akorn would be unable to timely complete its assessment of the effectiveness of its internal control over financial reporting as of December 31, 2014. The complaint also alleges that Akorn&#8217;s internal control over financial reporting was ineffective and material weaknesses existed relating to the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions and accurate and timely reporting of its financial results and disclosures in its Form 10-K. Plaintiff alleges that as a consequence, when Akorn announced on March 2, 2015 that it would need an extension to file an annual report for the year ending December 31, 2014, its stock dropped.&#160;&#160;The Company and individual defendants dispute these claims and intend to vigorously defend these allegations.</font></font> </div><br/> 5 5200000 EX-101.SCH 10 akrx-20141231.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Statements of Comprehensive Income Alternate 0 link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Statements of Comprehensive Income (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statement of Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Note 1 - Business and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Note 4 - Inventories link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Note 5 - Property, Plant and Equipment link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Note 6 - Financing Arrangements link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Note 7 - Earnings Per Common Share link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Note 8 - Leasing Arrangements link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Note 10 - Income Taxes link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Note 11 - Retirement Plan link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Note 12 - Segment Information link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Note 13 - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Note 14 - Supplemental Cash Flow Information (in thousands) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Note 15 - Recent Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Note 17 - Unconsolidated Joint Venture link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Note 18 - Customer, Supplier and Product Concentration link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Note 19 - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Note 20 - Severance Charges link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Note 22 - Legal Proceedings link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances (Tables) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Note 4 - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Note 5 - Property, Plant and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Note 6 - Financing Arrangements (Tables) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Note 7 - Earnings Per Common Share (Tables) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Note 8 - Leasing Arrangements (Tables) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Tables) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Note 10 - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Note 12 - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Note 13 - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Note 14 - Supplemental Cash Flow Information (in thousands) (Tables) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Note 17 - Unconsolidated Joint Venture (Tables) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Note 18 - Customer, Supplier and Product Concentration (Tables) link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Tables) link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Goodwill link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Major Categories of Intangible Assets link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Amortization Expense of Acquired Intangible Assets link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Fair Values of the Company’s Financial Instruments link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Assumptions Used in Estimating the Fair Value of the Warrants link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Warrants link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances (Details) - Net Trade Accounts Receivable link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances (Details) - Summary of Adjustments to Gross Sales link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions link:presentationLink link:definitionLink link:calculationLink 058 - Disclosure - Note 4 - Inventories (Details) - Inventories link:presentationLink link:definitionLink link:calculationLink 059 - Disclosure - Note 4 - Inventories (Details) - Allowance for Excess and Obsolete Inventory link:presentationLink link:definitionLink link:calculationLink 060 - Disclosure - Note 5 - Property, Plant and Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 061 - Disclosure - Note 5 - Property, Plant and Equipment (Details) - Property, Plant, and Equipment link:presentationLink link:definitionLink link:calculationLink 062 - Disclosure - Note 6 - Financing Arrangements (Details) link:presentationLink link:definitionLink link:calculationLink 063 - Disclosure - Note 6 - Financing Arrangements (Details) - JPM Revolving Facility, Interest Terms link:presentationLink link:definitionLink link:calculationLink 064 - Disclosure - Note 6 - Financing Arrangements (Details) - JPM Revolving Facility, Interest Terms (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 065 - Disclosure - Note 6 - Financing Arrangements (Details) - Net Carrying Amount of the Liability Component and the Remaining Unamortized Debt Discount link:presentationLink link:definitionLink link:calculationLink 066 - Disclosure - Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes link:presentationLink link:definitionLink link:calculationLink 067 - Disclosure - Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 068 - Disclosure - Note 6 - Financing Arrangements (Details) - Maturities of Long-term Obligations link:presentationLink link:definitionLink link:calculationLink 069 - Disclosure - Note 7 - Earnings Per Common Share (Details) link:presentationLink link:definitionLink link:calculationLink 070 - Disclosure - Note 7 - Earnings Per Common Share (Details) - Reconciliation of Earnings Per Share Data link:presentationLink link:definitionLink link:calculationLink 071 - Disclosure - Note 8 - Leasing Arrangements (Details) link:presentationLink link:definitionLink link:calculationLink 072 - Disclosure - Note 8 - Leasing Arrangements (Details) - Future Minimum Lease Payments link:presentationLink link:definitionLink link:calculationLink 073 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) link:presentationLink link:definitionLink link:calculationLink 074 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Weighted-average Assumptions for Stock Options link:presentationLink link:definitionLink link:calculationLink 075 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Stock Option Activity link:presentationLink link:definitionLink link:calculationLink 076 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Non-vested Restricted Stock Activity link:presentationLink link:definitionLink link:calculationLink 077 - Disclosure - Note 10 - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 078 - Disclosure - Note 10 - Income Taxes (Details) - Income Tax Provision link:presentationLink link:definitionLink link:calculationLink 079 - Disclosure - Note 10 - Income Taxes (Details) - Income Tax Rate Reconciliation link:presentationLink link:definitionLink link:calculationLink 080 - Disclosure - Note 10 - Income Taxes (Details) - The Geographical Allocation of the Company’s Income link:presentationLink link:definitionLink link:calculationLink 081 - Disclosure - Note 10 - Income Taxes (Details) - Net Deferred Income Taxes link:presentationLink link:definitionLink link:calculationLink 082 - Disclosure - Note 10 - Income Taxes (Details) - Summary of Unrecognized Tax Benefits link:presentationLink link:definitionLink link:calculationLink 083 - Disclosure - Note 11 - Retirement Plan (Details) link:presentationLink link:definitionLink link:calculationLink 084 - Disclosure - Note 12 - Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 085 - Disclosure - Note 12 - Segment Information (Details) - Financial Information by Segment link:presentationLink link:definitionLink link:calculationLink 086 - Disclosure - Note 12 - Segment Information (Details) - Carrying Amount of Goodwill by Segment link:presentationLink link:definitionLink link:calculationLink 087 - Disclosure - Note 13 - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 088 - Disclosure - Note 13 - Commitments and Contingencies (Details) - Commitment Payment to Strategic Business Partners link:presentationLink link:definitionLink link:calculationLink 089 - Disclosure - Note 14 - Supplemental Cash Flow Information (in thousands) (Details) - Supplemental Cash Flow Information link:presentationLink link:definitionLink link:calculationLink 090 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) link:presentationLink link:definitionLink link:calculationLink 091 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Lloyd Animal Health Products Acquisition and the Fair Value of the Acquired Assets and Assumed Liabilities link:presentationLink link:definitionLink link:calculationLink 092 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for Xopenex adn the Fair Value of the Acquired Assets and Assumed Liabilities link:presentationLink link:definitionLink link:calculationLink 093 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business link:presentationLink link:definitionLink link:calculationLink 094 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Disposal Groups, Including Discontinued Operations link:presentationLink link:definitionLink link:calculationLink 095 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Betimol Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities link:presentationLink link:definitionLink link:calculationLink 096 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities link:presentationLink link:definitionLink link:calculationLink 097 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Unaudited Pro Forma Financial Information link:presentationLink link:definitionLink link:calculationLink 098 - Disclosure - Note 17 - Unconsolidated Joint Venture (Details) link:presentationLink link:definitionLink link:calculationLink 099 - Disclosure - Note 17 - Unconsolidated Joint Venture (Details) - Unconsolidated Joint Venture Condensed Statement of Income link:presentationLink link:definitionLink link:calculationLink 100 - Disclosure - Note 17 - Unconsolidated Joint Venture (Details) - Unconsolidated Joint Venture Condensed Balance Sheet link:presentationLink link:definitionLink link:calculationLink 101 - Disclosure - Note 18 - Customer, Supplier and Product Concentration (Details) link:presentationLink link:definitionLink link:calculationLink 102 - Disclosure - Note 18 - Customer, Supplier and Product Concentration (Details) - Percentage of the Company’s Gross and Net Sales and Accounts Receivable link:presentationLink link:definitionLink link:calculationLink 103 - Disclosure - Note 19 - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 104 - Disclosure - Note 20 - Severance Charges (Details) link:presentationLink link:definitionLink link:calculationLink 105 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) - Selected Quarterly Financial Data (Unaudited) link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) - Restatement of Previously Filed Financial Statements link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Note 22 - Legal Proceedings (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 11 akrx-20141231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 12 akrx-20141231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 13 akrx-20141231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 14 akrx-20141231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 15 graph.gif begin 644 graph.gif M1TE&.#EA6`*Z`?<```$!`0L+"Q,3$QL;&R,C(RLK*S$X)#,S,SH_,3L[.STW M1$0V54\_9%$_:$E./D]>+VE_/4-#0TM+2TY`7U-34UM;6T](=%9&:5I&VA*=V!4;V)4V197!/=V-P1FIZ26)B8FMK:VUD MW)N;G%F?G!I<'5T:W5[:GI^:7-SUY1@EA=D59DFDQ^NUQXJU)] MMFE5@G%=B6EKF&QSGG5FB'QKDGURBG]PD6![HV-^L'.(1WZ44'V#9TZ`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```````"'Y!`$``/\`+`````!8`KH!``C_`!,1&DBPH,&# M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$D0$:%GZ5*J7,FRIS8P7;^G4*-*G4JUJM6K M6+-JWO8,.*'4NVK-FS:-.J7//JW##B!,K7LRXL>/'D)\6IANYLN7+F#-KWLPY[.2ZG4.+'DVZM.G3 MA`VC7LVZM>O7L.%^CDV[MNW;N%'/SLV[M^_?P/7N#DZ\N/'CR*$.3\Z\N?/G MI)=#GTZ]NO7`TJ]KW\Z]N]CLWL.+_Q_?'7SP>XDJF#`1@UTZ:YH3G9B&EYF) M"C#823Y1H;_Z]16<<,\]A>1'%B+^54"(?O<@6$$B;3VSG@DG/,/.,W"EI^`] M72%R`FA@8?*??P!B(A8[,/3GR53II$CB?85P2-YWJAEWSR4`),#)4YX<```S MF;$S```PW!4#`#$0`L`)41T)`")/L5-!`>PP(P``)I)5"```%"#C4S$4N5:/ M`Q#"83H4+&F7!`!$\&55G&1IS96%C$4(!>[Y6$`Z4L9@%3LQO#G5,U="2-66 M`%S2#SL1`$``AEAYHNB,4IG7VSTQ!'``?5!-@\,$G`:UB48IJ.G?M;X*M6L$@@JE:D`>!O5)0&4^Q0S0U8@;E36%``K MINF M5<_X:"Y9Z9S)ZYZQ!@M5!0"$>Q6Y&S^%8P"&DFMR59X^26]4EO+&)@"Y1L5. MKH@D8$("L')"+`67$%L!.X@,$`"MUE`0P-("!%``I.Q<4@$%`]#:CZ#"5000<-4G<"EG\]0?$D$%1RP M8UR%5"#!``#CNW0B`DA@L,I<,B[5/1C"\'0BSQ";@'Z%LZS[`(FD4T$``YC( M]9XP1`VPQ?H]`X,)!Q``))KI^CS-"4\C@DG4`M29-`P<)I)Y`BM6I6V7!O?\ M,Y0$#CE`!3M.,WT"!,AY:LK]H*MN/_A"%52>00$*R.L>QLN>":Q!".=Q[0#P MT5VQN)> MX)+IF'4`IQ3"A/&263^810`$#8`9-TQ$#B&$B>3=B''L.%61XE5#:PP@`>7C M4@62ID.J<&(`%+@',]04EP((,&``(,0TT#;`*YF(60*`SS1,P*$&,N,>!XC` M[*3RC"$1P!J(R-7WH%2!`5@#60'PQ#.>ECZ(Z0UD46%6HJSB1'71T"EU+-DE MT'@"3+`I8OW8$@'2,8U_/<5B""P``0@$@!J^;4@M&U*=CA0`(%GC:/V(G(DD M@$@6?:PND2-A``#6*),Q2@!5ZQ)]4%:5E17"&L\098R>XBEW74(`$)K&D&#E M_Z\P]@,&78)/)$V`K@KT@U<"((3G"&`MXG#P-NS@$@BKDD,3<2*;_2"9'/OA M11/$!95;NY*B.KG(3)V`75Q4TAW3<8EI!0`&`2R2)C%Q#_KL3$U5XQ;AT`."',6ZBI-T))D# M#`!#6S(3R1+A/T.E"8K/.%U4V/0X1IX*2DHZ0/1.I2A.I`NG']6/)E/BQ>`Y*UM!40Z<9I5,QKH5@ZT<.&8<)^O\T2HXQM.MQSFD;=G@Q M`'Y[FPM7],X`8(AD)H.H8O%)J!?&Q4=NDQ`,O*@L):8+@@OJA0@&HAP(2 M$"(GMLN):13"G-MJH09YET ME'Y:N,GU6?5B!*6`YP;`57R&](OC9*!3F/&T\:IN7I6ZI69-&\-6]B.N4>($ M23^X(F)2964LO5(!K,4KGZGN:/6%E66MB5CXD*NO<=VB9(U#6=LHDE]1V2*% M70@DT')(M.G`YS3,>%HDO2W_`9OR46N;-4`DSU9,S.!5R08$T=SNEK6Q="%P MB505=J2K3NEDV8'3VBJ!L8-5]JV+"PAF<.A7KA M*@'07JI`UX7!2HEB\8I-^J*4NNF"CR;W"^D<_O>\3\/C5IWK59'V M@TT#J$OOC!RK!%DD524_^BC)$=3]X.)T%W@2?8[_R$"C61E[?\EK!'DP/>/[U!! ME@L+P?A\JQ728#)AKFU']K$NFA!UC:8JJY(X0XW<>@"\D@28@8EH^XB;T[A' M+SGA([-&$L*\Y"C`HAQI4DJ@TG;E9#Q<$@$F)Q6IPR6Z93O3 MPB4%L"+WP"P2P`F-(G96`GM7436TM!XGT'A/H6HEPRP!P#B%DR//(&4G,"Q< M$B/W<#.$<"H'P'A7(@!TN>8H#(4PO2(CJK9+3[%H$>`Y M!W56Z3(UE5B&9\,EQ;9![C$H`(GH!DX%A,)A`!$L`YA4`!_VAR MH3<5]\`)__\Q#1WVBYD#(!7P#"$$`Z$V0!,2D5=A/^MQ">TH%I<01UAA#3`0 M`:M"%5'VD%EA*Y-S%BW""5:CCR9P.K82-XRH,ZEC`B?QDF&)G".=MC6GEA*K_#%IX`,%LT*?$X.K7$%6:3([.#7H(R M2+6621&@1A$0`5!Q`C,V+0*`)X,R0A))"`D`*9AP.(R4`!#2(+_5*2%D%8E0 M`'"9%=B4`)VC6UO!DD7UF(69#O\4)050`%,1`Q`6)?C!(6I(9OVC-501`3>U M%<_`/>R'&^^H&$Y$B8F14`!U:3"G M>3LF(`!U!Q7L4).*95(P`%)[%IQR6)S'"14Q,)51J'Q4T9)?$@.00IE&F16: MHQ6(T"BO:!\DIQ5.9"Q8,83@>`+-]5")&16(H)Z="!I=614G((]140%FM15; ME)JWL9J)(4X%D&UR&"7.@D!SE!*SXRRU(H<*EQ6)D)!C*9LA@YM1@J''P6GF@@A[@D!O@D`D2A6>@`BZ0S';,RYS$YF2P3<& MXRLQ,&-043A]90TWVE=#YDUR>)E^4YQ"Y0GT,2N;(J(FNB@:&IY2FEDL%'^S M`P,XHE&R8J+Z\7:=9")="J4.NEH60A4GG=0P?_8,J3,>/E0AY^]F? MBQ(R"\H.GA!(R!FA+NH4"JH;_U")&>D@.TK".3WC";@W#;RB5)(!`S'P,^F3 M"%]75Z?3--0BE/RS*!V((WUEH?@B`6)*")`J+RH3`3'@.810"`?@"6S2FZ)F M,ML3`3VB6\ZR@#$`F&#!:?3)J@59,B)7"#$0-^OH"8G0=@*0)<,9%850")W$ M1D.5(^F3,\V)8RIDI$_1K,_Z)2VDGSN$E5*A0KO$(6]'70DP`#``)8`"`S#P M=5"Q@#"@J_$$E^R`-2^H+_'HE,QT`H$E)FAB`LVY(Z<)-'591XK"+A%04)D4 M`S'00_Q'FI[6.:]%46SZ%/,I,?64*YFE+=X:3V;%#KZ:)HA$F2>0D`"0/I<` M?060'_]P\U;HDGFF(:"'(1!O(P`%1W[6Q0R>HG_6X%1U`EV&$H;,4)`!L)'Q M,E'0)2#IP'?@R`E%LK2V64><<".),&MAHC($@"UILGVJ0P!FV+/$`Z(:J!\G M,``]9`T8M"+^N%\C]A4H*A5)$P/=,CFVXA2,LI528:Q;!,D(]'%)'$`*PQ^()A8DQN@D5N^MB!;!2^+<>P'F. MDE*)3[04@4:S_`=?42@_\U*M4C$-`:"XL60[,>0KW!.Y7X2FQT-P=9&K^L$, MB+@H`R`!.^0VY\4AF@-$!\E2.R19AB@K)&<-Z<.^\70`,I*>B<`J\?(?$3!G MF61*\44`@0:?4W&Q5%$8V9.._4`!5ERGN5*YHI<`3"(TD/*?8?R/]R$`%R-- MJ,H:VQL8JH((>.PTOA*^67)_\,$H_TS2L"06,1;J5U[2=F*2`'H'%P MR'GK*ZHF`9X0:'.#QPTTL0F*"`*0K&#BH]=9<+5L$EWC+&@U%=QSC\+)*Q-U M5HZJRZ2"-`PE!ADA+)=,=#IU%!`78Z,OUY"6W;=FSDQ^O"IV^87.(KJ,8;&LB"+<_P M#.RBPSPR`*?#SX!,::3REF_SS]2C'[\9)SAH%9IYT`==`$R\:010"`GP,BK$ MHXXF)!1SF/]_C,8-7%,O.0ERS M!3`IZ50D7UAL<1W76Y.UO2,F\0*MBF4BA5#/R.F[30(`(((L1AF/.18`Z_B% M>$O&*J/8]M2M_;PBM%07Z,$AE[![!:#6IW'9?8$LFZE"Q1:^#9U8C-)>4P(? MG"!VZILE%()G/"=>P;"A(#<^CW%,9"RH)F]:F6DJC(5Q`LD M]\"T%MLW3U&VH$(@!-#;:RX5;2[7#LDI_SU"/NY5`)>:L!9K0E`"`X^"9[5E MY3R5Y8%S6KT]%5IZ+#_C+)QF3^+G)M9PKHA@/(YZ4A#R3+#B*@D[H?J!+JHM M*$,XL8HUTKEB/VB&"4[A5%6[*.S*(=:`"3FC+6OYA4H>2TJNSXM"O&6.3@`5:",.2`*2;"/1,T[5;/0C%GQ&04LE>`9QRVM`5TE6!*:2)QLYR M2":@J`4*)91IMO_+I#.B$L#Y1E=X%@$$``,>OEH#SU"%@`D3PJ_+63WC=1\5 M8+KK`O,R?RPT_Y*+8NYO"32%V7V1:@*R+"/:\BFQ0M?L82W(?N_T$>XK^PPP M3S3C<@)QI-:4EZVKTC>`0@`3S*@$(.V$.JC,(38B"II_,=UOX0EK:4XMY^7.40&JGQ;B M)!BI,AK4'AL(`AHX>1@$);QI`42D2QP$$D=@S!Q,^>1G\0R`"QCLP`G_2AD: MNP\;S\2!P?B3@F$-R6\6/0P=3;X>S)\<:[2.ZC@?@:&GI5']L($BK=S]VQC_ M`-069ET>IB__^)__XL'^^M__`-%/X$""!0T>1)A0X4*T^A!A1XD2*%2.F M(T0HG46.'3U^!!E2Y$B2)4V>1)E2Y4J6+0]BU.A2YDR:(3OIL&<.U\B MO,?.)\>@0XT>W0GS)E*F35=.,Y%`IT)$!3A=C)'U&4%F66-@FI@H`2*.GKS& MF-8/T]FE#.\1(I"VH"<))Q[>0Y2UT+UG4SOB/6NM(;,*%/PZ19RXHU+%C1U7 MO!=CP('#!#=ZBA``;$1VB`0@9`C;#BI``3)B*'<,H@D^^ MBM*I[[[\)&*FOWX*&^B``1%BYL6"$)GMHP4;=.@>"B"TL$BF_R@T,DF2TH&A M,`J$2@<1&*RAH(!$!K(&!A.&_(X@:WA+X(1G/,3DD@(DP,V3$PH+K2!V8&"G M@@"N["?.J2ZAP(0(RLO2!$+H[(>3"DPP(;XZ":F@`@EZ],2$"F"(P<"#Z+-O M(/STLP81/1'1B9T8$EU4H!BG>4L``DS@T,9I$CB@/(-@``!$+`6;)L\("-'I MF1,P(82T?M3R``@JA,@%)E>06 M)"2[!=>B$Q+H9QH""&$G`@`.B"$1"0H0+!T*P(*O2R\)X+"?\2I`!!$`?$N$ MTQD/P&V@=!I,YP`!KK+S5P(,K("`]?\J8*9$;<-E M>Z)OVX:[H4O(2K>]?IP5R),`*H:!7($P-,@:`NCT,-^H^[%FK$02.2$``-V, M02=K"A!@FH:MB6$C1`)(!V1TRT5\0X%2#!1`(2/@"[2\%T:(O@$()51.WPJ1 M8/%$*(?6=`I0[V=4@7"NL0*!+@F@QX'N(0``XPEZJ^)I!+CR&0%22QR1Q1M_ M?%@&13M5H$3_BI]1^/6&Y$OQ1"C0;&)V3XZ[?87>=C_^@NZQAFGQ(Q`_QJL* M$+\?P`L27+X\5)X3%&`U!?`$,Q3(#.TP:2"<&$`$GG$B_W`B,QK[#"9T@HD" MC]\UP_@"<1&`N%$`(0U$'4M MSTW/X$WT!)`O3R#0A0DBE@U?IA:;X0=(]WC0/<3B0F8@QQH"H*#\M%@0^&W1 M?=9@%F;LAK\.!0!M6!S(_^XEP`\)I(#L@&""[A.Y@10"`#B;"NTP40C."003 MMJE`9UA7+D.]J0*>V-T]"D&`V;#&56XB@`1SO("6*5$$02@C5"S%<<&9+$?A1@B9C0(3MZ(QKR(2(!ZKD/!9KF15[F)CN] ME-\]#B"RN@F$C+T#P%4.0(";J!%+`R`<`0AH0`\1PF!K4Z$E_Q8``>BD$`5( MR^;2\9KU%&*(F!``D*P1'R%-YW12'"0S3(@0%E5*A3J"`2,'@@D3N3.1R+R9 M)&WHFQQ6S"#F>A(`Q[3+YUWI>6RTIG^P648@=?*5-KO'`&ZYGBA"$%!CJM.4 M3J!/8,JOBR4%5SH&@#!G/:.8^C)C/S8VK71D)I``),`)K#&F-O;CC6D30"'8 MD24?,NDP->VF3W_6#SMZ`H@;.0\G$C9$=O^@\UHAJQ,%0%-$`KB4CX]$F3US M\[H22K"J0J79V$##CAF^*QT5\V1!$7*)=/K%&F#A!`"V(D^T2"]?0!5JE@HV M$%:ZTH\Z].F(AJHP$]2T:>R8!@PVDHBK$.VF*&W?23'+K1,((".4"]L`!L<, M49J@+X0`P!T+`U8WWE%7`:@`)_[HV:#P!@`(-`@G8)!.@X)0*KT30`4*40&E M9>E6?LK5`0#`(`&Q@X\Q*$0"TAFHY-UJG@8A;0`&@*U`B?)<&^%$`5(+)Z8R M*+H!(,0TB&N"BA%/FHD00`(2P0P3_&NP`T%D`3)2"$1`*0$[BX$`"G`)&`1` M`IMAAVUQ.[_SK:O_$,_8W`'F2]PI02>U0Z(8XBB0V@2DA6D<>@8@?;A9;FF6 MQ$:B'[78H1MKM#C%U`*A-3[FGO7(^,6=:_%L4HQ+2^68Q^I)AS7&"6.9M?@^ M0LZ-:%K\L1X%>34#..%0<]RI',.X3D96LHQ7?(\76Y'%0I:RE0]RXR,+1LA= M/MZ2Z5GE(H-YRC56L5]V[!\9PUG,)^Z6B?&\9R7)\X1\!G2@#?9+01@$ ME*$5O6<]+]K137G&NR30VT=7NI>-MG2F-;UI3KN-T)T&=:A%/6KLQ(34IT9U MJ@V-:56WVM6O#A>K83UK6M?Z,;*V=:YUO>N9X)K7OP9VL#_B:V$7V]C'`4[_ M"+&1O6QF!UO9S89VM&?];&E7V]JCIO:UM;WM2F>;V]\&-Y^]'6YRE_O2GS9W MNM4-Z'%7A\;KAG>\?6EJ]U%:WO>&=[L?PUI\]YO<^G8,O_T]\&T#O#$")WC" MI6UPQ2!WD.003"Y"8WA4D\ MWA20B]SE\E/&'5HP\Q8000\J1[=)\%*!?"DG$3L452)P\XR?$\03B9#C05K^ M8:@+H&4'#SDJS<4B>0$H&M,=_P@I43IH1!6KHR=N\5PA-342=899%M.1L5]50%YIJ=50#1-*X+2SW?!:=#O4X5[_ M]9PO*0(GR-Y`+C$@3.2L3@FHC4[N(4'&C8YW#%'[X44?H<1+G>I+:CQ)5E6` MDQ%"6)H2C7[MN:<8+'%R/$8()[B\>][WWO>_!W[PA3]\XA??^,='?O*5OWSF M-]_YSX=^]*4_?>I7W_J]-P8>XK#].-3A]".Q.O.J))]GY&L@L*_3M2IU#\S' M(*+3*`#N#X()*M;?_O?'?_[UOW_^]]___P?``!3``23``C3``T3`!%3`!63` M!N0_3G"`$@@&8J!`8BB&N$LZD-@]1'@&<$(L0(EF( MT!N]%G2,W2@`>SN)\.L=M$D$D)F&3!&*'#08"A`,_]TRD;TB$2J9K(@"/1=$ M0B.)DZYJ"1JTAJ6A`)YC!O%*K9])A`Y2DT(X@1TT`2V<#4PX`4*(`?E3NB0T MPPBIJ00`.I2@P3IAAF/)C3$9$\&`(TG9*;](!Y?RDM(HO#/TP\?8F@Z3B39< MI?XR"1;\PT1<":(Y@!%+"4+T"414Q$DLB6DX`+[KM=1C&TFDQ$[T$6?)0#;4 MQ'#A1$\T110A@(2J"4C`QIF0QFGL1/B* M/*/(1IG81FY41$0@@+UHBA=P=(EQ)$<_1(3M0@QU;`EV;$JS'%HR!P5$,>60)?NQ'PXL,*&L,@5P)@BS(IKN'D9JH=-1';F'(AG2YM)&F M6YM():E(B^2X=*@`7]'(8X2;CO3(BC,1U9F0C4P2DSQ)A9,7E5Q)DFP;EWS) M@=N:1MP.A50)F[Q)?".:!'#$@&1)(\&$*D/*I%3*I63*IG3*IX3*J)3*J:3* MJK3*J\3*K-3*K>3*KO3*KP1+I_0$5F$&L`Q%C^#)E-"]ZV/+MG3+MX3+N)3+ MN:3+NK1+NLL8ZU.)M$0)G_S)=8._YJ@0OCP)O_Q+ M%`GC/$Y>BXP!:QOF#`GG?,Y)-;,9A"D"/G$ABS6)M+0`O:0%%RZ\`LVE`2=0AYX81" MH*\5BY@UK#Q^"I3,(83-*(1$`*,`S:T=!;<<.0$3G4X@'8R?(0M.\"^@0Z39 M&!LSRYC`4XL;20@/I=(]*^.B+40I&C01"C#"W)`@+HJ`0GA2??FMS8,PWS@- M$U73-24Q"!I-%JW,Q2@4V22:'74 M3O743P754!7542754C754T755%7556755G755X756-74HSF!:9!56171Q=#2 M(/&.B*JI'4($\4F1]=,6,1R=2F4(3)B&96769G769X76:)76::76:K76:\76 M;-76;>76;O76;P77M-9"4&D7KVHKX6KNMD'31R47;6XKH6[_ECM.(4,$MVXDS MW%;#T`0X5)Q=W(QKW%2S1,'LMLG]N,H]-69(@%FTM,&=B,+EW,3H4:+E6+JE MR-(--4\S$$TLG=O(;4S6[;3P(J]-$UV)(%W:-0K6L,9.R]V(V%W>W8FC<5I. M"UZ(&%[BG8G0G%/D_]51[M"B\7=Z&6*Y9W>E5BDFP5>[$4*[=U>E%@D MZX5>U;7,\>6S>Q1?B43?EE3?/;L'&&"]5$O>AU#6==7?_>7?_O7?_P7@`!9@ M!A MV2U.*FZ?#I1,6S/BF05CMF%&-(6U,E[!,][$9H1=;)/B5G1C<(G-.);C'BB> MW3I6DO+]M7&3&=351CY&L4+`1UXCMDO("`.)$P`8(K,EY`J9WZ3]_V/NG$)# M1*W4$H"UK>%(EA#H:)6+L^30X`0!N*-+6!K&]>3MB$].)F/NI)X!8`[1>-[P M7>7K2$.Y[3CB9(]+8(:@$-7?F>?$I!Q&8``6"YY]AZR,0$->I,!V"'E.`$)L)LW<=F; MT)4PQ%**)EZ\F)YJ(S83D(N9`0!M28@0B_^2M\B)L=PA(TN7O3B!J^"$*XV3 MM.`O%@;HF4#:J2TV7WL+@FA9*YH:JR"+<:)7*26$L--7V<`$AOYE0'WJFL@G MJ9YJ[H2!1+B$MZX`MW::BBH(#DK<7TV(=/6$`^`AL["]K&F(_&W@P2;LPC;L MPT;L_@6B^$CLQN;6!T9+7E:79:9LI>GI`LC;144(H@N4]=L32`$A9%W!6R7M MTC;MTT;MU%;MU69M37V&"$"@UI;MU:9F3\OHR:[LU.H?@\"+1%@JO.8))7UM M?(4P(`DQLSYKEI"7>M4VJD:Z%8/NSDD'[]67DP69K=!L+KH$*-F:C:`2=G@& MN]$MIT[NDS@-V?AE-F+CQ00A#&MXTIM:E?)0$R'3*@J@@!.8[LR!@U;LB@-WFB>?P!`P?70TOB;TFD7__`])T&"G=I@AK<.4.1?&1L-*+1F;V MO(?BH.Q'_><:[XBCD=EP(S:,.`"/!@#I8`9RZF8@[PA]!FEN(S;BXC#A,%]; M=G*.>$?J!C=BNP?U,J61P7%HSG**B(R>4C=J([IT?9S_CL8RGX@S5^OFUM)$ M@*[_^'$XQXF1FG$/S^@Q`R*&WEP]=P@328`^]_-G3@B\R'-"?PFM`2P1!E]Y0-XAG.`!5W/2.K>HF M5W51.94QI_,_3PC=G.=9SQO1K&U)%][6B?(IYO70_/12YV5=&H!E9_9E%W$L M#_5[$'*((S;<+<[M9]_U4-_RBKOIC_7V;R_4;"?T,S>_AR,V3D;T079T3Z%D M:I]C6W1TK4UW>?]K-QB0L'E?1T*/R4B_-WW[96P'8;L4^($G^((W^(/W/2H! M#81G>(3?RXYU(,0XRK"D^(JW^(O'^(S7^(V'RBF,@++D^)`7^:]4](M86ET' MX3)741-_]8S694:7=10/,0GX=7KG3NC"TYS'4T)`=5`'J^7[G3J*G;*,G=@W/S'`7.:HN]X*X>F@O[X$U/"]_CD:G9S\^/&KS M:[0[N/*^QZP7>O*L*21?+C<%>V)^DZT=/?7.#`'`>[SO#5OOR[-.&_5L06(3 MBT1CAU[!]WE\:KSE]X]DZQ%[P[B/Y+T31"2D:I1G*LCGXYHZYB0DMMLZY:)C M%_=;9G6:/T-B(P2=*@BHJ/1\CV96[W#.Y\[G>9T(-X'/*'FUC.8V7?J-4S8( MJFR9'/159L;?_?_#9],59N- MINV1934>:P"(:??Z$;0FD"#"A`K[<5KH\"'$B!(G4JQH\2+&C!HW`)I\B3*E"I76DQ'B%"ZC"=B+G2)\=Z)$Q5@).IW"08B$\P(7HI!J-!` M3S`*Q6!7L2'+J%*G4JUJ]2I$=A4*/,/J]2O8L`1=PLP8`R(AC)"***:JX(HLMNO@BC#'* M.*.*GA!@@C4TZK@CCSWZ&"-5`UXDFT)$5L0.(H1$D(X)S[!C@@GWQ#`=)A0D M@EUK"<#&H6]=>OGE2IV9L"&899H9D9!@89+.]%O/%.!)`D[=$R$S=?5#2"+3 MX-4/)AC&=B:@@0K*'`%8#GIHF6E^A MG."78(B*.NIA[IQS*JJ7$$#(EJ2Z2INB7S%32`4E07<)(H/=\QEL]W"2"&5_ MOCHLL2S5TX<>R2:[AP&!%?LL8K&2:B2TU5H[$3UZ=*`!MQKHL2*6B_`!7?)SC2> M)&)"`@,@H,>ZW?9K,,4:"8PHP15KC-@]Z7!"R&4%#%"`"85PHF\('JCLP<0; MNXS_IKS/9OPRS4$R_!2!``(<-\]N$-T"VHWX17?PXXU4#-\7P$4$()UCHE;#G-9 M2E_.]#28@'Q`WPE(A_7FI4MD>*"(FP[M/=,PL_<`!$`(`R;3L"/XZKDCG3FQ MJNN.J(?I.![!`000(+G;H/Z^?.%)]\X\Z\]<0@@%!P1`0`0G=#HO]-TGA#J@ MOGMO&^,W/TC``7_#<$G6N(__/OAGBO^^8^QX4H@)$12P_S,%A6#R#/?H)\#= M!;!<`PS+,(:6+&*@B1E]HL``=B8!Z3##?0>\8#_B9Z;Y89`CII`#"D*(@CFD M(B&,H]0)B'>?GOW/&F3J(`P)*+,86L441&"7'%+A,?Q%((('J,#DWD;#(3:/ M=\/B(!$K8D,<0F``!\@>(IQDP20.48-E0B(5);+$;LG!#\^H7!;#6!/G'5&, M*$D'(NIP0RZBPHQN_!X9Z<6..=*QCG:\(Q[SJ,<]\K&/?OPC(`,IR$'J,1V> M(D`!AH"'.S#R#G@X!2$C*T&1'(7K(3F9NU)T2[1)% M?^<)$_BMHR4U:#PQ%D9K7$)JH]'F2TT:T[%1T1H,'<`)A)C3G)[4-RE-G$4E M@,M$='*H[RQJ;XYZ-VL4HGBU(JE3-PI5WDC5;/4<62&LF=6L;O4V766:-1)1 M/`IP`JMC?6E9;7-6FK4.!L5SZ%OS*D/->>\>:PF`!-RBU\%R%*<\A=XT"'$? MH;B5L$3=:=THF/?558G5L7J-:VWF^J]:@HX"MK*L93%+&\V^ZQ[/@$$!"C"I MIH)VJ/^BG0UIQ;4KI29`L*V][6LQDHZ?/)0@]$R()]I)D&=PPK`)B:VUI(G( MH++VMF2%K%285(@3'`4AER@`0A"!B*(XQ7.8T-13!D=/"J0VK,X];SE=BI6U MM(4=%&I-!`A`$#TYA1#AC)!/#,6EN*6CJ@)0#7H#7%C"/.,`A>C)0)!D'X*\ MA""8J$`B$`1?UB(77\PX`?IBW%\&$[$#E-F9@US(]Z0>_@B[$@``3C!C)*0&#H5>"\G#@"#P&B((IC@!">"J^0D,WG) M3FXRE)\LY2A3>TG.4QB[G,9#[_LYG3C.8UJ[G- M;'ZSF^,,YSG+NJR0X$8E(`,A,H-295)=//Y:P:RA,,W9PH@*R M*T0^9TQCZ$8%$RY,A)M@T^/64&`@A+C$79PRO?!N#(T)"`!;62QIW%*:)9ZH M0%``3)!-G\:^3_U>=<:A`+WD(P,H=8YO>4VMX>=&&@GY@\MZ`"\ M.U`'/N0L`N%$-[[3:]S#A>L/*F!7'!Z@FEWGN\.MEE^__]VM.A2CX`X?,%^A M9<@\*)Q;<6CXP_.M;L2PFS#3L&L`:NA0<0TP/./DE$="]*&/J&S\,!WWBFD) M40!<%B(=@,`#SG&N!V28G)OZ,`,MO"&&;Y3!%BP_^`;Q54N!%B`&%23(.O_7]]WZ@9E MC4:/S`1M17M!\3&/=8@#&]+HA2@JD84OQ&(?T47Z%0%EVI$H!]1XY^8^[C$/ M;$"C%YJ@1"/>P(8>]"`'..A!&JH`AB^``1>'![M,R\0,A@I``HB`^^,%N'>_ M^T(4F7B$YGF``QSP0`UO:`0E*#$*:$A#'?/HAS[04`:U\R(,IF=)RPWSM0!S:H`7C,;Y[S/5`#&]@`?%'X`AKB6$<[YC$/PS^$ M%_#8A]>_X8VWS[`W[I7```Q`#'A"YFE>#^S>Y_V>\/6"-&"# M.+1#`1)&]!7&]&$$39%=`9S`9QG@NZQ<_TK@0SOTG33XPBAD0N8UH`=\GN\U M0B-HPO!APSH,2@82Q@92A/V8P'U0@+:)H+CP0BS(@RWP@C<4849XB/>IP]^) M`OFEGQJ8G_I1@BA((#:H0SM8(/V-2@Z*Q0Y&Q.K-7&`!FQ!62SB,02R(01F` M@2V0X$/<@SI0`S2LX`*J@>YY``^PP1L$'_M!0Q8>W[E\85B$H4+0D\QA3SA= MX!FZ"CR(P1=\`2[$`SN`GS34(0N^00/R`.?Q82,\0B;48#O@`SYT(6_D0S<$ M">+UDV%T#"+D3-,]72.B2^3=@SA(@R18P16X0?KU``_P0`Y4(?M-H`V.XJ"$ MPA*X@I[!'L*)1?];5,#.X-4L7HL(RC_9`G,.,T?LG>]1TT7*/Y]4#Z@:(O2,,ZY$+IH<$: MQ@(<$DL^F&,1)*02O,(Z>MM57!CH2(#CS:.HM`/E:<(C8&/G:<`>-D(F8*'Q M+80WF)XF1$,XV`+*'0H^]!T*]H)+]@(D&$%"SJ02-.01*=,IS5T,Z$P"3`I. M_B10!J50#B51%N4L60,=5IXH9)XVON`O5N'PR9(Y*L$U&*4H(24U9.4S.`-7 M-D,OC,)7=H(FC&4F.$(C'$(C&((/\,!:BD`&O.4%+(!;ZE>9YG!G!`>J;G!W0`!W1`"OB` M?/K`(3B"?3H")XR"?HY"=4H#-5B#=);2]QTG.JHC]*TB0K$$DGB@0S$B18+% M/(A#Y=UA#FRC,/:C.`CB280&@1H!`B9D@HYJPE=^)314)S6H0QU112@H@8$>*.H=UDET MH!.!H(,^J%28H#A40QV2'P[D@#Y")2"68C^08T5T'_A1@S1X929,PB&PP0I\ MP`5,`'G:P$PFI!$@@2'"G`N(-4@0^\)TT.,,HI&I:^D":KND" MD"<*I,`:L(%]:N$\!&I"2-YS(B4T-(,F9(*(\D`*E"<'?(`( MP.H*K($A3,)'`B*;W,X]Y`.A<@0^@$*\RO\K@DY41J`1`!8`([@6C1X+D."8$/DQG+W3"),#F&O!`FG8`>88K!Y#KG(9B MK5:#-0BI1LVK5]A-6DG`VDBCF71#.Z!3]YFJ=%XB-*B@?@;?`N9>%5@!%8S` M'KX!/TH#;JY#^#F#Y;$@>.:E7))G",0GR'JD)J@KNSJ6UV+%S+AC:MF=/$;& M-3`!$YRMM>C#_D$#*=R#-S`K59"BY)7J.I0N:]ICV]K>Y.`A0&'^N^`?JI00[<+PYT2P[0[A2JWQOL8>VNI0\80GBR@0"SI7B&0`B( M0`=,017L0!;P@!1(00>LP``?PJSV0C-,0S5PK"RZ`48;PJ$)P^4:+DF[R2(['X. MGR8$00W<@!IK@KZB&PA+13'4@0BA`!'\0>O8$OID7QN#Q*6&B//^,3N4_ZX@ M4UYV:N>LSJJ9'H$.9($56($4V``2L*XD3S(ER^`D4$(F8+(F9S(G;[(G<[*. MAK(HCS(IZRC`.B>;]*E%N((2).0G.&PCOG%4%$,< ML(L*X(%2Q:+3..=SLBTT^*TFB*587MXI3T*-GB4VAF'&YUNB=]O\"\;7OWNHFY2K!-<^C-K,$ M-WNS'2@`!K.S_!K"&QA"^GGQ+R8T""#T"R[T[@DUEB)L[=;N&SPU5$-@*M-@ M&>LG\?GP+?69(H(K*.SQH3:_$37>+"MP!4O\BENJCYC5V)HB" M)D!V9-MF(1=R^UZV?^(F:S;G^\G?Z'KV2:!#&9Q!%WB!&UH+.(QO&DA!)(`! M.-RLQ+WL;10VMZC`'U0+$>H#$H9#+`AL^/;#-;A"/J0O;!?+8*O$,>!!'2QW M'=P!(&1N0H!O<3O5<:=H!#TD`W9;`G9KPW1WMU54-TL8HG=#*7BOA'B/-T66 MMTJ<-WI/HWJG!'NW=S;+ME')MWVGQ'LCQ,>Q4XM!VK/=-X"#1'YGB/4B`J?T M@W8]0S616H`WN,70-U7@3^=85*CQB80)BX-G>$O_0/A4*,@)8`)!((*$3<-K MA(J&G_A$##A#),`!=,6%%$0![%I;;1*-U[B-WSB.Y[B.[SB/][B/_W@=[7%% MJ#B!YU@,8$B13<0T/`.3-[F3/SF41[F43SF55[F57SF69[F6;SF7=[F7?SF8 MA[F8CSF9E[F9GSF:2WEE-5/T8F`_%-N?,#JHC[HSBCJIGWH[FCI5+`X*BY+[N/KW0$3';$AH$)Q5L+ID:$WA MZ/I86!"O9U`+1\4<(41H_Q10QP0+KCM$LH_%8R3[L;_ZK^-4L#2O8_!ZK3_$ MM1.[6PV[;XG28]P.L7N[LHN[;[G5LA,$P6DZ=2R&4[1%#%!`!;S0/0!&!;`& MDPQ`LIG0D<-`8TP#HO/W8=Q%`?B%7SU*`D3:Q\"`7/0#.Q""`(#X0MP#(@C` M>\T[#-`.8H`8EE!5#&`?W-P#4^32G!]``.G)`8`*DQ#`FHL%G-!Y!B'"NT?) M(=*[A*6#HZU\.IP`OCL8(33FN8E%PS]\A?2\9RR$-?1\`CQ4D!V'0W!"U0R$ MQ!."!#A+8?B5`,X74X`3W#1\#$3`>S&#!,2)0SR#!)`\LQ4`:ZF[7Y6X-<0$ M._](@*4DA$$PO`2`RC,PB$-@?#UI14GDAJ-BQ3W`B5\P#G2<`&L0^T/974%$ M@+G$Q7NM%,-7P,I_A4A@B1!9`P&$8&O,Q<+[2@($4.!_/D)4Q^2#Q5NXO`ME MD+TIA#7XA6C0!.D_Q-UWA6DQ6`(@AC4P_G`1R@L]W:&C.\A@.R)T6H;$Q.LC MQI,@^4!,`P'\_-/1%W0X/4EY/F7PQ0"DO:I/A2Q(P.;16H"'&1(D*(JJ@\1(%F?V8P3A:DVE3@C`2.DS@*2.G MD029)6!',D'/?HDN$5B:,1TA0EZ=IE6+$>;1>R=4&KR'B`"B@NDJ7GQV8&L_ M"I<*,"-HHM!:PQJG19!HL-#`BY<.Q#AYT_'%>Q4N];LGD""B$X=!.XP!PR$[ M$V@)EB4@F."SKER]6HL0-W1MCV[A6J8+E*!LV@;QNC1XR6[MT)0=/B.MM\)K M@HF&9BQZDAVB`96-@X9:ND)?@]9B$!#>S[7WY,Z?89HFEF;9L]GA:_0DP3RS MS"B?/>LYC=#JU"U3R\^:K$Z2_^`2&"1XAI,#J(IO+8@6ZPT1D-(1L+>P>+LI MIW[8R2^NOSB,@#5$3'!PK=$>LR:\O"._*R\2U./G( M(&8VK/&9&\-C+:4`]?MO/,T0,6_'FC24*Q&)7LR/(':8B<"HSJ+KA\5G3IJ. MH'NF@:&`)9^L:;OAA/O2Q6>:6ZR\WFPD"**&K,ELO;%6,@NU-&MKZRY,7*0` M``"N>FJYX)XZM(+$MMJ,*DP0,=-)0#=*+$)V,.D+!D=E0H2",25P[))#^=*L M`MXH:#"&1#'E"$6%'$N'```":%"S"#9<:"MV)#BT,"^=0VFV6)FZ;5"0V(E` M6(-.N,G*-X)..+3$?A@=$Y,_D<4(N8(X$>Z90P7P;J?%H$MM`%Q9*\JARXKK M=J,U6VLP'0'8+>B>!!R;DYT$#BW.M88*H>`$"@0X(4*-W.-67J?FZRM/D*RY MAT^PE+2,`HNLH:`O=BK8\&&N%F/GDH;8N?2@JZ+,",1^$!GI'A-8&_FB63\NQ-(T2")-HAEH2[!Q,J'7ZXY7["51HCT_H2 M"FB9Q#2($%V+-HA>9AI<."1QM8+-H&<(4/G_HH;+3NL>R%Q*K(`((C#A*$XJ MJ%$RK`ZX9"Q,8)@FALS2X80"[.K6S),#!DK'!`+XIF#A:2AXQAI"%I.M$)6M MD2"&K:RI(#VE(K_RX(:8(>"`"!*`M9]"8K"&DPDUXR0P;WW7E9D#"&U]3$0. ML`BBO2,PR2!,3!B0D).&+_ZBX0V_!P;,(TC0>-'9F6L`OOF5ZX0I$]F0'4*$ MOJ@Z&1.!P1I/"N'39M.ZZ\<3`A*@?=@QS:*[1+@($[^SC.]JYB7VS(1NQJ/) M,\S2)$R8Q2QD0TDA"#'`*V&0$+_!"B%&U"0'IH:"Z6`&!0EQGX*P`X.C&U,B M*FB92YBE5H7@C?&L_Y)"=L"0@K\Y(2$J\SE"%.)/[B$BARBHMK+],!$F0Z$% MIX%!PUTIB9;AX#3X0T'>1>X>//1$.C@X1"=-D!#C\819-.@0)K[(+"(S'ADO ML4,4JNV'E*5X<:>`(`1E(00Z2D(4TY"$1V:T_)I*1C73D(R$9 M24E.DBQ^HN0E,9E)36Z2DYVLY'L\&4I1CI*4I30E?!9Y2E6NDI6M=&4D4_E* M64M=[I*7O:QE+GT93&$.DYB3!&8QD9E,92[39L=DYC.A&4UI M.L69T[3F-;')S&IFDYO=].8O+?E-<8Z3G*W<9CG1F4YU,O*];0G*L-9SWMX0CT*P<2V"C(-U%@#$YX(G_[^F=`_,6,L!%61`Z=1T$$] ME($5B$I-(HH)3EA,H1SQW<(24:SK_3,=Z;`?1X!DO9688#F,M$:$[E$(^F0G MI2>=YCR9V8Y\T(09<;)3#!#1DYO\#R5_*8I@F$&!"G""$S%2H68(`+E+F$"C MT3)1./31#V\09*N9*L1U4G.)$Z")+!5H*4W`0X"]0()P@@D0[U`Q,' MX-8]8F`"IA)"UAE/(@YPU@5]C`)$-0X\=M$/66BUJQNY M!P7\@Y(^HGF@:2S09G<:=6*DL70ZU_76I\G MG+.9BWZ%N/$)!R]BX8W:;F2',-AN.NR2.A/T%7I`1,D)8D0:=D"X54AD:1HY MFX`5)L`E+*Q`!4P*`Q.4"EL%&%`!#E`(V335;Q,9`-D$FKH*]+5'ZO5$F2@P M/8-,!2D"@0&('VR"YF%EP8F8A@0"(^+'KF7_NM75P'5I<@G\VM&QC2T,,TY0 M@>C=C0*(2$!C.0%A/GV7/+R*0>!0\N/305.\MF3'(=C`AC7(F1.#E/K;J(S,"D,"F MB*(1G?;TI]N0!2Y\FM2=]L683D8!CUG#+I6ZK>'\%M';4D71GA@5BA!1&$3X M"%P$,,&O*_"[T9H&!EF"V5!L53$3V`4O03T65@3@041(!D2)J`LS^%/2J.J+ MQW`]"V;\,A`3?":*6".`"0,35,,4XL/M;C<'40E!A7>>U\(%[I00P@QU]USJ`%<3@ZTMJ)I@&]X\$ M3B:#VZAB,_X.$6#BZCX#AL:$<%S+.)JLNJ#,ML9F&B:'-R"B`JY"Q,;D3.:$ M)23B]"PC]2A`,`C!]T3JF6"/F%Q!"9R@'7B*-69F\?1'A13M*U@C7?J!7K[* M(A!!.-B!>`@B+%AKOXQ#'G1!'V*A'W@A'&;"9`HB$0*@?KB/^P;"(_;'!TD# M10C!!)I%,+SN*,(NN`2#`ORF.MCM*T8EV>JO,([_ZVJTI]'HBG,R`P"/Q58R M@Q-JAN]"Y.\"3_2^XC,0"&;PS\AX+#XBT+IFHMR>(CJ.+#&H`C(:`B\JA/08 MHO[<2%](Y>K^*ZZ1IL;R:LX>94XC((+0*N`F0$(#,\(^5* M4'\DP*A433`6I&D*H$%V#2PHP`B-PQNRJJL&;&LN@<0(HA`*(P8B`+4ZI\N` MJA^H0`"("+@ZA*"C1,P80`,IV`P M`1LG1[(T0\A2#A$L@GV@,:*\KS,$(`!81_@(8'HF!Q\EX#2TSAH)!08"0`"( MR`0,:GL8[S"*`14LTB)5_X$C2F?-\`H`F@@1"F!W"D=[_F)LYB(DZ:H`5"X! M8`#X;DA_&*Y#4NS_-`<1_G$V%D(4@VD%LXD=/,$3(L2DYJ=!]LD3.NP>T$9. M?O(G&S+)&LI)#F*%"C-("F_)M?K)DLM(K\3+N#$HO/8%,C'(H MPT+.(9"O,GS?(E+7`P+S,R M&X(SY0I,+(X4[ZEHYF(@3PD3-FLUTZ0Z'M.;>%(VLR,=6*XV+\GA<`(W9_.= M;DH3.(FS.(53-8TS.953-H=S.9WS.:6I.:%S.JF3F*2S.K$S.VWI.K6S.[U3 ME;CS.\5S/#DI/,GS/-$3DLPS/=FS/0EI/=TS/N6S;FW<0S]*ZC[Q,S_U XML 16 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
 
 
Current
   
Deferred
   
Total
 
Year ended December 31, 2014
                 
Federal
  $ 34,799     $ (11,674 )   $ 23,125  
State
    4,991       (2,698 )     2,293  
Foreign
    4       (2,134 )     (2,130 )
    $ 39,794     $ (16,506 )   $ 23,288  
Year ended December 31, 2013
                       
Federal
  $ 27,985     $ (3,050 )   $ 24,935  
State
    4,145       2,051       6,196  
Foreign
    —       (598 )     (598 )
    $ 32,130     $ (1,597 )   $ 30,533  
Year ended December 31, 2012
                       
Federal
  $ 20,843     $ (504 )   $ 20,339  
State
    4,232       (911 )     3,321  
Foreign
    —       (1,538 )      (1,538 )
    $ 25,075     $ (2,953 )   $ 22,122  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
 
 
Years Ended December 31,
 
 
 
2014
   
2013
   
2012
 
Computed “expected” tax expense
  $ 20,698     $ 29,013     $ 20,125  
Change in income taxes resulting from:
                       
State income taxes, net of Federal income tax
    1,490       4,027       2,159  
Foreign income tax expense (benefit)
    (454 )     622       1,468  
Deduction for domestic production activities
    (1,444 )     (1,361 )     (1,277 )
R&D tax credits
    (447 )     (1,652 )     (508 )
Other expense (benefit), net
    2,329       (116 )     155  
Valuation allowance change
    1,116       —       —  
Income tax expense
  $ 23,288     $ 30,533     $ 22,122  
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
   
2014
   
2013
   
2012
 
Pre-tax income from continuing U.S. operations
  $
67,114
    $ 86,382     $ 66,087  
Pre-tax loss from continuing foreign operations
    (7,978 )     (3,487 )     (8,587 )
Total pre-tax income from continuing operations
  $
59,136
    $ 82,895     $ 57,500  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   
December 31, 2014
   
December 31, 2013
 
   
Current
   
Noncurrent
   
Current
   
Noncurrent
 
Deferred tax assets:
                       
   Net operating loss carry-forward
  $ 4,277     $ 16,190     $ 439     $ 14,061  
   Stock-based compensation
    —       6,408       —       6,630  
Chargeback reserves
    5,391       —       —       —  
   Reserve for product returns
    12,255       —       3,189       —  
   Inventory valuation reserve
    5,764       —       2,193       —  
   Other
    8,570      
192
      3,325       1,751  
      Total deferred tax assets
  $ 36,257     $
22,790
    $ 9,146     $ 22,442  
      Valuation allowance
    —       (1,116 )     —       —  
            Net deferred tax assets
  $ 36,257     $
21,674
    $ —     $ —  
                                 
Deferred tax liabilities:
                               
   Prepaid expenses
  $ (1,982 )   $ —     $ (1,120 )   $ —  
   Inventory step-up
    (1,619 )     —                  
   Unamortized discount – convertible notes
    —       (1,776 )     —       (4,223 )
   Depreciation & amortization – tax over book
    —       (285,022 )     —       (16,576 )
   Other
    —       —       (81 )     —  
      Total deferred tax liabilities
  $ (3,601 )   $ (286,798 )   $ (1,201 )   $ (20,799 )
                                 
Net deferred income tax asset (liability)
  $ 32,656     $ (265,124 )   $ 7,945     $ 1,643  
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
Balance at December 31, 2011
  $ —  
Additions relating to current year
    1,265  
Additions relating to prior years
    220  
Balance at December 31, 2012
  $ 1,485  
Additions relating to current year
    589  
Terminations of exposures relating to prior years
    (1,229 )
Balance at December 31, 2013
  $ 845  
Additions relating to current year
    408  
Additions relating to acquired entities
    456  
Terminations of exposures relating to prior years
    —  
Balance at December 31, 2014
  $ 1,709  
XML 17 R54.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) - Assumptions Used in Estimating the Fair Value of the Warrants
 12 Months Ended
Dec. 31, 2014
Note 2 - Summary of Significant Accounting Policies (Details) - Assumptions Used in Estimating the Fair Value of the Warrants [Line Items]  
Expected volatility 79.70%us-gaap_FairValueAssumptionsExpectedVolatilityRate
Risk-free interest rate 1.80%us-gaap_FairValueAssumptionsRiskFreeInterestRate
Minimum [Member]  
Note 2 - Summary of Significant Accounting Policies (Details) - Assumptions Used in Estimating the Fair Value of the Warrants [Line Items]  
Expected life (in years) 3 years 292 days
Maximum [Member]  
Note 2 - Summary of Significant Accounting Policies (Details) - Assumptions Used in Estimating the Fair Value of the Warrants [Line Items]  
Expected life (in years) 4 years 36 days
XML 18 R48.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Goodwill (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Sep. 30, 2014
Jun. 30, 2014
Changes in Goodwill [Abstract]        
Balance $ 29,831us-gaap_Goodwill $ 32,159us-gaap_Goodwill $ 285,080us-gaap_Goodwill $ 190,448us-gaap_Goodwill
Acquisitions 260,911us-gaap_GoodwillAcquiredDuringPeriod      
Dispositions (11,454)us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit      
Foreign currency translation (514)us-gaap_GoodwillTranslationAdjustments (2,328)us-gaap_GoodwillTranslationAdjustments    
Balance $ 278,774us-gaap_Goodwill $ 29,831us-gaap_Goodwill $ 285,080us-gaap_Goodwill $ 190,448us-gaap_Goodwill
EXCEL 19 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!>WTR6U0(``-X^```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,V\U.VT`8A>%]I=Z#Y6T5 M>\;_K@@L:+MLD4HO8&I/B(7_-#-0N/M.#$052D&HD?IN8B7V?-^)%\_NG)S= M#7UPJXWMIG$=RDB$@1Z;J>W&JW7XX_++J@H#Z]38JGX:]3J\US8\.WW_[N3R M?M8V\*='NPZWSLT?X]@V6STH&TVS'OV=S60&Y?Q7?]$;=]"[X?.=_?DAB=&_#X/SAP=VN=:CFN>\:Y7S2^'9LGVU9 M/6Z(_,GE&;OM9OO!QPCC@QMV=_Z^X/'<-_]J3-?JX$(9]U4-/D9\U\>_)G/] M''$@Y;39=H]NIN1G\&XCL;+1J[59K-_31\]$# M_#G[E1R-ZIOSK2_\'ODE[.>^M-^WD"_,-%O?QS;Z[0&>"M>[TZO9#]+&=7I? MN3Y47=YO]%WNMR]\UIW6N[9XJ]L#N^.EG7[Z&P``__\#`%!+`P04``8`"``` M`"$`M54P(_4```!,`@``"P`(`E]R96QS+RYR96QS(*($`BB@``(````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ(NR%4'L`D[A^UC:,D M0/?VA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[UVIXK9]6#Z!B(F=I M%,<:CAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+\>QRI9$P4P>J/OH\^;*W-$UO>"_F?6*73HQ`GA,[RW;E M0V8+J<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;',@H@0! M**```0`````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````"\F]UJVT`0A>\+ M?0>C^T8[^[\E3BY:"KEMTP<0\L8VL24CJ3]Y^RXFE1MH3F[$N3%(QMJ3V9GO MS$[0]>WOXV'U,P_CON_6E5RI:I6[MM_LN^VZ^G[_Y4.L5N/4=)OFT'=Y73WE ML;J]>?_N^FL^-%/YT;C;G\95>4HWKJO=-)T^UO78[O*Q&:_Z4^[*-P_]<&RF M;=37<;;2O5O=/I[+TVP_O'Q[V;?[< MMS^.N9O^LT;]JQ\>QUW.4WEH,VSSM*[F6V-]_D;[JZ*YJE^1(VPY@N18399C M-903V'("DN,-68XW4$ZI)6HJ^XCD1$N6$RV4D]AR$I(CLFAIC;MFR)MOTU#` M.I8_]!D^+VY#.6P,"L2@*':EEQ5A?-A<%LAELVCRS!9U29SYUK-K&V+8S:5/:2R9U/98RK+HLG3-H?V MTZ[9=Y>&9[Z%>!/9^(L0?Y&-OPCQM^R)9NY`+WLTWWIN2@7B3]CX$X@_LV@& MSZ%X/3H&XL^P\6<@_AR;-P[S1K%W2Q3<+E'L_2HK(A0ZME\YZ%>!3>8`R1S8 M9`Z0S(D]O4AP>I'8PZ:$ATWD,PV,#3LT.#+L-!:8QIH-90V9K-E(UI#(AITZ M!N:.93NZA8[NV-V@@]V@*/9NE161GPO;0`4:J&$[EH%4MNQNQ\)NQ[$'30Z> MM#P[=SS,'<]V+0]=*[!=*T#7"FS7"M"U(KO0(RSTR,9RA%1.;.XDR)W$]O0$ M/5T4.WG*BLA$V;N%-XM\K,%;Q8:@0`@*&X("(6C8=67P9BFV'E%0D&$7EH&5 MY=C]CH/]CF/W.P[W.VP+#=A"V0>_],;!CYW+HF`RL\,#HQ/8AAZ@GR?V.2O! M MELB7?Q.?+^OS)V2?9Z/80SF1#;\(Z2=L^@FDG[#I)Y!^ADT_`^EGV/0SD'Z. M33\'Z1?8]`N8?HJ=/*)@]HABIT]9$4V9V+,+.+IP;)MPT"8"VR8"M(G$'GLE M./9*[-1),'?8P8&QT>PJU[#(+=LD+#0)SS8)#TU"LSU"0XNP;`A:"$'/AJ"' M$(SL.H^PT",;@A%"4&31Y!FGIT-YA_[R!NCY^F\[4;]XK?[F#P```/__`P!0 M2P,$%``&``@````A`(U#UF(5!P``OR````\```!X;"]W;W)K8F]O:RYX;6R4 MFMUNVT80A>\+]!T$W3?B4B(E!K$#QW%0%T'JUDYRN5A3:XD(1:HD%5MOWT,J MILY:LT%X98]MG__[;F\>R^G9?EM]&$"CJL_&Z:;:O)Y,Z7=N- MJ5^56UO@-P]EM3$-PFHUJ;>5-G[]YR'+[Y5#1R&RWG\P&>3_EXU%NZN9JF35V M>3:.$):/UOE!M=N^VV4Y?IM,@^EX5.-EO;![/+F#N4]J\.O0GY!^YR#^G>[KJ.C*>W9$7Q1+?54T6;/7U\7!_:Q$"UO7KU&9&H^JUQF^ MJ:Z7JDV<52YA8IEG2P.+]#N3FR*U^K;]:,T2"I7T(N$`$7UC2&=**IW;WE1N M&V34-KS6Y8.^+#>D,B.5V4]S.5&!%[TOL+XO*?HUF3:7V[6I2$4I]K<#XU>+ M,FSQG+*9O\SF4]E8K?2[79T5MJXU#B>:56>=.3=.-B'I+$2=4-_N-AM3[;MJ MLE61X8"9HM&.#K?-U7^[S!&*R15UPF^71:P_ M9`7PQQC4%U5EBM6!/T>'NZ1.".YTYOK*5`54:GUCJQ;=35FTU#A"F+$]?/!( MJFRA/UKT^&?I)*QRPG"73J)OFS+]IO_>=@-37VVV>;FWUNEV.ZB.Z9Q`W`FI M`&U*RXW5=^;)[5/(1T!YZ%6@I,FJSM2N5>Q'R-@JF5L%<.VJG0DTY[!+CK"% M#*V2J573KB59%61R?6GJM?Z`#>,( M,<&P212*NO.#LGZ.!]Z[F3$",,P46BN/Z/5 MM!G^*C/D]\418H1#&6&UT)>[N@$TU<&L#-^TECM"3'$H4ZP2>(2=CR5U8]JS M?H<#6INT8:$I4WS8T3R*.XK#`!#AXJ?;CC),-&A3'08XHBOP`ZZG5K;7H$Y\V_*/(^QQAL MO]\[%D^99]@D-=V[%N#(\62T%S']I(!9DI)W,;A*3/14)MK9#)@[6#"N00PS MW)*R\2X(-QNF&79)2KX-X5K--,,M2BI#_6)/"%V;,=;3$ZP/VT8<]B\+8ZQAE^2U=]Z[A3'6\$M4\@U\ M5XFQGLE8*]^@=I48;G@FYN2;U*X2PSV3X?:.:E>)Z9[)='O'HZ,4,=TSF6[O M2`*&_4B:.3;)='N%0.)1R'%)AMLK!!*/0HY),M]>(8#8"SD>(9`(\`J!PUY( M1?"^'P$(!BG!X%XIX@F`8)`0#.Z%E*LDX^TM#@[W2A%/`00O4L*]28F%CUU] MV][6,H01GWH$+S[9#2+O,F,&5<0C+9)I]BHQA!'3C&!02@QAQ#0CD(3<]?K> M-B;+Z_9FC-Q5KKTRS;+01`120MY=[9K-;8MEF+U*;+9"IX['(I9I M]FY])BGF_B.0BO,*<7$QPXQ@D!#7%CLFR6Q[,V*0E(-D++/M5>)Q%C/;"`;5 MQN,L9K81#!+B:::<4Q++<'NOUKAO'>[]@JA$,*$O?44(+AAK! M$)U/I*.<);*0J?95=DM""^#4GPX$8D(G3ZSTH66LPT@O9*3EYU;08ATF>B$3 M[=5Q.L9$+V2BO4)\6!=,-`+1(=^S-$>(H5YXH/8)\:E76/74-`_6OILT3BEA MK!&(M?GNT1PASBCQ<.T3XMH2J/8\(AB4$4^TA,%&,$B()UK"9",8),3+.F&T M$0P2XF6=,-H(!@D!POZ&(6&T$0P2XCN/A-%&(`KY[M`=CGA@)QZR?4+,$5XI M$DAM-"@G)DGA>OC(I`H\=/N>\')Y*G"E/'S[I-P"&7!U>&?;=?;':]'#TR/? MXV(>E2I@Q-M(\DIZ8-SM`0)*.9?_"B]U127?8V/7*J97)I/G M_WMP_C\```#__P,`4$L#!!0`!@`(````(0#;'IP%^P@``*@H```8````>&PO M=V]R:W-H965T&ULG%K;;N,X$GT?8/_!\'ML41=+,I(,6A=J M!]@%!H.9W6?'5A*C;2NPG$[WWT]114E51;?MS$N[4SRGJ,,BJ2.)][]^W^\F MW^ICNVT.#U,U\Z:3^K!N-MO#R\/TKS_U73*=M*?58;/:-8?Z8?JC;J>_/O[K ME_N/YOBU?:WKTP0R'-J'Z>OI]+:O5IB/M=W/?\Q;S_6I[F&*&Y?&6',WS\W9=%\WZ?5\?3ICD6.]6)[C^]G7[ MUO;9]NM;TNU7QZ_O;W?K9O\&*9ZVN^WI1Y=T.MFOE[^]')KCZFD'NK^K<+7N MF^6J@OVU,",ASAZV["OQ^ MG&SJY]7[[O1'\_'O>OOR>H)R1Z#("%MN?A1UNX81A30S/S*9ULT.+@#^G>RW M9FK`B*R^=[\?V\WI]6$:+&91[`4*X).GNCWIK4DYG:S?VU.S_S^"E$V%27R; M!'[/)+E`#"P1?BU1P7\O$$)+@-_/]01B.IWP>UM/"TN`W\_U%%LB_%[L:8Z5 MZ`I;K$ZKQ_MC\S&!U0)CW;ZMS-I32TC25Q1'9:CQSTH,M35)OI@L72ZH7@OS M\MMCO+B??X.IM+:0#"&P$PP0Q1%YCS#SQF0M9*"4`2T#%0G,0>$@$R:+E!G` M]#\_<7M5AB14Q?R:,X1053Y'Y#UB4-4'QH'P$\XI>TC/T7U@Y,2"4_40X##E M,,6I\LN*#?AA"JF&(L4IO[8,(8NNR%$:>/)"<@2$W9KMRD@9@8IC)0I?2H:F M##]:J$B*)0PF%E8J%6MF<_C3_:DOLR%QT8DG1",DZD3[:10FXH)R!!#1E*'" M*/'$S"DE0S.&%X<+L8(JPF"B02`5?;G"!BS$BG)D".G%QE$J1B-'`!%+&2I6 MJ1?R\2LE0S-&F"Q2L6PJPF!B88>D8DV%KR]D0Q*B17\90E`T%'@1<`4YMA/- ME!`%D2=F1"D)FA+"Q(M$#Q4A,,6P*U/%E\MKP$*IZ"=#""H-?!6*B9EC.U%* M"7ZJQ,B5$J\I/E51Q$>R(GBFTYA$ZK-.`A4XQYS*$]--8I6(CR[&=Z*0$ ME29RTRDE03-"Y!`J0F!*T\\H-6"A5(QHAA!4&H:>W#AR;"=**2$.?5E1B=<4 MOTABL1]4!,]T*KC#WE[2#BV4BBTPLQA;5,]+8C$6N440L8R3!+$G+K]T*)I1 MXC0-Q'54E,(E&P-R\RQ6:%?H_381RS&S&)2<+F+E*,8D5#%&D)(DOK,=VYPC M1;->H,21HYCTPA4;XT$4W[8C*[0K3+G803.+01EWRE>^7,(6,>HHAHCQH'=) M**?VT#Y8JR'2,>)$,*JA71HK\_!`A5_>L#JTF-U"3F8Q5G`0+2(Q&7*+H(+1 M"EE.L@A%TM*A:-Z-\L)8;)T5Y?!B&P_R^6*C3))9"IJB%21U+F]OV47+A1$HGHIU(12-C=BIE0H;PWYT-S/J6*(&$*0BLVX')I[@G8B%8UP><8P$'DW;J5H M,YA,L:`S1:U*E"IY0\LM@):.4A(_<:4B8*1HWDL&L:"]& M@RD6A<@4]2Q^X#M/;!8P7G[!*`$8=#%92H>B&<6'.Y18,A6E,,6^\$:WU;IC M\;M(*N[4F<78325*0G%?S2V`*&>4R`\60D;I4#2C!%$@7P-4E,*5&R=!:GVC M51:9>GL6_0HIBB M5IG%],4,0C'/2CV>9 MCYCQ*G,G4CB1THEH)U+1"!?SC]R-[[H;)7>^S(+2[@V2-PN<,DJK4@A&)+;T MTK:/XZ,%(Q#+HZ(,KEN8GQN+Z)H@Y4D79-[KPQQ'W7?>3`)R"QAE%$ZD="+: MB50TPL4)&W2C.-<.*4_LBIF/H*&HHD2Y;:?:.,,M*K:/#"W[<(I*&%RW\$HW MZG8]DY+[:.8CZ.>ZL=T\)`_K&QXS^'N@0F0)Q7VLM.V7LVB1)1`UJJYEX6-F M+,WG;TUHA&"+)&K%`L]\!%U8"-).%98R3H;2B6@G4M$(%R<\UHT3PO5:RA.E MRGP$#1/"N?%B^ZBD$`RW^)*A!<,M-&$PW>;UL"SJ]8\"'0O>+;.BBL676="H M*W44S>A6^'$5?68`@J]D/E'(T(X)J9AP5 M)*EP:Z7-.G(T[T=YD>RGHARNVAB@VU6C76+S5?:5!0@:KR]W(H43*9V(=B(5 MC7`5PE-=J=T9+R4_%V8!@G[NB2U@E%DPRCE/[%`THYQ[P*$4+OD?V:G@C)V2 MWUHR"T+I=TKYXJ::6P"5CGG'2.E@M!.I:(2+,WZ#S$IS%UG`#GNEKNA2V)I4 MXBZ1!0CJQ<72,>06,$HI.&7A?+8K'8KF%/BX*8:PHA0N73BJ*Y+/."DE^LH" M!.'7],"/E+C#Y!9`)5,*?%B6#TZE0]&L%S]UW_=2"I;W;M9-U\VX.9)D9-D3Q ML%@&A\6Z2LFXO\R[O")>^$LXF`+]B;CVEW#XQ(U_"1(XC9:<:8$!Z\^IS8=D M<$[L;?52_W=U?-D>VLFN?H;+]F8QU.R()\WPCU/SUIW)>6I.<$*L^^\KG`BL MX<"0-P/P<].<^C_,X`QG#!__!@``__\#`%!+`P04``8`"````"$`'K/[J-H$ M``#P$0``&0```'AL+W=O_N,R5.@AIP!+1I__V.;1+LH6W2ES8Y/A[F MS(R'<1;?7JNC]<*:MN3UTB83U[987?!M6>^7]J^?Z%/E'7QM]DY[ M:EB^E9NJHT-=-W"JO*QM96'>W&.#[W9EP6)>/%>L[I21AAWS#OQO#^6IO5BK MBGO,57GS]'QZ*'AU`A./Y;'LWJ11VZJ*^8]]S9O\\0BZ7\DT+RZVY9>1^:HL M&M[R73]DGA'?=E8+&:!_2W9NM<]6 M>^#GK"FW?Y8U@VA#GD0&'CE_$M0?6P'!9F>T.Y49^+NQMFR7/Q^[?_CY#U;N M#QVDVP=%0MA\^Q:SMH"(@ID)E6X4_`@.P%^K*D5I0$3R5_G_7&Z[P]+V@HD? MNAX!NO7(VBXMA4G;*I[;CE?_*1(13EV-T-[(%+SOU_W)E/KA["M6X'G2E7"P M0B=TYA,_N.V+HW3),,5YEZ\6#3];4'O@>7O*1263.5B^Q$>IN4;LHX"!2&'D MN[`B;4$L6LCRRXH$KK]P7B`U14]:OT/RIM0D;=XA30KON3#L=AE1H*O=+%>1;4A5'DXJ!&`.)`GPI]8&0 M($2'(#4(GNN[9G%D%XNB[SSX[K#=D!I\1:H@WY*J.)I4#,082!2@I%+Q#C&5 MI,;Z-/+0>F:LNYXW5(4A%1KY_5D59"350Q%>*XXF%0,Q!A(%**G3*")(J;%, MIEBHL4R]H5L9.L64IKV\/C^H@GQ+I^)H.C$08R!10%^]-(C0V4_U=>KZ*`[9 MQ9ZLW8@,RX;0Z"M"!?F64,71A&(@QD"B@+YV:81>MZF^')`(-?!,7_8\^H%. M`F_5^S,JV5CI4"JJ]_8D3>H(B4=(H9-\4I*8471!&XM[0P$EZY%*GQ!N)NAA17137<68:(+XW%+JI6(P)]RM6 M0X7Q^M1.>Y]"11K4;`A&XA&2],B@U]+KE(\7J(;V!3Q2+.>)^Q6KJT!43 MBI*Q)MIH(F.P&2'Q"$EZ1#GL16&$S*8F@1+\F)QDX6VH_9'N.T;F;X?!BMOD"X)XFH^ M/(!20H?NJF*C+M[J1EFQ9L\V['ALK8(_BTLU@9GNBJH+?R(N_/+*?EV`^_8I MW[._\F9?UJUU9#O8ZDY">':C;NSJ2\=/\C[UR#NX:<=Y M=_DB?A.X_E:S^A\``/__`P!02P,$%``&``@````A`+UTF+31!```4A0``!D` M``!X;"]W;W)K&ULG%A=;ZLX$'U?:?\#XOT&#(%\ M*.2J2=7=*^V55JO]>";$25`!1T":]M_OV.-0?Y"2I`]M,6>&XSF>@_'B^WM9 M.&^T;G)6)2X9^:Y#JXQM\VJ?N/_\_?)MZCI-FU;;M&`53=P/VKC?E[_^LCBS M^K4Y4-HZD*%J$O?0ML>YYS79@99I,V)'6L&=':O+M(7+>N\UQYJF6Q%4%E[@ M^[%7IGGE8H9Y?4L.MMOE&7UFV:FD58M):EJD+?!O#OFQN60KLUO2E6G]>CI^ MRUAYA!2;O,C;#Y'4=\XS;^9!IN5BF\,,>-F=FNX2]XG,UR%QO>5"%.C?G)X;Y7^G.;#S;W6^_2.O M*%0;=.(*;!A[Y=`?6SX$P9X5_2(4^+-VMG27GHKV+W;^G>;[0PMR1S`C/K'Y M]N.9-AE4%-*,@HAGRE@!!."W4^9\:4!%TG?Q]YQOVT/BAO$HFO@A`;BSH4W[ MDO.4KI.=FI:5_R%(S*A+$L@D(;"7]X-1,(U(%`]G\9"1F.!SVJ;+1&9S3/D:)'/(?)D9\NCF>FVJ,$>>Y(EG25Q8[C"+!O1Y6Y)H.EMX;U#43()6 M/2`=L;X@N!;`KR,)4U=)]I?]PH6#.1WP@'(W9$+C.?V(*8=1&,")5*9 M\'*%L)R^9L2#`*<0(-',[QZ`+!$T[FBOE0&-PMBF,+ZZ%B]%X4&)"_/L:@`4 MB$$!0606"@7]41CI@#4"!$>-$CS>K,HP)1YD43*462$HQB5%2.S[1MW6*N+S MGD8OMND-B\:#+'JA7I`5@B*D!Z9LTT.$7;+)(YQXD,5I;'!"$'**^B@AP*;$ MWU:&%0R7B0=9E(QULT*0LK:5`4VIV2,4>-!@>R%(H:`,:!0(M+-:AJ];6Z"M M^<>&)!*%FDQZ19$06Q7"3?%N6424Q6MB\D+#5:HBXWIH<(^\GP8ZZX#U$42I M-)0171WNB@J-`7700R&9:GN6.HA"=<)I7\L0A/24Q7#C`3Z]-OSYJL$W`5%L M5HRLU1&]'#W..]RS?.LRW#$2I:J"<3U5,!QVH`J]UFJIHGDK"7MEN>:NQ+#7 M`4*]OFIM7Q3?E+(H([HL#UDI05>$I::NUL]WFEP=BG=*&LJ(3L.PTX$JH",. M-0NBL%F"WE<>N6:M@6&MM^V>1)1A9;`/,*Q,HI35JHYH90D>D?DUFDH7JNK8SCKU[W#/\#L;9!I:1*%ZO"M+/SHRW@M M(3WJW&6Q08_%QKZYN98H595KAAH8AGJC*FB00ZHH-HJ.)IXF==)5,8QU0!4T M1FUM1C-+%42A*I/^GKGFL,%=#BO0EI.9WQ02I:IRS5#YJ_[^EA51@TXF40H- M=413!8Y>'J&!QJBI$_OFUXS(G;CX!6AVB[RI=`L>X>`)1TGK/5W3HFBMNP(G.,=W3GVF]SZO&*>@.4OJC"?1^ MC6=">-&RHSA7V;`6SG+$OP&PO=V]R:W-H965T+N&2BT*J)JB[*^U*J]5>GAUP$JN` MD>TT[=_O&">4`9JV+VWP'!_.G!F;6=X^E87U2(5DO$ILW_%LBU89SUFU3^P_ MO^]O9K8E%:ER4O"*)O8SE?;MZO.GY8F+!WF@5%G`4,G$/BA5+UQ79@=:$NGP MFE80V7%1$@6/8N_*6E"2-YO*PIUX7NR6A%6V85B(]W#PW8YE-.79L:25,B2" M%D2!?GE@M;RPE=E[Z$HB'H[U3<;+&BBVK&#JN2&UK3);?-M77)!M`7D_^2') M+MS-PX"^9)G@DN^4`W2N$3K,>>[.76!:+7,&&6C;+4%WB7WG+U)_8KNK96/0 M7T9/LO/;D@=^^B)8_IU5%-R&.ND*;#E_T-!ON5Z"S>Y@]WU3@9_"RNF.'`OU MBY^^4K8_*"AW!!GIQ!;YZ8I;2L[2L7+?P;DGZD,R>1,$H+Z5SYT2Q:NH]@:G8&K4=`&+&Y(+2#FC?M++@@N%4-7G15C]?A(DZ#M;@+Z]HL M`'>K=M(3,H*884@ZA$Q?($AL\!&Q&IS80-YJ\Z/0P^]>&U#89K3I+Z2=!:0% M2MPU[E+NZP;J3="R2-,L[FDRH(ZF_D+:64":X`AT-5W7HL'8G]B;]J083&3Z M,/:\GGT;%)\-XBF*!]TXTAU_1+<&OZ7;8.;G\^,$/8LW*!XZ<8#S3E'<"<(V MC&1//R);@[%L.-A]OPW(^!T$TZYAS3'>(`!\NWH%25$\ZL:1FNN6`R`^$MQD'8?G/ZX^\VN019]^\^HUSL?`T)GWF-( M$6#N>/.V@#@)_4'IM-#U"OCF\X,OXT'WGU%7VA\A1HJ48@"ZD;!\_='IR-?7 M]]LG`":CD4[J.;@^HUX_`P@P=@@P8.04F/G*C!\E%7NZH44AK8P?]>PT@7NO M76WGNKMFK.NMK_6\I[]^;AN`<:LF>_J#B#VKI%70'5!ZSA3N-T, M/5NN8-!J?AY@L*8P;7@.@'>*7$25,`1T*;]]SMF2/#8 MW8:^-,$PL8FFYCG_K^O'+=KCCQ.N\<<>8-O#F( MMLY[>&R/;G=N>;X?)M65ZWO>PJWSLK&18=7.X1"'0UGP3!0O-6]Z)&EYE?>@ MOSN5Y^[*5A=SZ.J\?7XY/Q2B/@/%4UF5_?M`:EMUL?IQ;$2;/U40]QL+\^+* M/3P8]'59M*(3A]X!.A>%FC$G;N("TW:]+R$":;O5\L/&_LY6F>_9[G8]&/1/ MR2^=\MWJ3N+R2UON?RL;#FY#GF0&GH1XEM`?>SD$DUUC]N.0@3]::\\/^4O5 M_RDNO_+R>.HAW1%$)`-;[=\SWA7@*-`X?B29"E&!`/AKU:4L#7`D?QL^+^6^ M/VWL8.%$2R]@`+>>>-<_EI+2MHJ7KA?UOPAB(Q62^",)?(XD+')8Z"V^P!&, M'.'$X3M^'+%H!HN+40TF97F?;]>MN%A0>:"[.^>RCMD*F*_N8"PWO_[/+O!) MDGR7+`,7.-%!CE^W+%I&:_<5$E.,H!V"8%U-((I(KPB9!DE5R[WA_BJ3DPSUC%J[0Q`D6ZG@ M6!.97D&WW4`9(#IEJ];VL/LZY21#9Z#I1-!BW-%B+]%668J`J:(S98!H3*C& MSPM8@JFV*)ERA&L),5B_8<`6:NT-B!01BC9E@&ACL+I5`S\7-Z#OJ1M!6)^1 M$VK&IN-[19PZ0M7))J"D]XXZ;!GJYFAZQQ"DU5](DY_>4+<"5$>H1KGCS]>( M_>&.1@2-M1?X,3,\1(3JH3)"]@$R1&$%LG`9F15((('/ M#$1&$,RG$!J";`WS0\!&0D,P-E&&**Q2/W8B+<:4`.#(MM2."QD%^$XR`:AZ MV2KFJ\?&0M6;"5#;ST/H^Q_L`?*D"UL))NEA$4`&M$Z244CL$18:A&P;\X/` M)D.#,%.@MB+F)%JG2)GZ/G28=J3(R'OFQ-,&3:7+WC%?.G8:*MWT'U&CMXE9 MW2DC"";/!X;[!!*30P:-0':6^1%@'Z(1F.8C:JQ_WXFFZL46PE0`"QPM.QEY M#\>0J853[;+SS->.?8IJ-]U'%+J_"&)2MJ-Z%?+A&2]C!*(=\D@,<$?]0@P# MFC9)%AG^CRCTGS$GU%L0`9C'/'EQELL;"4)'.>>A=KP5XX6OYNV1I[RJ.JL0 M+_+&R^!<I_&A M%^?A=O4D>K@&#U]/\+,'A[N'YP#X($1_?8".ZMY^2-G^!P``__\#`%!+`P04 M``8`"````"$`&Y\@%C0$``#>#@``&0```'AL+W=OG>D&6FTVLLS`2=!#3C"I-/] M]U.%N=@FG4[G(0GEX\.IBUWV^NMK61@OM.8YJS8FL1S3H%7*LKPZ;,Q__WEZ M6)@&;Y(J2PI6T8WY1KGY=?O'E_6%U<_\2&EC`$/%-^:Q:4XKV^;ID98)M]B) M5C"R9W69-/!8'VQ^JFF2M9/*PG8=Q[?+)*],P;"J[^%@^WV>TIBEYY)6C2"I M:9$TH)\?\Q/OV4E2>@V.5%WKRUI*91IJOOAXK5R:X`OU_) M/$E[[O9A0E_F:<(,[!A[1NCW#$TPV9[,?FHS\*LV,KI/ MSD7S-[O\1?/#L8%T>^`1.K;*WF+*4X@HT%BNATPI*T``?!MECJ4!$4E>V]]+ MGC7'C3GS+2]P9@3@QH[RYBE'2M-(S[QAY?\"1#HJ0>)V)/#;D1#/(G/'_P3' MK..8CQRNY2X\XMW!8@NOVB#%29-LUS6[&%!YH)N?$JQCL@)FC(X/,1:^#/%Z M+UP0)R1Y1):-"4L&IG/(\`%9VR^0F+0#A5=`*B+J$9@%Y(TE@PV"!]40 M1UGU]5SVXA",XGK64!B`>U#K:D*N(!8J))Y"@A&BB(7$R6(QQ,&[!=B+QDE0 M:I)&B*@F,Q2@^>!9I!MBR:!H@E3+FFX'$,$;$QP>XC4C,S46V#PC6?'`]K7Q#`9(V`]T02P9%"X$@ZH']>(=J9WVX174H2=;$$LL651CN M_U+&;T>)B&YQ>Y_J0$.56O,Q06T91U/$[+/J3[#(< MJ[2,A$3J8EV.=$LL8U1!V&0D0?>U7R):$[QFZ&=7^F^'DHM;S!LML8Q1A6$K MD81]4-RB\(!;C!J?JQ\9ROW[1AE3] MD^(6H%Z_:Q&MNK\]:$>@"*X.LLO$FD\P>+V0,0M]`;CR`A`^BNN$."F7M#[0 MB!8%-U)VQJN""XUBL`[7F$<7#V*:/<3K#=KM80!N%Z?D0'\F]2&ON%'0/5!" MKB!YM;B?B(>&G=KS^8XU<*]H_Q[A'DGA8.Q8`-XSUO0/^(+A9KK]#0``__\# M`%!+`P04``8`"````"$`*U`;\FT$``!>#P``&0```'AL+W=O[#;5T"84<"7'6E76JUF=I^-:<"* M[49N$Y*_WVH7F.XV29@7$A^?/JY357U;?'NK*^.5MKQD3622B6T:M"G8MFSV MD?GS1_HT-0W>Y>6Q8L# MK7,^84?:P)L=:^N\@\=V;_%C2_-M/ZBN+,>V`ZO.R\9$A7G[B`;;[D:OS]N5T?"I8?02)35F5W7LO:AIU,?^^;UB; M;RKP_4:\O+AJ]P\C^;HL6L;9KIN`G(6!CCW/K)D%2LO%M@0'(NU&2W>1^4SF M&7%,:[GH$_1O2<]<^M_@!W;.VG+[9]E0R#;4251@P]B+H'[?"@@&6Z/1:5^! MOUMC2W?YJ>K^8><_:+D_=%!N'QP)8_/M>TQY`1D%F8GC"Z6"51``_!IU*5H# M,I*_]7_/Y;8[1*8;3/S0=@G0C0WE75H*2=,H3KQC]7]((A_H@+?ZT,);RK.Q)GZQ`^^CL5"7WV:XKS+EXN6G0WH/8B<'W/1R60. MRM?\H)LA8Q\E##(E1)Z%2F3"I(%<<*CRZY($=KBP7J$TQ86T0A+\WDBNYZBD M]1V2%\Y44GR'Y'JN2DJ0I,2D,M(K0Y1=V,@DP(+\#$F"`LI)NM\\UUP(LLC% M576%`&@/OCTUD/67C'C,@-;1TI*,25IVTSN,J1I+-J:$-XJ2%5?-BF@=%R;H MY]D1@X`G)0,ZY?:!O@XK)'E#"M.T%6:Q=X>NF0(WG6@5@'$AU(=2"3`"7Z0(W^L=*)06KI`D^O''(D%SH0 MZT""@(^+GS>#C.N%DQF>[80C1B8S'.(+D:'XBG%8J1\OFR!KAOV;+LXXY$B& M=2#6@00!-/SD^9X<;"^:RHS`@9./]M5,)A`O4)I=\2N.8]HN]?52(P;IOK4% M<84K]\RDJR+KG8.@AK#5R M),\Z$.M`@L"UUIX2+-9:89#`OU-MA>+;'U>;P"XBE_MSRSU;\QQHG;:ZD"33 M(R0>(C(DX?TAM_H5O/*W(>U`0Z/W= M2T:F[!N'W9!XQ$DN"/HF]TREPR!QV-.RG0TOQ=%F2O]>F@$#QEA-GUN4"``"V!P`` M&0```'AL+W=OXG-"/YF=O<7-$W+!=<\E)Y0.=;H=Z8I72<_2,6;/Q:$3E26)#R1 MS$#]*1YZ81JC&/^?Q;>*3(%;HLAZ*?C1@:&!9\J.Z!%$"V`^5V9U]+7^JU2H M49/<:1;#!55(:,_C&F$4+/U',#4_@386!*_$!31&9&>$=E#S;@<'/@CN58,7 M4]41=/7E?IQ%ZJ2QR#`9"]B\`!DCLFM$DHXAVVL(BL.P!XT*B=Y3B$Z"$1H: MB1'J'V"LVUC0S(R0]C*;'FP'!R--,`9O-U(JC].*9G89A'.,@O71OI!]>J;?KUTE3_7BL;V,QL=%_D\RGC<]&\6@V MT&?UC^)I/(B/]./WZ-=)$_W)]`6T&.M_/$?1I+YL&$_#=#[I'VQ8_8Q3?A(' M%WZKW^Y/NUX:*O8THW4MG9P?]&Y$X%M_:M?V!M:V67)^'X"UV9$]_4;$GK72 MJ6D)J8&7@'?"+EY[HWAGWN4=5[`PS64%WT<*DQYX`"XY5^<;O=K[+^[Z+P`` M`/__`P!02P,$%``&``@````A`!ZB[](7!@``6Q@``!D```!X;"]W;W)K&ULG)E=K]HX$(;O5]K_$.4>$CO!(0A.U6!UM])66JWV MXSHG!(A*"$IR/OKO=^PQ9.R],#PSO!XQIDQ[OK#:WWRGLNVJYKSQF?S MT/?*<]'LJO-AX__S]Z?9TO>Z/C_O\E-S+C?^M[+S/SS\^LOZI6F_=L>R[#V( M<.XV_K'O+ZL@Z(IC6>?=O+F49_ADW[1UWL/;]A!TE[;,=]JI/@4\#$50Y]79 MQPBK=DJ,9K^OBE(VQ5-=GGL,TI:GO`?^[EA=NFNTNI@2KL[;KT^76='4%PCQ M6)VJ_IL.ZGMUL?I\.#=M_GB"=;^R."^NL?6;4?BZ*MJF:_;]',(%"#I>6^XW_D:UDQ/W@8:T3]&]5OG3DM=<=FY??VFKW1W4N(=M0 M)U6!QZ;YJJ2?=\H$SL'(^Y.NP)^MMROW^=.I_ZMY^;VL#L<>RKV`%:F%K7;? M9-D5D%$(,^<+%:EH3@``_WIUI;8&9"1_U7]?JEU_W/B1F"^2,&(@]Q[+KO]4 MJ9"^5SQU?5/_AR)F0F$0;H+`7Q.$P?%@RP%P=\G5!F8KB*S2$D%RWTX+Y$/Y?%1.VA74'=3R^8$)QM?!,Q2@ M,*(,1?#\#*(H7MBB[5CDA)%O*):W(`&LXK842.7]2U%.]E)X<@NO5YNA9*DK MJ9:_=0V2&"PB*!DE>C^I2@S))_D22>2@H"8>4%R#)`8+!6H['46)-SZL:BB= M8"X+BH0N_VPIPM!FW>+G`ZLD!@L-GI_I:$H\0HOMK\Y0-'SUUC5(8K!8Q#TL M2ORCBJ&&H+@&20P62G(/BA*/TN(\;!F*"`L:%KJ$,4^O6`QU%Z2[*% MJ08D:2#O[W$EMC%%(FYQ\7%##:%$`U(NHI39>DGT%EAZ#Y@2VV#0T5PR%!$R M-"`9XWSA)%S2SR.V_$X&&?3;Z2G4ZA&J4[K,J`BKL9@T)L)Y9J3U.6?I\+A; M666J'T^NMU;;L#QU.GQF1)05FSZR+F'*.B4W'OAY%/$A[S:KZLO36;&+.UUO MF#6X.]7`AIU"8=%B8&`6.[60Q@4%*8N';673JM8]G18;O4,[[#!#2\:!MFP9 M6MZA)2XVG^K?T_FPVT.PVPP12V?/98R,!(/G6B35V#RJAT_GP8Y/\Y622IAT MD;%@>-""Z9JQ=.EL7JG.D+`?K@+&A[UJTZHV/YT6AP*E98*$-KAD=!A93S7XZ'XX&RO?&[$0S5."XJ=A,YVRQB* M:/NQA@P7BZ&]Z&5)XX++2E)R!+>@^5U32*OMQ@XY=FF-BM".+)):;*"[)@W' MD6'UF]'QV8@H#[H-%DDU-@]4AE;U_9,.5VHW06P85+@)C6KX^JVQ8+7@#)(. M_03+:0OB4'QG$W+5Q\DF_`$N=GVZ^:">PQG`X***XJ(%<44<.N-2:HIK>Q0B M&E9CY_:NV<)Q2%#8*"D5U MLI2IW^_VH<)8$(;S9+P-Z-SA/(Z'9\_.K&KXTW%Q/#BXHVU`AHC>&%N.%L2= M,>8>G:41Z&K8?'?-'3Z>.^H9L8^'F5'1TJ.?22<3B7,2D=3%YE,]?WK^<$+` M0_'.J8>CB.*Y%DDU-L]/S18^GBWP>#M)R(R*@M'A,F.)^V--&A=3^)B3EF%A MJSLEFL9I(U%[N4V4G/:Q*QD5P3860P5W9*$[FJ0M86)!EF:3WS6&(IPG]@,T M.GL8%25&OQNQ2%*G24CC=)6$23KL>YL8OOTGT#N-J]Y(?R2]X>JG/GG&ULE)E9<^)&$,??4Y7O0/$>T.B6RW8JH/NJ5"K'LPS"J!80)WJ:LX4VG]6G3;MM3J]/ M\[_^#']QY[-^J$[;ZM">ZJ?Y][J?__K\\T^/[VWWI=_7]3`#"Z?^:;X?AO/# MEKJFVC\]EQ\Y"\GMJN>CE`O[\QL]I<;(]?B/ECL^G:OMT-"S"W%`VE??:6WA(L M/3]N&^@!=_NLJW=/\]_80\GL^?+Y<730WTW]WDO_S_I]^QYUS39O3C5X&^+$ M(_#2ME^X--ER!)67I'8X1N#W;K:M=]7;8?BC?8_KYG4_0+@MZ!'OV,/VNU_W M&_`HF%GH%K>T:0_0`/@[.S8\-<`CU;?Q\[W9#ONGN6$O+$F_+I?GA39?B\5KZ['PS22$05XG8Q8RU,W7+< M>^+*+H%EEU]AO&PFT4J((!8WD6'JJFA]$?'QP4W[ M&`08A!A$&,08)!BD`L#?6]M,!W4@^T!DF(;:@?QB6K*D*HJ+XM+%4@)+B,LU M.!!S$AP#$NKC&>42"UY+C87NJ"U8?2!1%6NJ@&Q%_O"IR%3-!%3!3%=312$5 MZ:XJB:@$[#!5%'\H0OF5?"A",4RI"'4LHPKJGYR*4&N*#Q2HZR65.#>)DBXP MYROI\N,TX6I88J2,Q_F^$A)S7%QCX&,08!!B$&$08Y!@D&*089!C4&!0 M2D!Q&LQY=SB-JY_F$)+;-*%9*'M60F2/TZ"N.R[.YK4L8(;N&"@M?$5@,M>S MU50/9(&GV3HR$,KEKNGA)D9*.=A']6.YW'$TALH3I=QP+30\4KE<-W2+W5)V MG-4S66#8EFZA22&7!99G:%+2CQ8*66`PQV%H.BAE@6[9S+JU06!19S#)1TOEQNP_;J%N\Q8P*YW/1L"PVJ4"FW/0*@+=<*5U2W$S/[+>X>=1KF:G9'F< M>5>31O(S(3XA`2$A(1$A,2$)(2DA&2$Y(04AI4Q4'_(CW><'.!,G0&5?21?( M225[4=2[$9]H`D)"0B)"8D(20E)",D+RB8B\U6$GB5?-0E$PBS&\[I>J0O=< M][9JJ5[G9Z4[O"Z.5LCKMP5OREVANOEXS>]B8&JY$9^0@)"0D(B0F)"$D)20 MC)"B4O%L3XA,2$!(2$A$2$Y(0DA*2 M$9)/9%JW-#@+7O>38R(4BL!P7`UM64M5`.?IV[9;=3D_JMSAD(*24B>I#OOV_PX?BM*"D[0?+ MEE#=ILLUO,*H/O,)"0@)"8D(B0E)"$D)R0C))S+=X3B&A^YX"E6@.?@&AK\T M\3X*"\QUI;.:<+EX1Q*7\<>Z>ZW7]>'0SS;M&W\CTN$8?*7B_6K%'N#>&BZ- M$<_YNQ;GRVL!/"N=J]>ZJ+K7YM3/#O4.3&H+!W*U$P]3XLO0GL>;XI=V@`>E M\=\]/"#6<->G+4"\:]OA\H7_P/5)\OE?````__\#`%!+`P04``8`"````"$` MUK%.ZS$#``#$"0``&0```'AL+W=O#:)0ZPF<62;TO[[7=L0;-.UK`\M MN3X^/>=<.Y?%W7/7>D^8<4+[I1\'D>_AOJ05Z7=+_]?/AYM;W^,"]15J:8^7 M_@OF_MWJXX?%@;)'WF`L/&#H^=)OA!CF8(!W3`/:S4E'5(P"/;A7Q@ M&%5J4]>&DRC*P@Z1WM<,LK0M@7?S_$4E2=N]7!!WY&244YK$0!= MJ(5>>IZ%LQ"85HN*@`,9N\=PO?3OXWD11WZX6JB`?A-\X,9GCS?T\(F1ZBOI M,:0-?9(=V%+Z**%?*EF"S>'%[@?5@>_,JW"-]JWX00^?,=DU`MJ=@B-I;%Z] M%)B7D"C0!)-4,I6T!0'PV^N(/!J0"'I6?P^D$LW23[(@S:,D!KBWQ5P\$$GI M>^6>"]K]T:#X2*5))D>2*:@_KD^"R6T:I]G[+*%6I`P62*#5@M&#!Z<&_B54,6INK7^W`2)\&.N&F>V?]Z?0F:V(C-*XA;&U)<0O(S MQ#*0V`9D[`D-R$V`,P/,$M>(!DW5T9$9;MQ"810L3=#^ZT.5X*4/AL_- MS)+1:<6V%YD(/2>`N][4&"'0]9ZQ!AB:W4!@%2Q,,M_\(2*&=A"Z[?$3I-N>!>S^MY3@-G(#EO)66QU-ROOM: MN1ZF>M9TF.WP!KFYU^(: MMD9!#M>3Z2FL'P0=U`M^2P5,3_6Q@6]+&%Y_40#@FE)Q>I!S?OS^M?H+``#_ M_P,`4$L#!!0`!@`(````(0`NEC(`.@,``,D)```9````>&PO=V]R:W-H965T M[B$7):D:2''3#! M*F!D.TW[]SO&(8!)FVY?0AB?.F2^8F[?KSY^61\H>>8ZQ,("AXBLS%Z)>V#9/XX3VB4BE:D8%NP]'#3+2()CFAQ*7`E% MPG"!!-3/)A7U&&=@7H?G8# ME+3N8OMS+37R\:? M/P0?>>^_P7-Z_,)(^HU4&,R&;9(;L*/T44(?4AF"9'N4?=]LP`]FI#A#AT+\ MI,>OF.QS`;L]`4%2UR)]B3%/P%"@L;R)9$IH`07`KU$2V1E@"'INKD>2BGQE M^J$UF3J^"W!CA[FX)Y+2-)(#%[3\JT#NB4J1>"<2N)Y(W(D5>)/I[']8_!,+ M/+=E\2QO-G$GX?5:;*6KL2E&`JV7C!X-:#VHG-=(-K*[`.;6'Z7F[-AKAH%3 MDN1.LC1OHYIB(A;A-PL^?!M M+V"#JK,TL+LO[?*6MPHD6%,03,/AHS<70*$W'X*B,<@;(N(+",VK[1@R[2`# ME=`6?95R`WUX3=Y6*Y,`UW-YZNIB%29H.EGZ'.F!6`]L>X%!C<%':I1)*Q., MZ#HA])VAE1L%ZA6I`G/5@Y;677%_U;$Z1U4CO;8ZT`(OB>YW`+&W_99)(RVN MID6!W+G?%"\/I"$@T@':>JS6.S.VOH&!B.E81'BU\6722(36)1L%ZDJ(5*!3I1NO)VQ[@4'-\JM".VVOURR3 M1C4'P][8*%"O9A5H:]9Z+=;A,(/E0YI\5;$:J6I6E)CM<82+@AL)/I&T+HY>W=4P`QM M_N;PR83AU'$L`&>4BO9&3OOS1]CZ'P```/__`P!02P,$%``&``@````A`)-@ MM7DT`P``7PD``!D```!X;"]W;W)K&ULG%9;;YLP M%'Z?M/^`>"^W`+DH2=6`NDW:I&G:Y=D!$ZP"1K;3M/]^QW8@-NFZ;B])\/G. ME^_H*U%#.[QQGS%W M;[?OWZU/E#WP&F/A`$/'-VXM1+_R?5[4N$703._I7WO2K`5^:4N$+'1GRCIX^8'&H!U4X@(!G7JGS.,2\@ MH4#C18ED*F@#`N#3:8GL#$@(>E+?)U**>N/.4B^9![,0X,X>+EB";<'S8#GRJJ;;:4RL!,?!I73* MFIG69#'QS;4UT2,0I9=P+,GIOTB6X(GD<#:1K#%GRG!$^579I(%UMC M#&73@WPXD+=:%%W\+5W+?]$EP;:N,$JG*=,@/3;A59-FIOEJJF`7RG\X.YM3 MI47K1:?W0(O9`6>X:;A3T*-<8B%T[WBJ]^L.]JO:1OYH@/W6HP/^@MB!=-QI M<`6N@3>'"6!Z0^H'07MUZ>ZI@,VF?M;P(H/A4@H\`%>4BN%![N#QU6C[&P`` M__\#`%!+`P04``8`"````"$`9;H>5QD1```D;```&0```'AL+W=O8_&+[?L76V@R0;+9)U'F`PV'OF MVG&4Q&C;"BRGT_WOAU05Q:KULB-%?='=>;)8MC[QL!9E6>_^^>?3X\4?FY?= MP_;Y_>7DS?7EQ>;Y?OOIX?G+^\M__TO]X^;R8O=Z]_SI[G'[O'E_^==F=_G/ M#__Y'^]^;%]^WWW=;%XOVA6>=^\OO[Z^?GM[=;6[_[IYNMN]V7[;/+=_\WG[ M\G3WVO[QY/?:?O^[KP_?=OUJ3_>G+/=T]_+[]V__N-\^?6N7^/CP^/#Z MUW[1RXNG^[?VR_/VY>[C8_NX_YS,[^[[M?=_P/)/#_W5ZU*WUX]^FA?01=[![5_70+7EY+-9'Z]_(4U9FF-]JOV:TS?3&\6D\6OK+),JZP.J]S^^B+M ML;'/I/UO_ZU,WLRGB]7-KX1RFU9I_]NOLOSU52;M'A&?H&[7B.&?\9`FA^>Y M_9_^VYF>\>WT3_4D>Z[;7>O$Y^DJ[GW[G;F^>[W[\.YE^^.B/4.TW]7NVUUW MOIF\[9;N=N-9^XCC3G?8L?]NOVYWZ&Z5W[IEWE^VSUN[^:X]&/_X,%E,;M]= M_=$>0?>I:#U25%94?45WN'3KUA*:'K(O-)U,RF547]0OHR48"39"^^_A`92+ MNKZB7]1+"!E,FYC+3(>/T7T47;5793]UUE'R+^U:?FM52,5-V5)S9*5 M*&E8,EE,K\MU5"JZG>^?Y/EDM13A:UDQNUV5:YC1+R26L:-%XH$[^;562U'A M1Y>9E=]0*)>9W";;`B5!2S`2K`0GP4L( M&11YMOL5=K;ET3R[K9#GLLQB'8L6\43='L0C:51YS<4T[L3ELU+G M%9/%6)ZQ(LM3@I9@)%@)3H*7$#(H\FR;O3/R[+9"GN)BM(Y%,<_I]>@.&DN& M,&H)C00E04LP$JP$)\%+"!D4<76CG^RUCA_0W5:(:[@^[2\6ZUC4GDFRL^A, M[H%]4=]9U!(:"4J"EF`D6`E.@I<0,B@":SMX!';\-?3C87<245?NDY5PV.N(#6D@2B(AAB(A3B(AX1B>4U6>5-QND!HU#41!-,1`+,1!/"3D4B;5==@R MJ>,7BDELS,M6>B;GC%0UY%)!ZB3QH)YU!VQYO#9%P$'+MU$;*<5R993Q^G.4@-:9), M;F?[QKR[<5CFKK"-AAB(A3B(AX1UUC*Y$]J3V)&+Y.2,-LGZ]I20L@5>7)Q>T&J5'30!1$0PS$0AS$0T(N95+MJ>>,HW':;79T M6$A50RX5I(8T$`71$`.Q$`?QD)!+F=1YP\+TI&$A5>5)Q>T&J5'3)(E7R_;5 MV_E$M%H*VVB(@5B(@WA(R*5,3DX`/[\?,AWK_.=B,EJGJB&?"E)#&HB":(B! M6(B#>$C(I4SHO$Z_^^&#$XY"=/IINR&[&M)`%$1##,1"',1#0BYE4F.M_?$^ M:SK6VLNI;YVJ4BL]]N)6592,OKA05(R^_)4JAO@51$,,Q$(W&6/,_E2WL-%:E:*_C*S?ET%VEFB&7&M)`%$1##,1"',1#0BYE=F/M_PG9 MC;7_4S05)85!`30-1$`TQ$`MQ$`\)N91)G3^UA+H[DZE!U.,-!&HB":(B!6(B#>$C(I4QO;'CH]LHC1^38\#"7H_Q,C@H5 MI(8T$`71$`.Q$`?QD)!+F90<%D[\T:\X-!P[(F-5?D1*J6=2&HB":(B!6(B# M>$C(I4SJO*%A%L>!8T=D/S3D1^2UN!=>I;6&/&M(`U$0#3$0"W$0#PFYE.F= M-TC,Q@8)^0K'.E4-N520&M)`%$1##,1"',1#0BYE4F-SP0G7R-CQ'SLB8U6> ME)1Z)J6!*(B&&(B%.(B'A%S*I,:F@!.2&IL"YN)86\_Z_CX[(J>WXH9/=:@: MKI']=KTTJ%$0#3$0"W$0#PFYE.F-30$G7"/'IH"YG#]GL2K?SZ34J&D@"J(A M!F(A#N(A(9I>>S3Q352SN6I:GCIXUK.Y*EBR+*&-!`%T1`#L1`'\9"02YEAZKAEPJ2`UI(`JB(09B(0[B(2&7,JFN_99)'3_KSV/7?N3Z MF*KRI.)V@]2H:2`*HB$&8B$.XB$AES*IKK4^(ZG8D8NC45X?YWW?GET?%]=R MACQ4]5?#&M)`%$1##,1"',1#0BYE>F/]_@E'Y%B_OQ!GJG6WOY8_#@2I(0U$ M033$0"S$03PDY%(F-=;;=]4_G[;GL;<_=D3&JN'XJ])V@]20!J(@&F(@%N(@ M'A)R*9/J6FMY1)ZP3\6.7!R1N#[&JN'Z.!%W+JJY[.QK2`-1$`TQ$`MQ$`\) MN93)C?7Z)R0WUNLOY#W6>:SJ7]CE+>M4D.]R:/-1HR`:8B`6XB`>$G(I@SNO MS9^/M?GR9]W6J2H%U[Z9670>52K(@Y-S0(,:!=$0`[$0!_&0D$L1W$)V_3\_ MF^W+T8F)Z^$Z50UY5)`:TD`41$,,Q$(7\ASNKK5#7D4D%J M2`-12=+!/&O/@O*E.XV-#,1"',1#0BYE=%W_G4=WY#",[;J(3-RV62]B51Z9 ME!HU#41!-,1`+,1!/"3D4B9T7IN_B`U\^[BS%X'P!I14E2?5-_Z'EAXU#41! M-,1`+,1!/"3D4B8UUM*?<,(:;>GE0+1`2P^I(0U$033$'*3[C13BFFL/?]D_ M00[B(2&7,K3SNOM%[-O%@2CO$Z:J?/>2_7Z-F@:B(!IBDO1=WH1O?;38R$$\ M).121C?6[I^POXVU^PO9[B]D,U]!:D@#41`-,1`+<1"?)`8^B6^D%SMKR+C[^,O?J1LW^J2B>(]MV48]FAZT]; M#6DV$`71$`.Q$`?QD)!+F5W[\,_9[;K-L-O)T_\R5@TI5)`:TD`41$,,Q"9) MSUS\+2KB9.NPE8>$8IWX!K1AF3+,KD'/YX#3WIVSC'U]N2/*W^VT3E5YF'&[ M06K4-!`%T1`#L4EBF/%'=8<0]F^K99RAFA0HR`:8B`6XB`>$G(IHQN;&+J3Y<^[D>78Q+"4/X:7JF)T M\]F,OVJC2B5Y='+,:%"C(!IB(!;B(!X21259Z4'!QJU#00!=$0`[$0!_&0 MD$N9E!P*3FSDQH8#_,3/LA\.LALB_(F?0U4_7=>0!J(@&F(@%N(@'A)R*=.3 M`\.1DUAL^,7Y7]Y]7,JQH(+4D`:B(!IB(!;B(!X2$C(I8RNZ]QE)WM\;E]UFV$LD#?44E4?W8KOGJE221Y=7'J0!C4* MHB$&8B$.XB$AES*ZL2'@A.C&A@#<4%O)EK^"U)`&HI+$IV#_!.!U%&QD(!;B M(!X2Q2'?[R<,6$-!`%T1`#L1`'\9"02QG:>>W_ MZJ3V/U7%_:3]#>ER+ZE2P7!8UI`&HB`:8B`6XB`>$G(I@QMK_D\X4,>:?[Q] M:16KVCTS>^4*;U\Z5`V[7;]=+PUJ%$1##,1"',1#0BYE>F,#P?'1:14;>]&P MR=<^4]6P5U60&M)`%$1##,1"',1#0BYE4N<-!*O8ZA\9G5)5GE0_(O1[4(V: M!J(@&F(@%N(@'A)R*9.2S?]IH]-J;`C@I3-6Q5-9?",_K@)R3JC3TD.\#41! M-,1`+,1!/"3D4D1W,S85'+\)M-],-FQ+V>NFJI_\U%ZJ&'*J(0U$033$0"S$ M03PDY%(F=]Z4<#,V)2QEJYNJ^E9W>CV?B9(JE>31Q:4':5"C(!IB(!;B(!X2 M\VU2P1"]@FB( M@5B(@WA(R*6,50X0/[][U'Y&$*Q5DOB9"&._SZ4N*L9^:TR# M515$0PS$)LDO:^63Z;"-AW2?UG3X6?^8:/SPI?AY-4^;ER^;:O/XN+NXWW[O M/EBI^RVI!SU\Z--OT^Z34X2O)V_K_2KPY_T7Y&T[>[+YO_NGOY M\O"\NWC&ULG%7;CILP$'VO MU']`?E_`W')1DM6FJVTKM5)5]?+L@`%K,4:VL]G]^XYM0DC2;#=]"8$Y<\Z< M&3,L;I]YXSU1J9AHEPC[(?)HFXN"M=42_?SQ<#-%GM*D+4@C6KI$+U2AV]7[ M=XN=D(^JIE1[P-"J):JU[N9!H/*:Y%O.6VU(Y&T(1KJ5S7KU)Z-YV^AXT0^;KN;7/`. M*#:L8?K%DB*/Y_//52LDV33@^QDG)-]SVYLS>LYR*90HM0]T@2OTW/,LF`7` MM%H4#!R8MGN2EDMTA^=K'*)@M;`-^L7H3HW^>ZH6NX^2%5]82Z';,"ABK]P`PE\O*MTH+_=B#< M4SF2J">!:T^"(S^:ICC-_LT2N(JLP7NBR6HAQ-X6N$43Q;!$_0P[T%K!X)78`!%`R(`]:$$D#TM(881_;VY M^Q),TG$)T6D!#C*UDQWKQ?^C9Y)@;",W8'DZ&+)]63M0*1X.CD73JS'R:6FFG4^>E=>;ZH!CP0/GIX7$8U]@83R^,$E;I%48M^E@81\DP,F>W![EC MB_$D.0S`.7:[UZTF3F5%/]"F45XNMF:O8AC,\-3M_#7L_,B^:4,`5FY'*OJ5 MR(JURFMH":FA/X$#+-W2=C=:='9U;(2&96O_UO!QI;#:0A_`I1!Z?V,^"\/G M>O4'``#__P,`4$L#!!0`!@`(````(0!QI9P02`8``&\=```9````>&PO=V]R M:W-H965T>?GMZK^FNS MR_/6@PB'9NGOVO:X&(^;;)>7:3.JCOD!OME4=9FV\+'>CIMCG:?K;E"Y'T=! M,!N7:7'P381%?4V,:K,ILEQ4V5N9'UH3I,[W:0OY-[OBV)RBE=DUXMJ].M\L_9=PH>+8'S\_=1/T3Y&_-^A_K]E5[[_4 MQ?JWXI##;,,ZZ15XK:JOFOIEK2$8/&:C5;<"?]3>.M^D;_OVS^K]U[S8[EI8 M[BDHTL(6ZQ\B;S*840@SBJ8Z4E;M(0'X[96%+@V8D?1[]_>]6+>[I1_/1M.' M(`Z![KWF3:L*'=+WLK>FKR&*'"]+I79 M$&4ZFD33A\F@;EH8)6_/8>3^7\Q1W;LRM;+'D-S?2Q?#P(>GOQI$/07Z)9L94B3?HX2"@@* M2`HH!#A90P-=OUB:O/1A4H92F09#%9AL#6G6E6PB44D!10"'"4S.]1H@>V6-U=/:#R6W%UI M^5B64S_3@.P+DI[5%Q!#)$,41EQ!V@=O%V399 MAJQ!-35#)$,41AQM=QEV-$YPP[I4X)E#:DF#!$,D0Q1 M&'&3AS*^O8HB/>KB_=2R3K>CHZ9\V\+0S+M$7\^$@?O1,;!B^.&3(@DG$4 M1EPM=SFU?O_&MAD!-0C+,EITA[,6IU8N[!"LA7(4YKA:B'%_;!#1.<,.Z4.I M90T))0P1#)$,41AQD]8&>'MW&-N\8!`1-=>$(8(ADB$*(V[RQ)*O[(1SULP[ MP;!L)\`+(K)3BIA1,T0R1&'$E:*-\O9U,/9*[E*L$0S+2)G-N!1JTB*BB&2( MPH@C1;_%P%(^[H..3>TZ).]=5I:%^H`A@B&2(0HC;M)W^7-L_/E"'U@63MZ, M&Q#!.)(A"B-N\MHQ;RZ>V/@L*1YZ![*L(=6$(8(ALD?PLU1([%/U+#!&5]!= MG@U'4MP60OI.R;*P(#-N0`3C2(;H`S!]-?,6.IHX_F+$F/,MI/X+..XZIMO\][3>%H?&V^<; M"!F,'L"N:G-@9CZTU;$[+GJM6CCHZO[=P<%F#NV-!I"EU+YO,]'D4ASH%CSA.NW@M2VTFC^=9L) M2=<)U/U*`AH=N8N+%GW*(RF4V&@'Z%Q,M%WSS)VYP+1:Q!PJ,+);DFV6]AV9 MW_N>[:X6A4!_.#NHL^^6VHG#9\GC;SQCH#;LD]F!M1#/!OHU-K=@L=M:_53L MP`]IQ6Q#]XG^*0Y?&-_N-&QW"!69PN;QVP-3$2@*-(X?&J9())``O%LI-ZT! MBM#7XO/`8[U;VN.)$TZ],0&XM69*/W%#:5O17FF1_D40*:F0Q"])X+,D(:$3 M^.'T9@"+BQD5!3Y035<+*0X6=`W$5#DU/4CFP&PJFX`^F$=5ZZ52H49#R0@P!@&N1S2+EC:$.942!),J`&:!H*#HK//:@GK$ MZY$,&#*J1YHV(B&H'0F::[B*!MRJZ:81"4%D-BXV.72\^HL\CL;5BMJ&3NJI M#)/9+&JE=-I'E!E![>*G]8C793;@7ID1U(YD;/[L#%V/9,"MFIHR(^@H,W&" M6?WU./*[99[54QDFLUG43"GTJ@`H,X+:Q1,X+,.K+]"]0I>HCF#&0P9+3=!Q M&L>TJ76).HH];8H]O=C3Q/C,63;#U"Y6M>0^^2#*7:(Z)&@8UO5N(VA"/?Y1 MHCJ"OB- M;M2G]R7/(N\RK0+=[*2@U=]H6T>]/<<[]5K-HDG#QP:VAA:>G0"DOHCKD M;3A6C[SH0GWR7O(JF!%K#70]6('NE;=$G``!IP```&0```'AL+W=OKY[?/AT6IQ=G)YL'VX? MO]P]?/MT^C__7?^R/#UY?KEY^'+SX_%A^^GT[^WSZ3\^__N_??SS\>GWY^_; M[/M'_?;AQ=_D:?MCYL7 M?/W/W^]^/L>KW=\>['WGIR?_NA^_;P M^'3SVP]\WW\5BYO;>.W=?\CE[^]NGQZ?'[^^G.%RY_X+U>]Y=;XZQY4^?_QR MA^_`:3]YVG[]=/IK\6$L+N>GYY\_[@S][]WVSV?S[R?/WQ__;)[NOHQW#UOH MQ@OE7H+?'A]_=Z7=%X/EOQ[_;+=WW[Z_X/6^ MQ+?DOK,/7_XNM\^W4(K+G,TNW95N'W_@"\`_3^[OW-R`DIN_=O__Y]V7E^^? M3N=79Y?7%_,"Y2>_;9]?ZCMWR=.3VS^>7Q[O_\\7%>%2_B*S<)$YOOKPYT`' M#EZ$P5=F\-EL>5E<7KWC2[B.WP>^TO@U7)XM9I?7R_=\)T7\5MR_Q.OL_5[. MO=3=:U3>O-Q\_OCT^.<)9CZ^F.>?-VX=%1_<%>.KXUV^OE[_ZN7"Z^2N\JN[ MS*=3K%F\$L^89/_\7,P7%Q_/_XF)<1N*UIFB65&D19M8Y":"NW09@;ET.J2* M%7%(S:#Q`/^T7Q[]S6VV:);^75VF2+Z'/E,T7]!?-V2+YNE?-\8BM\#PBKV^ M;'BEDIY/E2U9+I`NJ*"V M!==++6CX;VT9=`QZ!@.#T8!$(YZ9B<;#YI@;)3KI9K7V14:G!Y<[>\LKF&$W M)0^I&-0,&@8M@XY!SV!@,!J0V,(C_PA;;I38HMOKVA<96QYX6[-BGM/%8RH& M-8.&0@ M9S`P&`U(;+D6A[/7_MN]&R6VZ$FX]D7&E@=OV>(A%8.:0<.@9=`QZ!D,#$8# M$ELKLO7V_=]5BR6*`FM?](:4C:^8/)8,*@8U@X9!RZ!CT#,8&(P&))8*Q`69 M5`O6R]?N77^$C M.5**3187'3:24FDI(+:01T@KIA/1"!B&C):DIEV&MJ3USR4=>REZ4 MB]>NV<0*G7QLA)1"*B&UD":0\"#=/48Y=[0RJA/2"QF$C):DSER,M4*->ARKHSJ3FTS4PJ&54+:82T0CHAO9!!R&A):LHE53:U_S%8 M^("+[_+-=6AB\,[+)HR;W)5"*B&UD$9(*Z03T@L9A(R6I*9<2CW"E`^W-*?D MCF4B<##%I'3;=LF:K8340AHAK9`ND&(UWS4+%V<7]/7U,F80@GW,Z>M+S;G` MRN8.6(T^YY(Y[B(+DX:#.2:EU%1":B&-D%9()Z07,@@9+4E-N;#*I@Y8C3[C M[EN-)@D'4TS*@DDEI!;2"&F%=$)Z(8.0T9+4E`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`H2JR,F M=Z602D@MI!'2"NF$](&D[\=1%!IDV&A)*B\7^P^XE?GX3@N2HN%ZSB%_(Z04 M4@FIA31"6B&=D%[((&2T)#5U7.R?^WB\;T%RB-Z$<7::<4TE-;601D@KI!/2 M"QF$C):DIG(Q_X`%F8WYO`4VEY@OI'PEN\].%XNSXO*2%G;U6A,_QUL+:82T M0CHAO9!!R&A)ZNZXX#_W`9[6(V_UA*II3FV$E$(J(;601D@KI!/2"QF$C)8D MIA:YX+]_ENV&[=W,#U7&E)!22"6D%M((:85T0GHA@Y#1DM34<4%_D0WZO`D6 MJJPI#M+E:XW]>,$U;7U4KU6O*U)((Z05T@GIA0Q"1DM2>RY]'S>1,M3$`%Z<\:U,+E(+:82T0CHAO9!!R&A)*LZ%[R/$^ MWLJ6W)DO?-6D:2.D%%()J84T0EHAG9!>R"!DM"0U=5S67QR4]4.5->7'3:24 MFDI(+:01T@KIA/1"!B&C):FIX[*^6ZZZ&'G/(E1-7C9"RE=B;V5+69'<-=2O MX^+-K1'2"NF$]$(&(:,EJ;UCLNZ"]R07\I=S)? M9;TQ*<.5\"PPG_G4.QF/JU_'37\]D- MVQO*0I6Q)Z0,)(:RB[,5!>-*QM1"&B&MD$Y(+V00,EJ2FLLU`_N?`9>Y9F#) MS7FHLN:D&9":2D@MI!'2"NF$]$(&(:,EJ:E<\#_`E`_P>S9\+CGF;X240BHA MM9!&2"ND$](+&82,EJ2F..GO6879A,^;%?@U"BZSV;G$I`PU_MZ_O+[,_)A? M)=>IA31"6B&=D%[((&2T)'7&F7^/,Y_9TZZ(?SYZ?_]&>X6QG6">F%#$)&2U)IQ\7_RVS\IQOV.E39"<H?XY[SZA9[@K5RD$](+&82,EJ0JN1?8,_^R/0!MX:POI0<04@JI MA-1"FD#"_,/O6-G)X_G'?WTG%^J%#$)&2U)IQ[4%ES[>IXMW1:MG':KL_).V M(-2L_$^!GUW3`[B2:]1"&B&MD$Y(+V00,EJ2>CNN2;@\J$D(5=:;-`FAYE\V M"7*-6D@CI!72">F%#$)&2U)O+EF_?POMT@?R=+[Q;P%9ARKKC8-\*365D%I( M(Z1]);;9X!W@[K4JMA:]D$'(:$EBSWVN0.SM#W"[8=(DT`UZ':J,/2'E*['? M]8JV,JO7JOA=UT(:(>TK>>O:W6M5O'8O9!`R6I(:/:YYN,HU#RLQRJW")HR; M')="*B&UD$9(&XB_CQ;84JB&#D-&25)R+^[R0#YB*;AA/Q17M-JZO M?-6D:2.D#,3?`.>S;%*64;601D@KI!/2"QF$C):D[KB[..RWK%SENHP5[UJ& M*NM.NHQ0,ST\)/E62*M9!&2"ND$](+&82,EJ3VCFLYKK(M![>\ MHD%S((&2U)Y1W7=USE^HX5181UJ++R MI.\(-5Y>_O=057*=6D@CI!72">F%#$)&2U)WW'N\O4%PE>DY%GR+6HU%->9EF+!#\-UJ++JN,DHI:824@MIA+1" M.B&]D$'(:$EJZK@&XMHW`OBG>8-4?A=HJ+*FI(&0FDI(+:01T@KIA/1"!B&C M):DI[A?VW,%R?<*2H]JU]`E"2B&5D%I((Z05T@42[HV+L/.>;ASW,FP0,EJ2 M2LLU!VX+98^\3'.PN.#^U/UT9/HNF)!22"6D%M((:85T0GHA@Y#1DM04=P*' MM:/7/MGO6XB<_S=AW+0T2R&5D%I((Z05T@GIA0Q"1DM24\>E_NM,ZE]<<.,> MJB8O&R&ED$I(+:01T@KI`HE;`@>\&=;+108AHR6IREP/L/^C(M>9'F!QP;U[ MJ+(JI0>0FDI(+:01T@KI`HDJ%V<+L[6"?UW*^XJ]7&00,EJ2JN26P*W?`U1F M6P-Y3'"HWUPS*8540FHAC9!62">D%S((&2U)3"VY%3CL3K<;MO>'$T*5F71" M2B&5D%I((Z05T@GIA0Q"1DM24]P!O/W47&:2_UQ^%WFHLH8D^8<:'PSRNQIR MF5I((Z05T@GIA0Q"1DM29;GDOW\9+K/)G[>$0I55)\E?:BHAM9!&2"ND$](+ M&82,EJ2F7!1__]LN2Y_@]P2.4&5-^7$3*:6F$E(+:82T0CHAO9!!R&A):NI] MR7^92_ZZ#"7YAW'6D*\)RS"WVR-C:B&-D%9()Z07,@@9+4F-Y6+__K?TEMG8 MSWN+H6KRM!%2"JF$U$(:(:V03D@O9!`R6I*:.B[V+P^*_:'*FN)&H)2:2D@M MI!'2"NF$]$(&(:,EJ:GC8O\R%_L+_GQ1J+*F_+B)E%)3":F%-$):(9V0/I"8 M7F?\J;BB^H7>HQGD(J,EJ4J._7MR12[N\WE*ZR6'^XV04D@EI!;2"&F%=*_$ M;$C-^!WM_K4J?N1C$#):DEKCA+_'6B[9%[P/N^0;9G5@95@MI MA+1".B&]D$'(:$DB;75^EA2JK4KH"J:F$U$(:(:V0[I6X7THPP_%\ MM`?Y^N>OZU;(:$GJ+=<2[`\CJUQ+4-!7M@Y5UINT!%)3":F%-$):(5T@<0KB MMYG3_:67,8.0T9+4'+<(;]_Q\#O5Y1-9BX*WA4*5-2:M0:CQ=[SK[/N<@VQPK7V6=,2E#37"6GV8\J)8+-T):(9V07L@@ M9+0D579.4J>&4$KXS@E1&\,H)71M#&"-H, M(FW<;QSVT"XN?`.!Z[Z5;V)9HDU:#ZV"-JZ"-D;0Q@C:&$$;(VAC!&V,H,T@ MTN9B/;_Y=<@J]NT`9O&D33=3B@ON&G!^)2,\5!A!&R-H8P1MC*"-$;0Q@K:( M\OLLD!@+XD8+)!I$$G--R"$2Y>@N,CT);I-$,L27=*9:!5T<15T,8(N1M#%"+H801,VB6L5FDZ%&&U&0$CXR@S:!4V^Y87WY2')"CPW'`^QZP]M3@<(:<(!S@:V+^K@HG^#+" M$;Z,<(8O(QSBRPBG^#+",;Z,<(XO(QSD:Q!I)ZOY&0$CXR@S2#2 MYH+R,=I\P-Z[6GV9?5C8XX;C].,J:&,$;8R@C1&T,8(V1M#&"-H809M!I,T% M9:MMWVKUP1HOPQ2#Y_+##84]8#C.,A/)HRY&T,4(NAA!%R/H8@1=C*#+([\T MXR&C]"B%01X(@P:109>2K<%#UZM/UXG)A7P\I;`'#D>3)I='DXQ@DA%,,H)) MCV)WG]L?I5L(5/-EH)H15#."5T;P:A!Y=3':>MTW,WWL)I_26]ACB:-/$]BC M3T;PR0@^&<$G(^AB!%V,H"LBL[#D8RQ0&,NF-LTB4N@B]7L4^@A."B7PV?.* MHT(3WJ-"C\)3<+7,_G*-0JX%JWPM6&4$JXQ@E1&L,H)!1IB$!I%!%ZJMP4,7 MMP_C9))6TKJPIQ='DR;&1Y.,,!D901LC:&,$;8R@C1&T>?2.NP*\\F7@U2#R MZE+W,5Y]6B>O_-&,PIYU'+V:G!^],H)71O#*"%X9P2LC>&4$KQY%K_JI#6CD M4=!H4*IQ=U*QU;CG'AE.-B9]_#F-PAZ`'/0)*K6J4E0K:A2UBCI%?43^EE*L M@3ZVDT#^U$9AST&.`DW@#_,O5/EO9W:1^^5]4,KC MH)01E#*"4D90R@A*&4$@(P@TB`1"Q;L$NGKZ>%^FV[/'(T>!?N3TNF(&>N0% M7N>F`_SQ,/AC!'^,X(\1_#&"/T;PQPC^#")_+IG;"7C@`R:// M]N'W"NUT3](VBN"1JZ"-$;0Q@C9&T,8(VAA!FT=A)8<>67*X#(1)31WVFF*`?/3+"3&2$F<@(VAA!&R-H8P1MC*"-$;0Q M@C:#2)L+Y*SM@%W"<)`RIO.T@/5C1H4];SEJXQ8`VAA!&R-H8P1MC*"-$;0Q M@C9&T,8(V@PB;2YR6VW[5JN/Z.DLDY]$*.PARU&7"?=QM3*"+D;0Q0BZ&$$7 M(^AB!%T1F5=[QK_S#`ICV=3=640*7;JV"@]]=/A4GJB<7TEO8D]ACBI-GH\J M&4$E(ZAD!)6,H)(15#*"2H_V/3IX(":C0632!>QC3/I@GIA33+" M&F8$DXQ@DA%,,H))1C#)""8]FKH1/FD$$Y)'0:-!J49WUQ.-!SQ!=N,H$RYF M_-G4(I39+".HU*I*4:VH4=0JZA3U$4T:\;1(WYP;8LWTM8\)(H\N;?-T/,2C M3^DT'?DS@H4]P#E,1T'P:"+_K@H>&<$C(WAD!(^,X)$1/'J4+FP1R>,@TB`2 M"15'B73C>$+.*9ZN"WN>? M)OE'GQ&Y#P71](;:^*=Q?D`M(ZAE!+6,H)81U#*".48P9Q"9 MA3O%[A-<_!DNB.1Q$&D0B71!_!B1/L`G(A=SBJQ(-R;G1Y&,,/\8020CB&0$ MD8P@DA%$,H)(1M#&"-H,2K7M#H0^0ELX2'K?LK7G30=M@LI"4*6H5M0H:A5U MBGI%@Z(Q0:3-I>QCM/ETGLXV^6'JPAXT';697!^6K51!&U=!&R-H8P1MC*"- M$;1Y%`-@[AT[&06-YD*D$2*.TNC&24LBNZSVV.FHT8^T+8E402-702,C:&0$ MC8R@D1$T>A3N?O%7SG-S)P-ATER+3+I,S1/R@-02SIO&=:?'[V(NFS;V6.IH MTJ3X."$9P20CF&0$DXQ@DA%,,H))CZ8)J9L-,@H:S85(HPO8QVCTP9PTRJ:- M/;,Z:C21/FID!(V,H)$1-#*"1D;0R`@:(W*M#[6CN#/&/XVM#PP:1`9=L#[& MH`_D9%"V:]R43CZ=N2D$X8'"53#("`89P2`C&&0$@XQ@,"*[CA;414)E+#,J M#2*5+FQ;E7\5BYO;#U_^+K?/M]L'+-@+_(H0'/.VFS>_%N&DZE3A@E[.=2R; M;H%0:&)]G(019:8$;,8_C=\';#*"34:PR0@V&<$F(YACA$EH$)ES>?L]YGP^ M)W.RCV`/N([+UR3[:,ZCY.Z>WMOACX?!'R/X8P1_C."/$?PQ@C]&\&<0^7,Q MV_H[<#V!YS';0)*@M!E:):4:.H5=0IZA4-BL:(_-TD1,77 MNPEY=#G[&(\^GR<>%PO9N;*'8$>/)MF'Z2=5\,A5\,@('AG!(R-X9`2/C."1 M$3P:1-KPC1^ES8W;_XL5[(G849L?.3V!,?T801LC:&,$;8R@C1&T,8(V1M#& M"-H,(FTN1!\SVWSXQG7-S4[?<+>'8D=M)K;'V<8(VAA!&R-H8P1MC*"-$;0Q M@C9&T.;1U>X,7FGPO,CSY^_;[4MY\W+S^>/]]NG;=K/]\>/YY/;Q#Q?MYACZ M2D^>ME\_G?Y:?/AU=HK$17Q=?-@4&5X6'^H=/W\=\/SYX\^;;]O_N'GZ=O?P M?/)C^W67(MUI#$]WW]Q3_N+,_[_[U^_;FR_;)%>#/ MOSX^OL3_P!=T_N?CT^^[;^?S_PL```#__P,`4$L#!!0`!@`(````(0!N9/9O M(P0``!`/```9````>&PO=V]R:W-H965TZ6]TFJU'\\$G`05,,).T_[['3,4;)+FXZ4-X^/A MS!G[8"^_O5>E]<9:4?!Z99.9:UNLSGA>U/N5_<_?+T^Q;0F9UGE:\IJM[`\F M[&_K7W]9GGC[*@Z,20LRU&)E'Z1L%HXCL@.K4C'C#:MA9,?;*I7PV.X=T;0L MS;M)5>E0UPV=*BUJ&S,LVGMR\-VNR-@SSXX5JR4F:5F92N`O#D4C/K-5V3WI MJK1]/39/&:\:2+$MRD)^=$EMJ\H6/_8U;]-M"76_$S_-/G-W#V?IJR)KN>`[ M.8-T#A(]KWGNS!W(M%[F!52@9+=:MEO9W\DBH<1VULM.H'\+=A+:;TL<^.FW MMLC_*&H&:D.?5`>VG+\JZ(]O`GZV5LUUZ+.5?_/0[*_8'">T. MH")5V"+_>&8B`T4AS8P&*E/&2R``?ZVJ4$L#%$G?N_^G(I>'E>V%LR!R/0)P M:\N$?"E42MO*CD+RZC\$=14-26B?Q`/V_3B=T3@@07@[BX.,N@*?4YFNERT_ M6;!JX)VB2=4:)`O(K"KSOZP,2E)SOJM)W51`"VC'VYIX7K!TWD##K`=M$`1; M8`!1$Y%<0,0#Q`&"`TNH?UO^3I9IDLJ31D+XK9(.0N&N9JBS1`@8! MD.9Q`FH2M%I3`&0*)Q00Y(\4M(!!P35H^@$!L8!W$T M`20&@`8^]0;R!C58,+HZUZDIL**FMHG2?(.!X&L:!N`*C?`1&@IL*N1[[E`> M,D,,,GL*8W<^UM\!$@,0^'XT9C`$BAYAIL"&0!CH!2)1%/LFST0'1.X\&&D: M+-3G2-OKU]NDP%-]QKRH#V*0&`U==\I+'R>$!*-%&+SFC_!28$,=#/3J^%X4 MCQZ"3=(!,27N.&ZP(&`H]\O3H4U]8(>-J5&@'J7M;CUBOOZ"$]_V.((>>L-C M>I1.`^=U$9.&\GQKZJ.8S M!"-?T]#'K]"8&+'Z9-[1J(N./#,ATR7GKGOAN]2CL%&A%_L3?HD!\$,:DT%'D]Q#ODO.C+>/7"&B M.^\U(@]9+SGW7D*GWYY-C]*;A/,N;.J)P]ZY5M`X;ZT51.DTM(C1#OJ0PW;H M,X>='%$V/0I;1`B--'M'=S$041AH)S"3W<2`KW\>*1JH9B]]I#].762"0/!\7K%VSQ)6EL+*^%%=+BB*)NA"IN#,,P'VD M2??L9]KNBUI8)=M!2G<6P<9N\4:##Y(WW:%YRR7<1+J?![AY,CBIN3,`[SB7 MGP_J!<-==OT_````__\#`%!+`P04``8`"````"$`S;]:PT4$``#'#@``&``` M`'AL+W=O#ME_>Z\MYH MRTO6['PR#7V/-CD[ELUIY__S]\ODR?>XR)IC5K&&[OP/ROTO^Y]_VMY8^\K/ ME`H/'!J^\\]"7#9!P/,SK3,^91?:P#\%:^M,P&5["OBEI=FQFU17012&RZ#. MRL:7#IMVC`N/&;X^?V>V7MCS^5C84H@UY$MGA M+UK17-`C9,[W,",'QEYQZE<8"F$1W@EP$?Z_6N8YPE4"O8SY6RWYTJ7MC]8[ MTB*[5N)/=ON5EJ>S@)46$`:,QN;XD5*>0QI@K6FT0-><56`!GUY=XGZ",&;O MDJX\BO/.GRVGBU4X(R#W#I2+EQ(M?2^_Q,23:.G!5DL'T"9]R[PK5SFHUT"&9PN[FDFLOVV93T67G0[E"0#FD_FT?;H,W2&[>*V*I@$^M(+8B40K, M))JFQD``M!H96`"1(Y($/%S%:D0\5<*RQ4R+B)BM&= M0?5\CHR30&>$:J'=N\C$4C'7-Y6X`ZDQ8`%!BDV@ST%0O//A9G7.E@Z(5,"G M5JQL1:(4*OZI,6"104V.)T.Q3?9DKQM+A4FVMA6)4F@R8\`B6SY"AF*;C+BE M("5S*)-B/YF0:#*#4BBP:";$A51:#6D,6)`K&W+<3L-)#JQ3E;&4&%M-#BRZ M(B=DMH[F*^),2HU)%B0^SXUF\_GN0[$#YU1J+"4&G#N0RH&EI%V%9#5["L-[ M0BRZ]2-T*';HG"X12XG<@H?O-<5$*71VC0$+C4#3&!^Y3NW`W1N4;"&]!G?A MVWY&B%/9B?Y?LYDC-APVZM%I);*MFUV%N/VMUYC5.P24/O?DIWH6(-N`V*_' M`\KN;@$Z72TF4F,!.ATHT9I[!-6L`2"VZ_&`LKE;@$[?B(EZ`-P[TCGN?%F^44@&<,9S MHG^;,D;LT&&W'@\G>[L%YRP>PU$"0V?F-G)*/-&:>V[5++WYY#%!OJ[6M#W1 MA%85]W)VQ==^`IG1H_HX0X``!D```!X;"]W;W)K&ULE)==;]HP%(;O)^T_1+EO$H>0%@14K:INDS9IFO9Q;1*'6$WB*#:E_?<[ MMA,*=L!P`P1>GX_7)P_.XOZMKKQ7TG'*FJ6/@LCW2).QG#:;I?_G]_/-G>]Q M@9L<5ZPA2_^=Z%UX2(CR(T/"E7PK1SL.09R6I,0]82QKXI6!= MC05<=IN0MQW!N5I45V$<16E88]KX.L*\NR0&*PJ:D2>6;6O2"!VD(Q464#\O M:Y+1_/OM"'@-NR3W($U8R]2^BV77\'BT%K]K';@9^?EI,#;2OQBNZ^$ M;DH!VSV%CF1C\_S]B?`,'(4P@2XC8Q44`*]>3>5H@"/X3;WO:"[*I3])@^EM M-$$@]]:$BVMN6"U?^T",FB]D'B/@B\]T%0'*`D2MTQ0EV/:N\)"[Q: M=&SGP#VL8KI/H$I]U*)$;>YAQLEQQO.9 MI!AV["A3DJ-3%J4:..#CXZ/+(5-O-Y2NE6F1G0G"['39W/I526UV9IO:JP=7XQ*2B$0:Y?56KK!(^^*)O_UXU MTJ^!'$>_&B,.`J!3L$&2#0>3XTBF20+!#L%FF3OP1N'W%`6001_)]PN\'<-0 M&AE#JV(O_1%O#?8XVM4\<7E[BCKH*NPHM34UEK<#>+2W)P?7X-"%YHX!*46F MN0.1Y*GD\(\+&11RF*O)XC+W%'_050!2:K>Y`X+.#FYL\.@R;]4JLX(T-KSM M5?;@Q@:)SGNKU$[@]JJ19%<1*-9L<4"A5[F(&TMV'/#H0G,U<8Y+2">FN5HU MTJ^!(H>Y&D&.P8VU:B3950B2YV?[3]JD0J\Z::Y^>-"GZQ9OR`_<;6C#O8H4 M0-THD.?J3C\ZZ`O!6G6*7C,!1W[UL81'/`)'["@`<<&8&"XD!O8/C:O_```` M__\#`%!+`P04``8`"````"$`0AV8IR<#```X"0``&0```'AL+W=OTT[;_?M9T0[+9)M9SCWWVC?+Z^>V\9X(%Y1U*Q\%D>^1KF`E M[;8K__>O^ZO,]X3$78D;UI&5_T*$?[W^_&FY9_Q1U(1(#Q@ZL?)K*?M%&(JB M)BT6`>M)!SL5XRV6\,BWH>@YP:4.:ILPCJ)IV&+:^89AP3_"P:J*%N2.%;N6 M=-*0<-)@"?I%37MQ9&N+C]"UF#_N^JN"M3U0;&A#Y8LF];VV6#QL.\;QIH&\ MGU&"BR.W?GA%W]*",\$J&0!=:(2^SGD>SD-@6B]+"ADHVSU.JI5_@Q8YBOQP MO=0&_:%D+T:_/5&S_1=.RV^T(^`VU$E58,/8HX(^E&H)@L-7T?>Z`C^X5Y(* M[QKYD^V_$KJM)90[A8Q48HORY8Z(`AP%FB!.%5/!&A``GUY+56N`(_A9?^]I M*>N5/YD&Z2R:((![&R+D/564OE?LA&3M7P-"!RI#$A]()J#^L!\'<9:B='J9 M)32*=()W6.+UDK.]!UT#[Q0]5CV(%L"L,IN]FQFDI&)N5)`.!;2`%@<0+<&!$=@`,4V(G\#D0V0$`0.*B%W5^4$JOBV_T>5*LA6&<\&>IW( MK8%DVF>563Y:L`2`-:Z`RS:I("CUR`&P*74D&%!RDC!:L"0DKR5<]D`%K7S( M:BA"&KF%,IBIJ2-"29(A6V-N(:)LED8#P)((C3-VZ7QY%-B6!NY,!V)3(`,: MN3-:L%X]M5_]L3Y601<+9$`C":,%2\+,EG`^>P6VLT^CB9.\P:2'`S:?G%S7 MYN3C_3A*9J=]2Y>:0LX1O]PX*LC5YS:.P1A]69PFCOY\O(_.M,W\?P2J(%>@ M>[8,Q@A,YIE[_XRW$5S%[_@'D\4R\'QA-=H5YK;U`63.W#QRSYNU'4>3D_&F ML&90F7N\)7Q+2LYS`X]7HX;,#&ULE%;;CILP$'VOU']`O&_`!,A%25:;H&TK MM5)5]?+L@`G6`D:VL]G]^X[MA&!GLY>7!#S'AS-G?)G%[5-3>X^$"\K:I8]& MH>^1-F<%;7=+_\_O^YNI[PF)VP+7K"5+_YD(_W;U^=/BP/B#J`B1'C"T8NE7 M4G;S(!!Y11HL1JPC+41*QALLX97O`M%Q@@L]J:F#*`S3H,&T]0W#G+^'@Y4E MS4G&\GU#6FE(.*FQ!/VBHITXL37Y>^@:S!_VW4W.F@XHMK2F\EF3^EZ3S[_M M6L;QMH:\GU",\Q.W?KF@;VC.F6"E'`%=8(1>YCP+9@$PK18%A0R4[1XGY=*_ M0_,,(3]8+;1!?RDYB,&S)RIV^,)I\9VV!-R&.JD*;!E[4-!OA1J"R<'%['M= M@9_<*TB)][7\Q0Y?"=U5$LJ=0$8JL7GQG!&1@Z-`,XH2Q92S&@3`K]=0M33` M$?RD_P^TD-72'Z>C9!*.$<"]+1'RGBI*W\OW0K+FGP'IC'J2Z$@2@_IC/!I% MTP0EZ=LL@5&D$\RPQ*L%9P31?`(IN9'T-J`8$^<039BN6*O#2AX3[DB8(V7:L#28UJR)"T/9^S0IL:X:UFMJ?71O0P#]W(!L,6%I26XO:4&_75$UZ MLZ8&--#D#F2#`4O3Q-;T>DT5V/8G"9V:K0TFT36-49C8[FVL,-Q5=CB[&K9$ MJ\MS<#*]+EJ!'='(^>S:8(ZBQ\C9^QLKC-#8$3T,CZ?1><-9HF3)V4-E8TCAW)PV@ZN[)W$)R;[_=9HVW-L'O24"-HJ^A8<'/=SJ'U%G[HNH/_;6>O[2/YX^(1JXH`_*C068A8FS*E1;H909 M@NDD.N=BZFYZ!G.E-H3OR(;4M?!RME?]`(*Z]:.F5UFK7D7GV0>@5>CPCOS` M?$=;X=6DA*GA:`)'##?-AGF1K-/WUY9):!+T8P5-(8'S/1P!N&1,GEY4.].W MF:O_````__\#`%!+`P04``8`"````"$`1_JG2W8)``"/+@``&0```'AL+W=O ML]C6>R190K=__=IM>S^KPW%3 M[^_ZQF#4[U7[=?VPV3_=]?_S;__+M-\[GE;[A]6VWE=W_=_5L?_7_3__KD9#H_KYVJW.@[JEVI/EL?ZL%N=Z-_#T_#XNVI]DDD.U79WH_H_/FY=C MEVVWOB;=;G7X_N/ER[K>O5"*;YOMYO2[2=KO[=8WT=.^/JR^;>FY?QGV:MWE M;OZ!]+O-^E`?Z\?3@-(-Y8WB,\^&LR%ENK]]V-`3B&;O':K'N_Y7XZ8TK?[P M_K9IH/]NJM>C\G?O^%R_!H?-0[K95]3:I)-0X%M=?Q>NT8-`%#R$:+]1H#CT M'JK'U8_MZ5_U:UAMGIY/)+=#3R0>[.;AMUL=U]2BE&9@.B+3NM[2#=#OWFXC M2H-:9/6K^7S=/)R>[_K6>.!,1I9![KUOU?'D;T3*?F_]XWBJ=_^33D:;2B8Q MVR06W7V;9#28&*.9-:$D%P+M-I`^WP(O!E"ZYG;ILPLP!K;I3*;-_5ZXU+B- MG)PCK[M'ZBG-)>FSNR2I=.%*LS:`/KN`*^_1H,12#6KO+E:1X\)%C4X#\4<; M:IJ#J>/8X^D'*ABDF[SL6<#)P+!'8U$#ER[:Z6>63GLO@TD6'LK&/9G>#G]2CU^W3G/I1.5W=K)L4W=: M=$ZBAXO4+@<>!SX'`0R\ZC M>\2,@YR#@H-2`4.2\DU/ZC2@IT6]\?UAM)-/1.GR32;Z3<_1A2N''C24L29T MT<)WW5B#Q:]Z\1DC]&)/5B"'M@^J712 M^PB[FV7G\58]'3@7'&^+O'/I8HH.G&-X;RT[%XK1*HR&UC^H,!%%4[+6OZ:L MA>;2R6ZF9-'W%QRX''@<^!P$'(0<1!S$'"0O,DFGUL M,'.JFBUG:K.G7TK[N9XS-<`QK3%K[IP'%&J`Y5B\@4HE0"L9J@XHF8^G`1$% M)<,>>BZ=S@^UX,#EP./`YR#@(.0@XB#F(.$@EZ!P\HU(#WNH<2H,E#+[H@S\?=0T3I*N?11U.'` MY<#CP.<@X"#D(.(@YB#A(.5@R4'&0Y M=)HUO7LT@)E+-7\9#0PFE*O:1X,1JTU/-[-@GUE9%PV8F>4.+YLC9F;7CIF9 M)4]T\XC-,*ENMOB8*,WG\LUT?X>]L>7A_3"Q`^;- MS.%E<\3,^LM-S*PL=Z*;1\RE.>MU[EK+8"X0#P@/I``2`@D`A(#28"D M+9'+@R\.'R27$)$!R8$40$J5Z(J(;0Z^/76%(G)WA-93;\7G\*%N;D@G51!. M7/#Q@/A``B`AD`A(#"0!D@)9`LF`Y$`*(*5*=`G$/H`JP>6I6^S:XH#,!L%Y MZZ6VO8P[$Q=\/"`^D`!(""0"$@-)@*0MD;,(S0M\1%Q"2`8D!U(`*56B2R$V M"#XAA=Q/T'<`9FPG%*OP332\7[6H?,>P96\?,Q7=F6DLO@+A`/"`^D`!(""0"$@-)@*0M M:3=$3'AGAHA,CW#X!F0.$84>04L=_:6_5"-TE<32_1,JR94^4XDM1N?B&T6F M$B!O*:3QA&Q^9EF=LSUB_R:]+4VAI;#JQP+N?;-"_OQM=;;%Z M5=7^8-*2BUU59<<&D:63^K['B6MPX@'Q@01`0B`1D!A(`B1M22OR;&RQF7@) M(9D>,ID8;(\NAY!"#W$LD[TJEVJ(II/Y9QL'39B^<>#8K##GK9.B%Q`7B`?$ M!Q(`"8%$0&(@"9"T):U>IF487#"(R?08PYK.6-_)(:9@,2.'7Z=48W3)^,[" MY:YERJT!6B5W7Z'/$2T0N8@\1#ZB`%&(*$(4(TH0I8B6B#)$.:("4:DAO>%I M>-+&M#\\<62*/'KG,?@&X[QU$BOJ\^!OL"ZV.'MUXKJ(/$0^H@!1B"A"%"-* M$*6(EH@R1#FB`E&I(5TVL:)6IZ+NQ>.3!\7H""G(!K/QO/72=;-G;(-X<78[ M"R?S4V2'//3R$06(0D01HAA1@BA%M$24(K M#D_5HMINC[UU_4.Y>4,'F-`_,V_HD!+R0MS2._RK*8XC-U<8OEV:C@._K)ZJY>KPM-D?>]OJ MD1Z4SL;2HOP@#Q3+?T[U2W/8[5M]HH/`S9_/=/"[HA-'HP$Y/];UJ?N';FGX M=I3\_O\```#__P,`4$L#!!0`!@`(````(0"RY%F,.`(```X%```9````>&PO M=V]R:W-H965T?6[)X/LD&';FQ0JL"9TF* M$5=,ET+M"OSSQ^9IBI%U5)6TT8H7^,PM?EY^_+#HM-G;FG.'@*!L@6OGVCDA MEM5<4IOHEBMX4FDCJ8.CV1';&D[+$"0;,DC3,9%4*!P)<_,(0U>58'RMV4%R MY2+$\(8ZR-_6HK57FF2/X"0U^T/[Q+1L`;$5C7#G`,5(LOGK3FE#MPW4?7 MX)U]GM?<,F@H8))![DE,-Y``_"(I_&9`0^@I7#M1NKK`PW&2 M3])A!G*TY=9MA$=BQ`[6:?D[BK(+*D(&%PA<+Y!LG(P&^63Z`(7$C$*!:^KH MRKVP(_7F_,BC)Q[SXH!`*:@O3."ZST21?D"/TD%U$ MJW=$O8*`>Y\"V+Y-X=_67GQG/>[!(;_5O6C0*VZLA_]C[<70'8SZJO-!UG.C M<]2$5;PQ&MT:/=9F'U1@**8WA#9/_G*,HEF80IY,^Z?1/JYTG'A+=_PK-3NA M+&IX!=`TF<#^F;C0\>!T&]J[U0X6,=S6\-WA,/8T`7&EM;L>_"O3?\F6?P`` M`/__`P!02P,$%``&``@````A`!^M(NRE`@``(@<``!D```!X;"]W;W)K&ULG%7+;MLP$+P7Z#\0O$#EE5G+*5I%O!.N-) M%&N)@?QUPWM]8!/T/72"J,VVOZ)2]$"QYBTW3XX4(T%G=W4G%5FWX/LQ3@D] M<+O%,WK!J9):5B8`NM`G^MSS-)R&P+28EQPE&[KXJ7G[G'8-B0YML`]92;BSTKK2O(#A\%GWK&O!#H9)59-N:GW+W MC?&Z,=#M#`Q97[/R:<4TA8("39!DEHG*%A*`*Q+<[@PH"'ET]QTO35/@T3C( M\F@4`QRMF3:WW%)B1+?:2/'7@^(]E2=)]B1PWY/$29!,LC@;7V8)?4;.X(H8 MLI@KN4.P:4!3]\1NP7@&S-99^JHSL&1C;FR0"P6TAFX\+.(T'\W#!Z@AW8.6 M'@0G8``E`R($]2$%D#U/800M>KFXAQ1LT&D*23[0NRR7'N*VQ8G>Z'_T;!"T M[<@-6$[/%#TH=7OIV&%ZJOBV,PLN,"0_U"V+SZUYS-B7/DJS:$CDQ"DT\KBR M;^M:\"5=C\F<[C2?YMG+NN./Z%KP)5V/\;KQZW[SC^A:\"5=C[FH:\?\T2%Z MN\X6?$G78P[]C:)L,CFKM)]5_B@+IFKVA;6M1E1N[1R*H4/#6S\BES`B$[';6U-#"&ULE%3;CMHP$'VOU'^P_$Z<<`<1 M5@LI[4JM5%6]/!O'(19Q'-GF]O<=V[`EL&HI#R%VSAS/.3/CV=-15FC/M1&J M3G$2Q1CQFJEVT"B>44MY&]*T9@+FV2/T$FJM[NFPY1L@&(M*F%/GA0CR:8OFUII MNJY`]S'I4W;A]HL[>BF85D85-@(Z$A*]USPA$P),\UDN0(&S'6E>I/@YF69] M3.8S[\]/P0_FZAV94AT^:I%_%C4'LZ%,K@!KI;8.^I*[+0@F=]$K7X"O&N6\ MH+O*?E.'3UQL2@O5'H`@IVN:GS)N&!@*-%%WX)B8JB`!>"(I7&>`(?3H_P\B MMV6*>\-H,(I["<#1FAN[$HX2([8S5LE?`92844OG,ZT.")H&SC0-=2V83('9*1N"/V\K`TDNYMD%^5!`&ZC&?I[T M1_&,[,%#=@8M[D'=-F+Y!F+QJHY5+KYW+8Z:Z(&B,5DZCY":G`+K*Z78CN]IHY03%?=P? M![[U9W13OD4`)9.>[X!>-(A;O]Z'SDW$\K\C8*A]ISUT1I`;ACCT>$,W_`O5 M&U$;5/$"BAU'(Y@X'48X+*QJ?"^OE871\Z\EW+0<&CV.`%PH92\+=TF\WMWS MWP```/__`P!02P,$%``&``@````A`$2$+*4>!0``[Q,``!D```!X;"]W;W)K M&ULE%C;CJ,X$'U?:?\!\=X!$R`7)1E-`.^.-"NM M5CNSSX0X"6K`$9!.]]]O&9O@"]--OW2:PW%1IZI2T+ZX7434ZKK8UF MKFV1*J/'O#IO[1__XJ>E;35M6AW3@E9D:[^1QOZR^_VWS9W6S\V%D-8""U6S MM2]M>UT[3I-=2)DV,WHE%=PYT;I,6[BLSTYSK4EZ[!:5A>.Y;NB4:5[9W,*Z MGF*#GDYY1F*:W4I2M=Q(38JT!?^;2WYM>FME-L5WNPC!?YEE-&WIJ9V#.X8Z:FE?.R@%+N\TQ M!P4L[%9-3EO[*UICS[6=W:8+T,^BO8?>O^3Y.=+"^D.0!$3MCZ^Q:3)(*)@9N8% MS%)&"W``_EIESDH#(I*^=K_W_-A>MO8\G`4+=XZ`;AU(T^*Y`K\/*Y-=",5B^'TLGNR"PX/2Q3A. MVW2WJ>G=@L(%VBD>X?Q5M"#,S\I59Z6Q!(!LHD9<="OWY MQGF!O&:"M.[L]D.@`E@`')#UT0<)T77,HO?&BZ66P M1:H,;Z&ZN!^AJ(QHA+%4*;%)@5I\N7?4!B4Q`*]?WAX1T%8TYH8N7HA6R M,5TK(ZM:/:07*N<$7&KHKI"NE1.&S,4ZD.@`E@#%>6@IVBP5AD)T8")8151(;HM,E\9$K2S([+^(DL6F"T`VTWAP)QN!Q;"") M@6`9436P`3I=`Q^WB@:C`2-.$DUJK`,+AJQ!FN/=L$L,#I8150,;C-,U\#$J M:QCIPZ@?MNR%=*01B_M"Y$@G?AAXM&(#P3*B*F+32&G)C)'M%`L30]X2`\$RHFIB0W2Z)CYR%4VA[ZG;=X^DP=R5360@L8$D M!H)E1'6:C4O)Z8DMEP]9J.GAA=)\_472*!;.ZTAL^DPDR)8_-L$A0O]A3X2!"DI M!I(8"#N981U#F!U)"C]WX6<"):G/)")%T5@9O;$S%00OL0^4G_?LT1H^U*$C M.H\;<-QR3<_DK[0^YU5C%>0$2]W9`GI1S0]L^$5+K]WG]8&V<-#2_7N!@S4" MWXWN#,@G2MO^@CW@<52W^Q\``/__`P!02P,$%``&``@````A`+6MBQPD!@`` M#!P``!D```!X;"]W;W)K&ULE)G;CJ,X$(;O5]IW M0-P/Q(203M3IT21@0-J55JL]7-.$)*A#B(">GGG[+6,.=E6V$VZ:R-R:R9:627M-SGE^/&_/LO_N7)-.HFN>R3ZC%>DCX8JD>GN_?DG+X@HA7O-SWOQL@YI&D:[CXZ6LDM%L>:/4\\I>V1#IY7F?@P.1=J/*#AOS&UO'SMRT7Y[;!/V3 M9Q^U\F^C/I4?897O?\LO&60;GI-X`J]E^2:D\5X@&&R3T;Q]`G]4QCX[)._G MYL_R(\KRXZF!Q[T`1\+8>O_3S^H4,@IA+&D_+QXUX710X]E&\Z4:6710X]E$< MRWE:L(4W(:DP0]LG`\:[*#P/F,U1# M?4W$ZL#6$+FO.5DA0Q7^7Q%"]8D@WT24-A;45PTSY_L+\USOV?X.Y9YVHJT4 M00Y&T=QENFC7BT1YB]!^#Y11#D.C@E[4C^(2P-_Q6OJ%PE[1#XDPB!5@0[:& ME$$EJRF[/3W[S`@QRHR[Q)FY(?+8N9+HINBM#CBV^(%LYX.2W[L*2HV1<%.X>E]O.G(`9M3+C,6`[>8KQ`6VE; M*7+;Y5"4W@X#'X,``XY!B$&$0:P`S2@L@].-BD&0$-WH7'\F6RE2C&+@8Q!@ MP#$(,8@PB!6@&84U?;I1,8@\41<9E2+%*`8^!@$&'(-0@I5?T*,7&[0&ZE2'&+@8]!@`''(,0@PB!6@&80MDS5X&,350RZ6[]2 MI!C%P,<@P(!C$&(081`K0#,J^F^TA=Y?D<0@\D3QOB!%BE$,?`P"##@&(091 M#\2VC690W)^#75+S#*W"=,]B$/&,MKFM%"F>,?`Q"##@&(081!*PU;R=QC.+ M.2CWL3)$<\Y@LU&M?SYQ6S7QC';M;:=23!/B$Q(0P@D)"8D(B56B6Q4=T.3* M9K)ONK,'=2K5LAPW$I]H`D(X(2$A$2&Q2G3+HA69;EDV,*B_0%O#EDG5:'`W M$+4O\5`+Y0^JOE4-".&$A(1$A,0JT=,@FA(E#7>*7+8PNGT/-7E;)E70!8Q- MF+-`F]AN4/5F?4("0C@A(2$1(;%*=/NB55'L/[9W,=G@H#3@+K-3N>W"XUIH M*=@-IT?_2M_4-JH!T7!"0D(B0F*5Z/Y%TS+=OVQUD'_-&XA--0`@?B$B/B[,7 M#J='__@RL:K1_8M>;/**`!\_B'_/P_^!ZU2CVQTA/B$!(;PC\D6+:Z$TAV1` M1(CX6C/T&M*__/@BWX`7677,=MGY7!MI^2X^K#C0E`U4?O39LC6\DX8<(^ZS M-;QU!FX/)^!;S#4Y9K\GU3&_U,8Y.T#(F26^653R:X[\T937]HWP:]G`5YCV MGR?XZI;!*\>9!>)#63;]#W&!X3O>RW\```#__P,`4$L#!!0`!@`(````(0!" M<\),MP(```<'```9````>&PO=V]R:W-H965T:R-46V`2)1CQEJE2M)L"__IY"J:5496-@"X.@3[->1;/ M8F!:+DH!&;BR(\VK`E^1^6J*X^7"U^>WX#LS^(],K7:?M2B_BI9#L:%-K@%K MI>X<]+9TK\`Y?N)]XQOP7:.25W3;V!]J]X6+36VAVQDDY/*:EX_7W#`H*-!$ M:>:8F&H@`/A%4KC)@(+0!__3XS2,GY7#DG[PIH`]VX7Y(\GR[B>Z@AVX-6`00WH`>E/2(&]3X$D#T/8?1J M",[I-(1TTM/[*%`" MI[ZL:4*R,XU@SD/5TQG)>_M)DC!7PZ*^+.G``\DC92AD,&=>-ZZ8#XH)O\8G,E[%!UXH'@^K<$\#E4GSV?HMOG@KKQ<4P=V>L?Q)^FX MYPV%#9A]+V>CZ7&>0B_#0@KW57*]X9]XTQC$U-8M&P+!]F_#'ES!'DS]^/4& MV$,=W?!O5&]$:U##*W!-H@DT58=-%@Y6=?X^K96%#>3_UO#!X7#?DPC`E5+V M<'"[LO^$+?\"``#__P,`4$L#!!0`!@`(````(0")/M:5`0@``*HC```:```` M>&PO=V]R:W-H965T"=X-*NPC; M-YI]-3`QR[,,LJUH0`22V]U_/UDJ!)6G=+&[_6`@S\FL)4]EE9;[OW[N=XT? MR2E/L\-#4[2L9B,Y;+)M>GA]:/[GW\.[L-G(B_BPC7?9(7EH_DKRYE^/__S' M_4=V^IZ_)4G1H`B'_*'Y5A3'3KN=;]Z2?9RWLF-R(.0E.^WC@GZ>7MOY\93$ MV])IOVO;EN6W]W%Z:*H(G=-78F0O+^DFZ6>;]WUR*%204[*+"^I__I8>\RK: M?O.5+?)]D<*\9SNTN)7&;39V&\ZD]=#=HJ?=S3NG\*--U7L\H<1 M?I]N3EF>O10M"M=6'37''+6C-D5ZO-^F-`(Y[8U3\O+0_"8Z:^$VVX_WY03] M-TT^3<-KR'9096I\8V>8G? M=\6_LH]QDKZ^%91NCT8D!];9_NHG^89FE,*T;$]&VF0[Z@#];^Q3*0V:D?AG M^?F1;HNWAZ;CM[S`<@31&\])7@Q3&;+9V+SG1;;_GR*)W:DSXOC30<*5W:7/BL'T7)M+PC+_MYHRC][!E?/K_615DK9 M)'U635*6;K04G1WHLW+X8A\%!5;9H/FN?+5TW&A45#F07\ZNMG/-Y"U72IMJ M]9H__VN32LH^NUXS^-56JU1*M9X[_-56JUP*^O*;8Z7TJ[%>=7"[U;9:,.7Z MZ\=%_'A_RCX:5-0H1?DQEB52=`1%JU:>FNG+6OR[I4AK4$;Y)L.4P6B5Y50_ M?CR*R'+OVS]HT6_.I*XBD0*O),>U.:E7D>0BEZ'[:!B@88B&$1K&:)B@8:H, M]/_:-S>(>-]F-23'=3AI7H76(G'&HF)40WQ"PQ(-*S2L-4.;4GG))ZT;(Y\. M+`^5M7%/)A"J/R^@<*DUZT*^OK*[(\GHVN(I7GC'+M]]#01\,`#4,TC-`P M1L,$#5,TS-`P1\,"#4]H6*)AA8:U9F`S3KL2F_';:UFR'YJ4O4LEBU#V7<7Q MRT)MVT&(@NGI!.'8@0,J[#."*\+(Y[D!!8`O`)PYW0@]4XU7';L3T!^I_I!,?W;`]JT%PG>)%CX0I:*,)5SD^ZAR." M0$`Y6J+'2O>P/5]XT,NUYL$T0\>1W]",9'/-"-^%\785R5.[NQTZ(4QY3R=X M(G!@ROLZ[M-9%\8RT'$W\CV0U)#A?A1`!T<,=XC`)3EFN&VAI"8Z[D3"A?(T MU7$A`C>``J)7JLF(<;4C?X-*PU M#R89.H;^AF0D&R1#RYPWU54D)1G9>CI^)X2/L]K7"70\ATD=Z'!D['Q#'18^E2F>\Q'#;1O/,&..^PX, M;\)P*T3)3QGNV#YH=L9P7P`\UV''"UWH_D+AFF1T!\]V?*@62W18Z0Z.Y^`$ MK34')ADZTQJ2<:D6W3[-2"]#,C"HKB)%YADZ@'G<5J=*)'4;L#U35T]EULM'Q&MD`#-&''!:NQ?X@ MTR-@`SR^#4\`YA5M"BC$GG'8`GC.83SS+10L;PE>+D<$;DM//(8+-6WYE1@K M'@-KP/J3&$R!LK=,@K=+5$E'[>%9I7MFJ6NNNGV-$6HW-L:P(URQ`X;7;&T, MK]O;.*%F8WA=S6*$FJ(%."SV M(<*XVR$.R1M_@D\0A_:GB$/\&>!&L0+.RDLUX\:N9WBLL`V8H[7N MP94C[[C]@7+4C3I0#FSV7?E`A3;(:AR?[7V,7BLD'@\/%P,6@(2&VQ_@G^U_ M2`=AC#_!)XC#%H@PA)\!;NJ*SX8#NER<_75=<0]CSS,\5M`'7/MKW8/K2MY7 MU'7UR7:F;D.23*N[Q5UAF'JFJ6^:!J9I:)I&IFELFB:F:6J:9J9I;IH6ING) M-"U-T\HTK9F)3[R\.:=/_)\^7%,W^4@Q?W^&ZLJ'F+3`I0JN++QCT+NRJN3V M3=/`-`U-T\@TC4W3Q#1-3=/,-,U-T\(T/9FFI6E:F2;Y.L-YOBX/.-3K">KQ MZ#XYO2:]9+?+&YOL7;YZ$-#EY<6J7HN@2:_>BS"0#CUCI,A@G\L7*>KL=H<> M[)C\)[M##V],^\KNK.OLWX1##3C2HWUIFMZ4.,:OR2(^O::'O+%+7F@X]-H` M77R?U+L6ZD>1'](E%_?Z)V8A)["6BTBOV194?V0#5S>LGG\/P`` M`/__`P!02P,$%``&``@````A`$V:/JAU"0``R2X``!H```!X;"]W;W)K*^P'+QAQ2258-^'S;M5\LR(/7O(;!R$<*G7RVINR59BN__^+EYZ_U9[?;K>OO0 M%P.KWZNVJ_IIO7UYZ/_W/\&7:;^W/RRW3\NW>EL]]']5^_X?C__\Q_U'O?N^ M?ZVJ0X\L;/TK"W>[:VS4S\_K5>75JQ^;:GM01G;5V_)`_=^_KM_W1VN; MU37F-LO=]Q_O7U;UYIU,?%N_K0^_&J/]WF9U%[]LZ]WRVQN-^Z<8+5='V\T7 M,+]9KW;UOGX^#,C<4'44QSP;SH9DZ?'^:4TCD&[O[:KGA_Y7<5?:H_[P\;YQ MT/_6U<=>^[NW?ZT_PMWZ*5MO*_(VQ4E&X%M=?Y?2^$DBJCR$VD$3@7_M>D_5 M\_+'V^'?]4=4K5]>#Q1NET8D!W;W],NK]BOR*)D9V*ZTM*K?J`/TN[=9R]0@ MCRQ_-I\?ZZ?#ZT/?&0_4(DO>^5?M#L)8F^[W5C_VAWOQ?B41K2AFQ6R/T MV1H1]LU&G-8(?9Z-V%-7N.,;NC)JK=#GRBFC:GJ?F[F4E34EKY*LT\]"GJ-.GVM)S\^2BFL_']\$]:`U:M:-XA M!SX'`0)`O3[/(#19&;V+>T0.2/'%&5'TYHE M4Y$?%<AH1[%Y"CX&2:AFH8]MS!:C!T\!Y1%!! M\XBYQD/1Z-3=)HX^*L1H:IFB`$7VU)2$*"$[9]\TC46=(C:PN%/$PIF@B`TL M107Z)T,1ZTW>H6!#+U`R89(2)<(9G8-E9`XM34;FR+GOT/)Y.8-D+=)I"4-3 M?6(&::Y$S0-$$Y`%!QX'/@E!@Q_T@IO^/.R M'Z7ZH4_Q.DT\\B,+YUR)QFI%=5U[-K$L-F<62G/VM<>!ST%@F+6G4WKZ959# M7B?B(.8@X2#E(%/@XG!R0]/9MX+;+35@1(0VM!LB(M4L(N,ICX@2N4U$;'LR MM:?@NX6N$8X]<="_GJ$9R=T2[/BZ9F:-;303Z)+I:.8Z8"4T)-006HETR61B M"93$AL29NB-H*-$EMF.[`EV3ZAIG[-HNF6&IE^D:=^98$[23ZQI'3"9"@)U" MU]CN6+AHIU2:9O(8F4./PT;FR+5Q_.G:*&NQ#)K.SJMOLQ3.E>@\7Q<<>`JH M''-'[@R&YO,J`0)`FUJ"^&B2U-#,N[(DTQ7N#/A8%KGNH3FSTSF M@+E_%+K$G31)PB2EDF#DZ`!C1.[R*BS59L0<'B\E:=TRF4XFF/H+0S-U+9EI MK,.>KA$S:T1//USC*\TY-P*]DCV;.AB3D->).(@Y2'2KO^E*JFOHN-(UI,S0 M=+LF-S2=(RATB6.+CH0OE02C+2^$^/GE\V<86,FH,R*ITML.H%V3&8ET8*NUQ&N,\8Y%/(Z$0&!)[ M,L;GB-20"(&*3%Y(TU0S M\X;6`W:FG+>J6?/H9PT<=H!;&.5?K(%V8&\V?L\06`.+'35]5L[:#W@Q.W.% MO)R9CSXICWDY:S_AYL'*'C;]LRSNR0EZGW+Y) M"'4+8YS09A:+^KQ5';."'F>,'W9\6!CRSB11K1[M\?9\PP`E$6L@8.5"/JQH M/RRH(9>S\NB3\IB7F\]Q"2]FYE-6CCEC>L-A.9>S^B-VY5BP,Y6D%8;^>MZKSM+8!X0'P@`9`02`0D!I(`28%D0'(@!9!2 M)\9^+N_##;]>N4*K.Q?ZK=^6L!5@WAA_Z.O^U>YJVD68$Q]J!4!"(!&0&$@" M)`62`% M(]2]@A$5O,-I5?J,T.XCVI5&D4M^\<%.`"0$$@&)@20MN=1Z>H4F`\LYD`)( MJ1,S*O(@KT?EDWU5G?OU:,#]C-#N!AK/+UK2CMUUQWC3XEVA\<%R`"0$$@&) M@20MN=3#]`I-!I9S(`604B=F=.0Q7(_.E;NS.KWK4>JX3Q':&;^-DR(G+TSP M=LMK:UW2^&`Y`!("B8#$0)*67&H]O4*3@>4<2`&DU(D9)WD`UN/TR2Q2YV4] M/G`O(K0S=1L=3KQ6<\D;/M@)@(1`(B`QD*0EEUI/K]!D8#D'4@`I=6+$POY[ M=PY-M4_O'%J5ML\`\5JB3HQTI+1<\Q#F0Y4`2`@D`A(#25KRVZ93$+`#6@8V M7+X!X0'P@`9`02`0D!I(`28%D M0'(@!9!2)Z9?Y1%67_VOVZ5M=?*EWY?.T*U*]R\_,7N@\8$$0$(@$9`82`(D M!9(!R8$40$J=F/[E9^@K_=MQEK9=?E](;]6R\QP0#X@/)``2`HF`Q$`2("F0 M#$@.I``BWQ^6(U5O>ZA_HNA7`LKEZ@UA]4KBIMJ]5(OJ[6W?6]4_Y-N_#MVU MG^CIS>2OMGQ]C?&YN*.W^I!GXH[>KR,^/%6@%XG?ER]5OMR]K+?[WEOU3$U9 M@PF=JW?J563UY5"_-R](?JL/]`IQ\^T5N)UH#$SW5].'Z1#9Q>0G_\ M"P``__\#`%!+`P04``8`"````"$`W29R_%\"```Y!0``&@```'AL+W=O]*WNH."GH`2V]6'S\L=]H\V0;`$63H;$$;Y_H%8U8T MH+A-=`\=[E3:*.YP:6IF>P.\#$&J97F:3IGBLJ.186'>PZ&K2@JXTV*KH'.1 MQ$#+'=9O&]G;$YL2[Z%3W#QM^RNA58\4&]E*=PBDE"BQ>*@[;?BF1=W[;,S% MB3LL7M$K*8RVNG()TK%8Z&O--N)@:J@M]EB/:9LM0S^_)*P MLV??Q#9Z]]G(\JOL`,W&-OD&;+1^\M"'TO_"8/8J^CXTX)LA)51\V[KO>O<% M9-TX[/8$!7E=B_)P!U:@H4B3Y!//)'2+!>"3*.DG`PWA^_#>R=(U!1U-D\EU M.LH03C9@W;WTE)2(K75:_8Z@[$@52?(C";Z/)%F>Y+-)-IG^GX7%BH+`.^[X M:FGTCN#08$[;%YEL_EXR9[10W$$ MK2,(3\``R@<$P^Q#"9CVO(2W4WOPB]3CZ^E`'.I;1]`L]/0\T^@RT_O$^B`T MY4Q'EH[_2HD9(RB,X(6V\67&M[5Y<$&Q^,$QM'7R0EL$S8/K:9(-NS%M'.'8 M806FAD_0MI8(O?7CF6'4\#>>G#6>G#P8-6S@Y/:\AD=N:ME9TD*%H6ERC:-J MXNS'A=-]Z,1&.YS9\-G@%04X(6F"X$IK=UKXTS5<>JL_````__\#`%!+`P04 M``8`"````"$`?/=10V\#``#R"@``&@```'AL+W=O&ULG%9=;]HP%'V?M/\0Y;WY@D""@*J0=*NT2=.TCV>3&+":Q)%M2OOO M=QT3L`TK;#Q`(>[3%#?RS MIJQ&`F[9QNN[LY MDZ])P2BG:^&!G*^,GM><^JD/2O-I2:`"&;O#\'KF/H23/`Q,[AWH/7#.6R0[.9R`43$;6,^1DR8?G&N!# M5*41&TP.T5 M2?+,!?%3W'$X-.TM%&EX+'MI`YD-Y!I@F!N:YF0G#>!]?3]V.0AXNLDD22V3 MBJ29M(',!G(-,$Q"B]^>H"1;"29I8)E3)'B>'G-LDI8]J>^NS`9R#3`,CTS# MMZ4J!UG&XW!D>EHHTJA[6Z-A`!^3L%2$4^R9#>0:8)@>FZ;?;P%)MLPFJ;4L M+!3IY&5I`YD-Y!I@F)-;N[7B7>]3.>AJGRJ29M(&,AO(-<`PF?Z/23GH+$EK M05HHDF92`;%:M5/9!U8C9#IC?(&0ZX38)!A5P4YO9/]^8W3LLWH&9I+1Y MB.3":N%+>>21N'_\`TX<+=K@KXAM2,.="J]!,O#&L"@P=691-X*VW8Z]H@+. M&MWE%LZ6&';!P`/RFE+1W\@''$^K\S\```#__P,`4$L#!!0`!@`(````(0"' MQ4#.SQT``%RV```:````>&PO=V]R:W-H965TW__/;?__7+W_GO[ M],9X^/'XZ]NO3T]_?OSPX?'3U]OO-X_O[_^\_6%:OMP_?+]Y,O]\^./#XY\/ MMS>?CT;?OWV8SV;K#]]O[GZ\M1X^/KS&Q_V7+W>?;L/[3W]]O_WQ9)T\W'Z[ M>3+'__CU[L_'T=OW3Z]Q]_WFX9]__?GNT_WW/XV+W^^^W3W]Y^CT[9OOGSYF M?_RX?[CY_9LY[W\'RYM/H^_C/^#^^]VGA_O'^R]/[XV[#_9`>?QZ_W?RY MO/MQ:T;;Q&F(P._W]_\WI_[^[_3V[H^O M3R;<*W-&PXE]_/R?\/;QDQE1X^;]?#5X^G3_S1R`^?^;[W=#:I@1N?GW\<^_ M[SX_??WU[6+]?K69+0(C?_/[[>-3?#>X?/OFTU^/3_??_[\5!F^VOQN,V?H^7N?;"PV9[O7':JY8(X=FC_'#E]YJ#MG:?X<+5]UJ(%)!AL;,_K.YZDFVI4C*=8:]!HT&K0:=!;<)P>/YC8G@)L+D,$>&$N\.EY>HSG8"7CN=G( ML]A3HD-)A9G;U9B&%"UE1Q$5P7([DZ*8HOE62A)*C)]`BM))D3JQ;%*D\B"G M2)U8007'I[0B_Z)11U.-BE,ZC>"<@7HLFE$RVK0C.-MLU/AUHV2TZ2TPB7>^ M9E;S\]&)-#0S^D^DX6#UZUO3SZF'Q4H&;&\EZ^.@TZ#T@PF[NQB+LS\\Z@UJ%>RW#N;>2U3'$+S(GB/$HEP$A4 MNL_:MY@ZCT9;M!IT&O0>$($W2ZDK`C^H5>!57/=68@,_WVPW&S6;'H1@NYKI M6T3H"X+=;+E4$UQD!5[@?8OY;KM0-XM$&Z0:9!KDOLNI@RA\P7SB-$HAF!B( M2O=9"PN>1J,-6M]@,0_T/;O3!KT'1!:85?$563"H918LU96VMQ*;!<'C=3 M<3@(Q79C,N2\'+%/$T(Q-\'$?Y!+<._4L'=6\G2/EW* M2_8PMHUKTW`$PZ/H:J-<16/K*(\M<*FUU!->HO6I!ID&^0@F#Z`86\<#*$=P M?'26)U>-;:.XMN#2T39:WVK0:=![0`31E(ZN".*@5D'4U["5N$-?+(.UNI@. M5G"^_$)A,5NLL5[3%K%OL0[F2]5%H@U2#3(-`D7FR%T6Z^ M,S5\F?L1;&)A$VP"4WB5-@EL4I`,)!=^IXZE@$TI;(*IDZY@5$NCB1-H8-." M=""]3V2TA]J07^1[_BDLL*4D_ZE[K2]CI['17LTV@9IA#T(0K%&P"85@O@WT M@USD!.=LB85)L%JLU>HP@4D*DH'DPNW$D11",'$NI1!,C$:%3FMA,G$N#4Q: MD`ZD]XG,@:%8F169G@"LXFR3PDL&DK]X+(50+";.IY2*B3&IT&\M;*;.IX%- M*VUFP4P7,CO8],(F6&WGL_/25^;*4,WQ) MJ47K04JF5KZAE$PMGR,G.:=`+(RF%K\);%*0#"07?J?7\E(R=4JEE$P-3(6N M:V$T=4H-;%J0#J3WB&5WFD?FIK:CJ]4' MH0@6\\U"/]9)Q3+8[M2](1(*,[Y>H?KX9!@+P7:YT\>92('I0AU$*@0;4TM6 M@DP*%MN5*E[D0C!?S%?!^1(]'F4A%(OU:JY76:50K':F7JQ\5$YQOC9J8;,( M-KB?-[!IAXIK8+Y=K%5 MX3@(Q2K8+%0X0B%8;[8Z&I$0+'=K71F.I6!MRLURC!(I6!B%%*12,)_IK,N$ M8+$+].-.+@1!L%GJTFDA%6NS#%>A+(5BOMNL=NI$*J?PDTH$8#-4.^6Y-;!I M13_F]9PY%FG3P:;WB4RJH3)U15+90I9(*A6-_?">_Y14PRDIP4$(WJUG^OUV M*`2;9:#&,1+M\\5RJ02Q%)BT53-=(@7F[JB"F2J!F67D&&="$&Q76[7TRX7` MO'73DU`A!'.S^E?'4`K!;KT)U$-#>TXS1]`0D?<$Q=*5!$L8I`$)`7) M0')';,_S(-#I4DB!*5W(="I%^\I\%Z*B4*'/6IB8!8$NXC:NI2PD= M3'J?R%@/]3`_UB^LX_[A6A_-WNOB^VA$,S>S]2M-%+M M:ED1ZV8UU2>Z7;E/7VC/=+OJ/]?MRG^AVF?J3E.J=CW!5:[]G/2ULM!UF`86 MK;+0M\,.%KU/9"K]7'EUSO*J^<9:/THXU>5M4VZOV3+>K_G/=KNP+U:Z_("E5NRX)5:[=SR5Y1LPEVWZV:'4?:HPZ M]-'[1.:2+LB^;AD[GRK,JJ':.]&82N8A3/RGEI0'(9_,+-OIZ(^SE&I7'<2B M`S,++F?B/Y4)B9:K]O2%]DRWRQ5TKIN5^T*U,]'DV3+1;/OP4M>[H:O+O5:] MZ._E&M?^O)=6>=$WH.Y57GJG.B:Z3%)=W'UEDK+(:R8\]62Z'[9=F3OLF%4O M9JDOG\Q27V#F/W6SB51_NK`5J_87LU1VIV_MJ7:GTBS3[3I+GW=?*'-FJ;37 M#^F5LS]/;K7RR(RT'L\6K;)@]FF+WN]59MI0`?2?ZI^OV\QMP=!,T.=+3!=D M]TYT/N`#2`@2@<0@"4@*DH'D(`5("5*!U"`-2`O2@?0^D<'0!=,7@L%"::`O MA_W%8.IQ6`HF'H>%8.IQ6`BF'H>% M8.)QV&^??!RV@G/6UV+H)Q^'M4DK3"8?A[5)[TR._>VXBKF\;6JJ>Z=Z!S: M`T@($H'$(`E("I*!Y"`%2`E2@=0@#4@+TH'T/A%!&;[\N>*F>I3KDH?.H[U3 M>=$`"4$BD!@D`4E!,I#<$7NQO1LV+ZO'CT(I3`E195@I%;O54K_MK]!O+6V" MY5SOLVU@TTJ;N?F.1)7..]CT/I'1U67&URW.%_Q(5-==]D[CQ]A:G4D(3002 M@R0@*4@&DCOB)E2^QQ3M[X+E:\3 M&<6AAN0_U[SR(K6E)W-HY^>;G7[/ME]8U?G0#R`A2`02@R0@*4@&DH,4("5( M!5*#-"`M2`?2^T1&92C1_$14;&7'CPJG3JOQ8V*)S?)A%[B:1\*%+S#[(G2^ M14YP]AF#)"`I2`:2.^(F5G9=",'$P9?P68'4(`U("]*!]#Z1\1P*#7X\7Y@K M;5U"Q%'=B/<+7;LX.&+'ZKBQ&X&T-B[2NPUN,A&\QB`)2`J2@>2.7.Z[$(JI MXR_AM0*I01J0%J0#Z7TB8WE=)6AA*T$BENJFL'>:\_5S<,2.UMQ\5*QO[J%0 M!#NS64%E2`2O,4@"DH)D(+DC]NBF^BZ$8NKX2WBM0&J0!J0%Z4!ZG\A8#E6" M*ZY+6U3P8ZFKD/N%+CP<''&C-5\N%OH;@U!(S.YC;E:!VQ@D`4E!,I#<$7MX M4WT70F%V/?($2KBM0&J0!J0%Z4!ZG\AH7E?(6;"0LU2+K[W3^%>FM7+1W&[6 M6UVZ#IW1&/!AA[UZ`Q;!;PR2@*0@&4CNR#.=%U(R=0HE_%8@-4@#TH)T(+U/ M9#QUS>:%NZ:MU?A7I_Z@=+^P&C^>FH0GS?!89?:>R?5X=&H>GZIBD`0D!2.7.Z[@$T)4H'4(`U("]*!]#Z1L=(EF>>OJ"5+,?K6 MM7<:/U8HQ3B-'2^S`7JA/["/X"4&24!2D`PD=^1RWP5L2I`*I`9I0%J0#J3W MB8R5F[+H1@XN!+^*Q`:I`&I`7I0'J?R#CJ"LL+UQPK*_KURWZ)NHHC;JSF MLX7^@CT4"O,R9:F]1O`:@R0@*4@&DCOBLFRB[T(H%A/'7\)K!5*#-"`M2`?2 M^T3&6K,],[#YV*C^BNF83 M.HT;0_,#'G3!.(*7&"0!24$RD-P1=U4N@X7^84:%4"R&+87J.::$UPJD!FE` M6I`.I/>)C-YU%9DE*S+8XNLT?NRLU9F$3F/';V.VPJA[9P0G,4@"DH)D(+DC MXZ6W-AO7Y5-*(16;[6RMCJZ$UPJD!FE`6I`.I/>)#-UU!9@E"S!;=>9[ISD' MZ@`2.N+&;SW7J]H()C%(`I*"9""Y([;KX>=SJDNJD`+SHV@0.%UAJM!+#=*` MM"`=2.\3&3A=:WGEG9`U%^Q975J-'T!-0J=Q`31?L.B/9^`D!DE`4I`,)'?$ M!=!\**R^G"V$P'P:I'\060F?%4@-TH"T(!U([Q,9P.N**TL65_3KT+W3^(%# M<<5I[.BM%CK[(_B(01*0%"0#R1UQ*6/V1JJ)HQ`"\[F$>GM2PF4%4H,T("U( M!]+[1(1MI:LMK[ONCF;RZ5!OM=T[C1<^D-`1.XB[V4R]R8A@$8,D("E(!I([ MXL*WW>KWY(40F%=;*KPE7%8@-4@#TH)T(+U/9/BN*\"L6(#!/DZG\<.&`HS3 MV,$S/U-!ORJ"CQ@D`4E!,I#0@!4@)4H'4(`U( M"]*!]#Z1T=`5E5?.@:RL<,?D"J45D-"1<6,()T'M(X:/!"0%R4!R1\:>`S7] M%J)]\U[L8IK--M$[M4PJT44%4H,T("U(!]+[1,;SYZHJ*U95)K8M.M7YFCJ` MA(Z,PZIWWD2PB$$2D!0D`\D=&7O6/P:J$.VO"J@=E//I5NBT!FE`6I`.I/>) M#*@NI[SR`ITJJZC'H_U*UU`.(*$CXZ@RGMI'#!\)2`J2@>2.C#WK;S(*U:YO MQ"4\5B`U2`/2@G0@O4]D^'0]Y97A8UUE8E?=2M=1#B"A(W847Y'U$5S$(`E( M"I*!Y(Y<#J@]G;&=`=6G6Z&/&J0!:4$ZD-XG,J#755E6ML!@[F+GY0LVKSG1 M>:(Y@(0@$4@,DH"D(!E(#E*`E"`52`W2@+0@'4CO$QD,73EY_GW0BA43;EYS M(C\8*)DXS>5G`&T1PVL"DH)D(+DCSSP#V*ZM8.H90!]:A4YJD`:D!>E`>I_( MN%U7,%FQ8,)M8D[DQPT5$Z=Q<3-[W62E-X*/&"0!24$RD-P1%[?==JL>&PLA M,+\P17V'7L)E!5*#-"`M2`?2^T3$;?US%9.CF?GAQ/XDB)U?3N3%#R0$B4!B MD`0D!E=/X52+(.=NKI+>*U`:I`&I`7I0'J?R&CI\L?K M%H1K6\XP_S^M([`=P6G\F*$(`DT$$H,D("E(!I([8F/&7P)7B':S"]S\V%PY M'Y?P68'4(`U("]*!]#Z1$1M*$/Z'"L\O,M:V8N%'"INSG,:/E+4ZDQ":""0& M24!2D`PD=\3=%\W%)>-0P*($J4!JD`:D!>E`>I_(R.ABQPN1F2IRZ+RU6SKD_DFQEMC_+2RQ\21#!9PR2@*0@&4CNR,5C*UX2E/!9@=0@#4@+ MTH'T/I%Q')[4K[@.[8.]'T=LJ%KKA_^#(Q?'*GQ)$,%G#)*`I"`92.[(Q6,K M7A*4\%F!U"`-2`O2@?0^D7&\KMBQ9K$#6ZFK=5IK/0'=*$S&07)B.-&%S^>7VT>Y?(S$;TC M8.\T7AQ!PA-Q=R3UB51T:A_O.3%(`I*"9"#YB4SW7)S:QYY+D`JD!FE`6I`. MI/>)C--U]9`-ZR'81.4T?IQ0#3EIIDRY M!*E`:I`&I`7I0'J?R#B96]45][?-()?7D_[4=.\T?IRLU9F$)\WT:$6G]G&T M8I`$)`7)0/(3F>ZY.+6//9<@%4@-TH"T(!U([Q,9I^OJ'QO6/_3G@7NG.4?E MX,AXC\`M('Q)$,%G#)*`I"`92.[(Q6,K7A*4\%F!U"`-2`O2@?0^D7&\KEJR M8;5$;W/:.XT?1VMU<:Q"9W)1$,%G#)*`I"`92.[(Q:Z+EP0E?%8@-4@#TH)T M(+U/9!Q_KLZR89T%&Z>DRC`1 MG,0@"4@*DH'DCESLNGA)4,)G!5*#-"`M2`?2^T2&[KI2RX:E%NR6:Z6)S*`U]5;MJRW8+^4T_B! M0[W%:2Z.7@0G,4@"DH)D(+DC%[LN7A*4\%F!U"`-2`O2@?0^D8&[K@"SM048 M\__3IT(3OV/.J?S06;LS":&)0&*0!"0%R4!RD`*D!*E`:I`&I`7I0'J?R&CH M,LHKYT&64[AC:FM%YQ`<0$)'[%?RYG?CZ,_D(YC$(`E("I*!Y(Y<[+J`0/W` MMQ(^*Y`:I`%I03J0WB8\CFJ8(CB)01*0 M%"0#R1VYV'4!@?I0N83/"J0&:4!:D`ZD]XD,H:Z9O/(BG*J=J*K'?JL+)0>0 MT)&+PQC!)`9)0%*0#"1WY&+7Q4N"$CXKD!JD`6E!.I#>)S*"NG3RR@BRA#*Q M,6JK2R8'D-"1B^,8P20&24!2D`PD=^1BU\5+@A(^*Y`:I`%I03J0WB3YKQ.V+(AP*Y03^<%`1<1I+JZQ(SB)01*0%"0#R1VYV'7QDJ"$SPJD!FE` M6I`.I/>)B-SNNHK(42XK(MP,Y41>Y$!"1RX.7P23&"0!24$RD-R1BUT7+PE* M^*Q`:I`&I`7I0'J?R,C]7$ED9XL;8B+$=B@G\B.(F@@T$4@,DH"D(!E(#E*` ME"`52`W2@+0@'4CO$QF4Z\H<.Y8Y)K9#.94?#10ZH(E`8I`$)`7)0')'[`7$ M-W?%"^TE/%8@-4@#TH)T(+U/9*2&@H/_@>OKEH`[6Z/Y M1<:.-0]LA7*:^$C+5B4(!5(#=*`M"`=2.\3 M&1E=TW@A,K8F$01OQZ\!]CN@`U%(%!'%1`E12I01Y40%44E4$=5$#5%+U!'U M`LE83!4G`C.\G_YZ?+K_GM[>_3',=.9V_D*0IJH5ZO/?_;K_\^M;$X>/@R`RO;@D^9L?+3/$R M^-A-\OG':C[AIYY_;*9X.__83?%_[%;FB%:#IP^GKA]_^^7/FS]NJYN'/^Y^ M/+[Y=OO%G,[L_?!MTH/-2ON/I_L_CPGZ^_V3R=CC7[_>WGR^?1C41OSE_OYI M_,?0P=_W#_\\#MEO_RL`````__\#`%!+`P04``8`"````"$`O?9(-%$"``", M!0``&@```'AL+W=O&ULC%3;CMHP$'VOU'^P M_+XQ@7`5R6H1HEVIE595+\_&<8A%'$>V(?#W'=N0Y;):\4)B,Y6+>I/B/[]73Q.,C*5U3BM5\Q0?N<'/V=*[22O;2#1O*(6_)M2-.;,)MDC=)+J[:YY8DHV0+$6E;!'3XJ1 M9+/73:TT75>0^Q`GE)VY_>&.7@JFE5&%C8".!*/WF:=D2H`IF^<"$KBV(\V+ M%+_$L\40DVSN^_-7\-9LDO\"*':F.I+^B02N)Y)X%"7] MX7CR``L)CGS`);4TFVO5(E@:T#0-=2L8SX#9)1M`?SY.!FYVGA)*>G`M M_5AZ5P1=PN@]?1PGG4"P$$")7ZO+L,FUXN=A'3C%D.9=:1I/;I0"*/%C&';/ MKF+"DEUV^+&8KNA.?-H)A)@!-`WBT6V7PPL5]JVA&_Z3ZHVH#:IX`8EZT1C* M=7B=PL&JQ@]WK2R\!OZVA*\>AZ7K10`NE++G@WMAN^]H]A\``/__`P!02P,$ M%``&``@````A`/MBI6V4!@``IQL``!,```!X;"]T:&5M92]T:&5M93$N>&UL M[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3HD#227T;VN.` M`<.Z89UC1"SF67 M"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73- M\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[66\/7.=K?; M=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ M-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW] MN\*1R5D1SBB!4-?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS- M;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&, M]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q M509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6 M]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UH MW(=!O-29#`P<7""P68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[A MO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[.CALY&2-58,ZT&:-U3>"LS-:O MI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ: MFNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P M5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6 MH0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'!\*])`79T74LF$^*KHK,+(]IV M]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(& M9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX= M-@U-9O] M2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL_CZGL?/FS&7GY.)% M&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%]LH&``!>'0`` M&````'AL+W=OK8=*<$(MP-M\3H=[MNTW[L-\_']C1!D*$]-)/V/^Z[ M\_@:[;BY)=RQ&3X_GS]L^N-9AWCL#MWTS09-%L?-W6]/IWYH'@^ZWU^9;#:O ML>V/*/RQVPS]V.^FI0ZW`J-QG\M5N=*1'NZWG>Z!2?MB:'?KY&=V5TN9K![N M;8+^[=J7T?O_8MSW+[\,W?;W[M3J;.MQ,B/PV/>?C?2WK;FD'UY%3W^R(_#G ML-BVN^;Y,/W5O_S:=D_[20^WTCTR';O;?OO8CAN=41UFR96)M.D/VH#^>W'L M3&GHC#1?[;\OW7;:KQ.1+56>"J;EB\=VG#YU)F2RV#R/4W_\#T0,0T$0CD&$ M=H_W^9(7BJGL^U%6X,AV\&,S-0_W0_^RT%6CVQS/C:E!=J_-9%WHL7O? MHWF(>,POX6TW*I`4-KNF7[5W(3"@$^(;>+]A(]8&_9Z7I&&0V$*U3FKO0M"P MG-.P$:\3W8=+RD5*&@9)9H(+)."+"?V'YLL7*%46+D`PC/D<7T9,?`GB M"R3@2P@9#:-_/R^ENCP>N#*KTLU3WHB)*WD)"],)).`JYYD;(ZAQN&V+/K!1 MAC9NF]WF(6+']1+L@`23E!8YN5_[]U6N7(X#=TR#YO8L637Q16JY0@T8DZ44 MG."A#A0L*PKE8H3F"+5ORQT#\@:@H&A$#9AD4N0%':RY+W8P-OA:37CH* MH3,?Y2+ED3'_/LN\Y\.4S6(]BV$O2957J)&P9GN3'Q/F+P8LU:\IE\4B-$;H M__[6BL78]Q8WS)C/=59D)*,UQH"A%,Q;.P-C?!;WK3KDOG0]!F.HP?+6ZV-> MD*36H:1("V^.A.X(^-]/&X^!+RGP48/NRC0K4S*#ZT`B3>JN3%`^"_E6'6Z8 M)>%6A1H/^?Z5,#6SD,]CY$N*?-1`:J1DT>XT$'!>EBY":(T0_[;EFL?D5P0# M%6K`8BZ+:.@@!HZNS+E+<.AP%O;-ZR;!OB(M5Z@!3I";-=Y\M:6NY6T6\'D, M?$6!CQIL6*3>/`-^!8(L3=U,#?,U"_@\!KZW[41*!$`7,B,3M<8@.-19Z;H6 M.IM%?!X37[DNH[,0Z9(688U!XAT^GP5YJPY9JAQHT(L/>9['FS`,`EGBREN^ M@BR9SPBW[P^MFCBCE$<-5E9>"&*]#@2J8%=J7LPBO%439Z1P*M2\UKQD660- MU@E09(Q[:VN8M5E\%_&67CG\P'BBQN.[?R5L?!;?1LT(-NE,\95X=V0[4H41_">/.?YB[68`7`&]=Z9>/@QD%/&K\20A/ MO5%9A.BFLG)=;=\I=Z"V_WY-&50)G^Q",1X#U%=P4?J*($-R%MRMFHP?*>L* M-5Z&\`J.J/[6YAX)O]>GV.V^M0E76KQKN^GUQ_F!.YR M,OKP/P```/__`P!02P,$%``&``@````A`!7AA3UO`@``/@8``!@```!X;"]W M;W)K'&296TN'&/>\_*<OW.#;Q<$--J3@L?)&LRB..,2"H:'!QF^BT>JBP%X_>* M;25O;##1O*86^$TE6G-PD^PM=I+JIVU[PY1LP6(M:F%?O2E&DLT>-XW2=%U# MWB_)B+*#MQ^:%@`Q$FW MM?VN=I^YV%06NIU"0BZO6?%ZSPV#@H)--/`83-4``$\DA=L94!#ZXO]WHK!5 MCH=9E([C80)RM.;&/@AGB1';&JOD[R!*'%1G,MB;#(%^/S^(!I,T2;/_NY!` MY!.\IY8NYEKM$&P:6-.TU&W!9`;.+K,AU.=R9D#C8NY&$ MM'3#OU*]$8U!-2]A'\71&#QTN`#"P*K6GX2ULG!P_6L%]S2'8Q)'("Z5LH>! MNV*ZFW_Q!P``__\#`%!+`P04``8`"````"$`!5),Q6D@`0!&'@0`%````'AL M+W-H87)E9%-T&UL[)W;;ES)E:;O!YAWV!#D:19`4B1U+I?52/%0 M15NBV"2EZH(Q%YN9FV2ZDIET'B315\9@WJ!],0W,`(6^'LQ#:-ZDGF2^?ZV( MV,>D*-M2^6(`=Y=([AVQ8L4Z_.L0L;_YY_>7H^QM,9T-)^/?W-E/^ M9#`_>;. MQ7Q^]?6]>[/^17&9S]8G5\68OYQ-II?YG!^GY_=F5],B'\PNBF)^.;JWM;'Q MZ-YE/AS?R?J3Q7C^FSN/GCYX?"=;C(=_7!3;_JO-IUL;=YY],QL^^V;^;&?2 M7UP6XWG6&P^RW?%\.+_.]L<^`X1G*Z^/=[*[7WUS;_[LFWMZQ5_;W,I>3L;S MBQGO#(I!\\\[17\]N[^YFFUM;#YH_G&O.%W/MA[;'Q\V__C;Q9@W-[K?3,3" MM2YB?]\[G7_^7YO#AI4=%>=#/<%Z#_++HOE4[W>OC@ZR_8/MYA_2Q"?7 M5ZVW-C?6?M=\87LQG8JK>\-9/Q]E/Q3Y5)S*=O)YZ_U`V_;D\A*&'\\G_1]7 ML^.+?%K,LE>+NWNWBA?-L`V=$ZA M<9^-?)_]KKANCA+I"TLZ*JXFTSD$06H^7\R:C_]0M'X51G@S&2W&\WQZ#5M& M*$;SS8-)\S?A17L\VX9WYY-IB[X7^?2\R'K]?L&@/#/PX9>,]7TQ&JW].)Z\ M@]5%/D/U!MG^;+8HILT7TJ8?%M/A1`+7O7_IN>IF[Z%7K04VGPP#=SZ[]T.3 MGNW)>#89#0>VQ.?Y*!_W"^0$S9\M4]/]<79R,5G,T)?9*E9@5,QFV61^44S? M#6=%-KLJ^L.SX[]%Q^NCH]V#DZQW?+Q[-YBQDGTWQ09'G?#-4LFQ;]@D=/1\5J-BY:HKP_?LL@D^FP8"$=?]\IS@I4 M;I#-\_=ZI._2VJ2N]S8?CC1)AHG+9E"6S0J>Q>PM?>=P6ESEPT%6O,?\SE!* MK#4>CYMN'T\E@T9]G MV`P6(RV>#L\OYMU,?25)R8;H[/A\"-.ZGTJL/QN.D4F-V9_,E@R9'@[[-)Z, MUY;LU8O)^'QM7DPOH>!M,9O+D+5X["161KEQ+V['.]^W)>(==O/%?N_Y_HO] MD_W=E@8T!/LJOY;`M39B,>U?Y"AA'[4>#F2YY&_#TTN%<1\(<5FXE,>'FT-C M"J<+5&$ZN?Q=[VCWNUG&IEG*IX]6'SYZNKKYY%%\ M>BAW.W`S6N*;+)]GX,;B\A2;$[&C/02(O-]D]??Y5#!NELTG^!"\S%2:5!+? M?/ZHF`.+F14D-L9$=>G$XG(Q,N<:C#O:,2TN9"81XM%DUGK'.?\)[&UME=G[ M3QC@1@QP"&0$DQ?S(9AS]M4R4!"`9M<>KPS'V+JWD&#G/` MG0&N\K\6*&TU23[:?;-[\+KM(+;QCJ);\`/H!A&CA^&\PNVBGA0;@.'F\SH:3&:O&OMV+='KXZ/,[#&WGX+3QP#B!EB M-3LOQ@PW,I5K6/`X?'.%/6G>#%.-%Y\6KCSF^YL/'A4S%*_OR'!0O(7**PM, MEHZ\G`_-L5VI!*-Z)_L'WV:[_WJX>W#<9GOY!!'>JY>[S7%ZC2D'$5(V<$WS MO?TQ(`5\$C>A$Y_NPBA":S8M&B!)P`)O7A'K/TS8;G(&8UQN"S`\)\S!A&57 M$3CHIR8MW^J)L^GD,KL*0&^`\9H1UG>,6&*G4I`0,?!%YQ*<:]G>T:N7V?:K M`WC]6NP.;'UU<)P]W]U[=;2K`!KV9B>]?VUO0M!.T)\H?(OP3%J+^.A$S56_ MP#;[J@?$V^0EAF,YF+`J.&SK$<.9M_DR2SE^]6)_IW>RNR.\'\?[V[>D MZ19+'`Q'"X7FMUOD[S=;&9Q;K/O3YEBZ\IW]%Z\E"[ETW_N/GK4@G%[DVDQ/!^' M0+I_G2DY-\.1*!82Y*IJK@WRY#&9P[OW5^]O/3%/Q3\W'FQ8.`_TR:XQKS,2 MK?*2+31I6<7[$5-NK9)T4`I$6'UTW5QV%PN;S^R`BP5`L_X%(;*@?R8BY-3Z M0!0M8GX!KKW,Q_FY`1;^>4W*83XG\Y"/1MG90I:9H&)ND6#(%\\R,CW0Q-O3 MR>+\(B%G'U^+M%7\<9%/<3[+URMJHEKX[KJ=[#1$)>0C>3/J"PQK!;PGU`'4 MCH,)#Q=G9ZQ16\)8D#U7@B!35&B4#14NGK'0[%2K$$\,Y3`>K^#F:B[37NGP MMXHL7XM40FUIM[6M.* MVP#-6\+N6XAZEW>JXH-$C7AHFB^%))/Z3UG`%Y^">FT`0[Q-%H3@*OO]2XO& M6K8X!`"6JE[Z4(JX=D/$M?1)T@8I]'),THWHY0*^6CK*R62>M])=SWMDU;9W MC[/>28@O4UUBL[GJZK.R_<&T?O2]78*(:5_Y5';%HBJ,"^6]9IBE1E1[23U86L=!'$`7G6,9>%"Z';RWOV9IMIR##T1^Z M0U;]H9HG:#+M%H%L9TJV$?^>Y6\G4ZN5K"S&Z8>OM$!06G_>L@7->96V5\T& MP#,OKM865TU"#Y3\UW:XA:DJYS)CD%YI0HBE8RM,%E8];<3/S1=2OC?@),S' MDH)'AWVQZ*Z]BN8!M4KJNB6L"J*W>\??*>'T M9G^'P.CY#S%-0,*@5*KFI/L';W:/+7@JGVF-?IA?>^9/Z,Y2OYZ`\A2["HZ6 M9TD5HQ1!F*2%7/&@.?7A=-(OBD&91KB:P#5Y].[:7HT*SQ?>_@'0 M21F>FS:CQK8(1FR!70*9N+P@0".];(#&P9))E?\B9;C$F9:529QG;V2*T`.L M3%42DOITN*L=!2@?2>@E*DVK@U*B8.I&VK MZE'7MC1?W"UCLU*-B_=]#U+5(\$.$73+]-ZF5$]"[FBW=[R;K>SL^K^^LER' M=%P%:U-V5:W?]%Y0MCYNTF-_[WI0L/SY[K?[!P>62=S+?MCM'7W2V[M,_ZK[ MO0/%U)M`O^=DU\="A%KK5W^M\A_V_V)Q7UZ$K;N'/OV3?]R<@#Y4O:T#;UF^D>BN6/G`PO(?.@ M>)<=34ACZ*]G.:'V=1A!O[AG@UK7VM>SJ[S/,,"563%]6]QYEO5^G$R)RO?' M](3-)^<%$?G4*AC9D/K=.T)8!J,?1Y'&XI1:^#!7FT>V\O.?_Z>]^S-%1PCD M1\6%^?B:7WQ%Y$/>Q3I8*')?9U=4(B^9&AM)\L(""YXD_`=BAH(#R216L#@# MN["S+@Z7^?1'-=!8\8,DK$3D%"M9\B^N,KJ-I\^WM1_>Z?#>9X=7TTAE7G2 M>^L("P\])=/WKLC(_TSZ7I==3-.0A;@X"`DP@CU/#FU?0/[Y!&E346LB&2%Y M:2L(72;(FAHD50W.)HRGR?O#*Q87B54<#_,MF_\2&/.6 MC!:U&/W^A\F4KD#MQ&&.;L*U_&)XNII]A^AAUT?9H=JI9A?2,Q2(1RORF:DA M0=M->23AB`S'5J@YS!;Z[6(Z+I@K\LWG(L&0#P96W^/M^$)E65;1ZJ)UG=;% M*5NWI.PGM3CZ+_GEU:]W7#4@D)5KMTC[^F[#KC?%%"%GD:/1K$K;-F*:GR]: MO/D>&S`<2R?HIRK&X]GUZ"W:*7;`.63I(B=U&7&!JL'&F[FQU"TQ-U^HRE M;:X?&?SCWF8+*_N7OYI<+,+\V7:*?TF!_<*NYX3D;X[7-:\AL94)3CV4`08B MV;.RG\!M)VG]\"H.V^!"U8M)F%J^:X`>4VCMFV!@AZVN475H9C9ZN`P+7?$0 M1I57/!3Z0YJ]>^JMG3,7UM.B(-P;#9%KLX%H1;D(3W=#C:CM7`X2YY;9S`)6 M@AY+8-$+QE-JSWSL_N$+4T)3#ILO5F%XPC"PO3S.IHLK)>2QM:_7C]>S0>@4 M\50>>BHJW,PV*CD..2$]5`T&M)2Q&WJ>($C-M8KEC,_Z'5T8TLK60N'/U17` M21[,N'G"PP$3P*T9'A'FOIV,WGJM16T2P)0IS5NXS#)C``930UN''Y,$J_F^ M#6-ZB;J;J@FVI$C1.RC*LX<;OS)T,[5@$J8!4P!7M5H_]EX@:>T8ZXP5QQ6^ MH/8J5F`G?VM=`6^PD,*C87#;L)5CLL*.$A]G;CE8@/XGD#<$F7T>H/?LYS__ M6VNZSS-5]V9\T<6^KC=IU+;C"W'AV?I7+7F/1@B/CKJ<8WBN*`;2PD.'"8TV M%SF];L`CSJ"`[5`V[_,U"S-3UUZE/X*'L"GSZ63D-@J+.15\'`%$)(11H&5* ML8>R"NBK+ F]*;BL!!]5;(JMS*GL)(XXU-AZ8/5-V=BKPZ7D'O=S/'=>C8+LQ9W3KWART M+ZXWZ2.TEH:9J2H^!7I#$@T;GU;92;X*OV1W\1*\)`[GIZ?3XBV97X8<`P0' MT\5Y-(/BBIOP@YV>682PR5CHPS,J]@*:"KO8FU0,IYMRPZ2@KV[5BA3,LF"6 M>6)SB6U\]MK+7+MX.CJ#B]D_@(,G3$/R/7 M7@]$:HE&<\_.2`BA'-EF#M+Y$6AXOM%>K219[6=U-X6T!`N5RJ)5^`5<)P&$ MHX?:.W/3D^A.-6,7=QP=+Z,'Z2MHI_+18[M>%)7R)>FW^_)U$AUS&1[80P0K MM5@@TPII,4YB#`Y9,;]!"\P`(I58UB%W\V=56)N>;#%7-DGT1&OE?0,Q,F3& MR3M52DG.\2`Q$Z>&3O/^CWC;*?]`EDG%AJ:Y:8&O5=L8I%^AL_:72^QHQ&B# MR>)T?K881>O%$SC[F!!PKEC^PS/M3+UV2;<;/)+9GIRBY07F+%9(`"-N:?M4 M`*[UF/=1F1UA_LG!Z[AR)X9&5`1$"JZ=I0[X3^"3O[!',D=.0NJL$# M3>$#NFT&OI6J!S'R776+1`[I5DD&`F-/HL2*"3 M&^DT">3HO7G4%"P:!1H*.O5:AM,,K&4`L=MK@2R`'"77F%AM!#I@6HXQ&=1 M3Y<8[RF4O)A_K:S3E\*;)S4[*O#$TH*/XG#.R'>)(XZV0VY29Q?#JZMHXB@U M#-16CJ`@`B8B+E4.Q6APZWPZ^!=>23U?#9&2.ZFTSW<(A^G^=JQMV#^$\,(Q MQ%_8`E09*[BHDU^P%KPG,ZGL7!\\L)J1>KI`S3P_:WXB-AL8>`FGLBRC1(\@ M82!GAW4<&TU&OY56ETT)!4=3J5-AWB4%'X?]-YV_8?.NV(GW!FP@[.[6^M/8 M<6>RSB\>IU\(G6BNBP+'KQX'@"AQL"2#Y]S_"Z)`M`E+R03ID/\NP*1P M[J&E!9\QU+T2NKS]Z4\%WR'^_J(!L5CU)=GB.515($)>71X!#-JBX?-PX5F] M=W>9%>AY;#D3!`BGBW]I_5]VZADC@$.RH!''80YF.+6.(>^^MA26H<(40`)] ME!$R)4JPU^+?!)%"-@S$$*(8"^R5BL8?4FE8S6:5?/0?%H-S[ZV0.$6G*@.N M5F",.9ZYYF`='O/W`68X7'@F)/\79!4%$-"6Y.9,_EW MY5-4A%.S=8G!,%-**^J!:NRO.F8A)%";ND^+ARI-B0D5]MD\H18!!RW8-TP2 M[8RB,^3E#R^C/5,R. M$T2=DB&ZDG9[;,#>6N`P6^=:B:`?,=3@\@W;?)9@=02$AK@^KH9-#&?"%8F@ M/'ZLH50::%!NY'3AIP4"`3%%D%3--E!%%=(O<`VU-;KI\'7]8,H::Q[5M=U6:),\E$I;Y>;&DQT6 MQ)T6\W>JX4B+_%G#$TYO-"'QE$3)$%MI^8Z%Q#9&N+2CGXA06.)F!:Q%0B.P M8OG0OGO!DJC^1!(D'$:5]L->LF12Y*JQ`L7%31DO[(RVGHV,\"A,,4VY@O7L M]9S0\4_F."X@*^1\:=2`.J]L7"1>(Y3,J/%PDIT(Z'=?+E&']\-/D5.X4>0]^M20:Z0)4 M6+>QIYM,LX7<<4<>E;L@*B41TA@<#D`RPHZ7:RGWL[[[0KCZGS&E/8A$J&L0 M[9[JEI8R$S^C#%<>KHAZJJ:B,KKPIB]'``B@,QS;Z*D1ZCJAABGJRY6SS0J\ M8X*BPATF,+(KORI?"PRSMAMY[>G`[A8RGV.PQ"&&^'>EQK5&6:A47UM=J;6> M,1")G=.:Q=FOA694=G/ MVN3IEB-;Z.D5E8@")?):ZG6C%4%*`$,U3EP`_Y*YCB<(,9O>"B>3[AT_)LTD M'H-21DRE=#S]?_FT61V,;54";*4*F6<(\!=FC"#:-C=NG?DY1\'HQ?DT!YW7 MP$[$F^R.([?*=LS<#%9\DZ2?'X-]*Q,@_,[62][4KC)*,+:NXC5G6!DVN#RE MG[N'L66P>ZQ<+0K!2)3M"BQ=J<8*[5PS84714Q;?(4>FQFZRE13S/996Q`VT MW0RC)O=77TUT5U4/J'')^LM\)4MFE*4QHK>)$\G1^A.6`$27`YJ)BN*`2L(5 MO:;HU,_^XEJ+Z0U-BW1*^N-J2)I! M7>_,VPP)P!6TH%B:T"*TD9YU3IBX6.)IC@CKJ#?,#@D%\3T%?C9"18[AHH&\ MTAHQY;*:1M9#S@E6-:=1XHZ-M$;\32R$A*IZR$I$^X*KB'GRJ#Q.N"B444W0 M`($(FNF*GM8<^``!:@J/,@3X1^M=9$18"05"%TE$E)7(16QQ(&AKN1X MO):RL$XA@+7B9+]GSTC3F7\OAL/A$(F$$K.&T]1QK?Q=/_JU`&[-':[$YWWW M9"Q`$KXLIL-5M20'_,[JHELG0VMYQ])R]52><@@-^'4Z'>;5/-E!Q M-G_GWHZX'(2/!NL+DOMV+8`Y$94"N"`?XC8<8-J!9J2`%W78! M.BI@L"*^26IK[$AQ4V1/J5:VIJ50J,)SV^OH[#X!%L60+4X=)(_=^%13C@E/ MG?1FSGO)^XEMV[$)X9"+?2I-"-N3-0Y#J:G;BIM,2YGN%S;^)U59ID:,!?8D M,998UQ*9+9/,JW::]!8`0*++4MS1X<8(#VE1]6@;&X!B3;/OBL;9B=<*;@&6 M`C12PCB=V3)ML^/:NN>/83]R''<^VB+O:@T-&)7QDBV!>E3/25;D?J(0(8W" MOU/@T6GN32YY*A:'9=)IO1](BU/$$NUN)FJSZB3HC0BJ1M==9@6-+!AV:@`Y/4H2') M#D+9GZQQAJ^AB01D73E/W7''VR!+<^CL0!@OO_?*O=<6)S"SI9MW(EM&3W/2OS2%N^P MA(,RUJVJ%6>8S&=."ZN/*-_*[IL0-'37;1I/8%"4HKY$41$QB?KQMW;6IF>;J3N,S9P$FQ71=CT` MZEA'E:X2D\DZ=&^XA_&!3%3%+-\[+I,MUG0WD!L%@`/I!N4AK,LHF)L8#?@[ MPFQBF!9#G$?F12>V0H::#(4%<&@NL%U`1G16;I+$9'"0K6\&!\W*B>8&W-L4 MVUE,];6(-*=W0P3I,M;&U4HSX_LQ#!9I2GV46\)3I\4U:10W:1!XQV3`(>L;Z\RB@L'A M;>H"CA>LUBVSFL;)ENDF'3U]]]'6^H-J4T=:O&<40J0@AQ)+CYPD5+9/(/'N M_4I'B-HXN%_"?/XX>[0!2ZX5%?AF.-"-,D^V`TTB#V0]+624S43PX??#UW0,+UA6DUJ8#)^%ZK+BK->S64B-H"**'=!`T(?L1.Y@[;NJV![``Z5`I7N"H=6!P MM8(6*EDEL5]\B9RM,LB)KR0S4Z:^3`BQ37I=-9JSV*Q?N+G)79!@_NH>2F70II$%LJZL-I?W%) M:GS.2>%:2E;+(XLJ$EEA M298W.()^F@E/1^0#M&[.L58@CVP,5C\!I836;0.WXPY]_<7:];H/R50EE1B, M!@[=*%VJ"L\K&M?D-Y;X,BEP%'-`RIWN"P)E'N*TSPHCHD"L<%:9:#( M!.IL?U#P?8Z!2.35?J\33: MHP)Y*%OKH9!X3$`U#.+O8LM<"EUX9811H1:8K6^1!QY4*M"M:'HLZ1/._`CZ MUH4]38-;$!RTKR#$*G;4/YB'>0]_-A#"RKPO&)5)309J36RT=[]S5;&^W14.8$_E7>PG/P7VE4Q\ MJ#ZMS(IPI/&!'47F>%9E>)UQJAN!&XI.LX^=NE`7>\JFHF"HH2ZKPO483@DT MHI7(+[>GA%JQU$87>>';"(3*MCP[B'5P],9IW&-)G+7A@B84\IR/<6B4,$-= M':,*!L?K!@C/E![':&!U9%B5HP8?6'V4>H),02CJE4EJ?@G%6COPR2+T2AY: MOAP0[<8#R^)%99*'?"!J;GZM`IM*`BKISSKW#0"E*HHX,\V95\:1K@0;L(Q# MRO$4)U4I-&AU#][A7K0HS-ZGW>.J-R)Z=(LN).&!M6Z8-E=4SN_G;V;PHE]H M6@&!NYM;Z_7Q^D[!PH^G,0&$*G[SFT#T;XH9LW=W:7-^* MHQN7N,"T[)Y&*B&H!=7M07T+H3%[:KE-.<3YLY,*0SCIJ+8PCII49-#T#Y,V MFTUTK1SL2M5^K+WG'I*(`;CH@C3EL!H`^7L#:!4,6CD&%[M(24SYY;:(`(B5 M::0OYE"1T&I(-9V<>NX/-H=W\)KC";>6(.]^@R.O-#(1KH">@2NWO]&DT2:< MY9DJ:T]+50^+5@,NWTJ2QGO3JX(Q1>1H8%IZ'`'_%@I("E`]9M"RB.1(/AIP M)8%->.N50,:)0W1H4>2'FP',QHB3,<.S!,,C@2W*4G+>GG(<,4;;%2C M6CA_UNMH\V]9)+;#39>*JAX;F8ZLETW_E5I^N,FCIOQ:AYB&N,ML-?8N9I%0 MT6#&>"#6VM2J&;)SDC"K.DS1$\%:+7 M$`LS2E*VKN]DE#-^^"ED79A4?E2ABA+X'.G4Y,6:#@9:OT_M,L(:+2JK^>2T MPU/B`X0OK)U)SIJ#J2)20Q-+#R9C$:G5!_%5[Y7GV8(L8Z;PI!89VW%.E%0I M3@$ZQ\R>N;#6J_"`1TJR#:5SGI7-K_RN[_-A`^Y;3%;N;_AO_-S^(0AZ>KI,+5[ M*.6K[C[9:KKI^T]+6-!EH1XL<](ZO->K7K`J@T@<9162NP\>E,."/1Z72,/& MN_NH8G>UZ=J*3T-("%:ZZ;[N?=RYT\TE,.#]C2[)>$)OE0HJH8DKDI.R_3,E M))'Y4("N-E9$;(NH(G"AIB;'6\OAZJ38&8#5MV3?)2T:4PLBD:-4C0G(A2VE MJ8]N-ZCBBC[U]XDKT66:3M17(!50[5K?IC._Q)C(FW@Q]=D@.?&NA+*S8U[T+^RKLRRAV4A2$09X:V%#<26]-T.D MGQE<-LS^YFM-QK=*6LP&URBS>GY)"#PLC7@26J\WH.LX7PEDZ*@-OS!%<-16 M3S;6*=N]LI)P?1SX&B]9"Y!_*`_TU.MDXF"<)9)B/#IPHQ^K*!/,>GL(^ M968+L/.6ID715M>5YC*\1^$,"><:7SA:2J4WPIKY3(UW#6## M762E'D3?7;VY8OYNI?5/TJH):R,_:NQV+E+RH? MR`H)H_)O/__ES\W']]/Z6D_OP8-E7TII#K.RI<^C-'_;_H[,<,8MQ]8`U)IN MA:_X/7C8NE=]Y6'[>\XG$M]T/,RNEP1J(E9L6S@HY^EDM47S`5\UQP:3&HQ\ MZ+:JFVN)I>O&.SO_7@S68NZHM*&S3*B?-@X.K1:@Y"/BR0%% M`SO#4%KSE5I+@IG4&P3@6YTU:3)^.]B`YN][ENMI_;:$)*T_50!$\V\'[6_F M?A_XEO4\Y]9\Y2BY/"@1ZG+H<^AL7#&`T1*:P]#85H(^OW.H.?C*XP>K#S?*_;:\($8;K;35^1F+A),EW671OL9FENSP1@ M/!2PDS2$^;=W5S^`(,@=6/FKFFYL'AH/()CG6RLU?D;L('.0QB M6D\8W:OIIKMZ[!HNO`,_L/]$V[4,Z&RA&X.DB'T5U':68S3= M7Y[H+6@WF7#E3_L3W@)O](9SG3G%6]T-;2/-)F=S_5"?S^P#$`7_3(ZIL"_N M\CX-/MDQKQ6SP$]:/%5'("I$V\*7+U4SO-WHTJK6#.$$&MI1I:LV5S7SHC$& MFEG^P6_=+5,7#$(7$7VTX3MEMG%D/%F,?\:O_-Q3Q9[12Y]SZ9>^YJ-WA6II_)A:J?A/T-C4HL!1$R&$G1-D+C-1@E;UN]H;JUX/& M1QRC-<@>WW]HGR7/GCZV?QB!#Y]LZI?A^XGUPIE^(EAG/FQNX`1Y5NM>B=?> M=S.E(VEC`AZ$^T1?#OJ%)3J08A\Q\F27]S.R6H$)-ZT2$K.UQJMX1<".A0N0R!739E"F?(R2V'AGK[99B<3 M2S>@WT?:B!T]\R81"7=)D32R*^3TG*>:163H*[6<@KY.RKX.\'VX&Y*N5G`V M@B]-IN%*Z;>+,95Q206C\?;V8F^8)$]V:);R*L,./=0S12;SSA@7+SC8PJF!K[[2MY5$EC: M[3[GFVE%8AO%UQ!26EF$"V;+5+9JYI81`C:FD>F?JM+A;S-2Y3T@.@EJDJI6 M8-+9;:<5+Z/YR%=2PG-ABX?&0Z70U9>776]1Y=B'1:5D/$-96634%OLZ@P;< MQLY2HPX0!E6V#U[P\J7NTK.:H:[9T-F0T(!++:7?P)N,&Y\K+>,/!0&<; MOL6O0KC,J?Q2++))@;R257H[N'W"V@F&8YR+7L$WD=IO/KD8MY\U3>Z2"L[K MMP9.'?TLF>U(-Z3:QG6QQVN^(I2E:I,E>6)8VLQRYT2U3$CX=@WV*!G4,#2< MS5FN+L2055=?YHRC4K(]*@<"@^D&QTHZBBWM++^$?QSDZ5A_=4G^G,D,7^>I MK;"3%%&LQ53>BZT@;,(IH"BN]>_**?<'8I6;M@Z&B:I3)`V^X`G"6:7R8WBF MP41:U2;C#A?O735E8:$48M162(:+C/%`8K+WP5[7^:OUSH@_@MJ@:,LI%<$Y3\KFN<[!'_I>:PHX8O*([-MW4R+ M<3QDMTJ!1]>=N6F=\:A5U;!7U@47#PD*HGK)0`=DS'KZ!Y5F:-WD;7JK/:G(C66=%$$R49`9&X8M#`(0;+YT-;6$ MI>W_=UN\$*XVFJ6'>\WH/:73-AYJ"9(MW^-W=G9^I"6Z]]H77L0_,NM\TRM^ M`T;IHCS(TI:S^691"AG;?RQ1ZH``Y4:RAWZ-OP0B>7=W-]H'1^N5.K>!![16 M%UPC+M0KJY[:K^Y.:;,;E+W6Z^!7'_A,])"W>J:(W+9==5K[#)]U/7VWGKT@7CPM"/I[]XY3)UKYRS[6 MQNN(:GZ&0Z08QUH[I*4/P'$RK/H5BBV+XS>M@!L%Z7XR?+HDVRV7%OA1AF"D MCP&@'#\Z)-50^0S@]@3BYYRGT&D"?\2^DX$.Q(*.8,-'N1@Z]`[H-_'F/#^< M9X!80[>_O_&<-JK+2?@@?8?4/UY__/?\]N*S#_\GA7*:[8M_Y9'-_2T?5]2M M=+ZU)&ID-L3:A$=2IL=V]2U'^DP6E9%03SKR&3_;ZU='LTTA=X3'.QCV)^^S MX_5>AZ%Q;-9*]]IGUZSQ61,"JL!+P&^H0C<]\J\3B'UN^E89UQ3_ZBZ@$/]F M*S&1#Y4WE(3W"'L^_/1&AOO#3R]]4@N@Z>2;?_CI*':^?/AIAU!I]<-/KU5! M:*&MG?);E'7HP0;?O!23J9J`3,5 M"9RHI;A!*!DCZZ%"1%6EH-8Y6PHWS*$$FBJDB0^0SLO\J3Q\D/:`L^OQ?AX% M!'(OG#1Z]*LZVZ@WH;O:F[)//+FBY#X#\F<;HE&@WMBU86EV/V>A-%,U3=`! M>TT**I%5S6UWS:1CHYRA>O9"QTD9`1VPCQ`H^DV15ZIIQ_1L'2,K&$X?`27_B!]#$C1U MGRP.'\55-SM1>BAYL#$&$FZB>RDD*5O5/F9+K4W5,[.HLU$R#`DE%3N4L]8^ MAH;YU$5@9YL=RRJ9Z%B6K[3;AGZ?SV<`LQ=DWQ`^:[T+7X03:/6_&AX>L%[" M':Y5LP(+V>PR60N+*X*11$L28F4D#YW+P#.BOJKE"0J^3QZ"`!B4/3]-D>#VC#( M:O*6]Y':EI%!J$VG<#;XQS+'69<)V!D/Y^><`%U_DKI;*JOWXF*RQC>:`3L) M6NK\W2>5DQP06@)(R\JA<5R243DDM%Q.I%0(L$XP^!(J"AI876X_`EP>[8^E MS6JZB<&Z?`#6(SDK2DPSSCZ/NI]`RQ"P5,2RC`L66 MK(C\$@=^L041C]T0+DPXGGKN(08RRPO+4T21056^0!-G(;TR'_)P9C%:F2Z< M9&2LNA3WLPXI;O-;%9CL6_VI.2(WZZP6-_XE;-!^48J%@['8\E&O%+B9>2-L9Y?Y-]\HD];G]ZJ(V:KY?=PV6-8]H7&MCARLV-\WUJ0B; M#[`S6E=4L/[D(?R(6BI-L+A)$YN;QMT)'%2DQ$5#VW&7D*>\0,")LTXUO5W7 M1FY]YR(Y'[ZF[_'2FKF^C!KJYKIYRRF.)^$&Q2F74,2+*C5\Z>XDXG:Q?8)B M6R$7:.P+6$4O^/=%?'M17\/?45-+J5QF_`(J*,54US=4)/O6P/$$\B-52)_5 MQX@B!*)5PE5D$;ZT&?.4]?2*9#0>D=+-#*ZW%!K[\U1V68S/\K?`;_5SANMH MK3CI!\OTQJ=68X3=7Q_OF$42+JA79O37_8,C^ZM8JD95-0C$P,&"(Z[<$]17 M]-C;/WP1^T]H/0I+!XOQ`(+*^'9G!3_X?7.#!@Q<$LEY-`@!#8[98$E^?.DP MBVG"S0_5HZ$EI!&GG5*)7-@SZTVH%"MXQGAAK'LHVKT9JPC[1H+64XT/#TG-;NBY%_66X%5>D>$97YZ>H(J4&FO*Z M`'U16;Q(2F/7<<$2,XO%](IVG/29D,`F*B^LQR;ZVU&5(I5BKYF M$:P+86#W@[LN?7\4A%MN>]V(I@@"=+U1,5`"^&;?RRCSEN.+]B\)-QU&RA"4 MW8:>%VA1\7E09'?$*^99$JTSE6&Q2K\CE]&1IE!4_>S[T/3Z#]33-P3D8'_X MS)%=68P5H;\-KQ3D9&MCXZEL)U;;VB0,RTQUQR#YS^OLMY.+<7:PGOTNOYI, M^(S1X<7ZSGJ032ZRHT28[IZOVI+G$]70T8$=*_1/N"$YWKOA(V614S*O"7*% M(4A/869#JP]T2*65*C[T5S*E=ET9'X9/-AVL/ M-M;X_T"5EO1]QI!K1Q``#*GN!1FW[V@K`#^T2/B2"K":K?P_]LYMMZXK.].O MLA&XTA1`JG@F594V0)VJ[,B6(=%5"(*^X$D2(XHDN$G9RE6_0_=M`_4L?I1^ MDO[^?\S36G-QDW+95=WI($%B<:\UUYQCCO,1SDI;(7QES[[:?SY;!3*/_K9P MV:NZ*'O!F9G!-)TP*]ETHMGLN4_M=R@*H*^+H5^;X2L'$O8\D&\OR;U[K8S[ MOQ&\OW2'-1P(&9-3/SZIF3'K0EB+\B!)E,1%2L^TO"I*:W)90:0XBA,Y6R<% M"'2#@A#2VR/2TN,H1\K0D@82RV0-!3%'*LUY-$([.,2/2PD*."";B*<+28[7 MM-I13`OVU!`F2I!(%45&.W*=71Z+E*<7/)8K9.7UD8=\EM"%/7B1N9M-+39\ M5(O.M6S*`2G.*OVMY3GP:97!N*@B.%15J+,8IM<#_(%:H&F(A145N>^I"T=8 M.>@JL1O)BTEVE#ADX6LV[N06R][UY`0'O[-7/6DKPS-,>=0MAI+8E*]31*)- MR#PCX4T*,7$/2K8GQ-+UER])*+BAB42V\+H\ZOE%VO2<< M'+I\%=_)O3T5D:WKS>?&A0G5JXVN7F*)=!+1X#"9:^";Y=UBVBGXWYT"!).S ML212M\"$'!25PW`0,D:K-FA*<9R+<]]3ZM@+*+0)&NMRB\.=USA*N]U7-SRY MN;:5$??U">(N!#:9!_KKVJ.-#6?G#&[G=8[*%#.F`0MOM40#7D#!H<<6/L/M M=\B6Y&Y35AV$PXG*;0@LHKK3\QMEPT>!!Y(O3PIT"YGIK>([`\3&4B)<*DC0 M`7]'SX@'_N.QK'>"HNER$RD/R:BR`G4D@>3%V0J@13'5A8P(/&V7ABX#2QL] M/OAH&)_US0PL-Y*4MD%T\/PMBT,-Z.9)<7 MC/05KVUNRLC00IX-1YJ@VM+S)_;8;C+*Y]P?7*L/];39_M4-0'MJ:GU]"XV0[0&)*I.GM@Q,]ZWIS M0R,1P)1@FG)H=1CQWWOR+?#X4II'+F+PB4K&CH4!T`G#HY$(8M$B41C^XHIUW5256O>6V5 M+)UAI!.YHXYJQ#:L('0I_0)KF2@4FFBF@!-2Y7; MUE;!1)Y/8988G&:.4V>F]'7<&`L-(=,G3=5L*8E]$5`4]!K%[K9S!YL,O^G. MP]K2$JXW@'*XNM&&JDWG.,$49#C_:.C&+8?B(^8)$@<^P_/:.T>3A`(U=/;\ MV5#`?5W)1]:(OEM:1?'%Z"Y449T%,&RX-NI37UV;\OS'UFI18$KIY,>+,VS//!Q$ MJTYML7@4]4`SCJ1_^S:!&\RG?-;JMB,ME^:>PI;!1ZJ6OD`SCT6O3N?O5^C0 MII02.)84`T=!LD)3(PO"+(Y=RY6JM=%2XP*M6K-KZV M1A=/-D]LF800I7(=SZ)V(24R@`$-;+7M-)<4X.2QA+F!KTM?'7G"#D#$F#CO M<]*.?^YSI?4F:G.XA)8YE-$010)A=;2,L3W,09DDFM:1:UESILGUE\]RX6[% MGS$]E4=\_6H,YDX871[I3W_9>-BUAJ%5T7B]5]-(,G[LZ>!BQK\*5'$F0\4R MN$A-DO_`%3?7'!3"E=*\,6%QJT"R!'/2S)B-+C?Y#W+-@1O[%],_6:,;;_7/ MV:.7WA[__BQ;.M\I=WG\Z^.+B_>S/REG<;;T!17^\P[N6?T;O[EW>?50/;3E M01S_E@!@Q7+\V][-VX=K.]/OO<3BQ,"G\@U5-9H4F`^%[IS]':A"5>ET2*]D MWNPTC4:;[A$IG27C<9!F8F!P^I0+9-6*6SYBBIQO;+@V22BUV7C)C,F\.&\N M.U:U[X4I+D.XV'UL]]3*8P<%M3ORYTSX?V=W";*=-D6FC4<>)`B@SAD M]#0FMHVT`9OMV#S#A\)6V^2]Z3/%Q="KNX=HJ7/@#)=6'UEH:'XL/``P(U$:1Z% M\42`HUHK\9VR[EA"M^LV:Y[0TOCB$[*W8/KE`9.*F)-L/TSYF?+=ZY5\.0$N M(S'0T4CB"YQ-XJX_2Y9'=Q&AW.#DBR3XOKPO[K92)3@PR?:U-85)B9Y=E_P8 M>JXN/#=ZL=PSUN2^^=."/K`PH:7#K"U$?R&Y'YL:8D]6->TM?'-2P]0Z!5JH M7:"!]H&+)%(FFLFO"HUK1DFB,]P"-*LIG4*C%T[,A82NRH9_&[+9ZR]?7.":69[I<_R_?0\1%`0B0-FN02K<$3F+N,-G_[I/:V24=:(' MW8)IXY10__RMBR`BGTF*@JZH19G#G*IW>H[UCI4(+R&B?W$&E:D6T2_@:";) M!P<$T+N:`[(V43U76.F@NE(,=\5+9JQ!(8-E7>.R2@2=C)7DEK4>A&U6P&]+ M!VFIPD=XV;4FII,*14;I6\;''[WG'VG*.]Z1/&LRF=7QA9R!@[=&GD&9OF4( MDK`9,N=_<7LHAX+=MHT%,IPNAW6*I^?'-UP\WCY.RLOG>"72O,"C['M+H!4W M1[0`M;)S(*#6`$B+Y2383CCAG0"U0DB.!9TL";:8O"0F.,% MM`E]$N2MS3&XR^9@_N]4(\6ZS4(VX:F>)S%F@,U`2'&7NJ[7MW. MU3[N[FJV%#Q;Q`%B\D5=M?>K;95+[%YU(F"G>GK`X4JU9_%;FK M\E#^)!V@!;JG5NJ/OBY`6#[+XVR*7S+#3]_H+,,_RT^J!]5(.NSTQ(?8<:38 MF]P[.LY0@-2J:=2AAD$9E`+CE66I!8U3-XWP5JU%7M=#P@KS*]VJ8ZTWQ MZV1Z$#;0G$;@L*?&`V$Y.!]6-$5H+\\[WT^Y>-Q.<$EAO5OXZ#8AU(GZ%:.< MGAH7L`1Y@#%Z-^T`/23/1&4G*2LJ%,"0+%F852K#_T092MI/2Y&#[>01*@RP M(8>PN[!O60*.C5]\@HY],")TA7@J!._HN^VVRU-+=E)4F>/E%I#\G<'ZI`H" M7WIB7..%EM:VMI;7'TTTC5U?WMWM^KY^-Y0WW6J;F\O;FWVOV=WEM>WNKY+O MT4%4?+H*MFY1DB^W'_6M;M>F/G7KR+].7:'U\%1?W"!/;#4PAX]*.VQ7WG8W7=C>6-U7=[L471I>WEUIT/<=J(1_//- M25^1OL24QYW=?J./EC=W^HV*`KN--IB\K(A1#,A$%1&U6-OHH+9#-^K.%[1$ M__+U[@QT^E[=Z.[CE2)[C+0WCQPOOP_.I0D+"JU^3)$-H6++1@LA6V(5D=$* MQGZ#EB>[*CHUS2#R@XPV%-8U7**Q@ M+YUA_$#B_$?'X* M]#R=J>\FSZ"%]?4.&Y;65C>7I_J6;S%2H>-N\-/="0I:H]/I^G9'"0N.VK/2 M_EM0S&:WYI*XR:.=CI*6$#\]4*"+[:U>[JVOKB^O;G6.[@7[[;ZWE^I`05=E M-3<5.QVBT5H=V=9];6E[?9NF[?W?U\0J>@#M+*_O]$#:WN9:5[MK77"4CDU\ M*Z_`)EX!E9UIK"C9(&.$RS]]4O%:L=AO=0!,/WZ7@1]35/.[$[L0=Y+6Z%BL M-:_3NN70^=!'"W,2'T5C1&,-,7JGI'R.&Z4.01W#X,_JQ(E.F2AL_/.K9IHH MTA(&;EOUEF-D:9_3'_1&W;G9:AHX8U&@8#]^43X?5Q0]AW(8J_P5FP7G17)& MAM^8#:>%`(UL+6G&D>ONB(OK757I5;VMI$[^L8\1/L7[HPA;$KQ7+I`T4%<].*%(N"D!J#," MWLAC*CWE]*<_X:4[<&\W)"JVW*7Z60`[%;O5WY3IMSS;>W]Q=9[:7.ANM)S\ M3@K"_2!7W3%>49S$1W8IN\\=`J4D%_IU;YO)[[BX3LA(^E\/,#OQZ_%R9!C3 M^&2S*3C4ILJQGQ\<1;K*UQ>X=7'$EDSB\HWV\0*E67[1WVM3+`]B._==ISSG MA131/)X1O<8=3.N9B$\3U+K^X42^:T#?GUBB@I8A5QK=CL3/3MSPU=)5E%/Q M9]_=U]]]T^?7 MC1M7<>SP/+'U%A+:[C3PRJ&C7!$/N+V4*C'5F$.]V"B40YQ"YL[^<,(Q3I7" M53H6CK"+,$G!29VGH]C]6S>7;U;6F--PV1SYM6@"F343D57-;6+4_8TH7I*G M3<]QZT8"%:ZW:XJ>\FNM.K>X:]YP8.<%O]S#ED" MQ"D4">%IQ]%T'%=[JO>%V<(D\+NL/ES?^DT^0XZZG<$W4I,;_32BMZIM%`;R MYO0*!-?X-J5.7T&MC;S3]6<.XQ!_`O0=N)1PG+;Q+D3/.T\OUPRP>KS#9(JJ M1!DGMJLG9?!K2"I#G'?2\-D:V\B[R;M+:S_[$4>HB*6RAX+A02A5VQ5X!=7` M)V5APQZS)UDGKQMM??-UTRG"<6-NI1?N`(M.IGQ\N>?17`&TJU`5G57\Q']- M20..%'C&]_D%+%=[@8B"5_IAOI88BB5P`^(F-4VNHH=H\-`!\Z)=/I*_+PX7$D1.8. M_$#DN/8C$?KJPY=)&17`3.ZLPLMRY8#JR;$^"H?JW1Q&Y=HC..5QMQ$@F;ZH MEMT0W@@66,8E:<-!+//3'V=+VP^8`G!^_2[B!R&%Q1`9I;[ZFX195HFX!%@^ MY'5(2.TF2H;97N>)'02`W"[@+KB6_3HE=W-SXV'-R94$;R]2CP`KT_D1=BLI MK>+O9@/BIPW6')%S`_>W^#]E\B\X<'9S#.L-YYJXXQEQ0M0OQP:)O+2X0?17 MU4*GI#+K9R:",9^+_]=($?XE,W'N+&O]))/$5YIL/I2'CH%^E5-`B8!CAMM>;A[E/!Q$"7RTX__#2$ND0AS/_GM&TKRKPX8O`Q\D9?(>4NLO<>O MK"]8^@O7>#>_^.*KQR]?^:EG-X0D4(J([4I%\\-:`KWX[`8!#>M"'CH8I;S< MW]C6S$NGLVZ4'T:K0:S/Z#.!@L7_20L9=8Y/4GW+":"?.'B`^J9*D`P9>V$<%\/^H&^Y?S] M`/LRJ9_,%J\N7!^NSMW'M4DDJH?9N;C6&R&[3S>C)>'J;SH\:Z,FMP=-6M(J M49+R_9S$!K@82EZ[8P$GU[PI6BF.SYZG.5&566,;8,_\IF,>S@M!"R%3QQ+, M=&W=6\*0C<771NK`'1\?!H/:D?-?K*TVO(9CE2$[P37UT1`^>Y?P[Y*O.>@5 M!G08`R/A!8PW,OE%Y#OZP+]7!%^T;G8:\+2NO6T)!WR&A\FC"LU!S?YH\U#L8)/3 MZ9';%@80]T&4Q.!"E.2=&86JFG+++91&I`3?/7E)8?B"K&G"8DFTA$(_Z`@_ M!SM[&AWC[^?;L'\\7=EG*'HQ`O._1V;%E#DV-CZW5VF>5'K5644L,C0W+!@> M(?]L/C^T`<3^&QLUV8N(&-*9G>^\MEGV/%QT^*:7_L7M2OCM/:S&C%2J`LU< MV!=O>LCZ[:7(S.*0_C?P+JB5OD$-**W702R2@HH365E(&4R)(?!.U2NJP(=E MQ9J(3KS%RG^>JU+XOD;M(L#>;M%.H%`G!T1SP]4S+OP'L4:'AQOB)-S8YH9& ML=@F_$5LT2'Y3=BBV/C@P^<:HXL.\O^K);H()O_QS=!%I_\[V:"WZ&V+C#X+ M8C/B-]DU:D-OZ]%NTSGW/PV]SS'T)NVZO[O]9K_E?UINV2[\O\1R6WO4="&> M,-UZ+M,I$;=0_7VMM:'`[+^WP$!;;_N_?X:!MM.<^?,,-!CKFV2D8?1N%C5; M/"O;*W^%P=8NR8?,%X=65?L93BS[Y3,,MC8LI;<;`RPL-.JMRYEX8/CM?$); M=$-'L[T<&0"_ML'6XT@U43KLS%&FV1,B=.2S9P5W;+.]+&6:R:X)O.NC+>-H M7UJW>#.*/<27\T?+C[:#AK&QQ2:,7$K'CIP)\^C^0-8^71J_)8AF[]3\$[9% M-`&(2)E]7Y-!.8827>=`Q_+TDO[8G\EOGP.GJ[<7)60WVWOX(+QJ(ZL()?HC M13ORA>#?$H"+',_&IN!`$F1Z*L-?D&#.*+E%`="!"V<*=$,^(+T!W[4;T03Q45Y4/U?D]#:3B4W=S-=949GS;^^\@A6(%/94/9@>-_FW.AKEY4SP= M)<>CRVS_B9E"2P==G31=A[4,?6#>GJJ3C#Y_(Z=Y3?W__1@J#"=:.NQ6DJ5) M[C0E#BS8??Z@(]OM&O73B%.]Q=D0GEPS3N/W)%65E(NRO:LN)) MO*!_@XU.W(*N]'/^9Q8/SY:.NLO;^3F7@4^D2>[[12#_V7#^Z_9`@R/1=O/5 MQ;=:D&NV!)8FH`V0];;]//B]..\8T2#)X^XNHC:`,(,-T47%/D2$[U MZITDQQ)&;MH>"H_N\]^7^+,X?TF&F.:O5/.FW46RS9T;5,"$8)NXO"8P!;I7 MY8?/(5S:+N*6A7(&HNO@--Q8->.E&MO57\<'GV`=8@>M[Y'0:!/X=F,&LHV@ M$MEV36=^@@1RR3]\-X<='!4; M>$4].!V9D:XY29%;Y!/D\07IT/5*)RY.;)_(U/R=DJM\7#D7<\6]DUT$JASI M!RF1HX,8CWZ>WL`0RCG65H+];"^R'VY?(;J8B0R(L9PZ?"@Q0/!@:6N0D*&& MBPHG:PALD?LU/\"!=\WM"1+S5I1W44(0"`+MHLVRR`DACK$C--P`@/=1*2KN MV&3^V=%>*YQ@KSW;*4(\%>C5<^/P;AXW$+&AL>HQWB*75BL/WYRJF>V1Z^6X M3OI;D,:5@K-+*53+Y;2/S1\HVAHJ2M]TY[D7C#SA,9]\DM=_)7D[_C543[@, M`>KQ;Z\OB_,7ZZ!K+'OSQ!$7U[0O_^/9+ M&K&Y@O6@V\VY\^PTFTEA4C'YB.I#,Z`C86_I7L*B]*2Y'G]:R'$Z_O*4GJ&P M2CYXG^C]M+RX?]2>I)>\^VXG^[=RJ?\'@RGN9X*ZHNSB@S:LE7BK+V[".`91 MPLBHXFUA\C`0Q&T\]1;`XZ$'@LFJAN/OI MK3F_EIDTZOV@Q+^'&(B7VC"T#(/%`W=PF7U$XUF M*T"<#1/,:76VE"8?'S,5,9M':9OYQWN>YWN(,;`6:<]YE:RD=$X!V M:5J-9D/SB=0-FAT:D)/.A$E:;'4O6!$LPGEVT0G+68F5C=UMB0L*XSF+YVZJ M)0=-AE%N"9`SA>F3<4/.L-K0)+:6=Z6WI'6@3,0\=?+!0G7@I'8G_*`VZ*@O MM!>7=B1-V:LD/TOM,M&J%#=RJ`A04I/E($$C&7W:"D4X3&YWWMSN(IGM391. M6`]#&W;F"NC5;JF!L@Y-,=G@Y\X&`#5T@*I_CEJ6K34MR^[2[!_.]CYZDOC8 M$"A>*A@)-]/E&AE)QQ_>W*UY3I,H-\6#5$(B7\_?,K$PW_@$@P:ZRM]#P5;N MG!KJH*B!7G+SB7Z0RMCMY'0S:&U*^J_KZ M;1?'K_\_]4-U*Z!BDI.^-C'#ER M[BYYM$GDP^0O`^O8OOMQD_>C\C)HP;*%(TC)ND%*M>5X98Z*O`M>***V:4I(P$P4:6XX&4RSL"9!% M*ME_F$44Z'!UPC[B6!EY8VE9U2),Q*!(=_?ASK;5\#GF)>9XZHJ$`8_+%5\K MF"G\`#H3RV1(#5D[!?4/:=JRD?OO2\G_8HT&&*N3#,%G+Y#H-JE"GNHBJ'T\ MK"7DT(RM%2FQ>-Q.%6/@HD03A2#:JI[\4E4K!JW-4M:H\N\'KIQF9SZWD.@X M9UGK8\T#`5^Q](/2UU_MZ>UYL)`D58.HIDK; ME&W^.S&EI;4'N0FJU,@C8=DQ^;1I5%^P$UZ'KU_9V`&.*B23*[+L6LN# MU0Q4,9\8^BL'JW$PK9S@2G=SJ*E^36_[$&,(E`G5`YA//]IVGVQ0\(**8-4. M0C_5M;JVL?J;\E$K`PT[``%3I0W;-0N#KHO%4'?]^]G2^@`4=O`U<,I'7!'Z M)#A5?-"5W^<-MA.DJ&-GH%7"TE^#<.[#7\PM?";35%Y.&U2V037@'NU6`*5" MV?NCEN[9Z]L6_4#1PRD`A`23U&?/YRNY(+>Y*_&3WPOAEC8>A`M5I_,-4KL; MG#IUI&.QRA""[9EWOD0E@]M8J':T290QS4NQ#OJ-C^78@8-J3[(4!V5R*$UQT+^ZGQ3HM=W M\A42V#5#FE:BB@54%93R?N(TFQH08Z;57%6$%0X8R8&T\"$RE-B>_-@A.$4OU!.HDN3=W[=B=1@KK()5D M%VGT,I_.Y76D2)!OPF+%49H92W2(";H"7NG7@QL:LII3'9\@6P5'2H;LOIE_ M8ID/*.:D)6AI74I:5HN23:YRQ11H=J9(8MY9_\4'Q?<(%U>SJ/\IHV)@$BDJ MN)_"J,_$&;@**U0H()3L#P?O\=3D;R>$S9Q24>:,2-GX%J>[N'GKSIP4)2=` MI9DZ^MX%44(,/2`FGHV/5!T-$0:T4#,4RS%=.L2]"[0J*^[8P-ZT9R=X;>S1 M1E_&<:TUP,1-0L&;6;9R;'Q&C,G57`%W\9"LA$R$46Q;S'(0ZP=:7VR0D%3+ M58_P=7)B'Q)D&JPHZ'^QNU,QOU`V^6$R\2KFU7P2860QC' ME;4O%T-`+Z<-%RZEOZ7;_B\BK]I?7116MV!3?E086>2!=[X0^+=\(GEK^!*` M>PASE)IDL=;!F_.)@WZ0)!.3LTX8>3:9P0=@`,#P4EFZ*5L+H9=*,TM'U?$] M-F#I!.K0XDHG\U/-H*B(G8(M9Y_RO8+Y7!JN4AHLKT`Q#G\1O/+?S MOSMCNE8?<83W'KJP7Q!#%):RMD`\P4;X.LHBVV."++UT5N@$^4^>#,0B^M_O M^#^_XNS8G_[RU)QSEW9,94[;;.K7F2;[I2R][ZT(-A#A MFI@VG%SOC3?24DBNIRO:C7O*53-J,(:96=S8WV&W?+W&UK:')=A1Y^?J$#1( MC*LKB@1\<4Z'`U$O!E:Z4=^G,*7.;EK2MHBD`T.Y0P@R+=7/IE;_#T39E]'4 M+:-CKHW/\8(*`/909:<^IE)@9EGD)]7>J#C)I#;IF2$IIIV4K_+1:(6>?*R2 MY0@(#B^S@S+16DT,IJ>W<_X%FZ<-<.)`V7GBU!W^QK$/<<"E"EK7@8+V21RV M@!!S;O6,<_F6'56\H"T5]\EKUN<,H+U0OF4CB4DXX_:$,1\ZJAR,M2/4!^5' M9E%:KZ4=) M;=5]/89^D/C"5[3!B;D?+9&0L1*>16GAZPT9\@_J\6\D9?=]Z`W.?1MLOUW?TV MY)3U=)>V[+4"M:'0@AS%>OM6V#@2>E^TG2_8>?]%\+=N*OQE]7OE(\;``8UU M;XTQIC");!1W;TQ]QQIZG8X'C4^4;ONBO26I,">BATH-B6YOK^=N)R/BN\9Q MX61"H>_`WL](:;C*5-,3]G@`R,H6[$O6J%-^O?6H8^#8$A%/S%.1(]0D9@:^ M-9;&Y<'I\0K2-_482(EG*:MLL,.12+_^\FDDN6A?,J5P=2.E?J%&USE"(<7` MA")O.SO7QP)>=S0$_"KWN\BF$PI,)I/OO$!S^NDO?+K>[7C9[[4S<0*A7#GKT!&#_0@%1Q:S^F&EC5P? M_-AP1S"(D`19';C?!;J&V6A9DVDYJ!YNY64NW75T4L)?N^$5ZBC&ZW(ET'`9 M!UYH\I9MB?K:_,9 M708;KNQOX>T[J:*P!]]U2N:XSV7O58]4U3Q.`>-15CBX7C07]1..](7;,4DP MJ@='PU,J>9G2H5_;"QJ<-5V.Y!?6%Y"1V3RC[5 M2KV2`O#X8B_O=*).;G2F*'TK[^ZI.:0_K(]$Z+UF+3:)`43)E-6BSD$?94&9 M%'7W7B'HB70$[>6%A.M5=/;,"D:*,4-H'J3-`2EE&&1SU%0J9[Q"T$$;)3Z= M&XSIQ<;EV*4_YL+6_*_;)H/X^I!#M*`VZ. M)-;T`O]A4:P#H$8D[YOEA.#YPPGC$6U#XIQ2ZGO[/&H^G7Z95W9L:5]U.Q8F M0(OG_/3L1B]+,"(Q?^XW2;$6;0L5F]T.OMXZ(K3O8WU9?"YT;L>L$=,N>Q[, MC>3B/3A*;#;A4-6U2(81CR(>F+7K)HFU:=14)Q%?,X6.4>NPP^,.@VZ!AAV# M6.S4-PIGV3QNS"YW2W^/C<46A(Y(1_>`/.0G:3;A=(&D.8B\RJD5;E M^?RHIM?)2JU($!X)?>Y)J#8S/.[>UM$[C;D2+/RV7F1VH?Q;-@;8``:)3S,? M5NZ\X\O')Z`9/B9'!C2(BY#&I88`:DEM6&I9>!R:LSA"DQVA#5AX/FXQSN'' MV%<%DOVH<6A2)UN%XR23K[`_8']T<*8!<'($R4=Q)<(`?[-U$N$@V4#>9NY0 MVV5&;,ZMAE-[ATL(P1"#W&A08L)K##\+%K2A\:7DF/;\9$.VG!%K4)GX`^ MVLV-^UO]R!8_L8?"R.[Y4U]:^GTXX,<86^W:U>2K!YS_N8B M$U69W5CI'0.!5I4*W:D=>!@SZ8T)J..H("COL2,)S*9HFR"4A^)9E`4QZR,/.AWUJY`^_CB[Q62QO:S)"8GN M7>0C(M0&CB:09GSP)[T/'3X*R;L/J>B*FY'D$T`.?AR_?O>.2D-3[2JNI(D; MPY3+EHUL0*J'^>=_M;#%#H8_X5C\Z2_6(L;+QD]9P)%D-GZ`F5==X9:<&X$. M36ST&-]^OI,6?/6&NWTMD8SS>M@N8:?9!>"#FW!&J>O<(GT(\KX M;@?%G\=J42!-HO5&*QI_V2"27E*#Z-UY8NNOK4KDF<8#/B&B'R_0")$+G&;DW9,\?!Q M,AJ.KH/)F,61_8]*:@D6Q<'7#/MTELV;&ZMMY]+9Z^%(9V4:CNR!=U>.W:>M MI/4M203H>\G8?!S$O:A^`6G>(\1-\.VJV)6 MW1B1I+ZI`M3C?63,H:DO-ST!R)\0/D@99U3GL`&-[9Z;^+Z0E2 M$RJ6K[E#BTI-K:NHN^UO17F[6,LON!Y]9-%8%ST#F!;,!8\'0,D7:KUR,I@! M5O&LK^3[[V*_ZG#.4V1/8=68,@8A!+/Y!Q@;_33PZ<8US96\HK>6&R=Z2 M]26#V_B"=Q);X@:ZY2UX%Z!0\G,,!\^F1/C^<"F?&95$MFA[U^]6KB^D]JDN M21X-ZQ0/9Z]0+?AB=E_'9[A$/A]+VVE*F*U$LY?EJJGY.UJ?/Y2?!P2=K9Z2 MR9I2]/KAHWA;T]AGLD'^R?D6-1BKZ4IGA))$HE**ZT#@&F`JK,E3NE@@J!`N@]*71"]!+.^NSE&ERP M;J\@=W>'!IP\BR^4/O:<)%DT?)WC#\RU!DV3"TPLP^R*$7F4I'!WBD.Y72J[T.)>'17](2Q4M?KY>+)B#@ST3GY@T10[")7!BU=\[NY'YZN) MX<`5:!^](YR@(0^$#;2RO26)QU"#Z=)E717?2B,L1"#N/9MG@X\PN2*]H)(# MA@E+Q?M<$PIC`A0=PF&L-*I^K],SC7'5T`;W;W$Q[R=!SQ/DFK#3>4GW^!,$ MG:8M'8?G"B$`DD/'\'MSCP?GS.:1\(/+ MY[Q&88JBI&(<8PCMS%+8+5TYTL*XD-=H8K8;",L7`W M,`(1."@B$)944S:4H@4;DV?JLO%--DJN;&,0]"0G3^F@\DCS:W(Z9 M+C0,#^`\NHWO`"BU1>%%&<-^?O)6;-%.'M**PMKBMIOK;2Y^Y#0^(S_S6E// M?*T'B*:8`WW")*E_Q459'*MF^US7I_0'H M/)BX!Y>N5F5C,MQ*I_>8894*[.T:MP#(-]:M31\BW07G5\J_*"$+@=R^@.6A MYQ8>'$A,JR"V8%Z<7&-2,>,Z]!BMLM^.F[SL"NR8P:65DLJC<%X;3@G>;53' M1/YA]LHC<9\RA$O/"<+L%UXR^R/!Z#ESSC2I_@+\2A5B<`S$'S?#X1+UZFL+ M%5)92/L:81`?=Y\;?'S9%H@(1:3-W!0Q;3Y;_1IEA>.84:PI/0SY2';':J0L`7#=\Y(MS;X42BF MZ\LPDP\U$0X/3,-M>!GRQQH(>/V,T;J(6Y84"IH-4]&7+^'U$5-B((288[Q/ MO__SB[.+MY\T2\Z33E^_OWA_BAS);R3A5F"OHVH%B_GG)X=7\!%ZSACK$^CC M>G@BWX_V!UN%$#+=R(K"VV.E:[3(IK_HU(B/!^HJ"@3.@$U#5/I'V+'ZSBTR*XT*G"U]"YE]CJY7Z!J'-Z=GED5!1$4M+8',EUG%>8U5S->N;0&<1!6Y$F0!Y<4YA$&NGTG_^[O12/C_4)N^B@4:D*E-Y!ULX0G;'B$5&K;>2 MZ@+;":_!#9(8RTGW761RSH)#B]I97]FN^]RCTZ(RY?.!B-P64"K.,8W5>19A MX'0B\$C_KSS'=YOTZQV*J61@-KHA""OF:%"CE&$UA-A62DS2#\`-P9A-?[&Q MN[R[NF:GE5G3N+\7$0W\FM%[DI:\\`R.WS@K'\Z^@OLTC9+*!P=89Q]$XHM& M=E=S@X!#'F?S6+<`GV-(GX1`C;33/.P\5.5/[DQ3`$I9,J4C1%O&-=(Q\;A:KBC46F\-`]HG[&T8Z M5AAG$KVCSF.C/(?">MG$W25&\`)N\QTTX MB(>M^5,51YX^63Z)Z M)C7KA:QB-T^`ILA/27IJ[%(87_!\>4/E[%!*C^9S1IUIVE?E=8NT6@-[I%9\??'NG#;2LW\^N+RXD#'U[N'3A\N:U'H*"A;::K_P^(+R M5A'=4X8T'H&X<]=J"V3?86LP$2<"T>UYJ@I33W+4JC$IPR7@'TJ;F#EK2E\) M8Y]_U+<+P$>P+56SF00*'PY=$N`-,+9P6FT'?C!6(!,OC0#!?H,64CK;(RY, MFP&[FPWK51VMGD84FA4S$)@K"\5%CE7X8"HG]_1,O6>U4^_0I?7JXHT8:E3U MU-L?)%P.]JD$Y`&7&YI;7ZQOAM1G$V'FWJY=1[N3QH2P4@C=\@&N+3BS*#O3 M24=Z]G0^PM,9`9N7$3KG3ND'=O$))U#\_;M<#?S=&4@I^+U",JK3*9_R(V,/ MVE.)5(\TE4D+Q61&=%:'*,"OXI).KMWM2_=N&['*Z/ M['#]I<'1KC<3$,?P:E$[V[Z8#%$\!&U4\.%U0GV(*+DR;UM<,@OJ&82$^EM& MGR++!W$Y_ERZ=I,VX1N'FP3G(K]=%WVP$N[+Y`5 MZX_$K%:W!NK=;>X63BT+3DJ+-H>C0[J8[RAJJ`&$SIM-J-6M$-[= M#KRH*%-'$P7YG^=U+2IF_-3VL3"(_0'42P2L(JZ8T'J=M8P:10/ZX_ M7?(&BR=,/4"].F:)!K$D@4_5S$MI,H<64.F,2:V=/P2/]!`:V>BX@`W'D,R( MM'"+2^@9QTE(=0!)`@__5TD?KGEXECE%IJ6C)NEM(1144HV4%?D^9)@`Z>3P65#>17,%IZV&QO@Q$?"4Z"RFL%& M`)''0:PWIV_%;OG[FILFF0B17EI+H01Y+?`X-"I[^X6>:P3.#SH$RPCK%U'^(L]V1!L(;CE MV=K6\NZZU\Q(%#$*ZZ'Y%OA0X6I&\<++EF?;RUMP$%G7F4U55V%NX@:WVES> M@/U,/\:85V)>XFFB[8MX$^NV/ZMRF@O6.]D7%7)")\(/!.^W11G^]Y3NDIQ6CH4#`:.P_;R@*S#\WFWK4@,*LV(MU5[?DZ4B#B'2RGB=W3QV*"V&WT4 MQO!#;Y*G345H^L`\>V'@M'(=TB7@'='(<`@I==?K1_A3Z04V,3H8$ MS:W3JPE>05\!S',JMSZ&#-NV9KT1L&I3"BD];ZSWQ$:4#W*(J]XU,PL1XO#D MD\886AO01_V!/S)6`,`)+R'`X,B]?!WO[3Z?LW8_@=_`?%S-#DYQ6;8>.JCN M!5-JV8_"5[.]Z*/W36I]PI5;.4RR<((KBE5D25F8M+#YX#C(.E1@9/[[BZOS M(M[YU&LK0H$[UER*>/=.LE@/>5O^Q,V[1F<^:WI$9&XW$`XE!SW0E:.$4(EM MH61)."<%.K@E>M=5<4$$TQS4M=.2(ZMB.!%#6TLZ&DXE%8=+PG:P_KX(R7(* MV.?RYHYET`3WR^2[B'NJMVRB]DFVN;5S+Y[)-I*N.(%3TUK@73S3A^PO]^_" M.)4KZH9E8LLY5#[-1(FTHN';09?X<<+?RNUNY;.#BVJ,P47QI%^)($`,TS$_\GOS8)G>`J7G.$Z13@7\]^_'#V M.UOG__4?+A.I_L.7^ZR86(VYU(T441&K*3)9GJA'U<2:8&?JQ+!_<8D/>F=M M=WD6YEO3"^-7;-"AO1?C^7__]_^1>%?[YVX[OTYKCFGXSI8`)N$2!.SKYWNO M$7H/B;%OS)8HQG+W(O2V3=QIW29_19A9;C`WK7$J=)__V\+(H`$L2Z\>/'C0 MZP&WXJ)#'FCWTE0B$I%4^LH9'%QQ--+$@^O05:4VL_47JP"AI>J?>479!'00 MT=!Y>&V.^N5^"4XJT.-91PJO=`C$3$YD&(2]^)A4F/KFT:YIG$ MTJYS3*/9\YO!-@?"D=*KD_#&Y?=J(4KR?*#LHM\1M4@*KS\(E-[A'%94*1J_ MPCZLFZ%U@,;W#U_S+?1A/'V#WFK2PIT6TF8XY-1D?DPN56XA"XK6M(_]'Q/E MPYM]//MT>D++Z:L3VIXK#M-"C"O#/)`Y#@[_P,Q$_?^4]17@-V2P]CF`A4NY ME/[4\=F,W)GB+"S>4"R&=F@(5(D0,2U[2-)NV&:F1>*2+-B2$K3>R`Z= MG)ZTNFDKRR50]L5V+84EVY*N7Z6/@D[&'S;+'T8*!HS#SK2QCR#">1O&6W0R M$FH`7DVXC'26*I<+(U&Z[=G)BEE6JI8ROJK)0),*,3B7&9JT(*RR!/"1U49>G68Y=K3E8-$.9.\ M#\0PW@MIR=J[^*&?N?337S;[@46"7PBTFK3ZO')46=?MQL>/1CA%_W M7!U).1O_L+2[NCW^V_-@4:`]=PH3P0R=>&]G_-H=6^U&;2UM;W2#LY;6'G5_ MNV/=KE)K:7-Y?;T[U-*C#E9W++PY/F`"8F2]]W?1/2]V7?W1R.1TT6H!$E*Y M)4!$5GO7DO]Q:?X>E$("ND,G4(P(+82'16';Z^JS?(%)N$GF(B2T:G`WLW'] MLRHF>1"`_GK:U'@.^`ZN_7U^C[Z%Y\^(#]OI9_$.QE9%H6]ML&DTB MW'8?CDH)'CUJ.3M`]E3,^CT3J(IT;9U_J1$5? MG\M39:7W8GEW();7F_9&%LMKM4]I*Y`^!V*C$X\Q?,]1DC&30;;KU@=S2-G\ MS7EC4?0".F=D(*CE")#Z"H2&\)RX/]I[[.3[25HCN%^5N`MY2IL/@P%%SY'* M1S)T*GX.X-KDY?>"[G330RPL3(D?\D_T(-4/B_^O#L3TS.5HZ8 M9T5DG1V\A*@^V!MLH,I4Z&,NLR7:GY3$CD@H>M5\10[/[-+5?YIU8+^%4JJ( MNS291/..#V3$;44WEZ-*0Z2IKWS0`Q:SM$A MI_*J0Z"NX[S=9(Y2B]P+H"JT)NZUL9G=X.R0]-CDJM9^W9U:X&TW3,*O,"C8 M9$F7;@X-D0S`"NWC6YB]A:^Z_%0V)QM716?N:T4E0,B;<*B'/?!7W_<8@MQZ M0M.-".K<"5$BB+N/'DT#5&P@`PMC`*0.-"7`^6AS.\,T,\2H7&B(Y?2WW"J\ M6YAP%_MK`/#NX.Q-[C/1GEOX]G_8.[/DNHXSSV_EAD..AB(("C/)X5Z0$BF' M94=4R1+N.7DRO_SFL?V-(VG7BBV*DP.)ZC5FLX;@YF[;:\[6\"YX8?6N%LDQ ML)";<793G#5@N`AE5,X,A):.V"^+J]9=(W6'"X:Q-RCG M+S:7A^(&1M9GEE;T2&XELS^_&3-:OE*S"1/W,-Z^-C%0P[^Q1_NJR-+0.-B) M`'S_T86?&YH=ZP-%?>$"0_MB=6!<+%Q@\+D/I&4-+]E#P2-*%N/@:[-G9T#O M4\G:FJ-D/4Z'Y@O3GCI9AMU+573G8?5:"-';D.ZBA4I@]_&+W5UI5!+[9^*[ MP]PW$9L5W*%:588G_A)<<9@EE%4L%!)=L$#Z!>>G#^`-P`&,>/-?0'NS$'7S=IB8^?;YC M"J+`D@"P2AJ?%J:SE-PKR#-<.+89)1@HM4NQ;SYY^*]T,73_UMGT][]9U5^NGN`(DC[^^]_L M82[,K,[F.<-$SO7KRWU2^]_XS_;X)];6__KA[-H1?>13JROO\TMS8G=<>L.0 MY^[EUW9L:1&B+L^SZ.*`2M;^B0`Q>.+O'N\?&EMX2H)2V`Y.^M4N%R^P+*A^VC?LXINE/'.%MF%]8%VX5IP,<44;5*F>1[U$?Q>ZZL4@9,$R2- M<_J/UER19GPUA83)0^\4$]Z\`L+)A@$ZR^NQ,-O)=IM$5K)TQ;^3Y98D(05D M6WY/\DX=[$6J MMGR`U.KGP-F']1$*=^A4*-8=*]JC9@K#W*%A3)K-5HLN%U.EHG)A6[D881VW MDQM'`XE*5%5OK-_/;]6LI]C@]:L;0CC8'SJUI!+#4'"Z=Z>QJK MXEWA`506QO,($QA/%1HA9M\R+-@H5UP6!30H4&\;ML3J,F.,(AT.CU56L*SK MU]0=-\'!%BGT^0:7:S3M*_4`6EVA-`9$4X^L/=6ZNX"L3]7?.EU]M@_0\@@* M_>^W?/ZVHA3V\=__^=?.3EQA4?0IN@$^@_EXK+O_T3W.2*JX#B%WB27Z6]>M MI0-JA2A?^M@74VWJL+6@D@MC@IJSHVIA=B-L`]MQQR8ZAH)38?8H.OCWM_DG MF>]ST*;_[!/Z?#(8O?_G)3+?M^X-#"S*"ZX'D;2EM3M;#^[W5P")<1>?]__, MPZM#.]'^.HA/+:V27#Z,HBTXWM"DA*0WAPMO#O>[A`OTP2#TMN!;0_MWMX)WF<`=3<8"G=Q_SQC`V MGP6%:74(?U!A`7:`C=@1!5L:2N`$S,.;`7207@DK)F'7$9$HO4$/"QK?'4SA MS.T:)O%+G/ZV_CX[N=?YY^E#9Z=T5:O4RJ:QXV/(G78[H#)#[CP/D-4VHW%G M0J0NU_]DH'OS>KF8PASZ[RQM;`X0YE%:O9:L45K5PVK"&LYT`GRT@_60KAN# M%4$K9L2-/+MV;X#NV?9">.7]WHKC%H3](7C'/T%(>BP_+.+3;[K\]I)#^$^+FQ],+')N7K]3!R;H&*#4&72;, M:N$>N?_FK/A)B([F=?U:77.,L"1<10OP1;*U4LIXS=E;T\,N19ZZGSG[L0_5 MQ?N'SK?5VG0@K(9[Z[^^=._.@WN#6UU:O[-Q?X@5]PDJ#?[JG4,O%Q]B_OZ_ MHK:^-(RKY`AUCWA$-TR=,76+1]6.^S9F@[\Q!A+T3Y["UOBH>E9?^ MJ_&18!^\@;_L?,X+3_$MDP=*!I/"$$X'\8G^)OP+1LSC/_D#T26V'33DD%OT MT@B)]Q^'WZP.>8-_<_C/#LJ(#F^@@6N5- MCF^3I=S4FT$.V]+:UB9X,1#=DE`A@B!=F72PN88ZJPQ$$<,/?G/H\QM'&&0@ MO30VZ7G>19U_A6L2H!CM+LNC^`T(#],@=LH8#UP_R"R8&.WJO/<8$?+3-]:- M4]%6QET@VV_;G[X^=W\F"IOL7CV<`)@Z5Y(/2$NHB;SD*?WA%86P5@W6*M^4 MT\85Z]%Z,LHAA1N\].?XH2`*%P<.`!I3$%08!X+6S$2!T`K.!PS>-6+Y"!@; M?$(&O!*73_@WF&D9ME$@*;3MN)TZQZ34G+Y*,Y5%CL.273#EN^1:D0FWK_HV MRYDOD*U\3HF@O#*`R,`WHJ+.!(R`S,%!,+VK@XVM;!FWXV#KX,Z<+:S_SLJ( MKN1[TE0(_&E5\E3A^_/=V4O`FNJ:HTX1!=E3@,L9/+$^7' M^X")CD'')\BD8Z)JJB(^+DZ81N>PU6;P;0R8R,Y]D\5OKK7^(L'-)U&D.KGD M1/&Q5K'3?'2OHF]!P]MV:LA6YE5EM%"D\R4IN-].MIO&KH(%DZ@X6#@EU=T+ M9W'638#3T@HY)5LIF14?VYUKQ:97J`#\C8JG=U&\SG(]^@00S.LNM\%JZS7\ MZ[5)>ZRV"(KN1DRVW**)*%C*(Z@;ASABYB$J+!O2'BD&6P$]@+;Y4,76WL"8 M#,-]RJ#W]@8(1T0[@_&[D%?D'HE)U;(4HX M$#@T!5FVENL98@`U.)S8-H*J%QBZ;$AG*LMQPYXU/@$WP$>:[]K]V*!;C(X;I$&R?VM MC3LW+8N$FYDJ'>S"9#!Q98 M(5O0S$-=IHA[CM-XO>HPT^^)OTO7"KH9)%6\P")5.\0.;MK99NT`\,2T)@I3N_N8F+29T?"']$T3US3@ON&T_H):I,;JOYJAMN]_* MQSKLH&'^S;:$I>2+BEM%#\B7(ICW`_`U,MO\)XQ>JF07([ M^G2B+$&7NL9$?Y3Z!E@-I(SE)?,W4OX2>YA4#CC^-7J>`)7]&Q-8EU MVX-S0B"B*Q6\G2)$#S-PLV"'*]T=9CN%L4V"`1)//=I4@M5XB@@TV^_MH6+X M>QLKRZLKRY*&_VK3$YH,E@]8V/VT"<81*OBOR7.O8I8*.]A')B^\WTR:AUV4 M#>-2?OKO3J:O35.4Y2$LI%#76O8KCZJ:?,7HQ+@#X0D0C(D;"WZ8H3M8+,EL M=@.V&%^S;.`&%5W:47.J%C#=G4AO.=(X#LC^@I`U%&MM`QT9T:A9DSY15T?= M8Z;7KEL)K39.3$\#3U$.O-U?B$52'YCZ*ML[NP28-E@B[,F[]@_PES6(;K@9\[`;SFX2L[;(4SC.M%-2^O54 MH^NU.>/1;TCQ+UD3:NN:\:01UGD,KND-0Z-'U7BXP9"^$J$XQ_7YCR3FF#A6 MX3:#M=#JW(HHN:%'=OKH7FK$_K0%(:R[_)1BE`SML'B+:1*8P8UM0%B*>13F"JHF,IY.`R9OKB'2GP M[^W8L1BXF3W2Q[VO+`%CE02,YU.9!];&Z=NEP0+2-K_ZJ:=)J%*C=#7]7[?F;*Q:SD:SF;'-;\-^9?8N6XV9 MY327##(@#!1+EC*`NLQ>BJ@(@46M[K"QLKKT[&JZ'Z[Y=D9F36N%% M+*9QZ!XT\V'_?#GSA.)6X7.4*"(RNBE(F(?K:9A9)D[-(AE*S(ZX/&=F@J;ZJCSUPNBS=-V@?C-<$Y%OR>(W;\K=%74J7\TEM?Q_P((Y_'UCE#W4N:)J*,2C&VD4`C'HO[E*X4 M\A?-`YRYML!/7XRF^14@LXM;1B\+`9JEXB%P#'(QON$_2KFSP[PZF;Z/OOP8+*XE^?#FVC!L[3Z4ZT+KE[&1\I*?)[0&'_]@AI$N M:=`U>Z7)[L@Y;Q970[#2KK+ M<$&Z+M+W;/(YL<;K5_T'=G/JD?9H0;3C<]-A6OKP\F2Q.WQ/FAG.R85(L#NX M#JG<(/NAK)>"]X&LOP,?7X&PIVS2VLB\(C)9:P`Y)Z>_YEJ(AV; MW^U>)%%)2H4Q&:<;EE_OL8MT%!Y>G!VPG4P)D9`S^C"O/>/V';$ZR<&X)6O)LL9<#X=]S=EVQ_8$N]"W+=@EI/K-_>W"^9%ME' MQP9=^C_]KOA^VVCYBE>,@!OG$I\QQK3SJBMZ_]!"*] MVM_C+X%AC4PYH-(L6?O[KMCZ\?\ZK+L\<]Z1\JJ<<;6\=_+YSJZ!T;GF9$(\,?-R+MS8_X]5K=5XE=D'"Q/^.'&:.GWR`=GK+KB"=T MK!/]A]L,;E5;1!1,HU^Q?FY[" MKT?(X>D;:J%5)RS#V9\!;>>QH%^`_8CA[?*/_-3[]>Z/!T$6>;N=/G@ MD^(''VH-@FI8)X830YX(U62'T1N28=`\N&C5?%=%Q5\*':PV$3MTQV:R&8R3 MYOLCZ/CXF:4W,H437-[9H8LCI@O& M]A9/9A&-\`]I*- MHN'Q`E3!O)QNU5('2!-Y(7A<,3@C)X@"*-D,RHX_"*7VKJ=2LXT69#1 MMM1@I*JP:T*BA_R5_,0P"/!\P:0/^*(YTP<'_I.$_8B]W5=^/*,4K4)]`@;Z MI__JJ6-0/65?@_.*]46'XM)NIN.!@ZV+^E%1%@*Y:FR:5)*;\Q;A-^;YG-Y^PV[>N;M5F-/A@ MU^Y5EZQM_Z.U!TUSFA%B56)?($W720O)0@Y>(E7LN)PTBJ*#R+":$)-,&M)A MOK@7^(ESZ(81W1MOU<&]DEG:%\`=D6WL<Q+!*,AA"=W>M2@=7"_JH/$!QM2B0KB4 M#(%*/)1HSPP]$S4-+B"-T(SO:A'G@6R7/*)0'QC5>4!AH..;4V-'%(XCA4/S MH'E%JWHHQTF3V'AP5CFM'%*'S)[F)SXFZDF/MRF[D1K41M7*8VZVFUME@)R? M19RMUNRUXJV7A+C8FM&^OJ32&ZB';[GW^BR9?=`,]_?OZLQ-WHV[.CQ+\^.B MT+%@&:?,JL0S=&[<-,$!T4FSQ)UF!.$28:[V%1S,#C$2?XX%D()9\= M2+&O+"JXCGL=G*.W0E594+7E&:8!ZD@@>^'#G;#>W-+MMU_BULC@NOGB%R[8 MEYJP46PG23&4/&4)&`ZAM30\VY#".`_%?) MK%8PUITT`5V33!*4+C`@F'\T<(9D\,"AB8_:!Z#A:%T-S$K-$'VRD0/B@*Y- M7I^8P9.-2RWJ9^0OM4_<%QZM$+3<%.`P@ZV*L<]5=59.L1=Q@D-ES>7U=C;? M37^/D8KI0NBO:H+;V(I2*7(]MN*891I2'12(Y5"'='RT47/TW2GD2@LO\U-- M:&Z"V])1I=J4D"UYVEN_[<'4BYF0`U%:9+Z9$%HO:P]X^PNJ<:G?&B\U+5\G M6$/%E,1"DSZ"T7^!A+SZSJCDY)SR>]0E+J63;(7EMNB['/A@JC.77(%0*>`+ M37;57L/,9(>"0;Y.+2W!?:I2M+.A/0P%ST M^J3&7]5S\E1WB&D*F5#:]01UO@*:P7VE^W8Y]O7#Q^HSMFC;',P2@@!H-H`! MOVSOLQ@J9VFH8+D+-JP-W&EH9F@5\:1?!NB=YLNB#\YP<,E.HB//U<4;8E:& MT"9!BVZ0TB2C;=)\1;^RU5&:&W*8MYEYGPBU!9UY9(]*;,'Q/_`Q7!RZQDIX M4#=XU'!CXW8@6P5`,',22HY1`X4/MH;6E($;Z_:A3SSKACL$%<]B M(ETJ]RV>\;=CH`1_0FA(V0;,O$?(E,:P1$+ M;1>JL2NG<-P@*^)9C&?<_=R;AF-AA`]C9Q;`23ZTI0N510',B4PLZ3(8'EZL+0T;IN=G=4VFXB%DB.FVZ@``0AV'%#+*YH`I[P&'1"RY!F$[9I[+(ZZ&,@V03`)H6JA*YOS!O'UHFLEFTD^$ M/M9DTG9:8QL]N0(QIG:.3=5"PK34+W"M'TPI!F3%$GNB,9N9Q8(I6ZVW5Z99 MM>M`:?&)PG'\`!!,44I2`\;`9.-]/]+=.A@!R&-]CH//,VOJS8ZBS5I>Q M(J5J"NV(O`JG0Y4!A?7'=9M'Q3YO+,\GG,I%Q\>,@2IA77RY?%$&W\0DQ6UF MZ9=%?N[&I/D^.^HA"/F&AB+L[71Z#+9Q]8?3Z1$;<99;SWIXNG]"_(NPF/7@ MC]-0_`X)PFC0ZZZ0?<"]=:DZP;C_R:="G5,1PT/J^",VVJAO=I_AB1)G-2#P M#$1H%7#GEE#?:&::HZ:T$`]/$6A#G4*W+.FXEL3+MW"GG!R'.'+?K2DA_-)B M&#=^@M24612NV+)']X)8I8/V;AOK`TK>K1G2.Q)YM-E()2G28O^(6!TP!,%"IHDN1YB];%FS@*/?='9@JR^\K4[W5T\@KE11FL`NSW5>,.3 M^W[N,Z`.AXA MY[;[=D7HNU<7YQA#AW8Q`T<0J%TBVURTRA_GOLM(2J\RWM988(3R[1#=!*)6 M7/0.F\**LM3*;'`,B;>#)]HM/30^(AH^CCW]] MB>[HVL/VBZ_M<8W6Z7C),@YE>5W"Q_,!"[(JHHK>OBZE%N+)GC6%[O`8 MV7#M_:BV#V*PX@6"6"*#.@TTU?W)9U8?R=\P9(Y0;UI&?"9Z?-CGXFZU%X$$8+8AP.9NY=!1R MVH1?W!Q`9Y961N*K^_!LS?T*()=P"2`O(.5O`I"3:-WD54P+>'EQ<7TNQ@9/ M3@9REV347'(J&Z[@="QP*TMUZN])K:,UR8XBG('284@ M:\9N][[)IL*3(Z7X8L#\8UID,/W0T0P@G)C\`QE,O%FE@05IS7@5VV^/6Y"G M.!>2,B/4`%F*T@#%3#DZBZBL4-;*@SN_-&D]EY'*[9N."&&8SAV)BCLW'J$9 M)H']4I2R\L`IQ;.'@E@(_"6U"+4BK,C_6A&9+-X&&5>HE;!*!ZE2:L(L)N'J M1;1AYD]2;LP#)&*0*10`J&$RD,EA7V1 M?501+"(_,I8P#J29','3I%&,'(N_F?O=$1)Z\F'16RO4Q\*1\RJ1+GQ$.YXB>]KJL0*-JMPH@0_\7.5GE=K.7F82K3;\L4`^?D@7\7L!B;&0U MNUAFC,N%<;WP,,8F8J%`TJAY0N5K7)S9W.CA97+5]=X!LLQ2 MBV'YQR+5PB\)?&GB4"9.=N7I;[O*(@<#2 MGD-`F$]2_]TZ`VH3AS+/P4SI>]HDEB3(9B8,_CH[?ZXEN)IDL[]:QGE@>-R( M?8AB/=#XFA9,D1+@AK2\O?`:/5)F?HT_)EM6!W?!V2R=]'1W\M@:F!.?!=8GEX-7> M%D>%U4_)X(7KPTR:RQ8;M6@>R5/[=R>,]IG=H/I*\ZL8QF5>G(.DO!?0(F,! M%X%8&LOAE(.%>+[<[-7)R^OJD%>](STT<%VX_SJ#0M!6_-)MD3$9-;;R\K:6E`QA_0V-YUXC"^(W,;7O)U.W5UCXX`4:P^^8,4JWT< M(]?)JT#=+]0XD)*+JS=0N'IDB6!>1#F6WM8#YD?;U\"#R0X!6)2S]HW)X^]5 M/WF.BF:_`XO)MS4C(T=T61#Y.;JO:XHA&+"!XZE=J"PF+_ M;KRF@'-NTP6@)/4&3H%U$=UO?G%!]+1I?7-G@'4?!O+F(`&@R4MP=. MZ@`7M=)<;EMI>O-LQ(W'8VUWS4'8`2IH:3;H>1=3*!%9AZM(/RN;&`[E[7%Z M'V]ADD860HOS`WMK?:`3SCV3ZXHR+51BFT`8B@!L;C2!,T?\F'/$'V1>5XG@ M)?(9LOKQ!X:.!ENU8,5<9]&//TRV&U>1*0IE*]D[H2\N:EA`=9@C2&>&?_U[ MR7X,SS]LJCB$LDY_"\_SIUEWB\2CY-65NCO2Z%!*S%1W%>^9WN7?R"4J'85)DO[V`L>EA0TWL4J;?-] MT/U4R%MF"C;Q3T.M)_SX':)K6R2=D4_19=A*.3$)MJU$:4ERJ6ZVJ*GA.74= M-YH"KQZ6FY-[?@>9UT+!A.9K/E&4)#GOFV>D7YL.O=8,GY^\L%>>D-UZZ)6D M.Y\_<4W<6!^]***:ATSO;UW1)'H'D"(_';NPV09FGGP9D5;>Y!R@%4>B,"+N M#V!OF0I#=QY M9FA:&H/;ARVB=`[E;?'^`V)#/*,B/+?$?X6FGK`'&M M&(L.Q&J$$CMT<170J6D]!@@[6'ZRD6PI&2*=7]@CYX7//4D(ZWFX6%3V=DN) MV]2DK/M>$M@17`[-A)_)+AS6Y@DGM-\&/4,;1.VA^.D$O\[>&)O7LD$^GIK[ M$258J\H7/85$[MS"J2UG'`4Y#,UF2R;ZI/,X+^IJ'-9Q`I4-LDNUL>36AQXC4 M2BC05=W/MK=WQ5G*#;P\.;;DI@.KR395'XHQMPUZI,[8Z&,R5S'98Y=*<':3 MS,YV*3E"WVBQ+,B^5":\+9`BF9NW:PD$%CC27>%5$W0*[FA+BA#YP$(/RI.8 M21:QY12W=J=W"(G==FFWIU1?/]QI==%!IM6V1S=9RK38L4RK)YW2"S!)OO/0 M4<4FN_+P^J'7@7PN?]<%PB]'?4??KK[W,8_/9(&ID+L$G5`C_(L MFY/S98A;.?S\Z.UW#`%ZB?^R%R">@^C"G+9'CY3N3OY`G?0K\R#AB52OE-KO M%MN.CG;>Y2YZ#1B$:7%Y?FQE%[W3@-;>UD1?<>1J-<1*S%E4982L2N[5%0JA M+;W6A4ZM#?1E4B21PRKW:'2KE5X"NTA>=XKO%.L)"O?78]BDAX5#!XJ$`((. M*'PVG:<*?WI^UI'^1;ST3(7, MGC$C6L7YI,;SA;?EZ[Q-7^P*O-U4AUH>*W!!_F0RV*W9(FGC^A[7,=T.]V$Z MQG/(QB7!(&-!>*KD,%^;F MI?BA,@,N7E,T0RS';$(.JW;ZR?]T13KENT''KSW?[6P6SW'-V?R^:AOH#UGGF!0$3M),!%)`&&\L-;ZB)@X]QA;K=<( MO_*>X=R'F/]T7_FX"IGP7WY^\U%Z>?9WV=+$W-GZ2A4)Q2_N^G!L74W`B2+C M4W4$<)_5`/?_2,25CLTXSM0IR8RF%]&PNI<5*V/GX;.FH,:+R+O>F/GV"<"4 MXV>1??("%1G4.Q\T5WMZ?H@+;Y^,\]-]-GP*KQZ68>+2H;BX;C-D!+_L M8A7[NC,)2#@_Y[#ZO[83T*^MA'GDQIG'IY0.^B)/KRYH%/7F"#'UZA0EY&CZ M\20MND297;_1XH[\:&,S];YW-L-Z/LK6:2%=-9$'AJ7Y+)*:&O*I5/T#49M3 M#24=J3GDRW7B?2R5#,Q=]J=$8@SCXP6)WBL M^E3>74=M?&^?J,Z)&?Y3H[? M`'JQ!SSY=?%="/\AI5I5<]GM?QAZ"4R@,*7KAVU>ERF;]&I&/X<^LOZ3U-C@ MF@1.CQCI=O6MV^Z72`7UW6W\9%HA#Q*BJV0VN=T!JT29D&B`8Z8R_%]L`VL]5^_%(3SQ6D,OR6KW:34(.@X@3 MY8)HXW.G6R6W-]5^K'19_&W_!G7T2K-K&?/NS7"Y&>TRKTP<*I=*X$I'K,%2 M^>@)B3')X9!E`$J_#-$^A`,>3M:]9A[F)%2?J\*^;SCOL8F?[LG*FVU15$?1 MT?[6OJS/<$\5TOJ'<4WEC02M#>X[:=!U.B?;5.P2`_LX4CPV>(["V^,N@J5$ MWT6K]=HF7S_L.G:D@X+Y\MF$0=$K/#0UZ=V]+4)!$EXZ'I?R!;XHWJAGDI0*BT4V=9^\L.Y[+>*ZUGUU6JG,O/FH4/@;A,+^KL2Z3/7/IDS8 M(->[M=1-+B!BE76"AN'"T@L\>+\7]-U87V^C;XW))3J=GSTQD[J,!MC[@`RM MTHW(R5M^*"(,G12>DKN-!8PWR&AS!'C*R.'/;B2*=JDX0:B95T_59AUPN$>' M[WL+,%2,CS8V5MK#A?6;#5GP8%TO)S?P((E\[1UMI@<`%"'L3C>#38.(\ID2 M%Q\"^%[=P1@BJ)J1JL1:-I%J##L!-A+\\KR`,:FB*FJO[- M;OZE/&ZJ>N.\`9YWR87&T%+XX.8L$I!U!__'O*F, M&B.C7^E6$OOHFB^G5]JF_VU.QM;)&?:Q6MB@#H.(BHI%ZP/UVR'?C$]'SJ2[ M\6;Z,OW9I^3E0[,R%7';D4SYIH/_#U5Y0`]`IST`E=G M(J(2QR`GGGX_O6+8C)R.YA\IZ]ERW`+&J3S4=M.Z!/.KZ3L>;$&L@92L%>ET MY6<]6]M(1WO,3E"HXT-Y#W@_BO,"2B1N8>5/#SB+1J!8<5TVG(%D8`&1IQ?! M/D>LN.0Q#-'YYB.I^>X)[OG`\9@%H+WT@.S-Z>;BNGL(1L%.O,IS%-SAS$W3 M&P3%)8*^0DQV.$)S/4*70C.>=;>G&VP=\HH97((YWSE>:_V%X(?(>U^2*EB4/#+8^'D2:$L*#Q6&\6QC_P:6Z.FJO?7*9>)N1J9[#QN_RJRDCF7[U9'>?C3,<:4N'#K?"@6@/>'ALC M[4#LKD)FN^%<8$*TW_'E/&=3D;LN;<5A:[J-9+HN`_^L5T`+),R@)Z;&W@$) M[?18XPCF2[7UM+/3MG&_HDH>)\.:W-B MX:X\@WF(:%5ZPWTWA^2ZL_&T:>#[@OX.E>/2\IUAGNPQ3MY8H7`J6G*J]M%"6:DQ?>85U]=.WYQ>O M4:7"1W].X`2@H*>5=([9BP7L'!#(5$%+5*\#=),W MJ<)D9L:^S(?-AF=SQS[`ECO?`QLILT,'?T+2,;VWK/-%U=>1E5&^[9?MU*$8 MN<&Z08VP)2(=I":\NRHK:P//*!CPTKVC`$'L``JI.@FE`FPD`M7GQV#\J>(9 M<`Z(2!2DZZ7M16FUA.CX2NUEO-YDP+H_H!1YXDV4`,/VE8TG,H-KL(,/(SP> MCG+Z]^IKN-^FR`+FYJ+[TWCGYE"/HZM1,Y=:+,T6=4WGMUE8<*A4\[W7W4M- MB1'AN<73;`C56I:WLZ9JMA2](W*&T`+;E]+3;R_#Y^18PRJWT&K5#,HN@4&? MN6BSI1502:J0*!65,*9#J4F0NVL7TG.T`EHQT0/K:R%^0@E;CP>X=/KIGNUQ ML!OH]/U_.KX_KZX8\_C&UI)`%4;+D>T`WC M5Q:Q'GYKF#ZJM\/@;1:)&OZ%RXA8&6O-^Y(']$>,;-_!5[$V&<>.X$70%&JV M=Z6/0*9-\IJ[[XI>V(?C6+)J+W.C_TIS*CD4?-,HA>"@YTVFVTX"LO]R?&\D M0:3_).&-DAQ6QV@L2HPU?M"FCD0,;Y`PN[1R=ZW_.;>A4C%P"NH_LVM>HRAC MDIO4&J'WGZ+^,N(<:/'&V?M/.!""2HV!0[7]A[8CZ__5P=G`1PQ063_]!Y?6-NX/;WYIZ^[&\,G- MC2'X]I`UF'ED?YN"4%,EBUR6TQ+$@(VE;I>-IH.6I67F>Y82E3(;JD#F,N415O$L2)+X4[\%X&`HT"XO!6:%^R0Z,KL$GK:C0-F/=G.7FH9&SC MLK?Q$(B5V1NBY<>R?C`H9%FS56N=IU71#TH5);O4GX""(4&CXO1C@)$]>H0E M2<)QMFD1%RL=K`3;[.@FA8@\H6J0<-9?)+]<-[^#!B13KPP;4Z=)&2A*()X* M&*8!<9%8AI;FZ7:AP7PVNZ`@$EA"\1*9 MX3-4:29,AF3%N"7@:;,@^CNYQ'*K$\TVUNM$+WW=MP$L[=-WH MW`,*>O?8^/"B"XF[76#]*CI0KP20,K>W\6:'"Z/KJTRN\W[@,HB."6/1TPZO MX6K]P54*3UP>UB;PX$JLH`=]P_5$(*

KUYA#!%9"D-8#?FOR'I&>-^\.@S M?.I86?UQ84FCLE:\M&`D2IN?T8;I/_]VL=BMS29<^;/BJQ$_@^YR(^RVANZT MJX^@T,V5&E82B5L'0JKZC;4"8;PC,[I8%A82BYGOJ1/+\2L@7I*B1<4EI]-E M5M"PCN2T4B8CJ&)<)$W5W"21LD-\FJBV#'6F_XE%*4T8BJ@Q'.G8%_,A':1F M^.(:](QZ4RIQUT:K;'@./E=\N5*IK6HW",; MHBH`3.\H[JVPKI%EZ;[C\60CB,CAU3H1DN36NP#HQY?;&V@1%5?6ON8U2X(1 M_%A9;=%U3JQ9N[:X,7YEJ9N@L>48H%S(3V&^7D=PQ9YU.&YJ\L#BT MW+G$;KG*=P_=!ID)?3%(6(5*+%%8;NO.!+$@#PWUDM7%H:=DQQDYJ?%Z@'AF M#E\0/O?=MN#H;GJ`9$^':94Z>;ZU756VQ<@WC-\]$L5Z3XV"F>8"-QGO8;LZ MKX4;R)C\^XWD+<-FI":I[;\X7+I,.TQB`)8\OX5YHJ,*YEGL5VB.PD/DS;1'X(>=J4%`S*":446";\E1->"V245B']R-=&@SXCC ME`'Q$@TGY*J0;))7.7I]J;:5;<8,"\&YP0H1,*7.'B+0;62BED#/M?H5;]-& M]LUWM%9`+5(*^9_H'>0;U1;/"/JI.-6CA:,+/"=&AG@GP^2;$\RG<]HZ=,U- MRZG<&R=W13B+`89N[XJ-93YHQ_RD_Q&OV'$J&(^TW1K(DYH4T*]4FZ-'`.6@.:354%X$X.UHF\ MWAYVW%IIS`#3Q3S"AZ_CYT<8$^%=(0[_7VOA-69=CX=(V!B2=D:S16-J MK'D9%H:;3'"50`S2*:)6N<+;A*P&:WP[M9S:]!1XCLA;.!P:=P)6X7*X$[IZ MDF8_U=CBY)NW""9./'I(R5AV%AR$)#I`GK\H$8I!X($XTO!O-,SJ;WOG!O<$ M]O;DN88(27-_=7(YV,C2&DZ?_JM+<.!!9&1I;>1OE`H,7E[E[4&\9VEC)`:R MND8'L>'[H_&2M9%3K^(>&WQ)8O;O/U[BCI(!MG?(M02?+/CL>^[QB7^%3D2MKJ2$Q'NM3?,$ZR2HRW'GM>H"0/FGJ[ M-8JHT<\6*_J<91`E(5#YCEV:WBTVDGMM-H4SH"@XF;)0ZPXWT7-'(R/(@2:: M$6?'W.UW;5JUI^R"TZ)&7V[XORE<#YJU%D1&PD^W&PUD'M6$]BYDY4H8KV9X MNMC#^*75*F4+Z8XU0_[BF%NQIM3/]RNB5'CNO3FSLI2Z2:0O\5O@@A/83&3F M&A?CK*!69'63RF19I]L'!\IRL9?DE'FDU.QM]]&Z1_R___.ODYT3WF=4Z?=8 MAG1J;ENY,++A%7&UTS,,R1?A7[LS^6+Z77U^Y`F[LB].CFC_K+DHW17_#4?< M&]I]_M6>4DM*SQ--%.D=09,CAAO_ETE9_I-=G'#QI3UW(FA$$%O,WO)9 M)*V]*B#A7&MK0V3^EP$O;4D.4XI)_2'8;D$7%9;AY)*GGZP.;\Q(0.,[I>U& MR.+)WHZR@".RDDW7K(E)LIIXLOU^(;/2LH<-217&4ZEOFI*L\\IKWJ\.;/U_ M#9?3CC97?LM^?1):?);-ROTY(Z;'2*)P8P63E,_NXELRE:EB:$[AT:^-GU-E MTUY=^FGD/XU&?(F'SB!P`]6,A!2F[AM2O-Y2'&J/WCA74@$Y&.?>=`DDX-4SE4;+]P'S+M^QHU2)1J)?!^'.O#W4;EC+J!^*I`W M\,QF<8FO9.Y%*-CSE70W[D:0'A1B`M]IB1.%QMWUW.U$6E0$,JWZRG*00D(F M"K5DU?%*=.5EKSVH_&#T5!AFCCVM2!HB*S?<7P\[<6`'%5-A[DNK0^/+T>*V MKZT,+<%=\G;VR`\RV`C7R9ZBV4E_HU^W86%8@>YI/A`7A1T1`(HDH?XA@`F5 MEF+H-L1(TSX:E76Z^;NGW?D;0>0:/K/(:B/23(DB4T-IKQ;PQ@WLB>:6-H;6 M,&5N`PAU_?K"98$3?(DI>T%-XZ%M%P/C^CUF_+218"4.ZJ%%Q`7?\I&J1))F M9\P"IK^PMO62\_.<"FEA:*I(/KQFZ)C)#2J(O>$N)9K$DQ6^:OK:HG(J"06> M[BDK=A'6=U)>@KHZC_CU#"Q1Q:%K]*(U3+PG^[0="OK8Q5LQ.J MPZ,.^!0$JC$VAG(,8W#&EES*24^KX3:!)[?QBF57G*5(.35W^O.D%%VH MB(TH81+H;I>'W&+W,!'FZNP\3YV6M<_0S%!LX8N8496'=`IG8;5Q0N-*[-/L MCT.B\%+33<-51"*?$AQZ:F^HLWNZ]KSKU((E&X*(&62FI%<`261LAEK M8$C:26[0'XID42J+JN)EL6PKKW'[2SXTD"?HA\B3]>^_UMK#&:I$V?+0MH$[ M6,5S]ME[[36/$EEV?9B;W\R==7J6=*KBRA97E:)J_H<;MTG"C)Z8KA)9DMRY M)@F::H/6D(0DX$7PN0]9VUTC\^KNS?QVTJE#.-K;-5!`T(9BY&+M6%)L=F*Y M_^2H8!"$.K"J9OLF8*00S%KSYJ-)X/_(VO,2X"QE43]FS;O,M&XUG5VZI'V[ MG.X[Z+Z?V!6W%(#!2H6W3Y5U^>\P*]5::[0?ZI205+KLDK?H@MZIIV@IL\O> M[`8FAA$%KWA?IMWV?I/B^ZFX2F%][@^<@94N7*58/-E,E!N^0+5.!3-$"IE.)( ML.D%#C@*7]1:V11-#56;J;[%RM6X8](_N#1J*:PQHA=FP^JF&_@&$%&OSD<+ M2,9F#,=[K]_!Y>APJ20S>BTC5912>T)NEA)#+XR3[LQ>DT:*%DJS+TE@>T#R MM^$0L)2IFDW"6']-=[I$YTOYMCWT8BH,UM!OP]50]0@)?6"+6?,#5M:EE),> M*'_L_K+VV;[<_#*=Q+MT4]2QG70*]'YL6BC"=05WD2:?@E3@I"NV(R!5=*6F M+8NP2$^4%J;00G_@9RNJ2GJ<0,:>^[P7/2!LJL/-L,9JMX6Q"@[M7HOXES(# MDRK6\E?\8CG^$NX@QEY[45"%5[MD&)SAFJ4CDB7XUUJYY?NII9]%@9)/I>$4 M<+[ MW4='V1E68F5CF]./,9RGAUMZ&4WX(7'/&S5]G*D\R]CC+[E? M;Y@#UO)05P8OHWN7P77)["%C3/@K?JAQ0[UW;D.5?ILSE)P9I:WPFLLNC4RON77N_QH.FY1D?^+5:GLD#9C:G-4A!(9!=*ILU MF9G9FDSV9MB/AWANQ]/O8AO^8J&^1/M+MF$/.O]F&]H\D>\Z?J3/-NR!\H]F M&YK:?$PS#S7GD&JN?!PI[PV?NKE0Y-A64,#4AE\;1>"]$H<^FUS2T=8^V7&_(K>?2S0S/$J[]8?4\:B!E$+3949GGR^GA^4U-]_RY;3M??<@NT#/7IST MSQ5NG%\;V_IAW3ADZT#=O;X\/)9&P\6*UZ"+QQ_B?Z8)=?4]RL477R`FH$;:-S^_#P MR>#!YET_P2\M^4BD'?*IAY"_;X?/'GHW0:6O_BP*$MV@*L'1G@UW^@P^(?Y; MTAZ]`T[*\J#M/1%^<*N]L)I4EJX^QKR5Y^`)%:U/N"O\UN&MGX\1F#U7&BV5 MJ*7-G9MGSCZN'L_CKXT?_T2>1Z.U]T1D[M:IE843MN]62F#;=^HY0><,?]^0 MESZ06;GE%5<)5EVE3'Q7IZDSH^0Q5;<`I>M(RT'%H;>[CY:>?4/&4!XE*(Y> M$2O2*;0%Y$:K(N%.4;;ISL19D7'2GTQ$$(U`IB)13L8;/FQ)<](WU%8H^E=) MC]&CRSZM$)MEM:"*:].HTQ?(HZI]7]$$+;V]E_Z;HQV#OF0-_K".=H_8[Z?Q+<-5 MR5[]3DZ2YE]0.V2U9%MW+0OL=I./9N6L9!\93S4]IB2#D:):I5=1,[M6]QPXNRGUDXX^LDM2!>WD;IX^9_/I*M5Q*Q.[?4Q)?D,CD=[$V9\X.79;^9\UP-JXDG M=,U<&"X,?'%X?&RH7JG1D)R+H.&1E`J?*X%O1'G+/.Q.VA8^#O\Q.L0P=R4< MP:?_V>?__`*3$W-&XL+T'3IPX7B\8@KF24G?_FHQ50LC"HO"]]`"EVC)=1J5 M%V6:I?208@BTJ/#\&AEZ>=(ZJ#@GR;0#X5^R%%9.UZ_PV/M/!PQ>9L#2):FM MP>S5D51.U$+PIU#[R1447$2%NXE^A2#+).1-WZIHKHBD;U$K1X,9[1^OE#,XC],BH:CD0R\V]';9LW6^S&O;H2 MO9J@YB:-:NU3H0L9:^P\#WQ*9PVY#!-'SG("]7B,467JA/EXVC6,SRW/H@LA,+ZFGL0&&N"%S0M[&`\5`.%N M13VE6X+_4_V,:*U\0B_6=[2AGI#)V6AN\0.X"#O"=:6#L#G$/#]:UQ&@+VE* M1+-V6O-Q-;]^FV&P M_S0+_0R+-@YYO-.?2_X'/3,V#W'T`>BT!VN,6'%5O^H14-8YLG[VE7\%UM`R M$=J?[OJIVT]828V)KN/1I140)M'6?C*IPPKJM-CI:J6W8G+R#QIE&L]R;39G M&!1WCE7(T3GT\MT&G.J;T>7IW*H\7KQ\QM3G_W/3B'XQC0QS"-T"[AL,X#S1 M=#7GDU2%8"CYG&Q-U:@@RQKT];'*:.LB`8<3YV8_+@.J/@?'XZMOQF-W9V9@ M]ZZK8VJ#;H4MWYW_74_WKUGC`W.?$NW0PG)'(EK)GZU^M M]4,T,Q!H0!2^J^AA18J:Q,-+O"H4%&R0T_B M.E0U:DPOX*CJWI[GW:22SLH)FDLKN=/1.1('^('7]M4EMV=SD2T(9W5&2C_/ M"0?%$ST=J60^K:6+R?!VV\W!:%WNXX.@0'2\Z%YP/783$'GP7C8"*--['(N_ MO\\760;-L#NOETA)&1DYLE*%4YW6!`0G)XPSW3A7GR*_^GQ/74%J11D)[.T& M.@\=);IOE48/4?3/074CPC8[%[ME&O8KE=*B!MGT]MBF+YD?%/Q_8BGZDTB+ M)NEYB<(4I_,Q5!]U,0HVRQ4C6,%S8^(/!`.D44YKW^?L6/74=@G%)>&#,3Z( M$Q])4PQ]$WJCU[(-.QY',BLXH.T,N4C@))H#[TJ.YS2K=QF:8T%%%-.I1:+Z)WVV9N MIEV8'O[YSMXS"U/\^U___I>YIVLQE"(;:9T*.*:\BU(1>/.%VJE`BJ99U"5^ MV>]_E!+,<@'>("W^^&AHBZ&SXX^3KY:5X%B1%AN06!]HJ]E'\-9B/KF4$`I7 MPY++P2NDZH4=74\#J))9->//[/""XTKH2?!0\AB6[?)AN5)GO6 MKTN@L),<@2H7EZ1.@'IF%>5,/H>DW4C/[9F1X'?_3S6'G"Y([D/+ELH::7[O MY*C;'PDBI%F\GAROT_'S[8A\TG/PF?EPFL9D&,5.I:R[.T^(F5U4@J=EX#6_ MD*)5=@2[5B'2>/K*2J\"].45=V^E+.N+1C@F648>G\O?2]U!'2(]=2(-*A(\0W'O'P=@A%0=UW=T""Z#VO% M^`P-'=1U#Q#21^C4]M\H5-,Q^M`![-4,#[<-$H[:-_3&!:2%BLG%:^/Q5?.T MVO0@]JY;+Q>F`S5F?60!S.D0T7B,G$60WVM[IRML%1I+J=C$7PHXN9S-85970ZS MCI!LK64P`]G(6KI:P-=':C*5L!KBE=*"X6GK<^T'"PR$K:V-S:VUTYNZZ@/' M-UW5X<9?C:E%9';]5Q26U<5TL#,AGR6Z-0+=R^X!6/<'P'MUV.'>_C,OR-!Z M5,P@F<_!;EU+,X?KB\.=P8U[F[>VJYE1*X4/))!6U-M>[=3Y_XV[5X4$4K4PU2:CJ(Z(*DKX:#(=-R-*YB\J5!]+0:XO$,I+/YT@7G;*::2-@ MX"9\>X&[R-KBVD[$.).2`5E"OC#D5WU04TN:6F>/4TQSA MB78Y4N[`&^TZ/^8!.&?/F9I!+@D7:Y58DM,%HT<83*U^ M/%VOO19<3LX[D4[Q^,9!LNLR"+J;.,DBY).A.$94"2PM7>E$[%_2&Z0C>66U:YK*P-5:*YWOQF*WI']]\T_Z9ICUT]>L;% M=&!9+H]<5C4[-\4+V^@<-WM[!8;#=!H!\UO/D)7NX)8*B$V8=0YPV.%5IO\E M9@7U=%E4>Z?]7ZMYK)C[O-585A/'Y/,G_5:MGC4K]=7HG#N_I"\@>,N5=KA" M\S#M?3Q./)0(.;N^LC4D12_$S=M/IT9T./9MW/H$3VG[F9<@E>9KY`[CCDWO M?\6?:R\W##RK<*_]"*-YNC>\W8,)#-ANOWL$!2R91H0I8H$G,,Y#481R4`%' MYYF/]PF=`N07.?&E`&2&#Y7W*EX>=9HDL;1@A$$]G MEBJO"O')FZQS?AN`@>#80VX+EJ?0AL6Q2P!1M^^'[0&$5#AQ0YD'02<>C>0WB^B=$OR("!$OBT@;&\%NNE+=%-?W%4:/EB+&0FV020"Z1$LRV9F. MV'"+-Q>V':9NN"O%&]F;?KRZ7!"N<:\5CB+H1DV5<^U1X!(#\1**K!=+KE<+ M:;]L?E2RSCGAS=#.]&[JHUP>V` M?Q'9P[7+@XE']`1.?XOJ#5D&\KO9PUG(.]Y#T&X+V1X\CNZ*!'T/:LIG#5D7 M';DIC"1_9X'7@]L'NX3>M*CEX.2'J#%F4ME@%8R]C_HWNQ?A9NX,G5X`'EED MRVYA0M-<=!5W^5?^.!V3H51;6%_"$D9615#_[D![,[N<#@XF:`L7B*KPDZ*Q MJ_NR>6HL2E.M8#X.Q3?9780)`+[PJ&=\VOJ*:2'V?76E;G\LK=/^4ESJAS8A MY[X`E*-ZO21^!_8]>D-&%I:$,S\=5-@`Z9XCTB/A9=&[\K6G;FX MZEZMW0T^KA3[-A8#GLQ(A!4R9.]VQKG"NHR*RS]#-88+(\C9"+SJ=(QZD(QC MXYG:>WT^SEVW3>4P91`2'K\+<#65$4MEH3S:W6OFX+K_K=16&5*V;A*4 M!$G'9V<>7N7V!?5@.<:R!VN5)^.*KCAS[@ZGD9Q'%X:X.)4DJ7&CCKH>CJ>` M44O^#50?[$K+:XN``_2*Z:)C.[_`F1088N:7_&.3Z4*Z>>%2[;6N]9)U;+4] MMU]W>_T05+^"4D]0IL6KI`MTW"LOIX/AXM4"BO&T#?ZOCIE4RX9B3)"17$4T MEN'&-O'%E#!X>#4[>3/83WUL2O08O`K"1=,EDC-C1)K77EW:3)Y,K+#5X;MS^EN*MV($6IZ^J!:I)>^31CQ`>)[8$)"157[0@ MQ[PH=?`7`'$\L[RN]<%S(L>2J*@<#?^\TB0I2<_6OFK[0*E#S:CSF7@^`&@5 ML(:R!4S]>C&[-3!G_7>'7JEQM_LVO63%:AF>.EPKPL%T$CH\J MIN7L9(X+/7MG(D+OWGTHTS6W/H-E?\<35*&#[W*81NS!N9'QZ@N`4-H25(=L MF'GFG1^]0O>F3E\E.HFFA=8.,IDW-Y@;D=5'"6PYB6]5#Z"NU;0CS;$FH$0Q M9\P'"!=#_%DL:XK=FC+KTQ3-^FD'4P&(Q8Y' M1*>P2S2VT-088+PD?"Z`4`^ZC"=IHZ9X;F_^WK_DP"Y\SE1KXU^%Z,7F,2_9 M0G+C>;Z#LD`BV52O<<8S%!8?^>'C_#LR-7;'68 M4,D2PX8_T)_;A&62D_8YF83D,ZMJDZ7%XGW5XQF./7W$*^MFE_..@@YS^-," MN1TM5`S;P>'MX9D/V@:A/U;[!E>`"ZB@)$-CN[+=:5=-<4(="!^\3-N*?)_2X\YK2H"/.>#/,J)$_9X13)8A9DDN\+X+BSR+;Y"!5BA<,N-JB+/ M8J!*^E!IAY);"H%DCM%D\VY`\V3V$W<@+,S;0*T`E:0L&;MV8'D[>BE0%PNB M9`KND1BB)"0[M4ZVN[@D6ORM`KN7Z(5H7MB.KVRJ:$FT3M%LO9#0)V^L*)^8<>R M@B@LE!D5>]:WFP#$TW`O"U0JNL\G_]`91<9O\V0N*U,*GF%;!R"^8F?O>PI6 MR/O8[&9@4Y<'#S0UL0+5`!CR*"6I[%6?9J?)1VV>.4-Q%2<)S9QG%8??BK'<:&<4`F/BDNWI6DRJZ%QR/\4-B_AZ]A!;<& M3^/2KWT_.JJ/#Q5P>PZL8Y:9D#BR`3+.V`5.QFU30T#<0(MTD++:EI^BD+/-2?ZU#/"ZG36_<'&X,OB))4V/>G&5)U\"4;7;3'DEX]VL7)C'!\ M/L:F/:TM/3MYX]7YX._#8Y4TG5S]K[;)^$'+[#!)#XQE-X._'XFA/Q8JM=94 M,O:C?__+/Z2BDFB/49?S?MQ:TD<)@AH>_WX8LJ&JMO0(]$GRQA+#;-PWT;HPO33/I6:OC'B(=F*W-[="LN3J# MNJ8GEFF"!/>NM$@K!H#)FT!(;_.!W2\Y`Z@HH@R%-7`_N.RVOR\09SB1>#^E M/3J>AQ_7,CR%LJ:OH(42JK#=E&S:YI;P=FKTR[?H[]$A178QL9P3Z?O0`E_QQ;S.TOW^&6+B,=B[!F)&#56^XQM5^CSP$,G?A M4\H>[/`887FE;BI80M1(%AQ%;OBV0JK`1B+Z`#D?L=X&V6G8]0X^>?EB M9_?%X>[.X/!H>+3[?/?%T>'@Y=/!WHLG+Y_O#M:^2/&-FVV^^R1BTR*+CG-N MK9,#\])I#"()5W/GG4^Q.IT)./%XT.>0Y=N?CLT]WGWZ\F`W;?5H^-?=P\Z3 M)6J_=@S'.9M#Y\-7SS9'1Q^MKL+L%:`:'AX MR!.=E5`#VK\]VQL^WGNV=[2W>SCX'X1K_C!XOOO\\>[!(>0VV/WS%WM'?VN_ MSF*B'IE"O]X\J[HY='PV>#ZM2^KZ9@ M>^YE.`*!DL"NWC4W3\)B>Y7KPF[83['HL<3P%B8DV]Q)]F'2ISK,Z84I0`]0 M@)[@D"9/!,Y/4LL%H27%,$[Q.;L$?#)#D$J/E2G*WU MS`$L26#4`H?**^+V@F29!T"V$IP?#FZVK>M###4\LZPU3R5^H^LJE MOX3?ZW3P_.1SDB*`^XX\JG%D\X^EO_BCTAQ1HS#:,A3[KBH(1Q#V8^C_6X]@ MB,'HCH**RQGQ6?.D:8G7?BC96EZ[HY5%#J[5)3AV@YN)[!>R,A,-<#E($ M;_SJ0!5I'P1.M1!J[];F[_5Y1RZ38V[)AD;*9JWF#\R#8F&VY>9=\Q&*1$R0 MM66T.8ZZJM/U1_;H,+4*H^5X50Q"#N40XC4.]I&!\#A^[\/0*[\L0U>T!;Z1 MP=BX24$F-C"9GBCP]5RCDXB&:C$^PC3UX7;[9!T^\3&5^1"R9H MH4*J,9GCM6R!A/T1^R4DKBPRI;2R^!F)*62&X!"V1@WR6&F1^H;S^V,FJ2,\ MFFWCJJ>U12.,T=31O;K-CGS*LF@EESXJ>P'5+04,?';:-2>VY7>R_>S$N1B=OA-$7S1!G/JMPSPRI;W`Q@9Y":QGQXRRA\6PU&Z"VYQ M?9/\!?]':Z-<%":F#Z;6<\D9Z^?2-69HW!H\5]36/\I1*L#8Q[XFNF.T:'F&?:C$@FA9MH(ORHOP&]!^*];*@W#J)X>KEYG5E M/P^&"/J%JD=O#1Y'QP-5>WJ@`"#RJN2F\M,"&:J+!>6Y:>_[@KO\]9AVWL!5 M[4DPP4+W<7;O,/T`(,;I69&]R"-O@8/U07MW`HKB:NES073'XM2V8ZY4%6!V MP?7WP3>;PM1S@E.A%JDAJ#ESNADIVU+JI#)E1Q+8VDPP#[G[R&V);&;G+YQ1 M'$=X*Z<#EVUTI(T5;&HB!^M7&)NAR$T[S33IN69XYD]YR\E@1S+BTU8JE#$: M+[0'L\0W3:`QM:]R^)C_@ZR+X"_D\N)!A0H\10;DKH]MWHCD)"(>E3.08`T> M;S+"[DW3Z7!)T@4E]3R7L"!5SHH'L4UC"!4".%878#LAO?8$^H)90;\5D*_C M;P#TRKKL[&K_.J;#CF=Q:C\KW#]WN!QX0]_&4YOL%8>5YAV:47(X!Y=:=;S; M=@&>3[KTXU4WS!;KS>C2V!BYKK^W=8'77=/AVC?A$\4:6P8)+K_L:O&O9XYM=B#D:8J#=4?8B]>A!Y@00V M$>SX%"BKA5_BQ&]K5,N?7.&<7_'2!QFJ#\U07;Y:>[,8G,((*>S*[AG-KYJ: M7-4.(A7+7`8DI&Y8_#=#PC6//\U>3PUT@OFE/-[/8*@(W M(#;V;N/Y+J*AH? MM8SXQK;0B%0*+P%[`4V6S*CM.YOKFYN;D@H>M9,2Z;>+5BAAI^P39<_BY!X# MQIQ18Q6G."XY'&=R+$'4YRVW\$(.O?X^0E`$S(1L5KO+G)^ M(3)XGKI@(2SS4/J>CBL@D%>`^BVE^(I"A!.OI9/>H@>X.)LL`/SI0P.K:=(> M27.JK4E?]F2A2,0SI7+G,E&9XP'^'&-8VS]N_XK#!:D$)#UQG8>EJH#L(_04 M="E4LWV8*^I5L$I@K_^I&^E_Y"BAYWS6R=5DB45`R-D2*?F6T)A\#TV':DM+ MN'8$I$;RW&/0\WH4!_*&`T)]`84@],.4FD%\O*Z^$H+P0^YAY8LV0 MSC%I"5:^-17;-Z%3SR](MS8^6,'`5+W#\72"6>LZG`,I5@K;R@79HQR0&$&^>&"AR6DN`QHT7(X:; M!?/$)KA!S+$0H"5Q#881.HM89#6)8Y5.>L<@K]!(")>%GQ%)4D)-4GC<+X*FI4/65+<2DSWG:<( M3_E6Q";E>L6Y09E@85V4#)B)RN[QC`$Y^4`AM9*K@WRR<**`MP0;MPP;HQG< MGQ>0D)%6T2-VE&.W(BC6]\Y>%?VLL6QITL?[%EF>W)&H:@O\_&_P\WN<9,^# MBVO/B$W<'#P5YWE2]/4(>/9HTB\PI!KOMK57>NEQ.I!.2C4*.#G/8 MOYP1^&Q_)4=DVW]8N;=]?"*4<$].VF\=*JVR_:.>WIDPPJ%;=?(W<,SK4;K\ MO.-SOD/,(^Z\_8G;N`B7_&GMWOKFG>WV"VM;6^OW[FYV?H80.E'K;1AI+$X9 MCCQAEEUPV@']%G4H2W:QXJ"W.P>M/MC>8-;XH]2!IH.54,(!9&J5)F^+N&$N MIL+C84$4G8AE606S7AFJ9%&>(QI&JJE-L%I^N,!I8>*M:[JLE]P8\3"I[D0\ MPC#``,+!JZ(1*Y*@<%&I%?F#;.GK"?B,#(YM%D]-E:XA:Q=-F#=A1-79;$2OF%-<0J%(TW03[XE]#0%D8GQK-QB M=Q72/DB+J5Z.W)7N8=S""<#CBZU<8A6@B7H-^TIR+<4`]T: M5'HM0OV.N<`V%)JQVEQ6F6&:S@6:N$.IE,7]G:\TEX6G#)O`[DCK"O<+R[)T M3X&PUNFSL?I/G+R>7`$Q(<=Y-BC+SWG,X,14O6.")^([2KA2*!5H-('MSF=# MSK1FZWP0BOL*X'QR,L(Y\E5L]Y2S46Z]:&9%*,4 M3]UCA5!71N(M=2^A0_5Z!]V.6#Z#R;8;--FS34'"FCE;IR99VE,E$#LI6YLZ MWH4]X?5Q%NEEE-@AJ$\XX#@*:I16H2G%(@XG1!&-4!,^ZPH#T&@7EGV3$46)ID%$#FAO;$'$T(45[X5W M.W7PT>6LV)+37>RAYI-V!8N2N5S:V M.@Z\YUW6VU`C$DZK+C:M)8RA76,5>;Q]A?72>T3,4.:MR6V@[BF*^L+=4J/A MG@L!M%8R/E`X]C("A[:PX]S[7R<[LOY0$=8.\Y*^T;.%Y!9IX%_)O/4/GDZ0 M9EZTWCY5=7=G5LK7_F:1YNE373D^6',GA%EQO@P(VB==ZG-VU:$F_G6_GKIY88EA@=[LROTJ0O067T-QN*O/^`/?;>?E`F/# M2]4QA64_SJ;OV6&QUNOM-QUH*^@C!_V#7145^VQ!3I?L_7Y-,;/'\?E\;$+1 M&2SG&DY-E+HV;I[:/01.%'R'>\**6$O/!3QB\&L^'FB),E]($VMB9&D=7O#B MO)UG@1\J.8DY[L\G$BP]/`(*F:&@LC&HP3,T#>8B&KID(%XD^)K6PB=#K>KA MZVR9.)5E$BH\(JA"C`Y\QMR,W9LN9@JG7;$--S>)7F1"\E?QBPI"):G$+LJA M*Z7<:$HJ>[6%Y:;)`A-QT*1Y/M?H)V2[E*0JU8='O1[WIX[$_.[-N^C+6MS?N= MW^ZNW[WWH.?7>_?O=G[=VNQTSUSC_?L=#\Z1Y8@??C8\V/WLY;.=U2GUG7QR M\JO(\[_6NQUT_AY7%'(L,X<6)IHG(.D.U[XZF.-)LV%,^!$[=[KV8/W!W=L= MF-]>WW[0\::5BHG!_NZ!`ZNSX)ZKG69K@HL$SUIM9%"O^GR*M,O=O-?>1_GB M^N#Q\'#O2?L!O=7!F&ML(32)]G+U]QB-\<71[D[[$3&Y)B_[(2Y_GCQ(/^#5 M?]23%/R%'UOUZQE]T)($0MW\S@?J8!B9*W4U#&9A=-1K7]7:]OWUAP\[;&)M MZ^'ZUNTN][F]OG6_\^N1-1:[FM%N&_>`B72D:5-421B*WR@L&)E*[-?,:82NDNBZ#T@PW<@45#+/5M?$LG^0WF1U%J;1I0$08\( M^/$E4-1YG?]U@=^ES;OK.^ M];!S26OX(F_?Z<9B<%1N;S[LT"X]*N]T:?E[$&47F3J4^4*Y?-O; MA&6?J?\Z*CK>;A)S*!1MPZ\*K9;B=R]4\XXVRQ,$?.WGRFN,(/P3D^/4)"D# M9D4U?0JX;EO`M;/'SGG^`B?%Y1II>.1AVZG,A^^G,D.X3`VB,\*$Z5IJS%*Y M_SP!Z5(9E`ME#R.`U*DVI0JK1QJ64W=M"-U&M5NYKOF^]VEC_8JF4:\'>U_* M)4^O?Q+#S<2,P@N5355ISI>TSORG@@Y$+SSMH^XM*O9L"43CRXTY18U(0S.D M8/PXR=FI4NZ;RTF,H$]O@-_/3O_6I#3SD)P("L(&UH>=QEF9!;W#ON@W:D]/)G*.8XI1WRQ M*E=D)^KL0Z\OG)D$763JR0TB*[7^1J>1LD6M/"^_X#!'P$&Q+"F\B%;=;C'G M9/JP!WT?R,DN-0QPR0H<@1>9[NK'81H)Z(`D1L8"+;=290)Q#%Q:0(8397S# MTLVIZ5UH\F1U1)E.0B>M80BE*6<;1V-EAT@B?PDM1>]6KMCZ$R@?,FQ'+81/ MQ'`7'/$K8E_)F/^\0SK$X0K#B%C/;?RA>G`SZ;+2`@PKB! MCYQ^](T05-A7_FB"PXCJBG05G+[$O1MGFM(JEYY(P)O]4Q)"#*O3U1"&0319 MK8ER>H^OJT\"&DB,-JT1L+:$%'7))MP,KD4P1\"Q=XQ&G\,93D:X9`E"3T^@ M)*M7D$;%];B+Q1_&O!2"IF=WC)&3I2J*_D.64H M*CW@+9$1.U*^:*"F;=L,%40%A8,P#1+9R))+ZN?SR>DI;K7\UQIQQ%/3E(GD MZ(+$/'JFOCO6;H&/^,G%F,D6<)^BOFO/@M_@F_X9?>%5;WJB(`Z]G546Z:7NF,HQ\'-F_.2R&*UE4B+6#M1N$9"29Q_M*59*RSA+#HN! M]:`D^V2J#,HY_?94WW1,PM^$[%#Q%YD:\CPI2U7QZF>,L`"U#;.>OZ/&)08Q MIMZ>7"76J'<(M;];?:V+`1ZV7MX)R01/92B(,=.<$L7PWC=WP]&_X#5 MDX+TCE2/NDTB?A]BD+B(D$921/R.\9.VVG-8`W>[^@LX@ARFY+9Z0PW>@9Z% M8&*(G#2@^-(+>!]KSKSVP0#O.;+ACY]C4W)2[AOT9I2(PQ:]!)$\EN..9 M!$%"S3QCH%3)(=*VH2;^[U.X89<4K$D))>SZ:TT(@Q/25KV2LPDU;331OS8> MN@?0R+5;%:,+7#ULC!B!;0F]_L:HK#YVR5X;T,C,THGG:?#US`6;//*0E&P$ M!?7TB8=6GW/!+_Z!)+1BK688":3<\\ZT6M%\&Q-$6$]\XNR95)A`TD%R=N$>@],,'X M#1PD)WP)/H[-5#6;%/(2>6(E!(-3N4>YJ)6,FL40$X;R]@%_7;2F;(W+=\IR M4*XN:-1*>@NH)8W:N'PF+X-KC2$CBE30C2G3UXIKP_,S<$[_N=_04N;K^@V\ M_(/^OU9!]6C\]IB2!_WMW__:W+QO?RG/__M?/.Y_])<'G]&HTV^'-6]R;Z4O MPCZQ+.16QF?N[6A,E0:D%SRD]<#%^8D6()'!-%,B&L1$8.^FWY)H[O^]9?>] M+3301='\STJ42`5W4K>*'GBZ;N42()C6:2(G&4B(M5@X,Y*6?"YR&1UO#@<4 MI/%VH3:,Z!(AM3)''>=J",:0YU1C&<]0RCN_6OOJ[8WM!P]IL!Q\8)5RLTN9V`JZ#:;] ME]$[DO%T<9#NSCOZ"H\&SX@ZX;.C3;CT-`EW^K^@D5[PWZ?$K_QW;E\S$\Y% M=ES8$[IK"V:A/ALCDNJQ=2\QS`*(G1'*+'FRYXB6C//7A\"=[8<_'P@TSKPK M;G5-WA99C1*%AT00YH/'@'9\N50!^/]6U^BOX))+P6T6^4>P?/$P6.Z]JX6J MHZ:U`!%VU`G0RKODD99&PL\,I>`U^1)I!2?6!,\F[T6YM0')266&AYAPD,6F M6"RY#A@&KQ5VK<4-&B66MJN)[,UR:*.HR[0/=F0,GMTUF58J\'"K0#M/=I,; M0.H0G/+AJ$Z5@1;*2M*G_*/.%/G;B7H%;22W4%"MV&"X:Y(IR;I'IDK(P,%A M4"*D/`Q,KKYATBR//KP3.F@3&7@V?9#4*. MJG,*L40G8&G,QZ/IF\O%Q=7)NQ#R,I?TR)1Q,98&X;J:J6$)",:G,VNPW+UA MDN3&=ZN>=L%+;CO;SZ?-QJW`XI^P,#K*'@;(2]/TQ,%5OL.0_F!8*J%B>/FV*WPV@Q?TU467RU.'UEA,V^SD9?PW'@YHDT M=0#1?SCJS,A"F1=_PI*2S8#?1`\4SLHSN-I#JTQ^@CAS\?G*_)8OCO63A6H, M;`7@3,F,OXO_P:#H"6:,'H_0*;XQ759618,[F/ZJ2F2,VLK]`R]'Q;]B`^\& MZ9NN,4M/KJ1>.D%D69F3V;@N4^W8/(1?#B#]R<\%%!>T.H)_TR**Q*8>CGCU MZ*G5G&;!E684&%#H#'$^>X>"?S!>T)026_G\BF:Q'%-C]8S7N:&9CJEYB'*? MX;XWY@7$8_0-S/9.%Z&R.>'6(&"4`]X_:^B0+3^_I*)*P!H]T8ZV<%1AQ\[, MOBNOVS54?\[#'5S`!XA!''U4[@R[R-;8]L`:DT1>*!\A#:$7J<.Y_K=SZ1#7 M!05EYO1`7"9!;]B&YZJ##N$-!).;BD[<6TE[@Z0:O@T\K@M\L.H.U;`VLNP= M'.+&P@AGMM(">G&YGGSFHIPEGH(7"C0T+(W4)B';KA$N<&EY,/H*)_7!:+(^ MP#<&O;[#MT!5B%#B,66[X\'G^/BF\S=8))F[5#X05[A`@P-LL#FB_'CCKKV\ MO;DVNIGHF?#LG<%NC#:@S/W*(*]R]QB@ZTB9E74JO;!"1V(MN8F$=N3\)+%& MU(CBW().TSMVP.)(%?.$65)!(:H[1OO""8C'#T=AI(QJ:7W;HF7ZAZ^02YE* M]Z/\JI<=>=41#&`^-^0/]N7Y.ERNK&W!0+$X,X@U_T,\Y')&+P<(LCJ?9PX: M<[1W.I7HH<V;:.HZW],Z>WDUUL&H-!1Q\]1J&_&HS?F,8#: MU.*:>W;C'90$X,)#NS,JL.RH>IDZG`7=U/%G-V9$V&4MY/8+\DS1/_,QZ.&J MG#C/BP[]NY3VI))L6';^&Y]#Z.K;<3T%E`'[@D4I9*>GY6;PCNTF775)XJTJ M^OO\UF`_2:TFC"5!=(7N9--L[.,5XNXBVY4?< M4&;U'+G?D1EL3_?9Q_5:,O#:3$_TO5!&7FEG@5EGO1(FX,=:ZG'1J7B5E>-C M)KAFVN&H%\:[P=_C_Y?\@E9S_:M'7[!]KGQW#B*`$_,/>?<@>L4?>!6]K+'O M_3H=(?'`"=>>$LA[]1JS]OJ'>:(8LMZU_]@MV54?LD@DK['*2\F%U&)$F;4I MC>U#EMM1Q,R2+,'?J/+FLCYDB2>Y]-`)^&!\K*NZSO7V7M$ARIR.0W\*6,(U MD*1G%6A$1;G7>GU'$[8I;2B@O,8WA^HT=^5I).IN_D$0VTO5@!\"YCWJG:>O M;)S<$`&E+SY5W'.\\0PVCT/GNH@8)GAKM3O0DS8H>ZR<7 M3NCCEFGIHZ.EKF]@PZOP%R;-^##URC*!`@LYGUU(%2A?Q*/L?)"/:B$)$(T$ M@XWZ?4@S%V?.$+83-?:B7)3FW&KL!!5IA/2%5RGK9(33YW0VK541]JD#N5>. M?\B-%.%7\67-P0,S+,`B7Y^3I*M9EBX3#WC%F)R#>)XG:L>CR40Z,Y$B$%O_ M8@^T'V,I,;H-DDJ\E`IE1HH.W`=C%`5`I&,SOHEO"T/9130L'0_6MFYZP9`I M%Q-U2UN[O>F_1=OF:G11?-KO2'K,C0?;1;FWW=VX_;#J0<*==R2G/8:M<]O2 M>7(7/U=0ZT&X=:>5&W?NE&5M4D^9]R.@W+AW*Q=1-@1XRN3L;,/\\K?39E`: M0*RRF?`F6@\%_O)J01-R-%@ABOXGZ9>)X(,DFFBK-'B_)>_H0H`?GZ/U*Y_D M5")L6Y.(S$)1$;_`X_*>$[#(2D1!(,( MN8"HIO:XB^!\)9Q2ZCG&0GU+:D`H)N! M!\R?1!J;+D8_XT"U_-_\3L+/V!:?*&NG[>7U>DWR??.77V$CH34J"L^G)+"# M%5R7U3*X*!6Y$@0BML:AK\^HE6`"/Q@/CD;??LA;3W737XK_"7`("9I!B27B MS*%QDY@)'.+Z1TAMPJXCBNV$&XZ84E/1A8V:U]$MS!TN0'(J]B#;1,"=?\!6 M7EC^JKH*7;O?VF#MR"K*.CKI8<09!:-/9[-3RQW\NST\6*&1UJ_5\I=3960? MN@1[_V+/Y3$'%KS*5):BM`,00(4". M5=;-3P)0**U(K[?B$R\]D+B]SIZ-&FY##6&7-6T`5Z,%I2$C@+Y1 M0[CYM8@AK;9N>X-5/)N)2K52\!(`4JR-:P"W!L(^U^)]U[%D2MO4I,-?XZ:( MJ]&C3A/6R\E,)N?Y(CNIQ0&%QZZJ71N<=P!G4L^%5=?A'NEYI,43T$[T_/YC M)`[VDA8MZ7[DK9!737KH$'"_/,9JQA63=X3-_%Z,,ZRXRS$2^?7*L*4'6_W6 M-3]_C\\77!F6.;C7`^BG)/(@=0'&2X:L>G+X=6X0Z_S2FLK`TA;<`IP]<8AW MYC4A+AO"_``G.=HZF/Q%I6SLC(_1*&42Z_7W'S:XI7F;#B()1NH,_@XS#]5B M7?=QGS7K<>]];M!V?DU0S1 MMZJRLK*R\IVV`OLI0K?V:6V'L`OXNL$2$F"+Q8;T@?>8]F=YHHO''T+1&&UD M%_+3&^$%QZ:60B4X;'AT"A9-E/2UW(O<8I$P_'"P315<]HZ@DZ""X<\J[DF(L!-G M,`\FO8!ZQ*<.M=8E&)!J>3^TF58W6&D6HPM4`$0#89V[+6/!X*$X47!"_?3T6I`(<40_-S2'\A M[J(VCU5/@9O(]*JS"_"MM!Z7[F-0*"DLUD+!&W<"[MH98N1%#"=& MU<;M<4-1RY;X*!'1;E89_/Z4!K`A>C4L$C=%R$C(+DP7[.$M'BK-U#%*RZ&- M4.+FK&Q"8A%.CYONLE$]2ZFN?\_9[;?"88/ZW MB&N\&X/[^3+/@]*W1V/8PN"GK?E6XG^JOE1RZVIH[6[98.^9C2$:?">MEE^# M2*"X.K`32T77@%])$HV/3>@+41ME@Z6!B*D0QW130:I^<)/$ND]>M]"W2:9# MV=$:`!4M#^!W?(YAXYP@3XK\J#P?Z#JWU#SJ(3Q2>\:UYU`$B1?*BDT MW\'^"R]H?R'D1(K1@HSPN'O>"DT<^X1=$@5F!X=![:3:K3SX24+F!X,7>#_?+[30H`0FH@I/2R*;B=M-P<"\XT&AD@Z+L0.A&NQS\<\#=>S41^C`<<'FXL''LP@HFJMTBNT^%'TSYP'VQC?P&G M>K!@#!?E_I'Z`+\984Y3IY[F`@=D/,8M(/HWS8W!QPQWNXU'!*NP#CXMM>7I MSU822PZ,@Z29S@*4S<6,:[40,')P\9NTCERT!7PORI4:YQ!X$EASOQW?XO8= M@PE^!&>% M&<\):91%3Q"[S"X,9B2VJ.,2`AC"ND'O&3F4%]+B2?V9;((.)SX':A$>#$MK M@5@.VF<;&2/$O/R45M3KP#POC^BJ2ZJMX5QV-6][)=MS5K#&UV4T.*(0160% MY:4D M[AJ*DQB)K?PJ1EZL#X6=5MG!%:VR'E'Q]MQYJLHAHAL\'4*>#5"*`QN$T$"] M-N!3`U`\W#(1>U_CWUO?QD?>D?D\/9%ARM\[6\>'.UTA+[U;BI1N*&B:3 MM:OG1;P27;V1&$S<1^N,]FZ=AMBF2DX*2&?4UV#O?_[\EW_[K__]]^'YQ=^. M/MS__;'\^[__,WDKL1$)Q3J52A@T5UH_;L%R\?B)WHG!XU]\A52\A^1RP#_* M5`[&<)7V__COS!Q/'G^=G<.Y1*UWBGI'RWQZO1-0U`R72+Y%N'YIP/I*&Y$D M\XFJ@^@06-==.F(+5#);$4^;WKO@\J<[+'"3G:[9=EGUGL-TB!##E)YM"&+^ M]T0.!H7=+31U/YYKTPTVKI_US>!!E8>0+HMJ5*\Q4YEU;[PMZB!502]9KWN, MY:/51,H]%"_2#PQOZ[MA]5PZN1E5%V]._+`,=QD,F32FD4[E6XXN@,R(2'C% M MBY#7GS&*7!W)B?+L_.5/?T9&2RZ>KR06;$H_ZP/4QL2NI/7M2.*XXH/2WU!Y MQ09VQ1]XD&)-Z[$[ET@_-:%A)O(12@0,9'RA2\]J>8DG;LS.EGBZK24V/?LP M^(":$J7L$WBL:8(&\DB<'E$45OD7JXC'I_:#`M/*QIX:6>7)UT^R(I2V"%L, MGN:EM$TW9A%6NL'/IK@GQ*XU5$!'$,FR=5.P);D6S79DF6=>A'4/%]W?/\,# MCLPW>$H8?/G0/0#%_B0Q%!8`[?+(`)VS'Y=J_; M]@!!Y&=C9&J?#+9,1>GF]'H`+B.MH-!Q4A3Z9`\^C99UB7"%`<9QX0R50>1A M8403K$SB6M4X[!J)X1)C47H!Y7226-C@?EG/C02ZY/UYX2<=]->V4G//)CI6 M8D/2Z-@"K?69H@/2BL!:AZ4"-(+;/O.T43+.$O;[8J(*.-JOHNB`ES#5PW(L MKS4C]\"1)1:D_#ST!CB)/=9L-2\_%S#3NIG6]\Z/1,$%)NN10,8^8><=79XQ M)D[Y4>D&.-6,'[E_5&DR@J^V$.@N"GD\:/.$/VW]]>O67\47?J"=/?..\H,V M+[JQGR8CD1D/XZI.FW1]0?D1>.YUVE_$9Z!N_5^*YS[Y$96)OQB@:"*+.29K MUF.Y[?XTK`MX@(UV!?GV&3,I8W`;$9=!_);DXC+-"@/#Z.9T/`*X?1X63.UA M]+D)/,\/TI;-%S:U@=(X=$.)Z&;X<#I(70-!;&@CLMCF'*3C"*$NAI`?N(61 M#=2QUDM81?;)9"46TJ9ZV9M%+R"\*)!;SS04WCQ2^'OS#S$H<'=@XJ6D/.N7 MB)NF!SC^\!R5%3067!TRB%NPMR``0G9#'1!F9_';,*_%VQ\=)P!(YJ/3ZR(Q[)E1GP"+9K)\>"1Y3P#Q'*8`OL.]DZ^,C_ M&@O@P4=F)ON7>'GQ`V"M:(9'*&ZAGN$C1`G-/I&.GXWN(>`O'^(IKJ#FG5)J M0GH&+@S.]1)1+".$$0VN4`:OZ:0Z#'<)M&YCBWU/9^#WA/0%=SB$'HD61I1O82"9.%+[;%9ZE/_UG#'MY0L4 ME!7_8,+.VT@YL]&_HG/ES425ITEQZQ$':[DC)U.M.F'E^0=X%SH(J'YR2`[? M0U57?W[[89WC]4#,`KBW96[*J3\+2P%#'_SD\:.#@P,HC1.3P0CA@8$-8*=G M\#8A@$>P77"2:JZT0W3I8+!C3NG])= M710=@E_ZDWV&O"N#]F0/"C=9A06;`FW'H9ZB\`&)#_^2%CGR:]!7W5FUKPAB,GDL'D5Y":I]GL8]TZ>/ MOA5-_`9&BA?.9;PZ!DA-C:G])775*'/NDQA%"F@XB:2CW\BU8I2;<<2%^=-8 MG,/BJ?+Z54Z1Z13@\U.Y4)%0`$`8'BHD,9Q@/+]&B6Q(]5!\0>Q\(A''/#QZ M>8%<4*]S=BZ>G)W6D+A$5/=(JDN\AJXC@L%8-BAB MFN1'T981?.E*8F-\/!'JG/*YZ21R!U M2+S3,;C2HM7+?0_^V$DX[7.>K!#0)Q'RO9A'^Z36R+(],#>YZ^VP;G"]VR?N M/)B6VV-)C@'8%IG>NE.R6"43TD27%UP`W&?1)Q.0_"Y(S0V>=8(:*%KWL3ME MJVC?:Q(*BD/;F]]8RG^5:&_KS*PXII"WY8E]9`RE\7@T)A*FUJ2V&UKR48#6( M.B2IF*@!>3KC<^JQ@]9Y(0!*(3,Z*I"M.1EHE$%RJ.34]1R49Y1M5-?A@ZAR=G3,<<;,D2H?ZSZ].1F>SNC!I=H2 M^%ZA,E7^._?\\]Y:]TQTI=TW25K`,V@A2.=`IR[W#=T]=$,T!);X3`HEL(3* M\C4H5)9<."WEH]520$()"\N#E9%Y8KC`ZOX>V=`-?$S+@?TA2J[!L*K^[$7Z'DL+PPC+H77A1D2`:!)[!<\6R M>2))SWK+4W4DK^6AVN8."W/5PM6@\#RVUIIJ/;#ZW)]&MI@7%AE(G#,\,12' MOWGYJ1$^P>)X+JNR$&+T(X&N+21%;8L:]B!J@I7GXJO79R_UE0JW@+CZQ=KP M8$L$W(A+@K;LSX2`A%L73R1Y[G=T)#%$;6C3S@\XK=\2"9:>GWD M`_(?#>X0J8`#6:(N8N!.2N;JAE5G-?!B.R[,399&XP.W&2D6@P][;@=2``S@ M`9`M53XL^;)70]T(X M)LJP?OX)18%AA$A_I7,0I0/H^V(*(YQ(>A*6`5#2X.4%GWN2G/'OGR2EZ,3; M6#A@`D&+J3<++OIV3)%:'F%-KW`YBV:!#.DGW,O:A!T M)PBR@AE,:$Q6_"FZLDAE!@:.WK-$#SVP@!H!O3-I$*OQO@0&Q>>9/OH]&[BA MW>*=]'33-K/H%2AYGUPC.!NTQ4+E'/E$7D$ M]S()(QL^C)?O4?*,AY#B'4T+0!<_Y&^3CPGQN M_+HDEI)\*D&BC!5-JSZS'T0,A'@-P%Z?F;).,2`H&)Q-$.ZY#/8Z_H0[P^7B M)9!CA^!<-@JG5?SN;O$P_3BZFXSL;E%_O9!A8[((XPFC738Q#5,?C7C3AWC4 M(:X\'YH+U.1BRB4]V3;#05CTY3^O2.=P8RP3S@3:0O60Y7($5]H84 MS^]P/;^%S+2`70R2T]T,;1,2WWT,Z"63O7!985E$'QC3L[9Z%),`Q^]G>.N4 M$(O(/?G.QN43'[3:W8,+@O+PTGY1'&5J8\0P1T>"_8;4S_JV>`W$/H=+`6M- M//ZL\NJC`KZR+V?\EEE="$=!?&L?5!:0!*SM%#/OXEXB)AY\F<_9$.YU(-46 M#Q(!4^HTFCR1)*%#\D0TV^/@ZRS6M[R]-A[);(8;W#LD1_$9S+2TL?PRE)F2 MRU@<'"2)L/9C^)VA$%LD]&Z,&,6>&$FH#F<0E*F^8+8`$ABU(9R\#8B@I?51_E'2D/E-8`,Z%$++7F M#R&]W>**4K"PO83P#SQ%H'<\!X@#].66V_:^\]7%CLIW]F#2+'W`<3+DQ5<)$6W>WX1H1\?S5BO&\!$L'SX#70SU/1\D[. M>Y[Q$SNC08-ZPYV_F2S?8V>W:,APRVI8^-`E=,E"X#_##Q^0;0]6!(GW%7H? M2'(6X_EVL$/O5A=T(2OFHRDB*F0M.(Z7;:./%Z,[X$5+05DT MMS*)W1;NLFR3#=F*`M46]@H=8Z(&&\/5XAUE`/.L6_165_%18-T[N3P_]_&= M\73`Y@W%.'BO\%B);^0-_H$:%[AY[\=(8""[=E/:!RV>QH8:]4)79M`F6SG4 M)M()K$2D;UG3]@8&VX>0*VU1KV:*":1RD*==H4\8WEN;7+%"'U1*PFV3UM_1 M+9"/X_9:WT3OI]Z85B"?'!P\;8@JVLO''F=\W-N$M"+^8IO+Q<]@(9YR"TNF M;\4*9I4Y.\?&^#S$"T#3E!S#KEF,ARL0<&6_>,Z*(&X!(8XXK7PL=4GS_'R; MR\$V\W8L%=*T[(CGL2T`7,$HYH^#4GW](76_%)OPN2V@QCF!Q48-@PA3#"4- M!'8GI@>0U\&'L@L1RE":D>"=IA9?"?E,'B3$E87*32@>'AG%T'S74`Q-+)?H M8&JH]<0-%<%TMTN6E2U_`.8Z7ZH9`1EV-'C6NWIK08DO MT.?$5QME^%?./#LQH/8*N=+(]E521MCYN6,A8$_:9H$*JMCH]T2W2,Q+KI[Q M+_.)K(?OWJ$^%K@N7>N)T0JR@QYL,J_6)$9;@5P6Y6[.@UG-Q@*5J+>>G).? MK#SY>?E-%;"MM.1V:R.$_:L2TXE?#$V+X^K;(GS*PPK7@>U!GLX`"L@T?^RR M.LM)MXUKVZ+/NC/.>?8VO"`MTE3GXRU0.`IU#<>W>'6F>&00`P/K%HU/-_!T M2"D=#G)&GWAO]UVXMQ:C)/Y>\!$%=^M`4\7/V\I1>A8G(IT=H!GDGS2?$!O7$!USWGA<61K1$ M9:TW+0P^X$+K01FO#:D:XAC\^'A0RQ#Z8$X*;Z]@O)RC%QA><]S"<]OP4>S^ MA=Y59Y34VBY_V$J6OE+TV(#QO10C%=QG_VV';ZUZ]0Q;J8`C-ZH,$56&%;U3 MICW!&-UO;_!OTYU`0I3X-^1&Q2=6@4HJA_`=OYN/[A$7`O(VWC!B%"8R!E00 M@$99:H/2@E=S@QG+2*C8"0.,'8/UIPX#8`%0SWE'Y0IIT""980[JQ43:56I9 MO$\$80;I7",NT"P5P3$C]"EG6R[RL_A\(%6P_YD8)N]-4XGY&($P=XGRY2OR M?'0/QER'Q[-JL02P`05]B8N7K[]-<"L^\TO#3W>_O[JO6'!:+NKMSDAQ"BG# M,((B6D7%,&Y9/,[..QC#$4:(2[3:"J$N6DW]7_^C$?]S!QZ3H-@6N1?&+AU` M!B.$+"TG?]3WV(MFILUSUB(TN4N(5' M3_PU:EWO$LI"AWX2R(1#108D[1N4]Z\1D07^P7GISV4)ESK7;TZH1K.3&-3,N:I!8_-56584V):64[*PDLU5-;P."LR6["^1MA2+2NC,.W M"(&18GOJY<'V-"$-R+Y4[_KG6%\JI%5#H'>@V!&\B])JA[=I`5YIUJ;B$O=I MNH@G-W]X=CP\C-%8"P6"?X(V#>#T'Y1=,-3#]#4OW&4M^0VI!#WLX]519')Q M,Y^H?4?D651.PK5B4EF14>)&+%:LR?TMHLG@;B[)??5;$VFK8/M8ZMDEYW.]&:$]KJNXF M(T/^^F5,#F'0??*C+1N&RK10.VY&X+?VY*&)29?XAZ#XZ2=&(GP[6]`]ZSZ, M%^R/K;:S<9Y,GU("8)LQ<\;DO6#4"TW:4,Q);L\U[)F\)X:Q9=_QIZX['X39 M:]9DQ?O$A;0_7^`]XA5J;[:8F\KGHHEL#[![37G%+HENA6CCZO+)`+LA6V'D\R'Z`Q0+"(ZK!51&N$`/A MU.=XHC.1*_NP+_1,=!1B"R01]LLE%!18'&X<]/AUOF2GZI*JU'^B+A&4;0"$ M.$0$A=XI+:Z?3Q'./[SSCR@]&]Y<'#06KQN=]P6Y=*][Q$+&>#::(V1\$$/N M`ST(UB/(G2WH`-?KWAHZQ&ZD+?4\VJE0+:1^-A#>]=JH]Y`^#UXUG^IF7"(0 M%==TBVBO]$(Y]O"E2MX;>0!-"_;D&=-"[H42\/JC%H]/1I[-/J)XO,8:/XV/ MY?GXVG5V3][5,)DM'VM<"D06@$I;40P=Y(.?=T4&;<]HCN#8W1QADPMT+H;* M9=EDMJ(]GKOQW0HF;2C^,7Z]O.Q8[C%[9(/GQI]&+;<#?\MJX*_1%05B MK64%B! MC)8+*LS&!A2BU$IR\0H(ZUJ@ZP6?D!,<:T/DXT:GQBQ:&G\Q>8LFIV`I]@.` M\;K;>-Y^^+IM>/#':1)>$27QS@(H'"WV`_+;R?[5&$ENN>'N-_H(1K1X/IM] MP>#Z&X>)&*#3R2TL_WCG?PX3.',%**A=S>[%7@IM?.1]#?XL3T?7,[RSTMY7 MIB]GK^AQ`Q)($*M[^7BZDB`]_`+1"I2Z(M6J9=$(KKS),:#_.$%`0!#5"6A\ MCUHGZ)7UQWA\/+^](]1XX6'8G[(U*>\0REEJU3(Y^8R[\-5B_'8U!31I[TA+ M].'%10E9B&;D:,`*;C&"[6-8CL:0$L9>\`XHY'0Z>P#'N$/[NJE5A1-2Z#'? M$4QE'V8PC0>,UBX73Z/V&CFW5?-2K@55>;H^0&E8%([JE6A5A]?7MXOH*"?P^A%VDPP+DGD+7(.5IM)`EC\1KNLJVUA#E\G^423O=K=JK#[>>2 M"Y`)FN'-[-T=79^#X2VX*VH(B`5)69M[+-0MZ&W=`PE>&B-9 M)_N>,8/2V[OSI+.-/5&!TQ*:=M?`<@7CPU<5)>!@FH32`XI!C(=([PUZ";BW M73S>Z&/3>KH8Z]3*M.JVDJQIXZN>?)D/6='G*>%ECFZP;,766/LZ:N2]R<"* M,XLW^G4^<[:C._AZ2(4:^]%V[6F4K\%TAS>3\1\\C3@\QO`ZK1KL?+`'-NUK MN/_,9/^HOB0DI_%EN$?Q--8H8&D.$/3C`YD0_GX35,APZV$9J6%J489T;9XQ M,.D8`1!@U)V#-\_??W=''?X!0X:.\=?.FU\C5:[UR,'=_B`I+*6[^5M(T7>@ MIN'=^Y'V,!]NA9+GB()'=B*U'[Q9OQ=<:@P`C/I0.6-LXF]5<^$:D^M<:-_VQ8VF/O\X& MS#D,!(*+R?<$(=57RG=7M&#X$KH&*W=LQ@D\7PRAW9**S6C7);[`;_*-XEP>ZJR%#9:ST%>84%YJM_(00'1TAQI4DB_G;Q['T.PT5*F`PM)6BVF M'4>TSG:"-2R^=[4'.__@$D$N6UVD?":GLT];7URF(,"+[[8,MR# MAC]TEV2OG,E%5,7[,.)=8+71U//XN]["=?!R!YY):_T4)Q[LB1,DGZ.@3'+H MFBY$I7@L%A\<:FBBQ+-CD$5WC7Z<3X`MFI@[S;UF;/WEVD?!*M:C+A7?R>`Q4?V-@*U.R5F?6 MD]_BQ`^7ZC06.PCHB5MGM!?$(!66EU)A.]X/ M6):K0C\!F)J:;3>PH/,IBX<6'5Y3$]FXY8X_$MK.92[HT3RC6A%(G( M*=9]5/'6?X/OS4=PN8%(NPO0G8F_=?MN/GIE@T?$\UY*D:WJ4R!2BMU)Q$Z7 M>T&$\"_R%4-6S964?$\4OD-E";"5T36-8^3Y>ZUK636Z-;WE\?]?[+1YX3X[ M95CU=W1+9SCKL=F$F]Z';J<*:>E'=]86R,WW^V,X1LI5[E(Z`:$0$OBY:"L/ M5!NZ0HJ9FV"<0MJ!&`)$IKR:A<8FB>-F*U$P?$MTHEFHY<61M5J[@B\R!JOD MF:'QH7Y-->>`)>YD4:WG9'6SW!.&I"-8)3LE:T+:'TG2- M'6S$$@V,=1\G2$P=O/PDH5`O84)*_>$[.(&P'#:;<5D8>.41<&M)7*-=M M^X#[+KJ=K8IW`G;,V=NW6]]18>[M`.YY*41N:R0.&&E/[F)G,%8ZV*@&Y3.@Y=?C!ZH_VIO[,U-%>>W=;#QO MO+*.&`K%J2&KW[7O9S'<%)X*+/4#*!36?$A@8#LT06B[1,HZ,#S35/DA.B3# M:89$&A\0CX=W]SC8^D$P0AZ%[R<(];Z!%_$413%0[UY5;&H["^UHA]LYMYHM5JRTQA[]S;`%@7NQ MQ8KC:UVA8E,U2YQ?2%+Y\=9I;[C>S.L<1&ZE':*G8NHU=M$="]?-SW>R[&ZV M6Q'9V+W??J)%Q9+;E!@JEJM`;;\M=J.LAB>8H+.RR6P-.NN&K-].VT^J8I?M M$ZRQP_8)^^VN@C`JME@QRQK[K)BUWV9WYUYHNJWA3(;CN36)I9AK:CS6XB)F M>9)'*(F*0B+210)-<$1I"F(8Z,V&J9(Q-.RNL08<;5Z/**C7BAVQZ+X[O&:, ML_3=T`V8RP"A1MG71=AT"^=FM=O^47F#=]^,?1)>OH6>J'!2J%P/X8G[]5EN8(OTUS(9&>BTR]]68V M8\^?KS=\=ZP*Y;>0M4C;/#;/4B0?T$PM6QIGS[Z%@8T028/E)%B2,0.J<@%4 M)::TS37BT_TQ(+&-=!G)-=%"IE(7G8%::1M5!$-JY\=>(5'L;XNRC@ABFDTG MJ$N`\_YN-D&NXVL\UGB&?4F#&&O&]?=">S+Z*@BHU"XNU_>3>P:#F=)7\6C% M>?WJ76#B945F'W/+G:A!SX$-F,N7CO"#8C$%(@_B>DWZY"DSA(?+\8=%TCKT M\/O9_&X?Q2!09<:;=S_?9IO"U%X>G-*=\MMO3N,P6(L%[2&UT))Z?_KS8"R= MGV(L7+V\.CP=G`X/CX:GPZOAR>5`R_*].'EQ=')QZ4:?_.;5\.IW\6@E&';N MM`H_PIY73',%W9.C6!Z-79'F3):5J\BQ[?D&K3?6E;RQP"Y M3!;?IW&Z4L$F+/,0OA'Y[7(B]U6\Y71-5V@/K77BKS=%.$[*7W\;VL:0]T;U M48WPY?F1RVD*"O^5"<\>[%ED9K#G-IV$*J,]!DK\SE;@1.XC//ZZL"Y8>O93 MA+6>N@/O)B3!&*\%>!22[&E7SI!#67%GJ%^*QWS:&R.9<3T@1P&Z9-D^8+^X M^37R#A"^;/=5>9"Y<3W`S@WO`W8-K?4`I\_2>HO9*L-Z(ED=ZD'S'%$>3`H$ M."99JAC5P&:+DM2*!QJ%3TP/69?<&I/[^6S*LEP(3'?''G]2W!OR M/*3XND28PU5UM]`]QQ,XE"*JB"'QK!F@)LFB-F+1@"%K MSA9EG>C$:G/6`/%#CY`1B[J1"[3)@.F#494QA+H@:[U>CJ=2,GKPFQ5@0]_O MAT`P/V9IJ3TGO*,Q?%=)JLTG;CMNQS-)6S:[KT'5FO5`^Q:;NM:E)>3&(\!`"H37S>"K)JIY ML;5EX^9'W9OZ\H)W/Q(N5Y\S)('`Q@;I)'<'HH7]`-9%I,X\G\\^4(I(:PQ++N*G+3:K9L/MQ\7\%$:P'/1)XGF[!! MOH0+-`B18B>42VVHL/#1*7B`-W-X3:CX,IY<#89GSUZ^.,'-/[P<3X=295Y<( MRU]"O6(I'I:.23-4><#F:C%.Z@'5&POZ*%FB*@I8HFST^ M5(I*[!3]WSO+YXS(Y>Z2R\>U-9JS:''VVV]FOIU]4+K]^L6Q!S^:_M'RW-5P M#DQWZ^TL]VDU_//'S<7-<'`,#'=GV)YKKH:OYG'X]=TO?W%[#%YM\\.S M:08#,.$>5\/G(#B\&8V.VV?3,8Z7WL%TX2][SW>,`%[Z3Z/CP3>-W9'=Y-BC MZ7A\-7(,RQU&%MXX6QDCCN%_.ATNMIYS,`+KT;*MX#6T-1PXVS??/+F>;SS: M`/5E,C>VB>WP1VMKYE$N1\L16+J[=4_.Q@F.@ZUW M&D1_^6:W&EX-!U&7U]X.0/SF7R61W$/[F[WGHLZ<@TT,;;>?'*] MG]P-^QL$`W2/O>WN]OCSX$?#ABL3!F_KV9X_",#+T+_PBFLX9O2.M6%;C[[% MWK8W',M^C2Y/V84P,.+W.1:XB5T<12VTV\XC0Y/TZ8;!('V:L2NX3PYTR6`7 MR_MD_+.@3Z2MA;BM.OR1ML)>E/=+6UOYN,AQ6*>MU%>H'?_I<37<;$!#)N,Q MHQ4[K*'&ENLQM-=:8U>+UGHVV\PVUUI[1F(Q[S?6X&RCDTI!@YNWU^]:HU-_ M8[S>Q3+<5@:PA-/+H@6I6Y+?UQOVTT:&_^-/C>\3O/O)-UXGT[!\E+OAZ-G6CJ%X M6H?E>EPNK:\>-NN'L%V$3!8%Q^AFL[YNP.C#_7*M'^EZN=1M=+J!'\U&WR[8 MCV:C&_C?6ANG\1`RUP4RM3<(+#:]'E]>+Y?+F\G5SC(JV%1J=&KL!K8 ML5<1@HZ\BA!TY-5P75*C5V$1N6.O(@0=>14AZ,BKVHK/6(&7G7L5(>C(JPA! MVUY-IE7KAX=-N$J5K\RTU<=Q6^]F[(<5W2IMA;-&F*<^>OX.UH;2+:PKF"-& MU^YN;7,?@%G?>GIF_P;>@37B!0'LC=W=[BSCR7,-&WX=)78>./F:;!;)] M1'?(]1'=(-E'=(=L'R%UBI(K87+GG6#C^MS!F\W->!RMB,JV4VX0`2^(F&(0 MZ)X\G\);"A@5WJ/:5]"77&[<3]E/N#Y1T%/!'?E^"FXHZ*7@#MD^TKA)O$N, MITL73)X+D)SQ3=Y>#08T%-V8X#D3P5B?V'Y1M&,D+7>TN[EVSKJBJQWI;B!V M`9O:L%BE$>E[9/TH;1`E#?04^BU])^)(^IY^PI=PL70/EF M5$F2-ISA3X-)^EY54-`"4GH5SS4&2=IP`4_0G:(A.I["PHQX:]KV!S9'_>L^ MG1;#3M/=['<&$<['LC"([XW<^-=H"AR]@+9X-TVY-PV,P\%^?7]R M'DU_$QZ6#9L(K[)MX^S5?3AWSUZ')SX<,]PK&T9FOO.]P-P&X6'><*>>AV?& MP3.)#N8`PC/+A#`2F:"``(T0P!P2J*B3AY,D)I!#&1-0OM- M-0D:D_22--E@+WGR"^V7]')#Y+<6S4AO(=`SFN%%"8!:3?(DMBN)06Z'3,LH M@!X*,D!UA`#R=9$56)TS( MB-$B#0A"5PJ)HF':E41B#%UI9.:*:5<2B2!TI9#8$UU)),;0E48B5W0ED0@" M,-*)0F)/="61&$-7&IFY8M:51"((72DD\L2L88D#9\^W M?H99)GO"?0L73'_(/A$AL+;XRD^^PY6U@1+LR?!09=W!8&B!`#B\BN,82K&UV#8/Z.,6@/0TUI M"J-D`E$Z.G7'"Z:)X8D7G>$R*2(JJ9DP6%'CT@1PM;/=UFHH$9LY=<8S/+2E MMW&<"^Q0B>((`56:5B[JP='NFGIP)KK94P-C%*OCXC(Q7$]/7G&E+H=3K2I# M427`7!M=>`JBNB0T#4]2L%!AU[W#/P=*"_,&C?:81;A"3=2$G,0E`>*$NQ%+2*XN2XV8J;B(>-V1HJ#ZD5?9ZZW`_ M2WH+E8]7,;04IY*C'"=,"4CXV,6S;*(E0I-Q*9/L>7PR95P7`&Q?P@6`J()_KO"$,S:I-,U1U= M488!;/)V=1M=7JA2PU3I7]W=2-:F*!GSY3(-NHQM`1H4:^%K83ZJ#CI=X<+W2$(CCO(H0<#>8M`4Z1B@U''`AZ>"(CT"N@,UA MZ&\!R^6Q$==J#;X,65G:LHTF):WM>:#S>"')W7Z MCY^)>IQ)9_3#`WYG\*L=4&N&7'B4Y0Q=R3GK'@8'[)Y^SOC9&-%__%,0E"2Z MB3"S!\;*X/.\?X#XQS%L$HA3G)$5F$:A5XJ7ZD4_-S[,?K&ZA M.=J[?D#\)&N++4]LTQF1^`'QGA7+W-D%D$G=35;ZI*!#2/KZ[+"4*1QZ49['4`Z@'74#JK@.-J^02V),ND M1MJ/6`N32*NAY5S`[///^P[X3,US&WETN.Q('#'#9X!S.UT]!RP2HQXP3,23 M?:-#8S&L1Q8$(5!+%K0@%/F\-82XZB1>AA=E3N:N'&`EC:?#30AI(Y-,R1J( M-WNG.I0C4&;V3G-=BN0\Z(I[1\3]^<4'JJ*5`E1V>020[`LFQ91?$4)*95MX MI^P3Q8O6\W/A0/FLZ.KJLS0!'LH>%UV-U,;*<^;9W-8'Y8IBD_9L#:S8JQ2K M'AJQ:.;SN;J3&\J1.DRRW$Z.R,+!\\?T`;>&L-:C%CL>D&=H!7[G)HQ*]5"2 M(8+F*V:("CA^`:Z$C4M4SF^B+-#NJAP"I0,D&$[_)*-U[ZEQ!R%4+!(-Q19! MIU`^81H!6GUY*(^Y%)G$WBJBL$UD:GNK[2>&`H58?@F%7BR!8**)0C&J\PHS8(F M=DEJ4D@`BAB4GMCTD#,M:=K(ZGZ]Z15Q8"-'2-3QM7R,2D7B"%WY$XUT6E\I MWN/-FGZ!JB=]00CQEEE^&(4=&3B8BHB*Q.0,OK";^&%[]V-OH#W0_!JF\?!UCNQ M#U^;3^%;;M-OZ1VXAF.NAM/QKP<7@[=;9C1-$!8.CR?+#BR7?5(Y^P;E[>D8 M>,Y]=#'^RMLR6^F!!%:.8ELP"JG:2J<$4ZB]L2W8,5:UE0Z",^@ML@7D*-M* M1X,9^\[SC*\Y1(DJKO1)[!GE?B')_;S(CTRK$2[691E2W%\5^I'&*OLJ M;QEF0XBJQD7J-1/I.,\LA*YB\:WW/)^(ZL M9)X">ZA'<_B#?(]2'\THNW-)=N^-75(\T(!AXXP,C+5A;T^V$5B>FQAB3W&B M#K$E02E+S^;VTV!MVG9JB.8#&T9E##V\'&S#-0+/?QVP;Z=/S5&G+R3-_=[S M4HZH!;81)0/H#Z:QL]RG`?`2U6DTAMF'O*B827.!TL.6.57,P-T1&AI_[`R: MBAFX.S)#19753S)FOG$/I]1#5$O9T"UCXEO+_63N:.10AMFL6L;2>_,4^$8: M?S2EII+$O/=\)[-!)6(\A&G(>D'6=!22&(6GC+X;OLFPAJ7L6HYP>A:5_5/'?W>Y> M]FG='_(>&(^V2><#0-3.W!LG._B8_G$US'[_H[FS3@X$4_RN[ZP?O2`TL1IF MOW]K/3T'D,7@6Y";;X]!^._@Y%NKX;\?[J^7[QXVTXN;\?W-Q7QF+BZ6B_MW M%XOY^O[=N\UR/!VO_P/N=VSW^.9E,E\-GX/@\&8T.FZ?3<.WCZX MW'K.R-OOK:TY.AY\$)7CLVD&CCV:CL?+T7+D&)8+\QLP\N9HP[O\N+,Q^`_9 MM=40O8C@,_0C@!_]-^S$Z,@F3Q]8(W?_%0```/__`P!02P,$%``&``@````A M`''6$('E!0``'QP``!H```!X;"]W;W)KRY)\D1?K#2(-TA9H@:+HY5DKCVTAEF5(VFSR]^6(6@_) M<2SM/B1K[AGZD(?FL3V/'[]5)^^K;MJR/F_]<#;W/7TNZEUY/FS]?_[^_"'Q MO;;+S[O\5)_UUO^N6__CT\\_/;[6S9?VJ'7G089SN_6/77=Y"(*V..HJ;V?U M19_A+_NZJ?(.'C:'H+TT.M_UAZI3$,WGJZ#*R[./&1Z:*3GJ_;XLM*J+ETJ? M.TS2Z%/>`?_V6%[:MVQ5,25=E3=?7BX?BKJZ0(KG\E1VW_NDOE<5#[\=SG63 M/Y^@[F_A(B_>6_.ZUQ_KUEZ;<_5Z>-70;=#(*/-?U%P/];6="<#AP M3G_N%?BS\79ZG[^3AV(/<2*C*%/>R^*]T6T%%(,XN6)E-1GX`` M_.M5I1D-Z$C^K?__M=QUQZT?KV;+]3P.`>X]Z[;[7)J4OE>\M%U=_8>@<$B% M2:(AR0+8#W^/9E&R#)>K\2P!,NH+5'F7/STV]:L'4P//V5YR,X/A`V0VE:V! M$_*XUOJC4J%&D^23R;+U8=SA>`OZ?'T*DW7\&'R%IA8#*+T!XHCL#6$Z:/(J M$@B`\)4U](*ROJW#&SD#-N3>LJ88@-Q7MI$@<@.1<(AR(6L+861C3M:T.(81 MO$_:'-KZ\"17CM#1!>>0(FAQK2R3`44"C!-(/;V!!@R<.9>EX((@PD4&%`DP M+C!NT[D8L-.7E>""H'`3]Z,XG\56F7ZN,@D(-SR#N@-@W%><^S1MS2&GAC5G MD"*(]%,&%`DP3FO.Z?Z<&?"HM@@B7&1`D0#C8AR0K)?[7`S8Z8O4%D%6VRB9 MLQ^Q=3*)#Q<,/@]YW]5T/"MTPPN=-@CFD%.PF-440:3Y,J!(@'$*8>3QR'$[2]VH)R'`64'8B$0F8.(Q.Y2+B+9L!^K":_' MF`"I9YKJ(5J'J$MLH'1`T4;C.1M1%,.)F;U/B-U_W87H$B,+?D#9I\^GHEDTEXA-%.J"(TDY$T0@G!F,T7>G(H$>-?$!10GC.1A3%<$+&,2:/7F30 MXTHCRBHMEW4VY+$(N?#5/00O0/C11*EO^5)BIZD?R#1"E.UCYD04C7!BPF?N MOZC-!_\)4DLWR89SEJ*B$4[H7?X2H4_PM>>L\P%%A!3O?C(7(5:GNH?@!0@_ MFBCU+5]*Y`?P"%&VCYD3433"B0EC&9$:C6%D?T?2/C(GHFB$$S*+??JK&FU@ M3&I$6:G=5[5$A&)WJLA!_-#]63WF6Y;I]?1HN:42\5$A'5!$<2>B:(03$@9S M7_$8C65$\0%%">$Y&U$4PPF9E3]9\1@-8D3Q`6457TO'=A#+-?NTM9$&_HX# MO#QC*=/+0P/BY26"2QHCRG8W)<]Q;?L*1'SF0XH*C&>LQ%%,9R0 ML)L1B=%`QB1V;":6$44CG-"[;`:N42:\5QM05F+Y,LDUW7W]@">.+A>[3W]#P``__\#`%!+`P04``8`"````"$`"G`-)N<"```+ M"```&@```'AL+W=O&ULE%7);MLP$+T7Z#\0 MO$>;=\%R$%M(6Z`%BJ++F:8HB8@D"B0=)W_?H6BI6IRE/MCF\/'QS9O1:'O[ M5!;HD4G%115AW_$P8A45":^R"/_Z>7^SQDAI4B6D$!6+\#-3^';W\%$5 MM@RA?`^'2%-.62SHJ625MB22%42#?I7S6K5L)7T/74GDPZF^H:*L@>+("ZZ? M&U*,2AI^R2HAR;&`O)_\.:$M=[.8T)><2J%$JAV@//;\[.JO?.45`[.A3*8`1R$>#/1+8D)P MV)V6I^SSS1>81G2V>Q\F8^P-&1*7W/#25&]*2T*/]8D'^ALB3!A60. MZB_[@1.L%_YB^3:+:Q4U"<9$D]U6BC."IH$[54U,"_HA,+>961U=KB^E"CD: MDCO#$F'H=LA"07D>=_YZN=ZZCV`JO8#V5T!#Q*%%&`<-;VP#C0\N".Y4@Q=] MU=?KT(HS8".N9=W;`'!W:H.1D"N(43;Q%++Z!QF(G0W%&HOG+S9/*]H<@C;I M:01'-T.9>PN:=YD=QH&X%QAH@E+W#32:9O!8O&ZD.11A2+SSS5^OO)$F"YHW M33`;[AU>V8NO[PU$@VG_+]HX&!IN54T]O%-8?>+*X% M]32-`W$O,-"T&FIZO:@&//%G]#SL+@[,K:&#APG"7VT&GR$>IK6Y MMLG.:K?#U\ZFDLF,'5A1*$3%R0S6`"[NHMW,OPM,ZX_B>S^$00)QM]N`65R3 MC'TC,N.50@5+@=)S5E!4::>Y76A1-Q/Q*#1,X>9O#B]=!J/(XWO_@(``/__`P!02P,$%``&``@````A`'-[.G_O`@``@@@``!H```!X;"]W M;W)K*]$`BY*J1JJ+I; M:5=:K?;R[!@#5@$CVVG:O]^QG;"8)&WZD@3/F3-GQL-,5KJ9",-XD7 M^B,/T8;PC#5%XOW^]7`S]Y!4N,EPQ1N:>*]4>K?KSY]6>RZ>9$FI0L#0R,0K ME6J702!)26LL?=[2!BPY%S56\"B*0+:"XLPXU540C4;3H,:L\2S#4ES#P?.< M$7K/R:ZFC;(D@E98@7Y9LE8>V6IR#5V-Q=.NO2&\;H%BRRJF7@VIAVJR?"P: M+O"V@KQ?PAB3([=Y.*&O&1%<\ESY0!=8H:>'?A M,EUXP7IEZO.'T;WL_4:RY/LO@F7?6$.AV'!-^@*VG#]IZ&.FC\`Y./%^,!?P M0Z",YGA7J9]\_Y6RHE1PVQ-(2.>US%[OJ2104*#QHXEF(KP"`?"):J8[`PJ" M7\SWGF6J3+SQU)_,1N,0X&A+I7I@FM)#9"<5K_]:4'B@LB31@60,Z@_VR(_F MDW`R?9\EL(I,@O=8X?5*\#V"IH&8LL6Z!<,E,.O,9AARC'SUT[`A-Z!(P$:XOKL-7B0/0RK06@+FIK>B0:ZT@M&1]+T M(Y(TV)4TC\.!(HN);3>[MO2\S=$S^X@>#7;UQ,/.M!`K)QI4+[U@=`3IU=-[ ML=_N6`UV!4''#J)N+.B"I`M&1]+"E71=)VNG$VG#:EG0H9T&NF$Q:(83HY5F M9[X=B345!4UI54E$^$[/\PC:H3NUJV83+F%LP(P?G*>P@LQYT!E@!;2XH-^Q M*%@C445SH!SY>KX*NT3L@^*MF5-;KF#XFY\E['H*`VGD`SCG7!T?])KJ_CVL M_P$``/__`P!02P,$%``&``@````A`,B?-&#=`@``8P@``!D```!X;"]W;W)K M&ULE%9=;YLP%'V?M/^`_%[`@02(0JI65;=)FS1- M^WAVC`E6`2/;:=I_OVL[H4":-LU#@I-SS[GGWFL[J^NGIO8>F51F8*7:\_?UKMA7Q0%6/:`X96Y:C2NEL& M@:(5:XCR1<=:^*44LB$:EG(;J$XR4MB@I@YF8;@(&L);Y!B6\A(.49:NHY"[(`F-:K@H,#4W9/LC)'-WAYBS$* MUBM;H+^<[=7@V5.5V'^1O/C.6P;5ACZ9#FR$>##0;X7Y"H*#D^A[VX&?TBM8 M27:U_B7V7QG?5AK:/0='QMBR>+YCBD)%@<:?S0T3%34D`.]>P\UH0$7(D_W< M\T)7.8H6_CP)(PQP;\.4ON>&$GETI[1H_CF0==23S`XD\'D@P7,_GLV3]`*6 MP&5D#=X13=8K*?8>3`UHJHZ8&<1+8+;.PK/6P),)NC%1-A:R5M"/QS5.TF@5 M/$(1Z0%T^PIHAG$/"B"#/@V0'J;Q>F&/Z@8\48^314]L4[Q]!;1(TAXT4H\^ MHF[`.0+Z%^\X2WIBI^Y`L9VJH<]XK&3*G<$XONW7!,'(#!63-)XH.M"I(O3R M\LH:\-A;"Q M:I)E$U6'<:KQ&:OFE)]LH>C=GIJ@L7B*IQO(89SXU5G/V5C^[5$RX(EL.*VT MPSC9A?^2U*B_&!P.7;\M:]%CW5GT4D[7X0/HT.+43\+AZUP>DP/LG3S[B2X24R1SDZXNR;<*=J1+?M!Y):WRJM9"=LY]!/8(=)=$FZA16>/JXW0 M<+C;QPHN@#N!1"'Q?F&NK_'JS_`P``__\#`%!+`P04``8`"````"$` MWS_>RD$#``#2"@``&0```'AL+W=O]7VG=`W!ZN0)F,Y;78K]\_OAYN9ZPB)FQQ7K"$K M]XT(]W;]]Y/_?!:;W,*>Q`A=WAI%BY=VBQ09'KKY==@/Y2$;I_D/ MVA"(-N1)96#+V+.2/N;J$4SV3V8_=!GXR9V<%'A?R5_L\)W072DAW3'L2&UL MD;_=$Y%!1,'&"V/EE+$*`."_4U-5&A`1_-I=#S27YDZV5Y(5O_3(M1;:9.P-X%K;X)B;Q+&R>P:EZAW@>O1!0S/(_AZ.UUT[K'$ MZR5G!P=*#H!%BU4!HP48=F$)(;H?QP4"HB;=J5G=7-BR@&2^K!'L8>F_0`:R M7I1^(`J1)=H<12IW@/3.!3L:#!P;"Y!0!!:-5?F@6L!L,LM!BT M:,`P>&`PP'+#,)S/E!*;VT_FB;6RULQU64T]%`S_[/K1X@[3H)I>0Z7$-I55 M&:G63#25-S>9-V.C!E-R#9,2VTS6JJG6]$P6\.8X:+]9ZHLV>.//YTN)38I9 M8*4@U1I-$7C6Z&9LU(C,_!HF);:9[.K5<4>K&5K;%1@PG!NWQYH#JU215& MUKII+^H3%EA48Z,FE=6PSZQ]O'[M^K]#BK= MQQ+``TB7[5W@G,_GXYTBR[$JEN22E#CY]KN',R!F]1];@)@+6_FY9SA@/UP+ MZ`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`-M+CPWF>T=N-1&-^6*N, MW/ZPN7[]/0F9?CSFLQAM_NX.;0Z-GOYP?%3?>S42D_EJ5GG9_'!W[>[ M_&=PXC.=M7SRW^"MH=63W\X7,;V&9=Q6`VVJU8_X]LR MK1R/W][I#\?K^>X5[K`R;(U>?W=FMH=N3W\X7,XS?J*VAVY?K7_`SZT/K^;% M_W$OL=]\??/+3Y\__?5"MFAI]9<_WTP;_N;'Z8R'761>\Y_VE?]K6Y']9#K+ M?CK-X\EDQ_@BN^&_?]G<[JY^>O5OV<#>+D4/)XJVFXU99,U%\CTZGNGJ>FL6 MV8>B:5>;OKZCP=7@:?`U!!I"#=$,\L_CM5WO[LUKBP]'K8JNKM6W(CD4'1Y` M>H#54>9YLT/%X9!<0W&`U3GP_2T/18?35!IJ#8V&5D.GH=313=FD<4B'6Q6R/,HE3"'1>IJ7%9LKN]>FU?CL6A[9Y;X+)'SJ`8$)XO4 M`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`XBC"WM?+PWYY>`FNH-30:6@V=AE[#H&'4L-]#T,8]^KA?-])(E0RL MOB-54[5.U;U:#1[FHE6J--@:'`VN!D^#KR'0$&J(-,0SS'O%_;2NZ94MT8>D M&C(-N89"0ZFATE!K:#2T&CH-O89!PZAAOX>@F7L+->MV&MF2`9V1K6EN>/Z% MS'04,J9>PCW,1:N,:;`U.!I<#9X&7T.@(=00:8@U)!I2#9F&?(8YI]-S4AW3 M0A]1:J@TU!H:#:V&3D.O8=`P:MCO(>CEWD+-NIM&Q&30C8B=?V$S'86(J=?_ M#W/1YO[J\:FDW"`U=PAK_N_'"-H:'`VN!D^#KR'0$&J(-,0:$@VIADQ#KJ'0 M4&JH--0:&@VMADY#KV'0,&K8[R%+*X^MVJ-Y^W7WC(1--TN-B'W[1S72?)CNZQN7:2VR;$#;6[XLLW&0`W$A'L2'!)`0$D'B1;YQ MR0D.2L\?E.&@'%)`2D@%J2$-I(5TD!XR0$:(A%-W7<().B1A%6&C\V8XIZ'W M.IR7/?^;W@["W5E-U!^6JN.%6!`;XD!^= M3.].4LNB%ALU#L2%>!`?$D!"2`2)(0DDA620'%)`2D@%J2$-I(5TD!XR0$:( M)$XW3!('LDA&7\W$3+.;,#SK%SRNTH:!BC3&]E4TK38J'$@+L2#^)`` M$D(B2`Q)("DD@^208I%Y)Y=[JR=>_Y8XJH+4D`;20CI(#QD@(T2RIULHV0-9 M)*/39O:FV?$Z>]/^>O[%[_0&1^ZOQWO1CV^6>EBJCHNS!;$A#L2%>!`?$D!" M2`2)(0DDA620'%)`2D@%J2$-I(5TD!XR0$:()`[W%MA5>;F!*J.O9N*FV;-. MW/F)WF8>6!`?$D!"2`2)(0DDA620'%)`RD7F'5?>6GABQZUP5`UI M("VD@_20`3)")'NZA9(]$!LMKR9656;VIC'T.GL7[J_S]-K,X#TRJ&?!XD[_QKB M\3!UE^/V7M_E6*I6S^@@-L2!N!`/XD,"2`B)(#$D@:2++*]('W=']1Z(#`?E MD`)20BI(#6D@+:2#])`!,D+DK=.X._%`LDA&H\T(3E/F]:+W[:=XVWDHK;97 M_;;`I6H=/3W,ME'C0%R(!_$A`22$1)`8DD#21>;HG1J%9#@FAQ20$E)!:D@# M:2$=I(<,D!$BR=,-E'?H@RR2T61(B(WF7/<';3H=A\=/OK5NJU@F8*W5!WS94%LB`-Q(1[$AP20$!)!8D@"22$9 M)(<4D!)206I(`VDA':2'#)`1(HF;&WULH20.Q+;*YXM656;BIAGS.G%G=M=Y M)"TI7X_JL+OJP;6UU6)#'(@+\2`^)("$D`@20Q)(NL@R^-B<>JM=AJ-R2`$I M(16DAC20%M)!>L@`&2&2/=U"R1Z(C9;LK:K,[#WO!L7T67R]OTHKU%NHEJKC MCXH%L2$.Q(5X$!\20$)(!(DA"22%9)`<4D!*2`6I(0VDA720'C)`1H@D#K<> M'DALJR1N=:"9N&G:O%[M+MQ?YR'UN?U5C[*MK18;XD! M-I_;7UBKF;AID/R,Q,WSYW,;[&I*O21.BSW]:B.5."TN M:CR(#PD@(22"Q)`$DD(R2`XI("6D@M20!M)".D@/&2`C1!*GFR&)`UDDHZ]& MXJ:;$4C<^3L4CX>I(=WNM?H,S\-2M7H1`;$A#L2%>!`?$D!"2`2)(0DD7639 M:!\_LJU>/V5&R4X;P$I(16DAC20%M)!>L@`&2'RJS1XRX)DD8S.FYF< MYLYZ%9Q.\.TG?U?SN%KMN_KC%TO5.I-ZS&VCQH&X$`_B0P)("(D@,22!I)`, MDD,*2`FI(#6D@;20#M)#!L@(D<3IANT?2!;)Z*N9.`D-$G?^G0%7TV'G?RO0 M7+5.G!9[.=.QQH&X$`_B0P)("(D@,22!I)`,DD,*2`FI(#6D@;20#M)#!L@( MD<3IADGB0!;)Z*N9N&FB_(PU;AY$R]<^#I"W-]AWYZICFJPK+3;$@;@0#^)# M`D@(B2`Q)(&DBRS[[N.O:=&#RPQ'Y9`"4D(J2`UI("VD@_20`3)")(.ZA9)! M$!LMO[5J565F<)HLKS-X9G^=!]%&]G:O]2?'KE;CZOE5!L2&.!`7XD%\2``) M(1$DAB20%))!5[L3OW5O-:Y>$J?%OM+B0%R(!_$A`22$1)`8DD!22`;)(06DA%20 M&M)`6D@'Z2$#9(1(XG1[)'$@BV3TU4S<-%%>KVV7O?GD:AY$JS5.?WIGJ5KO MKZL!]F,&;=0X$!?B07Q(``DA$22&))#T258_;S=ZA<^>J@Z_O"F'%)`24D%J M2`-I(1VDAPR0$2(IU$V4%((LDM%K,X73:'F=PC,[[#R)5NG3[VV_6LVKE_5. MBXT:!^)"/(@/"2`A)(+$D`22/LDJ?;>W&*SHQYH_'7?(8P$I(16DAC20%M)! M>L@`&2&2/OW`)'T@BV3TVDS?-(Q>I^_"-7">8:L4ZG,D!&B"1.MU`2!V);Y17%JLI, MW#2,UHF[X'G>/,,^]SQ/3[JM*RTVQ(&X$`_B0P)("(D@,22!I)`,DD,*2`FI M(#6D@;20#M)#!L@(D<3IADGB0&RK)&Y5923N^GGW+QX/4_!`?$D!"2`2) M(0DDA620'%)`2D@%J2$-I(5TD!XR0$:()$XW;/]`LDA&7\W$R7.S9VRSU]-A M9V]7+%7KQ,W''<5&C0-Q(1[$AP20$!)!8D@"22$9)(<4D!)206I(`VDA':2' M#)`1(HG3#9/$@2R2T5/H&N[V4'`]R("[$@_B0`!)"(DB\R#@%L0&^)` M7(@'\2$!)(1$D!B20%)(!LDA!:2$5)`:TD!:2`?I(0-DA$CB=`LE<2"V51*W MJC(3-PVI=>+.O]Z=*B[8B/4$W%J.._XPV!`'XD(\B`\)("$D@L20!))",D@. M*2`EI(+4D`;20CI(#QD@(T02IULHB0.QK9*X5969N&D@K1-WP48\S[&-->[$ MZUT][;:NM=@0!^)"/(@/"2`A)(+$D`220C)(#BD@):2"U(LL[U$X]1;\!@>U MD`[20P;(")$(Z@Y*!$'LLT1P565&<)I*/R."\S#;B.!NH\;[#]=ZY&U!;(@# M<2$>Q(<$D!`206)(`DDA&22'%)`24D%J2`-I(1VDAPR0$2*)TRV4Q('85DG< MJLI,W#1OUHF;ELAOWTZ[GL?4\J1R]>H#OQAOJ3INJA;$AC@0%^)!?$@`"2$1 M)(8DD!2207)(`2DA%:2&-)`6TD%ZR``9(9*XU?V(QSNBDC@0VRJ)6U69B9OF MS3IQ%VRS\YC:6.-.;+.K8?9\`_=ZEN7%XZDAJ;V4'&/J0%R(!_$A`22$1)!X MD6]<2.D-Z?N M?9Q?%A\/4_<^Y.^+4Y]/6ZJ.>;,@-L2!N!`/XD,"2`B)(#$D@:20#))#"D@) MJ2`UI(&TD`[20P;(")&_((^W.DALZ][HJYFX4[!`?$D!"2`2)(0DDA620'%)`2D@%J2$-I(5TD!XR0$:()$ZW!`?$D!"2`2) M(0DDA620'%(\R?07-:J/2Y5/__'PYJH*4D,:2`OI(#UD@(P0"9WNG80.9)&, M%INAF^;0^MG?!-57]C:M0TD!;207K(`!DA M$CI]01(ZD$4R6FR&;IHIKT-WV3N2;^91M!&^W48]57E8JM8;ZVJ$_1A'&S4. MQ(5X$!\20$)(!(DA"22%9)`<4D!*2`6I(0VDA720'C)`1H@D3C=,$@>R2$9? MS<1-,V6=N`N>RLVCZ',;ZVI@O2QW6NP;+0[$A7@0'Q)`0D@$B2$))(5DD!Q2 M0$I(!:DA#:2%=)`>,D!&B"1.MT<2![)(1E_-Q$TS99VX6QG%G-E@YU&T6N/T MIVMO5@/K)7%:;-0X$!?B07Q(``DA$22&))`4DD'R198[J]5D`I2 M0QI("^D@/62`C!")H.Z@1!!DD8Q&FQ&="LUCB] MS2Y5Z\2M!M3S2PG4.!`7XD%\2``)(1$DAB20%))!\D7F;?;4[^@N<$P)J2`U MI(&TD`[20P;(")$$Z@;N'T@6R5Z3F4`)$1)XP9HW':9N4>PV^D/>MW/5.H%: M;-0X$!?B07Q(``DA$22&))`4DD%R2`$I(16DAC20%M)!>L@`&2&2.-TP21S( M(AE]-1,WC8_UFG=!XN:I\YD7L[=SU3IQ6FS4.!`7XD%\2``)(1$DAB20%))! MSN_]TO_5K,2 MAU60&M)`6D@'Z2$#9(1(^'17)7P@=GIOM-H,WS1L7H?OLFGQ[3RC-D*XVR"$ M>I)M+<<=%T`;XD!J,A,W#9MUXB[88.<9M2RUQV6/MV%O]23;@M@0!^)"/(@/ M"2`A)(+$D`220C)(#BD@):2"U)`&TD(Z2`\9("-$$J=;*(D#L:V2N%65F;AI MV*P3=WY4=SO/J,TU[K4>U2U5QQ7-@M@0!^)"/(@/"2`A)(+$D`22/LGJYVVW M4;\Z(7NJ.MQAS2$%I(14D!K20%I(!^DA`V2$2`IQ@^*!Q%9+"E<'FBF])#R2+9/3:3.&IVQ87I/#4;8NM M_LS.3L^X+8@-<2`NQ(/XD``20B)(#$D@*22#Y)`"4D(J2`UI("VD@_20`3)" M)'&ZA?L'$MNZ-_IJ)DZ>GCUCI]U-AYV]-;M4K=>]^;BCV*AQ("[$@_B0`!)" M(D@,22`I)(/DD`)20BI(#6D@+:2#])`!,D(D<;IADCB013+Z:B9NFCGKYW87 MK''SJ%J^]G&*LN-..U<=\V7MM-@0!^)"/(@/"2`A)(+$D`22/LGJT6]WZA5] M]E1UW&GUHR]04T(J2`UI("VD@_20`3)")(7Z84@*06RUK'NK*C.%T_#Y&2F< M9]9F"K?Z0SP[/=FV(#;$@;@0#^)#`D@(B2`Q)(&DD`R20PI(":D@-:2!M)`. MTD,&R`B1Q.D62N)`;*LD;E5E)FX:*^O$G7]-NYNGT9+CX[K'Z?%2M5[W5E/L M^2TIJ'$@+L2#^)``$D(B2`Q)("DD@^20`E)"*D@-:2`MI(/TD`$R0B1QNF&2 M.)!%LM=D)FX:*^O$7;#3SM-HZHZ[K3ZT1>H*2$5I(8TD!;207K(`!DADD+],"2%((MD M]-I,X?/N8>Q.WBKF;AIK*P3=\%..T^CS^VTJYGUDC@M]DZ+`W$A'L2'!)`0$D%B M2`))GV2UT^ZVZLW6V5/5<:?5C[5`30FI(#6D@;20#M)#!L@(D13JAR$I!%DD MH]=&"N^>=P_C\3!]#V.K9@L/2]5JIX78$`?B0CR(#PD@(22"Q)`$DD(R2`XI M("6D@M20!M)".D@/&2`C9+\GL:M[BU5&7\W$G;I?<7ZGO9O'V&=VVJ5JG3@] M_K91XT!FQW>K MF?7\"@-B0QR("_$@/B2`A)`($D,22`K)(#FD@)20"E)#&D@+Z2`]9(",$$F< M;J$D#F21C+Z:B9N&SSIQYU_3WLTS:UE?CXG;;=7\]&&I6O]^8/,WS%I+Q?%' MR(8X$!?B07Q(``DA$22&))`4DD%R2+'(__W=*7%,!:DA#:2%=)`>,D!&B"02 M-R\.73_V5%YMH,KHLYG(:1#]C$3.\VN52/5^\(<[/>6V(#;$@;@0#^)#`D@( MB2`Q)(&DD`R20PI(":D@-:2!M)`.TD,&R`B1Q.D6RAH(8EMEUUU5F8F;!M$Z M<1?LNO/\^MRNJZ?(NV'7G^;6YQO'UK9YR6W=:;(@# M<2$>Q(<$D!`206)(`DDA&21_DM7SDIMK-6TNGJH.KX%+2`6I(0VDA720'C)` M1HBD4#=14@ABJR6%JRHSA=,@^ADIG.?79@JW^A,_=WK*;4%LB`-Q(1[$AP20 M$!)!8D@"22$9)(<4D!)206I(`VDA':2'#)`1(HG3+93$@=A62=RJRDC<_:E[ M%^=WVL?#SKX/>:DZ/N^T(#;$@;@0#^)#`D@(B2`Q)(&DD`R20PI(":D@-:2! MM)`.TD,&R`C9[TD/)+9U;_353-RI>Q?G=]K[>:1MKG'8:9>J=>+T*-Q&C0-Q M(1[$AP20$!)!8D@"22$9)'^2U4Z[O5=3SN*IZFFGA520&M)`6D@'Z2$#9(1( M"G43]P\DBV3TVDRA!.D9.^W]=)B>)%^I3UX]+%7K%,[''<5&C0-Q(1[$AP20 M$!)!8D@"22$9)(<4D!)206I(`VDA':2'#)`1(HG3#9/$@2R2T5?79U[3WL]5QWQ9$!OB0%R(!_$A`22$1)`8DD!22`;)(06DA%20&M)` M6D@'Z2$#9(1(XG0+)7$@ME5VVE65F;AI$+U.W+=_3=3]/+>6E*\FR%?ZTXQ+ MU3II>MYMH\:!N!`/XD,"2`B)(/&3K![9[:U:M9.GJL/.F$(R2`XI("6D@M20 M!M)".D@/&2`C1-*GFRCI`UDDH]=F^D[=Q[A@O3MU'^-*?]+G7H^O+8@-<2`N MQ(/XD``20B)(#$D@*22#Y)`"4D(J2`UI("VD@_20`3)")'&ZA9(X$-LJZ]VJ MRDS<-$Y>KW?3;R:[(''S%%I6T>.ZQT_ZW*]FU?.]6H@-<2`NQ(/XD``20B)( M#$D@*22#Y)`"4D(J2`UI("VD@_20`3)")'&ZA9(XD$4R^FHF;AHGKQ-W9H>= MI\_&#LM?Q'B_FE$O2=-BH\:!N!`/XD,"2`B)(#$D@:20#))#"D@)J2`UI(&T MBRQW>Z]O3OT%OQT.ZR$#9(1(^'0/)7P@BV2TV@S?-$7^CO#-0V M^]5H>@F?%ALU#L2%>!`?$D!"2`2)(0DDA620'%)`2D@%J2$-I(5TD!XR0$:( M)$TW3)(&LDA&7\VD3=/C==(NW%CGH?.YC74UFEX2I\6^U^)`7(@'\2$!)(1$ MD!B20%)(!LDA!:2$5)`:TD!:2`?I(0-DA$CB='LD<2"+9/352-SF]:G[$N>G MQ/-Q:D"WO=$O'PYEJU>Q))ODD%R21_))`2DD1:28E)!24D;*206I)%4'FK?/ M[>;4WTE0'XJ.W^>&U)(Z4D\:2"-IOS]A#R?,.F%F!E1$GWI-71WI=ZR(1!G";5.I#G!S2;U_.$^\P3R4.9 M$C4OXCR/#4\\R]01=KD^37)XF":0F":0F":0F":0F":0F":0F":0F M":0F":0F":0F":0F":0F":0F":0F":0F">1,\Y.&S=VIL8U$5!\G$=4D$=4D M$=4D$=4D$=4T110F$86=B,"TB:_J5$2G:?,6Y>S]-Q(YJWM^I=(')A MJR'Z_*J;))>EJR2:FB2:FB2:FB2:FB2:FB2:FB2:FB2:FB2:FB2:FB2:FB2: MFB2:FB2:FB2:FB2:,RW1O)47%/(_\P,V$DU]G$13DT13DT13DT13DT13TQ1- MV(D$3-LYZLP,J&A.P_-U-"_[FV`VK^>ANXJH_JC2H>RX=\OUZ7&]7)XFB:@F MB:@FB:@FB:@FB:@FB:@FB:@FB:@FB:@FB:@FB:@FB:@FB:@FB:@FB:@FB>A, M2T3O3R=4'R8)U20)U20)U20)U20)U30E%"8)A9U(P+1XKNI40J<)^W,2.D_F MS83>,*%Z@"_7ITDN3Y,D5),D5),D5),D5),D5),D5),D5),D5),D5),D5),D M5),D5),D5),D5),D5),D=*:-O*_EEY_^_9ZLJ?HTDEA- MDEA-DEA-DEA-DEA-4V)ADEC8B41,B5W5J<1.D_KG)':>\!N)Y:_IW;S6-P+D M^C3)Y6F2Q&J2Q&J2Q&J2Q&J2Q&J2Q&J2Q&J2Q&J2Q&J2Q!YH]>1\=Z5_Z\*Q M[/!V'TGQX<@#28HU28HU28HU28HU24@U24@U24@U24@U24@U24@U32&%24AA M)T(PA715IT(Z#?>?$]+YIH`9TBL^-]7W#N3Z-,GE:9*0:I*0:I*0:I*0:I*0 M:I*0:I*0:I*0:I*0:I*0:I)E59,$4I,$4I,$4I,$4I,$4I,$4I,$4I,$4I,$ M4I,$4I,$4M,42)@$$G:BX5,@5W5F(#>G[A9=,%AZ/.[LQU@V2]GZF2C(9I5# M

R2<%I)`4D6)20DI)&2DG%:225)%J4D-J21VI)PVDD22!1"/W#R?,.F%F MQU4@I^'],U;(S3ST-U;($X.EIG20*I20*I20*I20*I20*I20*I M20*I20*I20*I20(YT_Q"Y?2[?AOWRMXUC^Q)WUC;Y'(->G22Y/DT14DT14DT14DT14DT14DT14 MDT14DT14DT14DT1TIO_E[,Z:W#C.-`K_%8?NAR9Z0U,AZ8;[OJ]W')F2'2.; M#HHS]OS[.5]G%9%YWIP&U+YPV(=9S93J8:&060";CMFS&9#U49!U@JP39)T@ MZP19)\@Z`=0)H$X`=0*H$T"="F@T@$:;`.!^LQ\GH+5`.@'4":!.`'4"J!-`G0#J!%`G0#H!T@F03H!T`J03 M()T`N:;N@G%Z74\Z@'0=MJX+@-0)I$X@=0*I4R&-!M)H((TV*A#26LSOD>Y[ M@6^+_P/.C3\_S,2\1\"\G)B6$SB=P.D$3B=P.H'3"9Q.X'0"IQ,XG<#I!$XG M<#J!TPF<3N!T`J<3.)V`Z`1$)R`Z`=$)B$X%,=KD?+-/E./&,RZ(M3[?0SSL M\>'-IJWK<[7N7\YCN6@9MKN]9'[=CL#%!93I.0'2"9!.@'0"I!,@G0#I!$@G M0#H!T@F03H!T`J03()T`Z01()T`Z`=()D$Z`=`*D$R"=`.E4(*,!,MKDA-?+ M=S=.(&OYW2`/>.QCTY;MAROD[-UYM[J_OGP[,3TG0#H!T@F03H!T`J03()T` MZ01()T`Z`=()D$Z`=`*D$R"=`.D$2"=`.@&RI>5=T7%[IE1;\!CU@1AUPJ@3 M1IW*:#2,1L-HM!&!C-;J>V]TWZMW6ZT?;,[>GG>+^JM-)Z;EA$TG;#IATPF; M3MATPJ83-IVPZ81-)VPZ8=,)FT[8=,*F$S:=L.F$32=LMK38/+G8>O?C(=CT M@=ATPJ83-IW*9C1L1L-FM!&!;-9"?&_SP`<_-FT!?S2:3[XOPX87]&[I?WU! M=\*H$T:=,.J$42>,.F'4":-.&'7"J!-&6VH6SFKNOK<;?7WOT]VP];WQLTS/ M,[W(]#+3JTRO,[W)]#;3NTSO,WW(!-(XDVP29;LY::,"(:WU>E]&SY"[YZ7^ MJ*WS#Y?1[7$\G;0,&Y!ZAX#I.8'4":1.('4"J1-(G4#J!%(GD#J!U`FD3H!T M`J03()T`Z01()T`Z`=()D"WURZ]Q$QJ'(=0_":%."'4JH=$0&@VAT48"$HJQ M0>@^F37>E\]C73.86!LVR&QIO6\_FCR7R$1]'%:=L.J$52>L.F'5":M.6'7" M:DN731Z]/@Z]^X_#LX_#LQ.>G?#LA&#K!%\G^#H5WV@3 M)2P\Y;A1A?C60G]_@=W'MVT,,)?=@M/VV-^CNSGR_@'S,$L1;N>X@'KH`>M05_?O\=R/QJHLTR;+B>>JN`Z3D!T@F0 M3H!T`J03()T`Z01()T`Z`=()D$Z`=`*D$R"=`.D$2"=`.@'2"9!.@'0"I!,@ MG0#I5""C`3(:(*.-9UP@:Z'?(`]Y?]0V"(8KY&0%],C[",S/B>DY`=()D$Z` M=`*D$R"=`.D$2"=`.@'2"9!.@'0"I!,@6VIW"V?+UP[I[A"C/A"C3AAUPJ@3 M1ITPZH11)XPZ8=2IC$;#:+2)@;IH=N-DM-;OKV*TK?L/1B=/@1QUVP/+2F@D MIN=1&'7"J!-&G3#JA%$GC#IAU`FC3AAUPFA+C=K19OX-"\.@S=GDSAO&_MDP M=L*L$V:=,.N$62?,.F'6";-.F'7"K%.9C8;9:)B--J*0V5KCOXK9MC0.H'4":1.('4JI-%`&FV"H"ZLW3@AK<7^JR!M MFP0CTA-_0?#FR'L)S,^)Z3F!U`FD3B!U`JD32)U`Z@12)Y`Z@=0)I$Z`=.*J MZ03(EFZTC[8=7]/'DN#I8^#I!$\G>#K!TPF>3O!T@J<3/)V*9S1X1IN<_N+9 MC1//6M6_"L^V&R">^J@@$^PV#=;7?2>FYP1/)W@ZP=,)GD[P=(*G$SR=X.D$ M3R=X.L'3"9Y.\&QI6(.A71:!,! MM;`4XT8#(]%ZIW05HA?'>7WTQ-_!R7T:/YZO+OYN?6V[N:9V8C;GL\]MWUH' M[8Z[G>E.IKN9[F6ZG^E!IH>9'JWILLD_7@?M)O]D39<=]W0=M#ON6:;GF5YD M>IGI5:;7F=YD>IOI7:;WF3YD@G&(8`,JVSMTT$ M76GUV"P3]%X#\W-B>DZ@=0*M$VB=0.L$6B?0.H'6";1.$'6"J!,@G0#I!,B6 MUD^Y7\\[@3@(G_XY^'3"IQ,^G?#IA$\G?#KATZE\1IN+C]O.P;[U^V783A_S:T?N$M-S`J03()T`Z01()T`Z`=()D$Z` M=`*D$R"=`.D$2"=`.@'2"9!.@'0"I!,@G0#I!$@G0#H!TJE`1@-DM,D)+Y#= M.(&LU7Z#K!?Z?5?(MDL`]-V&TF3]_MB;"DY`=()D$Z`=`*D$R"=`.D$ M2"=`.@'2"9`M+3>7T\]/0M3'0=0)HDX0=8*H$T2=(.H$42>(.D'4":).$'4J MHM$@&FU"H(AVXT2T%O9[HOMHMHV`@>;D`>;C;K]@>?L>B6EY%#2=H.D$32=H M.D'3"9I.T'2"IA,TG:#94J.YG7VR%YD^#)E.R'1"IA,RG9#IA$PG9#HALZ5+ MY@[5O6.PZQ^-7:>R&PV[T;`;;40BN[7HW]L]\`'GX[99(,/Q9-XR;/?BSOS: MD>U?V\ELHX;Y>BL"U$Z@=@*U$ZB=0.T$:B=0.X&ZI4OFCG(?AO*]AZ'5.*'="N1/*G5#NA'(GE#N!V@G#3AAV*L/1,!SMFY$=F[K^=N-DN-;_KV*X M[1L,AB=;4DZ0=8*L$V2=(.L$62?(.D'6";)."'5"Z)JZNZ7M MB9;L0;H.6Y?K0.H$4B>0.H'4":1.('4"J1-(G4#J!%(GD#H5TF@@C0;2:*," M(:U=@![IOIN$MFLPXHR_HW)SW&TNK#B=F)83.)W`Z01.)W`Z@=,)G$[@=`*G M$SB=P.D$1"<@.@'1"8A.0'0"HA,0G8#H!,0U=7^.XN_?!.ZZ^GV1&\SWNV&K2+?9_J0":1Q%Z MNCV)9?T3[T$P/R>FYP12)Y`Z@=0)I$X@=0*I$TB=0.H$4B>0.H'4":1.('4" MJ1-(G4#J!%(GD#J!M*7VKK!]GD$V2=(.L$62?(.D'6";).D'6"K!-DG2#K!%DG MR#I!U@FR3I!U@JP39)T@ZP39EAI9+F231V$QNW\0:/W#0>M4:*.!-AIHHXTJ MA+:V#:YRG6W;#?Q>N\T!5A_'[Q1D@MVNQ/+F*A+3\RC0.H'6";1.H'4"K1-H MG4#K!%HGT#J!U@FT3J!U`JT3:)U`ZP1:)]`Z@=8)M&OJSMK1J=YMP'8=UMT, M.('4J9!&FQC@CC7'C0J$M#8.KH*T;3@(:3R$>M+M2ZQ(G9B>$TB=0.H$4B>0 M.H'4":1.('4"J1-(G4#J!%(GD#J!U`FD3B!U`JD32)U`Z@32-?5(_=UR(%V' M=4B=0.I42*.!-!I(HXT*A+1V#:Z"M.TV"&D\BEKWOGK.+Q+3\RB0.H'4":1. M('4"J1-(G4#J!%(GD#J!U`FD3B!U`JD32)U`Z@12)Y`Z@=0)I&NJ%0"][&'S MDE_E!7_]U54N3)V*:3281H-IM-&!F-8F@)D>\$42)VWS0$SC<=1EV'"7VFT[ M7%Q>F9X33)U@Z@13)Y@ZP=0)IDXP=8*I$TR=8-I2N_6;;;_!UD?!U@FV3K!U M@JT3;)U@ZP1;)]@Z8=4)H$X`=2J@T0`:#:#11@$"6IL"!GK`XRHG;3-!0.-! MTV78`-3;$$S/":!.`'4"J!-`G0#J!%`G@#H!U`F@3@!U`J03()T`Z01()T`Z M`=()D$Z`=`*D$R"=`.D$2*<"&0V0T0`9;3SC`ED;`099%]U_;TX^_OS]7_[W MUJ???_[T#]X'7;_&)U1_^N'B(L=LV@8"=\2[MTB3#^0OPP:0WGI@>DZ`=`*D M$R"=`.D$2"=`.@'2"9!.@'0"I!,@G0#I!$@G0#H!T@F03H!T`J03()T`Z01( M)T`Z%"U^;F[$XN@_"W4[TYU,=S/=RW0_TX-,#S,]RO0XTY-,3S,]R_0\TXM,+S.] MRO0ZTYM,;S.]R_0^TX=,0(RSQ@92MIN3-IYQ0:QU>E\D#WC5/FWK^_M>M9=A M`\AN9V!YGQ.C`.E1@'0"I!,@G0#I!$@G0#H!T@F03H!T`J03()T`Z01()T`Z M`=()D$Z`=`*D$R"=`.D$2*<"&0V0T0`9#9!=$TA>=P/D`:_:IW6KC(.H$42>(.D'4":).$'6" MJ!-$G2#J!%$GB#I!U`FB3A!U@J@31)T@VM)E_YY!Z^,*;3301@-MM%&%T-9Z MOJ^BAZ!M^P#\7KOW/EMO-##!-FPGE/DY,3TGT#J!U@FT3A!U@J@31)T@Z@11 M)X@Z0=0)HDX0=8*H$T2=(.H$42>(.D'4":).$'6"Z)KJ5E/KU-A3+9BW/7\5F6]:7S7B.Z=2K_\S/B>DY8=,)FT[8=,*F$S:=L.F$ M32=L.F'3"9MKZO^8YD/+WX:MYQ2OZY%KPJL37IWPZH17)[PZX=4)KTYX=<*K M$TB=Z@(:#:31)@AX**0?)Z2U.-\CW?=^J"WF"Z<>UV)B7O-G7DY,RPF<3N!T M`J<3.)W`Z01.)W`Z@=,)G$[@=.+"Z01$)R`Z`=$)B$Y`=`*B$Q"=@.@$1"<@ M.@'1J2!&FYSONEK&N/&,"V(MPO<0#_Q:T=.V>,]5??=*/EG%7(8-K^1>]F=Z M3H!T`J03()T`Z01()T`Z`=()D$Z`=`*D$R"=`.D$2"=`.@'2"9!.@'0"I!,@ MG0#I!$@G0#H5R&B`C`;(:.,9%\A:A#?(0VXMV^+]<(6Q'U@;6&%&U"H%Z\NW$B6LOR/=%]+]YM&7^@.?E8\JE7 M^YF7$]-R@J83-)V@Z01-)V@Z0=,)FD[0=(*F$S2=H.D$32=H.D'3"9I.T'2" MIA,TG:#I!$TG:#I!LZ5&\^SZ["_F*9H^L&A&FQ`HFMTXT:Q5^9[F@9\W.FVK M^2*:]Y=>]&=^3DS/":).$'6"J!-$G2#J!%$GB#I!U`FB3A!U@J@31)T@Z@11 M)X@Z0=0)HDX0=8*H$T2=(.H$T9:6J^?D&>4"ZL,*:+0)@`+:C1N!UB-%5P%Z M<9R6.[>G\0&.95A_OQGI%E]0S"3&#:%(=W+4W4SW,MW/]"#3PTR/,CW.]"33 MTTS/,CW/]"+3RTRO,KW.]";3VTSO,KW/]&%-"U#^4J3ZS[BN#-$X:1#-=G/2 M1@,B6FOUOH8>L$5TUM;XAVOH]C3V+)=A`]%N=V#9(HI1MS>1(.H#(>H$42>( M.D'4":).$'6"J!-$G2#J!%$GB#I!U`FB3A!U@J@31)T@Z@11)X@Z0;2E1G3Z M08\2ZN-*:#2$1D-HUR048R'T@/=(9W6<+Z)G^G/%!-NP0:@3TW-"J!-"G1#J MA%`GA#HAU`FA3@AU0J@30IT0ZH10)X0Z(=0)H4X(=4*H$T*=$.J$4">$.B&T MI29T.WLBM83ZN!(:#:'11@(26LO]OH8>(K1M$_![[9:5MF?QT8PS[R8P/R>F MYX10)X0Z(=0)H4X(=4*H$T*=$.J$4">$.B'4":%."'5"J!-"G1#JA%`GA#HA MU`FA3@AU0FA+32@OT_-7>1]70J--!'`CVH^3T%K#OXK0MO8OH=KO8H+>(F!^ M3DS/":%."'5"J!-"G1#JA%`GA#HAU`FA3@AU0J@30EM:SO')[%8.LSX.LTZ8 M=<*L$V:=,.N$62?,.F'6";-.=1&--A'`VGR.&PV(:*WD7X5HVP$043W]QP2] M4<#\G)B>$T2=(.H$42>(.D'4":).$'6"J!-$G2#J!%$GB+;4B)[/OBP/H3X, MH4X(=4*H$T*=$.J$4">$.B'4":%.)33:!$`)C7$C`0FMI?VK"&U;`A(:'\HX M\\X!\W-B>DX(=4*H$T*=$.J$4">$.B'4":%."'5"J!-"G1#:4A-Z-'NA1*@/ M0Z@30IT0ZH10)X0Z(=0)H4X(=4*H4PF-AM!H$P'U,M^-D]!:Q;^*T+;Z+Z'Q M4/Q9MTEP\$.B'4":%."'5"J!-"G1#JA%`GA#HAU`FA3@AM:1$Z M6_1&J`]#J!-"G1#JA%`GA#HAU`FA3@AU0JA3"8V&T&@3`26T&R>AM9A_%:%M M$T!"XWFELVZO8!7JQ/2<$.J$4">$.B'4":%."'5"J!-"G1#JA%`GA#HAM*7E M1G3VJ"I"?1A"G1#JA%`GA#HAU`FA3@AU0J@30IU*:#2$1D-HM)&`A-9J?B]T MSW[G65O]E\S83%J&#ION9'F1Z MF.E1IL>9GF1ZFNE9IN>97F1ZF>E5IM>9WF1ZF^E=IO>9/F0"8IPUEINRW9RT M\8P+8BWF]]?0`Y^SV[9-`):[=@NBD^?LEF$#R&[[8+F6QBA`>A0@G0#I!$@G M0#H!T@F03H!T`J03()T`Z01()T`Z`=()D$Z`=`*D$R"=`.D$2"=`.@'2J4!& M`V0T0$8#9-<$DI?G`'G`"OVVCM,5(.D'4":).$'6" MJ!-$G8IH-(A&FYQPWAGUXT2T%OE]S3R$:-L`O-S8GI. M@'0"I!,@G0#I!$@G0#H!T@F03H!T`J03()T`Z01()T`Z`=()D$Z`=`*D$R"= M`.D$2"=`.A7(UI;[[HM;:FUSUZMZ/ZA=H3QH0J+(=K^CR-9&P%7(M@V$D>Q6 MLV'&WF=@?DY,SPFR3I!U@JP39)T@ZP19)\@Z0=8)LDZ0=8*L$V2=(.L$62?( M.D'6";).D'6"K!-DG2#K!%FG(AMM^&VF:`5,9N_-9[!DS2B6DYH=()E4ZH=$*E$RJ=4.F$2B=4.J'2"95KNOAB MMVO:[X7H^NOK!]\@Z@11)X@Z0=0)HDX0=8*H$T2=(.H$42>(.A71:!"--CG[ MI;(;)Y6U>/]'5+;%?JG4&6%BW9[`LO`9B6EY%"J=4.F$2B=4.J'2"95.J'1" MI1,JG5#94GN9F^T*`=-'`=,)F$[`=`*F$S"=@.D$3"=@.@'3"9A.P'0JF-$F MY[^NG3%N%""8M6;?PSSP8?IM6^L74%VHF6"W);`"=6)Z3@!U`J@30)T`Z@10 M)X`Z`=0)H$X`=0)H2\O;P-FN$$)]&$*=$.J$4">$.B'4":%."'5"J!-"G1#J MA%"G$AIM`J"$QKB1@(36.GXO=-\+>EOW'V0>'<7*_-;;`\RKI78BS]OCKN/S MV,S3AT'5":I.4'6"JA-4G:#J!%4GJ+9TR=RQZ\.PN_9'J;Z5VF]YD^9`)G_!.Q*)5M M@H`+:S]..&O-O[^P'GC;>M[V"H8+['8;CSPMPP:D[P.H'5":Q.8'4JK-'`&@VLT48"$EH;`+W0?5?-MF$P MR#R[$?ORY]Y78%Y.3,L)F4[(=$*F$S*=D.F$3"=D.B'3"9E.R&RIR;PQ>4H9 MF#X*F$[`=`*F$S"=@.D$3"=@.@'3"9A.P'0"IE/!C`;,:!,`]::]&R>8M>[? MPSSTTMGV"P:@VVVLZ)][6X'YM=3.YTG;FA%L)NSC(.L$62?(.D'6";).D'6" MK!-D6[IL\B#V<2#>?QR,?1R,G6#L!&,G&#O!V`G&3C!V@K$3C)U@[`1CIV(< M#<;1OC'9W1`6XS;N__FW+]BU`6#8]24]^ZZ\;>-`L.-)_/-N?V&])W!BPDXP M=H*Q$XR=8.P$8R<8.\'8"<9.H'4";4MG_!U2__/3?\P^GHQ9'X99)\PZ8=8) MLTZ8=<*L$V:=,.N$62?,.F'6J9'J8Z5&FQYF>9'J:Z5FFYYE> M9'J9Z56FUYG>9'J;Z5VF]YD^9`)DG$AVDK)-3C@@^W$"66OV_97QP)O2&VVM M?[Q";N,*N0P;0'J7@.DY`=()D$Z`=`*D$R"=`.D$2"=`.@'2"9!.@'0"I!,@ M6[IQ\:)__=IU/74+3Q\#3R=X.L'3"9Y.\'2"IQ,\G>#I5#RCP3,:/*.-YU\\ M`18\#[E>UG'>)#K7>Q\FV(8-/)V8GA,\G>#I!$\G>#K!TPF>3O!T@J<3/)W@ MZ01/)W@ZP;.EQO/D^)JVB>'I8^#I!$\G>#K!TPF>3O!T@J<3/)V*9[3)V>?A MO!PWGO_&\\^___73IZ^W/G[]^-,/?__TY==/-S_]]MOO?_KY\W_77P9[PA_H M;_5/7S[]\N-W-S??/]A\QX,.ZH\VWS^>]2>;[Y_-^O/-]_S#U`_Z\[>?]/M/ M/_SSXZ^?'G_\\NO?_O'[GW[[]`MSN'ZMGL;^\K=?ZWK>_L_7S__\\3O^]/WG MYZ]?/__]XG_^]=/'OWSZ4@,8_,OGSU_7_U._P;\^?_FOBW_.G_Y/`````/__ M`P!02P,$%``&``@````A`'X_Q+*[`@``V@8``!D```!X;"]W;W)K&ULC%7+;MLP$+P7Z#\0O$P;)AC*9`NR$>##0+Z79@L/^Q>E[6X#O$I6L(OM6_Q"'SXS7 MC89J)V#(^%J6SP53%!(*-%YD95#1@@#X11TWG0$)(4_V_\!+W>1XD7I)%BQ" M@*,=4_J>&TJ,Z%YIT?UQH-"(&DFB%Y(8U+_$(R^Z3L(D_3^+[Q19@P719+V2 MXH"@:>"=:B"F!<,E,!^=.1VCUW]9!7F&Y,ZP6"YPH:`\C^LPS8*5_PA)I2^@ MC0/!E3B!YHCM$6%L&]YBLN&#X%$UY.)<]0*J^GH]CB+-H;G(*)L+V+P"F2.V MKR"NYY#B$I*=(#,;B[F-M^4;,#3.)'U9ELY?O7&8V/:-2>#V?*.8;,RD0.VG M&7U;B@'G&'R>*IEFX9D6!TIM-RS".%S,X]MI/%Y$9]U2S,(P[L;3,]EP?=XO MVX`O9$QDDRGG>ZW8QQ5[!CLF9; MUK8*4;$W\R.$;(V[;K1M8+390>"/`1@M`ZG9-R)KWBO4L@J.!EX&[Y9N.+F% M%H/M]YW0,%3L8P/?$`:-$7@`KH30QX49?^-7:?T7``#__P,`4$L#!!0`!@`( M````(0"LUSE9&S<``(E@`0`9````>&PO=V]R:W-H965T0<&[R6B_X"&0M*$V?5?=3$Q<<[,-4U1%L,BJ2!IRW[[ M6=D[$[5SK4)G%7TAV9]S)X`/N;M65A[KZ_ M>_GBW<>WGWYY__%O/[W\__^O^>[\\L67KV\^_O+F]T\?W_WT\M_OOKS\CY__ M[__Y\<]/G__^Y;=W[[Z^P`P?O_ST\K>O7__XX=6K+V]_>_?AS9?O/_WQ[B/^ MGU\_??[PYBO^Y^>_O?KRQ^=W;WZY%GWX_=7^[N[^U8?__Z//[Y[ M^^G#'YCBK^]_?__UW]=)7[[X\/:'_F\?/WU^\]??\7/_:W=\\S;-??T?,OV' M]V\_?_KRZ=>OWV.Z5_:-ZL_\^.KQ%6;Z^<=?WN,G"-I??'[WZT\O_[+[8=H_ MG%^^^OG'JZ'_?O_NSR_NO[_X\MNG/]O/[W^9WG]\!]WX185?P5\_??I[&-K_ M$A"*7TEU<_T5_.?G%[^\^_7-/W[_^E^?_NS>O?_;;U_Q^S[A1PH_V0^__+MZ M]^4ME&*:[_>G,-/;3[_C&\`_7WQX']8&E+SYU_7??[[_Y>MO/[T\W']_>K@[ M[##\Q5_???G:O`]3OGSQ]A]?OG[Z\#\V:!>GLDGV<9(COOOX_^^_WY]/N]/] MAEGP]:[?"OZ=9CE]?]R?'LY;OI?[.`O^G6;9?[\[WFWY3A[B'/CW/,?FGP<] M=OUY\.]YELT_SV.9]GX\^RPK.RWC-_C/,OFGVB7?M'AOSS-4UHFKVS) M75=P]>;KFY]__/SISQ=X7<`W\^6/-^%59O=#F#&LW2-^^[;2GE;SEK=0FX*IFZ3X-2UE'RWZE!_J5AFZZ1^/? M_M6&*KSFN]\DFN?^Z2M<.^&U#3H^_?XO#"H&-8.&03;(R6%0,:@9-`Q:!AV#GL'`8&0P.9#)"5L\ MGZYNKY@P.E\Q#X_\BF=CG!,&%8/:@'7#8;\/KY%NI5^O+@T7M0PZ!CV#@<'( M8'(@TX1%!N.7-AOD?#&H&-0,&@8M@XY!SV!@,#*8',CDA(V# MV"EWV+6LV&)QE/,CI!)2"VF$M$(Z(;V00<@H9/(D-Q62]OIVVUDP]Q%#^RT. M\H*L;":5C*DCN=US4M8*Z83T0@8AHY#)D]Q9R+;>V;K(&K:*TGR/\_73,FL< M-:NZ"*F$U$(:(:V03D@O9!`R"ID\R4V%7/L-IBP.XY\^R'*ZW[G0?'5W$5() MJ84T0EHAG9!>R"!D%#)YDIL*P=6;NGW9VUG.+?2A"\-1$),J3C0OMSH2Z\/= M,81_N?1)52ND$](+&82,0B9/[D( MJ8340AHAK9!.2"]D$#(*F3S)384@^@VF++^6VM"EW+C*F%0[)K601D@KI!/2 M"QF$C$(F3W)3(95Z4X4VM!#KU]+"Y=`EW2B(2;5C4D=RNPVYJI5Y.B&]D$'( M*&3R)%<6$JI7MBZ)[BS8>G5H0[H=]SJ.\FWH`O'59B5C:B&-D%9()Z07,@@9 MA4R>Y*9"7&53*U*II=Q2&[HL'%<9DVK'I!;2"&F%=$)Z(8.04A^?;&FW#.,@M)2&5D#J2V(9WAZ6KH52U0CHAO9!!R"AD\B17QD%^71ON M-="C#0]/-W6N2^EU'.7=2:*7,;601D@KI!/2"QF$C$(F3W)3>,WYAC;9*;"@G;OV`5VM`"N7])7VA#&S3K MN.R95$+J2&ZW(<_3RCR=D%[((&04,GF2*^,&-^11M*?(]UWA2/J65,(Z05T@GI MA0Q"1B&3)[FID)XWM*&%[4(;9I6INF$]$(&(:.0R9/,V(%3_+I( M>BW+TSRZD._^Q5%N;0FIA-1"&B&MD$Y(+V00,@J9/,E-+87W+(07NC". M\J8DO,N86D@CI!72">F%#$)&(9,GN2DTU(8N/(3A^5K2+HR#O"`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`OWTY/-F@6<=%2"6D M%M)$G41Z&5,+:82T M0CHAO9!!R"AD\B0W]6WY_60Y'+_9I[W/PE]0QU'>E.1W&5,+:82T0CHAO9!! MR"AD\B0WQ?F]T(:6OPMMR"']Y*4[OA2ZT].W7TD(FY8A^ M.3&IA-1"FDAN=B%/W,DTO9!!R"AD\B0S%K8VTH7E_%ALK6U.TNO`_#:2WI1XO$4=Z0U%]ARD)XJ0TYJE_NF51":B&-D%9()Z07,@@9A4R>Y*8XO!?6 MDH5O?S%<^(2?>X[H%R&5D%I((Z2-Y&8;\A?O99I!R"AD\B17QBE^W0V:>TWS MN!KR4S1QE&]#B?,RIA;2"&F%=$)Z(8.04226D%M((:2.Q-KQ?^G": M3HIZ(8.04_X*9I[#MD7(9606D@CI!72">F%#$)& M(9,GF:F';XOOU[+B?=(XRKU@":F$U$(:(:V03D@O9!`R"ID\R4UQ?+_=A@\6 MO[.UI*$TCO*&)+;+F%I((Z2-Q-K0WL_/W[_HI*87,@@9A4R>Y,;PPW]#%SZ$ M,LZD.WH8X74K!\OEA8MA M'#5[N0BIA-1"&B&MD$Y(+V00,@J9/,E-<7HO=*&E[U(7G^P%%YJ0\[JEU@WNZN$U$(:(:V03D@O9!`R"ID\ MR4UQ>B^TH:7O4AMR1K\\,*F$U$(:(6TD,9,NO'_124TO9!`R"ID\R8UQBE_9 MA0MI'A_=GE_*7^/#\,,EXJ(;601D@KI!/2"QF$C$(F3S)39P[OM[OP.IR"E4;2.&KV<1%2 M":F%-$+:2*P+E]Y%[*2F%S((&85,GN3&.,2OZ\+S0I@_[_@!FCC*FY,P+V-J M(8V05D@GI!32L;40AHAK9!.2"]D M$#(*F3S)3>&'S4P5NC`,+W>AC9I]7,Y,*B&UD$9(&TF,I$O70JGIA0Q"1B&3 M)[DQ#O&A"\.3S05S"V'^O./G9\XZN5,K(;601D@K MI!/2"QF$C$(F3W)3G.8+?6GYO-27DN+/3"HAM9`F$NO4ZT$A\F";%'5"^O(T M@Q2-0B9/,H>/G//7]>6UC)+&><=O[L=1\]JZ"*F$U$(:(:V03D@O9!`R"ID\ MR4U]6[Y_M)Q>Z,LXRIN2?"]C:B&-D%9()Z07,@@9A4R>Y*9"X/;Y_G9?/EH^ M+_1E'.4-6=U,*AE31W+K>BE%K9"N/$TO18.04XP1'+O<&5?AC+I2WZW M_]%&S>8N0BHAM9!&2"ND$](+&82,0B9/P(AE9!:2".D%=()Z84,0D8ADR>YJ:7$ MOZ(O+9)[Y/W`RMY%.&LJ/!-^+>6 M<%@4(YP6Q0C'13'">5&,<&`4(YP8Q0A'1C'"F5$.D3;>`]SNU-V=A?A"JZ9A MF2Z)_SH*NG@4=!FR#CX<#TO/Y\`@%\(@(QA<,1>D-:V MIH4M_!"P15S02H70BHC2&4$ MJ0Z15-Y9K+OR[NZ6MAA[?@0A#9M_>JQ%V60H@EP>A;7(""89P20C:&,$;8R@ MC1&T.43:EC83:UK8]@E8X_.:U%.@=W>RG5"$-691:V+8&Q1;F'016&2/H8@1=C*#+4.DJS(4PR`@&5\P%J5P( MJ8P@U2&2RIN0M2V\M!O9\_,+NSO>?$`N(\AE!+F,()<1UB(CF&0$DXR@C1&T M,8(VATC;TIYC30O;=J+8PK+KV-TQ@C9&T,8(VAA!&R-H8P1MC*"-$;0Q@C:' M"FT<#S'M=3"_KC7>!B8(!S!ZO+]=13.8#5D_7I:>IBV26/FJQ#. M8.69<`AK<285$0YF982361TBH2%>>Z$KVS<>]IJ+W?.##SM_)FP2 MZP+]%4$L(XAE!(^,X)$1/#*"-D;0Q@C:&$&;0Z0-/[AH6]&^\>374OOZ`V*3 MMO`5_:87VAA!&R-H8P1MC*"-$;0Q@C9&T,8(VAPB;2%>^]56:M\PGK=J\DC$ MSI\2FW19Y=QTT,4(N@S=;E\N@S]&\%><"4*Y#$(902@C"'6(A(9H[86&]@W' M9I3$6B3'+VI.@N<]/VNR\V?))K$NS*?V902QC+`.&<$C(WAD!&V,H(T1M#&" M-H=(6XC6K&U-^UHDQZ]CUK80H/W!LDF;"_-)&R-H8P1MC*"-$;0Q@C9&T,8( MVAA!FT.D+41KKZVTRBR*YZMLH7U=8D^Z&*%]&4&7H;@'WIT>%QX=A$$NA$%& M,+AB+DCE0DAE!*F,(-4ADAJBM9>Z]@ILD3R7N^='G';^'-HDUX7YM!8902XC MF&0$DXQ@DA&T,8(V1M#&"-H<(FTA6K.V-2ULD;S8PBZY)VV,L"8901LC:&,$ M;8R@C1&T,8(V1M#&"-H<(FTA6GMMI1:V*)ZOLH46=HD]Z6($78R@BQ%T&;*N M?EPZ%P'^N`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`&]26OXBCXE8Q4R@E9&T,H(JY`1 M-#*"1D;0Q@C:&$&;0Z0M1&J_"H.V-I,VJYRW(-#&"-H801LC M:&,$;8R@C1&T,8(V1M#F$&D+D=IK*S6O17#\&N9]QL(36/[(WJ3+A??4O(R@ MBQ%T,8(N0];/)YR\A__D'Y4"?UP&?XS@KS@3A'(9A#I$0D.D]D+7MJ]%\5SL M09Z^\N?Z)K$NQ">QC""6$<0R@EA&\,@('AG!(R-H8P1M#I&V$*E9VYKVM2B. M]3VOQX5]KS_D-VES(3YI8P1MC*"-$;0Q@C9&T,8(VAA!&R-HKH(\1])4F@DZN@DZ' M2&>(U%[GVN:U*)YK/&0$CXS@D1&T,8(VAT@;?G#1MJ)]XUG!I?;U1PHG;>$KYCL.&05M/`K: M&$$;(VAC!&V,H(T1M#&"-H=(6PC5?K655ED8GS]WI8?([/RQPLF6%HL$GU\$G(_@L3P6C7`>CC&"4$8PZ1$9# MZMYBU%)Z;E0VC2700(Y3((902AQ9G@ MD\O@DQ%\,H)/A\AG2.1;?%J"SWWJ"G4Y/_EDA"L0(_@T%'M^Z6]=X9/+X),1 M?!9G@D\N@T]&\,D(/ATBGR&J;_%IT=[[/,A;G?Y[\]);HTT:-7N`4YX>3E?,!:=<"*>,X)01G#I$ M3F%GD],P/H_RYZ-TOC^*.3FUPMD#UBDC.#44G3Y8YTN4ET(XY;G@=,5<<,J% M<,H(3AG!J4/D-.3^+>O4]@F8[RG=GT]RL?=G-2>G;H.1UBDC.#64UNGIL!R@ M9'Y(Y_FL]F1]6>3)873,9K'(EK#*"54:PZA!9#9N`+59MT^"MXN&T_!VH MUSM_!G2RZG8;R2HC6#5D5O&A(4GDN2%TQ%YQR(9PR@E-&<.H0.0W; M`.]TY`YTYO9\T`N6VV4DN8SPXLH(OOL()W??XVG'GW^\_H1_V<63 MH?TJ6[@9Y\^/3K;<[B'98@1;C&#+D#7U_?%QJ:DAD`LAD!$$,H)`1A#("`(= M(H$AQ&\1:*'?"]2;3/;1:2/T;PQPC^#)F_\^/2@8/0QW70QPCZRE-! M*-=!*",(=2@7&GIVB]#K>,J4=Y)_XJ@Y0%YP$#&^4'XS75"MHYJ$S.CI82FY MMVG0_`4[17U"MZ8:TJ!YJE'1E"$R&O+[AB4:SYWV2_1\)[<[_.G4<8T*JG:" M8-1M)ZZ%,&HH:C@LKU&I@U&>"D;+4\$HU\$H(QAUB(S"S2:C83RM4;TAYP^O M3D:MYS^/.UDT^T9DDU&L,D( M-@V93:36*!<"*&,('3%7'#*A7#*"$X=(JD9P2DC.#5D3K_;/_/)GE((ISP7G*Z8"TZY$$X9P:E#Y#1$_RU.;:N0.Y5[ MG/YH[N34[3'2.F4$IXS@U%!R^LPRY3HH902EY:E@E.M@E!&,.D1&0_;?8M3V M"IE1OK@JJ=H%I1DU"RNGS3LTW#?(:2^?LTZO9D M0QHV3S8JFC)$5L,>8(M5VS-XJPMW./V1X,FJVVS$M2JC8)5'P:HA$_'L_1$I M[%+AK`925\P%I_Q-P"DC.'6(G,).YG3E''T1XJG->DV%TD;(VAC!&V,H(T1M#&"-D;0Q@C:&$&;0Z0MQ'FOK:3+XC]^ M#4^Z%NYP^M/$DRVW;TBV&,$6(]AB!%N&K*E/BY_E"']W94@>&<$C(WAD!(^&XE5BZ2H.C5P&C8R@ ML3@3O'(9O#I$7D.*]UY+Z])2__[EJW@S_O7.'S^>Y+F]09+'"/(801XCR#,4 M%^%QZ3XG['$=[#&"/4:0Q0BR'")9(9YOD65QWB\^O.;)!QKYT\B30+<12`(9 M02`C"&0$@89,X/F9U<=E\,<(_AC!'R/XT340[AN#J/2P]L02C702@C"&4$?XS@SR'R%\+Z%G\6[KT_?6O' MG[&>]+E-0=+'"/H801\CZ#-D^O9XMUK?[($^KH,^1M!7G@I"N0Y"'2*A(:5O M$6JIW@M=>.;2G\6>C+KM0#+*"$89P2@CD1K_#GWS[(YM(?^9[4N@U%4LL(:AE! M+2.H98273T80R0@B&4$;(VASB+2%%,_:5MR'C,>WXZKV=!7'#DM[W&T2DC9& MB$6,H(T1M#&"-D;0Q@C:&$$;(VAC!&T.Y=JN9[)[;87[/?$,=[_*%K;@_J3W M:$M0A;>O\"O+MS@166?:*YW\I824M3I3E]"-F?HT9@ZV@Z)1T90A\AGB^A:? M%N]SGQ+*_7GPR:?;%\2FE5'U+J)T[5BX&#=IS&P!/GER^#1T8R;XY#+X9`2? MC.#3(?(),YM\AO&\R9'G+OW9\,FG%-:3[`^233K=-2,N3$70:,IW/V.0J MV&0$FZ6)().K(),19#*"3(=(9HCN6V1:U/CG/N5!(7_@?/+I=@C) M)R/X-!1?\I;VAO#)9?#)"#Z+,\$GE\$G(_AD!)\.D<\0V[?XM)B?^=1'6ORQ M],FGVQ\DGXS@TU#TN?A!?Q#*=1#*"$++4\$HU\$H(QAE!*,.D=$0V[<8M9B? M&Y5PZ8^O3T;=_B`9902CAM(*?:;EN0Y&&<%H>2H8Y3H8902CC(3(:$KTW MNG*[$X^J]V9Q;TI.%O`GVB>U;@^1U#*"6D98FHP@DA%$,H(V1M#&"-H809M# MI"TD>M:V8KL3SZW')>WI>KZTW?''VR=M;@^1M#&"-D;0Q@C:&$$;(VAC!&V, MH(T1M#F4:[MCXRE.RI_QI%%S=KPHJA35BIJ$THODXA^=I$'S%^P4 M]0G=FFI(@^:I1D53ALAHB.Y^(9:,6M3W?:M_QK/W1]K;^E,$HV[;"D++4\$HU\$H(QAUB(R&_+YEA5K>QWQ/ M+Y'Z1SS[.[6I()3K()01 MA#I$0D.$WR+4(K\7JAO)_9W;&"2CC&"4$8PR@E%#9G3_S(LHET$H(P@MS@2? M7`:?C.#3(?(9`OP6GQ;X0?#*"3T;PR0@^ M#46?1[LFB5"N@U!&$%J>"D:Y#D89P:A#9#1$_BU&;8N0&^6-.3Z743N>$8PR M@E%&,&HHK=!G6I[K8)01C):G@E&N@U%&,.I0;G3'6Z5U&_/]M2X/I-B82_/' M87-`O*3*&56*:D6-HE91IZA7-"@:%4T9(FTAV?N%&+25-^;[G>T(D+F>4N?" MQCP-FQU!F]M+7-L>VAA!&R-H8P1MC*"-$;0Q@C9&T,8(VAPB;>A$T5;^L._] M+M3EJTV?YT^C,FM6."-88P1KC&"-$:P9BJV]M"&"1BZ#1D;06)P)7KD,7ATB MKR'$^^58V)[O+/2[Y_GW$H=ORN`SR&$$>([AB M!%<.D:N0S[>XLCP/][YE^8F+_<[%_GA9%H3%QZ/@CQ'\,8(_0^9OZ4T*K#VN M@CY&T,<(^AA!GT.D+\3Q+?HLOGM]^K3T?N="?K+'"/88P1XCV&,$>X;2ZGNF M=[D._AC!7WDJ&.4Z&'6(C(9`OL6H!7AO=.'"ZU)^$LH(0AE!*",(902AADSH MXA,<6(]7P:=#Y#,D\2T^+;E[G_HD)3XC`+/F M]RP$P2>/@D]&\,D(/@VEE\^%&Y?PR67PR0@^BS/!)Y?!IT.YS_TW[E^N=7FB MQ#/:=#OV]3X.\ZE(4*6C:D6-HE91IZA7-"@:%4T9(FTAHOMEN'+_LK=HCW#E MPY#T=QR6:7.;@FO+0QLC:&,$;8R@C1&T,8(V1M#&"-H809M#I`U]F&DKY.Q] M&)^O,OU[[GT:6) M().K(),19#*"3(=(9@CI6V1:J/_=Y%_V23$6PR@DU#T>9B*(1/KH-/ M1O!9G@I&N0Y&&<$H(QAUB(R&D+[%J(7ZW"@_U[O'9]CRU5D0C/(HD1G&C M>>'""Z-^_2?UJCC&"4 M$8P:,J/Q0_KS^]T0RF40R@A"BS/!)Y?!)R/X9`2?#I'/D-2W^+1DG_O4%>KR M?_+)"#X9P:>AV/-+?^@)GUP&GXS@LS@3?'(9?#*"3T;PZ1#Y#$E]BT]+]MZG M;K[W+OXGG8R@DQ%T&C*=CXM_5@>?7`>?C."S/!6$.;XF#1JGAY.>2XX73$7G'(AG#*"4T9PZA`YA9U-3L-X6J?ZAO?!1LT_-)PR M@E-&<&HHK:W3XN?/8Z%R):0R@M0UD\$J5\(J(UAE!*L.D=6P`=BR4FW#@/F> M]DSGDVS1#VY;$5]1!<$JCX)50]'J_G1<>C<"5KD25AG!ZIK)8)4K8941K#*" M58?(:M@$;+%JFP9O=>%&W,%M+9)51K#*"%8-F=7GCH])H^96@%2>"U)7S`6G M7`BGC."4$9PZ1$[#-L`[7?DPP<&V#YE;_0@8?&#O]>5B_NGQ0L`(%C\)!QW-=5B0C&"T/!6,X-ZF0?,7[!3U"=V::DB# MYJE&15.&R&A([QO6Z-'2?K9&]89<'#5_5S#JM@GQ55,0C/(HD&@Z+GVT' MHUP'HXQ@M#P5C'(=C#*"48?(*-QL,AK&TQJ5XV/V1QN5&66$-EP^]R`-FK\@C/)4,%J>"D:Y#D89P:A#9#2D]BUKU%(^YGL*0GI3[NBV`O%E M5!"$\B@(902AADPH/A=_Z<8GUB@7PB@C&%TQ%Y1R(90R@E*'2&D([5N46LCW M2O4.TM'M!))21E#*"$H90:DA4[JTI81/KH)/1O!9F@@RN0HR&4&F0R0S1/DM M,BWZ>YD+]SB/;H.0;#*"34:PR0@V#9E-/`#SS`+E0@AE!*$KYH)3+H131G#J M$#D-.7^+4]L7Y$[ECWF.;O>0G#*"4T9PR@A.#9G3[_",S\+;<5BD7`BGC.!T MQ5QPRH5PR@A.'2*G(?IO<6I;A=RIW.,\N@U%>N`Y* M&4%I>2H8Y3H8902C#I'1D/VW&+6]0F94[W`>W8XB&64$HXQ@E!&,&HI&=_O[ MI><:L$RY$DX9P>F:R6"5*V&5$:PZ1%9#_M]BU?8+N56YPWETNXIDE1&L,H)5 M1K!J*%D]W2V]YP&K7`FKC&!US62PRI6PR@A6'XT\81!5#X51#_6V(KMBM$D!(($)(^!&T-B4KBR+CMZ_>,[RZ^>V;0LO^: MHYV5^3JV[RX8XHGXPI^/Z0\Z/`;\?"K\G/!SPB\E^94)/ON]]MD:DW]V;'S< M;)&N#[KWERJQZWP4CDXX.N$8J7_+V0^;^OED]J'7X>B$X_BID/4Z9%.2;)GC ML^S8SHRY/W_@;)$N!7H^)_BPG,!*25AE M0)^"%0-]WGZ\ZE6?.%NDN;\'=`+0"4`G`)T`C!2`S3L<^'D9?D[X.>'GA%]* M\BOC^!2_&-^S7^.V^B(-^3V?$WQ.\#G!YP1?I.";MX9P^+P,/B?X1L^$IY?A MF9(\RR`^Q3,&]Z%G/;ND\;[W=,+3"4\G/)WPC!2>S6MO/+T,3R<\1\^$IY?A MF9(\RP@^Q3-&]NS9^$CD(@WVO:<3GDYX.N'IA&>D;G^V;KCAZ65X.N$Y>B8\ MO0S/E(:>93"ZHP\AQ,:_299T^UNFJ3M=]ZO9GX];037_( MX1%\JM-MGUX^T>?^D,.)O@R2-,M4/F%W+F.*S[NS<:72'75X"&BF\7^_8=%T M0M,)32R$SR+,#KA&:G;5"],0]4Z0'TJ0)WP<\(O)?F5<7W*?HSQGO,]7]34 MW]Q9IFN`[L6R2O#Y*/BWU\'G!-_XJ0#U.D!3$FB9TJ>` MQE2?01L?>%ZFV;\7=4+4"5$G1)T0C12BO[0^V<+KI92G>,;@/_2L[D8NT^5![^F$IQ.>3G@ZX1FI\YRW;D\"ZG6`.@$Z?BI$O0[1 ME"1:1OLIHG$ID$4;=R*7Z8*A%W5"U`E1)T2=$(T4HHN77C*]#E$G1,=/A:C7 M(9J21,MP/T4T+@8&HOP"[.%'GS[,E^F:H2=U@M0)4B=(G2!U8DLZ`>@$H!-< M3G"E)*XRNV>N5W[<>1DS/R^]S^\]K?N/W6&#-^]TM;"7A,T)-B?8G&!S@LT) M-B?8G&!S@BTEL941/;.-W.59QDB?=UGC_F-WU$`K70OT6DYH.:'EA)836I'B MJ?PV?G^Z?_4J@%X(H!.`3@"F-`1<3;R2V1\_G!5;=WZZP^+K^:UU;^&"7][) M_[O\*R$NZ_2Q3E=UNJ[339T^U>FV3I_K]&60Y%>F\`D;]Z`_'7VZCO8 MW6%Y!U8)KG0)L-^4<#G!Y027$UQ.<#G!Y027$UPIB8LO?,#URI>Y55DW_FV6 M[K`!6ZP\)-B<8'."S0DV)]B<8'."S0DV)]A2$EL9K:?LLAC%\\WL59K.NS?. M*D'CHZ!Q@L8)&B=HG*")U+_,M:Y2P/(ZL)S`2DE896Z>@A5S-OCY+;2ZF;V* MP^*Q\]O;&E=8O*;E@YH_O(QQ''/8D1@[8>R$L1/&3A@[(>J$J!.B*4FTS,U3 M1&/.'HHN:M$TCO=;T@DN)[B)*F*7P/B)836DYH.:'EA)836DYH18J7D^6;UHB$G]?AEY+\ MRI0\Q2^FZNS7N.VW2K-WO]N<\(NT/#X_^_=\UKP41=3K$'5"U`E1)T2=$'7" MSPF_E,+OY.GK>KV[O-O=G9]]7V\?UA?KQ\>GHS\W__S@>?B6+^FY'FW7]^^. MW\].W^_?6M4_S$XO9\/:Q_O]L^?/OQ M=/2XON&ULE%?;CJ,X$'U?:?\! M\=Z`$W(A2C*:8/7N2#O2:K4[\TR(DZ`&'&&ZT_WW6X6!^-)#2#\TP75\.%4N M5]GK+^]%[KRQ2F2\W+C$"UR'E2D_9.5IX_[W[_/3TG5$G92').7BB6' M9E*1^Y,@F/M%DI6N9%A58SCX\9BEC/+TM6!E+4DJEBU1\-J>L4Z>K;J>15LL_![W<2)FG'W;Q8]$665ESP8^T! MG2^%VCY'?N0#TW9]R,`##+M3L>/&_4I6E$2NOUTW`?J1L:M0?COBS*]_5-GA MKZQD$&U8)UR!/>P8> MH6.KPP=E(H6(`HTWF2%3RG,0`/^=(L/4@(@D[\WSFAWJ\\:=SKW9(I@2@#M[ M)NKG#"E=)WT5-2]^2A!IJ23)I"6!9TM"9EXXF2V6C[!,6Q9X=BSSQUG"E@6> M'0O(&G;$ET%I8DR3.MFN*WYU(''!;7%)_#"Y$%>=\Q4G-5$`+ MR(BW+5F&T[7_!LN8MJ#=)Z"I"8H_`>DTM$-@BH#F7CBXK`K_/!LZP0@V!(>+ MN?ZEG0V:Z(CX+H+:"#)?SGH:S0/(`M4##/T<=L>P)S@),MAUU-"'_0>:]=E) M4-AD,"Y8;`Y094#3!"F@:AK6@N"-"R[W6J)@:4B1F'F3))%NBZ7M)I,J`YHJ M2,CQJA"LJX+DO"V!C)`$W3X=FP-4&="TS'4MXU8-)]U=-0E2-)D#5!G0-"UT M3<.KAF`]/E%`])7924PHM_;<,Q8U'C;3SFQN6>S(2JT9EHE@0R8Q2XS$2)E/ M,\_,KV$S[4*$P MM)ME.O6,TT9\#T![@)63V`;&JY5-0U=K5BC2=1;<'$\D\(P317P/0'N`I1:[ MP7BULG?H:JU"U#48J=8SCVEDV$Y[NZ456\)XK;*!Z%J-RK(C79=!K3,OB+0_ M*RD>0=.>V_(#N\)X/V0/T?RPSG%PPY/Y#-]JCE!Q.Q(UAX3`;+YX)>PGR,TF M;WCR]G%)3NQ[4IVR4C@Y.T)5#3R\=U3R?B=?:GYI#NU[7L.]K/EYAGLX@Q-M MX`'XR'G=O6`(^IO]]G\```#__P,`4$L#!!0`!@`(````(0",MJ[&D@,``+P+ M```9````>&PO=V]R:W-H965T8EA/+QX=3%Y=I\ M?BUR[X5)Q46Y]4D0^1XK4Y'Q\KSU__OWZ=/2]Y2F949S4;*M_\:4_WGW^V^; MFY#/ZL*8]H"A5%O_HG6U#D.57EA!52`J5L+*2><_UF2'VO2-=?SZ60])B#WZ\DIFG#;5X&]`5/I5#BI`.@"ZW0H<^K,D@VI`GS,!1 MB&>$?LW0!)O#P>XGDX&_I9>Q$[WF^A]Q^Y/Q\T5#NF?@$3JVSMX2IE*(*-`$ MDQDRI2('`?#K%1Q+`R)"7\WSQC-]V?K3>3!;1%,"<._(E'[B2.E[Z55I4?RP M(%)369))33(%]?4Z"9:S63Q?+L:SQ#4+/!N6>1!/9HOE""VA]M-&[*.`0:20Y`NR&"Z(A8(LO^S(,IYOPA=(35J# M]A8$)^L.FA#2!1T:$*8"J9-WJ-LM(3C1>@)1=CUY/\.-8`3W!,>+ON!W0/-X MU7[=Z#N,`25#T*2EZ3@!)>(Z@>E80=$_=@8W06&Z@5W&B_8#1N?>@F)3F!C8 M0]^0.(:.)B@+5]-C+0C>^N!OF^35M)?CO<6L3)TL@EE7Z.'A:O+1:DL;DL:`M1^WNSNJYK^B"L&HJCD'>VMP)/0-26,PQX\X M<>VH6/R*"@1W8T.6I)>PO04YROJ&I#$\5H9WKM.*'M<9@OO*XF4;>%OS%N0H MZQL2Q]")TJJK9=PYQ$T_/8<6Y&CJ&Q+'T-%$H!&,#Y!!]R,TR%V-N4:X\>Q_<+8F+Z<8+NZXC:%P2B>W5/^FF->HN MXS"P)*ZE*PP[K2/L<:7#>#0L]6$BG>YM+Z9ZWUTB#EK(9!MO%-S;LE5GAR@[ M'11,GMF!Y;GR4G'%`8E`NVZM=GC;DS7>:E\G)V@JU1 M@&..M-.7?=&B,M?O46B8FLS?"TS)#"ZF*`#P20C=O.`'VKE[]S\```#__P,` M4$L#!!0`!@`(````(0#V]]+H+00```P/```:````>&PO=V]R:W-H965TWDFQ$E0 M`XXPW>G^^RWC0.QR9CJ]+]WAU'%1IZKLPLLO;W5EO=*6EZQ9V63BVA9M"K8O MF^/*_ONO]"FT+=[ES3ZO6$-7]COE]I?UK[\L+ZQ]YB=*.PL\-'QEG[KNO'`< M7IQHG?,).],&+`?6UGD'C^W1X>>6YOM^45TYGNL&3IV7C2T]+-I'?+##H2QH MS(J7FC:==-+2*N\@?GXJSWSP5A>/N*OS]OGE_%2P^@PN=F55=N^]4]NJB\6W M8\/:?%>![C[DM0(-)NM?2P MLK^214:FMK->]@GZIZ07KORV^(E=LK;P'!8L=8 MG?85^*.U]O20OU3=G^SR&RV/IP[*[8,B(6RQ?X\I+R"CX&;B^<)3P2H(`/Y: M=2E:`S*2O_7_+^6^.ZWL:3#QY^Z4`-W:4=ZEI7!I6\4+[UC]KR21JROIQ+LZ MF4'T5[L_F7G^//R,%WA?'\K\YL6;>*%/_.#C6!RIJT]3G'?Y>MFRBP6]!Y'S M;D%>65#CF[M MYKIX"TA2T.\0?X;+M%7-'B$^6AYK]H"@Y"2JV8_(--`+F*KVT`LC7[=GJMV? M^ZX[VK6TP$'T>%H$&:4E#-!6W4B24E4,Q!A(,)!B(%,`+?Q`#U^<>!]O9K'H MP^:4)$4&!F(,)!A(,9`I@"8##NO'JR#(>A7PF;J1%"5X#,082#"0#D`_`'"5 ML\$JYK5ZNHIO+64$_7R;";*N)(KPL2HYBA0,Q!A(,)`.@)#RA/9A-ABQDN@S M2@195Q*B]VPD11&"@1@#"0;2`9`U0?,E&ZQ8"8'Q]GA1>K:N)8K0#-I<28H: M`XD-)#&0=$2$(G229*/1$"1F^\-=1N27@'J:A[C+KAQ5CUQU0V*#DQA(.B*R M0J@'LM%L*!+S^'%%!SVB2 M@QMI0BVQZ7VN;%63,O#[#[_8X"0&DEX1.;P)_KH5MQBQG_O72$WR4B*_MFO: M'NF65A6W"O8B+AP$/@)&5%Z&$G$9ZJ\SHP'N(N?\2'_/VV/9<*NB!UCJ3N8P MW%IYFY$/'3OWWYH[UL$MI/]Y@ELGA4\D=P+D`V/=\"`::;S'KO\#``#__P,` M4$L#!!0`!@`(````(0!YDP)M)P(``)T$```9````>&PO=V]R:W-H965T= M&,V5)ME;<)+JPW&\8TJ.@-B+7M@7#\5(LO5S.RA-]SWH/B?WE%W9_G"#EX)I M951C(\"1T.BMYISD!$A540M0X&Q'FC']^27X9%X](].IZ9,6 M]1G]!EU1B0,X%D]4R_JMB"$KRA3U`<-BP,8*0M_TIU*P:#>MX`-HX>8!UTV*]PL&KT1N^5A;WPCQW\!CA, M`>@8-4K9Z\%M\/QCJ?X```#__P,`4$L#!!0`!@`(````(0`YLL<'XP(``)D' M```9````>&PO=V]R:W-H965TOAYL$(ZE(DY&*-W2-7ZG$MYO/GU9'+IYD M2:E"P-#(-2Z5:I>N*].2UD0ZO*4-[.1L_30TT;94D$K8@"_;)DK>S8ZO0C=#413X?V)N5U"Q1[5C'U M:D@QJM/E8]%P0?85^'[Q9R3MN,WB@KYFJ>"2Y\H!.M<*O?2\1#^8`OP0**,Y.53J)S]^I:PH%50[`D/:US)[O:F*;$*#U(Q>N_%N2?J"Q)<"() M0?UI/W"")/*C^746URHR!N^)(IN5X$<$30-GRI;H%O27P-PYLSIZK^]9!8^: MY$ZS&"YP(:$\SQL_B:*5^PQ)34^@K07!E3B#QHA=A]"U`'V]2+`^%1E"$=]. M?Z=)!XTUQ?'XO.TE)!@C=F\@DAXRT@C)FVJ?"GO>OOHH+$\N';G_K3Z+&AA,NC!U%F,/I-F@RFJ*3NT M-^O+8=7:$6DG2$U%07>TJB1*^4&//Q\.Z9_:R;R%R6SFF-MOP&1L24&_$U&P M1J**YA#J.;I5A9VM=J%X:^[OGBN8B>9O":]`"E<`?&"4&ULE)C?;Z,X$,??3[K_`?&^`9.07TJR:K!ZM]*M=#K= M[3Y3XB2H@"-,F_:_OQF&@HVSD/:A22;?F7YFQA[C;KZ^Y9GS*DJ5RF+KLHGO M.J)(Y"$M3EOWOW\?ORQ=1U5Q<8@S68BM^RZ4^W7W^V^;JRR?U5F(RH$(A=JZ MYZJZK#U/)6>1QVHB+Z*`;XZRS.,*/I8G3UU*$1]JISSS`M^?>WF<%BY%6)?W MQ)#'8YH(+I.77!05!2E%%E?`K\[I17U$RY-[PN5Q^?QR^9+(_`(AGM(LK=[K MH*Z3)^MOIT*6\5,&>;^Q69Q\Q*X_6.'S-"FEDL=J`N$\`K5S7GDK#R+M-H<4 M,L"R.Z4X;MT'MN8!<[W=IB[0CU146=Y_:-,#W^EA8!J0Y^P`T]2/J/T MVP%-X.Q9WH]U!_XNG8,XQB]9]8^\_BG2T[F"=H>0$2:V/KQSH1*H*(29!"%& M2F0&`/#;R5-<&E"1^*U^O::'ZKQUI_-)N/"G#.3.DU#58XHA72=Y497,?Y*H MSJ@-$C1!X+4)PN:361`NEI^),FVBS+HHX=U1/,JK+A./JWBW*>75@;4'Y.H2 MXTIF:XB,]5E`9I1-6[%?%0PJA4$>,,K6A4T#[@JZ_+ICR]EJX[U":Y)&M"<1 M_.Y$IB*ZH0@8,T7\AF@Z"UJ1!XFUV4'%]>QN=_TC"11C$K@*,*L]&73@8-G^ MG5H2V1(V7_JFB-LB+8[!"SW6>;$;*UCSP]SH!.M2K^LR[#'L231KDXOZ!JX9 M#"98%3K3,`N*MRXDW/9X9:&09EXOD^G"7_A^#S8B10?+-8/!!BM59\-Z34?K MA4XF(UN&O56V)U&'$/4-7#,83'.;:;R'Z#3:0Q)I3'T#UPP&T\)D&NXABJWZ M=!N,]@:)0MKKTR7TT.HB23IXRFOOZ:(%M.^NUMU%U8)%EX;K%!,-!W0,;;S&C\3XR?QN5#D9^ MG87K&A,,9[,&-M)FFN2]2EEM)E739G]ZL\VDT1$'O4QH'-KW0].(-Z#9RGJ$ MT`X".H!9W\)UBPF$$UL#NN]TQ:?%\2WV!C;27AKR1J66 MH=5>4E%[0WABQ1]SLT1,.R[J:O+&\@LO$QJG^?W0-/MUZ-5L;O+LF7%`W"0F M15=F/N1C\N)P^J> MD:CI[CR\66'MJ&F(![T,YN!3QU&M-H^CE75I:$1=QZ/&TF01W'KTX,,:D[EW M&@UOOL`^A>P'W$:D,Y-;9\%++XZ5]BG8V)X$2)=:NJWEHCR)2&29K;6]3#\$]76X_0+NLI?X)+['Y2DME).)([CZ$[SBE70;I@^5O-1WP2=9 MP2VV?GN&_UH(N`;Y$Q`?I:P^/N!]N_T_R.Y_````__\#`%!+`P04``8`"``` M`"$`)Z=!OO@"```3"```&0```'AL+W=O';`@%7`R'::]M_OVDX(T+1K M7Q+,/3X^]]S+]?KZJ:F=1RHDXVWB(B]P'=IF/&=MF;B_?]U=Q:XC%6ES4O.6 M)NXSE>[UYO.G]8&+!UE1JAQ@:&7B5DIU*]^7644;(CW>T18B!1<-4;`4I2\[ M04EN-C6UCX-@[C>$M:YE6(GWS$;18OZ!N6"2YYH3R@ M\ZW0ESDO_:4/3)MUSB`#;;LC:)&X-VB5QJZ_61M__C!ZD(-G1U;\\$6P_!MK M*9@-9=(%V''^H*'WN7X%F_T7N^],`7X()Z<%V=?J)S]\I:RL%%0[@H1T7JO\ M^9;*#`P%&@]'FBGC-0B`7Z=ANC/`$/)D_@\L5U7BAG,O6@0A`KBSHU+=,4WI M.ME>*M[\M2!TI+(D^$@2@OIC''LXCE`T_S^+;Q69!&^)(INUX`<'F@;.E!W1 M+8A6P'S*S.KHUNBS&-A-&:'&NBXG#_-8<%YK-RK+#V&PO=V]R:W-H965T:R-46^`DBC'B+5.E:'<%_O/[]F*!D;&T M+6FC6E[@1V[PU>KSI^5!Z3M3&7+^'0U658/Q&L;WDK0TDFC?4@GY3B\X\L4GV M'CI)]=V^NV!*=D"Q%8VPCYX4(\GR;[M6:;IMH.Z'9$+9$[=?G-%+P;0RJK(1 MT)$@]+SF2W))@&FU+`54X&Q'FE<%OD[RS1R3U=+[\U?P@QD\(U.KPQ9PE`$=;;NRM<)08 ML;VQ2OX+H.1(%4C2(TD&ZH_[:90NILET]C8+"8I\@3?4TM52JP."0P/O-!UU M1S#)@=E5EH$_+U<&);F<:Y?D4P%MH!OWJR3+DB6Y!P_9$;0.(+@!/2@=(S8O M(!8]A(#`7B74_G&5+FFL,IWW]+Z0=8`LO,^NLLT@,!(`UGQ<@$L".P<.@$TG M)JP#:/(L81`829B,);S>(0W??V;(:`19K$ MS_LC97"&A^:\KLR!SY1-3I0%T,"406#TZMGXU>\[OB[IS;X$T$#"(#"2,!]+ M>+UZ!SZK_K0O`13ZDDYG<3QV!R:=(SGN)\E@/P@+VRL)`\X\U?+\X7+(X`G"EE'U:N-';?Q%7_P$``/__`P!02P,$%``& M``@````A`!@:':%(!P``>2```!D```!X;"]W;W)K&ULE%K;CMLV$'TOT'\P_&Y;)'5=K#>(1:0MT`)%TSMBO.N^)8G\OU_$?9SC\]_?S3XUO=?&T/9=G-(,*Y7<\/77=Y6*W: M[:$\%>VROI1G\.SKYE1T\+-Y6;67IBQV_4.GXXH'0;PZ%=5YCA$>FC$QZOV^ MVI:RWKZ>RG.'09KR6'3`OSU4E_8]VFD[)MRI:+Z^7A;;^G2!$,_5L>I^]$'G ML]/VX;>7<]T4ST<8]W<6%MOWV/T/+_RIVC9U6^^[)81;(5%_S-DJ6T&DI\== M!2-0:9\UY7X]_\P>9"CFJZ?'/D'_5N5;:_U[UA[JMU^::O=[=2XAVS!/:@:> MZ_JK@OZV4R9X>.4]_:6?@3^;V:[<%Z_'[J_Z[=>R>CET,-T1C$@-[&'W0Y;M M%C(*898\4I&V]1$(P)^S4Z5*`S)2?.__?JMVW6$]%_$R2@+!`#Y[+MON2Z5" MSF?;U[:K3_\AB.E0&(3K("&PUWZ^Y&G$HOA^E!4RZ@FSJMQE4#;RS MO12J!MD#1'X?&?(8QGIKJ#!&%>2SBM+'@E&T,#_?GIA@V>/J&R1UJT$;!,&: M,""*R-\1*H,JKK0,*R`\L(9C+&4%(G_-0,&=\.0'XU2ZIWZYVPCR;PER!'>:" M\R$E6!,(,G.>NP9I&0@7!JW53J,2B?M]JG_J;J/2*(N69Y&VA1)3^C!Z?AFJ MR9UNI5$XPRF+0YK&G/K#P%$Y2?QQ&MZH3*948CQUU!2;NM^O^I#KN:[-`+:( M+G6,@H`H<+N&)`%$DMYHM$Q)QWCJ*#0V=;]?]2$'ZAE+G.+--<"4B;0MM"B4 M7HRGA^IBT[O2M!BB,',+QN/,:4DY143&V:'TE6B,IX\20^C[ M34OM5:%!(/TPC$.OJ&V`7_22!$CMHJ?ALEKX1B/'F4%9O\E=Z%('QS(K(D-LM#S[J- M8*D(`].>]`HC"*;4^?H2XXZ>?9S\'DW5U6]@&H3\>19EYM5(7P-,M4C;0M++ M)ZE:CZ;TKC0PC4)^BQ@:F+O-SBD$,IPESB"D`PG")#331,<`TSV^1+A".V/P MZUNC<`PLBGCF[+=SBO!7@*0`L@(H_4D2QWV)@REP>NQ&HTP%Y)Y%VA9*R!&U M<8V,HVS=:60:91/#YXQ%VAA*;))-7M,T_-6H4TELP6/O.I.<4D3)7_20% M1&%D#L64OI*1T>K&473LY,+VT#D4;C0*Z7/HO@X@)P"_Y"7UVR5/N*N/8#9W MU2;N?QCKGW+:K_?-8*-1IBGDGD7:%DK,T;1Q_4O@B>U._](HFQ@^9RS2QE!B MDX1*C!(JC<+^XWU[(5YA]!,W,<2;W=B`B4GRU*/I]/JM2X.0LW!/+SEQ+\S* MT:11`/'AA;7R:*H=#?NX:PG4('MA^5U+@_#%J7LF&[S#]V3;0KE-DC%Q1<;\ MGJ51.J7#5A258'`:;A@4X,C4:9-9Y[%FE;*"%'HD:V(Y2J>^T(438QUR*%9:'$)HF/ M&"4^&J7GUSWTY<0=N5_!)7&+U$P#X1TZPO/QVN[1]SJ2!J%F)@DWO1!7$/'# M6=;LE;`I$3\/XALK*G24Z0YS5):/NU(?$CZ1]OM/_POQX!Z6OFVA:9VD3N$5 M=?+;DD;IK53"$Z>;YQ00QI%SS)(4P%)K&TO93Y(IN,`=<3;0*+Q-8IPYW'+B M][]P$+==[$@<;X#Q@O14-B]E7AZ/[6Q;OZK;7083.ECQYGD#-\_]->UJ<,#% M[Z5X*?\HFI?JW,Z.Y1X>#98)M/<&KX[Q1U=?^MO(Y[J#*]_^GP>XXB_AMBY8 M`GA?U]W[#ZB4U?"?!I[^!P``__\#`%!+`P04``8`"````"$`IF-72OX"``"\ M"```&0```'AL+W=OW MSU5I/3&IN*ACXMDNL5B=B)37>4Q^_WJX61)+:5JGM!0UB\D+4^1V\_'#^B#D MHRH8TQ8@U"HFA=9-Y#@J*5A%E2T:5L,OF9`5U?`HB MO"8&(9+78(@LXPF[%\F^8K4V()*55$/]JN"-ZM"JY!JXBLK'?7.3B*H!B!TO MN7YI08E5)='7O!:2[DK0_>S-:-)AMP\G\!5/I%`BTS;`.:;04\TK9^4`TF:= MM&=%Q!GLVX-^L/900V^6ZH0A\^2I]]XS4?N`(2:QDK[2H_IHDKRW* M8+6EW5---VLI#A;T&[)50_'V>!$`=S49A+[*,R M0X/)X/>P^&70XQIFDS-K[1[JF8V)T&)_@2T^T_E.&IZ#MH"@WK%PZ4Y(CTF+ M4=(98X'Q>F,QN67OG3614WW`/81M]7FA_5]]>&[,<(S`R8'B,^T+QZR7;PDF MCZE,Y%0,#MO)^S!S5S94=ID!SXT9CI&QF-<[,[KRJS'K92I,'E.9R*D8#V;4 M5(V_]*ZX>^W),4D7&@N:]?=Q),C#MWW@XV5%;?:$S8R+-S1-Q@->MR#PK]%T M'`W^Z[#`EPN]'&N:G]'TKHD!FV3:IF-HH,GL"C.0*R9S]HF5I;(2L<<]X,,D M[:/]CMJV]4_CLVAK=I?3_P*[HZ$Y^TYESFMEE2P#3-<.0:PTV\<\:-&`!;!! MA(:MT7XMX%\"@VGJXEN<":&[!]QO_?^.S3\```#__P,`4$L#!!0`!@`(```` M(0"?9(^R1@4``$L4```9````>&PO=V]R:W-H965T2%EEM%CHYF"H:Z1(Z3$KS@O]SS_\;U-=J^JD M."976I"%_H-4^O?EK[_,WVGY4ET(J350**J%?JGKFVL857HA>5(-Z(T4\.1$ MRSRIX;8\&]6M),FQ:91?#6LX'!MYDA4Z5W#+SVC0TRE+B4?3UYP4-1]WUIUH>_;,CM&64'`;<@3R\`SI2\L-#PR!(T-U-IO,O!;J1W)*7F] MUK_3]X!DYTL-Z1[!B-C`W.,/CU0I.`HR`VO$E%)ZA0[`7RW/6&F`(\E'V%I%10;F_+R<2:&V]0 M(FD;L\(QIARQ%A&L'IBLIX*-"GP5;%40J"!4P4X%>Q5$*HA5<.@!`ZSM_(7: M^S_\93+,7^',2H"[X8K=:Q$AFG@JV*C`5\%6!8$*0A7L5+!70:2"6`6''I#, MA,)'9MHP-SV>541MLE8P?TBU:=2K3#X+]C*HAM;A1FKEO!UC$V!:T0\1#:( M^(AL$0D0"1'9(;)')$(D1N30)Y)A8\4POOX,V-I:7[+T947Y,O^@/FU89_CJ MPT1D'ULRZ2;,-2(>)_:D5Z_V:"S7ZZ8+$BGR$=DB$B`2(K)#9(](A$B,R($3 M<];LQ_I+#PQ,JL6?LI:)R-:VI&^JE3,[.NEOYEZ4+2P M?155RZ)E:SEQ8$7KS:!*1:Z[(-$?3PB-NVK?8.1S9#E=T!8I!;A9B-$.*>V1 M4H2;Q1@=^DJ2D[!1_H*3+%IVLB60J9Z3$_G=7O.@]ONCV6^VS?@7"2.;-F;6 M5+)M.FK1^6W`W?LMD@V0;"C).K8UE+NV0ZI[I!HAU5A6A4]>6?705Y7L-J'D MON!W$RX;WB*E=J=R!]9ME'5?WSR!K*XN-P*Q"?YM.;9FRO3ABX!>+0MT5PX$ MNBN'`G%E:^*,%(MV(N(NO1?H+AT)=)>.!6JE36>D;'T.(J*1ENUG7P^?GSA@ MFZK6NT#W/JXQ\C#:8.1CM,4HP"C$:(?1'J,(HQ@C=E[1#+L9(_>/GS_P#]J< ME&>R)M=KI:7TE9TMP('#V(5M`&[A35Q86#$/)BXLC9A'$Q<6 M-\R]J0OK!^;!U(75`/-HZL+<#MSH.@I'.;?D3.*D/&=%I5W)"=(Q;'9U)3\, MXCGGV.$YB3!P' MMF=F]^]+ZN)(HIN96?1EO3DB*?)0%"7-ZO.WZNR]%$U;UI>U'X[&OE=<\GI? M7HYK_Z\_^:>Y[[5==MEGY_I2K/WO1>M_WOS\T^JU;I[:4U%T'EBXM&O_U'77 M91"T^:FHLG947XL+C!SJILHZ^-D<@_;:%-E>*%7G@(W'TZ#*RHLO+2R;]]BH M#X--,4YZ\#_]E1>6VVMRM]CKLJ:I^?KI[RNKF#BL3R7W7=A MU/>J?/GE>*F;[/$,<7\+)UFN;8L?Q'Q5YDW=UH=N!.8"Z2B->1$L`K"T6>U+ MB`!I]YKBL/8?PB5G4S_8K`1!?Y?%:VO\WVM/]>LO3;G_6EX*8!ORA!EXK.LG M%/VR1PB4`Z+-109^;[Q]<S]T?]>NO17D\=9#N&"+"P);[[TG1YL`HF!FQ M&"WE]1D<@'^]JL2E`8QDW\3WM=QWI[4?34?Q;!R%(.X]%FW'2S3I>_ESV]75 M/U(H5*:D$::,P'?`R!W%2"G"5RFRZ6C"XME<3']'&GE`*VL?ZAC2T\+">]G,IN-5\`*+)5``"+JPX+L_P]AH14,2SNTU<`M3N;$H"6T2N("J0MP`[!B@(7HQA!! M30Y7D\X$*D'=6)EP>-Y*F5#6#1*](TA"D)0@W$0LSZ$03,_O>XS"L/J`!6/Q M.+1NI=`4"L40BASN>Z&>?(*D!.$F8D4!D[T_"A064>BYMPHQ6"9(0I"4(-Q$ M+/^@7$W_L'1GL'WH'>?=Q8MV;-H-\U=M8[\`V--N= M.)_L*)10**40MR#;36Q'AIM(?C3'\[(Z2+Y[6P]E8P-&-&%;!3GDSUWRI2)( M:<7DIJBAE$+<@NRHL(D94;U!/DH[-:L@<^43*,'+!BK>I%(*<0NRW<3N9+B) MY/_0)A_*-F=QWW<^LZDN7.Y[*4UTHFP9Z4@IQ"W(#@I;FA'4&]RK!FBN&K,G MJH5/H"0D4$HA;D&VF]BK##>1^S`6NTYW*O.G;8W`X/$W@AN'NH?(AF?Q+B$& M[H$!>3EA4_$4`G<*B#1D'G`9J'3[E(MA5R^;$*V<"6XEIB0L)C3K.^' M):3MZM90K,-RO-LI`=@%-AA$(IA;@%V=6!?=78MW!O MCF'!?_"5"`\Q3E]7D'TBF3F+8W>3TLLIH5!*(6Y!=DA.JW^#>=K/X2'5.6OL M*)10**40/LK>;$DWY2.K?*JKBN98[(KSN?7R^AD?4&%%;58]+%]WMVRJGW?= MD7"RQ,,9D$=&8A@1NRH9`6MPJ!C2F<&(J&Q7A\$\L(H&=!C,`\D8&)DOX98Z M@"^6<#LH=W90WC>ED<_,L)@1.RR9"2"$7'0=4:2<+[$YDX]@%?T MAV%;8&I`?@N3#\K#U$,S/TS`_B#QP.X@N<#M(+60P4$[D#^1OJ"/&5[AK]FQ M^"UKCN6E]<[%`1;96!R^&OF.+W]T]546`MX0Q_@6&ULK)W;\)5/)]B8V-VYEJ6RK:B)95"56YWO_TF""03P,^F5'+?C-H??R3`1`)( M@"S.AW_^\?AP\?O^Y7A_>/IX&5S-+B_V3[>'N_NG;Q\O_^]?V3]6EQ?'T\W3 MW'9[W3W3EZ^'E\>9$_WSY=GU\?MG?W/6%'A^NP]ELWI\'+SY8'N^X]@?G/+MOM_@/G'^]N7P_'P]71% MYJYU0_&>U]?K:[+TZIGU0/?#D)N__7FQ\/I M?P\_B_W]M^\GZNZ8[DC=V.;NSV1_O"6/DIFKL&_&[>&!&D#_>_%XKT*#/'+S M1__WY_W=Z?O'RVAQ%2]G44#RBR_[XRF[5R8O+VY_'$^'Q_]H4:`:-1@)C1'Z M.V)DHF!D"M+?D8)OK'UNC%![1XQ,U+XP!>FO*1A&5\M@MHZ69&NBX-(4I+^F M8#`7ITT4I%'7>YO^+6*X_EB]8I_`NY7]1];N#.@_AFJG;O9:AW0_ M0I*;T\VG#R^'GQ4I?1 M.#C2"/_]TS*94?YESVP9B,-#SYFLX"*)#U(?9#[(?5#XH/1! MY8/:!XT/6A]T%G"<22/%<>;X!,XQJ=0T53LQZ47<5FL"/56KD-L!28"D0#(@ M.9`"2`FD`E(#:8"T0#J;."ZD(7Z&"Y6:9@;J#VM<>X&VU:(%_;%$D1>-@V@( M1R`ID`Q(#J0`4@*I@-1`&B`MD,XFCEMI;3K#K4K=NY6=L37$BD,@"9`42`8D M!U(`*8%40&H@#9`62&<3QV&43S@.4^M.&%^1_LR51QER?:G)BH:`%8]S+QX' M$7=!`B0%D@')@11`2B`5D!I(`Z0%TMG$<2]E78Y[IV=*I79]:(@5CT`2("F0 M#$@.I`!2`JF`U$`:("V0SB:.P]1>S\Z#IAVFU*[#-/&"+O:";A`-00,PM?,XPV.]W'6905[<+;RX$]40>(A21!FB'%&!J$14(:H1-8A: M1)V#7)>J1/SM`YDR/S\*&5EAB"A!E"+*$.6("D0EH@I1C:A!U"+J'.3Z3^7> M9_A/I^J4(7)D;56V2`/;"\FE'Y*#B@LF4I!1BBA#E",J$)6(*D0UH@91BZAS MD.M2E8R?X5*3N]LNM=/Y?F>\4Z<&:OJ4*$T0I8@R1#FB`E&)J$)4(VH0M8@Z M![G^4UGW&?[323KU!X?15AUL8$BN_)`<5%PPD8*,4D09HAQ1@:A$5"&J$36( M6D2=@UR7JKS<=JD^]KE29U:G[_>WOVT/E#O3W#B2!D5TO&,.?4QV;WO:(`G+ MG3II]2,54(JJ#%&.J$!4(JH0U8@:1"VBSD&N6U4^_NMNU5F]$\`:Q8LAIG1'`*Y=ZH2VU^_4YT>.[UGT)PF&*L9WCG*+AB7>2=I$.,G*I)8.;-S5$:PC[T$_-WS5#]E;@O!W2HDUE[S#-R;M[(YG*.G[#.[>:Y3%']Q)BR;"Z38,8L0,//ZU)O>TD'F].GC8^E@_:KE0EO>G.H)CFTV$FGJ^\:6RG;%/)M:U: MSF6^=ANH4A^_@?KP^)6NUCF3T]4&N>U;>S/-+M0RKWU_L4J&*F.QV_=*JTR" M8X\I@R3:=KU1\JV@!%&**$.4(RH0E8@J1#6B!E&+J'.0V[\J$;+]IP)P0:\= MO!Z`JJ07@`8Y';R<>QG#+M0RKX,E3-T&JKS!;N`K'6S2#+N##9+>W(6`$D0I MH@Q1CJA`5"*J$-6(&D0MHLY!CO\HY7?]9\TP9S[^Z4VY/6Z0>P`U]U*,G:AX M:Y\@2A%EB')$!:(2486H1M0@:A%U#G+=[6=XT^$:82K'R`I71`FB%%&&*$=4 M("H158AJ1`VB%E'G(-=_8TGBNQY61I@H&N1&:^RO/Z*2:-6VJ""C%%49HAQ1 M@:A$5"&J$36(6D2=@UQO^XGJ*]&*&6EDD!VM@!)4I8@R1#FB`E&)J$)4(VH0 MM8@Z![G^.R_]51L/;\DTR`M);TNR$Q7'7X(H190ARA$5B$I$%:(:48.H1=0Y MR'6IRD[?OMY')N>UUGM&=D@:E:`$52FB#%&.J$!4(JH0U8@:1"VBSD&N_\82 M]B`^\[A9[7/]2#7(VGH:56SM/`U:T!PP;$&6L>R3]19;5!S/&:(<48&H1%0A MJA$UB%I$'2,\S%&;ZW,B%;<>O05*J&R7&I6@A%5QT+_L&6@KQIS:T MD)#/62:V"T9BVSLC*"T%VZX,LVS7+!/;#2.Q[85!:RG8=N?8=B/;WZJ\LECA M_B32:$FKN00G)*M:I$_O]'&**:=>;N9VIB,L,XRV^RS+#;*L%2,ERQ%6H;4: MK34C)=L1UCG67+^>M\.B`UR8&C3JGV@-[R3[3PAVIJ#EQ(1MT?0\=$@8R%;? MS!;:/.UQU,O.\3QE[9F=4 M=.C+-YT81#LD1JE!BU#WWRR,O(D@XT*RBN=L6E#!*C%=NJ:CY6KF9?,5%Q([ M-9IN6"6F6\]T&"Z]?0'9=;#NY+&$G8I@99`R=C)`&8U/K3CUC MIX+.[&^0G6&-S#)&I5YO^?U3N)P%:V]NS=BVQ%[.2'J^$#0QJ96LTM4%<1"L MO`6H8HE45S.2ZAI!$]6UK#+5A>O5RDO8.Y:,C`9_^_N^E0-WQ?1P5'66,TB6 MN*!KE17_B2E(CQ!DWM$JFBMU_T5K;P'*3"%Z-X`+Y8PDA`LT71K$IF?+$+K* MW)N8KM%T@Z9;UW2P6LU@\K=-NY/4W[*KIL>V,-(8V2-F&7L!LS,EG:&F2ZJ) M=6I!-RHSU-;+V'_>EAG;%)/25[J4M=84K)JLKF25B?UEL)YYMU*Q1*JK#;*J M:U@U65W+*E/=?+58>^'2L61DJ/G[=W^HO7%!QWW]W"!9_W:($D0IH@Q1CJA` M5"*J$-6(&D0MHLY![ECQ]^G*K^\ZPJ>7-V"\F-TY!>@0]F]+9H3\#,)+8W"%*$*6( M,D0YH@)1B:A"5"-J$+6(.@>Y_J,%T?'?NR?76%GRHE4C+UJ]U'QG"EHS:8(H M190ARA$5B$I$%:(:48.H1=0YR/7V>7O3&/>FC.QH-2I!":I21!FB'%&!J$14 M(:H1-8A:1)V#7/^IC9X]VOT4ZTV_?8CU=M%^E8R1;$IVC.09?6*0^S#*/Y=. M1<6S;\9(3F1R-%^PBOI3)G=_2U6*BLU7C,1\C>8;5MGF@]!+IUM1L?F.46_> M[0^UP;'[8_H12FSV0[(%WC*B,:/V?O,@7'HMVAF)O5=A-)G-IZPR>Y59N/86 MRHP5LG?(&_/?5ZWR(2O$P\#;-Z>BXAC,#*)W M.1GEC*P#`"DH(PC,EZ)B6Q7;$O,U(S'?2,$)\ZVHV'S'MO!L+?8WC:^,(-P< M]A;H(,:-%R\:=D;E#")M2ST,&J8;<%9J"I**[R9C6Q+'.2.)XT(*3I@O1<7F M*[8EYFM&8KZ1@A/F6U&Q^8YMC8P+M8%R_7"FP$S5L@8R!G)&"@83=96LFIB83+MD=IJ M+B2U-8PF:VM9I6NCPVH_@>E8@0-PX>^=IWNME[L[#H.I,>+6>RMG.J)S!8&Q)I*6BLFUYJ7K&*DK\K!K]98=58KXP:#HO+$7%_JO8ECU.=.NM M&VJ,RGJAH.6"KG.\&^I8]5BC>HE&%:+^C&!K?2@Q?W MA^`[4]`95+J@_?*,4:DWY@=;8>@=>&>LLFL,K<6V/Q;/L<;"H$#M&<4^#C3= M,"63KC2-E46XQ@H:;IGL=5M&D[?4L>JO;LGMRK_EH$%]5\\[$C.(7@'OM[OT M-6$OY'9&885OPH5I*5NGJ@L72 MW_]5K)#::JRM8=5D;2VKS,TM5TO_G*!CRN;_M_H;T*-&?:]8?HWW+V\,/]2EFRB\^?1BP_D[T=A'SAZ+]*]%\H][?IXB$*U2&WDP?N3)?;M03 MP[$K*[K2_TC;MS9?TY5^<^)?B6<;]8AAQ%I`+="KAE\FI%;K%W/A"K5-O]T` M5Z@%]-;I2#T1M4#/TGZ9B#ZP39/U2!DR-FHK(%OTD:V1$@'9TC]"]6L)0KK2 M3[QP):(K_1DH7"$/T&=JL![Z)OCG<5M48$2_IV,0T6>FZ&]6QCBEO'R[?SI>/.R_TC(QZW]# M]**_Z:__<3*OO'XYG.A;_)0$TT?-Z?][84\?=YZI[\M^/1Q._`^J^GKX?W/X M]/\"````__\#`%!+`P04``8`"````"$`\AQI(31.``!TO0$`&0```'AL+W=O MRI=\G8OZ#0N^]Q>*^D0[;)UID M%>^,B8DS,\]J6;85;4D.27W[][-0R`0R,/+[N;V_?U!7KX^.6'E[]^_?K[ M=Z]>?7G[Z[L/;[[=/GS^\^8K_^?F75U]^__SNS4]CHP^_O9K/ M9@^O/KQY__%E[N&[ST_IX]///[]_^V[]Z>T_/KS[^#5W\OG=;V^^XOJ__/K^ M]R_:VX>W3^GNPYO/?__'[W]Y^^G#[^CB;^]_>__U/V.G+U]\>/O=[I>/GSZ_ M^=MOF/>_N[LW;[7O\7]0]Q_>O_W\ZH+M7^4)YSLM7RU?HZ^G2U?OOKQ^U&A__O^W;^^F/]^\>773__:?'[_T_'] MQW>0&XY*+OC;IT]_3Z:[GQ)"XU?4>AA=\+\^O_CIW<]O_O';U__]Z5_;=^]_ M^?4K_'V/*:69???3?];OOKR%I.CF9GZ?>GK[Z3=<`/[_BP_O4VQ`DC?__N'E M'`.__^GKKS^\O'VXN7^+^_N[A\4C>KG0\DY:XE]I^7@S7]QW]P]I^`L-\=?QNO&O-)S? MWSQVL^7ME1$?I"'^E88/-]W=[-IXC](,_TZ<(I;:>*7X=]H4E](0_TZ;8HZ,U.(RC]ATZV>UHD=!I#Z3^D[267 MOLHK8%Q0ZS=?W_SX_>=/_WJ!;0HS_O+[F[3I==^EOM)2NH6".0K+XOK6VL*B M2KW\-77SPTMX&\V_8$?XYX^/BX?O7_T3B_BMV+QFF\Y;K-0BK=C4[3J"/H(A M@DT$VPAV$>PC.$1PC.`4P=F`5Y"VZ(NH('W35C51W]1-TE>5>:V@"CX/8JJ% M-EE'T$\(\Q6GJC53%2H==$>B(#D0V1+9$=D3V1`Y$CD1.1LR5.5JSH";(FZU%6 M%>.U$!.'1-9$>B(#D0V1+9$=D3V1`Y$CD1.1LR5.,&0B$P1+UEXP(3,,4*-N M.0M15ZU4Z36CGM'`:,-HRVC':,_HP.C(Z,3H[)`3%#G:!$&3M1=4B(E`(FLB M/9&!R(;(ELB.R)[(@G#KR6F:RP"9L8C,F M.\6HA":1GLA`9$-D2V1'9$_D0.1(Y$3D;(F3%PF\D_?RO3I9>PV%F'@DLB;2 M$QF(;(ALB>R([(D@$),Q9ZQ6 M)2@9]8P&1AM&6T8[1GM&!T9'1B=&9X>\W"ECM^O_;LRT MZ;K!^@8;&FS38-L&VS78OL$.#79LL%.#G3WS^J84?H*^DO%;?6T1,-;3JW32 MD"2O(;MFU#,:&&T8;1GM&.T9'1@=&9T8G1WR^J5KW![;3G/;#61J`K]-1 M"80,V^E=#-UBI0W7M:&BGM'`:,-HRVC':,_HP.C(Z,3H[)"7.V7Z5NXKVVDR M#W'O'XIL[?ZI7!]5CK: M28U@HS6C$*WW,5J+E8;F6OI"0T4]HX'1AM&6T8[1GM&!T9'1B='9(:]VJ@JL MVE>B58H(*ZFM*V1S);3N"/6,!D8;1EM&.T9[1@=&1T8G1F>'O'XI[9^@7ZX2 MW`8JZ![KV11)X`3KET2=NO[C.;N6&P9 MCA977;:Z&Q]ER7%VH^&\"W/NI>&\&\_1.QSKS^S_A3IR$',\/4J"N*G.6R5% MAT=&2?1?W[_]^^M/T!Z9;2/\;S'Z>-5_'7OQ>[6@.<+;."\<#*[$"B[6W6/- MJ->^%GFZ-^'D<)"_=[?CC<'/+^;P:=.)M[&(O<1A#:2^8$=R[H'IM$"D&C6O_\<783>AGD[RU_I'3* MQM.5>23SL!5DE%QN?!`/%M(A!AH:P=>,>D&(__0$<7X3,I1!_M[%*RT3FM^$25FIE'2(-*^K%"M>;)M*%B!SDSRU_I(1A@C\DO[#K."/G MC_E]N()5VKFC/PCU8B7^P-FHSQ@'^7O3'^G&;2<2-ZJGW7KD]F_GEY&[]2QF M\=!@GJWBQA67CU[PK2YDS&E7Z+65C(*VEHZKPU MHY[1P&C#:,MHQVC/Z,#HR.C$Z.R05SOE.7;=7KY1W$I:9'8@139:Q:JB-5OU MC`9&&T9;1CM&>T8'1D=&)T9GA[Q^K0SN]EF/*6XYI1,4PC542*MJ50H+1CVC M@=&&T9;1CM&>T8'1D=&)T=DA+_>T1/.6$TU%-397C-:,>D8#HPVC+:,=HSVC M`Z,CHQ.CLT->OY1X3ECN.4^U]^-;0>XQQ6(6RWUC5H.R-E76-^R&!MLTV+;! M=@VV;[!#@QT;[-1@9\^\OM/R[EO.NQ79^!2KBM9LU3,:&&T8;1GM&.T9'1@= M&9T8G1WR^J6LV\9GRI.?N9WF!-[%;D9A.PWG#:O;8J51NF;4,QH8;1AM&>T8 M[1D=&!T9G1B='?)RIX3>RGWE[B_YO[W["ZJQN;HEM&;4,QH8;1AM&>T8[1D= M&!T9G1B='?+ZI?+`ZC>>WSSG4S.W4FA8:3,*T1I/W:2ARU5+0PW@GJT&1AM& M6T8[1GM&!T9'1B=&9X>D8#HPVC+:,=HSVC M`Z,CHQ.CLT->OS^MLKK+993=6P7Y:(U'/:MJI:&Y9M0S&AAM&&T9[1CM&1T8 M'1F=&)T=\FI/JZS2.44X2U1DHY4K*[;J&0V,-HRVC':,]HP.C(Z,3HS.#GG] M6I75L\X![KBP$A2B-1P4KZI5C=;[8:&&T8;1GM&.T9'1@=&9T8G1WR M:D\KK.ZXL%)DHU6L*EJS5<]H8+1AM&6T8[1G=&!T9'1B=';(ZS>ML+KCPDK1 ME4?`:E:/U]>"["-@1H-KZ*]]6M&"<6BGRLB=LC_2(V!IB!M474Z-AGQ(*PWE MX/VNHY-WO:3&(X2[5D4Q^:'HV$O()7*9X$_>N_BD1QK:DW=&O2`Y>;_E^>6Q M6@]][V(*_ZPG"V,O87XYC0\^C>FG-'0^S0W3"6]]$:D^XK:2!GUG>"ZAI:,5HSZAD-@AJ1=Q_3U;$X>,K#W;&E]X:B M*P]WQ.+3RD',6[O=?4Q3GK7;C;V$ M]953%>_.+CYFE(;&=VM%\&H):+Z#J55^S-BX@^DE-1XTIH2`#AFLBY_VH''L M)DQ:LI":GZW4JJ(UHY[1P&C#:,MHQVC/Z,#HR.C$Z.R0NX]@-;&NSRHPQIZ" MM#FQ"05&N,NMI*&I)M:,>D8#HPVC+:,=HSVC`Z,CHQ.CLT->[9B'7;YK8QW$ M)%-1#T8'1D=&)T9GA[Q^,?]/>>3SGC,^<&T@*(1K?,Y8K6JXYKY, M/M"SU'O-JQX+H2K5)%F4>W#UQ8,5HSZAD-C#:,MHQVC/:, M#HR.C$Z,S@YY_6)A=46_7"K95/6A53W-XZ>VJU4-R=)04<]6`Z,-HRVC':,] MHP.C(Z,3H[-#7M)IU=,#5T^*[`8J5A6MV:IG-##:,-HRVC':,SHP.C(Z,3H[ MY/6+U=-X%ONL[)0+JX>,_`8ZCP\3JY6&YII1SVA@M&&T9;1CM&=T8'1D=&)T M=LBK/:V6>N!:2E$-S16C-:.>TN2"29$) M249K1CVC@=&&T9;1CM&>T8'1D=&)T=DAKU^K8'I6!OK(]9*@$*WA*T8'1D=&)T9GA[S:T^JE1ZZ7%-EHY7J)K7I&`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`WKZGG*B*?:L#F[L_Z]L9RF M%?`++N`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`76;L_U(;JS:.BVOU)T3>N^ZQ_;ZR! M:47NDHM<1;CVFD+0NYC%RJT!Z:L&5U^MQDC"@\)0UPUJ48-THZCVLQ6$[Z.K M:KMJ92Z3UT"^)K/$#K6A]G7D[D_5ZAM7?E:+QAI(M:K=AU*A//DAZ9)K94%N M:5"EK$8U@->"\*X'G7*O*$?8D@]4U:!&Y89[WJI5[7FG*/=,N]Y>_UX[/G#' M1[6J'9\4R25W\;#QK`9CS^XT>YD*Q#_N$2FKZY6_'CM.SC6+97$7'@^LQ,HM M%BE9X>2ZRN*W/'MMF(\I[Y?X3O[2_%^X,0UZ->:T57NH*V>KZ.+0.[7*0S]$ ML?<\UD&;U+&.BBZ.=5(K&6N&C=J^>B!,\^R&]GZ>5H(ON007Y);8(K[W9*56 M=HV5VKVN,4'V)K&XBT\NM"_KBB`>U MJB,>%=413XK\B"'3.:O5MT9T3L0OQX35>KF&R?8^B2C,+\QP]UFIF5V9RLS- M!C\>F2XI_;:5<=(BWA3Q@Y)BAKO.!5^JF?G9$OS*9&YJ1L7/3)91-:;P.Y-E M"&7XH4FRPR]-4G_XJM>!$8?BG=+>X M#_DL_"IF=M3%?;B3P-79S,P5KI:F=52X6AC^,:/&G;28V5$ON#I5RG_X-MK- M4C?1U<+\`@M[)=9K-O/K5=C%>PR6L)CAQFL4"7LCO"\7@KV[F%E%\J2-@CL1U41S%?"\ ML(LCPO-B9H.<3ZV*61T5;J9Y8MT_952XN8R:2IG&/.%B,>%ZLINE\X%+:_YI M[S7*_<1%G_H&JRD&'$H,#B6&Y4P,:Y<8W$4,[B(&WQ##$B0&1Q"#(XA!=6*0 MV;*P;!`33N9K.4^RCW)FECY04N)^\1`>$4#A8J89!!0F!H6)06%B4)@8%"8& MA8E!86)0F!@4)@:%B4%ARX+"Z2C`!O(UA>4XHR:[K[N9,!>PQ"`G,-9I>=YVPE..9_#8A*#+(2@ZK$("HQ:$H,DA*#HL0@*#'H:5F0,U455L[GY[KI25',=86% MG3B+2T MTJ8PJ\%YX2%6`Y/)Q'+N:F/96(0GQC$)P;QB4%\8A"?&,0G M!O&)07QB$)\8Q+R23FQ+`Q$X.H/*^[4.%I\PFQR+3#^\E,_MZ/&7A MA87A*!FBYZ;VC87*["L+"ZO?SH'HI:U93O-P8`(_%#-=3O"#7'']?@+\(*P. M`3^4MF:(Q_!H$JXI9CH$7&.'"*Y)I:N?=D^W,.R/A"V+PA;#ZR6IL M1)F9_N"+S*Z\2M*8J5#P!0T!7]`0\(78U3,;"$\,PMO^@O"I_HG"SY_R$['= MK91.;BUDEDX(ZN/81WH<*TUQ+J.3QHV@T91?-%+,\C>^'F9A'X-_I)_Z25GX M1U@=#_YYRGC8LTK3.J/&YW/5K(X*EY6F.DNX["FCPHNE:?I\+LT2+A6#QJ=S M;U/!]4R7YEK-KQ]A^,>X-,B.'2^;H=K3R<*EI:DR+*EBEV9V-Z-?S"X6=6.# M`TLK[0D.I-[AK6)7+[;E+3&K0\!;I:D.`6_1$'!-L6M/`+ZQO8?EEJJWZ)O; MY4UZQ?33WVS8W4H1Z)9>9F'IA8T9?A*SNA3@I\R0BNG4X2=A>9W=W(V&@-?*$*/7KDP'/K1C!1^F M(C#Z\!GWJEQ+^K4FK"XB."PSO[`R2YM`69.MO3*;X1>*QUWD;AE?&@*W24]U M)K7C+#T$<^R&/AE<=VMV-6WWV'C MRRP%1VWZ&.H6>**8:;C"$])=K5O@"1H"GBAM[1#A\1N<4\QT"#B'AH!S:`@X MI[2U0X2G(O!7,=,AX"\[A/<7OLSD_76E:AWMPR&`,'=/HI?.=6I5%\FZ,)M( M-G:XVC2M_`5NI.%]-J6CFIAM"JL#;@N[.."NF*&D+!'32##TNNJH!]-4]3\6 M=G'44S'+-V.>YKE8-/+!NU3^VH5WS9&Y7':+;.PC561FVOP6ND[,W+VJ-M5I M]\8NN>W^D=YH72SJ'0)NRQ=F>H?;Y&+K'1,^*G;51XM%>.BR+V:XTU=7QB_9 MPVVE-[U^N(U&A8^*W3BG+MYKX2.Q:-R#TO<2)_DHVEE?8$'U'O\%&QJ^(O%N%A`GQ4AJAF M],U;^*CTIJ/"1S0J?%3L1A^%TR-XJ`R'?L)VF&KH*:LHU]Q^%0ESJXA>8-?= M93,3Y_!0::HSA(>*79H-7BQ(2;E:N%546FE/\!#U#@\5N]1[=WO#SA&+VCL\ M45II[_`$]0Y/%+O4^RVBR[[=8\:>L6,%SZ12>(IG"N MNQ,SMW9*4YTQ/%/LTNSN\`TXNBV)A5L[I97V!,]0[_!,L3,7NP@/+[!VRA#5 MK+5V2F\Z*CQ&H\)CQ6Z::5=P$G4/)Q4[HSY70FI6A\`:*DUU M"'B$AH!'BMTW9@"7B,G8?7!)JG"GN"17Q'[99.9N.?/X"A2X1,S"08M>\?KC# M=A[[(!:UWAS`XO>YBB["7PAW9S*^0TE2G"'<4NS0=_MF18E"#%^NC M--*.X`[J'.XH=O5:6XFTF-4AX([25(>`.V@(N*/8-:\?[K"=!W>D0G:*.Z3P MM<7_769^==!;.SLU".TE2'@#MH"+BCV"5WT#T1[K"=!W>D.G6*.Z2N=>X09E<'O2FOPS.V=.?Q MBZ.TU!G"&\4NS:9[I!?"PA]B4F,7RZ,TTZ[@#^H>_BAVU1^+QCV^#%'-6O?X MTIN."A?1J'!1L1LG];",008GE1'1E7?2?3PQ>-Y#O+&;<.\7YI82O8&M4RN[ MDH2YLVUE>24U\F8UJ.&S:72^568ZWQ6&8J]LPHV-C8Y:'7W&65V)?$;#KMJIE&W-LRHP^_AD:98A2D0'Y>/ M]*)<[0F?A]/>X2.YV'K&!Q\)LQ=+)TEP6S:3$>F7Z?;%H(X'AY6^]1K@L,(N MS!`^=.,M9O0@#%X4DW'$X,54J$[Q8BYLO1>EV/4U#^73Z?,*:4-TBZHTU7GW M7;6K\UXLPJ/?H9BA5JC+(YZZP),T*CQ)H\)MQ6[(A!=PF!O6F"+>51GKY M]'K#A]2&,LC&].+NW#B MNU(S=R^K377N<)T4UZZ[!9TFJ!F2V(NN*[WI"'!=N6!E<%VQJ]TM8GH$!XK9 MQ5'AT]*;C@"?TJCP:;$SHR["L3%\>F74X--4^5J?/O/.EPMHOTJEJ$:,%=$7 M_+Y#/./C59J9N77`U<*PM=3N%N%Q!%:IF-E1;4B/CZVP2FE4N)I&A:N;HX9X MA:N?,BI<3:/"U30J7-T:=1G.@>'J*Z,&5V.1_!FN3MW$)$>86X;W81EB51->DFQR\+V9(M*OWE^%@#]Z7$9#J%;.6]\7,W6V?:%A)(9,2(C?$N1$".IS/\3MH-\6N"W M@\SP?$F=CX#(#,FQ,@2$V+D%W,BSQ"SG60^M3PAH3_4&BG5/(V+=/V5$>+Z, M:&*+S\74K(X*-\NH-1.!FY\R*MQ<1DUI0F.><+&8C",&?Z9S@DO^?.(G!.[E MD*(Z"K=R8752<"@Q.)08EC,QK%UBS(Q.((8'$$,JA.#S)8% MF5/];V7^=W?WYNUW/_UG_>[+VW M86$N8(DA8(E!3F*0DQCD)`8YB4%.8I"3&.0D!CF)04YBD-,R+V?Z?4(GY_._ MI#)V%?(!82&60_FQZJI9C65F?<-N:+!-@VT;;-=@^P8[--BQP4X-=O8LB)^J MXPFQ_)"K:1?+RFPL,UMWS""G]%?;0DYBD),8Y"0&.8E!3F*0DQCD)`8YB4%. MRX*RCP&;60A82F`?BID)6&)0F!@4)@:%B4%A8E"8&!0F!H6)06%B M4)@8%+8L*)Q*RBD*2_5JLX4'837HL/Z)(6")04YBD),8Y"0&.8E!3F*0DQCD M)`8YB4%.8I#3LB!G*MNFR)G+/+_^,PL!&PX#H'`Q,P%+#`H3@\+$H#`Q*$P, M"A.#PL2@,#$H3`P*$X/"E@6%4]$S16$IDES`"G,!2PP!2PQR$H.X#."RR6X8@0@5W,3%P3@_K$H#XQ MJ$\,ZA.#^L2@/C&H3PSJ$X/ZQ*"^94']5(18]:\I+$6+"V9;R&@P$T,P$X.< MQ"`G,SL=FX?:D;SV.34/>JRR=$I8# MT^4LG#2O.K6K!Z;K!NL;;/`LS"9E]1."XU&J`!L/ MF$%AM6GC[%G,\!PQ?[:`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`=AB4%78I"5&%0E!E&)05-BD)08%"4&08E!3\N"G*WL M\YF_DK)LI*/"4L9H`INRT6JF(0SU.268PR=15WZ%4-DQ16,H, MI[`P%[#$("S6L78W#><5ZVL70G9%H3(M4>UA,H,(3-#Z,P00C.$ MT@PA-4-HS1!B,X3:#@:Y4X$R16XI:)S5,6_$S'H[-9[ETL3F:LK`/Q\-.8Z:A M"NEM)32Z"-(3@_3$(#TQ2$\,TA.#],0@/3%(3PS2$X/TE@7I4W5BI;^V<4@U MXR+95C@:R<0@)S'(20QR$H."6_^Y9ZQN84X;D``K:8F=V7&!0F!H6)06%B M4)@8%"8&A8E!86)0F!@4)@:%+0L*I_)DBL)2SKB`M26.!BPQ!"PQR$D,3C"(_QY8"#&N2^PPQ36FU]E.Z0DW\U9=Y)=FY7@C+<((KK;NG;%Z6I=9TT MM9_X5CM\XCL]S`RG4)ACOH+<),PQI;IVCE?N0PA`NM,+,^Y9S9FM#:N3;KDL M#Z'?NN"W5)J.L`6'^:3\<9,H.<$WG!,_-?<[F- MI__S]$C?^P4S*.QR3&6S\54L>/5I1^]I-AUQ3*6\PT[QF?N`I"_.=YGYKS[< MA@6,Z,MFWG?2G?U\AQK*YSMF\07X\*1K%5R9[OY_PCQS$N$]+,PM*6)PI[`K MG]Y0._GT!OP9#BLQT=H3.S3=ER]-]&D?WYAW_F&F9(>E M1PSS(+9IL&V#[1ILWV"'!CLVV*G!SIZ%>$K)0Y3Y65_IF'>2ASBE,_,%)KU< M7YO"K.;KTIUA$+]TIW80GQC$)P;QB4%\8A"?&,0G!O&)07QB$-\R+_Y\8GHV MVH?T3%F-V]6?%>EF M>!QA7B12HO@.7J]\B?&,)F3M[NOO2=0M*[^TFLT8_Z#M4Q<`)ZL*50`:F� M;>N'4W37]<:DN[+14E$KC-8K#+'"\"H,K<*P*@RIPG`J#*7","H,H<+PZ5G0 M::L4K_.UMQ/M-!?6VL/+JCXW#=2$VM619G-&2A:%3&#J%H5,8.H6A4Q@ZA:%3 M&#J%H5,8.H6AT[.@TY8BI^@L2Y?YM-:7,VX8CJ_7QW#/UAHGAH5A6!B&A6%8 M&(:%85@8AH5A6!B&A6%8&(8]FPWS4OR3#&_YPXJN,3_T*KM;E=TG[$W"WB;L M(6&/"7N7L/<)>TK8AX0]SRSHM/7&"0V6:VHRPE9F<^TQ;XB_>;Q=:[;I\EVO M;OS>!,5M&P/BN,!2.AR#3?)/.8:Z*/!CV*XR3OKN&.3R< M-+F@7[,QK=A>H[23URBYBNC1X1!M)GW*(9:9]S2N[`H+89+KRS7;'*92U#&B M5*LK/Z);Y;.YA,R7"L=C4UE_/*^[F+RK,^(IDI7-D92+R:WH%,E2=+JI5/,Q MYEO8^%9K$,9A^E+A,&T.Z0_SR-EU5^>]#A7*[[[&JV*63":)F%U9Z6 M7/Z?*@H1LZF2/YQ7-LPRXYK[7V$AD')!P+YISQQV#F2M;KK+43,R,);?;H:: MB-I4*ARGS6'\<1YKF77.,X6MLCEL\FS3KF:;PM;9B'@V9I9L-9(7EWJ#8ZH\ M'*)-(OPAOC*492XRA[*P$$I94^Q*MCF4M3I[WW1O[-FAEWPUNA=K6S4>]L6/WM6J^>E]+/V#>*Z-_B&_,31V5WJ[+[A+U)V-N$/23L,6'O$O8^84\)^Y"PYYG-O6O[XGKL M7:^\?%J_WCYUL^,.P+P[XP[`O#OC#L M"\.^,.P+P[YGP;Y-K;S](\-W^Y+[U)C+](S'8IJZV[7E&XS&+/G0*0R=PM`I M#)W"T"D,G<+0*0R=PM`I#)V>!9TVA?,Z;&?&'(%X9\8<@7AGQAR!>&?&'(]RS(M\FEEW^L+5O^>%*J M;+1;VK(P=`I#IS!T"D.G,'0*0Z&?6'8%X9]8=@7AGUAV!>&?6'8]RS8 MMSFWMW^L,=):(;(58GN"0;&1K;6@N]:=6ZJ M<9^P-PE[F["'A#TF[%W"WB?L*6$?$O8\LR`_K@./C,3UH]VSX7HEVK?EEF\P M=$H^=`I#IS!T"D.G,'0*0ZMI=`I#IS!T"D.G,'0*0ZUVY,7%W\+ATDD_09#)&U1Y2.Y M79`E\E]^^_WG?[RP3]6%V13=PN;?V%W(C;OZZ6C:2CMLHEN*\BQ=8W2IRCB0 MWAL/E^$-O<2S[@G_ZMEX-/W[[_Z7YSQ^KH,`(:ZUC:T2XLK&5HEG9?-6P^^% MB6?)9K^.^>NM$N):V]@J(:YL;)5X5C9O-1P$02W9_G*KSIC%<9]Q);O&[7RJ9>V_(=Z;4M6WE\Y^)6QW9I&V];[6Y(W]J[.L[\J%GZTV,?=3;J(PZR?\1!ZD.ZU/?<8HNCUP^+S&]!H[U7-MHVP7C)]HA/+SJ:3S+-:-G&5@E9+]KVA)"]9*M$L1=-CY*0 MU@Q9K[$EK`_IL5Y3EKSS:::P^5&@R[!@HM/4;*,S$,=>M!TUG:;GL\.YU$?Q M6H:I!_5"K2*")I43H9[/*C^+3U/1G6J&43FQZ85:Y<1&*B<0/9]5?J73O99A MJSST+5O\^D"\8KK7/N`]=3*K]^_?VH=)W(@6.@+!*=GF3E;9.)$0G,K*LZ!G M28\J&9C\-%?T**F>NK">YFB%N9D*/:7F8W3N<B*(MF[\6Q9=.Q,KR M>PYC9:.OT*>$$<;*QLF%/E68ZWN-\AN;*IM8N]:%9ZD.SU(=F7U_0;*M,WYJ/ M::ZKTNGD4-AT+6`O7P%;Z]?(70-%"[7X M$8&7;(^@]**CW60SL)IM;)7NT(NVK1*GEVR5T/6BZ5$21[^].8[R/?7SX.O-=MT7FEL5'?O\MGA+/K<=2LTFOE;5ZCI>^AL5/[8&:N[ MWK.3".DFWKNB;1-/G8U-?.BL7%Z4_7_N&;;]#^&P5><)W:I^^'TZ&50V=:OS M52Z@MJ_*CV'J;FW5#48X^D+8PI$\"]XRC-9,.'JAYHIP%%8>&=\N`!..GF^$ MXW`6)N_O>C;.KB-J\?H=$>JUM:T2(=DJ$>KY2H<)\U$B5#-LAQ0B9`O44R)4 M%K1SA`J;.LSA,DP);U=+Y]0T=YC*1H,C0CV?']`Q3A^F%FBLB))43 MH9[/J==KURW;V`3AZ$7;)@B';()P]'SI_A..FB'K,+:X/"4<=5$[_-VL5X7- M'4;?^U:S3>>ARER;)AQUO5M..LMY7(@1CYICZC&]5)-%/`ISM1./GN_K\9!- M$(]>M&V">,@FB$?/9_'0`R`@OO;0/VP5>DI`RJIU[A^%6=A[=S]!C!*AOQ)2`]W];=DQ]*MARC]3*$]5*M=@(BM1.0GF^S-=]38.BJR:-J`M&+ MM*H)A%1-('J^;;H&85-/>-P*?/@FFWN&;6Z MZ5126)V.721G]IIAZAB]4)-%'*1RXM#SF2SYT2&1D,J)1"_4*B<24CF1Z/FL M\HNXL"40OO(0"%L3GA*(LH:<>T1AY.&.4;/,9H[(15WI$SY>Z8H2J M&4:KI4/T0LT5@9#*"43/-WIO-L6231".7K1M@G#()@A'SY?N/^'PE8=PV-KQ ME'#4->GP1[\HS((^!JBK<,&(<-1EZN@##%"UNL$(1\_GJPMW>0A*S<:Q]:W* MG2;BU&MK$HF3;)4X]7RCNL-9F(70;5ZR54+7:VM;)72R54+7\[FM7H5['`3P MR%9#3&VAZF/ZNH=`KLIZ=^YYA4T];Z\_@ZM%YYY7BO(2BZ:$4%?&!+/'\'`5 M[CH0ZIK-GP&S4)=L;JN$6K9*J/M62W_1(/?MM5TEHE(Y$97*B6BO?!S2?A\Z M`Q'MFQC9_"&%B-J2]3\0T;J"GCIO9?YBV55=(8]>24\MS-XNT$.57&.HV7@: M;SLU)/>E6T7364TV2.1>LD&"6;+9XW]]OY+[TJVVKXX61%EVA"B_9$<(?-^1 M>N1AQ"+FM:)D';4_]@/I%UX.W>H)U^\:&]?&;E=E=PF[3]B;A+U-V$/"'A/V M+F'O$_:4L`\)>Y[9W(_VMI*-_>AU/ZSKE'[FXMB_KW.G\T]C4EFN^ MP=`I#)W"T"D,G<+0*0R=PM`I#)W"T"D,G<+0Z5G0::M.K]/.\J_\8:6UV'C9 MO[+0F,/%(1IS*&?6'8%X9]8=@7AGUAV!>&?6'8]RS8MZ6F MMW^L,9>EZ=R8*QL-%YW":,S"T"D,G<+0*0R=PM`I#)W"T"D,G<+0*0R=G@6= MMF#T.K<[[J_YDO%J=]>E+1=F\1R3A*LP[T-^S^;:LC#D"T.^,.0+0[XPY`M# MOC#D"T.^,.0+0[YG0;XM#[W\8VVY+"?GMES9U):%T9:%H5,8.H6A4Q@ZA:%3 M&#J%H5,8.H6A4Q@Z/0LZ;;%VBLZZ+O2S\GUAH<'*-;^1S3787K0Q#`O#L#`, M"\.P,`P+P[`P#`O#L#`,"\.P9\&P+9Y.,5P66W.#K6QJL,)HL,+0*0R=PM`I M#)W"T"D,G<+0*0R=PM`I#)V>!9VV+O$Z;?!]S6\I]V6!,WLN++1DN6A:BY*M MM5K4]Z*-H5X8ZH6A7ACJA:%>&.J%H5X8ZH6A7ACJ/9O5'^*Z[\C0N^4/JX[& M?$M6=K6=!IJP_?DH_I+*N5J<$> M"G._-[I=*W,/L:"SY+-GG,:<8A\N0F.X9VN-&,/","P,P\(P+`S#E6W7<((1 M6T"<8J0N./S)Z%#8;*2PV4AEW@CSCOD>$$9Z-F=$&$:$84081H1AI++,B$WJ MO9'771T]E+7!W'0J\]?26K[!:#HE'[^:LTM%?"DZ7/'$4<_A'-7:_=.<6CN. M>ME:>[BH]6.,5][:$,V;_?&CO6J.L^?VE!C!,9UEW!=E)Y6\KEKN.BJ MS!=-+CVV;/8[1I[XW>W.EG`)CIY7J_)W]W'')<9^]P\*QN="Y_"Z./":(K"\".,$X4P_`A# MAC`.7QB3$V%,3H0Q.1'&Y,2SH--FX*?HK#/VJTK8AX0]SRS8MQG^RQLS M4Q_R1\.5N<;<\PUVES!T2EET"D.G,'0*0Z!<.V MG#BEP=;EASO9[ M!9VVB/`ZMYGO:^Z/[,[*>L2?YQH+;3G>'W'97%LNU;D+=\@7AGQAR!>&?&'( M%X9\8<@7AGQAR!>&?,^"?%N1>/E?GP?O;'(FHT5E4UL61EL6ADYAZ!2&3F'H M%(9.8>@4ADYAZ!2&3F'H]"SHM!7'*3K+"F5NL(6%!AOOC^S.>C;78(5A6!B& MA6%8&(:%85@8AH5A6!B&A6%8&(8]"X9M$7**X;IHF09?OY`I+SS;G0FCP0I# MIS!T"D.G,'0*0ZU@:=O%[YC& M=8#K[6)`4HXUK:6EY5AQ69W;$\FQ3I8/EK:=KS5MM;2MA6G:SM*V^Y@QC:<& MV!<>'0NDQ.C"]K.\@5#3;#^Y,Y[5>6'[6=Y`*>7.K1Q?X)07D6G:18' MOE>7[#KFEG:SN)0?BT@=2Y6KKS61-)6*[?F[6RU.)3K^%K.XE!>*J!I M%@<^'Y[MYVIQX%O869J-GVL^?JYGYCH?/]Q&\Y6)W<2T[3V,^%NZ99VJ4YXST#6=H5L5WX M15::1FP7?NR3IEF,^-E(FF;;X^<%69J-NTL^[BZ7=@R\D2HK=TG;77A)4II& MV[7W@:1I=GP\%9&FV?'QNI(TS8Z/=VQD:1=6CC>MIFE6CI?$I6GFA5=`9FF7 MYH57!:9IUB9XYUV:9FV"%[-E::L=>SY&+JL=0SY&+JL=0SY&+C9&\B?=GHV1 M2SY&+CNKD^\1IOMIY?(Q><)3_G+#;N\B<]OC,K ME\];E\7BL.1M<+$XE*^AZ7Y:',H%$4VS."QIG[Y")[^13EK$%3*YDY.D+'8. MXT^>9C'(SV&+GS&.3GL$M4YJ.`#:KYF'J%1MY1DNS]%1)Y?466@D)^ MQIBE()"?]"[X-I/DX:L-H/HI>(B\?0R]1EX^@EXC+Q\\+RO!B\&2O M;?#,Q\X+7.":C_9F*;CFL:XL!=?Y:+S#-9]F M3;\-BNM?;H)CN]38DYGM-Y/+S"P>:EN`PTW&0@\R/D2W\ MU0A(2MIW%QO^LK[+G?C=-;?>,V?<5=]=QM]THYX=1E6\E&5AT>O;^QY22W' M8R3+-7^R-$PO9C.S0]IJ:5DYGEE8KOF3I=WP@RN.H5S@C",%OQZRM-05#YE: M6N;+OOEPO7U80(_/OOUPO7U@0-/L&Q`<0^K3/O+`,:1I]K&'Z^TC`UJG??3A M>OND0YIV96E9_.X6O-SS)XG1W)"FW2T,X_?\2;;W8&F/>1K;.]CVLG)O M;'O\R?;EK:7Q)TMC>_1-_N3[0M_,CYURC)!YG>^L3OYDVWO/DO9]NC)](N5# MNM9]NJ*YIRO=IZL]*=DYY-F6SFG*C>T=?[*]N[4T_F1I1(T>PI_$%&FKI66M MA#3KD6F=;]C+-^E>OB7E;9KR0,ICZND!3X^IIP<\/::UO:.V=VD*(PF[G;F] M.[^XOL^O&%+;35K;+2FW:DXC M=$.`GDM\ONNGDC]_^/[?/_WZ\<-/GW_]_5]_?O/'QU^X]7&V/<+V^?=?[:Y> M^9\OG_[-PS[??O-?G[Y\^?3/[3]_^_C3?W_\;!FXL?W+IT]?VO\P9'WW?Y\^ M_V.[O?+#_PL```#__P,`4$L#!!0`!@`(````(0"$)1!QQ0P``,$^```9```` M>&PO=V]R:W-H965T_WY:E=DMZ/4YFYMP,F<>M5W*K6VX)?//G MM_US[\OV>-H=7F[[P<6PW]N^;`[WNY?'V_Y__HK_F/5[I_/ZY7[]?'C9WO:_ M;T_]/^_^^8^;KX?CI]/3=GOND<++Z;;_=#Z_S@>#T^9INU^?+@ZOVQ>Z\G`X M[M=G^N_Q<7!Z/6[7]W6C_?-@-!Q.!_OU[J6O%>;']V@<'AYVFVUXV'S>;U_. M6N2X?5Z?:?RGI]WKB=7VF_?([=?'3Y]?_]@<]J\D\7'WO#M_KT7[O?UFGCV^ M'([KC\]TW]^"R7K#VO5_0'Z_VQP/I\/#^8+D!GJ@>,_7@^L!*=W=W._H#I3; M>\?MPVW_0S"O)D%_<'=3.^B_N^W7D_5W[_1T^)H<=_>KWQ=[]]6']^/O_[\#7=[AZ?SC3=EW1'ZL;F]]_#[6E# M'B69B]&E4MH?3^;#_GS:J[Z@1&1L1^F21R<7L\G(RG5V12D?+B6E)GZ;E5:<] MJ=7#I4]C'PS?U]/4M"3]GQPCI4K=)WV^:XS7QIX^>8QC<6F',P*:_;HG]8=I M>OF^NPMX'M4?/WE_``I5W^\;Z0#';-U"H3K M\_KNYGCXVJ-UA>[U]+I6JU0P5W(<_-K'33K\*!LH#93*!R5SVZ?II4`_40I_ MN;N^'MX,OE#:;8S-`FT"UV+)%BK'E&SH@\@'L0\2'Z0^R'R0^Z#PP5?]LR"@3A\Y#F3+;A)Z(/(![$/$A^D/LA\D/N@\,'* M!Z4/*@LXSJ14`6>.*=';5VJ.3=6*UF0G-KW(6V@;RGSVUA)(""0"$@-)@*1` M,B`YD`+("D@)I+*)XTI*=<>5W2Y4UK1"T+Q8^>T%W$(;S:A+RVCL165CQ(X. M@41`8B`)D!1(!B0'4@!9`2F!5#9QW$H/U9]PJ[*NW?YLG9]:(@5D$!"(!&0 M&$@")`62`;.\?3+1ZE MAT_C4EW74^7#GEG4"N3EJP8M$84&S22&(T0QH@11BBA#E",J$*T0E8@J@T93 M=8]NI*K:W%X??RU2=87ON-4@VZT&C1M/AZH$I1!WXGE\Z<5S)%8\:S&B!%&* M*$.4(RH0K1"5B"I&+9&J:O??][39`=@!;)#M:8-L3VLTF]6[^=$P\`JG2!U< MT%20@3A9HVE],_6:E!@K^F"K5!JJ4KE6;,GNKKV5U]M-9*E M(C0-1Q3M3;M1`&'>-+2LQC-7/F:M23.NA)'TF#+J[#%CJZ`.BF#JS5S.UZ6O M@I'TM6+4V5?)5K0"BP_\NZO8JN[1G3ZUY["G[]=6*K-SL6?5(/5LEM.N*]?M M2W6"3'-/SQ(.AY"1)%[$B$JI1FODWV1LK(+K1BOAAB*?,A+YC)$M?WWM14@N M\M8@1E[N%*PE/:X828\E([M'N*%*>B3GN+.F=C+VK+V1='KCXR2=04[2S;P# MGV6@K9RD,TBF.A(KRS,X/::A1'TB#7GV4T8BGS'B=/*6V)ROBW#!R$XG&'A5_+';/)DCM>4-54KXAN[L"*J*V%N=\780+ M1G:"P+A+L>H8=\56+0FBMG*_GR!F0RAWO*`9AP0)AD/ONY2E,7,R1+<<20A' M;$7WW_5T,5U**"?<4$(Y923R&:-.^=Q8T0YXN35,:(:\2H4&3SFU"Q%9V$$#!&;.5!'^"/:9LU=EC MQE;JE.C+73#U5H.4W\=7FEV6@\6 M*6'X&&RD-_9VFO,O?6#8-DC5O6HF0E*#3(/F5%%"-*$*6(,D2Y02TGHX3<>_ZE/5.MXKE" M[^^L^UZR57T^JW\J8Y`3.*.9]\53)%8<)#&B!%&**$.4,VJ)"+43^OV$,;LN M.V$,DN?CDDK@.IPD$T*#?GR:*0;B&"UCG3DFJ)Q*PQ^<9HH!*^<&M9PYJLVL MXZ8W$D>9>]%BT)1&WQ3]M()XD;"L>[KM6QNPT*"`9I&'&K6PV#!*?S9+4"UM M:9FUL-Q1AR5ZD@F3#H*F,M776,O*YROHS?V*@?2#E>_*5UJ59Q M(\V@*[N"F4V\:FAIK.S"SB#Z8!]$C,SFQ3U+C?FJS&QB$%4^K)&RE#1H3`_Y)JLA2")C=3G17]IX M<1ZSB!6/!E&;>/9O*?$I+6!,8M,1! M2!D[JWAB-9GZR"`K\&)&=LR`5HI:&3<4^9Q1RR+55D^KQ^3[?_V@XM4/"(V< M%8I\XWW_L30MK8@(#5(K1./5EG33^BK6Q0J^'F`M"9($>TS9JK/'C*TZ>\S9 MJF5A^[G"?(R%N4'^(]4_PN>6,OLAHL@@551W.5"/PBI+$M1*$67ODL_9JB4J M_9+^C?0TA;I,]&*LD;7^+!&%!ED!&#&2921F9"])()^RE0PB8R1:.:.6)4E5 MO7;1]6OE@JZ=[0.#L49>X`3^R;8QLQY(H4&T'/`S*F)D?IT`#SK3O75,A[HI MBXANQJA=-V<1/&P>^X6[JM.!?V:M",`R@R-)-K0`*3=,W3L_8 MRE25X$>M.[%##KI*6<0N!&&QS-BJO:N<+[=$I*K.NR+RG06#+O*=D#1($F,Y M!A0BBA#%B!)$*:(,48ZH0+1"5"*J'.048K0HN7[M7MUJ<[?X,,CYL2M%IW\` M+V:ULQ^H;/M6EMAV3]*9C7<98 M,8DH1!0ABA$EB%)$&:(<48%HA:A$I-[FE'O4_M-O9^I7T_;;X^-VN7U^/O4V MA\_JS4LZ([B[:;!^+71Q/:/O6NT&NI'^J'K,<7U*">/)^/:%AM?=-PVT;[83+_0(YJ&RR-M8U?SND] MBQ;[Z9S>#VCA5W/Z&7P+G\WII]TM?#29JV-@O$+GL'2EK>]P-*4K;;W3D=P\ MTH]TSU%TI$9MVD9&)U34IFUL=-I$;=JN+(+A7/U$N&7404!7VCQ,/S.E*VV3 M%0;CN?KE(ZK1SQKGZI>+>(5^EDAJ]95!D637A7?TMN1PPNJBQ\.AS/_A[H>-"^? MW_T?``#__P,`4$L#!!0`!@`(````(0!]<-G8F14``,IZ```9````>&PO=V]R M:W-H965T'W<]/YZ4WE^=GVY_WNR\//[]].I_/&O]Z?W[V_'+W\\O=C]W/[:?S?[;/ MY__^_+__\_&OW=/OS]^WVY77Y6+B^?[[]O'N^/+YU]/V[LN^TN./B_+EY=N+Q[N'G^>)A\K3,3YV7[\^W&]K MN_L_'K<_7Q(G3]L?=R]R_,_?'WX]J[?'^V/N[>_6]_Q^X?WRX?]H][[Z^O!%W%\F! M\IP_7'RX$$^?/WYYD#/PS7[VM/WZZ=R5*JYW53Z_^/QQWT*+A^U?S[F_SYZ_ M[_YJ/CU\Z3W\W$ISBU!>@M]VN]^]:?N+1U+Y`K4;>PE&3V=?ME_O_OCQ,MG] MU=H^?/O^(GK?R"GY,ZM\^:>V?;Z7)A4W;\HWWM/][H<<@/SW[/'!]PUIDKN_ M]__^]?#EY?NG\ZNW;V[>75Z5Q/SLM^WS2^/!NSP_N__C^67WN$R,2JFKQ$DY M=2+_&DX.5+Q**UZ'BJ4WY?ERP]7[PZ'>Y?6D[S1,SSR0#^D->7?4PZT)#TA$<9WB:31CSO44B9I M3HXC#[:D@O@_3CI<43`YW"#ED8>K2I:")E?''J[*4I(_3CIK M>I:#+L<>;EF5\7^<>;@J M:#GH>SA7JDR_H]36O=*4\W_<=KA MJJ!709>C#U>5N3HQU:XTU?P?QQSN13)#[2>\VMW+W>>/3[N_SN0R0AK[^=>= MOR@I5;PSG>J262*;_/[3W">3GO?BO)M/YU)?IK5GF;'__%RZ+%U]O/A39MG[ MU.C6,"I:5-7"3ZG>;RT&]1@T8M",02L&[1AT8M"-02\&_1@,8C",P2@&XQA, M8C"-P2P&\Q@L8K",P2H&ZQAL8N`R?548EXF9$8CGH)Z#?`[Z.0CHH*"#A`X: M.HCH\BI>2/_/DD`&FO^/)/!N?!)HD]PJ"%E1CCJ\6FB56@SJ,6C$H!F#5@S: M,>C$H!N#7@SZ,1C$8!B#40S&,9C$8!J#60SF,5C$8!F#50S6,=C$P#F03$R5 MRE5A`_4QT.%E=BQT>/O&1@=W;RVW,,7!_;K8 MDV\3([E.UO:I@M1`ZB`-D"9("Z0-T@'I@O1`^B`#D"'("&0,,@&9@LQ`YB`+ MD"7("F0-L@%QCHBJ.LKJJ*NCL([*.DKKJ*VCN([J.LHKSPCV'3?IDX7^+Q=Y M)_1_;RW71Y+N^:N;FR@!$JNW\D_>ZFW1JII9:9K40.H@#9`F2`ND#=(!Z8+T M0/H@`Y`AR`AD##(!F8+,0.8@"Y`ER`ID#;(!<8[HEHBR.NKJ**RCLH[2.FKK M**ZCNH[RNH*^A:20&YD3DL);[Y-"._)M2G(S`$@-I`[2`&F"M$#:(!V0+D@/ MI`\R`!F"C$#&(!.0*<@,9`ZR`%F"K$#6(!L0YXBHJJO2BKHZ"NNHK*.TCMHZ MBNNHKJ.\KJ!OH;/+S?H)G=U;%SM[2BZE+?+#_;MHN`]FFB8UHCI1@ZA)U")J M$W6(ND0]HC[1@&A(-"(:$TV(ID0SHCG1@FA)M"):$VV(G#/8K<&J!C,4=X;D MSM#<&:([0W5GR.X,W9TAO"LJ7\@2>2QU0I9XZV*6I"0W)8#40.H@#9`F2`ND M#=(!Z8+T0/H@`Y`AR`AD##(!F8+,0.8@"Y`ER`ID#;(!<8[HEJA*1%T=A754 MUE%:1VT=Q754UU%>5]"WT-GEZ>4)G=U;%SM[0M[+34=^1G@?S0B9538A@-1! M&B!-D!9(&Z0#T@7I@?1!!B!#D!'(&&0",@69@[.XIB@?\#]&`'\RR$9^H3M0@ M:A*UB-I$':(N48^H3S0@&A*-B,9$$Z(IT8QH3K0@6A*MB-9$&R)9`_,]1M9W MKK)'W+(*1E8U6,U@AN2R&D9_ANBR(D8[0W99%:.=(;RLC.7MBGGB%P/S*\2' MUPKD86L\+2C*S0M$-:(Z48.H2=0B:A-UB+I$/:(^T8!H2#0B&A--B*9$,Z(Y MT8)H2;0B6A-MB"0G4KF#MI(39%6#&8K+^C#K&IK+&C'M#-5EG9AVANZR5DR[ MHO+%G/`K?_F<2-Z:>./?=WOY_G#_^^U.;@'$I9$K5_)V1/K.1+)^*.L*.C'< M^C4&?U'U+D-5HEJ*Y*41_Z)%^;(4K<75@X%Z;A`UB5I$;:(.49>H1]0G&J2H M]"$[XZ&BT`BC4#$]X^C5DG$PT#.>$$V)9D1SH@71DFA%M";:I"AWQI)&T%W2 M*&%!Y>C=`:==0RSTI.65BZQ6QHSN(!,-[8P.(1,-[8PN(1,-[8Q.(1--8I>< M?3&I_&I=/JF,Y)&7YK+L21?W\MF3H-P$7?6O7$I"7;_-FJB6HM*[,&;5#=;( M6(C03-G[4+65F076-E@G8\%=-V.A;D]962ZRL^<(Y7+T8+F?,U.A!\K>A1## ME.4:8)29A:AC@TTR%MQ-4Y9K@%EF%MS-#;;(6'"WS%BHNU)VN`'6.3-M@(VR M7`-(;J$+2&ZEG2?7!R2=#!AZ2SAJF:4,RZR_R''K`@R.9]6GY&L M"M4/=`:9OH)=%COK24EK%'/-+V&>D&O)BJ?DKGJ_+26HD&L)RG6U6FIU(TG_ MG_MR/5BI^T:*KD-;-A6%5&Z%BCGW5]$XV0Y6ZKZCOH+[;HIR)]0+%8/[TF6Y M5+S!ZP(WF;F6D$F093=^$4)&L3 MECL'F0:SNN$DRG$;21IG9ED([7RY+BJ7FPRA?:UP%FPGR6'&T!Z8Q"AFL%^$ MS6?P?W<)FB[EYA,[0;E6JOI/7^))-$%RZ1':34[JLI@:];1F[@JED:*;_1K-3]@NZ7*XCJ7U4_Y'OH@6MAA;+\)7-\1(KNB=M,E9+:X98;45) MK'(4JZ/%AV-U&:NG-4.LOJ(DUG7TIMY`BP_'&C+62&N&6&-%2:Q2](QXHL6' M8TT9:Z8U0ZRYHC16),1"BP_'6C+62FN&6&M%J5[1.Y$;+3X<2X8(=$09(A*6 MZXDR'*3,;D89&M+R5^)IE\YU?!DN&$\[;=EN2KD[/BZ>=NM\O*POA]:4<:)P M?N6HF\C=\VOQBN.(7Y4_81Q)%_'#`=WZ3P!E@-@_UPH?]I0CF:NI6>ZQ54U1 M\GFL_Y:GGJ+]/;Q\'Q3E6T.+Y10/CB/I48:''BW&:JLS_[Q`8D4YT-'BP[&Z MZCC$ZBD*Y]579VFLZ$Y]H,6'8PW5<8@U4A1BC=59$BL>T"=:?#C65!V'6#-% M(=9FUT.+#L9;J.,1:*0JQUNHL/:\HUD:+#\>2<02=0\:1E(5H,HXD M+.V*<3/*.)*6OQ)/N[28ZVPIXPCC-=6?W45D'#DNGG;K?#SMRW*)D1V#=MST M_*ZBZTX91UZ+5QQ'_)L,^7'DO[O72-Z'*#Q$2%!\F1*I7RTE9KG1LY8B^;A4 M3[JN*)V*HFN=AA9'ET31R-!DK);6#+':BNQYJ*/%AV-U&:NG-4.LOB+[O`9: M?#C6D+%&6C/$&BM*SRL28J+%AV--&6NF-4.LN:(T5G1OM]#BP[&6C+72FB'6 M6E$:*[H^WVCQX5@RO*`CRO"2L%Q/E.$E978SRO"2EK\23[MTKN/+\,)XVFGE MR^G];!/&OD^2'EU=N=]*W M3_*7*0DJ7J;$=R!567/P%S.YP;.F*(R=]12E0^>[:#9O:/'AF:&ICL/$T%(4 M8K7563(MO(UTZVCQX5A==1QB]12%6'UUEL1Z'Z7V0(L/QQJJXQ!KI"C$&JNS M)-9-=!+#L:;J.,2:*0JQYNHLB74=M>%"BP_'6JKC$&NE*,1:J[-4KVB* MV6CQX5@RC*`CRC"2LA!-AI&$I5TQ;D891M+R5^)IE\YU?!E&&$\[;1KO.AHE M91@Y+IYVZWP\[BL!A5):H1 MU8D:1$VB%E&;J$/4)>H1]8D&1$.B$=&8:$(T)9H1S8D61$NB%=&::$,DWW,G M+SC)>QYZP>AN#68([@S%Y;MN^C,TEV^[:6>H+M]WT\[07;[QIEU1^6).^-=: MCI]:Y3G'?H;,3:TIDJ>>A;OR:%JL!C-MWAI1G:A!U"1J$;6).D1=HAY1GVA` M-"0:$8V))D13HAG1G&A!M"1:$:V)-D22)TD7R#_EOC68(;CD">L:DLL."+0S M1)==$&AGR"X[(=#.$%YV0\C;%?-$KL1/R1-O'LT=*0KC2U6>7.ZM`JH1U8D: M1$VB%E&;J$/4)>H1]8D&1$.B$=&8:$(T)9H1S8D61$NB%=&::$,D.0$A9>X@ M,P27G*"=(;GD!.T,T24G:&?(+CE!.T-XR8F\73$G_#LE)\P=^@I*-L'>EE,4 M?20;K^I4%?BLA/,'Y9H7SS1O")NP_*$PND2X+B M^Y9H1;6:ULQ=[M:(ZD0-HB91BZA-U"'J$O6(^D0#HB'1B&A,-"&:$LV(YD0+ MHB71BFA-M"&2%,KTULL%22$R0W!)(=H9DDL*TH1]0G&A`- MB49$8Z()T91H1C0G6A`MB59$:Z(-D>0$M)6<(#,$EYR@G2&YY`3M#-$E)VAG MR"XY03M#>,F)O%TQ)_S:=GY:>24GTN7Z_#.O!$5S1[R*7BUG9CKDU(CJ1`VB M)E&+J$W4(>H2]8CZ1`.B(=&(:$PT(9H2S8CF1`NB)=&*:$VT(9(\@9"2)V2& MX)(GM#,DESRAG2&ZY`GM#-DE3VAG""]YDKH2]0CZA,-B(9$(Z(QT81H2C0CFA,MB)9$*Z(UT89( M<@+:2DZ0&8)+3M#.D%QR@G:&Z)(3M#-DEYR@G2&\Y$3>KI@3?L7QA)Q(%B@+ M.9&BZ)G75;0N7?5?M_E+,;$+LP=9W;!K&*QIL);!V@;K&*QKL)[!^@8;&&QH ML)'!Q@:;&&QJL)G!Y@9;&&QIL)7!U@;;&$P2B&)*!AG0Z@J20X:EU1DDBPQ+ MJSM('AF65H>03#(LK2XAN52P+"23_^6'$Y)I;UY\YJ4H-\$0U8CJ1`VB)E&+ MJ$W4(>H2]8CZ1`.B(=&(:$PT(9H2S8CF1`NB)=&*:$VT(9+-IKF0?6NPJL$, MQ67#:?HS-)H1]0G&A`-B49$8Z()T91H1C0G6A`MB59$ M:Z(-D>1)?M$ZV3CDUF"&X+(O.^L:DLO.[+0S1)>]V6EGR"Z[L]/.$%[V9\_; M%?/$+TN>D"?I*F;N)M[_>E!Q<:1*5".J$S6(FD0MHC91AZA+Y'_=+CKZ/M&` M:$@T(AH338BF1#.B.=&":$FT(EH3;8@D)]`Z[M9@AN"2$ZQK2"XY03M#=,D) MVAFR2T[0SA!^_[N&0?DD)Y+?*4Q^MNEQ^_1M6]W^^/%\=K_[P_\&H;SU_/EC MAI-?2)29U/]$XOZ=;13M?SUQ?TF%HG+VPXIQ4?E:BF0M1V83%-WXHOU]#(K> M^J+]G@0H>N>+]N_;HNB]+]K_C@Z*/OBB_5?]<5')G[+L8V8<8+B6+X)S1;T#6BVGV\^L_5\XYEM MYYO.;#G?<%:[R:8%C-^`I"*O^UMG(V5R/G[7`K.>G)+_ZMDHDWU) MY%#L,FEQLU'W^AG.;O899)&_FOSXTRV2*F(N];6V6R/T[%;W[#6BL1Q&^W897< M2(GE3;;,J?B/]EE'7E.78_`?[QMELH%.1=Y/MXY"7F67<_:;)W?F")[*]4\1M`L$2V6:KX;96LDFLIL8Y:]HV0$LN;;,94\7M#T)OO*G[S M(*OD6DJL.-*SI,3RYA/>[VI`;S(*5.R,]@GM]Z-B'=F_1$JL(Y#\EQ(KCNQ@ M)B56ALHN<-*+K1+I`R^J_KM)E@B_;=B]T4_%/A-GEA'-I:1$NN, M9.20$BN.'R#\9A3T)MM#5=(1X"*;+.2'A'_=?=OV[YZ^/?Q\/ONQ_2J3_.5^ M;\&GY*>(D_]YV?V2IR7R<\*[%_D)X?V?W^4WH[?RJ?6E?X?BZV[WHO\CH2^R M7Z'^_'\"````__\#`%!+`P04``8`"````"$`0<-KX6D#``#V"P``&0```'AL M+W=OC^^?UT-W,=I6D1TTP4+'3?F7+O5Y\_+?="OJB4,>U`AD*% M;JIUN?`\%:4LIVH@2E;`+XF0.=7P*;>>*B6CL5F49YX_'$Z\G/+"M1D6LD\. MD20\8H\BVN6LT#:)9!G5L'^5\E(=L^51GW0YE2^[\BX2>0DI-CSC^MTD=9T\ M6CQO"R'I)@/=;V1$HV-N\]%*G_-("B42/8!TGMUH6_/:FD*])>SO3I[=U0J]E\EC[_S@D&UH4_8@8T0+PA]CC$$B[W6 MZB?3@9_2B5E"=YG^)?;?&-^F&MH]!D4H;!&_/S(5044AS<`?8Z9(9+`!>#HY MQZ,!%:%OH>L#,8]U&KK!9#">#@,"<&?#E'[BF-)UHIW2(O]G04:19W.9K3U2 M35=+*?8.]!O0JJ1X>L@"$G?O!3:!V#6"0Q?.(]`H*.#KBA`2++U74!T=0`\6 M!,\3J$)XP%I1`UU_:@0C-98%]_)@`^\SH1@*#[(.=6+D'&#ZH":U%&3"E4K+)R&_H5%L.&O*FLC M;5E`?IX6"^F/H`;7]>&J>OY#!&C.%4^[M4SKI->Y$%SGLI&V%O34LV/?4PNN MJN<_1!I:9MU:YG72ZUH07.>RD;86`J>Y*89,YV@B'_3&K*R3'$,-1?-N100O M^UD=KTLRZ`:==8L.40UW,--JESB1'((-321"YH`=H,F1#<:94,=C>JPA8#,>VAJ M.P/IM`;_@K&3F[S!H!N:+KD#Z;`'XL_Z'+ZV19AD[<-W^MNL>3>YR20,NB'J MDDWX'381S((>HLS*.LLQU#A]IW_(FBC_)ILPZ`9=RR;LE&5'F9S)+?O"LDPY MD=CA!.7#<%)%J^EN;>YH,SY:K($1[I57_0)35TFW[`>56UXH)V,)Y!P.IJ!6 MVKG-?FA1PCYA]A(:YBWSFL)\S6`^,9&ULK)U;D]LXDK;OOXCO/SA\O[9.55)U=/<&2Q)%2A1U/MYYW.YIQ[3M M#MMS^O>;$#,)(-\T57)Y+]8U3R?F_ MO_[___?SOS]]_L>7/]Z]^_J"/'S\\LO+/[Y^_>NGUZ^_O/WCW8W2Z,.?KSNMUOWK#V_>?WQ9>?CI\U-\ M?/K]]_=OWXT^O?WGAWW'Z\L6'MS_E?__XZ?.;O_U)X_Y/N_?FK?B^_`]P M_^']V\^?OGSZ_>LKZZBB.^>'UPVOR].O/O[VG$;C+_N+SN]]_>9FT?TJ* M=O?AY>M??[Y7'"P_O_CMW>]O_OGGU_6G?V?OWO_]CZ^4\#L:DQO:3[_]=_3N MRUNZIN3F5>?.>7K[Z4_J`/W_%Q_>N^*@:_+F/[^\[%#@][]]_>.7E]W[5W?] M5K=-YB_^]N[+U_2]<_GRQ=M_?OGZZ<.A,FJSJ\I)EYW0OX:3AH8];DC_]^T*?H#0WIOUZZ3?]*Q)[O=D/#>VY(_W+#^U?]=NNA>R5@G]O1OQ(P MN$X-`4EJEY[2O[<-\8$;TK_7SE.'**73 M\:7SU"%*[;@Y1X;XM(+M2NVX/[CITX;:E=)Q?]R6S:Z4D/N#FSYQJ%VI(?>' M#+6Y8+M2.^Z/VX8HI=/UI?/$;':EA-P?-PY1:JCK:^B*)KM2.^Z/IPSQ=75C M<;E/&;WY^N;7GS]_^O<+NOVC7'[YZXV[F6S_Y)S)'4HU(=3W+-^Z9:%[%>4GMZ6[D"]UI_>O7=JMW__/K?]'-T5LV>C2,8HNA6+@[(>=WI,%8@U2# MB0:9!KD&4PUF&A0:S#4H-5AHL-1@I<%:@XT&6PUV&NPU.&APU."DP5F#I,ZO M)":IDUD32%X"V4L@?0GD+X$$)I#!!%*80`X32"+=ZW.54I]?4_W7(J!9Z4>( MP+EQ(I!+\BC`JZ*C"EXLI,E(@[$&J083#3(-<@VF&LPT*#28:U!JL-!@J<%* M@[4&&PVV&NPTV&MPT."HP4F#LP9)`J1.IJ0J&8(-9"^!]"60OP02F$`&$TAA M`CE,((E)F,6HX&DMA8)W-P3V5>0Z#8&,@(R! MI$`F0#(@.9`ID!F0`L@<2`ED`60)9`5D#60#9`MD!V0/Y`#D".0$Y`PD21!A M5A-,:X)Y33"Q"68VP=0FF-L$DYM@=A-,;Q+E-](!W2!&.FBN?V=-]TDD^_`N M9Z`$4%G=TS^AU4-L-:RM1"8C(&,@*9`)D`Q(#F0*9`:D`#('4@)9`%D"60%9 M`]D`V0+9`=D#.0`Y`CD!.0-)$D2/B#"M">8UP<0FF-D$4YM@;A-,;H+933"] M293?2!3T['.#*)SU1112R(],@A4`R`C(&$@*9`(D`Y(#F0*9`2F`S(&40!9` MED!60-9`-D"V0'9`]D`.0(Y`3D#.0)($$68U&:(5YC7!Q":8V013FV!N$TQN M@ME-,+U)E-^HV.EI_89B=]9QL5>$9GLI_R&0$9`QD!3(!$@&)`7 M<4<"H#VG2`#5!M`K=^#R]8_W;__Q^*DZ8#)NC;JTT5-M_S@GL2XJ$NH"R`C( M&$@*9`(D`Y(#F0*9`2F`S(&43'S]+)CX\EDRH=OHX`[PKA57SZJVDIEC#60# M9`MD!V0/Y`#D".0$Y,S$;V@D"2,_V.01VB5#1)+K;CU7))+L`$FV`R3I#I#D M.T"2\`!)Q@,D*0^0Y/PRQD@7M)<9Z<*H?SI@$`$XZU@`%1E<#I=^=CGI8SVLC<3T%US-P7=2MO.MV MZ^XN[O:\MA+?)?A>@.\E$SK7J"])IZ,>GE:UD;A>5Z1_.8V_7.T-$W\7NJU; M>=?4;75)=K65^-Z#[P/X/M:M(M^JWZ?:2GR?P7>2L)$OD^2Q;N>]PT5)I+Y\ MQ25<8,%E2;B:^OZZ)%).X37'"Y-(C07^N5?79Q$"BWPSY56 M^8_42;XB=7[7JN61;G=',:ROQ78+O!?A>0JL5D#7XV8"?;=TJZJ/: M8=G55M+'/?@^@.]CW:K)]ZFV$M]G\)TDX#QYA';)$-$(?4FA!'*72E'W#^HJ M)%(^ON@2J1]?8XD42^!?JN6*?RFAP+_4$*Z6[J662)#-R^7%/)9>CG^I'=5-_PSLV6,J,7BF0Y$[06V:TS`TV16\S]%88+><&*]';`KTM MC98K@ZW1VP:];8V6.X/MT=L!O1V-EB>#G=$;'2^Z\OGE99!4.F"L6)O>R9!T M)9+]"$K^@[S202-ZE/Q'C:4"(B@U$'J4&@C[*#40-98JB*#40>4Q6LKHJ.0F MZ52'F+0++5?E\>+!J8G^4R@=];PZ%#M_WS@2Y)[VY.2^TU:+PIBMZ&T3=[)/ MMY&#CIJ-4C'QR9J(;Q\N$]08+A=?5;AV9]`=J"5X*B8^W$Q\^W"%H,9P<_%5 MA>NW'UKJGK`4"Q]M(:Y]M*6@QF@K\55%Z_8Z736VM5CX:!MQ[:-M!35&VXDO M]Z3RKU];KW2PO1CX8`?Q[(,=!34&.XDO"=89/$3_IVKF+/8^-LT$7-X^.,T$ MS!JCT]Q0F7&5&E>67DA@DR"B%#>]^R>"HI<2GA11*OSR'&A=77IS`0-*>8I1&\/=3M]7:NIF(3K-_C.Q,K[S@55ON_:_:ZZI9Z* MA7<]8Q3,]X58>==S072=Z\2U6_?J&;X4L_#)HM-15VJ!(9?2T(=<"5(AU9#6 M8M88S!I#'C#D41KZD"=!S2'/8M88DJ85J!.:5BH6 M%"'-(O^6Z.-)Q;W^L`-$XLS5X\"%;IL0"_-/. MF!&O"NU>>_"@'*5BXE>%B3CROC-!WG]5P:\DU)KZV>@THQ\)X7XL9[7@KRGE?24&Y`NJK/:S'PGC?BQGO>"O*> M=])05J>6F@7W8N`]'\2-]WP4Y#V?I.&W/)_%P'LFS<-5)I);I'D$63%,QMZPNCEA3W M^:9+;57>8Z&2G&\1JC-70A5$\TBX^JG[YZ'['(B^`ZA0,/F.V:I3K=(/K7N] M/J9BX5?I";K.Q,K/=+F@RG7OX?Y.S0%3L?"N9^BZ$"OO>BZHNM1AXSQOTO!4K[WDGJ,V/!>I)<2__W3L^H..C6'G' M)T'BN*4FE[,8>,\D5"@/$BK4!RW.S+YU/6A9ADM-.P'HO2XDWW-Z[9C;2M?5 M-2&=HG,IK'BE9;O`N=02/:%7SV'ZNI!.0^^Q3NFAX!:=.G.E4T$T%X0Z5U%.0;KJ2A1VM!WM=&&GI?6T&^X4X:>K07Y'T=I*'W=13D&YZD MH4=G0=X7*0H228J"3)*B*A:DDC3$+/`G*0^7(\DYF4L9D(;0GV0]7MZX+WZP M]`(_L\"?)#[LGV3>6M#<:QLWW'E6;WG03;`,X-%]=O"B';6@J;E@R':![$>, M:$'S$C-VTJH`O,8->@]WZAXI%3]^@IQ@M$RL&J/E8L7+WOU#7ZU-4['PT688 MK1"KQFASL>*5D!ZSU2);BH6/ML!H2[%JC+82JRI:^Y[NON-CLK58^&@;C+85 MJ\9H.[&2^;NM;G'V8N"#'3#84:P:@YW$J@[6:T7_IZKQ+/8^-LT`5:$%%4HS M`!=?8W2:%*(:-:XLS1%L$D0<&Q'K8FZ.*`5>KX[ZZM+:BP&ENL,AUO7<'%!J MW`=LOL*T.H?QX]79O>QRPZ13O1L333J"U-._NI4?TNP+JS,C/V>.V8J?9NB) M]$'Y2<7"3_`3=)T)\JYS:5@].?:Z-)_$DIN*A7<]$S]^JB\$>==S:5BY[G3: M`Z7F4BR\ZX7X\:Z7@KSKE32L7+<[G99ZOEN+A7>]$3_>]5:0=[V3AO+TU5:3 M^5X,O.>#N/&>CX*\YY,TK#V#YJO,AZMJ(GZ\:](\5`@)G-M^\XJ0P-&]5!;] M)UDOZ8D7W4LQU4^\^JJ0FM&[%%?H7O+>U94AK8;>8ZVZ%VENT&KU MWDVD54'A!$-[4^IEEJ'[.@#]Q%NAZ(F74;6&]?NM-FB5+?Q$.T'7&:/`=2Z( ME_Y.2T\#4['PKF?HNA`K?Y,T%\3K?*>C7XPMQ<*[7J#KI5AYURM!O*AW[KMJ MAEF+A7>]0==;L?*N=X+J116T"I?Z@)Z/XL9[/@FJ/:N*/(N![S.MSU6TLK0EJ%CM-#+[I/Q2YP+\7D%T)U54BKZ%V**^Q\74Z!=ZDG M[UU=&=)JZ#W6JGM7Y@:M5J_61%H5I-9555)#]P4<^JF7D9^1QVS%ZVJ_.[A3 MAP*I6/C)?H*N,T'>=2X-J_FX^]#NJ15J*A;>]4S\^-FX$.1=SZ4A3_6#NX&: MJ4JQ\*X7XL>[7@KRKE?2D%VW!CTU>:W%PKO>B!_O>BO(N]Y)PV^M?GLQ\)X/ MXL9[/@KRGD_2L/8&)DG#Y0C_Z,G-.'ZM'.R#I]L![MC+S3A^O1 M+LY\K`E:,EI6ZI5]6`*78<((H0Y0CFB*:(2H0S1&5B!:(EHA6B-:(-HBVB':(]H@. MB(Z(3HC.B$A"D"*2$#(CX20AM!L;S,@Y/;IC6R/K].B.=D;>Z=$=[>+,QQ)R M1[VAA)H_&$&[;:`31O[Y8RA6'HT0C1&EB":(,D0YHBFB&:("T1Q1B6B!:(EH MA6B-:(-HBVB':(_H@.B(Z(3HC(@T`;DE32`S$DZ:0#LCY;2LH)V1=%I6T,Y( M.RTK:&W?=C5_M4_O6H=JNOCIN&WDP6BA&B M,:(4T011ABA'-$4T0U0@FB,J$2T0+1&M$*T1;1!M$>T0[1$=$!T1G1"=$9%. MZGQ+(DDGR(R$DT[0SD@YZ03MC*233M#.2#OI!.V,Q)-.0KM8)^XX\P:=5*>? MT2,)([]0##N`1HC&B%)$$T09HAS1%-$,48%HCJA$M$"T1+1"M$:T0;1%M$.T M1W1`=$1T0G1&1)J`1)(FD!D))TV@G9%RT@3:&4DG3:"=D7;2!-H9B2=-A':Q M)MS!X0V:J,X9(TU42#]WJ//W(1V\\A(C4\X(T1A1BFB"*$.4(YHBFB$J$,T1 ME8@6B):(5HC6B#:(MHAVB/:(#HB.B$Z(SHA()Y!(T@DR(^&D$[0S4DXZ03LC MZ:03M#/23CI!.R/QI)/0+M*)^_[M&W1R,8^/0@0%:P>B$:(QHA31!%&&*$8&*PVV,-C28"N#K0VV M,=C68#N#[0UV,-C18">#G0U&`N+:H$*0!">/%K1*@;[:WFAN%0-]O;UA:94# M?<6]86D5!'W-O6%IE01]U7UD&8O)G3C>("8^H/37Z]']?%-\L#Y$-$(T1I0B MFB#*$.6(IHAFB`I$%.%V_01'48&3ZD$[8RDDT[0SD@[Z03MC,23 M3D*[6"?NQ/$&G?`!9;AVA&>6U13$:(QHA31!%&&*$CA!NSCSL2;(-FJA.(:.UHSZ8C)Y-]`=4W*]15DN, M3#DC1&-$*:()H@Q1CFB*:(:H0#1'5"):(%HB6B%:(]H@VB+:(=HC.B`Z(CHA M.B,BG4`B22?(A@8S,DXZP;9&SDDG:&=DG72"=D;>22=H%V<^UHD[5@QU\EU? MUNU^5]4M%N&2$IY7\I(":"0-_:[8&%&*:((H0Y0CFB*:(2H0S1&5B!:(EHA6 MB-:(-HBVB':(]H@.B(Z(3HC.B$@JD$B2"K*AP8R,DU2PK9%SD@K:&5DGJ:"= MD7>2"MK%F8^EXDX6GR^5ZGPRD@JCOO^Y]Y,`I2U MM\O'=..TN,.MYZ>%C\C"&8R1N_&HK[?^_KFA^UWF2Z+\!QE'S-QV:MT0OVZ& MK>X[U9>J]ML=]04PJ?CQG9H8X3(Q:PR7BQ7M0=6=:K<&*N94S.BIO#:#+T.= M&=THI&5C-^9L58^ZI;^!H*Q]7SZ(&>?:'=`\/]?5,4\D04:NSNIA=V&?@*WZ M_G.LHV[%Z+4#*=8QHU[UF?/N0[^MKW+*)O2Y36DU$10XS]!Y+HC*KNZHE4;N M*OU3FQEIQ`$5$L`/:,[(#PC>#2K9I-W'GQ^@3Z+_@*1=O,2W&()B@:K99"A6 M](VEB9EWG@M2VE.?^9B*6;/VC)B% MM/0QYXSJ`;5Z/;52E+4G5!KE^D\_15[O#BF/$9*T[]&/Q2K0`PC9J'2 M&-$_[IO[[A]:@P?A26AI'2JI97ED)N*;7:Z73[ M^NW#E&UHNU@T.S$"9F+6N`KE8J4$J=Z6GXH9#:)A%C6Z44C+QF[,V:H>-RT4 MNH#+VKLA4K^M3GV`QBQBS$("^)AS0=5H[OIJ.B@EF+40NAVLYZ>+ M]\&\#AY[C")YZA]/&XI5),^J9;005DAJLD525$)/V5,D1>Y"X#P3,[\HY8*4 M[B!CW*TKNL.8A03P,>>,_(#N]=Q2L@E]*:*;7*);SI[;3GE^TJI-F4ACC"*- MZ=\F&%["N^=`7X(C9I'&*F>\;CQT'KHM]09>*IY"F7$7`N<9.L\%79,9>[NR M$&+,0@+X,82B/?@XGA.Q,S7_2Y("4T5113,;LB-!Q/(2U]S#DC'D]GT-9; M!R5;F#IS&Q[/3QEOF_@+]MAC%.F,GICT2T9B%XAAQ"Q26N6."[/ST.OI[Y=+ MQ5.H-.Y$X#Q#Y[D@I33(&GN[HC2,64B`4&GQ@`8#N(<:MSF':=X-U9#MV$0JK3Y\W<]9ZY2R\CO^`_% MRJ,1HC&B%-$$488H1S1%-$-4()HC*A$M$"T1K1"M$6T0;1'M$.T1'1`=$9T0 MG1$EB<$>#68D/#$RGA@I3XR<)T;2$R/KB9'VQ,A[8B0^B3,?W2'>Z?VM9DU< MS&--,%*?H1CHVPIO)D_`(T1C1"FB":(,48YHBFB&J$`T1U0B6B!:(EHA6B/: M(-HBVB':(SH@.B(Z(3HC2A*#/1IL:#`CXXF1\L3(>6(D/3&RGAAI3XR\)T;B MDSCSL4YHZ8O6CN\Z:KYS7I1\&/GU8RA6'HT0C1&EB":(,D0YHBFB&:("T1Q1 MB6B!:(EHA6B-:(-HBVB':(_H@.B(Z(3HC(BD`KE-'@UF)#PQ,DY207]&SDDJ M:&=DG:2"=D;>22IH%V<^EHK;-0UOL[Y/*LZ+D@JCX%AY>(=LQ.S:4;,WDQ4I M910>-1L!,M_2W^?B4;.W$O]3]#\S_!>^I?=O'#5[,PE0UM[PJ/G.;1$^/RV\ MT>@?*QXOCBE3ZGE'__[(4.R"^_X1L^;'CS%;R?/.7:O?4P=EJ3CR_9H8\3(Q M:WS.R,6*RK[>.:<'.'4Z,Q4S*L':#(\IC6X4TK*Q&W.VDF$;/S!8UL[Q:>?. M;3`^/]^\3>FOZ^/%LU"67U$D>C3CZTH1ZDX M"C8D!`6^,_2="Z(GPKJ?5AIYB,T;$D;,0@($&Q*,>#S&#S>6M2/<^;MSFX+/ M3QEO+88I8Q1)%&_194\R.&R^=.F7E^'.'R,IRWOZYOCX*YU3:>1[,&$4/O1G M8N9WX7)!UY17]=1]^J+.K*$\'$\A`7S,.2,>3Q]_$),-K(V_.[>YJ#-VVP[2 MQ85:Z'C+,E+8@]I(&TK#0`4C9I'"*F=U>%WX*0AR%"I--4U_:&?K.!5U3 M&'N[HC",64@`WXTY(Q[/7>].+04E&UAO<]RY[4*=KO;=*UJ2;MCSNWA1&:OV M(>,U\$'OTDK#:`6L6D8"JQ`7Y%U7_[!GRG["(RS#=29FOM9S04I?ZA).Q>R* MOGC0P7`*:>ECSAGQ<#JMCIKA2S8P]>5V\W3";M07;PCZR>CQCE&L+[T_*U:1 MOJJ6EQ[(THB%FX;@JZW*9=/@.02LM`MH("9YFT](M6+L@[FTI+[VPF*)@#"FGIG6=EW1)O*N^I5G[`]79>U/5FI+3UH*;WX:4#2EO,KFA+K.3WCV`>%8-`6T:T M3,P:BSH7JUA;\.M68M:\-AK=**1E8S?F8E4/6MU=E[5K?.8C0?Z(7#LO*M>, MM+94WX:7#KA<^W(=,6M>Q<9B5;V:U'JE?\+Q-!0;1,_#0N5KE8Q6NF MOL6>2@":*/W*IW\\?"9603<*"=#8C;E8U8-6U[.L71NZ_B'[.?>XGR-(ZUK? MS8I=L'R,F%W3=164OE'"_LWJ5-R$NN:.!M$R,6L45"Y62M=ZS12S*[K&;A32 MLK$;<[&J!PVY%M>&KG_(7LX][N4(TKI6-S%#L0M*?,3LFJZKH/0M;B[7_5?1 M[\VV6OWQ_ZBW"%*)%0J=>QZ$SYX4/A>K:T+G`%>$CMTH),`5H4=7@68W->A2 M!FW<'-^[;8QGWQQ?O*A)G?='8J&WX7Z)S>C.7O:91^PM?&H5Y*U20:&,T5DF M9OZ9,1?DG4T%>66=S0=Y9*2V-=R;OW3;$\R\W;V;XWCY>'%,& M8JVUX78)MT%&W/2:U*J6_`1F/(I(#T)E8;3L2=%RL8J5!8^=/F;C$HK=*"3` M%65%@Z9W1]4R54H'+&61ZQ^0:N=%*8N14I9:R[TS5SEEY&>1H5AY-$(T1I0BFB#*$.6(IHAFB`I$4^,Q"=QYJ.#^GNW_W.#)GB[R$\ICQT0[1$=$!T1 MG1"=$9%.(&M)4`.2W&1HV(T,9J2<=((QC*233M#.2#OI!.V,Q)-.0KM()WU: MEB*=?-<++1&)D/#%2GA@Y3XRD)T;6$R/MB9'W MQ$A\$F<^EHK;$PZ7E.^3BO.BI,*(7NJ2:6;89Q:\#S9B=NW=+V\FWE)&P4;^ MQ`B0^99^R<-WO[R5^)^B_YGAO_`MO7_CW2]O)@'*VAN^^]7_(?O"%R\J+;(O M3/L;]0YINZ4?1X;2-'S287;E28>MY*:_1X_/ZHDY%4?^QF1BQ,O$K/$A(Q_Q"K8KALQ"T_8&/%^19O>(^JH.\=4/`4[%H("YQDZSP6I[0EU M$:?BC1;_.MUX*BY608\./MGLQ7S>_9W+QHE+& M^Y>1Q.#]+VE(/915>\0LDECEC$NRW6[KSVBGTLB+?&+XSL3,EWLN2$E,O:`T M%;,K$N-1!^,II*6/.6?$X^D/]*>72S8P%>:V]/2D>*/">%?07ZQ'JNO+#6:T MC#WH0R^Q"E0P8G;IP;=?`&,K60@&@RXL;-R#4'2,@G#9D\+E8J5TJ(0^93/Z MWBX_K1AK'7:CD`#TG^H)"=\`8RL9=;=SKZYH*3VPI.FV5W6B;Y>F\Z*DR2B2 MIO$*&/7ITC0HYA&S:[>H54O1ZZ#;55<^%3^^!"=&N$S,&F\-<[%2$E8QIV)V M1<(XZD):-G9CSE8RZDY?OP9>LH4I:[?9\OQL.R\JVXPB91LO@=%C7I5M+\`1 MLVCUK,SH]%HF[%1:^H830?2OF&7H+!?DG4VEI6\X$T3_BK-"6H;K(/2LK%OB MO:5['G[^];YXB:^W(*4N>`E,[$)U,;NB+K&2]R;::JU*Q2`0EQ$M$[/&JL[% M*A87O`0F9LWB,KI12,O&;LS%JAZT?EFD=HT/?P/J^P_(M?.B,3LRKHI5O(^E'[F3<6UU\9$4!`M$S^-ZU4N5C0%UJL:315Z(I4` M)+C:#)=-L0JZ44B`QF[,Q:H>M+J>9>W:T#45X`_(M?.B4^(C9-5U70?DEL-8K M^'92<1WJFCL:1,N>%"T7JVNZY@!7=(W=*"3`%5WK04.NQ;6A:[=Y\>S[HP%O M@?B5\5%0K&MXYTO,Z%[>3^&\[>*?[,9L1B]RBE4JR,><&,XR,?/.V520 M=S8SG!5BYIW-!7EGI;2DITWJ;71L,7";"L^_W+R#X7O[>'$,TH)WOL0LJ/41 MLVO*BK9#VL:SA_@.I<4=#<)E3PJ7BU4L+7@3R,=LG$:Q&X4$N"*M>-3&LX?T M@)Y!(-D_9!-HP'L?8;(9*6VI-68H+:,ELVIZ;2H5AY-$(T1I0BFB#*$.6(IHAFB`I$4^,Q"=QYN/5SNWYA*O=%4TXW!"-$848IH M@BA#E".:(IHA*A#-$96(%HB6B%:(UH@VB+:(=HCVB`Z(CHA.B,Z(2">0R.31 M8$;"22?8UD@YZ03MC*233M#.2#OI!.V,Q)-.0KM8)VZ++=3)=[W,,J@VZL)O M3Q;DUX\AHA&B,:(4T011ABA'-$4T0U0@FB,J$2T0+1&M$*T1;1!M$>T0[1$= M$!T1G1"=$9%4.-T^MR059$;"22IH9Z2ZA7N^5"Y>XI5&$+TW(6O(T&`C9FY;-%B1^FI%&GLS\98R"K;;)T:`S+?T M`?"]+V\E_J?H?V;X+WQ+[]]X[\N;28"R]H;O?3VX'=MGSV`7+RHMLA5,>P+^ M>L-SK;0,GCU&S*X\ZK"5W/0;S[7BQS^`38QPF9B%A0%'E[E877G4$;/F1QVC M&X6T;.S&G*UDU,9S;>T;-S$>W*[D\Y/->YO^LCY>'%/^X_W!>_6>S%#,`B6- MF(5':H(N#^;5]RI(RV"+0E#@+).6_E@A%^2=3:6E=S83%#@KI*5W-A?DG95U M2]Q&>'"[=\^_W+P'&%YN1O$V0NM!G7L-+QV@M$3BJMJ2N&1Z&+,9[=&%2H5O MZQ>SQM*>&#$S:>ECYHRXCNF%#W6D,94V?M@SPW4A9M[U7)`:CMY;K;W1MD,] M086G-O'R]4.V6Q]PNU50)!W]$<6A6`7[<2-FD7(J__Q^1:^K?Z$@%3^^]">" M`M<9NLX%T;UP?;7:;?TIY:EXH_N`VBR\J! M]`/N33.*]^':^HWLH3>3NX(1HC&B%-$$488H1S1%-$-4()HC*A$M$"T1K1"M M$6T0;1'M$.T1'1`=$9T0G1&13JH2H'Q+(I-'@QD))YU@6R/EI!.T,Y)..D$[ M(^VD$[0S$D\Z">UBG;@=NAO6CFI#+]QP>V#D%XHAHA&B,:(4T011ABA'-$4T M0U0@FB,J$2T0+1&M$*T1;1!M$>T0[1$=$!T1G1"=$9$F(+>D"61&PDD3:&>D MG#2!=D;221-H9Z2=-(%V1N))$Z%=K`FW%7>#)GCG+KR?JI!>._1I]4-M)E/. M"-$848IH@BA#E".:(IHA*A#-$96(%HB6B%:(UH@VB+:(=HCVB`Z(CHA.B,Z( M2">02-()LJ'!C(S3/1:V-7).]UAH9V2=[K'0SL@[W6.A79SY2"?THK\2RG<= MXE1NXCW0F@6KBL%&!AL;+#78Q&"9P7*#30TV,UAAL+G!2H,M#+8TV,I@:X-M M#+8UV,Y@>X,=#'8TV,E@9X,EB04?+3BTH%4+B54,B54-B54.B54/B540B541 MB542B:H)I2C:BJ+S$GW@$QI* M:[JVEJ'G`G01J"1*V;13AEL;=9-PZTR@5?.@,2,-YSHU^1U>BF352_" M'31AX<8X99(-&P]@2#9L%F6"OM`@_H4+RFT=UYSLHJFP5Q*:L0EU)8L7!@F$-Q MAKO<[=8/.9>HW.BIE@\K8OGJ,Z:Z:2S?JFVXU2V&7*V=A]9]3\W%E$-NYY]" M:-KE?@0!*(<0@'+(+%)F2W_W!"FS#M*<0XQ+.82XE,.*R<#H^P$&ZN23="C. M<..;JNS'Z+#:R0]W-2K76H<]U"$W#'4AK9DN-WRG>FO]CAC$3.+CHCU-SY0^MDL%G$%8Q%7C$N]TVGI+\B@3+.O2,+H MGS(-_BFMS)2$,:UUD.:T8EQ**\2E'%9,)$S+"T[#XLM:2MU6V@_(H'.CEU)F MD8#I%WC44D\Y9,-8PA6,%].*<;UV.ZVN_M$!2B*WB^2*`2B)$("2R.RJ-NL@ MS4G$N)1$B$M)K)@,K-WKZ^JDQ52<68NIV_S16:3RO^'7N^@]=2.%S"(14D]P M+67#6(85O/3CVU\*(H&E@K\Q"W.`2)L8E-+ZE*"4:3:CBUHO+C0PE&L=U]M9 MLS!VA3+]E*Y0\BLS/WYS%I8`AH;;>B^O^24">H$%,RTLW+1#-JK;>KNQP5*# M30R6&2PWV-1@,X,5!IL;K#38PF!+@ZT,MC;8QF!;@^T,MC?8P6!'@YT,=C88 M;=IA@I-'"PXM:-4";=H9/JUJH$T[P]*J!]JT,RRMBJ!-.\-2U42\$=2FF3Z: M.*])Q]FK=>[B0W_;,]TVQ3>2=`VKML$I-5U"8'0%@=$%!$;7#QA=/F!T]8#1 MQ0-&UPX873I@)"=@)"=@)"=@)"=@*X.1G,".Y`2,Y`2,Y`2,Y`2,Y`2,Y`2, MY`2,Y`3,R0DAR0FA50J)50M.3MCA4 MJ3;TYSUT:7UK'\8X50KLY+B'KC9$H8LM#GT4NM@"U6#4'B^ITAM*&)(E0^M4 MR:7G1^2*=TVC7#%3S]+Z`P24/S:,GJ497ML.8S-Y"G4_^0V[8>+*=XYT@C$I MF15LCDG*8;,X&?"]TK4=*;JN0.,YS.@*9?PI7:%\5V8R_/N[#GSGK=B8FV%M MMYGZ`Z3*F[?^"I-4F47/X7J/GY+_?ZR=ZW+42!*%7X68!UCH-FZW%;-$8'.Q M!]O?W]4LJ25'7.M!O"OPPG4Y6ES#Q5JE1U*=6J57B" M53$LL;+DW%O?6S6_%(&VV=A\Q5VPF0$B/2C.#!#6Q)KE=?/J`]:.1C:'-=5F M=@FKV"6&`U9N;+6_;#^8"85+8VXI'1716XAA%F6K&"9645B.F^946WK`"J,F M\`!6Q;!4+.FZLS(AS,NF;D!6;9\02ON$,+$;F3D:V1Q"M4L(Q2XA'+"\KR7U MS"9KB&!IRY3"%E'L;"/XG:6POHUVE9=%U(J"[:%X4+#46J=?]/`<,H`SAC!5 M#EC)U,7]55,7A8'95L5`;9_P2?N$+[$;&3@:V1P^M4OXQ"[A&["\K^5J(2\4 M4L.^3UI$D;.-W@\L(**9-H")5?QKWW81P%2K^3>`-?\&+//T/M]=JQ?\Q"^O MJNBGS1,_:9[X)=;0KWE*800=C6R.G]HE?F*7^(UVXQ-Z^^WISY"OM.3(%U7* M-GS?2[ZL=$Y>8_Y+K":?5EA*D;0BWP#VO=A0A4X3F;=[O`R4<&;K%1W5(N'< MQB(13C7\.3[2N!)TN7G41SWWZ*-=(<+;=(6@#VIE,%JU!Q$2]=*ZF327\_IS M/$7]V!JE;Z8A;<$JTK*%L'DN/5P4Q8JV"6Y^!GU#4^]IBLGVW7EM*CES5/Q:5Q[5C3L,^^2.Q#"?_]X MW3?3ACZ:!JLXS\N2YO4FH4_%V0+S40&K*3<5YZ=6%SW2NZSQGH[8K$$B.UB9 M-7@\8CTG^A_Y_E*P68//1FS6(/&1!@E&8E.#N+_%#C:\?8'W)]UDOF0 MNTRL89Z<8+THBC7SAJMO9%ZJ#>>^;O,5[&*NIF+V==8%`K9-%XCAV(5I="7+ ME(JIQY]-H[#Q!J'>IBM$?^Q*?O]='IW&ULWU[;^(/IJKR*M=(!<&<',7R(54JV=D.>6\Z,6\>0C3K%[( MA53DH:)."ZE6SH-N7Z8Q(Z?&U#7&[;18#P/;6"3TH\7JKG08&.U. M>N9AS'2%T&_3%4(_=N5O0S]H^!DYJANW$/HLDDS^)?2)M<.`/(<7Q5FYAM`/ M5V_F(`]CJ5:.?3>ASVY4K$]L9A'6;V.1T(\6IY#:&6"T.^FYT&M7"/TV72'T M8U?^-O2E=1V+?A_2RT3'V& M>(G5Q)-CQ4:]&0O@W7#QC;P;U'():!=!V8N*=XG-+!*>;2P2L52K9]MV\444 M1[N;>:==(;#;=(58#VIE_>L60:5UQ[NHB-P"[Z*9=A&46,.[9EIBLDV]V=1' MY`?PQLEV4,L5X-[Z?K/"8K+-AJ:<9+)5BT1^&XM$/M58V

ZY* MZXEP05F]LI'CV1:I4Y;1^K"R?_U\F,QL2TA<9[AD-5G9+T38=^N/'Y8GQA]% M08BT@*$6*[N0LEFXKD@+4F'AL(;4L)(S7F$)E_S@BH83G+6;JM+U/2]V*TQK M6S,L^%LX6)[3E"0L/5:DEIJ$DQ)+T"\*VHB.K4K?0E=A_GAL)BFK&J#8TY+* MEY;4MJIT\>50,X[W)?A^1B%..^[VXHJ^HBEG@N72`3I7"[WV/'?G+C"MEQD% M!RIVBY-\9=^CQ6YFN^MEF\]O2DYB\-L2!3M]XC3[2FL"84.;5`/VC#TJZ)=, ME6"S>[7[H6W`=VYE),?'4OY@I\^$'@H)W8[`D/*UR%X2(E((%&@*? M24)0?U[W'7\6H2A^!PO\7RL%OGN6_TEPM9TVG01+O%YR=K)@XD"P:+":7[0` MPBX6;:(/ZE\Y04"*Y%ZQM%P0@8#>/JTAEMG2?8*.I&?01H/@?KJ`QHAMAU#Q M*]ZDX^T*NT'!!0>]#4C6M!'`C-SN;J=:;1JK]J=C19L;D#%B>P-A&$^N(9#. M?,RSNP:%/6)D-1A;?=VB`L.H#C/W8Z\G;E/>:%#8CJJ*?6L6$K.P&Q1&XF"R MAWUX79P"KVPP?AD(/T:&.`V*VZ'RY[/`6-\.UP,?F;DFPW6XU;R9X7XW!*"Y M%X:7]HVLP=WQ=FL*/+;F(W.V-";2SF)OCDQK&G#I2V(6=H/"2&O\'JT*;&CU M`Z,+&J.U3A`*H\MPMC.TU8"!5K.P&Q1&6J?OT:K`IE:CH1N-"=M<)Q$RE>KE MLQ4_\"_MUL^<;GO_S!D41L+5F\'@T?GZK"OP6#BZGG4-.L_Z=#:=FMI'@.N; M(1FMWQKV(>#FL.L#5!\1%>$'LB5E*:R4'=7AB"#4OJK/[0U:P',;PG+[!3@W M&WP@WS`_T%I8)&PO=V]R:W-H965T:_X!X;\`W`E&2 MH[;K,D>:D4:C"7$2U(`C3'>Z__U4>1=X7^H$DSSD\K&J\*I=Y5IV\-UO M/W?;T8_ZT&Z:_?TXFINW;H5X]=8UVVVDZF\VGN]5F/X8>;@]#^FB>GS?K6C7K[[MZ?X1.#O5V M=73'W[YNWMI3;[OUD.YVJ\.W[V]?ULWNS77QN-ENCK^Z3L>CW?KV]Y=]\VZT/3-L_'B>MN"@'N:>,<^&$?'>KG M^_'7Y-86\_'TX:X;H/]NZO<6_3YJ7YMW>]@\_7.SK]UHNSKY"CPVS3ZN?5]^WQ/\W[/^K-R^O1E;MPCKRQVZ=?JF[7;D1=-Y.T M\#VMFZT[`/=]M-OXJ>%&9/6S^_F^>3J^WH^S^:2XF66)DX\>Z_9H-K[+\6C] MO3TVN_^!*`E=02=IZ"1W1Q]>3R?IHDB*^16]N/?K#L7]['M)\MDU?G$_S[U<&HPI#&Q7)[4ZKA[N#LW[R$U^-W3MV\HOI>36=7@J$`SG MN61_53%7*M_)5]_+_=BM6E>,UDVS'P])FLSNIC_3[V6`%S?9],I/9`J MHEA0B9*2&R;14N(&E[V5B8HR^F8V*LK/(C(V&1T;/S'ROURYIS'RC=P:14/B M#K4XOT%7U!)$^7D@*PX4!YH#PX%%@-APBQZ7V-O(W&GLXU+[1O=C-UKGRCH; MYI'CKT#2'[_B M0'-@.+`($$/N'(L-#9N/OI$PMJ1U*4$$QK)872I0(%\<:`X,!Q8!XLLG-K2/ M?%PH+^9^4C;/2A"!GR3-8H7"DC2)*!11Q(JM0=$/BN'`(D`L+Z^Q[,7",MNX M2A"!Y31);OSZHU6NL,0%(?]%%0HKYHM$]J%!@2QS8!$@EA-WZAQ>YDXM3+.= MJPRJ4.CH*8=*.M/<=9#TIK0@1A"+"37J(P.:S\/6:0)!@VX<*=N%RZ`"PXLT MS?SP@ED"6:USQ*PU0<56,U= M6)Y'K$)/H+G)4W>)QD9#D6[FBV[:TP'308*M0[\]L5A#K?OT,-PZ9`UFG6W_ M90*J,*WSHINU]*`KHKF)%QEWD_OAXZ.C0R^]42.(Q81:]Q$#61^6\Q(()FP( M>$(*JE#9S`\!'P#H!Q3+&ZE0I(]BX<>(]J&#`MM'L:F;AQ9KJ'T?/)#]"Y,> M8@JSS2.4O\!UYWHPM8#%2X^Y"I+^F)4@6A`CB,6$^O+Y8[@O2"O,%T].":C" MC([M/5608%\H"'6UT$)C!+&84%\^?PSW!6F%^>+!*0$5^(JML"HHL"V4@X(M M3HQH93&AMGS&&&X+$@FUE;%U42:@"N5:^!,'DU1!@GVAL!-\<6)$*XL)]>6# M!/(U3&-Y9Z,U:0,JOZ@*T&4(%H0(X@- MY'1F8AF2&G.SBL_(R_OT8(8 M02PFU,Y5Z2.-I8^,IZJ@@C4>O1L0%+T))8@6Q`AB,:&V_!:/=K,+)T4(!&P7 MXZ$JY;&A$D0)H@4Q@EA,J`V_HR,;`R<;Y(!+DXVGA2KE1`FB!3&"6$RH'98Q M+E0EFBUX)$Q/V>(4'RI!E"`ZD+!O^^M8GKB,:&0Q(;[\;6I%"[/-J_EL2_DI.P-5B&5I M]!9(T/16E2!:$".(Q80:BR0%/S`JK0#E>':[30&$$L)M0.2PK>SH#JQ!)#SJ\W,E#! M],NCD2%(L#]HU!,M-$80BPGU=U5DR&*1(>>7&4'5'V(EB!)$"V($L9A0&Y^* M#-F@R!!4V(Z(#$*C!3&"6$RH'189!LZZ6'20LPY48=;%SWD\7:B,$RV($<1B M0OSE+#H,\]>UXB?UG%].!%7PUV4,K00F,$L9A07RQ3?+Q'Y9`EW'=T^9?S33BH^H.N!%&" M:$&,(!83:H-EB6%[5`YIX<(>%538#K3KB1(:+8@1Q&)"[7PJ0>31!,'WJ*#J M#[X21`FB!3&!A*@%9QVV+"UN10VR3'%AVD$"8-..K972WU,C=Q0J090@6A`3 M2+\L9^Q:S>(VU-:GLD4>S1;\LCVH<-UX<%!"HP4Q@82Z);&08G$K:O"J<)%' MPP4;S3*HL#%HUQ,E-%H0$TA?-W;)9G$3ZBJ2-2Y'PAPR`YV5!5L"95#U7JI` M0@'RV-UV)5II00SM)XG]&\GB5M2RW_Y9J!]@&4(#L\S&NT3D;?52_VMU>-GLV]&V?G9O-9OX"$3^./8O'5/ M.#PV1_=P2/?KJWL8J':/%KC/:X]'STUS//WAW^#\>-'#_P$``/__`P!02P,$ M%``&``@````A`'*F>I.W`@``!P<``!D```!X;"]W;W)K&ULG%7;;N(P$'U?:?_!\GMS@X2+"%59U-U*6VFUVLNS<9S$(HXCVY3V M[W=L0PBTZF5?@#!GSIDS8T\6UX^B00],:2[;',=!A!%KJ2QX6^7X]Z_;JRE& MVI"V((UL68Z?F,;7R\^?%GNIMKIFS"!@:'6.:V.Z>1AJ6C-!="`[UD*DE$H0 M`X^J"G6G&"E8L\P5^_AD&7)*5M+NA.L-9Y$L888J%_7O--' M-D'?0R>(VNZZ*RI%!Q0;WG#SY$@Q$G1^5[52D4T#OA_C,:%';O?PC%YPJJ26 MI0F`+O2%/O<\"VSO1[\1KJ6^Z^* M%]]YRZ#9,"8[@(V46PN]*^Q?D!P^R[YU`_BA4,%*LFO,3[G_QGA5&YAV"H:L MKWGQM&::0D.!)DA2RT1E`P7`)Q+F#K'HRQ()]$H!CC:,&UN MN:7$B.ZTD>*O!\4'*D^2'$C@^T`2)T$R3>,T>YLE]!4Y@VMBR'*AY![!H0%- MW1%[!.,Y,%MG&?3G96=@R>;A!8W>6 MA@['YXJO-]>"2)TK?2!]. M#Y*3T:RW?2:9?432@@>2E[/SX:,DW).7)22TI_0N??@H&4>G^)E+ MN]('%^;UQEKP0/+4."_IPX=9)LEXW)?D)?U"\O=5,%6Q+ZQI-*)R9Y=-#`/I M__5[<`5[,'''KP_`'NI(Q>Z)JGBK4<-*2(V""0Q5^4WF'XSLW'W:2`,;R/VL MX87#X+Y'`8!+*[*_A6V_`<``/__`P!02P,$%``&``@````A`/FQD[I' M`P``.0L``!D```!X;"]W;W)K&ULE%9=;YLP%'V? MM/^`_%Z(R2=12-6NZE9IDZ9I'\\.F&`5,+*=IOWWNQM8IY\8!AD*')#6F7'J>CE*>,^W*DA?P3R)5S@QSD1!+,-2#>&022(B_B"C77]W1.O/6J,NBOX'O=^.WH5.Z_*A%_%P4'MV&?<`ZV^]R(V:4C&,W-X2(8E+9BT%&TH+XB;.%P"Q'<[2T8=90L"/0:!DQ/6]S:P-DU MZ@CNJ=..N@7U^YRWE88YBXLN.FM!?47,],8#\_$>(KC76]=9"VH[&[PSL\$U MZ@CNJ8\[SEI0OT\*`]IL=)BUU:J+WAY09T0Q(P:[2VVBM!_*WN`>4!U_)[4- MK#-Y:2>*!EILX^:2Q>^%$AQ% MKK'8)DUGB'H6'_.HF;]!UV)[@K$O^)RK+?_"LTP[D=SAZ83"F[F^6Y^<[OQJ M,.L_X.!2LBW_P=16%-K)>`)+1^X<+%;VZ&,OC"RKX\-&&CBR5#]3.*)R>`>/ M7``G4IKC!6Y+?>A=_P<``/__`P!02P,$%``&``@````A`/D"Z4,_!```71`` M`!D```!X;"]W;W)K&ULG%A=CZ,V%'VOU/^`>-^` M(2$?2K):,IIVI5:JJN[VF8"3H`&,L#.9^?>]]B49VS"0]&4F7!\?CN^]/HZS M_OI6%LXK;7C.JHU+)K[KT"IE65X=-^Z/?YZ_+%R'BZ3*DH)5=..^4^Y^W?[Z MR_K"FA=^HE0XP%#QC7L2HEYY'D]/M$SXA-6T@I$#:\I$P&-S]'C=T"13D\K" M"WP_\LHDKUQD6#7W<+##(4_I$TO/):T$DC2T2`3HYZ>\YE>V,KV'KDR:EW/] M)65E#13[O,C%NR)UG3)=?3]6K$GV!:S[C4R3],JM'CKT99XVC+.#F`"=AT*[ M:UYZ2P^8MNLLAQ7(M#L-/6S<;V2U"T+7VZY5@G[F],*USPX_L6>P8KDPE;9 M^Q/E*604:";!3#*EK``!\-2G?V6P)#GGFYRDI@*:0SE>MR18+M;>*^0P;4$Q@F`+W$"! MB=CU(#Y(/!!X4PEKMU6&HRKE)%-E,#<5Q`A9J#S+E>VT@"$`4F,+&$^3G`2E MUC(`:5I:$A`T_9"@!0P)4U/"<(4D>./":F[)#WWKQ0B)5/GF?K2PQG?Z>#@E M\T]*`PVL9V98E@3;LJRNB!&C)>0:D'T6^)_(B!Z1(<&FC&[[(F:FTK,(E\3, MW@Z'E4JC2O-'=$BPJ8.$OE6'&$$H9+[TY[82?3R<1.'R;3>?!)W9:/R))@4Q;DR\I'C*!/=>G#`[H(V(N> M+VF,4^C$X;RI61V%=H>W**W%]8A1-?+__!F==<1Y%#>LZL-Z](@I0_KBW=U# MT$4'W:?%M&7JL1\#,.`_1/KE_=+0775I/5M.<6[<`7%(@X`A<99IW]E%7?<& MD=8&BPFB]/)I$;-\TD*U'-UYRJ/QCG71U9[EUQYUALIO1K!-N]Y('C)IA3;W M4NAWMI+FP^W;KY'!XX(\Y-,*;4KIZQIT8KT@U\BP%LN:[VR2KD>#IJGIPC%! ME*Y)BYA-8EGQG4V"?CK6)(C296@10T9@&>^PX2JT69GN4=Z"<+?VG.7M>+=A M`\M]1[2@ZXYXB^*\>DN?&&3I$2-=5=O$(V(DVDQ,]P@/$-3Z7/<,-\8'#DNX M>STB#;ZHT7!G92=Y4TM`-Y; M%&^1,5G%@3P,K?A.WBYEW+L-P.6N3H[TSZ0YYA5W"GH`2G\R!^=K\'J(#X+5 MZ@:R9P*N=>KC":[Q%*X:_@3`!\;$]4&^X/;#P/8_````__\#`%!+`P04``8` M"````"$`:"`P+Y8#```B"P``&0```'AL+W=OST/=H5_&:=?N5_^/[[4WF>T*6 M75TVO*,K_Y$*_]WZ[9OEB0]WXD"I]("A$RO_(&6_"`)1'6A;BAGO:0U31"%81*T)>M\P[`87L+!=SM6T8)7QY9VTI`,M"DEZ!<' MUHL+6UN]A*XMA[MC?U/QM@>*+6N8?-2DOM=6BT_[C@_EMH&X'U!<5A=N_?*$ MOF75P`7?R1G0!4;HTYCGP3P`IO6R9A"!LMT;Z&[EOT>+`B$_6"^U03\9/8G) MLR<._/1A8/5GUE%P&_*D,K#E_$Y!/]5J"!8'3U;?Z@Q\';R:[LIC([_QTT?* M]@<)Z280D0IL43\65%3@*-#,(J*8*MZ``/CU6J9*`QPI'_3_B=7RL/)Q,B-I MB!'`O2T5\I8I2M^KCD+R]IN()L1'Y!*`<5;S$9"$#PJ!J\<%5CR.KS^;B(5(MLD9$K\1F((_$9 M1&9#BJ>0]`JQPL#_$X9:!`4TM1&CZP>T<1L#BG4M*B=S=Z"8#%B:H`BFUO[= M4@5>^1#PF%),7$\-)C%5$<<1P0XBGR((5'0:.XY.`3A+2!:-`$L[;*:7:U=@ MVT=,7!L-9F*C.U!,!BPIR6ND*+!C8QR.(9J,&@S1-MZD>)XF#B*W$"C#<8AM MCL)&H"B*KTY;ZM/7J%=@5[WSY8W!G-7#[14FMK3<`I`P1/9\84:[4A/K[O9E/H9=*GU M-)K;Q9#;@)A$KNDV`(?XNE(UXMBKG)6SKL:4Z;1G@5/ZHV!,$I,8Z:%FFC6B3= MY(P3T*'TY9Y^*8<]ZX37T!TL#6V]-`P``T@D` M`!D```!X;"]W;W)K&ULE%9=;YLP%'V?M/^`>"_? M$(A"JI:J6Z5-FJ9]/#M@@E7`R'::]M_OVDX(N$W7O"3!/CX^]]S+O5E=/W>M M]809)[3/;=_Q;`OW):U(O\WMW[_NKU+;X@+U%6IICW/[!7/[>OWYTVI/V2-O M,!86,/0\MQLAAJ7K\K+!'>(.'7`/.S5E'1+PR+8N'QA&E3K4M6[@>8G;(=+; MFF')/L)!ZYJ4^(Z6NP[W0I,PW"(!^GE#!GYDZ\J/T'6(/>Z&JY)V`U!L2$O$ MBR*UK:Y]4@;](7C/)[\MWM#]%T:J;Z3'X#;D269@0^FCA#Y4 M<@D.NZ].WZL,_&!6A6NT:\5/NO^*R;81D.X8(I*!+:N7.\Q+5:'([3)QXX84^P*T-YN*>2$K;*G=(<$6J\8W5M0-7`G'Y"L07\)S#*RZ&QD$)(\ M5$+NI,H0L MONW_4:4\-%<9+$9Z%O.^ M,`F>>Q*&F6&)QDPLF2S,;DXNN5F"#4LBS[A98V)ER94?QT%F5$PQ1P1I>BKJ MF;3%)=(DV)06&M(TYB`MBI(HF@.*&0"R==J?"9,S:?+"OY\M"3:%F06L,0=A M09!DOB%L!@!=9X1EEPB38%.8648:'-RNEGM%_/]X,QK!P/O$F&ZV&ULE%A=CYLX%'U?J?\!\5[` M!D*(DE0=C6:W4E>JJN[VF8"3H`&,L&LA(20ASD,29H[/_3H<["R_ MO-65\\HZ4?)FY1(O_7T^>YZPB9-456\8:MW'RG;A>^+?,_J3'B\90W\9\N[.I-PV>U\T78L*_2BNO)I M$,S\.BL;%QD6W3T:-1)).E9E$O(7^[(5'VQU?@]=G77/+^WG MG-G;I4TH".9&_Z\U`6SXP0'50$S19DJ# M9`',JK+H:F50DEKS52W22P$M8!RO:Q(&Z=)_A1[F!O1P`=0C?(C>IP!ASU,( M8427F_N1@EHT3"%)>GJ=Y<,80N<]9)!!.,S@=F0%A@&ZSDGQ).B),3:"(JVJ MTUHCFT@*O'*AC#Y22..S0(B)]1`2DM*0A#UB4",,];3+MVM4X*G(B)GA^),T MFEV..[.)J\##N"0DI"?&WB)HW-O$)I("3TX10>-(RM=/;IK;O53@84WC*2(F MT;T,TY1!I^(B!M5#TC"=A<>[>*`>`C?D_25K]%1L`TI10!XAP>GK M./1A'F=^=;OU!#WH]AUD0-B$:$ZO=4#9R=U#)V@^IY%!R?1,R08U%ABQ MLP8U#D:M_$JCIV9K0*CI*`BBX]T\:"JULBB-G@R-/F8T/8N#>7#E"4&M7$JC M)X.CE?6:CM/!J[>T81.L#(SB=NFVI@W(^#2AQ^W>,+*5F]&QFX&FH[XHLY-$ MU`696?F7VNQ/;SH,ZD(P*[^B:$43/470M*:M+(K>8U$&A..D`6@J/.YMAQ.U M`HKJ\#R*%Y*W^E2TX1+.D?KK'GXW8'!J"SP`;SF7'Q?JQ-O_$K'^`P`` M__\#`%!+`P04``8`"````"$`S4^N-?D"``";"```&0```'AL+W=O79 M,0:L`D:VT[1_OV,[<2'T0GG@>GQFSIFQS?KBL:Z"!R85%TV*JY(Q'0!#HU)4:MVNHDC1DM5$ MA:)E#7S)A:R)AD=91*J5C&1V4%U%DSB>1S7A#7(,*SF&0^0YI^Q:T%W-&NU( M)*N(AOQ5R5MU9*OI&+J:R/M=>T9%W0+%EE=@;6X&?,LA83G:5_B7V MWQDO2@WEGH$B(VR5/5TS1<%1H`DG,\-$104)P#FHN6D-<(0\VNN>9[I,43(/ M9XLXP0`/MDSI&VXH44!W2HOZGP-919YD3D\O!:7Y,*&@W)I6%)$;0[#%=0GX<-3N+9 M.GH`4^D!=.5`<'X&>40$Z?B<((]N3B^[?`QMP":T<=WD=,-,7@Z3],,8 MZ7-HC;?#F4%0OJZ())[[`"X%!YK:GNH*F_8COAW)@%,$:KQ="4Y.`CD,7B;6 M\SA<+!=Q]YAZ?,]@*/!X@PWX-(^%YW6"'>:8!X8\^L?7LU=J,/]()@;\(F&7/ MI>B5>/F1X`;<#P[&GC:U`PUE8I@S79WCG+6CWK7V@'HAJ%E,1IL+>\.IP*&[ M!]")O>>^TYV];H]P2VC-9,&^L*I2`14[L_YCF(?^K=^;+B=V)?`?8&MH2<%^ M$%GP1@45RV$H3%Z81=)M+NY!B]8NT%NA85.PMR7\!#!8Y>(0P+D0^OA@MB__ M6['Y#P``__\#`%!+`P04``8`"````"$`"!KLKPH@``#,FP``&0```'AL+W=O M;-QKC-M&V<0#=/?/W9RNE54O:.TDH3L_#F%Y:6EO2UM8ME95O__V?']_W M_KJY?[B]^_ENO_'F<'_OYN?UW9?;G[^_VS\[+?YUM+_W\'CU\\O5][N?-^_V M_WOSL/_O]__[/V__OKO_X^';S_ M;GY*RM>[^Q]7C_*?][\?//RZO[GZ4F;Z\?V@>7C8/?AQ=?MSWROT[U^B>/FY^/7N3^YOO5HY3_X=OMKP>H_;A^B=R/J_L__OSUK^N['[]$ MXK?;[[>/_RU%]_=^7/?'O_^\N[_Z[;O4^S^-]M4UM,O_,/(_;J_O[Q[NOCZ^ M$;D#7U!;Y^.#XP-1>O_VRZW4P#7[WOW-UW?['QK]RZ/&_L'[MV4#G=_>_/T0 M_;WW\.WN[^'][9?9[<\;:6WQD_/`;W=W?SCJ^(N#)/.!R5V4'EC=[WVY^7KU MY_?'S=W?HYO;W[\]BKL[4B-7L?Z7_V8W#]?2HB+SIMEQ2M=WWZ4`\O][/VY= MUY`6N?K/N_VF&+[]\OCMW7ZK^Z;3.VPUA+[WV\W#8W'K)/?WKO]\>+S[<>%) M98VV(JT@(O\&D<;AFZ-.I]T]ZKU[J660"JMR[]!I/FFW>STCLH&K+%^'#+*OR'C\9M>X_"XY9JL)E]# M^DAIT?T1OFKSC#6$DQJQ MEU[4P(T>:BA_P#>MJ*7JS,*M#?JUP=[XPC9NPE7NCU""%Q:@N0U,^2-DE:!Z M2;=NPK/N#V1ESI>6'2YKTF4=JM2TG1LXRI[E_H#]]LLZ2A/N=G\@+ZW6E_W` MCVWE4)E=/5Z]?WM_]_>>S#_2A`^_KMQLUN@[80R2OA+;8?.I45.&2Z?RP!ET\`L/0:*#0PU,!(`V,-3#0PU:<4KB&9#.3C?DI"M"$)=4PUQ\`[5<.RT&AYQR\2H&JH1!X$4.<0Q$G-P[0/#3PI=E)`&&!Y0.0? MUK?92(4*3VHDC=+D#)\,%T)**EP?4(Z=ULPCVX#JZN`>!$+DLX"DKM8!%4@^ MH)K'1RU=R4"P+G1[T1VJ5-+3.@%*W&5B*K!B?S$C>EH.UG$Y,C2[A\<-71-0 M;%#)=+Q35?PZ4H9MF#\I%>1()6UL'5=@14X*T#.1118L%M"J<(P48A?'.+IR M3(`2QS1;:?U M.ZXYW'F,]G=8&?A1H"WGNT=!+BBU6QFQI86@MC`#)Y$D#+36+C`6*<9H%2> M7:[,."<+\@M`E%\"HOPJ0)VD1[?4V+$F"_(;:-G%J#L'3+I!_>19TE5@^_54 MXEH#92%C.VF9IE[ED(6B%X#8,D-`;)D1H$1>S[=CLB`_`43Y*2#*SP`E\KKT M<[(@OP!$^24@RJ\"I/RJQHDU69#?0*O"KU+4Q*^O&\>=BG*WAQ)W&RASA\4N MWM-%GAH5D MAOX"%(;.$!"W_*,`R7P&[3%9<3F5_`0LRD\!46MFY>=@/5WT!2C47D*(V]Y5 M@-(94&\UUV2A@IM$/MGXNN=@B;_KQX:2GH[F`4K'AK9:#PW`8K!F@-AQ'91V MTLUH@*(XS,'R@=*5%DO'K0($ALD0$$-P9)7'9$41WE;+W@E83VUS_9`/%BW. MK,4Y6+XNK4,]6RY`8%V6D(E"'A"-K9'1[]GT.MJ=AFX9,DH!<$`E`%B'\X!A?!H-,V<#P;#8PB(TB-`E!X#2F-=+5M&AQ!H@6YX".RG57]T@%QH*VX-TE(*JL`-'6&L(AY,UZ M#ND5,2^].XGY5VWBW(T3/11X*.J\@\!*XCZPI%O3!V;]'S*V$3WM3N=8S2`% M.(R?H;4W`JO6WABLM/_J]1Y84@66W?8,7\.HTC-DK"W$'"Q?Z>-NJZ6?EBU` M89V7@*(-0(!D'$"O6@/B,+D!5#%,2#/8+B*7P:3>[E$I3O%>_MS4;19\=V'+ M-1H=M98[`8U]?V"A#-!1XBT]G>81#@E\CRBP<`"&`TL`='`*D#)X^6F7H.MR8+\!EJ4_PB(\J?,2'=U!V?[M!)_6EKTDG#`6P21_JQS:`96`S`#!"7 M33F@)+X[*N0*L&K7A4.P:'$$B!;'@!*+MN^&TG-$F3(C^^ZV)0#-R8K%&C:\W9`R8!M+D@$5C)@>RV) M4_@V!TOZ!G<_NED+6.0*;XB,'#A&@"@_!E0K/['R4V2D_`P0Y>>`:N475GZ) MC)1?`:+\&E`BKX]\-I2/FE#'U4=HT>(I(%H\`Y18U.XXIT7X\0(9*?\)$.4_ M`TKD.VH-?DGYZ@HEO5QNV^PRM)?T]+0Q0-LUN+U5!P9#.`.4S`?FQ`$LOZZ2 MO>FQ>=(`"D>,(2":&P&J-3<&*QE$M/W+!0@T MM@1$8RM`M<;68'EC[:ZNV08$&OL(B,9.`=4:.P.KMBW/P:+%"T"T^`E0K<7/ M8(7.TM)'[I<@E,;2()!2[K"^:3FZ"H(`)6.Z682'C/&8#BT&?@Y6>+XB!Y0= M_80%%*X$AX`H-++:8["\=K/B^>P$%&I/`5%[9K7G8(5R=W2L+D"@\A(0E5=6 M>4U6>6-="V^03N&/@"A\:H7/P/)%;MBG&^=@4/H"$*4_6>G/9$6CL`ZY2[!* M^;1/2F_?I4\ZNNJ3'G)/'J*U@5HG#UJ!Q7C+`'%]E0-*PMEVRZ#UU/JJ?#(W MI!:FOQ$@6AP#2BSJ]IN`Q0%D"H@5F@&B_!Q0(M]1!RX+L&HKM`2+%E>`:'$- M*+6H]M<;L&HM?@2+%D\!T>(9H,1B6SV9.@>KUN(%6+3X"1`M?@:46.RJ$^5+ ML)ZRF,:!?CQ6?T#2LL_!`"5CL[F('5C)V!RT&.@Y65%,=55,%6#)<1TC3R\I MAV!1?A2@Z$AF3%:D9>/`%U7.F1!34V8$-+/R<[)JY!=@47X)B*5?6?DU637R M&[`H_Q$0Y4^M_!E9-?+G8%'^`A#E/UGYSV35R%^"5#*&O^JQ7LNI MJ*'=0^G0;K:0(6-\]AT@60JA4^2`DIC5':P`B\$^M/(CL"@_!E0K/P&+\E,K M/P.+\G-`M?(+L"B_M/(KL"B_!N2?>^L#JPV2J?O1ZIZ"1=TS0+7%/@>+\A=6 M_A-8E/\,*)'OJA.E2["2!4(T3*5]68;/?Z`O.Q75ESTD450^PZEX;T+>>W"9 MDJ$Y9$JF$+M_#"S_0+Y7<7NS"-HMC@U#:VX$5JVY,5CA-8W*Q74H$FKTIM0&!QCY:8Z=@U1H[`RM4S5[4 M.0>#UBZLM4]@U5K['%B==O6%D$NHE+;2H'`/Y.*#\7*`__\\E)>.&`*$4XX< M?*@5QDF@N2-[KC"ZZ@GE`&(\0LH`I4^YNVI1F$&)DA]>NIWCKCHO*Z!3<2X@ M!VV[U,O1U>`6H#`D'.KB#=Q+S7ILV^9!T^=@86O=T]>)"S`J^J@^QW[&.?;` MVKU7Z5"!`\(3^5I2Z.0L=Z0BXP[>*)DIYZ`M#6$VJO M-PB$>)9AGFTEP((G&H=*IP##>D)NS^U4"4=7E?`0/:&VCX/21'JI$Q`7$3F@ MX(FFN292@%'A";?'-T/>KH]%VOZD0(8`CE\RS*D.<1)H'9DUHV%.=S^(1<-< M@%QH1QF5JW*RX-\"6G:0DWMO:<7KXZBD*^_Y39KK(%&AC`NW+!0J"UKB=D`Y MH+`P55OL`LD5_I.Y,/'?,]5P=%6-`"5MVU,E&+2W+)0Y`\1-5QX@";KRS58E M4B"Y(I;<0BKNAL]4PZ^[XBFG[:'4&_KFQH`L5L-G3+P1H'#[5PUK04/N]HE& MLGZ0E^MVJL5V<8#"G)0*XI_4&2J.!F0A8P8H=H:7#\Y0,W`1,O@CAK06;HK= MP1>.KKJ4AY0OU//H@7NC1C(*B[7P4.*+`'E?F%J$U`I?N&DWKL6K-NON14A? M.<:X#&RJ*B>@<<@:6"@+D+0\*IQ;J`A0=/8SA!;?11P%J"NC"P>?(U6N,5FP M.+'0U$(S"\TMM+#0TD(K"ZTMM`%4]H:T/[J%!CSI7J)[9FSPZY)D;/!05\:P MJ+'T\KH=6`RA#)!$4I11=<*<++1R`8@=8@B(\B-`8CB25PO:,5F0GP2HQ]"9 M`N*B;<:,D?RQVGO,R8+\`EJ47P*B_(H9:^379$%^`RWK:GE]>!=7E_1TZ`F0 MN!KF!H#8\!F@+O8GJB_D)$"F`!2Y%!"51X#2'J.6.&.R(#\!1/DI(,K/`"7R M^MK^G"S(+P!1?@F(\BM`J;SJD&NR(+\!5,HGT=N)5\G/1V])5R[UJ^3$I0%B MT3-D9`?-+50$J,MF&`*BU@A0T@SZDNN8+#3#!!#EIX`H/P.4R!^KL7M.%N07 M@"B_!$3Y%:!47O7P-5F0WP"J<&*\2WB!$[?;`6B?N-](D(DT<6*`6/0LL.1W M?)`QMU`!+3;#$!"U1H"29M"_/3@F"Q8G@"@_!43Y&:!$_EBU\IPLR"\`47X) MB/(K0*F\&D?69$%^`ZC"B?&.QSGQ52NBCM_/Q--K@!+?>E:7-37MS\F"_`(0Y9>`*+\* MD/R#C&L+;9"QU$J'5+<7>_F"2`Y"]0(]0++.YM2M?TUG`!*#,0,4YZOX04)O M4-Z/<[O`WF'W2'FF@`YGZ2$@6AL!JK4V!NM):Q,P:&T*B-9F@&JMS<&2"8A+ M-OUX;0$6+2X!T>(*4*W%-5BU%C=@E1;3WN(VLSOT%K_W3>([0/(/ZWRL3E\& M[E1'1OCXP"U`T?/O'"Q_X';4TLO1`@1NDH:`&$(CJSPF*RJE]LP$+,I/`5%^ M9N7G9-7(+\"B_!(0Y5=6?@W64^VR`:%43ATL-ZTY%+;P\E(P2S6-] MP-4)+';L+$#NAAX[C#XKSP.KZ\^A>\>'^K2F@`X/RH;6V@BL6FMC9(LL,(X<]< MDA$B0%S3##H&R@`Q$O(`18-&`8@A-$1&RH\`46N,C(0F@*@U149JS0`QXQP9 M"2T`46N)C-1:`6+&-3(2V@"J".;XV.KUB[3ML156&"<=#R7!W-)7+P=@Q<'L M,SX7S)Z%8.XVU':F",IR60Q%&EIC([!J^_H8K-KHFH!%BU-K<096K<4Y6+46 M%V#1XM):7(%5:W$=6$\VZ`8R%?'L#K)VB&=_[I7$16<)!,;:T!H;O'6:-R8+\!!#EIX`H/P.4R.OE[)PL MR"\`47X)B/(K0+7R:[(@OP%4RB?S?%=&KUU<[>C*U1Z*=_JEJ!SLL.@9H.WI MJIH+`J+\#%`B;TY7R8+\`A#EEX`HOP*4RJMSOS59 MD-\`JG"B.RQ[^7SMGOEI)WHH<6*`6/0,&6,G!BU"16`E3C1:(["29C"GJV2A M&2:`V,I30"SJ#%`B;TY7R8+\`A#EEX`HOP*4RJMQ9$T6Y#>`*IRH#^5>M0MW MDZCVK8<2WP:(-'@*@U`B1>Y[QL3E?)0NM,`%%^"HCR M,T"IO)KVYV1!?@&(\DM`E%\%*&J)M84VR&A/5V4FVRD:_;%7O'HN%W*$)*,W:\+>Z>BYN4` MQ3NIUJ&^"52:3P]=`7$$S`'YG\AKFCN.(5U^L!:Q-D06!M8($(7'@&3SSQYK M]E96?HJ,E)\!HOP`6(PFM`M>7>)/+I2GJW$S.92XU[/90< MQ]BSU9`Q?N4'4&VWSL%"V+:.U#*S`(-!-`3$(!H!JK4V!@O6S)`T`8/6IH!H M;0:HUMH<+'\CS/3F!=)I:PF(ME:`:FVMP7IF>`C.K!@>W+'8#DL[?XJ63"8! M8N\=R/1==B="&2!V^SQ`T>E,`8A'#D-DI-8($+7&R$AH`HA:4V2DU@P0,\Z1 MD=`"$+66R$BM%2!F7",CH0V@BI,.=\03^^)U0[4_*$I<%,Z.XJYDCU:[@<4^ MF`7HF:/5P)+]@WN<*I]:U1^P**##<\>AM38"J_;<<0Q6;8^?@$6+4VMQ!E:M MQ3E8M1878-'BTEI<@55K<1U83[?H!CKV<%7NW*6]J/XV8DE/9W9`Z9&W,C'4K`+!H<0J(%F>9[N+H97=AY>2^L3I>."E5W^WW MDA%'/W(9!%9\P1H9_4Q]^*9WW.,OV,M?RE`.OIW9G.U=*N;H*@X\5'X=%%^2 M;C54"0:EG7*%RQ9IZ??)LL!R#\RV"]&6V3J!Y5]/:+\Y/$[^QR52LMCKN=./ M>-YXQH7^L"2>($H%XRYUW#`(K,1=7DM2RJ%?W)7^+_^7VA#DB4A:C7_D@*)G M#R@"I/RH-J4#9.2$G@&*G=;4NX><+-FBNW!4AI\XC3@*M%Q\9 MMD`7Y);3L^UFNH7>).KN#+A5DR&&/&U@H MLU`>H".NU`H+#0,4O:9=YHJ5`8]SW*!&P4!1]>R+V>!%0UW>8!D4XP.4@`*(^!Q2WZS7=U` M&H+##=_(BH_!BLMN5D\3L/SFLO&FT4CF1[5*FX).TS-`[#US0+6F%V#YJK:/ MFJJ>2Q`J)F.W(]S!LV$#R78^Z04H693J3\$,P(I'[%;3>#9H,?!R9.3:JPB0 M_+QA.;=U#AO'^I.(0W"XBAM!B>)C0''9*SSK2R4+:C^7/N?90*?I&4K#2LQI M&CUV`9:O5ZNG?W)^"4+%8E'O4)]9:=BM:*]J*VH#U+-4@*H9.PM:28!NY5'= M`A9#@'8[AT>'JD,,P6&4C*SX&*S:*)F`M0W03KHD2E_6G().TS-`<8":>BW` M"M$HGVM/E9<@V&ATDW@2C:]:EY0JZ8H94-S16[I@`[#2(-7>!8MQE`@ADDY*X>1]V(&%,@OE@#B<%X!\ M[^TUCILMO3T<@L/0&`'BBW_C`$5S\@00`V@*B%HS0&3-`^1>RM\N#$P?6(`5 M1I3><5N-)TLPHM`[>/AV<_.873U>O7_[X^;^]YO!S??O#WO7=W_^%%/R4Y#2 M@;?XWOW-UW?['YJ=_@?Y,1AQ@$YI=?L?I&]4I+2;DE)V))VG?=3_(.<`%7EZ M#4DIRZKS]*0$4IF*/)*E=*?*<=+H7U;Q3YK]RTI^JW]9OF:B=#ZT^Q_D&]-5 MAJ5(_M5VE44N%O7=8U.;1S8O?;G=L2R+6SOKM45I72D)2JLLF5&$FI*IO< MLY"4JK+)4WI)J2J!W*OKNUMSM@1R/4M2JDH@=WXDI:H$24E4VN;PA*57UD9N.?7=IPY9`+CSVW=T-FR)O;_?=BV@V15[B M[KOWT6R*O,O==V]J5Z1T)!;D[=ZJ%(D%>66T*D5B0=Y#K$J16*@L@;S2WG=O MY]D\\F9[W[VD9U/D!?>^>WV](D5*[=Z"KDJ1**DLM;S1*2E5I9;W`26EJ@3R MGG_?O;)H[IHPD95Q9 MZI&4>EQ9:OF,O:14J4U$S7V^WMK)9(BO&JTSZ:!5O2/K]?-*G8;$E'\_7O6T M$[%]4FE[("F#RI1,4O+*VF=2^[RR]IG4/O=J!]LB/+Q_^^OJ]YOYU?WOMS\? M]K[??)55MSQ>DNW1_>WO;H?D_^/Q[I>LQO?W?KM[?+S[4?[Y[>;JR\V](PCY MZ]W=(_Y#&O'@[[O[/\J5_?O_$P```/__`@```/__`P!02P,$%``&``@````A M`&K==4:&*0``?]L``!D```!X;"]W;W)K&ULK%U= M<]M&LGV_5?<_N/R^-K_$KXIS"R8)`20(R;*^WQ1;25RQK92D;';__>T!^DS/ M=(]!*=0^K)G#GM,SZ#[3,P.`^NG__O/MZZM_W]X_?+G[_NYU_TWO]:O;[Y_N M/G_Y_MN[UV>G^;^FKU\]/-Y\_WSS]>[[[;O7_[U]>/U_/__O__ST]]W]'P^_ MW]X^OB*&[P_O7O_^^/CG_.W;AT^_WWZ[>7AS]^?M=_KFU[O[;S>/])_WO[U] M^//^]N9ST^C;U[>#7F_\]MO-E^^O6X;Y_5,X[G[]]/%+_'W[_\N<#V+Y]>@K=MYO[/_[Z\U^?[K[]212_?/GZY?&_#>GK5]\^ MS[C[]?$-T;UM.VK'/'L[>TM, M/__T^0N-P%WV5_>WO[Y[G?7G636;O'[[\T_-%3K_ZI$3S9G#@F#[=?:4.T/^_^O;%Y09=DIO_O'L] M(,=?/C_^_N[U[[Y=M$9]IFI)1DQ" M_S()T778$W/CE/YE^^F;T>!@,FV<=C0</ZEAGZ+:N'0?_G&_^W1-6Q:)U>!-?]3;U>_^$`WI`[N? M/>UZ]Q%9]^&?]QQAZX=QFQXI.?WOZ;"O0G-GJ?,(HM%K!PU=CQ+C6PTD"N@4,- M%!HH-;#6P$8#E0:V&J@U<*2!8PU\T,")!CYJX%0#9QHXU\"%!BXU<*6!:PUD M/KX(3.:#Z1$3O,Q$+S/ARTS\,A/`S$0P,R',3`PS$\0LC.);RG\O`IIO7D($ MCL:)`)?D/0!1Q4`E/"S09*F!E09R#1QJH-!`J8&U!C8:J#2PU4"M@2,-'&O@ M@P9.-/!1`Z<:.-/`N08N-'"I@2L-7&L@RPSB@XE090MC8Z*7F?!E)GZ9"6!F M(IB9$&8FAID)8A9&,4IXJI(FX5WM3N^-,,F[5K0+"B?YWDA/\JU1O]T&N3E\ M89"E058&R0UR:)#"(*5!U@;9&*0RR-8@M4&.#')LD`\&.3'(1X.<&N3,(.<& MN3#(I4&N#')MD"RST'L+V;!F-JZ9#6QF(YO9T&8VMID-;F:CF]GP9E%\(QW0 MVB_207?^.VM:)Y'LPU7.-)[2W[=6XY$O`PN#+`VR,DAND$.#%`8I#;(VR,8@ ME4&V!JD9:4YLFL79$2/MX8F3^C$C8S_V#P8Y,0`AY`"'FS;@C4=!.-A)%NR5XXW;"C[]_^?3'^[OVV"LAEB$M_=L-@2-I MM()R^;Y%0ET89&F0E4%R@QP:I#!(:9"U038&J0RR-4C-B.3/$2.2/L>,T"P: M9D\OSIX/W@K7[,0@'PUR:I`S@YP;Y,(@EP:Y,L@U([+$S3*&9+`9(CWTLT"V M,%098AU8(=@!A&@'$,(=0(AW`"'@`82(!Q!"'D"(>3/&2!>D_4@7B?RG4R`( MP%G'`FB1ZFVH-X:Z\JV$NM\[.(B[O?56X*X-]Y'A/F:$#JC\)1D,9C'U!V\$ZI,6 MF33W")HIZ2,CLC(]]:V$FKJM+LF9MP+WN>&^,-R7OE7$K?I]Y:W`?6VXLXR- M))39>]].V,U%R9!?DG$9)UAP63+.IHEV$RY%C`STD6\G-*A?S( M*<6O+DZ&1`OX.=-:_DB=='@6J?,?52U'$HN6$5H1^.RC*Z&W\:U5*&1&9&)9 M&21G1&;30\-3^%:1_U&<_J6W0AJM#??&<%>^5<0]CKFWW@K$^,MS'IM4' M@YP8GH^&Y]2WBOJHUMQGW@I]/#?<%X;[TK?JXK[R5N"^-MQ99LBS]Z9=MK#0 MTG(A40*Y(U/4^D%=A0SI(TF7(7\DQS(D2\"/;-G!CQ0*^)%#MEK267"DQ^YJ MZ:QCX0&A4XE`>6.U9EJT9B.9YI=H*&O=E87R%J+[/8CJH6$J;+/20FO#M#%, ME6VVM5!MF(X,T[%M]L%")X;IHV$ZMV\; M9ASC/MTP0[`RCG(0OXRC'*1"QE&.6G*<(XPC';)QI$,VCG34DF,=81SMEBVJ M453OGJ$)9QUK`@B=SX>:4+O0!9O)8G#)"*W"?;M!7TWTJ]:([@2ZVS>T,IP. MU`23LX7$X="X*I[BJHQ<]0?3X515U+5QM3&NJJ>XVD:N)OV9OBM5&T]'QM/Q M4SQ]B#P-1X.A&M.)\?31>#I]BJ53'%TI1X/I M+/J?RH]KXS?+C./L_5,\9YS$G(V)JYEQ4H>S`J

]H/G%/S3QC0FG,XQG% M0]&A)CTX$R\"%VP73(=+ANC!"USL%2!W#$1W@(>#B4[-'"9!X;7VZ:YB%>X'!0%VI(^OR&`W%Y0=`RJ4: MT@G,.EU^M"Y/T5!ZQ8(DS)"K`^5575NZ.\UMN]TBJ4.W/HMEK'3;FNF46W5]Z6;VD]PB MWT.W/L,#MTAQ/5KMUN?]CT8;3RPTB.=,+,Y<32PMU!P:^T=">F.UYEC0?<*F MI`A+M$PW;9,Z8G+5556\-"J#?@ M$>H*D%!OT;"EGHSZ:O-2PT"8CT`CS,>`A/D#&K;,P]%0]?D$!L+\$33"?`I( MF,_0$&N+GIH%SV$@S!>@$>9+0,)\A88_8KZ&@3"3YCD_A([>I18J(+4"4*>@"VX:S$=+AH+)=P6HK=(S6DBHP>2P MD"I]:*D+6,E,5P)JJ4>S\8&:`]:P$.J-I:Y@)=1;0"WU8#@:&:6V5RG8(1Y9 MZF/P"/4'0'Q!S)[J!`;2Z8^6^116PGP&J,^[`+4+/,?W0GQAB2]A)<17@$#< M4Y/+-0R$F83:7J`@/4BH?-&$FXHS8S^Z'E26S:6FQ\8LNT^D@!V91,6PW1FI M:T(ZM>1(K+#K/I4")`8]?&GY$/20#U$/BR?"'O(A[G%Y ML_U#Y%-;6EJ?/D#NRWHYAU>GM`ZQ:;_TQK;[CP*5M[9J!?]3V7C->S%-\T`)D-I!FBQ[A2E28'-?GAE:8Y@ MD\#C*N'1)W/G>&F-S'1^P.KJ4NVU#I'=@0CI26ZVZW:('/?EF-[WBOZGKC!5 MY]!_7)W=XRG/J,[MTRQ4[5$\W[LCOV8>HI5Z..FHU>\"=E(AEH!D3E\QQ+L9 MVI'.%$\."YG@#\$CU`4@H2[1L-TYCH8TG\226\-"J#?@$>H*D%!OT;"E'@SZ M4Z7F&A9"?00>H3X&)-0?T+"E[@\&/;6_.X&%4'\$CU"?`A+J,S3$MK2O)O-S M&`CS!6B$^1*0,%^AH6=6&7D-`V$FS7,B"35IGC'A)H&W&(Y$[!4A@;-)0(_, M"HLVD46S_*6L-"J(\L]3&LA/H#("X]@_%0 MS3`GL!#JCY;Z%%9"?0;(UQB5E>PT"82:LF04BK M)D-(JU&*T+UB?45(JR9':--KZ7/82==)J]S6]UU=%=*J94=RQ967[0)VY).4 M675E2*LA>ZQ5]W1+J-5_]%`632=FC0](E5N5:0LTE=ET"4AFNQ5#/)=.AM,# M=:\@AX5,I8?@$>H"D%"7:,@'M;/^2!6N-2R$>@,>H:X`"?46#;DF3@^F:@*K M82'41^`1ZF-`0OT!#9FZ-QVI.>T$%D+]$3Q"?0I(J,_0T!<6E4[G,!#F"]`( M\R4@8;Y"0\\OIO>-*S'#UQ-U/;9B!@>U9VOJ4!PK]YC`_K'BIS,H5G#ZOL^8 M>U7>7W!]AV4!*[KEAY9+QMRKA;YAXD"EY1\/VL<&)O3J>)P9.7BD,!TFW!4P MZW17PBJN'5/E`:-;P'>WWM(,UV"C)O)F-(ZP"GQ4A.UVJH]DWTFEA91+Q$U MQZ*CQE@L436A+!K_;H(-),H8212J73&$S)R->_I9P1RM`D$FR`N8"7D)2*E/ M+0/6,.M67\)GA9;B<\N0'U!O--)'$YXIH37JPPMHS;'HJ#$6:6UDM,9606HN MW?D?L45::R%.S?&L-YVI0>;6/(2D-*:B1IW=8?6[(`J.`BU M%@]H>C`F:2&TW*K3L[,:6K?RX MJ5;H#*[9AFY+N('')=$=[^X?\/:0."Z)C$4RU0R1&= MP$P*4PE(*<^$C+NU0WG69P4'XG/+D`QHK&>7FDV2*G.'/?M'K3TRBJ/&6*2R ML;H4"]H!6Y6U6*2R%N)B.*,'PGKZ3`=,H=`L><%F`7D):)?0F&U',;0^*S@( MA:8'1#\G&F^2:@PHI36WP]\_:NTY01PUQB*MC95"%G3UK-9:+-):"W%J#H<3 M/<:X"9I+V)2`E-945:YCMD)KU6:&E^-PRQ.,9T(]XJA5YS19)I5%Z MO4#,'(M>=C(6*8UV3JH4+:A&6:VU&/4;"X\5F['6!K,1/:00IV8.IE!KEKQ@ MLX"\!$36?M%!735A8[8=6K,^*SB0`6T9PH"F4[.2KMFDG](:]<'$S<7YZ3^> M0>>,-FB,14*C*V%V"VP7+`.7S+=KW=FV1&%(KSM;FTA_UF'Q)(!Z:P):, M[3H/%3-(-V*%?C7EG^3X*^DI?`GSD/%#`YJSV;/0X>4 M5B\0%\>BX\*8DJ)^#&S1](#:AE)DS/7;SV?V1)2MD)('OQZU)T\(D;KU`@%W+#K@C$4% MTJ3FB2A M?E)_D_!9P4%0+1GB\21>H*D]D=T$NM_K]3%S#VC]HSO$#8N.&9]#1"*=ZH4I M6D82;5N21#'-K-@,B3FF6_AJA<,6-%0T.DQP%S`3[A+0+NUQKRAT73'C40?C MJ>!`?&X9XO$DWDQB@]2ZU%U0$[+GK6\:"ATO/G"(-#93Z[P%6@8Z6#(6::PE MXYSLC^@W^W6\V%VH,88"[L)REX!V:C0'0M@[_?/)<:'"^%!:,-,873.?4[.]"X"5D%*+AF+)-8ZX)0\&.IWK'*T M"15F3SP*F$FVEX"4PM0U7,-LA\*LSPHMQ>>6(1[.H#=0DWS-!DF%N;V^CM@S M%<:G"E&X&(L5IODJ-T\P"H8=`4';N?VPT%OV8H';=_$K#UUHOBY4P0=Y^?O M'/@L(@HU8Y$R^SVMJ85+A2;8P1DH8[M6J&U+SN_I04_E40Z:4*[66P&SSH5A M"2NE8!/LUH%;;TC([+K&=J."@\YN;-D*HC9OF=9LD!2U.WO8/]B.15=.QIQS M/VSZVQ7J?'#A?MZ_";;H;\E85#M;,SKAP$HF1TMI>`@HV#H6EJP$)&1KM!2R M#:!(?MR-L`J:GM6^94)=;LN^_P7GC7^D+L:4NF9JBE\,V2ZJ?"VV2UULA4">]#MK815K"[SL#',=JC+=J-"RQWJTH-6:^R::5+JHL=87R#8 M#8M2%S"M+M6Y!>R"'%XRMJ-NPJJ]A]9[H]\KS4$MBCD$%'@KP!-.`Z9*E[`B M+863A9Y*X8!BXLULW815T(T*#CJ[L865'[2ZGK6GMLJF8OL2P78L.MB,:67K M-6W3`[=("NHF8]U:6\'**UOMS7,8!,I.>"M@UBFI$E9*V2;8[;!WU,U$-RHX MZ.S&%E9^T";8?-T3M_5'--WL/XTW+#K8CIDPK6RUDEF@;9#D2\9V*;OU0*74 MO8X^>1.]G];K35;_TMM2^`JESMT,W!=/L.CH\TE)+'7]$RT+-*44QG)HR1@I'=`*D%CE@$(A ML\^`K("9D)6`A&P-2,@V#-&OX?AN5#`3LBT@L:K1,J4V=]"P__7F4XUPT31B M+%:;?O-K`;,@VY>,[1);ZX`NAQ-;8D<"ZE!;W*G`6_$D;R6L8FV9^Y+BL[., MVFY4<+!#6]&@[>_>U.A`2EON)&/_6/-Y2!1KQI2V5-E9C.Q1RI*Q756T;8G= MYU#?>LE!(WHY3'@K8-99ODI8Q574QKKMU*XJ:@==P4%G-[9LA=TG_3YG?*99 MLT%R?>S.6?:/-9_61+$&)G/.8H13'7F18\G8KIN48H:Y-6)AP4TE*D M9F]2BA7XUY9_D^"OI*7P)VY2BAD8)A5VC9V8TM6V'80WIU5G6A9I.D$-T9QOY"="PZX(Q%!=;M/>"(GI\;,1;)U-RFA%60K4O&HE5H2\:I2:_; MZ`/?'(W"NL@]"+@+F,F<7@+:I;Z6;5<1M#XK.!"?6X8P'GI"39UIUFR14MH! MR=C$K%E#/OV/&#D*);.&EK!(9N8^):Q"F3$6RHPASLHA[0]54N8@"E0&*.`N M+'<):(?*P$81\6*T*H-5X+."@T!E#/%X!OV^?DJ^]D3V6.?`'0+L+;*&1_W]=.N.1H%(DMP%S"3A"\!*9'I.Y4P MZRYQ"9\56HK/+4,\GLE4/P9:>Q[[R,V!V]KKD#U38^WI0#0I-K1&8_I;9M=RQ4 MN244.QWJGP[/V2)S"Q9&R7OMJ6]&@F_^JJJE?.C#Z`.E6V]%6S6[:V$%1'XY0]5)1-L=K!C>VJ[4<$!Y8%W MD%@4MRUE.C/!!G6B9KM3C/V#S6L!DMZ7'8O&0LVK&V9E2? M897#*JS(EJR`F6P72T!"M@8D9!N&HIN3,!.R+2`AJ]$R<7-R3+K=_WHW+$I< MP&)QF9N3,`NUQ5AWMJ_8"GNOQ!8$W(&X``7NBB>Y*V%%N>MS/_'6)!Q0Y+V9 MW7'"*NA&!0?=XF(KC#JQ!?'<5EUC*@,O$&W'HJ/-F%*7FGH630>H:5@V&=M1 M-MD*6Z_95+^EF8-')'.8<%?`K+-@E;"*ZZ:Y/PFS[KJ9Z$:%EIW=V+(51DTO M7:B%2.VY[8:36KU$M!V+CC9CX5N4C3<7VN`&)6.[;E"*F9],&0KV@X<)!X6T M%+79&Y1B!?ZUY=\D^"MI*?R)&Y1B!@>U9[,W*,BD,Q]7[)0&Y[:E_=256@I9%M`0E;[EHD:YXX?]K_>?(@176_&XAK7FZFC MF07]S?)FQHSDU6+A$I+-W-NW?J70IQ=*XB=0\F05W!3*BW@-1P]-K?L]'VWP\[%&OT`U1C=TBP?S#YD"(*)F.1 M>,P/<#;^75&3=%PR%FFG)>-%V6BH?Y,D!T^H).Y`0%U8ZA)0M.SLZ^<]U^(@ M?54_O;I_]WH#J\!G!0)R$_=T:P?\3XI"&*&&.1_/0?+%N, MV2H27XM%XFLA"&&B19PS3W@*DZ`N8"9"*`%%0NA-C=*X4YVZWB1\5G`@/K<, M83AC?2.V]CR)`N5VX_M'C/?T4<08"Y:$BS'LI/=+C\67S/SZ<&"'LI4S%I20 M0V\F+@J/A2X2*T7T3G;/:^MAX]G$0^6QT$-JK6A=U&@[22P6W1'"_M'A@X@H M.HQ%>K(S(%M%>FJQ[L7;:MQ:<4[2#TWJ>.9L$6G,NBM@UKE(*V$57?Z^_J,F M:YCMD)WM1H66G=W8LE4P:K-C`[>5XH2X]P]VPZ)V!L#B(`"\L*2EX!()GY]0,LB=1778*.+ZI?[,W12E9_APGR`F8R^Y6`(O7U]*.2:YAUJR_ALT)+\;EE"`.B)]GT#U77 MGBFA->K#"T3-L>BH,19IS?P$\82M@M1<,A9IK37#6FPP&@[U0P`(K$EPL9L.\1F?59P$(I-C8A^_=,L5S"BQ+T_6DR\1-QXPQX6Q(:98AFI MS?P(,:PBM;5L.PHBM^1\I:>SQG1^HG9[;!.6Q(3#`F:=M:B$E1*E.I1=PXSB MTC65XHA#9ID*+3N[L64K&3<]^ZS?LV";U/T_6A2]1,`3!R@-LPLX+<7]R/6C MAPM814)MV2*AMA`+U?WQ,+7US4$4RI1[%7`7;!9PEX"43$T@F6V'3*W/"@Y" MF4;CZ5.Q4"<3-<:3$JD[[MA[U4H2LY,K8Y%(Z3Z,JM<+M(UD:@]AV(QSUFR2U)H[ ME-!QHTQ\Q@]MTDU&&S3&(J$E?F@3;0,Y+!EK.O'CQT_9"F4R/;=R+T+],10X M+)[DL(35+DEZGS+#)):IMAL5'(1SD[W7;L:=FEO!GEBZND,('>]G/Y-(5\^& MG#&:V+%77W@[R=>EQV*1Z+WB*K`#7\Y8N/?W9N*B\%CHPN[]`S-X6%L/&V\F M'BJ/A1X2>__`#BYJ8#2;$A:=?M+$^A+1<2QZB#?0/QM3P M1]'3,G6WM_>/6L.BH@8LDJEYDPU6@6B6C(7[?X:@R.%8__GV'(V"[7^"NX"9 M3(`EH!WJ@UFW^A(^*[04GUN&>#P#6I^JMQUK3V1W_U/JJ8G9\Q8Z#84.F*,E M+)*9?@!O@9:AS!@+E+!B"%G9'XW5(C<'4:`R0`%W8;E+0#M4!C:2D1>C51FL M`I\5'`0J8XC',QCK'Q"M/4]"8Y0R)E[/7JA,'8L.&6.1QO2!Q`(M(XVU+2.- MM1#GY&B@ES$Y\X0U+T%=P$S2O02D)*8.`]J8YID"2YS1-+1&8*I?"U@%";EDK.G"C_<1;,4Y2G];3_VZ M<0[J4'(X&9%<+Y[DK8254J'>UXO/SIC:;E1PT+V)8"M,-&/]E'*-#J2*GSLF MV'O),N4SB?`X#E@DS,0/;L(NR.4E8SO6J&S%:AV/]>-].6C"@HC3$UD1%S#K M7!J6L%("-L%N'=`,T1ELVXT*#CJ[L64K'C2]:ZN6Y34;)$7MSB#V#S:?9$3! M9BPJG(E7V*8X!1']+1F+2F=K%K["AI;2\!`0K>VPW"TL60FHJ4K-?:4U6DK# M#:"`K$)+F1BV@(2L]BT39<]MW?>_X'P`$%UPQI2ZS"ML4QP>2+XO&=NEKK8E MO\+VE%]J`V\H-^N^@%EGGI>PBN6FUV)KF.V0F^U&A9:=W=C""F^^Z"=W:C9( MRNU%3F,=;LO8157 M5O-&(QSL6-_RU0JZ4<$!?27K+%TXM[#"^S\]=4^@1@=2E97Z_@+:=RQZR@$;T< M)KP5,.NL5B6LXJ)I8]V.>L=V--&-"@XZN[%E*Q[T8*#_SF7MJ1.Z3ITQ/?M0 M<)8X9@(6WKT$1J?***Y+C\5741_[K0([M,T9"_:+A]Y,7!0>"UW8NY>!&3RL MK8>--Q,/E<="#XF[EX$=7-3`$G,D-;:2.;A+4 M%@LHDBKM/N*G.&O/1J-/:C5ZS&-&JZ$7"*9CT4L6QB+QF%<\&O]..Y*. M2\8B[;1D=*8J8Z+C8[-(89^=B\/#A,_"^BP!13Y[4W6]UV#K]+F!53#."@YD MZ%M`D4\:J(XQC],]SM$1X[/BYO'F]^_NG;[?UOMXO;KU\?7GVZ^^L[ MM:*U1`"_NK_]]=UK6E3,W8*!)BW?H/V&U@+S,OD-U?#Y-OE-UI]G39XKKO>$ M5\WV27\QH"^2+8;T1:I;V6B>]9L+J*BR_G2>T>6T(Z%7ON8K>NO)?D-O:LW+ MY#?TAM5\F_R&'B*;NP?$$FST39G\AI[9FF^3W]#/JL]7]/OB"3;ZIDQ^0[]D M/M\FOUF.!S32U/6D'R^@D::^H9\=H)&FOLERNJ*'J>N6K>F;3>J;)45AU4]] M4]`W9?*;BK[9)K^AOXP]7[4SO(HV_4GK>9G\AOX8]7R;_"9;CZG7J6N=K2?T M32JF645MJM0W2QIHT2!3^/%T_B&%GT[G9RG\XK)(OG- MDL:P3(TA6]$WJ^0W.7USF+Q6.5VKPV2;@MH4R6]*^J9,?7,QGE^D\,OQ_"KE M_7(ROTK97X_GURD\R\ASEOSF/7VS2'US/)Y_2.$GX_E)"O\XGG],X:?C^5EJ M#*>3^5G*_GP\/T_AE+;K%+X9SY,Y2RF[3?FMW"24F&GJ\;Q.X4?C^5$*OQ[- MKYL;=$J3F9N;L^0W[^F;3?*;BKZI4M\LQO-D="B9DQE+"9NG>GLXGB>SE9*U M3%VEPDWBB:M$0WB?[.=HODCAR]%\F\+KT;Q.X4>C^5$*/Q[-KYJG==75/CZ8 M7S7V;_T7#S__].?-;[?;F_O?OGQ_>/7U]E>J^KTWM#M[=?_E-_>7N=O_>+S[ MDU9@KU_]/>M^?C[[&C'^]NWO$?U!A>OOWW?T?S4*``";,0``&0```'AL+W=OGYMO^OOZ(_9OU>66U/C]M#< MG'^4+WE>]4#A5-[V7ZKJU1L,RMU+?MR65\5K?H(K3\7YN*W@S_/SH'P]Y]O' MNM'Q,'"'P^G@N-V?^E+!.U^B43P][7=Y4.S>COFIDB+G_+"MX/[+E_UKB6K' MW25RQ^WYQ]OK'[OB^`H2#_O#OOI=B_9[QYV7/I^*\_;A`./^Y8RW.]2N_V#R MQ_WN7)3%4W4%<@-YHWS,\\%\`$IW-X][&(%P>^^A`1[9 M_KKMN]#Q_K%ZN>V/IE>3Z^'(`?/>0UY6T5Y(]GN[M[(JCO^11HZ2DB)C)0(_ ME8AS-9M,QM/9-8AT-(2K=>_P4S5T+VL(X5LWA)\M/5YXVW,E`C^5R.C+0W=@ MQNH[$;\TM_)5!SK@?JE"\W"A"YT1-H5?+G+B0(9`'5'!MMK>W9R+]QZD*4QR M^;H52>]X#LREB*41#$M.8!-='P471)50N10D;\O'.@*-P,?D(8 M[Y31HL7(M/#10L2LT`UL$-H@LD%L@\0&J0TR&RQML++!V@8;#0S`MXV#87*9 M@T6R?M'!0D8X&#VS0$`>=RUGH@4V"6P0VB"R06R#Q`:I#3(;+&VPLL':!AL- M&,Z$<#>D9"1B)&8D821E)&,D24C*T;6C&P4D8L@O99. M+7>WN!56,.A785W[%9VQ4.2ZJ:(^(X$D,ZH'(2,1(S$C"2,I(QDC2T96C*P9 MV4CB3L6XC/B\MAPF5XI?C$\A8OI1$STW?>=+(Y?2/U!$+\^N8P=RTXRDW=', MU(Z4T;A)DKAIAJ-/+NDM;9K5"^VI-5,9ZV?9-,!^5I?TLVZ:=8QJH_=FS)?8 M'1D3]JWJ4ZN8$XD(GA/-1,[GUZ:W?66E=L!R-R'N"%:$E%TA6D'4-5I\YK#' M.4T=-I0;;"&?("+Y%)$N/Y];@9&1O'83KI4J2]2B'E>(J,J8AJH].ZC(5(H)>NJ9'WH2K918U MQ)!/$)%\BLB16]:I54DSO$["2T14(5:(2'B-J/.^-VA5RYNS('9`^BQ\+W?D M/@J6ENB$A5AFBKIHYHY=!965D3NRH9$["G6&6H0]ZKFC&E(D)]@C17**2#[G M["+'99?8@&17B$AVC:CSKC>&O#DU8F>E3\TG":(V8OH<*&0F"*M?TLI($(5( M*Q1'0:*D=09:A%84Q[%"8UH3)&A%\BDB3!`KBS.\3L)+1'J"L/M>DU5'8F_0 MJB5!Q)Y,GX7O)8C:V=&(%^(0S$X09VB?9?G*S,@0V=+($(4Z8RW"+O4,40TI ME!/LD4(Y1=0IGW'Y)38D^14BDE\CZI3?&/)FIHB-G#Y'GV2*W/=!YE&U4LC( M%)@-*PQ]43-7Q$;S?Y\CN5TUYD@A M.X6LYZGO2#OC<2/1&)[6S?3RK8]J.-:#@"TX([32LXKUF*!59X\I6HFC'GC1 M,+6J08;7J:^E0MKH5FC5V=<:K3I'MT&KEMR#@.#S"J_;P*?BA/"OXA568^J/ MBXX+':%8;XAH5N!EB[5T72@SXP`&%C,!Q9Q-S=QV2%$2(E2Y/ MJ*^>N=$,""J\SY::6=O"GU\^$8&Y!BIK!^_<>6$&GYP`$<&J)PI))6- MYXDKMECZ\Z0[<6ISRQ]"`=`4RG13_J&"6)'@JZ;:1B)HU"BLPA86*:;OV[E: MTM(R;6&9H68Z0^P_ON`,N5W1JX@K4?UBIWG##5^]F%GA*S-]I:.06)TU7N0/ M46I83[[EXP@ODS]CTL5H2`AU=)6BEGQZNE97&5[F+Q-@FDPO?FL96:M8D28W M.]?ZDW@VMI[JOFH((8\##A2"[Q40A8C4(MR)1J!S[OB45I-QO(=@Q7G MD=(=Z?&H;HC*9X)6G5VERNJ#KC(4:8E'L0K7L]KV+:ZM/BE];1;8>.\+A8P*!;ZQSO%]9:9%1*"0^*2J\6I+^9==CL1&`!\O M?`^%6A0D,>\Q0:O.'E.TZNPQ0ZN6PO:UA;G+%^8*V8]4^R@:6]+L!QR%"HEB MT>5`>1>01CBS,==*.$HODL_0BD>EF'ZC5'6G9VUNUGN%M/KCAC2RUP M%()R@/,?(E(OT^T''8IHQTV(2#=!$=)-$;7K9BA2ZQHK!OAPF+OM:P6LEK!\ MIA;SUWI5<(:.O`*9;']KCU% MJ_:N,KRL1:3\DEI^]WK,S\^YGQ\.96]7O(FOI&&O>7?38/R$>^;=@Q+$";OB MW;?Q!7ST7>>%9;]P/?BLL1O"1>!L?>_"]&;>_GWCW\L3"[L"9>>)0A3>! M4PVX4H>8U29PAY[8=K>T<1TOE.L7JPUL4*%-VQ!AOP=MV@8)>S=HTW9E,?'@ MRZ^6_J<>?.#4PJ\]^#JGA<\\^-Z%\P24U%4 M^(?HH/EO%7?_!0``__\#`%!+`P04``8`"````"$`3N-YXYP)```&*@``&0`` M`'AL+W=O"]S'HQL5A M>Z)!"-UC8V-G]IG&LDTT(`?"[>Z_WRQ5I;(J2\-`Q[X8^_CDR5)>2I5"#[__ M..P'WZM3LZN/CT/G;CP<5,=M_;P[OCX.__A/]-ML.&C.F^/S9E\?J\?ASZH9 M_O[TSW\\?-:G;\U;59T'H'!L'H=OY_/[_6C4;-^JPZ:YJ]^K(_SGI3X=-F?X M\_0Z:MY/U>:Y-3KL1^YX/!D=-KOC4"K=MLJK+NQ/FV^[N&Z M?SC^9HO:[1^6_&&W/=5-_7*^`[F17*A]S?/1?`1*3P_/.[@"$?;!J7IY''YQ M[DO7'XZ>'MH`_;FK/AOM]T'S5G^N3[OG?'>L(-J0)Y&!KW7]35"39P&!\
*Y>-A_[\[_KS[C:O;Z=(=T!7)&XL/OGGV'5;"&B('/G!D)I6^]A M`?!S<-B)TH"(;'X\#EUPO'L^OST.O&_ MDN0H*2GB*Q'X5"+.W2P(_,EL>KT(,-N5P*<2N7TA$Z4!G]U";KT8Z(QV'?#9 M:=Q\,7,E`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`WTBHFGJO.VF*^81LH0F9?LJUNB2SM-H00%?1*05KW M1@A1)ZS1D+1BA$@K04."4H1(*T-#TLH1(L,"#0DJ$>II&C%HWM`T:BYUNUOM M0CS7@B@;31-XK&"7R*+R"1&Z6#XK9.GE$WAL"XJ0]3==HY9*BXC1\.(B$F3I MB^CI&B6O=XWE,4>MBQX+9%WT6"*KIVO$Z'I#7N6D"W6"M]B%>)HHNL=L%6LW ME"RM"<(^PY[=L#.D?:XGKXH%<\2EW;#3PM7'5RTB42Q8O29OS4?(TCO1\IA? MY;%`K8L>2V3U]"L8WI)706='$PGY]`!F*7(,+`T*%01=C2%=(43=$R%$%;^V MM6)DD5:"$&FE")%69FOER"*M`B'2*A'JZ0LQD>I]*4AKI`@AJKLU&I)6C!!I)6A(4(H0:65H2%HY0F18H"%! M)4(]U2FF1SVZ?W,$D\.FL>NH^5/?'0.//U!Q%(M2'B)$Z5DA)`=X9^SY,_9D M($(*%=T:(=*.$2+M!"&I/9\X,S;*IL@@Z0PADLX1(ND"(24=.#-V^24R>LI; MC)XW)$!-L^1]X2C(J&F?Q6V)+*J=$"$JE)6"C)K69V/YQ!$-22M&B+026RM% M2*]IM7K2RFVM`@U)OD2HIZ;%F'A#2.54:=2T&C2-FO99O2P=Q:+B"!&B]*P0 M4@^E7'M^4#)4=FNT(>48(5).$%+*`7^8G"*!E#.$2#E'B)0+A'#-=CWK:S8. M_^YMDWA+-V]W")GUS(^GBJ55:DB&W1T06?/V(:TSF_+A#0E4D6N$J-9B6SE! MEE2>3,=L@2D22#E#B)1S6[E`EE(.)FS-)1+LRA>3JE'Y[;T2MM[KOVAJ)5A" MA"J?%WS^:$09P@=&/U201P>7E8(FKDR(%_!!.4(C*L>U@N`#I6-DD72B("4] M\>=L$T[1AI0S!<$'*N?((N5"04K9A[72AKM2+/55AC.?\.?Q$7K3OLRPI6.$2#IATM.IP^:1 MU);.4$?O$VO5!9.&"99MT*4A;:9%3'G7WR)<.13JMP@%:2?PI0V%"H*%8'VM M$**2BQ"B?7IM:\7((JT$(=)*$2*MS-;*D45:!4*D52+4:IGQ$].4'K]?V&CD M0&;$5$%F3?-G/?!26+L=476$"O+HHE<(B:^BX-T8UW,<=B2*D$([]-K6CI%% MV@E"2MOQ9G.V(Z1((>W,ULZ11=H%0J@]#OBZQ5MQ(@">MO_+M]SD>T:'ZO1: M+:O]OAELZP_Q!ML,8M"A\NVZT+^';_JA*!D>^_?P7;V-Y_X]?-MNX_"6WI>V MB)C.`M[>:RN)XRZ\U=>CL_#NX0V*'GT?]%O'HTX)WL)[W[Q6Q>;TNCLV@WWU M`M/^N_?4-WK>LX$'Z^`YJ[*6NS_@'>!YU M;W`^_0\``/__`P!02P,$%``&``@````A``IMM2,H"@```BL``!D```!X;"]W M;W)K&ULK%I9<^*\$GV_5?<_4+P/V,9@[$KR5;`Q M.]ESGPDX"36`4YA,9O[];2UM22V'+//-PR0Y.CJ26KU(MD_^^;W=U'YE^V*= M[T[K;L.IU[+=,E^M=T^G];O;]$>W7BL.B]UJLE<7"M'^,QKYX^-ZF27Y\G6;[0Y"9)]M%@>8?_&\?BE0;;O\ MC-QVL?_Y^O)CF6]?0.)AO5D?_G#1>FV[C$9/NWR_>-C`NG^[_F*)VOP/2WZ[ M7N[S(G\\-$"N*29JKSELADU0.CM9K6$%S.RU??9X6C]WHWLOJ#?/3KB![M?9 M6Z']7BN>\[?!?KV:KG<96!OVB>W`0Y[_9-31BD'0N6GU3OD.7.YKJ^QQ\;HY M7.=OPVS]]'R`[6[#BMC"HM6?)"N68%&0:7AMIK3,-S`!^+^V73/7`(LL?I_6 M/1AXO3H\G]9;G48[<%HNT&L/67%(UTRR7EN^%H=\^S]!A4DDQ$C@\4\TTTH MT*=`2H$!!884&%%@3($)!:84F%%@3H$+"EQ2X(H"UQ2XH<`M!>XH<*\!3=CC M+.EA165L0 MI2)VF0B44"UV_5;'W,.>X+BBA++(C"TDL9"^A:06,K"0H86,+&1L(1,+F5K( MS$+F%G)A(9<60#+F>=Q3&)M,2$"A7LS]H%L:A2>-6/9S7%[LVPW'_.?V?Y`-2

M;L,/S7_]'\KSC`7!1(P%?+OBLL5O>NZ9WXW?#3(D+*8(F$N@ZO()[C$@?H*P(JIRC#%\/--T!(*0]51W81!642 M)2-%0.4QRE28B15?W4P?Q*ZHU88]!,2NUZ4?M!TRJ9@]M`"KP3T?)Y4@I'?T M7'6LD@XD.[(3/=R[_;!%*D:*.NJ,,4!(C39$Z.AH(V2)T3S'#\AH8V3PT4R/ M8V>`+YA2'AETUY(0>)AF2N(YL2M8\N&A>)!0=D3K]I$5'$@(/0ND1LH2TZ\!C0\K%@O&D);?%-MU ME[*$A[;P"#L*E_*<%G'Z,1)LAV)/(`T+?:N2:HZ2F5U<.*) M>*8(J#Q'&;NL0*R9FW+<;3F=6Q^U>Q(BH4TO,,A2`9@@I.^D75:0):/==4C2 M2)&@13M":K`A0D<'&R%+#@8OY,S[P1@):K`)0FJP*4)'!YLAZ[W!YDBPDPTS MMA%*'^P:HY-=DY"1;%RRW)B/`UE?2S82TI,-LD1.\%LN.:>F2-"R#4)*>6@K MCY`EE5UZA!HC02E/$%+*4UMYABRAW.IZ)(',D5"1Q^B-Y`/CR\N"END]`;$A MU/'!)5>D&%G*L1*$E%8?(?$$)*#7]!3;E<<.$%+"0X24\`@A*>R3U#C&=B4\ M04@)3Q%2PC.$A'`G)/EKCNT5;O^O7*Z\\G*E>64F1D*_'5$4UD5KRA.>X MU/M2U%%N/;!'&R+KZ&@C9(G10J=-$N,8"6JPB3W8%%E'!YLA2PS6#3SB>',D M5,05N[KI9U>^=?#V'3R-O;^YS5]@2^0?GWJ9XXG+(#VED5-!#VD.A%'ITVV7 ME/@8:=I#.82Z'3RZD4Y]C8%QGDJLHUQI@#2E/41(:9-#^$ACH/;8UIX@36E/ M$5+:Q"=F&@.UY[;V!=*4]B6RA`?``P>2&ZX4`96O$5(6N;&5;Y$%=4O;)F*5 M.\5"^7N$Q)Z#*BHOSJJ.]"#ILE01Z&'1IF>/6++@+(632A#2 M.U:D"GDSQE3AT\M@BCHJ>@<(J=&&"!T=;80LF2J"4'NOPG/>&!EJM`E":K0I M0D='FR'KW;7-D:%&NT!(C7:)T-'1KI#U[FC7R%"CW2"D1KM%Z.AH=\C"T1RG MW26!P#XKXY=H/IZH8N(S,?%1RC;;/V5QMMD4M67^RCX!@]QY=E+"^'V:'YW# M=1?\BK9X3G0.7:I:.M#"JR[IDWB=B.4LNP_DHXAE'+L%LDG$\H7=`KD@8N%N MMT`L1RQ2[1;XWNZ960^^P^.[0'$/OL^KT.FU(GB!7*'/S%75`$^H(_;, MV.X"3V#G__NQ??,(H_#K)F/^0'^/:0E^]G^-8T@X\F'%;8'_/\@'_`;)OE MUZMG_P<``/__`P!02P,$%``&``@````A``DX)26=!0``L10``!D```!X;"]W M;W)K&ULK%C9CN(X%'T?:?XARGL3L@<$M(HE)-&, M-!K-\IP*!J(B&"6I[>_[>@M>Z%)1,R^5XN3ZV#X^U[[Q[/M;<[)>4-O5^#RW MW='8MM"YPKOZ?)C;?_^5?DMLJ^O+\ZX\X3.:V^^HL[\O?OUE]HK;I^Z(4&\! MP[F;V\>^OTP=IZN.J"F[$;Z@,[S9X[8I>_C9'ISNTJ)R1QLU)\<;CR.G*>NS MS1BF[6.!,' MF!:S70TS(+);+=K/[0=W6KB^[2QF5*!_:O3:2?];W1&_;MMZ]UM]1J`VK!-9 M@4>,GTAHOB,0-':,UBE=@3]::X?VY?.I_Q._9J@^''M8[A!F1"8VW;VO45>! MHD`S\D+"5.$3#`#^6DU-K`&*E&_T^5KO^N/<]J-1&(]]%\*M1]3U:4TH;:MZ M[GK<_,N"7$[%2#Q.`D]!XHT"+XR3>U@"S@)/SN*.DC`,HB3^_%`@DLX'GISD M_NE$G`.>PT#NE03RBXX#G@/'W9.9&Z MD3]S7L#Q%0]:W@A2(U8B@MB;\*YU8*,#J0YL=2#3@5P'"@EP0)=!'$B#_T,< M0D/$$;-:"N"JEJ<)(2)$D[4.;'0@U8&M#F0ZD.M`(0&*$/X-(7QPR^W-29B" MM()M2#)%X`7J1)R&%T9D M1^N/=?6TQ&QWO2&)#PG!TH200*:!S'*>Z)KPJ'@PS(HC]/AAB<&0"(8[,'E) MJ(J[&8*$C5(#V1I(9B"Y@10<84>:G#(@QW^7B9!0F<2XEQR)KI(P))P,R)HA M24*W'V_L:K)NAO>"-65(1&=!9=T:K-G0BFQJP*IM:OGP7K`6,JMB(3B&%&UN M6`7.:N$5$JV*P)!8=D_@)>J:KUB0=TVH-4?D9IX;J=%8&T@A=Z2H%]^E'HE6U6,(S5=Q1@7>1)5AQ8)X@45/ M($[$2BZ";'C,A$H5^4F@32'E`5>S;@W:S*#-%=H@\A)7'5LATRK*D$\`\PR_ M.`I];2$*F591#.HP1;&/,Y%$J])P1-JA&2(;A\=(QN$QS#AN$B9QK"YQ MRB,DYQB\F<&;J[Q>&.C96\B\BA"DY%.48/7?G=ZA+*I"'%+<$_AC=;XK'B7; MAT.R?P0$9=IPV`6^YL141"G[G*<55ENSQTPTO#HV%Y#:H\95B*B?]:@J38I, M.4L_]AQ41+KI!"2YCD.R[424Y#L1Q8WGQG&BG8VI")&<)Z`K469RYR**<#`&AO: M\4;2[F529QR2J',.#1NC&VH%7"$:46I5.U*HRG;ZFG:\W+T.?0EW'%1.V64, M4ES&(!_JP"$ES:*"<_FDJ($OPL"/$WWG%R&R\8SN,A'U87>YB&+=)9ZKGS/D M`H=,SI>\R"YDV#=Q@]H#6J'3J;,J_$PN6T@Q.:#L(F@=3*$@AL--Q\,IE)@F MGH53*!)-'"Z4'JCN&L^27#3=B%]Z4_@^,WF6_A2^6DS\(9@^P'SAA3/T`!=& ME_*`?B_;0WWNK!/:PQS'=+=OV943^]'C"V047!OA'JZ*Z+]'N!I$4/Z,1U#? M[C'NQ0_2P7#9N/@!``#__P,`4$L#!!0`!@`(````(0!?0Z<@?08``/(8```9 M````>&PO=V]R:W-H965T(@4H M$K6C*`*922:3GIEG#J*2(V*`<_O[V76#NGAZ-&?22=,N=ZVB5JU=>UL]__Y> MG8W7HFG+^K(P[='8-(I+7N_+RW%A_O4C^N:;1MMEEWUVKB_%POPH6O/[\M=? MYF]U\]R>BJ(S@.'2+LQ3UUT#RVKS4U%E[:B^%A?XYE`W5=;!Q^9HM=>FR/9D M4'6VT'@\L:JLO)B4(6CNX:@/AS(O-G7^4A67CI(TQ3GKX/W;4WEM.5N5WT-7 M9"E`;]@GOP%-=/^/09(\A&&QIHR.R`W\TQKXX9"_G[L_Z+2[*XZF# M[?9@17AAP?YC4[0Y*`HT(^1AIKP^PPO`WT958FN`(MD[>;Z5^^ZT,)W)R)N. M'1O"C:>B[:(24YI&_M)V=?4/#;(9%25!C`2>C`2Y(Q=Y4_\1%I>QP).QV"/? M\]R)/[W_52"2K`>>C.3QY4P8!SS[%WE4$L@O\A[P[#D>7LR,D<"3D7B/*V*# MI^@68W.Q[;MWBRUJ%^*^3=9ERWE3OQF0TF"(]IKA`\(.\`S<=]0EO1,_,R(X M$+.L,,W"!)'`8RUDS^O2MB?CN?4*EL]9T/I&D!P1\@CL;\R[48&M"D0JL%.! M6`42%4@%P`)=>G$@#_X/<3`-%H>O:LV!02VD",$C^)"-"FQ5(%*!G0K$*I"H M0"H`DA".(L3M4XF;`4?#^2.8P1W/Y`6N:8Q-SQ^\U:&&;#1DJR&1ANPT)-:0 M1$-2$9&6#J?8#0^,\%'6G5W38_6&)`XD`DT/3`(9!O**^6$KFK"H:6^4 MD"%.CVPH,H'7[9F0[\E$VSZ(VR?2D)V&Q!J2:$C*$%K+Q%0!.;XN$R8A,O'W M7C.$%%XB9<@001**^#XY=M#8=A4U^N\Y:T21"5D%8=UIK'$_"A]FP.K(K$G_ M/6=-15;)0E!_)&UN6`6*-/<*CI9%H`@2W>.J[Q.RH"&A-C>&(7LB+V/+@K!5 M7Y<3UW65DRAB`6YOP9TV4WS/3(DT$T*^K[Q**LXDZ3=]2#\<+>O'$-B?/F=< MU24A#6*]%:D]_3"^PUL6,R-BN8ZCY%W$OA_-_.5O$_%F201<9>HJPC=.2P-%\0?]17D81_NJHZ$ MD4@ZB`/MH_)&:QXFZ,P@;]8[:,,@J4*Z]E0Y]H8HGMR1#NUT*-:A1(=2#NEU M$CH>6;V?%P,2+KN-0X,'0AW:,&A"SZH;57$(&!2@??!D2.J=SAP/`S^IC$,` M9TXY1)AE-^&64SS$_D,/VJ%")\6YU[BK@H2'GHYJ2/$"HD!P:WC(>H,'CVF0)CV+EV+>5MCGE`60R64C>HO67(HNPA"S<1HZ1$RJ-N>`FWLJ).]%;@P0A'RA:C'*A`=JR*`35OE^DJVO(7@+*61^%D%):=GS&P<$QIQ]F M3#@DSZAL?LJY/IM1=B1N>K^N-&V=):-22#:JNNX0;C3Q%DE&99!XG&H'U98/ MI-Y%MCU5LC#B$:)Y*;60`S&/^NEL"8_Z[`S&-[-D'8*5Z4TKO>NJBN98A,7Y MW!IY_8)O44&JY;R'^RO>%4DB!5_CJU^]9&PO=V]R:W-H965T=[A#XDJR2]SO]UMX8XB34!-P"IC)S-^?EJ66Y&YO`K//R\2S)*TE=2_) MLFSN__ZU>T_\]`_';;!_2&9NTLF$O]\$S]O]ZT-R-JW_=9M,'$_K_?/Z/=C[ M#\G?_C'Y]^-__W/_&1R^']]\_Y0`AOWQ(?EV.GUXJ=1Q\^;OUL>;X,/?0\E+ M<-BM3_#?PVOJ^''PU\]AH]U[*IM.%U.[]7:?5`S>X1*.X.5EN_&KP>;'SM^? M%,G!?U^?H/_'M^W'$=EVFTOH=NO#]Q\??VV"W0=0?-N^;T^_0])D8K?Q6J_[ MX+#^]@[C_I7)KS?('?Z'T>^VFT-P#%Y.-T"74AWE8[Y+W:6`Z?'^>0LCD&%/ M'/R7AZ3(>**;R213C_=AA.9;__/H7">.;\%GX[!][F[W/H0;$B53\"T(OLNJ MK6<)0>,4:UT/4S`\))[]E_6/]],X^&SZV]>W$^2[`$.2(_.>?U?]XP9""C0W MV8)DV@3OT`'X-[';2F]`2-:_PK^?V^?3VT,R5[PIE-*Y#%1/?/./I_I64B83 MFQ_'4[!;J$KAB`Q)5I/`7TV2@E1>&Y>J^H'=S_\:[.?2NO+BV M+RFUW(:K=W5]6C_>'X+/!-P3P<''C[6\PV8\28SKMEIES4K^3PLYK."214B: MAR2TAS7Z"+>?GX^9;+IPG_H)MXR-KE2.J12M4<$:\OX@>:L4J%&@3H$&!9H4 M:%&@38$.!;H4Z%&@3X$!!884&%%@3($)!:84F%%@3H$%!984>*+`B@+"Y!<3 M(TPR#<*2)UCV!$N?8/D3+(&"95"P%`J60\&2"!L@[5+H0DP)"4$;"S(DL,CS6P294"-0K4*="@0),"+0JT*="A0)<"/0KT*3"@P)`" M(PJ,*3"AP)0",PK,*;"@P)("3Q1844`(AIAD8JI$A=5AV1,L?8+E3[`$"I9! MP5(H6`X%2Z)PLQ@Q/-P3(X:/WZ7CXBYKPW[<7=S3F7S4R65523UBA&MWA2%5 MAM084F=(@R%-AK08TF9(AR%=AO08TF?(@"%#AHP8,F;(A"%3ALP8,F?(@B%+ MACPQ9,40(3C$LRIX6@7/J^")%3RS@J=6\-P*GES!LRMX>D4DOQ'_PVXNXG^U MZ[F13WJGM^WF>SE0SYHQ\R('NQNUYY$DL&V"5<#=]!3)O-"U2N:N4&%(52&P M.Y0;IRR;6S53CFM/G2$-AC09TF)(FR$=AG09TF-(7R&9.S/*@4;LN(>FE1YE M+AJID2G'48X9,F'(E"$SALP9LF#(DB%/#%DIQ!FE$!JRPQ1ETTZ/D]SSA38` MI!L'*JP##,23+GC6!4^[X'D7//&"9U[PU`N=>S7BR`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`3 M$U$V[2+L)"A"&PSLA/2BROFUG9S."^VGB`]98(3VF$NO3>8846A+N?3:4Q%Z M'ARAC>;R:Z]YS0QG7,+="MUMU"6Q.U2/@$^O0++6U>5PL= MZVAI>VJM++&$0*_^HU9D@8!'MBL6"%D[ND`H)#PF,N^YTC2M%=W.KKA5C:@/ M'\('686$C\CPKHQ,J+HNA?W6N06"Z3293BNJ0S+5ODBGPW2Z3*<7U2$/P_V+ M=`9,9\AT1A&=+%F:QQ?I3)C.E.G,(CHT/_.+=!9,9\ETGB(Z6>*#U44Z0C`A M469*0MM26XZ&3FB/R@\`SGA.U+B6=BM\[8.W/]'0'9A??J5EC8O M?/IAB+5C72UM3SVN'-W_:*_^LU9D@9`?SD16B#_:]XT=6< M-;&J(?@:`J-00TBM]325=2PF^Q@R^1M&5O\(<)PHT;"X^C/`)@&[SA1Y: MVM4S/K:C@X\#-%]\*.%3@Y!<([N+;+16 M6'Q>"Y81G1TK!LL(RQ@L(PK35J1AA&5$EW^AAY9VMPSH8W?/@*;5>GFR2L(R MVMK50R^[>FA&'(?7;)X\-XPI*4,)O%V+*X$1PC%_7`F,L!+'-BEXDSA\6O#@=2-GFA8] M>`42@Y<\.&;E^+S@P6$KQQ<%#XY<.=XO>'"FS/%!P8.398X/"]XHKI_#H@=O M@6+JE[Q1',^XX,%Y,Z\/!H`WBC%XT8-W&3%XR8N=KS!=X MM_MCXMU_@74U'7X8=%`_:E'_.04?\'P'ORT)3O!CE/#R#7Y]Y,,W"ND;>+W] M$@0G_`\(I\SOF1[_!P``__\#`%!+`P04``8`"````"$`YR^VRB`$```*#0`` M&0```'AL+W=O+ MC6RO;&R2E392%&639P;:IC5`(QJ/9_X^U1=PT\QN/-*^#,/IXE#G5'71WGQ^ M;6KC!?44DW9KNI9C&J@M2(G;R];\]G?V:64:=,C;,J])B[;F&Z+FY]VOOVQN MI'^F%4*#`0PMW9K5,'2);=.B0DU.+=*A%E;.I&_R`6[[BTV['N4E?ZBI;<]Q M(KO)<6L*AJ1_A(.0\6$!GBT27FM?V MV@:FW:;$H(#9;O3HO#7W;I*YKFGO-MR@?S"Z4>5_@U;D]EN/RZ^X1>`VU(E5 MX(F09Q;ZI600/&POGLYX!?[LC1*=\VL]_$5NOR-\J08H=PB*F+"D?#LB6H"C M0&-Y(6,J2`T)P%^CP:PUP)'\E5]ON!RJK>E'5A@[O@OAQA.B0X89I6D45SJ0 MYE\1Q!5-))XD@:LD\3PK\,)X]1&60++`5;*XUBH,@V@5/YX*1'(]<)4DH16[ MSMK_?PY;6,.=/N9#OMOTY&9`^X)XVN5L,[A)9!JCQ<*0R?3O>0YF,Y(]8]F: ML._`3@J-\K)SW=C;V"]0W4(&'=X)FD>D8P0K)>,]ZL!)!S(%L$'2I`O*]1-T M,1:F:TSH,`)WH9K*=(P8'SGJP$D',@68:?#G&MYO^[$$+!@:7"E!&*SG_AY$ MC-BRW.!T@1P7R&F!9"HRRQC:6W7]QQFS8&@[4*]VC:_E+*)8AT]17A3,@U)) M%4^%.@HDB";DM$`R@7@\9B8#7O:X#!;,98P5/P@D]OA&\!PWU+(5ZYZ8,[S/ M):):X;G1_+&3#/(%;1AIUL`DS^3`OGY<#@N>RQ$(5(#M:Y"CY96*=3F! MN1S)(68R0TXR9BUS][5=D\GU92GBC^3.@N>Y"^1>BGCN:2K6U5)(Q+LWCD2D M[Y[OS#DRN;[TG9U#E-GZX]W`@N>Y"^3N^VK^WE2LJ[Y+#L7W*8;5+EZTC%Q> MVK[^2.HL>)ZZ0.ZV:ZV:BG75=HDHMD\Q+/4@TKHND\M+UUTX9ZBVBT^:Q2=( MA8OG`Q'?_'?*P4HL/VB,9*Z)\V[-V20*0WUORRBU*B-TGTXG"04NWP^^N]+W M@PQPUXO-#-/[)\@3GTV8O=/0XKP@3YU!KJD@ MT-J9G229Y8%247$R%.>5!O47E**ZID9!KNS4%X%Y$RI.I,<@@3D/FC0<3JI[ MKE7##^P$^T[\P4O@J[SD.?@)?/R6^#Y(]I`_+-C3&^`DVN47]$?>7W!+C1J= M(6>']V$OSK+B9B`=-!J<1\D`9U#^;P6_.1",3<>"F7XF9!AOV`NF7S&[_P`` M`/__`P!02P,$%``&``@````A`!K+<.`]&```S78``!D```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`%I'#[]6LF8N18<9M` MB4.B60LM($5_6RTJ[:'4DEG(K-1"<;.J:EJU1(>B$$2G(PHT8R(,AMV$`<(W0&@!XMW-:=BBQ++& M?.L6L.-8+3646F@X;J.W4DJ9-LLU5"BE4BE5VJS6T-I7"FXEK33.N)6&'=Y* M(#3)>+=2S-&)95%,$(*%LZ-VM6;#2(RXI3.;-5/_:#R=B=Q)'8'CL5*>LE,\ MY:T9-R<>"F]%ZXU)PZ&8V\I6"5VM3FE`[S47@?UJTC&09:I09A^*D9PXB$T;%( M,^]@#1R/Q)A++,E/+X]*6&E)#,EF;>2?-/CD;AA M12O-)!T9Y:U2WNI.;V(66;_B+4@L2,2!@QBWC31F(1/W<^0*H&5*<&0M3)`K)7#D*$"$&N5,&2M"A`;UC!D:`VHT0H2AO81X;WN7WSV3BKL%HNAP&E*2#Y'DEH(8N M`@HHO`=R]6#V0&3I#?^%@^CP%K/Q$BR["!I'8Q4\)\/#?`4;ELFT<@Z66UX- M)G+]``(KEX!8N=+*-5A6.8YFHCZL0>A()[/[U*=D9VXRS0FF#`H@NEWMD-.K M!F<99)FU'/&>9^E8(S_`PY'(V!0L7@VNM'P&%LOG@'SY6,H78/D=ZL@AVWJO M0Q4,V6,-J-?C&JP?>0SSR.Q4?SV2V`*W&7%CCI--<+F()PX*4LFR1O2G#7=' M;70LLS'^_GXTC.0:/W72(TZ"E?:6@=7K+7>LB<^*1W)'!2W:W'#+U99*-Z*" MH2^ONER#Y;H\F,C5Z1J,CNPT6^:^F)ZXL+`[;ZH"*',WYO.J)F.#XX>QJIF6 MYBTD%\Z29D^(+0'QO)$"\J6%A:D#S.DNX0#T%U$F$^D3$3&":0Z['8YZ1@ M^,FCO&6.96[%C[WET/)9\5C-64Z>_K"63A[5B.JD1M1H!+H\DMF[!J,C>DK`;6[ZB"@@/P"K(\EJ#(V<>%AM@#$@W$)R*Z1QD.Y@4Y!X&&^`L3* M&2!6S@$%PVXL]N<%6$&UTI%2?:E@R!YK0+8O(ZKCX5Y^#4)'FIG=L1^5GSJC M,)_GR06'A5XYI7"&0?)9PR'/;TNPZ`J/:KD@2-$(/B)?P9#7:QD@EL\!^?*Q M3.:"Y;U&Z("YUK/'"O+LL084>A1[^?5K'L/UAMD._WH@[:8ZR#JWS^;E4D*' M0BK#',M/337Y+IWAV&U,)H.I6LX['3_KE+<,.KW>QM1@^6Z/*1]KDQ.O\M!3(?!008UL$E.>CB%\L!\XH3EQND?/S6*S7:-!W$4 M78MUQ@UH/'$E&EHX**8E=IN6XTCL=9?,P@(EU=!*0YF&<@T5&BHU5&FHUM`: M4#/4PTA0,?_U[*)=B"R3@/P[[5@T$@$L5BZ3%@E3K,_Z0/ M-$\\`\;B8B&3>PR(%UJ\!,T3KX"QN!C_M<>`^#H0#R-!Z19$HG\984Z5Q,SD MH*F?M_%8#-O$L:@A:-0"D&^H:QQ8+N$'\4QNC,'P:AP@]I8!ZO66@^6\S0:1 MB%T!!GLK`;&W"E"OMQHL]$U_)`6&7FF8,]-S`F*4J&'AZ:FI`U4+!KF(C;ECB:-VP7L.01LV063\RQ/-],P>K=*Z[` M8OE,>\R99::G6*YQ"ESW\\'VF*Y@U%1:N(:AW7%&]#RM6#V!T)$=9INQ!(L]5H#88PTH]"@6WVNP?N0Q+'=F,^P'])4LPW%!.\!N M:!'2E67B?#YQ-&]H+F#)HW7)+(Y//!'E*`6+1D%?%-T^G^4S[3&'%F5.JQ5/ M1$848/5Z+,%BCY7V6#/+]Z@*HVO]CSR&430[Y#.B:#?402X""G(Q5K72TH)< M=!"/T^700:[JC^03/BD(/)^L`'$&9(!8.0<49$`LCF8*L'Z4``RLWE*'^:<-H+%V!HBUQ6C+/0:T"ZU=@L;:%2#6 M%G6F]AC07@?:8=K1"%!A.FD%.3*6(M4L1)^1<8F)8U&B$V<8I)HU-#MKKDVR M]"UA:(=C/(WD"5$*!@_^%2">5C)`O=YRL*RW:_IT7MSI`@SV5@)B;Q6@7F\U M6*YO\>!:K++68'2D6G#L0`6XV2/3@N7T0].1/HH`9'3:9S!CN8YT+&_N60#B M!%P"\B>'.!8]3.&1)I?6H]X-0(NGHPP0>\P!A1[E.O(DCR6TV&,%B#W6@$*/ M8PH%U_NF!&OS0AXD#%RQ?ZI$.4J9N1H_%8332T`$0+[.8Y=GK#6^R=EQX% M,TO:@:TZL*P#RSNP`A@O;TM`W/X*$!H;J6=L:H^"QJX[L$T'MNW`=AW8'EC3 MV#!SS8F("C:]ZFSVM2>_246/)*GD=1#?C`0LAA8.N@XF8OENQ9)9N$,IM/CV MKP"Q?`;(K.;;2AU/Q<#+/1H<%`ZC0Q%`)6CLH')0?_MK9D%K#2UN_P80RV_9 ML*?Y.V9!?@^MCH";\P$_X/T'-R-[G.!O^1TDRK)8.2;,0J,6K1;?TV4'ECJ, MCGAANM)J66O)LUW>@15:K=1J56O);:L[L+56VVBU;8?EK@/;!VIA7E+=/2=, MABYF3P<%RZ*I*)7)R+*"99$S-!4`ZZF.[:0SM(?!X^%4+9(<@6_H2CO+'/3* M`U%Z^QK`XA];4_RM8,ASM0' M\E!J#T;C+1PCYG#CC%2V9R%!*EM(I+)8F"0CRPI66`[B`Z\EL[QAHQX,`LO/ M;26?@<7R.2"W[Q@/U!+9R;!R"1M_DZ,:7C.KI^%KL%A^`XCEMX"XX3M`V##) MQWKW(#3*08!-7,X(<$,/BP"@L`C(O9%C^44`ACR@EV#9H3H9J?<'0>"\6`%B MF4PKY\SJB4`!%LN7@%B^TO(ULWKDUV"Q_`80RV^U_(Y9/?)[L'0:TQ'J65$V M=!%E"QD7;<6.94%.&C_A1@D0#]7*=@L&9L`+$F9`!8ND<$+6V M;:8^V`6+Y4M`+%\!8OD:D&WY*+J66UH06'D#B)6W@%AY!ZBWX7NP.O*8-FOG MY+&ABP@[*,QC40(3IA:+$W6L&'EC5;>@L7*NU`YFLHG M,O:P:93#6=F<+IV^[!K;PRA_V04HR&;YX&?B6$$V.ZW^I3D,;9Z,Z'M(Y-H< M#$Z4%2!.E,Q!KZS-8>BR@AE'`0KT%@9QM` M[&Q[DK,=#-&UL7QS8`]&1TDPAUG^*/FI3W''1D5,!18*2\*U^'`I<89!2;"& M04EP4._$ECHM.M='+5EI^0PL3K(U1+C#58W*&-EM^"Q?([0+WR>[`Z2L<_^4:S]V1)<@,6)7D*+$[T"Q!YK&#*T!L1:&QBRUA80&^Y@ MR-`>D"X:$QH09Q2-AB[B:A3>789%0^Z7$F?HK]T!\?RP!-0[2E.P.#E7@#@Y M,T`LGP/RY6-YY%N`U9N))5CLL0+$'FM`OD>5=FNPN$,;0"R_!<3R.T"^?"R/ M*O9@_:A#P4G`A.K(.0/"T,6`<%"0Z/)<*VG\A.=Z#O+/]9C5DW8I6)PJ*T"< M!)F6SYG%\K'\SK,"K-XZ4H+%'BOML686>^P8$/86>A_4;]BPK?Q:?LR>#@H+!YBL90XPV"58`U?V?0[PV!CK%^@ M=2SSP,F/[_1*-R*#(;6%#>4Z.'(T0YWY[:/VH$>'(-,=__BY( MCLS3#A(F]A31WQTYR#LU2#2T<)!_D`"(Y_(4$,_X*ZV5@<4%)0?$6@4@UBJU M5@46:]6`6&L-B+4V6FL+%FOM`+'6'E"C%<:((MD;HY.^ZGQB5,32PT%^]9@. MQ$JI7W/2;B:4%KTR,KN4Y%EB<$PM`P1PN)X@E M6+VSL_4&WH8<$#Y,=II/9:CN7'JZ5OAB[Z9J$@R?08;/R$3P`!XNEI"<2?4X?]N/\ M]WL:"=$WHTJ0'S=ZI4J,/V<8Q,T:TGO3;7Z!1H\/3OG\@NHR"ZYB!J53O6.[++ MLH((.Q8@HP'9 M![_:F].18%:>GAAJ)FU5=U/(>"&UOZ!H?Y3MX?#T^9`?E"7Z$7*^;F M10I]A5Z2F)N7(O05>N%A;EYPT%?H!R<_-'.+:/,-_1!EDR<2'\[WG?S1?-^\ M72SX'\;S#_8KSN2%X8!N5W.,(Z[0&V34P>;H45RAU[6H&UU7Z$4ENEU=MYC> M,2*UKBOTFZ0M_C-S??AJ=O)'WMW-Q\L9R^0M\9-S??"J>O MT!>^D5K7%7JMG/K3=85>"J?^=%VA5[JI/UU7%N/YLFM@9N,Y_2I51[O&<_H] M*8TO)O-EU]W/*&!=>#69TX\IDW3Y_O'YXNOAT^43H/F M=;8G^W.D]G]>W,]._'9\H9\1I7)!Y91^-O9`O\$V,-_I^.EX?,'_&`?M#]&^ M_W\!````__\#`%!+`P04``8`"````"$`,B5.0),H``!US@``&0```'AL+W=O M[S[1$6PQ+HH*DQS/_?A.%/)6)3+`O&OO!DDX=)("\(8%"=__T M7__Z^N7=/Q^>7QZ?OGVX*"ZO+MX]?/OX].GQV^\?+O[/?U?_6%V\>WF]__;I M_LO3MX+GXKY__Y__XZ:^GYS]>/C\\O+XC"=]>/EQ\?GW]?OO^_.W!U(W&2J8X->GIS\"M?D4(&K\ MWK6N1A/\K^=WGQY^N__SR^O_?OJK?GC\_?,KV7M)4PHSN_WT[\W#RT=2*8FY MG"V#I(]/7V@`]/]W7Q^#;Y!*[O_UX6)&'3]^>OW\X6)^?;F\N9H71'_WZ\/+ M:_481%Z\^_CGR^O3U_\7206+BD(6+(3^A!"1<:`=]3!V3G]RNV)V4L-K;DA_ MHJ&T.W'0%`)CY_0GRUA>KI;+Q?7JAL9S8-1K;DA_[*6"[)1;"W&6LBT#_4[1TOZ"Q1V8E/8MA#C%M+I85V_C\XV^N[F M_O7^YY^>G_YZ1QF!W.GE^WW(+\5M$!R\=DXZB7.8_/@M-R;_#5)^"6(^7)`! MJ?D+!=\_?RZ*=?'3^W]2P'QDTEV&E#)*,$)T!+D;"VPM4%E@9X':`HT%]A9H M+=!9H+?`H(#WI-M)P>0A3L$A+9RIX"`F*!B:N0,@&I\998*!)AL+;"U066!G M@=H"C07V%F@MT%F@M\"@@$29%#1.F0M29C['PCE#*_+JU#F-MNXBJ8CI-/A> MZ9"-0[8.J1RRX>T#ND'=1C8E"/(,#K"YZG+ MW476-?TQL6[6URFIC*3%]>3+FX@LM?#5;)DVVTXD^'/%@M:3H)T374^M9$2K MV4TJNIE($+UWHELGNIM:*='SJU1T/Y$@>M"B$X.0'Y]AD,`>#0+!=Q$AY0,I M(Z(U'1&C:6.@[42"H(H%*4T[T?742JECMDK5T4PDB-X[T:T3W4VME.BY65WZ MB031@Q:=:)J*E433L52[#-7&Z^?'CW_XY`4AJ0$8*<2S MRPAI"T1D.9^LM'5(QM"B$W73&)VZ9]>A"LYIF&"H.#1,51R169(IYB:5ETR25+[)-)L5 M9D;;J5DH7^:SV:5)$Q43),!V4Q,HH3ZEIV9J)@J>S4VH[%UO[=0,O76G]-9/ MS=Z8UZ![2@P7]J:V.#S)<*%A:CA&0H2A0ES-S?)11A(Y`":XF9H!V4Z-!2$^W3KB;1?B8; MJ5@)[%3E$3&QLD@S1,DD%2M3,\QI.W'&&5Q=&K-5_%S%Q=0",FHGM9DXAU3N M1+=3,XCNG.A^XN0'/&BIB5@99A0?IR\+HXC4$(!2YS?U3`%]^BH8CO`(GX'M`; MXQX2P:E-PLY*9Z'#<4`5O`T$ADPDF/1?@J5"`=!,Z3^*GQ51_\NK2R.G0B,5 M#H!$=`U(1#>`J(=#%N`!B/A6&DXQ`4C$]X#>'/D`QB@ZM4'8D&D;_$!SMME2.1P5M!\8F[(D(F,DPE4H(E[KL!1/,17W45 M%5C1Y19VO:_P7'QY!TCZJ@$=[*L!ZTCT\(2EQU8:2O1DU.+JQ5X:AF7&S6[` M\TPXA3W@&8:+6T9R!(SP+AS5A6@2/RT]M`$D'KAE2$53!4B53&@HXFM`(JM! M0X'V@$16BX8BJP,D#7LT%(A.ZV/@C[)2QZ>,D>CO!])1$&'2$4/75`1,3KV: MFSU5&0[OJ.5"=F<;ABB,8*`M(/'C"I#XWL[+JL$260T@D;4')+):+ZL#2V3U M@$36`"CCIV%+=X:?QAU@XJ<,D9^`@[NC/L M%C>`B=UX3ZAS[NK*Z+>D]#,:3IQI`TA<;@LHK@*%.2&K\%A<>0=(Y-:`1&X# MB.6F&YL]GHK8%I"([0")V!X0BS5S'O`X$RUA)W>&UN/&+]$Z0]H35U=FAUL6 MD:52^(8A,_LZM+DL0IBQ%5W@$1,[24WPI)(6"V,6?=@42!+5,W, M7%JPI,?.]]@+B^=B:L0!A$PHA+W>&4:)6\/$*+Q;3$)A8=RBI/+,A<+44(PR ML<:)7)I*JX(4<=H=('':&I`X;0.(*RTK>(_G(K@%)(([0"*X!Q0%W]C=SH#G M/AQF=B]]N#H=Z>F"#"@)AX5QH9)9.ARDX:1Y807-TWO3-%U4>*ZB`9#X9NT% M-\)2?N[6!;!$?`M(Q'=>?"^L[+@'//>>3UO4_[,!GK)#>D/ M*'L#2/QH"RB;K"L\%??<`1*Q-2`1VP`Z7/6#)>);0"*^`R3B>T#940]XFO%] M4MD962?LOTPQ"DC[_FQNO+9D5N+[+$O<:BNL,>O0F87-.V"(>^X`B9R:(;7* M-,(ZZ/UQ3#,1WTI#>$WGQ??">F/D`Q@9_P^;N-,S_RSN^73F9RAT,2UAJX4Y M_2S!$D_:`!)/V@**GK1TQ]9X+BZZ`R2":T`BN`%T)`+\OE<:B@6F?2^@7EC! M`F[<`YYG8N"\3>[,;W(!)3&P-(5&R:PD!EB6^.Y66*,G%4M7#X$A3KH#)')J MAI(8X'UJ,DR_`C!+Q+=>?.?%]\)Z8^0#&)D8H#$E,?!#;SI)M2X]12@)#;=3 MYG:4)N%.&X;HAA&@+:`8&6M_H`J"./W.2Z[!$LD-H"C99;T]GHO@U@ONP!+! M/2`>,MTY2ZN)`811C8%J_M1>N%F9@);-H?-#_!A#M MY:8LY[:_6[#B,>5RO;J\6:O_S,)4833JM!42I.L:T,&N&[!BU]=6V7O?5XLF MTE<'Z&!?/5C"DMLO%K8-Q=@4:823[!;MAU8$M4U('''!I!>EE8+LV_;@W6PQQ8L MZ;$#)#WV@-(>3:4S@/56CZD1PQ[Z#"/R]ET&=3=C*(U*LQ4OF95$Y=10C!BA MD%LF\ZSL&VGE9/1H>'/T`UENC M3\T3=M/:/#^VNL4]>5+X33MWK6F[Y9]-FWG,>\-0LKQ%UCQQRZ79Q%9HJ$O- MF0^]*$L=/==H**M3`RCMT92M>[!TCZNE62]:9JGTTJ&A]-@#2GLTJ6H`2_>H MYYC8-MQ!_L]M.TI)TRJ@U`]-*BR9I2,2$&77*?S\.@D6Q<3$6BU-WJLP"++G MQ-*JB)>^($O"KP9T(D`JL,@2L65@96B0.[%YZ@A6NL=$]LLP-`3#47@^0!%4-Z&!O M#5C:G?VU#;"DQY8A'=E@'>RQ!^O-^0U@^#WAG$0?-.!_/WTGRQR[%SB*,18, MDC]<'+EZS`WU?4S(6NM9^]O'BH9L7P%;B5IWOH<:--.#R0F-HJ&'/3#50^M[ MZ$!+>[@Q*;]7-/0P`(L]I-%VW@'*W!^@,*2O)#.46"`V/'(IF1L2"V.O($MM M,@!)>5)+0\FU*W5LW0D6O*PL*X]EY\Z\5W8,EM MZMY#`Z!QJ*F+4]ITFC[IANL\M#3:C5"Z8;LQ%57)#57>W0#2&2A36;#X>.AP M?67*JPI2=#*:FD"O-5@'^VK`HDPL]8D[T@)+>FP!J:T:H(,]]F"],;L!SS-K M2NY$Y30;^E.4.4.DN&GB]"G$]'BG9%92'4X-H>JML$(AL+AR[YQ`D&RR`R35 M5LV0/G$4EHPRL^C'(=$9!8;42D-`G1??"RL_\`&$47(:4.'LP::N^?K,CU:$ M=&&#*T(FN$R:+;EA$ERQ(=69F/*6652FC/.[O%('6?17([0"75:>G>^G!DOZ M:0`=B2(>H(AOO?@.LD1\#^BT:0R@C_VD1@L;><.B$_[_,P\R#%9$2&Q)M+ M9B6A$UDA2T\QETE_D;5&F91;VI,/@'R MR*7'UO?8G=1C+ST&I\S,;X"<3-2%G7V.?QJ$&?B@`*5[4G M0_G[<:#)T=(&T"I-JZ8"WBH:+%@!DR)L!T@ZJ`&9#LR.MU$T=+`')AVT@*2# M#I#IP.QF>T5#!P,P7^?1=C,UV^$;$B,]#3"&DJSHKM>!)&OR!M#!-7D+5DPP M*\KBZ3I8@2`%P`Z0=%8#.MA9`];A9`F6]-@"DAX[0`=[[,%Z:WH#"+[F6-`H MDX`[8KE`-Y9C*(D(=\%N[">]^\Z0*@>VP@JI8WGC/J`#@N2I'2!)S;67W`A+ M1?S*O('=@T7UQI07W&E6"Y;TV/D>>V&-Q!$<@M(QP//7Z!>6&',;B0YRA'.B(]!-=$0HC0YW'6_!+/&H#2#QX2T@KEV7;F\$@HX.)[D& M2R0W@-+H,.];]F"1R$,IR_78H:'TV`/BN=",LI6]73X,EXEM`(K[S MXGMAO3'R`8Q,8(1MLBZ>CZSEO-$7![BCP[-1NY0XQ9GLB]D2+!T84T/)40Q% M9UK;RPX5I.BXF)I`2@V6#+(!I./"GQF`)>);0#+N#I"([P&],>X!SS,Q$/:_ M9^@_;I?UQF3!D(Z!UH?^XYTWT'Z%D8?#WA.F[U\8H M$3_:`!(_V@**?I19%UB*..A.FD!!-2`1W``ZXO].?"L-(;X#).)[0&^,>\#S MC/_;S?N1_.,WY@N&M/^[RWA,2MQ_:H>9;845W*BX\1?EP=`!$.4HT;4,":(; M--2C7*WNU7YFGWFB8R9G8TN[-?^ANR2@E M7;`92H+%W>H"2<4*0_H<$U#T.5_.XKFXZX!ST?!J55H1&?DJF6@&_4SE'BANR:)AI+2-P(IQW0O_YE%H1!<[F9] MXZ[:@Z'B!Z+EO*D&I(?ISD0;R(J]N2^LV>.Y]-6*8`1F)]"!F?60%?M:7;G7 M&0,8?HD)KW;/,5O<@>HE9I1`!:PNL?QE2+!TV$19U!#SW0I+YKM:F?=T%5@' M=P@[L*3'&I#TV`"*#E_8HX`]GLNBU@(2P1T@$=P#TH&Z6IG750-8;TTE#;&P M@SR]'*!7PB[$IEVLTN_"')66W%`M&AO(DJC;"DO)6ME].U@'%XT=6"*^]CTV MPE(]V@\][<$ZV&,+EO38^1Y[8:D>5^:L=0#KK1Y3(X:-JS;BCZU>YP<>=[K-%0%IX& M4-JC\U.4`=P'JKQ]2VM";\#;8-4LS2R)!>K)T.ZQ6H+%E78$VMEOR.V@G@JS"96QMP\"+UB1NCP()K\ M(&P1>M(@6K!T=)\RB#X_"+-?'2#^+4VD3D%IX6]PBB#%.$6$Z%4(S%TN(Z26 MU`U#X2!8K.:+(Y852XC,*\X*:K`.]M:`12:1,;D--UC28XL>)7MU M8!WLL0?KS?D-8/A=X#)L_`]E;+S"/;P[',48"_(AQY&KD=PRU`J3NMPUR(VP MX`Y;#U48A;JVN&.,SH'0L@;-7%LT*T"C:&BZ!Z9Z:'T/'6BF!Q-JO:*AAP%8 MYF+D,AP2'++52=\?.DHQIHJG#X6^,,FT<'M#V<5DY8VP,(&MARJ&:'\%UHZA MQ"QQ%-0C6(V7M?>R6B^KDX8'1M\+"ST.B?@TU84]N];^D8B(6_RDB(G0C7;U M]=*X7;F,K*2(84@WS"QT4\.P!URZS\Q6D"PY9P=(]/ZK&%+.FQ`R0]]H#2'DT--!SK,8G):W(_9]BS;Y"-4HQM@^#DR[9*9NFX M9.A(^0%67)Z7"W=-`@2)DIWOK`;K8)0T8.GJ8WWMS,K3HYW0VX[4^D%T$']P M$#U8TXR=D:?^*?&F%B7)!RUZ6CUR'<08DS(D'EF")=`&D+CREB$5P14@*2IV M:"BR:D`BJT%#@?:`1%:+AB*K`R0->S04:`#DC\*NSSM>&>E&?SA>2>/7U#0E MMU2%^X8A5;AO`D`B:P"4 M65;"08*N",9EY90O&`\UL75/AM+`-:>#)3=4OKB!+-W0%P?2<'PGX:Z@X+EX MX0Z0^%=]4E^--%39Q>V`P)(>6T#28W=2C[TTS,YNP/-,7)#:$AL>KNJN`]W$ M1822HZGUM3D++;EALGI,#5%];H45YG%M#VPK/!>_W@$2CZT!B5\W@/#JPPQO MC^U]C7$4KNRZZO MS;:E9%821K$A585B#8;BES+X]UPLA*R28E:L*U;N MJW30EWCQSO=5@W6PAFG`BGTYX^_Q7/IJ?5\=6`?[ZL&*??G7Q7B>"2):C%T0 MZ0+XQ'(IB#%IC2%QV_+:01M`XI9;AE1L58`DU>_04,37@$16@X8"[0&)K!8- M158'2!KV:"C0`"BS+(2]M$Y.1Y:%N/5.$A%#(0%.-;;_U,*UT)!$-AELF\&J M"9./(>X84^%6,Z3*KP:0Y/8](.W/<6Q*5@>6!'@/2&0-@+R_WMB=^&&]CO34 M+QE*=MW^&V*9I9QP`UG:'KY.DH9A!9[9"[45GHO[[0")8]4G]=5(0_$0?X8" MEO38`I(>NY-Z[*5A=G8#GON`N+$[[2.&BQL\'1"C!#HNT:G07W)GEEX;`(G/ M;0'AQ;8Y0ZOP7)QY!TCB\_N`(F4 MFB%]6U%8HO^U_X8"EU,\UA?FZ*M9%82$E&62NE;885YK.R5LPK/Q6=W@'1(.,&-L&20F9#@ MAB*^E882$DY\+ZSLN`<\SX2$W7X?24E^SWT3H30D[*]%E,Q*0F+:K&-J6V&% M>13^!Z)`T#$1Q2C)-;.2F)A8!PW`+!'?HD<=`&[@O;#R`Q]`R$1`V,&>D93B MAC=9%")D(L"D\S(8B+)9$@$,231MA14F0K_(:T*Y`D%\=`=(AX"3W`AK5%'Z M:<0]GHK8%I"([0#)@'M`<36@'WXS`QY`R/A^V/N=H7G>4$KG=S<1"EVHW&/? M7C!+>>B&(>6A6V$%_="/**<:JO!0]XGO%YNU$^DG7\CO@F0JG/WYAW/26S$I^/#9.LSU!T(:>@"E+$ M-W>`Q#=K0.(>#:`CA1!W+^);:8C4V`$2\3V@-\8]X'G&\^V.]XC^_<[V)D*I MY]^8,YB268GGLRQQK:VP5!3=F-<=%5@'ZY4=6"*^9DC%6B,LU>.5J1GV8!WL ML05+>NQ\C[VP5(_V2YX&L-[J,3EMN@D[2YV^?NB>X"C%[`[CEC6)K96[)\@- MD]B*#?4]068E]P37]GMU*K!T#>??R?H>:S242Q$-($2%LRH/4@*I]8([2!'! M/2`=S>ZCNP-8;TTE,>'*[N1_R(2CE-2$@.0TIV1(QR)#1[Z\@UETSW%,\_[5 M*\3(`K+SG=5@4?$TK97NZ*"1SH3E7[U"UEMQ,GX%8^L'T:'AP4'T,@B>LXH.BF)M7F/=@1;N&DX:75_9-1`T<86- MA[8>JA(H==NPF=63/+Q\K`+=^&>$DA2S=M^@P`W5V=E&()FS\Z(MLR@W!0,6 MUZZ8$C&TP*9S"[NK,^86-V.Z'%]%*%T:W0\!,8M^D0A+_,9#6X8H:&6Z:_O! M\0H--4NGSW2"8?=RQ@1YLR/I\HYNU05[&N,9]RR9E1@O-E30EEED*3U!\V:M M`NNTI$IJ2";X8TDU2#%.RY!6\_K*[#?*\-8L--2&C1`%*FR]95;XRF05NV:M MJL"B"G%BO6U8RH9_P[R#%#/O"!E[F_U)N8HL9=P-0T7X,449O[M:C);\YL;L M>Y00%ZNA%V81*%=,TX9F:+52EO98E31-HS.4 MQWI*1U(K5],Z.B.4ODKWJ36R$FM-D,PZDUI9?$RM]LL\*IIY<)\H-YU94J[2 MRGAD9K%,2^S"4!)_A;T[LV*6-HN#MLQ*$VMAWS;@J$JT<'W0RM'N*]N,BA#QK#FO*1D5F)8ED5WTJ:E M@VG\#8C+8]^`B.%$$4E(KFVM\V/S]270*-C:>68K4["TG5E6XB$^"7%+WI+X MGT>$Y+CG3^=LRQ\[Y]-J]/54%DFRI!K=Q.H=T]0-_9(A>J4-BVX`T0HJZXW] MIJZML-"P\M#.0[6'&@_M`8W62%5&P9.$Q9&X#W03]Q%*U!"A1`T,:37,[`=B MM^N))6IPT,ZS:@\U'MH#RJ@A%#C_>7:(99)>U]8,21R4'MHP1)_L"'N:V95= MK+9"$,6P9+D#M?.2:VG(DLV2V@@!DO<0X[\8<1WJG4E-%"9'O(7+(TEP=Z.$ MX$!Z55K;+TDKF:8/H`#IAIGL$;ND7S\+\[V9SZ]L;5=!D)S)[@"I(U]`![MK MP(K=7<_F:_N6=0^*/ZE=AWKJ#&W&\BOQ+D!))6"_NZ,<.Z+70SHM<4N!MF"M MH^J*&SN5"@QU&`1(Y-0,Z3-9L*+HA?MTZ1X$?^BR#O6=5M*X#SCE#O'8TN0J M+A:-]YF8*+EEXGVQ9=(PXWW,POGD,ODM+O\-QNA(N^(D`O%8@W7$%:>&P?.O M+J],P;N'&.^(Q552WAZ-Z\@GAU)K&BV0I@"]`ZV0L"HSV":#;3-8E<%V&:S. M8$T&VV>P-H-U&:S/8$.*)B:8>1IAU&FG88:=IAI&F'D:8=1IIV&&G:8:1IAY&F'4::=AAI6F-&T^25 M2<(XIN'`'].$%&BD8I,32,7,2XYD;ZS3DX,S3U9\4GO$5(U$:G<8J5VW-=-* MZOD30M17[L55Q)(D1E^%DQ[*T`PB3>]5@"5-??Z;:-/A+,6$^L^\0Z0)\RCI M\]>4[LR,:9*)(6TU?]*-Z^(JB$F7`6#)=Q+T(>V_<23FIM4:.U[VFZMN/)5]X1)$)(U72E.UG08 M6=-A-(^(9=W4UL0G%RC%E:^/)RQ\SGK2/'VKDS-:;)L:S6$T&X?1;+C?['1" M8:C=\5CZ1`DZ;7DI54[%I9Z""7XR"-/$2&00A]$4(D;E:ZQLC"":3R1DIQ.J MHG.F$ZNH-(RXLM*QX"_F%E>1EEK$830=%A=SY,Q=1`2AR,TG?,?_.?,9^2;[ M`:/8G#S,?S5M`9HVC\>VX+%Y"N.I%9YG9Q.6\3.L0Y6DR^6,)4ENYK[DM6!: M8AV/T6QB%_QZT7_/)0AYZX3U6\_'IK33).5=V+T/SS-0HP&AJXM?N MC=34]*TUB\5DUZPBK/2'#'SBFC7*<1LH4XG=%4PCG\1FD&8>BPV%;3(86=CQ M*!0=MLM@=09K,M@^@[49K,M@?08;4BRM!L.IL=/\"1NHL=WQ#133E%9)TUR\ MB/9)TPXC33N,-.TPTK3#2-,.(TT[C#3M,-*TPTC3#B--.XPTK3&CZ5#K:!\_ M4@$47"_IL,MMH,`[MH$"+UEW8A_)!HIY"B.U\UC&MF9:H>@Y9UI<)"7)*6)) M2#'C,(H9%A?7'_^%]B#DEY]00?T-TXR%&"V%R*Z4<;DX MT\Z;&WTTF_`%B,3>W(N?H[MC7BMHEQ/$:SB?(4CV:#/C(' M$B'LG=N=.)W0U$Z',,R_!^9D&)&UE*VH#N2 M\^G]BI]/Q$(O,A]W-Z[@IDKK-!]7S=%\6%R,DVOWI4`@9!,A??+0F^K\0Y51 MC#5;K*&20CRS>^*F22'N,9HFB^-$N#K\.S+DH%S"Y8Z2R/9_RZRY-M!Y<11M MRW+[FI*<-39-C1IAU&FG88:=IAI&F'D:8=1IIV M&&E:8T;3H6;29<^Q)!UKK+#5GQ)RKC`/%U7#XD0^./'6[M<*"]"2A2@V534X M:=UAI'7N(E.7ST*]<\ZLN#Y*LE/$DJ5G/3?GA)2=(BW-3A,FD\]E)^XAKD8W M_M`ND9W:+52$R0Q_K"H?Q9C%"!BEV,ET8%< MX7%L8N9H2[TCOAD^-&0+(L:4>>PC8*DTEG3,9-J:(;W\IDME*)<#.? M4$V=X97SP+?&84RT3O-Q&,W'860)AY'Z-6:&&XJEV^"R+QJ MIAFX6HUFX#":@<-H!AHS,[`5VS$'XCI(IP'^/?GTTQGNX^H%T_0M?H4=]BFN MUOCLL'`_`Z8$N=W;^%/IVD@_F` M>.62MC*F#,7,WS!/KHD2"S.6A)3#R"$9"\=<4V+,Y8C(X\NF12Y'B"1OT+!6 M'YKHB44G_P(XA?812-#J-H=-@N@]49 MK,E@^PS69K`N@_49;$@QXV*AGK":/Z'HQ$]UIYHV.8XTS>6*E.VD:8>1IAU& MFG88:=IAI&F'D:8=1IIV&&G:8:1IAY&F'4::=AAI6F-&TZ'PT9H^EI=CH72T MZ.1?WTY7&_N1$]+Z5)[AC(ZTCB[DD)'4[D'2NVZ=SHLJBK/F-?+-`@],)YFU M^^'5`C1)6AN%2M M%^Z0BFDT7#&3Q[8%Q,5U)?,5)&!$2<9DH?[1\_FQ]9-_%3FI?8"EEG3K)VB) M)6-5EM31S.,ZFG[0V"BL*IB1*Z7'7Q;6TSP2XB6I"_3-R\O:8J3(.^99Q9[_$.]Z12Y`$Q-9NZ@TA29EIC,8>29 M$>-(R[P/3P09QZ0Q3(Y)]<(/^F608C-,Q(P=C:IIDI&6VI'%)74=$Z>ZSD@B MHR6MS#1#*03'I+\?\TNNG))TPACU,I4ZZX4Y7J/Y,"TQVH1)TUS&C#2VX_+: M[]03X6:&H2)2,_Q!0W)=E4P\8L:0IL2CB4=::D@61X8\///(8]LN9YFU0B3Y MD`PEP'\^=2XDDJDSEMC<7]#A'V)-=F7`CI7QS.,RWG_=7J$$33-___+YX>%U M<_]Z__-/7Q^>?W\H'[Y\>7GW\>G/;^2;]'4M"G[W_/#;AXM?J*"X_24((R%3 M$SPKKND9^9U_%LZ+;\=#U.RSF_!L='4G<[8BF;29R;6;AW94PV>?K<*S[#C7 MB]M?Z*,`N5975]2*/@N0?5:$9V-![$9Y-:-1TK697+MB0>WHWDGVV3(\RVGL ME^+VE]&'3%]W810Y6;/;(];NO&7&QJ]%R>!X<9"KAT9?CQ)S3TC)QSKWZR;4IZ$GY)R[--DG'3WILT]V MU,\NVT]-3YKL?.KYG)[DYE/3?)JLM#U)VV>?M/2DS3[I2#DYW71+_QA+ MC9__OP````#__P,`4$L#!!0`!@`(````(0`G`V?WI00``#T0```9````>&PO M=V]R:W-H965TB8]NWNC\G#JE7KKG$/5].MKEBHOI"@3 MFL]4?3!4%9+'])3DEYGZUS?_RUA5RBK*3U%*89C>0 M>$K2I'JK154EB]WM):=%])3"O%]U*XI;[?H"R6=)7-"2GJL!R&G\0?&<)]I$ M`Z7Y])3`#)CM2D'.,W6AN\>QJLVGM3]_)^11]GXKY94^-D5R"I.<@-FP3&P! MGBA]9J';$T,P6$.C_7H!_BB4$SE'][3ZDSX"DERN%:RV#1-B\W)/;QXI8S`4 M9`:&S91BFL(#P*>2)2PSP)#HM?Y^)*?J.E/-T(B1B,"WXV(/AZ,;=L:C9W/JT!D_2CPW:C8`T*V=DOWHY6# M)6,J"R8S4Z%X85%*R+:7N:Z/)U/M!7(D;H*6'P2)$:LV@B4$T_5DL):!+X.- M#`(9;&6PD\%>!J$,#C(X]H`&WG8&0_+]'P8S&69PZ\RR!>^.&Y*9;40[Q)/! M6@:^##8R"&2PE<%.!GL9A#(XR.#8`X*9D/G(3!.:T\=MI4U.-@H:2"\Y'<<4 MS5KR&)TW$)9Z*T0\1-:(^(AL$`D0V2*R0V2/2(C(`9%CGPA60JTC*W7H;-#F MJFL2/R\I[Z\?6&M"@?.R9R+0.6"Y>G4_&4K>-E%.E[PK1#Q.3*>G9-HC46C= M!;4I[2.R021`9(O(#I$](B$B!T2.G.@3-E7!;K#UO]O-1&J[V_DO&]*S%A&/ MD_&P;LO&4+IIA^Y^JWKLJPJ.CR3'/TADV$NTF\C(NHF9U)ELZI:<='X3\.[]!LD&2'8KR%JF(?6O M'5+=(]40J1Y$53A^B!,^]E4%N]D1J+\E^[G=+%JTFQ,I<Y\++!\9[MKNOZD.(#VX4&C.-#VX46 MBKDW&ULG%S;1C%"]T+E[X`:(KZ]*^_7IYO?FT/Q]W^]?XV:+5O;[:O MC_NGW>OW^]O__#O[8W![//E^WK29,^*]/;FY3$NOK_N#YNOSS3OOX+.YA'< MU1\>_SK]N+^->JUNOQT%)'[S=7L\93M%>7OS^/-XVK_\ MOQ8*#)4F"0T)?1J2<-#J!^UAU'\_261(Z-.0=*\>2,=PT*?AZ+<&W6ZG-U`# M.3,#:JV6@3YKQ:#3[JE%.*/6,VKT:=2"J\?<-QST^>%Y4S17PZ=/PS%XW[R' M1I$^C>*PU0F[_4%E_C,S#VK'H7]\>-P!/$?]P[#TWSD`^$O`#O-.8PC=!#@Y`K,8*$ M2A"*-Y%`*H%,`F,)Y!(H)%!*8"*!J01F$IA+8"&!I016$EA;P!W9IS82>:5G M))5=KS22HE%&PNH^`&"KA<(@D(!*(H%4`ID$QA+()5!(H)3`1`)3"$CI(1,/F7K(S$/F'K+PD*6'K#QD;2..26BO]4P2=%MJPSW] MV#W^^;#7YX<&$T64L'0:4R24">B2YN_IN9`L/3&T$@+<\P00>N[WW9ZG[^EY)ED&'.B. M&>F0=849E;1K1HU4F0BGHTAFB)%1XTDF-:+BM-L2*26MFQ%-F4:Z'$UC3R:O M$7:&;E]D@*)12/A=Z?4VJ=4PHFF-J"F("BMI=[TU(L)& M>,C(".F,/6@-W?^B]`\QW\0HG`\CAS5L!2[K,/U#+'6F%8(VVWWL_ MP!M9_IZ1%0YKT.IX0RG]H4PHX1=*VO4+ MC8@X%-EF9-38'DF-<,B$D5!+:R'X?J81.QH]F;Q&SE`7M1"H2X]ZXLE,:^0, M]A)PM8?5AA;T6NV^'49RY7V* MK*9@*XY]L;P6TSWU6D/>`*KS8.$KE;42G_;XZ4>^5`"B(]2J0]E@*RM!A#3YX"8J_"A$A!S M30#I2J$J!$P!T9[-IYA(Y.@92R%6YH"8?@&(Z9>`;/KN0.Q8*Y8"_1I00PBI MRZ-=6CE_.%;F$_G*0([%M)0%)9!RABZ]+64I##T#Q"LS!F0;T?3HTHN37@%% M-G4)B.DG@'CAIX`<^H$X?,Y8"J.?`V+Z!2"F7P)RZ468KU@*]&M`#7955]`K M[&INK&&=X1Y4J9!,;1EQY$,)(&?H\J";LA2&G@'BE1D#LNUJ!N'0#]KN.;J` MHFU7H\CT$TCQPD\!N?3B]#-C*8Q^#HCI%X"8?@G(H9>7FA5+@7X-J,&NZI9K MVU4_P[BR@A#HNS*Y#[I\`$1E7F"C!BPQ&!41.,51"=RU2,I2(,L`\8XT;N#/ M(6;S1Z%(H05+@;\$Q/R3FI_--(68S=\="/X92X%_#HCY%PW\2X-UJ\=8U?Z\ M\J&U0^8<'U7%U#'PA82LK_6.)37DGFD&8J,=5?W%P,QI`)2@:Y/M0:BLQ("W-G$[VP**9[&#!`7 M;.:`F&OA7:3EW][51[(1)-I8!=Y4$]^"*KB$@4 MN7)DI)Q(U(I.)!J(CM%U"'5EA&2&*W3N_Z'8T,9^CSD4>?0%(!V.04LZ70D! M#J&)SSR%%#//`'$(S0$QU\+G6D**N5:`F&L-J"$-NG'=D]=&G!RKH'4 M09O-,Q0'E9%Z=DD.T67_2PP4LN.F@$C8XO)BU71)M^-:*O1-[?68@YY[+``- MJO#MT$-E=S\OC4`PK`\'$T!,,P7$TYN!F:$Y(#MZS5R8:^ESK:#(7&M`#=&K MJ@:VJ2]$KRDRL&<]T&3]Z!V*E1D9*2=ZM:(3O08R^V@_%`D\,S04N#APC'WF M'%(7]E'3F0[<3DLZ10D:[FSB=S:%%"_)#!`'VQP0@(>IIX"8>@9%AN:`F&L!1>9:`F+%%1096@/R`S&\KDY4B0O3 MZ=+1A6W4*-J!:"`[$`&Y>5H<_S-(G=]&_1YS*+*?%X`0C8'8_TL(<`1-?.8I MI)AY!H@C:`Z(N18^UQ)2S+4"Q%QK0`W1J*HM=F[]T#9*9JG.K#R*!T`7ME$C M9F^C!K*W44#N-BJJ91FZI)QY9AOU>\Q!SZ%2`-+;:!"UQ)Y=9:`6*N-:"&P)75HPO6],M$ZF:AKC14*JC#Q;^.&BDZ MB,-T"2#VNM1`N(YV^F*!,PBPBX]!P\PY(&8NH*CW4?I^;5>6$B#!U!/P,/44 M$%//H,C0'!!S+:#(7$M`K+B"(D-K0`V1J*HS5T2B+N;8EQ3U_=S+UU$CY42B M5G0BT4#N/BI.*YGA4I.JO<6_H_@]YE!D1R\`X3HZ])*K&1*'T,1GGH*&F6>` M.(3F@)AKX7,M(<5<*T#,M0;4$(ZR.O2Q?=0O&H4&NK2/:C%G']60LX\:R-U' MY04&75[81[T>'[,5OK*I`3U08BC(.L.Q0[XZCJG^J][*N)#Z6` M]#VU%\FR<08!#HRQ@0)Z:`%CY!"SQQ1Z!5](F>L.?=]#G,Y*2'!WDX;NIA#C MR`CH[D16D]+(%W4%[*.)C#9&&+*"*'W9BKSR# M7BPA>ZKOA/Y[_T;W(?/'N[X@&IIR"B_'`R#UX*%.Q5U9SA_58KP$B<$B7J@4 MD%[<3B0MFT&`M\1Q`W4.,7M0#6ZBI]/M5-4I^HZ9N*Z5H.'>)@V]32'&$YD9 MR%#3JU]B4YE#AZD7K`-W7T+J[#Q6D#+N'H4#^37)-40:MG]5U/&\Q/KJ,-SD MPI%.UX:<9$$O00AO?:`S676.'W!N&]48%P$38$.JS]1NU6N+@UQJB6'-LAKC MK7(,;,!=Y,"<+D+YI8K"$D,798U573CI6+T]A`2;NZYW,&MX6=T5.[%_I@*7Z:HI:`U/@^>I2]P5BZ;O?,ZB:>A26C.*G&N2R(-2 M`R&MB>=S&9KMM&9(V(]RG[>`HDEKW58D]L\2$@UIS;GL74YK_JTNTI#K5GY: MTU*.6WE0:KA4/9_36N`ME%&\D-:TE.-P7H\%]UA]':33DM?1$A(-WJ5.^[9W M?2ROZ3N#XW0&NI37M)B3USPHC0Q$'_6:-N0U+47/-9$CQT;1R6L>??$N^M)( M:7HWKSFWA4V3.&Y6 M\UHK+B^>!;A,5TU1:WA\SZ/>7,\[?QBIQ-WCFH$NY#4H62!_Y[2BL&"Z>UXP4 M#00.F1C(]BM`;F(3Y_,,4N<3F]]C#D4NHQ2`_MF](-'@7LYM@'SM0XF-"GCR MP`;H0F(S8E;F20QDY;H4T/G$ABZMQ.;3Y^!B?RP`G:4O'7HGL='/P[@.^+%% M].\1%3%%,_DJYY=>(&Y)HUJ,BYV)P6C0<-84D(DQ/WCU`#I6RFM@SD%CC\D_ MRT'J3$#;W>GUU#^2HW]EXV5[^+X=;9^?CS>/^Y_J!W`ZZIW5&C:_SA,.XR_4 M%TU2M@3QEVKR`G^@W_.I2B\2#^-UHWP4KQOY._$7>A&IJ6/5P[4TF0X^C8\M33U0R]4Q>HK^WX_]%Y5K+ZY[[?0ZU6Q>GFJ MJ26DEJ:QT2L>U-(T-GH3@%J:^J$7QV+UNH+?SYA:U%L+?@N]1A87C6/+@Y!: MFL:6T]C4NRM-;!UJ:>J'7I"+U;L:O@Z])Q>K-S;\%GI=+E;OQS6UA-32-#9Z ML8=:FL9&;X!02U,_(VIHPL9Y^XV26KMZ2^:@?_=+_W$RSU:^[D_T>UV4 M_FE7IM]GV]++?&WU`.;;?G_"'ZJ#^A??/O]7`````/__`P!02P,$%``&``@` M```A``2%0G32`P``<0L``!D```!X;"]W;W)K&UL MK%9;KZ)($'[?9/\#X7T$&A4EZD1%9B;932:3O3SW@58Z!VC2W1[/^?=;?0&Y MN!,WV1>1ZJ\^ZZM+6YO/[U7IO!$N**NW;C#S78?4&\OVE5V%:NX8AYL]PL/.99B1AV;4BM30DG)180ORBH(UH MV:KL&;H*\]=K\REC50,4+[2D\D.3NDZ5Q=\N->/XI03=[\$<9RVW?IG05S3C M3+"SG`&=9P*=:EY[:P^8=IN<@@*5=H>3\];=!W&Z=KW=1N?G+TINHO?=$06[ M?>$T_XW6!)(-95(%>&'L54&_Y%IG^/:3'X.P=,3PM/@` MS>9H$:UTR%-/STC6&4RPQ+L-9S<'NA)B%`U6/1[$2]=I4V<8NF3^6RXAB8ID MKUBV+HP3I$E`_=]V0;"*-MX;5"VSH,,#T!!Q;!&J1(HW&1M.8T/:,W@@J=,% M9?@?="D6I:L-Z-`:[D+12$.+:%V2L>$T-J0]PT!#.-40PG`\;NNV%,H)&KA7 MBF@9#&,\&$Q@&E@E^CBQ)!/+:6))^Y9!Y-"]T^S/(FA76=#L]<#,.#U0$D+W MF)Y2'-"5D)Q^4ZU&4@P*13T46LZ'H*.EBKHZ)L82]MVBR!^ZG3I06\O4$NF[ M;"`8E/4%/Q`&5TFK3(&ULI;W8"P(Z=%!?K`81G*TY_>")9W'/3LH6`[=3A:D M<@H3B=9C0&H!QGO3.H\W)R6+6 MFB-$BU%U4GN^G,0.17T^=@4>QFXL]UJ,KK&C/>_5HO/H8K<6D_@0^:-+(K7G MT[RKC61R'?_'P5$<0TG6TI5C-$1'<]XOA[7<)^9D+2M3TM&-DMI?F`[&>BCH MYX.AP,/(C06*<6_S`(W'VX)Z%7G@-IT."[+3L0Y7Z^'XP,JBPD&]*ID5Q/R! M5H1?R)&4I7`R=E7KQ1)RTUG-YI/,8[A&H"]&=MB(]NB!_0";DM8QPA]0#'\3 M4YY#&,,M/+7OY_'>%*,C@HVGP1?R.^876@NG)&<(V=>]Q&PO=V]R:W-H965T&.`DU@%/`3&;^_6U9:K?4 M\CC)S+Z$<'QT6E)W2VKAVS^_'P^#;]7YLJ]/=T/G9CP<5*==_;`_/=T-__-7 M^,=L.+A'[:$^57?#']5E^.?]/_]Q^UJ?OUR>J^HZ`(73Y6[X?+V^+$:C MR^ZY.FXO-_5+=8(GC_7YN+W"U_/3Z/)RKK8/3:/C8>2.Q]/1<;L_#:7"XOP> MC?KQ<;^KUO7NZ[$Z7:7(N3ILK]#_R_/^Y8)JQ]U[Y([;\Y>O+W_LZN,+2'S> M'_;7'XWH<'#<+9*G4WW>?C[`N+\[D^T.M9LOEOQQOSO7E_KQ>@-R(]E1>\SS MT7P$2O>W#WL8@9CVP;EZO!M^M/\'E^?Z-3KO'_+] MJ8+9!C\)#WRNZR^"FCP("!J/K-9AXX%_G0/VZ^'Z[_HUKO9/SU=PMP\C M$@-;//Q85Y<=S"C(W,AN[.H#=`#^#HY[$1HP(]OOS>?K_N'Z?#?TIC=^,/8< MH`\^5Y=KN!>2P\'NZ^5:'_\G28[H5"OB*A'X5"+NY&;F^Y/I+'B_RD2IP*=2 M\6\FKA_,FJ[TF`<3S1C@4S5TYC?.9#P50^AI-U7MX!/;?7CHD$>-;?A4&MY[ M3,]5,_A$T\[[!NO@9(M_L.W')]OQ5`_$/TKFXXYWT&?BG[8S[PR?D0S%)K+7 MV^OV_O9+C+(0PQK1T91OE/PMR"$RA\DG(W`W!,1"_%\C, M;_>.,YON8D[24'$>NL2+D5A:RMI"-A806 M$EE(;"&)A:06DEE(;B&%A90Z8DPAY+@QA3+A;\3><7W>[[XL:[D%=4RM!XDM MTUV(P(H!;M+SW6=SJUC3-FA7$O'G+;*6R!2ZVRH%/HOD34O"4`XM)+*0V$(2 M"TDM)+.0W$(*"RD5(L\/>OK#M!K3W3&ML'/BO`IV,Z\XT*5"M#FTD+5"?*=9 M>-VQPQ;>#1%0-Y30E.(^LG1C:B86=-#U3`_*M^`?^\60,)&=./C?+=4-LY5C:T5I!+H;]!B)(L1$C; M36RM&%FDE2!$6BE"I)796CFR2*M`B+1*A!HMX@J)+S(2,I(DL'9MU5"+_S5"%*`;!4U4*1%X M<[;IA-@!JN$BA"B$8ULZ8=+CP+5).P[2UD;%&:`:U6'M. MLVJEC4;#H`H5-J6C=H0T,A`CQ`RP@WRBT=!`:AO(D$8&:P6RI#7/=7QV M`U(BHR/71(WZ`:^IRIC6GZ4C(6/_5&=M&KD.6_HWJB&P M,`9#U*+#6H20OH>]1SZQY5/4(OD,(9+/J6%/[PMB8>]+U.HX'HHZ]0.^D&6M ML6E)R#@>N@Z+AI4C64822WI?$`OE2]3JR`M1;NJ^^+7CGBQ:#1=)R$B7@!>[*T>RC'11$&U. M&V2!6\AK_#>24+'$A\9BVW&$6A3B,3;TX6!'+7F&)AH-)S9%3#\+6D/*T28- MJ4"H=T@ER6L=TPZDQL;D\ON!_HVIH9OW``BU&]/4XSFE*'I.(=2[>&^0I;:* M8#YE*V"(#,J!""'*@1BA7FL)LGZ^,2&#K&4(D;4%E3(L-. M0)A),P'?\)I]^]`H0*ULWDWSC4FQ]$Q3$!QU,)XWR))7V'`_-?:94(@4VC8B MA$@HMK439$GMR8S7&"D22#E#B)1S6[E`ENKU=&S=AI=(L7>)[+TVH%RQM.PNL*$Y M.:SV*)'ULP&9FXXH[W6/_=+Y`7Y[M))*0B)6VFF%NP/S)X"5:@C9C;.S5I#^ M,P]"L':V6J[+W@,(D:5;=&U'JGZ1Q5@U='QX1/IVHJE!`@T[FY)-A#(%:4/* MD47E=(%0[Y!*9/UL2*8KQ>7![[M2J+#U44*>W!XG\#HH"[D5Q*UHI(7O6D%O M_$B$+/DKD3MU._8K99VR);+-Q2ADNI#5S@FRI#EG&O#Z+T4&6JT5 MR%*#"V8!OR<0[Y&*B?.T;4V^%RK?GCM6YZ=J51T.E\&N_BK>^71G<.7=PO*% M5%B)%F*=@1"TGDS@21.O[`F\Q/JI6789OH276YO4X+@++[UV6%AZ"W@)R+;\ M:;+X!#=G'0\<'RPWRR@SL79FBPU4.G8;J,L6HNJRGT!)M1`%D_T$J@)HTYSK MN1W778A-N:,-/$DZG\!FN1!;H=T&KMF@UUWC@?LQZ$'7$[C8@EYW/5D[`:@U M=0;K=0Q/Q"V`W0,H\4&MZ\EZLH"7B.P6:^ARE_48.MR%Y]#=+GP]7<#[*+9^ M/%W`VR4VGD\7\*X(X*-V`IKS\[-2.B8;#P^^ M<>"CAI`ED@U,N@IM8W0,XR"W8$0H4L.F<-UX(V(Z^@UV0KZ+#>`)(9?80!1* M1($[8.Y&(AJ02HY(]^'K'J`DAAH,V!@P+2C^[D;P)OQYH4].FD;'O4LS#;JG M;"4/X=C>!3T6V[8MVFFOD?PI?EG>/_:CYMIVNY*`>+>?6H2X3*M<:U`W>[Y[ M\W46PK;$O[-2R=Z.20\B@LK2>^Q@=TR>I[=WJP7B$T(O M2WQL#??Y"#2#P+^(UR?$(X#WWC__G'\!``#__P,`4$L#!!0`!@`(````(0#[ MGGU]Q@0``),8```0``@!9&]C4')O<',O87!P+GAM;""B!`$HH``!```````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````)Q9VW+B.!!]WZK]!XKWB3$AUS*> M8@BIF:W9&78AV4>58@M0Q4A>23!AOWY;,B$FZC"\G'IW71 MV0ICI5;#;GS2ZW:$RG0NU7+8O9O??KCL=JSC*N>%5F+8W0G;_9C^_ELR-;H4 MQDEA.S"%LL/NRKGR.HILMA)K;D_@LX(O"VW6W,%/LXST8B$S<:.SS5HH%_5[ MO?-(/#FAN[:2YSKQ_]GZ^*\'A-!F592$S[B#*]$^9&6WU MPG4F3YDHDJC^,0'O9B+;&.EV:2^)ZC^36<8+,8:)TP4OK$BBEQ?)9\$]:5,N MC4V3K;O>BLQIT['R/Z"MW^T\<"N\.\/NEAO)E0.W_+#J1W@N2NM,^H\VCW8E MA+-)!`.JE^&Q/K;^+`=IW+L*0^#Q>*B?HG(%/AP[.9>N$/;[8LJ-:_`9IJQ[ M'?RH?*Y<>LXC&ZF<390#QM@75>5;ZKKOARC&6EE=R)P[D;-/O.`J$VSV)M9? M&<^F_.V??2 MRXAEDW59Z)T0!*EQ#RC*]%JP.7^B.(IC8-U)$\(,-.%^QY!=L?1576LW18P_ M#71(5S6"KR'H0R,;D1W4#M%B*(9H,11#M!BZH!&\H1B"-V01 MO('#\:$77QT;4`A1!NC"282#8HAP4`Q1!BB&*(/7B_J^M7'2$`#[T@)"\(R9 MF;_?S+?W0V8$Y,T!B56<$9#&A'-T^?OJNO>K M5(_VKISK&[CH>+[0/GZ9^+M,D<-%[_/WEQ?)9[C+-H6?!*X[X((N?Q[S]H._ M?K^O_F-(X\%)[[0'-^NU=TFTOR&$NXKT?P```/__`P!02P,$%``&``@````A M`!R$&OZ5````J0```!````!X;"]C86QC0VAA:6XN>&UL/(Y!"@(Q$`3O@G\( MG[GI%Y4)18VL!]&4,2^ M+)&?!NZWZ^X(2IKCQ:7"9.!#`K/=;K1WR5^"BZRZ@<5`:&T](8H/E)T,927N MS:/4[%K'^D19*[E%`E'+"0_C.&'N`K#:JVK@/(&*_0.H]$NT&O\C]@L``/__ M`P!02P$"+0`4``8`"````"$`7M],EM4"``#>/@``$P`````````````````` M````6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0`` M`$P"```+``````````````````X%``!?&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`!ZS^ZC:!```\!$``!D````` M````````````H1T``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`-=+Z!F[!```C1$``!D`````````````````C2L` M`'AL+W=O#@``&0````````````````!_,```>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`(WC9];E`@``M@<``!D`````````````````CCD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-:Q3NLQ`P`` MQ`D``!D`````````````````QDD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&6Z'E<9$0``)&P``!D````````` M````````"E0``'AL+W=OH^("``#S!P``&0````````````````!:90``>&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`&@G"PJ5`P``S@P``!D`````````````````\FX``'AL M+W=O M``!IP```&0````````````````"^<@``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`,V_6L-%!```QPX``!@`````````````````>I4``'AL+W=O&UL4$L!`BT`%``& M``@````A`$(=F*&UL4$L!`BT`%``&``@````A`++D68PX M`@``#@4``!D`````````````````;*X``'AL+W=O&PO=V]R:W-H965TS``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`$2$+*4>!0``[Q,``!D````` M````````````4;8``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`(D^UI4!"```JB,``!H`````````````````[\0` M`'AL+W=O&UL4$L!`BT`%``&``@````A`$V: M/JAU"0``R2X``!H`````````````````*,T``'AL+W=O&UL4$L!`BT`%``&``@````A`-TF&UL4$L!`BT`%``& M``@````A`'SW44-O`P``\@H``!H`````````````````;-D``'AL+W=O&UL M4$L!`BT`%``&``@````A`+WV2#11`@``C`4``!H`````````````````&OL` M`'AL+W=O&UL4$L!`BT`%``&``@````A`/MB MI6V4!@``IQL``!,`````````````````H_T``'AL+W1H96UE+W1H96UE,2YX M;6Q02P$"+0`4``8`"````"$`Y*:J>LH&``!>'0``&`````````````````!H M!`$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!7A MA3UO`@``/@8``!@`````````````````:`L!`'AL+W=O!``4```````````` M``````T.`0!X;"]S:&%R9613=')I;F=S+GAM;%!+`0(M`!0`!@`(````(0#1 M'Y&F5A$``!7%```-`````````````````*@N`@!X;"]S='EL97,N>&UL4$L! M`BT`%``&``@````A`''6$('E!0``'QP``!H`````````````````*4`"`'AL M+W=O&UL4$L!`BT`%``&``@````A``IP#2;G M`@``"P@``!H`````````````````1D8"`'AL+W=O&UL4$L!`BT`%``&``@````A`'-[.G_O`@``@@@``!H````````````` M````94D"`'AL+W=O&UL4$L!`BT`%``&``@` M```A`,B?-&#=`@``8P@``!D`````````````````C$P"`'AL+W=O&UL4$L!`BT`%``&``@````A`'X_Q+*[`@`` MV@8``!D`````````````````[)H"`'AL+W=O MG0(`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(RVKL:2`P``O`L``!D````````` M````````D]D"`'AL+W=O&PO=V]R:W-H M965T9,";2<"``"=!``` M&0````````````````#!X0(`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-3,8'QX M!```3!$``!D`````````````````.><"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!@:':%(!P``>2```!D````` M````````````$_("`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`.2MDY1=!@``!AH``!D`````````````````1`(# M`'AL+W=O M\NL2```28@``&0````````````````#8"`,`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`(0E$''%#```P3X``!D`````````````````96H#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&&:/RI_`@``)P8``!D````````` M````````RM4#`'AL+W=O``"UI```&0````````````````"`V`,`>&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`*KN2N.O`@``%`<``!@`````````````````$Q($`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+N6 M5/]L`@``DP4``!@`````````````````8B@$`'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`$"\IO.B!@``CQL``!D`````````````````GHP$`'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!OB MV#`*!P``@QP``!D`````````````````1\0$`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*-.`S_=$```PT\``!D` M````````````````!@T%`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/7B#6I(`P``MPD``!D````````````````` M$"P%`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`/FQD[I'`P``.0L``!D`````````````````R3P%`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``OK>V]- M`P``T@D``!D`````````````````BD@%`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``@:[*\*(```S)L``!D````` M````````````9E,%`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`$[C>>.<"0``!BH``!D`````````````````@*@% M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`%]#IR!]!@``\A@``!D`````````````````AL(%`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#'[?^XJ$0``-DX``!D````````` M````````;1\&`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`%''D\HT`0``0`(``!$`````````````````'T`&`&1O M8U!R;W!S+V-O&UL4$L!`BT`%``&``@````A`/N>?7W&!```DQ@``!`` M````````````````BD(&`&1O8U!R;W!S+V%P<"YX;6Q02P$"+0`4``8`"``` M`"$`'(0:_I4```"I````$`````````````````"&2`8`>&PO8V%L8T-H86EN :+GAM;%!+!08`````=P!W`+0@``!)208````` ` end XML 20 R70.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 7 - Earnings Per Common Share (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Earnings Per Share [Abstract]  
Exclusion of Interest and Deferred Financing Fees from Diluted Income $ 5.8akrx_ExclusionOfInterestAndDeferredFinancingFeesFromDilutedIncome

XML 21 R55.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) - Warrants (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Class of Warrant or Right [Line Items]  
EJ Funds 7,192,313akrx_NumberOfWarrantsGranted
EJ Funds $ 17,946akrx_WarrantsFairValue
Modification Warrants [Member]  
Class of Warrant or Right [Line Items]  
EJ Funds Apr. 13, 2009
EJ Funds 1,939,639akrx_NumberOfWarrantsGranted
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_ModificationWarrantsMember
EJ Funds $ 1.11us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_ModificationWarrantsMember
EJ Funds 4,829akrx_WarrantsFairValue
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_ModificationWarrantsMember
Reimbursements Warrants [Member]  
Class of Warrant or Right [Line Items]  
EJ Funds Apr. 13, 2009
EJ Funds 1,501,933akrx_NumberOfWarrantsGranted
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_ReimbursementsWarrantsMember
EJ Funds $ 1.11us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_ReimbursementsWarrantsMember
EJ Funds 3,740akrx_WarrantsFairValue
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_ReimbursementsWarrantsMember
Credit Facility Warrants [Member]  
Class of Warrant or Right [Line Items]  
EJ Funds Aug. 17, 2009
EJ Funds 1,650,806akrx_NumberOfWarrantsGranted
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_CreditFacilityWarrantsMember
EJ Funds $ 1.16us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_CreditFacilityWarrantsMember
EJ Funds 4,127akrx_WarrantsFairValue
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_CreditFacilityWarrantsMember
Subordinated Note Warrants [Member]  
Class of Warrant or Right [Line Items]  
EJ Funds Aug. 17, 2009
EJ Funds 2,099,935akrx_NumberOfWarrantsGranted
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_SubordinatedNoteWarrantsMember
EJ Funds $ 1.16us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_SubordinatedNoteWarrantsMember
EJ Funds $ 5,250akrx_WarrantsFairValue
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_SubordinatedNoteWarrantsMember
XML 22 R78.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Income Taxes (Details) (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Note 10 - Income Taxes (Details) [Line Items]    
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 35.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate  
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount $ 1,116,000us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance $ 0us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
Unrecognized Tax Benefits that Would Impact Effective Tax Rate 1,200,000us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate  
Unrealized Reduction in Goodwill if Realized 500,000akrx_UnrealizedReductionInGoodwillIfRealized  
Domestic Tax Authority [Member] | Merck Acquisition [Member]    
Note 10 - Income Taxes (Details) [Line Items]    
Operating Loss Carryforwards 7,500,000us-gaap_OperatingLossCarryforwards
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_DomesticCountryMember		  
Domestic Tax Authority [Member] | VersaPharm [Member]    
Note 10 - Income Taxes (Details) [Line Items]    
Operating Loss Carryforwards 3,800,000us-gaap_OperatingLossCarryforwards
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_DomesticCountryMember		  
Domestic Tax Authority [Member]    
Note 10 - Income Taxes (Details) [Line Items]    
Operating Loss Carryforwards 11,300,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_DomesticCountryMember		  
State and Local Jurisdiction [Member]    
Note 10 - Income Taxes (Details) [Line Items]    
Operating Loss Carryforwards 2,200,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_StateAndLocalJurisdictionMember		  
Foreign Tax Authority [Member] | NOL Expiring Beginning in 2022 [Member]    
Note 10 - Income Taxes (Details) [Line Items]    
Operating Loss Carryforwards 1,100,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_ForeignCountryMember
/ us-gaap_StatementScenarioAxis
= akrx_NOLExpiringBeginningIn2022Member		  
Foreign Tax Authority [Member] | Indefinite Lived NOL [Member]    
Note 10 - Income Taxes (Details) [Line Items]    
Operating Loss Carryforwards 6,000,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_ForeignCountryMember
/ us-gaap_StatementScenarioAxis
= akrx_IndefiniteLivedNOLMember		  
Foreign Tax Authority [Member]    
Note 10 - Income Taxes (Details) [Line Items]    
Operating Loss Carryforwards 7,100,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_ForeignCountryMember		  
Prior to 2012 [Member]    
Note 10 - Income Taxes (Details) [Line Items]    
Liability for Uncertain Tax Positions, Noncurrent $ 0us-gaap_LiabilityForUncertainTaxPositionsNoncurrent
/ us-gaap_StatementScenarioAxis
= akrx_PriorTo2012Member		  
XML 23 R104.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 19 - Related Party Transactions (Details) (USD $)
 0 Months Ended 12 Months Ended
Mar. 03, 2010
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
EJ Financial Enterprises Inc. [Member]        
Note 19 - Related Party Transactions (Details) [Line Items]        
Period Term of Sub Lease Agreement 8 years      
Operating Leases, Rent Expense, Sublease Rentals $ 240,000us-gaap_OperatingLeasesRentExpenseSubleaseRentals1
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= akrx_EJFinancialEnterprisesIncMember		      
Polsinelli [Member]        
Note 19 - Related Party Transactions (Details) [Line Items]        
Related Party Transaction, Amounts of Transaction   1,900,000us-gaap_RelatedPartyTransactionAmountsOfTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= akrx_PolsinelliMember		 700,000us-gaap_RelatedPartyTransactionAmountsOfTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= akrx_PolsinelliMember		 500,000us-gaap_RelatedPartyTransactionAmountsOfTransaction
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= akrx_PolsinelliMember
Accounts Payable, Related Parties   $ 200,000us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= akrx_PolsinelliMember		 $ 200,000us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= akrx_PolsinelliMember		  
XML 24 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 21 - Selected Quarterly Financial Data (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information [Table Text Block]
 
 
 
   
 
Income (Loss) From Continuing Operations
   
Net Income (Loss)
 
 
(In thousands, except per share amounts)
 
Revenues
   
Gross
Profit
   
Operating
Income (Loss)
   
Amount
   
Per Basic
Share
   
Per Diluted
Share
   
Amount
   
Per Basic
Share
   
Per Diluted
Share
 
Year Ended December 31, 2014:
                                                     
4th Quarter
  $ 227,828     $ 128,382     $ 71,907     $ 34,232     $ 0.32     $ 0.29     $ 34,232     $ 0.32     $ 0.29  
3rd Quarter
    132,732       51,734       (6,042 )     (11,650 )     (0.11 )     (0.11 )     (11,650 )     (0.11 )     (0.11 )
2nd Quarter (as restated)
   
141,896
     
67,818
     
7,410
     
3,438
     
0.03
     
0.03
     
2,935
     
0.03
     
0.02
 
1st Quarter
    90,622       49,656       23,440       9,828       0.10       0.08       9,828       0.10       0.08  
Year Ended December 31, 2013:
                                                                       
4th Quarter
  $ 84,953     $ 46,970     $ 25,176     $ 16,678     $ 0.17     $ 0.14     $ 16,678     $ 0.17     $ 0.14  
3rd Quarter
    81,892       43,697       22,188       12,205       0.13       0.11       12,205       0.13       0.11  
2nd Quarter
    77,012       42,092       22,251       12,637       0.13       0.11       12,637       0.13       0.11  
1st Quarter
    73,854       39,145       18,589       10,842       0.11       0.10       10,842       0.11       0.10  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
   
As Reported
   
Adjustments
   
As Restated
 
Prepaid expenses and other current assets
  $ 17,120     $ (107 )   $ 17,013  
TOTAL CURRENT ASSETS
    397,180       (107 )     397,073  
Goodwill
    196,016       (5,568 )     190,448  
TOTAL OTHER LONG-TERM ASSETS
    690,898       (5,568 )     685,330  
TOTAL ASSETS
  $ 1,223,773     $ (5,675 )   $ 1,218,098  
Income taxes payable
    675       (104 )     571  
TOTAL CURRENT LIABILITIES
    103,777       (104 )     103,673  
TOTAL LIABILITIES
    929,304       (104 )     929,200  
Retained earnings
    33,700       (5,571 )     28,129  
TOTAL SHAREHOLDERS’ EQUITY
    294,469       (5,571 )     288,898  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
  $ 1,223,773     $ (5,675 )   $ 1,218,098  
   
As Reported
   
Adjustments
   
As Restated
 
Revenues
  $ 150,749     $ (8,853 )   $ 141,896  
GROSS PROFIT
    76,671       (8,853 )     67,818  
OPERATING INCOME
    16,263       (8,853 )     7,410  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
    14,312       (8,853 )     5,459  
Income tax provision
    5,303       (3,282 )     2,021  
INCOME FROM CONTINUING OPERATIONS
  $ 9,009     $ (5,571 )   $ 3,438  
NET INCOME
  $ 8,506     $ (5,571 )   $ 2,935  
NET INCOME PER SHARE:
                       
Income from continuing operations, basic
  $ 0.09     $ (0.06 )   $ 0.03  
NET INCOME, BASIC
  $ 0.08     $ (0.05 )   $ 0.03  
Income from continuing operations, diluted
  $ 0.08     $ (0.05 )   $ 0.03  
NET INCOME, DILUTED
  $ 0.07     $ (0.05 )   $ 0.02  
COMPREHENSIVE INCOME:
                       
Consolidated net income
  $ 8,506     $ (5,571 )   $ 2,935  
COMPREHENSIVE INCOME
  $ 8,353     $ (5,571 )   $ 2,782  
   
As Reported
   
Adjustments
   
As Restated
 
Revenues
  $ 241,371     $ (8,853 )   $ 232,518  
GROSS PROFIT
    126,327       (8,853 )     117,474  
OPERATING INCOME
    39,703       (8,853 )     30,850  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
    30,004       (8,853 )     21,151  
Income tax provision
    11,167       (3,282 )     7,885  
INCOME FROM CONTINUING OPERATIONS
  $ 18,837     $ (5,571 )   $ 13,266  
NET INCOME
  $ 18,334     $ (5,571 )   $ 12,763  
NET INCOME PER SHARE:
                       
Income from continuing operations, basic
  $ 0.19     $ (0.06 )   $ 0.13  
NET INCOME, BASIC
  $ 0.18     $ (0.05 )   $ 0.13  
Income from continuing operations, diluted
  $ 0.16     $ (0.05 )   $ 0.11  
NET INCOME, DILUTED
  $ 0.16     $ (0.05 )   $ 0.11  
COMPREHENSIVE INCOME:
                       
Consolidated net income
  $ 18,334     $ (5,571 )   $ 12,763  
COMPREHENSIVE INCOME
  $ 19,886     $ (5,571 )   $ 14,315  
   
As Reported
   
Adjustments
   
As Restated
 
Consolidated net income
  $ 18,334     $ (5,571 )   $ 12,763  
Changes in operating assets and liabilities:
                       
Trade accounts receivable
    (27,991 )     8,853       (19,138 )
Prepaid expenses and other current assets
    4,329       (3,178 )     1,151  
Accrued expenses and other liabilities
    8,799       (104 )     8,695  
   
As Reported
   
Adjustments
   
As Restated
 
Prepaid expenses and other current assets
  $ 33,078     $ (3 )   $ 33,075  
TOTAL CURRENT ASSETS
    494,098       (3 )     494,095  
Goodwill
    290,648       (5,568 )     285,080  
TOTAL OTHER LONG-TERM ASSETS
    1,243,363       (5,568 )     1,237,795  
TOTAL ASSETS
  $ 1,876,833     $ (5,571 )   $ 1,871,262  
Retained earnings
    22,051       (5,571 )     16,480  
TOTAL SHAREHOLDERS’ EQUITY
    320,322       (5,571 )     314,751  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
  $ 1,876,833     $ (5,571 )   $ 1,871,262  
   
As Reported
   
Adjustments
   
As Restated
 
Revenues
  $ 374,103     $ (8,853 )   $ 365,250  
GROSS PROFIT
    178,061       (8,853 )     169,208  
OPERATING INCOME
    33,661       (8,853 )     24,808  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
    11,465       (8,853 )     2,612  
Income tax provision
    4,278       (3,282 )     996  
INCOME FROM CONTINUING OPERATIONS
  $ 7,187     $ (5,571 )   $ 1,616  
NET INCOME
  $ 6,684     $ (5,571 )   $ 1,113  
NET INCOME PER SHARE:
                       
Income from continuing operations, basic
  $ 0.07     $ (0.05 )   $ 0.02  
NET INCOME, BASIC
  $ 0.07     $ (0.06 )   $ 0.01  
Income from continuing operations, diluted
  $ 0.06     $ (0.05 )   $ 0.01  
NET INCOME, DILUTED
  $ 0.06     $ (0.05 )   $ 0.01  
COMPREHENSIVE INCOME:
                       
Consolidated net income
  $ 6,684     $ (5,571 )   $ 1,113  
COMPREHENSIVE INCOME
  $ 7,840     $ (5,571 )   $ 2,269  
   
As Reported
   
Adjustments
   
As Restated
 
Consolidated net income
  $ 6,684     $ (5,571 )   $ 1,113  
Changes in operating assets and liabilities:
                       
Trade accounts receivable
    (24,193 )     8,853       (15,340 )
Prepaid expenses and other current assets
    (11,209 )     (3,282 )     (14,491 )
XML 25 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 4 - Inventories (Tables)
 12 Months Ended
Dec. 31, 2014
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current [Table Text Block]
   
December 31,
 
 
 
2014
   
2013
 
Finished goods
  $
64,442
    $ 22,886  
Work in process
   
4,335
      3,883  
Raw materials and supplies
   
62,533
      29,213  
    $ 131,310     $ 55,982  
Summary Of Allowance For Excess And Obsolete Inventory [Table Text Block]
   
Years Ended December 31,
 
 
 
2014
   
2013
 
Balance at beginning of year
  $ 5,700     $ 6,819  
Provision
    12,275       2,089  
Additions from acquisitions
    8,220       —  
Charges
    (5,016 )      (3,208 )
Balance at end of year
  $ 21,179     $ 5,700  
XML 26 R79.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Income Taxes (Details) - Income Tax Provision (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2014
Jun. 30, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income Tax Provision [Abstract]            
Federal       $ 34,799us-gaap_CurrentFederalTaxExpenseBenefit $ 27,985us-gaap_CurrentFederalTaxExpenseBenefit $ 20,843us-gaap_CurrentFederalTaxExpenseBenefit
Federal       (11,674)us-gaap_DeferredFederalIncomeTaxExpenseBenefit (3,050)us-gaap_DeferredFederalIncomeTaxExpenseBenefit (504)us-gaap_DeferredFederalIncomeTaxExpenseBenefit
Federal       23,125us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations 24,935us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations 20,339us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations
State       4,991us-gaap_CurrentStateAndLocalTaxExpenseBenefit 4,145us-gaap_CurrentStateAndLocalTaxExpenseBenefit 4,232us-gaap_CurrentStateAndLocalTaxExpenseBenefit
State       (2,698)us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit 2,051us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit (911)us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit
State       2,293us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations 6,196us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations 3,321us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
Foreign       4us-gaap_CurrentForeignTaxExpenseBenefit    
Foreign       (2,134)us-gaap_DeferredForeignIncomeTaxExpenseBenefit (598)us-gaap_DeferredForeignIncomeTaxExpenseBenefit (1,538)us-gaap_DeferredForeignIncomeTaxExpenseBenefit
Foreign       (2,130)us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations (598)us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations (1,538)us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations
Total       39,794us-gaap_CurrentIncomeTaxExpenseBenefit 32,130us-gaap_CurrentIncomeTaxExpenseBenefit 25,075us-gaap_CurrentIncomeTaxExpenseBenefit
Total       (16,506)us-gaap_DeferredIncomeTaxExpenseBenefit (1,597)us-gaap_DeferredIncomeTaxExpenseBenefit (2,953)us-gaap_DeferredIncomeTaxExpenseBenefit
Total $ 2,021us-gaap_IncomeTaxExpenseBenefit $ 7,885us-gaap_IncomeTaxExpenseBenefit $ 996us-gaap_IncomeTaxExpenseBenefit $ 23,288us-gaap_IncomeTaxExpenseBenefit $ 30,533us-gaap_IncomeTaxExpenseBenefit $ 22,122us-gaap_IncomeTaxExpenseBenefit
XML 27 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 28 R73.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 8 - Leasing Arrangements (Details) - Future Minimum Lease Payments (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Future Minimum Lease Payments [Abstract]  
2015 $ 2,569us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent
2016 2,532us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2017 2,230us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2018 769us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears
2019 466us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2020 and thereafter 3,182us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter
Total $ 11,748us-gaap_OperatingLeasesFutureMinimumPaymentsDue
XML 29 R89.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 13 - Commitments and Contingencies (Details) - Commitment Payment to Strategic Business Partners (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Commitment Payment to Strategic Business Partners [Abstract]  
2015 $ 12,916us-gaap_ContractualObligationDueInNextTwelveMonths
2016 3,250us-gaap_ContractualObligationDueInSecondYear
2017 3,202us-gaap_ContractualObligationDueInThirdYear
2018 21us-gaap_ContractualObligationDueInFourthYear
Total $ 19,389us-gaap_ContractualObligation
XML 30 R57.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Summary of Adjustments to Gross Sales (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Summary of Adjustments to Gross Sales [Abstract]      
Gross sales $ 1,442,537us-gaap_SalesRevenueGoodsGross $ 528,574us-gaap_SalesRevenueGoodsGross $ 386,582us-gaap_SalesRevenueGoodsGross
Less adjustments for:      
Chargebacks and rebates (739,760)akrx_ChargebackAndRebateExpense (183,403)akrx_ChargebackAndRebateExpense (112,244)akrx_ChargebackAndRebateExpense
Product returns (20,006)us-gaap_SalesReturnsGoods (5,001)us-gaap_SalesReturnsGoods (3,783)us-gaap_SalesReturnsGoods
Discounts and allowances (31,178)us-gaap_SalesDiscountsReturnsAndAllowancesGoods (8,464)us-gaap_SalesDiscountsReturnsAndAllowancesGoods (6,074)us-gaap_SalesDiscountsReturnsAndAllowancesGoods
Administrative fees (50,786)us-gaap_AdministrativeFeesExpense (9,471)us-gaap_AdministrativeFeesExpense (5,293)us-gaap_AdministrativeFeesExpense
Advertising, promotions, and other (7,729)us-gaap_MarketingAndAdvertisingExpense (4,524)us-gaap_MarketingAndAdvertisingExpense (3,030)us-gaap_MarketingAndAdvertisingExpense
Revenues, net $ 593,078us-gaap_SalesRevenueGoodsNet $ 317,711us-gaap_SalesRevenueGoodsNet $ 256,158us-gaap_SalesRevenueGoodsNet
XML 31 R109.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 22 - Legal Proceedings (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]  
Number of US Patents Licensed 5akrx_NumberOfUSPatentsLicensed
Loss Contingency, Damages Sought, Value $ 5.2us-gaap_LossContingencyDamagesSoughtValue
XML 32 R76.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Stock Option Activity (2014 and 2003 Stock Option Plan [Member], USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
2014 and 2003 Stock Option Plan [Member]
      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Stock Option Activity [Line Items]      
Number of Options 9,228,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 9,727,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 9,399,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Weighted Average Exercise Price $ 4.45us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 4.22us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 2.89us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Weighted Average Remaining Contractual Term (Years) 2 years 175 days    
Aggregate Intrinsic Value (in thousands) $ 158,097us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		    
Exercisable at December 31, 2014 4,316,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		    
Exercisable at December 31, 2014 $ 5.43us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		    
Exercisable at December 31, 2014 1 year 3 days    
Exercisable at December 31, 2014 $ 132,813us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		    
Number of Options 1,475,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 321,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 1,221,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Weighted Average Exercise Price $ 28.59us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 15.76us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 12.96us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Number of Options (4,226,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 (630,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 (806,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Weighted Average Exercise Price $ 1.91us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 4.18us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 1.87us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Number of Options (91,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 (190,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 (87,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Weighted Average Exercise Price $ 22.56us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 13.10us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 4.42us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Number of Options 6,386,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 9,228,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 9,727,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
Weighted Average Exercise Price $ 11.44us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 4.45us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member		 $ 4.22us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= akrx_StockOptionPlan2014And2003Member
XML 33 R86.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 12 - Segment Information (Details) - Financial Information by Segment (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Jun. 30, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
REVENUES                          
Revenues $ 227,828us-gaap_SalesRevenueNet $ 132,732us-gaap_SalesRevenueNet $ 141,896us-gaap_SalesRevenueNet $ 90,622us-gaap_SalesRevenueNet $ 84,953us-gaap_SalesRevenueNet $ 81,892us-gaap_SalesRevenueNet $ 77,012us-gaap_SalesRevenueNet $ 73,854us-gaap_SalesRevenueNet $ 232,518us-gaap_SalesRevenueNet $ 365,250us-gaap_SalesRevenueNet $ 593,078us-gaap_SalesRevenueNet $ 317,711us-gaap_SalesRevenueNet $ 256,158us-gaap_SalesRevenueNet
GROSS PROFIT                          
Gross Profit 128,382us-gaap_GrossProfit 51,734us-gaap_GrossProfit 67,818us-gaap_GrossProfit 49,656us-gaap_GrossProfit 46,970us-gaap_GrossProfit 43,697us-gaap_GrossProfit 42,092us-gaap_GrossProfit 39,145us-gaap_GrossProfit 117,474us-gaap_GrossProfit 169,208us-gaap_GrossProfit 297,590us-gaap_GrossProfit 171,904us-gaap_GrossProfit 148,692us-gaap_GrossProfit
Prescription Pharmaceuticals [Member]                          
REVENUES                          
Revenues                     542,846us-gaap_SalesRevenueNet
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		 279,911us-gaap_SalesRevenueNet
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		 223,881us-gaap_SalesRevenueNet
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember
GROSS PROFIT                          
Gross Profit                     270,197us-gaap_GrossProfit
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		 151,182us-gaap_GrossProfit
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		 129,884us-gaap_GrossProfit
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember
Consumer Health [Member]                          
REVENUES                          
Revenues                     50,232us-gaap_SalesRevenueNet
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember		 37,800us-gaap_SalesRevenueNet
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember		 32,277us-gaap_SalesRevenueNet
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember
GROSS PROFIT                          
Gross Profit                     $ 27,393us-gaap_GrossProfit
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember		 $ 20,722us-gaap_GrossProfit
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember		 $ 18,808us-gaap_GrossProfit
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember
XML 34 R81.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Income Taxes (Details) - The Geographical Allocation of the Company’s Income (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2012
Dec. 31, 2011
The Geographical Allocation of the Company’s Income [Abstract]      
Pre-tax income from continuing U.S. operations $ 67,114us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic $ 86,382us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic $ 66,087us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
Pre-tax loss from continuing foreign operations (7,978)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign (3,487)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign (8,587)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
Total pre-tax income from continuing operations $ 59,136us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments $ 82,895us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments $ 57,500us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
XML 35 R87.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 12 - Segment Information (Details) - Carrying Amount of Goodwill by Segment (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Sep. 30, 2014
Jun. 30, 2014
Dec. 31, 2012
Note 12 - Segment Information (Details) - Carrying Amount of Goodwill by Segment [Line Items]          
Balance $ 29,831us-gaap_Goodwill $ 32,159us-gaap_Goodwill $ 285,080us-gaap_Goodwill $ 190,448us-gaap_Goodwill  
Acquisitions 260,911us-gaap_GoodwillAcquiredDuringPeriod        
Dispositions (11,454)us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit        
Foreign currency (514)us-gaap_GoodwillTranslationAdjustments (2,328)us-gaap_GoodwillTranslationAdjustments      
Balance 278,774us-gaap_Goodwill 29,831us-gaap_Goodwill 285,080us-gaap_Goodwill 190,448us-gaap_Goodwill  
Prescription Pharmaceuticals [Member]          
Note 12 - Segment Information (Details) - Carrying Amount of Goodwill by Segment [Line Items]          
Balance 17,968us-gaap_Goodwill
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		 20,296us-gaap_Goodwill
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		      
Acquisitions 256,057us-gaap_GoodwillAcquiredDuringPeriod
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		        
Dispositions (11,454)us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		        
Foreign currency (514)us-gaap_GoodwillTranslationAdjustments
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		 (2,328)us-gaap_GoodwillTranslationAdjustments
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		      
Balance 262,057us-gaap_Goodwill
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		 17,968us-gaap_Goodwill
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_PrescriptionPharmaceuticalsMember		      
Consumer Health [Member]          
Note 12 - Segment Information (Details) - Carrying Amount of Goodwill by Segment [Line Items]          
Balance 11,863us-gaap_Goodwill
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember		       11,863us-gaap_Goodwill
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember
Acquisitions 4,854us-gaap_GoodwillAcquiredDuringPeriod
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember		        
Balance $ 16,717us-gaap_Goodwill
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember		       $ 11,863us-gaap_Goodwill
/ us-gaap_StatementBusinessSegmentsAxis
= akrx_ConusmerHealthMember
XML 36 R77.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Non-vested Restricted Stock Activity (Restricted Stock [Member], USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Restricted Stock [Member]
      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Non-vested Restricted Stock Activity [Line Items]      
Nonvested at December 31, 2011 16,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 18,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 13,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
Nonvested at December 31, 2011 $ 15.36us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 $ 14.63us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 $ 1.34us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
Non-vested, Number of Shares 337,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 32,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 35,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
Non-vested, Weighted Average Grant Date Fair Value $ 35.31us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 $ 15.36us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 $ 14.63us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
Non-vested, Number of Shares (16,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 (34,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 (30,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
Non-vested, Weighted Average Grant Date Fair Value $ 15.36us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 $ 14.98us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 $ 9.09us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
Non-vested, Number of Shares 337,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 16,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 18,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
Non-vested, Weighted Average Grant Date Fair Value $ 35.31us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 $ 15.36us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 $ 14.63us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
XML 37 R71.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 7 - Earnings Per Common Share (Details) - Reconciliation of Earnings Per Share Data (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Jun. 30, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Reconciliation of Earnings Per Share Data [Abstract]                          
Income from continuing operations used for basic earnings per share (in Dollars) $ 34,232us-gaap_IncomeLossFromContinuingOperations $ (11,650)us-gaap_IncomeLossFromContinuingOperations $ 3,438us-gaap_IncomeLossFromContinuingOperations $ 9,828us-gaap_IncomeLossFromContinuingOperations $ 16,678us-gaap_IncomeLossFromContinuingOperations $ 12,205us-gaap_IncomeLossFromContinuingOperations $ 12,637us-gaap_IncomeLossFromContinuingOperations $ 10,842us-gaap_IncomeLossFromContinuingOperations $ 13,266us-gaap_IncomeLossFromContinuingOperations $ 1,616us-gaap_IncomeLossFromContinuingOperations $ 35,848us-gaap_IncomeLossFromContinuingOperations $ 52,362us-gaap_IncomeLossFromContinuingOperations $ 35,378us-gaap_IncomeLossFromContinuingOperations
Convertible debt income adjustments, net of tax (in Dollars)                     5,825us-gaap_InterestOnConvertibleDebtNetOfTax    
Income from continuing operations adjusted for convertible debt as used for diluted earnings per share (in Dollars)                     41,673us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted 52,362us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted 35,378us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted
Income from continuing operations per share:                          
Basic (in Dollars per share) $ 0.32us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ (0.11)us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.03us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.10us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.17us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.02us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.35us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.54us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.37us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
Diluted (1) (in Dollars per share) $ 0.29us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ (0.11)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.03us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.08us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.14us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.10us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.01us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.34us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1] $ 0.46us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1] $ 0.32us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1]
Loss from discontinued operations, net of tax (in Dollars)                     $ (503)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity    
Loss from discontinued operations, net of tax per share:                          
Basic (in Dollars per share)                     $ (0.01)us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare    
Diluted (in Dollars per share)                     $ (0.01)us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare    
Weighted average basic shares outstanding                     103,480us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 96,181us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 95,189us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Dilutive securities:                          
Stock options and unvested RSAs                     4,234us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements 4,516us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements 4,289us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
Stock warrants                     1,874us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants 6,702us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants 6,564us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants
Shares issuable on conversion of the Notes (2)                     13,522us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities [2] 6,499us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities [2] 4,468us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities [2]
Total dilutive securities                     19,630us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment 17,717us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment 15,321us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment
Weighted average diluted shares outstanding                     123,110us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 113,898us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 110,510us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
[1] Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $5.8 million, after-taxfor the year ended December 31, 2014.
[2] Shares issuable on conversion of the Notes for the year ended December 31, 2014 have increased in comparison to the fiscal years ended December 31, 2013 and 2012 due to stock appreciation which underlies the shares issuable on conversion of the notes and the Company's change in practice on October 1, 2014 to more likely than not settle future note conversions solely through shares as we are now utilizing the if-converted method for convertible debt conversion obligations.
XML 38 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 18 - Customer, Supplier and Product Concentration
 12 Months Ended
Dec. 31, 2014
Risks and Uncertainties [Abstract]  
Concentration Risk Disclosure [Text Block]
Note 18 — Customer, Supplier and Product Concentration

Customer Concentration

In 2014, 2013 and 2012, a significant portion of the Company’s gross and net sales reported were through three large wholesale drug distributors, and a significant portion of  the Company’s accounts receivable as of December 31, 2014, 2013 and 2012 were due from these wholesale drug distributors as well. AmerisourceBergen Health Corporation (“Amerisource”), Cardinal Health, Inc. (“Cardinal”) and McKesson Drug Company (“McKesson”) are all distributors of the Company’s products, as well as suppliers of a broad range of health care products.  Aside from these three wholesale drug distributors, no other customers accounted for more than 10% of gross sales, net revenues or gross trade receivables for the indicated dates and periods.

The following table sets forth the percentage of the Company’s gross and net sales and gross accounts receivable attributable to these three distributors for the periods indicated:

   
2014
   
2013
   
2012
 
 
 
 
 
 
Gross
Sales
   
 
Net
Revenue
   
Gross
 Accounts
Receivable
   
 
Gross
Sales
   
 
Net
Revenue
   
Gross
 Accounts
Receivable
   
 
Gross
Sales
   
 
Net
Revenue
   
Gross
 Accounts
Receivable
 
Amerisource
    38 %     28 %     46 %     19 %     14 %     25 %     19 %     14 %     29 %
Cardinal
    16 %     14 %     17 %     23 %     16 %     26 %     23 %     17 %     30 %
McKesson
    23 %     19 %     23 %     16 %     11 %     12 %     16 %     11 %     14 %
Total
    77 %     61 %     86 %     58 %     41 %     63 %     58 %     42 %     73 %

If sales to Amerisource, Cardinal or McKesson were to diminish or cease, the Company believes that the end users of its products would find little difficulty obtaining the Company’s products either directly from the Company or from another distributor.

Supplier Concentration

The Company requires a supply of quality raw materials and components to manufacture and package pharmaceutical products for its own use and for third parties with which it has contracted. The principal components of the Company’s products are active and inactive pharmaceutical ingredients and certain packaging materials. Many of these components are available from only a single source and, in the case of many of the Company’s ANDAs and NDAs, only one supplier of raw materials has been identified. Because FDA approval of drugs requires manufacturers to specify their proposed suppliers of active ingredients and certain packaging materials in their applications, FDA approval of any new supplier would be required if active ingredients or such packaging materials were no longer available from the specified supplier. The qualification of a new supplier could delay the Company’s development and marketing efforts. If for any reason the Company is unable to obtain sufficient quantities of any of the raw materials or components required to produce and package its products, it may not be able to manufacture its products as planned, which could have a material adverse effect on the Company’s business, financial condition and results of operations.

No individual supplier represented 10% or more of the Company’s purchases in any of the years ended December 31, 2014, 2013 or 2012.

Product Concentration

During the year ended December 31, 2014 none of the Company’s products represented 10% or more of net revenue, while in the years ended December 31, 2013 and 2012, one of the Company’s prescription pharmaceutical products represented 11.8% and 12.5% of the Company’s total net revenue, respectively while no other products represented 10% or more of the Company’s net revenue.  The Company attempts to minimize the risk associated with product concentrations by continuing to acquire and develop new products to add to its portfolio.

XML 39 R50.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets [Line Items]      
Amortization $ 44,066us-gaap_AmortizationOfIntangibleAssets $ 7,422us-gaap_AmortizationOfIntangibleAssets $ 6,870us-gaap_AmortizationOfIntangibleAssets
Dispositions (11,454)us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit    
Finite Lived 963,359us-gaap_FiniteLivedIntangibleAssetsNet    
Intellectual Property and Research and Development [Member]      
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets [Line Items]      
Indefinite Lived 230,788us-gaap_IndefinitelivedIntangibleAssetsAcquired
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IntellectualPropertyandResearchandDevelopmentMember		    
Indefinite Lived 230,788us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IntellectualPropertyandResearchandDevelopmentMember		    
Product Licensing Rights [Member]      
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets [Line Items]      
Finite Lived 115,900us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		 63,654us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		  
Finite Lived 668,457us-gaap_FinitelivedIntangibleAssetsAcquired1
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		 57,969us-gaap_FinitelivedIntangibleAssetsAcquired1
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		  
Amortization (39,761)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		 (5,723)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		  
Dispositions (40,378)us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		    
Finite Lived 704,218us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		 115,900us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		  
Trademarks [Member]      
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets [Line Items]      
Finite Lived 8,656us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		 8,972us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		  
Finite Lived 6,500us-gaap_FinitelivedIntangibleAssetsAcquired1
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		    
Amortization (877)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		 (316)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		  
Finite Lived 14,279us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		 8,656us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		  
Customer Relationships [Member]      
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets [Line Items]      
Finite Lived 4,638us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		 5,588us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		  
Finite Lived 300us-gaap_FinitelivedIntangibleAssetsAcquired1
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		    
Amortization (1,934)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		 (740)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		  
Foreign Currency Translation 31us-gaap_FiniteLivedIntangibleAssetsTranslationAdjustments
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		 (210)us-gaap_FiniteLivedIntangibleAssetsTranslationAdjustments
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		  
Finite Lived 3,035us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		 4,638us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		  
Other Intangible Assets [Member]      
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets [Line Items]      
Finite Lived 11,234us-gaap_FinitelivedIntangibleAssetsAcquired1
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Amortization (879)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Finite Lived 10,355us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Noncompete Agreements [Member]      
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets [Line Items]      
Finite Lived 1,311us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		 2,171us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		  
Amortization (615)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		 (643)us-gaap_AmortizationOfIntangibleAssets
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		  
Foreign Currency Translation (12)us-gaap_FiniteLivedIntangibleAssetsTranslationAdjustments
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		 (217)us-gaap_FiniteLivedIntangibleAssetsTranslationAdjustments
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		  
Finite Lived $ 684us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		 $ 1,311us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		  
XML 40 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 14 - Supplemental Cash Flow Information (in thousands) (Tables)
 12 Months Ended
Dec. 31, 2014
Supplemental Cash Flow Elements [Abstract]  
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]
   
Year ended December 31,
 
   
2014
   
2013
   
2012
 
Interest and taxes paid:
                 
   Interest paid
   
31,413
      4,320       4,200  
   Income taxes paid
    6,294       27,450       21,455  
XML 41 R75.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Weighted-average Assumptions for Stock Options (2003 Stock Option Plan [Member], USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Weighted-average Assumptions for Stock Options [Line Items]      
Expected volatility       
Expected life (in years) 5 years 146 days 4 years 4 years
Risk-free interest rate       
Dividend yield 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate 0.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Fair value per stock option (in Dollars per share) 16.08us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue 6.95us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue 7.76us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Minimum [Member]
      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Weighted-average Assumptions for Stock Options [Line Items]      
Expected volatility 46.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		 49.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		 77.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
Risk-free interest rate 0.90%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		 0.70%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		 0.70%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
Maximum [Member]
      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Weighted-average Assumptions for Stock Options [Line Items]      
Expected volatility 71.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		 68.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		 85.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
Risk-free interest rate 2.20%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		 1.40%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		 0.80%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
/ us-gaap_AwardTypeAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
XML 42 R97.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities (USD $)
 12 Months Ended 0 Months Ended 3 Months Ended
Dec. 31, 2013
Nov. 15, 2013
Dec. 31, 2013
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities [Line Items]      
Gain from bargain purchase $ 3,707,000us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount    
AzaSite [Member] | Merck Acquisition [Member]      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities [Line Items]      
Product rights 13,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
/ us-gaap_ProductOrServiceAxis
= akrx_AzaSiteMember		   13,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
/ us-gaap_ProductOrServiceAxis
= akrx_AzaSiteMember
Cosopt [Member] | Merck Acquisition [Member]      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities [Line Items]      
Product rights 21,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
/ us-gaap_ProductOrServiceAxis
= akrx_CosoptMember		   21,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
/ us-gaap_ProductOrServiceAxis
= akrx_CosoptMember
Cosopt PF [Member] | Merck Acquisition [Member]      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities [Line Items]      
Product rights 20,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
/ us-gaap_ProductOrServiceAxis
= akrx_CosoptPFMember		   20,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
/ us-gaap_ProductOrServiceAxis
= akrx_CosoptPFMember
Merck Acquisition [Member]      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities [Line Items]      
Product rights 55,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember		   55,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
Prepaid expenses 100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember		   100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
Deferred tax assets, net 700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember		   700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
Total fair value of acquired assets 56,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember		   56,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
Consideration paid   52,800,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember		 52,800,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
Gain from bargain purchase     $ 3,700,000us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
XML 43 R37.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 8 - Leasing Arrangements (Tables)
 12 Months Ended
Dec. 31, 2014
Leases [Abstract]  
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Year ending December 31,
     
2015
  $
2,569
 
2016
   
2,532
 
2017
   
2,230
 
2018
   
769
 
2019
    466  
2020 and thereafter
   
3,182
 
Total
  $
11,748
 
XML 44 R52.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment
 12 Months Ended
Dec. 31, 2014
Building [Member]  
Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment [Line Items]  
Depreciable life 30 years
Leasehold Improvements [Member]  
Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment [Line Items]  
Depreciable life 20 years
Furniture and Fixtures [Member]  
Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment [Line Items]  
Depreciable life 7 years
Automobiles [Member]  
Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment [Line Items]  
Depreciable life 5 years
Computer Equipment [Member]  
Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment [Line Items]  
Depreciable life 5 years
XML 45 R67.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes [Line Items]      
Deferred financing cost amortization $ 12,129us-gaap_AmortizationOfFinancingCosts $ 842us-gaap_AmortizationOfFinancingCosts $ 782us-gaap_AmortizationOfFinancingCosts
Convertible Debt [Member]      
Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes [Line Items]      
Interest expense at 3.50% coupon rate 4,105us-gaap_InterestExpenseDebtExcludingAmortization
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 4,200us-gaap_InterestExpenseDebtExcludingAmortization
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 4,200us-gaap_InterestExpenseDebtExcludingAmortization
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
Debt discount amortization 4,317us-gaap_AmortizationOfDebtDiscountPremium
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 4,113us-gaap_AmortizationOfDebtDiscountPremium
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 3,828us-gaap_AmortizationOfDebtDiscountPremium
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
Deferred financing cost amortization 780us-gaap_AmortizationOfFinancingCosts
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 744us-gaap_AmortizationOfFinancingCosts
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 692us-gaap_AmortizationOfFinancingCosts
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
Loss on conversion 990akrx_OtherExpenseOnConversion
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		    
$ 10,192us-gaap_InterestExpenseDebt
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 $ 9,057us-gaap_InterestExpenseDebt
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 $ 8,720us-gaap_InterestExpenseDebt
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
XML 46 R61.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 5 - Property, Plant and Equipment (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Note 5 - Property, Plant and Equipment (Details) [Line Items]    
Property, Plant and Equipment, Net $ 143,788us-gaap_PropertyPlantAndEquipmentNet $ 82,108us-gaap_PropertyPlantAndEquipmentNet
Outside the United States [Member]    
Note 5 - Property, Plant and Equipment (Details) [Line Items]    
Property, Plant and Equipment, Net $ 25,600us-gaap_PropertyPlantAndEquipmentNet
/ us-gaap_StatementGeographicalAxis
= akrx_OutsidetheUnitedStatesMember		 $ 21,100us-gaap_PropertyPlantAndEquipmentNet
/ us-gaap_StatementGeographicalAxis
= akrx_OutsidetheUnitedStatesMember
XML 47 R47.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) (USD $)
 12 Months Ended 0 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Apr. 10, 2014
Dec. 22, 2011
Jun. 28, 2010
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 50.00%us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners          
Restricted Cash and Investments, Noncurrent $ 2,900,000us-gaap_RestrictedCashAndInvestmentsNoncurrent $ 2,700,000us-gaap_RestrictedCashAndInvestmentsNoncurrent        
Past Due Gross Accounts Receivable 62,400,000akrx_PastDueGrossAccountsReceivable          
Sixty Days Past Due Gross Accounts Receivable 3,700,000akrx_SixtyDaysPastDueGrossAccountsReceivable          
Inventory Write-down 12,300,000us-gaap_InventoryWriteDown 2,100,000us-gaap_InventoryWriteDown 2,400,000us-gaap_InventoryWriteDown      
Inventory Valuation Reserves 21,179,000us-gaap_InventoryValuationReserves 5,700,000us-gaap_InventoryValuationReserves 6,819,000us-gaap_InventoryValuationReserves      
Research and Development Reserve 1,900,000akrx_ResearchAndDevelopmentReserve 1,000,000akrx_ResearchAndDevelopmentReserve        
Finite-Lived Intangible Assets, Accumulated Amortization 82,233,000us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization 39,100,000us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization        
Amortization of Intangible Assets 44,066,000us-gaap_AmortizationOfIntangibleAssets 7,422,000us-gaap_AmortizationOfIntangibleAssets 6,870,000us-gaap_AmortizationOfIntangibleAssets      
Depreciation 14,500,000us-gaap_Depreciation 7,100,000us-gaap_Depreciation 4,600,000us-gaap_Depreciation      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) 735,000us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 975,000us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 581,000us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount      
Available-for-sale Securities 8,391,000us-gaap_AvailableForSaleSecurities          
Unrealized Gain (Loss) on Securities 1,700,000us-gaap_UnrealizedGainLossOnSecurities          
Available for Sale Securities Sold 600,000akrx_AvailableforSaleSecuritiesSold          
Unrealized Loss on Securities 1,800,000us-gaap_UnrealizedLossOnSecurities          
Number of Non Deliverable Forward Contracts 3akrx_NumberOfNonDeliverableForwardContracts          
Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 700,000us-gaap_GainLossOnForeignCurrencyFairValueHedgeDerivatives          
Fair Value of Warrants Original Value           17,900,000akrx_FairValueOfWarrantsOriginalValue
Fair Value of Warrants Using Black-Scholes Valuation Model Minimum (in Shares)           2.49akrx_FairValueOfWarrantsUsingBlackScholesValuationModelMinimum
Fair Value of Warrants Using Black-Scholes Valuation Model Maximum (in Dollars per share)           $ 2.50akrx_FairValueOfWarrantsUsingBlackScholesValuationModelMaximum
Interest Expense [Member] | Fair Value, Inputs, Level 3 [Member] | Santen [Member]            
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Interest Expense 300,000us-gaap_InterestExpense
/ us-gaap_BusinessAcquisitionAxis
= akrx_SantenMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_InterestExpenseMember		          
Kapoor Warrants [Member]            
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Warrants Excercised for Cash       7,200,000akrx_WarrantsExcercisedforCash
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_KapoorWarrantsMember		    
Proceeds from Warrant Exercises       8,200,000us-gaap_ProceedsFromWarrantExercises
/ us-gaap_ClassOfWarrantOrRightAxis
= akrx_KapoorWarrantsMember		    
Initial Value [Member]            
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Available-for-sale Securities 12,500,000us-gaap_AvailableForSaleSecurities
/ invest_InvestmentAxis
= akrx_InitialValueMember		          
Fair Value, Inputs, Level 3 [Member] | Santen [Member]            
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Business Combination, Original Additional Consideration Owed 4,300,000akrx_BusinessCombinationAdditionalConsiderationOwed
/ us-gaap_BusinessAcquisitionAxis
= akrx_SantenMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member		          
Santen [Member]            
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Business Combination, Original Additional Consideration Owed 4,500,000akrx_BusinessCombinationAdditionalConsiderationOwed
/ us-gaap_BusinessAcquisitionAxis
= akrx_SantenMember		          
Contingent Consideration Original Obligation of Purchase Consideration 4,000,000akrx_ContingentConsiderationOriginalObligationOfPurchaseConsideration
/ us-gaap_BusinessAcquisitionAxis
= akrx_SantenMember		          
Fair Value Inputs, Discount Rate 12.60%us-gaap_FairValueInputsDiscountRate
/ us-gaap_BusinessAcquisitionAxis
= akrx_SantenMember		          
H Lundbeck AS [Member]            
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Business Combination, Original Additional Consideration Owed         15,000,000akrx_BusinessCombinationAdditionalConsiderationOwed
/ us-gaap_BusinessAcquisitionAxis
= akrx_HLundbeckASMember		  
Fair Value Inputs, Discount Rate         9.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_BusinessAcquisitionAxis
= akrx_HLundbeckASMember		  
Original Recorded Value of Purchase Consideration         11,300,000akrx_OriginalRecordedValueOfPurchaseConsideration
/ us-gaap_BusinessAcquisitionAxis
= akrx_HLundbeckASMember		  
Original Discount Rate Used         10.00%akrx_OriginalDiscountRateUsed
/ us-gaap_BusinessAcquisitionAxis
= akrx_HLundbeckASMember		  
Correction of Opening Balance Related to Long Term Obligation   14,700,000akrx_CorrectionOfOpeningBalanceRelatedToLongTermObligation
/ us-gaap_BusinessAcquisitionAxis
= akrx_HLundbeckASMember		     11,600,000akrx_CorrectionOfOpeningBalanceRelatedToLongTermObligation
/ us-gaap_BusinessAcquisitionAxis
= akrx_HLundbeckASMember		  
Business Acquistion Revised Discount Rate   1.85%akrx_BusinessAcquistionRevisedDiscountRate
/ us-gaap_BusinessAcquisitionAxis
= akrx_HLundbeckASMember		        
Business Combination, Consideration Transferred $ 15,000,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_HLundbeckASMember		          
Minimum [Member]            
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Finite-Lived Intangible Asset, Useful Life 1 year          
Maximum [Member]            
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]            
Finite-Lived Intangible Asset, Useful Life 30 years          
XML 48 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2014
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
Note 2 — Summary of Significant Accounting Policies

Consolidation: The accompanying consolidated financial statements include the accounts of Akorn, Inc. and its wholly owned domestic and foreign subsidiaries.  All inter-company transactions and balances have been eliminated in consolidation, and the financial statements of Akorn India Private Limited (“AIPL”) have been translated from Indian rupees to U.S. dollars based on the currency translation rates in effect during the period or as of the date of consolidation, as applicable.  The Company has no involvement with variable interest entities.

As of the year ended December 31, 2014 the Company was a 50% owner of a dormant joint venture, Akorn-Strides, LLC (the “Joint Venture Company”) (See Note 17 – Unconsolidated Joint Venture.).  The Company and its strategic partner each had equal voting rights and shared operational control.  Accordingly, the Company accounted for its investment in the Joint Venture Company using the equity method of accounting.  The Company’s proportionate share of the Joint Venture Company’s income had been recorded under the caption “Equity in earnings of unconsolidated joint venture” in the Company’s consolidated statements of operations.  The Joint Venture Company sold all of its abbreviated new drug application (“ANDA”) rights to Pfizer, Inc. in December 2010 and ceased operations during 2011.

Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Significant estimates and assumptions for the Company relate to the allowances for chargebacks, rebates, product returns, coupons, promotions and doubtful accounts, as well as the reserve for slow-moving and obsolete inventories, the carrying value and lives of intangible assets, the useful lives of fixed assets, the carrying value of deferred income tax assets and liabilities, the assumptions underlying share-based compensation, accrued but unreported employee benefit costs and assumptions underlying the accounting for business combinations.

Revenue Recognition: Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. Revenues from product sales are recognized when title and risk of loss have passed to the customer.

Provision for estimated chargebacks, rebates, discounts, managed care rebates, product returns and doubtful accounts is made at the time of sale and is analyzed and adjusted, if necessary, at each balance sheet date.

Freight:  The Company records amounts billed to customers for shipping and handling as revenue, and records shipping and handling expense related to product sales as cost of sales.

Cash and Cash Equivalents: The Company considers all unrestricted, highly liquid investments with maturity of three months or less when purchased to be cash and cash equivalents.  At December 31, 2014 and 2013, approximately $2.9 million and $2.7 million of cash held by our India operations as of those dates was restricted, and was reported within prepaid expenses and other current assets and other non-current assets, respectively.

Accounts Receivable: Trade accounts receivables are stated at their net realizable value.  The nature of the Company’s business involves, in the ordinary course, significant judgments and estimates relating to chargebacks, coupon redemption, product returns, rebates, discounts given to customers and allowances for doubtful accounts.  Depending on the products, the end-user customers, the specific terms of national supply contracts and the particular arrangements with the Company’s wholesaler customers, certain rebates, chargebacks and other credits are recorded as deductions to the Company’s trade accounts receivable.

Unless otherwise noted, the provisions and allowances for the following customer deductions are reflected in the accompanying consolidated financial statements as reductions of revenues and trade accounts receivable, respectively.

Chargebacks and Rebates: The Company enters into contractual agreements with certain third parties such as hospitals, group-purchasing and managed care organizations to sell certain products at predetermined prices. The parties have elected to have these contracts administered through wholesalers that buy the product from the Company and subsequently sell it to these third parties. When a wholesaler sells products to one of these third parties that are subject to a contractual price agreement, the difference between the price paid to the Company by the wholesaler and the price under the specific contract is charged back to the Company by the wholesaler. The Company tracks sales and submitted chargebacks by product number and contract for each wholesaler. Utilizing this information, the Company estimates a chargeback percentage for each product and records an allowance as a reduction to gross sales when the Company records its sale of the products. The Company reduces the chargeback allowance when a chargeback request from a wholesaler is processed. Actual chargebacks processed by the Company can vary materially from period to period based upon actual sales volume through the wholesalers. However, the Company’s provision for chargebacks is fully reserved for at the time when sales revenues are recognized.

Management obtains certain wholesaler inventory reports to aid in analyzing the reasonableness of the chargeback allowance. The Company assesses the reasonableness of its chargeback allowance by applying the product chargeback percentage based on historical activity to the quantities of inventory on hand at the wholesaler per the wholesaler inventory reports. In accordance with its accounting policy, the Company estimates the percentage amount of wholesaler inventory that will ultimately be sold to third parties that are subject to contractual price agreements based on a trend of such sales through wholesalers. The Company uses this percentage estimate until historical trends indicate that a revision should be made. On an ongoing basis, the Company evaluates its actual chargeback rate experience, and new trends are factored into its estimates each quarter as market conditions change.

Similarly, the Company maintains an allowance for rebates related to contract and other programs with certain customers. Rebate percentages vary by product and by volume purchased by each eligible customer. The Company tracks sales by product number for each eligible customer and then applies the applicable rebate percentage, using both historical trends and actual experience to estimate its rebate allowance. The Company reduces gross sales and increases the rebate allowance by the estimated rebate amount when the Company sells its products to its rebate-eligible customers. The Company reduces the rebate allowance when it processes a customer request for a rebate. At each balance sheet date, the Company analyzes the allowance for rebates against actual rebates processed and makes necessary adjustments as appropriate. Actual rebates processed can vary materially from period to period.

Sales Returns: Certain of the Company’s products are sold with the customer having the right to return the product within specified periods and guidelines for a variety of reasons, including but not limited to, pending expiration dates. Provisions are made at the time of sale based upon tracked historical experience. Historical factors such as one-time events as well as pending new developments that would impact the expected level of returns are taken into account to determine the appropriate reserve estimate at each balance sheet date. As part of the evaluation of the balance required, the Company considers actual returns to date that are in process, the expected impact of any product recalls and the wholesaler’s inventory information to assess the magnitude of unconsumed product that may result in sales returns to the Company in the future. The sales returns level can be impacted by factors such as overall market demand and market competition and availability for substitute products which can increase or decrease the end-user pull through for sales of the Company’s products and ultimately impact the level of sales returns. Actual returns experience and trends are factored into the Company’s estimates each quarter as market conditions change. Actual returns processed can vary materially from period to period.

Allowance for Coupons, Promotions and Co-Pay discount cards: The Company issues coupons from time to time that are redeemable against certain of our Consumer Health products. Upon release of coupons into the market, the Company records an estimate of the dollar value of coupons expected to be redeemed. This estimate is based on historical experience and is adjusted as needed based on actual redemptions. In addition to couponing, from time to time the Company authorizes various retailers to run in-store promotional sales of its products. Upon receiving confirmation that a promotion was run, the Company accrues an estimate of the dollar amount expected to be owed back to the retailer. This estimate is trued up to actual upon receipt of the invoice from the retailer. Additionally, the Company provides consumer co-pay discount cards, administered through outside agents to provide discounted products when redeemed. Upon release of the cards into the market, the Company records an estimate of the dollar value of co-pay discounts expected to be utilized. This estimate is based on historical experience and is adjusted as needed based on actual usage.

Doubtful Accounts: Provisions for doubtful accounts, which reflect trade receivable balances owed to the Company that are believed to be uncollectible, are recorded as a component of SG&A expenses. In estimating the allowance for doubtful accounts, the Company considers its historical experience with collections and write-offs, the credit quality of its customers and any recent or anticipated changes thereto, and the outstanding balances and past due amounts from its customers.  Accounts are considered past due when they remain uncollected beyond the due date specified in the applicable contract or on the applicable invoice, whichever is deemed to take precedence.

As of December 31, 2014, the Company had a total of $62.4 million of past due gross accounts receivable, of which $3.7 million was more than 60 days past due. The Company performs monthly a detailed analysis of the receivables due from its wholesaler customers and provides a specific reserve against known uncollectible items. The Company also includes in the allowance for doubtful accounts an amount that it estimates to be uncollectible for all other customers, based on a percentage of the past due receivables. The percentage reserved increases as the age of the receivables increases.  Accounts are written off once all reasonable collections efforts have been exhausted and/or when facts or circumstances regarding the customer (i.e. bankruptcy filing) indicate that the chance of collection is remote.

Advertising and Promotional Allowances to Customers: The Company routinely sells its consumer health products to major retail drug chains. From time to time, the Company may arrange for these retailers to run in-store promotional sales of the Company’s products. The Company reserves an estimate of the dollar amount owed back to the retailer, recording this amount as a reduction to revenue at the later of the date on which the revenue is recognized or the date the sales incentive is offered. When the actual invoice for the sales promotion is received from the retailer, the Company adjusts its estimate accordingly. Advertising and promotional expenses paid to customers are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 605-50, Customer Payments and Incentives.

Inventories: Inventories are stated at the lower of cost (average cost method) or market (see Note 4 — “Inventories”). The Company maintains an allowance for slow-moving and obsolete inventory as well as inventory where the cost is in excess of its net realizable value (“NRV”). For finished goods inventory, the Company estimates the amount of inventory that may not be sold prior to its expiration or is slow moving based upon recent sales activity by unit and wholesaler inventory information. The Company also analyzes its raw material and component inventory for slow moving items/NRV. For the years ended December 31, 2014, 2013 and 2012, the Company recorded a provision for inventory obsolescence/NRV of $12.3 million, $2.1 million, and $2.4 million, respectively. The allowances for inventory obsolescence were $21.2 million and $5.7 million as of December 31, 2014 and 2013, respectively.

The Company capitalizes inventory costs associated with its products prior to regulatory approval when, based on management judgment, future commercialization is considered probable and future economic benefit is expected to be realized. The Company assesses the regulatory approval process and where the product stands in relation to that approval process including any known constraints or impediments to approval. The Company also considers the shelf life of the product in relation to the product timeline for approval.

At December 31, 2014, the Company established a reserve of $1.9 million related to R&D raw materials that are not expected to be utilized prior to expiration while at December 31, 2013, the Company had approximately $1.0 million in reserves for R&D raw materials. The entire balance of the R&D raw materials has been reserved, as the Company deemed it unlikely that the products would receive U.S. Food and Drug Administration (the “FDA”) approval far enough in advance of expiration to be sellable.

 Intangible Assets: Intangible assets consist primarily of goodwill, which is carried at its initial value, subject to evaluation for impairment, in-process research and development, which is accounted for as an indefinite-lived intangible asset, subject to impairment testing until completion or abandonment of the project, and product licensing costs, trademarks and other such costs, which are capitalized and amortized on a straight-line basis over their useful lives, ranging from one (1) year to thirty (30) years.  Accumulated amortization was $82.2 million and $39.1 million at December 31, 2014 and 2013, respectively.  Amortization expense was $44.1 million, $7.4 million and $6.9 million for the years ended December 31, 2014, 2013 and 2012, respectively. The Company regularly assesses its intangible assets for impairment based on several factors, including estimated fair value and anticipated cash flows.  If the Company incurs additional costs to renew or extend the life of an intangible asset, such costs are added to the remaining unamortized cost of the asset, if any, and the sum is amortized over the extended remaining life of the asset.

Goodwill is tested for impairment annually or more frequently if changes in circumstances or the occurrence of events suggest that impairment may exist. The Company uses widely accepted valuation techniques to determine the fair value of its reporting units used in its annual goodwill impairment analysis. The Company’s valuation is primarily based on qualitative and quantitative assessments regarding the fair value of the reporting unit relative to its carrying value. The Company modeled the fair value of the reporting unit based on projected earnings and cash flows of the reporting unit. The Company performed its annual impairment test on October 1, 2014 and determined that the fair value of its reporting units are substantially in excess of its carrying value and, therefore, no impairment charge was necessary.

Changes in goodwill during the two years ended December 31, 2014 were as follows (in thousands):

   
Goodwill
 
December 31, 2012
  $ 32,159  
Acquisitions
 
─
 
Impairments
 
─
 
Foreign currency translation
    (2,328 )
December 31, 2013
  $ 29,831  
Acquisitions
    260,911  
Impairments
 
─
 
Dispositions
    (11,454 )
Foreign currency translation
    (514 )
December 31, 2014
  $ 278,774  

The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2014 for those assets that are not already fully amortized (dollar amounts in thousands):

   
Gross
Carrying
Amount
   
Accumulated
Amortization
   
Net
Carrying
Amount
   
Weighted Average
Remaining Amortization Period (years)
 
Product licensing rights
  $ 778,734     $ (74,516 )   $ 704,218       12.4  
In-process research and development (“IPR&D”)
    230,788       —       230,788    
N/A – Indefinite lived
 
Trademarks
    16,000       (1,721 )     14,279       18.6  
Customer relationships
   
6,427
      (3,392 )     3,035       11.0  
Other intangibles
    11,234       (879 )     10,355       7.5  
Non-compete agreements
   
2,409
      (1,725 )     684       1.4  
    $ 1,045,592     $ (82,233 )   $ 963,359          

Changes in intangible assets during the two years ended December 31, 2014 were as follows (in thousands):

   
Product licensing rights
   
IPR&D
   
Trademarks
   
Customer relationships
   
Other intangibles
   
Non-compete agreements
 
December 31, 2012
  $ 63,654     $ —     $ 8,972     $ 5,588     $ —     $ 2,171  
Acquisitions
    57,969       —       —       —       —       —  
Amortization
    (5,723 )     —       (316 )     (740 )     —       (643 )
Foreign currency translation
    —       —       —       (210 )     —       (217 )
December 31, 2013
  $ 115,900     $ —     $ 8,656     $ 4,638     $ —     $ 1,311  
Acquisitions
   
668,457
      230,788       6,500       300       11,234       —  
Amortization
    (39,761 )     —       (877 )     (1,934 )     (879 )     (615 )
Dispositions
    (40,378 )     —       —       —       —       —  
Foreign currency translation
    —       —       —       31       —       (12 )
December 31, 2014
  $ 704,218     $ 230,788     $ 14,279     $ 3,035     $ 10,355     $ 684  

The amortization expense of acquired intangible assets for each of the following five years will be as follows (in thousands):

Year ending December 31,
 
Amortization Expense
 
2015
  $ 65,966  
2016
    65,739  
2017
    65,312  
2018
    65,108  
2019
    62,244  

Property, Plant and Equipment: Property, plant and equipment is stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method in amounts considered sufficient to amortize the cost of the assets to operations over their estimated useful lives or lease terms. Depreciation expense was $14.5 million, $7.1 million and $4.6 million for the years ended December 31, 2014, 2013 and 2012, respectively.  The amortization of assets under capital leases is included within depreciation expense. The following table sets forth the average estimated useful lives of the Company’s property, plant and equipment, by asset category:

Asset category
 
Depreciable Life (years)
 
Buildings
    30  
Leasehold improvements
    20  
Furniture and equipment
    7  
Automobiles
    5  
Computer hardware and software
    5  

Net Income Per Common Share: Basic net income per common share is based upon weighted average common shares outstanding. Diluted net income per common share is based upon the weighted average number of common shares outstanding, including the dilutive effect, if any, of stock options and convertible securities using the treasury stock and if converted methods.  Anti-dilutive shares excluded from the computation of diluted net income per share for 2014, 2013 and 2012 include 735,000, 975,000 and 581,000 shares, respectively, related to options, warrants, and convertible securities.

Income Taxes: Income taxes are accounted for under the asset and liability method.  Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and net operating loss and other tax credit carry-forwards. These items are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce the deferred income tax assets to the amount that is more likely than not to be realized.

Fair Value of Financial Instruments: The Company applies ASC Topic 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC Topic 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC Topic 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability, and are to be developed based on the best information available in the circumstances.

The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:

 
-
Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. The carrying value of the Company‘s cash and cash equivalents are considered Level 1 assets.

 
-
Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as directly or indirectly observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. The market value of the Company’s forward contracts to hedge against changes in currency translation rates between U.S. dollars and Indian rupees was a Level 2 asset.

 
-
Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. The additional consideration payable related to the Company’s acquisition of three branded, injectable drug products from the U.S. subsidiary of H. Lundbeck A/S (the “Lundbeck Acquisition”), a Denmark Corporation, on December 22, 2011 was a Level 3 liability, as are the additional consideration payable to Santen Pharmaceutical Co. Ltd. (“Santen”) in relation to the Company’s acquisition of the U.S. New Drug Application (“NDA”) rights to Betimol® on January 2, 2014, and the fair valuation of the available for sale investment held in shares of Nicox S.A.

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

         
Fair Value Measurements at Reporting Date, Using:
 
Description
 
December 31,
2014
   
Quoted Prices
in Active
Markets for
Identical Items
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents
  $ 70,680     $ 70,680     $ —     $ —  
Available-for-sale securities
    8,391       —       —       8,391  
   Total assets
  $ 79,071     $ 70,680     $ —     $ 8,391  
                                 
Purchase consideration payable
  $ 7,613     $ —     $ —     $ 7,613  
   Total liabilities
  $ 7,613     $ —     $ —     $ 7,613  

Description
 
December 31,
2013
   
Quoted Prices
in Active
Markets for
Identical Items
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents
  $ 34,178     $ 34,178     $ —     $ —  
Foreign currency forward contracts
    208       —       208       —  
   Total assets
  $ 34,386     $ 34,178     $ 208     $ —  
                                 
Purchase consideration payable
  $ 14,728     $ —     $ —     $ 14,728  
   Total liabilities
  $ 14,728     $ —     $ —     $ 14,728  

The carrying amount at December 31, 2014 of purchase consideration payable includes estimated consideration due to Santen related to the Company’s acquisition of U.S. NDA rights to Betimol® on January 2, 2014. The liability was initially discounted based on the Company’s assumed discount rate and revalued at December 31, 2014 using this same discount rate. The Company identified no events that would cause its calculated assumed discount rate to change between the acquisition date and December 31, 2014. The additional consideration contingently payable to Santen was initially estimated at $4.5 million discounted to $4.0 million based on a discount rate of 12.6%. The Company performed evaluations of the fair value of this liability at December 31, 2014 based on utilizing significant unobservable inputs and determined the fair value of this liability to be $4.3 million. The increase in fair value during the year ended December 31, 2014 of approximately $0.3 million has been recorded as non-cash interest expense within the Company’s consolidated statement of comprehensive income for the year ended December 31, 2014.

The remaining purchase consideration payable is principally comprised of net working capital amounts owed relating to the ECR and Watson Laboratories, Inc. (“Watson”) divestitures, at fair value as determined based on the underlying contracts and the Company’s subjective evaluation of the additional consideration.

As of December 31, 2014, the Company was carrying available for sale investments in shares of Nicox S.A. initially valued at $12.5 million discounted to reflect certain lockup provisions preventing immediate sale of underlying shares received for the Company’s investment in an available for sale security or an approximately $1.7 million unrealized gain. During the year the Company sold $0.6 million of the available-for-sale security, realizing an immaterial gain, and due to declines in the share price of Nicox S.A. stock from the initial valuation, the Company recognized a $1.8 million unrealized loss as of the year ended December 31, 2014. The remaining $8.4 million of securities are still subject to certain lockup provisions and as such, the fair value of the investments is estimated using observable and unobservable inputs to discount for lack of marketability. (See Note 16 – Business Combinations, Dispositions and Other Strategic Investments)

The carrying amount at December 31, 2013 of the purchase consideration payable for the Lundbeck acquisition was initially determined based on the terms of the underlying contracts and the Company’s subjective evaluation of the likelihood of the additional purchase consideration becoming payable related to the Company’s obligation to pay additional consideration for the acquisition of selected assets from H. Lundbeck A/S (“Lundbeck”) on December 22, 2011.  The underlying obligation was long-term in nature, and therefore was discounted to present value based on an assumed discount rate.  The additional consideration of $15.0 million, contingently payable to Lundbeck on December 22, 2014, was initially discounted to $11.3 million based on a discount rate of 10.0%, and subsequently adjusted in final acquisition accounting to $11.6 million based on applying a 9.0% discount rate.  At December 31, 2013, the Company again evaluated the fair value based on utilizing significant unobservable inputs and derived a discount rate of 1.85%, determining that the appropriate discounted value was $14.7 million based upon the likelihood of achieving the underlying revenue targets and a derived cost of debt based on the remaining term. On December 22, 2014 the Company remitted final payment for the contingent purchase consideration due to Lundbeck of $15.0 million.

The Company entered into three non-deliverable forward contracts in October 2013 to protect against unfavorable trends with regard to currency translation rates between U.S. dollars (“USD”) and Indian rupees (“INR”) for planned capital expenditures at AIPL, which all three matured and were redeemed during the year ended December 31, 2014. The forward contracts were based on current and future anticipated investment in AIPL, the Company’s subsidiary in India. These forward contracts include projected currency translation rates between INR and USD. Any difference between the actual and projected foreign currency translations rates on the respective settlement dates would result in payment from the counterparty to the Company, or vice versa, as the case may be. As all of the contracts matured during the year ended December 31, 2014, the Company realized a $0.7 million gain in fair value during the year ended December 31, 2014 as Other non-operating income in its consolidated statements of comprehensive income.

Warrants: The Company issued various warrants during 2009 to entities controlled by John N. Kapoor, Ph.D., the Chairman of the Company’s Board of Directors (the “Kapoor Warrants”).  The Company had classified the fair value of these warrants as a current liability in accordance with ASC 815-40-15-3, Derivatives and Hedging, (formerly EITF 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock). This classification was made as a result of the requirement that the shares to be issued upon exercise of the Kapoor Warrants be registered shares, which could not be absolutely assured.  The Kapoor Warrants were adjusted to fair value at the end of each quarter through Black-Scholes calculations which considered changes in the market price of the Company’s common stock, the remaining contractual life of the Kapoor Warrants, and other factors.  Any change in the fair value of the Kapoor Warrants was recorded as income or expense on the Company’s consolidated statements of operations for the applicable period.

On June 28, 2010, the Company and Dr. Kapoor entered into an Amended and Restated Registration Rights Agreement (the “Amended Agreement”) which modified certain terms related to the Company’s obligation to obtain and maintain registration of any shares issued pursuant to exercise of the Kapoor Warrants.  The Amended Agreement still requires the Company to use “commercially reasonable efforts” to file a registration statement pursuant to Rule 415 of the Securities Act of 1933 (“Registration Statement”) for any shares of common stock that may be issued under the applicable warrant agreements, and to maintain the continuous effectiveness of such Registration Statement until the earliest of: (i) the date no shares of the Company’s common stock qualify as registrable securities, (ii) the date on which all of the registrable securities may be sold in a single transaction by the holder to the public pursuant to Rule 144 or a similar rule, or (iii) the date upon which the John N. Kapoor Trust Dated September 20, 1989 (the “Kapoor Trust”) and EJ Funds, LP (“EJ Funds”) have transferred all of the registrable securities.  However, the Registration Rights Agreement was amended to provide that in the event the Company, after using its good faith commercially reasonable efforts, is not able to obtain or maintain registration of the common stock, delivery of unregistered shares upon exercise of the Kapoor Warrants will be deemed acceptable and a net cash settlement will not be required. The Amended Agreement further provides that the term “commercially reasonable efforts” in such instance shall not mean an absolute obligation of the Company to obtain and maintain registration.

As a result of the changes effected through the Amended Agreement, on June 28, 2010 the Company changed its accounting treatment of the Kapoor Warrants, no longer classifying them as a current liability with periodic adjustments to fair value but instead classifying them as a component of shareholders’ equity in accordance with ASC 815-40.   Accordingly, the fair value of the Kapoor Warrants, which was $17.9 million on June 28, 2010, was reclassified from a current liability to a component of shareholders’ equity on that date.  Following this change in classification, no future fair value adjustments are required.

The liability at June 28, 2010 for the Kapoor Warrants was estimated using a Black-Scholes valuation model with the fair value per warrant ranging from $2.49 to $2.50.  The expected volatility of the Kapoor Warrants was based on the historical volatility of the Company’s common stock. The expected life assumption was based on the remaining life of the Kapoor Warrants. The risk-free interest rate for the expected term of the Kapoor Warrants was based on the average market rate on U.S. treasury securities in effect during the applicable quarter. The dividend yield reflected historical experience as well as future expectations over the expected term of the Kapoor Warrants.

The assumptions used in estimating the fair value of the warrants at June 28, 2010 were as follows:

Expected volatility
 
79.7%
 
Expected life (in years)
 3.8 –
4.1
Risk-free interest rate
 
1.8%
 
Dividend yield
 
—
 

The following table provides summarized information about the Kapoor Warrants as of December 31, 2013:

Granted To:
Grant Date
 
Warrants Granted
   
Exercise Price
   
Book Value ($000s)
 
                     
EJ Funds
Apr.13, 2009
    1,939,639     $ 1.11     $ 4,829  
Kapoor Trust
Apr.13, 2009
    1,501,933     $ 1.11       3,740  
EJ Funds
Aug.17, 2009
    1,650,806     $ 1.16       4,127  
Kapoor Trust
Aug.17, 2009
    2,099,935     $ 1.16       5,250  
        7,192,313             $ 17,946  

On April 10, 2014, the holder exercised all of the approximately 7.2 million outstanding stock warrants. The Company received cash proceeds of approximately $8.2 million from the warrant exercise during the year ended December 31, 2014.

Stock-Based Compensation: Stock-based compensation cost is estimated at grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions to be used in the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its common stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. Treasury securities of similar term in effect during the quarter in which the options were granted. The dividend yield reflects the Company’s historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises the estimate in subsequent periods, if necessary, if actual forfeitures differ from initial estimates.

XML 49 R62.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 5 - Property, Plant and Equipment (Details) - Property, Plant, and Equipment (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross $ 185,877us-gaap_PropertyPlantAndEquipmentGross $ 125,423us-gaap_PropertyPlantAndEquipmentGross
185,877us-gaap_PropertyPlantAndEquipmentGross 125,423us-gaap_PropertyPlantAndEquipmentGross
Accumulated depreciation (68,093)us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment (54,470)us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
117,784akrx_PropertyPlantAndEquipmentAfterDepreciationBeforeConstructionInProgress 70,953akrx_PropertyPlantAndEquipmentAfterDepreciationBeforeConstructionInProgress
Construction in progress 26,004us-gaap_ConstructionInProgressGross 11,155us-gaap_ConstructionInProgressGross
143,788us-gaap_PropertyPlantAndEquipmentNet 82,108us-gaap_PropertyPlantAndEquipmentNet
Land [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 9,323us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_LandMember		 2,606us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_LandMember
9,323us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_LandMember		 2,606us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_LandMember
Building and Building Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 63,846us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember		 46,281us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember
63,846us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember		 46,281us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 112,708us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_FurnitureAndFixturesMember		 76,536us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_FurnitureAndFixturesMember
$ 112,708us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_FurnitureAndFixturesMember		 $ 76,536us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_FurnitureAndFixturesMember
EXCEL 50 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA M-6%E-S8Y8C4B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7T-A M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,E]3=6UM87)Y7V]F7U-I9VYI9FEC M86YT7SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO M=&5?,U]!8V-O=6YT#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?-%]);G9E;G1O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?-E]&:6YA;F-I;F=?07)R86YG96UE;G1S/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DYO=&5?,3)?4V5G;65N=%]);F9O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?,3-?0V]M;6ET;65N='-?86YD M7T-O;G1I;CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DYO=&5?,31?4W5P<&QE;65N=&%L7T-A#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DYO=&5?,35?4F5C96YT7T%C8V]U M;G1I;F=?4')O;CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DYO=&5?,39?0G5S:6YE#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DYO=&5?,3=?56YC;VYS;VQI M9&%T961?2F]I;G1?5CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,3A?0W5S=&]M97)?4W5P<&QI97)?86YD7SPO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,3E?4F5L871E M9%]087)T>5]4#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,C!?4V5V97)A;F-E7T-H87)G97,\+W@Z3F%M93X- M"B`@("`\>#I7;W)K5]&:6X\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O5]0;VQI8WE?/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,U]!8V-O=6YT M#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?-E]&:6YA;F-I;F=?07)R86YG96UE;G1S7SPO>#I. M86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO M=&5?,31?4W5P<&QE;65N=&%L7T-A#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DYO=&5?,3A?0W5S=&]M97)? M4W5P<&QI97)?86YD7S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K5]&:6XQ/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,E]3=6UM87)Y7V]F7U-I9VYI9FEC86YT7S,\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K5]O9E]3:6=N:69I8V%N=%\T/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO M=&5?,E]3=6UM87)Y7V]F7U-I9VYI9FEC86YT7S8\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K5]O9E]3:6=N M:69I8V%N=%\W/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DYO=&5?,E]3=6UM87)Y7V]F M7U-I9VYI9FEC86YT7SD\+W@Z3F%M93X-"B`@("`\>#I7;W)K5]O9E]3:6=N:69I8V%N=%\Q,#PO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DYO=&5?-%]);G9E;G1O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO M=&5?-%]);G9E;G1O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?-5]05]0;&%N=%]A M;F1?17%U:3(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?-E]&:6YA;F-I;F=?07)R86YG96UE;G1S7S(\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?-U]%87)N:6YG#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?.5]3=&]C:U]/ M<'1I;VYS7T5M<&QO>65E7S(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?.5]3=&]C:U]/<'1I;VYS7T5M<&QO>65E M7S4\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?,3!?26YC;VUE7U1A>&5S7T1E M=&%I;'-?5#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DYO=&5?,3!?26YC;VUE7U1A>&5S7T1E=&%I;'-?3CPO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DYO=&5?,3!?26YC;VUE7U1A>&5S M7T1E=&%I;'-?4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DYO=&5?,3%?4F5T:7)E;65N=%]0;&%N7T1E=&%I;#PO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DYO=&5?,3)?4V5G;65N=%]) M;F9O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,3)?4V5G;65N=%]);F9O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K M#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?,39?0G5S:6YE#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,39?0G5S:6YE#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O#I. M86UE/DYO=&5?,3A?0W5S=&]M97)?4W5P<&QI97)?86YD7S(\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,C!? M4V5V97)A;F-E7T-H87)G97-?1&5T83PO>#I.86UE/@T*("`@(#QX.E=O5]& M:6XR/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/DYO M=&5?,C%?4V5L96-T961?475A#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X M.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!);F9O2!296=I M'0^,3`M2SQS<&%N/CPO'0^+2TQ,BTS,3QS<&%N/CPO M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^9F%L2!#96YT3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,#`P,S$Q-CQS<&%N M/CPO'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^3F\\2!&:6QE M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^3&%R M9V4@06-C96QE2!796QL+6MN;W=N(%-E87-O M;F5D($ES'0^665S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA M-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q M,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&5S+"!C=7)R96YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XS,RPT.#`\'!E;G-E6%B;&4L(&-U6%L=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S&-L=7-I=F4@;V8@86UO MF%T:6]N(&]F(&EN=&%N9VEB;&5S+"!I;F-L=61E9"!W:71H:6X@;W!E M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E8W1A=&EO;B!T:&%T(&UA;F%G96UE;G0@;6%Y('-E M='1L92!A;&P@9G5T=7)E(&YO=&4@8V]N=F5R&-L=7-I;VX@;V8@:6YT97)E&9O M65A7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2!T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M&-E<'0@4VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\"!B96YE M9FET("T@&-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\"!B96YE9FET("T@ M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%SF5D(&AO;&1I M;F<@;&]S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F%T M:6]N(&]F(&9A=F]R86)L92`H=6YF879O&5S+"!N970\+W1D/@T*("`@ M("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6UE;G1S(&9O2!I;G9E6UE;G1S(&9O'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M&-H86YG92!R871E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P M83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X M835A93'0O:'1M;#L@8VAA'0^/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`-"B`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SY.;W1E M(#$@)B,X,C$R.R!"=7-I;F5S6QE M/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@ M#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE28C.#(R,3LI(&ES(&$@6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE2!I;B!!;6ET>79I;&QE+"!.97<@66]R:RX@ M3W5R(')E6QV86YI82P@86YD('=E(&AA=F4@;W1H97(@8V]R<&]R871E(&]F M9FEC97,@:6X@06YN($%R8F]R+"!-:6-H:6=A;CL@06UI='EV:6QL92P@3F5W M(%EO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV M869?8F,X835A93'0O:'1M;#L@8VAA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S/"]F;VYT/CPO M9F]N=#X@(`T*("`@(#PO9&EV/CQB6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;VYS;VQI M9&%T:6]N.CPO9F]N=#X@5&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960@ M9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D92!T:&4@86-C;W5N=',@;V8@ M06MO28C M.#(R,3LI("A3964@3F]T92`Q-R`\9F]N="!S='EL93TS1"=&3TY4+5-464Q% M.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^)B,X,C$Q.SPO9F]N=#X@/&9O M;G0@2!I;B!E87)N:6YG2!S;VQD M(&%L;"!O9B!I=',@86)B6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3:6=N:69I M8V%N="!E2!R96QA=&4@=&\@=&AE(&%L;&]W86YC97,@9F]R(&-H87)G96)A8VMS+"!R M96)A=&5S+"!P6EN9R!V86QU92!A;F0@;&EV97,@;V8@:6YT86YG:6)L92!A"!A6EN9R!S:&%R M92UB87-E9"!C;VUP96YS871I;VXL(&%C8W)U960@8G5T('5N6QE/3-$)U1%6%0M M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE&5D(&]R(&1E M=&5R;6EN86)L92P@86YD(&-O;&QE8W1A8FEL:71Y(&ES(')E87-O;F%B;'D@ M87-S=7)E9"X@4F5V96YU97,@9G)O;2!PF5D('=H96X@=&ET;&4@86YD(')I6QE/3-$)U1%6%0M M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE&EM871E;'D@)#(N.2!M:6QL:6]N(&%N9"`D M,BXW(&UI;&QI;VX@;V8@8V%S:"!H96QD(&)Y(&]U'!E;G-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=& M3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^06-C;W5N=',@ M4F5C96EV86)L93H\+V9O;G0^(%1R861E(&%C8V]U;G1S(')E8V5I=F%B;&5S M(&%R92!S=&%T960@870@=&AE:7(@;F5T(')E86QI>F%B;&4@=F%L=64N)B,Q M-C`[)B,Q-C`[5&AE(&YA='5R92!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(&)U M2!C M;VYT6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY5;FQE6EN9R!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@ M87,@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L M:6,[($1)4U!,05DZ(&EN;&EN92<^0VAA2!E;G1EF%T:6]N2!T:&4@<')O9'5C="!F2!B>2!T M:&4@=VAO;&5S86QEFEN9R!T:&ES(&EN M9F]R;6%T:6]N+"!T:&4@0V]M<&%N>2!EF5D+CPO9F]N=#X@("`@(`T*("`@(#PO9&EV/CQB M2!R97!O2!E6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`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`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!R M96-E;G0@;W(@86YT:6-I<&%T960@8VAA;F=E6]N9"!T:&4@9'5E(&1A=&4@2!H860@82!T;W1A;"!O9B`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`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[ M($1)4U!,05DZ(&EN;&EN92<^26YV96YT;W)I97,Z/"]F;VYT/B`\9F]N="!S M='EL93TS1"=&3TY4+5-464Q%.B!N;W)M86PG/DEN=F5N=&]R:65S(&%R92!S M=&%T960@870@=&AE(&QO=V5R(&]F(&-O2!M86EN=&%I;G,@86X@86QL M;W=A;F-E(&9OF%B;&4@=F%L=64@*"8C.#(R,#M.4E8F M(S@R,C$[*2X@1F]R(&9I;FES:&5D(&=O;V1S(&EN=F5N=&]R>2P@=&AE($-O M;7!A;GD@97-T:6UA=&5S('1H92!A;6]U;G0@;V8@:6YV96YT;W)Y('1H870@ M;6%Y(&YO="!B92!S;VQD('!R:6]R('1O(&ET'!I2!A;'-O(&%N86QY>F5S(&ET2X@5&AE(&%L;&]W86YC97,@9F]R(&EN=F5N=&]R M>2!O8G-O;&5S8V5N8V4@=V5R92`D,C$N,B!M:6QL:6]N(&%N9"`D-2XW(&UI M;&QI;VX@87,@;V8@1&5C96UB97(@,S$L(#(P,30@86YD(#(P,3,L(')E2X\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^(`T*("`@("`@ M/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!C87!I=&%L:7IE2!A M;'-O(&-O;G-I9&5R6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!="!$96-E;6)E&EM871E;'D@)#$N,"!M:6QL:6]N(&EN(')E2!D965M960@:70@=6YL:6ME;'D@=&AA="!T M:&4@<')O9'5C=',@=V]U;&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^86-C;W5N=&5D(&9OF5D(&%N9"!A M;6]R=&EZ960@;VX@82!S=')A:6=H="UL:6YE(&)A2`H,S`I('EE87)S+B8C,38P.R8C,38P.T%C8W5M=6QA=&5D(&%M;W)T M:7IA=&EO;B!W87,@)#@R+C(@;6EL;&EO;B!A;F0@)#,Y+C$@;6EL;&EO;B!A M="!$96-E;6)E'!E;G-E('=A2!R96=U;&%R M;'D@87-S97-S97,@:71S(&EN=&%N9VEB;&4@87-S971S(&9OF5D(&-O'1E;F1E9"!R96UA M:6YI;F<@;&EF92!O9B!T:&4@87-S970N/"]F;VYT/CPO9F]N=#X@(`T*("`@ M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!E>&ES="X@5&AE($-O;7!A;GD@=7-E M2!B87-E9"!O;B!Q=6%L:71A=&EV92!A;F0@<75A;G1I=&%T:79E(&%S2!M;V1E;&5D('1H92!F86ER('9A;'5E(&]F('1H92!R97!O2!P97)F M;W)M960@:71S(&%N;G5A;"!I;7!A:7)M96YT('1E2!I;B!E>&-E M6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY';V]D=VEL;#PO9F]N=#X@#0H@("`@("`@("`@("`@ M(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY);7!A:7)M96YT6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W)E:6=N M(&-U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,BPS,C@\+V9O;G0^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$ M96-E;6)E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXR.2PX,S$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXR-C`L.3$Q/"]F;VYT/B`@(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(SDT-S([/"]F;VYT/B`@("`-"B`@("`@("`@ M("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$:7-P;W-I=&EO;G,\+V9O;G0^("`@ M("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY$96-E;6)E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@/&9O;G0@28C.#(Q-SMS M(&EN=&%N9VEB;&4@87-S971S(&%N9"!T:&4@=V5I9VAT960M879EF%T:6]N('!E6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@ M("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87)R>6EN9SPO M9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\+V1I=CX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87)R>6EN9SPO M9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\+V1I=CX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@("`-"B`@ M("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M,S`L-S@X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M,S`L-S@X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M-BPP,#`\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.#6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE M/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU M<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY#:&%N9V5S(&EN(&EN=&%N9VEB;&4@87-S971S(&1U M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY)4%(F86UP.T0\+V9O M;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L M6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY#=7-T;VUE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY.;VXM8V]M<&5T92!A9W)E96UE;G1S/"]F;VYT M/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV M,RPV-30\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#@N,7!T)R!A M;&EG;CTS1&QE9G0^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH-S0P/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY&;W)E:6=N(&-U6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C$W/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXT+#8S.#PO9F]N=#X@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXV-C@L-#4W/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR,S`L-S@X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXS,#`\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH,2PY,S0\+V9O;G0^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH.#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXS,3PO9F]N=#X@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@ M("`@("`@(#QT6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXW,#0L,C$X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#`S-3PO9F]N=#X@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,"PS-34\ M+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@/&9O;G0@65A6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-2PY-C8\+V9O;G0^("`- M"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$V M/"]F;VYT/B`@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV M-2PW,SD\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@/&9O;G0@6QE/3-$)T9/3E0M4U19 M3$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY02P@4&QA;G0@ M86YD($5Q=6EP;65N=#H\+V9O;G0^(%!R;W!E2P@<&QA M;G0@86YD(&5Q=6EP;65N="P@8GD@87-S970@8V%T96=O6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@ M("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!3PO9F]N=#X@("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY" M=6EL9&EN9W,\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXW/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY#;VUP=71E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXU/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^3F5T M($EN8V]M92!097(@0V]M;6]N(%-H87)E.CPO9F]N=#X@/&9O;G0@2P@;V8@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE)SY);F-O;64@5&%X97,Z/"]F;VYT/B!);F-O;64@=&%X97,@87)E M(&%C8V]U;G1E9"!F;W(@=6YD97(@=&AE(&%S"!B M87-E"!A6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE&EM:7IE('1H92!U2X@56YO8G-E M6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$ M-"4^("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1'1O<"!W:61T:#TS1#6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4 M+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^3&5V96P@,CPO9F]N M=#XF(S@R,3([26YP=71S('1O('1H92!F86ER('9A;'5E(&UE87-U2!O8G-E6EE;&0@8W5R=F5S('1H870@87)E(&]B28C.#(Q-SMS(&9O2!T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<"!W:61T M:#TS1#6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN M;&EN92<^3&5V96P@,SPO9F]N=#XF(S@R,3([26YP=71S('1O('1H92!F86ER M('9A;'5E(&UE87-U&ES M=',@9F]R('1H92!A2!O9B!(+B!,=6YD8F5C:R!!+U,@*'1H92`F(S@R,C`[3'5N9&)E8VL@06-Q M=6ES:71I;VXF(S@R,C$[*2P@82!$96YM87)K($-O2P@87,@ M87)E('1H92!A9&1I=&EO;F%L(&-O;G-I9&5R871I;VX@<&%Y86)L92!T;R!3 M86YT96X@4&AA28C.#(Q-SMS(&%C M<75I2`R M+"`R,#$T+"!A;F0@=&AE(&9A:7(@=F%L=6%T:6]N(&]F('1H92!A=F%I;&%B M;&4@9F]R('-A;&4@("`@(`T*("`@("`@("`@("`@("!I;G9E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@ M9F]L;&]W:6YG('1A8FQE('-U;6UA"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED)SX@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q M-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QD:78@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`@(`T*("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`@#0H@("`@("`@("`@("`@("`@("`@(#QD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^:6X@06-T:79E/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/B`@ M#0H@("`@("`@("`@("`@("`@("`\+V1I=CX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O M;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@ M("`@("`@(#QD:78@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^3W1H97(\+V9O;G0^/"]F;VYT/CPO M9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@("`@("`@("`\+V1I=CX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^*$QE=F5L)B,Q-C`[,BD\+V9O;G0^("`@("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@ M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@("`-"B`@("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^(`T*("`@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@(`T* M("`@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^26YP=71S M/"]F;VYT/CPO9F]N=#X@("`@(`T*("`@("`@("`@("`@("`\+V1I=CX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX M+#,Y,3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXX+#,Y,3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M4;W1A;"!A6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@ M5$585"U!3$E'3CH@"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX+#,Y,3PO9F]N=#X@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY0=7)C:&%S92!C;VYS:61E6%B;&4\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E' M3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@ M("`@("`@(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QD M:78@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@#0H@ M("`@("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^:6X@06-T:79E/"]F;VYT/CPO M9F]N=#X\+V9O;G0^/"]F;VYT/B`@#0H@("`@("`@("`@("`@("`@("`\+V1I M=CX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M3W1H97(\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@ M("`@("`@("`@("`\+V1I=CX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^*$QE=F5L)B,Q-C`[ M,BD\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@ M("`-"B`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^(`T*("`@("`@("`@("`@ M("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$8V5N=&5R/B`@(`T*("`@("`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^26YP=71S/"]F;VYT/CPO9F]N=#X@("`@(`T*("`@ M("`@("`@("`@("`\+V1I=CX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR,#@\+V9O;G0^("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-"PS.#8\+V9O;G0^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-"PQ-S@\+V9O;G0^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#@\+V9O;G0^("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY0=7)C:&%S92!C;VYS:61E6%B M;&4\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU M<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@8V%R M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`W,"4[(%9%4E1)0T%,+4%,24=..B!T97AT+71O<"<^)B,Q-S0[/"]F M;VYT/B!O;B!*86YU87)Y(#(L(#(P,30N(%1H92!L:6%B:6QI='D@=V%S(&EN M:71I86QL>2!D:7-C;W5N=&5D(&)A2!P87EA8FQE('1O(%-A;G1E;B!W87,@:6YI=&EA;&QY(&5S M=&EM871E9"!A="`D-"XU(&UI;&QI;VX@9&ES8V]U;G1E9"!T;R`D-"XP(&UI M;&QI;VX@8F%S960@;VX@82!D:7-C;W5N="!R871E(&]F(#$R+C8E+B!4:&4@ M0V]M<&%N>2!P97)F;W)M960@979A;'5A=&EO;G,@;V8@=&AE(&9A:7(@=F%L M=64@;V8@=&AI2`D,"XS(&UI;&QI;VX@ M:&%S(&)E96X@65A6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!OF5D(&=A:6XN($1U65A2!S;VQD("0P+C8@;6EL;&EO;B!O9B!T:&4@879A:6QA8FQE+69O"`@ M(`T*("`@("`@("`@("`@("!3+D$N('-T;V-K(&9R;VT@=&AE(&EN:71I86P@ M=F%L=6%T:6]N+"!T:&4@0V]M<&%N>2!R96-O9VYI>F5D(&$@)#$N."!M:6QL M:6]N('5N65A6EN9R!A;6]U;G0@870@1&5C M96UB97(@,S$L(#(P,3,@;V8@=&AE('!U6%B;&4@28C.#(Q-SMS(&]B;&EG871I M;VX@=&\@<&%Y(&%D9&ET:6]N86P@8V]N2!P87EA M8FQE('1O($QU;F1B96-K(&]N($1E8V5M8F5R(#(R+"`R,#$T+"!W87,@:6YI M=&EA;&QY(&1I2!A9V%I;B!E=F%L=6%T960@=&AE(&9A:7(@=F%L=64@ M8F%S960@;VX@=71I;&EZ:6YG('-I9VYI9FEC86YT('5N;V)S97)V86)L92!I M;G!U=',@86YD(&1E6UE;G0@9F]R('1H92!C;VYT:6YG96YT('!U M65A2!T2!T;R!T:&4@0V]M<&%N>2P@;W(@ M=FEC92!V97)S82P@87,@=&AE(&-A65A65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^5V%R6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY!8V-O=6YT M:6YG(&9O&5D('1O+"!A;F0@4&]T96YT:6%L;'D@4V5T=&QE9"!I;BP@82!#;VUP86YY M)B,X,C$W.W,@3W=N(%-T;V-K/"]F;VYT/BDN(%1H:7,@8VQA&5R8VES92!O9B!T M:&4@2V%P;V]R(%=A2!A28C M.#(Q-SMS(&-O;6UO;B!S=&]C:RP@=&AE(')E;6%I;FEN9R!C;VYT6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`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`-"B`@("`\+V1I=CX\8G(O M/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY!2!C:&%N9V5D(&ET6EN9R!T:&5M(&%S(&$@8V]M<&]N96YT(&]F('-H87)E:&]L9&5R2!T;R!A(&-O;7!O;F5N="!O9B!S:&%R96AO;&1E2!O;B!T:&%T(&1A=&4N)B,Q-C`[)B,Q-C`[1F]L;&]W M:6YG('1H:7,@8VAA;F=E(&EN(&-L87-S:69I8V%T:6]N+"!N;R!F=71U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@;&EA8FEL:71Y(&%T($IU M;F4@,C@L(#(P,3`@9F]R('1H92!+87!O;W(@5V%R'!E8W1E9"!V;VQA=&EL M:71Y(&]F('1H92!+87!O;W(@5V%R'!E8W1E9"!T97)M(&]F('1H92!+87!O;W(@5V%R'!E'!E8W1E9"!T97)M(&]F('1H92!+87!O;W(@5V%R6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@87-S=6UP M=&EO;G,@=7-E9"!I;B!E6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^("`@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%2 M1TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>'!E M8W1E9"!L:69E("AI;B!Y96%R6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S@R,3$[/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R M.24@6QE/3-$)U1%6%0M24Y$14Y4.B`M M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE. M+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY2:7-K+69R M964@:6YT97)E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!0041$24Y'+4)/5%1/33H@,"XU<'0[($)/4D1%4BU43U`Z(&)L86-K(#$N M,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>&5R8VES92!0 M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q M+C%P="!S;VQI9"<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!<'(N,3,L(#(P,#D\+V9O M;G0^("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY+87!O;W(@5')U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ+#4P,2PY,S,\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C$Q M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY%2B!&=6YD6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+#8U,"PX,#8\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C$V/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#$R-SPO9F]N=#X@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@("`-"B`@("`@("`@("`@(#QD:78@"<^("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^-2PR-3`\+V9O M;G0^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^,36QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T2`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`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE28C.#(Q M-SMS('=H;VQE2!T:&4@ M86UO=6YT(&]F(&1E9'5C=&EO;G,@=&AA="!W97)E(&5A6UE;G1S(&%G86EN6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY7:71H('1H92!E>&-E M<'1I;VX@;V8@=&AE('!R;W9I6EN9R!C;VYS;VQI9&%T960@6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^1&5C96UB97(@,S$L/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494 M.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@("`@("`@ M(#QD:78@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`R M-W!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`S-G!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,3(L.#@R/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M,C=P=#L@1$E3 M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`S-G!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)U1%6%0M24Y$14Y4.B`M,C=P M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`S-G!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR,BPV.3$\+V9O;G0^/"]F;VYT/CPO9F]N M=#X@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2PV-#0\+V9O;G0^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=) M3BU,1494.B`S-G!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH-#8R/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494 M.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q,SPO9F]N=#X@("`@ M#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q M-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)V)A8VMG6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY'6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ+#0T,BPU,S<\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,97-S(&%D:G5S=&UE;G1S(&9O M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[($U! M4D=)3BU,1494.B`S-G!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH,3@S+#0P,SPO9F]N=#X@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C`L,#`V/"]F;VYT/B`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PP,#$\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,RPW.#,\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@ M("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH/&9O;G0@"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E3 M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,36QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR-38L,34X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@86YN=6%L(&%C=&EV M:71Y(&EN('1H92!#;VUP86YY)B,X,C$W.W,@86QL;W=A;F-E(&9O65A6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M"<^("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@"<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/D1I6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@"<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX] M,T1B;W1T;VT@6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY"86QA;F-E(&%T($1E8V5M8F5R(#,Q+"`R,#$Q/"]F M;VYT/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW-#,\+V9O;G0^("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS.#8\+V9O;G0^("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+#`W-#PO9F]N=#X@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY#:&%R9V5S('!R;V-E6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^*#(L,C(P/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#4L-#4U/"]F M;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/B@Q,30L,C8V/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY"86QA;F-E(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT M/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXS,#PO9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE3X@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ.#,L-#`S/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH-3PO9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M,#$L,S@W/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@U+#(T-CPO9F]N M=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#$X,RPY-S,\+V9O;G0^/"]F;VYT M/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/B@X+#$X,CPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@T M+#8U-SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#(P,BPP-3@\+V9O M;G0^/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"86QA;F-E(&%T($1E8V5M M8F5R(#,Q+"`R,#$S/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-3PO9F]N=#X@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,"PP,#8\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXW,SDL-S8P/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@("`\ M+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,2PQ M-S@\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXW.3DL,#$Y/"]F;VYT/CPO9F]N=#X@("`@ M#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M/B`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX.#PO M9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M/B`@(`T*("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^*#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C8R-BPY,S@\+V9O;G0^/"]F M;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT M/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/B@\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,SPO9F]N=#X\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/B@W+#(W-3PO9F]N=#X\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^*#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C8V,BPR,#`\+V9O;G0^/"]F M;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT M/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,C(L/"]F;VYT M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^-CDQ/"]F;VYT/CPO M9F]N=#X\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@ M("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/C$L,C$W/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`@(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(R-"PS,3$\+V9O;G0^ M/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@ M("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'1087)T7S)A9C!A M,3(V7S-C.&%?-&4X,E\Y-F%F7V)C.&$U864W-CEB-0T*0V]N=&5N="U,;V-A M=&EO;CH@9FEL93HO+R]#.B\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA M-6%E-S8Y8C4O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U714E'2%0Z(&)O;&0G/DYO=&4@-"`F(S@R,3([($EN=F5N=&]R M:65S/"]F;VYT/CPO9F]N=#X@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF M>3X@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q-#PO9F]N M=#X@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F M;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L M6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q,SPO9F]N=#X@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-"PT-#(\+V9O M;G0^/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR,BPX.#8\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS+#@X,SPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ,S$L,S$P/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T* M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE2!W:&5R92!I=',@8V]S M="!I&-E2!I;B!T:&4@86QL;W=A;F-E(&9O&-EF%B;&4@=F%L=64@:6YV M96YT;W)Y(&%C8V]U;G0@9F]R('1H92!T=V\@>65A6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N M/3-$-B!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@#0H@("`@ M("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/B`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N M/3-$,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,C`Q,SPO9F]N=#X\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R M('-T>6QE/3-$)V)A8VMG65A6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+#@Q.3PO9F]N=#X@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ,BPR-S4\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX+#(R,#PO9F]N=#X@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U!!1$1)3D"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@U+#`Q M-CPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^)B,Q-C`[*#,L,C`X/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG M6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N M/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C4L-S`P/"]F;VYT/CPO9F]N=#X@ M("`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T M93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2P@4&QA;G0@86YD($5Q=6EP M;65N=#PO9F]N=#X@("`@(`T*("`@(#PO9&EV/CQB"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G M/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F M=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY,86YD/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#8P-CPO M9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP M=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY&=7)N:71U6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,C4L M-#(S/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)V)A8VMG6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,36QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ-#,L-S@X/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M2!P;&%N="!A;F0@97%U:7!M96YT M(&-A3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E M-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9? M,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SY);F-R96UE;G1A;"!497)M($QO M86X\+V9O;G0^("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE28C.#(R,3LI('!U6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE2!T:6UE+"!O6UE;G0@;V8@87!P;&EC86)L M92!F965S+B!02!I;F-U2!C;W5R'1E;G0@=&AE("`@(`T*("`@("`@26YC6UE;G0@9F5E M('=I;&P@8F4@9'5E+B!!2!L:6UI=&%T:6]N28C.#(Q-SMS('-E;FEO6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!R96-O'!E;G-E(&]F("0W M+C@@;6EL;&EO;B!I;B!R96QA=&EO;B!T;R!T:&4@26YC2`D,2XX(&UI;&QI;VX@;V8@=&AI'!E;G-E(&1U65AF4@=&AE(')E;6%I M;FEN9R!D969E28C.#(R,3LI M('!U2!M87D@:6YC6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@17AI2!I28C.#(Q-SMS('!R:6UA6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE6UE;G0@97%U86P@=&\@,"XR-24@;V8@=&AE(&EN M:71I86P@;&]A;B!A;6]U;G0@;V8@)#8P,"XP(&UI;&QI;VX@8F5G:6YN:6YG M('=I=&@@=&AE('-E8V]N9"!F=6QL('%U87)T97(@9F]L;&]W:6YG('1H92!C M;&]S:6YG(&1A=&4@;V8@=&AE($5X:7-T:6YG(%1E2!P65A&ES=&EN9R!497)M($QO86XN/"]F;VYT M/B`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!2`D-RXT(&UI;&QI;VX@;V8@=&AI MF5D M(&EN('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$T(&-O;G-I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SY*4$UO6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LH82D\ M+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1T;W`@=VED=&@],T0Y,"4^("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@*&(I/"]F;VYT M/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O M<"!W:61T:#TS1#DP)3X@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:&4@;&5S6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1'1O<"!W:61T:#TS1#0E/B`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXV-24@;V8@=&AE(&QO=V5R(&]F(&-O6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SYB+CPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.#8E/B`@("`-"B`@ M("`@("`@("`@(#QD:78@2!L:7%U:61A=&EO;B!V86QU92!O9B!E;&EG:6)L92!R87<@;6%T97)I86QS M(&%N9"!W;W)K(&EN('!R;V-E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE2D[(&%N9#PO9F]N=#X@("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#LH9"D\+V9O;G0^("`@(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&%L:6=N/3-$;&5F="!C;VQS<&%N/3-$,B!V86QI9VX],T1T;W`@ M=VED=&@],T0Y,"4^(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY5;F1E M2!B92!S=6)J96-T('1O(&-A2!S M965K(&%D9&ET:6]N86P@8V]M;6ET;65N=',@=&\@:6YC&EM=6T@86UO=6YT(&]F('1H92!*4$T@4F5V;VQV:6YG($9A8VEL:71Y('1O M("0R,#`N,"!M:6QL:6]N+CPO9F]N=#X@("`-"B`@("`\+V1I=CX\8G(O/CQD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY5;FQE&5R8VES960@8GD@=&AE M(&QE;F1E2!W:6QL(&)E(')E<75I65A2!B87-E9"P@870@ M=&AE($-O;7!A;GDF(S@R,3<[6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@&5D($-H87)G93PO9F]N=#X@ M("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M(S`P,#`P,"`Q<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY2979O M;'9E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3<')E860\+V9O;G0^("`- M"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0R-24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY2979O;'9E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY%=7)O9&]L;&%R/"]F;VYT/B`-"B`@("`@("`@ M("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^0V%T96=O M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF9W0[(#$N-3`@=&\@ M,2XP/"]F;VYT/B`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1T;W`@=VED=&@] M,T0R-24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C4P)3PO9F]N=#X@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C4E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M(S`P,#`P,"`Q<'0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN92<^/&9O;G0@2`S/"]F;VYT/CPO9F]N=#X@ M("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M(S`P,#`P,"`Q<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C`P)3PO9F]N=#X@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A;&P@;V8@=&AE(&%S6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY-:6YI;75M($QI<75I9&ET>2P@87,@9&5F:6YE9"!I;B!T:&4@2E!- M($-R961I="!!9W)E96UE;G0L(&]F(&YO="!L97-S('1H86X@*&$I("0Q,C`N M,"!M:6QL:6]N('!L=7,@*&(I(#(U)2!O9B!T:&4@2E!-(%)E=F]L=FEN9R!& M86-I;&ET>2!C;VUM:71M96YT2!D871E M(&]F('1H92!#;VUP86YY)B,X,C$W.W,@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M8BD\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1T;W`@=VED=&@],T0W-B4^("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!M87D@=7-E(&%N>2!P M2!A;F0@:71S('-U8G-I9&EA28C.#(Q-SMS('!R M:6]R(')E=F]L=FEN9R!C2X@079A:6QA8FEL:71Y('5N9&5R('1H92!F86-I;&ET>2!A2`D,30X+C@@;6EL M;&EO;BX\+V9O;G0^("`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@2E!- M($-R961I="!!9W)E96UE;G0@<&QA8V5S(&-U2!L:6UI=&%T:6]N M6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^0V]N=F5R=&EB M;&4@3F]T97,\+V9O;G0^("`@(`T*("`@(#PO9&EV/CQB6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M2!I M;B!A28C M.#(Q-SMS(&-O;6UO;B!S=&]C:RP@8V%S:"!O6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`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`Q,'!T)SY4 M:&4@3F]T97,@87)E(&YO="!L:7-T960@;VX@86YY('-E8W5R:71I97,@97AC M:&%N9V4@;W(@;VX@86YY(&%U=&]M871E9"!D96%L97(@<75O=&%T:6]N('-Y M2!A M2!M87)K970@;6%K:6YG(&%T(&%N>2!T:6UE+CPO9F]N=#X@("`-"B`@ M("`\+V1I=CX\8G(O/CQD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY!2=S(&-O;6UO;B!S=&]C M:R!A="!C;VYV97)S:6]N+"!A&EM871E;'D@)#,V,2XW(&UI;&QI;VXN M)B,Q-C`[)B,Q-C`[26YC6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SXF(S$V,#L\ M+V9O;G0^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL M:6YE)SXN/"]F;VYT/B8C,38P.R8C,38P.U5N9&5R($%30R`T-S`M,C`L(&ES M2!B92!S971T;&5D(&EN(&-A2!C;VUP;VYE;G0N)B,Q-C`[(%1H:7,@86UO M=6YT('=A2!I6EN9R!A M;6]U;G0@;V8@=&AE(&QI86)I;&ET>2!C;VUP;VYE;G0@86YD('1H92!R96UA M:6YI;F<@=6YA;6]R=&EZ960@9&5B="!D:7-C;W5N="!W97)E(&%S(&9O;&QO M=W,@*&EN('1H;W5S86YD6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@8V]L6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M,#$T/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$S/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ-"PY,S`\+V9O;G0^/"]F;VYT/B`@(`T* M("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,"PT-S`\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UEF5D(&1E8G0@9FEN86YC:6YG(&-O6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@ M("`@(`T*("`@("`@/&9O;G0@2!C;VUP;VYE;G0N)B,Q-C`[)B,Q-C`[5&AE('!O MF5D(&)Y('1H92!E9F9E8W1I=F4@:6YT97)E6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M'!E;G-E6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$T/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR,#$S/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXR,#$R/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXT+#$P-3PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#@R.#PO9F]N=#X@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$ M969E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXW-#0\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ,"PQ.3(\+V9O;G0^/"]F;VYT/B`@(`T* M("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY5<&]N(&ES2!E"!L:6%B:6QI='D@;V8@)#@N-B!M:6QL:6]N M(')E;&%T960@=&\@=&AE(&1E8G0@9&ES8V]U;G0@;V8@)#(Q+C,@;6EL;&EO M;BP@=VET:"!A;B!O9F9S971T:6YG(&1E8FET(&]F("0X+C8@;6EL;&EO;B!T M;R!C;VUM;VX@"!L M:6%B:6QI='D@=V%S(&5S=&%B;&ES:&5D(&)E8V%U"!L:6%B:6QI='D@"`@("`@#0H@("`@("!L:6%B:6QI='DN)B,Q-C`[)B,Q-C`[ M5&AE(&1E9F5R"!L:6%B:6QI='D@:7,@8F5I;F<@86UOF5D M(&UO;G1H;'D@87,@=&AE($-O;7!A;GD@6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G M(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-871U6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY-RPY-S4\+V9O;G0^/"]F M;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ,"PT-3`\+V9O;G0^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ,"PT-3`\+V9O;G0^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ+#`P,"PU.#@\+V9O;G0^("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY/;B!/8W1O8F5R(#2!W:71H('1H92!!9V5N="P@=&AE("8C.#(R,#M";T$@3&5N9&5R M2X@ M3VX@07!R:6P@,32!E;G1E'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!S=&]C:R!M971H;V0N/"]F;VYT/B`-"B`@("`\+V1I=CX\8G(O M/CQD:78@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE2!H87,@ M=&AE(&-H;VEC92!O9B!S971T;&EN9R!E:71H97(@:6X@8V%S:"!O2!I;F-L=61E9"!T:&4@87-S M=6UP=&EO;B!O9B!C;VYV97)S:6]N('1O(&-O;6UO;B!S:&%R97,@9F]R('1H M92!C;VYV97)T:6)L92!S<')E860N($1U2P@86YD("AI=BD@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY) M;F-O;64@9G)O;2!C;VYT:6YU:6YG(&]P97)A=&EO;G,@=7-E9"!F;W(@8F%S M:6,@96%R;FEN9W,@<&5R('-H87)E/"]F;VYT/B`@(`T*("`@("`@("`@("`@ M/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXU+#@R-3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT,2PV-S,\+V9O;G0^/"]F;VYT/B`@ M(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXU,BPS-C(\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXS-2PS-S@\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#LF(S$V,#LF(S$V,#M"87-I8SPO9F]N=#X@#0H@("`@("`@("`@("`\ M+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP M+C4T/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q! M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C0V/"]F;VYT/B`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,;W-S(&9R;VT@9&ES M8V]N=&EN=65D(&]P97)A=&EO;G,L(&YE="!O9B!T87@\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH-3`S/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#LF(S$V,#LF(S$V,#M"87-I8SPO9F]N=#X@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,"XP,3PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`@(#PO9&EV M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY3:&%R97,@=7-E9"!I;B!C;VUP=71I;F<@:6YC;VUE("AL;W-S M*2!P97(@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXY-BPQ.#$\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M3=&]C:R!O<'1I;VYS M(&%N9"!U;G9E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT M+#(S-#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M3 M=&]C:R!W87)R86YT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV M+#6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ,RPU,C(\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXV+#0Y.3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ.2PV,S`\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ-RPW,3<\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ-2PS,C$\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY796EG:'1E9"!A=F5R86=E(&1I;'5T960@6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ,C,L,3$P/"]F;VYT/B`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3,L.#DX/"]F;VYT/B`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3`L-3$P/"]F;VYT M/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T)SX@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!S971T;&4@86QL(&9U='5R92!N;W1E(&-O M;G9E2!T:')O=6=H('-H87)E65A6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@ M(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!S='EL93TS1"=724142#H@,3AP="<^("`@#0H@("`@("`@("`@("`@ M(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,BD\+V9O;G0^ M(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0^("`@#0H@("`@("`@("`@("`@(#QD:78@ M86QI9VX],T1L969T/B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65A3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA M-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q M,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N M>2!L96%S97,@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,86YD;&]R9"!I;F-E;G1I=F5S M(&%R92!R96-O65A6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2!Y96%R+"!O9B!F=71U6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE. M+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$U/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q! M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXR,#$V/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE. M+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$X/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1% M6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,#$Y/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT-C8\+V9O M;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,RPQ.#(\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^("`@ M("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!I9#TS1%1!0C$M-S(@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,3$L-S0X/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/B`- M"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T2!O=VYE9"!S=6)S:61I87)Y($-L;W9E6QV86YI82!F;W(@86X@:6YI M=&EA;"!T97)M(&5N9&EN9R!$96-E;6)E65A2!I2!A;'-O('1O M;VL@;W9E2!R96YT(&]F(&%P<')O M>&EM871E;'D@)#$P+#`P,"X@06QL(&]T:&5R(&QE87-E6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65A2!T;R!P87D@;6]N=&AL>2!R96YT(&]F(&%P<')O>&EM871E;'D@)#$U+#`P M,"P@<&QU&5S(&%N9"!C M;VUM;VX@87)E82!M86EN=&5N86YC92XF(S$V,#LF(S$V,#M02!H860@;&5A2`Q+"`R,#$P+"!A;F0@97AT96YD960@=&AR;W5G:"!I=',@96%R;'D@=&5R M;6EN871I;VX@9&%T92!O9B!&96)R=6%R>2`Q+"`R,#$T+B8C,38P.R8C,38P M.U5P;VX@=F%C871I;F<@=&AE(%-K;VMI92!S<&%C92!S:&]R=&QY(&%F=&5R M(&UO=FEN9R!2)F%M<#M$(&]P97)A=&EO;G,@=&\@5F5R;F]N($AI;&QS+"!) M;&QI;F]I'!E;G-E(&ET6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;B!*=6QY(#(W+"`R M,#$P+"!T:&4@0V]M<&%N>2P@=&AR;W5G:"!I=',@=VAO;&QY(&]W;F5D('-U M8G-I9&EA2!L;V-A=&5D(&%T(#2X@5&AI2!I2!T87AE65A2`R M-"P@,C`Q,2!T:&4@0V]M<&%N>2!E;G1E2!L96%S M92!W87,@2!A;F0@ M:&%S(&)E96X@6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2P@14H@1FEN86YC:6%L($5N=&5R<')I2!M;VYT:&QY(&)A2!A;F0@14H@1FEN86YC:6%L(&%G M2!T97)M:6YA=&4@=&AI2!A<'!R;WAI;6%T96QY("0R-#`L,#`P(&EN(')E;G0@86YD M(&-O;6UO;B!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`-"B`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SY. M;W1E(#D@)B,X,C$R.R!3=&]C:R!/<'1I;VYS+"!%;7!L;WEE92!3=&]C:R!0 M=7)C:&%S92!0;&%N(&%N9"!297-T6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`\ M9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4W1O8VL@3W!T:6]N(%!L86X\ M+V9O;G0^("`@(`T*("`@(#PO9&EV/CQB2!T;R!G7!E M2`R-RP@,C`P M-2P@86QL(&YE=R!A=V%R9',@=V5R92!G2!A;F]T M:&5R(#@L,#`P+#`P,"P@=&\@82!F:6YA;"!T;W1A;"!O9B`Q.2PP,#`L,#`P M('-H87)E&5R M8VES960L(#0L,S,Q+#`P,"!O<'1I;VYS(&AA=F4@8F5E;B!C86YC96QE9"P@ M86YD(#0L.38X+#`P,"!R96UA:6X@;W5T65A2!B92!I6]N9"!T:&%T(&1A=&4N)B,Q M-C`[)B,Q-C`[2&]W979E6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY5 M;F1E65A6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6UE;G0\+V9O M;G0^("A31D%3(#$R,RA2*2DI+B8C,38P.R8C,38P.T%C8V]R9&EN9VQY+"!S M=&]C:RUB87-E9"!C;VUP96YS871I;VX@8V]S="!I'!E;G-E M(')A=&%B;'D@;W9E2!T:&%T(&ES(&)A65E('!O2!E6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^,C`Q,CPO9F]N=#X@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY%>'!E8W1E9"!V;VQA=&EL:71Y/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-"4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXW,24\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS M1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0T)2!S='EL93TS1"=415A4+4%,24=. M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U M<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>'!E8W1E9"!L:69E("AI;B!Y M96%R6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-"4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5)) M1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY2:7-K+69R964@ M:6YT97)E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+CDE/"]F;VYT/B`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXM/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T)2!S='EL M93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`@(`T*("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXP+C@E/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$ M;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY$:79I9&5N9"!Y:65L9#PO9F]N=#X@("`@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP M=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY&86ER('9A;'5E('!E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-"4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1'1O<"!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE3X@(`T*("`@("`@/&9O;G0@2!O9B!S=&]C:R!O<'1I;VX@86-T:79I='D@=VET:&EN('1H92!#;VUP86YY M)B,X,C$W.W,@65A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C M96YT97([(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@:60],T1404(Q+36QE/3-$)TU!4D=)3BU,1494.B`Q,"XT<'0G/CPO9F]N=#Y3:&%R97,\+V9O M;G0^("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!C96YT97(G/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@ M:60],T1404(Q+36QE/3-$)TU!4D=)3BU,1494.B`R+C@U<'0G/CPO M9F]N=#Y796EG:'1E9#PO9F]N=#X@("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C M96YT97([(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^17AE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^0V]N=')A M8W1U86P@5&5R;3PO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^*%EE87)S*3PO9F]N=#X@(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^26YT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^*&EN('1H;W5S86YD6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXY+#,Y.3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C@Y/"]F M;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY%>&5R8VES960\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD:78@ M'!I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M.#<\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$ M14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@ M34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY' M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXS,C$\+V9O;G0^("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ-2XW-CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXT+C$X/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$ M;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY&;W)F96ET960@;W(@97AP:7)E9#PO9F]N=#X@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F M=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY/=71S=&%N9&EN9R!A="!$96-E;6)E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR."XU.3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@'!I"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!0041$24Y'+4)/ M5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,BXU M-CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@ M,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+#,X-CPO9F]N=#X@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R+C6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR+C0X/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ+C`Q/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&5R8VES86)L M92!I&5R8VES92!P M&5R8VES M960@9'5R:6YG('1H92!Y96%R2`D,30Q+C<@;6EL;&EO M;BP@)#@N.2!M:6QL:6]N(&%N9"`D.2XQ(&UI;&QI;VXL(')E2X@07,@82!R97-U;'0@;V8@=&AE('-T;V-K(&]P=&EO;G,@97AE2!R96-E:79E9"!C87-H(&%N9"!R96-O65E'!E;G-E(')A=&%B;'D@;W9E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE2!G2!D M871E(&]F('1H92!G&EM871E M;'D@,BXS(&UI;&QI;VX@;W!T:6]N'1E;F0@=&AE(&]P=&EO;B!T M97)M(&9O2`R+"`R,#$T('=H;VQE M(&=I=F5N(&EN8W)E87-E9"!T87@@;&EA8FEL:71I97,N(%1H92!S:&%R97,@ M96%C:"!V97-T(&%T(#(U)2!P97(@>65A6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/B`@("`@#0H@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^5V5I9VAT960@079E M6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-3PO9F]N=#X@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+C`Y/"]F M;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD:78@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M.#PO9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-"XV,SPO9F]N=#X@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@ M("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ-CPO9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-2XS-CPO9F]N M=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH,38\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L M:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY#86YC96QE9#PO9F]N=#X@("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,S<\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!2`D,3`N."!M:6QL M:6]N('=H:6-H(&ES(&5X<&5C=&5D('1O(&)E(')E8V]G;FEZ960@87,@97AP M96YS92!O=F5R(&$@=V5I9VAT960M879E6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^16UP;&]Y964@4W1O M8VL@4'5R8VAA65E M28C.#(Q-SMS(&-O M;6UO;B!S=&]C:R!T:')O=6=H('!A>7)O;&P@9&5D=6-T:6]N65E65A6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%, M+4%,24=..B!T97AT+71O<"<^6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%,+4%,24=..B!T97AT+71O<"<^ M'0M=&]P)SYS=#PO9F]N=#XN)B,Q-C`[)B,Q-C`[26X@82!G:79E;B!Y96%R M+"!E;7!L;WEE97,@;6%Y(&5N65E(&%R92!L:6UI=&5D('1O("0R-2PP,#`@=V]R M=&@@;V8@2!W:71H:&]L9"!N M;R!M;W)E('1H86X@)#(Q+#(U,"!P97(@>65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!(&UA>&EM M=6T@;V8@,B!M:6QL:6]N('-H87)E28C.#(Q-SMS M(&-O;6UO;B!S=&]C:R!M87D@8F4@:7-S=65D('5N9&5R('1H92!%4U!0+B8C M,38P.R8C,38P.TEN8VQU9&EN9R!S:&%R97,@:7-S=65S(&EN(&5A2!I2`V-RPP,#`L(#65A'!E;G-E(&]F(&%P<')O>&EM871E;'D@ M)#`N-"P@)#`N,B!A;F0@)#`N,B!M:6QL:6]N+"!R97-P96-T:79E;'D@:6X@ M96%C:"!P97)I;V0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M&5S/&)R/CPO&5S(&9R;VT@ M0V]N=&EN=6EN9R!/<&5R871I;VYS/"]F;VYT/CPO9F]N=#X\+V9O;G0^("`- M"B`@("`@(#PO9&EV/CQB"<^("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@#0H@("`@("`@ M("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^0W5R6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@ M("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@ M("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^5&]T86P\+V9O;G0^/&9O;G0@:60],T1404(R+3@@ M6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@ M("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$ M14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@ M34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@8V]L6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D"<^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY&961E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M,RPQ,C4\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XP M-7!T)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#DY,3PO9F]N=#X@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^-#PO9F]N=#X\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^*#(L/"]F;VYT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M,3,T/"]F;VYT/CPO9F]N=#X@("`@(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG M6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C,Y+#PO9F]N=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#PO M9F]N=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$V+#4P-CPO M9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(S M+#(X.#PO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M665A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@"<^("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X)SX@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)V)A8VMG6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY&961E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE M9G0^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXT+#$T-3PO9F]N=#X@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T"<^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@+3EP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T.R!- M05)'24XM4DE'2%0Z(#4N,#5P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^*#4Y.#PO9F]N=#X\+V9O;G0^("`@(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@ M("`@("`@/'1R/B`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W,"4@"<^("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^,S(L,3,P/"]F;VYT/CPO9F]N=#X@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@Q+#4Y-SPO9F]N=#X\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!I9#TS1%1!0C$M-SD@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^,S`L-3,S/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U M+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M"<^("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X)SX@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`- M"B`@("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&961E6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY3=&%T93PO9F]N=#X@("`-"B`@("`@("`@("`@("`@/"]D M:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXS+#,R,3PO9F]N=#X@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@#L@4$%$1$E. M1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`T-#9P="<^(`T*("`@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^)B,X,C$R.SPO9F]N=#X\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M*#$L-3,X/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/B8C,38P.R@Q+#4S.#PO9F]N=#X\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@-'!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^*#(L.34S/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`@(`T*("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE'!E8W1E9"8C.#(R,3L@=&%X(&5X<&5N"!R871E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C M;VQS<&%N/3-$,3`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G M/B`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@ M("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^/&9O;G0@"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,C`Q,CPO9F]N=#X\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY#;VUP=71E9"`F(S@R,C`[97AP96-T960F(S@R,C$[('1A>"!E>'!E M;G-E/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U M<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@#PO9F]N=#X@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M.#0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^ M("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXV,C(\+V9O;G0^("`@(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#0V M.#PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH,2PT-#0\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2PS-C$\ M+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,2PR-S<\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R/B`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E M/B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@+3EP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T.R!- M05)'24XM4DE'2%0Z(#4N,#5P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE'!E;G-E M("AB96YE9FET*2P@;F5T/"]F;VYT/B`-"B`@("`@("`@("`@("`@/"]D:78^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L M:6=N/3-$6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@"<^("`-"B`@("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@+3EP=#L@1$E34$Q!63H@ M8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#4N,#5P M="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^,2PQ,38\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L M:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(S+#(X.#PO9F]N=#X\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@-'!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M,C(L,3(R/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`@ M(`T*("`@("`@/&9O;G0@28C.#(Q M-SMS(&EN8V]M92!F&5S(&)E='=E96X@52Y3+B!A;F0@9F]R96EG;B!O<&5R871I M;VYS('=A6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G/B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY06QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH."PU.#<\+V9O M;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!! M1$1)3D3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU.2PQ,S8\+V9O;G0^/"]F M;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$ M96-E;6)E6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY#=7)R96YT/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@8V]L6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#=7)R96YT/"]F;VYT/B`@ M(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-BPQ.3`\+V9O;G0^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT,SD\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-"PP-C$\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+#8S,#PO9F]N=#X@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4 M.B`Y<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M297-E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M,BPR-34\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXS+#$X.3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M) M;G9E;G1O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXU+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M/=&AE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/C@L-3

"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^,3DR/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/B`@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,2PW-3$\+V9O;G0^/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@"!A M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-BPR-3<\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,BPT-#(\+V9O;G0^("`@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/B@Q+#$Q-CPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^)B,X,C$R M.SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B8C.#(Q,CL\+V9O M;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@ M5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^,S8L,C4W/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,C$L-C6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@3X@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2PV,3D\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M5;F%M;W)T:7IE9"!D M:7-C;W5N="`F(S@R,3$[(&-O;G9E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-"PR,C,\+V9O;G0^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE3X@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH,38L-36QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/B@X,3PO9F]N=#X\+V9O;G0^(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M4;W1A;"!D969E"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#,L M-C`Q/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#$L,C`Q/"]F;VYT/CPO9F]N M=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@R,"PW.3D\+V9O;G0^/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1) M3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C,R+#8U-CPO9F]N=#X\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/C(V-2PQ,C0\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T"!A2!E=F%L=6%T960@=&AE(&1A=&$@86YD(&1E=&5R;6EN960@=&AA="!A M2!H860@8V]N8VQU9&5D('1H870@86QL(&]F(&ET6QE/3-$)U1%6%0M M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N M>28C.#(Q-SMS(&YE="!O<&5R871I;F<@;&]S28C.#(Q M-SMS('1A>"!L;W-S97,@:6X@=&AE(&1E8V%D92!O9B!T:&4@,C`P,',@86YD M(&AA=F4@;F]T('EE="!B965N(&9U;&QY('5T:6QI>F5D(&1U92!T;R!T:&4@ M4W1A=&4@;V8@26QL:6YO:7,F(S@R,3<[F5D('=E;&P@8F5F;W)E('1H96ER(&5X<&ER871I;VX@("`@#0H@("`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`Q,'!T)SY"86QA;F-E(&%T($1E8V5M8F5R(#,Q+"`R,#$Q/"]F;VYT M/B`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY!9&1I=&EO;G,@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ+#(V-3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U!!1$1)3D"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,C(P/"]F M;VYT/CPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"86QA;F-E(&%T($1E8V5M8F5R(#,Q M+"`R,#$R/"]F;VYT/B`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@'!O65A"<^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^*#$L,C(Y/"]F;VYT/CPO9F]N=#X@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R('-T>6QE M/3-$)V)A8VMG6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!9&1I=&EO;G,@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@"<^("`-"B`@("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY497)M:6YA=&EO;G,@;V8@97AP;W-U6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4G/B8C.#(Q,CL\+V9O;G0^/"]F;VYT/B`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A;6]U;G1S(&EN8VQU9&5D(&EN('1H92!$96-E;6)E"!P;W-I=&EO;G,@=&AA="!C;W5L9"!S:6=N:69I8V%N=&QY(&-H M86YG92!D=7)I;F<@=&AE(&YE>'0@='=E;'9E(&UO;G1H2!A8V-O=6YT3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S M8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE28C.#(Q-SMS(#0P,2AK*2!0;&%N+B!$ M=7)I;F<@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$T+"`R,#$S M(&%N9"`R,#$R+"!P;&%N+7)E;&%T960@97AP96YS92!T;W1A;&5D(&%P<')O M>&EM871E;'D@)#$N,R!M:6QL:6]N+"`D,"XX(&UI;&QI;VX@86YD("0P+C@@ M;6EL;&EO;BP@2!P2!E86-H(&5M<&QO>65E+"!W M:&EC:"!I65E65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV M869?8F,X835A93'0O:'1M;#L@8VAA6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^3F]T92`Q,B`F(S@R,3([(%-E9VUE;G0@26YF;W)M871I M;VX\+V9O;G0^(`T*("`@(#PO9&EV/CQB65AF%T:6]N86P@86YD(')E<&]R=&EN9R!S=')U M8W1U6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY3 M96=M96YT(%)E<&]R=&EN9SPO9F]N=#XL(&%N9"!#:&EE9B!%>&5C=71I=F4@ M3V9F:6-E2!T:&4@0T]$32!B87-E9"!O;B!T:&4@9F]L;&]W:6YG('1W;R!R97!O6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXM($-O;G-U;65R($AE86QT:#PO9F]N=#X@ M("`@(`T*("`@(#PO9&EV/CQB2!M86YA9V5D('1H92!B=7-I;F5S6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE M/3-$)V)A8VMG6QE/3-$)V)O6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^1F]R;65R(%-E9VUE M;G1S/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@'0M86QI9VXZ(&-E;G1E6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M(S`P,#`P,"`Q<'0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)A8VMG6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY8/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$-B4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^2&DM5&5C M:#PO9F]N=#X@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1M:61D;&4@=VED=&@],T0T,"4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY8/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$-B4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/5$,@0G)A;F1E9"!0 M:&%R;6%C975T:6-A;',@*"8C.#(R,#M(0U`F(S@R,C$[*3PO9F]N=#X@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$-#`E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M8("AC*3PO9F]N=#X@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$-B4@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE'0M=&]P.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-S0[/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY297!R97-E;G1S('1H92!P6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY297!R97-E;G1S M('1H92!P65A6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY4:&4@0V]M<&%N>28C.#(Q-SMS(%!R97-C28C.#(Q-SMS($-O;G-U;65R($AE86QT:"!S96=M96YT('!R:6YC:7!A;&QY M(&-O;G-I28C.#(Q-SMS(')E<&]R=&%B;&4@6QE/3-$ M)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($1)4U!,05DZ(&EN;&EN92<^ M8GD@2!H87,@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN92<^665A6QE/3-$)TQ%5%1%4BU34$%#24Y' M.B`S<'0[($-/3$]2.B!B;&%C:R<^/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@ M("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R/B`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@ M("`@("`@(#QD:78@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1&QE9G0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^/&9O;G0@:60],T1404(Q+3@W('-T>6QE/3-$)TU!4D=)3BU, M1494.B`W+CDU<'0G/CPO9F]N=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/C(P,3,\+V9O;G0^/"]F;VYT/B`-"B`@("`@("`@("`@("`@/"]D M:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,C`Q M,CPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY2159%3E5%4SPO9F]N=#X@#0H@("`@("`@("`@("`@(#PO9&EV M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT^("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY06QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L M969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T"<^("`-"B`@("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@+3EP=#L@1$E3 M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@ M-2XP-7!T)R!A;&EG;CTS1&QE9G0^(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;VYS=6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C4P+#(S M,CPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/C,W+#@P,#PO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C,R+#(W-SPO9F]N=#X\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@+3EP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T.R!- M05)'24XM4DE'2%0Z(#4N,#5P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G M/C4Y,RPP-S@\+V9O;G0^/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^,C4V+#$U.#PO9F]N=#X\+V9O;G0^("`- M"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N M/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-S`L,3DW/"]F M;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ-3$L,3@R/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,CDL.#@T/"]F;VYT/B`@(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@"<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)V)A8VMG6QE/3-$)U1% M6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#$X<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^,CDW+#4Y,#PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4G/C$W,2PY,#0\+V9O;G0^/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!M M86YA9V5S(&ET2UW:61E(&)A6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@ M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE2!!:V]R;B!) M;F1I82!02XF(S$V,#LF(S$V,#M);B!T:&5S92!Y M96%R'!O6EN9R!A;6]U;G1S(&]F(&=O;V1W:6QL(&%S(')E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R M/B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY!8W%U:7-I=&EO;G,\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@/"]D M:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(SDT M-S([/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT^("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^ M("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!C;VQS M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^("`@("`-"B`@("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(SDT M-S([/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU M<'0G/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(SDT-S([/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]D M:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@ M#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-C`L.3$Q/"]F;VYT/B`@(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4 M.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%2 M1TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(SDT-S([/"]F;VYT M/B`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@ M("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT^("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^("`@("`-"B`@ M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$:7-P;W-I=&EO;G,\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(SDT-S([/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]D:78^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH-3$T/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,"XU<'0G/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@("`@ M(#QD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(SDT-S([/"]F;VYT/B`@("`-"B`@("`@ M("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1J=7-T:69Y/B`@("`-"B`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SY.;W1E(#$S("8C.#(Q,CL@ M0V]M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,\+V9O;G0^/"]F;VYT/B`@ M("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[ M(%9%4E1)0T%,+4%,24=..B!T97AT+71O<"<^)B,Q-S0[/"]F;VYT/B!F28C.#(Q-SMS(&YE="!S86QE M'0M=&]P)SXF(S$W M-#L\+V9O;G0^(&EN('1H92!F:7)S="!Y96%R(&9O;&QO=VEN9R!A8W%U:7-I M=&EO;BX@5&AE($-O;7!A;GD@<&%I9"!C;VYS:61E2!A="!$96-E;6)E6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!H87,@ M96YT97)E9"!I;G1O('-T6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6UE;G0@6UE;G1S(&%N9"!I;B!C97)T M86EN('-T6%L='D@<&%Y;65N=',N)B,Q-C`[)B,Q-C`[5&AE($-O;7!A;GD@=VEL;"!B M92!R97-P;VYS:6)L92!F;W(@8V]N=&EN9V5N="!M:6QE6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;B!/8W1O8F5R(#$W M+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E28C.#(Q-SMS(&UA65A"!M;VYT:',@;V8@=&AE(&9I6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!F;W(@=&AE('!R M;W9I&EM871E;'D@)#$N.2!M:6QL:6]N(&EN M(#(P,34N/"]F;VYT/B`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@=&%B M;&4@8F5L;W<@65A6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY-:6QE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$U/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!I2P@;V8@=6QT:6UA=&4@;&EA8FEL:71Y M('=I=&@@2!B96QI979E M'!O3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E M.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@8V]L6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@ M("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$T/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR,#$S/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M,#$R/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXS,2PT,3,\+V9O;G0^/"]F;VYT/B`@(`T* M("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXT+#(P,#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-RPT-3`\+V9O M;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA M-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q M,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0@0FQO8VL@6T%B'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65T($%D;W!T M960@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@(`T*("`@("`@/&9O;G0@28C.#(Q-SMS(&%B:6QI M='D@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C;VYC97)N(&%N9"!T;R!P6QE M/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@ M#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY2979E;G5E(&9R;VT@ M0V]N=')A8W1S('=I=&@@0W5S=&]M97)S/"]F;VYT/B8C.#(R,3L@*"8C.#(R M,#M!4U4@,C`Q-"TP.28C.#(R,3LI+"!W:&EC:"!P7!E($-O;G1R86-T2!E>'!E8W1S('1O(&)E M(&5N=&ET;&5D(&EN(&5X8VAA;F=E(&9O2!I;F-L M=61E(&ED96YT:69Y:6YG('!E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY);B!!<')I;"`R,#$T+"!T:&4@1D%30B!I2!W:6QL(&)E(')E<75I6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY);B!*=6QY(#(P,3,L('1H92!&05-"(&ES M"!,;W-S+"!O"!#6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q! M63H@:6YL:6YE)SY);F-O;64@5&%X97,L/"]F;VYT/B8C.#(R,3L@=&\@<')O M=FED92!C;&%R:69I8V%T:6]N(&]F('1H92!F:6YA;F-I86P@69O&ES=',N($%C8V]R9&EN9R!T;R!T:&4@;F5W(&=U:61A;F-E+"!U;G)E8V]G M;FEZ960@=&%X(&)E;F5F:71S('=I;&P@8F4@;F5T=&5D(&%G86EN"!C87)R>69O2!B96EN9R!N971T960@86=A:6YS="`@("`@#0H@("`@("!C M87)R>69O'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M5T5)1TA4.B!B;VQD)SY%>&-E;'9I6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&5M8F]U2P@06MO2!O=VYE9"!S=6)S:61I87)Y+"!%>&-E;'9IF5R;&%N9"!S<&5C:6%L:7II;F<@ M:6X@;W!H=&AA;&UI8R!P6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY/;B!*86YU87)Y(#(L(#(P,34L('1H92!#;VUP86YY(&%C<75I28C.#(Q-SMS(&%C<75I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE)SY"=7-I;F5S'!A M;F0@=&AE($-O;7!A;GDF(S@R,3<[2!W:6QL(&EN8VQU9&4@:6YF;W)M871I;VX@86)O=70@=&AE M(&9A:7(@=F%L=64@;V8@86-Q=6ER960@87-S971S(&%N9"!A&-E;'9I&EM871E;'D@)#`N,R!M:6QL:6]N M(&EN(&%C<75I&-E;'9I6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SY,;&]Y9"!!;FEM86P@2&5A M;'1H(%!R;V1U8W1S/"]F;VYT/B`@("`@#0H@("`@/"]D:78^/&)R+SX\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!O9B!T:&4@0V]M<&%N>2!E;G1E M60L($EN8RXL('1O(&%C<75I2!R96QA=&5D('1O(&$@6UE;G0@;V8@)#(N,"!M:6QL:6]N+"!D:7-C;W5N=&5D('1O("0Q+CD@;6EL M;&EO;B!U6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY"=7-I;F5S'!A;F0@=&AE($-O;7!A;GDF(S@R M,3<[60@06-Q=6ES:71I;VX@86YD('1H92!F86ER('9A;'5E2!A8V-E<'1E9"!A M8V-O=6YT:6YG('!R:6YC:7!L97,@*"8C.#(R,#M'04%0)B,X,C(Q.RDN)B,Q M-C`[)B,Q-C`[5&AE(&9I9W5R97,@8F5L;W<@87)E('!R96QI;6EN87)Y(&%N M9"!S=6)J96-T('1O(')E=FEE=R!O9B!T:&4@9F%C=',@86YD(&%S60@4')O9'5C=',N/"]F;VYT/CPO M9F]N=#X@("`-"B`@("`@("`@("`\+V1I=CX\8G(O/CQT86)L92!C96QL<&%D M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS M1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^("`@#0H@("`@("`@(#QT"<^("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)V)A8VMG6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ-BXQ/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@ M(#QD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4G/B`@("`-"B`@("`@("`@("`@(#QD:78@ M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4G/B`@("`@#0H@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ."XP/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T"<^(`T*("`@("`@("`@("`@/&9O;G0@ M6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M=&]P('=I9'1H/3-$,24@"<^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)3X@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY);G9E;G1O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY06QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY)4%(F86UP.T0\+V9O;G0^ M("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)3X@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9"<^ M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XQ*3PO9F]N=#X@ M#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY&86ER('9A;'5E(&]F(&%S6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY)4%(F86UP.T0@87-S971S(')E<')E65A60@<')O9'5C=',@87)E(&EN8VQU9&5D('=I=&AI M;B!P28C.#(Q-SMS(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E M="!A2P@ M9&5T97)M:6YI;F<@=&AE('!R;R!F;W)M82!R979E;G5E(&%N9"!E87)N:6YG M2!I;F-L=61I;F<@=&AE($QL;WED(%!R;V1U8W1S M($%C<75I2!R96QA=&5D('1O('1H92!B6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY8;W!E;F5X/&9O;G0@'0M=&]P.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-S0[/"]F M;VYT/B!I65A#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%, M+4%,24=..B!T97AT+71O<"<^)B,Q-S0[/"]F;VYT/B`H=&AE("8C.#(R,#M8 M;W!E;F5X($%C<75I6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@("`-"B`@("`@("`@/&9O;G0@2P@=&AE($-O;7!A;GD@87-S=6UE9"!A M(&1I2!C;W5R6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@9F]L;&]W:6YG('1A8FQE('-E=',@ M9F]R=&@@=&AE(&-O;G-I9&5R871I;VX@<&%I9"!F;W(@=&AE(%AO<&5N97@@ M06-Q=6ES:71I;VX@86YD('1H92!F86ER('9A;'5E"!06QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY4;W1A;"!C;VYS:61E6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$=&]P('=I M9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T"<^(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@"<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY);G9E;G1O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD M:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY&86ER('9A;'5E(&]F(&YE="!A6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4G/B`@(`T*("`@("`@("`@("`@/&9O;G0@65A#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%,+4%,24=..B!T97AT M+71O<#L@1D].5"U714E'2%0Z(&)O;&0G/B8C,328C.#(Q-SMS(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@ M8F%L86YC92!S:&5E="!A&EM871E;'D@)#`N-R!M:6QL M:6]N(&EN(&%C<75I6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M5T5)1TA4.B!B;VQD)SY64$D@2&]L9&EN9W,@0V]R<"X@26YC+CPO9F]N M=#X@("`@(`T*("`@(#PO9&EV/CQB2`D-#,S+C`@;6EL M;&EO;BP@2!O9B!697)S85!H87)M(&%N9"!W87,@97%U86P@=&\@)#0T,"XP M(&UI;&QI;VXL(&YE="!O9B!V87)I;W5S('!O&EM871E;'D@)#6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`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`Q,'!T)SY4:&4@5F5R28C.#(Q-SMS('!R;V1U8W0@<&]R M=&9O;&EO(&)Y(&1I=F5R6EN9R!I=',@;V9F97)I;F<@=&\@;FEC:&4@ M9&5R;6%T;VQO9WD@;6%R:V5T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY4:&4@5F5R6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!R96-O'!E;G-E6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!4:6UE2!A;F0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@(`T*("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY);FET:6%L($9A:7(\+V9O;G0^("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY686QU871I;VX\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY097)I;V0\+V9O M;G0^("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!0 M041$24Y'+4)/5%1/33H@,"XU<'0G/B`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!9&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#M&86ER/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY686QU871I;VX\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,"XU<'0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXS,C(N-SPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ-"XR/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ,"XS/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY4'!E;G-E"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY4;W1A;"!C;VYS:61E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-3`N-CPO9F]N=#X@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY6 M97)S85!H87)M(&1E8G0@<&%I9"!O9F8@=&AR;W5G:"!C;&]S:6YG(&-A"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX,BXT/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT,S,N,#PO9F]N M=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$\ M+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ,2XP/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);G9E;G1O6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C`\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C`\+V9O;G0^ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR-3`N.#PO9F]N=#X@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY)4%(F86UP.T0\+V9O;G0^("`@(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)A M8VMG"<^("`@("`-"B`@("`@("`@("`@ M(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXY,2XT/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1) M3D6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY4;W1A;"!A6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XV/"]F;VYT/B`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH-S8N,#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-S8N M,#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@"!L:6%B:6QI=&EE"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@ M("`@#0H@("`@("`@(#QT6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-3`N-CPO9F]N=#X@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY4:&4@8VAA;F=E6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`- M"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY';V]D M=VEL;"!R97!R97-E;G1S(&5X<&5C=&5D('-Y;F5R9VEE&ES=&EN9R!697)S85!H M87)M(&=O;V1W:6QL(&%N9"!O=&AE"!P=7)P;W-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!R96-O6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY796EG:'1E9"!A=F5R86=E(')E;6%I;FEN M9R!A;6]R=&EZ871I;VX@<&5R:6]D(&]F(&EN=&%N9VEB;&4@87-S971S(&%C M<75I65A65A6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SY(:2U496-H(%!H M87)M86-A;"!#;RXL($EN8RX\+V9O;G0^("`@(`T*("`@(#PO9&EV/CQB2!C;VUP;&5T M960@:71S(&%C<75I2`D-C4P+C`@;6EL;&EO;BX@ M5&AI6EN9R!O=70@=&AE(&EN=')I;G-I M8R!V86QU92!O9B!(:2U496-H)B,X,C$W.W,@6EN9R!T:&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;B!!=6=U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`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`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M&EM871E;'D@)#(Q+C,@;6EL;&EO;B!A;F0@)#$N M-B!M:6QL:6]N+"!R97-P96-T:79E;'DL(&EN(&%C<75I'!E;G-E2!C;VYS:7-T M960@;V8@=F%R:6]U'!E;G-E28C.#(Q-SMS(&-O M;G-O;&ED871E9"!S=&%T96UE;G0@;V8@8V]M<')E:&5N6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A;F0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M0V]N6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@ M(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@ M("`\=&0@8V]L6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$8V5N=&5R/B`-"B`@("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-96%S=7)E;65N=#PO9F]N M=#X@#0H@("`@("`@("`@("`@("`@/"]D:78^("`@(`T*("`@("`@("`@("`@ M("`@(#QD:78@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY!9&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY686QU871I M;VX\+V9O;G0^("`@(`T*("`@("`@("`@("`@("`@(#PO9&EV/B`@("`-"B`@ M("`@("`@("`@("`@/"]T9#X@#0H@("`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M;6]U;G0@;V8@8V%S:"!P86ED('1O($AI+51E8V@@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^ M(`T*("`@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]T9#X@ M#0H@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@ M("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV,#4N,#PO9F]N=#X@ M("`-"B`@("`@("`@("`@("`@/"]T9#X@#0H@("`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@ M("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXT,"XU/"]F;VYT/B`@#0H@("`@("`@("`@("`@(#PO=&0^ M(`T*("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO M=&0^(`T*("`@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@ M(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S@R,3([/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]T9#X@#0H@ M("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;6]U;G0@;V8@8V%S:"!P86ED M('1O(&ME>2!E>&5C=71I=F5S('5N9&5R(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SYS:6YG;&4M=')I9V=E6UE M;G1S('5P;VX@8VAA;F=E+6EN+6-O;G1R;VP\+V9O;G0^/"]F;VYT/B`@#0H@ M("`@("`@("`@("`@("`@/"]D:78^("`@(`T*("`@("`@("`@("`@("`\+W1D M/B`-"B`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$"<^("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@ M(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^("`@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]T9#X@#0H@ M("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-#DN-CPO9F]N=#X@("`- M"B`@("`@("`@("`@("`@/"]T9#X@#0H@("`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@ M("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,BXR-7!T)SX@(`T*("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U!! M1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@ M("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M4F5C;V=N:7IE9"!A;6]U;G1S(&]F(&ED96YT:69I86)L92!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED)SX@#0H@("`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@#0H@ M("`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY!9&IU6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T* M("`@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!8V-O=6YT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T* M("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU M-RXS/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@ M("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@ M("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2XW/"]F M;VYT/B`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@ M("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@ M("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU,2XV/"]F;VYT/B`@("`-"B`@("`@ M("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`\+W1R/B`-"B`@("`@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG M3PO9F]N=#X@#0H@("`@("`@("`@("`@("`@("`\+V1I=CX@ M#0H@("`@("`@("`@("`@("`@/"]T9#X@("`-"B`@("`@("`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@ M("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@ M("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY02!A;F0@97%U:7!M96YT/"]F;VYT/B`@("`-"B`@("`@ M("`@("`@("`@("`@(#PO9&EV/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT-2XU/"]F;VYT/B`@("`- M"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@ M("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@ M("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,BXP/"]F;VYT/B`@("`-"B`@("`@ M("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`- M"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@ M(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`- M"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXT,RXU/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@ M("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`\+W1R/B`-"B`@ M("`@("`@("`@("`@/'1R/B`@("`@#0H@("`@("`@("`@("`@("`@/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4^("`@#0H@ M("`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXS-#,N-3PO9F]N=#X@("`@(`T*("`@("`@("`@ M("`@("`@(#PO=&0^("`@#0H@("`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T* M("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY)4%(F86UP.T0\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`@(#PO9&EV/B`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T* M("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY M+C0\+V9O;G0^("`@#0H@("`@("`@("`@("`@("`@/"]T9#X@("`-"B`@("`@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY#=7-T;VUE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C,\+V9O M;G0^("`@#0H@("`@("`@("`@("`@("`@/"]T9#X@("`-"B`@("`@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`- M"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@ M("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S@R,3([/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T* M("`@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@ M("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU+C4\ M+V9O;G0^("`@#0H@("`@("`@("`@("`@("`@/"]T9#X@("`-"B`@("`@("`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,BXP/"]F;VYT/B`@ M("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ-CDN-3PO9F]N=#X@("`@(`T*("`@("`@("`@ M("`@("`@(#PO=&0^("`@#0H@("`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O M;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXP+C8\+V9O;G0^("`@#0H@("`@("`@("`@("`@("`@/"]T9#X@("`- M"B`@("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXP+C8\+V9O;G0^("`@#0H@("`@("`@("`@ M("`@("`@/"]T9#X@("`-"B`@("`@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@("`@#0H@("`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`\+W1R/B`-"B`@("`@ M("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T* M("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY$969E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,3(Q+CD\+V9O M;G0^(`T*("`@("`@("`@("`@("`@(#PO=&0^("`@#0H@("`@("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@ M("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH-"XR/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`-"B`@ M("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`\+W1R/B`- M"B`@("`@("`@("`@("`@/'1R/B`@("`@#0H@("`@("`@("`@("`@("`@/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4;W1A;"!L:6%B:6QI=&EE6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T* M("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`-"B`@("`@("`@("`@ M("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`\+W1R/B`-"B`@("`@("`@("`@(#PO=&%B;&4^ M/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY4:&4@8VAA;F=E6YE"!P=7)P;W-E2`D,3@N.2!M:6QL:6]N(&]F('9A M;'5E(&%S2`D,36QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY796EG:'1E9"!A=F5R86=E(&%M;W)T:7IA=&EO;B!P97)I;V0@;V8@ M:6YT86YG:6)L92!A65A65A6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5) M1TA4.B!B;VQD)SY7871S;VX@4')O9'5C="!$:7-P;W-I=&EO;CPO9F]N=#X@ M("`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"="04-+ M1U)/54Y$+4-/3$]2.B`C9F9F9F9F.R!$25-03$%9.B!I;FQI;F4G/DEN(&-O M;FYE8W1I;VX@=VET:"!T:&4@2&DM5&5C:"!-97)G97(L($%K;W)N(&5N=&5R M960@:6YT;R!A;B!A9W)E96UE;G0@*'1H92`F(S@R,C`[1&ES<&]S:71I;VX@ M06=R965M96YT)B,X,C(Q.RD@=VET:"!7871S;VX@=&\@9&ES<&]S92!O9B!C M97)T86EN(')I9VAT61R;V-H;&]R:61E M($IE;&QY("8C.#(Q,CL@86YD(&]N92!!:V]R;B!P2`F(S@R,C`[=&AE M('!R;V1U8W1S)B,X,C(Q.RX@5&AE($1I=F5S=&UE;G0@06=R965M96YT(&9U M2!V;W1E(&]F M('1H92!&5$,@;VX@07!R:6P@,3$L(#(P,30N(%1H92!C;&]S:6YG(&]F('1H M92!D:7-P;W-I=&EO;B!A9W)E96UE;G0L('=H:6-H('=A28C.#(Q-SMS M(&%C<75I2!R96-O6QE/3-$)U!!1$1) M3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@"<^(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY);G1A;F=I8FQE(&%S6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)3X@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH,2XQ/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`- M"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH,"XX/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)V)A8VMG6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4G/B`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)U1% M6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T* M("`@("`@/&9O;G0@2!A;F0@;F5C97-S87)Y(&AI6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M5T5)1TA4.B!B;VQD)SY%0U(@1&EV97-T:71U6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;B!*=6YE(#(P+"`R,#$T+"!T:&4@ M0V]M<&%N>2!D:79E2P@14-2(%!H87)M86-E M=71I8V%L2!#;W)M87@\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@-S`E.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`G/B8C M,3'0M=&]P M)SXF(S$W-#L\+V9O;G0^($A#+"!A;F0@6F]L=FET/&9O;G0@'0M=&]P)SXF(S$W-#L\+V9O;G0^($]R86P@4V]L=71I;VX@;W1H M97)W:7-E(&MN;W=N(&%S("8C.#(R,#M,;W)T86(F(S@R,C$[*2!T;R!686QE M86YT(%!H87)M86-E=71I8V%L2!R96-O9VYI>F5D(&$@;F]M:6YA;"!G86EN(&]N('1H92!S M86QE(&]F('1H92!I;G1A;F=I8FQE('!R;V1U8W0@2!A;F0@9&]E6QE/3-$)T9/3E0M4U19 M3$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SYD:7-C;VYT:6YU960@;W!E M3X@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY# M;VYS:61E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXT,2XP/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3X@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!! M1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXU+C$\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UEF5D/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,BXR-7!T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4G/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXP+CD\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1) M0T%,+4%,24=..B!T97AT+71O<"<^)B,Q-S0[/"]F;VYT/BP@82!P64@9')O<"!I;F1I8V%T960@9F]R(')E9'5C M:6YG(&5L979A=&5D(&EN=')A;V-U;&%R('!R97-S=7)E(&EN('!A=&EE;G1S M('=I=&@@;W!E;BUA;F=L92!G;&%U8V]M82!O28C.#(Q-SMS(&%C<75I'0M=&]P)SXF(S$W-#L\+V9O;G0^("AT:&4@)B,X,C(P.UII M;W!T86X@06-Q=6ES:71I;VXF(S@R,C$[*2!I6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE2!E;G1E2!A;F0@;F5C97-S87)Y(&AI6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%, M+4%,24=..B!T97AT+71O<"<^)B,Q-S0[/"]F;VYT/B!A2`Q+"`R,#$S(&)E8V%U2!I;F9O M&ES=&5D(&]N('1H92!D M871E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%, M+4%,24=..B!T97AT+71O<"<^)B,Q-S0[/"]F;VYT/BP@82!P64@9')O<"!F;W(@=&AE(')E9'5C=&EO;B!O9B!E M>64@<')E28C.#(Q-SMS(&%C<75I'0M=&]P M)SXF(S$W-#L\+V9O;G0^("AT:&4@)B,X,C(P.T)E=&EM;VP@06-Q=6ES:71I M;VXF(S@R,C$[*2!I6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%,+4%, M24=..B!T97AT+71O<"<^)B,Q-S0[/"]F;VYT/B!I;B!T:&4@("`-"B`@("`@ M(&9I28C.#(Q-SMS(&9I2!R96UA:6YI;F<@86UO=6YT(#8P(&1A>7,@9F]L;&]W:6YG('1H92!F M:7)S="!Y96%R('!O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W M,"4[(%9%4E1)0T%,+4%,24=..B!T97AT+71O<#L@1D].5"U714E'2%0Z(&)O M;&0G/B8C,36QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY5<&]N(&-O;7!L971I M;F<@=&AE($)E=&EM;VP@06-Q=6ES:71I;VXL('1H92!#;VUP86YY(&5N=&5R M960@:6YT;R!A('-U<'!L>2!A9W)E96UE;G0@=VET:"!386YT96X@=VAE2!386YT96X@=VEL;"!C;VYT:6YU92!M86YU9F%C='5R:6YG($)E=&EM;VP\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@-S`E M.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`G/B8C,36QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:&4@9F]L;&]W:6YG('1A8FQE('-E=',@9F]R=&@@=&AE(&-O;G-I M9&5R871I;VX@<&%I9"!F;W(@=&AE($)E=&EM;VP@06-Q=6ES:71I;VX@86YD M('1H92!F86ER('9A;'5E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^0F5T:6UO;"!!8W%U:7-I=&EO;CH\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&86ER('9A M;'5E(&]F(&%C<75I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M=&]P)SXF(S$W-#L\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ,2XT/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T'0M=&]P)SXF(S$W-#L\+V9O;G0^(&%R M92!I;F-L=61E9"!W:71H:6X@<')O9'5C="!L:6-E;G-I;F<@65A28C.#(Q-SMS(&-O;G-O;&ED M871E9"!B86QA;F-E('-H965T(&%S(&]F($1E8V5M8F5R(#,Q+"`R,#$T+CPO M9F]N=#X@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!E6UE;G0L M('1H:7,@861D:71I;VYA;"!C;VYS:61E&EM871E;'D@)#0N,"!M:6QL:6]N+B!!65A M2`Q+"`R,#$S(&)E8V%U2!I M;F-L=61I;F<@=&AE($)E=&EM;VP@06-Q=6ES:71I;VX@=V]U;&0@F5D M(&%N9"!M96%S=7)E9"P@86YD('=O=6QD(&AA=F4@8F5E;B!A=F%I;&%B;&4@ M=VAE;B!T:&4@9FEN86YC:6%L('-T871E;65N=',@9F]R('1H870@<')I;W(@ M<&5R:6]D('=E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-4 M64Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^365R8VL@4')O9'5C=',@06-Q=6ES:71I;VX\+V9O;G0^("`@#0H@ M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`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`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R M:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ,RXX/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`W,"4[(%9%4E1)0T%,+4%,24=..B!T97AT+71O<#L@1D].5"U7 M14E'2%0Z(&)O;&0G/B8C,36QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY#;W-O<'0\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@-S`E.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`[ M($9/3E0M5T5)1TA4.B!B;VQD)SXF(S$W-#L\+V9O;G0^(%!&/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M"<^(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@ M(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY06QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY06QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$\+V9O M;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY$969E6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#%P>"!S;VQI9"<^("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'@@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;VYS:61E6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@ M(#QD:78@"<^("`@("`-"B`@("`@("`@("`@(#QD:78@"<^(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@/&9O;G0@F5D('-T87)T+75P(&-O"!A7-I"!A"!A"!V86QU92!O9B!!>F%3:71E/&9O;G0@'0M M=&]P.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-S0[/"]F;VYT/B!PF%B M;&4@9F]R('1A>"!P=7)P;W-E65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!H M87,@;F]T('!R;W9I9&5D('!R;R!F;W)M82!R979E;G5E(&%N9"!E87)N:6YG M2!AF5D(&%N9"!M96%S=7)E9"P@86YD('=O=6QD(&AA=F4@8F5E;B!A M=F%I;&%B;&4@=VAE;B!T:&4@9FEN86YC:6%L('-T871E;65N=',@9F]R('1H M870@<')I;W(@<&5R:6]D('=E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`\9F]N="!S='EL93TS M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^2VEL:71C:"!!8W%U:7-I=&EO;CPO9F]N=#X@#0H@ M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!O9B!T:&4@0V]M<&%N>2!C;VUP;&5T960@86YD(&-L;W-E9"!O M;B!I=',@86-Q=6ES:71I;VX@;V8@2!I M;B!086]N=&$@4V%H:6(L($AI;6%C:&%L(%!R861E&ES=&EN9R!C;VYT2!I2!T:&4@1D1!(&9O2!2=6QE(#$Q M+3`Q*&0I(&]F(%)E9W5L871I;VX@4RU8(&%N9"!!4T,@.#`U+"`\9F]N="!S M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^ M0G5S:6YE2P@=&AE($-O;7!A;GD@:&%S(&%C8V]U;G1E9"!F;W(@=&AE($MI M;&ET8V@@06-Q=6ES:71I;VX@87,@82!B=7-I;F5S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!25!, M('!A:60@=&AE(&5Q=6EV86QE;G0@;V8@87!P2!54T0@)#8P M+C$@;6EL;&EO;B!A="!C;&]S:6YG+B8C,38P.R8C,38P.U1O=&%L('!U&EM871E;'D@)#4U+C(@;6EL M;&EO;B!W:&EC:"!C;VYS:7-T960@;V8@87!P2`D-3$N,B!M M:6QL:6]N(&EN(&)A'!E;G-E9"!A2!S:&]R=&9A;&P@;W(@ M97AC97-S+"!R97-P96-T:79E;'DL(&EN('1H92!A8W1U86P@86-Q=6ER960@ M=V]R:VEN9R!C87!I=&%L(&-O;7!A6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@9F]L;&]W:6YG('1A8FQE('-E M=',@9F]R=&@@=&AE(&-O;G-I9&5R871I;VX@<&%I9"!F;W(@=&AE($MI;&ET M8V@@06-Q=6ES:71I;VXL('1H92!A8W%U:7-I=&EO;BUR96QA=&5D(&-O6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY-96%S=7)E;65N="!097)I;V0@061J=7-T;65N=',\+V9O M;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY686QU871I;VX\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,97-S('=O6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,"XQ/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1) M3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U!!1$1)3D"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O M;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58 M5"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^06-Q=6ES:71I;VXM6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@"<^("`@(`T*("`@("`@("`@("`@/&9O;G0@ M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+C<\ M+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$ M=64@9&EL:6=E;F-E+"!L96=A;"P@=')A=F5L(&%N9"!O=&AE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE M/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXY+C4\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMGF5D(&%M;W5N=',@;V8@:61E;G1I9FEA8FQE M(&%S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C$\+V9O;G0^("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);G9E;G1O6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY, M86YD/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+C<\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C8\+V9O;G0^("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)V)A8VMG6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXX+C4\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXX+C4\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-"XR/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY';V]D=VEL;"P@9&5D=6-T:6)L93PO9F]N=#X@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,2XV/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ+C`\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU+CD\+V9O;G0^ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH,"XX/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY$969E6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XQ/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU-"XR/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@("`@(`T*("`@("`@/&9O;G0@2P@=&AE($-O;7!A M;GD@86UE;F1E9"!I=',@86-Q=6ES:71I;VX@86-C;W5N=&EN9R!T;R!E2!H860@:6YI=&EA;&QY M(')E8V]R9&5D(&$@9&5F97)R960@=&%X(&QI86)I;&ET>2!V86QU960@870@ M)#$N-"!M:6QL:6]N(&%N9"!S=6)S97%U96YT;'D@861J=7-T960@=&\@)#`N M-R!M:6QL:6]N(')E;&%T960@=&\@:6YT86YG:6)L92!AF%B;&4@9F]R($EN9&EA;B!T87@@<'5R<&]S M97,N)B,Q-C`[(%1H:7,@("`-"B`@("`@(')E;6%I;FEN9R!D969EF5D(&9O6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY$=7)I;F<@,C`Q-"P@,C`Q,R!A;F0@,C`Q,BP@=&AE($-O M;7!A;GD@<&%I9"`D,BXX(&UI;&QI;VXL("0R+C<@;6EL;&EO;B!A;F0@)#`N M."!M:6QL:6]N+"!R97-P96-T:79E;'DL(&9O2!S:6=N:69I M8V%N="X@3F\@87-S971S('=E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY4:&4@=6YA=61I=&5D('!R;R!F;W)M82!R97-U M;'1S('!R97-E;G1E9"!B96QO=R!R969L96-T('1H92!C;VYS;VQI9&%T960@ M"!A8W%U:7-I=&EO;BP@5F5R'!E;G-E"!E>'!E;G-E(&%F9F5C=&5D M(&9O6YE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^1&5C96UB97(@ M,S$L/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3AP=#L@1$E3 M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW,S,L,#$R/"]F;VYT M/CPO9F]N=#X@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M2!O=VYE"8C.#(R,3LI M+"!A('!R:79A=&4@;W!H=&AA;&UI8R!D979E;&]P;65N="!P:&%R;6%C975T M:6-A;"!C;VUP86YY(&)A"!F;W(@87!P2`D,BXP(&UI;&QI;VX@:6X@8V%S:"X@3VX@07!R:6P@,32!E;G1E&EM871E;'D@)#`N-"!M:6QL:6]N+B!4 M:&4@0V]M<&%N>28C.#(Q-SMS(&%G9W)E9V%T92!I;G9E2!F;V-U2!R:6=H=',@86YD('!R969E"!A;F0@9G5R=&AE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F.R!$ M25-03$%9.B!I;FQI;F4G/D]N($IU;'D@,BP@,C`Q-"!.:6-O>"!3+D$N+"`H M)B,X,C(P.TYI8V]X)B,X,C(Q.RD@86X@:6YT97)N871I;VYA;"!#;VUP86YY M(&5N=&5R960@:6YT;R!A;B!A6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"="04-+1U)/ M54Y$+4-/3$]2.B`C9F9F9F9F.R!$25-03$%9.B!I;FQI;F4G/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"="04-+ M1U)/54Y$+4-/3$]2.B`C9F9F9F9F.R!$25-03$%9.B!I;FQI;F4G/D]N($]C M=&]B97(@,C(L(#(P,30@3FEC;W@@"!'96YE2!R96-E:79E9"!F"!!8W%U:7-I=&EO;B!P&-H86YG92X@5&AR;W5G:"!T:&4@8VQO2!R96-E M:79E9"!A<'!R;WAI;6%T96QY(#0N,R!M:6QL:6]N('-H87)E"!W:&EC:"!W97)E('-U8FIE8W0@=&\\+V9O;G0^(&-E2X\+V9O;G0^/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@/"]D:78^/&)R+SX\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9F9F M9F9F.R!$25-03$%9.B!I;FQI;F4G/E1H6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`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`Q,'!T)SXF(S$V,#L\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M5T5)1TA4.B!B;VQD)SY.;W1E(#$W("8C.#(Q,CL@56YC;VYS M;VQI9&%T960@2F]I;G0@5F5N='5R93PO9F]N=#X\+V9O;G0^("`@(`T*("`@ M(#PO9&EV/CQB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@9F]L;&]W M:6YG('1A8FQE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^0T].1$5.4T5$(%-4051% M345.5%,@3T8@24Y#3TU%("A5;F%U9&ET960I/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M)SX@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;W-T(&]F('-A;&5S/"]F;VYT M/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU M<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY/<&5R871I;F<@97AP96YS97,\+V9O;G0^("`@(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-C$\+V9O;G0^("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY);F-O;64@=&%X("AB96YE9FET*2`O('!R;W9I6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ-C$\+V9O;G0^("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F M;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU M<'0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L M:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^05-31513 M/"]F;VYT/B`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT^("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR-3PO9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)A8VMG"<^("`@ M("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`M M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=) M3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR-CPO9F]N=#X@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$ M;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY46QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z M(&)O;&0G/E1/5$%,($Q)04))3$E42453/"]F;VYT/CPO9F]N=#X@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5)) M1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-96UB97)S)B,X M,C$W.R!E<75I='D\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,"XU<'0G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-CPO9F]N=#X@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-CPO9F]N=#X@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@("`@(`T*("`@("`@/&9O;G0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/DYO=&4@,3@@)B,X,C$R.R!# M=7-T;VUE6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SY#=7-T;VUE M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY);B`R,#$T+"`R,#$S(&%N9"`R,#$R+"!A('-I9VYI9FEC86YT('!O M28C.#(Q-SMS(&%C8V]U;G1S M(')E8V5I=F%B;&4@87,@;V8@1&5C96UB97(@,S$L(#(P,30L(#(P,3,@86YD M(#(P,3(@=V5R92!D=64@9G)O;2!T:&5S92!W:&]L97-A;&4@9')U9R!D:7-T M28C.#(Q-SMS M('!R;V1U8W1S+"!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@9F]L M;&]W:6YG('1A8FQE('-E=',@9F]R=&@@=&AE('!E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/E)E=F5N=64\+V9O;G0^/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G M/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#M!8V-O=6YT6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^4F5C96EV86)L93PO9F]N=#X\+V9O;G0^("`@("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^4V%L97,\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970\+V9O;G0^("`@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`@(#QD:78@"<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E)E8V5I=F%B M;&4\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY'6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E-A;&5S/"]F;VYT/CPO M9F]N=#X@("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@"<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E)E=F5N=64\+V9O;G0^ M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!C96YT97(G/B`@("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#M!8V-O=6YT6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^4F5C96EV86)L93PO9F]N M=#X\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`R+CEP="<@86QI9VX] M,T1L969T/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@ M#0H@("`@("`@(#QT6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY#87)D:6YA;#PO9F]N=#X@("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN92<^,C,\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!! M1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G M/C(S/"]F;VYT/CPO9F]N=#X@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^,38\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1) M3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$R M/"]F;VYT/CPO9F]N=#X@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^,38\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$T/"]F M;VYT/CPO9F]N=#X@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY4;W1A;#PO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@2!O6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4W5P<&QI M97(@0V]N8V5N=')A=&EO;CPO9F]N=#X@("`@#0H@("`@/"]D:78^/&)R+SX\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE2!O9B!T:&5S92!C;VUP;VYE;G1S M(&%R92!A=F%I;&%B;&4@9G)O;2!O;FQY(&$@2!O;F4@2!N97<@2!T:&4@0V]M<&%N M>28C.#(Q-SMS(&1E=F5L;W!M96YT("`-"B`@("`@(&%N9"!M87)K971I;F<@ M969F;W)T2!R96%S;VX@=&AE($-O;7!A;GD@:7,@=6YA M8FQE('1O(&]B=&%I;B!S=69F:6-I96YT('%U86YT:71I97,@;V8@86YY(&]F M('1H92!R87<@;6%T97)I86QS(&]R(&-O;7!O;F5N=',@6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE28C.#(Q M-SMS('!U6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`\9F]N="!S='EL93TS M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^4')O9'5C="!#;VYC96YT65A28C.#(Q-SMS('1O=&%L M(&YE="!R979E;G5E+"!R97-P96-T:79E;'D@=VAI;&4@;F\@;W1H97(@<')O M9'5C=',@2!A M='1E;7!T'1087)T7S)A9C!A,3(V7S-C.&%? M-&4X,E\Y-F%F7V)C.&$U864W-CEB-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL M93HO+R]#.B\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4O M5V]R:W-H965T'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!46QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY);B!T:&4@6QE/3-$)U1%6%0M M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE65A2!A;F0@14H@1FEN M86YC:6%L(&%G2!T97)M:6YA=&4@=&AI2!T:&4@2!A('1O=&%L(&]F(&%P<')O>&EM871E;'D@)#(T,"PP M,#`@:6X@65A6%B;&4@87,@;V8@1&5C96UB97(@,S$L(#(P M,30@86YD(#(P,3,@9G)O;2!0;VQS:6YE;&QI(%!#("AF;W)M97)L>2!0;VQS M:6YE;&QI(%-H=6=H87)T(%!#*2P@82!L87<@9FER;2!F;W(@=VAI8V@@=&AE M('-P;W5S92!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(%-E;FEO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV M869?8F,X835A93'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M3F]T92`R,"`F(S@R,3([(%-E=F5R86YC92!#:&%R9V5S/"]F;VYT/B`@("`- M"B`@("`\+V1I=CX\8G(O/CQD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3=6)S97%U96YT('1O('1H92!C;&]S M:6YG(&]F('1H92!V87)I;W5S(&UE2!E;G1E65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T M93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R"<^("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@#0H@("`@("`@("`@("`@ M(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@#0H@("`@("`@("`@("`@(#PO9&EV M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^26YC;VUE("A,;W-S*2!&6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N M/3-$,3`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^3F5T($EN8V]M92`H3&]S6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@ M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B M;W1T;VT@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@"<^("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@ M6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4&5R($)A6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^4VAA6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T* M("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^4&5R($1I;'5T960\+V9O;G0^("`@#0H@("`@("`@("`@("`@ M(#PO9&EV/B`@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R M/B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$ M)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D"<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@"<^("`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@ M"<^("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,C6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0V)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0V)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXP+C,R/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXP+C(Y/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-"PR,S(\+V9O;G0^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG M;CTS1&QE9G0^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ,S(L-S,R/"]F;VYT/B`@(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH,"XQ,3PO9F]N=#X@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH,"XQ,3PO9F]N=#X@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@("`@ M("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR;F0@475A6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@ M("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-#$L.#DV/"]F;VYT/CPO9F]N M=#X@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M/B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@ M("`@(#QD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXP+C`S/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@ M("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C`S/"]F;VYT M/CPO9F]N=#X@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`@(`T* M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G/B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C`X/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXP+C`X/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4 M.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%2 M1TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/ M5%1/33H@,G!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X)SX@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@ M("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/ M33H@,G!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT=&@@475A6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT-BPY-S`\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$W M/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXP+C$T/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ-BPV-S@\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXS6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXP+C$Q/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XP-7!T M)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW-RPP,3(\+V9O;G0^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT,BPP.3(\+V9O;G0^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,BPR M-3$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ,BPV,S<\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXP+C$S/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXP+C$Q/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$ M14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[ M($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW M,RPX-30\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXS.2PQ-#4\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ."PU.#D\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,"PX-#(\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS M1%1!0C$M.3`@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$P M/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;B!-87)C:"`Q-RP@,C`Q M-2P@=&AE($-O;7!A;GD@:7-S=65D(&$@<')E28C M.#(Q-SMS($)O87)D(&]F($1I28C.#(Q-SMS(%%U87)T97)L>2!297!O"!M;VYT:"!P M97)I;V1S(&5N9&5D($IU;F4@,S`L(#(P,30@86YD(&%S(&]F(&%N9"!F;W(@ M=&AE(&YI;F4@;6]N=&@@<&5R:6]D(&5N9&5D(%-E<'1E;6)E2!C;VUP M;&5T960@:71S(&%C<75I2`D-C4P+C`@;6EL;&EO M;BX@1'5R:6YG('1H92`R,#$T('EE87(M96YD(&%U9&ET('!R;V-E6EN M9R!T:&4@86-Q=6ES:71I;VX@;65T:&]D(&]F(&%C8V]U;G1I;F<@870@=&AE M(&-L;W-I;F<@;V8@=&AE($AI+51E8V@@86-Q=6ES:71I;VXN/"]F;VYT/CPO M9F]N=#X@("`-"B`@("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T* M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE2P@2!R97!O2!R97!O M2`D."XY(&UI M;&QI;VX@86YD(&$@"!M;VYT:"!P97)I;V1S(&5N9&5D($IU;F4@,S`L(#(P,30N/"]F M;VYT/CPO9F]N=#X@("`@(`T*("`@("`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@ M97)R;W(@=V%S(&QI;6ET960@=&\@=&AE($-O;7!A;GDF(S@R,3<[28C.#(Q-SMS('!R979I;W5S;'D@9FEL960@2!A<'!R;WAI;6%T96QY("0P+C`U('!E2`D,"XP-B!A;F0@)#`N M,#4@<&5R('-H87)E+"!R97-P96-T:79E;'DN/"]F;VYT/CPO9F]N=#X@#0H@ M("`@("`@(#PO9&EV/CQB65A2!F:6YA;F-I86P@9&%T82!H87,@8F5E M;B!C;W)R96-T960@=&\@96QI;6EN871E('1H92!E2!A;'-O(&5X<&5C=',@=&\@9FEL92!A;65N9&UE;G1S M(&]N($9O2!H87,@9FEL960@:71S($9O6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@("`-"B`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@5$58 M5"U$14-/4D%424]..B!U;F1E2!&:6QE9"!1=6%R=&5R;'D@4F5S=6QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@=&%B;&5S(&)E M;&]W('!R97-E;G0@=&AE(&5F9F5C="!O9B!T:&4@9FEN86YC:6%L('-T871E M;65N="!A9&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@969F96-T(&]F('1H M92!R97-T871E;65N="!O;B!T:&4@<')E=FEO=7-L>2!F:6QE9"!C;VYD96YS M960@8V]N6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY!6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9&IU6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q M+C%P="!S;VQI9"<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!" M3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+5))1TA4.B!B M;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,3`W/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS.36QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY';V]D=VEL;#PO9F]N=#X@#0H@ M("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ.38L,#$V M/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PU-C@\ M+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@ M5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE' M2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY);F-O;64@=&%X97,@<&%Y86)L93PO9F]N=#X@("`-"B`@("`@("`@ M("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY43U1!3"!#55)214Y4($Q)04))3$E42453/"]F;VYT/B`@(`T* M("`@("`@("`@("`@("`\+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH,3`T/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,#,L-C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXS,RPW,#`\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PU M-S$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PU-S$\+V9O;G0^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY2979E;G5E6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH."PX-3,\+V9O M;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXV-RPX,3@\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@0D]21$52+5)) M1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/4$52 M051)3D<@24Y#3TU%/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]D:78^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L M:6=N/3-$6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE' M2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXU+#0U.3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64@ M=&%X('!R;W9I6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,RPR.#(\ M+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@ M5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXS+#0S.#PO9F]N=#X@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY);F-O;64@9G)O;2!C;VYT:6YU:6YG(&]P97)A=&EO M;G,L(&)A6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXP+C`Y/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP-CPO9F]N=#X@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T M('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C`W/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T M('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M,"XP-3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#3TU0 M4D5(14Y3259%($E.0T]-13H\+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\ M+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY#3TU04D5(14Y3259%($E.0T]-13PO9F]N=#X@("`-"B`@("`@ M("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@8V]L6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0 M.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QD:78@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@ M("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0.B!B;&%C:R`Q M+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXR-#$L,S6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'4D]34R!04D]& M250\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ,36QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXS,"PX-3`\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@0D]21$52+5))1TA4 M.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64@ M=&%X('!R;W9I6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE' M2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH-2PU-S$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PU-S$\+V9O M;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.150@ M24Y#3TU%(%!%4B!32$%213H\+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\ M+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY);F-O;64@9G)O;2!C;VYT:6YU:6YG(&]P97)A=&EO;G,L M(&)A6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXP+C$Y/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP-CPO9F]N=#X@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE' M2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$V/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP M-3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#3TU04D5( M14Y3259%($E.0T]-13H\+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\+V1I M=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH-2PU-S$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$ M15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q-"!I6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@ M("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0.B!B;&%C:R`Q M+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@ M("`@(#QD:78@6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ."PS M,S0\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,BPW-C,\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F=#L@0D]21$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@/"]T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'!E;G-E6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!" M3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE'!E;G-E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI M9VX],T1L969T(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/ M4#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/4#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY!9&IU6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/4#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+5))1TA4.B!B;&%C:R`Q M+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH,SPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY43U1!3"!#55)214Y4($%34T544SPO9F]N=#X@("`-"B`@("`@("`@ M("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K M(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT.30L,#DU/"]F;VYT/B`@(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH-2PU-C@\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY43U1!3"!/5$A%4B!,3TY'+51%4DT@05-31513/"]F M;VYT/B`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY2 M971A:6YE9"!E87)N:6YG6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ-BPT.#`\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@0D]2 M1$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY43U1!3"!32$%214A/3$1%4E,F(S@R,3<[($5154E463PO9F]N=#X@("`@ M#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,C`L M,S(R/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#@W-BPX M,S,\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#@W,2PR-C(\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F=#L@0D]21$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI M9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]2 M1$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0.B!B;&%C M:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S M;VQI9"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY2979E;G5E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH."PX-3,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH."PX-3,\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS M,RPV-C$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH."PX-3,\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#8Q,CPO9F]N M=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64@=&%X('!R;W9I6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH,RPR.#(\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY)3D-/344@1E)/32!#3TY4 M24Y524Y'($]015)!5$E/3E,\+V9O;G0^(`T*("`@("`@("`@("`@("`\+V1I M=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52 M+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXW+#$X-SPO9F]N=#X@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PU-S$\+V9O;G0^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#$Q,SPO9F]N=#X@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY.150@24Y#3TU%(%!%4B!32$%213H\+V9O;G0^("`@ M(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64@9G)O;2!C;VYT M:6YU:6YG(&]P97)A=&EO;G,L(&)A6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C`W/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T M('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M,"XP-3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE' M2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXP+C`Q/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY.150@24Y#3TU%+"!$24Q55$5$/"]F;VYT/B`@#0H@("`@("`@ M("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV M+#8X-#PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH-2PU-S$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+#@T,#PO9F]N=#X@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH-2PU-S$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI M9VX],T1L969T(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/ M4#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/4#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY!9&IU6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/4#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+5))1TA4.B!B;&%C:R`Q M+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,C0L,3DS/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE'!E;G-E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`\+W1R/B`@#0H@("`@("`@(#PO=&%B;&4^/&)R+SX\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY486ME;B!T;V=E=&AE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X@(`T*("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U714E'2%0Z(&)O;&0G/DYO=&4@,C(@)B,X,C$Q.R!,96=A;"!06QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY792!A2!T:&]S92!D2!C86YN;W0@8F4@9&5T97)M:6YE9"XF(S$V,#LF(S$V,#M$97-P:71E('1H M92!I;FAE2!D;V5S(&YO="!B96QI979E('1H870@6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!T;R!P2!F:6YE M28C.#(Q-SMS(&9E97,@86YD(&-O2!S=&%G92X@ M5&AE($-O;7!A;GD@:6YT96YD6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY);B!-87D@,C`Q,RP@26YS<&ER92P@82!W:&]L;'D@;W=N960@ M2P@FET:')O;7EC:6X@;W!H=&AA;&UI8R!S M;VQU=&EO;B!P2!A9W)E96UE;G1S+"!F2!I;G1E;F1S('1O('9I M9V]R;W5S;'D@9&5F96YD('1H97-E(&%L;&5G871I;VYS+B8C,38P.R8C,38P M.T]N($IA;G5A2!O9B!496YN97-S964@86YD(%!E2!P;&,L(&%S M2!P:&%S92P@86YD(&YO('1R:6%L(&1A=&4@:&%S(&)E M96X@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY/;B!*=6YE(#@L(#(P,3(L('!L86EN=&EF9B!-871H97<@2&%R2P@1'EN;W9A($QA8F]R871O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W M,"4[(%9%4E1)0T%,+4%,24=..B!T97AT+71O<"<^)B,Q-S0[/"]F;VYT/B!P M2!M87)K971E9"P@;&%B96QE9"!A;F0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UEB!F:6QE9"!A;B!!3D1! M('=I=&@@=&AE($9$02!S965K:6YG(&UAFET:')O;7EC:6X@;W!H=&AA;&UI8R!S;VQU=&EO;B!P2`R M-BP@,C`Q,2P@365R8VLL($EN2!386YD;WH@86YD(')E;&%T960@96YT:71I97,N)B,Q-C`[)B,Q M-C`[4V%N9&]Z(&AA2!C;VYT97-T M(&%N>2!386YD;WH@87-S97)T:6]N6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W)M M97(@2&DM5&5C:"!D:7)E8W1O&EM871E M(&%M;W5N="!O9B`D-2XR(&UI;&QI;VXN)B,Q-C`[)B,Q-C`[5&AE($-O;7!A M;GD@9&ES<'5T97,@=&AE6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY/;B!-87)C:"`T+"`R,#$U+"!P=71A=&EV M92!C;&%S2!C;VUP M;&5T92!I=',@87-S97-S;65N="!O9B!T:&4@969F96-T:79E;F5S2!O9B!U;F1E2!R97!O7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA2`H4&]L:6-I97,I/&)R/CPO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!497AT($)L;V-K73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^/&9O;G0@ M6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;VYS;VQI9&%T M:6]N.CPO9F]N=#X@5&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960@9FEN M86YC:6%L('-T871E;65N=',@:6YC;'5D92!T:&4@86-C;W5N=',@;V8@06MO M6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SXF(S@R,3$[/"]F;VYT/B`\9F]N M="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN M92<^56YC;VYS;VQI9&%T960@2F]I;G0@5F5N='5R93PO9F]N=#XN*2XF(S$V M,#LF(S$V,#M4:&4@0V]M<&%N>2!A;F0@:71S('-T2!A8V-O=6YT960@9F]R(&ETF5R M+"!);F,N(&EN($1E8V5M8F5R(#(P,3`@86YD(&-E87-E9"!O<&5R871I;VYS M(&1U2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY3:6=N:69I8V%N="!E2!R96QA=&4@=&\@=&AE(&%L;&]W86YC97,@9F]R(&-H M87)G96)A8VMS+"!R96)A=&5S+"!P6EN9R!V86QU92!A;F0@;&EV97,@;V8@:6YT M86YG:6)L92!A"!A6EN9R!S:&%R92UB87-E9"!C;VUP96YS871I;VXL(&%C8W)U960@8G5T M('5N6EN9R!T:&4@86-C;W5N=&EN9R!F;W(@8G5S:6YE2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&5D(&]R(&1E=&5R;6EN86)L92P@86YD(&-O M;&QE8W1A8FEL:71Y(&ES(')E87-O;F%B;'D@87-S=7)E9"X@4F5V96YU97,@ M9G)O;2!PF5D('=H96X@=&ET;&4@ M86YD(')I6QE/3-$)U1% M6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE7IE9"!A;F0@861J=7-T960L(&EF(&YE8V5S2P@ M870@96%C:"!B86QA;F-E('-H965T(&1A=&4N/"]F;VYT/CPO9&EV/CQS<&%N M/CPO2!; M4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE2`D,BXY(&UI;&QI;VX@86YD("0R+C<@;6EL;&EO;B!O M9B!C87-H(&AE;&0@8GD@;W5R($EN9&EA(&]P97)A=&EO;G,@87,@;V8@=&AO M6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q! M63H@:6YL:6YE)SYP6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SYO=&AE2!;4&]L M:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE28C.#(Q-SMS('=H;VQE2!; M4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!4:6UE2X\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A;F0@ M2!B>2!T:&4@=VAO;&5S M86QEF5D+CPO9F]N=#X@("`@(`T*("`@(#PO9&EV/CQB2!R97!O2!E6QE/3-$ M)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`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`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`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`@#0H@("`@/"]D:78^/&)R+SX\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A(&1E=&%I;&5D(&%N86QY2!497AT($)L;V-K73PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE)SY!9'9E6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#Y4:&4@0V]M<&%N>2!R;W5T M:6YE;'D@2!M87D@87)R86YG92!F;W(@=&AE28C.#(Q-SMS('!R;V1U8W1S+B!4:&4@0V]M<&%N>2!R97-E2!A9&IU2X@061V97)T:7-I;F<@86YD('!R;VUO=&EO;F%L M(&5X<&5N'!E;G-E9"!A2P@4&]L:6-Y M(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@ M:6YL:6YE)SY);G9E;G1O6QE/3-$)T9/ M3E0M4U193$4Z(&YO2!E2!F;W(@2!R96-O2X@5&AE(&%L;&]W86YC97,@9F]R(&EN=F5N=&]R>2!O8G-O;&5S M8V5N8V4@=V5R92`D,C$N,B!M:6QL:6]N(&%N9"`D-2XW(&UI;&QI;VX@87,@ M;V8@1&5C96UB97(@,S$L(#(P,30@86YD(#(P,3,L(')E2X\ M+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^(`T*("`@("`@/"]D:78^/&)R M+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!C87!I=&%L:7IE'!E8W1E9"!T;R!B92!R96%L:7IE9"X@5&AE($-O;7!A;GD@87-S97-S97,@ M=&AE(')E9W5L871O2!A;'-O(&-O;G-I M9&5R6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY!="!$96-E;6)E2!D965M960@:70@=6YL:6ME;'D@=&AA="!T:&4@<')O9'5C M=',@=V]U;&0@2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^86-C;W5N=&5D(&9OF5D(&%N M9"!A;6]R=&EZ960@;VX@82!S=')A:6=H="UL:6YE(&)A2`H,S`I('EE87)S+B8C,38P.R8C,38P.T%C8W5M=6QA=&5D(&%M M;W)T:7IA=&EO;B!W87,@)#@R+C(@;6EL;&EO;B!A;F0@)#,Y+C$@;6EL;&EO M;B!A="!$96-E;6)E'!E;G-E('=A2!R96=U M;&%R;'D@87-S97-S97,@:71S(&EN=&%N9VEB;&4@87-S971S(&9OF5D(&-O'1E;F1E9"!R M96UA:6YI;F<@;&EF92!O9B!T:&4@87-S970N/"]F;VYT/CPO9F]N=#X@(`T* M("`@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!E>&ES="X@5&AE($-O;7!A;GD@ M=7-E2!B87-E9"!O;B!Q=6%L:71A=&EV92!A;F0@<75A;G1I=&%T:79E(&%S M2!M;V1E;&5D('1H92!F86ER('9A;'5E(&]F('1H92!R97!O M2!P M97)F;W)M960@:71S(&%N;G5A;"!I;7!A:7)M96YT('1E2!I;B!E M>&-E6QE M/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@ M#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@8V]L M6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY';V]D=VEL;#PO9F]N=#X@#0H@("`@("`@("`@ M("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY);7!A:7)M96YT6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W)E M:6=N(&-U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,BPS,C@\+V9O M;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY$96-E;6)E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR.2PX,S$\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR-C`L.3$Q/"]F;VYT/B`@(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(SDT-S([/"]F;VYT/B`@("`-"B`@("`@ M("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$:7-P;W-I=&EO;G,\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY$96-E;6)E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@/&9O;G0@28C.#(Q M-SMS(&EN=&%N9VEB;&4@87-S971S(&%N9"!T:&4@=V5I9VAT960M879EF%T:6]N('!E6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@ M("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87)R>6EN M9SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\+V1I=CX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@ M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87)R>6EN M9SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\+V1I=CX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@("`- M"B`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^(`T*("`@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR,S`L-S@X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR,S`L-S@X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ-BPP,#`\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.#6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY#:&%N9V5S(&EN(&EN=&%N9VEB;&4@87-S971S M(&1U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@ M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY)4%(F86UP.T0\ M+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY#=7-T;VUE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY.;VXM8V]M<&5T92!A9W)E96UE;G1S/"]F M;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXV,RPV-30\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#@N,7!T M)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH-S0P/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY&;W)E:6=N(&-U6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C$W/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#8S.#PO9F]N=#X@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXV-C@L-#4W/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,S`L-S@X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXS,#`\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)V)A8VMG M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH,2PY,S0\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH.#6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,3PO9F]N=#X@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@ M#0H@("`@("`@(#QT6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXW,#0L,C$X/"]F;VYT/B`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU M<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#`S-3PO9F]N M=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,"PS M-34\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U!!1$1) M3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@/&9O;G0@ M65A6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-2PY-C8\+V9O;G0^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M,#$V/"]F;VYT/B`@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXV-2PW,SD\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@/"]T6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M2P@4&QA;G0@86YD($5Q=6EP;65N="P@ M4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@ M8VQAF4@=&AE(&-O65A M2XF(S$V,#LF(S$V,#M4:&4@86UOF%T:6]N(&]F(&%S M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@ M("`@(#QD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!3PO9F]N=#X@ M("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"=6EL9&EN9W,\+V9O M;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXW/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;VUP=71E M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@2!4 M97AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS M1&QE9G0^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M)SY.970@26YC;VUE(%!E2!S=&]C:R!A;F0@:68@8V]N=F5R=&5D(&UE=&AO9',N M)B,Q-C`[)B,Q-C`[06YT:2UD:6QU=&EV92!S:&%R97,@97AC;'5D960@9G)O M;2!T:&4@8V]M<'5T871I;VX@;V8@9&EL=71E9"!N970@:6YC;VUE('!E2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,3AP=#L@ M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T)R!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@ M1$E34$Q!63H@:6YL:6YE)SY);F-O;64@5&%X97,Z/"]F;VYT/B!);F-O;64@ M=&%X97,@87)E(&%C8V]U;G1E9"!F;W(@=6YD97(@=&AE(&%S"!B87-E"!AF5D+CPO9F]N=#X\+V1I=CX\2!497AT($)L;V-K M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^/&9O M;G0@6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY&86ER(%9A M;'5E(&]F($9I;F%N8VEA;"!);G-T2!T;R!M87AI;6EZ92!T:&4@=7-E(&]F(&]B28C.#(Q-SMS(&]W;B!A28C.#(Q M-SMS(&IU9&=M96YT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY4:&4@=F%L=6%T:6]N(&AI97)A2!I6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<"!W:61T:#TS M1#6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN M92<^3&5V96P@,3PO9F]N=#XF(S@R,3([07-S971S(&%N9"!L:6%B:6QI=&EE M6EN9R!V86QU92!O M9B!T:&4@0V]M<&%N>28C.#(Q-CMS(&-A6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY,979E;"`R/"]F;VYT/B8C.#(Q M,CM);G!U=',@=&\@=&AE(&9A:7(@=F%L=64@;65A2!T6EN9R!T M97)M2!O2!Q=6]T M960@:6YT97)V86QS+B!4:&4@;6%R:V5T('9A;'5E(&]F('1H92!#;VUP86YY M)B,X,C$W.W,@9F]R=V%R9"!C;VYT6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY, M979E;"`S/"]F;VYT/B8C.#(Q,CM);G!U=',@=&\@=&AE(&9A:7(@=F%L=64@ M;65A6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%,+4%,24=. M.B!T97AT+71O<"<^)B,Q-S0[/"]F;VYT/B!O;B!*86YU87)Y(#(L(#(P,30L M(&%N9"!T:&4@9F%I6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@ M/&9O;G0@28C.#(Q-SMS(&9I;F%N M8VEA;"!I;G-T6QE/3-$)U!!1$1)3D"<^("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^1F%I6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^1&5C96UB97(@,S$L/"]F;VYT M/CPO9F]N=#X@("`@#0H@("`@("`@("`@("`@(#PO9&EV/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q M-#PO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^261E;G1I8V%L($ET96US/"]F M;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@("`@(#PO9&EV/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M*$QE=F5L)B,Q-C`[,2D\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@("`-"B`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^(`T* M("`@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@(`T*("`@("`@("`@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`@("`-"B`@("`@("`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4VEG M;FEF:6-A;G0\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/B`@ M("`-"B`@("`@("`@("`@("`@("`@("`@/"]D:78^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@#0H@("`@("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M4VEG;FEF:6-A;G0\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O;G0^("`-"B`@ M("`@("`@("`@("`@("`@(#PO9&EV/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^*$QE M=F5L)B,Q-C`[,RD\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87-H M(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]F;VYT/B`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E' M3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#L@5&]T86P@;&EA8FEL:71I97,\ M+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+#8Q,SPO9F]N=#X@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+#8Q,SPO9F]N=#X@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^1&5C96UB97(@,S$L/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@ M("`@(#PO9&EV/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^,C`Q,SPO9F]N=#X@#0H@("`@("`@("`@("`\ M+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@ M("`@(#QD:78@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^261E;G1I8V%L($ET96US/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@ M("`@("`@(#PO9&EV/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^*$QE=F5L)B,Q-C`[,2D\+V9O;G0^("`@ M("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@("`-"B`@("`@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^(`T*("`@("`@("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@(`T*("`@("`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@("`- M"B`@("`@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^4VEG;FEF:6-A;G0\+V9O;G0^/"]F;VYT/CPO M9F]N=#X\+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`@("`@ M/"]D:78^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@ M("`@("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`@#0H@("`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^4VEG;FEF:6-A;G0\+V9O;G0^/"]F;VYT M/CPO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`@("`@("`@(#PO9&EV/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^*$QE=F5L)B,Q-C`[,RD\+V9O;G0^("`@("`- M"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]F M;VYT/B`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W)E:6=N(&-U6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXR,#@\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M4;W1A;"!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U!! M1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ-"PW,C@\+V9O;G0^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-"PW,C@\ M+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@/&9O M;G0@6EN9R!A M;6]U;G0@870@1&5C96UB97(@,S$L(#(P,30@;V8@<'5R8VAA28C.#(Q M-SMS(&%C<75I'0M=&]P)SXF(S$W-#L\+V9O;G0^(&]N M($IA;G5A2!W87,@:6YI=&EA;&QY M(&1I2!A="!$96-E;6)E2!T;R!B92`D-"XS(&UI;&QI;VXN(%1H92!I;F-R96%S92!I M;B!F86ER('9A;'5E(&1U65A6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:&4@2!C;VUP6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!W87,@8V%R"!3+D$N(&EN:71I86QL>2!V86QU960@870@ M)#$R+C4@;6EL;&EO;B!D:7-C;W5N=&5D('1O(')E9FQE8W0@8V5R=&%I;B!L M;V-K=7`@<')O=FES:6]N28C M.#(Q-SMS(&EN=F5S=&UE;G0@:6X@86X@879A:6QA8FQE(&9O&EM871E;'D@)#$N-R!M:6QL:6]N('5NFEN9R!A;B!I;6UA=&5R:6%L(&=A:6XL(&%N9"!D=64@=&\@ M9&5C;&EN97,@:6X@=&AE('-H87)E('!R:6-E(&]F($YI8V]X("`@#0H@("`@ M("`@("`@("`@(%,N02X@6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6EN9R!O8FQI9V%T:6]N('=A2!A9&IU6QE/3-$)U1% M6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE2!T M'!E;F1I='5R97,@870@04E0 M3"P@=VAI8V@@86QL('1H28C.#(Q-SMS('-U8G-I9&EA2!D:69F97)E M;F-E(&)E='=E96X@=&AE(&%C='5A;"!A;F0@<')O:F5C=&5D(&9O6UE;G0@9G)O M;2!T:&4@8V]U;G1E2!R96%L:7IE9"!A("0P+C<@;6EL;&EO;B!G M86EN(&EN("`@("`-"B`@("`@(&9A:7(@=F%L=64@9'5R:6YG('1H92!Y96%R M(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$T(&%S(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY/=&AE2!I6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE)SY!8V-O=6YT:6YG(&9O&5D('1O+"!A;F0@4&]T M96YT:6%L;'D@4V5T=&QE9"!I;BP@82!#;VUP86YY)B,X,C$W.W,@3W=N(%-T M;V-K/"]F;VYT/BDN(%1H:7,@8VQA&5R8VES92!O9B!T:&4@2V%P;V]R(%=A2!A'!E;G-E M(&]N('1H92!#;VUP86YY)B,X,C$W.W,@8V]N28C.#(Q-SMS(&]B;&EG871I;VX@=&\@;V)T86EN(&%N9"!M M86EN=&%I;B!R96=I2!T M;R!U2!R96%S;VYA8FQE(&5F9F]R=',F M(S@R,C$[('1O(&9I;&4@82!R96=I6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^+"!A;F0@=&\@;6%I;G1A:6X@=&AE(&-O M;G1I;G5O=7,@969F96-T:79E;F5S28C.#(Q-SMS(&-O M;6UO;B!S=&]C:R!Q=6%L:69Y(&%S(')E9VES=')A8FQE('-E8W5R:71I97,L M("AI:2D@=&AE(&1A=&4@;VX@=VAI8V@@86QL(&]F('1H92!R96=I2!B92!S;VQD(&EN(&$@&5R8VES92!O9B!T:&4@2V%P;V]R(%=A6QE M/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@ M#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE2!W:71H('!E2P@=&AE(&9A:7(@=F%L=64@;V8@=&AE($MA<&]O6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!O9B!T:&4@ M2V%P;V]R(%=A6EE;&0@6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY%>'!E8W1E9"!V;VQA=&EL:71Y/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXW.2XW)3PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R.24^("`@(`T*("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@(#PO M='(^("`@("`-"B`@("`@("`@/'1R/B`@("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4X)3X@(`T*("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@+3EP=#L@1$E3 M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@ M-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#LS+C@\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`@#0H@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#DN.'!T)R!A;&EG;CTS1&-E M;G1E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]D M:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@(#PO='(^("`@ M("`-"B`@("`@(#PO=&%B;&4^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@ M/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0 M.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0[($)/4D1%4BU4 M3U`Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY787)R86YT6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@ M("`@("`@(#QD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0[($)/4D1%4BU4 M3U`Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY";V]K(%9A;'5E("@D,#`P6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY%2B!&=6YD6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+#DS.2PV,SD\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C$Q/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY+87!O;W(@5')U6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,BPP M.3DL.3,U/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@ M4$%$1$E.1RU"3U143TTZ(#)P>"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C$V/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C4L,C4P/"]F;VYT/CPO9F]N=#X@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)V)A8VMG"<^("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^-RPQ M.3(L,S$S/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$W+#DT M-CPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@/&9O M;G0@&EM M871E;'D@-RXR(&UI;&QI;VX@;W5T2`D."XR(&UI;&QI;VX@9G)O;2!T:&4@=V%R&5R8VES M92!D=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,30N/"]F M;VYT/CPO9&EV/CQS<&%N/CPO2!497AT($)L;V-K M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^/&9O M;G0@6QE/3-$ M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY3=&]C:RU" M87-E9"!#;VUP96YS871I;VXZ/"]F;VYT/B!3=&]C:RUB87-E9"!C;VUP96YS M871I;VX@8V]S="!IF5D(&%S(&5X<&5N2!O=F5R('1H92!V97-T M:6YG('!E2!T:&%T(&ES(&)A2P@:68@86-T=6%L(&9O'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'1A M8FQE(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY$96-E;6)E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,BPQ-3D\+V9O;G0^("`- M"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^ M("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N M/3-$,B!V86QI9VX],T1B;W1T;VT^("`@("`-"B`@("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@ M#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);7!A M:7)M96YT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,3$L-#4T/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M-S@L-S6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T'0^/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;6]U;G0\+V9O;G0^("`@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;6]R M=&EZ871I;VX\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@("`-"B`@("`@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;6]U;G0\+V9O;G0^("`@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@ M("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY296UA:6YI;F<\+V9O;G0^($%M;W)T:7IA=&EO;B!097)I;V0@*'EE M87)S*3PO9F]N=#X@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY06QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW,#0L,C$X/"]F;VYT M/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ,BXT/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);BUP6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY46QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M,2PW,C$\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M-"PR-SD\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ."XV/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY#=7-T;VUE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+#0R-SPO9F]N M=#X\+V9O;G0^("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXS+#`S-3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR M+#0P.3PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C0\ M+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ+#`T-2PU.3(\+V9O;G0^("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.#(L,C,S/"]F;VYT/B`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/ M5%1/33H@,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E M;6)E6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU+#4X.#PO9F]N M=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!8W%U:7-I=&EO;G,\+V9O;G0^("`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXU-RPY-CD\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY!;6]R=&EZ871I;VX\+V9O;G0^("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PW M,C,\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C$P/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXX+#8U-CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ+#,Q,3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY!;6]R=&EZ871I;VX\+V9O;G0^("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,SDL-S8Q/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH-C$U/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@ M("`@#0H@("`@("`@(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W)E:6=N(&-U M6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,3(\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR,S`L-S@X/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV.#0\+V9O M;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+CF%T:6]N($5X<&5N'0@0FQO M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^ M("`@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY996%R M(&5N9&EN9SPO9F]N=#X@/&9O;G0@'!E;G-E/"]F;VYT/B`@(`T*("`@("`@("`@("`@("`\ M+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)A8VMG6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@("`@("`@(#QD:78@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR,#$Y/"]F;VYT/B`@#0H@("`@("`@("`@("`@ M(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXV,BPR-#0\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<] M,T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,96%S96AO M;&0@:6UP6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#PO9F]N=#X@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL M6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F M;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@ M("`@("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`@#0H@("`@("`@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^:6X@ M06-T:79E/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/B`@#0H@("`@("`@ M("`@("`@("`@("`\+V1I=CX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^3W1H97(\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V9O M;G0^("`@#0H@("`@("`@("`@("`@("`@("`\+V1I=CX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^*$QE=F5L)B,Q-C`[,BD\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/B`@("`-"B`@("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M(`T*("`@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@(`T*("`@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^26YP=71S/"]F;VYT/CPO M9F]N=#X@("`@(`T*("`@("`@("`@("`@("`\+V1I=CX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX+#,Y,3PO9F]N M=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXX+#,Y,3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M4;W1A;"!A6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E' M3CH@"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXX+#,Y,3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0 M=7)C:&%S92!C;VYS:61E6%B;&4\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/B`@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M1&5C96UB97(@,S$L/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@("`@ M(#PO9&EV/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^,C`Q,SPO9F]N=#X@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@ M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@ M(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M261E;G1I8V%L($ET96US/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@ M("`@(#PO9&EV/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^*$QE=F5L)B,Q-C`[,2D\+V9O;G0^("`@("`- M"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@("`-"B`@("`@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^(`T*("`@("`@("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B`@(`T*("`@("`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@("`-"B`@ M("`@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^4VEG;FEF:6-A;G0\+V9O;G0^/"]F;VYT/CPO9F]N M=#X\+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`@("`@/"]D M:78^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@ M("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`@#0H@("`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^4VEG;FEF:6-A;G0\+V9O;G0^/"]F;VYT/CPO M9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`@("`@("`@(#PO9&EV/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^*$QE=F5L)B,Q-C`[,RD\+V9O;G0^("`@("`-"B`@ M("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]F;VYT M/B`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W)E:6=N(&-U6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,#@\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M4;W1A;"!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1) M3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ-"PW,C@\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-"PW,C@\+V9O M;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+C$\ M+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@(#PO='(^("`@("`-"B`@("`@("`@/'1R('-T M>6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ+C@E/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,CDE/B`@("`-"B`@("`@("`@("`@("8C,38P.R`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N M/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY$:79I9&5N9"!Y:65L9#PO9F]N=#X@("`@(`T* M("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8E/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R.24^("`@(`T*("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`Y M+CAP="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0[($)/4D1% M4BU43U`Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY%>&5R8VES92!06QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$ M15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M<'(N,3,L(#(P,#D\+V9O;G0^("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY+87!O;W(@5')U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#4P,2PY,S,\+V9O;G0^("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ+C$Q/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXS+#6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%2B!&=6YD6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ+#8U,"PX,#8\+V9O;G0^("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ+C$V/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXT+#$R-SPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@"<^("`@("`-"B`@("`@("`@("`@(#QD:78@ M"<^("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^-2PR-3`\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@"<^(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^,36QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$ M)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q! M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)SX@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,97-S(')E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#:&%R9V5B M86-K6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@ M("`@(#QT6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY06QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY$:7-C;W5N=',@86YD(&%L;&]W86YC97,\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9'9E M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`S M-G!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M,C4\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY46QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXV-"PY.3@\+V9O;G0^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C'0^/'1A8FQE(&-E M;&QP861D:6YG/3-$,"!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q,CPO9F]N=#X@("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXU,C@L-36QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS.#8L-3@R/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY#:&%R9V5B86-K6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M,C=P M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`S-G!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`S-G!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH,S$L,36QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M."PT-C0\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M-BPP-S0\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@ M8FQO8VL[($U!4D=)3BU,1494.B`S-G!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)U1%6%0M24Y$14Y4.B`Y M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9'9E6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-"PU,C0\+V9O;G0^("`@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,C=P=#L@1$E34$Q!63H@8FQO8VL[ M($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU M.3,L,#6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M2!I;B!!;&QO=V%N8V4@9F]R($-U'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@"<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9'9E6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^4')O;6]T:6]N6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E1/5$%,/"]F M;VYT/CPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXV+#@T-CPO9F]N=#X@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3(L,C0S/"]F;VYT/B`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.#(\+V9O;G0^("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#`V,SPO9F]N=#X@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/B@R+#(R,#PO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#$P M-"PW-#`\+V9O;G0^/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@U+#0U-3PO9F]N=#X\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^,3,\+V9O;G0^/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^*#$L.#8T/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@ M("`@("`@(#QT6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ,RPT-3(\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ+#,V,CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY06QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE3X@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/B@Q.#,L.3"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B8C M.#(Q,CL\+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@R,#(L,#4X/"]F;VYT/CPO M9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,BPX.#(\+V9O;G0^("`@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#8T-#PO9F]N=#X@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+#6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/B`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9&1I=&EO;G,@9G)O;2!A8W%U M:7-I=&EO;G,\+V9O;G0^/"]F;VYT/B`-"B`@("`@("`@("`@("`@/"]D:78^ M("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`@(`T*("`@("`@ M("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,3$\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`- M"B`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`@("`@#0H@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T"<^("`-"B`@("`@("`@("`@(#QD M:78@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY#:&%R9V5S('!R;V-E6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^*#$R+#8Y.#PO9F]N=#X\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/B@\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C,\+V9O;G0^/"]F;VYT/B`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/B@\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG3X@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^-#0L-C0T/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN92<^,34U+#(Y-SPO9F]N=#X\+V9O;G0^/"]F;VYT M/CPO9F]N=#X@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`@(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(R+#PO9F]N=#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C8Y,3PO9F]N=#X\+V9O;G0^ M/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/B`@#0H@("`@("`@("`@("`@ M(#PO9&EV/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^-#8R/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M/B`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`-"B`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA2P@0W5R6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^1&5C96UB97(@,S$L/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&:6YI6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY7;W)K(&EN('!R;V-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXT+#,S-3PO9F]N=#X\+V9O;G0^("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV,BPU M,S,\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR.2PR,3,\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T&-E2!;5&%B;&4@ M5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!C;VQS<&%N/3-$-B!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$ M,B!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN92<^,C`Q,SPO9F]N=#X\+V9O;G0^("`@("`-"B`@ M("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@ M("`@("`@/'1R('-T>6QE/3-$)V)A8VMG65A6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+#@Q.3PO9F]N M=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G M(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ,BPR-S4\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N M/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX+#(R,#PO9F]N=#X@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U!! M1$1)3D"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/B@U+#`Q-CPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^)B,Q-C`[*#,L,C`X/"]F;VYT/CPO9F]N=#X@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R('-T>6QE M/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U M<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C4L-S`P/"]F;VYT M/CPO9F]N=#X@("`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2P@4&QA;G0@86YD($5Q=6EP;65N="`H5&%B;&5S*3QB M2P@4&QA;G0@86YD($5Q=6EP;65N="!;06)S=')A8W1=/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'1A8FQE(&-E;&QP861D M:6YG/3-$,"!C96QL6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M"<^("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!C96YT97(G/B`@("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4 M.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,86YD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXR+#8P-CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G M(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&=7)N:71U6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ,C4L-#(S/"]F;VYT/B`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ,36QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!! M1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-#,L-S@X/"]F M;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@ M/&9O;G0@&5D($-H87)G M93PO9F]N=#X@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY2979O;'9E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3<')E860\ M+V9O;G0^("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0R M-24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY2979O M;'9E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%=7)O9&]L;&%R/"]F;VYT/B`- M"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^0V%T96=O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF9W0[ M(#$N-3`@=&\@,2XP/"]F;VYT/B`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1T M;W`@=VED=&@],T0R-24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C4P)3PO9F]N M=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C4E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN92<^/&9O M;G0@2`S/"]F;VYT M/CPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@(S`P,#`P,"`Q<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C`P)3PO9F]N=#X@ M#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$ M96-E;6)E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR,#$T/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,#$S/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-"PY,S`\ M+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,"PT-S`\+V9O;G0^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UEF5D(&1E8G0@9FEN86YC:6YG(&-O M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@'!E;G-E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY);G1E'!E;G-E(&%T(#,N-3`E(&-O=7!O M;B!R871E/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#(P,#PO9F]N=#X@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY$96)T(&1I6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXT+#$Q,SPO9F]N=#X@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXV.3(\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY,;W-S)B,Q-C`[;VX@8V]N=F5R6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU M<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'0^/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL M6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY);F-O;64@9G)O;2!C;VYT:6YU:6YG(&]P97)A=&EO;G,@=7-E9"!F M;W(@8F%S:6,@96%R;FEN9W,@<&5R('-H87)E/"]F;VYT/B`@(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXU+#@R-3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT,2PV-S,\+V9O;G0^/"]F M;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXU,BPS-C(\+V9O;G0^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXS-2PS-S@\+V9O;G0^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M"87-I8SPO9F]N=#X@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXP+C4T/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@ M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C0V/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,;W-S(&9R M;VT@9&ES8V]N=&EN=65D(&]P97)A=&EO;G,L(&YE="!O9B!T87@\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH-3`S/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M"87-I8SPO9F]N=#X@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,"XP,3PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY3:&%R97,@=7-E9"!I;B!C;VUP=71I;F<@:6YC;VUE M("AL;W-S*2!P97(@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXY-BPQ.#$\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M3=&]C:R!O M<'1I;VYS(&%N9"!U;G9E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXT+#(S-#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF M(S$V,#M3=&]C:R!W87)R86YT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXV+#6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ,RPU,C(\+V9O;G0^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXV+#0Y.3PO9F]N=#X@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ.2PV,S`\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-RPW,3<\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-2PS,C$\+V9O;G0^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY796EG:'1E9"!A=F5R86=E(&1I;'5T M960@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ,C,L,3$P/"]F;VYT/B`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3,L.#DX/"]F;VYT/B`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3`L-3$P M/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E M;&QS<&%C:6YG/3-$,"!W:61T:#TS1#@P)2!S='EL93TS1"=&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^("`@("`- M"B`@("`@("`@/'1R/B`@("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DP)3X@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@+3EP=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A M;&EG;CTS1&QE9G0^("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR+#4V.3PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`@(#PO9&EV/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#(S,#PO9F]N=#X\ M+V9O;G0^("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXR,#(P(&%N9"!T:&5R96%F=&5R/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL M6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^,C`Q,SPO9F]N=#X@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$;6ED M9&QE('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXM/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T)2!S M='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@("`@(`T* M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-"4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW-R4\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#,E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX-24\+V9O M;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@(#PO='(^("`@("`-"B`@("`@("`@/'1R/B`@("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#8U)3X@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@+3EP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Y M<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXR+C(E/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$=&]P('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-"4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXP+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0T)2!S='EL93TS1"=415A4+4%,24=. M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/CPO M9F]N=#X@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0T)2!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@ M("`@(`T*("`@("`@("`@("`@)B,Q-C`[("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO9&EV/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0T)2!S='EL93TS1"=415A4+4%,24=..B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)SX@("`@(`T*("`@("`@("`@("`@)B,Q-C`[("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1T;W`@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T)3X@("`-"B`@("`@ M("`@("`@("8C,38P.R`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P M(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^/&9O;G0@:60],T1404(Q+36QE/3-$)TU!4D=)3BU,1494.B`Q M,"XT<'0G/CPO9F]N=#Y3:&%R97,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@ M,"XU<'0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/B`@("`@ M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@:60],T1404(Q+36QE/3-$ M)TU!4D=)3BU,1494.B`R+C@U<'0G/CPO9F]N=#Y796EG:'1E9#PO9F]N=#X@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^17AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^0V]N=')A8W1U86P@5&5R;3PO9F]N=#X@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^*%EE87)S*3PO9F]N=#X@(`T* M("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^26YT6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^*&EN('1H;W5S86YD6QE/3-$)V)A8VMG M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+#,Y.3PO9F]N=#X@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR+C@Y/"]F;VYT/B`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U M+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>&5R8VES960\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M)SX@("`-"B`@("`@("`@("`@(#QD:78@'!I6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.#<\+V9O;G0^("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G M(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS M,C$\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-2XW-CPO9F]N=#X@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+C$X/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE. M+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W)F96ET M960@;W(@97AP:7)E9#PO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/ M5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5)) M1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=71S=&%N9&EN M9R!A="!$96-E;6)E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR."XU.3PO9F]N M=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@'!I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR,BXU-CPO9F]N=#X@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXV+#,X-CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C0X/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C`Q/"]F;VYT/B`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^3G5M8F5R(&]F(%-H87)E6QE/3-$)TQ%5%1%4BU34$%#24Y'.B`S<'0[($-/3$]2.B!B;&%C:R<^/"]F M;VYT/CPO9F]N=#X@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@"<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^1W)A;G0@1&%T92!& M86ER(%9A;'5E/"]F;VYT/CQF;VYT(&ED/3-$5$%",BTU('-T>6QE/3-$)TQ% M5%1%4BU34$%#24Y'.B`S<'0[($-/3$]2.B!B;&%C:R<^/"]F;VYT/CPO9F]N M=#X@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,SPO9F]N=#X@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ+C,T/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE. M+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ-"XV,SPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U M<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY697-T960\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,S`\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5)) M1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.;VYV97-T960@ M870@1&5C96UB97(@,S$L(#(P,3(\+V9O;G0^(`T*("`@("`@("`@("`@/"]D M:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,CPO9F]N=#X@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ-"XY.#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP M=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY.;VYV97-T960@870@1&5C96UB97(@,S$L(#(P,3,\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4G/B`@("`@#0H@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U M<'0G(&%L:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.;VYV97-T960@870@1&5C96UB M97(@,S$L(#(P,30\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B M8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F M,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"<^("`@("`-"B`@("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^0W5R6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^5&]T86P\+V9O;G0^/&9O;G0@ M:60],T1404(R+3@@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\ M+W1R/B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY&961E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR,RPQ,C4\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=) M3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT M+#DY,3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^-#PO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^*#(L/"]F;VYT/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^,3,T/"]F;VYT/CPO9F]N=#X@("`@(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R('-T M>6QE/3-$)V)A8VMG6QE/3-$ M)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G M/C,Y+#PO9F]N=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C"<^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^*#PO9F]N=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/C$V+#4P-CPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4G/C(S+#(X.#PO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^665A6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/ M5%1/33H@,G!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&961E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XP-7!T M)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#$T-3PO9F]N=#X@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T"<^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@+3EP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#4N,#5P="<@86QI9VX],T1L969T M/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#4Y.#PO9F]N=#X\ M+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\ M+W1R/B`@#0H@("`@("`@("`@/'1R/B`-"B`@("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W,"4@"<^("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,S(L,3,P/"]F;VYT M/CPO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@Q M+#4Y-SPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M-SD@6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^,S`L-3,S/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4 M.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%2 M1TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@"<^("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X M)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&961E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)A8VMG6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3=&%T93PO9F]N=#X@("`-"B`@("`@ M("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#,R,3PO9F]N=#X@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`T-#9P="<^ M(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@ M/&9O;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^)B,X,C$R M.SPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^*#$L-3,X/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B8C,38P.R@Q+#4S.#PO9F]N=#X\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$ M)T1)4U!,05DZ(&EN;&EN92<^*#(L.34S/"]F;VYT/CPO9F]N=#X@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C"!2871E(%)E8V]N8VEL:6%T:6]N(%M486)L92!497AT($)L;V-K73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'1A8FQE(&-E;&QP861D M:6YG/3-$,"!C96QL6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,3`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!C96YT97(G/B`@(`T*("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@"<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q M-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^,C`Q,CPO9F]N=#X\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;VUP=71E9"`F(S@R,C`[ M97AP96-T960F(S@R,C$[('1A>"!E>'!E;G-E/"]F;VYT/B`@("`-"B`@("`@ M("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@#PO9F]N=#X@("`-"B`@("`@("`@ M("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1! M0C$M.#0@6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=( M5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV M,C(\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ+#0V.#PO9F]N=#X@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M,2PT-#0\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH,2PS-C$\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2PR-S<\+V9O M;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@ M("`@("`@/'1R/B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E/B`@("`-"B`@("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@+3EP=#L@1$E34$Q!63H@8FQO M8VL[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#4N,#5P="<@ M86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@("`@ M("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY/=&AE'!E;G-E("AB96YE9FET*2P@;F5T/"]F;VYT M/B`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@"<^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@+3EP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q M.'!T.R!-05)'24XM4DE'2%0Z(#4N,#5P="<@86QI9VX],T1L969T/B`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@"<^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,2PQ,38\+V9O;G0^/"]F;VYT M/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$ M14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@ M34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/C(S+#(X.#PO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,C(L,3(R/"]F;VYT/CPO9F]N=#X@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0^/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^,C`Q-#PO9F]N=#X\+V9O;G0^("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^,C`Q,SPO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^,C`Q,CPO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY06QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@ M("`@("`@(#QD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX-BPS.#(\+V9O;G0^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-BPP.#<\+V9O;G0^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXH/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,RPT.#<\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@ M(#QT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU-RPU M,#`\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E M;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG3X@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@"!A6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#(W-SPO9F]N=#X@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXV+#0P.#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J M=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$Y,CPO M9F]N=#X\+V9O;G0^/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,RPS,C4\+V9O;G0^/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4G/C$L-S4Q/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#M4;W1A;"!D969E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,BPW.3`\+V9O M;G0^/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXY+#$T-CPO9F]N=#X@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M6 M86QU871I;VX@86QL;W=A;F-E/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B8C M.#(Q,CL\+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B8C.#(Q,CL\+V9O;G0^/"]F M;VYT/B`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/C,V+#(U-SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@ M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/C(Q+#8W-#PO9F]N=#X\+V9O;G0^/"]F;VYT/CPO9F]N M=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@"!L:6%B:6QI=&EE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M06QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@2!S=&5P+75P/"]F;VYT/B`@(`T* M("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M$97!R M96-I871I;VX@)F%M<#L@86UOF%T:6]N("8C.#(Q,3L@=&%X(&]V97(@ M8F]O:SPO9F]N=#X@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)V)A8VMG3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN92<^)B,X,C$R.SPO9F]N=#X\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/B8C.#(Q,CL\+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B8C.#(Q,CL\ M+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B@S+#8P,3PO9F]N=#X\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4G/B@Q+#(P,3PO9F]N=#X\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@3X@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/B@\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^-RPY-#4\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^,2PV-#,\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"86QA;F-E(&%T($1E M8V5M8F5R(#,Q+"`R,#$Q/"]F;VYT/B`-"B`@("`@("`@("`@("`@/"]D:78^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L M:6=N/3-$6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9&1I M=&EO;G,@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#(V-3PO9F]N=#X@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D"<^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^,C(P/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY" M86QA;F-E(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/B`-"B`@("`@("`@ M("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@'!O65A M"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#$L M,C(Y/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@ M#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9&1I=&EO;G,@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@"<^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY497)M:6YA M=&EO;G,@;V8@97AP;W-U6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/B8C.#(Q,CL\ M+V9O;G0^/"]F;VYT/B`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'1087)T7S)A9C!A,3(V M7S-C.&%?-&4X,E\Y-F%F7V)C.&$U864W-CEB-0T*0V]N=&5N="U,;V-A=&EO M;CH@9FEL93HO+R]#.B\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E M-S8Y8C4O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$"<^("`@("`- M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@#0H@("`@("`@("`@("`@(#PO9&EV/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE M9G0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@:60],T1404(Q+3@V('-T>6QE M/3-$)TU!4D=)3BU,1494.B`W+CDU<'0G/CPO9F]N=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/C(P,30\+V9O;G0^/"]F;VYT/B`-"B`@("`@ M("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,C`Q,SPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@("`\ M+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\ M+W1R/B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU-#(L.#0V/"]F;VYT/B`@ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR-SDL.3$Q/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR,C,L.#@Q/"]F;VYT/B`@(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4 M.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@("`@/&9O M;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^-3`L M,C,R/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^,S6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,S(L,C6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$ M14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[ M($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^-3DS+#`W.#PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/C,Q-RPW,3$\+V9O;G0^/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)V)A8VMG"<^("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@+3EP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Y M<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^(`T*("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY#;VYS=6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/C(W+#,Y,SPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(P+#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$X M+#@P.#PO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY4;W1A;"!G6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,36QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$T."PV.3(\+V9O M;G0^/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E M;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^5&]T86P\+V9O;G0^("`-"B`@("`@("`@("`@("`@/"]D:78^("`- M"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY$96-E;6)E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,"PR.38\+V9O;G0^("`- M"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ,2PX-C,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXS,BPQ-3D\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4 M.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%2 M1TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^("`@("`- M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(SDT-S([/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@ M/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@/"]T6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY);7!A:7)M96YT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H M=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT^("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^("`@("`- M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(SDT-S([/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@ M/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W)E:6=N M(&-U6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,BPS M,C@\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI M9VX],T1B;W1T;VT@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,BPS,C@\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY$96-E;6)E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-RPY-C@\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M,2PX-C,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR.2PX,S$\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR-38L,#4W/"]F;VYT/B`@(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT M+#@U-#PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^("`@("`-"B`@("`@("`@ M("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(SDT-S([/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`- M"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1R:6=H=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#4N,#5P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,3$L-#4T/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T M;VT^("`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY&;W)E:6=N(&-U6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!C;VQS M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH-3$T/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\ M+W1R/B`@#0H@("`@("`@("`@/'1R/B`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#4N,#5P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-BPW,3<\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR-S@L-S6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P M(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY-:6QE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$U/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<] M,T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR,#$T/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$S/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@8V]L6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@ M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$R/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T3X@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS,2PT,3,\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#(P,#PO M9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3X@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXR-RPT-3`\+V9O;G0^("`@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D($ED96YT:69I960@07-S971S($%C<75I'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C M96QL6QE/3-$)T9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1) M3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@(`T*("`@("`@ M("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);FET:6%L($9A:7(\+V9O;G0^("`@ M#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY686QU871I;VX\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY097)I;V0\ M+V9O;G0^("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY!9&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#M&86ER/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY686QU871I;VX\+V9O M;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,"XU M<'0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXS,C(N-SPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-"XR/"]F;VYT/B`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ,"XS/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$ M)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY4'!E;G-E"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY4;W1A;"!C;VYS:61E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-3`N-CPO9F]N=#X@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY697)S85!H87)M(&1E8G0@<&%I9"!O9F8@=&AR;W5G:"!C;&]S:6YG(&-A M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX,BXT/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT,S,N,#PO M9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP M+C$\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ,2XP/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);G9E;G1O6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C`\+V9O;G0^ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C`\+V9O M;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR-3`N.#PO9F]N=#X@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY)4%(F86UP.T0\+V9O;G0^("`@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)V)A8VMG"<^("`@("`-"B`@("`@("`@ M("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXY,2XT/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY4;W1A;"!A6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XV/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH-S8N,#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M-S8N,#PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@"!L:6%B:6QI=&EE"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R M/B`@("`@#0H@("`@("`@(#QT6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-3`N-CPO9F]N=#X@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@ M("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY);FET:6%L($9A:7(\+V9O;G0^("`-"B`@("`@("`@ M("`@("`@("`\+V1I=CX@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY686QU871I;VX\+V9O;G0^("`@(`T*("`@("`@("`@("`@ M("`@(#PO9&EV/B`@("`-"B`@("`@("`@("`@("`@/"]T9#X@#0H@("`@("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^(`T*("`@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY097)I;V0\+V9O;G0^ M(`T*("`@("`@("`@("`@("`@(#PO9&EV/B`@("`-"B`@("`@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO M=&0^(`T*("`@("`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED)SX@("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`-"B`@("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY!9&IU6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^(`T*("`@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXV,#4N,#PO9F]N=#X@("`-"B`@("`@("`@("`@("`@ M/"]T9#X@#0H@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^ M(`T*("`@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]T9#X@ M#0H@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`- M"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)V)A8VMG"<^("`@(`T*("`@ M("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXT+C$\+V9O;G0^(`T*("`@("`@("`@("`@("`\ M+W1D/B`-"B`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^("`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^ M(`T*("`@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`-"B`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@#0H@("`@("`@ M("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+C$\ M+V9O;G0^(`T*("`@("`@("`@("`@("`\+W1D/B`-"B`@("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@ M5$585"U!3$E'3CH@;&5F="<^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,BXR-7!T)SX@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@ M/"]T9#X@#0H@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-#DN-CPO M9F]N=#X@("`-"B`@("`@("`@("`@("`@/"]T9#X@#0H@("`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@#0H@("`@("`@("`@("`@(#PO=&0^(`T*("`@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`-"B`@("`@("`@("`@("`@("`@("`@/&9O;G0@ MF5D(&%M;W5N=',@;V8@:61E;G1I9FEA8FQE(&%S6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`@#0H@("`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-96%S=7)E;65N="!097)I;V0@061J M=7-T;65N=',\+V9O;G0^("`-"B`@("`@("`@("`@("`@("`@(#PO9&EV/B`- M"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI M9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]F;VYT/B`@ M#0H@("`@("`@("`@("`@("`@("`\+V1I=CX@#0H@("`@("`@("`@("`@("`@ M/"]T9#X@("`-"B`@("`@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@ M("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@ M("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXU,RXW/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@ M("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T* M("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,"XW/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU,RXP/"]F;VYT M/B`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`\+W1R/B`-"B`@("`@("`@("`@("`@/'1R/B`@ M("`@#0H@("`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W,"4^("`@#0H@("`@("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@(`T*("`@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@ M("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,"XV M/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,RXQ/"]F;VYT M/B`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,RXW/"]F;VYT/B`@("`- M"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@ M("`@("`@("`@("`\+W1R/B`-"B`@("`@("`@("`@("`@/'1R('-T>6QE/3-$ M)V)A8VMG6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY06QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@ M("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@ M("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`\+W1R/B`- M"B`@("`@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@ M("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+C0\+V9O;G0^("`@ M#0H@("`@("`@("`@("`@("`@/"]T9#X@("`-"B`@("`@("`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT M/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T* M("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`- M"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C,\+V9O;G0^("`@#0H@("`@ M("`@("`@("`@("`@/"]T9#X@("`-"B`@("`@("`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY46QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`\+W1R/B`-"B`@("`@("`@("`@("`@ M/'1R/B`@("`@#0H@("`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4^("`@#0H@("`@("`@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-S$N-3PO M9F]N=#X@("`@(`T*("`@("`@("`@("`@("`@(#PO=&0^("`@#0H@("`@("`@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`-"B`@("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@ M("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`\+W1R/B`-"B`@ M("`@("`@("`@("`@/'1R/B`@("`@#0H@("`@("`@("`@("`@("`@/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4^("`@#0H@ M("`@("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@(`T*("`@("`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXW.36QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@ M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXX,#`N-3PO9F]N=#X@("`@(`T*("`@("`@("`@("`@("`@(#PO=&0^ M("`@#0H@("`@("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`-"B`@("`@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T* M("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@("`-"B`@("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+C<\+V9O;G0^("`@#0H@("`@("`@("`@("`@("`@/"]T9#X@("`-"B`@("`@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@ M("`@("`@("`@("`\+W1R/B`-"B`@("`@("`@("`@("`@/'1R/B`@("`@#0H@ M("`@("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W,"4^("`@#0H@("`@("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`-"B`@("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`- M"B`@("`@("`@("`@("`@("`@("`@/&9O;G0@"!L:6%B:6QI=&EE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@ M(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,3(V+C$\+V9O M;G0^(`T*("`@("`@("`@("`@("`@(#PO=&0^("`@#0H@("`@("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@(`T*("`@("`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`-"B`@("`@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,7!T)SX@(`T*("`@("`@("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`-"B`@("`@("`@("`@ M("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH,BXW/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T* M("`@("`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`-"B`@("`@("`@("`@("`@("`\ M+W1D/B`@(`T*("`@("`@("`@("`@("`\+W1R/B`-"B`@("`@("`@("`@("`@ M/'1R('-T>6QE/3-$)V)A8VMG6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@ M("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D M/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT)SX@#0H@("`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@("`-"B`@("`@("`@("`@("`@("`\+W1D/B`@(`T*("`@("`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@ M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$ M14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^0V]N6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T M.R!-05)'24XM4DE'2%0Z(#!P="<^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXU-2XR/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXU-2XR/"]F;VYT/B`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,"XY/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE M/3-$)V)A8VMG6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXU-"XS/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXU-"XR/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXQ+C8\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+C(\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`R-W!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXP+C8\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP M+C$\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C<\+V9O M;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXX+CD\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/ M4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^4F5C;V=N:7IE9"!A;6]U;G1S(&]F(&ED96YT:69I86)L92!A6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ+C@\+V9O;G0^("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ+C@\+V9O;G0^("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"=6EL9&EN9W,L('!L M86YT(&%N9"!E<75I<&UE;G0\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N M/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-"XR/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$\+V9O;G0^ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$\+V9O M;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z M(#!P="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,BXY/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\ M+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXP+C<\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH,"XW/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXU-"XS/"]F;VYT/B`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@"<^(`T*("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY);G1A;F=I8FQE(&%S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)3X@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R M:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,2XQ/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`-"B`@("`@ M("`@("`@(#QD:78@6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R M:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,"XX/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@ M("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^0V%L8W5L871I;VX@;V8@9V%I M;B]F6QE/3-$ M)U!!1$1)3D"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M,S,N-CPO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY';V]D=VEL;"!D:79E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,2XR/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L M969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`-"B`@("`@("`@("`@ M(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY!6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M24Y$14Y4.B`Y<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0 M'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@8V]L6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY2979E;G5E/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY.970@:6YC;VUE(&9R;VT@8V]N=&EN=6EN9R!O M<&5R871I;VYS/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G/B`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q! M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)SX@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXT+#@Y,3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`M,3AP=#L@1$E34$Q! M63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXP+C`T/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)U!!1$1) M3D"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+CD\+V9O;G0^("`@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^4F5C;V=N:7IE9"!A;6]U;G1S M(&]F(&ED96YT:69I86)L92!A6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@"<^(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M8V-O=6YT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXP+C$\+V9O;G0^("`@(`T*("`@("`@("`@("`@ M/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)V)A8VMG3PO9F]N=#X@("`@(`T*("`@("`@("`@("`@ M/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3X@(`T*("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0W)3X@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE M/3-$)V)A8VMG6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU M+C4\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1'1O<"!W:61T M:#TS1#$E/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M8V-O=6YT6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4G M/B`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4G/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ."XP/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$=&]P M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%424]. M.B!U;F1E6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M0V]N"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;6]U;G0@;V8@8V%S:"!P86ED/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)3X@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY06QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXS+C4\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D M:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H M=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXT-2XP/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$=&]P('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$14-/4D%424]. M.B!U;F1E6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M4F5C;V=N:7IE9"!A;6]U;G1S(&]F(&ED96YT:69I86)L92!A6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY!8V-O=6YT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)3X@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)V)A8VMG3PO9F]N=#X@("`@ M(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)3X@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@4$%$1$E.1RU"3U143TTZ(#`N-7!T)SX@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS."XW/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4G/B`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4G/B`@("`@#0H@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXT,2XU/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^0F5T:6UO;"!!8W%U:7-I=&EO;CH\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&86ER('9A M;'5E(&]F(&%C<75I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M=&]P)SXF(S$W-#L\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ,2XT/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4G/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,RXX/"]F;VYT M/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%, M+4%,24=..B!T97AT+71O<#L@1D].5"U714E'2%0Z(&)O;&0G/B8C,36QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;W-O<'0\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@-S`E.R!6 M15)424-!3"U!3$E'3CH@=&5X="UT;W`[($9/3E0M5T5)1TA4.B!B;VQD)SXF M(S$W-#L\+V9O;G0^(%!&/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY06QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY06QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1R:6=H=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXP+C$\+V9O;G0^("`@(`T*("`@("`@("`@("`@ M/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$ M969E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P>"!S M;VQI9"<^("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY#;VYS:61E6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD:78@"<^("`@("`- M"B`@("`@("`@("`@(#QD:78@"<^(`T*("`@("`@("`@("`@/&9O;G0@3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)? M.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@ M8VAA'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^665A6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[ M/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4D5614Y515,\+V9O M;G0^("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ-C,\+V9O;G0^("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,3PO9F]N=#X@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M1U)/4U,@4%)/1DE4/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^3U!%4D%4 M24Y'($E.0T]-13PO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'86EN(&9R M;VT@4&9I>F5R($%.1$$@4V%L93PO9F]N=#X@(`T*("`@("`@("`@("`@/"]D M:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L M:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,"XU<'0G/B`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R M,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S@R,3([/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^3D54($E.0T]-13PO9F]N=#X@("`@(`T*("`@("`@("`@("`@/"]D:78^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N M/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S@R,3([/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C M96QL6QE/3-$)T9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^1&5C96UB97(@ M,S$L/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q-#PO9F]N=#X@("`@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F M;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^,C`Q,SPO9F]N=#X@("`@#0H@("`@("`@ M("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR-3PO9F]N=#X@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L M:6=N/3-$;&5F=#X@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^5$]4 M04P@05-31513/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,2XU<'0G/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR-CPO9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T"<^("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#EP=#L@34%21TE.+5))1TA4.B`U+C`U<'0G(&%L:6=N/3-$;&5F=#X@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SY43U1!3"!,24%" M24Q)5$E%4SPO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X M<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS1&QE9G0^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`@(#QD:78@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/E)E=F5N=64\+V9O;G0^/"]F;VYT/B`@#0H@("`@("`@("`@("`\+V1I M=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/B`@("`@ M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#M!8V-O=6YT6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^4F5C96EV86)L93PO9F]N=#X\+V9O;G0^("`@("`-"B`@("`@("`@("`@ M(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^4V%L M97,\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY.970\+V9O;G0^("`@(`T*("`@("`@("`@ M("`@/"]D:78^("`@("`-"B`@("`@("`@("`@(#QD:78@"<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E)E8V5I=F%B;&4\+V9O M;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY'6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E-A;&5S/"]F;VYT/CPO9F]N=#X@ M("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@"<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E)E=F5N=64\+V9O;G0^/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!C96YT97(G/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#M!8V-O=6YT6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^4F5C96EV86)L93PO9F]N=#X\+V9O M;G0^("`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE M/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%21TE. M+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`R+CEP="<@86QI9VX],T1L969T M/B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@ M("`@(#QT6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY#87)D:6YA;#PO9F]N=#X@("`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^,C,\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(S/"]F M;VYT/CPO9F]N=#X@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,38\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$R/"]F;VYT M/CPO9F]N=#X@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^,38\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$T/"]F;VYT/CPO M9F]N=#X@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY4;W1A;#PO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!&:6YA;F-I86P@1&%T82`H56YA=61I=&5D*2`H5&%B;&5S*3QB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@"<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@"<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,3`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@("`- M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@"<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T* M("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R/B`-"B`@("`@ M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)U!!1$1)3D&-E<'0@<&5R('-H87)E M(&%M;W5N=',I/"]F;VYT/B`@(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$ M,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^3W!E6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^26YC;VUE("A,;W-S*3PO9F]N=#X\ M+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4&5R($)A M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^4VAA6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED)SX@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^4&5R($1I;'5T960\+V9O;G0^("`@#0H@("`@ M("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q M-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^06UO=6YT/"]F;VYT M/CPO9F]N=#X@(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^)B,Q-C`[/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX] M,T1B;W1T;VT@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^4VAA M6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^665A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@8V]L6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D"<^ M("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D"<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@"<^("`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XP M-7!T)R!A;&EG;CTS1&QE9G0^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,C@L,S@R/"]F;VYT/B`@ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-"PR M,S(\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)2!S='EL93TS1"=415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXS6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,3$L-C4P/"]F;VYT M/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`\+W1R/B`@#0H@("`@("`@("`@/'1R/B`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q.24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-RPX,3@\+V9O M;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G/B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#0S.#PO9F]N=#X\ M+V9O;G0^("`@(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G/B`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C`S/"]F;VYT/CPO9F]N M=#X@("`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXP+C`R/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@("`@("`@/"]D:78^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M.7!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XP-7!T)R!A;&EG;CTS M1&QE9G0^("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXY,"PV,C(\+V9O;G0^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT.2PV-38\+V9O;G0^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,RPT-#`\+V9O;G0^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+#@R M.#PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+#@R.#PO9F]N=#X@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M665A6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@ M("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/ M33H@,G!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X)SX@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<^("`-"B`@("`@ M("`@("`@("`@/&9O;G0@"<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@"<^ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@ M,G!X)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXX-"PY-3,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)2!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-BPV-S@\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0V)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0V)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ,BPR,#4\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXP+C$S/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)A8VMG6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXR;F0@475A6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXP+C$Q/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!I9#TS1%1!0C$M.3$@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY06QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-RPP,3,\+V9O;G0^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F=#L@0D]21$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,3`W/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS.36QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PU-C@\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY43U1!3"!/ M5$A%4B!,3TY'+51%4DT@05-31513/"]F;VYT/B`-"B`@("`@("`@("`@("`@ M/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@ M/'1D(&%L:6=N/3-$6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T M('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXV.#4L,S,P/"]F;VYT/B`@(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#(R,RPW-S,\+V9O;G0^("`@("`- M"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXQ+#(Q."PP.3@\+V9O;G0^("`@("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@ M0D]21$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-S4\ M+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@ M0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXY,CDL,S`T/"]F;VYT/B`@(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY2971A:6YE9"!E87)N:6YG6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR."PQ,CD\+V9O;G0^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M=#L@0D]21$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXR.#@L.#DX/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+#(R,RPW-S,\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#(Q."PP.3@\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F=#L@0D]21$52+5))1TA4.B!B;&%C:R`Q+C%P M="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY2979E;G5E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH."PX M-3,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXV-RPX,3@\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@0D]2 M1$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY/4$52051)3D<@24Y#3TU%/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@ M/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@ M/'1D(&%L:6=N/3-$6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$ M15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED M)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXU+#0U.3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY) M;F-O;64@=&%X('!R;W9I6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M,RPR.#(\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@ M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#0S.#PO9F]N=#X@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64@9G)O;2!C;VYT:6YU:6YG(&]P M97)A=&EO;G,L(&)A6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXP+C`Y/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP-CPO9F]N M=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K M(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!" M3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C`W/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K M(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,"XP-3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY#3TU04D5(14Y3259%($E.0T]-13H\+V9O;G0^("`@(`T*("`@("`@("`@ M("`@("`\+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY#3TU04D5(14Y3259%($E.0T]-13PO9F]N=#X@("`- M"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY!6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI M9"<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@(`T*("`@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9&IU6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M5$]0 M.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`@ M(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY!6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52 M+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,S(L M-3$X/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXQ,C8L,S(W/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/4$52051) M3D<@24Y#3TU%/"]F;VYT/B`@("`-"B`@("`@("`@("`@("`@/"]D:78^("`- M"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N M/3-$6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY)3D-/344@1E)/32!#3TY424Y524Y'($]015)!5$E/3E,@0D5&3U)%($E. M0T]-12!405A%4SPO9F]N=#X@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXS,"PP,#0\+V9O;G0^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH."PX-3,\+V9O M;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ,2PQ-C<\+V9O;G0^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,RPR M.#(\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$S/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.150@24Y#3TU%+"!" M05-)0SPO9F]N=#X@("`@(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXP+C$X/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP-3PO9F]N=#X@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C$V/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T M('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH M,"XP-3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXP+C$Q/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY#;VYS;VQI9&%T960@;F5T(&EN8V]M93PO9F]N M=#X@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ.2PX.#8\+V9O;G0^ M("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ-"PS,34\+V9O;G0^("`-"B`@("`@("`@("`@ M(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@0D]2 M1$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;VYS;VQI9&%T M960@;F5T(&EN8V]M93PO9F]N=#X@#0H@("`@("`@("`@("`@(#PO9&EV/B`@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T M('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX+#@U,SPO9F]N=#X@ M#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`\+W1R/B`@#0H@("`@("`@ M("`@/'1R/B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-34E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0 M6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXT+#,R.3PO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52 M+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#$U,3PO M9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!8V-R=65D(&5X<&5N6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXX+#6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE' M2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@86QI9VX],T1L969T(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]2 M1$52+51/4#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY!6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI M9"<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX] M,T1L969T(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/4#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY!9&IU6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/4#H@8FQA8VL@,2XQ M<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!" M3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+5))1TA4.B!B M;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,SPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY43U1!3"!#55)214Y4($%34T544SPO9F]N=#X@("`-"B`@ M("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T* M("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT.30L,#DU/"]F;VYT/B`@ M(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A M8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH-2PU-C@\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY43U1!3"!/5$A%4B!,3TY'+51%4DT@05-3 M1513/"]F;VYT/B`-"B`@("`@("`@("`@("`@/"]D:78^("`-"B`@("`@("`@ M("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE' M2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY2971A:6YE9"!E87)N:6YG6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N M,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-BPT.#`\+V9O;G0^("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M=#L@0D]21$52+5))1TA4.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY43U1!3"!32$%214A/3$1%4E,F(S@R,3<[($5154E463PO9F]N M=#X@("`@#0H@("`@("`@("`@("`@(#PO9&EV/B`@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXS,C`L,S(R/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+#@W-BPX,S,\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@ M("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#@W,2PR-C(\ M+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F=#L@0D]21$52+5))1TA4.B!B;&%C:R`Q+C%P M="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@ M0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0.B!B M;&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q% M1E0Z(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P M="!S;VQI9"<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY2979E;G5E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K M(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH."PX-3,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T* M("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA M8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH."PX-3,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^ M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,RPV-C$\ M+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@ M5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH."PX-3,\+V9O;G0^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#8Q,CPO9F]N=#X@#0H@ M("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY);F-O;64@=&%X('!R;W9I6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH,RPR.#(\+V9O;G0^("`-"B`@("`@("`@("`@(#PO M=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY)3D-/344@1E)/32!#3TY424Y524Y' M($]015)!5$E/3E,\+V9O;G0^(`T*("`@("`@("`@("`@("`\+V1I=CX@(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXW+#$X-SPO9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PU-S$\+V9O;G0^("`-"B`@ M("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXQ+#$Q,SPO9F]N=#X@#0H@("`@("`@("`@("`\ M+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY.150@24Y#3TU%(%!%4B!32$%213H\+V9O;G0^("`@(`T*("`@ M("`@("`@("`@("`\+V1I=CX@(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64@9G)O;2!C;VYT:6YU:6YG M(&]P97)A=&EO;G,L(&)A6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@ M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXP+C`W/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O;&ED M)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP-3PO M9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@ M#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4.B`Q M.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXP+C`Q/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY.150@24Y#3TU%+"!$24Q55$5$/"]F;VYT/B`@#0H@("`@("`@("`@("`@ M(#PO9&EV/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X@("`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@ M("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+#8X-#PO M9F]N=#X@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH-2PU-S$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!" M3U)$15(M4DE'2%0Z(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@ M("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+#@T,#PO9F]N=#X@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&)L86-K(#$N,7!T('-O M;&ED)SX@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@#0H@("`@ M("`@("`@("`\+W1D/B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,B4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-2PU M-S$\+V9O;G0^("`-"B`@("`@("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$15(M4DE'2%0Z M(&)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@ M86QI9VX],T1L969T(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52 M+51/4#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY!6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^ M("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L M969T(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/4#H@8FQA M8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY!9&IU6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T.R!"3U)$15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9"<^("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+51/4#H@8FQA8VL@,2XQ<'0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T.R!"3U)$ M15(M5$]0.B!B;&%C:R`Q+C%P="!S;VQI9#L@0D]21$52+5))1TA4.B!B;&%C M:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D M/B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T M9#X@("`@#0H@("`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@#0H@("`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T* M("`@("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@,2XQ<'0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@/"]T6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@8FQA8VL@ M,2XQ<'0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@ M("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH,C0L,3DS/"]F;VYT/B`@(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@/"]T9#X@ M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`Q.'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'!E;G-E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@ M("`@("`@("`@/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*("`@("`@("`@("`@ M/"]T9#X@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@#0H@("`@("`@("`@("`\+W1D/B`@("`- M"B`@("`@("`@("`\+W1R/B`@#0H@("`@("`@(#PO=&%B;&4^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA M7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O M:'1M;#L@8VAA2!O9B!3:6=N:69I M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2`H55-$("0I/&)R M/CPO2!.;VYC;VYT2!7'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&-L=61E9"!F M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D($QO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG M(%!O;&EC:65S("A$971A:6QS*2!;3&EN92!)=&5M2!O9B!3:6=N:69I M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2!;3&EN92!)=&5M M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O M;&EC:65S("A$971A:6QS*2!;3&EN92!)=&5M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!O9B!3:6=N:69I8V%N M="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2!;3&EN92!)=&5M&EM=6T@6TUE M;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA M-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q M,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG M(%!O;&EC:65S("A$971A:6QS*2`M($-H86YG97,@:6X@1V]O9'=I;&P@*%53 M1"`D*3QB'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6EN9R!A;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA2!A;F0@4F5S96%R8V@@ M86YD($1E=F5L;W!M96YT(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-"PU M,38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F%T:6]N(%!E'0^,3(@>65A7,\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6EN9R!!;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^-R!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6EN9R!! M;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F%T:6]N(%!E'0^,2!Y96%R(#$T-B!D M87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^ M,2!Y96%R(#$T-B!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y M8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X M85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC M:65S("A$971A:6QS*2`M($-H86YG97,@:6X@26YT86YG:6)L92!!'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X-S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X-SDI/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O9B!3 M:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2`M($-H M86YG97,@:6X@26YT86YG:6)L92!!F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@V,34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!4'1087)T7S)A M9C!A,3(V7S-C.&%?-&4X,E\Y-F%F7V)C.&$U864W-CEB-0T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B M8SAA-6%E-S8Y8C4O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%T:6]N($5X<&5N7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA2!O9B!3:6=N:69I M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2`M($%V97)A9V4@ M17-T:6UA=&5D(%5S969U;"!,:79E2P@4&QA;G0@86YD M($5Q=6EP;65N="!;3&EN92!)=&5M'0^,S`@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$65A2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG M(%!O;&EC:65S("A$971A:6QS*2`M($%V97)A9V4@17-T:6UA=&5D(%5S969U M;"!,:79E2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN M92!)=&5M'0^-2!Y96%R2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC M:65S("A$971A:6QS*2`M($%V97)A9V4@17-T:6UA=&5D(%5S969U;"!,:79E M2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M M'0^-2!Y96%R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA>*`F7,@1FEN M86YC:6%L($EN2!F;W)W87)D(&-O;G1R86-T M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O M;&EC:65S("A$971A:6QS*2`M($9A:7(@5F%L=65S(&]F('1H92!#;VUP86YY MXH"9'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$>*`F7,@1FEN86YC:6%L($EN'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'!E8W1E9"!V;VQA=&EL:71Y/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW.2XW,"4\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'!E8W1E9"!L:69E("AI;B!Y96%R65A7,\ M&EM=6T@6TUE;6)E65A7,\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^07!R(#$S+`T*"0DR,#`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!787)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^075G(#$W+`T*"0DR,#`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R M-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A M93'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P M83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X M835A93'0O:'1M;#L@8VAA&-E2`H55-$("0I/&)R/DEN(%1H;W5S86YD'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2P@4&QA;G0@86YD($5Q M=6EP;65N="`H1&5T86EL2P@4&QA;G0@86YD($5Q=6EP;65N="`H1&5T86EL'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2P@4&QA;G0@86YD M($5Q=6EP;65N="`H1&5T86EL2P@4&QA;G0L(&%N9"!% M<75I<&UE;G0@*%531"`D*3QB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@<&QA;G0L(&%N9"!E<75I M<&UE;G0L(&=R;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD M(#$X-2PX-S<\2P@4&QA;G0@86YD($5Q=6EP M;65N="!;3&EN92!)=&5M2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!;365M8F5R72!\(%)E=F]L M=FEN9R!#'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!;365M8F5R72!\($I036]R9V%N(%M-96UB97)=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,C`@ M9&%Y'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-2!D87ES/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-2!D87ES/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7,\+W1D/@T*("`@("`@("`\=&0@8VQA7,\7,\+W1D/@T*("`@("`@("`\=&0@ M8VQA7,\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S(&]F(%-T;V-K($ES'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0L(%!E'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^-R!Y96%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF%T:6]N(&]F($9I;F%N8VEN9R!#;W-T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!;365M8F5R72!\($UA>&EM M=6T@6TUE;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!;365M8F5R72!\($-O;6UI=&UE;G0@1F5E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!;365M8F5R M72!\($I036]R9V%N(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6UE;G0L(%!E M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-R!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&EM=6T@0F]R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!;365M8F5R72!\($(@;V8@02!;365M8F5R73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2P@26YT97)E'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`R(%M-96UB97)=('P@175R;V1O;&QA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`S(%M-96UB97)=('P@0F%S92!2871E(%M- M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$&5D(&-H87)G92!C;W9E&EM M=6T@6TUE;6)E&5D M(&-H87)G92!C;W9E2`R(%M-96UB97)=('P@175R;V1O;&QA M&5D(&-H87)G92!C;W9E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&EM=6T@6TUE;6)E&5D(&-H87)G92!C;W9E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D($1E8G0@1&ES8V]U;G0@6TQI;F4@ M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\2!C;VUP;VYE;G0\+W1D/@T*("`@("`@ M("`\=&0@8VQAF5D M(&1E8G0@9FEN86YC:6YG(&-O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW M.#`\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S M8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA'!E;G-E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA&-E M<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S"`H:6X@1&]L;&%R'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!T:&%N(&YO="!S971T;&4@9G5T=7)E(&YO=&4@8V]N=F5R'1087)T7S)A9C!A,3(V7S-C.&%?-&4X,E\Y-F%F7V)C.&$U864W-CEB M-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R868P83$R-E\S8SAA M7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^,3`@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!;365M8F5R73PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E M.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV M869?8F,X835A93'0O:'1M;#L@8VAA2`P,BP@,C`Q-#QB2`P,RP@,C`Q-#QB2`R-RP@,C`P-3QB'!E;G-E("AI;B!$;VQL87)S*3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$65E(%-E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7,\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@ M07=A2!);G-T'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE M;G0@07=A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S6UE;G0@07=A M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E(%-T;V-K(%!U'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E(%-T;V-K(%!U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$65E(%-E65T(%)E M8V]G;FEZ960L(%!E65A7,\2!3:&%R92UB87-E9"!0 M87EM96YT($%W87)D+"!%<75I='D@26YS=')U;65N=',@3W1H97(@=&AA;B!/ M<'1I;VYS+"!''0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$65E(%-T;V-K(%!U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^,R!Y96%R M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E(%-T;V-K(%!U'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M65A'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E(%-T;V-K(%!U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E(%-T;V-K(%!U'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$65E("AI;B!$;VQL87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$65E(%-T;V-K(%!U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S6UE;G0@07=A2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!. M=6UB97(@;V8@4VAA2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!/<'1I;VYS+"!/=71S=&%N M9&EN9RP@3G5M8F5R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT M+#DV."PP,#`\6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M6UE;G0@ M07=AF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!3:&%R92UB M87-E9"!087EM96YT($%W87)D+"!/<'1I;VYS+"!%>&5R8VES97,@:6X@4&5R M:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#4R.2PP,#`\ M2!3:&%R M92UB87-E9"!087EM96YT($%W87)D+"!/<'1I;VYS+"!&;W)F96ET=7)E2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!% M>'!I'0^-2!Y96%R2!3:&%R92UB87-E9"!087EM96YT M($%W87)D+"!/<'1I;VYS+"!/=71S=&%N9&EN9RP@3G5M8F5R/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0Q.2PP,#`\2!3:&%R92UB87-E9"!087EM M96YT($%W87)D+"!/<'1I;VYS+"!''0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ MF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!3:&%R92UB M87-E9"!087EM96YT($%W87)D+"!/<'1I;VYS+"!%>&5R8VES97,@:6X@4&5R M:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$65A M65E(%-T;V-K(%!U2!3 M:&%R92UB87-E9"!087EM96YT($%W87)D+"!.=6UB97(@;V8@4VAA6UE;G0@07=A2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!3:&%R M97,@27-S=65D(&EN(%!E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A65E(%-T;V-K(%!U65A M'0^-"!Y96%R65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'!E8W1E9"!V;VQA=&EL:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XT-BXP,"4\&EM=6T@6TUE;6)E7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA65E(%-T;V-K(%!U&-E<'0@4VAA2!;3&EN92!)=&5M&5R8VES M92!065A7,\&5R8VES92!0 M&5R8VES92!0&5R8VES M92!07!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A65E(%-T;V-K(%!U7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA&5S M("A$971A:6QS*2!;3&EN92!)=&5M"!2871E+"!097)C96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XS-2XP,"4\F5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S("A$971A:6QS*2!;3&EN92!)=&5M M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$69O"!!=71H;W)I='D@6TUE;6)E&5S("A$971A:6QS*2!;3&EN92!)=&5M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$69O2!;365M8F5R72!\($Y/3"!%>'!I'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$69O2!;365M8F5R72!\($EN9&5F:6YI=&4@3&EV960@3D],(%M- M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S("A$971A:6QS*2`M($EN8V]M92!487@@4')O=FES:6]N("A54T0@)"D\ M8G(^26X@5&AO=7-A;F1S+"!U;FQE'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R M868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869? M8F,X835A93'0O:'1M;#L@8VAA"!2871E(%)E8V]N8VEL:6%T:6]N M(%M!8G-T&5S(')E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E("AB96YE9FET*2P@;F5T/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S("A$971A:6QS*2`M(%1H92!'96]G>*`F7,@26YC;VUE("A54T0@)"D\8G(^ M26X@5&AO=7-A;F1S+"!U;FQE"!L;W-S(&9R M;VT@8V]N=&EN=6EN9R!F;W)E:6=N(&]P97)A=&EO;G,\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S("A$971A:6QS*2`M($YE="!$969E&5S($-U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!S=&5P+75P/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M"!A2UF;W)W87)D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S"!A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA&5S("A$971A:6QS M*2`M(%-U;6UAF5D(%1A>"!"96YE9FET'!O65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$65R($UA=&-H:6YG($-O;G1R:6)U=&EO;BP@4&5R8V5N="!O9B!%;7!L M;WEE97,G($=R;W-S(%!A>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA M7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!396=M96YT(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!396=M96YT(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A2!!9W)E96UE;G0@=VET:"!(;W-P:7)A(%M-96UB97)=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T M93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6UE;G0@=&\@4W1R M871E9VEC($)U'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA&5S('!A:60\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E M-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9? M,V,X85\T93@R7SDV869?8F,X835A93'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!2979E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$&-E M961E9"!/9B!6;W1I;F<@26YT97)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S('1O M($%C<75I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,3$@>65A7,\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M,34@>65A7,\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^,R!Y96%R'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$65A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!!9W)E96UE;G0@6TUE;6)E6UE;G1S M(&9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&EM=6T@6TUE M;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^-2!Y96%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^,B!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S('1O($%C<75I M3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!);FAA;&%T M:6]N(%-O;'5T:6]N'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^,3$@>65A7,\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'!E8W1E9"!487@@1&5D=6-T:6)L92!!;6]U;G0\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S('1O($%C<75I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^,34@>65A65A M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^-C`@9&%Y'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%SF%T:6]N(%!E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S('1O($%C M<75I3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S('1O M($%C<75I'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6%B;&4@87-S=6UE9#PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV M869?8F,X835A93'0O:'1M;#L@8VAA"!!8W%U:7-I=&EO;B!;365M M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!A9&X@=&AE($9A:7(@ M5F%L=64@;V8@=&AE($%C<75I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XD(#,R+#$T-RPP,#`\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!#;VYS M:61E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'!E M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E(%M-96UB97)=('P@061J=7-T960@1F%I'!E;G-E/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S"!L:6%B:6QI=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!S96QL97)S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S"!L:6%B:6QI=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S2!S96QL97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S"!L:6%B:6QI M=&EE'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S"!L:6%B:6QI=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,2PS,#`L,#`P/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA MF5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#D\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'!E;G-E M"!A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA M7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A93'0O M:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E.#)?.39A9E]B8SAA-6%E-S8Y M8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X M85\T93@R7SDV869?8F,X835A937!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!42!4'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!)=&5M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!)=&5M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA M7S1E.#)?.39A9E]B8SAA-6%E-S8Y8C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,F%F,&$Q,C9?,V,X85\T93@R7SDV869?8F,X835A937!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4&5R(%-H87)E(&1A=&$L M('5N;&5S2!S971T;&4@86QL(&9U='5R92!N;W1E(&-O;G9E2!T:')O=6=H('-H87)E65A'0O:'1M;#L@ M8VAA'!E;G-E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S"!P'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!297!O M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S('!A>6%B;&4\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$&5S('!A M>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E'!E;G-E'!E8W1A=&EO;B!T:&%T M(&UA;F%G96UE;G0@;6%Y('-E='1L92!A;&P@9G5T=7)E(&YO=&4@8V]N=F5R M&-L=7-I;VX@ M;V8@:6YT97)E&9O65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&UL/@T*+2TM+2TM/5].97AT4&%R=%\R868P83$R-E\S8SAA7S1E 8.#)?.39A9E]B8SAA-6%E-S8Y8C4M+0T* ` end XML 51 R43.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables)
 12 Months Ended
Dec. 31, 2014
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables) [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Consideration:
 
Initial Fair
Valuation
   
Measurement
Period
Adjustments
   
Adjusted
 Fair
Valuation
 
Amount of cash paid to VersaPharm stockholders
  $ 322.7     $ —     $ 322.7  
Amount of cash paid to vested VersaPharm option holders
    14.2       —       14.2  
Amounts paid to escrow accounts
    10.3       —       10.3  
Transaction expenses paid for previous owners of VersaPharm
    3.4       —       3.4  
Total consideration paid at closing
    350.6       —       350.6  
VersaPharm debt paid off through closing cash
    82.4       —       82.4  
Total cash paid at closing
  $ 433.0     $ —     $ 433.0  
                         
Recognized amounts of identifiable assets acquired and liabilities assumed:
                       
Cash and cash equivalents
  $ 0.1     $ —     $ 0.1  
Accounts receivable
    10.0       1.0       11.0  
Inventory
    20.9       (0.2 )     20.7  
Other current assets
    2.8      
4.8
     
7.6
 
Property and equipment
    1.5       —       1.5  
Trademarks
    1.0       —       1.0  
Product licensing rights
    250.8       —       250.8  
Intangibles, other
    5.2       —       5.2  
IPR&D
    215.9       —       215.9  
Goodwill
    90.6       0.8       91.4  
Total assets acquired
  $ 598.8     $
6.4
    $
605.2
 
Assumed current liabilities
    (18.3 )     (0.6 )     (18.9 )
Assumed non-current liabilities
    (76.0 )             (76.0 )
Deferred tax liabilities
    (153.9 )      (5.8 )      (159.7 )
Total liabilities assumed
  $ (248.2 )   $
(6.4
)   $ (254.6 )
    $ 350.6     $ —     $ 350.6  
Consideration:
 
Initial Fair
Valuation
   
Measurement
Period
Adjustments
   
Adjusted Fair
Valuation
 
Amount of cash paid to Hi-Tech shareholders
  $ 605.0     $ —     $ 605.0  
Amount of cash paid to vested Hi-Tech option holders
    40.5       —       40.5  
Amount of cash paid to key executives under single-trigger separation payments upon change-in-control
    4.1       —       4.1  
    $ 649.6     $ —     $ 649.6  
Recognized amounts of identifiable assets acquired and liabilities assumed:
 
Initial Fair Valuation
   
Measurement Period Adjustments
   
Adjusted Fair Valuation
 
Cash and cash equivalents
  $ 89.7     $ —     $ 89.7  
Accounts receivable
    57.3       (5.7 )     51.6  
Inventory
    53.7       (0.7 )     53.0  
Other current assets
    20.6       13.1       33.7  
Property and equipment
    45.5       (2.0 )     43.5  
Product licensing rights
    343.5       —       343.5  
IPR&D
    9.4       —       9.4  
Customer Relationships
    0.3       —       0.3  
Trademarks
    5.5       —       5.5  
Goodwill
    171.5       (2.0 )     169.5  
Other non-current assets
    0.6       —       0.6  
Total assets acquired
  $ 797.8     $ 2.7     $ 800.5  
Assumed current liabilities
    (23.5 )     1.7       (21.8 )
Assumed non-current liabilities
    (2.8 )     (0.2 )     (3.0 )
Deferred tax liabilities
    (121.9 )     (4.2 )     (126.1 )
Total liabilities assumed
  $ (148.2 )   $ (2.7 )   $ (150.9 )
    $ 649.6     $ —     $ 649.6  
Consideration:
Initial Fair
Valuation
   
Measurement Period Adjustments
   
Adjusted Fair
Valuation
 
Cash paid
  $ 55.2     $ —     $ 55.2  
Less working capital shortfall refunded by sellers
    (0.9 )     (0.1 )     (1.0 )
    $ 54.3     $ (0.1 )   $ 54.2  
                         
Acquisition-related costs:
                       
Stamp duties paid for transfer of land and buildings
  $ 1.6     $ —     $ 1.6  
Acquisition-related compensation expense
    6.7       0.5       7.2  
Due diligence, legal, travel and other acquisition-related costs
    0.6       0.1       0.7  
    $ 8.9     $ 0.6     $ 9.5  
                         
Recognized amounts of identifiable assets acquired and liabilities assumed:
                 
Accounts receivable
  $ 2.1     $ —     $ 2.1  
Inventory
    1.8       —       1.8  
Land
    3.7       (1.1 )     2.6  
Buildings, plant and equipment
    8.5       —       8.5  
Construction in progress
    14.2       —       14.2  
Goodwill, deductible
    21.6       1.0       22.6  
Other intangible assets, deductible
    5.8       0.1       5.9  
Other assets
    0.1       —       0.1  
Assumed liabilities
    (2.1 )     (0.8 )     (2.9 )
Deferred tax liabilities
    (1.4 )     0.7       (0.7 )
    $ 54.3     $ (0.1 )   $ 54.2  
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]
Calculation of gain from Watson product disposition (in millions)
       
Consideration received
  $
16.8
 
Intangible assets disposed
   
(5.9
)
Goodwill disposed
   
(1.1
)
Other assets disposed
   
(0.8
)
Pre-Tax gain recognized
  $
9.0
 
Calculation of gain/from ECR Divestiture (in millions)
     
Consideration received
  $
41.0
 
Intangible assets divested
   
(33.6
)
Goodwill divested
   
(10.4
)
Other assets divested
   
(1.2
)
Assumed liabilities divested
   
5.1
 
Pre-Tax Gain recognized
  $
0.9
 
Business Acquisition, Pro Forma Information [Table Text Block]
   
For the Year Ended
December 31,
 
   
2014
   
2013
 
Revenue
  $
733,012
    $ 623,922  
Net income from continuing operations
   
71,722
      4,891  
Net income from continuing operations per share
  $
0.58
    $ 0.04  
VersaPharm [Member]  
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables) [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Consideration:
     
Amount of cash paid
 
$
16.1
 
Fair value of contingent payment
   
1.9
 
Total consideration at closing
 
$
18.0
 
         
Recognized amounts of identifiable assets acquired:
       
Accounts receivable
   
0.1
 
Inventory
   
2.5
 
Product licensing rights
   
10.0
 
IPR&D
   
5.5
 
Accounts payable assumed
   
(0.1)
 
Fair value of assets acquired
 
$
18.0
 
Xopenex Acquisition [Member]  
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables) [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Consideration:
     
Amount of cash paid
 
$
41.5
 
Product returns and reserves assumed
   
3.5
 
Total consideration at closing
 
$
45.0
 
         
Recognized amounts of identifiable assets acquired:
       
Accounts Receivable, net (product returns and reserves assumed)
   
(3.5)
 
Inventory
   
6.3
 
Product licensing rights
   
38.7
 
Fair value of net assets acquired
 
$
41.5
 
Betimol Acquisition [Member]  
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables) [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Betimol Acquisition:
     
Consideration paid in cash at closing
  $
7.5
 
Purchase consideration payable
   
4.0
 
    $
11.5
 
         
Fair value of acquired assets:
       
U.S. NDA rights to Betimol®
  $
11.4
 
Favorable supply agreement
   
0.1
 
    $
11.5
 
Merck Acquisition [Member]  
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables) [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Product rights:
     
AzaSite®
  $
13.8
 
Cosopt®
   
21.6
 
Cosopt® PF
   
20.3
 
Product rights total
  $
55.7
 
Prepaid expenses
   
0.1
 
Deferred tax assets, net
   
0.7
 
Total fair value of acquired assets
  $
56.5
 
Consideration paid
  $
52.8
 
Gain from bargain purchase
  $
3.7
 

XML 52 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 22 - Legal Proceedings
 12 Months Ended
Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]  
Legal Matters and Contingencies [Text Block]
Note 22 – Legal Proceedings.

We are party to legal proceedings and potential claims arising in the ordinary course of our business. Such legal proceedings include Akorn’s Paragraph IV challenges to other drug manufacturers’ proprietary rights, and the counter-suits filed by those drug manufacturers in response.  The amount, if any, of ultimate liability with respect to legal proceedings involving the Company cannot be determined.  Despite the inherent uncertainties of litigation, at this time the Company does not believe that such proceedings will have a material adverse impact on our financial condition, results of operations, or cash flows. Set forth below is a listing of potentially material legal proceedings of the Company, including Akorn, Hi-Tech, and VersaPharm in existence as of the date of filing this Form 10-K.

On September 11, 2013, the Attorney General of the State of Louisiana filed a lawsuit in Louisiana state court against Hi-Tech, and numerous other pharmaceutical companies, under various state laws, alleging that each defendant caused the state’s Medicaid agency to provide reimbursement for drug products that allegedly were not approved by FDA and therefore allegedly not reimbursable under the federal Medicaid program. The state seeks unspecified damages, statutory fines, penalties, attorney’s fees and costs. On October 15, 2013, the defendants removed the lawsuit to the U.S. District Court for the Middle District of Louisiana. Subsequently, the case was remanded to state court, where the case is in the initial discovery stage. The Company intends to vigorously defend against all claims in the lawsuit.

In May 2013, Inspire, a wholly owned subsidiary, received a Notice Letter that Mylan Pharmaceuticals, Inc. (“Mylan”) filed an ANDA with the FDA seeking marketing approval for a 1% azithromycin ophthalmic solution prior to the expiration of the five U.S. patents licensed to us and listed in the Orange Book for Azasite®.  On June 14, 2013, Insite, Merck, Inspire and Pfizer filed a complaint against Mylan and a related entity alleging that their proposed product infringes the listed patents.  The parties agreed to settle the matter and the case was dismissed by court order on March 4, 2015.

On September 12, 2012, Fera Pharmaceuticals, LLC (“Fera”) filed a civil complaint against the Company and certain individual defendants in the Supreme Court of New York. On October 15, 2012, the case was removed to the Federal District Court for the Southern District of New York, and subsequently, Fera filed an amended complaint. The complaint alleges, among other things, breach of manufacturing and confidentiality agreements, fraud in the inducement and misappropriation of the plaintiff’s trade secrets.  The Company intends to vigorously defend these allegations.  On January  13, 2015, the Company filed a counterclaim against Fera and certain affiliates  (Alfera  Pharmaceuticals,  LLC;  Feranda,  LLC;  Baci   007,   LLC;   and    Fera Holdings, LLC), as well as Perrigo Company of Tennessee and Perrigo Company plc, asserting violations of Sections 1 and 2 of the Sherman Act and tortious interference with business relations.  The case is in the discovery phase, and no trial date has been scheduled.

On June 8, 2012, plaintiff Mathew Harrison filed  a class action lawsuit, Civil Action No. 12-2897, in the U.S. District Court for the Eastern District of New York, against Wayne Perry, Dynova Laboratories, Inc., Sicap Industries, LLC, Walgreens Co. and Hi-Tech. On May 16, 2012, plaintiff David Delre filed a class action lawsuit, Civil Action No. 12-2429, in the U.S. District Court for the Eastern District of New York, against Wayne Perry, Dynova Laboratories, Inc., Sicap Industries, LLC, and Hi-Tech. Each complaint alleges, among other things, that their Sinus Buster® products are improperly marketed, labeled and sold as homeopathic products, and that these allegations support claims of fraud, unjust enrichment, breach of express and implied warranties and alleged violations of various state and federal statutes. Hi-Tech answered the complaints and asserted cross-claims against the other defendants. The Court consolidated these two cases into one action entitled Sinus Buster Products Consumer Litigation. Dynova has filed for bankruptcy. The case has now been settled by Hi-Tech with plaintiffs by Agreement dated December 16, 2013 and the Court approved the settlement by an Order dated November 10, 2014.

In April 2011, Inspire Pharmaceuticals, Inc., a wholly owned subsidiary of the Company, acquired through a business combination on November 15, 2013, received a Notice letter from Sandoz, Inc. (“Sandoz”) providing notice that Sandoz filed an ANDA with the FDA seeking marketing approval for a 1% azithromycin ophthalmic solution prior to the expiration of the five U.S. patents licensed to us and listed in the Orange Book for Azasite®.  On May 26, 2011, Merck, Insite Vision Incorporated and Pfizer filed a complaint against Sandoz and related entities in the district court of New Jersey alleging that their proposed product infringes the listed patents.  On October 4, 2013, the court issued judgment in favor of Inspire and the other plaintiffs finding all the asserted claims of the patents in the litigation valid and infringed by Sandoz and related entities.  Sandoz has appealed this decision.  The Company intends to vigorously contest any Sandoz assertions that these patents should have been found not infringed, invalid or unenforceable.

Former Hi-Tech director and employee Reuben Seltzer delivered to the Company a demand letter in August 2014 alleging that the Company breached his employment agreement and improperly terminated Mr. Seltzer’s employment.  Mr. Seltzer further alleges that he is entitled to compensation in the approximate amount of $5.2 million.  The Company disputes these claims and intends to vigorously defend these allegations.

On March 4, 2015, putative class action plaintiff Solomon Yeung filed suit in the Federal District Court Northern District Illinois against Akorn, Inc., Rajat Rai, Timothy Dick and Bruce Kutinsky, alleging defendants violated Rules 10b-5 and 20(a) of the 1934 Exchange Act.  According to the complaint, certain financial and other related data related to certain Akorn subsidiaries could not be timely collected and compiled and Akorn would be unable to timely complete its assessment of the effectiveness of its internal control over financial reporting as of December 31, 2014. The complaint also alleges that Akorn’s internal control over financial reporting was ineffective and material weaknesses existed relating to the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions and accurate and timely reporting of its financial results and disclosures in its Form 10-K. Plaintiff alleges that as a consequence, when Akorn announced on March 2, 2015 that it would need an extension to file an annual report for the year ending December 31, 2014, its stock dropped.  The Company and individual defendants dispute these claims and intend to vigorously defend these allegations.

XML 53 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 21 - Selected Quarterly Financial Data (Unaudited)
 12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information [Text Block]
Note 21 – Selected Quarterly Financial Data (Unaudited)

 
 
 
   
 
Income (Loss) From Continuing Operations
   
Net Income (Loss)
 
 
(In thousands, except per share amounts)
 
Revenues
   
Gross
Profit
   
Operating
Income (Loss)
   
Amount
   
Per Basic
Share
   
Per Diluted
Share
   
Amount
   
Per Basic
Share
   
Per Diluted
Share
 
Year Ended December 31, 2014:
                                                     
4th Quarter
  $ 227,828     $ 128,382     $ 71,907     $ 34,232     $ 0.32     $ 0.29     $ 34,232     $ 0.32     $ 0.29  
3rd Quarter
    132,732       51,734       (6,042 )     (11,650 )     (0.11 )     (0.11 )     (11,650 )     (0.11 )     (0.11 )
2nd Quarter (as restated)
   
141,896
     
67,818
     
7,410
     
3,438
     
0.03
     
0.03
     
2,935
     
0.03
     
0.02
 
1st Quarter
    90,622       49,656       23,440       9,828       0.10       0.08       9,828       0.10       0.08  
Year Ended December 31, 2013:
                                                                       
4th Quarter
  $ 84,953     $ 46,970     $ 25,176     $ 16,678     $ 0.17     $ 0.14     $ 16,678     $ 0.17     $ 0.14  
3rd Quarter
    81,892       43,697       22,188       12,205       0.13       0.11       12,205       0.13       0.11  
2nd Quarter
    77,012       42,092       22,251       12,637       0.13       0.11       12,637       0.13       0.11  
1st Quarter
    73,854       39,145       18,589       10,842       0.11       0.10       10,842       0.11       0.10  

On March 17, 2015, the Company issued a press release announcing that the Audit Committee of the Company’s Board of Directors, upon the recommendation of management, concluded that the previously issued financial statements contained in the Company’s Quarterly Reports on Form 10-Q for the periods ended June 30, 2014 and September 30, 2014 should not be relied upon because of an error in the financial statements as of and for the three and six month periods ended June 30, 2014 and as of and for the nine month period ended September 30, 2014, and that those financial statements would be restated to make the necessary accounting adjustments.

On April 17, 2014, the Company completed its acquisition of Hi-Tech for a total purchase price of approximately $650.0 million. During the 2014 year-end audit process, an error was identified in the fair value allocation of assets acquired and liabilities assumed in connection with the acquisition of Hi-Tech, which resulted in an overstated chargeback reserve as of April 17, 2014. The error, which was identified on March 11, 2015, resulted from an overstatement of Hi-Tech’s chargeback reserve in connection with applying the acquisition method of accounting at the closing of the Hi-Tech acquisition.

The overstatement in the chargeback reserve was caused by a manual error made in preparing the data whereby there was a duplication of inventory units held by one customer utilized in the calculation of the reserve amount for Hi-Tech products at the acquisition date.  The duplication resulted in an overstatement of chargeback reserves by approximately $8.9 million for the opening balance sheet of Hi-Tech as of April 17, 2014. The chargeback reserve at the end of the quarter ended June 30, 2014 was then calculated correctly, resulting in the earlier overstated reserve amount being included in revenue during the quarter ended June 30, 2014. The correction of the error in the quarter ended June 30, 2014 resulted in a reduction of previously reported revenue by $8.9 million, a reduction of previously reported pre-tax income by $8.9 million and a reduction of previously reported net income, goodwill and retained earnings by $5.6 million, for the Company’s three and six month periods ended June 30, 2014.

The error was limited to the Company’s financial results for the three and six months ended June 30, 2014, but the error did impact the Company’s previously filed results for the nine months ended September 30, 2014 (which were filed in connection with the Company’s Form 10-Q for the quarter ended September 30, 2014) because the second quarter results were included within that period. The estimated impact of this error for the restated three and six month periods ended June 30, 2014 is to reduce basic and diluted net income per share by approximately $0.05 per share. The estimated impact of this error for the restated nine month period ended September 30, 2014 is to reduce basic and diluted net income per share by approximately $0.06 and $0.05 per share, respectively.

The error has been corrected in the full year financial statements included elsewhere in this Annual Report.  In addition, the above unaudited selected quarterly financial data has been corrected to eliminate the error.  The Company also expects to file amendments on Form 10-Q/A to its previously filed Form 10-Qs for the second and third quarters of 2014 to reflect the corrections and accordingly, the financial statements in those Form 10-Qs should not be relied upon until such time as the Company has filed its Form 10-Q/As for those periods.

Effects of Restatement on Previously Filed Quarterly Results

The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported financial statements as of and for the three and six month periods ended June 30, 2014 and as of and for the nine month period ended September 30, 2014.

The effect of the restatement on the previously filed condensed consolidated balance sheet as of June 30, 2014 is as follows, in thousands:

   
As Reported
   
Adjustments
   
As Restated
 
Prepaid expenses and other current assets
  $ 17,120     $ (107 )   $ 17,013  
TOTAL CURRENT ASSETS
    397,180       (107 )     397,073  
Goodwill
    196,016       (5,568 )     190,448  
TOTAL OTHER LONG-TERM ASSETS
    690,898       (5,568 )     685,330  
TOTAL ASSETS
  $ 1,223,773     $ (5,675 )   $ 1,218,098  
Income taxes payable
    675       (104 )     571  
TOTAL CURRENT LIABILITIES
    103,777       (104 )     103,673  
TOTAL LIABILITIES
    929,304       (104 )     929,200  
Retained earnings
    33,700       (5,571 )     28,129  
TOTAL SHAREHOLDERS’ EQUITY
    294,469       (5,571 )     288,898  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
  $ 1,223,773     $ (5,675 )   $ 1,218,098  

The effect of the restatement on the previously filed condensed consolidated income statement for the three months ended June 30, 2014 is as follows, in thousands except per share amounts:

   
As Reported
   
Adjustments
   
As Restated
 
Revenues
  $ 150,749     $ (8,853 )   $ 141,896  
GROSS PROFIT
    76,671       (8,853 )     67,818  
OPERATING INCOME
    16,263       (8,853 )     7,410  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
    14,312       (8,853 )     5,459  
Income tax provision
    5,303       (3,282 )     2,021  
INCOME FROM CONTINUING OPERATIONS
  $ 9,009     $ (5,571 )   $ 3,438  
NET INCOME
  $ 8,506     $ (5,571 )   $ 2,935  
NET INCOME PER SHARE:
                       
Income from continuing operations, basic
  $ 0.09     $ (0.06 )   $ 0.03  
NET INCOME, BASIC
  $ 0.08     $ (0.05 )   $ 0.03  
Income from continuing operations, diluted
  $ 0.08     $ (0.05 )   $ 0.03  
NET INCOME, DILUTED
  $ 0.07     $ (0.05 )   $ 0.02  
COMPREHENSIVE INCOME:
                       
Consolidated net income
  $ 8,506     $ (5,571 )   $ 2,935  
COMPREHENSIVE INCOME
  $ 8,353     $ (5,571 )   $ 2,782  

The effect of the restatement on the previously filed condensed consolidated income statement for the six months ended June 30, 2014 is as follows, in thousands except per share amounts:

   
As Reported
   
Adjustments
   
As Restated
 
Revenues
  $ 241,371     $ (8,853 )   $ 232,518  
GROSS PROFIT
    126,327       (8,853 )     117,474  
OPERATING INCOME
    39,703       (8,853 )     30,850  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
    30,004       (8,853 )     21,151  
Income tax provision
    11,167       (3,282 )     7,885  
INCOME FROM CONTINUING OPERATIONS
  $ 18,837     $ (5,571 )   $ 13,266  
NET INCOME
  $ 18,334     $ (5,571 )   $ 12,763  
NET INCOME PER SHARE:
                       
Income from continuing operations, basic
  $ 0.19     $ (0.06 )   $ 0.13  
NET INCOME, BASIC
  $ 0.18     $ (0.05 )   $ 0.13  
Income from continuing operations, diluted
  $ 0.16     $ (0.05 )   $ 0.11  
NET INCOME, DILUTED
  $ 0.16     $ (0.05 )   $ 0.11  
COMPREHENSIVE INCOME:
                       
Consolidated net income
  $ 18,334     $ (5,571 )   $ 12,763  
COMPREHENSIVE INCOME
  $ 19,886     $ (5,571 )   $ 14,315  

The effect of the restatement on the previously filed condensed consolidated statement of cash flows for the six months ended June 30, 2014 is as follows, in thousands:

   
As Reported
   
Adjustments
   
As Restated
 
Consolidated net income
  $ 18,334     $ (5,571 )   $ 12,763  
Changes in operating assets and liabilities:
                       
Trade accounts receivable
    (27,991 )     8,853       (19,138 )
Prepaid expenses and other current assets
    4,329       (3,178 )     1,151  
Accrued expenses and other liabilities
    8,799       (104 )     8,695  

Taken together, these adjustments result in no impact on the Company’s net cash provided by operating activities for the six months ended June 30, 2014 or the Company’s cash and cash equivalents balance as of June 30, 2014.

The effect of the restatement on the previously filed condensed consolidated balance sheet as of September 30, 2014 is as follows, in thousands:

   
As Reported
   
Adjustments
   
As Restated
 
Prepaid expenses and other current assets
  $ 33,078     $ (3 )   $ 33,075  
TOTAL CURRENT ASSETS
    494,098       (3 )     494,095  
Goodwill
    290,648       (5,568 )     285,080  
TOTAL OTHER LONG-TERM ASSETS
    1,243,363       (5,568 )     1,237,795  
TOTAL ASSETS
  $ 1,876,833     $ (5,571 )   $ 1,871,262  
Retained earnings
    22,051       (5,571 )     16,480  
TOTAL SHAREHOLDERS’ EQUITY
    320,322       (5,571 )     314,751  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
  $ 1,876,833     $ (5,571 )   $ 1,871,262  

The effect of the restatement on the previously filed condensed consolidated income statement for the nine months ended September 30, 2014 is as follows, in thousands except per share amounts:

   
As Reported
   
Adjustments
   
As Restated
 
Revenues
  $ 374,103     $ (8,853 )   $ 365,250  
GROSS PROFIT
    178,061       (8,853 )     169,208  
OPERATING INCOME
    33,661       (8,853 )     24,808  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
    11,465       (8,853 )     2,612  
Income tax provision
    4,278       (3,282 )     996  
INCOME FROM CONTINUING OPERATIONS
  $ 7,187     $ (5,571 )   $ 1,616  
NET INCOME
  $ 6,684     $ (5,571 )   $ 1,113  
NET INCOME PER SHARE:
                       
Income from continuing operations, basic
  $ 0.07     $ (0.05 )   $ 0.02  
NET INCOME, BASIC
  $ 0.07     $ (0.06 )   $ 0.01  
Income from continuing operations, diluted
  $ 0.06     $ (0.05 )   $ 0.01  
NET INCOME, DILUTED
  $ 0.06     $ (0.05 )   $ 0.01  
COMPREHENSIVE INCOME:
                       
Consolidated net income
  $ 6,684     $ (5,571 )   $ 1,113  
COMPREHENSIVE INCOME
  $ 7,840     $ (5,571 )   $ 2,269  

The effect of the restatement on the previously filed condensed consolidated statement of cash flows for the nine months ended September 30, 2014 is as follows, in thousands:

   
As Reported
   
Adjustments
   
As Restated
 
Consolidated net income
  $ 6,684     $ (5,571 )   $ 1,113  
Changes in operating assets and liabilities:
                       
Trade accounts receivable
    (24,193 )     8,853       (15,340 )
Prepaid expenses and other current assets
    (11,209 )     (3,282 )     (14,491 )

Taken together, these adjustments result in no impact on the Company’s net cash provided by operating activities for the nine months ended September 30, 2014 or the Company’s cash and cash equivalents balance as of September 30, 2014.

XML 54 R100.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 17 - Unconsolidated Joint Venture (Details) - Unconsolidated Joint Venture Condensed Statement of Income (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2014
Jun. 30, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Condensed Income Statements, Captions [Line Items]            
INCOME BEFORE INCOME TAXES $ 5,459us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $ 21,151us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $ 2,612us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $ 59,136us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $ 82,895us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $ 57,500us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Akorn-Strides [Member]            
Condensed Income Statements, Captions [Line Items]            
REVENUES         163us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		  
Cost of sales         (1)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		  
GROSS PROFIT         164us-gaap_EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		  
Operating expenses         3akrx_EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		  
OPERATING INCOME         161us-gaap_EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		  
INCOME BEFORE INCOME TAXES         161us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		  
NET INCOME         $ 161us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		  
XML 55 R56.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Net Trade Accounts Receivable (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Net Trade Accounts Receivable [Abstract]    
Gross accounts receivable $ 445,027us-gaap_AccountsReceivableGrossCurrent $ 88,165us-gaap_AccountsReceivableGrossCurrent
Less reserves for:    
Chargebacks and rebates (155,297)akrx_ChargebackAndRebateReserve (12,882)akrx_ChargebackAndRebateReserve
Product returns (44,644)akrx_ReturnsReserve (8,164)akrx_ReturnsReserve
Discounts and allowances (22,691)akrx_DiscountAndAllowancesReserve (1,644)akrx_DiscountAndAllowancesReserve
Advertising and promotions (1,217)akrx_AdvertisingAndPromotionReserve (452)akrx_AdvertisingAndPromotionReserve
Doubtful accounts (462)us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent (25)us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent
Trade accounts receivable, net $ 220,716us-gaap_AccountsReceivableNetCurrent $ 64,998us-gaap_AccountsReceivableNetCurrent
XML 56 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 17 - Unconsolidated Joint Venture (Tables) (Corporate Joint Venture [Member])
 12 Months Ended
Dec. 31, 2014
Corporate Joint Venture [Member]
  
Note 17 - Unconsolidated Joint Venture (Tables) [Line Items]  
Condensed Income Statement [Table Text Block]
CONDENSED STATEMENTS OF INCOME (Unaudited)
 
       
   
Year ended December 31,
 
   
2014
   
2013
   
2012
 
REVENUES
  $ —     $ 163     $ —  
Cost of sales
    —       (1 )     —  
GROSS PROFIT
    —       164       —  
Operating expenses
    —       3       —  
OPERATING INCOME
    —       161       —  
Gain from Pfizer ANDA Sale
    —       —       —  
INCOME BEFORE INCOME TAXES
    —       161       —  
Income tax (benefit) / provision
    —       —       —  
NET INCOME
  $ —     $ 161     $ —  
Condensed Balance Sheet [Table Text Block]
CONDENSED BALANCE SHEETS (Unaudited)
 
       
   
December 31,
 
 
 
2014
   
2013
 
ASSETS
           
Cash
  $ 25     $ 25  
Other current assets
    1       1  
TOTAL ASSETS
  $ 26     $ 26  
                 
LIABILITIES & MEMBERS’ EQUITY
               
Trade accounts payable & other accrued liabilities
  $ —     $ —  
    TOTAL LIABILITIES
    —       —  
                 
Members’ equity
    26       26  
TOTAL LIABILITIES & MEMBERS’ EQUITY
  $ 26     $ 26  
XML 57 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
Accounting Policies, by Policy (Policies)
 12 Months Ended
Dec. 31, 2014
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]
Consolidation: The accompanying consolidated financial statements include the accounts of Akorn, Inc. and its wholly owned domestic and foreign subsidiaries.  All inter-company transactions and balances have been eliminated in consolidation, and the financial statements of Akorn India Private Limited (“AIPL”) have been translated from Indian rupees to U.S. dollars based on the currency translation rates in effect during the period or as of the date of consolidation, as applicable.  The Company has no involvement with variable interest entities.

As of the year ended December 31, 2014 the Company was a 50% owner of a dormant joint venture, Akorn-Strides, LLC (the “Joint Venture Company”) (See Note 17 – Unconsolidated Joint Venture.).  The Company and its strategic partner each had equal voting rights and shared operational control.  Accordingly, the Company accounted for its investment in the Joint Venture Company using the equity method of accounting.  The Company’s proportionate share of the Joint Venture Company’s income had been recorded under the caption “Equity in earnings of unconsolidated joint venture” in the Company’s consolidated statements of operations.  The Joint Venture Company sold all of its abbreviated new drug application (“ANDA”) rights to Pfizer, Inc. in December 2010 and ceased operations during 2011.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Significant estimates and assumptions for the Company relate to the allowances for chargebacks, rebates, product returns, coupons, promotions and doubtful accounts, as well as the reserve for slow-moving and obsolete inventories, the carrying value and lives of intangible assets, the useful lives of fixed assets, the carrying value of deferred income tax assets and liabilities, the assumptions underlying share-based compensation, accrued but unreported employee benefit costs and assumptions underlying the accounting for business combinations.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition: Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the sales price is fixed or determinable, and collectability is reasonably assured. Revenues from product sales are recognized when title and risk of loss have passed to the customer.

Provision for estimated chargebacks, rebates, discounts, managed care rebates, product returns and doubtful accounts is made at the time of sale and is analyzed and adjusted, if necessary, at each balance sheet date.
Revenue Recognition, Cargo and Freight, Policy [Policy Text Block]
Freight:  The Company records amounts billed to customers for shipping and handling as revenue, and records shipping and handling expense related to product sales as cost of sales.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents: The Company considers all unrestricted, highly liquid investments with maturity of three months or less when purchased to be cash and cash equivalents.  At December 31, 2014 and 2013, approximately $2.9 million and $2.7 million of cash held by our India operations as of those dates was restricted, and was reported within prepaid expenses and other current assets and other non-current assets, respectively.
Trade and Other Accounts Receivable, Policy [Policy Text Block]
Accounts Receivable: Trade accounts receivables are stated at their net realizable value.  The nature of the Company’s business involves, in the ordinary course, significant judgments and estimates relating to chargebacks, coupon redemption, product returns, rebates, discounts given to customers and allowances for doubtful accounts.  Depending on the products, the end-user customers, the specific terms of national supply contracts and the particular arrangements with the Company’s wholesaler customers, certain rebates, chargebacks and other credits are recorded as deductions to the Company’s trade accounts receivable.

Unless otherwise noted, the provisions and allowances for the following customer deductions are reflected in the accompanying consolidated financial statements as reductions of revenues and trade accounts receivable, respectively.
Discontinued Operations, Policy [Policy Text Block]
Unless otherwise noted, the provisions and allowances for the following customer deductions are reflected in the accompanying consolidated financial statements as reductions of revenues and trade accounts receivable, respectively.
Chargebacks and Rebates [Policy Text Block]
Chargebacks and Rebates: The Company enters into contractual agreements with certain third parties such as hospitals, group-purchasing and managed care organizations to sell certain products at predetermined prices. The parties have elected to have these contracts administered through wholesalers that buy the product from the Company and subsequently sell it to these third parties. When a wholesaler sells products to one of these third parties that are subject to a contractual price agreement, the difference between the price paid to the Company by the wholesaler and the price under the specific contract is charged back to the Company by the wholesaler. The Company tracks sales and submitted chargebacks by product number and contract for each wholesaler. Utilizing this information, the Company estimates a chargeback percentage for each product and records an allowance as a reduction to gross sales when the Company records its sale of the products. The Company reduces the chargeback allowance when a chargeback request from a wholesaler is processed. Actual chargebacks processed by the Company can vary materially from period to period based upon actual sales volume through the wholesalers. However, the Company’s provision for chargebacks is fully reserved for at the time when sales revenues are recognized.

Management obtains certain wholesaler inventory reports to aid in analyzing the reasonableness of the chargeback allowance. The Company assesses the reasonableness of its chargeback allowance by applying the product chargeback percentage based on historical activity to the quantities of inventory on hand at the wholesaler per the wholesaler inventory reports. In accordance with its accounting policy, the Company estimates the percentage amount of wholesaler inventory that will ultimately be sold to third parties that are subject to contractual price agreements based on a trend of such sales through wholesalers. The Company uses this percentage estimate until historical trends indicate that a revision should be made. On an ongoing basis, the Company evaluates its actual chargeback rate experience, and new trends are factored into its estimates each quarter as market conditions change.

Similarly, the Company maintains an allowance for rebates related to contract and other programs with certain customers. Rebate percentages vary by product and by volume purchased by each eligible customer. The Company tracks sales by product number for each eligible customer and then applies the applicable rebate percentage, using both historical trends and actual experience to estimate its rebate allowance. The Company reduces gross sales and increases the rebate allowance by the estimated rebate amount when the Company sells its products to its rebate-eligible customers. The Company reduces the rebate allowance when it processes a customer request for a rebate. At each balance sheet date, the Company analyzes the allowance for rebates against actual rebates processed and makes necessary adjustments as appropriate. Actual rebates processed can vary materially from period to period.
Revenue Recognition, Sales Returns [Policy Text Block]
Sales Returns: Certain of the Company’s products are sold with the customer having the right to return the product within specified periods and guidelines for a variety of reasons, including but not limited to, pending expiration dates. Provisions are made at the time of sale based upon tracked historical experience. Historical factors such as one-time events as well as pending new developments that would impact the expected level of returns are taken into account to determine the appropriate reserve estimate at each balance sheet date. As part of the evaluation of the balance required, the Company considers actual returns to date that are in process, the expected impact of any product recalls and the wholesaler’s inventory information to assess the magnitude of unconsumed product that may result in sales returns to the Company in the future. The sales returns level can be impacted by factors such as overall market demand and market competition and availability for substitute products which can increase or decrease the end-user pull through for sales of the Company’s products and ultimately impact the level of sales returns. Actual returns experience and trends are factored into the Company’s estimates each quarter as market conditions change. Actual returns processed can vary materially from period to period.
Revenue Recognition Coupons [Policy Text Block]
Allowance for Coupons, Promotions and Co-Pay discount cards: The Company issues coupons from time to time that are redeemable against certain of our Consumer Health products. Upon release of coupons into the market, the Company records an estimate of the dollar value of coupons expected to be redeemed. This estimate is based on historical experience and is adjusted as needed based on actual redemptions. In addition to couponing, from time to time the Company authorizes various retailers to run in-store promotional sales of its products. Upon receiving confirmation that a promotion was run, the Company accrues an estimate of the dollar amount expected to be owed back to the retailer. This estimate is trued up to actual upon receipt of the invoice from the retailer. Additionally, the Company provides consumer co-pay discount cards, administered through outside agents to provide discounted products when redeemed. Upon release of the cards into the market, the Company records an estimate of the dollar value of co-pay discounts expected to be utilized. This estimate is based on historical experience and is adjusted as needed based on actual usage.
Doubtful Accounts [Policy Text Block]
Doubtful Accounts: Provisions for doubtful accounts, which reflect trade receivable balances owed to the Company that are believed to be uncollectible, are recorded as a component of SG&A expenses. In estimating the allowance for doubtful accounts, the Company considers its historical experience with collections and write-offs, the credit quality of its customers and any recent or anticipated changes thereto, and the outstanding balances and past due amounts from its customers.  Accounts are considered past due when they remain uncollected beyond the due date specified in the applicable contract or on the applicable invoice, whichever is deemed to take precedence.

As of December 31, 2014, the Company had a total of $62.4 million of past due gross accounts receivable, of which $3.7 million was more than 60 days past due. The Company performs monthly a detailed analysis of the receivables due from its wholesaler customers and provides a specific reserve against known uncollectible items. The Company also includes in the allowance for doubtful accounts an amount that it estimates to be uncollectible for all other customers, based on a percentage of the past due receivables. The percentage reserved increases as the age of the receivables increases.  Accounts are written off once all reasonable collections efforts have been exhausted and/or when facts or circumstances regarding the customer (i.e. bankruptcy filing) indicate that the chance of collection is remote.
Advertising Costs, Policy [Policy Text Block]
Advertising and Promotional Allowances to Customers: The Company routinely sells its consumer health products to major retail drug chains. From time to time, the Company may arrange for these retailers to run in-store promotional sales of the Company’s products. The Company reserves an estimate of the dollar amount owed back to the retailer, recording this amount as a reduction to revenue at the later of the date on which the revenue is recognized or the date the sales incentive is offered. When the actual invoice for the sales promotion is received from the retailer, the Company adjusts its estimate accordingly. Advertising and promotional expenses paid to customers are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 605-50, Customer Payments and Incentives.
Inventory, Policy [Policy Text Block]
Inventories: Inventories are stated at the lower of cost (average cost method) or market (see Note 4 — “Inventories”). The Company maintains an allowance for slow-moving and obsolete inventory as well as inventory where the cost is in excess of its net realizable value (“NRV”). For finished goods inventory, the Company estimates the amount of inventory that may not be sold prior to its expiration or is slow moving based upon recent sales activity by unit and wholesaler inventory information. The Company also analyzes its raw material and component inventory for slow moving items/NRV. For the years ended December 31, 2014, 2013 and 2012, the Company recorded a provision for inventory obsolescence/NRV of $12.3 million, $2.1 million, and $2.4 million, respectively. The allowances for inventory obsolescence were $21.2 million and $5.7 million as of December 31, 2014 and 2013, respectively.

The Company capitalizes inventory costs associated with its products prior to regulatory approval when, based on management judgment, future commercialization is considered probable and future economic benefit is expected to be realized. The Company assesses the regulatory approval process and where the product stands in relation to that approval process including any known constraints or impediments to approval. The Company also considers the shelf life of the product in relation to the product timeline for approval.

At December 31, 2014, the Company established a reserve of $1.9 million related to R&D raw materials that are not expected to be utilized prior to expiration while at December 31, 2013, the Company had approximately $1.0 million in reserves for R&D raw materials. The entire balance of the R&D raw materials has been reserved, as the Company deemed it unlikely that the products would receive U.S. Food and Drug Administration (the “FDA”) approval far enough in advance of expiration to be sellable.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]
Intangible Assets: Intangible assets consist primarily of goodwill, which is carried at its initial value, subject to evaluation for impairment, in-process research and development, which is accounted for as an indefinite-lived intangible asset, subject to impairment testing until completion or abandonment of the project, and product licensing costs, trademarks and other such costs, which are capitalized and amortized on a straight-line basis over their useful lives, ranging from one (1) year to thirty (30) years.  Accumulated amortization was $82.2 million and $39.1 million at December 31, 2014 and 2013, respectively.  Amortization expense was $44.1 million, $7.4 million and $6.9 million for the years ended December 31, 2014, 2013 and 2012, respectively. The Company regularly assesses its intangible assets for impairment based on several factors, including estimated fair value and anticipated cash flows.  If the Company incurs additional costs to renew or extend the life of an intangible asset, such costs are added to the remaining unamortized cost of the asset, if any, and the sum is amortized over the extended remaining life of the asset.

Goodwill is tested for impairment annually or more frequently if changes in circumstances or the occurrence of events suggest that impairment may exist. The Company uses widely accepted valuation techniques to determine the fair value of its reporting units used in its annual goodwill impairment analysis. The Company’s valuation is primarily based on qualitative and quantitative assessments regarding the fair value of the reporting unit relative to its carrying value. The Company modeled the fair value of the reporting unit based on projected earnings and cash flows of the reporting unit. The Company performed its annual impairment test on October 1, 2014 and determined that the fair value of its reporting units are substantially in excess of its carrying value and, therefore, no impairment charge was necessary.

Changes in goodwill during the two years ended December 31, 2014 were as follows (in thousands):

   
Goodwill
 
December 31, 2012
  $ 32,159  
Acquisitions
 
─
 
Impairments
 
─
 
Foreign currency translation
    (2,328 )
December 31, 2013
  $ 29,831  
Acquisitions
    260,911  
Impairments
 
─
 
Dispositions
    (11,454 )
Foreign currency translation
    (514 )
December 31, 2014
  $ 278,774  

The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2014 for those assets that are not already fully amortized (dollar amounts in thousands):

   
Gross
Carrying
Amount
   
Accumulated
Amortization
   
Net
Carrying
Amount
   
Weighted Average
Remaining Amortization Period (years)
 
Product licensing rights
  $ 778,734     $ (74,516 )   $ 704,218       12.4  
In-process research and development (“IPR&D”)
    230,788       —       230,788    
N/A – Indefinite lived
 
Trademarks
    16,000       (1,721 )     14,279       18.6  
Customer relationships
   
6,427
      (3,392 )     3,035       11.0  
Other intangibles
    11,234       (879 )     10,355       7.5  
Non-compete agreements
   
2,409
      (1,725 )     684       1.4  
    $ 1,045,592     $ (82,233 )   $ 963,359          

Changes in intangible assets during the two years ended December 31, 2014 were as follows (in thousands):

   
Product licensing rights
   
IPR&D
   
Trademarks
   
Customer relationships
   
Other intangibles
   
Non-compete agreements
 
December 31, 2012
  $ 63,654     $ —     $ 8,972     $ 5,588     $ —     $ 2,171  
Acquisitions
    57,969       —       —       —       —       —  
Amortization
    (5,723 )     —       (316 )     (740 )     —       (643 )
Foreign currency translation
    —       —       —       (210 )     —       (217 )
December 31, 2013
  $ 115,900     $ —     $ 8,656     $ 4,638     $ —     $ 1,311  
Acquisitions
   
668,457
      230,788       6,500       300       11,234       —  
Amortization
    (39,761 )     —       (877 )     (1,934 )     (879 )     (615 )
Dispositions
    (40,378 )     —       —       —       —       —  
Foreign currency translation
    —       —       —       31       —       (12 )
December 31, 2014
  $ 704,218     $ 230,788     $ 14,279     $ 3,035     $ 10,355     $ 684  

The amortization expense of acquired intangible assets for each of the following five years will be as follows (in thousands):

Year ending December 31,
 
Amortization Expense
 
2015
  $ 65,966  
2016
    65,739  
2017
    65,312  
2018
    65,108  
2019
    62,244  
Property, Plant and Equipment, Policy [Policy Text Block]
Property, Plant and Equipment: Property, plant and equipment is stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method in amounts considered sufficient to amortize the cost of the assets to operations over their estimated useful lives or lease terms. Depreciation expense was $14.5 million, $7.1 million and $4.6 million for the years ended December 31, 2014, 2013 and 2012, respectively.  The amortization of assets under capital leases is included within depreciation expense. The following table sets forth the average estimated useful lives of the Company’s property, plant and equipment, by asset category:

Asset category
 
Depreciable Life (years)
 
Buildings
    30  
Leasehold improvements
    20  
Furniture and equipment
    7  
Automobiles
    5  
Computer hardware and software
    5  
Earnings Per Share, Policy [Policy Text Block]
Net Income Per Common Share: Basic net income per common share is based upon weighted average common shares outstanding. Diluted net income per common share is based upon the weighted average number of common shares outstanding, including the dilutive effect, if any, of stock options and convertible securities using the treasury stock and if converted methods.  Anti-dilutive shares excluded from the computation of diluted net income per share for 2014, 2013 and 2012 include 735,000, 975,000 and 581,000 shares, respectively, related to options, warrants, and convertible securities.
Income Tax, Policy [Policy Text Block]
Income Taxes: Income taxes are accounted for under the asset and liability method.  Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and net operating loss and other tax credit carry-forwards. These items are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce the deferred income tax assets to the amount that is more likely than not to be realized.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments: The Company applies ASC Topic 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC Topic 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC Topic 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability, and are to be developed based on the best information available in the circumstances.

The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:

 
-
Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. The carrying value of the Company‘s cash and cash equivalents are considered Level 1 assets.

 
-
Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as directly or indirectly observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. The market value of the Company’s forward contracts to hedge against changes in currency translation rates between U.S. dollars and Indian rupees was a Level 2 asset.

 
-
Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. The additional consideration payable related to the Company’s acquisition of three branded, injectable drug products from the U.S. subsidiary of H. Lundbeck A/S (the “Lundbeck Acquisition”), a Denmark Corporation, on December 22, 2011 was a Level 3 liability, as are the additional consideration payable to Santen Pharmaceutical Co. Ltd. (“Santen”) in relation to the Company’s acquisition of the U.S. New Drug Application (“NDA”) rights to Betimol® on January 2, 2014, and the fair valuation of the available for sale investment held in shares of Nicox S.A.

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

         
Fair Value Measurements at Reporting Date, Using:
 
Description
 
December 31,
2014
   
Quoted Prices
in Active
Markets for
Identical Items
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents
  $ 70,680     $ 70,680     $ —     $ —  
Available-for-sale securities
    8,391       —       —       8,391  
   Total assets
  $ 79,071     $ 70,680     $ —     $ 8,391  
                                 
Purchase consideration payable
  $ 7,613     $ —     $ —     $ 7,613  
   Total liabilities
  $ 7,613     $ —     $ —     $ 7,613  

Description
 
December 31,
2013
   
Quoted Prices
in Active
Markets for
Identical Items
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents
  $ 34,178     $ 34,178     $ —     $ —  
Foreign currency forward contracts
    208       —       208       —  
   Total assets
  $ 34,386     $ 34,178     $ 208     $ —  
                                 
Purchase consideration payable
  $ 14,728     $ —     $ —     $ 14,728  
   Total liabilities
  $ 14,728     $ —     $ —     $ 14,728  

The carrying amount at December 31, 2014 of purchase consideration payable includes estimated consideration due to Santen related to the Company’s acquisition of U.S. NDA rights to Betimol® on January 2, 2014. The liability was initially discounted based on the Company’s assumed discount rate and revalued at December 31, 2014 using this same discount rate. The Company identified no events that would cause its calculated assumed discount rate to change between the acquisition date and December 31, 2014. The additional consideration contingently payable to Santen was initially estimated at $4.5 million discounted to $4.0 million based on a discount rate of 12.6%. The Company performed evaluations of the fair value of this liability at December 31, 2014 based on utilizing significant unobservable inputs and determined the fair value of this liability to be $4.3 million. The increase in fair value during the year ended December 31, 2014 of approximately $0.3 million has been recorded as non-cash interest expense within the Company’s consolidated statement of comprehensive income for the year ended December 31, 2014.

The remaining purchase consideration payable is principally comprised of net working capital amounts owed relating to the ECR and Watson Laboratories, Inc. (“Watson”) divestitures, at fair value as determined based on the underlying contracts and the Company’s subjective evaluation of the additional consideration.

As of December 31, 2014, the Company was carrying available for sale investments in shares of Nicox S.A. initially valued at $12.5 million discounted to reflect certain lockup provisions preventing immediate sale of underlying shares received for the Company’s investment in an available for sale security or an approximately $1.7 million unrealized gain. During the year the Company sold $0.6 million of the available-for-sale security, realizing an immaterial gain, and due to declines in the share price of Nicox S.A. stock from the initial valuation, the Company recognized a $1.8 million unrealized loss as of the year ended December 31, 2014. The remaining $8.4 million of securities are still subject to certain lockup provisions and as such, the fair value of the investments is estimated using observable and unobservable inputs to discount for lack of marketability. (See Note 16 – Business Combinations, Dispositions and Other Strategic Investments)

The carrying amount at December 31, 2013 of the purchase consideration payable for the Lundbeck acquisition was initially determined based on the terms of the underlying contracts and the Company’s subjective evaluation of the likelihood of the additional purchase consideration becoming payable related to the Company’s obligation to pay additional consideration for the acquisition of selected assets from H. Lundbeck A/S (“Lundbeck”) on December 22, 2011.  The underlying obligation was long-term in nature, and therefore was discounted to present value based on an assumed discount rate.  The additional consideration of $15.0 million, contingently payable to Lundbeck on December 22, 2014, was initially discounted to $11.3 million based on a discount rate of 10.0%, and subsequently adjusted in final acquisition accounting to $11.6 million based on applying a 9.0% discount rate.  At December 31, 2013, the Company again evaluated the fair value based on utilizing significant unobservable inputs and derived a discount rate of 1.85%, determining that the appropriate discounted value was $14.7 million based upon the likelihood of achieving the underlying revenue targets and a derived cost of debt based on the remaining term. On December 22, 2014 the Company remitted final payment for the contingent purchase consideration due to Lundbeck of $15.0 million.

The Company entered into three non-deliverable forward contracts in October 2013 to protect against unfavorable trends with regard to currency translation rates between U.S. dollars (“USD”) and Indian rupees (“INR”) for planned capital expenditures at AIPL, which all three matured and were redeemed during the year ended December 31, 2014. The forward contracts were based on current and future anticipated investment in AIPL, the Company’s subsidiary in India. These forward contracts include projected currency translation rates between INR and USD. Any difference between the actual and projected foreign currency translations rates on the respective settlement dates would result in payment from the counterparty to the Company, or vice versa, as the case may be. As all of the contracts matured during the year ended December 31, 2014, the Company realized a $0.7 million gain in fair value during the year ended December 31, 2014 as Other non-operating income in its consolidated statements of comprehensive income.
Warrants [Policy Text Block]
Warrants: The Company issued various warrants during 2009 to entities controlled by John N. Kapoor, Ph.D., the Chairman of the Company’s Board of Directors (the “Kapoor Warrants”).  The Company had classified the fair value of these warrants as a current liability in accordance with ASC 815-40-15-3, Derivatives and Hedging, (formerly EITF 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock). This classification was made as a result of the requirement that the shares to be issued upon exercise of the Kapoor Warrants be registered shares, which could not be absolutely assured.  The Kapoor Warrants were adjusted to fair value at the end of each quarter through Black-Scholes calculations which considered changes in the market price of the Company’s common stock, the remaining contractual life of the Kapoor Warrants, and other factors.  Any change in the fair value of the Kapoor Warrants was recorded as income or expense on the Company’s consolidated statements of operations for the applicable period.

On June 28, 2010, the Company and Dr. Kapoor entered into an Amended and Restated Registration Rights Agreement (the “Amended Agreement”) which modified certain terms related to the Company’s obligation to obtain and maintain registration of any shares issued pursuant to exercise of the Kapoor Warrants.  The Amended Agreement still requires the Company to use “commercially reasonable efforts” to file a registration statement pursuant to Rule 415 of the Securities Act of 1933 (“Registration Statement”) for any shares of common stock that may be issued under the applicable warrant agreements, and to maintain the continuous effectiveness of such Registration Statement until the earliest of: (i) the date no shares of the Company’s common stock qualify as registrable securities, (ii) the date on which all of the registrable securities may be sold in a single transaction by the holder to the public pursuant to Rule 144 or a similar rule, or (iii) the date upon which the John N. Kapoor Trust Dated September 20, 1989 (the “Kapoor Trust”) and EJ Funds, LP (“EJ Funds”) have transferred all of the registrable securities.  However, the Registration Rights Agreement was amended to provide that in the event the Company, after using its good faith commercially reasonable efforts, is not able to obtain or maintain registration of the common stock, delivery of unregistered shares upon exercise of the Kapoor Warrants will be deemed acceptable and a net cash settlement will not be required. The Amended Agreement further provides that the term “commercially reasonable efforts” in such instance shall not mean an absolute obligation of the Company to obtain and maintain registration.

As a result of the changes effected through the Amended Agreement, on June 28, 2010 the Company changed its accounting treatment of the Kapoor Warrants, no longer classifying them as a current liability with periodic adjustments to fair value but instead classifying them as a component of shareholders’ equity in accordance with ASC 815-40.   Accordingly, the fair value of the Kapoor Warrants, which was $17.9 million on June 28, 2010, was reclassified from a current liability to a component of shareholders’ equity on that date.  Following this change in classification, no future fair value adjustments are required.

The liability at June 28, 2010 for the Kapoor Warrants was estimated using a Black-Scholes valuation model with the fair value per warrant ranging from $2.49 to $2.50.  The expected volatility of the Kapoor Warrants was based on the historical volatility of the Company’s common stock. The expected life assumption was based on the remaining life of the Kapoor Warrants. The risk-free interest rate for the expected term of the Kapoor Warrants was based on the average market rate on U.S. treasury securities in effect during the applicable quarter. The dividend yield reflected historical experience as well as future expectations over the expected term of the Kapoor Warrants.

The assumptions used in estimating the fair value of the warrants at June 28, 2010 were as follows:

Expected volatility
 
79.7%
 
Expected life (in years)
 3.8 –
4.1
Risk-free interest rate
 
1.8%
 
Dividend yield
 
—
 

The following table provides summarized information about the Kapoor Warrants as of December 31, 2013:

Granted To:
Grant Date
 
Warrants Granted
   
Exercise Price
   
Book Value ($000s)
 
                     
EJ Funds
Apr.13, 2009
    1,939,639     $ 1.11     $ 4,829  
Kapoor Trust
Apr.13, 2009
    1,501,933     $ 1.11       3,740  
EJ Funds
Aug.17, 2009
    1,650,806     $ 1.16       4,127  
Kapoor Trust
Aug.17, 2009
    2,099,935     $ 1.16       5,250  
        7,192,313             $ 17,946  

On April 10, 2014, the holder exercised all of the approximately 7.2 million outstanding stock warrants. The Company received cash proceeds of approximately $8.2 million from the warrant exercise during the year ended December 31, 2014.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation: Stock-based compensation cost is estimated at grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions to be used in the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its common stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. Treasury securities of similar term in effect during the quarter in which the options were granted. The dividend yield reflects the Company’s historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises the estimate in subsequent periods, if necessary, if actual forfeitures differ from initial estimates.
XML 58 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2014
Accounting Policies [Abstract]  
Schedule of Goodwill [Table Text Block]
   
Goodwill
 
December 31, 2012
  $ 32,159  
Acquisitions
 
─
 
Impairments
 
─
 
Foreign currency translation
    (2,328 )
December 31, 2013
  $ 29,831  
Acquisitions
    260,911  
Impairments
 
─
 
Dispositions
    (11,454 )
Foreign currency translation
    (514 )
December 31, 2014
  $ 278,774  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
   
Gross
Carrying
Amount
   
Accumulated
Amortization
   
Net
Carrying
Amount
   
Weighted Average
Remaining Amortization Period (years)
 
Product licensing rights
  $ 778,734     $ (74,516 )   $ 704,218       12.4  
In-process research and development (“IPR&D”)
    230,788       —       230,788    
N/A – Indefinite lived
 
Trademarks
    16,000       (1,721 )     14,279       18.6  
Customer relationships
   
6,427
      (3,392 )     3,035       11.0  
Other intangibles
    11,234       (879 )     10,355       7.5  
Non-compete agreements
   
2,409
      (1,725 )     684       1.4  
    $ 1,045,592     $ (82,233 )   $ 963,359          
Movement InIntangible Assets Excluding Goodwill [Table Text Block]
   
Product licensing rights
   
IPR&D
   
Trademarks
   
Customer relationships
   
Other intangibles
   
Non-compete agreements
 
December 31, 2012
  $ 63,654     $ —     $ 8,972     $ 5,588     $ —     $ 2,171  
Acquisitions
    57,969       —       —       —       —       —  
Amortization
    (5,723 )     —       (316 )     (740 )     —       (643 )
Foreign currency translation
    —       —       —       (210 )     —       (217 )
December 31, 2013
  $ 115,900     $ —     $ 8,656     $ 4,638     $ —     $ 1,311  
Acquisitions
   
668,457
      230,788       6,500       300       11,234       —  
Amortization
    (39,761 )     —       (877 )     (1,934 )     (879 )     (615 )
Dispositions
    (40,378 )     —       —       —       —       —  
Foreign currency translation
    —       —       —       31       —       (12 )
December 31, 2014
  $ 704,218     $ 230,788     $ 14,279     $ 3,035     $ 10,355     $ 684  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Year ending December 31,
 
Amortization Expense
 
2015
  $ 65,966  
2016
    65,739  
2017
    65,312  
2018
    65,108  
2019
    62,244  
Average Estimated Useful Lives of Property Plant and Equipment [Table Text Block]
Asset category
 
Depreciable Life (years)
 
Buildings
    30  
Leasehold improvements
    20  
Furniture and equipment
    7  
Automobiles
    5  
Computer hardware and software
    5  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
         
Fair Value Measurements at Reporting Date, Using:
 
Description
 
December 31,
2014
   
Quoted Prices
in Active
Markets for
Identical Items
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents
  $ 70,680     $ 70,680     $ —     $ —  
Available-for-sale securities
    8,391       —       —       8,391  
   Total assets
  $ 79,071     $ 70,680     $ —     $ 8,391  
                                 
Purchase consideration payable
  $ 7,613     $ —     $ —     $ 7,613  
   Total liabilities
  $ 7,613     $ —     $ —     $ 7,613  
Description
 
December 31,
2013
   
Quoted Prices
in Active
Markets for
Identical Items
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Cash and cash equivalents
  $ 34,178     $ 34,178     $ —     $ —  
Foreign currency forward contracts
    208       —       208       —  
   Total assets
  $ 34,386     $ 34,178     $ 208     $ —  
                                 
Purchase consideration payable
  $ 14,728     $ —     $ —     $ 14,728  
   Total liabilities
  $ 14,728     $ —     $ —     $ 14,728  
Assumptions Used in Estimating Fair Value of Warrants [Table Text Block]
Expected volatility
 
79.7%
 
Expected life (in years)
 3.8 –
4.1
Risk-free interest rate
 
1.8%
 
Dividend yield
 
—
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Granted To:
Grant Date
 
Warrants Granted
   
Exercise Price
   
Book Value ($000s)
 
                     
EJ Funds
Apr.13, 2009
    1,939,639     $ 1.11     $ 4,829  
Kapoor Trust
Apr.13, 2009
    1,501,933     $ 1.11       3,740  
EJ Funds
Aug.17, 2009
    1,650,806     $ 1.16       4,127  
Kapoor Trust
Aug.17, 2009
    2,099,935     $ 1.16       5,250  
        7,192,313             $ 17,946  
XML 59 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 1 - Business and Basis of Presentation
 12 Months Ended
Dec. 31, 2014
Disclosure Text Block [Abstract]  
Basis of Presentation and Significant Accounting Policies [Text Block]
Note 1 — Business and Basis of Presentation

Business: Akorn, Inc. together with its wholly owned subsidiaries (“Akorn” or “Company”) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and over-the-counter (“OTC”) consumer health products. We specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.

Akorn is a Louisiana corporation founded in 1971 in Abita Springs, Louisiana. In 1997, we relocated our corporate headquarters to the Chicago, Illinois area and currently maintain our principal corporate office in Lake Forest, Illinois.  We operate pharmaceutical manufacturing facilities in Decatur, Illinois, Somerset, New Jersey, Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York. Our research and development (“R&D”) centers are located in Vernon Hills, Illinois, Copiague, New York, and Warminster, Pennsylvania, and we have other corporate offices in Ann Arbor, Michigan; Amityville, New York; and Gurgaon, India.

XML 60 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 3 - Accounts Receivable, Sales and Allowances (Tables)
 12 Months Ended
Dec. 31, 2014
Receivables [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
   
December 31,
 
 
 
2014
   
2013
 
Gross accounts receivable
  $
445,027
    $ 88,165  
Less reserves for:
               
Chargebacks and rebates
    (155,297 )     (12,882 )
Product returns
    (44,644 )     (8,164 )
Discounts and allowances
    (22,691 )     (1,644 )
Advertising and promotions
    (1,217 )     (452 )
Doubtful accounts
    (462 )     (25 )
Trade accounts receivable, net
  $ 220,716     $ 64,998  
Schedule of Principal Transactions Revenue [Table Text Block]
   
Year ended December 31,
 
   
2014
   
2013
   
2012
 
Gross sales
  $ 1,442,537     $ 528,574     $ 386,582  
Less adjustments for:
                       
Chargebacks and rebates
    (739,760 )     (183,403 )     (112,244 )
Product returns
    (20,006 )     (5,001 )     (3,783 )
Discounts and allowances
    (31,178 )     (8,464 )     (6,074 )
Administrative fees
    (50,786 )     (9,471 )     (5,293 )
Advertising, promotions, and other
    (7,729 )     (4,524 )     (3,030 )
Revenues, net
  $
593,078
    $ 317,711     $ 256,158  
Activity in Allowance for Customer Deductions Accounts [Table Text Block]
   
Returns
   
Chargebacks & Rebates
   
Discounts
   
Doubtful Accounts
   
Advert. & Promotions
   
TOTAL
 
Balance at December 31, 2011
    6,846       5,949       743       99       386       14,023  
Provision
    3,783       112,243       6,074       (82 )     2,063       124,081  
Charges processed
    (2,220 )     (104,740 )     (5,455 )     13       (1,864 )     (114,266 )
Balance at December 31, 2012
  $ 8,409     $ 13,452     $ 1,362     $ 30     $ 585     $ 23,838  
Provision
    5,001       183,403       8,464       (5 )     4,524       201,387  
Charges processed
    (5,246 )     (183,973 )     (8,182 )     —       (4,657 )     (202,058 )
Balance at December 31, 2013
  $ 8,164     $ 12,882     $ 1,644     $ 25     $ 452     $ 23,167  
Provision
    20,006      
739,760
      31,178       346       7,729      
799,019
 
Additions from acquisitions
    29,172      
29,593
     
5,161
      88       311      
64,325
 
Charges processed
    (12,698 )     (626,938 )     (15,292 )     3       (7,275 )     (662,200 )
Balance at December 31, 2014
  $ 44,644     $
155,297
    $
22,691
    $ 462     $ 1,217     $
224,311
 
XML 61 R83.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Income Taxes (Details) - Summary of Unrecognized Tax Benefits (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Summary of Unrecognized Tax Benefits [Abstract]      
Balance at December 31, 2011 $ 845us-gaap_UnrecognizedTaxBenefits $ 1,485us-gaap_UnrecognizedTaxBenefits $ 0us-gaap_UnrecognizedTaxBenefits
Additions relating to current year 408us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions 589us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions 1,265us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
Additions relating to acquired entities 456us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition    
Terminations of exposures relating to prior years   (1,229)us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions  
Additions relating to prior years     220us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
Balance $ 1,709us-gaap_UnrecognizedTaxBenefits $ 845us-gaap_UnrecognizedTaxBenefits $ 1,485us-gaap_UnrecognizedTaxBenefits
XML 62 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 12 - Segment Information (Tables)
 12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
 
 
Years ended December 31,
 
 
 
2014
   
2013
   
2012
 
REVENUES
                 
Prescription Pharmaceuticals
  $ 542,846     $ 279,911     $ 223,881  
Consumer Health
    50,232       37,800       32,277  
Total revenues
  $ 593,078     $ 317,711     $ 256,158  
                         
GROSS PROFIT
                       
Prescription Pharmaceuticals
  $ 270,197     $ 151,182     $ 129,884  
Consumer Health
    27,393       20,722       18,808  
Total gross profit
  $ 297,590     $ 171,904     $ 148,692  
Schedule of Intangible Assets and Goodwill [Table Text Block]
   
Prescription Pharmaceuticals
   
Consumer Health
   
Total
 
December 31, 2012
  $ 20,296     $ 11,863     $ 32,159  
Acquisitions
 
─
   
─
   
─
 
Impairments
 
─
   
─
   
─
 
Foreign currency Translation
    (2,328 )  
─
      (2,328 )
December 31, 2013
  $ 17,968     $ 11,863     $ 29,831  
Acquisitions
    256,057       4,854       260,911  
Impairments
 
─
   
─
   
─
 
Dispositions
    (11,454 )  
─
      (11,454 )
Foreign currency translations
    (514 )  
─
      (514 )
December 31, 2014
  $ 262,057     $ 16,717     $ 278,774  
ZIP 63 0001171843-15-001465-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-15-001465-xbrl.zip M4$L#!!0````(`!:!<4:>9SGJ9($#`+N35@`1`!P`86MR>"TR,#$T,3(S,2YX M;6Q55`D``\N)"%7+B0A5=7@+``$$)0X```0Y`0``[%U;<]NXDG[?JOT/WCSM M/GC,BZZI3*IDQYYQCAV[;$_F[).+IF`):XK4@*1C__L%2=T("11E@00!=2HU MHXB4Q,;W]06-1N/+?QT?'_V!?$2<"`V/GMZ/\-E_1Y/_.3H^.@LFTWL7'UWZ M$;WJ1O@5T??\5T3HO^GU<11-/Y^<_/KUZS>7WAJZF*`PB(F+PN2-H^/CKT?) MG__\CR_)CYP1E/S$YZ.'&!U=.^3([-*_G]OVYU;[Z*^'LR/+,-O9A^@GWIZ( M=_0V\?SP]T\K/Y2\_5M`1B>68=@GV`\CQW?1I^S.SW%X/'*(3ST[XE-X] MNT`_9;:.#?/8-N?,*OO_?5]A_6?GRZ'V*PHW?GE[9\/4X#%J6V2V2(;MC M_@$WB/V(O"\^D-X<(O>W4?!Z,KN8_([-BD&?-/`^`F#TO$TK>6M M0X0W?SF]L&'PU\8D+VAR^N`D5^HWF MR;^OK^[=,9HXQXLA_TJI?W3T)7FRSV%Z[0X]'Z7P?4XH]ONG$$^F7O+(Z7MC M@IY__Y2,X/%\K'Y["X>?3F9?Y`94=]^B(SS\_9-K/`["FV?;_(;/@K*"3(?^;/+?WWZ:J1_;-/L?#E9?FSU M^T^6/S!_:XH(#H;YGTS'(?J:0FE:%,HO)_/W%M^T_%PFX\E,R/DWY84VQ\<+'MUL.SE8#61*[G!LG<8+%O08+56!\M:#I;5],&R=A@L2]!@M7.V MQWRD`=4D\.^CP'VY1I,G1#Y]K6O(DN%`HPE:VI3TOZFB( MZ8TA#OS?/\T"I\_W$1V'Y./G_\3T.9/0,/#I/\/!&PX_?9W?MB;AEY.-/[%\ M"`K(_+D^;#9-06:SP^#UMT,(_;HE5GJ!E1./"U0CD>HR2-VAR,$^&IX[Q,?^ M*-14O3:+J92.]?+(-=!M5"!TG^ZZS<-+N0;HP"]X*XQ#)"/M,E% M>N"Z\23VDJS7331&)!DN@L;)H+ZB2]\-)DA3?2\M.3_L6'UD=#'%9^D1V4 MO[)`5-A:.5,A`!,^\1,^85A9#%803JFC9S:#'3C+YDSXA('@:K6$0_+ MJ)^RVES,(?C1"^D.%VDPYDV:^4@A1Y=+CES$J7(5W`7V'=_%CG=)W22)DR_Z M2&P-YD@,XWHE&:=J'5_SZ5;77%(^U_KEN*92OD`PO=0%UV9VQH##TM)A5;"[ MR#8+F:-Z=6?SZ2,Q,2:,0U8AAW:960&KM)K354$VNXAL$+TT`Z2LKLWJ7J"G M9%-\P\MFVL>&=6QU]Q=[5A)F?(_]Y6;5QHI-(]7.L6WL+S8_JW:-?3R))^HI MYYWCCU!>'7.RZ#Q5M/F)L&OG31\\5V71&L\>XS+OJ;(C7[ELTFD*72>C]WI^^+EGU0TA[CC]W0D\Z:^8*R5FP"US%+6HHA? MCVE#+!1&YV]3.K3HH.U+DWFWR[-EL_I%?N`J<)WEN"QOV@!\P:-H8(39Y-2E M3_GB>"DLZL2Q6?,QBE_ROV6J(.7[ND15(EJ%2"D=8 M2@\T?L(.$-9CZIGUE[)Z62;::'@FVD@RT59O?_>49;I,8S`E*9W_Y4R#@,P6 M4I:KUVKP^C5?CODW"U97Y,BA3]U\Y:,TR7S.X'@)`K@YS MU"IOCF8X[]M'DLV$W9)@&+O1%7:3H?-'Z0"%ZH6-%YC.O=`5?D5#.K5V_!%^ M\M`@#%$4GKY?._\7D)0**]`72:[8M*W-ST0!OG7C*SWD:*\G6B+D>C MHT*_+7IW_.$="E&2+Z,OOR7YL&":B*M:8=FE/T3/.Y/C`T.B7'ZZ;7.M`C"B M^8R0;T=:C!UY(,X031SRHF+U:7DZS#_$BEL$=R/UG[^;$I"L#DGY>MMA]/8L M#J-@@L@=\M*5J'",I^IMFOX0\@6BJ^?/^=5@@'#]",O7<[::+"TP9T?N,%A0 M(+IZ>LZO0@.$ZT=8NIYWV)S=CR"I,)FB"`U&!*5%)H<1Q_$%5RTV[_`S=H!N MO>C*UV^VLSOD;"7FY$5U[NVPW=]ASEV+A1:&']L1'N984F?1PG!EN\6#OY46 M30G#M,,ME`-?*G7]4T9178??,Q]\<$UQM!3<"_KF@^^6FQ^5P@=^=WWP^1+G MV#*XT&6;Z4-<('&.+:I'=)=MN`_^O9:X71A^;!-^\--2Y]C"<&4;](._E3;' M%H8IOQ__:8RI(/YHU7LJ`NJ\TN_6HT,S\(=),[>TPN_T_>%]RO2IR!ERUNJ8?PY"DF86:8UI'4!-BCSZ:OG@6R:F[#O?9\A_`7#T=[AM<';Z/GP(RQ'YR^MV/($*: M-I$L%E/G_L5]-O\)B%>+>!7ZF\\54D0]+_CE^"ZZ",B]XR$ZLX]BXJN&89*@ MR`[>F,L3#K)^;N05A1O6^0O%KFER9(H"U69`/1L[!(W0D^.^A&E;NR?*705= M:UE4,S];(+1J@+880&.>'X&P[=(%:Q)F-7-2V2NY:NOL45RJZ6QN6I(:SG3 ML2!FJCMFRDU]K!VF/I:HJ4^/2P:(M6J,M>03H<\E`L1H=<9HTIE@&D8I!\$- M[O1D@]3`K@&D,$N18G-$>`"4J"\D;``7V%9_6^/&`R"`M&2;J/93IL'V^ML> M`6J&:U/2;>(@9=O_;8_E-(.T,0DW<9BRK?\@*).>;1,';J<`7`BNZLRWB<.4 MW\D/`B>I&3<9Q0:F45`M!@&7K)R;'"KP>_M!H"8OZR:%"R:_``T"O`9DW>20 MPBQ%"@@,Z\VZR>$"NQL6@D>)63=1=8NFR6XFA2!04M9-'*2MM5T]$,S)R;J) MPY3=90E!F?2LFSAP.P7@0G!59]9-'*8%3?\@<)*9=9/1$LXT"UH"0L`E*^LF MAPK\DVDA4).7=9/"!&"Q?3LA.!18M9- M5,=+T[(96"$(E)1U$P=IBX$4@CE963=QF+8+K"\$95*R;N+`[12`"\%5G5DW M<9AV&4QOXBBD8QR-T5_)P5/#^TA1OYH^>/+Q/U`P(LYTC%W'6W&E18+6U@U) M'(X])B,..-:)H[`LN,4>A7%%PSS5IBJ['7*U$%`]K;/9\UT!K0;KEFTRNC4_ M68\*/7_).5Q.1RA+2:]8B&JS-5<`<4,@%J?%;":H^$Q`'6&5<2A@)=K*UET! ME#5#*4XKL\2/:0WB4:J5E[Z;G=#@>`^(3*X"QY]WGLT$>?Q^>QV0D>,K."?Y MAIZB2SIB)$Z^8V4RLE7J$DG:71[D"OOHYCG?V'?EK M>^67JV<6;M_E:KNWW6\64_#QEJ"I\YY<3SYPC]^NZ2^,55M=T9J@'\IWWKO( M=RB95GZZ$.JZINJB?#N;Z03CJR2W&S6C;!EHDA+LEV MG8@T@U:[_/I/:B:=)R\%CDF`Y>#4/9AHF>(BV\>KP!\&_B7]?O+D^"\WS\^( MPIL,YM7EZ3K#S=/)^_3>FE7,7Y!H!U MWC_2:@O4C@?LOJ`(^Z.<]Q8EU-8,\!L(<:JOQ6CLDA#*;M;?'8]>I M@&N:[)_O.8!,/`\QRBR^SYD,G/ MHEEC4QH)W+<^,E-^O';>\"2>K)A[('S#"7_G^".&Z3D4:RO,$C-);_,7JR#T M;39K%4XLMM=6I8Q[--W!<&[.M0,3FV\_]4BP&_TTR;6W'JRM/^VH![P56=`$ ME35!F65846K`KC/=H=?`>Z6F((_-4@<6-VP/3M30@TTD7'8,*Q@-L1K!54?^ MF&\EIJ)14B71=G/`]X3$^NS8,A:BJQ3Q50N6XD36=]`0"U>J(EV$*U MK6CW$4NJ,F4>S=*U7C5.Y?%AC*Y0&")R\YQT6YT-W<.OX"SPD^94)&LNI]ZL MI.G:J*P/$J:3NS"OM@ZQHO2U+U5?3T%?05^EZ.NIFOK:,>K5US%!B.-A05U! M7:M35Q[QU)M^=DS)*GL**@LJ*T-EM_O8IJHL6UAPA:(H$3=#XT,940V4;],H M".ZVII_2-8O8-K=:#++_X&=D4UY^25FG55&P=AM$R1`XGEXN`?2D`?$8PRWE MO=FFN2>EW8'"%0/@7::S<9/(1YBA[PGYV;? M/-]'@?N2?P(NINIUU>C.]NC.R)QL.`#KURSRBIE^I(PI.?U8L&O?Z4?78J(R MX)3BG*HB[NKRMYP6^]9;1$R*]"W!OHNGCC>8),=KWSSG.06D:J*7+U MSB[4]>^&[?)[M!8KQ'PP32"_JN1G(-28P(5HH$P-H7*T^=C;O"\IQ1ES$U;OK2E2ZSQ&M7Y&ZK,VK[1@%Y-^=TV]"\ M7@/6'5#1:-'TB$%;L-XUM8=^4I1=9P%WKU.#HF[HLP]Z"GJZGYY*;?=?NYIV M*U13"_SI`>EI^70C^-,/*&JO!D4%?PIZ*EQ/#\N?]BM44QO\Z0'IJ0W^M$)% M[1LU*"KX4]!3X7IZ4/ZT+ZS18[YDK$3*%Q15(45M3G'9(:27J^@VTV?[0U:D MZ9M\,F@[:+M:VEYC$%")LMO"E'WUR-(RF6=0=,45?;.2_H(B`H^8'A'S'Q$9K-CK!Z3;>OD!.B`2')'"SYEB68Z8RHA*Q: M^V)^`]6_'3))2(;(+?+]\-U[=7SLY*?)*BET,0_*2*MS*UW+8,^1`_QKQ+^2 M.3#;S_+:(02C*'+^0`$9;<)2"RB+Q50LC]'GVF=`4W/?;!I<['\BX@?^G]CS MPDO/PWZ`PPV&61,&;!6V:/5(!QZ8C!V_#R:(A"CZ@7Y]3UZ\Z^J4MPBJF#\V M+:X^`Z('$&&;-D>/:>R)QD$/[]`ON.[V+'.Z>?(%."0Q1>^JYF\?@6.>NRX$;2YMRP2Z&_N'=O M].?9LMB;KV?,7I:!'_`7B+]U;'1W:(G?%:/]68ZLEX)NM!X??@4/B0%T_.'` M'SZ,"4+I6<+9@<&WWLH!]&I@GSSR#V>RBG=9&6MRY$8K!;XGP)%G?>+F8#X$ M`&O=L*YJ]!+8[1J]O'=OC'8`3;@V2DE<6"TF^0C`"M9& M81E&BU^9]3!&<^EH/,"%4%D$2\BG>8+1XA=D94%?^`>AY$+#R_2Z\N_S\_FUK5+82_*JN+71;;0$`=*NSG8+*=,M2=?/H M\2%8Q)%W--`FV*4A=;I$,&/9-TR0&P7*':LQ^.60X?K&NXU"EIDG[O+;#SCR MT,WSI3_$KW@8.U[^&?)#6F_B,`MDRYTKT19QP+MEMW8CW+7C.UGAR*IE`]+M M23IV6<)HZI03$.S%E=Y4;AM#R'`(2J40B^9VD M6OST_48P#IAC"J@(!R%2A+Z?_7XO?_`Y2K0%F.Q69+2P';!N]?;_&K M2\\G4R]XGVTQN8V).W9"E"SCG=_?WG(6R=5`=,.*90EA1<=Y![U.WN(7MI;B M';-:#KR#!?-RO.-7V9:`0ITL2'544QE\M@4B0*Y@Q-+GSA4!3MVGD&U^!A+` MUWUFV>;O$@?P:P1?RO[Q=JG"VL*V"(K.5IG\@[!.$#!IW9F#_(WQ.[0?`=JI M3P1^U\?RQDC)%$;CC='!9#+:;>X\"!SBX3E$.=.QC@`.@AW4Q0[*X6"7FQ(` M.WAX=E!.9J(G@(-@!W6Q@W(XR,^+P^14TN14BD/L\'/D0`1)1)!B$3HFTW*3 M&85D-DH'*&FHME*4I3#PV^2KYX0@87TX.Q97D0%)C3UYQV9.3P:TZ]!;86_\X$O?I1(\.&^#.!H'A#XJLQE^DWRJM:CM6FOQ!PUGJ$>^"ES'^QX3'`XI M->G`:(??%DF50Y(]T_DB(`B/_#7UTP.]3=(I%CMVV=W*UXBX+P/WGQB'>$E$ MKB%5`\C3.,0^"L,5N5:F`YM%W@XD&'*63&V&3#\1"9W;L4,F6VBT\JQ*4XD5 MF(L@<(C'H4X)%_+XX^;J_&V*"?9'IVB$?9^^2,[*L2P%*56-F]GE"=(P)!'@ MWD6^0_%:H?2VH5;O1+$NF^_:2+%+?XB>L8\C=(5?T9`.`X0O(GG%&U_5`BAV M3_4M_3AY")(DA'K9TB+`U@134//[O!V4M86RRFPX[+'G_7Q#SX@0-*0&!85G M,7VI8,/Q4\=S?!?=CQ&*DDDW$[_Q953,+/76,F&KDOT(?)LXO0`Q6L4@7%@3BK91I,"?U:8QDQ&(V.&(QCHU4V8C"$10S\ M7GHW<112X:(Q^BN)^(=IG!FNQL>*L'\1(/^!@A%QIF/LYLZ,*!)4]UWA/?YN M2,#_`#9>]/@[$0'_`]AOT>MQ[?_E#R6S(.L@NUFR[//E#ZU+`GO\S70`I5I6 MN<_?#@=0JF5@^_S#(&X)"EV"LYK69/W1<5$<)2.DM)>=K[;>9]\6YM+16R36 MO)EKGW]F!)!!(AGD&'G^T1)`!HEDD.,F^-W9S@(_#B>(_(D<+QJKMJ!=!OQ- M$FZMPE'9#?#;H`'8%8(MQ\QWN&8>P*X0;#EFO,ML%`)/7J\GKV(_4;_'@`IZ M*U9O*P&MSZSD@B9*TT11*[NVP>[L`TVL3!/%@<:6-8$F2M-$465.ML'N_P-- MK$P3Q8&653=9LR3#XRF*\"3PUK91*:5_Q9M[>"+6IW#)+,02@!V;(`(4F[M< M,,-\S]FD;;![\PJ@!IB;9&CG&^*NG:0$L?TXWYJ1;-]QG7"U`%@1Y#B[3!:7 M-PI8TT;&]K%AB\%M5@UUXT99KL[LSEX^/@Q_.JY+R:M::',5^*,'1";S$[C. M@LD$1VFL\WY&,1T%Y/WF^9*".[]CN-J7-B]V?4OU23ELZ>2=<6QV!9C;>2U4 M[,W78&8O`?U:T:<.M+N#L^V*2-W:QCQA!)C7A'D^3.X*L>"FP?:/CJ=3[WTP M(BCU7G_C:/QG$$XQ<=3SP?L!NVTD5.O*1@3=6*7[=V]=;^XQC"2V"#0\N)$Y]>?&4`2($:`&"%`7:?J MK&-+,SW=S]/=T_,F<9B)B]%>K;CFHFZK+^J^C8D7>O'P/P$9VQG`R%XJT[NX*D\5H5Y@451QH M((E_>KZUG+4QL-+_-G:MH\* MAF4M_OP!STC6=&UZX2F*!.\!!]4D.71Y3IZ2F[N:3>"R;"2.J@%K,O.QNX\K M@!4_6.6HN+&+:CB!2JL$*@!0&VTX9F:4)\*Z/Y0OO)=S]P8KA'BEJU91I^M;6&9Z>/W[OA^,&=HN3*[ M]UC#&:_VCK.%._<1NZ^FGGRL*JW.7B<2T5L$;-_Q_,G6W7`JA"RZ='7K('N[ M!!5_Y//]%\>=(T!?A:ZG+C9,_R/236M[271\1W.1OGFO\]T2'=S-F`*EK=O@ MC9ZQ'ZT[4Y+85^3E!LJ+A&Z775CV]0*P*N>*!9^5=FE4/I_9_:*GM8MS938L MQ?;:0;#OR-L#WBU1%]&F/=_&W-Z534X*O8^[UR4^D13&GILO%IYX'O:]#^LO MZ&_'G5K(\]([`IA*/^5J30MPR2[A[N'RSE]@-ZO1+3(!EJ>`Y0&=]_Q:85EF MUY?WH/GD(@,OD?NMBZ=_NX;)K++;>H*.%P[C*O5CDW/S[_9CYA?1$? MQT;6U"$SY[[%:O88FTO8E/!P3KG*I\+E((\<'4XO;6JP-(]J2V2[NK,\6>Z3 M[0QLOKO%`@TL^B&]"! M),]PI;1\,?5>3G!FUWL[[8O:&T=:D">RGT$!F_?S8DY9SCXI"Y;NS%J`S"[) M'D@^XC_MKPA1">S*[`'8'@!:P0-81%6"\IC56&79`]@ M=1IXOK/$[@..MDAZ"W/5KW6#-D/U@/;[OH*@L-_-.51>Z.]:0IMQ>F&K"DJV MOOR%#!W[V/C#-K`[>7EQ\:M).C"^XN_7;C"?K*@64&)K^?-?R/<<^Q:]."[R M'=?$7B=7'PZ=T3[)F-E5X%O3<'1$0O6]:UK13T_.BM[F/74Q6I8C6C=X=F"R7TH+ MO)8>6DBT%J0A[*(U0!0@VH8:NS)B[[\)M\=]=6R'M$D"LSTG6B&3W9L?*Z)2 MG()H;.-KTULYG;WB/!K>-G.Y=:)T)&?/8(%22M2I*N52YMPF8]5)M$S,/+T) M,7VH;V21F1^9X=D>TC-STL/6:706V/PN(R5>@]A">YLAM"T_VM=5XZ%JS-+5 MH6I.&?)W@_NM*.WTA>A-@U>-[A26A,]!].+&S?0A\XK/M?F*/3*8P.W<;=&9 ML/0!6,"8Y\@8V(8H:&116\LLAR/C)"@9`.8?[E.L*+IC!48)%B%MQH1 M$>T`&W=1!*,`2]SH5ZRY!K>_#:\DH?Y,4657J@$H707*^6=WJG2@`,%8P7S^ M?]-9^:AKK\(TOHS+:7Z9TG;?JPTJ^SJ1+.H20VDY\L"XL7&5Y/W6\+K860), MZ?N!^-PIK;(KW/#.6"\SBNQ%%RP],*\7OG3C5YIMM_9F83Y;<-7L]FDFFO+O M%`8L=?\Z84Y(BJX3%M6OSFNX>O4%N_JW?1Q]LNEC-9C]9'0?()4_=KY/;$PI M5+"[(J%G_14MDUGO(1TWMG%!OJ*/1*DA;[54O:&DS-PT-OC5?; M0RNIF=X!X\6%@XGQ=^"%SU+VKE98SZQ\ZP=9-3>(+$XSOZ%:&EGA-#1X0/8\\TQG2J%-Y;12A9Q6 MXI;3CH[!&_H!>..*MZ1"^XTWK3K>(*WNNM'95TV`T?NZ+6,D,$_X@-'[>F9F M%!=$HQ=U1&KT^,?GB6[B'YG77/IB[[RQ-6AJD3X74]+4X6>YF#JJALK"(U[% MMM[\R+0U&)N+L<=7LE#6V-%G:QM;9I^%R]/'\]2Q7['KT\VP]*;/WM72C@9! M%1%N'7ON8W=)-?BT7F4F#;DJ[O/5V*-XH^)@B'5U)I$$:? MK0U"M1H((>QUV=A#IK&;2UV[HZUH5Z4D;5YCAI3_1(M8X4O*$H?W(4?LNVC! M>#VKQXPS>Y[!P*=C)Y_%0(U][6G\_GM?3[FPAM?S4RY:7#Z+`RA)-S:A]("] M$X,"F]>T.0FKY6TN<#G*ID47R@N2]EE/D+>Z1:3PYNV\]^H[^;>%8!G9[-I$\[=/R"[JZ_LF>Z.&9(M.> MWWB^N20$_;#>52_BXR(L@W`_`G7\Y36EH-%)JI)XMD=ROZ@=]"1?;O:ONV$*VST2P''DT^9G(& MJ@U/%]'RN08\@X!VD4P;<0YJ-Y[N.M]A/@81+(V%7F>&&N]PM<0$WMUWF[1R-\NV!0R[\$!5#B8-WMS0//7&`N\85H5[0+Y+ M#F]`/WDL60R]3AGAWP?&N'#CZ33.)3Y2K MPC,@VN7%-J":/.:S\8,>F;A':V>'HXOC#9:L&I&\MBS9=1B2?'0VP4Z%5[KO+@(Q.(H)C;`<2S^08TP\F1LBJ MN^-_K!4A"QQ<[QW<28`U+@+61C,;?0"F3H"I?"5W#DZ*(!P?`9_)/,O`2^1^ M2VS7!I"U)1Y6$>JHUTFSYN]:D%8$L4:0SD4_P+]%<1L(4$@`J8;WC]^5O=V\ M4?Q@SA=^ZN`.D*'WL2"4[1`2&GORD1$`"X`&%Q,4^D&$89UH-#KI]$.<+\<3]]9P&].\N[?X?^;^83U1?QR.K*FSB=;+_;X MNT,NT?=[?)\26T']CPE&CGV11N425OMX'UCYZM#R2G/%B)$Z$J+#X>9%WA+6/$JV/&-TG1?Q, M\D?\0IJ5GAQ)BW]\_MVT3%]?7+O!W+LUET0Y1LFM`7T@`W/TW('7_LT!J8TK MTI4@E=VX$GY6TNIO7)&T(V!Z>$\!`+7%CKO+4(U6B<&/MAB>Y]]DM85;W0`N M"Z7AQMSV`E@[(=;.O/N%']#$TD"#P'MY@?S6Z1;4QLXT-@$H7:\_YMA&HEKCMQ#++I`5ON6"XX@)I&QID@.T/!,M5;[A,F&0<,D6&U-GN2(6##]T\X/^F,S_ M@)"7'"4KH*6I2]+.P\(AMUE5908"!4]%P1H3,.!?L_P[9LGU4'(*)&P+"3N2 MF`(38R8>LZI\(!^]#O`U^=X_PY^MI*8 MG4A0:\"GL1N@SL/3,;^,M39'@:2G(FG[4UA@*(.ABL`YIP6:MI:F'4ER@:LL MKI;?R'$@UPV5F-THO2,@L*_SF>Q1&^(/P*)[^T\4J>;>NB*6`$U.19.&)'WT"*]K( M!V0ADFL_+C#V298],8R0`,@BJ;IN.5[@8F+F3=[^+]<)5AYIP@KH!@CZ&8$SLJ,KH@$&;8=!]LIFL?R5S3%H M:L_6AAF/<3-]B(_HXL`G,V/+NZ8O`9#!$,UV;0+6*'9*:*ZY\[N\?,HH`X\/ MF`1ZQTID('&&=;NY,&\R=W&H[9Y-UUDC;\6\F*G]S@4QK2S@BE)Z`-TEI,[\ M@#=.`4]^_H)=_=L^[";_1H^FW[=MG_F#+=Z=446".*NZ6%'%(#G7>Z3YO=E6C`?J?=_TDL*)2MKA)=21 M*CQ%%8A(@[9Q,WW(*\%T`Q2-5F#J:K7?I3XU51]..1^`XT7#4:X`1W[><T/!:;O?$06]A[P*R9IR%<<#V/SN-G4(=F-[4>IR8/I?>M.$-W%R\P0 M/JP_8%M?T%N1TY$U5Q,E8FI-:78;GC(E)X;RFYORGB$`#$5F4@=`!:"V)QL= M2DR@DFF>YX4VVI3?XW<[&'IZGI"_F9X3N'KWE@6+41L&T*Q.^&\I+8/7`D-P MIE"T[!UWF9S7[]F[WTR1*[KTRZ9+ZYP\D.8-EJ2-M*.-!%D99&4M98I4@2D2-Z:,F4R!K`RR,B!-'FE&`I,TD)5! M5@:T8="&O=1>.2N;(M01>XT?\C'( MQX`R.91A+_9#/@;Y&)`FES0C?JN6O0XQD(^UA2?GJ2.S5_,,Y&,731J9WWIEKT,,Y&-MXUT?\C'(QX`R M.91A+_%#/@;Y&)`FES1#?NN5O0XQD(^UA2?GJ2.SU_4A'X-\#"B30QGV$C_D M8Y"/`6ER23/FME[9LYC2JP2LPQ7<,7M%_:A,J&UC\U!(.EH M>=+19;A*W%;'>N96(?KO(?0L]<(Q>_T6HC]$_Y:!E;V("M$?HG_KX*IR6XOI MF5N%Z+^'T+-4I\;LU4*(_A#]6P96]I(=1'^(_JV#:[1<)G]!+FE6('"-?WJ^ M^?S1M)&MF^';SMA=N::'Z8O@.U!V`Y,/V"(:,NZ)4M=/+K(]I%,+>Q_6R;\D M0G[!R$ME`'P@(5P))">42T%B^]G:D&`O!MT[EF?:V++,SGFFRBC(CK5!LY^C M"J@*['=WP>R-F/TU60,P_: M@_D:,!^O-^Y508G,)WP.[&@/`YEY(-+$Q/B;S$:HF%LS=L.(CSZQ%/WZ=B3I MV@1C?`TR3QA>R0('TZG9[!B,V-;,.#9Y[5@9UQ\G*Q=,?@Z3*\V;?+3'\D>\ M`I.WDN5C/B:/-X[?Z7ZF[-&898_3%:W\-%TKV)2(`BM#CY;K2A@UCBM18$6/ MMNNJ>;UVI=R17\%;EV5]EMUU6%0C,O?S5DU#SN7?QJ M.H%GK1_PRG%];"2W:?0JIV8-]91KS*X^+WI.8HD MCM[]\7C]R]O-+P>[]NCW$_].-G>/76^!7.PE=LP:YBO14&K4]"M?@R5VD>^X M[P=)`A0*L8-GMI5T^]?8=I:FO?E;7A^4`N:[2."YZR;:UU?5N;`6ZV6HE MHVN&"(<;6Y'/I'Q5NC7ZYWV='9#MGYF?VUS@N^_H'Y.-Y39EF?:W=S/'\6W' MQ[?D'X,?X:_\]8IPB&"/@!0;;^+?NHZ59A85^V?'G;^5"*7>TC^_I1],8"C\ MGN7HJ7;)OZE%-LU:Z`5;O[YY_F3KSA+?.IY'?<"4@-^T`].>WZUPM-W=(RB] M-JV`.,-'JO@KG7W->`K3<4<+%\]^??-?)^SH;6;D&]6FAD\^Z`2NCJNH==-0 M1FRK/Q[?O+\.\,!W!FB@+\BO\<"T!_X"#TC0P+H? MCI'\&_F#);+1/`Q'Y,?UP,.^;^$!LJS!+/`)<`:A],01O9(Q4LT,/"*.M2;? M=IU@OAA$`]^TO\;('2#;&/P3$$=(W'&(GP'1510/9?&G`=7:3^&GC4C%Y,O4 M'H,9T3#M*K;&P-F:8["BGIWV--"1I0=6-`+R/2LP2._;QLQ7,L;9C(QQX,QB ML7WSA0S)P"]^*)GID3_-R$`'+^M8)Z05.C;Z%9-NI<>>'VK*]G#X%0//L.L2 M06?1CGLBVPR3;MUHYQ=5-&UHKSO2WG^K/VN#I6E9I/V?!FA&6K_RT8^9X^[T MQ=#1S[^\36$HYOLC"C)FF"F;ZSP[+C M&MC]]8U(R=2,%V&?V^?L14IVQ/(B;;1S-=V=U\X*R:N-Y'K`>NZ9O8.^2)F/8^ M<8=OWS,<^4G3!#$G37B,H[?G!71<`Q($=[&>QB\:I+Z2!KU!F9`U6*!7FFL0 M!2(O#.RDN>6*S&<]FG!$87)F>B2(A^UXC(;D,.Q2=`V,*)'Q?$?_-D"KE8MU M,XK^WQ>FOA@$I`&2.\=)@%=F/'8X'MH#_=>4"FBO_P>M'.]_O42^M'+I%F\] M;.1.]QTJWV:<1**E0[(1R_P6)4/(ILUN\J=JN1/R!M])HA%^X?N`)#&6^6^: M8U#IS-E5G%80-2VQOW",T!)[N49RF"^6.8]HG)M#G,OE-$/CK>L1TZYG<.R< MI)[8[/AX(N]3V"'3^[0?`V65V3(,L&/GB3!0V&&',5!6F048R#A&6OO8U=DV M9^Z1MYC8!OW/S3^!^8HL(C<1=8I<=TT\])_((M&)EE0>J.%H56X0U^S"7^A" M^OC:&^*J=7.)+._7-U?RF_GK/2:H"K0V5\5BK(%1*ID^$`39Q1FOR MB1J:$67ROS3&DBTGJXH5.RX8O*J.->EPOZENK^,:RQ/Z,?%(&N7=FNB%9$*4 M]%PP(LM*AFSENGS/6\X"Q8W&BGJ4F/MD>T6F14'VT7'IM3L[+UI?FR-IF(%V M46(5,XR8JM1%W#"]HHKBL8K336 MPHB5UUDF4/EDJDYGP!%4R-AO:"G?(.D'AU&/!$42M4P$*^YQ+XFL*V81*]Q+E=*[7:?5,KQR MPA;&.T7F(BQ5_Y>P+$C3ZVC3FU<'C)E(D]M^CH4KRU&D("+%L)0D^UXCIC$/ M4(G:4-[W&-D.WM<4HFCV+68F+F6$X*D$DNN/-"4G.TOVGI^2\F&+)FB90)+7 M?T[W=48]%H9C(:]7UEAKC%"A-E89?>76*N[1.JR5N*%H>=&,W`2M5(6+G'-LZW2MJ$9:J&ABQB\QN]DO*!XG4F%> M,Y*R7ON@3&FA2,C!&XW61U):.3EMUQ:@4!OJN(0,6?RZ`38>G#6R^-1'1%G( M>JS\/K)NN[HD155(05#*";)GF)OERG+6&,^6\>>/V%W25

!`KK`LF9,II/W]:%UN:K.81L92N3J$F51/WPFM9#?'V!>(PK9M<&6I(4.0D M14DI%H#);CYIMB@JV>0BOY/:DA1.OJ+*>0E!#DWU$RH,WZ?@HB4R%QEGEAY* M=\F;-E86I[#0(.?,'Y* M$04Y,Z5F2L(2I(XF5/+;++]V+1\JWNB](!>5RY^[^0ZZ)H^O1@SA>^=Q?X]'@CK:'7LL%82;N'0QUE&/F` M?63:V+A!KDW^ZI%P_1_V_KW);1O9&\??"LM/SE.3*HTBZJYXUU43CYV=/8X] MC^WL_O;W3XI#0B/&%*GP,N/95__M!L#[191$2934I\[&&HD$&HWN3U_0`()E MP/U1@$#<"[C#'(UZ$S5M>]9WE^/:;A2NXQT@ZWA7"A./<"3$ZD^7+7"3YA-+ ME$4[+C,?;6'Y=7'@K]AT$N\M_LC\3W.P.3LP_5H=J;.<4]@T@071[B%YL&9: MKP$;,I'@`7C`57_A6`9S/5P]]5]VP;?I>#)**T^^_=TH6`=QXUXV2;R>@@3Z M`_HTRI&BY.FZ[LK]CXVIVSS;NIZXPORBM"$?G7O-S9NIQ+:(NLSKO7I3;*;B M+JI,Y8:$5/!I1T)D56?@+QS7_"\S8G(VY(_6+?=C%)V[\4M7)8#C#+>EK.LJM)VY#SCHFS<:C\4R=CFM0LYY!A9[8WKA4 M[H[M0%@#_$K1E6-:YI:]*JPLW5>1\Q!G@UZF"CC3S9NMB2@M[,^OA4ZR?FIC M1)16EN=C_+$ZVH03N';]:8ZU-]RZ,/?)U)GW!0Q,(S/3GXV&T_RZ?7&/!:B] M#7&U9TP=`JLFAR6N]DRJO/Q+@)?N>![8RP<\ M]P6#01T\>,_D]V6*U3M>L]:(9`SZZC"-;?4)R/N"S1!?6TCZ,[6_`^U[(+VV MM,S4T:@ITC\SCVFNCMN9;L&`6PZOI&X2/X#1F4*6RCZ;H[`^],^F&8?F0!36 MMPZCW2B\63JN;_Z72\:G>;;FMY%I'@Y[&5^BNM.B9=ZMJ:P]U9-AO[\ID0W1 M6'NRQ]-);R<:Y4$6]J,4AV8F&/B6W5*4ZZAHG7$38FK/XW0PR>0=BFG9GI3: MTS69S;*+GAN0$B=TFW'6QA.U9([BGO)U,IM14W^6IOV,2[T':C;1JU')1%50 MDU:^]^$96,UY46I?S6XZJ^@R6S&W)77UIW!8A9=9VIIB7GWEF^Y"WIT\[TQ, MO]36CX[MA'+15/;H>C`:C]*N+YCYJIGT?@&>H>>Q7^/R9ZEWT(V@NG*D?B)RTEL;^-6@);>!$IY!'GRR;TUOY8CPY=-<^#EJ,P8RFXZK M[K-D:UY2CE("UHPKG75M*KLLKGK=BL+Z\S\KV$I8G\+U)[#]PN:.*U>[>0G[ MN^^^JSFN`<+EOMSY;,DKE>!-U^&)DE#=&TKVJQF7;H\4YT'S*,RICUS]:6;V MSY\YM0W12)2.'I,YT(34NU^8S1K+S@_ZT^Q^\,+>G\S,C3?0F1GR:VZ!]0WK&O]_7%K+2"G^-8>.U$YQ"P@R8>;5OE!.03*'HO. M.]B!MNT4[#"T;2?.]6G[-\.=:\RX>0)I>&0?`SS+_],\5ZB<,7;;S[$HWPJC(XSGCNNECC#.[R>\QVR. M8Z>3//?:NHWI]5-/JMHO.,-D?U27G8]0T&/1ODN\*@4:MHW*79C[Y]HD6VUS MR#'4EK2#<[!^U<,X6^I.'-RP$&.4W41Q7`X6=%QGU_8&)?`C-;N]I[3'POV/ MVY!76Z"'HVFF]OH0Y-5?+)MEJW8V(F_7[?%-"<%T,JDE\AO057BTZ_Z&6G_) M=9`Y;+&9L1YTL/674#B4[7FP.VRD':4VTJI_))J2-\-G(Y7A;)`_*[-B9^T. M9S9L3%Q?[8\S53>U3B+8C*QQABQY`DTQ2?D#:_9`T21#4?9J+W4.2O-:=9CT=H5T$+>B*WXMQ!%V(_W_$YZH1C\ MQT\KGNY[]YVYNNFM/QF@5SJ$M>HP[15(WD;$EQ+'@?C`AC;E+C\+NVFAUC?=6EJ/!M(YV?F042F8Q8*'[MYUER#[V'?HW!F M=LYL1U]-'>3,JC'(AB6SZ&RM38G;2#*W&N(&=4D-C6<#_)=K_[@'>HDUF-PM MW^NLCY:@[@ MH!S90S*O]C#Y&+5O[O?PPNOYX4""_;.HO\.FJ?$<(L>QP[S54[^CYSAVDQ"V@.ZZ6& MVY#CJ#UU30[J<#F.6>DL;N]^UZZ%:F..8P\E7P?,<>SB=,[Z!\MQ;'#69FVB M&LMQ]-/GG]=@'3]W_%`YCLW)*[C(I^'8O9\YF?W(.8Y^/T-.O9@X?U-.2=Y@ M)]H&&=JVQ]G\#3"UZ*V_8SZ5BDSM.ZQ=1U&]DW[_28;^J'0,Z[.^F!S<-!F&G4:H;I`L:B@DWVZ0M;?K-3>BO4??N\S<>##:(/U\W"Q# M[E+RN^TRS<(C:_\!`1DH9GQ>;&*OJ6MZ\%-2XMT94]_;>^O83Q#E\R.'Q6I-I?;>^QK`/-.3:(-CT^`XISI/2>4WE(NOL6LC0A&\BZ;9JXUF(XRV[_K M=-TTN1O/Q@T%2]O=O54LONUM_=M M1_E>KJ7*TMTXU7NYK:J0:I[6R+RE/3DNIH9^M^?A1[#FOJOI#4G)I!^G5#;H M^\T>:*Y?UJ/.>J-MR=X'M^MONAH/=B`\GX])@M`^C$J_-YD5'`E3T6V!22[, M<#SH M2KFU_17X'A`FN`Q^@L;YOW=VF/M/7*O43!JY/^K/BK.]\'T379VZ_-U.W MI+E9DC5XE8C MVO-XZE\*.YYF[U+?O4[G:^=@4XKKVYK9 M)'=)<2V"-[#F=8G>Q-M<)RB[$.T&S/A@:@^FU5R``Z9G6(/F3->U1'D#>M^1M^"BO@6W_]YUGDR#&;^\_.YAT+RWB+*?O5N='_"DP(<`//M!G& M:6"6PL0A".!\#H*G-97NG4TGTU[:F]VD^3`]6(JR6C:UOZ$_&V4.'*Y/0`WHV8KX#:X+ M&P_74R M%)*^)];77R.:@%':GO.5M@AK9C5;9PVFOM4>/T:AU`JENRQ`EL)G1?'K[[;! M7(@.0%70?ME&\9H$WT0.CUD!ELDFM](W8[JR95E[);GV#!Z`1?53H?W^A;*H M?M@[S5S;/R5%Q4I->T&5$KL:$&&15>H$"4D'6\O+`9MV^:/6JG MHL=R5VE#\NKK6K:J:0UU<;E+DO6)(B"A\+Q'69XARAX6#^\SVR5TL"&XN5>)@.=[:9F M1G1?*C&;]`>]6BG1>JC>#/GU452ME\\M(7X/I->O>HJP/V@CXL M-/N1?=9\]LG&U@"9\1\,7)\TJ['##*[5:;K.I!;!F2X+C-/.I*ZY]4=MR>KJVIN;__WT^:-R]_'MWWXJ:RO!%WSD MUM$#?OWORZI^-VKO^G]%#\G7T^,0EPW[[TU/UZS_,,U]9QNW@$RU.[F^5OO7 M`U7T4];:FRSC=MD(+NZMZ4_>LP<@892J]WAKK[ MX,$R]?>6HU4O#\B+:GK_#.PLB/;P=-L>6##A^!2V_28Y$3

ZS- M_3ETQD3SJ0;>Y$3U+<--7M:=;;#O_\M>:O<@4@K@P8U3[$RW]B:O&E(4P)'& M;5N8,-'\P*O=[7^8E^JOL+6,DHA'_^58@>UK[LM[TV)N_1X_.LD.,ZT4]L1_ M>@OB_>BX]1GZ07,?F7*CZ\S"-71F*+R=9.>IAO-3^6]F6?]K.\_V%\!ZQP;W M$T]G<+?E;4ES;PK@)U;L]_!-?=[B?]-(E&GI35E?PKYMUMO[_Q3UE6CI31&T MBM\WA3_\;Q(!"UO+^1,0^)H>+A MRG^MW-Y]N?]P\Y^?E0=L_+7RV\WG7^\^7G]X]SY\0G[S^>[7?XBO1%.*9@&] MLET\%F;9DV>ZV\__3QZ_7[F]_N/L"7 M7\TEQ&\?V;/RV5EJMOSUR]W__]W/BAI1@/ULT/B_WXD1/#B6$3>`6]445?F_ MVG+U^O],^VK_M1(6(2A@'A0^58HS5Y*3A;W^A-V&)$1_*-'`^=?`__"1!_>G M\&/EK*C3YJ;%8O,$KXXX(^+IK__Y`(^;/I"H)X8H.HQ;"/G_LKSPK&L%P5@#!#5"QX\TS`U7MY]%:MQ'] MK;Y6'%=)_(RY*,U^23SPHP*SKRG>"G<\J7%:;^@;_1>UU0*GAH-NF`K"DNR+#.'1,G<*,F M&4J/\5>@N3YZ5;X#(L^4MPN8MD<'M-*"T3A(#@2@?.9TX;*!3BXUT\:3A'A[ MV+ENKKCJA"T[*'1<_CYHWYCRWL&JK[C-KI!F==Q['7\"T75X$2++JF0LMAA, MP*>PH!;:!^,(CJ,;M]U1OCB@&AZ#_I#M_\3/+QWE9@F>T9-I64Q\_Q_'_28D M\EZ#*04N:@OSH:/\`U12!XD%\Z`9S%L@/@'P=%)ZJ^C"70;UB@M/E&=@U<() M/#[P7P/79BQ)%_:EV8IF&"8^#F^'+R2&]<*GM8#6KO()F(TF2W/U!6],HA.O M&TK"Q6?^&?]WFX8-9O.IAEZ54"*@MW\Q%P``!FZANL;TO@45UAZ#'+_^#9-C MVH@7'>6>V;;W8CT!DFGB5Y"WA?8$<\G1/"L2?,YN;/B?^^#`^[^9^L)\1+TH M&O-KWB)P\A&F2$[$)I@1)P1V\<\*SJ8X7;\N@VPGY=3U4T[=EV`)-O@%/;G$ M?"CQA"CAC%0Y=Y=MO0P(,]<++"@ M,P`*R<2)S\+A8-P4:7);"\YPTE5$3,@YB`:`/D0LP@\#YX4!8U->8Z'-N0$\ M-Q$4KR.W#UPX#VP-KUSA/ATZ+PA<'-4>&+,59ID`@"%\ZDD."`Q$Z@N'%XY$ M0!F8&/,)L?$#M(>MI1S;N_L/*?2.^^$P%,97-!1#&%I\?L6C7G2J-4X]?F<( M.,\-'/BU6H&TH%M8R&V4!^F0PV@\<#NATR?'>N+<$9[_$TP6WZUKREIQ!:MX M?#Z!F;#LLE7W)IJ/%_`(@$OH&H))X6<0*@.UHZ!Q$3Z=Y/DS=UU&O?_A.N/B M^QJ(";A:0..?#G!?P'GQD`?_\.'M\H5MI60T'_R-_XEWE"* M(JVK+XPI(AZ?%'-C(ZR)T%_-H/CN3?]NI[`I-;147]T?UXIVB$^8^_?9(V#2 M"GQL9#@#SQ(DWU`8N-V6\N1P,^6:CPM?@`W/CQO2#Q8^(CH1KF,5PQ<@I(OA MF04.;G*F)70R#H6<&#,JFT9%QV<+IT\1SBC^SL0YF$M>=0N\IA5N_99A/SQ:XBJA.&*> M!F6=&\]80\.HW&(R0Z6AJP2_LY5T6U#$?[>YVX%K+_"U1V&00 MGR5&\"PD5D2QGA]/$3BA\U4KLA^4QK.GI MEN,%;NA2(/78<]D[?LH'*?.T8C^LB![0+V8'D@(F]M5[2;?'#9>EI`/4A;#" M1\@&]@26CT`06`9/KH$>(6/`:T$.DJ%:N5"AU4K:,Y>A MNQOFJ(#3SK-PRO%!?8$+<`^:_@VFW84//GHL,B<*7P#:VO`%3-G*L<4O2R=V M\`TG>/#G@17%&ZE4CY`&C[E//">J>-#U]=)Y0MG@>=L'P&_F,VY@Y5D@'6F7 M1*T!N+18WB`$&8PPQ_EHMYZ4<_%*X#$D)'IL;GYG1NJ)3*/PC"&/APA-I:]] M+]$=T4*2S=R(6KP];I>O1:R@)PHX.\@6W$VN/`2X=AZI$Y-WVX%=YC6@\);G MYVP5Q>OB$Z7'_ M"A[Z+TSP\P+\+8`_+]#PU'6%\=UV.ADZA+5\[4%F M2Y%F7.6&)UZXY$&;W7!(G@#D$`M$+^B`9L<)(:9<"W%-[QL.T<)[W3BY*U0G M(P0?/?!\3#"36Y224UX^ZXEE"C="=J,$G(WP%.N.=#8,1#96BM[%0(V3O\1S M5J13`'URZ<1I%E$8OJA9+SC-')CX95\H<^8 M4;C@U"RAAX6'%LA"]T380GG6,!>)!_3%))'\`XN)+,[5^`79.7P;JYT[&."[ MSG<.FD#H#_WN3%F"D".@XD/PQ23Z`@,E['+!(`9Y>.&KL"*AG(C@PWPMAB(& M=[*?N1[$3.&K=?P[Z=(A+R`RW'WZ5N+DLCBTXIZR6!`4B\C214W/)CZU>^>B M'RQIJ.@+;1$62N`&4>N%;'G#^AN>2*;$9V!F-9`PF(AX7C#;]<0=KIQ5](AQRHB&+:"_C>'$CO,2'O! M:F6)\EAQQ468:L$T-]8::6XR.I`86S85N(K'T(ZF2-"9RPM,(N8DV)I$$^`L MSYE*EYZGA@'2X)]`KN&%=2T%7?ME,DAXD,*#WVUN!#G+GTVP)[;CAX';*O3[ M"T64I^<<_(XO_\KY34Z/F+DYAG1Q7G+#16-NPZ(6L_F]TEDF&[!?'RZCL9^% M*E=X<+(\R;01^22Z8-)5>P27+`$E(3B`M^(:`G5@5%Z`95$0LSO>"HD#T'AT M`7^OI=\6.OJI@--Q'S5;WD'#L<+#O%_800B5:(=6".(B&<$K/#&=T17)>DD` M3Q8P*678J1]2L8PXM/ M(L/-O3(IN((/X`8&F#V7&IF6%!CT/YQG,"INI]296*428$FJ,9\9($5R'4$L MRB=S5IQ)@H[8=*6RE)1CR-BGWZ(URMC5=1X0M;T(OI.B)5=G7F2TR_%.X[D` MF2*,E_YD-IGQ`$%*?Y%LIS4!@TS\_Y)&4)T*%00D&1?WHQ624+.+`2`JY@(@ MP<4F+(_6Q`$%+R'@_15HLF1*+#6%(\>WN(_F9S%V)3&UBF&\I%SC!2="L<-] M&LE%9RRX?"D#-5E/%@Y%Y/*0Q,)NN<5Y-C&58_EA7N2!B7()/M)U]JG".B6J MXC1`?F;S`A?N00@U++#,Z>D.Q%0C9,5#"L>J(#^LY!SQ/A#Z#:SB8))>U':! M&=Z"+RC#^#"AW54^H5@">8\.\O4!JY/Y%]=$\ROW M7H!B24J05UA3[XBE0V`7MA-/%KVE" M_)NMQPHW3&1,,]H!&>$FT\V1-Q$'NH`*CZZVS#C`4<#):4AXY+TA?B2D3QX(<3Q=!NAWQ&O M;X5/"##+>5/"R49RDHYV3-YUCEL5#E:.&MZ=Z4=^$7<<0ZY'?A8Z&_)=\*I* ME[HR%81BW/K)EWE/I'CG#(]RC%$6)TJ)U1$52$L16+YLJ-QSVS4#*DLR+7KO";\"59 MQE!="@B`<*8S=)Y=OM),PT4F/6?*!UZJ\))+NP'(KSEC'[EVFZCCT M0A.Q.H\8N)//7UUJ6$R#>U6BTF(PJT;4%2=QJ;W(DD&D-(SPHK$DQRQ3GTHB MG)\'N(XA[$'Z73&C"(O@,8JA"D.>DZ8G7OH9NF\&6XI=B$;LT"U7S."OG6N[T%?PV4X3!`;5>EJ$T]5\<*Z4IFC1>1&B>+_ABB%J6/0/%[N*9TF M/;:=N'S_-MS1_X_LCO[?Q0*B);1L'G47":X0Q32`)A*!$5Z'N[?XMK"X?C1L M+T).4=P@2,8\W%<,W,?$1K1_$3=Y$V]"SP>I*G(3IQ<=,Z,[U*J<9G?1: M1FRV0K!W`A^M.(B\<%*-P$U52<9R4HAC5U*>L6\%8 MBEUKA+UB^14Y)DEJ:!V?78B4KIWY/-R)P$LOT">R9.4<3W&G"U:$1O(!81K( M-_&@$+FD9C^*[`)`DA-OUW$2QP9&3,8?5YJ'.Y-95`/*,2W59^D>2?X\LCL< M/4NT%^9LD%3,T\73A`K+7AQ)&3[+@X\X`@W+%>)45I2Z@_$ZN5\E'$OIPO4D MQ`D!>5R(<*O5"CG&*^T)&`KW/.?**-,2CGM%->`F8`0^_<.XWQTF2R>CB1>I MO\+"$+XH@0#PPR!1=XG6?HEN!"BXK8Q[(`XO7M1>.F\'RB2.4.*5I+@U`6-K MM+V&R*W)0\B$48Z+WY"P2+*+:J.$,H0F6HO7P<,`/?0PO^$)@&G,@4;9,I-@ MU"S/"8]=\"*)KH84GL46/@S'.C.YEZL`ZT1.!K>XRAK0J,XKL0R36$<)EYS# MF4HP2)9AL*>=D&V):%J5#7V48!YA4:LY,)$V6%R8N_OGSSAC\`E-J*# ME)D8KKW/!F79!:^7L`8T+`3TV*:!V;H$47:EA`-!C;BK--#J2'\L*M61+^1+ M:&291I@&QJ4[-WT^BBTMB&B_:(.=K(^4"&]Q8IW$!@^90AR[=$:20/ M'*+`3C82[I\+`U,SM&?A&3'I8:;"51ZF>*GU7[G0ST^6P%`Q+>S)R8I*_,-J MKH2A>IT&-A*$FJN$5P3QP4?W2J4W%)RBK]9ZE&TY>7?QEN],?+FV;1M7%:S" MIO+['Q2P)P)>^+ZS*PV3^H],_"7.9_D1T40FI:^\\-2=8>K`M(0");I+*E(: M4"N*%M;N@G])KEO%7SYCN">\%:3=%*=.\=N$P@BR:*='2OD_?OY7FN;W0-`< M$U$+X-BCXQB)'JMJD>("I$S5$1HO7!T,JXU6KHDP*TMDXN5!AX=OR`M%\B*Q M`BCC7EE9$)9H/;SP\^=%1%U4]I18<"KPTZ-5>5Y!H#U':PFR"C5,'\3MA;,5 M4L@C@)^`AX)OR`<\/\HK.T"*_W<0;E3K%V7;4$X3F)(NA$R4GW$9\72,;)$` M'IRI_>X@C*\ZN,M-C?^2^]Z&\3>I>GUQO%QZOT%Q;R"(('4_]-5N/[VI;I0( M[K3BV#*Q1:]\MT#-/U+.;NH\G3AXCX7F.+LY`B@H- M(\*:@>`%YRN*?,#Q`J1%I@+"K$PM(VW-"ZA9YLX*]QSG+")(N3*@6I9(X M0B=V(B=J%!-G#*<,4:(4%TUHR9I*K,()OUI$QFCBP\SVX+ES[;S'0OI&+:Y(YV<,7WV>.>XM`8,X/@^0+2XH-6ZJ9R%MJ9SMOL&I)$!TO=\%WOF<#D+GOPE,!W M#VM(09MA%8^U]N`Z&=E%S75.$).(\2=-'OY/[YYUDV7VBV&LN+(UF MNL+NFO9U:*/*#C*/>]R`YQMDP](G8_([&#"7RC"`\-FU98I4RM4\J?S82"=,HG#C"//);$^4&O!#E/A:(X9R MR8W.O)Y+/B`8Q)>S(@]*GF^SQ%/K_AMFU+G!?USXU]SX/HA[3Y[$7@_339TV M!MXMCAB/Y<)L$>X$O%)_%$?+RLT6$+U<#7KBN]+<>;`,A(F0I&A1F<0/TW[6 M_1[,8G>_"/?+G>^BSI,=AF>X\(Z'PV14\<,DL1S$R1B#A4M!2?CK?*L`*1^D MQ.$2>GVNE7`&A2IE=3*M-[$SZS%>SA=6^24K6N.*]#F\ECAS+K7JBJ>&S"%B M*IZ_NU3*5>3KO.1]!<(WYXXWUJ!BQ?]WG\GUT=`IY`J5UY]0?KG@0IOQLKE8 M=A5Z%$MP>,0.C]1%(R8OYHS7BKU@J8@D;2CU4K@E6;P\/VP[Z;/R]BK-WDD8 MO=,U>;]*^\)+F9@7'50M+R)/;[1P[\^IF5NQ!1 M('U1Y9O+<>:/!NV(2AB\N*##S\6/*12;^K@I2YJI:$M-M?O>^KAZKSCS-H:) M2+L2Q_SZSTZU<1>90\V3AYAXRA4OD'`"#[,Q/_Y<$BQ5L-L7A0,0>JW0L-J/ MOX70")_(;]3>[W_D5_G0H602S[G$MIIMY!+95^4O)^T0+&K M),;JNYE42?0#!\Q8!AX6!93?W]S>WGW\]?J73U^_?OH-1*@[6J6-7J;U MK01G'4O61@\%0_S)-XHII/'S\>L.RG/(@+X<>SVN_/+I\^V[SQ%3'BQ[ MZLI7^)%`93(9=G^H2Y7$Q5K5T[7G"0L]JJKI2@-3T7RMFTS;>7:UE21=_-'H MA+Y6^!3=?+C[]>//2L[Q/3$=$#^Y99B9(AK+4?"X(MNX!HUQW)^5__/V[;MW M[]^_+LQ%)^:DV,963$C2D,Q".U+%X6/=379@%[A@%M,MMGZN5?/'+?11G4/'`3;A-N$VX3 M;A_&B2Y.N#21_KT0*'\OK_,NNKQZO_G.9O(S%Y+IWX$IEY47;B+ALQG'\E;N MP#R[ZG<&_6D[TT*["M]A.?GCMDQL9YQ"JQ$U5R,&+4P_T6I$:]UC6HW`WOJS MSG2@MM/LT&H$V8K+6*4@,]%:,]&*6*8]YF+%J'OY!U^)&:LWJML7NT$'_TPC.5#%[%&OQ:U3D)2U=SCL\&M^MC3;\[`=;P M^RXL5HDVE[.6ORFCCT)V8FI;8.?$U'H/">[%:<1I- M1-\6+-WL]&-QD@P_@88?!1,>^"9O118W;N#-+H_B-/B*>S#R!\=%]]HRU$)F M7(='Q%'F`1YR%)_"=I6Z;4/> M*51Z9(Y@?-)L9D3BS$[,23AY!?K2W($Q>34].%(4XH%1XO=>\,"+5P'W?=9* MJ3=S2`<_?W+.,<.-^N?X'(VB/#G[EO&3;?Q7O-\OI9CE?Y3-<](FG287WLJS M!JO&7AW&[I6\&^XDK*$G'51OB*['/;/J]*P1F6$RPZ=BAD\3DA/GI%>C\E%A M.8H2:ZT7$#H3.A,Z$SJW@B(*DFHW_I'YY39HO4&B*(FB)++#9(>;/\^[4+S) MXI+%/76+^V^Y-J?]V*E\HI?UY$MO=J\"H?, MY%ZM16KI7\G^LDT%>$&_NU;$C=,;BXYG;8Y=R7B?NXJ0%_&LW6&TDR8UN;GH M9/1B[[N*#LB);%7:7CBP\3:BP_)@@N5F@TRYV;[MR8[[SDY/60@J""I.'BJN M)L/.2!T35-3;34$001!Q:1`QZ0T[?75*$-$B93F\)A`F'(43+<<&M=^MW-5" MT+"_;%6#":@6K&T<.]MT9U^O7(=?A^TRCVFNOI"W;3\QRUGQ.Z^OPGTN_=[K MN_O/_"_\WVWTO5K@,1XS.U6P"M)BB=]P&?,L14GZWV@Z3]5>6ZLKKT%H66]LKG] MU3+_=*-$)E5]K=S9!IN;MNDSQ3*?,IMM"AEUM+J@\]#2=8D4*OMI4R+FJZL9 M;*FYW[QRZT1%/I2"IQ2\3,&/.[U>[_"!VJ6DX0DU"#7.#S6NU,ZDG[M2B%`C M[HY*?P@M""VDCS'L]"IMUQE@L$#6C]CQ] M;P,/.,1^"?.Z^IV2?C8\[ MP_XD-=69>3_RBLZEF$I"4$+0+3C1>-%90-)'"X6'!0U6ZN'(&@H1E)69<-I%*V-J4./_D+YB;NPZ*L M(9F0=G"B]2:DT\^>7[4I(\B,$&H0:EP2:EQ-\S4JA!AA=Y2_(J0@I)#^1:\S M&.436(06Q]6;,U<*@H<3@8=)-XL-!`S-R,FZ_-7>4U(IGFQQ#\JEI*X^.O:U M[BQ7S&>*]N@RA@=@M3]_M>OTME1MFC`T%W+'0Q.6:#-6U3G(@^KK=CFLI#/L MI0/["NO52"1X)'B\* M'L?3[)(P058[)6T[B+HL=ERD8-1+_+Y6VF3.U-P5!T>'G0O)!C=5S=ADCEC- MH=;I\/N0#FB.3Z?'I:;]@GYW`CQ1#"=XL-@:S^"0[#K>)5>;LJE@6?"@EJ#3 M&XXZH\R&N0W9=3@_="-Y.T'])!0C%",4VZ),LM_I#P:GD/QK+8*U/P%(R$7( M=6[(-1L/.H/1C)#KI'5S?41]4>R@/.`&><`SL&J4$"QG4EE"4'RO`92&R]8/ M[D_AQ\J23'5ZD)K,+7CZE?/T(_#T\[H3"!>:_0C/FG9B+[&B>1[S/<4(7--^ M5/P%4_QG1WEAFNLIS#:8H=PRG2T?F*L,U([2[ZE#Y9FY^*(R=RS+>?:4*VC2 M7SB!I]F&]^//Q6D-_JVLI\JPGD^)HC/+6FF&`73(D?\Z1J#[ MBF4"(1ZB&;?^N6KSHQ=Z4HD)(0`AP!ZF*GV9>M5LD=:3UI/6GX?6'^"F/])W MTG?2]Y;H^\%O4B#M)^TG[6^)]A_R,$12?%)\4OR6*/[!CY(@[6]5]?U.![<, MZ2QAT6-V,:^R!GE'!:*S_DZ\EN-X%67M.<1K/.B,1W2&\*F4X1-:$%H<$2V$ M-$S[:C\O#@09!!D$&009&1Y,.[-)S@LGK""L(*P@K,CP8-093:>$%805A!6$ M%12*M$AI"#((,DX>,OH==:*2>W&DA;(S6ON:XBJG)*5J]>N@2U\W^E^!Z9F\ M8HQ6O<@2M((3+;<(HTEG-L[=AD\QNEH[KF__E9S/00AN9D59P MHN5FY&K4F?0'9$'*.=2*NQ((+0@M6H`6Y'12O-HNA2'H.!'HN!JHXRJG_+(1 M@YP,0@I""HD4DV&/D(*0@I#BZ)QH.5)0.$+A2+L4AJ#C1*#C:CS,93T),79S M,M:MENU]`2S%B^QQK_W5]S0_+WBE[+WC,J!&T0/79;;^HOBN9GM6XYGM_AKTT8H\U8E3=7Y.@V(G,G*'0$8P1C!&,$8P1C!&,$8P1C M!&,$8ZUG$\$8P5@Z!=I7V[?.>CKHU8J%6$(M0JW+0BUROEHE=`1C!&,$8ULY M7Q-ROEJV0$W;.=NT2)V],K"R7J,5"]/G#;FMKFVB8[1A@M119];+Q/1'-RJM M*6IJE<=+4$%00973!!D$&009IP$9T\YXE-O!25A!6$%805B1X<&P,Q[0?8&$ M%805A!44BK1):0@R"#).'C+4SD"E^P+WI2WK5LEHX6O/TT<7!I(I:!TGFC$) MA2J<;$"6CU;D%L/U/R3X;'X^GG>$H7392.?,[`@09R1I,(A0E%#T;Q[H_ MZ'4FTTSFCB"#((,@@R"CQ"GIC+(E1QNR@3"#,(,PXY(P8Y!##,(+P@O""\*+ MLL+F3G\PI-5!0HT6Z`JAQHF@!A46M&"QD+;4M6IED6Y(;`MXDADY$3-R-9AU M)N-,N0F9C["[5AR#0U!!4-$"J""/DX+5=BD,0<>)0,?5=-*^\V!:@QCD9!!2 M$%)(I%`[,TJ&$UH06K2"$VU'B^ED1GX%(04AQ=$YT7:D&*LC0HIFD6+=ZA@M M>.UYVFY-;^705KHVP!\9@E,Q!'MM?=CK#";I'289EI/1(?>44(E0B=;6:&VM MS0I#T$'00=!!T$'00=!!T$'00=!!T$'00=#16H4AZ"#H(.A(?WTJ.]=2U&1O MR.QU1ZDC[RYXP>^]XS*@1M$#UV6V_J+XKF9[5N&.M_:M`.XZRRU5M2;L%%V# M>H[7H+;;TIW.?:BM\J()Q0C%",4(Q0C%VLPE0C%",4*Q]@H=H1BA&*'8YF>+ MMNVD%@(N`BX"+@(NY;S*M!#F5UJ;#'F^9 MSI8/S%4&:D?I]]3<(2ZGM1Y=8V;/`Y/KHTJ_.P&>*(83/%AL#:XA.[U![C@]@C""L-9RB2",("SMA_4Z@U$>PPC$ M",1:RR4",0*Q%*/&T^PJ&\%7"S99B^\U&"OO`_YZ<'\*/U:N!ZO3@RP(;\'3 MKYRG'X&GG]?P].N"*5KB*DZ%?5\QVV.*,U\J5:@5%@QL))=E M7Y2\7V;,$H41>56JQ,?="DOD-ZG:AMJB6U@D4%%!L:;?K56HR#?8.PS]!X1; M838*7UI^#U:Q45VLD2W7*"CE"-&QZ,?:,K>VAO#`-2UEYF'S\>L.8DC(@/Y: M.[N))E8)[B$KD'1F^\RMGJX]3UCR"FCEG;`[^Q;M;=RH!BOX3DPC4CY3WFIM M?B[-AG"3M-FS0I/=O%F[3*/6[^6N7&E:]9H\%^W4%*F)K,!&@=B!@_Y],6+C MT]$.RH7QJ#,;CW=FQ:&/1CLMU5EC@\BLM-RL5.L'F14R*\=C2.O-RV20K3XB M\T(A#MFB+6U1]EY[LD5DB]K"D-;;HD'E?EJR113J7+IYF9)Y:0N:DGDY-?.B M]JK5A\P+A3IDBVK;HNJ\`=DBLD5DBTIL4;_3'U:5:I(MVILM$E^WK1CS()68 MA8V+I[_^YP,\;OI`HYX8H^@P;N'>=5;,]5\ZRKVE04.:;2CO_@K,U9+9?J;6 M,GYV%3W+PF<5TP,J-)\!S/N*[GA^!Z3-\Q1-UX-E8/%?#+9RF6[RZIVN!+NNEF]"JZ%.N0!<+<\6X MP3F#IG5MA9(AAN0A[TU;MP+L_MGT%\!@HV!\7>5KJFQ7U-6&M;W^0O`76*D] MLE(^BEEXZRQ7FOT2'1HY>&?`8C4_*6"FGW7'J;$+R=]189LV_//&JJFS5/4THT6!R^C/:HD MY^MH#RK'H>U"+/Q@SIERQ>W/FN,;=Y3HXQ;1GHPBI'Q<)0_VFR=<"OK=/.-2 M'K5<#/K_$I@6N@S>D8"_(A5R,M*]]R3(N7*BY3?^#GKE(?T^#`-=\KN#ZT\` M7SQ5'S`87CB6H9A+3$4PC#MS:$]8O]]A$M:W'.O[A/7D^5^487@?N+;I!RY+ MIR0K)YE,0_/#)-/0D`=D'.0^FQ;+N/T'\ M?H=)$-]RB&_C@8H7`O$4`!S+'F"U0N`S5UEHKO&LR4#`<^8^_E$>#I.%:'Z8 M9"'(0I"%2/-5?-^V"L@,@2TN@OS(?.7.UITE4^X!Y0'NEXZM?`&T9YDBL[T. MY!?-,W40(Q^K\9"8%9;J"6(\)`8+]1XT#VOJ5O#=,T-%QX)+67.7?-93G,#W M?(V?.=A5;DTKP$?KMXYE>KD>[("7)CKS\KXZLI8P+.$TL&<\X)/-YTSWX>$^B[3O,!]D>_B.^8\ M?`TH%36B7F%=Y(WMF]<1/9)T]EU6/LY!>66Y*)K[J'+2*&:=X!E6KV.,IOP#_R)T53EGP4%Z8)._$L4R_(25F/_,F*W,35NS=5.S0-)66"0,FH7M8?,/O!XX+A?.]"/$#Q5!%D_#JY;C MB><<&*++6]&!:!,K)5WWY1I8`-(+&HG5PQZ@C,^6@N`EU^14O3>S-9W+/K0" M[3-)@?;LP<^:'QT/;-H23I3G!;,ESL1#Q=:Q:%F7>N0RT)>P@%G6'L.7N@-T M*1IZ%H%0=PUKFX$[3+QE!+JH(#?*IP(>]$6]=8"EYT@E`.G2`1(L\QMH-'YG M@U_#Z]*!=@`PR_PO,[HE+@#IZ+8Z^EXS7>5?,)G\*.KWD9S?V9[O!GPY/Z.Z M27G05BL+=>GFRUOEJ[,"4SSM`W`_+TQ]@>7LX%^9W@*E"TR%MF3/CON-*[B0 M8WZ0-1+PQ`G@.&UIKCG'-J4,F;896I7$H[+DGHM.U'(W38=X&UI*=H':`7(. MJK9R39V%M)JB/_Z=5!LGL`PA>SH#,R.`"5X6B`2?5YK)-<4',^.!K,,@8XPR M[8JB?=`(`)+!LRS4 M?'Y(N6`?^`0P1!CZ4OMN+L,M(X$XSMQY\)C[Q"ME31N<`H%'`+*Y)P,[_RS' MIB+IZ"J?<@^[;&XAH$E#$2RE5\0GL(@]8E*Q>Q@J3G8(HM&DQC.(5`L;`3X& M8'?"1,BF@;,:#-?7N`'AOI#G!"ZBJ0D&;(6;4^QH%TW"MX^-B&!E5_F]@!7) MT8GG4F+D/-NI01=2QXU4\?M_!L8CUV]%>P!?="],[$1<%#A>P$M\\0&$$!H# M!5M*F_*DF9;DA?`O355P_2@O9#O+ M]?[6:(NQL,[T3+)2>+SI.?I)`3O[]1\X**OI_$9H_OMB7UX^)D;T!;=,,W#] MB!D=!=L#H.5^L0>/XK<(_QI/O83N`?NN0[SV")89X@;NNU0"/D?QG+_34;P` M/''PT-.=FIG>Q*TX)KI68%RL,*9,N!V8V!'F#:-I]$Z>P@"GR"$4X1RY+;IF6?)6]9CR1W=5HJW3U.1@TLF>;CY+L&=FSR[)G_3)[ M5MOL)#*^(H4JK0S:%,STV+[(MN#J1DGBF!M)SUQ"A"HSU18W,OR8BPX:L&<` M7/S7,*%);!`-EAW_56[Z3%0C#*KB3.Z+R2#S_2%;?X5,)G_!T/K0V-@-6TG MEQW_&/<=_:R^_A$XI]PR&WD")+LK1XRJ@S%Y=`I6O\]+*]24 M?1VDLO(BKO7K,`H8]$4#++*5^X7F+C6=!2+P?NO`8'RCJUPE!B`>39*,K@)G M-I_I#;@M&8@)\%MD\`TN-LI,=;++C[>O=V]O/H1%<#[[[E]'N)2P2Y-AQBX!??_4[`"GO!^>1Q8NQ$2*I"4' M&J]WH&A[FL4*$<6TP0?TN>8MT"DTXV*BN?+1U)WORI?N379YY$@^U-D7T16> M[!8L03?-_\KUZP?-,[$22^",1,X,H%8>\!87GICQ@KQR%9[E5WW-,ZV$9#R/ M[8X(ZZ^^GY?O>U$CW^5TM#7\.#UF['JBV,5L'FB95L@O_OU.V,$'QS+J,&-[ M/5%[&\G%!L<(7EA$73US-?J+G\92O7BN>_.=O<53FQ=]J?OSYA$E9%U_G:9^FNVO_\7\-JB M>UXP5>[HU/RC0EN.Y1)1?\WVA]L)>>7V5O)1BO`D'OOI[[>XO'Z'.;JD&;J+ M-B'JW213;MC(`H'*1S,PP>%@Q0.4CA(_1VEOR_Q_O[= M@\%*=;D4=_+<^_N$IUUM*1X4#!YXKJ*:_NWS.9C8O=4\==I*_RN;2Z]KC'MV4'HU4%_SLI5G+TB6M9MKK:YYRVI)W, MS3X_5.-N,QQH^8T^DUYG/.WMQ@BZUH?0@M""T(+0@M""T(+0(BT-_)`N@@R" M#((,@@R"C!8HS;K$%N6J]CQ]-^$I>GB!WC4_12^^ZG&OR6`R$B=N).@VZKB[ M:6"FZMRYY6)$2W*OL[(=9LB56G)@&TZK0E)UJ^ZG3$NS@O9>F) M$((0@A""$((0@A""$((0@A""$((0@A"""MQ*,ML#MIGV2YE=8)@BV"+ M8(MJ0@B]"+T(O0B]"+T(O5K*)4(O0B\*&8^OD.NRI7M/@%YZ8K-HNZXB]NM: MIO9@6L7GW+4NQWF!AJ@M"$!GH;;6C)S)FAIA!6'%^6!%NP-F@@R"#((,@@R" M#((,@HS3A0R*2(Z1MQ+?\YHP[`/^>G!_"C_R[Q6=6=9*,PS3?I1#ZDD^X2_> M2M/SOZ38VBLLWMN(#65?E+R?F*1])N@V6G,HE);SSMK)+XJOS[UEGNZ:*RQ+ M3`MT@ZFZAJ9N[UI>R:B=[AF.6*$[J*HA+_H;R?:ZY'YKQ%QGML_<\JD[-C5Y M>HX@3@?7F[HAD!.P%['BS: M!^Q'HRA/SM%95$32T8DJ(^O\[3+UUVQ__P\^,$.Y=TT]4W^PS1\5VG(LEXCZ M:[8_TU9N=-]\8EO)1RG"DWCLI[_?-/<;\SUE[K@[S-$ES="=`?;6U#5+N?/9 ML@(3B\SP,1EU]8$],2MVS]4?J_/S%`Y2.-@65E`XV`)J*!RD#E>IR*>[DN??WR5^PNJ%%E8=`LG&`N7KPF/N4.TIGHWS. M)R@$I!`P#Q\4`IYF"'C.MO#<^]LQ\B%G]M#] M_6X[&[NS%[^V<>H.[8`+K4SF.MXS=YUW7'O?X5O,6BF:#SXT?V%^! M"0P$1R=S`$6#BD5[O6BOU\GO]1H,.^IDNALC:+<7H06A!:$%H06A!:$%H45: M&NCH"8(,@@R"#(*,MBC-NL36WG-5NRX$7TI.Z[WC,J!&T0/79;;^@CL>GC47 MUY5MW]7T;'*K6`KI"JFV6IZ6I]:/Q*I3/Q>\W\M&R$Y MNM^$8H1BA&*$8N2`M5_2"+H(N@BZR`$[211;ER"ERK\V94F+[J&*/XD+J33/ M8_EL:>MRI><-SK3ZUO+5M\&P,YB.6VAXSF3AC=""T.*LT(**`0DM""T(+4XS M*44'@20A!"$$(00A!"$$(00A!"-$*U3ESO2"$((0@A$A^?2HU2+2CLYY,W`>N MOM`\ACLX/=-@KH:W;BLK[25WY&/[JI.H&K>4&R=3C7N\)883JL)5AYU)OXV5 M#9=2@$O`1$7H1>A%Z$7H1>)Z&7A%Z$7H1>%#2>BDJNRYCN/0EZ MZZ@F2"#((,@@R"#((,@@R#C="I+CY*[$][PV#/N`OQ[?H1>/IY#4^_+IBB:Z[[8MJ/BK9T`NA'\Y5;IK/E`W.5@=I1^CUU MJ#AS955960>4Z%9@0+_,@SG5?&9D'C0"IOB.\D6S?68K+K/X,_"-#T2\=98K MS7Z)#.?DM:=H^E^!Z9G\9>C_]^Z7KO+Q]D8HJH=O_L*@*\?:@$6""9/>_[Q6 M_O7N\]>[MS;@7I1G MS8-^@73-LEX4P_1T9"T,]P$8:&`#I8/VO&`)CX3O*,`]QJ]==1EH<0`_%4Y0 MX.$4^@O34SQMR=+O"_)D=PI,B>V;]PA3>AV66#^,V-B7,F),T+R:Z9KL+G1WP#TQ!+0^&$1;T'/CSU7YP]SXQNDU>" MQ$7E,%"\@9NS,0D-!O.9NP3A-M;3`(-_8#C^03A^,3I06Y>A5IMVL@$C<(4\ M,>6%::[";(,5S"%VI*U6KO.=LQ]FXH=>W(,"<`&]32"Z7#50/G`YA<^SY\,_2Y`.)$&'IUVV@$;,)SXD!S0` M)FLM_=VL*1&L3:;(6V(2#F8.7+;40+%@\ML0$AT<\55D,^!R65Z#O8< MP<3]ALWHVLKD)T1R\P(:\\P,`?]X)O,Z MRIVM=Y6K4!;ZO=?BJ>@+]?6/H,%/"`)^X.(;H'$)80:A2ZA*"H(#D`O7XN8O MNO*'$U(FA%[P\"?3?92S&`9"%"@#L],3LQT\NOKB1HV?6>,WW![F4+:3U"9N MN6.?\TDS+0XG"->>QHT=:O*2>R5@#;R%!BJ-[7XT=>>[\J5[TTU8_M@G^@%L M=IG==]G<`JU5=.;Z@&X*:DRP`OQRGL!103L.]@,=(:3)7(*1-]$1X/1`SPF4 MD.2`06.``49D98JP(AX)#D2SBT;K,1U,+1AH^`*?2!M3M3N)1A388*C!4X!. M'V$,7>4V8Z.33`9#::`M'D>OAQ`5DG`-)%RG2.@HH@,^+S:R`:AP@G$&TQ'0>$3A*URKJ`YT%D\4_G%<3YWG@_,5^80[O%7Y50J$9BFI04]!_"* M<-0:\F-:Q`_+\=!S#L=8:?&5M)'[8=H=)GDDF0%V1\$A@4FQK!#TN;M;*D'( M'@T-A+[H%/IC&=%.1DK">T]X?-A8D0N(O`]]590A7FH"K2\U]QOSI;,'QO(+ M8\I'!T18'2N13*JOB_%H)ZR(@(=;Q7Y!6!OR&&7HP;>$& M=Y1;TULYPN<7K/@$`W:5+SYZU(^F#D8\&GO*&OZ8^FOG/RJ*'5IB8EL6VP]" MX5SC[H5`]P'`\(&!U"6CO$R\6^)LX;>1DC;K>5GF-V:9"\68S]>X[0@D(,N@_?<"2_\CV`(RZ+&_`D&'9OP9>-@:ALXF#B,YU9K.6Y$Q#O8V+NAMM1+S MHBDSZ"01VJ_EX$V!*J=-IX9F.]25?(Y@RP0$S!)W?(H8U9V.@%&A^@OG!""' M:P$Z-N`@X*.)B1"DX#S]`+9YDN%0L)+(D59O35^8["GT?1+2S7TX]%`T]Y%) M>K6(8MWQ>+;`8`]^&IAB=P`I[RJ?"J0IXY4L31_I%_,.$LF]O%#E8W$MPQ[I M1\7RFQ'YTXL8]V[+0MXSGC9"K>,X[8*G@RDE`P3D"=@K;57Z%E]4T4^Z[_`) M19O'80S\(W#JN)IX*/!S[3TC!7#]B6^C[A;<$0Z.V9XF91.'W MHO0G3U(;CF5IKI="\=^_W*8`'$7SSH8P`UH(5HREG[[[^#GU-`K6RM)L-*EA M/H5GS0R1\4##?G-W_P$@;V'J"Y@O2[)FR4'=X/T]`]]@.`9C'*3KI?B$PYSG M*&\LTB+!&I]W,P^P2_CHFY@<$@B9C(0$I15V'A3%Q.PZ/,MYQ&GPBN>5KSK@ M9/XIS&J-20+N:*[&V"71T,%I\PU@*!][0. MAAW\%<29)?@D#PS&Y7$ID-Y0S+%0(&I.?S8:DQ&7AL%E#-?"`D."L.MQC2\Y1P&E.18K\LJ^R5I95SP'SIT+S[A/T;@A0`"^_G M-&M32U;@6')OP36=`)1'OA$*5K_7FZ&.8`*'A^Y\P]WGZA9]*0TA37A7_V#&(\Q`:N8ZRA5?*`.G3'EW]_6]TH/^ M9TWT?A/[U&@18V*4]^"'V3KFD>[`EKN!T&$P'NP[=_>%^WX/%M^6T<`7CLAH MFN"WPGG_]&PK7S!9ED)+T@T$]I]G5L5V_'Q*>T!@"W@B40, MS.#I4EG,]L&->Q3?`(W)U10_`A8D#[`<*67@E"M_!6"M&/K`KA,\+I1?,#UU M_45?.!:+5Y.YH0SI%4XQVFV^CAQE%$5"*TXIEB\*+I?`-)Y4[&2<^=#H!7Q_ MS+R,HT(V'&XVYAI7\.*("Y15KG9+(O,9OAPC-2^U^"G7)N&1<-&SHA:@PC1) MTX:JDI`JJP-"7!4E1_))-#.A8R.#;7`#8'M4@98HYB)J;6TWR("PF2 M@_\\1N'*3':&#D$4B$=>0-&;(>?Y@ATJK()+03P%`6$E6".>#7OA M+8`9Y?/BR'P]*+R>EUIU..2+B=`0A&<0;;GP+0\9@<8DD=S;$&3B=VDO6?GJ M@O%7;CGJ?&$K7V;#`#35V716Y@'SMW*)CG?_5-Z#3`&;/MRG\ASA#ZDW%MJ3 M'#X$Y3QWL8Z)A5CT#^>907PL0+X:J-%*:Q*(1&;H";P2H1E2-/GJ<#H(U^;H MZXBE.XPD'S$]"2Z!OU#6P%('5__02POSV!*M@8&E8"WT(^GLR(S7RXX8A>NH M&7>RGB/ZC#@-HBOS21!]@)A$JY<:+P+BA5Z)Y`=_1_JG$N*-W&)>?=I%[';SQ8[M#`A,2H@:'(PP:\B#+6":'-62:6(A1+K>2:.<=F+K MV.ANCC/991N\D%6&#\(P\$#:1&$^$42TN%%O$EG,#4YHC&#JW5R(0<$ MQ`^+#@LC";`RN*8&HB?CPQ>9^%J6Q>T\4A<..Z"YB+F$FY\.NQX"GTL,>6U'%%%@;#2Q@V!75N7;:@V+6+XR#^(EJIE[)"AQQ?A)D1ZSR3[BRN MN,BYY#)BBA,B/"-:Q#GTRS<:-`^U-)&!+1SC>\>RG.>HD#H.]M+!/I]FF>5. M!L:)N=/<&-_R<=AE*V^Z5![F(ZV'83Q;%$IG*V:T3(HAK@N`.(I90K`S(@JZ M%KFO\)]'GDU"&?NAWQWR-")\&!4K`9*.@3L'F"<'DQE\$!71?VJA$:0*BUIU MK'?*O;W.#17&+NJ>9S3XBOLJRD"5K&I6)#]D/93I?;N>XWI15)3-%W7#N8@Z MY>:S[F@U7(][C'(YKO2,^1H90JD7@/.2<(5QM9JC=W+!(!%TR/22(!E4!#$]]:'FBC&%9?Q/K/Y(2:'S"AT+HH7I7'LS6S$EA M1?JP;W[OL_')K`LL+H]`#R_8_=G:.T\/=1*C'H9@]3.,*1$N569D.K<@PN\@TCU2+7 M,*Q7GCO1"!R=NF;-)>CL3,"D[K M$'HOAGG6G=8TS6>?6!+?7_(!?/.XZD!4;X=%2UZP7&HNWV]EVKBE0BQM:P]. MX!>NP&J%YZ\,LJMGT>`N;0%M7^[1L#"#L?Y:&/G$UT_W!3\?'I7:>>G)KRC; MH`)?G>)5X%U`:5-;L>7U/W7G^6)C0C['O-CXR/':EA-<>.W:)OI]>DZ[[B#^ MAPSM;X27TSW#Y<7J4>0)2-#<'V"VY"*U'6UHVY6,0(M`Z^Q!ZUVXS^0>-_ON M-:%&J$6H=7K\)-1J(6K]XCC?E'_Q:N:K'WJ]7D%Y#@'7:2C:#JMJ&^:'3HXU MVR9(SGV@ZJFON35A4RH\M+8/GZY*(E4@52!5(%4@52!5.)MZWXRC?;F+IM'! M.GN,21L+"2XD8W"S5IJ=EZ,M=)ZLJ3J#>V_;53YYY/MO.[/!K#,> M5&H&V6]R92\('^A>;-S0H>9VKQ$D-*PK24XDIGLKJ#B]T1-2G`52##O3?LY[ M(*PX4/A/$?V>IR]UP.ZQHT<*ZBFH)U-\?$ZTW"2KG5$/`_M!E6:05::@_H+P M@5QU"NHIJ">D:!DG6HX8@\YDV*/@GM;V*1-`:_MM3`,$CUUU0FD`,MYDO`O2 M`.-1KS/MC4`FAG,<`FTT>9@C9E"C:8N9-!LR98L?D)"9?@+A4Z"9NQ M*N]&'))9-1J/G^YW>K-99S88I3B;8?/179#=)/5L194`[C2"G!:E0_)'3-7Q M/"E)Q&$GNV(DM@=QK)BN/C6(VDQ?`,XDW*7=1@T@%R%^<@ M2Y?B9!TODWK6SI4ZZTX&M^]^.P MPR^*7#B6P5R%R9M6T&A8>%4D_J:M5J[SW5QJ/K->E$FWKRQ-R\*+)IW`]WS- MQML?@5C@AO(L[Y?J*GAQY5MGN=+L%\5E.C.?H%5=\Q9X?:7.F,&OHDRW_<,T MT?@:CGLEDA-LFRB)=-_D*DO;%P\ M_?4_'^!QTP<2]<00LQCW!>?X^A<-!03GEMD>OW$T<^^B>.R!/Z8G'H,_/%\Q M/85Y/I]R$#-?>>23:\"?BG@%'L2IG6NFBU@7L$@001*,C@("Q_\,6P/I M\?)6_JOH#D:T`,,'I'O!PY],]T%S^)A=]E=@ND#6GX'QN&2V7S`&S>8,T)&W M3XX%%%NF_P*M:YQ5*08O3*#6-77-2CX*@S!]#^=M"<_Q\8A^HG8M0(=@EI>6`+[18\CU/,^.SX2?*PB5!BG#R%?!I`)K1'8+CF?F.R'?CI]^X7Z,MEFA>X MP'VF`\[X)N-`Y9F`2X`UO'68+S:?0W=)*/HKT%SX%7]\7ICZ(D&`ISP#Q4)J MF!0](W5+/$SNW((&A11&>"#G-KH;>_+:2['X.PHSLW6<#^@#,!O^G0=^X(8, MT43_D194L"DM3J&.>LCA.3.Q30_U%5]`&XXO"ST0POEDADH4OHJL`!GV0&Y! M6J7B>1W%G(/YUYGG:>X+_TO3_4"S4AT9)C#8%48`],->/FK;Z^0M`L#D'YMG^C:X[@8U2=^\`[,$\?V7?_5\0U=^(]OX6OO466(B+ M.YR9_.F7Z%G0%)C4[_YG-O_[*[W_QWN@6/VG9J,%^NH,5#!+^/'5FR/:EY:; ME11[,[8$15+3=2&4J&IZ]#`(\1RPPM91-L`/\1F"H@?-ZU9@,*'I8I*Y"M]\ MI>++,+<,P`]&HEG&UHSG"6*F,Y_!6%DP$\NP*9A:J!G('>Q1QI] MN@&MXY!T+:E4?-`*#V2::QZV]:!90";P$P`-K!QC@!^6R8%.H+^>Y$!LX0J' M%XX$!@)DX9UX3ZAK'Z`];.TJ!(L^D'9W_R'Z4WW]8Z)_3J,EF(@ZQANS%3=8 M,<9M$P=#`[BCN1GT!%AT`7->HC808ET.%87`*/1>`9P6UX_C=]QTPN?LP#WT M"$%:T#TOY'82HA;PN.U`IV"^GCAW(`+R%V"-79/?3AY9"OB)(_FFP''V/N%- M-"-5GC1_(.3Z,TZ2,NK]#]<:EWOQ("CN$DW!GP[P'%PM&U&\(P3U^HOOXG7U M'>7#A[?*%;:5D-%_\C?^)=[(&CPNM%=?P.A_=$!@U$DQ-S9"F\B8JIFPF M?[=3Z)0:6JJO[H]KA3M$*,]'U7H$5%J!?X$,9QHX%PL-7*B_`NZ[<<^))TL$ MW'@+S45U!<7C>@4/H9%R':L8P``C78SAK)=.:J8E>#(.AIP84#50)ZYITF(`?.P4?A]'0M27@^$B2O'Y:,!0>`C#"6W4H+XRV`1 M`-HYSSCX8<3@HJ0'MB'](ET3KF)",M\)TA'3-!==>*XK07J.4P*?$-N0/T7D MI!I((WLT9\6VYFLIQZ'!*&C'F=(>'M`EXUU@KL5P@\<06_E`(WQ)&8R/MSP@W@#CCXO[Q\=&PI^J"IC^(1F$)3N&LK MX."KM`/7^^/&^S2/W3;%8#HXG9;W]U?]5V]ZW5$OIG=K"MXHN='\[K%/\W>1 MSTU.YN7`:8*M0!'BUQ)G$N`/^6B`7E$T9IJ=;CA>XH=.%U&//9>_X*2^M MS!>-/=4B>@!_F!U("F1:QDLZAN*E9$[F1@2"P)[`XDF(P#+"4!`9`WX=5$!KZV`\UI&FVW5Y:"BR<$*6GT3:!DRE9C^:&`P( M41>O!!Y#0J+'YN9WGCV,G\@T"L\8#*30Y6K-O0E?^UZB/IU#;A\"'%R*-BA)E#X`P<]/G><_\3":Z2`2^^"=R\P$],N;QO-Z# M3+!Y=6QRVBZ]R9JMST+'/XL4+*5']F'))(^5!),SQBQ\(IT,?UZ`JPO(Z@6: MASEDQA...A=F"/7YJHHT0.R[Z:'D&PQ5PA6AM:/S2)]'[JB79CJ#X6*P"#\+ M:?-&0&7",QX6YT,$3PL3D@\@W?0 M>'"L#S%&](*^?W:<$-];,DUN>M]PB&#O)+DK5%,C!#4]\'S07Y=R`1E)O7"!*%<(^NA02Q84G@ZM[?&**[4*Q"<#I7VH&RR:6<:)%"(PO:M8+ M7]U!R#/^A/E#J4MGD>%]'A?+5!O`+&-BA:8.RJV%L0*//?_.6^"3.A9._/10%R:JXS2]`0\GN1?PKH8PE,"/%`^#@8OJU"GV,!_['X M'U[HS7;D:H=HK?CI:`F2B00K=)(!,$\L7DI!KV6(MQ.W`KE]JWD+>`O_P0P' M^#?HRI.8-KZJ@;4.*!?\0X+5!9%H**68&0(C#;*(J1QT`CT?3"K'.[DH;)G0 MDI'(Q'DB*@6LQN7*%Q&OX3KI$GI8>&B$+?3\A#L0N`#GTAH^,%&0P:TR?F`Q MD<690K\@-XQOPX=!)UO,T>_.HF(.?`B^F,2E(W/1Y0(7/Q^`ZL"5"QJ)_%&X M7H"!GL'CEV>NB3%3L%WQG?26D1<0=^\^?3PY8"8"5QZ$@(URY0)(&#RG9Q.? MVKUST8_MV-<5?:$Q]E:B0,!ZJ95@JZ/Z^4S;YXCALH&[6/@PO25)C-)J@6?4 MSZI=CUZ]Z<]Z^'])L*O38Z%1WI54-47J($?JI"E2O[K@]\#SGW"NY6*T]YE7 M2J&S+&:%<'AG70I9J\2\S2*PRSW0\#DW>DZ$&CS?94@/U02UQ)(1!KW^ER\R M\@1!:;;>UOP@7JHH6@V(0G.YCHD%$B)QR%=EP+O%C(KK@>OA)7(Z81&03*]% M&1[N=/`L@)/VW$5:!GXWF,@9%*1N\MZ]\@CH8J?]).Z'IU-#.<>^D"&W#+"4 M5PO*I61)@,R8P&_7@<!WO(Y$ M3G!R?L34\4*L.'V_8?4)=T:B%K-I\-)IWMR8U[(?N83=+2HVY@4#9GR*/"WR M_DG("H6LEKC$'J/VS?W^\]L8'D$\/PO4)`EK/+[,6"')Z(KHDI]KB'X&6G-I M,7&Y37N$<#%A'D.#!Y&4:PA+"J/R`GV!@@?1V`J)`T.(9SZLKF5,&:9!4ME` MQWW4;'"4(OOGX7)/V$%H_M&W6J%C(G+%\#)/),M=!"$!/)?+I-Y`4_QO4!Z/ M)>V_@>76'B[(HR,`!#XN$G9=KJ0^!"])_R/>:Y"LOHE+5[$6&^DV?6G"/99F M3E?Y-T;76M*#P#>\>(CPHF.'CF#V?;F^B\ZFJ/G&Q[74)(G4>C15`HO$TBA/ MZC\P_YD7]O%AX;,\?$V['!AI\RT5,9F1P\3?B0MB(J=YD-[]CZ?I_Q6P4$H*MF],_"E+*Q.$!WW_BPD+_$;EAA@U2.7ZI1,FI[8 M?8/K(=%J>Y+]T:_A=$:9*1CQ$\8BV65X6=V).4[Q22QM\EA#BJ[@`P0W`2Z; M2IU,RPH,^A_.,Q@Q-S5EV1*PQ/I$DFI<<`J0(KF`+`K6DDL*G$F"CMA4II:1 M:#DH8Z%^B^I3X@#.>4#<]B(`3XJ67)9_D;DXCG@:SU3*%9RX[$,N]S$>]DKI M+Y+MM"9@"LP+]QCD&^&[5HH4!"09"]^BI?%0MXLAH&@K"]9R/_%]-$ZXU4,6 M%(L:@W#D^!;W"?TLRJXDJE8QK*O429*#CB;E09K,EJZW`H M8JT#22SLEMN<9Q,3S98?9FT?F"@EY"-=9Z$J[%.B9EP#[,>-+KC:@3Z$4,," MVURX)PLA*QY2M+4$^6$EYXCW@>!O8(4CD_2*?2F(&=Z"%Q,],+[>V%4^H5@" M>8\.\A6(-;T,6S&Q(ZK:^1QDL%+L&HIWX(A<-)9:2DJ05W-XS1$U(\`N;">> M+&YGPDU#FA=N1@*>&J9PEZ`S^S&?`+AL6/HB-F)E:Y67&I;ZF';&-*,=D'F; MY')*T%ON.SS8!W MO!8IJD$H=Y'RCE#DG.2:"9TX6U3X2B2(=U)(%B1H[\@2[0<8?($6<1`3$I_8 M8P:,B[=V\<"2MUH"UZ'CDO2%^(J^K2-X1SB>;B/T.^+R@_`)`68Y;TJXV4A. MTM6.R;O.<:O"P>\V5T#)STR2X*U$NXI5BCA4=Z6'$&72(WW`[;JACX<5 M"2@U8FDAY7?))5H98&*P+S:&L^0#KUE\2:Q8`+DG]B(S M&W]"9S>1%."!"8\E^*M+#0$'-XQ&NWO`>AM15YS$I?8BJ]+YIF892$9C28Y9 M9G0320.Q(5M8G?2K8D(1?,$O%2,5[D).F)[XYH+02338DIMH#O_2;5RNF,^! M4UCO)PW<)%ECR0N;@@>8<#_PXT2#W*>.W8=&691LRL^I-;D5!-B1T\X;Y".I M!1E`3R+$2$AV)-`IMB3LE&!38"%<*L>$MU&5?C<]+^!;NWAS,N>, M!@(EE_\;@B&FPD'#^:X%Z0+JL8G&4JFW`J5#I#4:JWQE M82]JI9*#*&T(J)#LL"H=@H9FW"[`W\!1/Q7A&^F$W#8 M`;#DBP/@L`2(AM=(*8MWL$193)EHRO$;E]CDVMW$X"N;`YSM+@A6W?8*;043X*K+O6(*":9QH/21N\D8R M&_$N33_/RQIBTZ(02MVY7N4THY->FTG8Q]"JX'%2)KIDC\(95>;N(QFI3\U*AR*A#P98C]JD#@:=F,4$$,5M=4).(P_MZMK.()JPG( MLC1M64(.*R&+,_8B$:$4EE5UI,\F"PCD4G^\PA\?-<+1(>.:1@;F`4(L]A1+ MKBTWY9ABETZF@DGCWB7$,R*9_.57[ESA_VZB\E@.R)E3LM))C8*Q%(<*B*_% M>B)2;ASC]=AH9.7.L\J7;TF#Z7#`6'VS#=UO0IENBL@';;RK@'LO#B1>VEV)O`.ZWPT0!6GA# MY",],PKIDF6P2%@DUD55DD(30D=`BZL'PFQ#Z,=^LYUG.PTXT"A;9I*RFN4Y MX4%.7B3.U7C",__"4Q+GW24W/A<`G4@PX9$9LJH_JOA,+%TEUI["9?IPIA(, MDH4J\;/10G2<[99[G!,M)3D*Q#P?(92`[$`=Q\L*[$>F@)(-I_SM=C$ MP5/?%YKT,FSC)^``AYDY+Y[!9773U8,E(IW.`_)'C1\-DT[T79E=$*P'S?[F M!BM?A_C7Q(U//V96W^2RKMQR&I,E]GR"2[S>DUGCD:0"Y'N8F-N`_8H*E*^' MK*KY+W=E,M7_X_Y0EO_7Z#%3%O?%_.Z_W()N;D_GFFT4@TF2N)K]O4GGX6\, M`'_?Q,6AM[C/G%S`QI,+,878E]R4LV0\K:CVV M:8R^+B>970+D:%TC!"^-N3O28XZJT.0+^=HP67\4+CS@FK2;/A8O>8"H6[BU M7Q8:RQ1ZF%4&&X('W3WQIQU>&6C(RD118\Q#R"C&EXV$._?#'(49.AWAT8#I M8:8R%SQ@]5*%#;*"A1\GAEF#M+`G)RO:61<6*B:\"7E^J>V)",2TY5$$9KY" M)C['$X_8L0T>\[]U#+Y1AH\H=<+5E[>I`ZZ2>8AQ;W0]ZG4:V+\7:JYRK[W$ MFW3NPOE)[^.KDR=>`\OY/7MWX`J1+(Q?>R7X6'*O._Q'E_/R)0R266*R\\Q7$8';*G]E\G#]Q+=)?4T316 M5Q3ZK#TRZ"6Y"!M_^8RQOO!6Y9'B>.;?=SU16%BTYR^%*Q\__RM-\WL@:([I MS@5P[-%QC$2/5?5[<=%>IE(/[2(N=8<5>BO71`27967Q6K?#8W?DA2)YD5C. MEDD/68T3EC4^O'"O4Z13BDH%$ZNG!7%:5,G"JVZTYVAE3-9NA[FCN+UPMD(* M>03X$_!0\`WY@.>1>F4'DO+_#L*MY_VBE"[*:?(ZB'3U<*)FDPN)IV->`RG@ MT;G:[P["`+N#&]?5^"^YE7T8?Y/:5"-.+$YO"BKN31P*_D-?35QZP!L?):)[ MK3BYD-AUOV9+S_H_TC=CM"N!PM?(8HG3AZZY7F.+@[5C*IS M(Z8.$%H`6/LA.)A<3A?^%&WDYX<#L>O8\GYG.T"5VR9(+0 M=1[$VB`>4RT/>X??G:6I1X>$F04K=%JT/%%:5)TG7"Y\2VP(@3(ZSP0]+HZ7 M8M^Q<'%%GCG;0ERU@QV+1!`.RW<1TGGVP5RNF&$NP^6?L(D"S(G3Q=R'73!K M+BXF2&^FR%,6_X2A!TJ-R`.%716I1@L5(WW/S6'=D<82IP7'B>1,(TBZL*%: ME$OD")TX7"11V/LY6IJX35FB1/TZVM"2E;M8A1/V%&(QBT=K65H'!1G>]`DH M:K<7$G'Q/1SQ`PW(4:N7GO@^^EXELIM M7!SY62I_(W,U2R9**_M[TP1AM:=.S-PFA,5L#0\ZO>$G!;W'2U/8!\SBT$DR MIQ&V1R?5BAG,!.]WV9-LA0ODX=X$D"#7M/A:-T::N*(, M?W&;#H]A.\GM7(GJWKEPQC33%:ZI:5^';IPKI5((!F=OHU` MX_&_">'AG$OZM66*Y;8TEU+CBP>D^/*^*;&-#$-4BX71L_8`(W/LI2QWD/81 M&^F$.4SN/\)\,ML315_\]%1>C('ICN2Q,+R"5SX@&,37^Z,@0QYKN<23L/\; MKCIRG_AQX5]S_Y1O3HNN<#+=U/'%$`#BB/&<7TS6XA[S*_5'<9V'W,0'$?[5 MH">^*UU?#):!\*(D*5I4L/;#M)^-4`>S."(N$FH4E8GTWH3QWL>XP7< M85UW<@M#O-,I<96<*%))E*7@67ESRWDNGK^[U(J'2)=[47TDO__#$R&5RW#3 M`>XD^^XS64`2QDU(8*)3/V:^A^E?:%%Y4R+[H<)I9YS;8# M7A2/N5]%YT8R/?%/T4?>9;#M>2@U'E$MSB8?7AS?G1&>,[ZF96[VU$@?;&O([<.D+]KH"-*!?&ZN`Z_C2RF M4&P6YZ8L:::BK9J5.-;^U--><>9M#!.1=B6N#O&?G6KC+I+K>!LF/XS+4ZYX M$9D3>)BP_/'G++?7L]L7Q57,LE9H6.U'.>*>Y!C^XJTT/?]+ZEKN7J_H8NZ- M;L@N^Z+D_:0%RETT[F:RB=$/53>])RF_O[F]O?OX:W2G>*\[6J6-7J;U(UT: MGA]B=&=XT:7F-'XLV`-Y#AG0EV.OQY7"B^;5KKKR%7ZT79E,AMU78ENO.6C3 M^9EHU=.UYPD+/:JJZ4H#4]%\K9M,VWEVM94D7?S1Z(2^5O@4W7RX^_7CSTK^ M=OO3T@'QDUN&F2FBL1H,#\*SC6O0&,?]6?D_;]^^>_?^_>O"Y9K$G!3;V(H) M21J266A'JCA\*#7*SO>!52AK_?ME9WDUIT_)T?/##C::/+7&W+57.VI8R*+! MYB6Q%"T.RY`?2E((33-BLHX1"4$J-0)[X\*@WU%'LYU9L8VAV45:3DMUUAB6 MYFS%\5VK(]N$&_VOP/3$H0XM-`>9A.!I2._:X6X8,E1.QZ'D-`NZ!Y=4,2VS MX:2?RP&U+@QHD]D^4R__XI'[+LJ@YH&;<)MPFW";3H_XM;V1#GV?O.=S>1G+B33OP-3+BLOW$3"9S..Y:W<@7EVU>\, M^M-VIH5V%;[#E`;:?9 MH=4(LA67L4I!9J*U9J(5L4Q[S,6XUYFI67M!!H-63"[!BM"*":V8T(I)>N)H MQ80<_19!]*WIK1QR]-OGUY*C?U*._I6J=H:C(3GZM-1`Z_"T#D_K\+0.?R'K M\",U9_5:8_=H(?[HA6'B)!E^`@T_"B8\\,U?R-M%\<(;O/WJ4=R84'$-3?[@N.@BUGSK^6+-AXUN;8E8SWN:L(>1'/VAU&.VE2DYN+3D8O]KZK MZ("G!!$M4I;#:P)APE$XT7)L4/O=RETM!`W[RU8U MF(!JP=K&L;--=_;URG7X==@N\YCFZ@MYV_83LYP5O_/Z*MSGTN^]OKO_S/_" M_]U&WZL%'N,QLU,%JR`MEO@-ES'/(B>]PYC7'7FVUU'W![W.9'I@K_",W0%2 M;5+MEJAVM)NSX"1#4G%2<5+QDU=QLMX'FOY3E>?&ZMI;$%K6*YO;7RWS3S=* M9%+5U\J=;;"Y:9L^4RSS*;/9II!11ZL+.@\M79=(H;*?-B5BOKJ:P9::^\TK MMTY4Y$,I>$K!RQ3\N-/K]0X?J%U*&IY0@U#C_%#C2NU,^KDKA0@UXNZH](?0 M@M!"^AC#3G\R([1HB;10%1#!0ZO@8=H=9[E`T-",I*Q+7E$^:L_3]S;P@$/, M55PF[A3Q%N8JMPF-LE-D&D[8-!0J<[(!N0.X&?TNR.?N>TKVV?BX,^Q/4E.= MF?NK_;:^J`SF/4KL(NP*>R.\H&$281)(6KT!J.= MV'#>6$'90`*'BP4'5>WFRA$(&IJ1E'790"IE:U/J\)._8&[B/BS*&I():0"1X/&BX'$\S2X) M$V2U4]*V@ZC+8L=%"D:]Q.]KI4WF3,U=<7!TV+F0;'!3U8Q-YHC5'&J=#K\/ MZ8#F^'1Z7&K:+^AW)\`3Q7""!XNM\0P.R:[C77*U*9L*E@4/:@DZO>&H,\IL MF-N078?S0S>2MQ/43T(Q0C%"L2W*)/N=_F!P"LF_UB)8^Q.`A%R$7.>&7+/Q MH#,8S0BY3EHWUT?4%\4.R@-ND`<\`ZM&"<%R)I4E!,7W&D!IN&S]X/X4?JPL MR52G!ZG)W(*G7SE//P)//Z\[@7"AV8_PK&DG]A(KFNPFR#&RG&=/N8(F_843>)IM M>#_^7)S6X-_*>JH,Z_F4*#JSK)5F&$"'''E/<@]_\5::GO\E)=&]PLSK1A)8 M]D7)^\40(K+.6R62+W8M_LP'7GP/5CUVK%L<7NL$7L@%6?>N8P2ZKU@F$.(A MFG'KGZLV/WJA)Y68$`(0`NQAJM*7J5?-%FD]:3UI_7EH_0%N^B-])WTG?6^) MOA_\)@72?M)^TOZ6:/\A#T,DQ2?%)\5OB>(?_"@)TOY65=_O='#+D,X2%CUF M%_,J:Y!W5"`ZZ^_$:SF.5U'6GD.\QH/.>$1G")]*&3ZA!:'%$=%"2,.TK_;S MXD"009!!D$&0D>'!M#.;Y+QPP@K""L(*PHH,#T:=T71*6$%805A!6$&A2(N4 MAB"#(./D(:/?42@@Z"#H(.@@Z"#H(.B@/687LL?L9NFXOOE??C8#+;21&6D%)UIN1JY& MG4E_0!:DG$.MN"N!T(+0H@5H04XGQ:OM4AB"CA.!CJN!.JYRRB\;, M%\!2O,@>]]I??4_S\X)7RMX[+@-J%#UP76;K+XKO:K9G%:Z#7JU8B"74(M2Z+-0BYZM50DV,1[D=G(05A!6$%805&1X,.^,!W1=(6$%805A! MH4B;E(8@@R#CY"%#[0Q4NB]P7]JR;I6,%K[V/'UT82"9@M9QHAF34*C"R09D MB4$S6IU;`-O_E.RS\?%XVAF.TF4CE3._(T"0D:S!)$)10M&S<:S[@UYG,LUD M[@@R"#((,@@R2IR2SBA;>I^W6 M]%8.;:5K`_R1(3@50[#7UH>]SF"2WF&283D9'7)/"94(E6AMC=;6VJPP!!T$ M'00=!!T$'00=!!T$'00=!!T$'00=K548@@Z"#H*.]->GLG,M14WVALQ>=Y0Z M\NZ"%_S>.RX#:A0]<%UFZR^*[VJV9Q7N>&O?"N"NL]Q256O"3M$UJ.=X#6J[ M+=WIW(?:*B^:4(Q0C%",4(Q0K,U<(A0C%",4:Z_0$8H1BA&*;7ZV:-M.:B'@ M(N`BX"+@(O?KI(2.4(Q0C%!LB],I^ADN$72=^R;32I!3:6TZ[/&6Z6SYP%QE MH':4?D_-'>)R6NO1-6;V/#"Y/JKTNQ/@B6(XP8/%UN#*(=EUO$N#-V530>'5 M(1DUZ0T[?;5M%Z#M+FLGJ)N$8(1@A&!G@['R/N"O!_>G\&/E>K`Z/OV8\FL$C1/(_YGC)W7(5I M^@(?\Z&)N6-9SK-I/RIS\XDI+TQS/1`_RU(>\!WYNZ=9AO>CS^7 MS&-RN3DS(7RB%)U9UDHS#.A0\J,G>8J_>"M-S_^24H9>8<'`1G)9]D7)^V7& M+%$8D5>E2GSO$P&V>HC,B\4XI`M MVM(69>^U)UM$MJ@M#&F]+1I4[J\`/&]:9L^^V`^,>/>L4S]Y8UHY6_A"XD',N_^[K%Y8'TPYTS1@6SV MW?_,YG]_I0_&?[R'8:O_U&P\$.>K,U!OF8X?__@-&EL&R]]X`=:K-_?J?V+* MZG3T)AS]+N1-RLG3OJ?(&_2VH:\N@=Z-K@?+P-)\9J0J>`)X@],:>,:K-/'J M'S?>IWE(\>"58C#=7&J6]_=7UZ-7;P8SM8?_5X?JLNX+QG#O.BOF^B_WEF;[ M-[;Q[J_`7"V9[0N1^0KD_8+6/$UKOXS/K]Z4.@_[KPC>0IOK%P$7-BZ>_OJ? M#_"XZ0-E>F)DHL.XA9#5'84S6]%L0XG8G2GSC9]=1<^R\%G%](`*G%Q%\V%B M/+\#0.=YBA9/.TC/R@4!XO/>56X3?^'K*]=Y,@UX+/"P(!G+DSW?U="D7"/5 MRI+Y"P>KFK'R.;!]#P7`@U>PUMD+YG-3-Y$4WPE+HQEO!:D)"YYE'30\@H/A M?7N*\\1<_-5T%>8!F')B`ZYFB@6R#$^X,!K-@_:8N_0RM(>EU\^:I_R@#KLC M96E:%OS247Z8=-7P+\ZP'X;=O0I5QN.->%BW!`70-.ZMD+)$$/RD/>FK5L!=O]L^@M@L%$P MOJ[R-54Q+DJZP[)R?R'X"ZS4'EDI'\4LO'66*\U^B) M/F[Y]LDH0BJZ4O)@OWFJKZ#?S7-]Y?'RQ:#_+X%IHT^_ MG2LG6G[7]*!7GDS:AV&@ZZ5W//^+,@SO`](W^\P">);#O%M/,KS0B">`H!CV0,L5@A\ MYBH+S36>-1D(>,[4*OGMFB.Q88"MK+)//>HH3 M^)ZO\>--N\JM:07X:/W6L2PSUX,=\%)49U[>5T?6CH8ENP;VC&<)L_F`95NP6%.6& M];/*9##J@*IWE-F$?^!/C*8J_RPH2!?PXE^B.)J7)'/.=!1P+%T`;?A4SJ1N M2E3S?TB_,T:=-<"2-0/(O9!Y7Z)>WTGV(>R\C1GW:9YM_8:7:,?X*0:_C0FY M^_@>('PP2D%H(]05[#TXQ*AKV2T^:I"BLQEU+7/)1PWZ1F;*G_R\2>%1].ZCA.$D`SH*G8H1%LU.`!:IO9@6J;_(N&^$.UO MV9RYXM3[L(-PUT.R#5/V:C#_DZKI!)8AY%MGN%V2TPTO"]2#SRO-Y-KH M@R?H@3[!(&,<-.V*?52@=>8*F(R,P*UOFO$$SB3X\TX`JJ:YW[AGBYV!1C,7 M=0[[`"Q!3H3`)Q]<:8!YV![NMY-Q@H0BON_/`-R1.\-B/BQ,P#M77[PD9HEO MW$MS\)'9\)QE(;KP*TL$^\#XD>+ABN<$+B*V"49RA?L%[6AC8S(C M%%LJPNX(KV`/'B7KC8B=@H MC$4!,_'%!Y!":`PT;"D-UY-F6I(7(@8T73U88DRK9R.K!&>35@<_M^#"H602 M<&]V`+4[MOJQ#YX=SFH40Y>!&<0S>,`3WK38\>NG$2@!48(40=8Z$H1&>KIK/J`0@3`]9_>9TC;3 MJG4+WUD5#&:<64T\G:3[)J,PQO-Y?X4PQ%M:9GDE6"H\W/4<_.&AG MQ_X#!V4U'92%YK\O-DOG`V]$7_#+-`,7]9G14;`]`%KN&'OP*'Z+\*_Q]&CH M'K#O.@2%CV"9(7#@ODLEX',4S_D['<4+P!4'%SW=J9GI35R29Z)O!<;%"@/7 MA-N!R5=AWC!D1^_D*8QPBISR,3A#NN8M1`""']#9A5>$<^2RY#$6DJ^RUXPG MLKL:U5M#/$.#1O9L\U&2/2-[=EGVK%]FSVJ;G41:6>1II95!FX*I'ML7Z19< M@2S)3G,CZ9E+B%!E.MSB1H8?/=1!`_8,@(O_&B8TB0VBP;+CO\I-GXEJA$%5 MG"Y^,1F$VWK@/C$9E&?,)S_/"5=_H6EI.GDSP`!I!Z69KK2"F!*0R6V>5W7! MZ'*&+ICQ")T\:J8-=$E#CU892,($MS[3%[;Y5\#D`@`86A\:`ZMI.ZET-OL.$:@7GIZ2P0@?=;!P;C&UWE*C$`\6B29'05.+/Y3&_`;3^PD#Z'&L#112J-NG]SVOE7^\^?[U[>_,AK$S&E>;K")<2 M=FDRS-@EH.^?FAW@E/?#,R+#A9A(D;3D0./U#A1M3[-8(:*8-OB`/M>\!3J% M9ESP-U<^FKKS7?G2O[ M7EA$73US-?J+G\9:O7BN>=%>_.=O<53FQ=]J?OSYA$E9%U_G:9^FNVO_\7\-JB>UXP5>[HU/RC M0EN.Y1)1?\WVA_L)>>7V5O)1BO`D'OOI[[>XO'Z'.;JD&;J+-B'_T5J&Q>[ MIXZ[2-^O=FEU[7&/;\L.1JL*_G=2K.3H$W=E;77?VCEM23N9Z]9^J,;=9CC0 M\FO6)KW.>-K;C1%TUQJA!:$%H06A!:$%H06A15H:^"%=!!D$&009!!D$&2U0 MFG6)+M>D\%D)$[<2!R4$RTW%M/.8*;NQ`:R M$H09A!F7A!GD8!)TM$MA"#H(.@@Z"#H(.LX7.BA2.68^JUV%6I6[(.H8U8:]:7E\:=W:\]9G-6)0W=8>L$)EU M>I.\J3N^K=M-S$Y0)0FY"+D(NRGU;?>!JR\TCRFZ8WNFP5P-;^!6 M5MI+[OC'$ZMH._Q9SFTR4K0Z<4ZK$Y/.6!VTS[)=RNH$P1;!%L$6U800>A%Z M$7H1>A%Z$7JUE$N$7H1>%#(>7R'794OWG@"]],1FT79=1>S7M4SMP;2*S[EK M78[S`@U16Q"`SD)MK1DYDS4UP@K"BO/!BG8'S`09!!D$&009!!D$&009IPL9 M%)$<(V\EON53=VQJ\O0<09P.KNUEGI$%8HEO3=T4S`G8"]CQ8M`_8CT91GIRC MLZB(I*,354;6^=MEZJ_9_OX??&"&J;^8)L_*K3E6"X1]==L?Z:MW.B^ M^<2VDH]2A"?QV$]_OVGN-^9[RMQQ=YBC2YJA.P/LK:EKEG+GLV4%)A:9X6,R MZNH#>V)6[)ZK/U;GYRD4SD;YG$N:GSM[%?AK M(L!6AX!]"@';'?=0"$@A8!X^*`0\S1#PG&WAN?>W8^1#SNRA^_O==C9V9R]^ M;>/4'=H!.;2M].+$UZ=R'&\9N\^[KCWN\:WF+13-!I\;/["_`A,8"(Y.Y@"* M!A6+]GK17J^3W^LU&';4R70W1M!N+T(+0@M""T(+0@M""T*+M#30T1,$&009 M!!D$&6U1FG6)K;WGJG9="+Z4G-9[QV5`C:('KLML_05W/#QK+JXKV[ZKZ=GD M5K$4TA52;;4\+4^M'XE5IWXN>+^7C9"/;K@NY4QP@BZ"+H*N0QW<'JF MP5P-;]U65MI+[LC']E4G435N*3=.IAKW>$L,)U2%JPX[DWX;*QLNI0"7@(N` MBX#KW!9/";T(O0B]"+T(O4Y"+PF]"+T(O2AH/!657)\P)-45L0@"J@6VQ(SF1EC=""T.)\T*+=03-!!D$& M009!!D$&009!QNE"!L4DQ\E=B>]Y;1CV`7\]N#^%'ROS2NKT((FE+7CZE?/T M(_#T\QJ>?ETP1==<]\6T'Q5MZ030C^8KMTQGRP?F*@.UH_1[ZE!QYLJJLK(. M*-&MP(!^F0=SJOG,R#QH!$SQ'>6+9OO,5EQF\6?@&Q^(>.LL5YK]$AG.R6M/ MT?2_`M,S^.M0&+!!,FO?]YK?SKW>>O=V]O M/H3"[;/O_K7OK'(2-QEF)`[H^:=F!YK[HO0%?[H*XQ?N^HRT.(`?BJX4F!+;-^X0IO0K//3F#A_:X!S+()7^J:I0=BGHKI M@CD`F;`?F?+`_&?&Q+B2$V>$Y.=(%D1IAL$?U*R,N.`-'#`D(`XX&`I9+#]I M#L_A9?BI%_T4S866&14(F]KOCO\GS;85<^>.BSS@ M$\&I]/!9'/)<,UV%SX_X!J8AEH;""8MZ#WQXZK\X>YX9W2:O!(F+RF&@>`,W M9V,2&@SF,W<)PFVLIP$&_\!P_(-P_&)TH+8N0ZTV[60#1N`*>6+*"]-`">N7:KCNNP<4(9,Z^YE<(FS`K+LR2O`WQ/68&0Z.:*JR"?`Y/+]!SL.8*)^PV;T;65 MR4^(Y.8%-.:9&0+^N80)_'_W]C,7[W]KO@=]?-`>'.C.<4WF=90[6^\J5Z$L M]'NOQ5/1%^KK'T&#GQ`$_,#%-T#C$L(,0I=0E10$!R`7KL7-7W3E#R>D3`B] MX.%/IOLH9S$,A"A0!F:G)V8[>'3UQ8T:/[/&;[@]S*%L)ZE-W'+'/N>39EH< M3A"N/8T;.]3D)?=*P!IX"PU4&MO]:.K.=^5+]Z:;L/RQ3_0#V.PRN^^RN05: MJ^C,]0'=%-288`7XY3R!HX)V'.P'.D)(D[D$(V^B(\#I@9X3*"')`8/&``., MR,H4844\$AR(9A>-UF,ZF%HPT/`%/I$VIFIW$HTHL,%0@Z<`G3["&+K*;<9& M)YD,AM)`6SR.7@\A*B3A&DBX3I'0440'?%YL9`-0X0*;>7\=#HO2B3>8CH+" M)PA;Y5Q!*;RB^-\[CP?F*_,(=SCK\JI5"(P34L+>@[@%>&H->3'M(@? MEN.AYQR.L=+B*VDC]\.T.TSR2#(#[(Z"0P*38EDAZ'-WMU2"D#T:&@A]T2GT MQS*BG8R4A/>>\/BPL2(7$'D?^JHH0[S4!%I?:NXWYDMG#XSE%\:4CPZ(L#I6 M(IE47Q?CN=#GK__Y``J-IMK4$]9%0$*LX[\@K0SX#3/T8-K"#>XHMZ:W

#3VE#7\,?77SG]4%#NTQ,2V++8?A,*YQMT+@>X# M@.$#`ZE+1GF9>+?$V<)O(R5MUO.RS&_,,A>.8Q3X8B4C@U$X2^[HRB'6R$DX M#S"QXG5X"EXL#V!#AF72&!Y#2R0B:@9#YD#XCV[,UYN?OJ2#I[FM4)^G'.+,=^O,9I02`'70;ON1-.`MA,!Q`0'TL;4S"5'MHT M`6UQ%&T7)PE*R2KE''#I!W441^J=TF1`Q+0"?H#;49J&P50`,&Q0+Q?0Z_;^ M1[`%9-!C?P6"#LWX,_"P-0R=31Q&_#0PQ>X`4MY5/A5(4\8K69H^TB_F'222>WFARL?B6H8]TH^*Y3[=EH6\9SQMA%K'<=H%3P=32@8(R!.P5]JJ]"V^J**?=-_A$XHVC\,8^$?@ MU'$U\5#@Y]J3(QKP77`?/9Z0@KE^Q+;0]PMO"89&;<\2,XG"[T7I3YZD-AS+ MTEPOA>*_?[E-`3B*YIT-80:T$*P82S]]]_%SZFD4K)6EV6A2PWP*SYH9(N.! MAOWF[OX#0-["U!P:^P7`,QCA(UTOQ"86*1%@C4^ M[V8>8)?PT3->/FK;Z^3V,_%\X\$_S M]V`?;!W\CSN`&#?@3=]#=_K+FXA9?].^N=]_#N.J1%AU$SE(;Y/&XQ,F4`-P M:SZS^=]?!9[QBD\O^RZ^T`?3/VZ\3_.!"@Q&MOXAEDQ^X\Q^A;$[1)V6]_=7 MUZ-7;X:C'O[?WW[:@H@WZ1&\C:Q>^DG7?$0K^2ER/3_-PU,Z4@\V-Z9>]\?S(U[%7P_X\,21_`#;,&)7,SV$G>4M-P)Q>0WLGUHRKZU5JY1I^Q5P_H/C>9_L>H3VR[B>(V^2H:ZZSPSR1$.99X?R!?.@31`X3HIM M=7_E[-L/ZZ:EK,NS;2_8,.#2V.\+`M4__A&&-3=?2H1QU-O1ZB0&$@+Y9[G& M+"WOQB9FBV&H*3#;A)`W!0-((OGO7I+G!:9D..3R$5'[U:E)N#`H.:*SG>=L M.WB[NK"2GP#)P*#^HD%`HK//(FGVU?G@V(]?(7R.#6HEM[>E7S!^G+;P6Q#7 MH%G?;2YZLUY-XYY7WAN><,+A?&9/N/A>G^91$E\&,;X,JDD>6G:E'^Z2QLY6-7^5]MY3AN1[E?=&^[,H^R@-F'`89IF:+\UR\.IKBPCL)$ M('(PD8C/)M*#HF4E'$DR55BZVA*.;:$9BFYIGBD)3K'"X!B*C2)3>?'FK3-71];!W#?\==!K(Y22U%--PJ#,P`ZF9ZRA7O"[3 MM5Z4=W=?WRL]Z'_61.\W\1(.)F!C8I0HK:,D\CJ8JV3?^>J26"VZ=WP4$;[X M](4G`#$3"K\5SONG9UOY@K41Z>5QS'V:7C1E>KQXM]0,)J9'IA&E4+D,3+$K MDHW1^HNL6Q%EH%*^^?(*4.SJ8+##MS.RA8^[[!%,.T^ZBV;"-+/.DYBVX^-3 MVH/G6`&O6\%U0'BZ5!:S??!<%\HO6!%Q_45?.!:+"YAY;C:D6=@[3!7STN6HB$744,15+.5UJ,LE,([7 ML70RZT=AGC7@1S+,R[@JY,/AF)$/%%866$LB\T4E.69J7JK>5I;# MPB-AG6U%^7E%-E1F4Y&3T=+V:@4:Q%=,X$?3,7++5I>^#>T%.F5+3`2-TN1*,?'/C,^&_@!E5&&LY_%5HB;1Y<)?<]:BK") MZ(G4LI+0B*5C"%L0UC:).HV-JR&'*HC&'Q:BS8;(1*?R##=Z-PNJ+/!8)=6 MDXN3*0G\$HXEMUZ9F&JQEA*!IK!*8J$JLD6XBH^<3U.90!CID2A:.&W>9D.0 MA2U.+)SQ4GV`;AY,H%BMX^5M6*H3@'84CU9!O\`2UDAS+9/QTH*?E2OS1_XE MW_9B.PD&I$W8.KN"=@WL!YK22'8>XEI-7A9_928[0Z<@6ON-/(&B-T/.\QI1 M5%@%JP_YJC=$?YHNBJ->>`M@1OF\.+)$#!1>STNM.ASR^E5H:&E:FJNX\"U? MI00:DT1RCT.0B=^E/67EJPL.@'++4><+6_FR``-`4YU-9V5>,'\KM[;^[I_* M>Y`I8-.'^]32>OA#ZHV%]B2'+X+?]4PLQ*)_.,\,XE0!\M5`C59:DT`DBA&> MP"L1FB%%DQW$UK'1!C!%?9*W%LBQVY]&Z<-@! MS47<)=S\=.CU$/AM^LYEBA&^X!Y'7$X%U&GW'S6':V&RP2/42['E9XQ+\M$*/4"<%X2KC`6 M2'/T3M:H)8(.F5X2)(.*X-YY0WDQ&2_>F\M2_@2/D6S7Y*6$&B:VP$K#OU)S MQ9C"G>-/K/Y(2:'S"AT+HH.PL"(@F)R2U$Y.SRP'I^ M"S]4AQE?X./71F>FE'U1\GYR;U+V2-]6 M7((VFNYR_N_U;*VHS_*B/NKV1AONYDI2M+=3<-[E34'UH4$['OA;\X3FR[@^ M<[)NF(6"*,^7T7EZ5YX%WLSAU$7ZL&]^[[/QR:P++"Z/0`\OV/W9_U0I^UKP M:?#P<2$_QYOX$D7;?4K*CN;:]['R9%8*S`KWVZ_`D\*-&MZ/+;(M+3VX+]:+ M03=[?M\13C$LMS(;6I5C<)&?45`M<@W#>N51AXUP<3,GH:S;'5V$0\/)L*M6 MNF/[,104K+3,JGPNSO'L030H7FDN7CE#WW6?C:O=:57,TKJ0);XYB+SS$\'1 MVU3BN44^^87@YY&\;46AJS@M`ZA]V*89]UI3=-\]HDE\?TEG_D^CZL. M1/5V6+3D!9W.-FW[TFU`BU"+5.CY^$6BU$K5\A:#NLJFV8'SHYUFR;(#GW@:JGON;6A$VI\-#:/GRZG9=4 M@52!5(%4@52!5.%LZGTSCO;E+II&!^OL,29M+"2XD(S!S&)I=EZ. MMM!YLJ9J7XA\KIQ86SYYW)U;:FXT@H6%=27(B,=U;0<7IC9Z0XBR08MB9]G/>`V'%@<)_BNCW/'VI`W:/'3U2 M4$]!/9GBXW.BY299[8QZ&-@/JC2#K#(%]1>$#^2J4U!/03TA1.RJ$TH#D/$FXUV0!AB/>IUI;TP^?RO$A?#A^/A` M:0">!B!(H#0`(45[.-%RQ!AVU/Z$T@#GNL:?XDEVHW]_];TRZKZD%$`[BP$V MF3[*%+0I4[#!S)T,FC7!BLU/2+@$=ZG02=B,57DWXI#,JM%X_'2_TYO-.K/! M*,79#)N/[H+L)JEG*ZH$<*<1Y+0H'9(_8JJ.YTE)DA,,>!I.DNP1) M'0*1SM:3&G7ZHW011^N`[5+7>I_D)UNY6;FF!5_SNQ^''7Y1Y,*Q#.8J3-ZT@D;#PJLB M\3=MM7*=[^92\YGUHDRZ?65I6A9>-.D$ON=K-M[^",0"-Y1G>;]45\&+*]\Z MRY5FOR@NTYGY!*WJFK?`ZRMUQ@Q^%66Z[1^FB<;G(!Z\?]EF1)QB!"Z_#!-^ M>V$:4&T;T';V5LMA-Z^,LECB;S]IW]SO/X>78=T[EJF_?&7?_5]P2M^(J?@; M?^:]9KK\$H=/\_#Q3X!+IJU9XFZ'P#;]SVS^]U>!9[Q2=.@-VN%?Z,/)'S?> MIWE_^L_`!H)ZKQ2#Z3!6R_O[J^O1JS?J9-;#_Y/DK.OJ32@DI93][@%??D&E M_J+#C#(/?^=W@O[F&,SZS;3-9;",2?86FLN\#:B^^_C^U9M^=S@K)[D>#;N/ M1?N>'@NP_YZY&X^HC^,954Q!/3K>I(83OOONNR[U:>ZX;U'VJZ1ERJE4>Z"? M*+Y_B!JNL*W?N'!G16C23TI0:;]O(H#Y6^!=/VK:ZN=[J87O0^$]2UXE MF;,_\!554OG5V8S@:4AP'3K>9&C^@K/[BP;C0F1AML?GX=,*_WMC&W9W'VO0]G?LCRFNAI;]17&> MP!#@XT_8*QB+%7--QTB;I0!%'1_BZGTM]5M9HEXKH#DAQ:&Q2="<)E/8/H?+ M(9B^6^8S=PE`)]_3/"]8BA\5WU$>&/:,5S;S7T5W,*(%N+M`NA<\_,ET%&,^ M9I?]%9B`:M^NYRZ\8&)1)CR/4\SX[/A)\K")4&*"'@8O'68+S:? M0W=)!^2O0'/A5_SQ>6'JBP0!GO(,%`NI85+T`&%,`_P5Y<5D%D[NW((&A11& M#J"<6^'^3OOJY+678O%W%&8&8(>2_\S`4X-_YX$?N"%#--%_I`45;$J+4ZBC M'G)XSDQLTT-]Q1?0<\>7A1X(X7PR0R4*7T56@`Q[(+<@K5+QO(YBSL'IUYGG M:>X+_TO3_4"S4AT9)C#8%:X?Z(]OXG!#DJK\N1TLQ)N<:00@8$9@@1/PJ^,8 MS^"/1K[A1N;D+*Y(+PA.W9+,K`*I1-%_6KT^)-Z%.3.VU/33OVOKQ[8(9D5U'V MQ8B-]]L>E`N#?D<=97>I'<;0["(MIZ4Z:PQ+<[;B^*[5D6W"C?Y78'HF#YY; M:`X*"UG:+KUKA[MAR%`Y'8>2TW4U]0>:EMEPTJ]>&VU"3G<-`]IDML_4R[]X MY+Y;KC33Q?3XNE,/";<;&B[A-N'VZ8CSP9SHXH1+$^G?"X'R]X[+@!A%#UR7 MV?J+XKN:[5E\(6>_^3Z;_>'LHSYMC>]GQ>V">7?4[@_ZTG6FA787O ML)S\<5LFMC-.H=6(FJL1N0N16A#&T&I$:]UC6HW`WOJSSG20O3>H)6:'5B/( M5ES&*@69B=::B5;$,NTQ%^->9U9]SQP9#%HQ.5,K0BLFM&)"*R;IB:,5$W+T M6P31MZ:WJSDE8NIIS?#:XO8]S[RYG+7_G(QH/NX(SF78F MD[8&=KL>MGA::EIBY\37X6F+B8-:RL]8><-?CTYC"7^O.I1,'?.ST\+S5_JI M4\<&K]X,^NIHECIV+&PU>\181$T<[-P8?P:>SU=*JF@8)`^#&<2'P0RRQ%SW M!_UI(3'%G18(G9XU M(C-,9OA4S/!I0O*-K@?+@`>"U:A\5%AV??._!2NM>;((G0F="9T)G=M#$05) MM1O_R/QR&[3>(%&41%$2V6&RP\T?KUXHWF1QR>*>NL7]-\."!68H-^(RF/KF M]UR-[V>VU/A51>D!)V-012XL7^%M>UZV$F[SHB@RDT>Y^'+[@OR"?GSQ!!4'%J4'%U638&:EC@HIZFUL((@@B+@TB M)KUAIZ]."2):I"R'UP3"A*-PHN78H/:[E9N,"!KVEZUJ,`'5@K6-8V>;[NSK ME>O@+=R*RSRFN?J"7^1ML"=F.2O<9J)/]WNO[^X_\[_P?[?1]VJ!QWC, M[%3!*DB+)7[#9?&ZMI;$%K6*YO;7RWS3S=*9%+5U\J=;;`Y M/Y1`L?!4@JK\R9'K@LY#2]KW#!VJ7DH8GU"#4.#_4N%([DW[NAB="C;@[*OTAM""TD#[&L-.?S`@M M6B(M5`5$\-`J>)AVQUDN$#0T(RGKDE>4C]KS]+T-/.`0A/2Z6?/K]J4 M$61&"#4(-2X)-:ZF^1H50HRP.\I?$5(04DC_HM<9C/()+$*+X^K-F2L%P<.) MP,.DF\4&`H9FY&1=_FKO*:D43[:X!^524EW09X_>LMSY_ MM>OTME1MFC`T%W+'0Q.6:#-6U3G(@^KK=CFLI#/LI0/["NO52"1X)'B\*'L?3[)(P058[)6T[B+HL M=ERD8-1+_+Y6VF3.U-P5!T>'G0O)!C=5S=ADCEC-H=;I\/N0#FB.3Z?'I:;] M@GYW`CQ1#"=XL-@:S^"0[#K>)5>;LJE@6?"@EJ#3&XXZH\R&N0W9=3@_="-Y M.T'])!0C%",4VZ),LM_I#P:GD/QK+8*U/P%(R$7(=6[(-1L/.H/1C)#KI'5S M?41]4>R@/.`&><`SL&J4$"QG4EE"4'RO`93B3W_[*?"N'S5M]?,7?<&,P&*? MYN_YA2H?\#Z5NVB_[8WG,=_[BN]]9=_]7[",ZHUL]F]A&Q5O_NHZGJ<$\/MG M-O_[J\`S7BDZC`C:XE_HH]X?-]ZG^4"]97J_IP[_N'<=(]#]#Z;.;,^T'S^C M&'N_L>4#<7[F]`PQ%,?,WQE!"WV0@_,G]_H^D-^^JT[G"`DC>UR?[, MEAK\:C\F1W[/7-,QU,P(U#_>@\JI_]1L',!7I^98WMRK_?^HP_%M+>*KZ'F3 MF8WX]J+"IMY]UZW`@*9^=1SCV;2LROGI9^8'6F.6Q70_T"P8WXJY_HMF&Y_E MA;SP\3:^CK=XVOJ#WF2:GK9-2=Y,!C>8S$'I9&XU\._>S[9I_?V5[P;LU4_U MQ6\]K`TS\Q+?R5/,=*[VFR+9/F%LXP%,^NKNR-44;&U,_;`_F6V$5'L1[U&I M>.<&`/@T_4]?G36"3XU:]'&&]^'QOY^3I_\63\,8IJ%-2K##4`:#6;\!2]Z4 M0NPRDMY@='S5F)2J1M500$O4_S1NP7=2CVEF)O@1-]EF2E!*[6_A[NY30788 MS+0^X.[?7NPR*:`>F^K'/A1D5JH@58-Y`-?1.^_W!H$WYCC7TSL:#P6BS.($3IGUSO__\ MF_/$1>S.7AL_IQ-N:1+[9>+\Z@W/C^*KB@ZQ\$HSL$V9GNS)G"?^XJTT/?]+ M*D7:*RSEVRBE6?9%R?N)A&NVBG&KPL2+W=MQY@,OOE>]'CO6;398NZAX(1>N MR\RH8H6I4;&:E#N]X.@;AVG+$B$`(<`>INKN_C.?+?S?;>5LD=:3UI/6GX?6 MQZL,Y15BI.^D[Z3OYZ'O![^9D[2?M)^TOR7:?\C+-4CQ2?%)\5NB^`<_FI2T M?Z?B[:9/<]CI(.`AW4TE>KQE.E\K5@9J1^GWU,H][3LJ$-T=<>)[@XZW0[$] MA\*/!YWQB.ZD.I5C'0@M""V.B!9"&J9]M9\7!X(,@@R"#(*,#`^FG=DDYX43 M5A!6$%805F1X,.J,IE/""L(*P@K""@I%6J0T!!D$&2,4:K7F0)6L&)EEN$T:0S&\]V,XUD$P@U M"#4N"34H]"3H:)?"$'00=!!T$'00=!!T$'00=!!T$'00=!!TM%9A"#H(.@@Z MTE_3'K/3V&.6/.B2%MK(C+2"$RTW(U>CSJ0_(`M2SJ%6W+U):$%HT0*T(*>3 MXM5V*0Q!QXE`Q]5`'5-&.1D$%(04DBDF`Q[A!2$%(041^=$RY&"PA$* M1]JE,`0=)P(=5^-A+NM)B+&;D[%NM6SO"V`I7F2/>^VOOJ?Y><$K9>\=EP$U MBAZX+K/U%\5W-=NS"E?.VK=TMO,TGP?"%K+C0@Y_;<(8;<:JO+DB1[<1F3M! MH2,8(Q@C&",8(Q@C&",8(Q@C&",8:SV;",8(QM(IT+[:OG76TT&O5BS$$FH1 M:ET6:I'SU2JA(Q@C&",8V\KYFI#SU;(%:MK.V:9%ZNR5@97U&JU8F#YOR&UU M;1,=HPT3I(XZLUXFIC^Z46E-45.K/%Z""H(*JIPFR"#((,@X#/KHPD$Q!ZSC1C$DH5.%D`[+$H!FMSBV`[7]*]MGX>#SM#$?ILI'* MF=\1(,A(UF`2H2BAZ-DXUOU!KS.99C)W!!D$&009!!DE3DEGE"TYVI`-A!F$ M&809EX09@QQB$%X07A!>$%Z4%39W^H,AK0X2:K1`5P@U3@0UJ+"@!8N%M*6N M52N+=$-B6\"3S,B)F)&KP:PS&6?*3VTK4!_L@0G(HAV&OKPUYG,$GO M,,FPG(P.N:>$2H1*M+9&:VMM5AB"#H(.@@Z"#H(.@@Z"#H(.@@Z"#H(.@H[6 M*@Q!!T$'04?ZZU/9N9:B)GM#9J\[2AUY=\$+?N\=EP$UBAZX+K/U%\5W-=NS M"G>\M6\%<-=9;JFJ-6&GZ!K4<[P&M=V6[G3N0VV5%TTH1BA&*$8H1BC69BX1 MBA&*$8JU5^@(Q0C%",4V/UNT;2>U$'`1,MTMGQ@KC)0.TJ_I^8.<3FM]>@:,WL>F%P?5?K= M"?!$,9S@P6)K<.60[#K>I<&;LJF@\.J0C)KTAIV^VK8+T':7M1/434(P0C!" ML#.YPI$0C!",$(P0K-9M3^""Y0^M:VLB@4",0(Q`C$`LNPS=Z0URQ^D1A!&$ MM99+!&$$86D_K-<9C/(81B!&(-9:+A&($8BE>9E?9"+Y:L,E:?*_!6/&G MO_VD?7.___R;\\26S/;O[#O;U^Q'$WZ^\3SF>^^^ZU9@F/;CKXYC/)N6]15? M_]ZQB![G\P=69[T/]GE&;O-[Z,^THQ MF&XN-G_[J1XA;R*.-$'Y($/Y5UYGYG8INTMS%4)T:/1=+HAAYNB>I2A^J-CZ\YRQ7QV M\^@R+K@Y.H_-1L('WQUPC$,-I+N MT60VGA4,HYJP[&"2%]!^FF=?.\`PKD>3_B`UC&J2"I1TAS%,2L>P3EVO!P#! M&Y'=%,W34IHW4-SK"2+C1EQOBOY9*?WU5?AZ/-Q0:.K"SM?X>(H;XT]@**?B M`!/25WMU0:F8QOI&=XLQ-C)I`+R[#K%!"SWII2S(9K"EJB,$WTVL2%-DJQFR MUSH6X]'X*([%I)^A=`-U&(X'1W(L)H,,U?4%7!VHQW0L1FI228>QD@XWI:SR(]G#O;8//U+U:.:%`Z(FB.61;3_4"S8'0KYOHOFFU\9A[37'T! M'V_9$[.<%3B9' M\T@/V%.[-^NZ?L,7ICS M26?&5^>+9K%/\U\"4#OF>;_#.`Z@P\/>8)(VPR@&I%+M7:&L.X@O^@+9@06<^85C;T/_,!E225X]WT%3^5^<\M M4;BY\MX::SR[;8Z3WZ3V9]7>CU6XT:EB%]B:?K?>%U:TOKGWI93_0*B@,!NE M+[V6)H/L#DHR M+Q3BD"W:TA9-R!:U!7K)%IV:+1I4G@E(MHA"G4LW+U,R+VU!4S(OIV9>U%ZU M^I!YH5"';%%M6U2=-R!;1+:(;%&)+>IW^L.J[>9DB_9FB\37\8;R?10<;E:9 M6M#<1VCIZS.SGMAO,.Y%905G>K?8,+\/8S:NOU;5^?G9U& M-!D4;3#>D(+Z&]_*VEBXC.TTCD']NMDJ&G86-VSIO1.X.PT&O.L=!X,D;+)A MKJP9>':7D?0!FW<="3P;C80?67'SQ%SMD;WS``&QH/UWC\T#"]L$6L)]8O>6 M9OLWMO'NK\#D^\,NO8XY#=N5-U0T7SM98&H.53J)A?'F_*6"FGT73J)T*SI( MZJ/COF0\E4+6;'T!14.EP'F*6GK2S<%K@(\JR?DBX(/*\2U;N8#N'`L_F'.F M7+T`/'MK[L_94:*/6P%\,HJ0,SCGRHF-4S>'Y<6@5YZ/V(=AV#'-=S)2LLX:$,`W.%4?F.:Q MA6,9BKEN;>(:AZ+9AL+"/&3E M))-I:'Z89!I:;AJR==X;\H"L0SF3*!)0E"P]^TOT!\`CY\&T6-;])XC?[S`) MXEL.\6V\T>9"()X"@&/9@[?.\_<7E9 MC9[R19>;DU=^;'&T&G"76`R(:.UO3NN.E(Y+*8W24]#.>_,[?HH)G6S!TUU) M+3\B-A%8112.-J5P1^JFY0?82C,?M;$]C6DBPS+J3_/WFNG^2[."L%+2-CZ8 M&O##]$UDB>;!Y!F?[,],#UP7E.,7S3.]2R]XW$/)8[9RKK_ZGN[Q=(P"C7RG MHL$U_#@]9NQ::']W(A1^`->C#C.VUQ.UMY%<;%!=>V&5M=4S M5Z._^>#^*YYIY"_*?T#T192O2MYL>?/[,5;KVP'^.O;L'W[\1__H[W#_R< M$J+]I;C/O.9W?QJ[PVI/DK$Q1YH[6_R(RGV<_;J5LWS+/-TU5[C3Z0AIP';M M!3FX`;OHW2%G?V#]SE:U63TON09B31%06O4/337F`?8&2V3<=T4S`G8"]CQ8 MM`_8CT91GIRCLZB(I*,354;6^=MEZJ_9_OX??&"&J;V;9L_*K3E6"X1 M]==L?Z:MW.B^^<2VDH]2A"?QV$]_OVGN-[R4=>ZX.\S1)3, MG(/WD]GMNIVS7Z4NE^).GGM_G_P%JQM:5'D()!L'F*L'C[E/O&Q\ZWS.)R@$I!`P#Q\4`IYF"'C.MO#<^]LQ\B%G]M#]_6X[ M&[NS%[^V<>H.[8`+K_1]EL7&Q>W)7XSA]PL6EU;7'/;[5O`4_T4+' M#WB^'3`P?_9I@XK5Y"UFY[0E[60.O/BA&G>;X4#+#[J8]#KC:6\W1M!I%X06 MA!:$%H06A!:$%H06:6F8]M7^FHB<((,@@R"#((,@HQ5GM%*N:L_3=_.DF1;F M^*_GCGOM:193/#PLC1^@MM=D,!F)$S<2=$AKW-VT,YBI.[&!K`1A!F'&)6$& M.9@$'>U2&((.@@Z"#H(.@H[SA0Z*5,[ASJ%FDE^5NR#J'-E\*5FRA%`4?/KJ M^)JE:/P&@JS0M"YAMO.T^`7GIBLVB[KB+VZUJF]F!:Q>?8&& MJ"T(0&>AMM:,G,F:&F$%8<7Y8$6[`V:"#((,@@R"#((,@@R"C-.%#(I(CI&W M$M_SFC#L`QF)?R@ZLZR59ABF_2C'T9/,P5^\E:;G?TGQLE=8L;?1V,N^*'D_ M/3-[SG*.SJ(BDHQ-51M;Y MVV7JK]G^_A]\8(9R[YIZIO!@FS\JM.58+A'UUVQ_IJWXWYGO*W'%WF*-+FJ$[`^RMJ6N6S904F%IGA8S+JZ@-[8E;LGJL_ M5B?F*1RD<+`MK*!PL`744#A(X>")&6OJK]G^OH"&Y][=CY$/.[*'[^]UV-G9G+WYMX]0=V@$YM*WT MXL37IW(.;QF[S[NN/>[QK>8M%,T&GQL_L+\"$Q@(CD[FY(D&%8LV>=$FKY/? MY#48=M3)=#=&T#8O0@M""T(+0@M""T(+0HNT--"9$P09!!D$&009;5&:=8FM MO>>J=ET(OI2NRVS]!7<\/&LNKBO;OJOIV>16L132W5%MM3PM M3ZT?B56G?B!XOY>-D(]NN"[E,'""+H(N@JYS=;\)Q0C%",4(Q<@!:[^D$701 M=!%TD0-VDBBV+D%*E7]MRI(674`5?Q(W46F>Q_+9TM;E2L\;G&GUK>6K;X-A M9S`=M]#PG,G"&Z$%H<59H045`Q):$%H06IQF4HYP@G""<*)E.-'N#-B90,:Z M!%=%SFJKY-0)L69+/#FU%.;Q5QC:!I\[\X+`DQ""$((0@A""$((0@A"" M$*(5JG/F>D$(00A!")'\^E1JD&A'9SV9N`]J;!7`UOW596VDON MR,?V52=1-6XI-TZF&O=X2PPG5(6K#CN3?ALK&RZE`)>`BX"+@.O<%D\)O0B] M"+T(O0B]3D(O";T(O0B]*&@\%95Q+TTI.;1=LO%;'_TC*U!],R?9/E MCZQK79[S`DU16Q"`*J!;;$C.9&6-T(+0XGS0HMU!,T$&009!!D$&009!!D'& MZ4(&Q23'R5V)[WEM&/STMY\"[_I1TU8_?]$7S`@L]FG^7C/=?VE6P&[X$5_A\XO<20*O\"[WWQXWW:3Y0;YG> M[ZG#5XK!='.I6=[?7UT/7KV9],;3'OQ?/*C:O;[9![F369K>/Z+WQ0W#_-9> M]3>V?&!N_)OD\!([C'@L'FIVP.D1WSQIIH63^-YQO\!K7[!K/N4[S,AT,%-3 M])7W\J8)7,'A[9GMU3WFV M;T_9X=E>8VQ[L+IJ:IB#+)6#H3J9MLA)F&;H;1Q/=QMP>L3R^JBW\O:HMXZX M-(HC6K/3U.^E:=ZPY^Q4-4CXM%]CPOH[3-CN0V_`+*[5HL%T?%C'XPB*LE_' MX]!R5#U##1GW-7*C#B'HW\TV[^!X#&IP?!<+N/GH&K+M&W-]8].\@]]Q>*ZO M&QT?F?;-_8XZ$2Q7N&/.^]UCQIW]SO.A:1\ZB][\-/^WYKH:$)).LLU7]J-CI77YW8!7S#LU7XJJ(SRUIIA@'-RV113V:@\!=OI>GY7U()JU[A M]LB-$DQE7Y2\7Y;^$A50K=@S.IKN4BYU/5M;+S7+UTN-NKU1S9*I@U9,O?N^ M8KK/#.7)L4",00E>JG.L.]9'U2QHNXS3!B;KAEDHB#+7K`/4,5>63C93RU>D M#_OF]SX;G\RZP.+D/&8F]>""W9^M/97P4+6:0GZ.-_$EBK;[E!RK"I?,2H%9 ML)F3D)9MSNZ"(>&DV%7W4/1_CI#0<%*RZS*9]/[=CUW&8.&`)68 MYRNNYK,]B`;%*\W%*V?HN^ZUT*D[K8I96A>RQ!NMR#L_$1R]-9],@]F&\F(R MRVB13WXA^'DD;YNR27LI6L\*3NL0>B^&>=:=UC3-9Y]8RI;([KQ2E%]@3=;8 MALV&.99_19G[S^`,QTMKJ\!EK^HN.B76R`:OWO2ZD]DD45%0N_K8K&.+\WGW=8F)9:?QJ'?.+KI_N"GP]O:MIYUL2O*,_,4+XZ M/Q]]56G+4U?JSO/%!OI\CI7;7([IX#.\Y007GG:UB7Z?7B2F.V@!0H;V-\++ MZ9[A\F+U*+3^B@3-_0%F2\ZOVM&&MEW)"+0(M,X>M-Y]9ZYN>DRY=TT]O\A$ MJ'5J6D:H1:AU]JCUB^-\4W@&1[GZH=?K%=1<$7"=AJ+ML%2Z87[HY%BS;8+D MW`=Z\M?T-6%3*CRTM@^?3J@A52!5(%4@52!5(%4XFR+NC*-]N8NF[_ZIO`?N M[_4(_L9"@@O)&-RLW*XZZ"C]7F]V]%JVDS=59W#<:+MJ8H]\[&AG-IAUQH-* MS2#[3:[L!>$#'4>,NW34W)9$@H2&=84.+B>D.'FD&':F_9SW0%AQH/"?(OH] M3]__:BO'<96O;N#Y1X\>*:BGH)Y,\?$YT7*3K'9&/0SL!^3!MT)<"!^.CP_D MJE-03T$](47+.-%RQ!AT)L,>!?>TMD^9`%K;;V,:('CLJA-*`Y#Q)N-=D`88 MCWJ=:6],/G\KQ(7PX?CX0&D`G@8@2*`T`"%%>SC1IT$G8C%5Y M-^*0S*K1>/QTO].;S3JSP2C%V0R;C^Z"[":I9RNJ!'"G$>2T*!V2/V*JCN=) M29(3#'@:3I+L'+ZTG4WD21T"D<[6DQIU^J-T$4?K@.U2W*A#57PTF0`:KLL@ MM)37>TFG7`@SMN#%1;&B$*_ZW+K4&LLV57?=-:P:Z"U8[VFM=) M1YWU.P-U4&5BVVEA-Y+8LQ59`KO32%8<'\=J)"V&9Q!O4NZB!I,.D+LX!UFZ M%"?K>)G4LW:NU$EG-DPG8ML';9?D6Y5E,,3W\26A.U^5YTIZAX MP?/Q]C*\5/'?"U-?9%N3=YR(:Q6=Q$6,TV'R)L9!?!/CX(_?',.*T.XA'N1I:\493?J?HQP%[B6U/#*_BB>S"]A>8R+W,3YG3T MQPWT7VL`B;LQKP>OWJBSP6P\F/5Z/7FK:PD%;^I,A1]>*,/ODXG;"`>MQN,( M/.,>I*#!T?1A,%U5K9Z5M11&X^3,"'^.[@Q-#:"Y61A.^XDIR/5:<+=KHYHP M+M6$S\QTWGET(7*\7T6IVT2BEFF6FH'$16*<:C MWK0W;IE2;#LBH13CHRK%+K,Q5/N3(RG%K%>J%%^"!\W7[58G?% MF*F9J5@SD,QD]'NSV6PPJJ,:!]*+'0;4F&9LJ18[SL6H/UIC+787EPR%61(F MZJP_4#=R'S9GTQH:U`G$RVOXD)+%#XYF>\A>[ZNK&>S&-C[Y"^9^9CHSGU#3 MO%O3TRW'"URVW:WV1]L=D(Q--PRGO_)P^B.$TY\+PVGYQ;_?"8(>(*R-NT9N M*@-%!-K3OMI_K=SHNA/@#<$Q7SO*%PVXJVBVH=Q8EO.LV3K+GBX@AI`L2_FZ8`JH/TB>XLP5$$OEK;-<:?9+Q-K):T]Y"#SH MQ/.@-Q!<\"NM%_CXY%A/S.O`)_ZB0!+W!207W<^.XL'0>(`&M&M+,3DX%5[P MX/GPI:E9"K01(*W8.:B1I^D8S8GGF.>#VH':*"ZS(,JS'Q7?`8Z%$ZG,'5=9 MN8X1Z#X\`H.P@1H=8.61864'_.'"!Q]IQ"21/P\L10O%!'LP0._$7X_F$[.Q M>3WP?&<)V-]5OBY,&#$\*3@$U.JFJP=+)%Z/^+6"_I::S@(?1FH!,PQH`;B` M[3;]1>FL/R\08I5YCFVMQ@&3`>?#YB./X!M@LFP@>Y4;1'EW&&QOS,S9UR]8S^%E<6$-0D MO:E)C5X,U3^>?*;!^POM"4>#K'6>;>"-J>/?B5GM**(G^&CZ"'^FS_4F*031 M>'^48A[R&)15L9AFX!O\>9"JE?8BI$5[A(GW@&&!CSK`!1=AP$1EU#P^D"3S M?>T;XU_R:0-6)M@,3.8LA>^1H[*/;G'=W*6B\[\C61V0R1#157,T"U3``OC4LU^PX2 MBCB>ZD^@+GXU=Q")408B&0>=8.X3$UJ?ZEB#/^7<8_\N`[@-4#:%^"/=7"]Y M<]`+EB2B5PILA7^$^*'^PU,N6P!=2*%IP]\2)"2.2@J4!\T2-@(I@>>L`&2/ M]X8N6!'6=!2;^2$]1?B4(DNVKW@+QGR/Q#8EMA^!D:5\YGP$*8N`-):C*\Y] M)_!`&KT??RY9/*G@JB\Z`.%>:0;*@QQ83S(&?_%6FI[_);4"U>L5K4%MM!A4 M]D7)^TFG>H/-R>4K:E6+WOQB\>(>6[XT=G(#KPQBRGFQ"2O2-QN.UZZU;E(4 MOG8)]:RW-E=.'L3?/$FB#-1.127BCIN=MUE,/Z'-*?M3CW7;`"I`=>,3'S:" MG*.JT7%.=]ARE@]T:L"%&XSU5^&2P6AD\C!;6^GSD*DXLF(01A!&'!TC* M$$:T0#'6N9.M.$=\&J8MRMA=J5C7_&ETKU[K69=>O=9@/T(`+F]HP=& M5]!?P#H*'<4X*()=S<;:L)X"CNZM';`!V`!LB%@J47!C4Q]VP]A\G\FSCQ+P MV[0X$8:`1CD9C7+1ZNCJ8"!KDXIX:TV2G[;B>KU?5`BX!%PZ'5Q2-7D\ULJ/ MI@$5]:'B=&.C73%7OZ8OYI:S-VQ4Z`+H@D@7]/ORL-^'+H#9"*@`5%1"!3M= MS]\H`%JT;#DB*BJ4F7F]*N'"2QB45?DIY#S8G%`D4"3MQD5;'5S3Y.%$+8^Y M(@`+2QH`>'1*B`Z`:M[GKDL(H`5BL.(9QU?3)^+ZEL$E_X/#Z:YD- MA6T,U0#54*@:-'4$U0!#$F@A`"5$1XO^0,M2`4C1KA$I5CAVWTHQ9V.97F^6_;W%+I\&/J.-^]FT<=;G6@G=B`8$`P(MCNAAGUY,AD+>'IV3B!69IZ'[_.BN`^^*.VILA.L M2=/M6U1]C)J8O1##]5CS,#*5DBU=)%:NG_];YYD3](4FIQH(4NO9<=G/TCVL MC.F_`L\/&Y;YCO3`*Q%[O`TIVEOE.1/MK;J\\.B-PW4B4&.&;KP50K+,S=V#0[(=ND-SO:_)`SUV6._IAGS#GQD(E(P`N`!='A(N!-I8'(Q0Z M!%0`*@`5E330QT-Y@/K8A\T.:N/\$"YF:0_!9-9001O!!IU--!'L"O8?_]Z7 M.#H`W33.7UP'6K3L9^+(52BG%.W*!85/*)+.*!)55D>9JK+0(K`Y M`16`B@Q4C.7^$(V]@19`"Q$H(3I:#&4E>R,=:(&3T.X[G5?3A65;GN\:OO5$ MI!F!OWET,(1:Z(I:&"CR:(P345B0@(IC4T)TJ)C(_1%.1($60`L1*"$Z6K0Z M^D#6)NGC5E@P73QWK>GK5I+XC538,BHJMIPJC!U_,5\)>W-M[!Q_5;C;J=DU M6)^[Q*W=PO&?M-?<+CN7ML&VW9C"$W%]R[/L!UE:TF\[ON78GLS/M1W_D;@5 MX%.\+>MX@W"QB!0)C]]W32330O!2[B+9'O5(E;=.#FF``N`!>`"\!UG'"0+BMZ52D9P..I9T%4`FI_B^9S M9U.1^Y8\$3L@GDR_[5XGY,-N')(J9GT&4`8($Q8,@'"`&$I0FF#H:P.1+N;>DX05A9F"=\WZ%IC M0_K>_3%^61G94,?M)81D)EB3IG>I%)9N!19B.N-"6LGA[+\J"C1%4,V!?8 M,/ZC2XCT0@S7DXA-ORE=$Y,L[NG/=%66-$7M2Q;]'?L%&]V3+O@$G,`S[*GW M^J8_28F+4A@=J\6Y96^4 M_#ZY_35B@.7B7Z5DM1-0LO5MD5H4.1V"F`[C^/@3K1:9-D7?-]&L$D'WB^ND MUFL2VR=NL0P=8@>//?CZV[<%54TK@T5'CA6=\P$F(`P0=A80EFPH5`_..&.Q M?Z3;@B9$U5%P0)MXD@QH`[2=%+35@[-5F3_`6*>E%C`&&#LI&+MV@GM_%LQK MFF=79ETX`Y@))[L`,X#928%9>`>U)ZV=QWJH]G5U;;6&F09@$TZ.`6P`MI," MMGHP=G=S=_5Y6P0#?(F2DA"?^AZV4D@_717SF!+\K\#SK=E+:CH'E>%WQIQG M.1A^+ELA7\5+N'L?'1.#)K+F1+D"=OR+C>*4L1K*X_YP+S*<=GDIH5)R@1G` M#`$P8R!/^OGB,L`,8`8P`YA13(M1/]L]$'@!O`!>`"^*:3')&!A`"Z`%T`)H M47+Y.-OA`W@!O`!>`"]*:*'V945#._.C'9KA'*S!K?KJ.D^69SEV-3_CU`OX M#_R/[$5Y-,[#/]`?-B,P`YA18C.JFJQEH]B`#$`&(`.0499<4]22')@!S`!F M`#-*&@F,-82R2V@C1&L3X`1P0@"-#M+#VF<=Z(9O$\\@TRP+"':75NQW='3EJ0OF2(*]ER-MTMM_<<7UYVL/9',57U'7- MIL8*>"Q_VM`K=*K7\1J=BY/B-9;["FHS=L3=!U8`*XZ9#JK+_4%>I0(M@!9` M"Z!%%BUD?5AM?P,K@!7`"F"%_T9/9Z`!)8`20`F@1+:/Q'B0H0)P`C@!G`!. M9*ZZZ_)8'R-.<68W5W$4AM*N4!+"44)P93&0%:6Z_2=4!0Q+8`8P8_TX=:S+ M?06E70$9QQ840$9'(&,L]X M:+`L8%D(("G`C(Y@AJ:HLCX>P;SH=C/#.E=AS_A4#+5:11&-)O0)[CCCCO/% M0-;Z53><:](8EYR/[TX#\X!YP+RJN@YC79Z,JDIY`?(`>1V48T`>(*\8\L:R MFFEO!S,/F'<*@@S,`^858EY(VK&F:F\`?&*Q*P`0``@`;-WHZ\O#P0C8!Z/O MY`09F`?,*^D]IVBR,AA7H!X@[\@U6W&KM70W6][/B@*OU1W-A3C+/VV<%CKE M"\40V,43%1=/NA(;`%8`*XYYKU63QV,4>`5:`"V`%EL4>!WV85D`*X`5P(J- M%TYPE14H`90`2E1?9`$\")7(%7=3C:CQ!`BW(B;3H*P^E6@UN% MFJW`?=$H(3K^*[*B#('_L!8%D!6@1K.H4:CXDP-$B4;-V`*Y:%3[6]+FX"-] M(H^&Z6Y*E3N_IUD!%-V"2$!1H.C)V%ZZ*JLC-%9`!F`#.`&0)B!N([^^#B9"(K:AH9$=\1\Y04%P9+,?&P M\ZF^,]UM0+B:3BW? MR.H(UZ/@EH@@*T"-DW1+CC"-,H/H*%,IFDR7[;/N#DZUW6!246VZC@^Z$O:$ M'7DP&Q0J=PLB0>5"Y4+E'EOE=E-3M#KX0%:':@W%`[TB%)Y`KT"OG$P`:)S) M>P-:`"V`%D"+LDQ9-4,$X`7P`GC1<;R`URK$5!`H%F7P85_6,_6=$"@^-94; MOHVFYL*4C4!3 M0'/!5(JF,M2&\D2OT$O-_@$-!PW71=B&AH.&@X;;?BKJ0-8F6L.ZHRZ_0G]` M?P@"BM`?T!^%0%F1@P^XZV[6`6`/L`?8JS";1[(VJCA6!O;!U.NH(`/S@'D( M%71R*L.A)FM*18%M!,.[I>'"MX6KXE2I*?O(@HJ>]\Z8&[9)),.7KHE)%O?$ ME715EC1%K6Y-*WY&5!_F4`YWM-YH0(%GZ@3W<[(!>0Y)KN,U9:M+IH(4=W'- MH7X_UV*Z(RY@+4;MH&`#_X!_)XQ_@MSQ$02&!9J*.F"GQJ-RE5"E+$2_*@)- M`DT"30)-TM,8CVQ7WK7EF?.'2]PR1WY[K]CN/*6/^'G>(QOYB.9 M!G-R,[LR32>P_7!`/C0=\*-E&[9IV0_K05O.T=5K8K*7K]YR5F$_E4PRGR^-Z90.&&V"$FT_^\1;&F;^DQ2W*(6I M=[4VKNR-DM\7(CU?T6[EU*HL)Z4W2&-Z9[BX?>9X1U3H.M/MTR\" M_MWAYE-"_^.711-'"S1$"RB"+8BT%ZRG@*-[:P=L`#8`&TW:CV<2U-:'W3`V MPRZ?;!\\R;"GU.Z\-WSBM6EQ(@P!C7(R&J7=@KH;JQ'5)/EI*RXA*I`#EX!+ M(N"2JLGC.7O#1H4N@"Z(=$%! MF6/H`IB-@`I`118JV.EZ_D8!T*)ERQ%14:',3';W/,SR93%18SYWGED7D'Q8 M%#8G%`D4R<'CHJT.KFGR]G5F:^XM=",`$`!X%@"HYGWNNH0`6B`&*YYQ?#5] M(JYO>9;]P,WC)?V!XUM.-AP+VQBJ`:JA6#5D"\S6%@BH!J`%T.(LT*(_T+)4 M`%*T:T2*%8[=MU+,V5BFUTYP[\^"^:I(0Y7<"&&1"E8$2"1=)'A9&)&453U2 MY=790;794#QMMA^KB:_N`%H`+8#6'J"E90L.`+)./OA]W?EJW>]JC55.FZ5/\^_4W>5W>]X'K$DJJ MP+;"IDZ!-WV5[O*D_'GEW\G;_N6P@D*J-Q]IV4UG/Y#:\0;@_)?K]8;^_?GIZW-3BMW_D)HY0AQ5/ M7#\P3F.G=+A:Y;#OOV)-&T[4]?.KGI+EQ5UGM(D#4ENP<4+K^21RF>BWO\:9 M3`W(AZ8FI*/Z,6\;FM(&(O4'6HT9I;$M)N-'QXT/V?(@U``&#[4TT-5Y[HJ, MC<]Z`V&UP5Z33LUYK2B_NA95B4MC?N=2)6F8/,/NECP1.SCC/H92U@I!*\,N M+SQZXW!=9U1EHZ%?)\R>(%;-$/!)MYSY@QBN1.PIF4H5+0V;#`>C"4W'>QIJ MR^\59QBGB[G9=7>:F4I`%ZV^#K1Y:`6'34,^8YXH'"9<+=WJQSL[<=T1C-[I!B$< M-A.TC?-#N)BE_6*-Z;\"SU\0=@6KH&5L@\XF&L9V!?N/?\=7'!V`SH^B,0P0 M`@@!A`!"`"&`$$`(($3B[;,_W>Q*P3UTCQ821Z%1.J)1VNV2,M(G\FBHI,B, MP]5FZU0!EX!+)XA+ZEB7^THV31A@`;``6``LLF"A:K*6ZW4$L-@/+$[W8+4K MWBV:S8N#@=`&7=$&FB(KBF@%)CNN"P`5@(H3A(H!10IU/X$`6@`M@!9G@1:Z M/!KG+ZX#+5KV,W'D*I13&A>W#`]KH`UF;I(];8<%T\=RUIJ];2>(W4F'+J*C8X2MW8+QW_27%WPZKK5K3-VRS&%50="65K�@]F9]K._XC<2O`IWA; MUO$&X6(1*1(>O^^:2*:%X*7<1;(]ZI$J;YT?.IB+W M+7DB=D`\F7[;KT0N\6,3VVSL:>#_]JBB]4;4?)"F3G`_)QMPY9#D.EZSA[ID M*C@XJ1GPY2,T'_$]*$ZT>WXSH2H[<\VA32PZG%*O)7X=A"N@>H-P!507#=7; MDU,]O*5-"6FM3#FWM]?7>JOWJK]OC;01XJB).9;^+BW^\Y)3\Y)7\]) MS\YIH(T'H_Y64VJ`5/WDM+3UM+3LM/3Q<##6ZDW+^,O]_M.Z!/Z5/;WE]>\_ M?%\2VR.-;.%(GXR&"I_7AL>]W7]66V^B.M;[BGZ@66V]AZJJ:?U^G5EEMIJ7 M>>1;W,78:%K'4^CFE<+#=5+:7.D51-\]D]XEL+V>CL;[+1%9E3Z*OTAV] M6M4^:6[+=%4=C?/SV_ST-F:]]>Z.^\,"1-UJTDW/>6M&&"I%6J#^G--7$S\2 MXC4)OP-E-$Z+<.GS"O353G/;>MRSG)L`><\Q96%^(WXS84OXK MPO',LS99O1NFL_5FZNIHI!;JWR:GL_6^42>3^IC;3H>;4E?4FWFR_)=/]@J. M/SKN^\"C7B1QKPFKD\WR[(V2WQ>>(FT\FR]WRZN"7]H)!+_JQPAK M4>1T"&(ZC.'C3[1:9-J4%;.)9I4Y&_N=MZ;6:Q**$&YR-J=S$KO-X.MOWQ9T M&Z@\Q#WR&>XY)Q8"P@!A9P%AR4:?]>",,Q;[1[HM:`Y:G9T":!-/D@%M@+:3 M@K9Z<+8*4`+&.BVU@#'`V$G!V+43W/NS8%[3/(L#=G`W.RR[`#.`V4F!67AX MU)/6SF,]5/NZ*B=3PTP#L`DGQP`V`-M)`5L]&+N[N;OZO"V"`;Y$216.3WT/ M6\&OGZY6?TP)_E?@^=;L)36=@\KP.V/.4A0DPY>NB4D6]\25=%66-"5[/:B0 M3JA;C_*R!Z"$X.5EA_*X/]R+#*==]E6HJW+`#&"&`)@QD"?]?-%'8`8P`Y@! MS"BFQ:B?[>H-O`!>`"^`%\6TF&0,#*`%T`)H`;0H*0J4[;P'O`!>`"^`%R6T M4/NRHF4=DIJ$`&J4$VG3H1G.P1K`$<$(`G-!D98@0!FP+`20%F-$1S%"UOJR,1>N=G,ZT@7 MQ>IP#Q@'C"O`O-4I2^/^E6H!\@#Y'50C@%Y@+QB MR!O(_<$`9AXP[^0$&9@'S"O$/%6OQCL`7D?/B0!\`#X`7Y5_*X^'_6KP`_;! MV.N@(`/S@'DEF*?V96TXK$`]0%[+D+?I;+^YX_KRM(>S.8JOJ.N:38T5\%C^ MM*%7Z%2O'_8S9TXBQ6LL]Q749NR(NP^L`%8<,QU4E_N#O$H%6@`M@!9`BRQ: MR/JPVOX&5@`K@!7`"O^-GLY``TH`)8`20(EL'XGQ($,%X`1P`C@!G,A<==?E ML3Y&G.+,;J[B*`RE7:$DA*.$X,IB("M*=?M/J`H8EL`,8,;Z<>I8E_L*2KL" M,HXM*(",CD#&6.X/4=H5F"&`I``S.H(9%P-8&`)?1`%*`"4$0(F^/-!@6<"R M$$!2@!D=P0Q-465]/()YT>UFAG6NPI[QJ1AJM8HB&DWH$]QQQAWGBX&L]:MN M.->D,2XY']^=!N8!\X!Y574=QKH\&565\@+D`?(Z*,>`/$!>,>2-9373W@YF M'C#O%`09F`?,*\2\D+1C3=7>`/C$8E<`(``0`-BZT=>7AX,1L`]&W\D),C`/ MF%?2>T[19&4PKD`]0-Z1:[;B5FOI;K:\GQ4%7JL[F@MQEG_:."UTRA>*(;"+ M)RHNGG0E-@"L`%8<\UZK)H_'*/`*M`!:`"VV*/`Z[,.R`%8`*X`5&R^`$[D"K^IPM!\A@!;E1-IT%(;3K0:W"C5;@?NB M44)T_%=D11D"_V$M"B`K0(UF4:-0\2<'B!*-FK$%DS<%'^D0>#=/= ME"IW?D^S`BBZ!9&`HD#1D[&]=%561VBN`M0005:`&EU!C7[670->`"^`%\"+ M$C]&'FF3O<@`S`!F`#,$Q`S$=_;!Q=3?6>Z MVX!P-9U:ON78GC2C7Y4,\]^!Y87O5(!$T6ZL,0+'SC`P.FQ@M'?L/)'5$:Y' MP2T105:`&B?IEAQA&F4&T5&F4C29+MMGW1V<:KO!I*+:=!T?="7L"3OR8#8H M5.X61(+*A6)7J&7FOT#&@X:KHNP#0T'#0<-M_U4U(&L3;2&=4==?H7^@/X0!!2A M/Z`_"H&R(@^=,3=LDTB&+UT3DRSNB2OIJBQI MBEK=FE;\C*@^S*$<[FB]T8`"S]0)[N=D`_([BFD/]?J[% M=$=S%2@; MB,<@(M,=E1.^G4]M"]\WZ%K91S__:/SE?O_IRO2M)\M_^61?S>?.,\NJ^NBX M[P./$I>XUV0:F+RKW)5I.H'M>W?L]W?DN_^.0,[7*VE*3&MAS+V_O[K47[T=COM#15%^_K'6 MA-ZNJ-3@0O3,0EC=+O)`6":A9["A[@V?E"QC,.E/=EM&PXOH9Q81_98QB.$] M7EL>YXGB18SZ^DYK:'@)@PJ&NJ:"[\^">TW3BFUD1OB>D\$=>B2%Q%[M&?'RE1U5\-F\Y5 MNW/B:6LU$4D?C>LL:CV[6LBZY:+&I8NJ@TZJ2FT,<18U*5U4';0:*J/^CDMJ M@_]41=F*`;=#L,NQMOO:VEB#Y]_\/W);&]:CW3%/!=:AICNJV76#+7FD;-+BMN!A4O5:7/(:0# M*VX&,B\'_<&@B?6VN]IFH52M@S@5.]SV'C>%L9?J>%A',98ON=WU;HV]EZK: MUX9U[.%FY'0+`UE5TMYO7<@=]Y6=7)6F5Z%G5E'+N-3[@SK&2HLN/`7TS$+J MH*.J#W==1]/+&%1PU7:HI]?1:ZV%(U1E6+&234@V&-=15NTM(K.&G%&KC_7Q M`01@6U,]90_J:V#5:X(3)?ZN%F\;RQJ7+JL66HWUOK*S#]+"LB:ERZJ#7>-^ M+9W?OL.H*EMQX9;>.H MOX;5?DUH8J2O8QRE;=<6%C8N75@=M!I1^V=8)V[2LF^H3DJ750>[=+KQ=31D MJX>_JJ9LQ81;1KEJV>CM>[V:NM7B-H';:*35"0NWOBZM;%6YB4\FBKKKU&M, M^VK*ZIDM"&6,`R'>1!W543B)"=;>DZT7UPSJ:9/!I([7EUE:&PMK!O<&ZK!. M_#*]KA:6U2CRC>L@>FII;:RL&=BCBDJ<16V-><.^7LN@WIG/=HH;-`6`EZHV MG#3D9[>_ZF:0\7)(UUSK:.>($;&&0/-2'6B39D)B;:^X64NR&[O<$-)>CK11 M(XE`+:]W:Q"^'`[#Y#4!XX!:.@Y8%WG[_5UC3TVO0\^LHU8D<$!Q9:=02-.K MZ&=640<=-:H0ZM@H;<8SM4$%6VT'>GU1$EZT8<5:-H$9!<4#Q-BV6(:27D2> M>?KU+-QR[OED/U'[T7%?&+O.'2]PUQ>\MD70MZ5W5`]2?CQYQ:WFK;P[?BOO M"WF6;ANXB!G]_/QK$OR5B5[ M?>_^&+^LI+PZ;K?R^V&H?_=(*#,NEH[-G2UG1@=2 MX4DSA[WG21>6+?F/3L"TB_?ZI^+B$14TYC$W[SK1TZ*R,.+! M+]IWJ'-5>^)1=L%^"U!-$G9-D:8@YZABM+%D@DB[W*@@06&4*`P-"N,PF]=V MWR.HBGT%`Q@!C#@Z1NC`"`$%8Y,YV50KPMJV9S)N,8[#%F7D/FTS<_W$CY9M M>8]D*CTXSM3+"523$M5,9"CM;HX&FR>/Q<#]"`"W*B73(0"Z,Z8+M^]UQ M_Z)C2$O7,8F7L:9A24,;'(42L*B/;E'W95T?5!G4L*=A3XN&&T#0CMC5.C6K MJV/AP(SVK&JQXMG[GK^=BZE^:SQ+"\,GKF7,/Y+IB.WRE9U M5=95I?R`3!P%<*)=-8%@0#`@V.Z$&@SDR5C;CUH`L8.T!F9_':.X0"5E=Z!J M*Z4==JM<\-Y9+`W[15H8ENW3?U@$?5VL0)HYKD2^LQ08'EEW[JG_1'RR*G'P M(K-*!L]D/F?_7;TK/3\2EW[+]R33\7S)8I_%`[$*";['"R.XA)+Y/[Q^`164 M@/027+1ZQ:9I1-V@)5XK@13.4%Y-3^:3+7I`8HI&6#2&#\"&])\=Z848KB<1 M>TJF4O*NL\3NL4G/=(E;UFTHAY-DN"_#SR=1R*$`']V"$.]&-5-EAFC+[^5& MR)%PKB"H&\-<$0YOO?8DPH=WM]Y(QZ='D[>;-Y"IS5(/:06ZW=6XJM.1>(.: M/A[)T>8HV[K%\];?_H-#Z8<Z.;N6WKU?O M*>O_).ELMN]O/M_<1ON:GF@Y$A?MZ?K\I3Y_'O=ZX8E(>\K^JZ-`ZN9:U)3K M`^1+""#893O8M*@TMUE"D*<.@Y>HLWJ7S*N5%;35[MHJ5Z=BTU8?7V_4/%BV;=D/++S)PHA5T:'] MQ7"7VRV'D9/#1LKVO+IP6()DC^3:(D3M2RX'I<)`'BD5^0+MJ:%]>*6C@K,7 MV&?0HZ,D`':<$'8,Y;$Z`7:T*3@'B\3"L"S?Q:^N\V1YEF.W')"%&=E!57!H M@HBM$E1-UD:#O;4CE`(,2J#(V:*()BMC&);'-"P1WA3."KV:3BW>D4Z:T:]* MAOGO@!JE_)WV#QI@FD*I=%RIC&5-0Z13)'X!7``NA(6+1/M-N+.G'./<]V[# M^5B@8?MRX:S-.AO8,=%H@B(=R&@73`?M6_3ET#3;8O#UMR\&LJ*FB\4+:13O MR[:'W8/7>]L(C<1R:T#A28LU@+`NQB#T<"*'CN*)B_.+')E@$0'O,X(7R[H';9SS\&WN6#82Q_^A17H[JV M/'/N>(%+[LAW_QVSN]]&3_DY_O(W\Y%,@SFYF:U^]CYP7?KJCCUD]4/)I"N@ M?]R2V=]?F=J?'RD!U%\-F]UQOW-T]9J8[.6KMYP#3J'F5)KF.]8]KM(_)UV] M7:R%[WC/M@XIVJPH51G_V.A_-UAF9KMB5H?758/%): M3*H%JK4=@%J0P\.':V=]=>D\?C MX7Z$`%J4$^F0@5P8TP7;][OC_L4:%2U=A_4EVGBJ#$OZ3+7!\;M-PZ(^I$7= MEW4]7:I*K'/0<]&00%`@Z`Z4$-RNUJE971T+!V:T9U6+%<_>]_SM7$SU6^-9 M6A@^<2UC'K8X]8+E MW=)'=!=ASRO#W9,^P'ES&`4X%PW.VSL%F,A:0>H.`$P4AZ;"1VG2&5'SZ=Z= M(>$A=4".3MVCTA$O%)[)(>_>UU\/2RA55V5=K2B1*XX"J,5K'91-(!@0#`A6 MOYGA0)Z,M?VH!1!KR9(-WX\OX*]OW6][D?YM.-3/N=OZ<;;T+RQ96@IL*[QK M'WC35^G+]\J?5][-;'WE7IH2TUH8<^_OKR[U5V^'_7Y?4Q2EH"!`ZA%OXU7M M,14U-14].Q5-&X^'^TV%I;U\LK^&22][4*6OZX/BF:2>D*N/4'\B&VBBC\?Z M7A.Y-9Y_BP\7KNSIM^AH81^.T09ZR9Q*'E:Q83M,;Q,73:A/O^/TC+_<[S]] M"Q8+PWUQ9E?SN?/,RK?-'/?#=T9FPY[>W%,/G/AD->BY%[XHP,>J\N6[7=?; MHB*YN+59:JX]J1+#RVYOI./3H\GKX!O(U&9MC+3%L=U=PJKCI'B#FCY/RM'F M*-NZQ?/6W_Z#&*XG?;"G9"J5UME8#6E-8VI>O=,N]8*M_/SA[HYNY;>O5^\I MZ_\DZ6RV[V\^W]Q&^YJ>:'E%JJ(]W:>XYG'O8YZ(M*<,YCH*I&YR2DVY/D"" MB0""7;:#38M*N<'U!J M=B-)$6OOSAHQNL('KIW,W8H.A'7%Y M+"C1S^&>/%BV;=D/Q5T=FA9#-!M0RY,4]%\T?`#J:'SZ2;: M#-AGT*.C)`!VG!!V#.6Q.@%VM"DX!XO$PK`LW\6OKO-D>99CMQR0A1G9054@ M1%M,852"JLG::+"W=H12@$$)%#E;%-%D90S#\IB&)<*;PEFA5].IY5,CU)-F M]*N28?X[H$8I?Z?]@P:8IE`J'5$BI,984[4MBC`" M-;H;X]SW;L/Y6*#O'PWW(5?Y+,?TA[8VZVQ@QT2C"8IT(*-=,!VT;Y6<0]-L MB\'7W[X8R(J:KJXOI%&\+]L>=@]>[VTC-!++K0&%)RW6`,*Z%#L_(%Q3^$*7 M-64,2!0$$KL4FJX$W#Z<9_VJI@UH%Q67#`K]Y2WC4QGF)J/EBLP-E8G6\\G MG!"G]"J'^J/CKGY2-9'R\ER9&:F:-@KKP94_Z.T^,]&3,]'7,\E7-U/&DXT3 MB=DUG,SJ@U5V#WO652*WIQ$:C35-6<]L\T.3](I.?:X>#,OV_&;W[G*@J,/U MQ$H>E27:#C/:>@\O=;J+=6:TG[AM*.>GJ=32KBEN\3+V?8C3?00'=<07TA2J@V_H7RK\X/I$&TBHE M0'TCQ=25)4Y?WAIJ1>$R2R`9RV"O[]T?XY>51%7'S5'U7X'G6[.7@Q%V_:`U MR98KDI&89(P#/]_/:`NH"IB50`ZA10HO^4-;&*E#C6$:F6%', MRLP%I3>H.DDX,\OU8^#:EA^X))T&6Z"*Z]><"8'N$B1LIDRXP M:1`204AD!TH('A)1QP-Y/!H)9B^>2#P$D`'(.$'(T`9R/YO6`\@XC`&&$&I' M0ZA7IADL@KGADZDT)4N7F!8OB%#M[""(*@PJ(PQQ-F&(B^%85B:B:;CNQ""R MQ72!6D`M\4G5>=0:].7^J*)I&%"K!=1"Q!3A#X0_FJ2$Z.$/=22/QGW!8/9$ MPA^`#$#&Z4'&2)$G@_P]2*!&0]R"H.F)!DW?.[;GNX')`J5T+&GI.@\N\38V M=4305!!@1OA!M/!#51D>_OOFJ_`<%#):'5P;RHHB=)&P$XK'".5)`,X!YR+" M>8MA#ED=#`3T6+ ML4)"P:3?1\_U=7DTKNJG7$CS#ACUM<2O@W`%4&\.K0#JHH%Z:X0::[*:O2`, M$!/$N`_?C_L^LK]$Z;J5GGM-LF[?=JO5P:]\*=G$1F(5_WE%"U8C6V:G"[SE M5W''+\-U7UB'+X.RAR_=.\Y?C-D#PGJ`_:`->D-I8B+S%UEZ-CR)[@_/!7<"W[.FA+<1^X=ML;>^^?03KU=MDJ19)M], M;-V$KTYKO8)6@:4__T+)4-6;4QNEVP7^>1,NE:XT7&BXSM_X?J1Z"0Y>O=4& MPTPKT:IY;-U-<..GT$BND9!'E7V'/G('7'GT!OK( MH8\<^LAU0[#VB$&CC]SQ=[C1P!4:+M71/6BX=*2]C)^'/G+0;(`UP-IIPQKZ MR`'6NIL)7T;N,\IP1Q\Y44\_1:">!_K(X?JW(_Q9BT@: MK%/7O]%'3@!F`WH!O8!>Z"/7-0#;(TR,JL@(B2`DTK60"/K(`3+$$!1`1E<@ M`WWD$$)MQD$]HQ`J^LB))FH(0R`,@3YR;=`/?>2$$46@UOF@%OK(H8^NC*U$ MARN`>G-H!5`7#=1;(Q3ZR`D@GF7&??A^W$=NBX94B0Y@;(S-7:E^<1W/J^ZE M-&1)JEF*!E7 M@*/#Q"\_)8J_%<]_J(_[-1<@-;@&+4/HG=;0'VIC]7AKT#/[L*IG0L?Y:'UG MKTHFKJK:2!D?;^;]#/6WG_EH.-!KLTU#\TX+9S]'U/%@/!K5FEM3!$V3,S0 M0RQWPXX-^OV1TO)RC;_<[^5\<#7SB9M\TCLRI2O7->R'@O+`&<;]N'^C"]]@HI%=+U[H_/E+"63T MY)H!`&-'9T8WR9,,DR*Q9_',+/K6/XGK&5\?#4I.2E_'73HNO^IZ$?.TIKQ9 M?V?UIOKFM2Q=_>6XMLQ^U^/U!=GPSX_.?/XB.<\VNR_KT(G[EBEYP;UG32W# MM>A"+MBL$L/S8?AF2E\-JM^)EWR,Q%M,T<$LVW6P_N3\\?Q[=<==?3\U\)03 M^BIXH.`GJ5K4'OV>^,^$V'SK\I21#(]*A>LZSW1/9,FD*M:PZ$;2;[O2G+!5 MT[?YWO_Z]3?'?:`_??]H>$1Z9]A_R=*7WE4OM;?QM]([:U`5PUJOT^=-%Y9M M4:UCL&;JDO%`5]&3[NCDJ.MH$C+U)*K)"?ULFJ(4F_X&8DAT#40*//I+^H,9 MQ\VP+WLIC]*92;\0.F'+D&)F95\JYE;I:CU.EFK43*\B2/ M4&RAFW7_0B<\9QO#]\KS")7[Z*\\Q\ITY2]J"[DO[-(]!3"?,H7I!)0`:7G,?AH/;,1$I?B.=LXTUK2[[MD:;QP\:7?HG_375!ZVN!O\592M/`M^OZ< M#6DL^*;0CS*P?4\H&]B,$U9Z:F:Y%`=G`66MZ+G2C.H2YYE]*ZG(&&[&3]L` M,1$4&AQ=YE(\\^C'])<4/-F0Z^7=&W,.0].`LK8O+0P__1">;3)#(P$`E<*7PUI9X-F=K,7Z63DJB?N;!\IDNW)@!?-)G-^`+I MUSUC3I=,E9SMS>@(],.IY7%@B7:!/7@9N;1\BQCJR9'>]1\-GN7.1G)/12S`D4YEJ3U'^%C$9)S_=CQ75*:?WI"O^DV2G^-`:2?(;(_M&$J_F M^TR-!RKT>F^R$GK&'\D]95^AB^`B;]+WYA87O5!DZ7L)!C(=*GX4])F!:9F/ MD4ZAA#"I\>1P/3&W*!=PM^X!_+-/O$O:?A)W!]=03M5:Y MNR;SN8:[RVRA)XNI,JB2M"KYQ"USCRM?-Z`_NJ>&YE1FZ%*FU,F<\.B%+'%^ MH.8E<_V9[4BU/?EQ1BAW47Z:43:C_,Z@-6G:7;V[#9V^I!G-I#$QT.=/[VYN M4[_Z$+C.E&H2P\W_F#U"EI;S@*(716)J6')QUWH#*C`S.G3\R(@E]-4'F5&I M='\P*&-Z`?U7-!"7L"FA8L(,<&HVA8HRDENF4,H)Y1&;@2Z7.0JS']Y]NKN^ MDKBYRQ_/Y&>E)JFP>.Q;&AW_)R;LC"CWA.K.GG0=N-R4MZ,'TM5-R].#"*6':Z26X=:"#=,=FP[6%#@CR"C>O30>DB. M3GDDW$YF3'B228>C>,^6&ZY.ZK/MR(CE>-S_Z&[_(.J)%0R?31%`.(RJVNVBER& MYMK5DEH\WZD3YA/J`?R@)CB!VZ46PQP_=`DHW[`I3T.SGRISJHMC2R/6V=S= M-\(CG-#GCQEM&F+4)KX-[>;L1`J?N'Y,!&Q5XS+J>Q;7'HSEU=XH29_TT/'( MH10PE?"#TE.3WZ=6\E]K(B8M?0Z6\$0H0V6!J_'Y)&*\H/)H- M%@\5)0&:?,]6'DKV<>FMK1\+CN*YU)*=2^HH@I;JAU1$AQN/`V\7U4U&)6*C M+G3R$_&<8,D)P*SN*=\6BC$_J(,$J;F#39&.&=>N\V1Q5RV:9(1PQCSAU:W= M+8K%X9CT39=YYK[ES2PRW3;H7$7@\HAS`:O!=LE$#8OEXV0BP]C@2M%I)2B< MAN>"H##E+(H'=:/"U7[F>8:$*S?WY./!U1QQE&!P6<@U:?%6A%^YK<_E:98* MN0XFX][@=$.NYXW2!XFX%@94CQXHY?8#0J2-A$C/7(J:CI&JDUZ_*DB:WU.< M)#4:&DV;D7ER5T1#-:6G[Q(-'26VO%XT5&;?#U5J:A2FFAN(CF8FUGAT-!F$ MSD0[PW"HEA:&BO#I$:.CE;8X0J,[A4;7"8=TIZCCO8J@P/>7&S@0(Y;(` M7R:2&=&T//.44C_WI51`,9T46AT+#&TXEC+*!.9J00'7-,+L46X2>2_4)S&C M,Y`'+MM4IQ9&(:4+:IRN&C>)T[R\%.50U6KRZ,?&>,ELKMEA55+MZSR>;.&`*85`?9 MMW$8(R=T2A:3[>BP(C[?8O)>?%ULGRTL*V(!B6Q%(J6+^PTM:B")QY?$.WYP MX7DLXC\K5<[[[-=VM6-.4.4?%E\$K1S4@+3VT\)ZOK)JE!P+[2.=#>S/>`@T MC9XX7)_]SUF.$C\.=SR?IP49[E_$9P0-2,KX<8UG=KI.'6%C'@83GQWWKZA_ MA,F.=]EY(?7.W1RS4O# MEA6>MQ7)C3/9K]#T\<-?Y_%*VO#QA9F)/;2O1TR'R7O\@;9K-.)\5*ASUBFP",U3!\<9]J$.PZ;532;%9A]KHB`F(/H.U0[YK`? M7D?W/!-/K7[::GCI@BJ12,&D=$G9?%Z_*8S4=MW0/;NC[HOI,5).X'#NN8&? M6?0QO.=`G6YA1SE,A5Y?PII9G MNJ3@1G6[$EYI_QUO8P]VF3>\C!!=`S6>#&O.;=Z-Z8[1-3^/Y]PF$UGGQ/*E-[DKSO:QK>(ZOE3"6?W2-, M%'UP";^63.>7N`877`WJYS\ M:1[+W?"FFQ/>=Z_8P(!EZ3/=0KXOK:CP\XSQ\,4@=07?\E@5"#-S9WVECWCU M32_D9'8(QZ:R-!*W-IWH\G;B[G5<`H!7UZ16]P$*'>Y:XS!=R#M]87=*P@L+ MH9K.)K*7+87!!6O0S*\YS*SO[`KX(QTPO"+N4AL@NG1[$5W!Y;55UE_S7O/K M##SQWUL.C3U7$RYL2ZW1[ M#V50N.S-K;BC;X2P]5\*_Y^4__SNYFO!QY6F[!GY11^Y$+SG0K!':.6L:/8^ MAI1;!BEM.`QUQ$<;0'R.Q@JA"4!X:0F(SW8T^[:DUG$VD'8&,K/Z.-J<:J$Z M6_:(16J?(-U9$2QA5^]Z;GE6]&H)?]H-X[=C)(MR:'44CH@2"J\_O+^YO;K[ M=//EIS"RQ89*'!QL\>"$:4@=T`=VNJ2F^`NF08U3&O98M3=0F(^N]I364@./ M9B>PJE^GM[NUS+RSW7RUC:K;6P^;)B.\4.K-HP.&V8_);RV M8:"$3W6[>>M8*.'SW'RMC9>=8(N='59)CV&:XSH9;55> MU"M(HN,]8FRJ%7E7*S8%7F;;F44]%%8M!N*TMNB;F78RQ2EWR)!,[5&]/A$E M=6>W[@^1;`]1E@=SKCMQ5Y&_WMEV9#P5NJ@Y7I0E6U8IG`[/ZN3STMNI$L/A M[:Y4^B:_UY7-P3Q0"N9)U1W.7DHL4(RX,GOR%Z>$+;$\PJ79^(F_63:_)/*9 MWUWE5Q&V5=84]&W'Y[58PLLS=+^E'U0M>2V*9]A?W+^6$NT.2U13\BI+HJF+ M_T@?&%XM8"K?\23]ADHE=P$"A$U`:C\`#0^"+U84/^' M6^[K'K.SJ%>;[QH41"D@]N,/O=?%K5#VX0;$)FIT9ZO56#1Q!73=8C319V=S M\`$>;_*:;."1N`]MV!"=7WU;M@2C\HX&XI=BXSE[H'8 M_**BZ;A+A\LEO?<:7J5FOI434JL0;IU/?I>N2=.67](&D4^+S MHM"5NA6ZIC;O76NG9YZ[,!_9FNO;RD:ZIZ#:TU9FY:;MH[,MOC:^6JA1(K6\ MSV#FP?UQ;UQV+1IR5^0<2)R+O8,V0RZ/7?'KO!07;#ML&$9I%EZJIMOLQWVM M37:/P>?2_/QH4?BE'SY9G%5G<_+=NE_CP@/E:P;<4??H1SI[APK*JGMUP:2J M8*#I"A&'L9@*^2IDE(/U5'R?\-Z^,.^M84IV73QO[*1WK&8:O]&N0#CM9)S?B6^A9\_V@CCP)'?-LX\%PNU(= M&--]U'](3<+:-`\V?/A(5N`@#%T4U5_@)EA8/42U:^)^S2ZBS7O5G#YQE4]3VP;]GK(A!%JI=!GNT';F3V%71T-**B M'E>>YYB6$19(H/K(=UEA`Y*CX:=XQ%2_QJ)"Q^O9AA8$VVTZ6X9&'I4HR@1S M7@*$.@]S:V9Q\GF^Y0?1C.Z#%TJ4TJ%MXF=,+=[7SYB3]-;PAV>UJSI8]QBF MRYWY'*2G0=B"DZON9]?R4VUT0^SGG:1YS0K>"K@`2,]<_M?;_FBP>E3Y\%@J M>,8HFZKU02U.5EC#M@-6S2;Z22CQ'EE8X0?S%RZ=KLMKC#@QY/#15O:5RDOA ML<[VK!2)+-V3!\NVHU.8];="G-K`PDS@DG&[54?2XO(WWU,%`#X?DM<&H5,@LWZ((Z+Z$4-X4=ZT?YS6RJ"_3S>>P&=2>$T8<47PT14W2JB M+M,0/O>C68PK\ATC6>/6`^/'E=$;.:*KOZ<,218+ZAB$?+Z.VF?D?1"JGX23 MMCJB-2W7#!;,9Z3>Q$^%;3S5U_%I0=B]GM5?,MPX#,;EGX0]T4/5\HTL_3SE'"6*]Z+XJW8DQAFY=$PS M<)DOYB5*IJFZLCK:R<./'?6>9]/E^)\,<*UG_4:ZT%*DX*6K"DAPR988T6G- M)VSKM_E%:F'QX]=HL[94M@%A_A.^)@XTR3U@481U&'V)_W'OJ3[Y)(PCR*)NF\8!U[HK]=Q([ZE]*OA1+PE,4/[ M;PV;H7(HU#C4OV!LS^4J)]245-9\;ZS@AJ3/S;R4\2)'BB'$+(^O@>$'3VEQ MP^!?*HG+6;E9X58PDRS>M9(]RZAK:.N0D^^)23,T*Q6+U,+ M\8,R)%@0XJ]R#E*:(5&\,Y9A8D]7#DTH$]&H/>EZK<.8JQ.MIR!RGO&#=:TW M6(4[.+TL+[46%C#EBB5EG?$`)!>YU,:Q.3,/+M1VX2JCNH9VLG[H#VHBR,)6 M%+K2K,&V\V!;_V$5BH/54=0:[N!KEXNEP<]"J"UH\7*4/,#V$J9=AC%A\CW" M7,HWT:=&P.+DO"`TH:8!XR7N)#\ M@GY6'M4JE:/2`%B\I.D3KW&:!/(51+-P0>CV+HR_PB@#GTLDV+'6C6TU;G5$ MX4:F-9W@@=MC+RO".?=T+SDQZ)A31_(<[BTRC<+*9=,=M.P@/.!;+?NO"*!B M78[D[&T.J>5L<"X!]6E\ZE,4[O]MO>DS=DK)VQ;($;RPG_&#EK"V=K9+S@_Z M4.E-5EC#3L&-J+9M=L0PTC):XV$IWU)O/DC'6%8#)`/"847:V.JDRV+1Q0*? M9168\'GY9+Z`8B-]Z7@9,XR1+&D.5IA3A5;:)\%1F M9^C*F4I<&'F*I=V?_.FK/E1[H\K]^!1%>U8:/.;KB# MZ#4RI?5#TTQ=)$)AM?X$@ MD/6=U]'E)3NR9Y#.OA?^+KH:Y*8+HGN$?C4$I_C22(QA38I5$.KFC"J%7LFZX)DK*M0Z>(6\[Q-W_0U/7Q%C_,>R09 MR(UFMII%8A+2'?,"HKC3,\]9F5&B,`OO!V6=E,(M]W"4N+P[[U;G16HH#NOS MO@AA]L2]0UDM/(_C\;EU_"A)H%G&+^$IT@F(8:,[)M]QIH*89UBLW$)'A44( M^$$H(R4K$>]'AX>FX;HOW.Y('>BN-W)%G)5Z#OV]\(B0_HIR#7=6&!MR(Y%3 MC*]O55U=NN![Y`0>'<1[_5-.FHJ+*9_ZU9_=$](I$U&WI6#J<9_F^`:RTAML M:L,L>H[ZV2X\W3]J6)3Y74J.31?1-]Y<.).KY$FSO]AQ3>W6KEG\MO/L&LMH M[N$?C6YG5)`D:IZ>31[K#.OO<5]GFWL2NX-'(3<(2D0`YQ:-]P"<^];@4-1^ MN>66V"=`)J0=TMY]:=__7^_85G-"*0209P6>.WC>*8 M"JS\K9/B59/_U6W8/\5`!Z3$#]5XW0P%1ILHD&"=W429#]"\+!]4CEL=7.W+ M$SU=Z5*P0,9^(M-!]`!V`CL/A9TMFOQR?Y2MH`NTZ&2LL]!H+\,7`:XX'V3[ M"JSKDJ//%O4I5$7'5<5!*2&XRAAK\J"_(4X$E0$#$Z@!U$@XL,I8'@TJ>CX" M,L0/&,,D;6*O_Y%,J(MSZ6"7"HJKT#`(`PL3!N[+DW%E]TL$@6&CBX8;0-"N MV.BJK&5-=*`&@L&G:7FSJRQ1PQO>:L?S<_4M86I#44!1Y&DQ4=0*NQ,J`H8E M\`)XL7Z<)BMZ_AX!,*-=LS)\_US[AB1[5E@VK\(7&7WI.]S\%G9_77QC5?:8 M-4+UO?6WT^4J"BMT5)5.2->IGU.2AD]A-]#STV*U4NC.L>O]_C,A=B8XG+AQ MO[Y=GYIAICC)#WJB.`QO'9HG1&)23N7]\-3=^-RO*N[;IR_]Q\7HMGHNK\PU M-SPOK)\8EG\A?%,S1GS8!("5;XO2/B*#/[I_'];+9)7*5G68%\1_=-A6N'&Q M)(D8[MP*^V>$M58*^IY%M5SP>0JO^5#"JP5G;DE?1A!D.`@J9,K'>>7UX]AE M&,Y*K$)>6GI7^Y.NIAO726?RQD$D:J>\YI6J`@EK8*S8FY,HB%`C['&VU]W. M=N&XY]?^5N%6KV!,#VF'M.-6+Z0=T@YIWU_:-4C[\9E^TUFO$"F9(QP,AT_\ M%(>"X@+MAA\UXC(='EEAI3!Q.HS3GA.X2XH$S+T2,%5ED-KKBH-P)&#BG!S( M>3K(V2*J:$H^[Q)8`:P`5@`K@!7BN.WPQ%O>ONM4AX$H>X,?I;=G:$,O=%PO M(--'/7F4`7@`O@!?`BV):#"?9 M]&C@Q6%J3**ZP#$FLR$7B3(0[@%.7 M3`51YFU#?K@+O6U+-UF=5':C:3)^>#CU64OX.@A6@/3FL`J0+AJDMQ>)E96! M@!=K`&&`,$`8(&RKUMWR2!/P[O@Y05A9("-\_UR;-?PCKEX?%V?_$O8P2%9= M)QXCC^4]LL+XZ^K_OO$]T3"`-7,8]X9%S1QXE?[4[7+V94WMZ?&WY;!IPZKD M/F^>0']B^;EQZ7BFLUC05YY/Z5W:XZ!DFJS*?W(]]\0T`B_L%9"\-!`7\D_/ M^X'8A!6DH_SJV)>FX3VN>QG$!>S\1X,U>*#?H#\DT\#T+58Z?N:XK!N&LR!\ M1LO`73I>23^+;Q9K)9#8@E4H=/2&B8J?7IWA49)YTC.=AS0+YG-6)]\C[E/8 M>H'"0V"L>B`\\RX%=(9L="9ZB2+Y?`#&"V2:+;M/ET%'8UTYBH:C3TGM45BX MC]?JC]FJ9#LJN:2`)TPZQ(Y,<>51Y@U;M*0$&##DHX_Y&R M#5UTOMM"$:_/*%1S;M@L,HZ-AAB%R'OU\."2!]:\Q`P6`6M:\;1J=\)8D%)S M[M@/EY3D"\FA>/7`J>QQ3B?A72?+9DTR!I+ADEQ/BXW4/;>6%K5S'6L=N!:: M0I4,?#G9R,"3/`,/>LI@2PMBJX!G2/F[/SY3TK-^-I:9F-.>!MO%IV37E6I? M8<\@95=*>T=O_/XAW,U[9YXHH%UNX-8A!8I]'V7S&!!7^B5'",-W*$GB`((! MC`!&'!TCAL`(D04#&`&,.#I&5!]V`2.`$:*0`AAQ+(RHK@`%C`!&B$(*8,11 M-N_ND;C$F+%9M1EX`U3L*!]EY]%-)];O=<5_L%>A.3$BW$U%LW];G>&Q M+7)@)[`3V`E+"V@!M`!:`"V`%D`+H,59HX6L*(H\&.?.&0$7S0A,6?P_?'^7 M^VBM5LI-3J^!)/+M[TF\,^R_V&6(JP5Q+=.0WH=W93X:)K_/4D+ZI`==AX9= MOU5R8TLWIN_<$U<:R>QRB)J^RL7N&[&+.U.'CNA;IN0%]YXUM0Q^[>F"?36^ MLZ0I;]XYKNL\$]=;O:>^>2WQHTYV'#A47I^M,Q'B5W;NO<- MNF?L(M3"-?ICXW9SXE,+K[TNS MB-E[$MW?JZ5KS24UW-Z^S(I(4[J[)+XQE[JZR;8JO"D475O[]>MON1W(L\B* M*I+!OL0OZ!'#I41CUY$H^^^^8/+X-!_@Y^;5/=)O=@#V>`@.Y6O"[9X%M^;=D M]O=7@3=]Q>CDTR'X&Z:J#_Z\\FYFJG85/#`Z_OG)IL1F`QCS.[I&QM4QQOQ& M%E2@_J2D<]P'PP[_?"5-B6DMC+GW]U>7@U=O^]2XYO]+S[]H8F]7@/^S\9?[ M/?.]KW3'G*EE?C5>HC]95H-K'L^I:4/+D%#L,%CBB_E"UPM6<; M5]A_]99RMJ(-?OYQGRF_72V\F$9L8MEUC/[\2#6Q&NW3G5.Y91M6]/;KZ(^R M_6%#;-@9ERS#%7XD)%JD\4`V[,-X,Z-5S_K/]7/9#[Y9WW]C%S:]LEU2&0]N M/_VWV2WY[-@/[$&\(WBE#$WXTG3UFIC[LU@H1/HD(T3)V51+_CO#L[QO2Y<8 MTQO[GU2C,2/JED*56KU#?:64P[9"@C_I@_ESRC9$&Y2"0OF<<]O2T&+5YL3I M3[HW4\?^Q)3,/=79-[,9,PS8+#Y_>G=S6T8/?2]Z%'&VX]-_4Z2Y#2_(#,CF/ML`+X,*KJ'9PBM!*%+)K@!"CY%U_(Y4:@(_L[5O# M?B"_6;:U"!;BXT._'!]JKC7!#_%X\0@?PGH=&Y5<7P\)\JMAAP1I4-V-QAEE M5S"Y(I,I+.SPD3LYY+WC^=XOKN-Y!U;6JI+5U:4SRRKNJT3=B)O9Q[AY*__! MT79#S>Y&U2R;6U&_N17]27VXA>5')EZ!@6^1=A%6$J MEEEKE?L[E/VLO[63%SE4E%I>Y$:3(-8A=\YOQG<&B6%,AZW<8,4]_)<#K$H= MK%:UWURKU]R,X]P?A4"I_!HP3E7K+[DY9[F>J]P?1[H[W"NJNVMNVS;N\6ZN M8C^K?7;BH\%D/*AV#]MQF@;*?H3ME(@<0]$8]N?W$A9>M7T&BJ'I1?U=\A6O#;:GF*IY=;% MK02QN3[TK"T)IQZ9<$VS6F;U]?&?`^8G^XG^Z;@O]<3V-*BYB0:[Z`Z7&K#\ MQW6$6E1JUA#J\K5GG>G&S+1A-F#TF:PR'3&#>HJF+;?[A#0".#*UJ5.PH&P(=OO!O@1L;FPP MVR-FP")O:M"B9?EM.[K#?$N:N0LME@;&]8:7F M0=U!=GRPZ2AOXR[^PPX\,HW7F>*1;;-?#[#2XG.7O==5;KWM=)HP'&28>W?0 M5[3:V6,;T8N:6X;M1['VT.C:**Z-K(B#M:9L@=;%4WR[Z]JNIO3?U-`RYNL] MKZ'BFUD]-^DVZ/`=I[^-M9,:.CQ3NW,^6M^I<#P:[@/Q^`G;@0BA]NHP0.EL MZ[-[Z5"_4?$)7"Y:06B59]<^+$6W.DBM:K\UL/#\;*LPOEJT1YF#FQ:P6J&L M7PS3.7N+^Q!>_/%-X'N^8;..1:&!LH$_QYFU[#I;-=ZC#=,I..$H_\D6IVC- M+""!LPFJ;YC7-D;"+5D8E#.IYUG/V#L`B_$U]\?9M,YZJ\C2@!K#3\3E3?UX M4[.OQDLZ1%^TV$DFI8S_,IK_-V);CIMXIT(];IC$)E,T>>;^S6?G'EO;<3NO M8&/&3]6D\@O:A?PCI<[D_[RA#[B:SQVN1V^6#$FK'8<=]N6KZYB$3#VF/A(_ MVIC&,(IR-J*5L"//W7A*'62S`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`HO!R:^ MP**8)HNHWCF?+>,^3O58.C:'YYB M7+DNNSJV.1UI'$:&M2B&FF.986WF/[Q^V$=XB(5-6X&ZCEM@PSTV2 M6_"X/.S2'2'3Q.5+=I;LV%PVJN>6#4EOI.96SRR].T=I?^5YQ/<8\H0)T)2! MGADWM;779<\KDS]FT87)%S7(J&7(J-8D8^$CV\K5&NN'#]M=N-E\ M@"+&;:-Q/[VZPBS6CKM[PZ,S\U,\E\OC2FS&2/"M$J42%;]HG'9I3[)%7$6BFJT+Q+A\7< M&R6_3UU2B9$MZ^LRQ8^J!PZ9O;64;?"&L) M_U?(*5+^\[N;KP4?EZX^GOM)]SM=/XXGOTAA]LL>K93.BF8LC\AE!_T\6ZC5 MIK!;B(\V@/@K=+<1G.YJ%94@RU#H#F5E]'&U.M5"=+7O$(E79 M"@+RM'[G#`-#9\\..Z+I#;5I/0,-B+3"(@]5NT-%-8J0^TI M.X.:L';"64O=^G%*CX':R>UN+3/O;#=?;6/SH8([Q@^MJF`-*G@_%:P-(A6L M2/>!#^=B:_+-TQ9,ME7L*6BYLX:MI`TS&L"&.=/-5]O8?-@P'>.'5FT8'3;, M?DIX;<-`"9_J=K/=A1(^T\W7VMC\,B4OCVRL=7C]@L$V1L[(5;E_4;4<:9>OWMD2C*@9JADHMTTEO MC$[)7EDUM%,'>*FQVIM* M+=.I7INL[84V9N45_9T5>4P>2&0 M50V.+@7>,5/LF/>)5.6H%XIV/;6X=WS?611,_.O5]?6G+[^LHFE*;Y",`A4% MP-H-+_^7.E1R`?G=`XOGM'#380PZ.FL3<$"&?N)3`?1`]@)[#P4=K9H M\LO]438;'&C1R5AGH=%^[(3H_-X=W;KV'XDTC\\QRXSL1O4I5$7'5<5!*2&X MRAAK\J"_(4X$E0$#$Z@!U$@XL,I8'@TJZAV:E>'[ MZ_I<;5WHW;JY??;9=X_D`\]T73V[LGWB9))IO)P8FCVSH&NB_NJMVI_H6[8? MWCR_`RU54Y344O7MEJHI86_?5I;ZV;$?[HB[8$-^<6PS<-UV-FRL#?IZNL]E MX:/S?3IKSW!'.JM*U"!]FRF&<^2R5]`OEU,^+X,MD+4_&6OK_J[;3^5MXPO8 ME>JJ-E!V6T%6:,,.O&%_Y;#E]1?2!LTGK(A70>_?S)-+>Q+7F.'.D*'WMYUB M@A$^?%\2VR/>)_N6S'E=QSLG\;POK&?WN5=]J!7?.=M[?6>[<%QH;'^K<'U9 M,*:'M$/:<7T9T@YIA[3O+^T:I/WX3+_I4%N(W-,13L##)WYB,DL\7R*A!R\9 MOJ2S[I,4LX*E8TNNX1,<@^-8ZP0NS2+3=*],4U49I/:ZXL0?F:9("`!RG@YR MMH@J6J[W'+`"6`&L`%8`*T1RV^&)M[Q][$Q^??TSRF7@1^GM&=K0"QW7"T@J M3>H'71U!/\"6/+ZD`#,Z@QEJP1DQ,`.8`-C.*UOXNSP MS,5IN*_"@"G42D?4RFB<#6Y"I<`,!5X`+TKPHI^]R@"\`%X`+X`7Q;083K+I MT<"+P[BLK7NA^UZ?.!=O];/C>>NM=FQV!_F)N%[>217/2SWU*S)[4.-,+E8T MH8[JD2JOL`Y(K,E$.']X/T;K(*&8[E#GX4V&'-0L&G:(WH?4&CDZ=8]*34NPUAM1FDA3)[B?DPTR?$AR'>\" M3ETR%429MPWYX2[TMKWK9'52V7:GR?CAX=1G+>'K(%@!TIO#*D"Z:)#>7B16 M5@8"7JP!A`'"`&&`L*UZE,LC3<"[X^<$866!C/#]3%>*^O7$UP7)X\KE<6FS M:"QVO_K#=W,>3,,V!ZO\].HJZFI99?(MJ^RKRB!53WW;6>5JP#>SG%2A=7V] MG"W+P_=9RP"!EJ,GEZ.MEZ,=>CG)#V]FR=XH7UVRL()%NURFJZ/4.C9.)R\N M>ZY@7\925?W(*]B3E_2Q-FYV!1_C.S6\Z4*K##0:*Q5S3T]D`^_7F?6>3#/J M]X\QZST993C1ZL^::\4;_Y&X$33=V.]7R6NMLL9DDFBR4C:#K;1OJ]-4%35# MUX(99#N_U)[DG@P[H8[TYCGN-\4]N7,\TC:JQ,P4TTVEXN_?&C[YYM-_3;\2 ME]6&-A[(>N;+P"7[]]3IOWJK]!1]4-KAJFHR[:QBA[X[0JZBGUK%%LS3Y"J^ MF8]D&LS)S>PWPP]Z MTE4A>N/W#^%NWCOSZ3:QA3JD0)^%HVP>Q=9!94CH"">@'R0N M,69L5FT&W@`5.\I'62I0TW>:]JJN,MBKQJ<8$>ZFHMGK4YCT;CP M$Y86T`)H`;0`6@`M@!9`B[-&"UE1%'DPSITS`BZ:$9BR^'_X_OHJ\*[7`=ZN M1EW=*$A^>3W(+5D:+^QN`AWNJVO9IK4TYI_L+W2@NVO)?4'Z?LT>\TD>X&IUF!_$,.]>W;V6,UD1)WYW5<332!_6:S^*(\N(#MSJNX8L>L?!CK:;\=410*N;LN)36-/(-],%S; MLA^\K\3]]FBX.]X<$J!/P@ZH?L=1_0M%]=OZY[RLTH(TDA*U0*68EM*2N-)[ M9[%P;(D3M>AL,!G.8Z_OW1_CEY745,>MD;-%4JZ?\L[P+).J4I\.9#H+PHEE MAL3R&+$DRY/N#8],I6#IL+M"1'HFS.RA[QA/Q&4W])+?]R0G\#W?L-F--6E* M98'^A_V*#FPYTYYT;+#T;KFM0R:6?3_EOUQTXI!EA(D["1Z\N&U)# MRJ>/#[SX:;Y+#"]P7Z*A%\1_I,OO&.\=@`.[.W@))XL"`A\RQC]&?] M1@,Z&\HZ:Z8*V8>7BI&>G6`^E>[I1X;W*'G$]^>,YVWVSTN2";TE9:_I^OOQ M5T/^2XF$3.?"'T8S^-A\=R^1\S'_-?D@L=G&>KB:<@!.MQNM)=ZD! MIE0KTB=XOFMPH926AN?3=1JFSX9D$[:HO@J7FE@+4X?2C`Z;(0O]?B@FB:^E MB)18=$^ZHG(IT5D%U-8VX&83D>CS\MQ!Y/(O:4SI8^E\W`B:89 M0\0WLO3Y;6%)5V2):5/)L>BK>3;RE%B+?]\;G2X-!#%JTQN(JJP M.;X@(H,HIO, M/O"8;3@EOF$Q;+LG<^=9NHCEW4K<9:=@]-VDB)YYR.N?BH6Y8I=.H@Y#-G6U M(ANU*WGQ!PR+B[5P7`@XU0L!S*JI9&'M(SELN%NTQ^#Z0![WTTEZ+<("$OJV(!*P M$]C9^?S?@2;KP[R=#[0`6@`M@!9Y*T0?Y4N2`2T:DI=-KGWKWOJ^T<5S\>H3 M'2*D*6M3$N7N&=-_!9[/$[9EGM/'TA6,[\)[\()%E472/X+'&8]$JNT;99:2 M*J_*#FGWRF.MNH[_4?38?LS606X#?`&^`%\[$HO?41+0&@>*`<6`8D`QH%@7 MF`[Y!%V*/&S.)PAC$%%.@9D-5!B)A(/X4@12#@0#=@3"D7)P])2#OBH/1^DT M8:0P$=B+E`&@!M`!:"(\62#DX\90#./2;'/J55YZK.]"H!;Z+6N@. MGY^27CA^D%D<_=`0+:`B@!!`""`$$`((`80`0@`A<,A\OCYI87'"U2M>[SG- M!#@?AF:)G]:AJ"7.A_<87.GI5^X9\R%^CJSNW##H20ZJ"3@AN^G"-,F,]QP&-?`S7/`S18Q MI3^$<0VD`%(`*39:'[FK'$"*P[CA.#,7R6?_['A>F,4]M;PHD9LZZ>L\[O*" M<'#;H52@5-:/NQ@HN?9$4"KQX[)!/R`$$.+<$$+LRD'"0`4\54`&(`.0(8S+ M"B]4)"^T_&9Q@QXIK@1U14O@2E#CM("N`$(`(8`00`@@!!`""`&$P!'I^3JG MN%8L-IX*K5DZ%,-$/O,^A[]*3U%3>]U>;.JT52L.BH&8'4%,G/ITV0H'9``R M`!F`#!P4GXHO'ETQSNXL_'&HB@ZJ"OCC\,<%T)CPQX&8'4%,&-==-JX!&8`, M0`8@0\"#])V\]`[1$2E+G<-8I"PU3@L@+1`""`&$`$(`(8`00`@@!$Y/3^KT M]!N[-.M)@4>F="C)=!;+P&=M>ZVPF^_%W/&\U^C<"ST!/0$]<7PB`2&`$$`( M(`00`@@!A`!""'@R",>TB;W^G3!YI%ZI\41B$>I(3^)YOV%/J MJ698H4%O%$DG4#`GHV!419?[8R5-"*B6AED%D`'(.!G(F`QE=:SFZ`#4`&H` M-8`:9:@QH*@Q`6K@R/1$/5-^I=1Z(I)'S,"U?(MXF5-1G(BVNTSH`,%U`**9 MHC$,$`((`80`0@`A@!!`""!$XFV7%&!&9S!CH`Z!&<",XTL*,*,S MF*$5G)$",P[CU\)5%3R"^7EU??_KRR^6[F[N[F]^H\]D; MI'I%P.,M\WC#6ZN6YP7&_9Q(#JNT9#\1U[/H2V(A'6]='FAY*_KX*G$_=NL@OP'``&``L!TL^OY$P.,FP!?@"_`%^-I\6MX? MC@%?HD8L$(00)`AQY_C&7)KF[R>G=QT!!2%1&@KM;!2:.I&'NI(C%%0:+'(A MJ00``X"E`6PDC]01`.SX_`8``X`!P.H#V$#6-1%K&YX+@!TJ#0)]>E'E(QGV MZ;S@G%:N&:I\B,8P0`@@!!`""`&$`$(`(8`0B;=%/0)6<00:Z#3`P"83,`@1 MOL\N5O-GT+_NW1_CE_S]%/:9Q/:)&]'RWG&GQ(T^4:(W33*?+XTIR-DM^7XTQTW)[B0=]9;@(F MRM#)N?_^Z?KNO^E$QFG\+PQ^Q$&%[&<[,=\=7^<7NL[;G9FO:)+KT$=!6"3F MS>8)LR%(M750JN0I+9/X0GU=CH\-4'8#[:H#<0>FQ75`)-^1#,EDB$#H<+S* M`_F^)*9OL#+]]&_#E^@HQ@-94+"@+U\DC_@^!ZRY-`O\P"54;_@D42["8WE` M9/Y"?^TZP<-C'-F+QG\AALO+__\[,%R*KH#^;AY,Z=-7 M@[&+)V0VHVMD=2W":?L6P^`IN??YS"R/?C2C"Y7N7R*:T%'B4A@60V?B^9Q2 MMD?X3Z9D1ER73G1FV8;-X%>:$?I8E]")T+^\5V:.>Z:8"5$ZK7"S2D]EE5O@JJQD7!J##H,.JP5'98MP'/&.JQ& MW:)MX%1Z-)Z8(C1=8GAU3!\'*]D()WK!/I"DZ:A MEO5X26%CN72):86JZ?G1,A^E@`[@SJU(0WG;K,?FZV%/8'^]9Q.T7T+!&VOJ MZ(V7T.A+US!]R^0CW9B^PR89+Y9.:^%0?3FW_@K5M6&SL6,-7T^[&Y[T3/&? M_^!9HFIV;OV':4$V16MV&2D^2JL%\1^=*=^.G#9,KO6>\EFHVGM9*#F6GOOY MQ\"[?#",Y4\?#->FJ_.^$I>SX!WY[K]CQ[)OI?@A/QM_N=]_^A!;#C>S3Y'= M<&5/KR-KX6-L+'RDML)'JD"N0W/G4VCM!+;EWY+9WU\%WO05-WOH8_@;IO8G M^[KZJV&SK;QS=)7R('OYBE+2M!;&W/O[J\O!J[>#L<+^]_./>T_G;;RPF`C? MS$;D9I8EQSO#LTPV$W MCX%.FRDGNX17.W3/ZP""`8P`1AP=(W1@A,B"`8P`1AP=(ZH;&@`CCB,89<>S MJ_!L0S=ZT:*K";_RT\83GX"%Z%@B]A!#]-#I^/^F' M'`$.E594^UY2H<0G!X@0NQD0*#U2:(\IVQQ<'\CC?CJ]LT58P!6M+8@$[`1V M=OY.YT"3]:&(+1>`%D`+H(5@:$&M$'V4KQ`.M&A(7C:Y]JU[Z_M&%\_%JW^? M3?F($CN-Z;\"SV=)IIY,!^*)D;[Q77@/7K"HLDCZ1_`XXY%(U?6ZE-2=U@9[ MT0E5*<4QBP%?@*^S@J]5FJR6IQ90#"@F))6`8D`QH)AP3(=\@BY%'C;G$X0Q M"%)R-\5()!S$MU*1@RL] M/9U!WQHD0+%N023@)G"S\Y:XTAODBE<"*8`40`H@1<[Z&`$I<"9\AOYW5(Y> MRG6!@AL.)=%%)0$W?#]%F#:9X8;#N`9NG@-NMH@I_2&,:R`%D`)(L='ZR%WE M`%($@]L.I0*ELG[" M4HD?EPWZ`2&`$.>&$&)7#A(&*N"I`C(`&8`,85Q6>*$B>:'E-XL;]$AQ):@K M6@)7@AJG!70%$`((`80`0@`A@!!`""`$CDC/USG%M6*Q\51HS=*A&";RF?M6G%0#,3L"&+BU*?+5C@@`Y`!R`!DX*#X5'SQZ(IQ=F?A MCT-5=%!5P!^'/RZ`QH0_#L3L"&+"N.ZR<0W(`&0`,@`9`AZD[^2E=XB.2%GJ M',8B9:EQ6@!I@1!`""`$$`((`80`0@`A<'IZ4J>GW]BE64\*/#*E0TFFLU@& M/FO;:X7=?"_FCN>]1N=>Z`GH">B)XQ,)"`&$`$(`(8`00`@@!!!"P)-!.*9- M[/7OA,DC]4J-)^(:#T2Z9[=J0R?4DYS`]WS#GE)/-<,*#7JC2#J!@CD9!:,J MNMP?*VE"0+4TS"J`#$#&R4#&9"BK8S5'!Z`&4`.H`=0H0XT!18T)4`-'IB?J MF?(KI=83D3QB!J[E6\3+G(KB1+3=94('"*X#$,T4C6&`$$`((`00`@@!A`!" M`"$2;^-$M!M^9W6AHV\^79KD+'EO',FPIU)@/Q&/G:#>?KOR<$H*I2,")017 M.GU9T_O0-SCP.+ZD`#,Z@QD#=0C,`&8<7U*`&9W!#*W@C!28<1B_%JZJ`*[J ML^&ZANUG/=-"/H-S"J4!I:'*XQ&<4QB:`D@*,*,CF#&41XH&S`!F'%]2@!F= MP8S!$'8&#EUS._#UZOKZTY=?+M_=W-W=_$:=S]X@U2L"'F^9QQO>6K4\+S#N MYT1R6*4E^XFXGD5?.C/)?R32%\>GW[G0LMT5A'.']^4)006S"77V[N;V^L/M MBACW.OR0,M;T<=7B?NQ M6P?Y#0`&``.`[6#1]R<"'CW/2*?(`-IF`08CP?7:QFGWT\X^!=_E@&,N? MOIF/9!K,R^71%A-57ZT2?;=!;DL^-Y5T^&->FGOM>;QM=25ZB5Z;A,T?:B)O))^B5:=B7Z0!^-&U[)M>6Q MR5AV0*8W2^(:K-;\>DPVL\*OQ`Q+I8\+'A?!U"KI)V%\:A<6U%Z]O51ZBKI> M:J,3?9N3L@:&CTC^[UKW@1]R6`RY9/K5 M>&%?OF*5'Q_X[[SUZG=?-P]G\'/?J>5WOO7E;HU4_0'5HIU?[M9PUM?& M$S&6^]Z8SV_"+AO4@/@]*F+:%!>KX]$.7%P\IP+[H+T5;LVXPY&B=7*%6_/J M<#`\_AZNJ@O=S)C-^&UU%5"RIG]_]>>>@UR6<_2?,?&:D@A]H.W",*5SWTV' MM4[04@':DJ#;"V!_L@.45M)30'*62NN6Y-Q>,_6'XS;)&1_H7H7GN5^"Q7W: M)O-NUD>Z5]-_!9[/'MZ8^$V&S+5+K&_'">7$KIV%;2T&ZFBDCCJTL*T94AWH MFMK*PCX3:DIY-[//Q/,(87[#W/$"=QTYV9;'WAXU(R,9-JH9Z;KCD:XOY%FZ M+8QT16_\_B&/9O7]I+$4QL#&FJJ]D1A%*R02!=&E8;](<\Y]DDN,.6]O1UU5S['I'TO7H:_] M%_HP7D?1=EPJ#907`]F89N$!TGX\RB2^X^7OG/)7TC&@TO"#>M)MQSM)?)]26R/1(^A M4Z&OHUD_&Y[T@][3I84UGU/4EZ4?M-XD_HN/3]]8?2S-'#Z`]$(,UY,('7`J M4>DA3'(E794E)D?\WSK_,0,"F=+&6Q*3U7Z8O_1*(JSGRDJ?*9GFCCMEFTRW MB]+(DUCPQ24F?9EKE^$QHZNQ<%S?^@]]B^T2G9AK,"R]9%.1 M[JGP4C9Z"C<[W&K))^ZB5U0#E#&)1#S3F!M1C\;DT_<>/B$J*X09O?&DA4'% M(LOJG+\LZO)\-OXBTD>'Q9GY>G\)7)L0:6:8UCPTQQZ-)RI$KO5@,5ECC_=X MP5)BA\Q9.IGDT-%XD1!37I@[S^$D#&E&M^*2#<6H3IZ9=/M\P6$OR[@Z:K0V ML'4>(6<.HR?;7R0S&LX"GZIJ"C"VM0@6G,,9=H9Q$0:K M_PXLEP>?&7AE\&_-/XQ)3&-IL1]'O$3Y:SDW3,(DB#XH!U/2!0=F"KGTQ][K MGS([N''_N,DLT:G,E\:4H7-$0B7:`O:)MZ07HV+LPDK76.5?9&R>\+ M6*'M=-G)7@V(+B<;96&2EX5!3QELF0I[T$S8/QBD$&[3IG@R!R!-YKV>R04* MTV$2%Z]3J\6CX\Q-VPXN'S<%RHFTZ::`$.7M@9/K!U(5/6@5$]$;I>-WS7ZH M9@^1[I@5RFUR@"@;JIDX4RX%K'VF;!4)Y,$P726ZT%1O!!2@0LN)=*S+=M"* M*:V8[^D-K0BM>!Q*0#N*H!UU#=KQZ)(#![-[JG1#I5"H4JA2J-)S4J5:IOHY M5*F(JA3:L?T=I-HQW]H&VA':$=KQ3+7CJ#H(VRPZ0#V6$PF>9O=T:;[+)70I M=&F7=6EKM.@/LR<<4!PGXE=5%NG1EM_3=#UWI:$I/*W5?R0N,68^<3N@0_;> M84%%IPEE@XX]1^S8`]?/)@=R%.M-19?5<<7Y9<==3K1-$M$GK=12?=@AA=)L M3>/%7KU3+T=:`2E3:TPN*">\O"5T>Z8 M)(P908T9595'_7&YS5)AS732DCGKBI[L+P'N\V8GV.*=7FJS/3SR:\^&^>_` M\JSX)O0_B>L97Q\-=R%-`Y==;0P+`3B!*ST_.O/YB^0\VZS=1W#O65/+<%^D M]W-^AYS_RC!)X%NF,?>D]XZ[[(5W>*D>9[4#B.&:CSP4,B5/9.XL>5F2U=UM MRY9^IT-8MN<35Y:^$MOV7N9/AFT9X55NFWZ%SC2Z)EYT]Y+-=B3)5`C\Q_A^ MM^^$%[_C,=@=7_8!'4:/KIA+O[&2"W1MX;W\\'KX>BZ)*7J2L5RZSG=K8?B$ M_N`'"A2*HO"Q58V_]/X=L)OW,T+"*^_T-P$C`?O*U`T>RBG!"P),V0UJ=E&? ME1"@VT/_$UZ4=\G<8-4[Z7K8;GREPYBN%:XQ2WN//+`1>]*5)RT-UX\ON2>V M-['Q8NDCN6&_L'E0].US^?2PX+O,67R5FY`I_^0X>_?TG1@VV5[ZT9F]%\ MZ5JL4(:3$Q5>M>">$#LQ7Y0.2,/,C;V6S5`TM32G$5Z!F%7,H!2.^2PLVL#D M]99C/_OG6C+Y=QF3T2VSZ0;\MS6?>[+T:4ZGZ%`1>WZTJ$2Q,BCD.QV[37WITG!`UKRA34.A0V*\I#X>2<$]I37G`2ZV/ MKFIIO&QDU0%C55E:S@./UYIA%4$RU;WQG%458>01>]8N5]S!" M=B8VJZ10N(ZO,0,OG"=>P(%R>)*N"7RA7RJF;7K3'HUI#.JAX,>E/DJ&9=(: M%@<,TW2#4!'$%8$L7F&#,0.' MVI`;^9BK6D'QM#BQLE!U]D#U:\`TTBAFE@2YY12SE-A`LG3UE^/:T@5[W*]4 MJ9"7UW3[;+/'&&_-^":UB9QPN^4L_'G4$K##0C7W@36?KJKIK$M!21=L8G'Y M'4UY.36T#"G]K>^/*\QS38K!%9RFM MIRX]4'O)Y=5;7-]F!:.MI1P)3\SD1:6`'-,,Z)OF"Q,>1JU!6L4[CD\!RPZH M.>6'V+RNV^.87.53VVND70[7\[VB1`DH"L0+E!/S[$EEXA_:"['P1Z@9UJ!> M`SG?\]AH[$G_""5E58"(5?JBC^*CRZQ8$@D1G.F8R`ZEOVFA9]5 M;(J4S316,(S4:<7!*_RQ!U'EP17-=%W%C"L2NN$>-8>\L#@/+S^VUB1\FAZC M+LEQ(",C_:;'+?JPG!(=^)FQN$Y02@NN2RVE3/%@R?Z>,5LV89*OJS6% M1/-2;E'`P)8_CS/BLVOYK%"4[?C,$(VXCJ\C_3RZ0VPA%#ZL[^'^)&V[!/1' M&[^J1Q79OLQQ>%DOF,^L)WT,7&9:+AR7,@C]\:^4MYFZT,+*:6J%L9-R0\*' M,)472S$W@E)FPE`>9HQE.M78'&>T"-4-'=OSZ7Q61>B6*<^`T6X:F)1(6219 M/?KWE8F?@Y*0(V)S)IPUDX:5#,@ZG6.Q"'C6PIJO=K5"$$)[BIOL:9[F3,EJ M0+&9EP!?,<]:X11#_X]NT7RK2F!\(H_T>=S,Y[_@Y:M\:[[FIWC+(Q@9P@?( MJ=;?N*^K%ZC6G$SP.J*A]%/6NC[UK:C:\?S0L*KF53W[G&.Z4UT2S7"IGCLMJ3(8" MPL(#UC3R.)+K+C>CURM/ZU+N[T2JM-C)B"S,E.XLV,#,7CU3(S?E(*UU+/>% MC#*E5N(`16JK:(:%90RY@*=FQ&<:&M8IIX`NC1$HL9`HGR>Q2@:$B=B%%=N4 MU.ME=(M1@^]RDFERR%<)?.OBP1N+_F8+ M5O,?7-G3L"CJAU5-U#W[#`U>O=5Y)6HE,[?LH][N.9WM*DC3Z6B30TQGN[K/ M;#J[48?M:E2&.%F%^":N^!CN_QWEK9O9>SHQESH'F?U3!J7-`!C,ABA+>3HL M+OIQ55OT-Q[H>?7VJZK\D9SV+E/*=_/8=IS;T-9@PS6]KL$.RTI,)R]9>Z]H M6+JB=3@]&=B/%O6R6I*^]Y+"-1E_N=]_2G^/\6G$I7&\OPHU]EU+0GR45V_5 ML&3Z5M/*%4:_HB!],[LE5,IX,/!K[,NM2[K_>^;G%C#Z\XH"ZW[33K?&*)M( M7CIVG/(X,V5J/(9G"M&)0N5D-67KR3;%(Y-2'JDU5N;>G/7QV/6AFTW M.-D?Y_=81Q-:JQ'FT4N89Q4`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`FOB1D_]9F"?S@=,I6IJV#S4J-AVS?.)A"4^KQ9A"X,8''BU45Y]/BIX M6[SD7,'G>!S^=2X"J8*XZ]XKX3H356#9[,,#.-9WPPA;IE#>H'ID_K*>['U8 MF)SO[2.5/K9U#J-#7&A?&83EFG,SX8,R_&,?K#KCN.%B%U%-V_+=Y=\.BX1G M&G+P`L*\ESRM`>?T:* M?WMT1NQ+K!%#>KDR$Q'NID4#)WDNT:DA1Y"2FKVLM.Z#2U@M>,D..!?2N2>Q MEI?,]:J+%_,RL.$*UF7M5[O(NWMX7L!KPRX#E[WB!;VC)6PQ>[Z=89,3UI.G M1#ZBDOTAJ2;E\I'BIR^'[9FXH$>UOJE0\>K& M4V-37>>BZLJ\.+F=E_K"F=#]>3*L.:^)%.W$/:LZ'#+;.)Z9S,E))\WJF?LL M`,P>&L)3V#^!_W;5H:"(QK*D#N2Q-DY!VKI)4;Q+C)-C1$WCJ"P-Y8$V*?D] M^4Y\ MHY@THV;SZHNQ_!0NCG>HRBQPW7I-EYX(JY1/M1$K_<\<(U9?GY=(I],A!M4I MT?1GENOY43\%VZ93<;VPB17'A!@1PB+GX=39_(H5:);BELTK8EO1H[VX0\@\ M[`=DL)X:).K;P";,&Q)$P9]\27P85P6,Z[*])%$/LHAT$6*RUQF MAEQD]&*N,DW'98(V?V'&3++;1`3<"ZJ8[@GGS0TB=4]>'*[NC9!E"A_XW\XS M>6)M^WCY\?`1>7G/SGV;Q_,R\04(0O\T^"JY:HI5NQ6U<.D519'/E>.N_%*` M8Z`K785=,7XC)&[5QR,$D9:MT,6);Z6M5&.:[JF1-E#I(S<;J/QK6<,TM!A7 M'_%>BBY%'&G4&T@+RBELN$C7IDP7WCF&/2&R]V9IHTWFYF7D:(>_EUG;E[B- M2JBR6?%D-PC;E%!%DE">D59UXPYMMA?,?68CUBN+?_*):V8U_&,UUSG30+F/4332CQS/7C M7E;T2SP1>%`::&+:/�RH";,^_E/>\SF0HX%:C]JV_OI3MG:9G22!W+.P<8 MU[-*QLW7T5LUCMXF/TYOYP6=^H*PUC'?/EY]H^9.3U(U7;IPR1.#(F;5]%\W M,4.NGR4>PI>B&'YF)GP"].$7MZ]?O]YL(Y;2FW?JHC[UNI-L6/WRV\F-498DU]G2N:.B*8CDS2?X53*/&S+E5L/97E`3<`'ER MYG3.882*/8T.G"+QH\6:O/&&;HFO1NWO^%+"!ZP&G%NSY")2`R8&6\'<6A<9 M/EVH':KO* M8YE))1.K#_IAU)AI]DG3?&7_RKK8& M&X+J$H,I"79J%ZTOZLBZ8NR*5:?Y(Q8]CHPS8K$QO5@,>4NIE&(/P8:O?!V9 MC=LIRI(UDVRJ6#V/]RVE?[%NG,8\-?;4HB1S0R/`?W18%^1X#F@=6Z:_&)ZY MS&Y)@DD:3&.0RW>!'O:4V'^1V5_:RIMA6TK?Z*_>R!A+7IFU%+G8[/=A[VVZ ML\L0E>8OI2'E'+2R`OMS5!F^C1F4K`F[P389O MDDHE\*(H6UI?Y75I^J@L$S!D7PBIS8X:'-8A-3[Q>.:]%3_5ME>;Z0&@*D=M`M#P%4#?61:L<3C(U%:OF5!_F//ZY'0:SDNL M/*.O2%5L,BDT71M?+]J]A36=SDD1D^YTMZ68SPZ]XR8W8F29(7QM=W%C2T,K1,0@O)[*RD( MZ-[:MS"E,R"''>[6VK'#)[K#FZ!=B/OO&?5PUM?:/^3/(%IUO[?;H?ZFZE.A MK51TO;?>==[BU57=*RY_\GX7B\6[6;Q'Y;*_55];.3Q#Z<=EJ-9(?5E-6TAC M)Z1QI/ZM4MDV*2+5UE;[6]P94Z9;0M(>F$^RO`ET!CJOYWGZZ#P<`YV!SF(B MS&@$=`8ZGS,ZCP=MH/,>1Q0(334=FN+9K!=6=%7AM0#AA%-5)P?5R4?6*\)` MXU$FDI]*ER..K0X^Z*73E"ICFT4;O`:CLP*J%9;LLS(X1*?'&"=#Q%/UC-9$ M[/>4#!U/CA6%L0,.(1,ETH%P5K>`!^C=??0^`]QI]5RJ5]FBNI#D!S*V"UV! MNN8P,JDZ%JZZ+;[T?+"CH[-3%DHO=S1]>EH"IQ]0L16[J/6T_/$'S/F.6:*G MB]"YXVD@-!`Z,<_31VBUUP="`Z$%Q1@@-!#ZW!%:Z14D>"*'Z"2",M>I2FX" MQ0A/#0H1N3\E2#P`J_#V6#52:4Y<-I$L(S#>`+0!V@!M@#9`NT-X`]`&:`.T MQ09M9,I4L_II!F4^KJMJA*K$)6AQ]':[1L&P-QG44-N%FWRF%Z%%DC-H=6AUD07E M-(@(K0ZMWH7!?QCU1L,3T.JMQI'#]UF7NY@FVW8MW(^;4R';?P6>;\U>B@1N M!P[9OG%A8>V`RE=7DAY#"D9))?,[N,'H=\UN5"F5Q/C6Y+-8]!&I2GTVV`"#J"CJ#C MZ=%QD\74*F:_D;Y>75]_^O++ZBM*;U!M=HM#YCI43/=LTAHF8M[_Z8XO)\9> M-@4]IT[!+P$WAYW9/@>J9TR_U?.L:;SLJW?JY4@OD/O4TE2EU\_Z[ROZ?WLT M7.(5>A_8D.H-N>`.HQ-XU*4KJ`'=H"*UG6?76$8K"O]H40UD#9934*(P16"* MG`KNP!1I2Y7V-ZE2K3<>E*K2WXGU\.B3_)U>;,H^FS+8M"G#WK!T3ZZ>B&L\ M9$O>84.VV9`/WXEK6AZ1OKJ6V6K50-@W^VKF0QDRIT"K-JV8W2R6%J*.>0/J MV'`2JT>I$).%#=^*1\A;LC`LV[(?6C(TSH*([^FS7,/T`V,NW1%W`6[<-0KR M1U$++!@'`BD\&`?;TPK&P5$V[^KAP24/>Q8G/W![_E4GJCK(AE^+D-2K>*!@R3OJI7)NVV2 MYJ!W`39>2Q:@H/7&.4P`)``2SA028"\T3@L@!!`""`&$`$+L0J1-82E$FMK?P5]< MPR[(Q$-`J=UE`OX%AW]5UK19`AP$(-7``X`!Y'``8ZC M:`P#A`!"`"'."B$VA9:0\>2(%8>*K]")T.<5^@+Z0B1]<3%6DAI]^O6 M9QV&^NBX,V*QVBN.*Y'O2\O-1J2.%HUJN`1!=V3I,/0ZZM5?D?14/5+E-=E! M`V-9)_CH^FL_1CO9N!G`"^`%\$H1J]_K:\*%\+H#7\<7R\VEK,^*'&?)&-MY M^B>IT.#^`UX`+X`7P(MPT45DMSEBA14WU/.J]`.0\M;\,J%9!#^BFL@C+9?@ M`OUQ7*DY<9$0&AQ0SXM%S#3Q(F:`A#-8II"0`'L!3J>X#`.$`$(`("+6\!.$5@`/`021P@-,H M&L,`(8`00(BS0HA-825D.SEBQ:!0RPOZ`OJBY,KB4%>0PR#$G<03%P1`0D<@ MH=]3QX`$(3@%T`!H$`D:X%V*QC!`""`$$.*L$&)3_*GUD!)J>>VTZZCE)9XL M'89>*(>S$ZF.6\M+G8@7&.M..1Q4\Q)0)@%?9P-?JMY3<_@%`!.4VU!P!]X^ M"NX<`'].)`0`>`&\`%X`+\APJ^#`,PHM;JCGI5<%,I#VUOPRH5D$/Z::R)J6 M2W*!_CBNU)RX2`@-#JCGQ2O@#X0+^0,2SF"90D("[`4XG>(R#!`""`&$."N$ MV!260J2I_1U$/2_`/^"_(-]"[H]RSB.0'[8AP`'@H(U[@PG`00Q>`3@`'$0" M!SB.HC$,$`((`80X*X38%%I"QI,C5AP*-;V@+Z`O2JXN]F5-R]>0AK)8/0YU MO0`+9P<+:F^2[3D!2("'"6@`-,##%(UA@!!`""#$62'$IAA4ZV&E/CD[D>JXY;YROO'1U5IW:N5TJ=@7T`OH=7+H MI6F]@8!-([N#8%T03"`9D.SDD4SD.`/@#'`&.`.<`R7+6LJ1<'#&DRM#JZJO7[:Y*HX8-O3_`*\=P2J`.\=AG?8 MK76/Y7I]\3IIGR6L)5<4]UO%=ZR8:@9V;J-:EZQZGZA5+UMOF;4DUREK[EV)[D)#.&[:E$$L%8RY.F9$9G M0S65)_ETY*DUFQ&7V":1[HG_3(C-WUX8[E_$CY[AS/A[[YW%TK!?0A8::^KH MC2>9SF+AV-$,#)]_C]"'1C]9$M=RIGP:_).HP*FT="US-:YE7]+_7-)QR$MZ M+3V)+=YW?&.>6SC]<7K=\>!3:1JX;/%L[!=BN!Z;$7T[%X8.^TCSV=$7FO1, M:6(LEZ[SW5I06L]?I!_4OMH;20MK/J?/D*4?QKU)_!?_W0^3GKK^V"7>DIB^ M]41_VY.NZ&CLK6#NQTLMF;&5B).IZQ34>#IDKJ$9>\Y@<47@SUYMH/!ONU&,_,8GK&Y8MD<5R[KP0^E0F?@O.1)RC+/K[ M=P[].FDV\13'PV7Q$]E+SG*3F-,-^>. MQQ`BT@LI_-ZH%YQ0ITR-%_83ON*52@CY/J5G^"087Q8SHFLP2^,E9$CV?<;\ M;&YK3F3OAH3-LJ)T[MS8W<%O;.DWRD%:$C534L38).(GR@,C51Z,M91@,1;G M(N41VZ)V$WT>1;`%H1,.L9!Q$N-X;?`WQDT,!=<3'%/]/_<<]NO262\<:GU9;-HIE-9Z^@JC8RRGDR;??1()3?BNY!-W MP0W`"$028&'1^3Q9T\"8>_2U]"U<\&^K!?>D&_;NT@]UT6!+HFJ#D=Q7A]M2 ME0GY6%;T?N);Q@JBV%\+XR\2&8'K"3\_.FLC*%PV*SFV7K27(2O[!;5N'^@/ MV-)-EQC,#O2-[]+<,NZM.36:2&1-1C,A1A/[G:7@F-.5S4P/3:6-%*56P'@R M*28H`_:U;;+"<)G]+F18=2!/^L/X)Y$58"T69&J%O!0LZ7(LSPL,9N''H.N2 M!642M@`VP$#/#.`DE]#O)7S&U:OKT&`,C<"B)>H#65&4>&`ZX?P*UQHF8Z4H M"V&Y;_\M(,QPJ,J%-;G\R5S_NR':%5*1!7VB;^3_E6-W+WR2%QRXJ=89Z-VUF(=@K1.CNB-WS^$8GOOS*?;4*@.@4R' M<7I,"JT6?>K5A3"I\4+'H[? MD,EYQC3.]U3D'S@:QI3+^K=]IEOT`"/G^XNZ,2\.WK MU7L*%#]).IOC^YO/-[>1.*2G)^@%QPY5%SH`(D)E0&5T`.Y^CV+&TE48,X;* M:%ME_,*#%-9P<+Q7GD!&9#0O4O[,!@SOE^^ASQL0R@!V(996N@#V(8"<`EL0\""2+"@]GO# MW$5Q@,.!K$3$(`4S*?_)`Y#MG03#H(3F.!'-<:$K%7)RWEKCH"U53UP,``@= M`81)3YD@W'BBX<9:.04;I/&,[,GW[#;*/!^C%,ZFK)DSDDVI4_)5I[HC7$TH M),'3;$326)UK`#G65"U/K>/KMG-I`7D8^=P(::`7\`QX!CQ#5/CP>)N@L1IQ8;4<;F4("Z$[(,S@@5DIB+KX,2#Q3`9D9L*-2`0)017 M!WJ%#P5%`.L0L'"6L*`.>KJ`3=E.!!P0A>R828G[B*[1& M_#CDI@(0S@X0U'YO,MZ+#*<-"AT/."([%=FIR$[=AV3(YMJ)5,CF:HGG3I;I MD)T*/`.>`<^$93K$A3MFQ5=FIU94A!3!L$>XN)L@<6+1H6&YE"`NA/R#,X(% M9*`8\$Y;INA7HW;Q%6F]$H5*:.L']G*1G M==XV?F5.:N9NML!F?VI_\XI2S=\KZXPH'HIF)Q)L:$U=5I"K('AUYLD0^S/< MR7(<0.T<0>UXZ;I=`S,Q$SC."=#*C/_P?8-9T.P9]*][]\?X9:7-K(XWVLQ* MWF96MC284Q.L2=,[3M,OE*:W&VAZY4G.+&\BRY+_2"3?\8VY9"RH$^2SKP6V M2TSGP;;^0RUKTUDLB>T9ON78]`_/EUPR-YC-[3OTI>>[ELG^\GQ*%LEX-MRI M)ST;GF0LEZ[SW5K0[\Y?I!]4I3>6%M9\SL9Y?K3,1\GR)/)]2D5&?]+8K[/Q MRO'V/=S(NS\^TYVTZ.Y89F(F._%"],;O'\)IWCOSQ&'1A\5R[KP0(GWCN_@U M<,U'@U+^Z]RPR["_@U1M2IH2"+7EJSLJ9E=_.:XM2Y]LLR=5$5RZ8$(9AY(T MYS2H?#+Q8..] MIW)LV"^K"-7HC<=D>T&E,11=_]%U@H=':6F\N,Y\+DW)-#"9U%.A*ED1FYA$ MYTU%E[!A7/J#P`VE^=\!W:G9"P63*97>;X0/)?4U/9[0)]LGKDV!YY8\$3M@ M,YP2Z2*Q[D^W[Y/++IS&A]7*GQ\=2A#Z'/;TI>'ZEFDM*?C0S>;/XY-=&"]4 M7?J/CY3]I1G51)+Z-_9]=?`W-J][M@?/%%L8(1F4\5\NX]VAW^"T*IS)MY#< M]%^K'_"XA,$'GUJ>&>%KN/PY\3Q*F(@8"\/]B_C2DH(I83]B[]V3!\NV+?M! M4FPR*R0Q%9'V[M/[Z\^QP:&3[[[E[ZS7(N4YZ=Q MANY)0EL=ZJF&'>ZX0__E9B@0S$]]^85\\\FF'/Q@41&->&.--4R8B,W!@LH8 ML3C1EA3!9.D^\*DIZU,UXS\6#ON5?I7*-Z4Q%029$I[RUWPE.!YCRM63N$S- M+0IY(;3\H`UD15&D9\?U'U="*3,+.0@MATA$$A(4OK&-H%R9IN,R09N_R!PK M^"^3,IREP0I0;$=:.'2N_B-%\1\T5=8&"E\)HUPEHD0P&>-4QHR!QJVO<=LU MI^F^4],V6+`-U%9F;4V-RWB'&KV6YS&VS7)`H2R:\X#K@.A)_*<>ES[#I?A$ M;?I!TCY?2=!:'[)Y)C7B-.`"$7H#1N0+T!6HT3N-.N'K3RC6=;-4GIT//IOC8_'7T3< MF9YNR#-4X4=.5((HQ2!4P['Z^^I M.^EQN^D=LY:^&B\+8OO>'554[QA*O0W1Y>=XN/57DX-=N:YA/Q#VTW++DA>Q/XGF]P*^I+P/<@L"W_ELS^_BKDEU>4S#;3D_P]D\KLGU?>S6Q, ME;^F*/T_[YZ=NT/^-[^TK:CV;=$_FWM]???KR M\=5;94V3QA?QMEDB\5N[WB?[*V>,7US'\S:2:?SG1VHCQ62Z<_8GF#90)U2. MFR-;P;*:(ERX#3>ST`.X"OQ'Q^4QC$UDFW#NTD:_&2^46H,_KQ8<(NAKO8(T M`X7_KP'2E$W\;:S7CT<;3>&T&5T%#Y0]W)*[QHV3JWPQ(O"9QOFL+I4X.!U`"(\.[9J>Y*?^ MFI_ZVU)J,-;&[2-YCE0,'#YQF_&:6W#AMT,B)Y##^_"=N*;E;<$I^U)B.-`R M*JWV')LVB*A].J-^>\`8SYY^^+ZT7#["BKJM$Z6OZVJCW+%Q20V;2[5M2JV? M0IRM"349-BM&!79D(=[<;W[$??81:[)';)0AP:"4:ZC+%Q.";E\Q:=Y^'?R1 MH4,3DVR*,?B_V-WEE42KV?4/2]>?Q#@R_<0_7RV[GUUV0]-KSH#98NVCK=?^ MP7#G%G'_8,[SB@9Z:S0XLB$R#IT![@NH*<_IHQ.X/B$E5N[EX-7;T>`8UDCS M*G92C@O;DB/G;N^B9`6PNYHBA=KGS-$)1[HQJZ0IX@U&A[9-CFRW;!CNT_Z907 MJJ\GK>;>L"&S+[FV9NOQY"C$$HV]MI:HB2H$O:ZF_PH\/SSS=-9A M\J^&1;W?]\:297Z6J$IF/H:/I+Y:PHMI1/IR9P`M3+0(4@]+CJVE2QN>`SFV M%AXU&VPX##GB3,]OQ'VR3%(LL:L;H5PX/2Z%R<]9QL$7Q_^#T$6O4LTKB))Q MAW*8M_+6L*E2,("=/KP^@`$*9QFDS;/AW\' MEO_RR69YS9RY;UB"X]VC81=&0C:ZUB'>Q`&^.V<5ZKM=W:+@(A`Y4->62TS? M<4M<[1$[6&M`@=5<96/^=]*7N647.SSZ`)-^RFYVK$BY#%R2(V2_'B%_,VPC MG$N>E-JKMTI/&S3@F5:M)S(KC;_<[WM;&K\Y4VMFL?!XENT*%+X^*"/5-V); ME+R#*D6ORIAL,VTC%*:1GUU>`R1%9/* MHWI4WH"'8T7OBT';`Z-A8V0\%!8*JZ##+$8]A$CF$$2O=F-(71U/)L=3T!RQ MK\F,N&[I(W^W_,=/]M1ZLJ8!-[@6CLU7&%;>_K18D*G%$XO_L73L3U&J]H'I MJ`XF_6&D@5I93_/I>]'A:9SO3FU4OD<;"1?F@^I[V8647`.]^8/@[%H$-K3[ M2IDGNZ,@-W1^6E^0MSIOY[&ES,+X\S+GS`7F88.48M9B+@EAEPGGEMW`D4:_ M_#"O<)VYB,<>IP:-KT4K"UMMMY9<+&OKI32^$KT>]V57LONIR/'C2EH_FP6X M'2,JXP/&F\0)-]468!:&TM2)"'$H;KBL[=^;&7OJ[^R..3-7'LF<_38N`!!% M0:M-_GYY^N1JE6R4>%!V$,TN=!5F*&0=`$6-;*V:4W[;VFK+DR6W6FTJ#R&[ M6G6PUVKWM@FNHRO%;(6_\1H`7UD)@)OHGO(UJU]039WR=,HMJ%-(CT,LZFU* M.J[X[>\,B>F.K*ID5")I2_RAL(C-.OBU:8Y)_E\QT+?@_E_48+IS?H^NB-/E MW_%KX%YJ3D=;H$J7&"VP]J2;=`%VS9KMCS-JM";37P[9(;(5,X<&A2 M;^T.-88048J?IO3U<0/4*EI,5F\VOA6W9&%8O"3$86*K=,E>-E/7A3%)//YTI@R:RNJ5J-$!7C8)][2,/.?I"I_ M*H45Y6L5X2Q[H^3WI35"&VF-M2I5E5KF<)!NOU>W`OYABB$EI]-PH=3*0HX5 MM5.;K(!O.HPA8SKH1;NWL*;3N%M!FD]WZDV1I//Q=IR%"(A;/I?#;WB^T4&S M.[WEGG:])2886B"&UL'08.A38FBM!8;>U.2HPOC:KI+\%H;6"0A!>2']%`1T M;^U;F-(9D,,.=VOMV.$3W>%-T"Y$_[J,>JBI\4^K#]V'N(O%DS,W?&MN^2^M MNM_;[5!_4U?VT%:*6K^D;+&M;:^*U17N_\8G[VP%'LS82TAYFX/WAW^KJ+][ M%(;2C\M0K9'Z\A#MK2"-+>_B2/U;I;)M4D2JK:WVM[@SIDRWA*0],)]D>1/H M#'1>S_/TT7DX!CH#G<5$F-$(Z`QT/F=T'@_:0.<]CB@0FFHZ-#6W9D2ZL,(N M;MYK`<()IZI.#JJ3CZQ7A('&HTPD/Y4N1QQ;'7S02Z=+KN&3@QT=G9VR4'JY MH^G3TQ(X_8"*K=A%K:?ECS]@SG?,$CU=A,X=3P.A@=")>9X^0JN]/A`:""TH MQ@"A@=#GCM!*KR#!$SE$)Q&4N68%]8D]E5XL,I\*%",\-2A$Y/Z4(/$`K#+6 M5*U.*LV)RR:2903&&X`V0!N@#=`&:'<(;P#:`&V`MMB@C4R9:E8_S:#,1\-R M&=D"(BT)VQY6==KAM:B%X4QH#6B-,]4:/[1['CKL*>-R;53)G>>``&?`O+B$ M@U5N-(X?OLT9W[*-$?[Y&V^XUV9*8!5C9$TGB:7$UK7^NZKS? M;NS0/2CM_O?GW;-S]^@$GF%/K^SIW:,;M3H,U\L:'6[5LKT_;*`;[_;+;:KW M>6,$UO3;-@`@2LY>-A$7_(.$WA4V@2X(0X>C/!T0E\O_F)]W6> M>$?9PC6RO1+NHL?A%3E/& M3DT).RNC\I&N\E-41.7(7HK.D$U1VK)^BE;[5C3ZMN.D"+7$-AV4D(4T[9Q9 MJ$W_)!+1MLR[3M"W3?OK$]%E]N/I`* M3[M[+?MZR;4=*J19@YX-.#:@9[,.T&G0,SHO^H5^T?<^V5^):SG3WXGU\$@? M>O5$7..!\`^OZ8-7$UQ3-_"F]#<>&]MK'P5X,F\#E-YMU9VA>^-HP9*QCDMV M\:G>/*:PPW*1J%YP_IR:BNE3D/)?TN?,&2J5(<*KM_P@GOU4,LE\OC2F4\M^ MB,[=E>@LGGWB+0TS_TDJ*4M1BO)A:N4LE+U1\OM$6D";97>2RWEW^K2ESQG;DT+IQ0_O/+VUWY),1MN?ATB2S!ZX_HSC84A\QU MJ&@Z3(_']-(:)F(^[;,[*:QB[&53T'/J%/P2,+M=6IBJ]?C9M>45_[I]XF2W!AFRS(:SMK1_YJ@6M;QM4I+;S[!K+ M:$7A'RVJ@:S!<@I*%*8(3)%3P1V8(FVITOXF5:KUQH-251K'"6'?-+HI@TV; M,NP-2_43ZZEIFJ\W28-_LJYD/9(6_)PK!LRWYHR=`X"R*^I\]R#=,/C+G$DN?! MC;M&0?X@AIL+?\`X$$CAP3C8GE8P#HZR>5L\N*PL399&(4%U=07#Q^X$W@>SZ5)^JZ2(8O71.3IW)* MNBI+FJ*J53QPD)I%:F7-HC9)<]`2:!LK\>7XY%0I,=I$"9?%+*I$IE5:3&1] M,MF+#+LHE_U8Y61Y!>!P?'#XH=JF/0M0T'KC'"8`$@`)9PH)L!<:IP40`@@! MA`!"`"%V(=*FL!0B3>WO(+^CF\_$0T"IW64"_@6'?U76M%R8%<@/VQ#@`'!0 MM=YD"'`0@U<`#@`'D<`!CJ-H#`.$`$(`(V-1X`$(3@%T`!H$`D:X%V*QC!` M""`$$.*L$&)3_*GUD-+NUZW/.@SUT7%GQ&*U5QQ7(M^7EIN-2!TM&M5P"8+N MR-)AZ'74J[\BZ:EZI,IKLH,&QK).\-'UUWZ,=K)Q,X`7P`O@E2)6O]?7A`OA M=0>^CB^6FTM9GQ4YSI(QMO/T3U*AP?T'O`!>`"^`%^&BB\AN<\0**VZHYU7I M!R#EK?EE0K,(?D0UD4=:+L$%^N.X4G/B(B$T.*">%XN8:>)%S``)9[!,(2$! M]@*<3G$9!@@!A`!"G!5";`I+(=+4_@ZBGA?@'_"?IX6>J^8%U(=="&`X>V!0 M![T1:GD)PBL`!X"#2.``IU$TA@%"`"&`$&>%$)O"2LAV.`0E"<`J@`=`@$C3`NQ2-88`00`@@Q%DA MQ*;X4^LA)=3RVFG74`.O'T4W#D`_IQ("`#P`G@!O`!>D.%6P8%G%%K<4,]+ MKPID(.VM^65"LPA^3#61-2V7Y`+]<5RI.7&1$!H<4,^+5\`?"!?R!R2L.!1J>D%? M0%^47%WLRYJ6KR$-9;%Z'.IZ`1;.#A;4WB3;5\ MXZ.KM>[4RNE2L2^@%]#KY-!+TWH#`9M&=@?!NB"80#(@V(JTW&M`]FCK!_9QLA,PS"KENJ(+6KTI^$"P`F]KC MO"#FM:>:J=W9(?D\%A&K./5TR+6]!JT@5\'9XR$)-I3U<5?"&[68[F2Y;F=Z MY7`M5Y48-!,6V(Y71*X=0"NTG=*5D5/FE++1FE+RUE2*@H'N^Z1\ES0[M2, MV?8,O<%85B:C-+D`O[)O&.#L1$03<-9A.(.=5KL*BB)>%92SA#7$9(%V M,-Y:0CE=D\?9OJ^`.0%BLN'[+-S'/OKYQ\"[?#",Y4_?S$;D9O;MT7#) M.\,CT_?.8DELS_`MQ[XR?>O)\E_NV$_OR'?_'8M[ON7C_KP:I/BGKFO8#V1! M;/_=R_HK7XT7]M;5L^%.;Y;LBUXB@_9+P,.0@6WYMV3V]U<>^YWW2C(I&>C3 M^7NF-E3_O/)N9KIZ34Q-4=4_O_ET5N%H7^>&S2*85_944Q3]-Q[7?"5-B6DM MC+GW]U>7^JNW$WTR410E08>FE_`VIGX;5/J=,#DGTZLGXAH/)*Y*^M6U3+*F M7>!-OQ*W!0IJK]YJO?&D%>I5+>VMU#A1>6,A[Y--"64YTU]Y-A#6HVM](" M<6=3_^1Y`9E>!R[E['`0_CPOL2YO55/X@(PW5H9IOJL]V;HJ8!.IXX'%Y*O> M>-0@6]5::_.*)*H1%%"2T45_8$6"^`BKZ1R2$4>-XM_&I1V!FB(Q9N2^U"002NK('$$6S)/T?O-3[VO_=1;LC`L MF[[_GE+--4P_,.9WQ%UH#8KXVZ_:'^IH<)VAXF'7TUZ2RB?Z(,OV+/.?QCQ( M$UO*GED&1VBBTJG_H#0+K#JLI@8EF)I%&)+5E<-6U ML:KG<:&5I639<)5Y^<6QGSB#W])_4X:EK_A"_D&7[A4G8&8(4<9.K][RO%I^ MR]LD\_G2F#+4CS)6E2A7EGWB+0TS_TDJM58IO'9?*\NU[(V2WY>DQV^L+E"> M*YR<^2E6`J]=5Z$.05HG1_3&[Q_"V@GWSGRZ#87J$,AT&*O'I-!JT:=>Y6J3 M`@-Q-W)45;&_<(CFJ_T=HM1$Y5Y&1I\SD\*`7OF%@0VU)LZ8AML\;_WM"\N6 M_$:9?]`@GX_.'NCDK`MZ]7[RE0_"3I;([O;S[? MW$;BD)Z>H"48.]3_X`"(")4!E=$!N(N=$RGR3J`RVE89_+!1NC9\(GTT+%?B M7LPVFF/0GN:`[A`!&C<5?A.BM^)M-98_54H47G_?<+7]H#?;!;O4+DQQA*/(RXD+@]"P<+QJ&`+!04^O M+)$*2.A>66$8C!G?CTRK6!RVX3DK`=B&Z\?I`]B&`G`);$/`@DBPH/9[PUPI M6X##@:Q$Q"`%,RG#'+[V3H)A4$)SG(CFN-"5"CDY;ZWQ.L<>,"4!""<.").> M,D&X\43#C;5R"C9(XQG9D^\-VR3S?(Q2.)NR9LY(-J5.R??%Z(YP-:&0!$^S M$4ECU2-57J<=G%AC3=7RU#J^;MN/YTZ6Z=J"--`+>`8\`YXA*GQN5GQE9JI6 M?JXJ@F&/8'$W0>*T8D/J&-D'`G`)0L;'AP5DIB+KX,2#Q3`9D9L*-2`0)017 M!WJ%#P5%`.L0L'"6L*`.>OH05B*BD#`IV0.1FWILO(3FZ(CFN,A=?(76B!^' MW%0`PMD!@MKO3<9[D>&T0:'C`4=DIR([%=FI^Y`,V5P[D0K97"WQW,DR';)3 M@6?`,^"9L$R'N'#'K/C*[-2*BI`B&/8(%W<3)$XL.C0LEQ+$A9!_<$:P@.Q4 MY!V<>+`8)N,!LE.!^%U!?!B"Z\?I^@AY`R+P"8`!P"`4,%"34-V+#`"'`<^`9\(R7;<"O9NW2.N-*%1*4R>XGY/TK,[; MQJ_,2^OJV7"G'_X=T-$_V?3) M`7O3N_$?B7OW:-@W2S:$MYK=EX!;N0&=U2V9_?V5Q\;S7DDFI1.=%W_/U(;C M/Z^\FYFN4K.8&L/JGYE%_<9MY5?2E)C6PIA[?W]UJ;]ZJ^J*HB1H/`FWXE;E.4UBBA>WK_H'3> MN-BW!]L`_FSODTTI:CG338SEG' M(F=#3+T/U1E[L\KKAR?Z-DQ^J&T)D]<.QN7*@;@\O:S#E1\6S1P0U2$9*2DUNR=7J M$`9)7;:N3^E#XO4I&"1J$C?Z:]SH;PG5^NA8%DFW39(]Z*ZQL%1/5V&2U#!) M]N3S@X'W"9DD^['XP5#\)$R2?C^E*(5#[R*;I*M&27U:'Q*QZQHE/___+B^E M__?WW_[9___^W__'7`;?_[`'D^E_1D\/?[S8_[@.GG\9N9/1_VC_^L?=BS:_^N-_O/_\=?K'_\[U@?W_W-^\O_[T\LO=O]4__J,Z#^_^=?U_;O[X M].%___.D_A_W]__5?O.#FX_D]NZ/X??/[__/T]W_?/KU^N/-++#^K_I^_-M_ M_]\_[O_Q;CS\\)___9$$_^?+/T9__/4+&?PZ^#1Z4KQ??WD,M+_^]WGPQ_O` M_>?UY\_7VK\_?'K^];]O_N>_W^F?WDW_L/1OPZM?EY/?U<6GSUA,_Z_+R_CZ4R_^[\WWX/W_]2F??7EG\/_"?[[P]__/^G]M]O+RZQ$ M?[)-9T'NC._7EF?.'8_"PNJ\-L,'9?#VZNW&1$IE8QZEDL^C5`J3*/\5>+XU M>TDM-_Q@_8OY%FZW730OOW@OW\(5W#OS*<[#;#M["J?]\7Q"?V6 ME$BSEL+MENA^TW%G=#^E]W1&EAU8]H-TLZ22PX4JE4I0_D5C*&.SXLSZ@]^]TCH$'S7?..[M'2=)\NC>R1=W!.;S"S_=;B/YGH?G=4^ MLG<]B^?\.C.)(J:IXM()IG/ ME\9T2A\144*)]HI]XBT-,_])*B5'*4SUKI4=4_9&R>\WI*Z[)1G1N^2T)Y>4 M3?+3EM\KTXBV2%AO$&>K+]&TE-94C9]EF4Y%9%JGJQ>DLL=Y4$4?9G8UD2+7 MR+8>(.-_-R(6$F-72ID.D_3X$ZT6_6I>MO4P/3I19U M#OCY"-8TIM_5.^UR6+!/GS_$UFA(+A=!LL'+6'A0##3HHXP'!; M2@$,C[.YM<#PSO&-^39(.&X1"8&%0DIXZKY0/E)2OU9`(V&53_S^(X4J$CC+=4"6@;>NED3#:04LLE,E8 M_;7OHRDW!A8[2I-]$3R+S_E[U@>WR=H@$\0&8@.Q@=A`;"`VK9%I@R/0X)%I MJNI%NM]#.S9_F).P8TVO@UC]ZP=^)-38SWCK4AEA#GLF6E$$OF.\WD0%FUH% M0PY329[$V*0U>#[ZCH`#^`'W4)(39^7*BJ/!SULZH7 M"%+98P;(`>0X=^30=%G5!K`\CNF@'NFD"MYLU:9_\PV?M'VJ!'UR.OKDT`01 M6Z_TYNFX__U27<^=WJ55KFGY[LY8[L@=5.@FZ[K!WYT7$(GTY4CW#/(ACE>T[C3 MIE@K_0H/3;,M!D]XY"G""JD4]^78KK(LT+!1V08:UJ78^:'AA2;G\'#[7ZMZ M]>T388(4W4)444(90%(@Z8X4`Y+615(%2"H0DAXF5:')($__1.YX'$!U]:&Z M]FJG>3[Y:7MW;Q588>F3?136:-)ET[]&Z]B.H@-@M%%T`(P"1DOL_GVL_J$\ M4(8=#4B+BJ&=B)X`.X&=P$Y-E[7Q&/@GEGAOB'V4AS/$OWF!VF&IVF%ZA>@U MG^S2WN%#QP2LC63+TRIETDKVY282=95&!TG,/%7B`90:I`A`":`$4`(H"441 M@!)`":"$H@UG5+0!)0C%0U[AKTRB$!`/28_DR1B%@#J5I0#\`'Z(@A\7NJP, M%.!'%T[H@1O`#5%P8S5XLI^7>CDJ:O.:[H+6&PZR`ZVHJ?7EB9ZU9@!'.#`_ M1:\7I0JA>80FB-@:J"^K_<&^A("B`(HT*S1`D4ZA2)D=6]2B.V5I#'O]#LE2>*RI6IK$0IKQW:IJ(YJQ#UP$+NY(L?/#Q8O!I.K&:R$Y@8F= MR2D`%@(+=Z08L!!8*'35P_+0"0H9YFF"*C);$@I59!HEU-E5D=$UN;I\KLA* MY&2KR``'VQ%OX"!PL,2:5N7!9`0<%,.6!OZU(];`OS/$OTS&QJ1@9=MG;-2T M+A5YH%<62@.L(B4$%0W%J&BH5883FTXK09V>!BF".CVHT].F?CSQ.CT`I38H M`E`"*`&4`$I"402@!%`"**%<0\C5 MJHS>BXF*DH;POP610$!2IR!)EW4-Z''*I\2;4F#69_)1@"7AU(;O]/O#Y2;R M5_K2RB[)YXJ(;C3J#`HB5$UH)=2000T9U!GL%O,"%QN5[2!K(P&'=4X)UL]!CC8CG@#!X&#)>$(39X,JLIH`0=/-!H!_`/^G33^ M9=+"M(*5M56<4--D5:NL>098%2=W)'S;H(N--^K>_3%^69F*$=Y9J,S%4+;- MQ?A7X/G6["4=QLC,LB9I[SAIOU#2WC9@-.P\^"?;=!9$\HWO$OF^)+9'I*DU MFQ'7DV9TSR7_D4CQ<;&FO&'?,7TR7;VEODG]E@ZV#.CGTOV+9"R7\Q?+?N!C M_*/WK2=%Y0OHM]REXQH^H;-?/9[][4G.3-('?Y-\)_Z(S\*DR[?L@`WF+.D0 MON78GG1/9HZ;'(-XLF30B3OSN?/L21>639_M!)YA3[W7/VUA2"5S63*\QGE0 M,LE\OC2F4SJ3:"/B:USL$V]IF/E/4H*N%(;,:@E=V1LEOT\S;:M9654FC=)+ M`?@.]Y0VYU9M+<]'R:V*WOC]0SBS>V<^W8R?K:9;'693A2!C(3DVTD#3FU+*>#4<3:W+DY5=FHID6O@E.C2!YS: MEE+`J>-L;EV/]G4T)+]*93Z^>]C\]PMC_WR?''\8,&*$LA M:ED*E(4,]9D\G(SW)@4*4@`_FA4;X$U<;Z/,A3>;^.S6 M7'RW;OUA]E`69[)00:(01&P5I,K]B0+M@Y,5L80&*-(I%%D-GBEVH1=,.F61 MC'K]\F(7?5G11CBV`3@))HL`IY,`I_Y>X*3)ZB#;E!C@A#/E$W3%H_Y(R0HV M<1&%X7T(`17`0?5K>[S69!B:KPBK-'%>:4@_8\RU3 M6KI._+Y!__-D^1;Q*HU4^,#0/=`])3XP53[]K!<,[0,7&/@A"$&$QP]]J`(_ M@!^"B`OPHVOXH8V0:W*4/JYP9`^S?[=W(+_`!^`#\$(8C@^#%0LD4U"Y<+`&G! M:<51K8`>[HW_2-Q\;C*_.`PW5Q!0A9;IE);19%V;[$N(DU8QR"T$BAR?(&*C MR(6J#F&KPMD51UX`()T"$'60+>`,^#BQZ[8IHFSH:7SNGNX_C7E@A,G'\[GS M;-@FD4Q>_'F#E(CBZNZ[V>)*41-ZJ`/MU`135/4HEN\1>&B:;3%X0OG)6?-9 M6%MZ7\[M*NL"%1N5<:!B78J='RKI5[4T%-@(7@8M=(!1PL1V*G10N9BJ8 M#0J6EG)I-:4W*B]AU@;?UZ=!^3BJAZ:`$.VK_R+J$RJEI@7T739>U\;A"CXJL1;=GUJZ* M-W"P4?$&#@('BW%05^2!K@,'!15OX&"CX@T`('CR[>)4&5 M\&V#+C;>IWOWQ_AE97`B3#&I#$XH^>"$4AB9^%?@^=;L)4G=Q/1W(.P=)^P7 M2MC;#82]>R32`W$>*$L]6J8QYTDH9IB/XLPDGW[\WEDL#?ME%30M(]F3ENNNL;?<]_)L26_M'[UI,,>\K*\/%R](G? M/1N>1/\_ZTR_\YA&R5A)9@_YWDHFF<^7QG1*YQC1 M3XFV@7WB+0TS_TE*@)3"@%2JQ(VE>90TR2V M3]P#JZ3JS:MG*"AJO\),*#3)5@'AF@RQBP71W!',*8@4X`7PTC5XJ8K&`%Z$ M$BG`"^"E:_!2%>0`O(@@4JFHAY3]9)=_]("4R,;Q6Z%`[0NEVPMW#C08G=YV13!:"XH41EH57J#Y6[^ MS2D'+^:.Y^5"%_FQ2=5Y^%1E_M"&O4`+@`7@`O`50I<8WD` MX#H"<`F::%$)@"IB&LF+,(YOS*5E=5K&J<0TRLVW,PFR[WU)3(P836=6KR\>*GO.PO_!U$*P`Z3?+,(@!A` M3%@J`<0`8FF;;20/%`4@)F0:2?B^B/4_DC-LK?K'%T*WFLR(ZY)INE2'X4O7 MQ"2+>^)*NBI+[+(Z+]G!KI6RK\Z#*=E0G2-<0M(%R1`8Q3FVN>1YT@<5)[[P M]%76X4;0QE76^EN5PRG!0B(X=H/@0_`/(/@Z!/_8_+_I'!3&$19>@I&H\]'& M5KT/J&]'MP?(*`K70]QW$'>A[^,<6<2_.+99).4"R;@HR5T086ALT<49&ELT MKH>X0]S/67N?B;QOBEVTGL-=1J^SR<&^CH\B60JVX7G$]WYJ32IJ;X.@;+LK M6A\A9Z2AA<(;`2.#D<'(PB\(C`Q&!B-W::%@Y/7;+1;=&J(2>-%6%;QB&9K1 MK5/[(2RX91JN^W(Y<]QGPYVV&"9$?4;49^Q\?<:^K(WR!1':5@GG4IT16`&L M.!VL4(>R.A'QI@[0`F@!M!`,+?KZ)$,%X`1P`C@!G,A8%7U9&:JP*D[VV!Z1 MK9TB6]]\NK;+>\,C++Z\6!+;XZ75JB4%,:WSUBC'+P:CG#]:`&@!PIKH@`]`!Z$#J5G(LI&[Q5[=AX$N:.:ZT=)UI M8/J22_S`[4!?3.@7Z!" MRA""$H*KC($\&N8:<$)7P,P$9@`S8&8*P#*`#D#'R4"')JN37-M?8`8P`Y@! MS("Y(6Y4ZTBI7:G'9COV:,_$C?-%,*%P^IL=)?DJ@FE=";] M_)K06O5(E==KAR36%H.OOSV6!Z/TC?RJ"/=1-.%^;-I!/@7R`?E.&/D*K:?D M[Z,AFS&H"LP2H0!8H*FH$ZU<$VRM(_8T^Z!"H$($PT6H$-%4B""`JZIAPG^NKIP;\[GS;-AF[M)YH_8]#LRV(A,.S!HFU7D= MF)5=-A'/W#Z7C M3SRI!@`"``&`G6#737'E`X6*^P@5Y[?SH*^^$']S+FHA9XL<:>Y#Y^903.N- M!A3&IDYP/R<;<.P\CE'KDJG@J%5@6M MZZ"I\G#4+]<(%;I"]#QBZ!'H$>B1T](C@J!FQV-7`$&`($`0(`@0/#T0W!3$ M/U)R^!'$_B@HV;4SGR:4P6F/>FEN^1;R?6COY!NX#]X'[P'T@ M!!`""`&$`$(`(8`00`@@!!`""`&$0+90>JRS"455W]#]ZI*E84TE\GU);(]D MK^8V&*!"1>*.:Q14).8%QB9C5"2NH)`0-<.`$D")H]N;^81V0(6XEW0`&8", MXQH6JJ8`+6!8`"6`$C`L!`YE(3K5SE85O/ID/Q';=]P7^FRRO`R6V?U$?`H* MXBB4$%Q14'-RJ$Z@(V!.`BT$H(3@:`&S4CR600X%,$(\C$`.A3@,`X0`0@`A MS@HA-H6FD&55"@-'C6/]PS86CNM;_R%3:6IY)MT47UI9W>H;R73L)T*_<#\G M5`#\;!X6PEQ0.5`Y<%R1:"&ZP``Z.@(=%ZH\&@V!&HB0`RT$H(3@:`%#`X:& M6`(#Z.@(=%ST94W3@1I-&QJ;8F$(;[4CT`6OKLG2):9E^)9CAV$M]H\4Q;P2 M;T?1+E84RWDBKG3O.']E-A^A+J@1J!%8H+!`11<80$='H..BU=&U\4!6M/2= MZ"S-@4_[V;K`)>#2Z>$23!J8-&()#*"C(]!QH0[E0?;X#I"QGY6Q*:)VI.RR MU&.S[5.U=/M4A.A*0G0W_B-QR\5%B$A;G8T^K#P=7PD5=AY5>^J2+MB96]/J MOJ.G2JKM>^66DBJOQPY)K"T&WVPO[T7HP_7)W9I;.\BN`$``(``0``@`!``" M``&`+0'@Q5BM`#Z@7K>.88!V0#N@'(^=&<.C;3>:$#A:.H$]W.R`8\.2:[CE76M2Z:"$T]Q=>>%+@^5 M*F>A)IT/IS9K,2I\!N`><`^XM\8]@>:BC8?R:#(N!^'.Q7*`S4=L M5F4--BEP#[@'W#LKW-,4:@=.JH$/R'?&*]G6@GRAB71:B#M\WZ%KC+;IW?XQ?5L:+U7%S`>,*RNY`TSM. MTR^4IK<;:'KW2*3WSF)IV"^22TS'G7J2P5@J"-L%&?.Y\VS8)I%\AWYA&M!7 M=E5LV6-?].FHQH)WU_8?#5^R/&GAN$2:6W^1^0M[SV;MM=E7[PD=EE+B/V3: MDS[9TI*X,\==6/:#9-'!#-N8OWCT]\Y,>GXDK'KJQOFQIY?'OI\-QFTF\3S# M?9'YEV,"D'!<=@F?#6'X!GW^E([E$S8C_CY=C<%GBJ+&F*VJ?S ME4PGF$_YTDS'-N?!E$0$")];3`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

/KH^$NXO'\1\N=9H;KT]'TWG@U M6NE*JZCLDCE%VMBR*&(O7C4G5)/19*;$-*8D5JB:HB@>7PG'":8@7BA'],UGCZ5#Q)-+/=,+O"6A_.>LU';@\6_S'::3Y^^]$,/U M&"5"GM7X)!B=RRA!Q^`#K+1Z-"'R?6G1S9Y1,YG^7E/9>_2_@S64T6^$N!?J MOM6*G@E5HO>$<2*;DN6&8X5:+@$,3)UYI1L4,W+E_N2,EON7TCU+6#!TS[AX MR-3(L\Q'KG`YNX4F'"=LII5Q#R):7N4P#;;0D9G MBTXAHC2=+U5^=`B?,&LE%LSDQ#/FTTJ=5=A(*SZ)QG-#3F&CL2_5(059;+3Q MEBYYLIS`FX?F7@2@!4P5R?%*!IGV^95B#GDI?,9_.\_DB;AR+"XF7>3#&@XX M0!C/:FS"6^/FJ'1L^OX7)(6=%XS^D"7[6DHTR6A%`$-@H.8`]2C MX]#`-$&:]L\A>UDS*Z8^L_%C59=PVUSB!ZZ=PE,J;XS#<];\&C/)=R/?J;A87$ M3H`$R`*9$V?FR""6K*S,+Y?*RB*`6H$Q5#7X2A+:0"=]<%UYH MGU]4AT+1DJGEQJ^(@2G?+,CP*?X>?47(\[*HNMI'HJG,99;3">?Z?T/X>"06>*=A M_F]F4_<0@OS`_P*0A0&Y/W_8,GD2Y.DY#1!EH>HT:1=)KA#I-?W%7:A:_I?4 M6HA06$W>:%FB[$+)\^6+>V&!?/.&!_F%E\S*[@K7:BX13:K;(.RV@KZZE?B& M\%Q_K>E3E"P$@<_J1[IS4B&35C7S!?7T\=)4T8\MGP^ZXTT'90MTS9G0V8Z: MW3(DN[+>%2,:;\#:@U@4G2_&@VW903:CRWL!U-!2F7Y:>5QU&B0N(5C MQ,F]/D0SV\XUNQK76;%Q_5./#IMCG1S5M6N>-:H[EB2A=M7Q'HWFME+;,['% MT&S?EK`BI2?UP0@>!5PS'Y-A2B^,Q09CC,4P%D/K4AUG8>(/C4P/&,*VL1F. M)QG=82:(.19K@\D\)HS,-*C$B;#,\P!TJ^-,[V]B@>+ M85F/PS*T&)C70\/17X:P;4`&PA@-"*XBH;599VV6G3!HFPG/(/U(ZZ')09/# MG,G)')51/%@T.3V.67`I"9>2-IY\=K4*EY)P*:GEI:2R?;FXGK1_X>U3W%8) MNI5',AZ5Q:U8>QI424DO;&N-:697V3JSK?5;Z1_/^M769SXP;%%%7A&J:C.* M^ M@HRBSSS9MDZ?+.RD]GG5']JWHG,;PHZ+H('/5*K#]IXZ_:YM^O''%K9'\[?I MCHO)AI4%C2V#=F>%3?#H+6&[8=KB-FKY&_6ZS?=)CWO?`QF^M9J8=-SIZ:$>Z"5]P0$70\\T%J35FAJ8&W4S#%KMQ_]OPW(HW>/J5F"^TX[#E/:_M MJ!DT*@Q&$70XI0TOB>L%[%L02S5INIL+CE](\(RVW2YM@NF0L"NZ9:_F)S.B M,*T1],^F?:7K`7;2"TM`Q:^_^.[9DZHN/H0=$:?JVV?#UU%Z4-D'V/=MY3]T,XS.\>S+[[60! MWSJAO9\]^&!P19-^?`%8%?^E6E0"IK8L@EC0/T]H:W1CKIKN;R?2R85P+@]7 M8VB!J@LN-];5[ZD7707RTPOA^J[>F:DT5[6RU;6%<1+BOCCTKV=+:?GQV>@ MS/4,[8JJA?/^+5#EY%#.AB<7HB@+]#^K(95__J(=.J4,G4%C[DM+_TJ[R/XK M<4)&,<62U(#@UI@K9XC^$C99K^2M(C:CM!5"!QE"@^,;$JJKL-S$032!]`ZN-/5 MU`9+9[E,Q1$D?R+ MU(A_ZQ:AUC!S5_J17X=D0$,:)5*O0F.1B\R#-QAZS+_+3]+9J&">OEY/IS!/ M#W>75R#N'SB9$G=U^_7V/IJT-%WK&M*WI;R;)')[MG[/@((C%-;E%$+A?B:W M$13&N:@Z6*ATAX4(AKU4<03#NIQ",-S/Y#8"PZGMJ68=)!QWB(2(A4QJ.)LE M;(O@67S^R.W=)^N"3:@VJ#:H-J@V MJ#:H-@>V`579NHU!#9\_+#O>S.G?]7Z7J$BP^^@9VQ4<3KL";*U&OR8/>&62 M;7K-R,815C8QM:.KKD#1K.920]V.W6]JH3VY'#L"1/]BYBQ*P-^,A'WD?8\'JN" M*-)<:1!%>H4BIQ(_FF2;1B..8%2+^,$(0]C÷)I7G_!P]>O1]\77=\O]J MI3M?.[TLJ]PR\EU?L5U0NLG03M?5!Z,>`GU9PCV":ACL_ML-QXZO^V]5O30C M1O'(>OXB&G:CVXB&33EV?&AX*O$Y/*S_M"A7[SYA)DG1+T1E)96!2(I(NB'' M$$F;(JF`2,H0DNZF5*'-),_@0/9XX*$--1F%AS:TRJBC.[1!GFQCL)1)GUW_ M@SWP`6&T&W1`&$48+?'[M_'Z1_Q0&%7@*&+H@69/$#L1.Q$[)9F7QF/$/[;4 M>TWNHSR=P?[."^P=ENH=)E>H7OO%+MTM/O1,P;HHMCRL5B:=5%^N8U%?>;23 MPLQ#91Z"4HL<05!"4$)00E!BBB,(2@A*"$K8M.&(FC9@"T+VD)?Y+9/8""A( M22O\9(R-@'I5I8#X@?C!"GZK%5(5H>IAG"M@4:\.)@N"TCT%`@ MBK2K-(@BO4*1,C^VZ(CNE*D@H*GHS.SZ(?:( M%R?I+3P88!_S&O2V35..*6+'/HN,*%@;A@_[X6`_')+E\%@2I32+F73C^]75 MAC5G'W$1<7%#CAT?+IX.)U4[7@O9B9C8FYH"Q$+$P@TYAEB(6,ATU\/RU`DV M,LSS!+O(U&04=I%IE5%'UT5&EOCJ]KDL&Y&#[2*#.-B->B,.(@Z6>-,B/YPH MB(-L^-*(?]VH->+?$>)?IF)C4C"R^A4;#;U+@1_*E8W2$%:Q)`0[&K+1T5"J M3">V75:"?7I:Y`CVZ<$^/5W:QP/OTX.@U`5'$)00E!"4$)28X@B"$H(2@A*V M:^CYY@]L4L@/ M'D!86?E'X$#@8`4X2A;DQT(!T0VZ%`J\+$^J%^N.'HYPQ9P[OA@96QJBF6*: M(6R;JP$OR=*VC$"K@BC2KM(@BO0*1%*PXC*#(%BKLI2<#FA'F>8%.:FHS"IC2M,NJ0FM+4LCW2D!>484\MSL%V MCT$<[$:]$0<1!TO2$1(_&5:UT4(E MRIYG"*OLU(Z$EU48+/WEUU]\]^Q)515[SCP?+2Y/O%5P09-^?`'.B/]2+4D0!U-;%C\3C?YYPNE$,^:JZ?YV M7C+056L]$<:0,4L36^WJ6YNJ[ MKX`XP_(-Z^EV`;=YAFVYK=`OR:(T3)'?G)`+CBL1DV!_R:6E?[6UKH1E,)F( M1;)2_>F<7,>3EGJL4\&11I-QH=S4(2%'?YV'NA,B:2*GAK(I-1?%8!.65W4D M/X5`4_+%4K&)'NA68$2Y!&@J/Y[A:?7-G8D(I5Y(XTQC0LIQIDN^RQ-E4B@D M%:I9(B7=&J+14!@5RD==#-G"MLM),N45F7(.*I3)>+A?VUZ;UC-9&`H;F?8. M+7M]3@\F,HN6O?8`!N*@4%+V9-GK,UX8BML8]L[M>NV1C,3)J`N[OKW5K*_# MPQ(O:YW1S`E^NX9S\P%L:#=;,INUZ99S!G^79K,^>\7A1&EH-=LRFH,DD=** M2"F/*..!O%^C69O6LZ&P83B<4[A6[68#9LORA$&[67L``TF6&+*;]25G(K)M M-VN/1`;P8]-NUI\,<2AO9C@[-)I;4+_G:+,^^@P%I=#KW8G9K,]@:3*4MS&; MJYST]6Q&-,]X(HZS'"4 MS(];2M%?W(6JY7])+3H(A>5[C18`RBZ4/%^V/-'Z_M"JQ57A/+64M$''I/6[ M/`6F=WE&%_ZZ#BE[M$U]_4I.IQL_=S.I3+"QD!WK>*795*&MI>8VXE6SRF@- M@)DX25;65Y#4*Z+7MJ,T9;7#NY]8>I*6RUWGCM*J6O?<7EDV66'NV?:.[M5I M3>W\CNQ/]C`.-$`,&*!ZA5SUI_4@]&4MI])F26H5D=8P(4Z]J'.%674XA3^YG< MICA5?60VXA23VK.A$LS.?G8?](`&^2RVB`7#Z@)[1D_FHRW9@6VQD7\:%=M$#_Z M@1\3/ANY(WX@?B!^('[4]3]$:8CX<#>+99]5Z(O`6^#]:%T@#5WC4 M(:YO>H;UQ,W@#1^Z+239S$[T3-H/S5`PT>^4&8/1'C?09B!F;#E:Q`S$#,2, M;;7H.%0$,0,Q`S$#%V9+`MG>G;*>"F-Y>,[C[!D7;2U._)A=E,4U631!K#"$ M;1,D\H.)@-8'5U;84AI$D5ZAR/+EF;:[<@'1*8]$.1^4M]T=\(*DX+(-@A-C MNHC@=!#@--@*G"1>'$X0G'!-^?!#\:@-4"+>CHNAN=/'L%--]M`+#,'1/K'# M$+;MT^E@.,BI#]H2-D_500!!`&$-0$:9TV:*!WO4\(%Q,L+(_AG"-HR(_&`T MWI81B"*X$'U8T>]GHOL:[:?*S6R'TR$"=CU#XQ:.'5]7:2=6PS.(6^FD8@R, MM@=M3TD,#,9GD(V"T?I@"(SXP0A#F,20B?B!^,*(NB!]]PP])P5J3;O`# MEW&9"&3O`Y6G__TZ?ZJFKX;%QZ9IOZJ61C@M:/Z\1DM8"76W MG6QVM:@-.]2#X]08,U3-.)8_(W#7/*OQ\H3QX[/N,[.^]+:2VU?1151L5<<1 M%9MR[/A0,3Z@490^5F`CXB+B8A\8A;C8#<<."A7K,"'P*=SD<.E%IZ+1<]-\SW;>4Y_F?,OP[LGLMQ/? MU4\X>*$'7PXN:-*/+\!)\5^J)0GB8&K+XF>BT3]/.)UHQEPUW=].SN23"TD8 M3<:"(*Q&W"J->V2!G&2!O&*!G&/!!"X>)`L&219(*Q9(>2D0I2$#+`@."+RT M]*^VIIK+>P`:VA!U<3`1ZHRQC(B+#@=16U@'@J2P.HCZXB8.)[L81'3(14H6 M/QN`XPZQ/$,U6Q&KL\%P4&2;*([&G@ZPM MIF>BI-3"^+8'"1>NPOY1]\0EJJ,]MP20@UK#R7_^H@.R&\C::%@+`XOH[H#P M^O(S%&K!W*;\#G9D+R]93S<>F;>#89(LU?(+"BFHR?3&U#<0&`A+6:.^OG$< MU@H`2HBO0_M5L)?A!F`++"D('MQPZ;K$JEO\EE0`2"@LV&B5CRBZ4/)],%7'9E$NT\/568 MA-)+*GMZ-/+HPE_78:3>4Z9H:T-M_9I&!L+;LJRY*$M55) M0KXJ22@L2=(@LB#.CK.JU9/7+-<-.-6T@G!9T]10(#9)@K=717@(*H7P@O#2 M-WBI*BA`>&%*I1!>$%[Z!B]5Z_0(+RRH5&KAGLO^LLEVB(+OUJ]FJ>[3N$OM M^X_O>L;L/47.3FLR[AQR1K4,]BN1=(..9$M1>N$`XU[(M57[N0+(AQN1]]+JP+W0,;.^^+T M]^4CA1>K\B)5)6PU-G[MT@79LLU:_^`4C0D:DUT9D\YX,![Q\CA['`6B!:(% MH@6B1=Y=&?'">,WY5X@6F^O+N@Q&>TF)RD2K<#Y<;!;?''+RPK1=-Y>ZF(5E M&^79"_;2%\VFOC>ZT]FN/'92IWMB52?-E';(K--.WZ[P$Z5N3X>]V,8M>R+M M<**RK?`1'A$>V6=5[^%1Y@=,.O4(7`A<"%P(7*7`->:'"%Q[`"Y&"RTJ`5#$ MG$9B^%/;4TUN45V6<2@YC=S4'RJ@=]*\Y4B2[%OW&:H/*+LO`NEG<<1PPHMR M]0DHK-<\;*]\/00KA/3VL`HAG35([ZX40^+'D_QYAPAB"&+,<@E!#$$L[;,I M_%`0$,28+",)KU>UL-RH2\7%\B.9!A]?;=>E+2NNECF%VV5*(?,-XL9?::6S MQT@1Q:)>5QM15-*BK/71U>[$,A[)XZ+&0TR/3E(FR?&)J_&)N=D;">.BAE`; MCV_[$4:"WTZ[*V6B%/5?VH2@PL8Z;8^L?F,I>;#]Q.UR9`V$\FP\;'%LVTOD M-\.R'<-[OZ$[:T'2`9W3;[G^KP\_?R/>LPV_O,`MRS7D*N0,=K%`Q4?%/S3% MEU'Q]RW_ZVJHT#G"@9=@)/8(ZV*JKGR'GMZ`R,B,U*.Z;Z#N3._EW;.*?[B[^MR%YWO_RKCU]'LWXI7 M&CFZ?4L-UAH_=*85C:>!4;'=%*WW4&_:TD`Q&D%!1D%&069^0"C(*,@HR'T: M*`KRZG*'#3M'>(I(T505_/6=>'''"NLI;-:IJ8[S?C:SG5?5T3M,$V)O9^SM MW/O>S@->4O+-E+HV"9+B` M.($X@3B!.)'Q*@:\,!+1JSC897O,;&V4V7KP8&QGCZI+:'YYOB"6&^QHKM84 MS&D=MT79?RMQ=BQ+R(NQ)$IY9J!Y06<4H0.AHX07(WX@C+=B`V(&8@9BQC%A M!KH;"!UL*0Q"1T^@8\2/Y/S"&F)&.[*R+@.V]Z36Y("26E?/JO-$:!Z12.T<(,U9H!]`.%/91Y^5)?BD$[0#ZCH@9B!D8=NY?9!`Z$#H0.A`Z$#H0 M.A`Z$#JP="OY+BS="OZZ#Q-?W,QVN(5CZ[[F<0[Q?*<'9VJC?4'[PH!]$25> M&K)X+.J!F!9$#42-PT,-]$H1.MA2&(2.GD"'S(OC[(9%Q`S$#,0,Q`QT-QA. M@F%>JYNI*OB+GH9J>;;S3CGK![L1XR(OS&NAR6""$XR;C"&OC'('<**M0#<3 M,0,Q`]U,!D0&H0.AXV"@0^+%2>[87\0,Q`S$#,0,=#?8S6KMJ;0K]=GLB7W2 MXJT:J#!-%OQUZST3)RT4S*7#FDQTG_2J#:-T).?YM6&UFK$J;]=VR:P:+U_= M/>:'2GI'?E6&>R^6<#LQ[:&<(O(A\ATP\A5Z3\GGHU>VXU`5N"5,`3!#I(@3 MJ=P2U+816[I]:$+0A#"&BVA"6#,AC`"FS,O2L#8P(O(A\C'#)D0^1+YM7$5> M&8J(?"S(Z;H,>WM)\_+%!TR(U_AK:GNJR>ED1AR'Z)RGOG&JZQ(OLU>:N13Z M8>,VT\NU>&X2.-DC7AKFCV[=OX$YD!5:1`M$BYVC!>:`MREVDWAE4G_1CL6$ M+&(G8B=B)V.>UH07!Z.M!`&Q`K$"L>(8L`)\D,%`VHX1B!;E3%J7U<.ZV4-- M$_ZYW'*NFJ;]JEI:;M-YJ_X]+IC58A,NF+7,JN-:,"O;;,*>NWTLZV8(@`B` M"(`[`\!3D1?%$6)?2\S_>;O0"S$/,0\Q#YV^_@$?.GWL:34"(`(@`F`OQ'5= M7GE'J>(!IHKST[G3O[X3;WTM:J%DLYQI'J#-S:&8=*X,`<9TVW\TR1H<.XYE MU*9L*EAJ9=?F%M3+]L3<-A+4'BHVXA_BWP'C'];T,MK701+YD3(HMP@5MH+U M.F*T(VA'T(XQA:>.YFJS\FB1]-0'PW3\`SB?NALY1MQ'W$?<1]Q'Q$"$0(1`A$"$0(1 M`A$"$0(1`A$"$0(1`JN%TN\ZFE14]0[=.X: MPBJK4AC8:Q[K#TN=VXYG_"_1.=UP-9@4CUMZW>)'3K.M%P(W/)H$%,#+UF%A MF@M-#IH<#%RQT()UA4'HZ`ETG(J\HHP0-3!#CFC!`"<81PMT--#18$MA$#IZ M`AVG`UZ29$2-MAV-=;DP3&]UH]`%?WTF"X=HANH9MA6FM>A_N2CGE;@<9;MH M4RS[A3CJ"L*PQ"1T^@X[33MTOC(2](Z3W169XC M/FWGZR(N(2X='BZA2X,N#5L*@]#1$^@X%4?\,+M\AY"QG9>Q+J.VI^JRU&>S MQZ=*Z>-3,457DJ*[]9Z)4ZXN3&3:FDST;O5I_T:H\.11\5Q2M&[^ZKU:QD&T0[1#M$.W;W^B.NZ#/&.DKX#3/KFI[/Q7U/;4TU. M+SFIM,^YX@':SAP:2>?*$.!(M_U'DZS!HUVR:W]M79NRJ6#%DUW;>2KS(Z$J M6&C(Y]V9S4:"BC$#XA[B'N+>"O<8HD4:CWAE,BX'X=[EDZ"R4'5=^.4T+C!\SZ;OL,"038C%10U5$:E(-Q!4PC1F/!#6(S8O,A8;/"3P;#2M<440\] M4V;9A.B'Z+<%^HG\:"`C^K&BUF4IZO"Z"F.E/_WZB^^>/:GJXL.#]DQTWR2W ML\]1'G6JOEW2]*E[:>E?5SNTI_39*7GS/M&,\47XYE_CU^0>OET01_4,Z^FK M[;I7JN.\SVSG575TE_,MP[LGL]].?%<_H6=1>_#6X((FC84?E^[M3!8_$TT2 MQ,&/Q(N)>^7#GY;WCN M>#L>*NL\(/KY]0[I>B*W<]4F4CTR6R!T"RV4I360U!HWM_.JE.$ZIVK)SC6D M_NZ`U]65=,HC:;@FZ@B^O]Y\U2!S*_F4)&5=*!%1NC6=FXOG1!R,ZG%S:R*W M$D])&@S6J'LM9OZIFG[HXL7&K$N$$L4US,V3LVX`M`!K?ZH%7Z\!J&MIW$ZO MQ)&RQOB'9)81F6?B+SJ8@3.SD(Z)R4BX2M/]A1:==$_VSX6JV;WE7-MP.EQY-\MWV MUG%^.R!1E-&*^!JT),QT.^1O!=X#29(W)7^=N-D+>/#]SE0M#T*4Z__ZQF(. MA'2)/^.A(-53YQ+BZBKV1F/;S@L<#952DU5O:#5&UJG#/2YU8[,45$C935#9 MG'ZF.[,K%)-<1$2Y]6U.\I9:,%(FQ:G(KNG>PHA)>V+U=KZOH$R*,SEE9%>[ M9XF;N_0FI=%PC?>;)F2=Y]N$[*U$^PPH%Z4U+F9WM&\NWLIDL";7D*5ZO2_? MA/(M3<]@38HL3WR*]-7"ZA^60S3[R:(N!CP=I_+O;=/\$JX#I==6,^/X\<6Q MY^*_5(N*SM1>2M')1;!F3A_E-&*:"U77#>LI6HT6HG5P^HN[4+7\+ZEERR"R7/5RRPAYNIFC?'R2_29ZJ`5@O[-L<;U,J*.9HS MH;/=E[ME2+8*JRM&--ZLNP>Q*#J+OCD_=KUAMU_ZDZJ'RAL9M!N=3^$EN"4T MI^QR#C&#,AC.L[G(^>+>B>I4J@":#S0?^V,(VV9$Y"$VW)81:#^VL!],!2F5 M6Q6DJJ81:)"XA6/83F".*@^C8L4<;3O7[&I<9QM3ZI^0=]@$T9F2IRY8:FAG;%G''E;V*[O MD)K)/49M#F;W,+NW(<>.+[M'#_J4JLZ[8\0R]BN]5Z-E-D9I!V!`*W*`M+^A;=/<5N30V..V.)6K#T-JJ2D%[:UQC2SJVR= MV=;ZQZX7N-4)R\QVZLKT:6KY.7YYGDE-]Y8FD-4E[CWQ/5-&O/1[EM1F[,[ M`K$?O?O.=J.<9`71@V3C+FG5N$O*MP$Q:V.0DZ^45Z^7<41694SC:D[4Z(P:BVA&UVN,5 M):G6@!M15M"I-_78?$/]JFOGH!;4;.B2*7 MR%)Q]\LIX&CWZ[59JV3@3/]^='Z)_ZSDO3CNG/GLL+_YRR]-DYOYIGE&/7CN M\F_;L3@R7YCV.X$WJ`[A"#"`=I0/UA!4QS,T8Z'"?!H6!^K$T>/<5.M].;7* M1Y<;".+IWS\'\WK.??:=8`4"[@T6'SABZ43/YTW"REU.M?1@&S_/+>#QLV`% M@RZ7AR:L*_U<7"L=\`(#QBOG,_B>/.>FJS%P\,H70Z?CYN#%VC.EFX*`8SSZ`>P^T@/L./I6;D$< M#817?2)TR86.3IW3'ORK!^#.QW>.J-KSDJ,\]_ILP+\-%Y@>L"%X5UR"!J\W MW/-$A+3\*TFEZP/]P<,44@-"Z6LBIB?I=3D]9#ZXK9.`$[I!8U`O>JKP$>_9 ML?VG9^Z;ZL`MT>P(A51=SV8A([G+A6.87'0OGQ0,8+=AN9[A!0PI8ZSJP4\. M%2M@IC3\1\S3F>&X'C?Z1XZKL8@6TG5K<8#3ONJ\1R2):9*,R*0E.)BC"*1] M*%32P0<K, M@U=YKW:D7D`QC$XW**?H*70&S5,"H;15WGU6F/I,TI0.25B=[4 M\!:Y48/X46>GCD_=('V-XE&H*7$9QWF6Z>O?[31:WBMR.X7I0`!(\W MI+==QU"@O,MTI?4[R%8K\:P`'G+]5V/A@%81E%L-0PA.0SIY$(X MEX9KQU"#G,*3$39\U^TL^+&U$0JC-D8845570;:>PCIZ'@QON%X(ZTW@+J>O M]NA:GKQ@C/%Y3U4O]B<8*KATM_27+JD-FK[:_Z;VYW9V%5F?A\A6M3?! MNR)Y*=YM?Y":Z0ZY))X+'7"IG.BLNCR0)^H)W),%/NII#)[UB5J.U6I$ MUE(JLH[8RMU8,]N9!V5A/0NH.XUX,_%H>3B:C!B69=O_-,ZF!(":>M0J#12= M("O&>U:MIV6$;#M/*C@RP42H9O"D$XL\C-#Q-0]$/HXTEO'T MPG8_NM&=P5DI;CBO+L^!XL$5PPW"`NKY)]X7W03O@I@J"#[#'VE`$[S_V2`S M[A;"U[`R$`9N4"\=XKV_8?BG5[>?O_W,T['I(2;085P^7'%3>V%HG#2&\*YP M?D*&3__]%3AN0)!N:`DIR:ZNQC*ZU/V4A(:154CI]1O1_"#&O)W-`$0HB=>W M0.&]^A_XKW'.W?H.C<8#8:=%&:\0Z'./$/2X+G%ID!=RW+5]AQX3OOS9!,E5 MHW@RX`R,?!7A!U&?38\333,Y-14?"E??CU6SSK@[8+/F&(L@@KY[5F%&-`*S MIX')R<:1Q\XK,*6N/P=Y_B=13>^YK+K@6!D4K&#%H.60@)P`,I*P#*\`OT,/ MKCWZ+GS/=2ETA0D.W:`.BN85P.-'0,!G@$AS;F@`J/^TW07%+.ZSXS^Y`6#< M6/\A6J#M;@1'U/51X6V1-^.>HU5=?84F*$.SYX+/-G^$=W%V:&3"I")8HV<5 M4%SE7&-NF&!X%XZM@^WCO/<%X8/<$Z&/+E0G/!K,=ST;]".<#E77'3JY\_6RJ=V#"[2ZM2HGDO-+S+K*\+@$6>P;^*/VJ'!VRZ M),R3@0'AP"2"D3%`5,`&>R2TM:^&]\S-;7@7W#OS3:!DZ7IQZJ/M>\&SL?"= MEZ34*F3G($Y+2Z^7Q"4\!36QF:(TSUX4#$;)[$TKJ"#:>1%3P6"654PXRO)1 M#E+[1OLW1,VFVA>/42HJZ2L9^&BS`OGHCM`P_)\@JRIP^=^GMW=5/T=6)'?# M6I';5:1-$PO$V7&M8F7`'=5VQ$%VY9$;Z5KO>B*5JF[DNL+,&M*V>*NS&:-_ MJHI<:HE+@T)?8AUT(5LV0O0T(B,@)^/$IBF'U&0WA.Q9N.BF42;H$ M"4F<7<:FD[,+UV:-1V_=&]$3&>OVFSU;\FCW.])'Y+JO/ M_;]]S^W>W=:]*OF^9Y\[53,-S/>:4T)[P*X]J%ZT;%N(T$(P@Q%H(7J4.]Q5 M5@"1FEVDSI6.["HQB?",\(SP7,7;+7SCUI-JK>+MD>E?9=XL*MKN3C'1^+)K M?'\G%G$,+;LVR)W&>R8D(180+KIW^8N8.TT,;77_L0)M]6'::@RE#A_-;Z=7 MW"='#?9L52+ZU5TYBA\%A#.JQ`)>WB&-ACDN1M+._]E^DP<=1J?3563V)`< M1?C'1^[/Z_OIS=7EUW@'3E!]"G-7F1:.(%`9-#PS9S\.+T+(1A"2#6`00GH# M(7%6/M]XA?OGU5TZW1/LZN"N:,/:N["O@%N9Q>]0K]$'*M8/!+"-`"P;&+4B MNPA@>P:PZZO[J!?T*VVU9=!VON`=Z?6:DP7%GJ_/MDNB_F-NV%SED1"+=CL7-U*28+ M$`?:;]TTWVDK1-=PO:`5S5.TJ$WEX#%>#JG8"1LWVW$CH:.%*YP*C]JJSCE! MMSIXJV'I<'?8L0>D\A5L4=CD[D5U#.*]TWMTVZ4]SVE_&S<2-9#8#\`Y(,BD M37\2?96,53URU*'GF9ZP[!`NT$%$05J09]_+*Y=MC"_@9&H@)'C!?:A/NK,0_Z6R<]ALN;NZ]) M#X&GS:3\F1KT!`)^9?@'XPVX0-5ZKCI_$SH/ON<:.@GH^.,AU4H^-=&9O:=K M)U>U:(].[CF\.VA$]$*<,_C,F49;S)-E[R3@SZ,-]\0B0.]=1(,VU4=B%K=' MGUZMY"%""SK+KF^$#=B7/])1T]%Y#E&]@&8J`A"4.=F@L])!=^7ZLNQ6E>](579X0T&;0WI>0=@8T5_8U,"`"-)6EJMF M6.%#49\O]>G)(4]4!C7BT+[XL=4!RY:@HT)AKF\#D7?I&11+BT5[9P8M'4.: MDET=XV:.`7(E*`U[QX4&,MM?LWK(\4D-8<^R%]4P@Y_#,Q0`9HE'$L-/CJHL MU#A6&7P@)M@`F)$TNXH_^NGRZG]^O[_]X_OGLZO;K[?W'[C_,PO^4]%+]/$] MW^"/2FSDD]$&G\2T7[G3H!\K`#A=F_HY??('/<7!(4%+-STZ*7T1'-^4L'%K MCS!9'5Y"^Q8Z9$8''CSE>O0PB"RJETJ5Q+,=(M'F=V[SV)HL)]C01\'4\J-%:-<\9%.02"Y4T)^+9 M.&X>EB0C-6;E?#+,GD69-U*U[![-6]=>9]^_]:FV+<>A>X@_B#^=XH^R6_R1 M$7]ZI7N(/X@_G>+/>+?X(R'^,*5[:X+KYOM)]QF)GTW6:O`DK\'#_^^L_K[W]/!*!N4[\9,;",O/56>K>Q`!D!ZR@+$CP/" M#TF9\!-11/Q`_$#\0/QHCA^2S(_'B!_[C5OWM')2'.0V*?L_[D!XS2&9;$:_ MVTXONTK6AH7J01'U_CBV81?^*F.W>YXU*D(8"KPDUR]#V)NAW%9L^RJWK;CC M#1"QIVQ"0.R&8\<'B++"CP4!`9%5N45`1$!$0-PE($J\I"@(B(S)[9X+!2H1 M=-!]#B5L@K)9$F77692I[04=<5Z(Y>>.>NQA#J7&]+*K-YU92.E<`>GC=-M_ M-$DEV!S/*D!31N5,(\-V<3B1>4$95QA&IBUC?7'MJX)W'RD,,%)`'#QV')1% MA5O'4]5(&(&8@9B1I8;B!F(&5N.%C$#,0,Q(_,3[IK?ZV:! MW^]O'QZXN_O;+S?33.*CA#?=G`J`U@&M`UH'M`[;:M%QJ`AB!F(&8@9B!F(& M8@9B1@]6&C%DQ49OV.B-)6N#C5;HUR1%X,6)DN$%&AFFR_H*)ZDW+$#\."#\ M$(SX&KW!;+DNMW#LF>'UH8A@VQEF5\\Z MLZC8VV-[1O6JM\=$X8>3JJ[03%O2@^WML/0Z*BLA/A`'B(*L* MCCB(.(@XV#T.#L;\:%*5:48<9"BQ$EY68;#Q1#TZO\1_5B8HPNQ#98)"R.MR+GF:$PNN>#;GP M<\DQZ#:5*-OCGM47PNF&JSG$(YSJNH2.ZCT>#P^7.(TXGFI8E'A_!A_UG9CH M5]4AS[;O$@ZN&Z;A&?!:UU\L;,?CYK9#@"[5@O&0Q`OA.3I6,J._+PEQ2/!0 MCH+S0EA()GZ8$L>=2./G<`8D01SP]'_E@*GPAP3L78``O,&,>\1\YWX21^8&_,R7DOGZ;)LP;OO5@I>X M_J-KP./..R4D>!,P2`LH@9^!,NXGY5Q*\$<.7^#OO&<[7LN!1HZO#\L MRF/NP8,;X:?79T-[!J!P.9UH5&Z#::4W:K[C4""B9'.Z3^AW51@N)9FR:WE; M2`-%,9+59]1H^J'?;5M_!2$+]:A,N%7MO[[A&EXDBI?ZBVII,!U_PD6X=`\B MI#K:,P^2H)U3[G]3WZD,BJ&^9!YWB0E2"8]'F`N7_H=B.$SV9\=_71\JD^A9-.WPL0^P=R^&MXS]T_C;$K@>2J#5/G(?WTJ'V!?%C8H M2ZP_?ZF>2_4K^J[%72XCZZCZPB6!,X)7_\L&F2$+X0&Q3 MLB/\$^1>#78E!A_QGV!^.4IW\%!@^AX)`4+,&*\BZQV`*-!$(2:ZCCO@;6,0`*H>HKG&C0*H,&+\2Y^_2O81OK;#)#,?H5I M"-0(K"Q\U_WY0U9_UJI/X+>!$3?-A:KK0$PDNT*D`?07=P'V._=+RCD6"A>T M&CFJ91=*GB]SH\-%OO)UNW)OORHN%\Z'"Z]8]?OAN_=R_-&%OZY#7'X$H[>> M)<4C7\<6S:9B'O-%6AL:-EE?7Q?Q59HPH3T+IA$:(53/XN[GL?XN\3*IVV:1 M=Y.T0,]*@G:H10@N""Y,@4OU-AT$$Y:U!L$$P80I,`D*T!!"V->5/E6`5C'^ M>+;3?B8:F3^"G9;%(`&3:U3!ZI;:@\T&8(^&(JUEND>#)/#29,3F2CDK11O= M%`,A?B!^]!\_1)$?CV3$#\0/Q`_$C^9'$X0/PZC0]2&6:"#"DLO5R4# M.UB+:FP14HO\?1'@M<-MF."LG(Y=)2SS.]=W+*GAM$P&BI1/G+&6HV3)U%[65QD59S;7^3!P\C[>S!>JX02;GCI7"81NA&Z$[D,3 M9]1>U%[4WKZ*,VHO:B]J+Z/BO+,EI&:%VL<=,7V)=\('VZ:U=V[JJ)9KJG3M MJ6J>]U$(V:S^OE_*46-%OL5Z:^1-5?/GG7+G5.)E:9RQ1+NW-#THX%]]\.>M MV87@TZ6CN>GF'_1+>^*7]@HM]ED[>12H@2X+NBP(0AVY+&PN-N*FPOJ;"K-; M&TH8A)L*.X-:+.HOTEJFB_I%A9^,]F-CCJ>H'_&CN=H@?O0#/W!3(>('X@?B MQZ9-#2;\6!81/PYD11C#U;YN-D1+P:RE8.*H7W8LQG#$"T,EJT)H,]#GW+?B M()+T"DD&_'@XV)81B"*((NTJ#:)(KU!$&@G\1,R&L(@DN!GT2`);W`S*>IU@ MI9G`PK\.Y!0WI*#VHO:B]J+V'MQP47M1>_LCSCM;^MLP$MI(R.L&0D73U751 M:G!R*;.K?/V&Y#;T]VB&7K![8;>#/Q5%?I!-L!\[H.]A2V6_=1[=,'3#]JZU M&$2AQ>Y^Z&BQ6=3]0]M1V&W3GD.+YW)]>[Q5WYYL@+?WZ`ZWP>,V^`/%F%P09?@7\].K_0/W_]Q7?/GE1U\>&!/-'- ME/=D83N>83U]-ES-M%W?(5/RYGVBT?\%%W_NU_BI[SZ-J&]GX6/T`]%[7,ZW M#'C;[+>3!;SCA--@+/"BX(HF_?@"K!#_I5HT#I_:L@C!.?WSA-.)9LQ5T_WM M1#BYD%;TE7^I@*Q[\D(LGR2(\%T]2\-X6$;%CUO?,_D#W@!T1\\U2/N MMR!]D"3Q;'AR(8Y&`OW/BM3XZQ<;435*4B6OJ)(;424I MB>Z;Y':6!8,;:V8[\Z#\Y--[].,2%NJJ]D4`\U1S.8V8YD+5=7AUA*!"!-WT M%W>A:OE?4D@O%&9!&Z%NV862Y\ML0NO)WBHW4EJ\K[1-?;W];#VQV[R@4`.5(8(H-!+^9JM( M(7]3VE%;-S)3U**^E`5[>YC8&M];W?UOHCHN1RR=Z%QRW20E%,M7&GK,SW7[]?8^FM@TH:E/8,$%Z_J^LY70YS6MOLIA@3Q,!7\>##;>%H2`76JBD.1'/QJ,"V$V-63F?I+*KQ4:JEMW+ ME054Y6'V;WWVOV-E_[J'^(/XTRG^*+O%'QGQIU>ZA_B#^-,I_HQWBS\2X@]3 MNKJ2W'`]F]'3H?8?YKK@ M"@HV"C8*=H_&A8)]G(*]L^4=/,BO?!;O'.)JCK&@-3CC;%#.2,4R*R7PW6RP:&P',@#24Q8@ M?AP0?DC*!`_?0OQ`_$#\V`P_))D?CQ$_CO+PO@VZN=2H$3^>0/C*MEQ_3ASN MGT0UO>=J)6(E^MUV>ME5LC8L5`^*J/?'L?H[A)OT)=LQSQH5(0P%7I+KER'L MS5!N*[9]E=M6W/$&B-A3-B$@=L.QXP-$6>''@H"`R*K<(B`B("(@[A(0)5Y2 M%`1$QN1VSX4"E0@ZZ#Z'(HZWZ(>[XRS*U/94DW.B1B"56=E>Y%!J3"^[>M.9 MA<3F:MLS:K_-U1IF3B8R+RCC"L/(M&4\V+9L.XP4!A@I(`X>.P[*HL(KF0(- MQ$&&%!QQ$'$0<;!S')2&(UX+CAD#9T_3:H14#,I$G M9Z8H<+^;UXZG*A`Q`S$#,2/+#<0,Q(PM1XN8@9B!F)'Y"7?-[W6SP._WMP\/ MW-W][9>;:2;Q4<*;;DX%0.N`U@&M`UJ';;7H.%0$,0,Q`S$#,0,Q`S$#,:,' M*XT8LF*C-VSTQI*UP48K]&N2(O#B1,GP`HT,TV5]A9/4&Q8@?AP0?HA#D1?' M$N('X@?B!^)'<_R0)OQX/$#\..BEUFV;>QU/;(N]VYC2FS:,#G;FP,X$7"9I;,RBT"(@(B`N(.`5$< M\V.A:DLR`B*#.12F"@6V[01V?(W>8+9!P=C?C2IRC0C#C*46`DOJS!8^LNOO_CNV9.J+CX\:,]$]TUR.WL@3W-B M>?=D83N>83W=6#/;F:MT7\"G]^C'*7GS/M$,Q47\V5^7+U)-XMZ'#=Z_$X_S M+0/>-?OMQ'?U$TZ#<<"SP05-FH@_O@`CQ'^IEB2(@ZDMBY^)1O_\D=R.D-F- M\(W,'XESPNE$,^;P[]].SN23B^%`&@]&@B`DQI0FY6(;2J4DI?**4KDYI9(R MF8AB9Y3*24JE%:72!I1*\GC<':6#TMF_LBW?G1,GK-B.N%'I'-JEO\EY:8)A4LKC5RFL@LESR<=ND8UN^6. M9U6(*)P/%YD%NGZYD;TS1-O7U+"D>^3JV:#:5\Y@OTMHHIFP*5ZQPB"">/[8JP74!31K#=+D`2>&DR8G/1EI7Z@6[J4A`_$#_ZCQ^BR(]' M,N('X@?B!^)'C2U`[6HAI;A(+E M;_8%>.UP&R8X*Z=C5PG+_";J'4MJ."V3@2+E$V>LY2A9LMQ[].=0>U%[47L9 M%V?47M1>U%Y&Q9G-=3X,G+R/-_.%:CATBU$^;L*P":$;H?O(H1NU%[47M1>U M]S"&B]J+VML?<=[9$E*S0NWCCIB^V`X!6CC-=QQB:>_I#O%/NG$J\+(TSEFCWEJ8'!?RK#_Z\-;L0?+IT M-#?=_(-^:4_\TEZAQ3YK)X\"-=!E09<%0:@CEX7-Q4;<5%A_4V%V:T,)@W!3 M86=0BT7]15K+=%&_J/"3T7YLS/$4]2-^-%<;Q(]^X`=N*D3\0/Q`_-BTJ<&$ M'\LBXL>!K`ACN-K7S89H*9BU%$R<.LN.Q1B.>&&H9%4(;0;ZG/M6'$227B') M@!\/!]LR`E$$4:1=I4$4Z16*2".!GXC9$!:1!#>#'DE@BYM!6:\3K#036/C7 M@9SBAA347M1>U%[4WH,;+FHO:F]_Q'EG2W\;1D(;"7G=0*AHNKHN2C74?:T?H^85BO$\T!7#!Q=_\-7Y+?"/G6X9W3V:_G?BN?L)I M0#T\%5S0I(GRX]*]GZ<./\DJND]%],@ MBN.17$9#"16),W%%!?1=='>(`:E@ZC#Z,%X.-B>ZK\58MDGWP40=MT_8`0[FPM1')0,JA:=)5JW"7:T.*BSH5@\IC+HV,@V MR(*8TM9--&$DE6E"J?Q4DR1E2*H%(",([6H"R)4]GQLAV\#6PML]D'AB:09Q M/QNN9MJN[ZRL;F:.RV;XY&*7*_-TWHW9>W%8LX&?-`W\I._@)]VO\Y/JO_RO MZW`(C[:9J&CX;GN$$V4N=+C&DBA]Y!(SPJF6SJ7F).6/E2T<))<+Z-^/SB_Q MGY5S(H[;FY32H(F5"6G^\EN+`U'W5>>=D\*5&\Y[)G2^%JKUSJF1T0@N_G'^ M<,Y]_WP9QD0NY]G<)P(.N&TV(#$D0A'^\9'[\_I^>G-U^34.#Z@2GGGV(N>S M*X.,6,Q`1;D'%=36.N>F0)IG>ZI)%=DU=.($V,DMU'?J77,!'I'_^G"#>#Z, M(H;$()=RJGRDD00,`BR(R]FS?8W.L`+R9H;C>MP[41UN9INF_0H*$TY(N!LQ M''D\4PO5T#,,@!'\I,"(Y\``^F]_`?]#T8^^R'LVW+#T5=6"NZE:DK<%T<*9 MM5\)I^IZ\*4L:WGN]=G0GD/./A+-GI,EMU/$`],=CSB4$A"M84AQV5L#'`Y` MP3/?E^\#4L*)YEY5%]X.CZHF_$X`'^?4XG.JQ_TT2`Q3!XBW?8O^!`_#3\+R MIT?5A:MTL,N[./@XH02*TOGH'QF>$F=F.W-XA$"4[(8(2JX=#@V2?A M%6"G::B/AFEX[Y2FW)+HZNNIP!)LKVG\+YT2%Y#&F($EMJAK93^ZQ'F)>+KP M(^#4"?!S#@*GKR<"1O](*`/DF`'GU5";M"^,8>V.C%]R]I]!WD`6"84_PP)F MNAZ5E2=#XQXC[Y)3GQQ"0K,&DA),B4Y>B&DOZ,5@QN:J\S>A&+=P;-VG6OAJ>,\PN>"H^V[VIN17M(!@,*3G)3/*X'P> M@NV\5@$#JX0"/J"9O@ZO4[F9[X'326$M^,6-LD.!V*R`CRHJ()MM+>\,U1Y0 M52..I\+_KY1"'EY@&7-_SCGV.SC3[\O7G"?R7\N_DN(>@3D'X<&"PO)C;>+* M/DD!"#3")44T+\`R6,1Q(U0,;!-5'UN+-F8$B!9Q#82];`CK)T$G,WHI>+L' MKLL3H0%P^$[Z#8,J;_'L\)SKP^L!".8DU.%(.5/Z!]?@8_!-ZEI0B7*#YS2X M-/.7^@P.@!N\@K*,)EWUR)8F;M7@Z4"]7<_7#?J>6/V_@-M%'[1A%`[,T9,/ M$:(-7INZ@/?#Z]S$SS,PZ3:P5J7^S),-%M,+,(PCE%E+SA3R\SN=WLC$54\] MR$;IS!O45`.V&+H?6&MJJ1TPW)%(Q$)72$&%C4(#!?[Z+4PN]2M$)?`KP&U/ M>NPIBZ7"E+\!!+G&"Z$>#XC_HQ]Z>TOU"*P,?<,WU05?\-EWB0OR7^+'GY/`,&.%32?:#^(-X\$_W3#<6SU3؄].`E:D/3O7X;>Y4^CGPMMUSCD9%/HAMY+FE.1PZ8(%*T\-IJD[%D*+0*Z7O6CVN!1&UFZ;,C@,VZO6-EVXOO&K%F+2' M[AIOW!R^^[SR:\$Q!F*"N(-8.@PCZ\D.>^AG[,QK-$+3%DX&8/MB`7*4T3:5 M>NJ.'MT8*P7%<0CMPOFB`AE-B&']!X*R(!!(.X'N*CQ_?$\)0A`??_4M'8*S MOVG$L9Q"*9Q"D8J4D;22#@E>52I0L14+!V`EXJ\X]G8#:QK8H[?@)QCX3^+Y M9"F&('@%TH.B$\[M(_@3KR`PLM)=J%IKOKFQKE56@G>V[/_OR(Y104\:LEI[.9;EZ053 MO:P2V%@&&N[5WTMU1,.![VC/9/%T[6IM1@M\[+T5LGQ;FH"[R`143MF6HKS? M_4J]T8!4<1"7-QC->X,4?+=VY=NDT%BV;U'JJ^%A&17J2W5J0-H\7*4W.M1& M'6R#[;0[K7'MA`.-CU'9+0]$B9^(H^T8L>LC5';+H6YM#IH1]LW(&O5`,W+< M9F2GG&#4Y]#"F M,!_?@HTY5@LS[H&%.?0%F;9W]QY>YKZS3>4-6MGMD%E2YESCO5NQ5ELD,BQG M&&`MJ3P"\S>E15'EFL:$[3MLH&8ZNL+E(9B@"2^/)[@\M&N#$UZ/&Y;0?S%0 M;)DE<%>UNFI4A&M8,-5/X>XKC1!:+A;NJ%B57FJF:LSAHF,$&RBCXDK;@7OI M]EG-]AV7Q!M*XGTHT9;'.=UJR'/&#-[YSM.;?#.LGTWLUPM*:^GV&T)KP.VP M)A/N\6@MIZ9:ENW1#3JK+8#GW&>XVX"7A'7"S\0AP=[!:*^09X3[6.'MQE.T MVP2XHSZ%);]1?7',C4=B&N0EJ`!6O>"7)8WZZ@Q,^E1`6)91Y&T1[*MWPYU$ ME-AG]07&OMK\H>ITUP!0"A^$(=IQ(;JE6EI4EA\6P_.4#?#U@'I[$6T0=7FZ MYT13W6=N9MJO;F8`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`/W79IT> MF7?O>LFZ*P8[Z`^[:XXUFIV[YA`?V<$".X^PVU]SA.'K-B'C)\NSW=F.@^SW MUASB\FUKCG$71KP`#%L]KI20$&?VR;">>9(PSP\FQK+TR&G>2:51<)'A;*^B M@TI/8@>51I=`8>NBL(51;DQV4IM@C_B)"#$LSE-?4?..?<;C$3(T\<'&7EH^ M\7@6<"]@W]+3@`\V!?C/[*.:"A<-\X!EB/(@3N+$SHM"Z5=.J>G\JWMC?*L]AP1WWEBD=&R^'I.R[+68W;D>P-%R391N]:B,%&5GRB2(C(R,C M([>&D2N)GL=2HKK_6,4I!V,S1I8JXU-H43([LLJ-) M<>U0MJ.0D26?*#(R,C(RW+`!.'A(=[)[>@=-5 M=$1U?JEP\ICOWDEO$#NL.OJ*]&'9ZPY@$!W`8#F`07(`)X-^M_#]6[W^)/KZ M_O+U_=3K^=O7?SUS?!^9WUO:"IR"2Y`80>PE66NP]BC67H;^V MQ]KKT>\!;&TXCBOJJ+:^8.=RWTZ^T>>1JEJ>Z>KF],ZV3/BHK^%T6GH@^7IZ+WWBOWE*7E*TOJ*G'RYL!H-/K# M/D>./2\D:^^\,KI62-7E6VY,9>1-/<=5&!\=*>Z,*I]TDYBJ3HPH%1]<8FK$ MUASEHP7_4]X%1.]WWW\:/7P,_^R]_TG1'<<#YLV\_;>%1F#9HO>/'GZ+W?[- MZO#A'$?6MM_-WM<7,WO\\PM,30O&1@3@O[!,1_<'IIL* M!7/'(YS8SS,*ZVBSQ829ZH[B>&,'%L!E:ZI9WM@-9@OX,E\0,SY;LIRM&IOM ME,]6%;,5R?;+0=O4(`RQ)I;EFDPPM:6YT%$BTV8#HI,)55W]B<+EMN(Y;`*6 M9\-?GNW.E+\\8H."8XLT@:?`J.'>4S#;X#=*;.-5(0P?`4J5!;7GN@LO[BB/ MP+OA]W!KXITP*(6^+."]E`]\1N#U!`@,;V*$$6-B-&="<)E!&)@Y+UP1\PRE M!$CK"G!18#+1:>=9M@>,-E_)JP\U##7608H0#;H71^7"P3U]HHRY)Z!5N6#; M1(5%Y&QV"9@(&MUV-I/J[D5]M_O4U5:PI6";!M1%"Z M%PKA'`F29[XJE*,2L"8!+M:Y>//R,R8ZOJ!&1J\&HV>,#C^8S@1NF%J6QGG4 MH?:3KE+^.?LI;'Q,#,)[09Y,RUPR/7$F`;J`$#J4S8_=DC$M^/R7I]N^ MD("L/UH+755.N\/8B@;K<;^\\RA*NR`..L3>%1`6(8" M(.N,BF"M6=&Q.6PW2&6WAZN@FZKAL3XB,*0'@,5@5,>#E0,[!GZ!(7@J_^/Q M=4'Y\,#8T*+?A5S5B4Z$(97C\WD"80"P%S:,2P>WBZ$67_`0IV%U#2.@[-]+ M6@/BF\#OX7(YC.7F.DP\8]'90H?\H3,@5\BX4#$UB[F0P.(&N_`5C*CC6$,2E+^J,F%/J\Y7ET/2X.@K`@\95C&,=^0]E MFIG/>4P#)N+@[<$3YHQ8__6T*6,KP1SDA_\U^$8Z0W9.0!.,?I@#T(0^Z9;G MQ+B%LB>1UX`7%)BMR;8UV3B`=V#`G`R<:#YQ^.(>!:]C][`??'*" MS#P1T"V\XU62D.'[S*6@$57H-!OHP2=$#(#XY7/3%\&#*($%<>B"V`PMLX<< MQY64`HXHO/!O7_&^LF8[8SK539.-`GP/T,VO2N^(/>V,#?)((3[GL+!&[%F, MKEPC\V]9O"/@>G]%^(L\SM*N;3%IYF,B"V!?-BU_+'-+`RF'E<^^[(B9)Z$A M$'ET\+:.QM!7;&P1L9(Q`.(^K11$T-6(ZE27%>NDFQL&S.',S7 M\*UG3;E=^)(OUBX226,<`G\N+`?T%?N#<81E"FMR$O%'-C-#SK/,$('!/K#; M.K=[?4LD&+46';6U'#4\P&"0/F/,Z%\7S(`C&,@(L2GI*'>>[7B$*1,KPOI` M9\L$Z='"J<([X68JC#X"%&?P-07]Z\ST"4"JXS$]XW`+_;\P1D9G1I&QY\`G MQSD*?YE2:VJ3!4R1V24P"`8;P8],9W`'Z0DPFDE/0(QGYAME^@0^`;BO0YR9 M,C&L9S`?9I9G:$P/^>.&._CPLDD&VDQ@3#!C4&U`*_!L#%`N17?Z^!6C'7N0 M;P%F:S`\+?"OQS-U]JY@YL:N;=?``^&_/X&[6 M(`/_M@S*L*<=]X`A=@?).R%`)&`F`+G?S-"HU91'\J)\I":=@$7[![-L"R"(P$#[,]+D!-X5O0.Y?I% M=T*S/)%#%N,GG]79Y)5GD%N?CLSR,N"5)B.<$/0G,*C]:,R"V84Z=S$"O`BG MZT7GZL+PQF*N#-*8S0<\KC$7YE(Y.^F6K)_\I#@>J#[*U2D12%&!I,S#(E&[ M*4,H4[/D5G?V1(6[0L`@=`/8@T4UV**JB45U_$5E=QO+165_JF)1HW<`!O%% MY4QN:]Q<+;,[#ZC_)7($17&!H'^"G13=98`KXE3P2&PFQY!Y;H^+^>K3N: M+HQQ/G88F27B;FQTT6%QZ_@YT!^>JQOLS4<*S%S$Z8!87#V.*1MSXN4Q;(P\ M-G`.;:;-*4?+\2N?;>[\!)`S-XB[AJ$?G-0*.@L*Z'/!CR;H`H/9QCKSV)9* M@DQ8C"YHP;D4G][PR,>>XH#=\@YE%#/,]4B@1-,UKEV2&L4WMBT_;IBC)9;? MAR9.2EL4*HOE#L]6^S?)G=&/OO$"&G#,D`,>MK0%MVNH?*"[/J>Q79^`KDJ$ ML(`5PK#6EX;W+9>WA]#6O`G-PK(WAJJD_`K:KZ$0RER/ZQ>5&@`H3'Q'G^-D M/&Q#[#8PQ/I'OC/*L.J+]P*`"9^F?%]&UW2PM(^4T0_+-A6^L2_X%T#KPMPW99AD6)[+HR$\_,8>RMU/E2P8!P%U&"S!%UQ'SBP#9F4]FU2+ M32'."=PF>]:%4'+_(FI>1JZ-F9E,^_1[G3,%]+[!'B0>\7F!(Q9;.J!OK5_"!].S$$$Y4`%1H?)W-8PCL31=Y$^/)7 M4,C`"5-J'K'QN']3V^"1;Q9^!B[[F[V';6$M9J"2C3D@RT($@ANY!U2Q6%0N M<[[S*J1N>!3S<7TIT*)BL";O1_F&L>G;_K!S$?+I;YV'#OCX!EBKCC+QN!ON MSFS+F\XBIB,/*,#58/'Y0<9X8-BF#F M-K?7..XPW^6\&T_,V-UWR53R,?'*].88&0`@%VS3P5_P*`5TOE\A(B>YT8DE M,/AK0%3FZ+%;@)<\E0;RSI[(]I@`9C(G_'%T^9_/][>_?;LZOKS]9(48EDT/__XJ->4!_$>ADK/P)Q@!">/R_G$_BF8GLD<%FONC8_Y6` MJF+M^D5@*8Z.5X*^[*[7[";_D:!N0!+FZMCL.KX=\,*W?6"`;[N=02B<>GPV M0:X""UF9C@AA@AR:5"P@Y^$":L1'G9^^*J'M*)/A^,6P7C5E9++$.E"QQ`"J M^_NG:6N\"5JS\9KS5G4M)FBAO2J,TM@2'8&-JG:8<9=C!P90$LAGPF+5*#CE M.H\T^(L=$\V$!ORY0C87XX17V:RC>PD+V=%<@H9C%3#": M;C+]RO5F8*HI[]BP(Q:F8-"0):-FJN<(RW#!!K',T?(#)N!3SJBCD_@V8@C% M[#7A2[DET3OM]`*P.EIA/;!25K;ERJ(&@)9^T-#?M9CZ!@$?#$SZ;;_373Z8 M;S@(G0ZT>=N+F"],M[)]F)/.\!_A=0K?4N;N`7>[.<8Q."% M[[Z$Z2TB9XGMBD]8CAW/0YSIX'#:?"\[&KUV/,-ULF&NV!Q=4V1;<2[?)BTS MLV%D=7?5&AMN%`2"=X"\-=/-[???A%)"W$=M\Y8EE=? M1O'LEP*6+K%MQW;G<_07+RM90M*"P'#FNQS0L8(>S2/&P;%!7EUHV2V--L78 MF"ZYZ*XH5I?#X:]XH4=A*G'H_!772U<&B?E]!)K#^.5P9FSVAV8.+-_XML`Y MK+6?UMDNP%'B`B6;*^QU=5A(:7](X5J+U3#1(*!8I2$K5WKQ7:--CD0[4$7Y M*;;ME8Z&%OG%>]69&ZWL>Z6%IP-62*]\D[09I"E'\>T-/%JC+#L7AO5KD:@ M?N<,:,4[B1@T7Q`/2P*D]X9W6M>#-0S..RNZFLID&N0O8&.P;`?'>ZNP\ICN%]6WOH51[QN2G05$KV`@DPK/VFH M*-E!ECAE\>9W8^042;&K_CD<4FQ@C*]*#6D,)6K?]CI,U;1\H]]5@+5'4JG. M$^WWYWX>NHW=^&EBVL3.*]'-R)K`I(GU9HE>4)-4S4U0+X<*!A7,FM-$!;/[ MF4>=](%'JFR6Z)S7KC*!BV]!5:O**85&`C2H$5>3>GV M*1'T4F32.#=W]WRYV;]7>S.R]! M#R._#8I$S@W6#F'M4,4ZKXG(4:N>?-?M]'Z*+UP]:A)+AZ3RW+!T:)O"W41N MG*RZ%ZN'M@8AK!["ZJ$#,0VP>D@2"T%\S[/IIJXTW4H3`ZRLFV@LAAIHV/#\ M1<4RQ<'NNGF\L"V5=:5EO_!&[?RD4=',TC_ER_HO/^/7&K/^RY$NQ8E>H!WE M#\I$CZ7!/U&;3*E_M@%OA3EG9S']38(#H71+XTGRIDO,J9Z1(A][B^A^&6L: M'7;&]`N.12=2=EI;K]LYX\WD@[.O1,-HU_(?$_9A9NU"P_.@6;-2?G);]G:G M?]9(X1&N&NLLK\4/,QP3@_="=684[A>C3G6WQ^,,T[UP@Q;:,^(?U"M.I^/+ MI_!#$,*CL!G'PG(S/G.2KVG`B>$YI**+>.1041L&L&Q3[9_N M$9YAS=JNVY&3[HS7H[!/;7"(PF;4$=P?W%M$(3Y9_P!2Q0'VX"<$POHOC]UF MIKPH?Q$-RG67=:<&ZEB.PR6>.X,\.2_XOPYXS7C7`M^&&SL3.^0 M!QR%LO_Q\ZXGBJK;JC=GI[FHP77\3$!VP*H05XT_@9W'Q_N6B\/(@TJ=;`,+]U376D$FE:,IY%S M'C+/4\D_KV&Q^KR&!\\$J83O[V8$1%BE'H-"PPD/C;BB!GGF1U9:]L+R.X5L M<;`#&_'8%J<=^^,Z4GQ&V(!\@D!GW7^\5WZ_OG^\N1Q].1Y]N?G\#6Q6^N(> MAS9UQ#8].TG8IAE\I[PSV$'Q8P]H:1G*[%4#RVIF6#9`U4^I@R8"!O;1-G4@ MVMN3X=:G0R1.18NV=&>/#M84E(UGF]SPLY\H@+9-QPPI!>*IL)I3RD)JD2LB MYV@'#>-!2=V2'\G%%^=WQ'JZPU7QP]M(X@01?O+(4?P<+)4LA$9U1;>9C/ER M[?WVI->)$,P?)S,=*J)%=/[1([CR?3\)X2?I1U4&0)5(::&"R!-<9I&8FB[. M^0M.3W#96;KB_!2;FUNLW!S:.H?I6*PX]TY6K*'V\(5A9Q;,TT&0\;7^X\ MV_&8-^*;">G348]"%>#:1*-S8O\0IL8"D$!47\8,C81^#D\)%W$!<1W3>P#_ M@0'443YY-CLTZ2CK<+E`6[&'WP7#&RV'%W-:85RA694PSE3/<8$:H#)A(J;/ M:$PGZ<+;J*FZ>)06>8GQGUBH;JXS^G:^MA+V'5<.#WPDVSN#O$C7'0U MX/30)HP<&Q,0EU%M27UV2!\@X<(`YN6'PW"_E8T=8,!VQ,'C1"!@G,GAXBD[ M[)TM3<[QW=)S?.5<7WD,9OOSB++04)83B=CA0GB@4`+@BDX42D7A\3PA/$]( MPCX\>)X0GB68!#Q/2-[(A00V;9+"_F,$VT/24OX"%" M$LLIDF)7_7,XI,!#A&K8ZSI,U;1\8]C([CX\1$C4@;U;K+&I]5/AFF,Z"$X3 MTRI*[!XWZ`REZ!Z'_A(JI2K7&H\;0OVRZ311O^R\$J>=@219".U3,/O-%&C( M+EO=>J8!1Q1A%V^DE_2;]JOI>*`:=7#>.6OD3OX:DM$@V6B6]X?-P+=I!F[R M+IG%#<'ET.+8#WQKA,)^X.U,`,1^X%+7T&$_<)G[@6]%U?7[^6S>FYMUB4GV MYXYVJ2EHP)W=?EN>+H`2=?[.Z$-TY=E!IS!&1X7R[I^I>^--O5C[8IM=QSL# MO?"VR<:K\I8U0_=;)HEF2,M.24'+,_JR8.-WLMJ615L%17N]9^]?19%L$Q&K M4(U'AU9WU^+?[VZ47^$;WHK[TK(7'=XF-4\_;$O-IK=_OS65D3?U'%?I];-8 M?=FJ77=3+3%_I[9#>#=:UF'V,[7LJ4YBK8=YTSF_H6S8JFYAZZ*=>$)\3@:# M3G?96#;2_(NAPK-E_V"BJI(%8Q^_[1AO_2+V#P.":.Z$TNL)0CL&$H MEN>R)N:\&SOKL^ZRKNBL]9\C4@$SF"?:7A=^CK?7Y:WZ`.A@D52?<#'RB+[F M,!YX&0P=9O3VY*0;G:S?._>)V+S]_,)RW.,`[",SC;9.3!#DB+<<$0U2>;M" M(J`E1)PTP<^6(\!C$5)R\96\*A>K6WB;R\Z2G/9WH(H8K;]2>PH:)-F_]?>[ MX)?PMEC_UDBS;F"SCO+;PN*:PO'F?L]^WQ28\Z<<*91UIG-F3,T*SDTHS/F< M-:UT@?ZB!Z=-)]1FPQ??B=;XHG5N1"KT^9QJNN`3T4\?!L;/"6#&Y9%BL>:; MK-V^Z??XYR-PE!DU>"-`UN;7\>Q7UK0S"A/L7`7>R-GO0,W_IUPSBL)K&)O> MW!SY[)OC+>Q9C^_XP2`/R(-LU5F#1@&U7X2XF#Y/VHP6[YZ M3H1(@=6T/'$`A`1,,Y@Y?:&V"J/2CA+/%6V(+1/L.S?@!#;R5\S[ M2X,C-)]2]%^05]%L6MB4K"^DPWIK^JTU=?%UAE`B(*9[E)+$.2Y61M?UE<#D'>>/M^B,`^.GQ,@9X5FB!G`BPC;1"]9M^+B(MA_FY)$[` MA;\2VSU^4"W7A0D`<%G*""0F^KI?'^ZCK^.LG65X1Y1UI)%J,?`ON_@F4?Y> MG\`?P%U7.F-O?DTVWO,!_$%@L_C2 M'U.FO#/RA/EBYQ%?+"[,V_HG$?.`*R/3,H^9IB"N.."+=8OEIMP:K]MFGCY: M%3FJR=[:6LA_L3'E]'D^5'"+"+_.SX?R^P';?LM?^P?K*,SX:NX9KG[L6.!J MT.+.\5%$$4]PA#40G/G$1-CVIESDJ4,,N)R=A0'";(@?P)G13?@NT:X[;"1N ML1O8OMLB<'T8&X(31DP_P@2_L_,4&#O#1Q5HI*M"]J:`V[8IC-8I-56=IGM_ M'SI7/.:J!=\M%K87/_2+GSO@;'#PP/B5RZ;MZ)-7CA[<\P33G(>CP.4%>Q7$ ME[*3NBS#FKX&3)09QEH.L_BUP$SZ@C*JI,X>!'MQV?Q;'"$4S)%WP+?`/["3 M$8!?]>-'"H:U?R0-<.>EE7$>S:\ZNRJF]V*V!#?.Q_S$'?^D(]T5AAXQ/=;K M6T3I8D,T*=7\PRWF*8<[[@-YMAUX9^'T`S$4@=.<90:QL0!I9\%Y9]F+RP+M M(:5#\CK1A[*3]:(GN>6>`,E,3%D4&C_\B32SW\K,62S>Q:<&,`$1?L-(?4>5`L[C$B;HYBL$&XO>D9T=5P:M8<(S[_Z%Y$%%@8%U\L\`;/2WYW)=/P1"4 MD0U.Z%3`9K$YJNQ'FGMXPSQKG3.!?M-RUVF\*Q)WM\9KK;IC&U?/='@I`C_2;``ACBBU-_BR["MI&?P MBEF\[QW4)P<"RK-5C2M9YLL_*&+/TH6"[X\?HX8@]VU2B`:""[;H6H;^KXCK-8$ M$5]Y^@1-;=P@J.96IG)/&XFU7@^C9>Y(=:40J(!0`:$":C1"[%81>%`$6S)\ MEBN$=$-GJ-&Z2'PM>4'X&1Y".LT\A)1%\"/;&CR;=V89&LN$KLS^VZT4MK=B M*265DS+*W9-0LL(BV5N9="44R"QYCE(@65.\7QH,^OV,AB15JY[=6*2!TH)8 M@5C1>*P(4T?Z:79`R$#(0,A`R$#S0B*G%?W0&OQ0O]XSXHZ*LE(ETR%%?Q05 M1BV4D%QQ]$XZ_2054&V@B8F(@8B!WFG]+(/0@=#1&NA`8P,W5M&A]1U:)_1D M6?$LJ[+R#P3$G514)C)00G9ETDT?FH3*!,U/1`Q$#/1XG0]5*_U,:OS;]CP9,&:@+#6/*SEJ)UHKU&L;:5P:G?F`4F% MJPR%M'G1PB'H[BW/:RS6:?M,&>J<%$2::E%HNS%:`SD-L0NQ"[&K;9X\PAC" M&,(8PAB:8/)RV@%LES>^&6(D]L!/?LOHM4KS! ML-LYW8D,&,E&S$#,."3,D-O91NA`Z$#HD!0ZT-S`C?.M-\Y;Y+]&BI39\;C" M=[4FD_!HIN`P7E;A++DGBV':?')@F+:-8=KS?BI.6[\..Y1`+:(7HA>B5VO= M=X0QA#&$,80Q-,)DYC7<+6]2M,'?+0^;I>5MDLL76V@W!$L=ML8NFN[[D\&@ MT\5P=3-,8,0*Q`K<%4?(0,A`R&@&9*!Y(>EN^%;^98-(LR60-"U*T2:\K#\V M*`]NED0+!$]$"$0(1`A$"$0(1`A$"$2(0]XDW&@?=X4$MWMCT?_BCVLQM+%E M1.AQ3U5K:NI_4U@7OZVU-5%TC9JN/M')V*`*<1P*7Q/U+T^WV76FIACPDV[H MK@YOAM^].=5^*8X0[;@_66)Z32]V^G9CQ+,*S98^G#Q.G,PU;`=]UM-W:Q"H M@13:BQ9L)^D0AQ"'$(<0A^HF'>(0XA#B$.*0I+&"RMW_O%20=KORRS=>LNQ@ MYHGS-&$*KCD0D*9.G\(,8?F43(QM,(5GKS3H=GH)*DBG)YIN;B!.($XT'B

(%[DX$4:,!`Q]N2HHN]9\?+=F$_4 M="W[%3U.U`>24$)R?=#O=BY0'Z`%6;N<(&(T!#'>=3M]1(P\ZORTVU88(@4B M16N0`FR+,T0*W!1%Q_36G5%;43W;!O_4KZB-KSKZIZA#4(=DZ)#..>YOH'=: MMY0@7I2+%YF*/UYI5J(MD*%AJUZ2*A]^DL#$2J/=]4-HR-T;CAQQ#7$-<:U! MN':6.&RXY;@FK^C@1G;-\8([VUI0VWWE);ZLNGD,&2DBO-[!L#^W,VJ4$\:(A>($N*D*'7`*#T-$0Z$!3`[=)6^IUWMF6YJFN M8N@J-1W=G`I1(%>JSULPQ"!T)':Z`#30W0_7N%OB&Z8[) MJ!30B$3,0,Q`_U,"ED'H0.AH#72@N8$[IMVL%;@;75W=?/M\_/'V\?'VZR]* M?_%2Z$P>DF?[V;*T9]TPY'=J=UY2206K#'7T\?;^ZOH^I,;8`/E3>IW>`B9L M&;KFM]++0:&VDBI37VU&JK1&VR.Q+KJ)+G\;4JD2=;8;JS60UQ"]$+T0O38G M5CI]$;$+L4M*,B%V(7;%+:]>YP0M+TDC#1@\D"5X\&BYQ/#/:%*(^I>GVU0K M4/H81Y`'HINMS=[NMCET&%IL>'$N8PG1H>@QQ"W$K3;C%A[@LL/#3Q,.1C%? M[&@X(8PCC".,(XQG\A/"^"XPWDU6/53G_B**'TSZ2A[O'$I@:>0XWIQJX3'@ MAD[&NJ&[.DTUK),NOM3NR#YF0S8D&_)=[[PSD"_X(TTVY$^[F7"(%8@5[<$* M&1/-$"D0*1`I9$,*L"JPQJ)LK*@]XP']3>%OFI9YO-KG1)<3E0,JAPSE<':: M.D`#E4-IAN0VF-!:44!0:`@HE$2+=B.#5#O4:$T@<$@`'&A-U.%JRK4/BIGX M:S+#%9U0<%LUQ24O1;NE$CJOF!"53X[&)$35K[@:E)?_KC<<9$11Z]=MS4D& MVJLKO0%"M57D$)T.!IWBQ*H.!(>)VB3Y3/TFP6$^AZ-)AZ`I/:F:#IKO*GUZ M;WC1.2L`2T3*MF_08R!DHY8$D0@(:T_`]O;S)0:C(/+H@6:KS#:5A56G*OLG MYZF38C:D%"HQ-/(1L1"Q8N/!0E9I'9C";@<)%BS1-$,U@6H"U02JB?T0J5H( M[0]/$D5:&`.2*@945N9,F9&A7F>X2M&I>50J6W+[G3.@B:)9 MWMB@*V3W@%51`9DRTB?W2:C!,*.J5U(UL1&S'99PKH;T@R('8E4;L4KN4Q\/ M$K+0ZD(D0R1#JZMY$);GJ(OO"MU4J`,K05SXPZ:J96M44QQO[-"_/-;VP+44 M%Z[73=W5V>$.JFIYIJN;T_`^Y9FP6PWXJ+'+;3J!J^$"=I]*#-43/TV(;C.> M]:AB3<+C(8(G\K=3_8FMAT),+G+@JIL`9Q7D]I3G2^TXQE\$2<@>V*AK/E8 M-PDC)UL>]A7<[:?,P')8\(T-PW.!;W2^1N*8#W=&&&0`3+G*7QX@TN15F5BV MXM`%L1EW,*::FGR=CI3GF0ZWWMS=6`X%SAY[KK]2#GO]F*9&LH"YOG"),UZ5MR>#3E^9 MP^O\!1/#B(SQ67=G0!YZ3%]TAZ_U[]1VR-V,V/.=QLHP8^*YGDV5!;5U2W-2 M\K>E`)8D;D4):$E]49DD5OKP*\\.`/85Y`(DE:'V%0#H?`Q+.>@=*?UN[^2( M7Q'P?(CN)G7ACR=J^D@<9ZQ^KW,6,E8$UAUBP.A\68BP$MS,^--)*(U<>,[& M:DG996\Z^0_*[%2F#I^H3:8,-N=$J%%0?K:K_RV@64@<6X:TO(8J50@T(+,9 M%_0X[D:!,K*>D86#!P<+KAJ6PP:C!0J_U^N<<.;C>$"F4YM.X;>CZ`\,0'SV M4`Q=I29_!+?('7YA-W)A$H7@"C;F0>02UR8:D,7^D4*Q.1N#'^"A)N^M'.``/&V/-0UT$Q-W@Q[#DZ93&IJ$',;(ZYP;IZ`IG@A`FN>$@Z4O5/5< M_0FFP,Q];P'7"W>%(8T*"VY;AC#G!&GA*T?7:/AH'1;%X5HN9]0J<69+M(SK MK:SK_=&RQ[T].>F<1NVN&`4X`<2LE:)9"UR-\Q<*8%H`O:GGN$I?4&@0ET`@ M)+6Y+%O[:>_]3 M:,"`C>LS1$=Y\,;,U0C\3WC[7"PX\)^FB_7WM67&XX]\1A:X$?&RYN)"*XTW ME(`T2(7!\!>P7^]5N`DEY4NG5PIIEQP:S]"%*POV?4T)3Q*^]UJ'.: M.@S6X&'"]Q-XP((UB1&G:.K+[P.'GR@YCSARJ<14J6'XPP"B@:7C!@O(GL4- M`Q%!8)$`&J`4DWJ0V"/NTC"`"H9Y!+ZZXW`?#<`4="=WF=A5,]!Z'(7("S,D M..D=WLA18[06\XA2(C[XM"P>N##><.`U@?T9YW+7DO.Y3[714O\5"RD)A33) M/5<,\%W^4[9(\I?^05P'!O"%C"W`5,O6V>HRZP5TC_(,JPZ:U'HV?537-9W8 MW'\?J2YY8@K54(^X3\W?IJC`@6!E^R9I$'9BMO0QX#8+"1C6,U>8$\_F]FE, MUY1KA3:=1P)F`#(3Q5E052>&^ZHLA*E)0:6K7%D+SGB>Z7"M'\J!181G>Q.B MLK""6`AFY[.5F%(3?!Z5?S>V"?=T6:1(M?6%<%+@A]O'R]`1[81LZ0]"_UL$ M+31],M%5S^`8$WD?^";`O@*6'#K7CWE^FJ)9#G/$8/5]G!!ZZ%O]Y.5!`#FF4N8WKY MV*MY7)I$5HL'+8G*JOE>?45B+RP>:;38\HJE'LWAYR>PTD#W,=[]T[)_B(&R M(3+/FLF]PXWWS`?<`W>":M6.E-]U>PJ..$'[++V+D('_C'7"B#/(F3!X0L:$ MGWQV"71$W-+VHP6P(.X$I-!BE@D#:]O1)]RO8"L&ZT1%`,SB?]L45A.@!8Q% M"XP38##Z:C%3)R(J<*F(,)BPLC0NW(['(LN.$&`!!LY1**-"*H7M%(AK7$;] M*"J\1K@E.60!:;!BM*'FC-E$N=1@>V,A1?0%9>O543X)5724IX$5$>_1EG`9 M%5?&W&)CQJ53KD"90*L\$B3$R=#\V06B+>C@!(9OUDC#&#-,WR:/+&*S`?,) M]CKK_N.]\OOU_>/-Y>A+L!GCTA?W&$:0V@P\.TE$$OEDV5SH*YL=BT['$(I3 M!;YZ`O7-J,-I!4NH`]J-Q#NX-Z48%IB(,9,1S*V@_SJW_P+WR0\PD*C=*7!%/#\, M?'!//]A)S-D9:AZP'\+>!5M.YO5G[V&D-RT&(2^Q.]_VEF&:([9]R%`7](CQ M>L3CUVJ M1L.'JN4`2`OK>$:>F`]"S>6\V6A@?!''*7IS,!7^D(CWQ)0;<^BYE>.8686X:AX0RE]RA M:J;4,9P&@PK<61$684L3;/+Z_)T11@UT7Q;"!V;<,JTC#'\MT M%<<[8!=?1IV?(IM-49;F&TY$^Z_GB%@1SQ>Q-6XW<='\/!K==2(90N$G/F5] MRAU*X<@+HP#,J+EN,G]$>&AA5,^F3SJ0TA\$,P4B0_<#O)XC3#>-N4+P&+HN M#0)G2E/`,0*75(3?`KGA<$;\_(8Y>>6^*B`#3\^8`8J`I<9LT0D,W&0^K9_" M$8WRKQ"Q=61,\`6+TBV8A61.?2[L^F+"?G&8793Z)99QULTL1MHH^2OOBYS[ M5R5"ANE?617:VW3E*7-^F9'H\E:3P%>Y%7D;QYI?\M(#H^**E MWUE+&:3_Y2QS.>N9/;0:LA^WH`"X=R#``0GZ&_'YJHI.F5A>Y6Y$X:)5O&PW M?L;D)]`-F7'B37C[T(CW.^A2C@N%";_KT6X-J=@FQ[JT6N4?57V@X;4(+O$"2;XMPW8\>?!^F`52)Y)9X\V4`Y*J,=P/J=_BHG2;K8OS)2;'$&Y9Z)<=H=IH^AW)-N*O/< MTF8)$N()XLDVI)`?3XI:'2&L(*P@K""LH)DBMR"MX3>C*[RO!.R MMH1GEV7[Q.@2HZZ1CB3RZYR3;F>X0I)0XZ`%BZ@B$4GD1Q5TD!%>ZB8#PLN6 M))$?7M!HDOE\2X\E0YDC=9CD<9BQ[IY M[#<6B[%W<^("9?"IU.!1ABX^M'R>,I3UC@?N[5N;=WIQ4(R+G7[AX7&- M(/1>%4FK"%;G46@'EN96P@%\^\Z%.[E(G\$GM3;9X=C'9LDM`ETE@HM`=Y!` MU]CH`.(=XAWB'>(=&G8-![J"4('X*>>XY98T'LUFL/31TRD.W*G_Z"8M7/(R M0FK*4J.MC/WV MQHDVIGG4#E-&\\0*CC+?7MJ[*D!4MW"DVK@D[U^%:]@ MM+&ILDE'G[)XO]:V/FT1&020*#400/:X@I%&GHKH3*GDMEI$&)%;JPDLL3VRX-)41,-\T&KG?>'C%%-FB4K$&FIQ?=,[6\+0K5%\[ M=@@&?82Z?<(_!(Y(OCKKG%A$9Q_21!##H8#$+W7!Z^0B1*D021Z&"0"*TAJ=USW&*7VY=_ MM(E&Y\3^@5WHI`=DU%NHK]!FKI\DB$$'@T'HOD`5+_!GR]*>=<-89WG1(T<=)#-YFJ&#>F<]+-22@JL0AU(D M01PZ&!S";G+83:YIDH7`TP+@Z9U>H`$DMR,NY39Z;%!WHZNKFV^?CS_>/C[> M?@5J18FUG6??K_F99Y7'3XF^P^?@E+W@B)+$,-?KR]O[J^#ZDS M-D!LE5X'J*0XEJ%K[Y5"3#LD^F7JR8@,*:?/G4:\:56=Q\-&P2=K2G2#-`Y[W8QO4%NYUK*](9=//%6I2Z,',>; M4TT)$A<,G8QU0W=UBDW_4&\UG3S-4&+O^GB:#*8'-TVV$'I:`#T]=-HEX"C$ MH!1)$(,.!H/>]7NX.;%G\Z<=>^*M],2C900%WC@ZX]+!+6JC5FBC#&6$N@A= M<8DE"X&G#<#3[?01>!!XFB19"#QM`)X!]B:1S?N6P)LP")7=$+!B=<4 ME[SD^_&R>_%8]X5U7Q70KR5U7^]Z_5[GHB0C%`N_Y#/I$?X0_BJ@7UO@[T3Z MB`7B'^+?)F1#_-L'_=J"?[W^::>'YI\\\"=/6@/&2C9N!A`)DK#&`"P9(H%, M^XF6;%TVM\&:9W-@>Q&_%1I3@@*\)BK)D_.DFX!*4@H?H3IT0VA#:#L`:,MH M>8#8)@>VH4&'J(>H5XU!-^SBII=,H+?W=)(R8R']3G_8PD!R]?HG13A40-F2 M#U8:$$K1+&]LT%6RCTIH#;(EU=#>:79Z&0D;"BC(P,*&P)\1`+*R1;.[`0;4+)A3D_3"%^(3![_D[X:VS_''S, M3(.(D,$/FZJ6 MK5%-<;RQ0__R6",(UU)"CQBZWZ02N MA@O8?2HQ5$_\-"&ZS3C8HXHU"4]>")[(WT[U)[86"C&U(![&0.;_D2-'@ M9G]$@8#0WXT!6];-E:<^Z80`=%S9U*",I?5E0E='>>36!7#I? M8\!E;#X(:.ZZ0++Z'QYQ.$9[HPP M[`"\;QPK94ZO`!4V*K,SX4C3Y1PUK,V;5PP7]A=HYBC5T"E`-6F=F6 M-YWQ&7#^NRY_DHY M[/5CFAK)`N;ZPH7->%7>]LX[%\H<7N&8F2CF5RJ#E3[\RK,#5'T%B0`9 M95!]!:@Y'\,Z#GI'2K_;.SGB5P3<'D*Z25WXXXF:/OPF6.KL-,)3$3!WB`'# M\\4@X"*XE?&ED]`349&+<4:>32DAJT3-BTI7\P_*S%:F_YZH3::4Z3C;U?\6 M,"P$C-$]+9ZAYA3R"RALQN4ZCK%14`P6,+)2+.,Q6%_5L!S&8EJ@U7O#SBEG M-B[\9#JUZ11^.V(_G/D_,+3P&4(Q=)6:_!'<*`=LZPE>91>IG@/V*HR8LQ=[ M]4Q?"`US$7F6:Q.-SHG](PDORM;:O?K4U95L(_C@\<\OP`@ZZ`Y=C8QD*U;R MO_CC6@QS;!E:A+N(ZP`;W?GK7ME]O[7Y3_F?!_4DNV?-"-"6:4:8(.9^++%7!4X+YR8_5(&?VP;)-95]3F MM@1#3298-N4VA?*.W13$UOK=]Y&%4T;!5>'OO?<_B5?YR\TL!GX#AWB5VLPN M\D4QL*F%O17B.Z`#S0!V)G^47>*!DK&5T7@,ND,8%XRL5[8W54:+!;"QD&0E M$@]4+G5XSL2P7H@*K__U50-+;F98MJY1Y78Q`\`RYKJJ/%B&)TS#+_1I>7W& M%7SL7W3-4IF=EWCBOZD!&BSZ?F[;P'6"V`$V):9$,B?RR_(U/]_9NN&_\=%: MP`6&`$)(XLD[,\KN-QQ^2J'*PGVE.T;8:KA M,37-QAV,6`PT8O)V8,RA%O?1"&SK-D[O85E^HZ4"3[K/.9)^898R)]G[YVH^F67#;O_@'$KH/_# M@<*@V6`\3@"^^.(KRXS&KD+HYO`JJYEAXY4R*0:!1>, M63]CZXG&';309"7*E.$7W/KVHM.-,%E-$1G*-_$SO'A-GTQ`7DTU9"+&CH"0MN#'<)TCBL#7%MH1#:*)>9] MD7-_U)J+NRC+VJVD([GK-O-%O!=M.C8I@3F[@^.\Y@I%35@_^G9U?7E[/WJ\ MN?WVBU!C<1E99RS+JR_]&*0/MQQ4N-CX9E.`:U&$?`?7^(#C_%0D$AGQY*`F M+(MCPB!U!BN5N1^W>,D-WM<5MD=25$B*S)VTPR1%F[DBNI,5OV6'=-NF:;4+ MN;5:1/%D&F#9$9C8"N]'@^2^7U+F;\PTWZ9FM]'T=LO7.9/$I%R5EE'I"C!7 M=E7>`$K:UFH&-4?%RW>3VO4)7'59W(^FL?2A31.5R.[UAL-DM6$:!W:2N/*. M3#^TR-'RC3^5#HCH8S5)4X9I;SD*$C4D:DC4D)55Y">[$*;E'S7DP6G(RI7> M3NU19$AJVLO"B[UK2?W'K=M4-D&U5-A")-^L;`9IRM&ZVY/L4#5UM^*`:/GE M]ILL*VKW0_5_B_5()U&5O"&?7+3'3[ZSZ?$C>1'9+WYAUM]I;UE6@R"YD`W4 M?)46[]9C+NVXT5ECD7@VJQ?5AO(G)(I#=],C^[<"+E:>MUB7P,O*X=7LHXKO M-RD[;U/IVV\L7UZUY@N#ND%%8WXJ9KR>,5XZH\R)`W\KCK=8&*^1.IIH5,%T_!I[#(\8BQ1^C\)33&]"5'=98!GFJ;,T>,)JTDPQ&F($M7FLA!C&0%]4 MRDIIGBU1]B!RV1?$%N73AF,EQ[Q\F.)0^TE7V77+$@/^>E%RR[)51<6!SBN# MR61"63FPXLPMBU48L2=-8/ZLH!,F!"^@O#+%8\.T+1BI^\KSO4W*:JF)_:K, M=,>U;%[DH1&7L,?Z2T'YJZUGD]JL,F_Y=+A$D!(+\K8NR+N^O/>W*K]>BM*<_V<93[J[[[??V@`W M834?KUM^U@'??I@`-ZP`.5)$]\6R03/&:AP!@'YG)44PX,2"*^\B=_K7Q&YE M^/WVI!)PV#RGMT:D+JVCC)P856;$64HOX6K&,IEV7D)S6*G$ M.I#`5;SOB)A?V*=#M,906`&BS5K0^&J;J6J^D!/#>G8$'(BR*"=0FD%1I1FM MFF3E9(/.2:R(D?!+#,MQ1&$(F!^!<0"$7O@9O/S>=V^[G>%/J3(YWRC@=T?) M$Y;D^F4E8F1CIKTM5?7X.HT=?@*"/K$J+6HNI\8,'5C;;57<4G1SIAR7 M8WU9Y\@B<)Q1'1?^-^?M9I@,P2+;=,:Z`#S1L%HNI[H,R\G6=Z'JCG/^UP/D MF[P6Q&`J\<3J*Q'[F=!;'6J=&: M(ZO6200-9,E5:QI+']HT48GLGA\V&"1[F,N6')8SJ$.!R4-/]*I;/.M>_TBA M4Z9V1/6(ZA'58V6%3MW.":I'B>&QA55.=4M'67&_X_W5JXQ%1& MRU*4K-V+*+]N0L<65!SZIV9E51Q&:IZH\EOGH:-\NQH%Q^BYEN(3=X,1EE,X M2-B9OHYJZW[%VO*@//I*%$'5E36;,X+:BTZL1(]?&"W0BQW]571(FC3KD#JC M,4O6HB6(NA.<+RU..O<7AQ77*6//@=$Y3NP,;G;4JLK.0"/L,"^^(J.'2^6\ M.UP><]C+.7%LHYJOC\';+Y=OCU=\^=7LRW)T-O>,"?L%ZO1EP58_[]R[H-QQ M8=GN!)PXBSTQQM.)VD3Q>M=R1=E?),&0>7!LY%#?*A_Q@7#9#5MK(#N[,/K.WU_5[`>1HO4.%W:S&#QG, MM'W'!PXO8<,'_Z^"5@\U(@;T-LKKXH M!;^!]F,EOHNLDR*3M#T2SZ=_L;82,03G4AWI*!&(DVHY[NI&&(_+1A@/02., MD>2-,")4W[B6M=6R_2B3K:00;M;$:Z3S#RGG32/,7+45*W<>$X.K96=&X2ZA M)E*EVBG@1]Z(-@5@*`>K\:3[S3D8((*)Z9?H8+&^`2(`%<2P%? MH2M0"1\7NG!YK.W+%C^;F1$22$^F8K:$-RZP&8*%AF6@!SM`*&93`E&-5]`G ME$&^;D8:'FVP"D*T"E2X3U3_]&;%`?[C;5>`(ZWJ>LC/&0H#T+CX0$H03V:S3X M$<8X@BB(']5X`+BBYBX1BGHHDXI09+%^JR,4&1/>>X2"^TR@)H3;!*_N=89^ MZ#SO[)W1/==ES1F`@H8EC/@E$BWCK7O/P"4&0V]^R] M18$]+9X8;8GEDSTF:B"-NJ:\/0.J!)E9%\0YNVQOEQS(FP< MH;V5TRXH]UYQY%G\B%QY2M<6")L"B?H_424M_U8P']D0, MCRL1G1M8;[L1`IM6@KAA_-H/!:@S1EH>NA#MI/Q^:O`NH'*,51CS8/AM=?@M M`RD+PV_9<3>A*2M)G2K-O(&SZ0YX3?VLR\^K,\>?!_I,%A&7$[0 M/!&W<'@SS-'=C;(P/&:P\(!8\'UNV]LC^.F'^(Z)*8SVR;)%(S:+;2`Q!>G9 MCL?<.9B7K_K;V?DV/^`G/9A4#">5AXPB2IHS'Z\#`@EV9V$7PJ56Y=9"8.YG MV7^!V3*L5?1$K37^4(%NIG@S&3:,@OQ0GI%65U92^0^IDI'!"&S8E;&'N9<-6 M;E7*M5SU3'G$;3=F+=]XF=;J86W"L`F[T-*7(DJY;%FO-=C[K M#.7)=FZ:G*W2.96K$2R+7;?*)P@K)MW)5YY@GN'QU\#^6!5[4$6"6!5;+MI4OUB`Z'HAUU9AIHA=3-Y3W>AEN#/HQ>_!C$&M;P0$XS=78 MVMII-G4U,>3?I!#,IW!'GJ=SQ#?C$[N3J+EQFHC;;5W-VL/F%4'Q15.@6)H: M!MSA;3M28&Q$@MC(2?$BH*053+-93D;=&\*-48&?PF3W9+Y]@DGDV!'"W>"V M;X[A;G#=;1^Q1[)4BK6\38=")#UI[XGQ&VN5$]0JLO56E<)_PC["S=^3;@2W MR]9)N,+RS>0`]]VRK:;2[)I;MJW3UG/HM_7DA=JYC!*Y>>L$F"WW9,$[V[=-?O_V4]LUI@+6@U$$\Q!U'S&R6P M7<\%\/H+?PBPTMN392N+CO*@LZ7GM?B\'!\XDC<_@V^/Q\2AHD_;,6N"MB"O M02T]NS3OU:Q/'FL5YS?[807VR?=WE^\?A87.O$4*-1E?I[@OWC;"ID^ZXW>+ MRAV&2@S64CJ@!KQU$#;P8.*8N7X?1Y?_^7Q_^]NWJ^/+VR^W][\H_S/A_Q2T M$6*MVFPVZK?=R"M@4D(L6;L`PEMBT)<%``WK%S5AW01X.Y-(Q;A?V,V%'`:\ M[/8"LUSR0.Y\K3&(A-^SCBVD31W/X*T8`G+%1Z*ZHN%10;EXKC:44.KWJ-9* M[S:9U5&@NFZ3\K0#VKS;9-`UK;)VDYE+@>TF]]1NCXG#Z38KNXW?"@G7R MVTXVP$RK%*YO3>6;]21LB=Y0P&9.Z\GE61/+HSF6?HL[`_M;&=N$VR>1;I"+ M8`T8M[\=]COGT<9FO+0\V3%1O"2G7V("K'U3?@Z&.9=F.N$=R82!L6R@*`25 M1%$Q(J_-;+QH6]Y4-.-)$2R^A$'S-DVY,9T%P^B[>!_%(_A!C9\5XE\9I3SK M^?D\LPQ`9-:M20,4'H-]I3.-"\3V&QT_,MO7H%.`.@`YW>47.UDL,_J;/.@N MW;.KF^I<&K8K]1QAC;M@5KK@]*F@-75A1O[7,YDR`MKZ_F>*^ZEOS;+>92'+ MZ^:393R)3D2)5D5'L#J.M7`EL#*89$@SF+M/RCNV/-1^(DS]`^Q0"JS'M>*2 MD37@3=4%3ERB4M"_4I*)A$S`0BLQAF-':.A@'(2,YUB&QT4\9$$#?%?;M]66 MK7*YH_,JC@RBUL*@FQX8%,'.9>=<>*I#E\,5/5KSVZ2FH3W2KU6X92SV$JB" MHVQA"ZS`P(9G!A'#D7C/M]B+N=W&S-!$>U@Q[GCWTC$U=#!M?8M/N..161OP MFPV6M,/;`88/%@U!00>HPB*.3%7\Z5J@9VPV\]FKHX,YQXZF%"XT:UV'1\Z4 MVD-"N\"_--I!+N@J%^LDEVK`M7+)6M']399\*0FVH^K.>?*] M%-^FC270>=Z^"4O3F(1D9%Q MFJ@Z#J"C2-,8L5F^26&LJ(?G,(5OO*(3:K.T29>\^*F4O,I;(A-K@[5LC#15 M%P19O*1#(,TCR]YB?AGD.ECMF/:KY)#Y%C(ZNF$UZ[U'%JV+MAA(M\#'6%Z[ M'3.,Y=6M0P]V)3Q=B7 M*H>_&:S><(]LDZ;(M4I&W?KQ,]%-T?UA3.PI^R/H#B'+7AKV=&Y6E]N&*$GL MZ9Q:N4&S@I82\#IV=*ZBVXGHR*6[3K+'3G'?K7C32]&C1+0JY`VT8EUP>.OE ML$^I8;$69<2V7X\GEOU,;,V)=?'Z=OO%B;;PXFU1/--OL+G$=H^]A:): M3M!$)W*_EKP@1^M&.U1V.0E^WF1UB]'?G?'<'C\MK%E_5">J.UX#K]A3!S=B8S9 M"9HN+6(YGH)*2:O#[QG)^Y(:\!MK7`GNN_X4M,XKH$>TQZT_):I:IL4Z#_&O MCUA7NJ!A+^<.P6J1-L*\D][$L)[A$<1XA9DQA0GI?10A8Q`^9]^(UKJ,0=.OCO8'!1+1%Y52UC*0 M24WF=/B3L;-2?IM=(*2NZ@O1QU3(2M"M-12,L+T7ZZ($([()8^5C-@:?[4,> M3;==8BU20Y9+MIZ^$.*0T:PI[,CN+*@**^XWI&:M9?RC>Q0IF`/BPL!P&0<3Q>ZU%V_I: M8Q=0)"+2C$2."^RXF0YY9/HBBR/\#F@T0NSE`L!CI:DRDZT-(5_8%8NJ@,ZS M0:!ZPV/>G5VT\$6PVD-/\#3@E-X1?-G",:,'[@9-N?WVE)7UY,X@!7;DQH[< M*]P>(:Y[Z\C]'V:*PW+FMN(^;(R\-95/=&QSL.J?<[3J'RFC'Y9M@H+7=*+< M@2_!#+$O^AP,(6U%-^8H6D1`$61#!:=1"%N&H^I0=O+&LJ\V?!4LW)7M`1"] MXX/Y*1A%S-O\S]7-EUBK[DB4(?STF&S&FNS^G<4H41>6P3SH7\4CK$_)(X5-,?31 MYMP0#M\+<#>WX':%;;`O..G8U3#%6]6UF,DL&JSW,NERDVXN+F8%CJ!O(OK> M*(PYT:+=`$6V7%8BFM(NK7[%#0BQM,FC[N?2;-24;Q__GV]A9BXQ_)QL":XN M(Q<6X*GK'[O$)Y_#`8Q6H"CL5]\E#,9G+R>9P05\Y:,\Q@,B(%;>!!2W9S-U M")_8C4Q#*7>$44YY(#-]?*3\"B\$1]T`.2*@DV9'0JQ@!LS5%4..=0-F=&<6 M0>(-@6+/G!I?<#9,:DZY41""AS^MY;.$@F'=LQP=+QBYQ"JF$]?V%:;!;PD6$V8+!XH`Z#-A`3)PP'Q"< M#.$8*M:"T:-N'/;84\LRP4I8@>>,:SR%U MV*)!V#&KGW+4/OC[.JN!PJ*1`$V$)=HQ)"_0;!^L%>57`@&,6H!D]3^YM=WDP8%0I ML,,J]-";#3U4O[97"_`]O$R<""%T3RY`Q\C.SZ4II*TXH8`?04)BL.S`G):. M<'@6GW\R9@2IH[<%S^>W)Z";;1CPT_N2Y_:%VR4A/*P\63-TO7ED`*ZVZ8P= M5?'$3R,%6R>7/&`$^W:O,(\9MH*9\\/7PEQJIN!-L?/0J%@8,*P,85$)N]SF MS,&6.12\R$$N;)I"CS/N<&;LT`EX@,*-+94?*03"N`A"(D?+,UY<#]X=*L[D MH+BY;/LGS?`HMSVE;NHR9D,Z;"M5=V8QT[^#7G,\LKC]`1,92OHH>4[/<4P4 M&%K?R=(HRT^Z*LK(`X!?%66V21/2B MPRDY220CBO=>X5.\NKZ\O1\]WMQ^^P7<2Y"IN&6]SEB65\?RV^-,7EG)5?S` MB,%&K+)9PFN-7*/R&%:V-%7&-,O7W;#C]T"!?0)<3`;+-UC*@Z+9[Z`^2-;A ME*6FL9G6LTT6_M#%'Z5*@(\2_O9K$KP:D]RV1MK?1BJD>1/?\%P=A,DMENJK MV*_DOL^=V&8;5U=TC!B`&(`8(`D&"($')S#+5D)C"8TE^?%B5;U<6<7G M:Q;19`8MDH3V21^3C`#!TZ(@OKDH$(YL.M0PJ%U=F+X=Z#@EBGK:_L9*JT1^8*P3V,8/.F9,H(2.\U(GV2/CA>3@VQ M$:LU4#01P1#!$,':[)A+BV#R.^>(7(AF42--M$<0)Q(G&XP3V%D/(0,A` MR$#30@)).8!=ZA:YK=D;R='#,<4YB'%.0$<5M4DME)!(%XD7=4H)XT1"\.$N5P")>[,=KK=P1+KS&F>C] MLZU]UKUZK%<>530=AD--E1X!STV)<<0V6I^HP;=7Q5'WN<>=%P>_I/!F=^4% M266L#*V$G1?;V'FQ*U\TMCE]%Z4RE!&Z$+H.#+J2_;00NA"Z9*020A="5P*Z MI-NM.!3HVM9E!B%X2`AM$[WVJBA2=FD2&QS@+$OQPLFI9\L).V/BZ MA,;7]U2UIJ;^-X75FL,BNPYKK:5KU'3UB4[&!E6(XU#XFB>`VU2TW#+@)]W0 M>7,N^-V;4ZVP4W:)*>';"+8\F)^QK.M(=2E:H'WQVW77]1#F7&OJ4XU*6Q[9 MWA\3'`Y7HR0WDW51DI=?-ZV+[&K;^4)NVWGYQI&J"J/6IBK5GY@]6[Q)NJ-Q MBM7Q#8_$8"\W]WU?OA*$"<0)]J#$]@F%B$#(0,A`TT+"22EYCT=]$LW M6NL;\XF:KF6_HC>**D,22DBN.GJ=5O?&S96G/NF$<*1K5F/^::G*$#BOJ$-0A&4DX MO506#NH0M#H1,1`QAX5KQ\M^Z, MVO`0EYA3?7E2!/JADF`C:HF&:(DA]AM`J[)^*4&\:`A>=+&+)N)%_5*">-$0 MO!AV+A`O<*<4'5;NL`HOM2@J@[XIZ@[4'6AKHJTIC90@7C0$+S"E%Z%#+H%! MZ&@(=*"I(>%6Z88N9B'U_`/L8Y[EW>CJZN;;9]^5[$9^HJ9IB*9YESZ'#'5-^#KLTXE(@4CA M(T4WE9N!2(%(@4B!2)&V*9*[K(@4.R+%OK97RW5R`Y?VX^WCX^U7\!0[PT4U MON]!>KY7=$)M&UQ?E[PTS/V-T2.330Y6I7V\O;^ZO@^),39`FI5>I[>`"5N& MKOF,FX-E;255IL[;C%1IK;A/I=CKG$BG%'=C-?FU)H(6@A:"UB[[4-*=^M4< MR))J8QNA"Z'KH*#K71J[$+SJCE)4%'A(XEDOB6=-%-,]X'Z*3LVC4MG"V.^< M`4T4S?+&!ETACOLDU]O=_)^R,;^`3!FQYWT2:GC2&30#]S=BM0:*)@(8`A@" MV#:&JWP9.2VB^\):T+%W@%_C>V?@X^% M%<^]\Y6[XMT22IZWH.DCI^DWH.G]"IH^SJ@RTO[K.2[5E$]$MY7?B>$1?KC1 MPJ8.-=D/9&P]445WE(EN$J,368CP$WN0.B/F%%ZLFPIU8%V)2Q6;JI:MP3,< M;^S0OSQXH.):B@N7ZZ;NZL10B*I:GNGJYG1YVS.U*0P`_K!UXQ6>8A`V$+C3 MIC`(=BU[A$H,U1,_3=C@018\JE@31:6V2V`<1/W+TUD20-!SC/#)LD.#G6`< MSY;]@SU0)0O=A?'`A:Y!V24*F;.1*1H\=`+LR2]WJ&%0.[S[TIHOB/EZQ$\D MYO11-.I2>PX?.1EM.B6V%HS8)2_'0=\SEI#PRD;+?@A'FFJ4EDMO?HNCL[<< M!Q1283C4=,2KZ0O[3&'\-GM_O]OK*\_$R28L+/>Q2:<6K$GJ00NB\VOF=#YF M<_?'[),BK.4[>P_+,&?/'1,'GF&Q!9CI]$E0$^YZ@M=:'CQ@06W^:"`7W`#K M;ID49IJ)D-&,#$D$="_"&71LAU7R9='A2ZJR]7%>36I/=7@48[P4T\#Z$`;B MH#A#"..>-YSW85 MVS,85X&4<<;R%C/+"/D\Q>/38#)L$/QY/#%GX=D+RZ$@F1%A@E>ZNJHO8)B. M,J;LF0R@&0>*Y_*+0V&//5HW@7-I[-ELB/R-F?,<*4P$[,(YVD1GQ&`Z$4`A ME'WVDDQA5BW'#3Z;()U!W5WG;ZYPP!##X*,VHGH`GD4`UP3#>=CMGX961 MX:59GSW&$CT\5-7VXM5/0C!T)AO,[@#I&%.#093"66A,&>C;KOXWY[B06@`Y%FJ:V`>(A14SMR!+6)388!LP_MMQF%D"C<#[X0L'8'N3$Z((^9A MX^4G6*RQ9?U(@(J5W7\T8AN`K>&CC%AZAGNP(+!H3Y0KNPF``>.U"7RAO%(2 M$\L0IG7!3\N'3)(#4L:>RRX#)O\O5;DEI(,$Z3;'!)>9/^8T5]_G3D"U3$<' MKEGJ=68"Y1Q4&;&4?`D$UR3@QB,8H/,;@YE'A3OW.ZO,*'),;\*M6?A+BE;NC%P$$WGV`0EOV:GD3G M?'FE$S.J?`C4`#!2!L:AFQA7(;R<'+'_#CB9&=K$]0HW`&$YSI?K!W^=Q18' M4"WR,[`:LU1`8)B.8I*07!!8(\WVIHPQN4XW=!4,3JYNF:_N*.^^78WXDT?L M@_CR)^5YIJLSX2`P:=,!G9]TS>.:QP%JZA-=!;[M*-^L0%#XQ:&T"#P`-6`* M2X6-03Q<&/&F%=,71%30)EGGL/FFX3H1QQ14 MM_7,7$*#^D8A0SV6+,"M@^`&X+30X6"FC&IX#D-R'R7^#WXTZ4N4.8^4WT$A MD[L9L>=Q0XJQXP_+-I5['7R=A0!6SK\:TQ:N[GK`;.\"GZC??1]YDFL3<*DX M)(=>4[_W_J>CT.K[53]^I,#?L;'\05S'BK[(`6VR',_UY7WNRX/GY;W9%R=+ M53UNJ_CV!AL*TW.*,">O`**9YZ<,>D<^6`#(ZH)\T4=S2]`E/\"8!>VA4H;- M[)HQG>HFMXI\FL.SP>IB.HN"1Z@EUU28E^FEYVNG+6TT00/'L53AM3[K[BSN M3B^59I:;=,2^`G1@YCJH"#IF@.*3(L"LZ/R.XF^&R2Q5$ABJBV-O<13CE\!0 M]5WQP%L+?93`12>3B?#K@K>FYBY(DB47+.I@JBR4HIO\FT3X1DA)@`NAW1L5 M&V:%J-QEX5Z$Z@*>*C"2I2,6]3A#)Y3'8]CHEN&1R.1AR"E'9?WQ^]:4":SG M.,*J85BO$C\[[(N3][QV;[W*;6[?WL:4+^%W]< M"Z-A;!G:.G/<9(JJQ5@PF./IJIV(_(VI'5N*KFTCJ3S>DK\,^U^(3S[._\FT M[#73LD4+LJ(L[=")&;5/"G+R=RSNVV8/3IYR[.I@H9+$UH--R6_YQ..JH[^1 M`*W*$%^Y-]UJA%R^CGEHQ8D9-2,A5I6@M*.TER?MJ:1NE'9Y,HP",ZBL+B0[ M'?)POM,A#\=KQ*W%)5LE/>U5;.[I$S4]FESI$N4&^U8UO&]5?=FM&_>K*FKH MPQ^P<4>?(O47VVC:#U-6^?"SP>"HVXOGYQ;R?@T*M3D]O*2JD$+T1/2LL=O? M:7]P=-%/9/XC5.S'X$8;NNKU^T;=8#.;;P"K%LLQ]?@^?[@=BQ8VZ@@I*-$J M2[N&8:3!I1>_HK%_@4.0;!&E,1,<#'0_9H!252D,1:Y^+YI;7X$D1[__`)48KUI=#4RDJVJ+`NSP&]Y9>R#R_J# M3'55N3%942%OEI.S%E&-)PE1"PE::?WKQ]'E?S[?W_[V[>KX\O;+[3TX>!/^ M3VK1(B0WE9$W]1Q7$965O7C==:Q-"%$>J,WJ[T;'?>7.#MI+/+A`/.7.L]49 M<:@R"GN,L%M$&23<.M=-R^;])YY-:CLS?;$L?=1A$*I.7UB%(8`)]5Q==6#U MU4ZLEI1?DRA;93T'GEB1G+68N3-BS(%M-/I$#4OT"UBPNE>B\D<2@W<58O,2 M_8'@O7_`^\<6>,73V1&LMJ@4?WO>Z8:EY7"12IQ91WF(=`8Y8H5Z#W3A^F4? MW97$&['.*'Q(WZR.TF/$V9Z:FJ;[S8NXH\CK#PN>%M*738XL%K;UPMM<&:^L MBCYCJHPK@+"&TCL+ZFT+N,*AJL?^-"U7E+D^$]MFK1L6P2Q(UBS\VXZ8&_Q$ M;9>7Q<+8YKKCL'I6]C@^L]RQ=R.]6Z)C_[=G4J6_YM`MUO1ENQE$UR%K,DMT M73$M,_HHO^D7JX7-G6ZL_4VD_Y4#`YVRCE\NY97!`CV7#,":O;SM=:/-*ES> M+:@3N0"&$Y4FUI\@*E*!#$TLU?-;-/D_LT"&:<%'1O*E(+,>/C:%%UFL69K- MZL*"M]S(79<,HTUVV&MPX2NT*=! M5R^FZOG0HU<+LBT)X[!>:40WPAYSK$(7:/ZDLZKS*-_PPFY&F`+T8@/EI<[] M[C_$F\3W2QGFU?OBNQ`.6!"(\`XF0=,X("L83@1XQ6]$X<\19)J:*F.>)VK[ MW0;F^L2SN3*-3,8OA0]F!,AA&*(X.:A+YJ]3?,$@;E",+)XZ MMHC-%T,#UE==RTZT2T,-79F&_K<'XM\7<*9\TU7K17GHC#I',>W(OX^U5B"F M8%(SD(EL$`0,8&`W3<,;\(=?YVYY+LB1R=NKL68\HH^48(QW[(*DFH;?PCK\ MZ*"*>$9ZAFD*RS1CE,#8MX`CS'[JQYF;&S6LFQ_K]?ADN:+'$F,S\?MG"B`, M_/R54M:PZH@S+=.5@&5+P(IPH$#C2-L%KN>8BO'F<^+W70@'1<)T;\'E)QX$Z"PB/"+-H$`ZRK(G4ZU M+$4=-UI$ARK6G"/H0W12953CEK&8OF$Y`2E2`XM;*B>=06A?9`^'=T1:=B&+ MXT!(6I!@;R%4F".V1EBC.M%&4)_/J<::KB@.,7@_#L\$"ANO[$?_I4NZ^<7N M6093G/H,#9_`(@B[[_&G<^L.0*\`O1+J+^;WRX5F*WQ^Z7`BRH1%/8'BU@V@ MA])=-I8#[F#&FJV+YJ6"/S)=BK!%'+`/4/%OWI?/9/S&VG2R+C&L1V(@.@'S MB2HK1&P8(4U/7JX5![!:5"5\S[XSVYI#!,'*'BGPU>?+2:L M?=`EEG>ZY&@-P,8Z(_DK&C;0C"]?!BJ4-F`?7G3JM_A)F%.J-_>;3(O6<4P1 M@7YDS>I86VR^H1RQL5@CZ:#I8JHEV4=B\!5XF%'61#7H`K*V7/E=>QDAB9E% M5D;,(_"^1/]9PKVBM[UH'T4GVC8[;-3,6^'I#N_)2+5EU2WYY'H@ED?+V+((Y M>KQ5U9@&T0'Q-XM7\*?`0O7$$H0*?NROD\/62;2!8JS*9L(;1JD&C$2?Z+RU M.&N#R7J&,0^3^;E'3,L"@P+=UQO,F+ZR,`@8`6(8L5=%%$;RK;RW31_!3/G(EON#>-X_"^ZZ MC%I=C\SX$U&Q'JRM[M[3R;_>>([VAG,2/)9_H0YZ_>^?8!7Z??"Z&/L_6N'' M[]A[?E\'-:V9AY)&8W:KQ M?5!24\H@2,2.O1?]ZBXMQUTQN1,^N9Z8$JS2H`?(M=XJ#5:O4M5&)AORKP!"[NQ.M%YTLN?3.^UMOBYK2`\SM.$I,7[] M$C:2+IS:Z?>1;^MEF4Q]-0#$5 MS[R7%+MM9\XG3G[8+WD@R\9P#]Q^.QF%`>G8\VZ?`?O#Z2\`D5/S/]]H_M&Y M#MY\8'O3PW_^O/,8TU#J"X+VB36*IU^87W@3MN,<\?#P'Y0%0*DV`K5(IO0W MATX\XXL^H4_??#@9KB>W^2JQ/,3M]\2T0L0-/FTV*Q#)D]YP"U58%4/N M,"_.D&4Q8R6:OBQ>A%5;PSA;4_&7)VG"W.SU1][47[O@X_=EY^8<)AP,=I6M M,H5KEYF<=),S*<>TO`M<0F+<+)O[WHBS0D;AJ20WIA_=I:/P@*8\NE5&A+,U M%K."^:2`Z3-XQ%^`PK?F`S%`S?*T'"'[Q7,?Y`IJB>1GZ>&'C.:%(TOZ)C]X8?F,&6ZA-1Z4BD`10.^X2;6OD< M]AW>9O-]/6(\4GO^Q2)FN!OM7_+ONZ^6/24Y\SE)J^^\H:;F5!;^#]=>G-1J M)/VBS0&?6Z)W-KU^T?GI*,%I*YSYBL#@H_??]79B2!W(C&3N>Z@I+*AY728L@IWLV^#NR.8_\`V[NYL MD*+8A.Y8EA?;TDO-K"]T[H;3Z3-X[PPS9I(YE@WBC("PMY-+XLP"3MC#PIR< MG*YOK:<&F&*[2Y[&QG-5[XA]:S^X3`VSDV`IK`.GRIJ+,]AV<;J=;F\YFS4& ME)X$VQNYG?PA,D=O[7LF=-V&F,&%&YEK0Y. MUI[%]\!87VF8&+?-NH@WPQ97ZKZO9TV)JJ9V&ET8H/EQ`8;3*R71(O= MXRZ1RX-<>%[`O9=BI MM=[$!1CDVY8%\NC_5+P+=7::G';*$ZC,H-I*_L!>'/[9[UU([Q`,\@WD@D4K M=`V&I>Y"5#;SDWQ+N6#FESR#GMH<25@X>*8O(G,OTT>H;.*];2:>X2QV_2))]=\H\]7MC<= M+1:&+G`QV"X59Q%^(6,+#'Z+E3QEPG#WS8>!'T?)&VK$KMEE2DG;+#ZE]$0V MGD=OG7GL/(V$<;;Y&.(&(C\BDAB?;Z^\N\HI7V-L*W=0@L<6+^M9 MOFN>LXUP+4[OC"VK+YI7RT-:\XSRY-+FC3JMY[:;GV]YAM,+A3@YM(M5VS_I MD7%TNO+\!)``GUC>8V(0%WF#*%*K*RC[X:[_IP^064/XL#,Z#[LBIZ;[;\\4 M*6Z7]W>QRF;_0?P`WJVUX;:@%8O`%?+`KA,1J1*`![XH7NOW5T9'B&'=E3L@P?U\\/J=RLXCB6Z\1O]*Q.D!TM:Y^=>_;I=G+K MN0QL'![O_Q78M'`IN\(!W'@!=TAG7F?,'S+6>K,G/]KZ=`JL;TYY&&^-D.FV MI.B=!+0H>[A)'W_71P=<60;[]_XL:;[!H,I<\N"9#PM2RF2'94^6#:Q*N?]B M/9?.ZV"&5R+O,-8/&_I!6RWB"B^G.C,D/_Q3)%_#ZG)!RBX:&29SQ?+FM5:E MS$G2-MBI7J2R.2 MW[SSD59[ZI[8CT!X8]9(L6,]7OL>@\5C='KAOI2>XSC!7 MK1GK"T%-QX\OV%]U\!=="RX:J3.=/JU(H2QEGF>#E1[OBC&N4*\/+IDOKCS6 M5.2.Z`QXOA!3&YG:1T_GG3KVL)AAWM?V@]S!)EO/"CWU_;@MQ'`_%N=]V''E M1F.]KR8Z62H8WZL!B@7/!%+";]Z<:E=^$UA0.)$?OUEFT+&CD"PG,>.\@"R^ M1[*L,RN,\122J[*IKK;?:J+R<&TJELD-LB"+J!=K`-)?6FW]/*J4.*X*@QVGIWGS*N".K_#>N;U4"Q.GYYO--P^@JVV^=8:XR MD.+/@+L6U'9?[PQBNH`-U_"U:`5=]6S/AQM--G>@F\W7+Z-V[GG[2-[SK>J) M]E=92JM&N-*57_6`%8Y8&7/L[3C'WAI>3/P9K"FXZ;*NZY7+Y?E&DPL'EIR2 M'^H(AE@)?:XZT.`*T M['(4)![>F*Q=FZ[IA!_Y4$AQ/[8E.@3TV#3\C]]Y#^%$-X#L&13%@E:-;IT8 MUVXS%)[JH/M`%_X4@X]K33&U#[_%%#.G!]XLK+E*J<9SEOS"99[X9$Y'H)&? M1,O/PLD-\G-"LR;W_7)Y_`2K@2L*LJ1GO.:(Y,4RG9_:0BW7I, M<;N(5^[Z%@7<9$92>6\GR0XWV;6X9WY[O["_W3JK=!*+]JTQBH0W(NYX8#VM M5PTOO[QO?3",C9.]-8N*['N>?5#,W[N-YS1[//R]6:F/09/FB66S%LT/86-E MOE'Q6]C2-T@H7R&L^0VS\HQQ-G:_Y(+8&9BZ:;L$$GQ2C^[B'M3XUTSG+@5 MV5+IQ^L,([W@#^J,:AXKSDA'&,&96QU??&2O#-L[[]+FAQ]3R=UVE1K&@AVM M94[]]NQ=OQ\^^\59$#7]2^RDRFXWZZS*C4Z6S/LBY_ZW'[[Q3].9.-S=997QZRN M7_9SB'/^`:S1(=^-KJYNOGT^_GC[^'C[]1>EOWA9R1*2GK<:SERUF#P'4^^O M/)!V`WHTCQ@'QP9YQ^X&L!D;\IBH/Z:V!0)^#%QCV;\H_W-Y>7W]Z=/[_$.' MM\38F#:YZ*XX_[ON$V#VLM"C\'A+?O[%@NA:\9G6;TP>#E\B%T:G&3G]?<,#Y;<"CA(7*'EN_5Y7IW?:Z>T/*5QKL1HF&@04 MJS1DY4HO?DK6[?W5]7UH>8P-4,E*K]-;N`H_JVH%&!^$HORT/'6**)[F@-IVYT2ME:N9C- M$:ERO=K5"-3OG`&M%,WRQ@;-%\3#D@#IO>&=UO5@#8/S3E<6+WJ7!6P,ENW@ M>&\55FX0:0XM1HO3S(UI-GV:AQ8NE,NI.4QG94]Y#,M\'H7PO3N'Q2/U2/6@ M./O=48B?WU.4["!+G+)X\[LQ)*F3W3>FN/)O2[5,B MZ*7(I'%N[N[YJ"?=>%N0U MV*=GK38D4U$CEKUY+MNI_=3?.'J49-8.B25YX:E0]L4[B9R MXV35O5@]M#4(8?405@\=B&F`U4.26`CB>YY-!S\MFS>6W(9QK8,/MS]\J2=. M=0Q[Z7XQK%<8%NM.^2LEACL+3O[+:5UYL;]S3K?H[=SS>SO[LWNTMIYGJ@W[ M9DV>5TUOZS.!HFU-(PCW771*SSC*&\^%9)PO2,J=J19?XVSRG:?P:I3 M5K9^PQ;'-Y3"9,7G$)8ZF97GM^RP/$`7@ZJN1XS@@)Q[ZE!BJS.XX8H^4<-: M?9S/C@0=KCK)9P_S2S;3K@`YHC_XP=<[/_9:(7&/]X")^3/+Z&3-/&#>HSWH M9Y\^(F"_^C)W0*F3':KM8WW>S>UC_7_`NB9]R3ALF)O&K>AG7>&ND02>6:NK M0+&;-7:SEFZ'K*5LT*QM@:W"_6UITHG=K.6-W.>HHW:;`PV*P->]3UAK)/VD MEY&-ANEH:\[R<-+1VJ(H@T(;F[J>;3H*,37X[%#["1Z0G95_%JZRKO%&IM:/Q6N.::# MX#0QK:+$W@6#SE"*W@7H+Z%2JG*ML=DUZI=-IXGZ9>>5..T,),E":)^"V6^F M0$-VV>K6,PUHD(T]Y)!>TF_:KZ;C@6K4P7GGK)$[^6M(1H-DHUG>'[:BVZ85 M'8M9KFI')X<6QVYT6R,4=J-K9P(@=J.3NH8.N]'MO1O='7EE;7V<1\M_1M#V MACJ?;P-5KIK3&W+1KIE;!6P]TZZ*VQ;/MMHK?M.A^OL]#MZY^W+;E.!WMJG!

$KJ$=W;HG0A!_9V&NA=3WA3X6)#-LWFV\!Q MF3I)=>(PE>,<:F+QC7=2-27OR"=.I!QH#2M!Z>S?LX4RU[7R.K"MI*,=@!8? M0)D<(X9W:KT88;<_R[L?SV[0Y?+JXYN[LYM/L[H%TB/$`!R>KMFZ/*AOVOKG M^E5-]MM!9QQ&<;H5&&K=:5?;C"ZOU5(.MY#TRV=.JDD_>P-7!H](,*) MAN5[R"61=>R98U#`Z1?@'*,A54PQ84F>49:K-)F)D-^4]Y5B79 M`\Y6Y*PVS4E*W9WG!%0U)RH?-^G^$8HX$.F620Q%,B#WF>-I'D'5!N+L'K?T MD^"*JCMP:'"H3JB59-UX=65+&%"FPZSR#6:>GKFH((V41)"H!CEP^RIV.+[) M7Z)TZIAZ15_4-XYZ.>I!%)1GPEE)-Z_`APQCB8K@,AN_.\S`?7J'B\TIOI\R MS4S6C=>]2\*`JMX&=P]NHHKG3T`9F+1Q,\>$0G#UI!&;B![5J(=L9LP-R9:7 M'ZW4TZ/G<[F>FQYU%,6;)$N@P@ZM*;?&./!=A9DT#]W0VO$/*1KA#U:S090K MF"0Y1&E+([1+S093$\')#XX\64F]SE9C_'237"XO%L<7EQ=W%V>AO;!F6#$Q M@:8W)Z1,]&<4R2?[U9%6:^,%KU"T`7\S&/ID&VUVT1=Z?,RSO>S]5RN.<2J4""KA8Y&7 M$P(GBUR8LQ,C)2@^-"C8HY8Z$%`B.">O>[5!\=Y'A@- M9G18P`]?9;96OODQ7*'R_#[\A[MW.59<1]#-4PG=@(Z)M5*`G:(!^]:^_ M?__N_1_1N]^\/7K[EOY_5#Y&!?@#=]5C7B1_QS'Y\[MW1[_[\&]'?WC[CN[^ M?_CMT6]^^X>C=[__;?UU4I;4-0VFP:Z"%S]B>B2JT"E>X'&KX+$?[7$PPX/R+QIZ5_EU5/C`I=!1('"V'-@C]+LD0Z=YFD9% MB;8$111OWP>W,;6"5"!H;QK&@=$M77^+9K%.#*:#[OR'H"DX,8)6J]2"QYSU MR$^!(>FHAT0R=NA>4"WN!4*\*]^A(`H^C,##]KCY[%HRF6EA(XS5/=CC@.JR MW>^]($?L+SA\!&:,,"081W,#DD2.6C3M#SU8A9L^SJ15;Q:7BZN3,_H6!Y@8 MK.'WWYA,PI7+Z>-,6D*G1R;?@D0&E=WY.2J*B`6>W]!:,1.K7FU_OE6OCAF% MZJV;H"I'T>IONZ2`3(16'0<_19@(5$17[QRX;^LWN(J2#,=G49$1:N5BM=IM M=C1>]!2ODU4RB>?:H%>O$9[]_"B@5C=$F+<,JK7,A2FBRW#PD\0E]5W)F_$F MV^D;R=1-T7="8\1;?Q_:,3JER-XZGQ`%>O2>#-XT+O`C%"Q[PBQ!YS(OR_.\ MP,E#QH)[5B]W1$F5*;TM7,1_W;&:%%>X6J[OHNAE\.$P-N+&9UDTMWW86HZ/N9I3#0BE(BM7J98,))>@H2;'O*A MO1F\_7%Q<_;C\O+T[.:67EW\[H^T3/;=+\%-.;7@[!H77PD*G>/^=.OGW*V7@_1)6\MCE_/U+@"3E=^MF%>OL, M\$I`'T^FD2OT"8<9[U>F\E9$9ZCGQN<=LPE#1F$QIM+ZEB0U()";6<;$NJ@P MF+Z+>TA&7$WT9*N\*]_',P4?^MH5S>?H+W6#_PZ^\GN$UZWFK1[T@"-.E.+R M!C_A;(/;3V=7GX$&."G%T[`W)>$;WR_;Z`"57T[@='SA(O[W'IN9:<3_D5P'>8VM^]"&)02/F2G$O[%'%XV[,E^@[# MNQK484M^%VWRHDK^SNJKD7]W'G](,GB!`\?H:U(])N3O6UJ)+7MHL_\)9_G7 MX)<@_3C8KWRMF<`ASVE!OMEUD:^GN?44R7O/PA`Z5SVL=;.\O477-\OSB[O` MJD@BB,Z#1GMC\6SF[74O,T;H)XA]$WIUV4WF0>Z%'R-OCPN9$:+`YRN8TW?[ MV\I+!KMQ2TBTG)6O)?^L.-/MN,+GZ-:;%R/ M!#\V^Y3=V_$]1`9^##L>I1>PG`(22!PA4:J<"CKYQUJ,[]SO"VYPB'GV7?M1RH[(NU`ZCL.`RDV8GB*]__/XO*_J9DAH/0JO0M3HMR088%U\?C1],E>HMK]1E^()P7NV-B@-R<=1\1`E6?T*[T?R\PU>Y0\95`Y< MT-0S_"@[98:CHN2PVG2S?KB%W5J4AG"!5 MF%5TOR?BH%Z-.4C6O;`,4`1]N,Q.DW*;LXB#Y9K=1;R;0BOU].@[=%C+C2HP MNT'BMLCCW:I"<0+;1[*_.P:)A#62:"K^$SF^6G]#)\NKNXNHS7#OQ M"ZCEU2TZ/CM?WISQBRATM_C/\*^@>("H^O@YOE0\Z\^)AR/;W3EX]%#Z)Y*& M3WV0G+.)1R6[J1FLMOZ)MA'D,@7:#.(1)QZ7K+Q`)_"%G5/:?E';,;JG/=>! M,K3O(]3I'='NCU"7`51S\$^0CBS,(:'Q3:?E3WF&._`$BE_N9;]N=*\/T+L\N[;79+O1A?=*`_LMJV!XY#9+6Z(^2=>]/,\P4'5 M>IL<.`B9*60%%J4Y^T_PZ.=]P'F;]#)M%G"W@R!O&G584)5R)9;=\O+B='%W M=HJNSN[FD"8IE8T(H\.!^4T8..A?ME^/7,LO[;Q*-9)QJ'S4[8.)#C]>$7HK.PS5B/\,? MIO5_7^/B&/R!]#7K,,[P+@LAD]1ZN=-?,*J=KT?4_CAS#5`)U8'2X=YV01$SZM_LW)HKU_(\#@P'U0VT. ML)XW+!MF0FY=%GRZ^VY?T2;F`")7EXIV8[-:!_4S[X0B)4;)3H%Q>4?>TPFD M;-BY5([0\>+VXF2FFE@K4!%OZIGP''.D9$1F"$D.6:]CAQPNET"A[$I^I+:- M]2IYG;((%NBMY$CF\ZD_IDN$?GZ$C$X2KU0J8T0V]QB@ITFZJW`5G^-TLM72/;'6'!W$Z_'I3-9Q8>#Y>P1XZCG1" MA1AJ6.KS@/P#K)E)8EZLO;@"0Z9^D--9[[OC"&<_5,9JO_P9)P^/A-""K)'H M`5_M-O>X6*YI'^5R5Y55E,6DX\EN#.P8\.RTMF).5=^S<9"R9H'];TX"%Y%H M/R?^"[1:\RC;BFLB*&)4^"TE51TERELJ_V@"'5+#3]&9>`80^_2H<90L^+47 M+;E3*!W1)ME7.S,":9_8#6"JG1CO%\\.3!JIGMI_H%$^_SAB'5#LG-://,DW MVP(_XJQ,GGAYG<53E*20NK+.BS)*\2U>[8JD2G"YB/^Z8X76&Y<%9+;D63?A MY9KP.4U5]*E9#E'$=+KA*/3AYZS`40I%J-%CG@*0$#BO49Z1)<8[?D-Z?@-= MH[+INY/W1?[G__WM;S^$+YDZ/8`/:JY.++'1%_1Y7A#%DIWL"M+'ZN6NB+(R M6E$>LIC^*Z6.R-DN[VD&X-73[G5HBH7/^T(KWAFJ6OI4!1RL\-__[G='Z/_] M_I,^KDQ[?_]I86."'C02\8?`@XBXDJ.<4K#-L5^O#N"(%\Z7\_T&;D MA_='B$SI%I.A/>'T)?2SD2%6BHD>F0X.0RX2)(S6W4ZA!G3=!2C&IF%'>:7P MZ?KF[,>SJ]N+G\X.GJ8-`7@#"8KP[!NRSY?5>GB1YJ]JY_\;$,``J_^VBBH, MBF.YOJWRU14%O:_@]K*5F(7D6@^1:[!&Y3L15GN<'Q*C.;LX1H721[_%*4[3/^V MW-)K\K-G7*R2O(BS+?>S2(7+F6Q(;3)F_L(RJ*"34L,6N9N6!3D,/O`[*?[%R1^=QV] MT%\OOD9%?%0#``KHL\Y*>.^4<138I`J'B'<#KAUU>^399IOF+YCME?7+A==$ MI+YM+C4COLLY.G&IVK;X]WS+:IXYW9*O4$+ZB`CJYJKJS`!B:HWIIVYT=+/U MI.QTDCIJKJQXOH5R9',(Q!5&VIS0;@H88UW>,Y/^`X,&<"LSV>B7B-%#C"#? MI8^XJ,D67H.#?5S3193P?#=S;R@8$DVD4[8WN*R*9`5!!/`5M:P^%A.5CW1C M9$[;NI)+AF\B:/4./.IY7HI)K%"U\#T6%\.](S;:-'I4%&W\SB MS$Q9\FVK#N37-1QLEL&=EK`Q";JRF4;[\UGTI7C^GU.\QF268W@]G[N!OK8T%S4$4L8`@KOV7N#Z`VW)$15&^BFSE0V@"*C M"1AB!JC@V<9K_\C"M3]&20:8769"F'&1E.1/HEJ?,D1O,EZ#%`R8:C0C!^"' M-K2G!JB)KAY%)-,XV4[R[(D@C6BSY9K]7"7W8BJ`;X.]GR&?<9R#.%4%VK;? MRM?)W`QV8XR8FNUF,S>5[V5.D#?E:$:A%./"?C8)KN-`QM@Q8[P$G/!_GF11 MMDJB]"(KJV('IM[B.9D$V*JN?!\W%7RHCI'UUZC]'/T%&OQW\$B&'N&)$-,- M>D"*?P1Q3M4GFAHU!6:Z'?A&2J=W!3[X-^@O[*O_#FW%2D72R<(^&-00>Y%' MS[-X>3!H\PQ.BU/I$'V'GN\A-*RHW`4L::+]]E"3!,V>T(E1FC6A'/O`?+Q- MGM%-<3K-M7B9()E.TE%]!>CI=D@*YVR@VNR$D8QW5Q MK.F`H>C)+SKD3"@O,=G'J"F+-A.:I=0B"@)#:R2(R+2;LT&>B"83\20J'\_3_&OI M*6'UL#__X6IJ9DP25*$1HJUD&:FA4U*5\E1DHLJGP-U,/\4$LN3P!U=1Y.<4 M\XH+BPU3O*2G!>RF!8-WQW<%(^T#YOV[3G"QY0OU48L-`?U%_-[6[2N*:$U M#G^C9BOYSKYK,T/6T3OTMGNOB^@I+^!N\G.VKG^$EQU`_YI%,=C0\[7!VC)F M"+BF(?INUU+YGC[]0^F$@IZK8)L0"-NY&A8X)NI?#QMR;Y]^3[E][!B", MB-F4%R^HK/#VS6X;?#LVE>U!2$#?9#@7(9&&/TYRK)#WY/E:4LJ$`DY7>?9F M!>>'P[BMF83(:H77.4.HQ^W]H70U+])D%%4FO33))-2Z'D,2#L6MZ,9$8`HH MO$2CP;S*CQ%K2B<1/X MP;>T[&SPK,0J9*E.+EN@U0OL*3H4[=88@"D5J.%%#[R$\G-!F* M`*Q)D:+/$(@I4B^AKW.,)+P/.?U\#%%UAX;I8L7NA&[P"B=/,(E^SBZ2?@,8 M@29\*4!X5T0Q1A'_'!7-]_MGEWF<7-1RUA]<%/,QYMUO5UQW?4Y24QYE+E.E MT$+KB:D%]G9DM7'![X\F.DWJ.PRQ3VDY4J@(X8L]I3`/B$F$J,?6_I#'Q=1U M@;=1$M>N$F[>+S(61$B3ZSV!S8B3>:#0A%4%/'G3^AJ@I"%:.8U1905`*A31 M]G/#K0U0](`VGKT)#V,.&YXIV[(MT$'J_[!B?^OLGU7OR]?1"RTA`Y:(7U.[ MTW.0JAIFO)D9W%O6(KACP4[29K;;P6RXNQBDG10[LLUPQY\W"T[2K_<`"Q.N MU(D<\*%,;Z9MXUF>(Q3B[L6B;&(&..FO<`51^M=%_I3$.#Y^^5S"A9BG"RJ+ MW@.\*&C.GDW6 M1G002#0.8AVXF,XMHP.O/:.J$PDG1/VX$=`J$_:$$RA;S#+!(725%UAK7J>E M-UT1ZSP.>UQQQXX(=,%R1.>[N1MT*O7Z]5^ M?I1':=:07??'2;G-RRBE=Q/=LU001!K+MH-`L[D8X@(Z`#G!-9E5B..;$'.] MG0:Z>.UES$1I,H,T:5K.`G^F8M8J0.ELN)^+#N@3=!,KHGJ!ES@P3TF?.G`B6/M2QYT`EM?$2?_*F:S9P2F!U&@Q:A^EIQC_:C= M\PE7CWE\T1@_IPF8P%E<+HO3I&2UB<%4FB2XSXX#G^G)=JRI8E#%;]@>OLL( M?,H\36):NN&O.=&I"&X_=D6H*.AA>.C$ZME/VOCG?M9QJ'._K/?YG/LEW/6= M^S_?DC/_Q17YOY_.;M5G_CD=^C4(,#CTJ^;(^=`O&+P7_%6ZZ>+_-+WY5)]J M-HQ..O7K?>5AG%_HDXYG#*K3?HYBW%Q07Z1T9-4%LN#I.D# M<.2S=`MB!QUT'B"G]J[D[% M7B`6F%!!WG36AMY;L%VL7F"T_LN47@Q9=T'=%A*&E-F']Y50`6@%GX:VE@VD M*/-"J`9M"R::/RNB5JA*2K0RKX6\7*\QE%WOXDJ1%&U.S8?M:\>2D1W,TZD0 M?L;%*BG#Q0&X":])F[:;%?>]UCQ9T-/..XPAKPZO(9P:YZV6)HFK\\Y;-=R? MA\_G@(/B#=YVM/<4T#[H(T">S3X/NMVXJ+\-ZTM0B:9;@EDRK/$]I9YTH$7O M\_&4FBLY:834^<75XNKD-41(&:HSRVEROI,B=L"*6`-$>SZ22<8W1`,L,^B9 MV`KP/W#%\!2EA\]9CK1?V_3O-8;$AC/5=DQ)T`,R)5&B!/*JV3]0`=$^D/[* M@IZRF/V`6[*A[Z<+JE/UP]N?/%S\M+L^N[F[#;OLN>.@\X6$[ M84/`"Q5]T[S<%?@./U?'*1S5)BQ_K^O.KRM2PXGZBI^W0-`$T3;2PO>!JI'W MB[)3A+QG`@:\``(9*/">7IXF*W@Y=4)`:7KS_,:'@@UU+@AO@.H6,B@%>KBC M1X![+W7H1NYPE*%NI!-FMEQD'_,\_IJDJ1Q$"F^ANK6GBO-Z+E2/3K6F6MTB M^+L:9L)HO'_Z(;NJE)K871%E9NA^IRHV^1\_O%NBY43VAF1E:UWN"9 M..++O%,N=&E_OJ-.=,PH[8@VQ2EX,(B)\&104HYW.(Y^+I*JPMERO;[!]#FQ MNYREHM394)^S9)HZ:58,A,FZL^)1?2K:YA(`AL2?E=!E@#2?D*E*N/26]+!F M5;87J83W#R(]EXV*FKF?HK_FQ0DA_4`K&2W7^ZE%5J<58AN,65)H!=H> MM03`$]V20(Q&Z`.OFRB;LX[='+EO9><)@2N^3)[@%J;;P_$+8R*-RLD>_[;I MWK?!9,&;ZI1$*;RA)"0(O7]!',I`Y_#=\#":T@$1HIZTG35')RH0[QHK>RF#6*-0C\5;2P?,:Q+/WCGN@$: M-'XL\M*W3F-]3A"=T&?0]?&DJF0,?R,[;5&\`+X6&_#&!O;OF(K44"FUPW=U M(&J("R]-3_T.H`,78K[OT'.C"L[#5;L-1OO;X-SPIZC=;S#RT37( MEOI;;ZNHJ!PW!>E;&6E?EH:1V;"O7],X83)9@/3[B('C!J:'0,"L2HS-6` M-(&*(:9[Y]#_A?<`;F5[PT7V9@O98B4\HU%B(@$6C!SC)YSFM.H1^NY7__K[ M]^_?_O'B^N97T6;[QU/Z[W=__'ZVVLLC!(;8F!=9C-=A/E=;TTHC=NN`XA/YZV M&L3"W^Q"UUO]<5<.E;AL*:&:%-6^-Z(J%LA)?-;>7=8#)-]XLEWG<#)5>_;, M*Y'4]]=[#C4@GN40R+66IB)5HL5+%\'JPY]^&43%5^D%^[C["D'??C, MN-GO7/?D#_U,=N<>!E`JV8B`D0YO`!Y.=F65;W!!(^(@W.\QV4X(#5UW?H]Q M&DY4:3B\!>HT"1VR82'(3C)IS_!=;]1I\;%]-38=GG3=^<63AA,%GF@+V;E? MHH]"(,I`E"*B^B;`%5%7A%,HE5/AQ4.!,Z*"(['XJOB)=S=CI3R@U"K[VK(#L!':88]H;;SW@ M(C"5AWNP/*4);_UZ^O6IFTP8TD95'QS?PMW4F(GS\%K&8/0#C'+-U8^_5&=[ M)N82P^:4#GU2IT/?R=*A9W:7:)Z5ZS9-PUY?KUT:VD4RK3-;W[7_&W)#SGHO M"P\]7X%=7T8REGN\^F?"!8;4%!#OQ?D3W,MU37J0!>A&V:M5Z,2B*E!;#+'A MQ"!GKR8WT^2]0?)O#$KWB9PBZ47"S15^KNZ^XO0)?\JSZM&W&6#"D5\GS#!F M%6N`3,QOYAI79@$*T]!UPWF:(N7FL.M?<%34"8K](>!MYF9(;X%AV[)MS.!+W`R=_B2;]7P M_=[9P3P[KP$-=?O/EWW93I9"8=.O9 @25TM1HW:(P2M#Y)%0NAG"UGO/6-H-#'.1N_Q+DDA MB'*ZJ)&]'KSN\MV^%1"J/YI'1(A<("(F)(.:1`O5VG`]B9%HTNUZ-W5C67\/C&8Y[&%YMMD3]-':VFZ\ZOYUW# MB0)/30LD-IE+.*V!($5@]0W?V5N^*\A)95?`H]7GR3/\-"&<-+UY#3!2LJ&* MX:@;4-.H;A(X,=%_K-`4?JCA9_K7H(YA+LE"/\#JY M'II!.]9P/8^2XJX10P]1]G++WX*,THNLK(H=W06M/%@N=+T5OW9@ M3K5A$4J(D0*W5/6($:<&V<;O?O?'$C54D4!6$9SMWTDU0/Z-9\IU.MUO<.4O MZ#5\M"^?3:("C3OW5CO"FC65GNQ]+C2(AK25=O]CBZHI&6*6/45)"H?J\[R` MUPAN\6I73/80LZ8WK\_B*=E0NO9Y@S?KO'A3DB:H;-H$WXO[9=@QXO2#G\`A MU*L`]"S):BI(!')[*)#7+HRW@[R.[$+1T_:B[FP*0/4][JOD1I6.#P111%L% M/H?U":V#'NTPG;V(Q!3:)"P=PY=QHN\QA$[2LZ2Z*MM!J:82(R+I,HEQP2+7 MM]$+K/'@&X698/?.;GVSX.ZL3J+[)*7*SA/,>GH,H:GT+&G55=HV#:NSS`39 M\5?WC]H]QI!EU-4)=2=Y1L]N5%=ZPIDM"YZS%.RX,WW'E1AB7Z,B!M5'Z84U MPQQ1T/&%.\R3\T5+3>_XI?GQQX3L'V0_>;F$^G"3O:-EUK/WQ`,CMGK]6T>H M:;0?HQ($E59B[H#1?#X&I!C4E"^R[:XJ*=EW$][W:;KSK!+5G!A`C#4Z0K09 M>C>7.V0#:4H1IIB#$53;)QR!I@1S\KS`?]N!6O6@UY3=^LY'Z6=)]6YE^SEJ MOI]'A68+\2KTF78NW,W`N@.!?'D#[I5BTE@\HWZ]AC,8,&2@Y,361ZAI/Y\; M21N!2Y'8-S]#*JI(=.M[OQOK^]ELK.\=-];W<]Y8W]MMK._'W%@%NA_\@NK# M;$#UP1%4'^8,J@]VH/HP`%0L6:,L=YLMKKF)JFF\@^:]!]*KO8PI(%Y_C)Z:K^?A;C&6 MLU3%FDW'%&"\P\7&-P1IG_,!'K#3!S?(!T'?$7WZ@J.B_'ZVF!/%:8JT9OQC MXNLF*;^0LS:&1V>(,"N?JD[:=RA/3`]?"N#!IV_6Y%NRA[./44&^GHL%:2CH M/@0J)\39)W,#%7*G^[Z4ZO:N\M>R;V532EXI$E/[AH-SOD#Y%SQ/+O].!=_F+O:ODS[Z9 MC_QE(NG(_V!0CGD93DX!V4'?SRG?\.2N/81[/X+W'JM51V77:$!X&7.YYE27 MQ0T\B#S5)J[NS+.%J&1$E8,`WX/7AK=`>8%HFUF4QNB582?F3SMT:^./8O)3 M'B?K9$7#(6M\6CR!JFGN]Z53-2.JO4!H('CSPOJ<#472:)2>43MN%E<[H-`` MK?P(_]VOS*X`A*JMUTK7"B94WHH_H?-=%I=6#4%X&QV(E,0].Y21C/C^:$_5SYE:4]* M*^,(U201I2E\4S8?E=1'>IJG:524:(L+5#Y&!?X^>.A&>%#L/T]K?^1I/&A6 M9YZVU?BHU%LR!QP8;UO!3CP'4WQPY.D.QKE6Y@U.-O<[,GLT%LC!7M42\+J1 M]+*CH;N=9TX*'"?5>;2B=X`."-$2\(\0'3NJ$R]M M@NHV\SK=%G&10]O0JK[`#2GI(^,R+-.!'`12Q$8)6 ML](F9E)JL&(P`ZX7M3=XA9,G2!15^$]'NB>3=./WQNR0`>4FU'P9^ETG`R%U M[M,48W0V2:YP1=]>7ZQ6^8X%*/,.K'SM!F2\8,&0&=5KP[A"M"6JFZ*V;6BD M6(JK];F8S<:06B\'E#\6>5FR!,=)=$U/CYY]^GIN%%BCGZ"HQEG1M`U^:C83 M9Z=>1/\$.)K#CU'Q@.^CU9=%%M^0'RI\@TM<[#]^H7[76M5\-/?^'Q@^,OP` M6[?:$%:RHG[,FC M$;MMO(OX"1=54B;9`Z%,5L? MST)";4Y,_]A=_0L-[L[SXC3?W5?K77IH$4YY&K!BP"_PG'A4J2K>KCDUA`X` M=))\Y^!@/2NN+M/-)BI>ENM%_-==R>J.W>7TD`+5$>WB"HV)^4PL-&5*Z4NE MS>D;Z"T!5.6(G5,IC=F4:;85I^!EM9@E5WU(*=W@)YSM\,<\CTM*?PK%I^C) M;R""G`FMUP/JJH:RL8(HP<[BK`)E870R8AZPMP0.F##^D0>4ET3-];@?%&#FTCZ`G>&,#"K\'6^2+`$+J4J>\#G&I73? M&NE0I^PLT`%.Q8_2;R!^C]8X=/WX/N%USF7:P3I':G^*BB^X8BX(P2$Q(8IZ M>@P#)3U3_7ZH(\$)=43U6%X]XB(HO,Q$VTT.[)T%9Z`=F.Q7>!+/D[2?$.6^ M98PH@U_H5P0Y&:[F=@@3Y*0]@M7#<_1N"VZGDUU9Y1M,B/E M-7_(C">5GJD;0^%M5#=';?O9E(RR$F+K"#>?'&?U`Z'B-*FMM<#HB9'ZVLOC M*(5?3:&/S#H>WS^TQ462Q[=55%0Z+67$GNJI;_;7X':ZE6Q%'68^^+%33YET MSC*M46+,GBQD0B*<;U,V;Z=2"C=XE1,;:*+WT8S[]APY9\J7VD?T1(S&/)LW M\`YE:XZ]O3F8"'W,LQG?Y2=Y21^0G^Y$YL:([W(L3EQJG=XE(F@E9$H46&U9DL!SJ8Q:EOSL$?6'@&!>3P)8"=Y MGV/OL/@M=P8'3=9F`%O=YC%%3K&12U555"+8A[< MH^$QOSZ-ZAM(J^10'8$`R:$:=C1[*19OD'FC>22'&LBG\]%VW"IQ&:B//;HY@SQ2,L\7MQ^OY MV>84O7I--.WGQVBS:\(YFV3#N11V-!>S:3#GP7,WP_'7Q#![0MY!?[Y5FXX9 M(\"UC>9G6JFDJ0*8=`+<%=M%]H0S\N>7]MW-*7/E==WYC=[4<*+`5-,"M4WD M=T(A,&4@2!%2?<-W"O"LB2:6@>6R=OZRYB6]]R`@486$>[>\-3/>&-RJ\0U( M?&_04%*4'(YQ,$INHJ^?H@H7 M292"B_)VM]VF$UT*]O89"#D*=I3O8'Q%F_ISZA(J>8.Y6"(](I4B2S<';D_P M";;SV3/@E9!=WI=D,!5NNG4.?3(@Z:WZOAU?1B=UAG17F37 M;;ZIA7%0)]Y\ZV^BI(AJ;SHQVN'E+?V^C"'EP3P>S/L^K)WM9KM5C\KQT8MV MBX[CA/I%SPE/B]7?=J0;^F\K%Y2&C'^/E)H99:X,_QZ!8%`DM)B#EZI?1@=. MJYXI<*T`Q4/3%@]1DI65G7)0M?6:ZJ!@0A^)%U`[]$SX7JJY?%S.@0%$Z1!; MJ'JY)I-"X_$(BK90`V/*JX[^3GU;&;T\(MY:R:'R8 MS8G[B>^23-9TU[0"=<\Q;VW/"M#`!Z&#D]1"$"&P-Y3QMO0,"3TW MO;IE"\U85B^N6QZA!V@;UC]N)E;+3G1L,=0IM/S9AW[O;8PXDGEUN,-Z&IO_B$VEX:$!0&AE=!% M+)I/D',!RM5JM]FE4';A%&\+O$JH^X3\G&(:])_%BTU>5,G?Z>^5BV,*R([& M6Y!B36-QKSJGM^11+-`/;">-C:>]4OGCS:C33:#:U%]7D`K?,G6,UWF!3W)R M`BU8?CR]['XH#@(8U/[#,;KR65!C1+X5H`_KFQQ1]*(S9\^H76%TBN\K/Q'`BI[\@D?.A*IR M'OEXEB&_>J&)L-&,UVDK_=-V?'RSB8A>*^- M]X<_]QA0F2S\*_0N;.*2;I[;JSO)D(;8(Q?4U`&H'$=E4MX2:SJ*E]E/!#3P M.,(-Z>[=5!:*4=^>_>NF?"E#Z4@#5-(6B%C`3[P-*DBCT(F7MO+>-VZ,Y\6_ MW]V&/9D'GIJ?+8$CQ`1YVPBRIH)N.H+\EL7HXL2G.NHRR?!RW7V?^B1_(CM1 M5ITGSSAF\0?PJR)Z@`Z3W&A#<2+L\35`%_Z4"4[D<[2BWZ,5;P!:),G#;4Y# M!-OL8,Z3Y!RB6.^9[QULE_>A;9?W9K;+^QG9+N][;)?W`VR7#J$/#@+]$%J@ M'\P$^F%&`OW0(]`/(QBC784PU=E3THOO`+%#%E10H!\V?HW#*FEAS`^UH#H^ M5/DHW=T3C0^D2WG*PD.Z#KV6A-&RHB[$SAUC!SB:1[R8D4"[E8?Z9F%(\9>N M93R5_I'TXEO_'+*@<\FW7\Y%_Z@%I3[H#-`_S`=[_>G`!VMA>VB:^TUW43-B MY6(/7DK*4"BM#UT_[B'E8MM#\W2%8??Z\.DJW^]<6>A5<(_,P56N$DRW;JMD M;`,*MAQ'):4U88ABMP>O1DBW;[7_L\;`+*H;RD72"2`\'-80,^)L5^1QGJ91 M,1T*#OKPJ1#V.U<`H?UL/D&F*MF(<)`.S_72[`I7)U%1O$!\Z@8J%2[7=X_X MDB@=[O7:;/,,TZ@F\OL;O(D2R+W_G$4L2`^B^%A,`32VNNZ?J&MOL0'3\*\` M*^D,U;TAUAUDW%>/]HJ9+&D\-?VMZ14*WJ(ED845>Y_&,?/H&OJ6(/9)7X@^22*:15R>E M3#56Y^2RDSRC+P42FQ"(3K>#RSORN8U+.5#'=-;?,NTVB_JN6F'MA7,JACK` MUN_Z%X0N)/H/(I8%Y3>]7\F.':^GB`&,*F],^,8=-1LWI@W1JFXYK\`+)["H M?5OV<^A\D2KNTWR/5FSP1C:J!3F/E_CF7"D`*1J#<6T'I:3-,PQO\9%@>/S)(.*6/#:TU0/[JJZ\N^BE_)A@C?8GM>T&:C$%;0, M?N[ND6!7M:E'[NB[Y^^"E1?9#4YIGA`\&=;HS*N\LBRD;4707STC&[943AM. M`A)W:B*HRI%H`%(ZX=,SG$7;J##K^1I4RIO%Z_,^80,_>UZENYAMUDU"YA1* MS;AOST=54[Z49>)YD@=F[:%2XH=?_^;M_X\HO1W9>O8B;L-4Z+.3>K=>G\7L M.!]XNY9DW2>XPVD&07R-B<"S*GJ8Y+%.B][]9ZZ9,:8\,5,(=F.%9W#T,)&P M^J31.Q'>+K/=^#,*_&[T"E`Y0HP.:@G-*?9[6G$.>(U:U%#+M>C3O2[P)MEM MIE`G_9UZ?U.ICR-=Y$US=(P$*J$]&<:"[52E,)H&1_-^28[5!=\EEQDSX,H# M4TIARBL;^S/;52PHO?9E"?DHJ^;#H/=*?;/?6-O:88YK67LRH@-D.4FXZ"T# M,AO3U]#*E?F+0IQ%5`9#8Q_P;X_HEIY.Y>**2U_:MF0(\7R:UN#X[>]:14HS*,L@:40&W5N,ST#M'M- MFM[;-5W>X&WT0LN[+=?719*MDFV47F17^+FZ^XK3)_PISZK'R>[XW1GR><$[ MB-->6`>]^1T%%?N1!,/FRA?&?\%1TZP,0LD M4T:F.#&-CV5@U0;*KP+)(A`&`;F9G6&QKH9]TO*9M-OD*;1*[O+B_1K!E=-O MQDR68L$1RXPW\MI5$56CBHK@OZ\539L*>L%B"3`;26! M%M`)CR]GT3;N*^OY&N&&HK[U:`+1KS#$3$;/4]Y7J#L-Y6)7B?$/ZJH:_C[REM<\)L`!F4`BHHKNH5, M$C`W*H,!?+>C#D!3@G4E+H=VD7P?/A1^"HAU0KQ&GV'GZL+#.>$+>\[KJ<-B M@+JWXXY`%8_&MYW^1?5*UY0,:".OJH-I'K)3D:X+6M\]2OEV"&3+1545R?VN M8ALE_1V4-XFOF9=F411$JNQAM&D.'8.Y\GE#/IQ=U9,!8)L0`X];=UF,=L2F MHQ;>S>TB\%WC>-#IGEI&F/4W#F!4 M"_^O_*/@9_#!L+#&N6:V)E?Z;60MB[2^Q2ONK`^'X>K9]Q\O!(-M<%*QA_M8/Z'J*Y M52YW55F1?1ARYQJWX13KP945GV]0#N15L0;NH#OFGTJ>,"H;X08_<@^$AXCS M(5/FG$MUB8G%I`BG'NFBOMN#5_.CV[ M`5A;-N:J4$4FU7C]W6O1JC+1NV&V.RL^]"M$'X?';,N%SP>ZW-E4@_;WH1T] M[I)W@FQW2IR/N^;])4\ST+$M%_/&:\VF&J]_>#UXW9>\&UX[4S(U7N\><8$C M"(T/"%>!":].'FOVE"A]_[:NOL^_?!V6[*'T'2"[-ST>+-F`4`T0\&G(F8E(;Y<0Y%@G)4T5(86X<0QK?A*?>GW0J#`I.[O@1QY+DTX MB%EE?%=-%&XK1;*(TT64\!%+`WE#:6O]KJ$6P#CHV@_]&CCA3N5U]NZ:%F6Y MV["8@O.\H"$6=8B!S36`/55_MP+6O"G07--Y$_%7TP5*-(J>!:AP8C-)9W(6 M=W.-X#9]`SP+BZ]1$4_YH$ZW`^_%&\7>%5"CW\A?S@FD`*5"Z11C/!B68^'% MNZ_YW6.^*XD]3I]S*C`64'9-YLGBA51C8MZ?;3?E3'ED>?NAHW`0-`G]!K.3 M`!M-8S4EKND#;;"HN.L*$:/'+X?QI(#M\R@I?HK2G:@!H>+=BNC&GW*H]`[O M4T#1VRETE@^V_=\]>1B5YDD"^!@]-5\'/O)[!*:HMWV)8,C9KK6#]3S>V_`( M92?>3;94I^$VA"]XNN'T++!D_^]U3RG2`I-?)!Z6JZ$$^?;,FWZ*DKEG)3>5_8)>DEP&@<-;?:&P\DMVX-Y][XTN;?M M(TW^NLBN<9'D\9Z3CO[QE+#8#&56"]5Q"#Z3>#V/31673OZ.GN`#EA-V3LW9E!(.&3IB',T(`Z9'-M$V-)MX+:*BFJ2H[AJ((K%P/X( MP12\X2Q\8E/`;,P]73Z[$_A2&5K.LM@[5F0O2NG`\D^LV,VN[R"!28;Q3F:* M"8%7G0`MH2]T_R(+T$*TPZ,:7>2'MM,CQ+H-6Y/H]2+NW5PV_[T3T-DS+E9) MB:^+9#5+GX(IZU,L:/_&@FZ(/5%LB+=!=2-$6[U>+[X;=B=:R;V"&?_TY=OX MZ!NBS"2Q`-\_L3>=8`8$9X[K7_M8Y.4D(9Y3L/G:;$#)&%R.E:]R)6I@-IVW MN)WBUQ0-H!^*3(N/>69@W:(D0ZQC^`WI^I4?5[SNU&$"SPUML0!R[W5[G8G5`\ MZGJW%Y'_P-UED^VWQ@ED;T/UZ;/G;<+?&:I9G^,YKI_I$3?Q/["%G>$'R."= MTECO'9;U06^6ZW#O^)UHED.]]- M979VY:0#FJ69.>6(OT6KTP?DO>J(B6W2^W[6[ZUO/6[P)DK@+RW]Y,I#<_#F$!5]!H9?H=HJAL:`DB@@(`$^NZ7;N;HJTH;'8[Q4?))!PHP MF&DA,'Q!^$JR,EG--A5&S:S7@HJ3#4-5Y^;AH:"G9=1\CNCW-+NEXL5`9I+Z M/246)PH%D`@A9%S93_2Q0F9DL'ST''[%#0IXSFF^L>;&O+^J!6LZ*F6IAN8[ M%%7H%*]H]@+Z\.X(@1S";[P>T3KF&K:2R[R7]&L[P0\)W[ M^3BH]ZLPS$)2PYSCU6RJ#A?SJMPT8!BOJJ23^S@'ZXG7>'0?`.LQC^ZNX@KF MUA,8[IY@YK[J][E]Y8M[;SC_Z&M8@<6)EJIL\JU7)$TVO\HS9A[ ME87\B$\;$/#FHK9A2A47DV9LGVAZU!'BM`5UY"L_6JY,PFY(#5G/D&EBX M1UM6KV(^X>HXPKT2MX$1Z0/D-OHC7SDY4IF"Y/U7:,:JW,E;+$JGCW.EV+ MKM@=Q57@))?1W=G3YJFZC%%:/*,Q">I2!A`U2?M\MD/#(Z.LJ MNCCFN*;*7I_#GN1:J]%PN_IF=8;?4]WL>SESVDW5L.;I#%_*VI!3EF M_:QZB5B"!$OW,BKD8'YC)H;5R+ZE0[3-P">P+;XU->*R0OPH&6M!#U%!%]DJ MW^"[Z/DT*5=I7I)>Y>%;X^@%77=^7]'3<*)8/:P%(DU0VV8&85P6HA0!W#(U)AW$G'X#VNDQ9=CS%#[T7JO3C#=CJ(4!FYUH1F)0\)+ MDNV2[&&YQ;S>S10H=.`B1-*(/9NFX`R!3'?1BRAUG!/G:W:NB6\K?H`V[$9K*4;,<&XW;U3M?*M]-%@'W9J'__#B$; M]LSP%W9WMA&S;(\VGH=!CE6#3GSMV,Z\^*_\X,BI$6R#>`\'PJ#C[QLR.0,. M//5Y*B]P\I!Y/3VKN@QQ>E;PHK(:V>M8-=XS3,Z,?XO2L[SGL MZ5G+FS'4`I^>C40K/3WW#W_`Z5E+W-OIV9Z+(*=G:S9-P1GD].PL^L[IV6U. MAIZ>/:K(GAZG`&)>1:D.B'J6%*"[`ZK!]:&9_"1[;Y_^&[3Q!MAQ-7CR"Z8> MAHS0%')G==A2^\^W`ZY8;\B!Y`;#`)(T8=$'3G>M&CH^:ZX8\--_`0MM4;>Q M_"HVW$ULO]@.KV1[IL35==?2[]!6H'917^K!47A'J+YT^)LT7&04!@,%F(S! MNP+Y$'JT@R"N7_WK[]^_?_M'S(LUTG^^^R.JR)+`K)_@&_(D8),&M(PVX2.O M*[D+"4]RTK%E819K0\6=SL&($J;]*_CP"&6X@B!H+EOACV'/0(Z(,("W=LY& M!O#^&0P6RFFR)K8.L9N3*/4(Y%Y6/+]GXLBF_MPNP+=6X^B[>Z:_PCY",A`@ M!K@VFCGG\YBBTU,<[U;4>?#G790FZP3'UT7.?\<+VR5>%;8I1[/0WX;,*D#? MM$;KO$`QZ:"LDA7:-A10U)"8(_@MP6.P!FSFX!*3R7GT M"'I)YS[OG(RY4E5G_%6TV?[QE*KM%6LQ5^M;+68#>"HF9,#]E*(CFB'1_"I[ MN*CPQJ<2EO?O/Y;$ACT%-EEQ@@-C@AK.LS21M;(W`*EZW_(Q\LRA)7)23K,+]-FN9?HVR:ITI&X&H&>M:"707(FP]15'^)5I3J+"'N M@!H#X-M.8XB+SG%8EY5V.2,G!3"0X"4XG7?X"+'.H#1+W1W]EG6(6B@U71ZA MQ2;?9=4<;=!90.FMDVJE'N^[1_P1YP]%M'U,5E$*9%=,C:_)G\#=&64OMXQ- MJ]L.)\)^#E7._*ENS!XQ$FFAEABXQLA^B#@]"E.^6GW.FL`3=VO#XZ.(!1Q1*X+O`; M.'UQ_QF@"ZT:NNCSKV]_C?*&^DP.9X.`?3\QK@GKZ9+(&:&]^U\-Q9 M[5D#*2%YL`+6W,'\NA?!'G(&K@%Q.MT#'1TZ_I1D>4%K0A"#F2S#119WJ;"2 M$9]P]9B3OT`%#UHX8B8KQIG]":J_]<4@>1R>+IX);?4;E'Q9OI)5.13.`Y?Q M('DY%;VXPM5!P!5U7*"V.=Y.6D4X*O94&;J\+^CI^9>E>OKN=D@!_+3`J\[\!$R]%L+ M'^)7_)P$:4]^`TGE3.ABE\)&<.C%HS^J-2,;S77PL2"G/B_88#T%<-C*.='Z M5N/:#P4.UH@VFAEH.G+3@J8=[6B@\1.*9AAK-AJ>S!]ML;%[&E5F0CTU` M6+B-P#S42Q*V=22+V_J&937D8>.#+JZP'T\=].,Y2TO&@\:5K-U)Y@$C05A: MW-0#'<,Q<)E$]TE*4T^N"[R-DOJP-;4MHNEX1-.DNY7\M@_-M$150"#714P+U*3$D M[6_46^T]&%D7O1,8,_=BIFVCV1P1=*+5UL+;GX$171<":5]>C+TN@U555#!D MXMT0JLQ0)P?ZKL;;R_>SV3AU`M9Z/B3S,>!^[CA*P>EV^XAQ= M[#?W]EI$#R-*J[UUTN,2\2;H+ZQ1V$<2^X4B#M8DYO(ZJZTP&WQ9S9'K&4Y!>PI+1]75 M%/'(6UPD.3Q#550ZNUK!4H_5$T$:U(HN<_3AW1$BXWT7UH3ND:)H\NB&/'[H M#Y/#6:9U&6I8DH4"<#$$/R./,^EOAQQ4%'3)*;S`48G+&USN4L@8Y=&`7]0-\UTQ@#4-TCX&*39*Q*`AR'\/,V+W=D,+V+9UY[C!/( M#-:/_1R/OG[D2WBQ^MLN8?T&WU1$7GRF%KDR:;5Q1-`.G$Y04GX6EVM#<>*\ M;>Q/X9`7:[LYU#>X(G,,00D0?)-2%23W4HWTC)Y%][Y-(PO>-"_^U!10E,6H MI8%:(L$K.0[`0N=)/LOY.3&SLE4"[^^L\V)#X7K\PONR\LB;4?)8E]:((=4K M-G5;)#1&]R^HQE)H!-D+K_'`F\_+D*QR^K@34#S>E4F&RY)W4$X5NH=L[..NB;R617)%H!Z_1@1R*[PKH+BR*7%/7,_ M%:\ON)OQI$Z^:=JAO8:26V?OBLE88HU2,IL):R\II7V29[MR@XL?<916CQ:0 MD3;T^=B`D@NEB9V5._(I8M\>0L$[$G1SWPA?.4*GA"M:2PX,)/K4P7+],<_C MKTF:NIDUYM1\^!CL6%*AA+?GCT&`@ZTF,3L3QUJ8+:BL9LG]^$4.>IN$U6$E MYSQ6Y_4!$P,+E]Z\!A8,>+Y[M&).[3BH:5"_08=*C^L@D.?`'A%[O@/+27/= M&.M^KJ,7^)^[_);0K/!#LJK-N.NHJ#*R/]DI31?"'H^&+OSU@A-Q6N">;:BA MFARJZ9T.^,U%G+E1IDOY^Q.CN4IAG,]L8] MMCKS!BW_.:Y2-G39T_.SO8RA,A0;M[OM-J5W"%%Z$I6/YVG^]8S]0G'\'.GF MR*1?GQ%$)@PI: M,64'2?%B/;Q+Q%'T?,*L&M]L") M;120"Y/;;R#03GY_WQRX7V;4I(68RLE*1"BZ"H6H/3[ZP"1\+@G9"(HCA?!D M$)(-VK$2P$_D6!71JWN+&_:#1GYK0>QWKZJ>W7PVA^`*U40W3GGIJ!RE"A$% M2\66:O\2++-E$*;NTOV8OMW0`E<7DR_,H*:#R,Z;/ER]X MV#JK;P/OF)00L!`+E6XL+YJ"L>?UNBK4*#5Q)@U#"#BBS_=4CQA1IA#CJ@Y# MJ?GJ*$VXR84&P!NM>8XA$`%^4_/'*Z+3+SF+2.`Q_%DF-`0/;^."XL0YP$_) MH,5.TD?#[\;2PXUB66G7SCR*R1B*JH&DR40,-U<%2[B)EJ@ZJZ'&["1O6KFP MX=.?Y,"?*BX>E/53K:Q7#1&T9=?_H:NDN>.AYX!E-%\A+L0<>965(+GNOKY' M]]WZ24HHKPBZ_Q]:P&\G.9P^X>(^GT3([PR](4=M2%V%.N2.&H/K)>C%1%BY MOQO;7]?IZJZ(LI(577OG;W=2].^OWIX+>]JRPZO.H22J$`1*$M&&=BF[R+\? MM)H)FI624O,IVX+"IF/ZEM3;&5B!:NYDNT?WX`\/Y,S2()A.9._\AQ#8LOC> M9M<7I"G0^<=:AN^=PT`E/=TTA2LN8JC-L2:&1(JY"Z5VJ&0='PJSK'E],/8E MH8*3)V@YZ=W+I'Q[SC3Q,295B985?9D'*K34G\[0Z)@,F3UK;QHIS,)0G61H M,KNH05C[[1'*X+V#K<&A_?M_HG%JD8WJPW3F\>#E][EN&BVCKWB7:`;1][;A MM[3\#B`VU7KKSJY;@N.8_'#OZ&6RPAFX%6Z2A\?]DN**NRD/;/B*FO$T'F7= M"[;9I?77J*"?!TVD]`>RYE;-DP#"+[J++*MPBFF@>?UBX`VQ;HAL'DF#4_R$ MTUSR-*6'A6C!FO_",F$&JMH'KV_H8Y>GW\PRM8?E)$O74C+.Z6$3F-'B'_C9 MYCIZ`1IS-UW[!^#WC3.?0^OS?VS99_.]+)X>MA,?/WMD,^2>4@C^ZO(SQ8I4 M=^;Y0*ADQ"@")N(1BKQ-Z(->KPA%=.I'[M^_IN5'YA3KB@*\8=^L.%P<3-3< M^$]B%63X68CTM(BI5#;V_"J?B@_%$N6?=U,TYO!:8Y\P&B-1.V#7]_=DT<%U M1W$6)%1_I.Y]OO$WW3#L8NUKD$=Q-D48_3SBZ,>%IS9.?D09NMXF\Q):Y5W. M>ZSM1UQ^+/)RDIO@WC[]I+F8LJ,Z@#2%+%>07]R)2PFQ\9M*4MS_C8;NO1:* M"5Y1;Q%-7JVS9:0C%LS.T3!E9+6`P=*8(TTLV@SS]PQ$*;01F`(/5+!N"E4\S$=3(=2[:7CV"'W^5M[OIME:^^ M/.8I66$V)?N-*'DLS&K.E;):.[&9Z+'O+D=")0*AO]F80ZIIKH1MG1<\\A5`*U'_@!P?(I2<-3-/O+K MD.-7GH5T,"#=U@R^#^K`Q^WWH2,L_`!RLI@N^?R/7&QBG(RG9?6XK\IGN$(/ M.7[MP9C"6!2+D_X-K=CG/`3JFUJ72AAZ2?5KIWXNZ[(.];Y.P3O+](.`Z&../2)W`1+^GFRFN/_Z&XJ1[L3G5FM5+8L!C`.,F;%0$#4GS,=4M M=X]15C]..O<5W#^`5[O?]@Y-F>5;M]O?>U_[6C9&ZW0IP"8B\>IA"C9,;<'& MH$FP_[C0>^MVV]W29F0MW&2*IKXOBN1L]"K($K&SRCS\IWHQ-"XTS5B=;XHN MKF_^Y]1&[,+W?AVC0L]]V;V'8O4OTL-Y;>6X-Y)Y>$'9)W,W^SB7`=XS'G\4 MVAJBZ@2RU[ZC=H$VU;8I3/%K/=*W0Y"97`PFZVX2:!W9>N![^R=H;&=\IC4* MYJZ@)1R/=Q#_`UN`&7Z(*AQ[NYPZ&)(J^8?GM-4>\+1M\0TM134F_5458O[M:]M4_A.M<*-1.,W M(-0T]WL/J69$@;L?DS?0`C5-B`7XZR-$FLTB8?5CFJX2,TEF5`!TPV[!&;)+M0-QV.97"$M.J26'L_)J2# M,7+KM<1\/K-KQ9D)L!B%!E\SS[$W$:HTR;YWF@;6"?D/_'+VC%>[*GG";B"3 M40A6MD'"C`F82#/4MIN7?M)(2((8U03,Y%A/7>6MR^%U1.W(F7[E03S206DS MH\2;I6\L0EL+RZD._FH)..GT_P#JJ\?38O=07B:;A&P<%OI(]`,[2/T8ULVS"K`!R305T8#K1@15-944,')0(F[DA$* M&ZP]$BQTS_!8SZISK)JF,ND5KI9KFA<^X>,;5OW[+W%@PYX"WJ%]^BX2-JQ= M*Y\"7RK)E4%I^E)/W6%"",)KZ8FGIC7;,L23B-4QP>BVBC;;TQW8;+RZ??WD M^7)]&65@UAWODC0FFL[F[.Q`UKL19L^CJ@0L$$*,4OOJ0DT,<`GD:(1`0W`6 M[AMWX3>;H^,D.F%5J"Y[@U.X,B9;\A9G)=V3SY[A1VP!4AMZ_GW3%MPIWUIK M*"!.`HDT$"H08V2.J.YF+IB4M8)H0GP>(1X!( M6Y!MX!S/Q!\*N\#MNIU!1 MLRIVM!K^179=Y`\$7,[^*"/:WJUK1T8U;X34'\/K0%O^>;C\\8%"UGF7C.?) M1][L4";-(ZWW(ZKW97Z]+_.Y>!=]RWU`ZNO)(Y$#OLCX@\#D5'9&3(@-,1^. M7^Y(^ZG>A#'JUV<:N`E#*EU$FP(BV\:H;DT?>B'M#UYX";3UV@A<3N#HWY-[&.1[[;E1;9*=^!6)K\F M[),=:H?CY98_4V#WJJ(;9:]7^TXLJEQMG!9BQ&BD.R.'1'JH)2A[?]&_;VV( M_%NOFO-$.AO=I)-\@V\KHB3A2N\X(M)8X=M'C*'Z["*.J>,Z2H&'-"]W!#C' M+W9\3F2V>^+<;U*3GT$9K3UT%6TD1X40!P6_(!6/&A[EX73M^'-4E7G&"ZA: M&".R=IZO:20L*'#)OD1UF=A9G$8T$]^H<]4(!UQ^=*"E1U;G::0I%+`S+SY] M*:Y,&KT'7>`53IZ"UU<<"@I1X0V:+Y^._#$8EOE_NYM@O_UYU'UD+;A3;2Y@ M>.MTF'+H>;_$];2EEL9A+$11PU$X-WT\`,60`%6%#G0<%4:.*Z-G,CVMDCHU M?S:K0\+0:';!)(OBD&'%8J@_E*R!^>\):IPXPE\Q;7YL8!:,-%F6HR,G,]?^ M`JO:A,37JNDEH'#$]OY,#='E'Z,DN\S+KNL[^"EPJ^S+ZZM'*BZ4 M;X[A-U"F[H$T@Y,7#Y\*"[L^J8G`THXWR.L_.HYD9R/X'GT'+;Y'Y/C+5@J+ MX<[734@695+O"YLK8A([WP#D#IE0/ MDI_:ULP?@2N?/L#A[/84_1:K M,[[X4/&A`!G_'(D94[.X M`ND31AM.JANP*Q0Z#L\1'_:UR&+R^SKB@VSRY%]-A#V+:LUBMI+%:'N; M&`U?O'B-ZO`T**.+EB9QE1RXD&Q!0`X6_*V)3J(O&L%OFI!M'L(-7S)F.@6O M)4$D`:+;_&*Z#9?S*.HQ7T;J\%WG]A:=FKX7;-_QE>5EPU'P3:&\C1` M[C.3)Y"R^Z/./-IP6=SBXHEL(E-%7TO[\6P>R'A07A[13QFL^>?E/(*;=1+K M%-U2C=;-&EC\/;I-K)+8NBT"%!T2^U=Y9-DW*[WGNG=[T@K\_G M),O]2=Z39F=(,RE1="*6I[XN\);8';QH6%-MZ564<3X0!.$ M69O0H11!<3SQ>^"&,IK9D\(^0MQ]L>Z[UJ^G<9D\'LQ")X]0AJO9.,9JLD2B^R-?R;'O=M_%YV%#V=I^TY M4V"\H0&YFHA200T9)-"1NY'\6X5.`FZ,1OLI&[J;"%ZFLN[T!C_A;(>GW`ET MW0:J3*EA20%._M=YZ%L#01GU`)Q-!W289.\S2-"N&WWP=/>W/'30_, M36;5S9_+WC85NNK4D!`2+H@9?'9RXY9:,+@3S_[&H?SV/*TL$#Y">[5&Q!07 MN#J"-(:9I2V,!9F]AYH'3O<`=7]&.JY>/N'J,8\O,B!.XU](;W_*DZSZB?P# MZNS(SUWCZ'I;%OQZ+"VY4V7D4"J(D4$"'0IT2@G5I(*'QP[$AJC/76;/]MP6 MX^1_Z+,(9V3CK%[TE_`E7OWZ(7_Z@31B""4_[`-31M!+LJ:D8^53?.0KQ#X+ M76%8,_\`!=6@!BBMD[S8YL0RPB*(I@O1U'7G5QEI.%'>#/(67243_)[00I2= M:M0]$^"41?HY@XCJ/$UB2.P7*9_D60QW%7%3E&ZY9DRALJ**&+(3(,<*SJ#4Z!C8$'^;`Z75U:4*A]N5Z4110J1FH3Q6I)N_( MIR=)RH$"F[0^/\&;\#6UQZ[R[$TD_([F&D0K=A*?23U_K4A%E:F>$-=LP,67 MO,ANJR*)L+:#IA0!;?!AV_XEW,X>JIGO0UTDP_.V5$MM]YO=YM- M5,#%H>P*9L(;DB'L^'^1>`"WJDN5LY_.KCZ?W<[Q5&@%BOX3HODT#2D#Y-(W M/*ZW7$,%DTDVT*$L^8[S&,BO.IZ1&H(E?!/$^!L9(D,1OS]E[CD++KU_+/(2 M;IO62375M>08;,W!,6C%L:JFXJ40Z= M\^(JV0./7C1[I'&C^63QY4-9^H5K$*C4+2SN_TE]9J, MM]Y(M''FS2UBQ\"!WGDU:.1+&BGMF=W/R'@<=C7#*2)*4A%,/LN+&1T4;.YD ME%/J[?1Q$I6/DQTX*'%OU3M<.51YBLB?0I:Q'2C,00>'9EH<,VZ<#BN0LM?) MZION('S8E?\:S*/PK:WLSU.G>)K:*\.R&@[#CL3R*72]_G9A8;H\[P'<3')? MFE=1.O9%EA;W=\N[Q25:W-Z>W=V^2AM9G3L]<*X\*O+%:I7OLJJ\9N4CFVSL MU:K8=4HJ3J;?S3GP6HIWTJ$HR^?!97WYJW_]_?MWO_LCPI2%<$%/7O`T:(.P MFW"OGA8Q83J+&86Y;"-2WB8H3#3%EB+C7;O!7%XLCB\N+^XNSF[1KZ+-]H_H MT]FGX[.;VWJ9G?WY\\7=+Z\OFD*'L*&;D7*676VOFZ3\`J3(.1L7542.U\KR ME>.L"WV'7A]=TK*B"O*!-C0*L=,J?"U(*X&*,.R?!>=J7M>82"NKH@=6^/$D MWVRC[.66WA23'J]P14,FH`0DWS!NZ"O"=,^P<0Z.TI%7,V8,CE6%DQK2=3U3 M3ITKUA+17E@H+:X0[8C5..5=H;:O\,`>'4F-93.:#)P-F$_17W-RD"ZK?$/L MRZFBOB6]^(Y#.V1!Y3#DW\RC'JE:/J(&50S.\;2X($02-OLVT=L'K7P7M#S@ M0!6YW7X7/,U)/^%MX+9T:$-"6T^`IZQB]]"P`[>ZZ-T4*D#;GV]EH&.F3RVL MQ+;!O5,F8NSFQ_6,W..B->5)]OAEIPV"1D>H;18Z*')LJ;QU?Y@KHF$EJ4TY MVVX3W^5L.[TK+_781S+U[;^8K72*VV*VAP-R%>:GU7_@LK1[*Z3;Q+,PN[VK M?)O\HUD(4S[%[3L@AP,:E*:^M^R/7XYQMGK<1,67J4SQWCY])ZSKV5$_L[&G M_E'3[,!PG\4.H!"M=A>0S8532`D]4-*CI(7J.&@T=@B(7G?L=Z_*A:">!.9! MF(,"44UUHT*DXW)/UY&`!A)Z/:J/IKO@FJ/FQ%QIT`3OF>J+?3'VJ(K.X%V= M\?4IYX#^A,53>KKT61N@AY>^HZ$$8&'SPBW%VD&8P50,,'VH`N1INE=8^F;* M./"2=^035%(.%%!B^QC_^(@ZQP-O:D8"$X&C'NX`N!RZOZ=#C+(OKU>#*BY4 M/DW9Q5KR=6V>3^7`.:L"$R&Y5[0IX-3:+>6<+TL63YGW.L8!GVKG/ M;="8*R40A?;TLKB&9DLB_%VQ,P"ZT+29J@';ZI]W!/VX2%]DD3ZG2;E*\W)7 M*"(AQ@&K+0M^E:8E=PKH-E04[V^TA.:0/340'"*07:;/R<%UBU.\(DODL,/3 MJ(J:IT&L0GIL:?I!I@MKJL,&IX)D^`1"Z+N&U/=S0.8043?^-Y>Y MU&N\+O!3DN]*Z#(5HBN;DHYVKW:[TO:9C^K(H\8$$*J`MO00)2B@MR4Y&]P. MA$*#WR%3ZFK.WJYP%A5)WG9W@[E;Y:2>1T:O7!(=/_3A:(:H(D:N3E>? M'`'['?GT\DDY4-V;?KZY.;NZFTNBMU9*A^B0C=$UL(_FIE[FV<,=+C8Z1:$X M"NK:>W1+:-A05;BX^_'L!ETNKSZ^N3N[^;0/!>^'-`-!-`>QOM$.T1C=+,O; MBFQ'CWD:XZ)D&9=3*A'COCW78S/E2_4BDI#MN[@Z1;<_+F[.?EQ>GLXLX==6 M]*)FLIHBYYPQH1YJF-Y\;FYJ-GMU-P%WP+:Y?<@HTC;G9U2I3!*O-9J=K M[W&ST["ATD#--C<'3)C*HMGO^@8\9+_SN\/I]S1_'A_;+6RN6Y;=)F6P+3EE M.@E5&IMRHM<0P+C9Y!E]$=A*S=C0\YJX;\&8:FM:7MTN+R].%W=GIZ@M1XNN MB2U.?OBTO&+6T;^',\0=I-EF7%E.D%NI64JG_%SB^"*#Q/T=5&@?&X2#._'W M-,!05G4Z[Q9]OB50O;@">%Y_IE7)[4$S3<-&PH]>6G:[+QGEW=7OQTQG'V[V$--P-9"/I0/^`AAALKQ'G8 M`2UZGQRYBYZGL/#&8,OO#[/S)QL#*H[R[8_5.6HJ'M$G:<1,ERAA#U*33Z"?ZU(OVC+.T;W+RAO MGK>*FKX#+XG)T=C6+YI4:LX&[2,\>5Q>M"]L\6N<+'9U3EJ2]/:J@AU?*CN8 M$2%(%]%,Z="$C+2E%/+4Y2;6UERVGRK'0FNLYJJ[/M>U]V@>:-A0`.GBZJ>S MVWF9!P:R:!#2-V!G\X#'[SH#0M?>(R`T;*C.*!=7BZN360'"0!8-(/H&/.2$ M?1R524DCO4NH"$9/)UE\2\XMR3I915G%DV9)[]=D,UV1OIL0MBF.UH/X\1PR M,(17!5(I29Y]T!"ENY]`%K5T44T8_:6-G@P?*#D&JL1C]N"9=HY&"+<2K##O M\5IQ"+S=0!SDTM$9JY:H=$U@>,3Q+L7+]<<\C[\F:3HM%C7=^4Z447*B3&5@ M+4"KUFT(T&@-"QG`34;K#26&6FJ(D=,A-C!DK;$BA[+=7#H7.D@D6,.V(6FD>X,E5UL\J)*_DZ-Z+/G+3PQZT^EC\)?"%T_!N.# M-X$CQ'I"8E>(]S57FV9,2,IVCM$DX[JE+)YP$3W@L[)*-G#7\+G$ZUT*[-`C M*_BRJY?K%,X#[$FK+;OYM=Y=1NG(:S#A&!RK;LX8:=301HPXHM29"X711[0# MZD1INIC+8AD=0.V=V%A3[^XZ:4V[*"E^BM(=EEUU?,(1),;&R^P&0Q`)V22I MN\?K.6,$!D.=@T?@W61C(KT@VLU1;=K!@A*Z0G5?"*K3UKTAYM&6>U>!__QD!(>V^,W22ASNO#E-`KO(*UUTNBYOD MX;&:V'GOS$RH;<223X,M0Z3XJVB;EW]$C#`"RD?M$-L M$,>*M7+V)W* M*5#NQHCOZUPG+E49R$#KB&IW\C^4'CTD4(I"Z?BR4Y)V/LI^$'0ZJ>W.DSK& MC7!=YIXR0%DA##0Q1"T3G@P@>W8\%\9S9M3`!JII-JN"TJ6KHJ'<>51AMK=\ MSJB26T!ND^T<^GB)R_(&E[AXPI"78U<10M'6JR=5P81*$Y.O4<$_1^N\^/=` MJM5D\ML2$)HQCN"%O"X2`JYME-X)[S'PIV0\Z4(S%D(=`8VX,U!Z#9WN@QZ< MTIP/>580D2LV\TET\N;!&A'275QTF:*YMV01-0\Z;18)F5)["BV,1M-+H:/4 M-*-US.W@D>`O%]DB3?.O9-?$A'+]JMHIP2)_;H9OLRYNW6%=>`QH&<:I\LDK M1A0\N@U90!YJ'N1K*3=VWFP,N!%1TKIVA\_SD!@70KY61 M/[]XB=@#)=.TPFOE.@S-J*G;\\Y M5Z9\&1Q3&@)'B).8T<6L*P;DAQ*#N7(L4[;;;*+B)5\W2I982&?/1->6418O M[TLRS`HWW3N8H<-Z\':H&<2F"JR,)EJN!0N46%R(T44+\*USRBV:9Q7:-@H^ MVOID@R?971DK0^8\[?I6_7OUH-MPID!Z3>)(&JO9>UL40C&[X$%4SM:S-N3H MI([W#`+9N0%U&#SG.-",>)=]Y%T'<",;+^S1YH`=\7Z%\^JX#W5IKF3))B6;MB54I$)B+#>DH M?D6N=.],.5\OGT1%\0(%6C;@^%RNZ_#N%R@-F6>8:M0;O(F2C'SU.8M80A*. MZ]4"S1P.1U/TZ[?:^/@#4%47XSTAUA5`O^D,-;WQE]]Y?TCH$#7*F3:?RZ8_ M-?S:NF4323Y;R77Z2DX,?Z9-TP6*O[->3`UF?"0SV[*E" M3SDAN-RJ24%I28$8"UB:%\[=I=[`V'$*AR?@>0`;DB!L5IDNXJ M'/M4DG:L!+O^LF+30&,>8O6(YNZNJ$G,J7?1LQ,.'4G[J_3OQJ`R M\ZGDT5.Q0$X`YA&MVD_4;!4]SP.DPV0O/-OH/(VN]7:DKU2USZXXP=66IL?H M5DO65%L]I8)VO$;!JB94OROQ'3S5\[T4FC-YV*Q?POIWS'JF;-#%%M@%R1.^ MA0(>FKKJ(]UMJ7OS61E-S8;J=HLW0&73(LP3D.9BZUQLZ<<[((#T$D4Y'[.%*FAT`[ZN>A+>>:76PJY4XFL=&JES5IK'2AA#7FMS#6`LT)WL`)9-2G&Q&I"MMB8SRUI%`[#W;*-P;Y)_:_#)81H3T>L-!CBG1VA MICLDUM.;[S7=F`A5%`@;2T3C+DA1+=39H&$6G@$G@8P_&QXM5Y%(\`@U&&PKR.XL"I MP8)HJ**6+-]0*&'#=1%V60Q`E7QUN,[UH+QG^J!N].PM[UG3G_^\9S4S^MM+ MTF:>&4TF\NQF/O=,P1BV1Q-=6D(6*^^0!_$=XPRO$Z\1=/;L!+)"K!DUT+PM M398^W<"Y?H'D.T[Y^QG;[LZ`DNM=MWEV3C3X!4?%619#5/4*;^YQ\>$=P>P' MJ[O./AK>8D)Z&%$@$EHA#,U0W0Y]>'>$H&FX1&=#P317E"9C=XSJD)-^/P)& MWL\%(^_=,?)^;A@Y$$P/1MX/Q(@DW&V]QF`AXD:!W405OL$PGB1-6)2\SPA, M>W["A6%:\VH2BUD3%3=9H(NZA.=[K>,.*45$IMLTNX5EGCP2P6!XQ(_WA:$L MZ2ZE;UB0`5MI4F-B/A.)3)E2Y=+1YA!'Q*.'*J``!6<9"1H*UZG0&"`GSE*( M;:*;S=P,SPMBW1Q#)9,6W*?D?\J*QAR?D]\G#U[UKQM+X>XSG/@U*A!%P7U/ M"0NJ^`C5Q%DA;T9^WF]<#8*9JJB4Z[2/8;2IF13AT@$G]NK-3?A+%%;5@UV69$DW6EK MH@BH(DYVQ@YW5S#)-UNG&1Y0]1%G)409\!>I?I94^IRU1$W36:+50M(=W6PX+2/8)?M=763KO-A0Y^_Q"_^CKTA$ M*U:"G?FMV#2)1CQ`LD#Q"-V_-%_,UR!Q0I$B)M%Z>IU7`7]":M+#WD$?WM\R MV>=``O$@ MX4(!B8\WR]M;='VS/+^X"[J-:N0CPD(ULG&BEB^RBDP.5+1K7)(?\SS^FJ2I MWYLD4S;"1"@;\V=T6U33$IWA-;D9[X?66%%=!]G,Y0`%>))O-@E[NHGTP6KD M/.!LE7A[VMN2`Y_8MF--=;_?$J$@[I`Q2*\/`F@W6'1>K;>?.]<:-FU7/+_K M+K\E>T"%'Y+5\:Y,,DPVAZBH,K)!NM2%=B?OM_RS,Y^]R&U2#JL<-3113135 M5.>3)#(2+MHXEF%SZWQ0.8G*Q_,T_WJ[VVY3ZIV*TG;Y3)OE;MRWYP.Y*5_* MVN7E(X+V1TBD(&CB6>6FVR*@HX-M9FH$EU)??SYS2ZQ8">92LF+3)*O$"-PS M#2-Q@H\BD\1Z7EV+CI)3-RZA7#\-;KR.DMBRQ*B&@%?S0<>),@F/-:%V+0M; MW9)689\3-Q&)4!ZT9]#.6K&F#!2G4'4=^GXJ*,JZ[D,&X"%X:(A,%MWDR[T! MN884"6'.T\F]VX7GK6NO>WUV;JL29I*,VQ6+-/]6&)?SVC_%Y:I(:!F1Y?H* M?^5ON),#\'619^3'%=V2RJN\^@57BSC?5G@2L+@QXO]=-P#`-0-<7.=6O_:- M;S.V%(!NG"Q"ZWF6/+"3NXA2BPD:(]OAI@EZNX@)^)-U@F/N9E_];9<4Y%^= MH'-:%,KONQGCL!BH7,(HS!L<=MM^4-M1?5]4=W601<%[F^\Q>%1XRH_'XTG( MN?A"RP)[!`]*/G!>HO;:J^;&YDCM1MGK6=N)157X1KL*(D8,UD8BD..Y'BCB M!,,4"A\N]>;4[CY];EX>I_[>3@?6MQZ#1P9P.0%@7PEBWXX#V;>#KD7MNI3I M^PG5KK8[?P_7C,?T:&"G!HN0605_AXY>C=8V09+CNN@5@.M:H3V4R7Z%9JL% MT$?#6YF?'D842!5:O2EX_>X5M`OKSC>43`,HD\$[UH(:#ZM3V`;Z_B9P$X]I M,FB9]ZA:7[-N'6IT],M@>(&6TZ3QU!$AX7SV*&AU>H>%V9#_&5;+)4\$:L++E M-,V]F7%J'E17!:P!$EH$?7FP7P;-3M4S5D>#[3Q*"GC:@6"VV>7LB[WT4_'J M.^QE1X$.:(>>H"&HU-8DVJ\#$P(IQH)J`&,V"VZZX[K(X]VJNDD>'BVA(F_I M36-(NU<5`V#?HH)^'%1/:.>[D;AZ<,.OJ@6]0[HYA[13(?O4RYVU*0M^0[TL MN>N[PQ;('$$P!J*4Q+3G&;Z_X@@2V06WS32Z'K;.2!?5RR=;Q!7W'@D9X M>`K!L.C=+Y+-&5.`F!%`C`(22-"CQ)_R)*O03^3?]`AAD-85!,OVX!!A;#F' MP]T%)WD60_'_>.\4X?>5"B,>PM7),F-0F>/%&Q\3S#44%ZK')HRG;9RW M5WAWX@DX"(XU#(3+@^EGKA?`7?_.?%/$+9#0@]R>R7([_72/468W%?MMO-\V M[#&@NN*ZO3V[NPUYU%%,;GM[)1F'[39*"0FN_$_TN8N2;=Y6Q]E>(GY,."-> M5._97RR.+RXO[B[.;M&OHLWVC^C3V:?CLYO;7_WK[]^_^]T?T=F?/U_<_1(2 M$Z:B:D!B-!5#2I^<`,=9Q3RX-TGYQ5LI"(-^_1:`Z&=(O2^U31&T-3@4A"GU M8"[L;H$'P[D94B^1[WDEW?3:[I9KZ/#X!?Y[3A"?%UZ,*!LV0M3@L>"OY]:M M9$_4B1"&@&M"A]:EHW!F%.?\4H,#;&06E^VT#@`\#UF!4A(O=T64E80\W*)Y M4L`VW?L^\%KPI@P885%-E`02:<=64RX M2%_.DXPNPN:"V#MY"Y"U&*"QG`SZKOS MZ&ZT822<[]R"2X,XM7X\S]94=D*.W#UI.Z>COLS[PKCQ?=\[QG M\B><@X9UF`K(]!GGMX/]6L(3J$61%R=Y46!F$A/;X;I(\N(:D__&B_BO.WZW MZ4E;.O`3[I5>:UY-7ND%HDB@2NU92AO4ZH<[LEXPPX2FN;=',7H8<50.,](.AV#H&:VCW:V#V'`5 MX;VT@989)PTQ+Q5AIR.&51Q@K[V7%QE/_\D>9&_X6NXGEC3'/[#UX,>./Q6B M&!649"BOZ339J]VDU:"VB:.$6^PYS)9SB2&U_ANZ;?F'F887UZUK3GN7S>8U M$!5:]3?"!A8@^DW/C]LF-K-=S'(;&Q`Y9ZFB)MG%@IR4+%D<=R>;_58V>"]S M/'_5'J%+_!"EGZ(*A+C_H,ZD3DJSCOU>HAOQI(H(A;:(-Y:\R#2;(L!6$A>= MA^:SXZ0@;Z.LPAF+/#52?IT&O@TGL7.5'YI^@O["/@J6;ZB??/23F%&M%UY_OY`B4G^G+V;6I4W0;]!5H%SU`U$.5AK7OU!+B_ M?L">43A[WD)ZBDQ#C/OV1;_?HA?_J!-0.`?.`_`S0^"-"0$_922%+:M1(+]4<2U>$5 M!UI)@/S5PW)T'%]DQ"".4EJUP\)ZD#3S?S@Z9$(I8/HAHE]*3(H`SR&I9EUX M!$DZ.+>KHA\O=UE\CU=?%K<60CYLY=M./.!`(>`?4?TA6MR&5>7Z^6[$*Q^9 ML__L/Z)MGA<_1T5!K-'20L;2AMY]93(N%*)FGZ+ZVQD(6S?WC;R5(W2NQU!; MBA]Q_E!$V\=D%:53G1/4G?D.>%(QHD"+^-E,S@6]@NN$'&G'Z[89+'=5F<2X M>L2?R1Z#8]J'C<[0$O!O!NC84<""-T&D#6*-V#E2HDY"^!M,)-1HEM[ANSZB MN2KX&YUWN-A$\_12MW>%7*N/Y+I">]J0C[%C4Z0#,@U^DBB M7A8/!::_&K:/[)/Q+/1^CJRVD:;M#`XTYC+3[2*RV7!%T76!M]$++01&J-\F MSY_RK'JTL5GU%#QC1\N,LC1LW8:AAK1"K-D,$&,D'Z%H;-_P77$RP%+5F:<> MH6%ED9I8H=ZQ8&AW]AB;MN)O3)(\B_.,7H_<1]F7Y7J-B7ER0XY$EQ?'RYOI MKK_,.O8]#&S-.4N]8L,8SY.JGNXJ@^.QR MS6_JICK[R+KQ>NR1,*"*@:5?TOS"^NYUWS$7`D,:08F(48US2.CK)J%W>>?8 MR@TG;1@BS/6`"V7UM?I3!-_.8*_2S;T8TRH?H5.@UEVR^H(A],M2VK)VGLU6 M"0LJPZ3^4B'H$&=>S<2W1HEBA*[VZ/%RO;C!3WGZ!#3MC5)=>]^6J887U0L# MH.,7J&FD]95ZQX.!;-J7<'K&[JS\@;`E'D(I^K9OO;AG$%YQ.*L=20Y6X>3H MDF10T\KR?-EIY#?)=K][S8F2?38'.:HFNG.(/!B58R34W2.^Q&6)B^7Z/"]N M5SB+BB2_^YJ?Y!EKF>'0L'L\;B\?C8?'X]6#Q>!`6CR?"(D$;'ELS*FEZ M]\+:\><`2"#5KQ[G@L@^8?=A4CMQSL:S:6G%R\?[_[V[I>_O\L?CO]Z^K^6OUR<_=??G][]K^+G_WK_ MJ=HMS_'-W2^_?;X\^5]/=_]Q\:?3\^5ZE_SYW_>WI;_NGCX^[]E__Z^IM?3G;%3Z>7EZ?O_W9V M\?5//R[_X\?C#Q?'\2_)A]O?+OZT_*14@H..O%[-W[0ORH/G7Z'5,L@3`J!2D"=U`'I`)W337;WQ$9*HN+E-H(* MJ+=5OOHR6;J)LC/?Z28J1I1%"UCA7/I=Z&128]%U4*,=L7,8^/()%XLTS>DU MZG(+AO9TJD7=F6?X*!E1I:60[]\T#1!K$=YX,A:B""3]V!UM95R\>_OV[761 M9*MD&Z6+3;XCQ->V]I8)'?\V=3]3*CN;'*C^WW='I#%J6B/6')31;"PX"_&U M-KGAK+@5S>%>@'<6V-EOXQTG>PPHR[AS?\Z_OIN#Z!4SW1;1D0QJD$C?.XCT M?6B1OC<4Z?LYB?1]CTC?CV!]7N*HQ`O(G7Y@SX&3-I-ED:GZ\IM%IN!"Z58C MGR/A^R,$+6:2\MPGOJY[33-PYZN"R^@+/L^A8DZ4Q1]W188Q#^-)K"P'$SK> MU81^B>A?3:]Y@-)\5IE_DY@KB3DHCE&F=9^9(^ M15D2.03X&1'RZQ(T84D!I[;I$1(;ZY.D_>/)1GP-H(SGQ3'^Z%-4%`FNJN@C M)@-R0E,/">^*2<^/`D1-HR/$F\TK;M1,3@UL#.;`207]A(LLSWY,TK2\2,E? M\Z1T0$P_%?_U&7IY4@"'M4.TX1&JF\Y-]QC+K4&0V7RX>51N\PW(HKK"7_\$ M/[PX8*B/AM_MJX<;U=F*MSI"I!UB#>>45&DHI_;P93`+COM439KLA_@QWQ%1 M@,7N@!%=H@T_/4,U(JAG!JXF,R"^X/)UV3NH`[. M5)Z=#GV_M\UBURHO/OF7O`Q0$)^-3!BBG^9@1$Y6[&(#Y8]B8`X(6J@'>4N_ M2D'*@T*\_%L$'R,JZUFX5K0":-:]>J#NR38UL446NZ/`A$Z(9(8^IC1QN2U` MP"-G`)L0H;BFPA/#;XWFQ/6&X"=)MHZ1/(^2]H+_2I/O?2+N02;2.0@ M[AK[XW%-K&8!!>5'J*:+XXL,Q&:A-C3-_>X@:D94(2*L`>(MX$4G:#,3YT:_ M6-JRI?J1.^XK^U3/HB)-<`&/V%M5N.TGX[GV0C]'YH#A;1%M/(>K9'.I*>&C MF`_G0F)?\SLX#Y,M^)Q(LL(XL[5,M!1\5^[0,:,`#E4K\S%4C232FAN]`W9` M1KV)W245A$9>9''RE,2[Z#L. M!@[Z\*DD]CM77NS6GX6W5OMD(\)!.CQ7PX)E9>@AH;HWD3?U_G:CE`U]]LR< M1&\@AO9Z1#U6YU"TL\TVS5\PIID5UT0VCU&)P3@YN[V^MKD?,:#CW?5EP)3J MJH2WY+DS=5MF@7X'S2751OU?F)@+K[TT,9P3]Q<>X>7(N^AYL:L>\V+"!Q84 M/85X*72?"?TCH>1KU'P^DZ!8O=@.GP:5CM@5,Z>$8%DEJQ/(IBBDT1XC&:?2 MCGQ:)U(.5)8J_W8?,$%=)$8RZ]BORA$/.,?09X7@%77R5?JG79&4<;*:-H^O MKTN?*.KA167^0"MZCT/;(;%AZ&`12\$>O$K6,QD#H`9AV\E#-KENDO;C.454 MQH,"3/S37MT4"$H;H>:ANR2Z+TL:RQ`&0]#>;6U/4RFPODT=I'%>)W`PWF7 MR1..26<6L%$V]OX6D9P/I5%'!(,V3W9X;(:?\N)X*V M41Z'K7QKBP,.E&\(@3.FRN'*6*(-_">$J^9;>"I(-C*7U;YB^\W_7%RI38GZ M97O^[0_T:7O^C_VW[05Z7CSN;7^J57UU>K$(!XQV`VK MJ)S0B:[HR7-=(BD3/2GA1ZC^//AEK9G8.J<)]8B=\\7S[`%J@]?>MO8)C^.7 M$W)V>2.K/@NX>C&INJE%]Z"W@:3-HT[-YY'+\G[&%(M:719L)[J%])0\1;SB%8S51: M[26BR42X7R<^KW#ZE)0*3ZSJ\O"@E6]X''"@NA=LOPMNV^@GO+WPDPYM2`@) M5.7#?]L1])P]35S^1M75%(F96CM8SH=2:]1?(_JYM/I-J.*+&LGMEUY4C=@] MJ6Z/ZH2G)VE'7N]H9!R8`F86L6E:86FP,H+OZQBOR?GK-"GIL=UB*Y$V]/\Z MF80+U3ME]%-4?SL#2U,W]^W+9:H1NB5>KLE\.DA;ULZSMUO"@BKG$K[4"#J$ M^:"9^#;=4C%"U[7]G_D69_CY(GN,4OK(Q6V>[FC^A(7D>XGXMB#[&%*`@C=# M;3O4-)R!+C"550,6HVEP/E[<).MHLTULSA9[33QKAV[O"@S4'\WB1E0^Q8U\ M)0-RU0,_D9F+KA^C8G-=Y/%N5=FL?V5CSP)6\:&N"L4_1_7W\]@(^H0AUG]2 M#]@YP0T7F\O<+J.MV\1W"ENG=\WSI0B^FH>(Y9/<>;UT;TBNXOPQN<.K1X=5 M+6WHW7J7<:$0\8_)&_A6MYB]RUDW^XVTE6-TLM\_1<477.'X5;0CT]*7"TL<"7&27?6LF(*U7M][KM#VUCQ%LCVGP. MII65!-OB[\;S,N16;ED]XN(JS_(M?3L6PI(A4>OL>8LS>474D=ZW,NG7Y\6+ M"4.J\C30%(EM$<_9^XXWEZ1]^C[,N0B\\Q:6Z?P,L[3XV>(T*;=YF5ANH#TD MO!\)]?SH;2[>"@G-YJ#+S*2T9W9I9\#IZ/A?2;ZMK#P_W1;^;:A._PK1\V]F M8`Q)Y[>1ZN%8G!]5I"E4N-A&1?4R9=U<:3^>XU-E/*B"3X5/%05U@^P>.G&) MNX5RJ&XV\$4&L6:8.I"C%=Y58`;9.(6T!/PK`QT[RH0GV@3MM9G#GF`B'2'I MJ6?H;@AAD06+^*^[LK*L2:-HZOL<)&=#'__1?AW>P#00PUXK4@]-\JL67:: M[+1"T"S\QF$GV,[[#?U3X7PPN<$IW"I=@P5[5T19&='J(.7QB_B7J8XK%KW[ M3>TT9TP5ML0^0_2[6=16M9>TB$'+"7'R=ESG:9ED.$T3BPWNH)%?@V:_>Y5B M:CZ;PTE&-=%M+K]L5.Z)#9^2C%;`N8##,BZKY=>,3.ICLKW&!:BTZ`$?OUP1 MIG.BWG)X..^!?3*%SG%GQJ\*EHL5360H M;_`*)T_1?8K--F$]"4]'!P-65-LSE.,@K1!MANIVJ&T8L/*.D7C:K;M__&Z9 M[\ES]7(:O90CP,64EI=J/38((?ODF)I\&+L>B%E*W#+)TA(X;%-D" M,6$1-K]3_(33?`N['_RV>#)3.'H*_M2,E@^UB4/;4-M&:(5XLZ#Y4":2:=.C M>D<_I!)M6V&0&/1D`A.BDA9EB:O/)5[OTLMDC:?0)T;]^HSP,F%(5;:6-GW# M*DVVC1%M?818>P0$`FLA&V%W"MJ:SLV05X3PML"KA'IIIP!UJNSZ("*N.6U[BX?8P*O-B`)34%5L9AS.LS5:.PK+I;%&BCECBJJ2/` M#Q+H0U&\N@?PCB':QQ%BO:#ODHS]IOP^^+72J!@45\EX`G&.>3C>@3>Z+$E' M]TE&.UK$,8VPC-*3/"N3&+-KL>57')M%P]B1]+&!._"E"IOA1)!`Y0@MB^2! M_"-%+4'4H8B`9$ASTDW.;;B-_=PYGD@(,8@-)]9KERR?X>5]FCSP]=`6FQ0^ M-(+HX$[\G6N&LJH,#ZW)[@.UAG)+&51U\Q)5Y^MP#I>Q8-(@?)1Y'G+(BI+B MIRC=X8N,:/RRKGMS$U73G*TTW?FU?#6`YDVNM>Z>IC7R'^6=#;*H50NAZ^PU$Y!R%] MS@H(J2%.XHUGEQ&Z7".>8V3\T.##TD?%YQZEE1G7WK1HBT M0M!,/`%#PX`1MD;B:6-M^\?ONAVU"/2KA60:*(#ZL5<]T$*A;^P]TOA'F+-E& M=5E/UU#\B8;ZY]+0.:9L[!]7^RST8:ASQH(;JZ`.K3XI'.!".EQ7#)SD18%7 MS!VP)&8Z/,L7D6E;81ZS?9?73Z*TG@-#UY0+95]Q%NXL*OU0-2U02IP:XN10 M'>I?Y0@H(EK9L*49TOTT0/Z"S\EU(AU37+D7=['ZVRXI::X+?DK(6E![FWI\ M_'I*?AQ)Y@SU^?3;QHBW5CN6PKGPC:1WX+GOGQCG.Z2K'20R+-=7>7:*T^2) M;++D!'&>%U^C(@:_:A&MJM((5X:DO*H[,YY4J0&T,>@VTAP)[1$G@!H*0=^C MM1)A^RJM^=0X>[!:?T7]9C*-RUZ]-'[3'W'\@$]QD3Q%<),ZR7G2@0O/GBY[ M#A60W7-YU0]NU^20X'ZG%)%`,O@)U1TMXLG5<2[==N6&YG+]-R+^WCIO]8AZK)NV5Y(TC^%,_E,Q=0H1Z-I<-YT)=0_EV!`IM'J MR^WJD0RIA+^S$I)YC--/299L=AM7.!E2#XLS,R;M`$AI(DKT#:>*&K*(TD6< ML#QL:0Y0M<.&#L,64^P3W-'SE.#FU.<-;L;D!.!FA"FX3_,TC8H2;8E16P+0 MOP]IM@[&R1"@"]/M#/2Z+W@LL5C!L6R=%Y"-:`1D=6N?=V9*+I3E*3GVV@;T MX@R:A#UA]TI#J$JI&_.`PC0KC.,2(C]Y#V?/C/XDAQIM?[Y3MW3,J&O2T"8L MN)@W0DVKT'%`)N+<*T:CGP'W,A&G^+ZZR,JJV$%>T'FTFC`R7MF7UV!W%1?* MY(K["K7?'R%HP8/1PQ9FZ!-=-^U",VCG3:I+]9H<>O,X65U'+_R?4-%AN;[( MDBJ)4GC*1X8MQ1;F2MOG!N?(HRG2:H*(4SRJBX6`H<:ILN><0L)Q#"0TV^>0 M&77=7+M]PIW*],J/]N)[(SUDP12)\&WH35,M)K6B:\;HF'.P!\<";QD2SS%N M"]:XJ#,%)8_'2".&C#55TQR1]D)-HW!>.2O1J?2/9E:&O(Q1W]U";U/HF@Y] MOT'[8M>JEU7()V\JN+"'CX*&R\H$(6J3@]$XE7'9`U5>D?\F$(\$%2:3/+O( MCJ,R*6^W!8[B9?935"1P6V9\YSZ$OK_HH@%<&JNAFBAJJ*(D0Y0N8H3AXJHF M/8.K^Q&@H=)=UA/L&O(TH-^SXXN[T\4-^,[N",3+1]/(\+'[?!7+0,;YE$OC M"+$>$>T2-7T&?31V(K2-L8J4\AEG9<&_3O$ZVJ4T-.6412OUQ!Z^"08O/#K M&R(!++TIGN)\;,N0S]2-09R:0KK)3>2*N*8LUHNE0*?$C^I[YL`U@D9!E?HX M[S+7@ZH*K7%1X/@\R2#T]B0OJY+6X9L&_ZK./(>+*1E10I=]CW@#1%LOQNYS?%A_G19%_3;*'DV@;K9+J98@9;$`]G*?) MG$E[V[:F"7D!=7!"0Q;5=.=HOYH#HL]2-9S7\8R'<^SOSA#CSC5/L%M#;'MI MB`_O#&>Q1Q\(3W-KB`\N#=V\GTF&E^L3HF@3N(E,4@)),RTXDG?4IG^O5],V MG"F?K$Y]7Q>]Q,*+8Y9UF>5*X?R*'KH*8'>4BBW^^ MN%YFYQ?GR]&0+J<^,Y!+F33#]QZ\&W0OUZBAB@A91.BB98:`\KRAK<6#%:K5 MTSHIH"^3O^V2F(;SFF?9.!&>&8SW^1N,8('@7HY.\'.7G>BM8"N=Q@D1"_6U MRT<-5Q.JJ&)?^LB>\#^A7H6P5,7#6O;*(G/O51"[QYA&4R*Z*W(Z\E$,;@ M>/`JX!V@]ND>C>4QRX5@BA[+4Z'!O(]QJZ$RWXLON*(]36&B:#H(EP)@Q^@( M1T0@S),W%=;,+/'>APW+IT"-F4.Q9-\LTDJ[@=OPGL:)MH_FP%\8!<> M39QAG-JZJ=NF<&=RU`:==3Q_0@5"\HB_QP'.<(T-=U8M/ M$V8PMR.BOJV*)O1!7WD->YH=#3<.2T`WZZXYC[+>/V>[$EZ\9A>E'5Y4R6[3 M7,YM\F53]L%PH@V%_3[*T:67S>CJWLK'/7=XYO/[XB6/CDP1UG%HTC9 ML=DT(L^*H+^L$QNV[-4YH],$(:.&U/R,<[UH>[2S9KY<4SQL.FH?5FNA/Y8= M[MIC\(.H(^,C@OQ(?-Q/",]7GE/GO1:,4>:T6,P$,_(QML,*R]*ZR\^39[*Q M/$;%`RYISM98JT?=07BKWHS1X8N#)PY6.:+$$:?.,@GGOA1Z$6*#?/TD3V6T M*'O]A*-R5]#,LIW%2R@C=^GUCFI&^2SIDM4]SES,\H!;*.L((5PG`N* MB[Q,?'3M+'`9UZ^'6NV=EQ#:48)I<-@ MT>=Z[9F[`8GU)WGVA(L*HI.N\@J7U]'+87[4.'A5=>4[?U3!A_+QL^9K1#]' M_/O`]1UZ!"RP8]3^56@S'XLR8GRNDA6^-T4V#+O/%QQ&PU7IOF;`HGZ'T`$42K]+T?, M(4?>`!CJK/F^*1RG-IBT%\<"DFI:H:KD*3D:"L).`HG9W1X M7:SY/W`3FT70G*V2;90.`YN6V(+MH^761BT/4P.7`IJTA@(PL79.Y MG701B,$EMU6^^D(M[KLB>7C8O\[QM1;T+(6M9V;-[\#5T8V2HM3Y@9#3#WKI M.!*\[%9*_W2/]'7P#APE\#:P-\Q*\`/P[82QLX@;@^XS>&A M[9D=(R;SU1GU[;U6KQE?.ORV[1O\DK.HB.H9%:ZT`<`^1HTGROWDJ>^B"7VU M?`;/CJK?4Z85;P-AV$99S^*].R=A=\Z0]I,WCCN/F^*,;I-+#*]"NM8JZ:,8 MKB1##V?&+^#Q,QRCTTE&IP^"=JN,!/9N&,I7X<\PF;$1WL$2C>"\BE*AC,-` M3]P^-6^YX\8LN1V?@$BGYL=<\&8@2@/?F6R.W,\\MV!94^-S"H-0H.[9Y&M[ M5H"(?F!\O1K"D#L4C6BJ[0UPY&N`ZR(_SXM-U&Z](V@<%=%Y7%HIN'/20806 MHL3$6]2YZJ(>6?>K)-W,.6<9F-R(T6XNLK/G%2Y+Y07KQ.X9$WX"G'==>1U^ M/\OJ;!&5RFC++VIGY;^Q@)211\=TFIT7!W_IN^0^T(NRW#5/\4P2X*?KS[=/ M7L>,*LB/-VG=Z'4K]@Q3<*>-B4`[H7Y]#3-@`.4WLB5H)# M12F?`]4D`X6CC2B06J3T8QS?Y9=)=%]7Y-GF&3T`'\88Z\Q$2[I^CZAVS!DC M"#7$(+FU(8<:>J"EP@4?#Q5ZUUYTF,,AJHN]3'<7/=<])+AD[]2!JZ8HX-E# M20V0<=\F-.G>_T6V,6]]#Q@2$DB@<80:*D@D$]C4LT:"[(E#T]D:Z\[Y6;2)D]>E"-26.!1YKW8QC MX<5N*"^39]2@M-K!E41\OS"@X:5O=R9PZ;SXSIJRPT)@GXV!F`[V7.TT#*OP M3ZG7KV<.`8V/&L;FQD)$&,>AHTT27?T:G>5;\P\S8,Z\'G7.H11!1`;DG!::)Y!CS*R M[75?F@:[#`BS!$=.&C':X33;&-AH,#QX>IT+#O:\Q5DY3>U7 M:4=>RP;(.%!@<[G%4&B(`(^V*J$L`#G6\D9A*^7H)-8M4*$:[X"([$MH4/``DU> M7YM2#9L(/@PW75@[S^FP"D!FW9+5AK]&*?0>$O4B&WZ5K#5_X\"=$Z2P#WY< M'@`6%ZCO3Z9K\&"7+.P;?-?X1%;18VI6&+N7B,V MJ:`:^])H(H:HQP4Y>"W7-Y@8&F4551!10;J[N*"P6FX'/8CJ$! M8BU0W82&;]W^;0?Q7,3$KX(';O5)4U12VGD8`JE#)5>#]G9WG]8XCM)RDDP0 MB][]7OR:,^9TMCE"-1G$Z03?3>V!(.+3JXOA1I"0IW5JA4W[ M^*7]A`<_++Y&1?/J"_UKN=A5CWD!3O(I0#T^DSYMR]&YUP76OKF/Z-,L0D^B M#8KN7Y#X'>\.T?[$YXU8GZCM-/ARF@RI!\&]H\MJ@.-B,$-MFLZK6*D:=E_5 MFE6/P\?J%5+1U`OY52[B?CB/NIQ[Q#AT8=_WLW:_SQJQ`A)63?X:%TD^W3(> MA3G?\0RC<3[=,FU[0JRKL"[.T8%XL`!'$\?`;"L714#_\Q,NP1)GG$QR;!N5 MOU>Q44H8GV[)T?]!O+>#5?>Z=D(-(D?9^E2"&;#7-0&H*_[DKV`.1=+KP1&27Q1782;9.*GQ`/;=TLKMGC.6.< MZ4FVNPG8]+XWCC\&U4;:]@0)0>(KJ:0S&ES*NCM2[[00]U=WVB8Y\GYGM?]. MA^#.9CV1]-QW]K/--LU?,+[%Q5.RPG)=@:U4E+](?X=TJBN\NH7 M7-W@5?Z03>4_G8Y9KY?,DPU#%9/+^T.\0^5Z/4)-KVR_+H^ZZYGF"9)>T0NN M4-NO5[P7\%WDWA]/(_`LQGO=W2A-,,1 M-^W1.B^0P%#0:Y8P2\.+VE`+W]FX=W92BZZRF^3AL2K;*LFSNI;1,AKB=#_V M('RYCEF_1T*!\-#&P*3@'>4JIU=N;B74ACH-/N5QLDX@&TEVCZJ($AZ]4Y_) M<&,S[\&'5G?9NM!F88E/"L`F^GD2>3F6HF$9?0H^?DZJQXLL3IZ2>$=W\#J) M]2>ZNU]L-CA.H@JG+Y^W>5:7)C%:<-/T[+?<[P0CZ"L5HEQWT!UJ^^ND3R/6 M)1+Z1-!I4T4G:%V<"1$HY&1/):O0\;E/49+"^[;$BZEO;_NP+\>'$\1Q"L5GV-)!O'Y'.CW9_)3"?KD$:=PFKTF^'V, M&M>WT=YH2]-C!ILE:ZKJD9UGF(`.HH1038F"NZ;57+\$M0H=!=UL02XS-\2+ MZKQ8ZFI(4-B!E46G1;&7:[*%TG?4]A_W#;S)F/#K-R5JRJ%,M]74G;.R)KS< M/^V?G-LX!^A4?+CXU84S6$![E'W'5)Y.9[=%EA%C=4]M$"U3>VB-MII>(A[W MECY>5+?]M-GA;@%^!=1<$\S&NV`JMF;C,)H6YPIDS59TN[O_*UY5=SG=D_(4 MGF*YRZG_GO7(&3""E3U5?Z]'6?.FP)U@MG!*Z"Y'`BW$B=5PK`$ZB]"P8<)O MP.DVF2'RYICM7Q=FFSC%9C0&7XGA(N-].DN%'X5YT#-U&2$74Q[45-?_>OXLJF=QC:UYF.]ERR%'3 M>]C];'IL#K_#,1.@JUOYC!PM5O#J.:O%>!<]WY!#!H149*LD31B3U3F.<1&E MMU54[0BME\['DP1$C<"6WZUP!(Y5D4LU95XRE)9_A^]1E_H1BBK$.T!-#_N- MFI"%T/$*(R*O$V\TDAQ<%U1;KB4ORY.H*%[6>4'-VBG6B:8WG\F?:C;Z:_B0 M%JC3)#0P^R4H+\\C'?J`DXN:G(4<:4+(/4.)H#'IGO?,3D6O*DJ M,S&"DT#X70"EQZWQT*G"+/E?`UZ_"W)P+\!^=;W.R!^328> MDC>F398TZ]CW^Y8&/*FC-Z$M$ALC:'W$DH]ZTQ$#/?AF+OV]I]X,9\KU3*[H M@5^(%I^B:O5(3.7.WYF3Q"-:3;@)\&:A(ZOVR*Z)HIIJYZ/&;07^Y/HFN_Q5 MM,W+/Z*/!9SFKJ.7P*GUPW%FL"Y,)W]T/6[0\7)-_SBO55,SY?T)^($,3[J$ MZ!?!/1RC(6V<=2-.O%LN6D_?I:SSML0:C_=E!]K` M?&-7S+/Q(EG7%V5&Y(^L5SR/%:WAQ./;GQZ&XW%1`Q,FR_HUK^I^!$^QKGO$ MZV[FUH$5-WB;%Q7D]]SB!UJP:@K[5=.;SYM:-1N*Q=)&\;1-4-TFN`'9+T/1 M,NP9_`!_[0U^PMD.3X*!. M7GQA933TFG?@,Y1["*,64&[S,VFL:/QC1W4C3YJ]@79MTEO;\NCPG8XP]_"&XNU?%`CLA`LWXL_/#Q;I53J8^(1].SCQ>5,X(-(5(-]:8>@+#AF,8RUA45V8SXGB4KKTOUT4.D7/E#4[A,9>[_%.2 M)9O=9B]OO6&A-%)E[M0]ZCAG)GN="#0#6KU#09$HS&' MS>NXJO1\5^T*S#OFB7PE2]:+@<=S8HM&J3\M:\&/YPB)(;S:J&9&M5D.-=TC MU%"&%<1H[VGN0*;F&*C2ZW7+F79_+P=<8@6.STE/%;Y,GB"EO"(B2^Y3O"A+ M7)4_8Z@%C./%$SF(/>#/)5[OTLMD/Y76.,*M^,`6N5%WY=O4H^%"EB5/,B)_S*AJ!\PMZ!-?) M_]8,V+5R<8'/GA,:HU4G/%(P&KEGE(W]11&K6%`=)8%8<_X,-=3`9=CL064(1%I`0,2EZ7P-/L8+P*\];A3[_.%Z\NM: M$\-;]:N*%JTX974$P-6P@5.&)Q4Z@,$PA_)1>+?2T34]6AF(4J0E`EJ:B!$- M?:R8!'X]BGV@")Q"'O9O>4X3]FBDT_U@T]B?`:IBP?QRKVX1T@#MDX+R4JXS MW`$&*#O@1^G'(M]MR;$FW4'M:!KB!3Z:'8YY\2L:T0@1X%.H5`$EF)]R=IBO,(%+ M5=97%[Z,!@-.0A_(#'BTL@*Z;P\QBJ@AB6J:]5H=EPID`9+_C,;T3HXTSR?1IJG&%:#800$[?U MZ[Q@X;05"ZVE.9]53BNB01QJGJ:B$@R[S;M@2=1VUC/NK./XXF%JM;DLY*D( M%F]/F]#QJ0$-^%'ZV&E+<<-%8N/]R/\`WG9CD0F.=[/I<#H#2_;F6CN?DV69 M?X5G=![Q>5*4%41O7>=E)7QKA*^A?03)"'1DULH4;/;OAC*J'C&BM&G@()2/ MK-X(;>:5U.J"%%V2J_5$CQDH=4+5],-^`(;PHD9Y`S\MU\M=!2J^I![?'Y.' M2>J3C1W_5"._161V],KCVM&@1]A;S!G`):HZ^>1B#N!>[&LQ@O\Z_S/C,! M@\%S1=QY]WM>(AW.+O-C.#"G.2O5PG&]Z7#CY.01?KS(F,&Y7"N:-$][O)O/ MZK1G_76X.JS'-<6:9DQ`G0G&!JTUJVA*UGG-R^MTCC@O@N&:P$W8X[E3]D.G M7`W8`SJ!W1_[_%BMD<-XN!EXUPV$IC,-I1/BY%O0)"\3%!=5\G?:(;M_.L\+ M>`%J5VSS0AH9"']P-NK%3D,:N<)S2?V3E;*36=DI3/R7B[ M[0U.-O>[HF1[/X'M2;1-JH@&L6=Q`H52G'=@(]J!=V43'BUKZ(H$J3KD))%( MP(91+?A5??$I27%8Y^6BQ>DSPDWO]W'["H>\&>OBS M/(.UU"AF6WJH)C@OB]-8\'KOI,DDCNG'OZVBS?9T5R6XO(X2L!,NHRQ>9/'Q M+DDA`-%9VQI0#EVNO)]%*]!2C@.+I#U&2E56=!^<*9)>N`EL1#BS;5#-O'5YU!_2( MU;[E7/>!>"=-^N:L`AH&8$BW%%PG?RP3A)\!>2K(=0%E1ZH7>/*I(NOQC/QZ M"]:0\W(P)!]:N1OR:85[2K)),Z+OE%54MS?DY@5P.R1H06TQF^,I^4ZGO/)7 M>8-7.'F"/(AQ("RA&]+KT,>_(0@]JHLH0O7LFN*\#&9CP0\!Z[O13WK='B^R)Z*N\^)E')2VY.:$ MS8:K88ALR,P9AP<"-4=?=YJ&IM1=)BNM?PNYZ!JWW6J,U,OLMO=?9G$250DTSS.:<^$ MUW1B:_94Z.-T(`N84Q*?$ZMIT1=0!&JA`T^<(=(IGN\TAV,@^SPOR-I981S3 MW&1:TQ,4)RWJN%A5R5-238QK4Q;\!E]:/8L*R->;JR92\A/*?.W%ID+(NU:PAI M5--&RSD6LAD7,KJ\98<)=\(_+2W)#UBD@TPH3;Y@9@ZC9/S92C\+E_A$"W>B#`%RI9 MAQ*V.+=[,FT&-%!T-+7`4GZL31@ATKX-)$F_F\%Z/9ACB1S;,;GF=BR>HB0% MQQFQ'\LHQ;=XM2NHR?2QR,OR!DD]$G4'2N=EZK<9M+MRA_VKBJ&S#YG%(7ECVK_R4L]XH[\4HW-_GZ]&%#D,WG80!<7>6&>3:BU= MOSZN1&T8!CHIO]B]66U*,\!+U8:L]9:P;^B@EA"*Z+]:4HC2 M"GCCZ2CD@Y+W-K/F?O=)M_\[7&R6Z]O=_26.2KQX*#`VCK334_#X,I>.#Y7S MGJ7:02/`%VF&:#O4-`QKRQE)I[TB[9V!`9LK?PW].BJJ%UJ+-%JU,:/E\I7P7GX&R<$&7PMJH-?>3I#H?O( MM\M<.6_.I+MBA^-;B+V/R`B/<8;7257>$7B6CZ;>^WXJ7ETKO>RH\07M4-,0 MU2U1TS1<$+NQJ)K=VFP>W+QNM0GY^?::`)0`EH5-6;YR==C:Y\6!DHO>8\+G M6\2;H+I-.&#TBN+`[I69U:T_?F&FXX9Y;.J0I,CQ!JAO_#_A=:(-O_OT+=0)H+MOIS: M,Q?N&/M37WF%%\9I&W0H\>Y\%(@D[:ET&3I+I(\Z%ECU`H( M(D;-)\T5H_*')#UH3[.._6+4B"?UZ^--V\[;I;,]+%F)?N^M<<-IB0DWJIVY;4JU(&^LQ93_J%`+L;5Q MHJ:3,N;QB#Z2=8.K79%-XM'IZ=%S6+N>&YN##7M^C3>U*A29,3&?MV>F3)DC#'$"O_<<\A'<^IG.F]7?J^[:MER,ER@Z>A>'/QM"V9JZ* M,.`SE'L7A2:SY+Z+*@N]>E!RQGU[/FN:\J4N'D>;'\G*!\\7GK9(Z!0YLIDQ MY_39LZC(H-#\-2YH90$/$.WKTFN.HIX7568B;P7IAZSPQWPA:"C@3CZBP:0, MLOG@=5)X6%*]$4C:LF!BB.=KFB.A_:RO4:V` M($+3?-*$7*E_$^G^29* M)DGL'I4_GXME3,;5SP8?&@'H+ZQ-6(_C%+#:BZT:=W8'UQ6"%9MGA.IT:T'> MD?]Z07L05@/!UL^COU[0/OYJ MO(.`5?9?HX/1N#WZ+$DU)N.J3'32!WKW6_0&R=[I(:=XL2LA<+KI32BT5J+O M6(??H[_0'X(>XB8!6IL`/[ILG"MOC,7*)6E_4>&-82FWT7OU%APT.NN>UQ;T MBVC'@7:7:6$W^AKKRLE^WXIQ\C]GY*Q;O?39125>_?HA?_J!M&`F$?EAWQ(Z MH.8#]_N=JLQD^HG$=O$*+]5\`S"D`QEBBOSN<[9JDOYQ_*<\R:J?"'9V!78R M-`SI>?7*6C"F566_(ZJL2P51,HC3T>W_H324G7R[NL=BRAQK'QGUXK`Q6]#T M;=":LS86%J7[Y6SQV+,?6D[?L""Y&*_;6*?],*A/T5_SXB2-RO(JVDSH,G!A MPZE-2E\+DL3947*(TD-`<":.A@%8Z5[]N\WE`#?8>7B$V[+@ M.5!@%&R+\:&.N`X4*S`X?OU1-@PY*=996+\N MXC;4GS)KU^T<]OYVM]E$Q4N^ODT>LF2=K"".FJ7-)=D#C7!(<'F*JRA)RY-' MP@8ND\Q`M6H.:J-VZK7B[-..= MPC/=,]/3D^*ND,F@_FU.KA;R-DLCV)L?=W6VW,!;PX,`# MKLOLQI]+O-ZE8`F6^;K#;"0R.Z$--H2C.>\:`\8UT7;".6K*1<>(\80H4T!- MNR`/S+M7L-F,`/$L%:L'GN#=D9(ZS1BP+.=:\5[G0$L]UCJ!>,1$AJCIO5,KL(M9-V' M1MG$^#IZ-?P035X]8D@^B;*74IK5-.%YRYJ-F5M1MN.9R&QJ%Q.UD0@GB+/R MJW_]_?MWO_MC*4_KGTMDOQ\L#[",G.0\P[4]]:')B17/,8O3CVAVJUQZ*OJV M5OJ8YR!GF0]Z,@PN#3YA>(ES"N-1).\S%D+H5U7Q&;Z0GD/"%`L_E$.G,OC> M>#RZRUE0NL98? M<(;%<"';LD1W@6X!)_A-6XOG%49%#`;Z$!?8(.D/ROJ:#>/*:,>IQ M8//4"Z\T@&,4V'O6#Q(;T>U%0P@L7ZXYV65Q`X\G3N=NU'7G^?5"-2>JEY%H MY@$!/6^#\@+15O,H%6,@R;%S@9- MRF2`GO$/B$J34E;8'!-":O\*/BRR^LP`#;KD=]FS09AT6[68"^?K-]AA:>6( M19KF7R/"/7LDKL3%$YZP8*!1OSY5F0E#"M@U35';EK\AR%J'+AOA(FP1@,9S M,\2!\^'P[57Z3AR9R+;;VG*L?['.BY-=6>4;7)SB>+>BQJ2=HV;L?KW?LHT\ M`-T1ZP.J]_3M^41@RI=+ MBLK<$M/-I"Y/2S>8'>?3@I+VI"=3@UZ]/D+3SX\;!D.[D>VE;)0@-:9:Q%E4 M)/GGK-SB5;).<#S="57=F7?%IV!$68^#?7^$A!;SB0GH%6)7K>G&[JS'3O%] MU0:>3%O"2-F75YVEXD+UWC/Y7`A[.II7X:$^\8D(T@Y\B#(Z*7"<5.?1*DD- MZI\.\,O*^O'MC97PH/+!TD]1_>UL,*,35\?9JAKJ`!=KD8#I=1-5$ZH922^^ MWPLX9$'I,&4?(OAR/CN36E!=9ZATE.Y7T:WI_G$7@88&$QD%SGATD+3_;Z:?%64/)R$YZHM-WZ-4PTK*B0)L" M8>&=9U8"%2'6/PM#3*7+/'NH<+$!6VS:JBJ*GOR&V,B94&`)/GX#7R/X7%4K M)02(]%(3T:,9L'-%K-_R#('L80'7W@\L!Y7[8:]P=1(5Q0O\=0/.6QHC=DGV M96JU-<]!15E,?G^#@1WR[>%WAGS&LOI>W2Z MFPYX'Z1A!XG\=*XU"%>H9@LQONH0S88UX7TS<+K!WQKVD,`?782HYG`^Q?I# MK8;.34D0;`QXP<(CO_87GT&8\UT',\0@9ZY1Y$;B-Z]5]'>PP7`RC7ER]@RO M`D/5PAN<4F.ZRD_R[`D3=HA>@_:604HC=>>WS-HX3(^PGNN^(*VC[@U5.1+Z M0[3#V00AC0LO\[5F)Y4AX7Z#V1AYR[7KTGN0WWB\^UU/X7TB$R)NW'5UZ&\) MM+*NHX*T>,15LHI2WQN5K//7M]HDH_"Z[K[K,C"C9^>F1.>XZU$EP]FLS``[ MH(H!SR&W4XTC\!I]-6?#$;`ZY5H=[^;B]I$0/HY*',,QD[#!TF`$)H]?VF^N MHQ?XW>)K5,3T/^`,7V0QA,1-&V0T"9]>[^&F&('J+=^_[<"!0]O-)_I@2JAU M;I.GFNA!!3O^<%OEJR]+5@W@;+--\Q>,Z>^N""2O08T2SSJHB654XIG_E M.N)G##F1.(Y8U5VALL`Z+T32=M:L7ZZ\F[E>AZ?;6_\`I3N@`>(MCE#-#O]] MS1"-G*Z3*SE/_!-Q%ZY9>\-YZU3X@.R73F_SL8Z#+(/.5NP?$^[VM"]>[0UM M_YQYML"]#W#6ZF-.AGNP11%$C0PW]<=B66B]6%7)$S$QO1H;ROZ]QH],-`BO MJU\DAFHVYE+>>6*4CKF(M<(<$--W@M#[ZC-"8E33AZPU@Z_$ZY0[_&-6X% M[3$7N[G,AT1]3,RD]WWQW;XF:90T0;7$0&5]3 M[7XU"^/+4?@=E>DREP.<&>;=V1LW+K1].Q\<>)P$OK.R&0:`PA'+PP[V36P! M?H!H@0GC7#H=^"YPT>E=58F`?2.M^1LHL$0FE$Y$R,&PQBAFP:G>X"UDX60/ M%]DZ+S9TJS]^X7_T4-S"G`V?QI\#?P:5+_CGJ"&&!&I'Z/ZE^6)F]0ZML2(O MCV$WEP.J\VLZ4NS2HZH_?;]><6S`D%Y1RL$ZA\01%V%+U&K_W`PZ[KSGW0C4 M^4:_GS3Y,<_CKTF:WFNTK\Z8'-R37Q_X8'ZU9B9];(HC6,2M:&U*4HCKGK2Z M.)31.1:4NB;H*&((M40[PK M":VR/,DW]TG&*D.=)N4V+Q/ZQF,!Q0CY+8ES0 MQM=1$I/A0`9_FK_$BRS91.F/.$JKQ^LBAU+JY6+UMUW"R+.<_NY3*SPAB#\'YW.^/)F(L:YT-!9"PCV_'?EF8> M<1'[T;IC8=0YB'ZF(YN1?3W60#Q?7,Q\.KY!S3JOX)^9R_\UJ=G!%ZW-96[R MD"7K9`5OV[4F-3R#S<8(%<**B(QR-6WPLA,??I\_<&%1%2/0DA*/NVPE-]2. MD$!O)O'00_#2"2)PG4S7$+Z31Z@#=)'Q5W&3[.&LK,BYLL+3OMQAU*_/T!83 MAE1OH-&F4`&N;8SJUJHG/D*%!]H(O/-0FNG\#+J['WU;(5M*O6_4I$-[`)0L MO?[SO&IH@6U(,!\;X[#IZAN^*.M#_<2VG!8&,SH`2_B'(:CS./6`J77.MF997[<5 M68JP`L5<7'*L7,0QNRU,@8LT+W<$3\QJ58DCP1LNG^ M"'53S:G;M.$!"4Q`4*[]@@Y<2BW0.A#7O4]YN^?R3<^EPKA^+WJ3:DYG8HV<_H=-Z&.QWC*MGDJ5MPT_QB?T8?D?_TH=8,3?:,.=U-AM[3*\__FZRN?G6M?2W'>,SN1IX9=IZ3E<> MG[-H%R<5CHFQ?PYUG_C;V%$JU($*8`Y;\/4J]:;Y^+SKOH8U*/Z`*'.HX:Y; M-O.;R1&V7P;CZQQ+2+P"O1'(7K/D[16&--N-<,X:1&'Y?.NJQ(,)XX"1`8'. MBZ*`!"W*P"*+KXAMU/Y&R!DL/^'-/2ZZ"F$605>D]FO2T'N\)4K,H:Q6K([`AORZY?I3]->\.-F5%5'B MQ73A-.K./*M1)2,J2/*/9E)GIU=H(J#T8QVB$5<$D.QJXB8IOQSC;/6XB8HO M$Y;+Z>O3N[&H94>MW]IF"-JAIJ$T1"N0*C,2[Y[JZI^/`39@E_C$E9DTW05& M67\EID.`*:LOS0);/367>B9@/$1->)"0]10:1_K3PCZ$9N-&T0A-#QOG.RLE MR:GM?55O7DO"*=FPP,Z<_!T](M1B:+2+BO;]SK.B()997A28.8\767Q=)'EQ MC0>CQ&X"O.@K"N[!N_+4M)(H$TO/"AUQ,BCECX2.IB) MQAP/:?+W9P=-_8`59-IO*70\J;X>QI#/=3.(4\62L5HF97>=S&9W&`53XC(9 M/M,#5LB>4_X2/DZFK-.L[]#K':*6%#I`_\9D/1!0)**M`_MJ.A;"9;ZL^#GZAYY M`"!T8W//H'M_N]MLHN(E7WED:_S-%DEN(X$L@O?=:'M.P37@4==$!Q] M+)A1!,.S6P>^*:E=4Q5"W681`#L`#)VH,]=)=0Y$M>M084*.AN3N]=U[L;[MD2XT(EXW=D)SG`C%F7.FT MW6^(MJN)'"%*AAZ!&T*:#3N8;K.3;4>567>_NQWY$M2'HM5F#.UVA` M5.RT\P2C?F^UG#WWF)G;"/R>MU6^^L*"*_P\@M7?JUO(,^O7ILC9A2.FI MH4VY%_H(T=:(-$=-^_E41K(1>-?39S@_`TX1H#^7ZY,"QTEU'JT@C?SE$F?Q ME"&#O7WZ#:+H8T\%A/MYTMEYD#+;$$"=E#SM22.(;6:_#`Q/[SISQ$6LS7$M+O$48F%'J:-9]7TYM.,4[.AVCFA@0@X M]4NB0;;,7B%V-DO]Z(>\&?I[H#W&/ME+R*M'I(\;G<[Z/=%9O+G%[AA&79F* MKZ.HC"9G0"4^#7W[G=&(F.\+7!.FAD)L3AXV&XF:0NU@1W3:#7_")5R`3;QP4.X^U;ND`F?:118G3TF\B]*?D^KQ!J>L MYLQCLKW+S[**'"ZG0X@M"WX]#Y;<*3`F-D!5CEB3N5A3CB`0,>DR3:XZ"^X9 MIGTL=:\'K_[];M^J.O/D7ZJ72H,4EI>*I%--_G!8@ZXG_T#]_TN6E7VVV:;Y M"\;T=]=$&H_$X(<>HRR&"-\B654XIG]U,LY'Z)?$^ MCE#="_]]W0^]"Z57H6U7_),9'@G&!%;'EAM-("'7C?T!9+0.O1Z`Q^+:YPJ: MTXEG;)B-N9(DOL0!>1YWT?-B5SWFQ:1&LK*O`-D=AUSH$SO(]ZAI,!>;MT]X MA^D/UU10\%[95\:$M/_N6J,`6)?,+KN^53[=PJW8.AKB9 M993MMV(]%?_ON.K8<8:-8A><#W[T>UO_I`QX>>L]CU462@"[*9T^0G[?FNKA M1@LEFBS!FG=*4\_P9&(JOBZ>3"9GR+-!:OH."LJ$F/<''PR8&@JQ.9GN-A(U MA=HXEQ67>?9PAXM-;>6?Y)M-0M,J3Z`,>EZ\+-?02_WW>,)[?4=6/*?B.+*I M"@H@U-Y4A%Q[,&T)0G%(1A(B[H!H\U4\CVCC@?#I1!0,F-'MA]X`^`D MI]EK.'/.]C6GZ%WKFG*F5;T?Z&->#1WJ0NE0FF'(GK64NTK8:M[<7Y$QZ,9A M_[>BZOF`:\/;>*"46P:S!6:/A6`]AT.2;W?W)?[;CG1U]C1YG)^Z,]_)MRI& M5%E!S?>(-E"7K`R3(=0GQ$YBD';LSB5W;_"6;^.+AP+3()P32!S'Q38JJI=I MKZ+-._<93VK,E;)68?OQG.ZQK44MPL]N4@:Y`\=X(2K`LXZ!\CW&X]WS6VKS M<3V-#KCQ7SP;(RUE%$8<[-YQN_4<:3(N][Z7V*Q<;Y/`;_RE)K/175?<[^O7 M$6YWVVV:X"*"6HUYO%M5G3+`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`N0/45;7;P!M0M`#.H.JA>\(>$";9A#^G"(HBQS1VB*K MEQ6H+:IO8=6!HDWS[`$7W_\ZZ*V3?BX/\6(P]:.'Y?4#8I,3IOY._[Y0$"^YRMZQ\AT*P@"[Y4H6/!]C]0"P(Q^'=#`WVW:PE^3S8@3C*P`,W'?BA- MVWD+L2-D&=F9ZSAJ7O;Y&A=UVJ]2H+0=JB-R0)(E39@F:[*Q![@9%*'R,2*; MPCV-50?+`F$V9\CJ'0U;&,'#5P*C]Y$;<]H!Q*.=P4H9?B.JFVBTS%C!M-?K@D_ MZ`D8`G)?.4M$9Y>[;FMF8_\ZW*EJR*0>`F>PA`*H_B=RM`-.B-T&=>%O\8J( MITIP>:LY4-W@+6SX(%3A\`/*OR9'[<`2*N:7#454$I(AA:T=ZZ$X#:8FA,"( M3?2`.;1P3)"VWJ67R1,NE^O.2Q(+X26)H>H@8KTVRSP&14#Z)0=JTC%\!=;8 M&_A7?(2VCR\E?8R(:`Y,,4*.MK!!4.V19**-1X1&[YL)B?LZ,(GHDRV]=<7H M(<]C=EX&"RE9\<,SG,:3K(*"W3&%&IEK(J)?A[S0&4,R$A".)>X`ML[^KWA5W>50U0P.R$0EWI'C4A&7G;(C*F`"(>XZ*1DIZDMIB9%_4FJU MC5);+?;VB7_<6,_2`4@/^#PIRNH78G%>YV4E?*L# M275 M&??%+]<_Y6!ATX=DB'G"&I`5K0)%2Z7CTZ=6!#%"GB@U\&;@K6D-C$]Y4!0 M-W5Y]^P5@0&@&'6/D+5S%6Q;$"+M%_PN+4H[V]CRJWK!PRZ0%\D#H9`V=W'P M(SNU@I#KR["$'&7NT^2A=F%OHQ>4@ZC7NPI.0S'YPQRL`;,)4,PIHBIZ%NZ' M"TX418PJ/8D"V="GA5'FQ@@:KE,>3N&+W%/70[T3U?=O-\UME"$ZMOR(76_[ MW*-16P/SL!4MAFTD>*.IFXMBZ&'VG:D/D[<4+BS)R:"H;[&^!=F_&T/X[V9D M"W18A?VK*MA]^T5V7>0/A`]Z[_:N7_HKH3$L]2UOOB]S4^M_CH"03Y`])G03 M/4/5#]F76947+X:*(*F_IT:^/GWW+VF6GL.0C\8MHEX%7,U M$QOM1+AQ.<^+3TF*RRHG'RU6CPDY29C>,W=N;O`S_-R-.%/(F/KV-DVO1`VP M;F;*BCK@W2 M;F*>=^0\O\&8.7^JI@>(4(8@;M*\@'M#=DL$/@$>T,!-1+N%N"&NU%)/E[@S@:[%#)L$AA1P#%HUX;F+7(8O#\1X,=3.]DT&ME M-YO-T&(4]'J6.>*T<=E-`!:[$Z<8!(=T-:V]2NL9V_A6'C/(;,F,F"+*< M_EE`YI+\\^>\^$)D>1)MDRI*;Q_SHEI':7J#UQ`D%1^_W.(TQ84RPE\9\_F5 M$2:`H92)0`D>N3[CK\EFF_(A&8.3.0MG[=9+/P;O,H?LN3O M.+Z(2=-D38W*/1]_%M?W>@G9[B"('3R"646S@R$5@GN+($N)3.TC:7!*3DII M;N.!@TB:E!-L;]7`_59PLO0?<4MXOAA#L/]>0\7+XN+Y,5SB#S M[H8J*?,+8!J?GM:M:QTG0^>K!J=\FB8%HDXR-_S<54<6&AZD M9B+SOL&;2=QL"N>A`FZK:+,]W8':NHZ2F`#TDE@J1)\=[Q*:86&\E?!:&325 MEM!$,25*54'*2H+$9.%SHOO'IU>@$?IGR@0=IO,=`!TG45&\0.X^#XUKXN'@ MSB7/,+U,O<%0\I%\]3GCN?!00N>^JAT'0W+Q$N'Y.S#;6$=PWEIQUH2#.:"F M#6AE9-0-$10%A0E`U3Y75.3J`OO=O&Z5Z))JJB0%A; MVIX=.[KPX1T$],F:#%@CN;Y9"B?#DL?'&\0@KJ'H6Z-^RR;MH`U'K&^")6HW ME,@.QJ>0DF(>0FR3S?MYU\P:O\N;=SIJ6Q2*V&9$'$.+)F"J3^M">$V%%%8C MB=MH_$Q`U?#17HYJS+^F=AR@NT+W44JKK)6/&%='HF(G^CNJ7\UB5?K*YN66 MYNBPY2,+#1YG(1SB:Z`\@T!0>@6]Y"EJ2Y:`!K]9M\_C&H1!=O/<.J>`IAZ" M\MX_"`J&S8,$"V-,;)"J""=Y06PRQMN2V*1D&,=LJ?/"VG=Y_61R.PPU$!)( M8VE\#QP+4?S779 MDT#'>?Y#:)`=X98<3L'!?DVM@5X/E'AG3X/1P)I@D9$\-IZ&"]VW*@(JI;!^ M`AOS!X,]E)YB/@*(!CP#1*E`=B2+-H)ZCW#C!BDST+)U>NK#NO;#+5HG<7MF MKV]=T&Z;9W6(%^\:EC3[5Y5`'"$X=@(O5>NY.1"TX^P&4>G`:\O8,5$PU+*# M2'U>1>$\R1)BR,60/6OL0VZK5_"]??XZ+7="]#?[(=^! M*5DF9=#+2\L9DJ+!>H:]!R'W<[E3<@F1O5"@Y>`Y_\QIL@!':;S'F@;Z6>>B=`\MQU."/I581T+Q<$U58)I:;C5)[J/:2NGTS_,4YF//,EO%_DYA)&T$-::H.1S1`/>1,=FQXS81XR@ M*^:XY!7C-Q>W=@+G).GF+;0K5G$:KW85T=5W100AG*?1BZGQF!&1KUH"-(() MW!^\4=E&@7[&+E'D%+N>\?)PZN M-F8DVKV!60A2.B4A0IFZ+-+05[R.=BG-@+[(5@76O-QP1U/_V#=U;DM=5+LI MI4P=TD_U+27S4-+7`VDW)>*76W.3LV(J>F2LG<#`]CN[/$U6/):F.7%<9$E% M#AR7>93U%Z,0/,=,VK0M2G,(4:IK+D?TK=0"\_S@VN5,>V^#HN!1F+QZ;!'# M'AWDYLUL-GCC:>N!AN7TAW857.<5^2]AK,;P7?Z)/:?;G%M/HFVT(L-_HE1MQB M8!^5-:'T!7P*946@!F8&>T&&O6JVHLD!4M\1ZC.(EL8L+FH;:YW[8-A`L:DI-$B;00R4EB.C)@Y%D&Q>S+M=HQ?)P MT*I(J%\&%-L&ARTF.6"N3'%B/N\SL#6MN#X[OK@[7=P`:8.GQ3%BWR.JEH03 M"=4Z=;FS3FN7;K1 M@UY#=0VJ`T.JCMR#8$UF2#5]H#5NW*.T'4$7_6L2UWD^K,A!TP`B0.=C6,DG MJP\LNBD.O&WQ@S@SXQH#[SQ:8?W!MPL#8HI@?OYM'-^"DQQ\X+6;)`J:Q6DU M^!ZQ&DU=()NX+'?@<3Z!Q[/2-%_QD.&#?%)X3>->>7HZI7+DM(C!"@>>FEIC M%TL2>@]\(&'D;#<)A+U5V"YRZ#+X@E:/6RE4[3R%%:!@4MA),`*9)/0ITH[PA*RL6%S1 MX4\$FO%J)*>;H`#;*7N-2*QR+53OA(=/+\C)_2F)=U!7I&'W)PRY+Q>;#8X3 M(IWTY3-1)+6Z40G[JKF:K@4,[\B6Z(D20TE+C87@-[J[`P'^OE2G>GDD%!QE MZ7I)PW78:)@)IE>"K$%Q0DZ!!<[@2>Q[7'W%.*-4V!$2'*4/.,,%,2!> M((*7"!W\K$)">'UY7O(F/)^D\:W1M*"CQN!(<'E$7T7+=OP1;IZ(4O(2`&@% M5;`STAV<1>A8>"E98&N[*[8Y^9A\BVGMDDU2T7?$J7\-9Q']FK[!%GTMT7>$ M"&G*[%NP=/FR@?Q8$/81G&JB[.4(EA@]1F-4[@@3Y6[3'(YRE&%P#$9I\G=Z MBJ8F\_8<)[T=PL$*;SK_QL M"Q^SM/K&BHX3[K7$]MG*7TFU=L,K9(;L1=P4C;\*2 MNG%&'%J\+F0A_VBOJ%2T;?+V!(GG\'C M1V>;;9J_X*+\%%6K1[CC$#X`:X/\JO4@+=85+L"EB.&E['*Y/B&C30AD;LDJ M2-1FY'4W`I;W60-DP[NF]?GKOKD2C!G;G3_1EZN8HGMB3U,#6]3QS"KVT'O3 M%6<-E8RW\,II^OF7(=*7U,.<84<;WM=\CI#^FIL`^C6#637O4T)9+^LP=R2\ MK,0BBQ>UB5\*A;B4[SW5Y2AH^Z^6N_2.H-VQ'IV,2"?Q4LB@8+\NMAAL7R_V5MD MS=+;,GITD\Z!(OP)2#8N1"A7E=/LGOL7ZM-AF6`;RCX])3/^NZ7U`IJ`DT[O M`;`\"#/`SNXRJI.H?#1#WXI\.116052-Z[2,@IIV?D-L*BX<+VL;G'LG#953 M:[J/I8->!U(.IFL4V"B$$.0LZ<0_J$:QC)PIBNAN5H>@\TIZ_RA*YW#2QL&2 M0A8!;*CG5;HKJ4%WP3-0Z/-8S,W-><\>SC$NS\E4GB;ICE:C(Q:M:5457'?! M7G?@:2[U-1-[$8W'#ZSK_B"HLVSO))J'.AF1F'$!MQB$#3C"LJB%H*?8(3-Y M"*K!8@D!):87+[(;'M=UEPO9?E=YA0?5FU8_#-)L;Y*8L@RZKQ( M0.$VP?ZA/582MCY#(,YQ&JV^W*X>"9'RI_K6]E,>XY0G3*D$R/^LD!K:T2@? M2OT-)R_<"F^@@_E)UFQ&3$1N,[>O`0M$`>NPP/[\#X4%-N0QL"#.K7\L0$8S MODR>P*:HB%"3]K%+]D`4;<_SXBYZON;!;R9!Q0*)^LX*G-QKVNN;%+H% M0Y'W6Y\Y]L/L@EI[`V;H$!U#9SO(&;0)>JD+4E-+=-&^@&[\S'K=GAEYS5LP M8/P+#ZJ'#!GN'^N!4$VG)XCL+G%%#A7-]?BR309GX>!FMEP=-RZ'LAT]R"#^R.=L,PL!V4RM)5YNJN\;%LE2T'%5; M+&(@=&8,&\6,#8".5@;^S^?FC#=)J(::1RY1!3 M)H*G)IYQS"+CX5=%](!I!0(='EC%"((&7D&BRHF9_PRQD?P1P"9&HJF)!3DV M\!XMK3A"_@_NV(N8!IBW>0R0=+CB?)4A#P(N$V8(%9-9GQ5`^*&5B?HN%S@O M>X&RX=X"WX"9%V+Z9M`*.6;BF,ON8\;S)QR5NX(6F=OUOQ58%1&A3HXG&]JL M"7YDKH>Z6$TPZ+TN[!U._:AH5$DV0-2.P3#8RP::LF^B3FN/6VG=;!0LS,E\2"S?95MC85P?PXWKY\)UC#PJ,"=05O;D#EK&&W[GM^^",6T$&]?@^\@R-: MW(W>U[+S79+!)Y!$C\AH4MAJOT9%C,K5(XYW8>/3G2?N`$8#1>`=,E=D9J+R M\2-1`/7-SQI.*81/T+%!?@[81L"I5<8Q_Q.X.$!$EJJO>>T6A0E2?\$+`JG:L[LHJW^"B/&G>=E[`S[!A,]UQDY1?3)W>-3'QI6CV MZ$Y+#Q5`4)]*%T"V=O-Q*&F7^?2_D7$N"2Y/,<0+%+#3G#,CH\X$U-P_KT&V M4#NG$3GL`7%+JC%85C4QV`4H#CJ;0N";,+-Y4`K99/H"KFF>85:>)JP8F=GB MY=3ZI)%H)O+ MW78+%<*:].?:XE0OY>#8,)[?7O!82BJ8+O]\>QU!!>SR,EF!16>XW#__^O;7 M:,M:DF,%:UJ[2/C:#WG:5`Y/*3C%1/CWT]<,U2&+'^&_IG)IXCP?6*N9[)1[ M8U$*03KF`'MADW5V">6Z;LBG/`O@$]FF'U.E^WG_>5KV-8*$(Z(?FQIO_`8D M!>*!)=0WT@-1F4V-=WU6Q_77E4:@7/]GC3H[>(.:IS\T=5_HNP@[KM4(+"$4 MAWMW>]D%$YW)\)7B-)^[,"*&5$RN.&J_1FDA3IH=VR2@-@. MI:6=AB"2N8[*ZG2'/Q9Y6=:5'FZ:"C?:(#32DA:Z>H"VLOHXX,V!HFY0K6-- MG\\-NM#T0ST0ELG,^#<7Q>LQ>,S[9_)3"76N'W$*:0O-D6.MK3XO1!'RTGOW M<.K["M3H5260:Q\::DZ%:UZ:OCX2THQ@VG:O+CD4X@MLZUA.U2$`7*;:NR7$ M$E:@(!?A8W=/S;2F7E>/^"$GJ"YB5N[NWU`+M3W"A]6JVH')A-4W#6'T:X'/ MGA-:/K&^I:27EP8['_F!['FL;7,)7!^ZF\M"(7DGH-=--MB?K@EVMLK$?68]C]TG1>)$*VFM$0F1W<<<=2Q6B6/]QOMS$H1)D8*,^Z M!IUP/U4)=.K/FF<5ON:HQ-N('C;I0\6!CXT&LR`3KMG,!3".&&O,I4<$MC^E8'G%JKHGXJB+0F^WAI*L8M[^R(FJ#5$7MAI.Z1 M%X0FAY7=9L0NOE$:93!IG1I!1DZ3\E<)8F MAGF3%=Q_-[VMFZ$-U'"N#SQM@G1*3G_2T);`9QO9<&4B54U*B#T7*D"3`3[2 M(DM/./W_M_>MO8WCR*)_A<`!%C.`>W>ZY^!^V4_.:SHSZ4Z09*;O.8O%0K%H M6]NR9$AR'OOK+XL//2R^9,LL97"!L-/<$YL$A%!?YGE:[(O-II%Z(D?^_%KUI54CK2%,"K\+/D`X M#F)5IA?QSMZ:(7?B;>,YU".IC"S_:SG?5>N<]U6\IQO1`<[]LF'K?H5\W;!0 MD\6K"C50K@OU$X&K-^51R-A4N!E6PN_N;`23`POJ$.D[_6]J![3*XK)UJ&T>4S(I?U?4"UA"+P M.WFMWJ`!S0@Y]A_^ST^\,]"/!V;;P\O(C_B^[(8P#>6@))J.O^7+^FDKYLY> MOL)3F\S-O7UBQD$K6H=;_*Z%2J!\6U%@N9M,.6#QXHD$W8I.235`CG$;BO"@N"=<;RZ% M7ZXUJ-TNV2*L7KB!ME+LJ.^HJF@N4?)[_K7XQ-D#EFA9L"'ZBI-&2=DP-*HT5ROSLS'%&7B+\F>NC,E:Y!$]O M_9Z)E^'A?!VK?(@J;KA>WLL_#DM#"GV!@H\G*M^EET4#=25(LB3JP]@+@1<# M-)(=P#B4O5Y=4(#MIU@D[/S+]B+;TU%[PJSO9]!7.9]OZE`L@BLR(V$](3E8 M$'Z=5@C5[;YMR[&A+3J3@4CFJXLSMI`/FG!J"HU"V>-!\*5/X3%2CJ"UC=6B M@BUQHO)Q90NLW!G_FE,'W;:4YHN$OM;%D%^HK?DT'TOJP>0?8O@_$8^2.O1[ MO#;3&'Z%,N'RT%&LD-I!;"-M(D-B,S-7VIN"@/[J\Y,/*Q)"6:VK.. M]O:J]RR2CZ.+Q&P64%4IT/'PRGC5:C-:NQ&%9[R.A#[+S81BQ&F-Z'@H_R(I M&'1XM60!+?6X4!JCV+LR]=[$\?$4XK"KOXKG^2B_&CL5'ZR/OY[5.AI18ED& M;*QJS[6[D'?+91Q%5M!#673)UR(9JV[.,%!#@YR;.$(\'T\B'K,A?,^+[*$J MDIB6#CN`D40.U9E!>"[W<.\SV4`>QK%"BXK'LL\G?E",_S5/F([_P?ZZ*U!3 M[`=S/ZS[SV3"%@\8"3=+'"HN!A,836#X5%9['1%];IM)1?%T3.CXN/EM04S@ M+O^1`@CLVVQHD0AX3G57`Z>CZ%W4=3S6$1?^**O#P\>'ESU720L`LJ]R&,]# MGE7_$STDE4N9_Q,1-SZ2-<9^??7HP_)%]+!S:JQB,K*W#.!O4USB[7<[M M2GI&;I=D/@D5;9#M<7&?CO`IK"X&#L4\B[+O<`KDR]0B0JW`]N9JR!05?/F> M/N?I81Y130WQ`-!GR#XV*T-3H>GN]:"OHLMQ`:WBJ,R`P.C;=::&ACXQB6<*Q$ M@NN_7W1<:K\E/([$:D?TU4PC@K=CP,5#[\NDDLGIELZKJF_$:H*C9!#4-Z)5 MLLG35@6#2]_Y>-*NV9E&[,1$B8;M-I)1DD,VE'16<)TMH0%'4U##BS-SHJ0S MF3*V4802."5T'A4Q7!&Q&X(:-8T#01?G'G=U)*$H>A^1(3%#-1OUB#N8U<'5 MMUS?14G\F%^6C*(7EQJ7:P+#R6-.Q(1)A&?T5&BX;28VN`=O1L:AY+Q[*>]\ MR-9PRN?B+MM'F.DLI?.,@K"3J&3_+7CQBZX5<]>BRN9#F!7&)Y)ET!!_@]%O].WR ME2YV%;S;-L#0V#S23)S87J,ARB(4(PN07"L'7IZFQ0SF.X6^3`H"9I'-R*)! M<\7D_Q;T.U+QI:BV^4?['^C.WC6;X`!U?^5P(B`!@D+#H]P@!,(P@ZE MWB+.(>Q#W=G\$1WB$FZ5J',AZER*FK\(B7P80I`QTH[7H"(ZKWT6'L4`TVW; MIX!!))")Q-`\B;5(T8-)R+NC$\,AEMF8H6QS2'I^YI]5D&A[:8/984>]MA7: MCWM3D=R0DX*3.XAA$0=N0PSON3:\J'V^F\3Q[B2"0XFH_,&?Y/Z MOZ_(8;@W/52IV6BU"L[-I/!)U2'X^<3@N\8G9?J!Q\PL.]^?4YXA$[3G4457 M>?'VT65S8ACY.`VKZB"M8;:&*`P;Z:'AW(,4FY&/78/YBZ&SGSQU]M.4=/:3 M@Z>?IJ&SGX;K[*=)Z.P`_F+H[,^>.OOSE'3V9P=/?YZ&SOX\7&=_GH3.#N!O M4)U=PQL!U]EE626;R'5#2(PFUQE1XR>APEH:^IRVD!K^1&M$QL>3%F)(^(LK M?#IJ@N58]H<\ET)C^15]BA;?H1?U/?NINW.(G#2-O*.%'IT$',1C)#X< M2.G,X5'80"&G\=[JA90*=&<5'7CE6V30AA>>.-]E:?*=IF^R];)Z&@0SW#.F M\,)F-/+-)N'5]5?4:3[U6`*#)[%A:-#O,]Q((X+W8\#%9Z]HV+^DR)GX8]@> MU"G*LUVYH<5G&J75VJ7>8BP1@Z>AWGWT-7PVT8BAWGI<3.4F.^#W6O"[I*O> MU:1WQO*PJEWF6\>%)#%F*LFL%L(:CNY3$]Z1WT/!=2K-RVV.>:UH$#]#>N;\ MTW=77JIY=S4I[518&_C9)0JG=J&'B$-/:T:CJ^H`YH:N)^`7Q=4]:]4KWJ'` MXG)YW0M`S9K('2`+17W^.\G'.$XZD/+QF+OW_^N'#)"SDF.*)NAA\8(^57?1 M6[YDP<:@Z?]UJR^<@.\\'\3EL0[@+NJ0% M,ZK'Z)66YSOVH^M6OYI!^!0BYTS$;3&3H^&]G7(<;;?AY'4=5$AC"\^2B;>` M^:U_);,*`*-;Q4@R0K24KXS&`XREF3:!.PA6@NRBT)./<@!PXN5A-5WS(%D- M!?&,,+)T`I\@+G;T@KEH*\J(O*&K*'TLHF?&N2R^90PO1"N#SIL@I>N`P4"2 M&B;A0(F`2AA8PN&2!G#KM9Q2>PH)+]'#>=*7]['\Q;'5X[`^^#4=4`!(GT': M+%8(S$@**,Q(Q9&8B8>,N1;UG]Q!V2>GHR^!5X_+\WM>[!TMZ*Y*%E%:7L!= MQ2J!ON;V58)-)7MS26OR)'+;'N3U!.C-DO!)#D_43/GNN"4=YJZ6NZ$/MLX;"A7TD]C[0F$C9S`GZK M@ZJ^8'RX@'':\T!,O^4MX8)(E9-(Y@H74`:R@/QARKM=P4Z69*!\/#T.S\E% MV1ON;G8"J84]_UUNMFG^1BF_@73'P*ZCDD(O_\N'NSN'046="MBCF@U5NGY0;< M.)I7YVE>LC7-86!\-NEV[."W[.85D1"FL'-Y$=D7UP#>(&2F_-%S6!H54EQH M6AJQ34P`PRSS.KGX@F:O+E\7-'UFAV576]/6P*GL4_NH]WFN)RYX$8T6#U?7 MTBTMJBC)9-_2_;`&.R.U)3+_!?46R(&B"%A_\TN1E^5#E+K*>?DXP@=.(TN[ MCWB/LWK*,$XR.DQT6BYX7-!GFD$H;E=P'6<*SE0^R6,"U).2P0$M7^5Y7,)= M$!B0@76D;&_8%25MM[:;J>[6,8UW"W[\*2@[8^[!MJ"[PQ:/(;TLP:K MZ/)?W]GZO<@@X)8@.D:V^FE_BZJ2>65%#DO(15)N<_'[>19?GM][!Y]5H]1V M`W@!FDC8I`67WY':A[0,>J84:2L5 M*6XI4B05J15*+\D/3!L%F*J(LC):P-#R1]2];Y*J%3BY)5"6J8(H/<^=\7BU MK-1SR'FNC\5C251'C4%69L(Q'%<[3HYXA3)3.3T'N?!(.P@G+[9Y`:E4U*UX M+.D$]C\%+L*('<>VVCCDZ$ED>'4$F#BNH3)\J-R$BZ<%R$T)N6#B**Z'#'9? MW]W_Z\*NUM=WY/Y?Y&(B`;<6PCV&]HC!6,?WD'"Y7.S_DBRF2^9U592D<%V> M,!!_B3;;OU_@*O$`5H==E-E^4%`NA/21%IN;/,KFJX)2]RN(K9D$IA*82^K) M4W!CW,3UA>')#Y1SBQ]RCM7=(3?4D\3)!!;X-*!!RN\57KUPK$_Q3D)*CI=> M/?F!D.;TPLRCEB!I":X"P:4@N(D\RGLB@05-;%[7._L-;.Q?;V]1B&$LXR2C#PK$.AV,9)00I]E."Z` MAR.EHTR"#YU$;*F/NXG5/?)0O"8=*@/4'32=(A\U#F1X8*^GW"8%W;N"X%)N M/J=W868::FZF1\-_%_$HJF]'RGGZU@H'.3HUIE0"VT?%&)T\I;3D5]Y:+6D$93^9_$%?:9IOO6)Y#:@2`L6:0$C+6C3L)JAU.O$>!@' M<0X:!R'KY9*UI+^5H&6/8@%?2O=^0+0ZE[\>S]"BFXJ7#> MN>'7G5.,M37E#,Y>'?H])IMI#%\C9<+%U-BB9C:TGKDH_DH$`-P#_%%< M#UDC]1OL$XOU1;%;E3?))JEH[%!Q,8'P&41.F40HRTA*G_%VHA%TWH:08W'7 M"@19^\>11$@[N(F^TZN<@:S88>.779%1*IVHQ'6C$::2>BX1DTDS>QK7'#T( M[$G'FRGA+<83-0_'**7,_XE;!^V*_[HE5=(2Z[+^".JYX(32#&IU"1-TE&3T MKDA2\=-COH7X]7E!HXW#[M1DTLPFQ+7G1V!>6/V>"1YN]\XUS+_50-FOA2P7`!4Y`W]B*0:,4]^D^5L\SY)-E(J'9/PN@/!I1,Q3;Q69 M+X.$EX^=JKYD?+B`$=?R0,RQJ=DDA7E+Z@0B"AO5^A(5WRE;KW[/8EK,O](7 M<%OGVVW*#-I=]:5F$SZ=S`D#P)UVT@(QA8B!'YD]<0WA#D*9@#]Z'C[CA@.# MV/&."S,B&1-F#,*,&I"H'N+)I1BTK*"+UM-309\38K4MX>OL%_L%!R2I!XZO,QR+A%95]`ME,Y+(+[5: MSR)RFC6]BB$Z"U$Z.3EY$#[&XL;*P^@8$`YC5@M*=P?G_0LH9-CDR^(W6I9. MAW-!Q+")I%>[6/=9K"$*9_OI(>)0Z/>''&_04]#EM(31XW,Z,S-"&:#V)X.:;CA9&P/#;ESQ.EM+I\BLJ M:,^8V'N?9F+ZS'?0C1%KL^/D7K]L$.I6>T562 M09^VZ^S33Y\^V8T#+A&KB:2>2:XS`G.G824NVGJ"\6-&\/W#!RT/HP&1426R MIUIDB1`9KO6<1%0!=Y>O>>4J5^!#)G%(;B';Y^L^(1C[PQX2#MW.8#2R^OIS M-.SR?KOE0:9?8(^A,1C(Q_^VJZF<0>04L:)__.\)N/YF6GH\=Y&-H=1VG'SN MBTG)K*1D$B$9Q!+BT22":Q2749$FM/@?&A6.-5QC''(RX;,GL;R[R7-*Q\01 ME+B0'W(.`](8#]C4&Y?:(HW*DKGD[/=12:B`CYFR/YD(`\>;;G<5O`K#./T[ M](R)'YB477Y2,X>(243,FL:9PD917R9.\A$2\BZD/':B%MTN/TP6;2F`N MJ2<3,9O<+HGAZ!%<,A[T]03DS9/P>3I/U#P,:JND%^=I"CM2OB3;6I"1$"3[ MW?Y1Y\\DP9")O+L\A>=UTC1Q6%4];A*>W3[:?59KZ<(X[>@PT1E"B\-)2:*Z M-'D;%9U,]?O@==ASS!TSH`P:,[F46`Z;P@[015G#5`U)""M['PW'*KY5,W!U M=C!W@ZZZ!=U&;\!X:*7ZD+Q^R;-J[7)LZDFB#S";1L2\*=3L6DGJ\]_-`)03 MMA,O'Q>FD1-O^PMOW3-1;3@DY(*^D:44^!#-\"D71<+/]X/ZW[4G3K()GI,R MG6Q\>(%PK/;"3.L!M:6TW9-225?=1D-_%AF%/5<725X\YI]^^NC(:O.!Y#&' MP+HNB8W`_3W,-=S6TA8\2:W%PV/?J))-_3[JEK._$NS'S>@=R/B`*6=Y*^LF M6=`,WMF^3U9K5TF3>J:QGD3$K&G$5FT4:=CO(A]E$[`CY>5'"1&EM8@*#@3; M'$843="U_YXFFR=X51D$5_I5_G7G6&O_@DO"1D]/$F[B$8S$A917#[D6"%T! MX/L62U@#29;19ILX:L'5J&GL%%V<^_S5D(1RL.XC,F`'4)-1U7HHHP.?C1\@ MV^U073%F(I=QV@CWV-FG)K@;OX_"@%8BH+N2U]L==(]%;6\XB-$!W?8'YA1% M[.CPT:&T@X5AORYK-J"4+!_`W9.!>?=X1/:EU M=A*ADSVDC3S=#YL@Z:Q_U*36V4^3T-D!_`VJLS1+\N)+E$4KCS=KU'5A)A\A.NA"RB.`$L6Q:%<@6\R6VV@!B:8J MA8,J&_"7:)N7?S=)4OP5-]X^JAR#AA,?JFBSO=A!;]N[*(FO\N*QB+)R28O; MY4V4Q?,L/MLE:9QD*T<4GD,B`A0!6-`6F"AH4-<,\`@#2&J($['"P3SHR_1` M-B(<8`["U,.,2R[_6,A_"_*'EP9XSECI0+XD*>@`_/^3^@CNGH@E^J!GJRI? M?!<7CNX8_^$N'T,*)KHLFLTCM[(@B?U)7"T%"X;)4PG1.JC3",R''>'/8AYH M#0SOYO$L%=):N\D+/^R*):-VM@4%%^ZT#:;>OX"".HR[[39]FZ\*R@.EWY)J_3F' MU[,CE]'`/%)/)#"3R*D3L1L[91K!^+`BO+/H@9;;65Q%H',K:4=<=E$MNY>6 M[)"C*Z<06L"8_V/\1[18))DC5/D8$SEN"OG8/:1[/-82%7X/T:"AT_OS/*N* M2+P5G3^ER4J8`#LGJ=H7DF3/[$-Y\<9,`=Z.+DD1O?#3TS9:?(]68"C,>!ZX4A40$.ZX6Y?EX6,*_NT^VEK&]ND* MF<5]7%,8!2&\>1;/F<;'-%:_<3";QS1_^ED$HR$.+:>W?CN%%=M-85\NOEQ! M<+'\4'.%"']!]6A.)[R@GL^:WM"RA"3455ZH MXK['-3L2,5\8>F@57.!SM\4).)#`A81N737*89$.,#*?B/D-(5TGS>&L"QX! M.`!+OVC:A[I@=0YM%^M_G2-;96B9A@P0>&)W-JJQGKTG8ST[4K!G[\)8S[R- MM6.H3ZH_:K5.BK@V6<3K/`ABQ;?7EWRLK?4E]]A8)R-5/=V^,K5Q#<79'8:D MQZ;Z'*4[(495?"'^*OH:-_=#P*BAP'$^/<,]E8@GX!+O(7?$'MNS6MT..U61 M#ER);5R;JM7Z[Z[<%::,LC4+NZ]:8$4(:MO)0KQ9>T5=K9?KH03&3B4$W<>_+P`3C3C!:#TV7BVDE`"6 ME*+;Q.&,#QV1?F'^;[XK14DQ=X7W*B(=>O\"QT`!@,=.Q9FP7^0[A5.A)ZU] M40UB$L)&-0`_5W)'OJ2JK^U%+7X*(KZ@VTN#UQ6#6E$ZU.#4M"F:6)\DFV!, M#,#9A5QX#<^0\J+YR=K3&+(*O'']08LLSSXG:5I>I^RO>5+ZU6.(B83/)&JJ M]0%[!-DXJ>O)QY,?")43&18.*ZC%\5ULJ$TX)YARP)D)T3CB"2PA_0M@J*LLJ+%'P$W@A);7V<)E7C"%M.<0-FD*)W@+-1IY."@/7A+AP,AA-#JQ)-DB M+[;P[\X]V?).4V%[ZLEWFHAPI:\R:1^K0399"&G0?A8\9N MK`:VA8A;4N(O5TI_NC5L(<)B[4--2>)=H6X+BBM,^%8VHFA#QI,[V`RRL*EX M$?R-B]K)U_N[@+R;UY%E]F55*] MM5S&^5/).TVH>=:^<5Z`@MF1#S:&/G)J*K_3*2:3MA_]#S4?V5T;(KE:<;SY M$C`)?)YOV,:RAA?[GNEUML@W5*'RDVD)M,U!30S;$.M)PTUY0#&H/EU745+\ M$:4[:EHJ>P-1SXE[N.C"]SJR@JU$7VDE)'M'BX=U5+AUVSP#=\$QX]5CNHOH MD)F2>UKMBJR\9ZYK\6Q4ZNXHO'V_BT>/L3IB@A[N+NB2%@6-'Z/7FR1Z@AP8 MC_3+AE,/%=WNMB8F>TU&7$V\\.OOJ?XL";;JG*\9WP&)6]5K:UZ6M"K9OM_" MT;W-#@.#*+J!F/:WXD,8%DR<]W21K[+D/S2>;_(=V\UNE]&2%P?Q,:\!HUP6,JII@]T.O)T)L;X01D.^0==+Y%7(FM M:`TZWF*LJW*%=VV/>\,P36`/E1Z'M12%4^UA.VK7DRK+W69T7\7Z"4Q!CDC& MD7Z-AQ3"*1!LL5!#6:WS&`Y,907[[<-NLXD*(.@JR:*,;;II*TQY"PV)SW?L MQ,5V9DZ;:7\;!SJFVHQ#04]CQF1[.&4YVY5)QCPLMJT\0=]/AE2C^@,U_CK+ M*II2WD5;^7T05&&"6;,)%_29ICEW_DS*A8,-:FP;A^2>]F+J0OFZ9CVP,39MGX.8#S'CII&(E M.F0^8![SXV`)JI'%S.@WN5A"K/D!^RS4,X(5L_Z1P8/\<'LZ^_XSPR7/KO*B MCIA;(E?]P;@VH$5)%UDR41E2\U5$!!H[IVG^PGP\ZLJ+V>:@[A0VQ/HI&B?E M`7<`$EBI&@:F/%W[PZ>VN&W$5O/"+_$A6Q.,5>\R`\_++D1]1'Y@"* M'DOEUYR?;6G\C2:K-?OOG&U]T8K^`@4A%\P'<9:Z\`]_>.)ON;>Q(RWTR-,; M:8^3*!*.XXP(+$D+37(KGE1BB,IF9>6,U+C.B,*62'0)QY<`P@0P)GM%-T%5 M;DI2:^OVE/`*Z$0ILO=P^KJ#PM"+)-VQWW%ZR]M=5591!H_DS>-_[T3(QWA3 M:U\%!4`B(0I]9XKT">C$/E$\H.8^B.T5>S.ALM-,!_+<_1 M^PK?/\KK[([?0]Y;2* M_H=&Q>-+;E)3@/6!/]H'T&:D@3:@%EW#`,R+RVZ$0^G))=>JA/DQ:7YZ1 MYMND_7$B8"G'-.:.:`L!(C%0NM0@05"3^,&XK%.\0*(-NC!]B0K1OQXBN4TF MHY5,TNE:/8OK36L>T232,/3#3I9.N#Z,"'L$K1.N-Y1Y.N75CNUN]$N2)9O= M1IVV+G;T.F-;&NQLQI6A!D0$I!D1L(@$IEQ7]@<&#UP$:$_.06++<3`/=*(] MD)'O===H5I76W_AZ$WCK:&T:K;_++05;L\)P_-3;B$O60?<2T3HK2G\I\MV6 M>6GI#N)X/%7(:,IV;-?;RJ>`KK.**6!2$]G08=)1!9QPZ#-2PR?M#Y#Z"S!" M?4.J;%LCL=5O%%[IM&M$(81<``>?X^#Y@E,MNFZ"S[LV$7YK$JGD+YD0!?C1LV M^R(H`/LF=+K>2XZB1BM'YJ%AWQY?3*T=W*N#44R3?XDV-M]HFOZ6Y2_9`SLS MY1ES3)D:-_ZLZ%PD6GFG7.MBI?7^&5R8[-,MUB-*XXVIHTOVA:892V`P^NJBET=W4='0-[42@H-KUJ[R8DD3B!^6 M7E5KAU87C%,#V<)V>!7D)$L/@@@N;!GD<)4*&9(R'1:'U(>^>LX7_-(PE;;I]+/>$W<";6E-9C%=)ED2473Y!DZNG2K!%0]BGFA5=,_ M\/G].HRZ=`B]$-F+4+WT!O#HD"R,\L>$)S::WZ0'&R@\9T3`Y51+;[KG+&%Y MTUJA['O2?0K#+KY*06]T"GKY*@N#X!CXDJ0I(/C);LTW!FO^H09&%+0?\5?E M8>3;;7P("P.'NL33JC&?-3H"T[E(8QO.O:,*/=24CM MBZ02&/E!@OMQ1AJ(395>B2[9X5S0"?E07H;-2/V>%;5/P)"4V%G>'VB&":BBF70OVXV,.OY*)3G#N3I4,]\V%"PQ% M69O$$?9B^'6=*`<\_1/DDTR.GU1.HY:+C*@YH>.&\\5BM]FE$4.J_;8+^SFE MG/H,^NG#6R+\]X,;*K7@D_8'9J3^A+B.W/K(S+OE$H;>CL4QG0:.*XVPW9J* MO"P90FS=;S^AJNW/!$.)&*M_2!:E&U.?`)V(C'2&="IE>JAT<5J-TW$9@\?[ M>.L8K*RY,@@B8:]H97A8,>@ MK@'E,3_A)=PGY?>K@D)X@3)$JWN9:3B1U]A4"9,6$DSI&!H$\"`*$=Z6Z)V6 M$OLR>E2W;YAT@_=.A!MHMQF4#]XN'^A"VMA7:NV;J.[\,1V#F;`@-7/Y;3_L M;=I&F7;#=K,B<(%%ZW:@+F8AWE6L@QRT_))D><'KT85.,4^O"T5?86*KJMJ_ MW:F-&I$GC@DQ%?24LU8LBO(B;;9CYT6<9%'QIMJ708,"N/F.LZ,C0NO)F*D-[:9_-1B#"Q; M2P6@&6I>3B"$[*!.&S#VXDA0ZSA/([87+;]%X%]4M\5]LEJ7XL(0(_?;.EFL MY=]*\<>J;`60C(TT`"ILUG(NR0O")\_$73&^R+\`<#6BK(>4[9@AZK)\'&]T M"C`&M\,V?J!+RI:0V)[J,/9SD+.)3ZX(^SSI1ZI.JD.8=.`MB#G;/6/802]H MN2@2[MP?7\FGA1KL?HSNZX8JOGHH:8W%.1NZI*%*^(S433-C?YU!WZ:16T`" MR+T>D!/.X[=8<$1*O\?(L-E>54CXC7GG%E?``-W24;1+OV;#Z<>8%OEQZ9$FS=$Q=YP40> M\$Y]L=HWE]Q"4"64%8H'W;1^5U'#,81TBD3R"%H3UDS.HQ(>"H;_0!SBF=DN M6YP%KOMW9HQ'&#:9JR#_H05FIJX2:.X7(08)WMC!SCF7F=5D61E MLN!D?0RQ[72JE.KO]][T0]Q/3L):XV9Q0D&&5J:+NKYZ1D=>Z$Q$?727$3F/ M$(<:.8W`A<+&&I?H$AO M;PH&;-T_`!AV[ON1-()I0&$'C/V)UHEM*,NF^@H#;T5GOZ$U_-D%T8AP_Y6H MB;^QT.*$-DMP!$^GWH+%+O]C.K#T7@I[/SU8S*IP+(L#IQ#`?1N_CD2QHQP*.C2\R/64/_DS2:,VV.'G,9UQ:#U/2!:;$X95C'5 M^-:WPP`!='TY'6M'#:MX"G*JSPI",X&Q'Q8$F+VG!2>=6&[8<%1F>9^;H<_1 MAGNU:MTLV8ZW2X$0J&:Z*Y*\$+D#>%HD+Q/K=7+CO6.XFB1GF5MBGI(/MB!TV M:C#9NQN.&4$Z+;M'+><<*N7#7_YDT'99%15O5TE*BQ&><]&##=AS6HN`_3!0 M#R9B-)J^.N72=?AU1(:M\S0]3`TW*ZHU'&P/?,%;`.#Q`.SMQ8=*K4?OS9UW MTY;$^;P=?\3.5&T^Q4<3!<+6&PN.EQ/?VY8VM@Q'W?A.HV!'/$G+5]9S!G*5 M%V]C[8Y=H.'#9IWOV[=&/I2HL6AO,5B$T=T2^Z0=(?R['5NW%U=I'E5CB;X- M,L16K?VR7>1B(.$C\6[N&B70E?<^5>_DEI]SG1,M0=4ZA[]/RM:Q]3[Y3B_N M#>1[V+U-)_-)O?Y[,&5?:G4ZC1K7(SDZ*3AH/V=G-6E*]LJIG)U43G1V:8^O;10&=!AYYT= M;(:Q?=1CS2$2#WW=)$IIR:\DBD>DJUV1P56FYEX3M,@R>FA\.JGG0\L##D$\ MJ5+#F/$W7G$+[JM:`@%U-Y4ZN3X4!6 MA?;)#)?#Q5W1,>[3UY"F?Y]>0[1.HD-9AEL3UV[3;7X!05LE^P?V8KD9=BR\#MDA%IO/G%TRV=#ZJ@N7@X M9$::3Q/Y;;+_A$R-`9$H$(%#7:8#VV:^!(7"C5&1V9QE,3-IIL:X:9!X&%TH]KRP5,82H7,N:"[[6^T<4\#'F`O36?GUOT M?80FDQ7PX8)?GL"?GT%3_W!2E@\H\C.QQ=<5L0,Y6$8(\)U='07&F("6TK#^ M5%\S>HO!X`1;O3RV7]?"W1Z]R/2S'"-_CJCP.Z>0<$VOLYB^_D9'*_#`HZ[T&(PX:,)&XYA>F:+D3/#BDPL)7>7&1[YZJY2Y5 M3<'NZ8(FS]`7[-S^F&`-A"SS@B@P30.U!M",G.\_-(@21QI"M3:V-)QM@5^& M$)\>6*XG9WE6Z:%8H)4NK>UY<`(G%GAH+>5[J*$\H'C2HVKR8#]5Z,`]W>8% MY$@>JJC:C79;UP`]7)68#0V'[RH-OIY$Q*P)7.&URVS/FS63CI#1;!X(GC]' M28C1]K3N/@^M':("QW>T.(O*9,'+:"Q-Q;6MPS6OB9N&-L%^_J83 MX1\5I5+H3PIQW(ZM'*H MGJF/N7PGZDR^+L6K`:^SBK(O,G=KOEPF:<+61.-RH2"!"RIAD088WUD4.'YG MJ0:(7#DTG`,ZT1_*Q\/ZTE[D"WXM](JI5I1"C/"*_6:$8ZL)<+@3JP$#PV%5 MC29B.`\%$SX!]9SJD(\ZHMIH16E=-,ZCAWLU_?=T$R496PA;L>Y3O[^@?]:R M=Z.C1HVT,PU[;S.\JY<9#I>&U@O&4HIW_$2FV,T]:J[.3O1$I@S-]K11Y?:/K,1K"5=XU\/A_&!)V0#V%C\!.XMH*=UR4.+\CET[!#;1:* M;)9H9,!!E6;*?7YDX\8[^G!HH3K(M3_J.N+`&+0",AVO]X\Q-1&!"QJ,)32/ MZZ0XIKZ(S]\K+YI6<5%-X;#:HCW&#`]"=,+D7/;@3YF-A#Y!Q_V3]QJ;:U`>IF-+E&'E%#TP-TPG_N:_6B) M0HV@!BBX%0*&$C[VG^AW+\R"TFI'E\IZA9!DL+]^5Z2P7[%_00B` MV^;_`U!+`P04````"``6@7%&F_AW7R>E``#&'@L`%0`<`&%K`L``00E#@``!#D!``#MO6F3Y#:2 M-OA]S?8_Z-5^V;4QM2JK6M=8SVL6>952G5D1G8_#]???/5!=YL'SSTU4T8TW_U8O0"Z>_"%TCH_Z;_OH[C[7]^^^V7+U_^ MYM$_C3Q$8(03XL&(_>*K;[[YWU^Q__L__X]_,"(7!#(2__G58P*_N@/DJ[,? MZ/__YW,H_=V:P.5_ M?0T^DU'-83QUU^QH9_N;RJS M`)\Q"9G\OF7_^BWWXV__MVW^_E@``L-X#6/D@2#28K<^EAWN;T+*"'R(Z<\; M2DV:X_KWC$O[;.KBW#.1*A$$81".GRB%"$EPMJM*FX4G,FQ*C( M.*;Y?O^0;#:`[/#R`:U"M*2:%<8SS\-)&*-PM:#`>0B*J:[,>-\6.YBIB7S( MB43WT(/H!3P'\`$$D.$X"ZC$F<$2GX;8:,9TFY'\^PUU`,(8$QFX*Q\99>>[ M!<%;ZI#L%M36TVW:9^MZ*VQ\>X8PK<;?7Z.0RH1JV(P0$*Y2>RD.(^=SHX#^ M<`5(2"E$"TBH`[C!86HUA7GD?6]P%V!D?KR%U.PHXMCZL3F/@)'XZ2'&WN?Y MEEG#Z(I^C'<0IK];4`=Y31T^IFU4V>YA%!/D4:.?_JOP')0)&-]2WF7[_R-X ME;`(U:\,*\?9V3UU/D@J6(:".%?U#XV#]?X!KMCH-^$2DXWDIMOVL5FU/?O` MUBR*TR5!E8SO#\F6?L+(@:#PG4H@(>J-XH1Q(C$' MF4'-3^D[MJ-77!*"0_JC)VGJ>@LD,<\@RB6G)0>&;-3_N&)&K*#Z_X+IHKQ*Z632&R:G8.8-HX_ M7B113$TO214<0;H'^E0I_,2+Z4)ERD(D[9+PB,;-Z4_W,&"`T2,G/XP7MXP-W.%*)E9%,%\X0DQ*SB4 MT56P!TB=[9XA3.Z&LPTF,?HK73I7KUL81A`O9QYUZ0E+(5"=@<*P1F?%HC(K M>!7%:,,LWU,$ETEPBUY@>B7>=7X1FY[&^.;VRVN`R*\@2!A1NDFQQ#`0[J*] M";D)J5^:'/8JH:E)#VIT\5"%2#:9QTTQ]5&80TP=*LK,GK>4M=\`.VI(::7R MZ`;-FSS;+:P8V[)A_$B`#YM!$W'V^L8PMFOM(U4S_\\D=\)B_)'@*$I#/.(L MBXUD,L18A)ZH(UTX,I>0.2],&24T6&`-LS^IKO7+0+/*3=L_\8A3#6$ M_OX>;@!B@45ZM,A<-.A?PN>8GGE3XRUE]8W3-0I,[G92+SJ]2J3V,<9YGCQS M/=GY2T)OQ4TCH M&<,8L[]!M%K3`Q;(#EPE!Y[NV.7XO(0W+3>D.>_U,/2,O=IA>>[B#BOO8Y/1 MUS2T">O7&?+,BHUDT+O>WV]0G^@%14444-!9;?_6Z%ZT)W(/8EA=\PJ<\@8Q MB.CC&GZ$>$7`=LW,/O.3O=Q$E8("!4>B,Y`?U:!ZP_@2+B$AQ7_SF.^_,=[?5!576RR#+H1$)OPL/:HY@?1';'F!V0JL'' M(E*>Q<=9ZA+S4J!?'*^DPC&N>#/[F+,^@__&]``#7X$?#H^>"=J&'Y'N6:3L M%3P4:U5QLMR1#+*>W;6#X"/!R9;M_$'"TCO3L`!+HTB@/]_F_$C,0V%8D_$R MSHH[IV?H#0[4UI?)I6^6D0&0NX.$'1]`GJU!Q^"Q:Y>]?L[.;?+FSA_KHPTZQ7![!Z.R:`QNJ-$U0`]/^R1LC9M&?2HF;95,[HZ8RRHSH#GOBD5I]HJ_(/`%X21BQ`/H M[SG8KPT)*ZHTL.D'-&+/&RYA#)!@Z%QA6-/YJ_P/ M8CRKD9..+\MUSS!F,VG;$O)E&>X:PVB&I6JNO>R$=.F83O8MI^;+SJ7U8\/9 MV+67]](L>BJR`YLV!=R'X](SZ1W)M*O:>$TN[95R1S"K/<+O%J0G M(#NP:1$TWIE+SX`[@@$17&(OS;R>43>=VGF6:R97KZ9S@`.6VU+1N%O*4(55 M^!K#T&<5![+?LH&52E7F>%!Z`?8J)-)K84P*"@%XAL%_?9U$WZP`V/ZQ/S'. MEWOE6.1[P>R9NFUTF5:1S)E+ZWPN0?2<%OO,A_N6(?PM#.*H^$V*^3?OSO*: MG_^7%-W<55"?5'Z\MLA^-7Z@SBG5#'A#?XRL:_\6WVS3/[1MOC8*];B\)WJ@I7HSYLL7$A^2_OC[[VSM]=7F@.RH@ M",]>D5TY5`@=V'8IALI2:06\BHX)W/,!G\)H"SVT1'0KPBRUU0KV7&('C]ZQ M"-K4KR()/EZY--YETAC#9/KUJ63RRLJL`4 MUQ-+]*&^+?LO%L=^`0&+`3K+3Q3*7-8?AE^(LQ>``F87KC%AF10/T,M?5MDTKKU$ MIR-B`0!SZ?Y]>.DN"-P"Y.JDYUR(8J?-;LQ,>$BR MTDP7/WMRS-[Z=\5R.)=.7=\[]E.[1=(Y<0/^B]*:*AYO>8/,6R*2HBND^":I`C%`#1R;%>3<#J?%BYM2)5+RTU$ M6U*4?*2<'^RSFTQX@2/*$0Z]S$&R),5^HE.QKP+PN=H'>^(,!RX=1&U*Q*=@ M@B6@-'*N5[SUH,IW!^,U]BMM>RS<[:9 M6R%,VW4(6DRBXE":V-ITI3U`[DP'M0DLT"ZLC&QS6ND5"[!+7TZSXLX#9%>T MD7,W7Y;;\BE;@F./&RVN06A=I&9DKFM14FY\&TS&(,LRQ[*+H^3BT#[9:D0E].7Y3!"G/X6V2&W'P>.X166OAQXDDEQZOI^ MU"E.G1,WL(BTW1.[MQ`<2HY$)J"%//>DY4Y"*P:C:OM*5\FE6:2E"P>[D>\@ M/`W!"H)H)B=*PQ4MIPG8O]QMI^8D_"TISRZP'$9K!A/?="77+32%X(R96]\2 M6Y;E-;'K)6<.Y('C(:]]NR]ZQRXW@7O=GQP\KL\JEC+>[+VCK]-P+*T^G:U? M&%7Q<95Z7S0,GH7^/6MV%LV3.&+%?5&XLB&U3GK.S]YR4NS&SMTC^7M61BZ$ M?E%">.9YR29)0^C4*T8>LF)'!:BZ+BDC(UP1$-W>$A;LI)XQ*W!/X!J&$7J! M6;'?6WK4N<8$HE68A8:\K#1EUL/ST,[Z$XSG2WI,LA0E-<[FQ*R$%4FYN]EL M3GX8IVQJ8F_#:>3)E2Z2*L<=V15'KMCM%1RXQG$VJZSZ;;VT:E$4=I"2J_5> MSJ<*K*<*K*<*K*<*K,IB.%5@=2Z"4P56K0JLI:#-)TRWQR$B6R5"XUC&G6X2 M!R$C=ZFZ(DO;)T6S)%YCPMI;6Q9<@]PD_-Q.O!R6CVCP=1-%R4`RS$F-QZ&1 MDV"!E(NB1URF+`>9.^E-59!MP66]^(^S@V86]=KC\+6&:M6&LGFDY)'261FG MD^3X3Y(]*B9^>-1%_G1\/!T?3\?'J1X?TW[3]_`%A@FT5#.K3F(TJM/IZ32` MHTD'E`N,Z?3]-X%P4L[ M*0[EX9V*J%]1*P4^RZBHBZ=Z3Z5F`V$0L)*4,(0$!)3UF;]!(8K21I\O,*^5 M;<4TBE%V[FP*+#Y1$)T5'CAO-N&=>?].4';YDC_F39PUJ?\RUD.T*XRE7+B@2;1%QW31)2XLK+HB9.3IVD M/3^'Y$"KDBN1<6L[-417ADK=[S&295>=19Y[$JZL^3N=]*;@SW8#IE`JY*=, MFB%&8*201U-VK&%-/:>7B)HFV>&CI?9M[&F97X83?%"1QW^C`S M\N14HYI">6>I;#E6/.ANBA,09Q]F&J\:3&_,6575A/*8._TXC,[A$I/\#55: MQO/J-2:`,DVM$-FE%TZLX@#]DK(4I-/+O!'[V[E9=L=Q!]]YBV=56HZ/='N> M\X5Q#D-HZ8J)1\KY06Z`U=A4IQ;(-4(S)IR&?ACYL6Q8A8W95V MH`S:C0I7"8Q,1PRLQ;)&U,`T972D'=YR:O2>IT5:*8"E@+/L;ZE"FC+C.9=P MMW98BRDW*2\F1#%]H).8DO:$J9`YGZ)J"YBTO9J$L4)'3: M;K>#"A-NSX^=^B^]`U31-9.0/,0V,*Q6R+$S2?V01-SA"^?Z!'/&AM@""E+. MC@*&-X(]=!H5AJNA0BF)9J]UGR+VS)75>DOB-)G%[!%/F\A(GF&U'OKT$727 M0_L;9)5`H3][H=9F!3\EFV=(YLO&$VYK#IX<`Z[N*$TMDDHY5CGH7;Y3XK!: MWHVL%^*59,'147!`1>&C/_A+FI8:H9(10/[WKA/*>N)]'1,WD$NO'W3_X]TP M87<7;EBOTG&CYPP5=V6>>'5U9R\`!>PZ8(E)!`+X`+V$9%4\&S5U%^RV@&)< MN43(BF!:RQVRR+*KC5U2B:Q+SMU5'6]J;86>*3IL!J'?6?9Y)"IJ9P*3L'D# MR]39A5;+%&U6B>\B-VIW10@O]6:WK8V.W-?K:JD-K1<@/97O.I7O.I7O.I7O M.I7OLBB"4_DNK66LV[O%DNMD@JU)N%A&\#=W%3R0%Y8&(RNM1A[I..\Q^?"U M^EUCJ37"T*T610@;V&I/[MAHW3$IY9-PSI3$L.\,O MD'@HLO/\1YZ)D1Q#^HVM'+0&'HF8U(+,L+A6@RXN1G.5K:()G?"J9Y;KO!03 MT=VKS3;`.YCI<%%.T__F5"G*G-YMA2<56/E"&Q& M%]`F"E<;MQGW,(H)\MA;)O97LR^`^&D/J*%M!I^1([`9'2@;*'5MQV:,03/Z M.)FPM]D+LGK%:RLN9^8=Y_446!^I#2O>F,+MQ%YTL3+IC:0?:!.%LXWG-8[L MX9$H2Q/97+21-U&=6TIG+G,2K-@BJ_A^R*ZLF0K.L^2N[\=RQ]8JLLZ)%V(8 MOM$B3X.>0@)!P%HM_(P#%J,\E.TO/:0D**+_5#93-M]X6>-UXJM=7U:%_FG' M-8V[%AZ#0\%,#6BK*/ MF/[(O+X%P2^(GG?.=[JFW!YU-[NJH!99!-U$C3Q%$W4)*4$/I3C3GP.8%_R; M;9C"_Y7^WH;U$:+KQ&FWOKC*)DD,?E=N1IF+_7MM5KHZBMDS[]2")HV+4T// MY$1INSI9#*HGXI(PT_]#,&'[YE.X+'YD36[8W,3NV&7&<^9\#")_ M*63-;",:U_AE:S;`'M)+T]'!AZ6;V$\XKE]]ZA^"9\^3[4 M%5Y>5&-+FED/=)X$4MV\A-E_WX1%ZFBIB[VEB*0`X;>PJ0N*0.$I!D]35%L^ MOGHPBB@[YS"$2Q2SP&J[1]*"@`T=TF/H^`-.F@)3>.+!U3CU^T$7P#.TH/XBH/.8P<=B[6(%S!Z*;DYJ3GKUGHWR+P MC`+Y>W')(8_7UY3%UM#;#$.'W9F77:51="!ZL975+$37B8JHK8SNTVL;I@J7 MVJ;=A2:CS*,)Z0>63J?=!!VUC[0@[PJ,VKE2!M+P:OPM"-P"Y!=!E?RH0V>< M'H"R^0\C?R%.CDSL1&%S=ZABJWYM M;:C292NC)('EB0ZF`G6ZQ^0:-#`U5LI0.;N^ZO<^12SP/E`$6X+ZJ!].J*"I MGKS6VF986/)9($L]);KK^U$+J7/B!O+)E-8?W0?R$^K,^W>""#Q/(LH\"RQ1 M2U.D1E#3L5Q2DP$:J25FUJ$"%ZZNKP74M[PB5?`=P6F-6A`/0C^-0F?!)/H; M/V%3AO9<=@&J;MQS6:$+H&J?M0%B'>L"FU,[0Z[6-JR/QE$UGSJCO9K79%WP*EPDC*:4-1^97B)F#\8 M^M&<7*(H>VW'7N!9R0J1X\#)X4I2`61!-9$/;/8\U3+A`<]3;=1'[:JKH*D1 M0]$Z3^T?*"F>I[J^'[60.B=N8`EJ.\ZLA!KE$-I+A^B@YL2N"N@BST^N@V7@ M'::)P\^!K:S$UE-(V;JAOPA39S[TVQ/ZTG+_],^"A!7C*G<1&4X-3#'LS#,W MHDW&Q&;@P*:MC84G>HU)>HG3@I!M_1)AP=&VH:$O0L"Z?/-9,)B9QT*]TS?) M-L]P;>0F(MTNP%R=TLHJ5ZK>2.U1W@MYOJ2\-!HK;2LIR#[<5TV-#_@T:4Q!I$QB%]Y@F,Y0YI_N!UK`$ M]5$?PU705%^>>K&2O76A6XI'-Q9J9=(TBWLZP7G(V*?;#OLO%O%[`8&M!R]2 M]-W6OY1?)!4S+@6TF3._8OWQ5IZRRO?U3!H;*B%%?R0E43OM@1R@ZD_SJQ;! MH.QG5/$)V5$=3UME#"?T.N%)F']!#-5;';;U/C>\VFO<6FH[("[S(Y%ZJ1>! M0B?#EE8$7PW:C8"5@CDKTG9`Z-,3"(KPLE0P.D$>=A3UY&[/4XL=U]70! MC2BO0#WL#56[''`EOG](-AM`=GC9.<>O5;I[5=_+[_/U'D[G8VR.\!B MH2ZJ3G?*4(B+3ZG*L+/'/I,@.NC>\JB;2@G$BKGOO,R\VU MN5SZB6H^QF@??:!E)$7?;6A26/JU1!`)?*>W!7U_"-:S"_45S*I(Z32R>(Z' MV87`)^8ZXM8GQ,J%)A^R*48`?KR%(&K9&-2.SNPJ MS^I)OT9!_9"?CC-?WK*'N'"H`WTO4><[0[L$*^?V?N2FYR#]5,[TOMIL`[R# M,/U=43N>N8;T?'(/V3LO+X9^^J\FKGWFRW(RVST,TJ;7+$TUM2_/+-VMR&4= MYF9(B2,-CTR4\'F9L%W/39,EY^O8C'I5/$%=*4W28SQ[5ZX!KUU:F0XS5/B. M3TZWQ6IE5,OANPYZSM>8@$B;E9UYX$US=9S=PQB1U&MD&Z3Z=EBV*#.VS1;# M#K-<9,AK!?(HD8Q$>MFQH$:3[&GEB>Y#72\I\^(DU5Q#42J1/F4!3/%P=_;^ M`:[8S&[")2:;?::26EY!-M2^.[/-]KS;B0(M,A*SKZ$>?8"O)$"(P M3G*I?&`!0915ZZ8'O8NT6_D*ACJY1*4A9[4A!]O7)!C0>$\A1,CJ2I/DP/4F M)J\7E:Q;2;@-OJL8,[`!RT0.>F$W="),V_FV)R'Y>L:[&+@3777?L1RL2K(CP2'] MT=._-CZ&7/=+&'D$;;,^DI_@%QY.%,O?83SS\38^",#L];(*(\[#)I+I[8IP M3S.>\GWQRH1N\,\H3$>.2HU+V5:7'EP?*%XQ7"&OW!5,?6&VD;6Y,COIZ018 M6@8>R/\4I.Q\^8F(NO*\1!#1B6YV/SR%7JDATR^8^I2_4A*)9EI(>^,^ZJR7 M*5A=8[(LJ.^('$H#+3P)ZH[?T2HJ17\ATB.*6/YXD40QWM`=CKG7"!*ZX^6U ML^DQE_FE1//!Y3V*/C/,Z<*')`84>,MOO+H)*D9,@[ M]QY%15\M^R2![R07V?MW#_"%;54>O%@#LM)+%4ESS.A^E[":=^D=9XI?7W5G M4]HH2EPU.-E+8;!UI\"'8P]26C6JZU`%>!,+/8``\B2-/^54*,#2;#+ M'\"`X!+$X"D$B8]8F$AYSV@.7+J6&.9N3Y8%]0VRDY+5-2I(V?FVJ*@.Y=4I M"O(T-\CWMW`%@KS2*WL^H;-!MMBIPV7,P!<*+835%UH*TAV(66/%^KVNY9<) M(H0=;WY28J\^61""=6KQDF8UDO-=^M-.XR9@\N5O+O;17(IQ!H?M<`B?GO.- M2:[433=VQM:'M$R?(CA?7D4QVMCJ/UFCX/8-NYS0ZN"8Z"NH?')]@6$"[Z&' M5R$::`'V$YW8*A1`T4@C"D,BO@!DA>FV>DT@6JWCC%2ILSC`NA8C/"E9"V*I7A%=4=;9W<4S\-+;TWOZ$W4H.T7, MZ4LD-)#3*V(Q@8D!HE[1W+PSEE;OO(=Q0NPT&NRAZ#JG6]>]JL*G7K)6L0^'!IB$W<6QRR?TTF.F\Q,ESO$R"8N=6D5;?&!,PF+TP%,$) M%UU=9_X+)#%BU8[2:A4#."]])"<@4F'T"M%J!9[TJLH.(%$NK2G%%?B`%4)T MTN+TAI6`72%ZW)E%$8RC:T2M/+Q%+]"W=Y;L)SJQ\*$`BH64702(N+56!UB\ MPK2GX0_)0UH(?O@&JK6JB0,(NX_DA/;>7O0*N0X?%]I7-1ID[^70FM;>RP.L M$*)6P$?5+%\#1-)>7?-E*0&))0QN#D%G&T(5(SRI^)X@EH6\!PPZ<2RH5. M:`>0QM<7[3'MK:-,_2\H".P6`.L@-ZE-K1,W4X\$ M-*19.N;63\"IR@\D97$VIF1#55`VD(D'"LL[WFMNA M$!SO1WWT2:QR#?",Y*+IK7[''>L+AN?DGF5\6^[@K=U2B3501!8,V\;)7VSK#[*[B;<6\MK3(HR=9>0E:9+2R#E&JWB MG>F1&+>P=?$S$5\:>,?]>Y%@ATQLK`)MXJUD.!JM(7-8ZOOQ+^@)K"=P8MIX M]M!V?=`1D'2[^>S#U%!'3F&I[Z\B]TM^B`^&-F0,B.*?Z&G2KFR^(:8,?2P'`(TU5^#S<` ML=3JIQ!D%Y'0+^;//E-P3&S0=7['UZ\35N`>.H4DOX".;K*NUJSP(K[`8?KP MC7*6QJH45$)A6-H1D@V;[9#'4$$> M)K#LU?$U5Z-H0'_JA])+'-:#$8=I>O'>H3+R-LIJ4Q@>+0/!\?K8[&K=HU;_ M$@5)#/TA%Y@<*ZZ-;9\"M"\T2;BG5MV4+;%!$XTT&'-[RFE7`TY.D0[\$ZR? M_U.:%9$]D8FN-ML`[R!,?[=(B+>FLV11$L#\>0H?8H7VTW_5CM$=?(WYLOQ: M)^]4D-:=2&W=,WO/4\A@F(K?2AR9<%@/#YCRX6=?`/'+(F*I3=G:.:1`#6D% MC'#HWMDUHGR<-",C,C17^M^(.I9!*BYYW:B=`">.8VJ#Z):(0%QD4#1Y_H33 MWH6POH,\A8A.VX$NJ3#D]!+1ID8I26>":1IG[_;%&$IY&GIE,(;*T>"3,^%S M[(.V$)L^.6W,OH`WM*T\!=Q=W*RW!B.42,L,`]US? M4S/$*C6&'@I0%A\>,@`DSX_K*)"RTJA@/_3-2EO*$F/VG"6U'!B_I/\5Q6D8 MBYZL(5H-JC1J+#D_N"@KCJ((1O#@=[Z\S.E2CMM>>@VI-G*L3-;,2"(^]*O= M)L-/(P`/J262',S7;LB#[R9=[U#'Q_>/\!55C3A MT*A1\W8B'_$>;EEZ1+BR>8C@TC+QEK$V=@FB\UW^CT.%B:18<6V>^Q2`$P.2 M@]M=)[>R\U$M!T%W$Y'R+.9]/E$VG(9[U-1"`N-)IHN??6!)&"A.8UN@WME3 MK]!9:>1ZS]!A8CQR#"@XU0<">7CP$3_0P6*X0MYY$J$01M$"D#B$1"7K36-X MYZZ/DO#3-$@-3"?9V?GL[X<>O"!@KR!#;T;:J-MID!,_U-H"S5+4=YK M-T6?ZB^\B>$F&G36!ZI.77<1O6=FR;!ZE1QZ]>-:P",@YFK\A*9SD> M*6>^H)7E7MY_N.!JB>Y7ZEF"Q1J0S1W"M\F7H?^,M#.%KB5D)X+D?N[W`%I``?]KJH82Z)*3D<`YCM,&!FARX'X]> M#OQIJ]_3:G-4OP:HB,+9YLQ\)A)>8/<0<:ANO M$G4>W!&0IP2$I:LK-[;"FI]BP?LOF203=PCW^VO&&Y_20TL$_3S2G4G)K]Y1 MI[G5P[Y$,\/BM#6K!D&]V$>0']]K;OV2W[ M`Q5H&G@Z!P$K]?.PAI"]F)_Y?HIR-1XU4%[+8--P%4$<6,$'U`L3UWFFG(X% MP=?L-J"<)F%3@V59<.1>#J)\TN(PE]PW9&C[AR>Z6L((!\AGKQ]^P2B,?Z4D M$NVW^6E-Z#L8K[%?0IZNP#(-JW%L6184P[R]$$J&K07'4P[$]XZO$'26&-/Q MF511+_=NO:BTM4*1/D1_W,(5"*[H[A;ONB/'$?3^ML(OW]*/LK5!?Z@OB;8! M';K&XFZ#V>X8HU8H# M0/,E(WB^8_]Y32E@,L@BE&'#Z06^D/S;5I\4T)/,EWU_]@`#R$HJ_"L!)(8D MV.4UFD%P"6+P%(+$1T7]-IU%V!R_%/$9)H5=E@43=T*=-(?<,&48<7XGJJ@L M[3NHE`A&4=3HBA!,Z-&0P+P7#=L8$28+2/_3G_E_)D7(=:#R!?+\N,["-JI! M*O(P5-)@H+W@8LTJ6D8HK#S(4LFOSD>ZV8_4;M%YKW2X7VLLK&(L&XMD/[8S MF]D+>%FG#U"H&[IMJO7T<$IB]33%.D/%G?IEPMK@9@O+IKQ:Z4U+ANV0F7LY MJ2S+WPB*J?F9+Y=Y^:]'S#I\SI?%]1^KW&53N&(,N-JBE(0MB*G"?>E/F?1# MN&+#JJ99UOE-&R=FA?A+^Z--H7,H3DK*/-1<52\I^/KCG?6]7?@3^K)LM2-M!LD;KS)+_P^N1SKZJ@M+_UE?$#QT?3CV/1T M@&)XBUY8S+T-":OGJE[JZG:X8^A&X-GDY(3H.HD&2BLII_IZK\94[QP5ZW?Z M<,DG=+[+)A.`*++U`$Z6!<<9*/)+NBQ>:;RY]\IBC(;WU+?(@R%K"72/5FNJ0^*6 MNG,`YT)04%@FA6Y4C-E>I35(C]8^W`#RN55*9A9:@X93FZDH1#Y@FD[//NZJ" M^H19ON`6QG"V(C`K-65/3AW4IFSOND"LO:JVX`<.Y?G+LC#MA2<->"[H[RJ+ M\9B\X-M&OO@':V>;CP1'0Q]H,IKCU=I&\%50;CF6;GWH#OYFGI=LDO1F^>LV+3]A,U9/F8"0L=$2F8IRH MPE'<(`^-M3/4Y&\KI4P<)@.*9`69US0CY;%/64,R+[1MF(I33M$([@%..46G MG*)33M$IIV@8,W_*.#IE'+6OT%/&T2GCZ)1Q=,HX.F4C.,JWV0HU4#BU;30L3-">O)65 M;K&8$--#=^I[C8"IZ4/>0/Z4II7IY-"N<>DF[:Z*_;`&I4<`IOKEJ5J0G.-$RO)"(JI,AK^11Z=#:0S]VY%H M#./D[6E,BK]ZC-5-+[O9"R1@!:^B&&U8C.XI@LLD8/..\+)X1+`(`,/`9XV2 MM_N6CE_+[J(=M.956K,2+;G#B!X)M7;?ED<=90:;=S5P+^%(()K'/@WFRW!+[9SKKO(.4[1 M591+)X!&'F!?)X3ZO*RM8.A?HU?VDT4)=5!SFA6O*)XN\&JM[=62:9(8;_`S M"FS*I$EDFFNE!:QZVK7:2RR\V28Q)'LV++["XI!R_M11421Z]#1,BZKM2F*#`A1*?W_,.0\^K@%&MB%^$*M>!F:26$*$+VV,\_G?D.0G(Q MU]Q[H-CB-4#D5Q`D#)=X#=D6`,)=5.II'<4DR5I/JS3N.XP_7S[NQW]H&U\J MB*@RKFQ$0E[MI-&T$_>29F.88F@2;-F.#"JQXLC1UEA":MN@O!8;*CA3T#W? M[7_\&5%#3KSU[I:51;)6:T:,\H0>PJE:HLIY65`>AJ5_$])32)2.?V8QMM%! MSO4#<:EUT"JQ-@RK44)C,GH_K(S>'Z.,WK<'"8W)Z,.P,OIPC#+Z8+`*S7[\ M.PBBA&2!XB:/%DMF2#'@.CQB0)!B0!LJ_'!@MT3VFL!_)S#T=@,X,5RRTSG! M&W9@^(*PM9SOH9<08O4N4XBNV_I%XDNA=]DV`*U=>QH3W9Z]8>UOG>R(K*ZN M[!J(MOHY1VN/A@J5-+8OQ2LT$*UGH<_^BP4Y7T!0V34O4>0%F(G6RJ6:,/'C M4YS.^+.$5%S7B[[&!%)D+JBY9HO^`H=I5"I-S1U(C619F$R9>%/J)"TC$P]Z M5!5J]D*GSJPJY9J5/7A@K@"**2I64BSXU-Z8S>G"W>%3G2S'?R!+PB?FVD'K M7Q456?)!T]@O<`P"_:(S5$$W*-X,Z69T4SS*]$C`G.5JM1R4Q%X1D&J MW`-I2`]%UXM?;,E4LE-[(#1H!89\'!5%R6:;E@I_BJ"/PCSG@ZX4NASV$TT7 MQV^`$!"6ZS/(OHZJ$KLI$7LL$4OO:0MB3\L86LF@^$. MA6B3;.S%^ZL$G*>9-Y2SC&X-C/H3)36`P:ME@"L$1@YP%0PCSXM2@O;@+0_O M]%JJ$]@*"*VW@\=O(P?W=&J9\YJ7>25F6/4'+X;^KYB5N:3'G]T]B.V$G,6I M3R;:;,1_;;T=%!"1N61ZHYKT",EF:/U):9ZTAB\.,[<3QG3E'D6?KPF$K-TK ME50\I,UII3V=@.8@RM,N'Q-7&@.&ONKA+"GM50I/M86AG9G.0< M&7YTT9B^1?$E71O7E//?ULA;%^LC9R"Z>H7$0]&0QQH)CL8HXZZCC^P_Z[T7>7?[G&_'N;6WRHX[?8."W4"0K M?535&)F0]#41-^;^*47&]G%#J=#8X:O)V->6"9O-]APH'OH)QH\$^#`/+;,' M@Q"],-M?2OB3,][<$:7"I@+#J!>=;(SYD>`HRMYU6&G0V4/1V4V#L*PJ6?$] M\)FY@Y03[2V,*#\1)"\PNL9$2M5XW[HK72,E%N[47;P^NE@#LH+/P/L\"_U[ M^D,,<][$HC/\SYW$,7O4*HW&=,Q8827P6LM*1S#CA(21#/:U3]SD-PH`7I^: M@IH;Z=_+W@&PY4G%/@L"_`6$'I0"O',`9\9'0`+=,U?P0#GRD'MGX+]`$J,( MA2O*UX+.!3.T9`32,X2K75I`(GV35_!-N89(S>4J](1.X!(GS_$R"9K;FTT/ M3(J!$8M:$5&%!DXF5B7?9Z1.SJ`.=XG>1!P[,>PT#ORU)V@#'COWV4VE#NHQ M3H\1[%6N^FNS?.!Y>>#'TL!2!P/AP30":^E`]_`%A@ED;9^C='@;2X)#R5'( M1590Y07!P\S(P5/ZV%F:@,K)D_.YD^..BE"Z('`0L&XYCN7-#%4/H,7GS@Z@ MW0K&.8/N)VWP#*ICX-(S6[I8+=JV$A%'9DU,7AW8F#O-JDNK.-\5K%7.>79E M*$#:76!"4K`B,)H[+*L>S/P-"A&;28Q>X#6$4:NY-.258%&CQ;Y`#`J/C2HA&SP?= MEK1!V6@'+1UT@ED`AFE;%H&1>I72-8#SY$5YV+L!,?9X2*U@2\8WVPQ`M"X. MZ18KN'31FZ!LQ7`TTARZXXIS&!O(H>HF!&76"O(`-=)1NDQHGXTPD,P:]":\ MQKIQK#T]LN!2VGL;)D37Z=ME=:F)85IM,GV4;K.U0VR]])45Y3\'`?O5\-I? M$'98O,ABZ$%\I>P%H'ZQOX4$8?\A!B36NQCKYI2BA%\H*3O-%81INZQ8-`J- M*A*A4QN"J:(,9JEM[A/^(+'+&D:XM7>FJ, M'(G_HJ%-7!&IOPH,+.Y7^<[ZQSO'SLV;UIF2$!0NF2L.SE7HN[B?O`E?Z%B8 M[;>JST5+0TA=/;9]IWP(+@;;7;/TCC7TK24Y<2@Y\O0[P"^K,0\>$_FV>O+Z M#9//-^&"8+JR[,JK2FDB\JK!8\(CUI/7/?AR!ZC+A$#`+.%#LMT&E@Y-O30G M(D,N9*8JKZI+TU(>4F7\B4BIG&&D4@&B^A3'48K1U2NS$]0'FC]']-]BN)^> M4KG<]:TI"F&H#NGC4Z%,6XMTB`'3(T+^B-F3+`M^*">0%7I5Q9Z5Q MVUTZ,XK73U3G0OC!6T,_">!\R:5CK>.",&V->P;NR(TPYB`RNZVDAKM+]1#6 MY,HK$V%=,9,-S*5ROK.9^2U"UG5>L.RR+8M1"%8#N?NWU/+:2X`KC>Y:&!)Z M6FFU7<*GFHVM!/=Y0AG,7O45/]YLMO3XD_4SL"<),<*."YTJRD@05"-]-:\3 M$J(X(9`2NT:O[">+4NN@YC0)45%07>"9R,SFFUGZL;VD41&R$S5_0HA6<[./ M;+^]-9[>R25EK<92#\71ZF;#_1>2F+.R2V*OX/P MO&23!*R7EDFZ.;R0UH5VR\_.O3"S+W'`T4CC2\^>#`$ M!&%;-QWMA$82:.E=?A7IM$.FTZ#Z@HZXPF1W)E/5I/:-:[^U4Y/2O([Z)-VT MGR[8>*^`]?NI8?W>;568@HT/"EA_F!K6'UKN`!Q4X"G8?`JC+3W[+1'T[=T9 M\(F-7FP">-6JM2B)XQ(^QS?IT2P]E5O:75NH.#_J*&ZO;8`UKBSDC@4MAPT) M@]3QN5/WA:]9#,ZN21O;>%6]SBKKG\#&XK4FEY;;K*ANZ?4#920-X(+*'<6% M>M@R3BU4IFJ==+`"K%G MI5KIN/:AQ,30#I&9\,2OU#-C:_&>.G/VJN_6:$PQ*-$$RD3]NG,0I2-:3.BK M4G!=^[%=VRI9>C5(#&137B4$^S@(`+&'M=PH9;N%*R7PT*T2;9V#,H50+.E;NA M794N-%4PC#B&=^#5,L`5`B,'N`J&$4.=$K1X_"D-[W0O[`2V`D+5$$_.R/7< M"^>S^U[3\%4C)M1;0]$#Q0CX\["\N9W9#S5UT'9]L!.ZHN?'H;I0-9:O/*I, ME#\6*:9K&",/!-$I,>64F')*3#DEIHQK@STEIK2C>4I,&1_6I\244V+**3'E ME)@RH>WUE)AR2DPY)::<$E-&:9Q.B2DCRH@X)::,0@RGQ)01&*938LHI,>64 MF')*3#DEIIP24TZ)*35X3XDII\244V**:R-G-S&%C31?5L\B%_@%AI3D-7J% M?E;OGOV*@!7;X!`6"O\I#>RXMHUPXHD::J9ZI@V4>_()QA>`D!TK^KIA'1/Q M,E[#6^KHY//=;'$(T[+R]/?WD+D]]&^?0I`5_6)5P9[C2Q2E[1:52J8T6)@O M']M8F(7^8S\+4FDLEDC+'G98Q\KOKQ%5+(]Q0@BS;&G%W;Q%I0TI">'C@K&1 MH]>P%6-"\+:2VN.D^ZK5U,F0NG: M@^1G-4@*T\C+!PTC_)@;ET\X]!)"+"D8A]+;,%V=RL.3@;GZ[E*J49Y"SC[G M-"!TEI(8[@WK@@SH1AJ,*N>Y9>0RN.`%CN+(4CUF'BEG%P=CT)->.9CH=3IH M+//J=0O#"$8HO(=!.F2,2QLH`STZM,24T]IB[)O]V(^-L:5"CU(#2I^,>A5, M'"LC42YQEPV2E8=@J6G8)E MQ['P3>^C)MI0%J_"<]),%%>O7I#XF5^\[SIE0WN%:4_:_G<>#<3A-Q-X4M*1 M,B/S9?G8LR!P@Y*-#>7H)^H\*4UV[52:OO5C:BK/15/>>_U/SZWV15VC=T12 MKB.I'C-4%/`\7D.2SV,>9H8J:AAWSI&,^[';G&<5\?!QV#DLA&[X[1>].T;M3].X8K8#=G=C0H]=JIE/A*K/7M6E]*G\!B<=D MLK)2Z%."^O$H2F>T3T8>!A/-!CK`W($X(2A&,,++PC@T7N;)'U8.P\Z71?95 M:5BI=B!V#[=@E^K5?+D@B&K;%@0WX2>*\.,7&+S`.ZI8:VON MF3I#3GP!28'SLO,4X#>PYNQKS>\0D,;C.E&B/.[GN&5)4,2@WT4D4U+6T9\$1P#ST04(RZ&.Z#GG84W1O00Q M4#T65,>>MXXM=3:0&E`CWX:B`V]Q%%U35:)GR1B%"24SWT*2:8^=.[]>JF[V M9Q4I5J__^N%TF#E3'/&+2^9]P/(39$]&P*O-"UX^46=[K+ZX>_$TD52A)FS* MPT$=9R\`!<8GSSX5$Y;:JR2'=.(DJ4I8%BXCCZ@L[>646]9&S4M9=K.Q5UEP%*Q1 M6P)R&WT-:X-=!NPI1VZ;W*I'A0DWN\%`^E&%VU1`SX!ZI+F_*%5E*7+BZHA_$._MJH\/-?R051 M''I:WJ8J?J4RRH->)+7R*:#*I9G8]5?,,NC(F]%;596$`+/RF.A&W`AXDH[7"R8SJR1JI[FS1DI1+9 M0\=1?X-HM:9:-LL*07]*6+KG?)E-89[$$2O30ME/C:$-PR''@*OT9UVG5Q+F M7"%^<-?(C]D>]`(?H)=?I+4O<%.;!Y?:I`)L(NCEHOUQ:`>6VA^29F""((_D MIKI7/6&EOV.=D/Q%=FM:SMRT=![6Y=5([^FK+P%4FG1#O%R`(YMOL MJC[T?P.,*PV''<8-0\RK#@]W(C9U-==F_#\X>ZA\@<:WH3D= M$C#R8MN<4UH^#I5=IIG_9Q+%;**#N:<"K!R5HRH"?:XM/QFX`S9ZDN'Q/N!9 MALO"Q,ZURD@7^Y!*^*RF'`/FV%TG<4)@WF/N%E*/+'?(E!_<\$>4"I\(#*,< M:LP#4>$J'3>JD"JH7";PPEZ%;$D.G+C_XH(LKQM9;$T%G6TJPDWX^`6S5%HK M+IL\$VY\>ZOZ4(;85118GF7V9&,$>G%@X_@,115E4Z]C[.H%>Y_A7BT.7+CR MTRTK1@EF,`LZF7+[9UXW$-"03LU8Y#U2@QX3:" MJ+Z@%/2E#+V1]QXV]<2A=KPEG=#R0]T=Z(NX!:[CU_PXQHG$>4W;29-\KED3+"9M!4GY*QS MX<%<'6@Z]95A+`Z'Z\='A^P,EMD'PRC'[Y"B<;YK9G"P>1\F'_IL1I_`QF(% M1"M\NG5QN=IC5S9&FCS=,Q9L6>G#X.Y:T#HWSR6$#=5XS,\]]JK$5@DX3R]I MZ&@9WAH8M7*PB@"#5\L`5PB,'.`J&.:LCCUXR\,[S<+L!+8"0FO'\K=B*AV= M5$L7$#KFN'=WYVWNUP"17T&0E+EEY6?9W'[%K/@L:TO+:L4Z<<0,L'W\VWXC M\"'E]YG0#+F3ZEM7 M"R-%OH;6^AR[C^D[IYMP`0G"?NT&*/W'2SK'/1:C6@.*4SCZ4ZN=]:"J,.H) M4O47=`/E.)2@G'DQ7>GQ;I_-(%?WH3F07(V'CN_E740#&LA%9J"K="Y]V9Q; M.[P,GEK0R8.K8YZ`UAN*I/'5T4CH]Y0:8,PPB"1;Z;-H25_^] M@SAN><>]L^V?O=/73Z=K_O&IC)-K_N,S9=;=A]8[MF$/AJ77Q]GKY#$>_9I, M3O5P)^).FCS&M8A7?;?8IF?!AQB0V%D`NSFOVMGTZA42#U$Q4/!'&<<09?W( M',6AU+Q;'=3O;=J5?^A+RM[YWD.V2=/?L_+C[#"6@(#=6;T?U>VEQC0F?*VI MM"J&UA(#M8Q<[P@W=$XHC)`WVE@VG]G))J@X-/EU>4_YHN97"BYDJ?W[A`/, M?I5O8^R$,EXW79CWDY(;UP8SUR]CU?FI^?B:,SJ=;H=1'/46&4XS%0OY<*?) M<^_&E<*H,8W3(<"NEJB7V3=UHV!FQE7/<.SJ7^?VI.5&9&ZJ1<`($K<^$AQ9 MN:.VP>8I@*DI9@,-$*RY]-R;0Y'\,??^NT'VC^H.5$_)32J%1I5L(R\LW M491`_S*A^\DJXSDKV5R!/6?;2B=M!2[>DM.@(".5`ML_97H5PA6(\[]U:EN+ MZ4S7O,K-X"VI],"Z42P'_8=L3KSC:TR6$+'2>U$6!4)Y`\)B]F/TE?N9/KD4 M!A6@4'&9&TV.Q1^GCH_.^EN=T&DS&$ISBH6C7P_;=4)`=DGVQ[LQKH;6W,:3 M@JN+N%!;A:O0+,?K*AS`QS>3T#9ZE>XUY2<]-ZL-A?8KW&DVM7_`UYB?6'L] M=IM;0[SQ-%-V1=*!?^T:6.JIIO!@"J;#@%Z*@2@VT8&8<5&`NX^SQEIV#=5M M[;6G$ZLIMXP,O9\1U&B]$L.GEZ!V+8U,;6C%\HU5+BP6?;^?]I[0!&];OJ!5F'O8,>O7OA')S$U(FDU1+YO$:DL8G'%"4=F2-'$KEU]!HYLFU$H[7A:1DZURU2KY)&MLBS$ M.QJQH*#V[Y>:1C6P>ES)$CVVJD9G9:0R[5RMCKW+&MKEI\9&1) M'"H!M-,BL:H=ZL]Q6S.:1KL>>HW"9)>*X)GFM-VXTROU9\(MBVS`S*F;D/X( M'\'K@N`7%-$ABUPIJ67>'$8J,ZKC<]5CWD5"F,Y>0RH7$-"A696/,(+G,(1+ M%-NP!'TDG6QU_9(I+Z=>U-0O8P)-C^HR)Y;SMI^7?;D*4G9F@^5$+(JCN29E MB@+O9I"5'4%A@L+5G%K0[&6"#>$K<.'J3EA.#U3@-18@US'I#Q1,EEER2_]X M4,/>0]A17%G)P/=A:*8(HI:=K[#HP-H+T7<3XU$S^&*`JI<"-!&;%V!Q*,.O MS,L$W#QUG!V'U0K_%!-Z*`L']>IY))VF[^HNF#;?GXNM`=]?S_//.'/A^7=3 M=N;YVU`#4;0=-S'N9F^PTX$\%ZY.!S9T144(SGL`YW9N0#/20_&8-*(/7(W4 M#QR#0%_ZA7ESL(MTR/\XA-^+K<;AHB)])Y+^=J?<&9/)^NC)YWY") MPK5A0R9#7QBRMO;WT,.AAP*4CJU<9:%C3+5KQ(YQ-"*3A^$K0W/LX*RX16,V M-Z&C[BKL6=UVC##H.I[=KPRMNY$9X0Q_SWFQ9BD+-P>.870/HR2@>_'JFB(C MM1*$!W-^5R4F97%PU,,2NA?4'`UL=[F@E7"$+`N.EKBLJ@NL0[SU@(K20MS)*SD00!/@+".T4?#;`U;'8#BE)J$=131F5-Q@GUPT^<$+A>F[!D.&] MQS7\"/&*@.T:T9,4TT;Q/BDUXU*8+Q_W%!XR"E(Q M#Z6!=?VN6QQ%S!JT79JF_L+=OZ;NXD:B;,ON.@A$.M5-=TAJY6:W9.4.5?X=Q(_4$1NI%WUN'DROU MWCV$8H'WLW?E/2Q_/=LQ=R%.%<:5M5IR-&ZE"ZBKC.VL<*>0(T72Q6&/N'0TQ-'8P2WM<&E1=)$P.#S86-6 MS%Y]^`YJHU];(HA5*XI/SC`K.R"M\Y:V$%F05\J!Y'_MLN*XAA-7,QEU2-S7 ME=@SE9^LPA4[+ET`0G;T?,5*QECQ@&3(.PNU].IRVRL`(4"-R-V0X.D/Q>_R M./Y%N:90Z.=A_:B]Z-`%CJP^'S'*IQO_0D^/C,C'2'Z@NN/.G0EE>06?@?>9 MI160EWI>C^@V(32R\VZT8C!OB(-J$FPP6;%(R9YY$$!-$]C!,2IK\I M[HV'V:/4N3L.NR,L"S/WOX9TBH5Z0Y;K/HB.'*@Y.3'HB;P$E;/DKJ8?Q?*. MAO%!4TJ.;DXTGJ_+-D,Y9>MF49 M94,:8AX+#KN]6=V+.T!7B%@,HRA#!#`:Y$9IS7N73+\"5`,=YK9F4W752JS: M%'DKO3%=3",LP1G:QDKAD7)F M!F6%55X67-S40TRM;@)!5'LDG*>J9FT_Z5\O<(0J!14'4`-9SER= MHRPHC;107,6UI/B?>=1;S%AVKD9E7IQLR(-I305U$_?Z)A7E$K:QO*`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`';E3GBS=^]9) MN+;K/%VM+)TZ+.9V5,45EKZE6!#,FIU87&1M9!Q[J(H+K14PUU5,2DQ9EIY; MZ]BAK1P9F7QR,%#L)RU]0#5RMF$)GGCY$6/_"PJ"1OQ'SHFNC#K?CZH6`A(? M3:D(W/M\E-*BS!-H!,$1F8,92M)7=+ID.?$@2Y.\K57" M&OI/72FDVNU))FFVE'ZEPFA4\O2.6Q*MY7><4N\'6(3Q=&T)/\;03$] M5,^7RWL89$]76&AMOBRL[U-H*1(BQ8#3IZ:V54-0!MK/40UD+!8L/Q(01D$F M`?_/Q&+GBAZ*1ZT8/)35*V09"I+F_-G)J*NX`$%?&8? M6/]#_W<(K+S9%Z+KIO.G=34H(^OZBI'/Y>,:$0?B/Y!UY4W95X`2M!H]MW2B MJOT\7N.$Q.OAY5^B>Z3+OXRL:^>YE0'5H#'3 MNV30T$P8(3]O5,OF0(U'O(:W`=[YLQ!M0)#=;B\(]A,OCDHU%D#HT[^\!HBP MLL0P;3]?7%IDY9+H7]`?D@V%X%`X237`4^/S&I-',3Z9,$M\IMU]JWS.VOB4 M#!,Y8T_>Y*8!R^\+-XJZ6L\H3!F/+E&T+5YD4^&EU=#V?E>I#W$1VG2D/"(2 MF?PDWY1<&S'P8Y7M+7+ZM->]&=VGITQ3?KSD5"7/JD"@C+*M-LX<4FYS*":M M`TUWD"M/K:;2W)E()%KVC>&V!6[W,F`(]V+@_)*F;1*9*D&+38U[B3H/40@( M5P+"VD(ZF2T=LS7AN93\12.OG?,H<_2(<^(%*M!><[!>FBZSD2>O%DWSTB]C MARV26N!F=Q=2BP$$FWJLV M\NFP;4@'%07KK%%P"_*'*71P'E8B:1DV>6WT["_I*!"]L"^M1HVL\NTT(_^( M%L6PRF:B7*_SM62UW[H=1D^K9;RKI=F37J$`LN+R,#F/'/I;Y$$JJW!UCU;K M^F,MCF,T`!LG+\K0$AA"9?)U\/TDU\%-&,8P@&GZ:-$/\)ZJ&U65-?W@$K[` M`+?TT1Q@;4BP=EHO(UPO,JJ5KZ$?M.^VG/M;N3M9_@TG7;_(89KP?]-= M*X2OP`^UTH!EKQ[:4MAR5F9^Z"33UQ!YA>M#JRO'A("=IW.:F,1Q"69$N;:F M)N+&Z;)OB:QGZ1A9XH8JM9ZR8<.[)23VFI1ZRC(T@[/26=GE1P+$FE!II8G?)*WY@R MVLX;E=V!E3(,WPD=4Q2'/FF9MTD!/ MJV+::9ZR*^"4Z7G2\HEF3`4O&)"A6S,9+5< M-P=6SU'I&FPTB0U<*-VE*'!9&C-H8\CMZ&1K!)D:`JO+WCT37]%-];M%=-=? M(@_08]OAQI&EFV1L@R`ZWZ4Q-CI?BRD62GP,2_TCT5I#UE'V+L?5[C@`XLT\=5:"1'TC6Q,M)VKV)P.:M$UL;?/.T6_'/* MH$R].-&QW&;6V)!H*V+&.L`H"O0JHI!\49)?Y=.C68%50`Q>$JE**/]/`E\0 M3J+Y%]:88KX\J)62[`0'=9X-94ZNHC`ZN:ZYHE.+=XTS]"R^"#"+E$C(6'"H MR4M6%#)3UPE2\KR$SZR]#%XN)237^,AIZ51=^30A4(]HZUVX'VS`S^@1>FM= M1Y0WRN27E`!0ZJ%:C=54=J:B&/H_(\J<"?^S6.?<\!"#S?8R8>'YHL1_GE,U7]ZR*'[H MGR<4$KK_RLA18=BIKTX5)-5?]FJMT]+\\J;P%WBSA71F[%=7K^Q'*"%MF?$F MOZ=*@5<$`_0C/'+>:@(O48!6,/3@+5P!UNS]!0:S/"J93:$R@TBJ18#.^-,V MXEK(%MI@H#NPK7A_:>KV'FTI\3'Q>)2>#`K->:_P3G)_PXY"%,-;ZG/X-Q2[ M<(7V21[GNSOP)R87`8@B6Y<\,N2/+)E'YG9'2DK5EV-*6D&5S8<;0#ZWVG\S MHF_0+^S\N9211^OLIVJ'*?`WVFU=L.)]$,=Y`DKJ[;&]< MHZW%G:2+W#37DA"0I2L/U7T^7:AUQNP)JHOA'E52>K?7$4QVM#3!#U$TN]M'<*$Z![1>WF9 MDY>83$H[KL+-Y0U5-02"(MD]Y5'*B^1^[M25D5'GS('DP^"HBE$QA8)QF4NK M]D\=6T59F?``,';4DKVD\/],V"VGZEKI^GYBHNF$PE75@_[)L*G8""XP#>A M)P%]Q^=C%T+7S`UZ#7+B^"=[;.JM+TFRBF[1AI[L?`EI\+]VG9XB((^.J;MV M$DZU096E*E\;M'`)WM*6ZN+5;#78I[HT3G4['>A/28K-E3;"*IPMD-S2__D; M)I_I\>`";%$,@HAQN;7KX`M3?M$@SZSY_!C5^64QY,6FQ6Y MQG/X$?G=Y?TF%<#8=;F%XY/?;4\9-)[YC\M.+PC>0A+O%@%[K9Z=+K9,#&-7 M>#[C;_#V8&#-*)@[(D"J4Q M\)#5N=6L/R)+D7Y<@_`CQOX7%`1CMY[]$SAY#X.I2K$R%.[C])T)FQI;4:8W M:"N;&!>BUNP0YMP`IG!]PJ%7]HW';O3:F3YE#=C5B4+EMNN6LQJ%'ZA[%K=0O')Q_5GC(4RBYSL_93INPA7+%D,\6,'1L3/.Q* MI7^;1%RW@_.3?1]`.XIE(',AQUL&8[#[E_D,'L%KZ1\/"(Q]/?3R_\:/FL/J M2O$(0>:RC[,ZG*^,";E"=1_HI.VFY5\HMLS]WDC,?A%L:M_JX)@L?"^K)^6V M(?]"N;6N[X9LLUV43?](<+*-;D(O2%B/#?IK#[/B.0GTY]L;"4U>C>/5#-ME0X;B'/'50$'-LS# M:G);$W(I+?X-Q!$.\ZX`$A6=VKYSVX)HV'7(Q-R*G;&":7)]<2_N\X)A,(F1 M!P+J-3/'&,5TGC)-<07&<5VR:WA!"Z%KKC2;TC8D-4&[=(4S!9;KV9-V M+ZK,,';LKJR2K8(#8S3Y0&(:1;QU-*K9PM#)0"J+4J'.&O\BR+8N9@UJ MK24I*G)R,H@*TE.H]V;4`I938982D[!K!@UP]99MH0FAJA>/TW0;/])3YBV. MHGGX``(X7Q;WHU9>KO!HO6E;QI>`>G&WQ@NF@>Z4*X>A!4#^$A-J?\]AC#8X M*)5.!*%/?U_TY8%X2?_7/I$D-=;T+[+K]=+R4KR%;G!UCYB!9R*K!MT1&%/=CMU&I'CU/JT9QI^VH%W@7[Z>NA9:Z%A9.Z,D< M"9NCJ3#>S$K:=ZW6MI!24N=%*Z6@>[V>.U?;L MY"H.HJ-G.KTE7R!YQAI]A$JW/+4K'AF?KW^44QQ$19L$I&,B&\A][9=3/>>3 M^H^M'+16+I7[1*H[2+S/QM*H3"11U3ERET)EF!/9D[3M16E2]&-(P3$YG^.4 MU;A2IDS/R576P:!V;(A@LU'#T'ZG(!E+S.HES,D#)"_(@[:N9UOI'%?_&*OF MOQ(N;)697IK3["_P@&*9XA35+YQ?UW4I,@.O-D%SEZZRGEF$MS*E72H?.,Y` MZ<.X.CE')3@R)A;7TACO/W&;2R`&\F%^ZL%40U<#.<-LC\U9CNPE#O")N^-3QM7;VM9%\ZVD]*+.LX15Y'SJ>`\22,OAS=G4GG]*LSJE61V9 M#9H&V]P4*ZD5F6_`]VBUEKQE:__R*).J+$7%F*YQ\#=1C.ETD7:Z2!NAQKN] M1AM5TIB9'O0+`K=4<%>O6QA&<);+W%[9'S<3.=(4M8DM-`G%,Y+7YGREE9H> MS08H.3@4ZZ>PQ#C64Z=ZJ>?ACL6]XF6Y+[2GJ2*TEH=*D(J-R("MZ8,>V5 M0';0C#T)OD8/7V,1CPC"`V]NS+#2VC-Z%2.S`AK)8Z?N:\?4?[7>7MI$CKT.,GHRPIG3,)):8 M5Y]/,,X,VJVEFCWBQ*>=PF17CVIB4D^JT"OZU,)BP>$5("'=C*(%16E-X;Y$ M01+;+;HCP<7)3"G)SF"-G,%BF=07BG"`?-9\Z1>,POA7.CCUPBXP'2>,H+]W MW?`R6U,:H4UQ8O.F/BK?`C_9OYV$G+8M$UJ697EP MP-*HG#YCYI;N4\B'K17M>>]TFY\Y?_31J4GI:]V6N1I\LJNF_R5^V>N]3S@$ MA]^D]^9T;3+C8J_?@"P+CA]K]:_LO[-&6Q:XG!N?%3X?X"1]1W89T2K;@) MNBPYWP:'UZ>*1`R$,H;4IK04,CTW+U%L*V)F@BW'6^[P.M60R_#/(%38SN]K MPE7^F$,LB<4,I2EN8X8P-I'A/YC).01^KRF"%]E5'YW.X:[O'-(_AE>O]%Q. M9T:'(#MK08V!9S!6O]J>)=,1MX&\?8V4JWZ>BWCK*XR:[+,G./1+R@XEL;H) MJ<](`;.79V6'W5$&B,2TU:H43973'<3D6K\5U6?J[1G&]CM0G3S[<=U+E3.) M;%Y)53*6#-]&M8YMXB*J//"`UU$=9*W-:N#+*5$>G`4J-%6Z->C9I4Z<;+G3 M-97TUM"_:*4OJTZW5:?;JM-MU='<5LE9"/E]4R__MMIEYYV8[:A],VZHN[WU MQOQ=%:Q6NF4`T=I:-#4=?,2;K/DH:@:GF=N:`>+J+)VR4C3)7F"]26K*:]X4 MV@8K@@\6]K%7,4>#&^>>IXXVF9"&^F5-C&,0J#NQI4H1F0\59=.0"IKT#C*6 MJUH%Z?8#-/2%A)*>>1ZKW!$MP"XMDU34T_,\DE1ZQUK;0L0YF+0QL"R<2=TP ME&MOA7XVPE@VGE;>)FRFS,M)_>ZAL24->`>Q@,1C@ZVR^D@7>+,%X2[K[@Y" M_Q,%E.5DL4I)^:J[AQY$+VSA'2XDY,J<[TFF_=!RD@\IR=F!Y*R-I%Q5=!.$ M=")=5$$9`]E%Z3V*/MN\G&BCI!ZK;@QH^^*!1\W)@=JDBM:"5:T*8>1ZX0[\ MB>F)*XKQAGI=MNX66JB,P0'I6&=E`;1AI//RA8Z"(IQ0;9&Y2FA\Y7@CY6M. M&O%K3M))PYH+D.:4!#+]TZJ?N,UN[$:Y/CM'3>KNO'_"*))KQU3]9,P@UV=G M+B"E9+%9/9;YLL*RO=HZ?&*N0Y/=,A,`J]ISQYC+<[X[AZ&WIB>!S[9VTUZ: M[H]8@CMK/WJ->SN[V>$-(SAVIRNJXNV@ON4F?S=%_6` M[=W.MQ.:C.1Z\-)KA[R_Z6^<.RQF2_!H.7\M(BT3/FPFWK,V.2KXL;>M]](< MVPXB(*5^'!L[OK$MG^7:#+C;[\F-34PR&_T!,U-RR1V\!BU[1JZ/Y-BVG[J> M5D34!U_)E3#I,#.>!K1T)7)C6ST]\ND"CELC>`SS$K<*MXV$N[\;UK9#D-9* MUY=.>N.33.DI* MW00'E[J(DAU3/:)4.W,,<#IS%CU2%%3'"4UG);Q`\HQ-9,>7BA;8D%YY>"*F8FZ');>J-L0J`#5R=N2UD-WJ1X6)([87 M#;S5UO;I2#:RCI,4[[Z!1I^RF07PEC__4>MIGEJ>*QDV+82FJJ_ MS8$ME^4/+JKT#==8H+M[P'$(M%[;_\>AGF;\#@&Y8J&?2^BEH>D/9U0,'^1> MU_8.,CWWJ1^77%(_Z1Z9!@K9W`+PDG$$`E**?:'U'WE4C$8'*!J92S!_RST%\0A`E=P@C[,__/)'NY4&+2 M6K*Y`:Y4B\J)$HQ*%!N1<:/;@Q9#3CP"S352":`:T$\S^3![?A\\&`)*T]8= M?CLAI[?#YJQ$1;;MB!IYJE`,>="^>[C%=)?T+6:5]=%T?(?[6Q+YP&+;%M?>/L]/"#7D]$!MZ*T+6M08;\5[+\A;" MVF6;4>MB;Q/P,4FX799ZM]UJ>0D8^U]0$%A)2BC&=BZ_5GVMY![L87"_K%A9 M;=LKJT3#Z1G'TL(J0V@@"T%#F/9$>)2",]*O0ZV*+ZMQGY>>L;BQM9%QZ[)6 M];12I;<-$C/V44E$I0(M%B740L7Y_F5\M;5!::"`E[Y@+4OTR(RFZ:)82M*[ M9VW+0^@7UX\SSTLV2<`JN%_")?+L9+P*4'5K5UN4NBPZ$=08DU4;8].E'(OM&H?U5P\N:>G5B3:==CE#-W#5).G1/'T3G1 MN+X-T4SQ3+]BG(;24I[SRZAS&$)+FPR/E/,3P0`+MZE.+9";JQ1U>E4W:7-R ML`H*MQIF'E2]E;O7FTAIWOX4[4[A3&>Q-^^G5E'LUV3G`\0BP&Z=">@JW M*P8"N17/_H]W-E9H\W`TO$Q%5)5[X/E#J\.LMC%MX9VR-U\^@E<;XNHB=VQ7 MGYW0%@M3YR6ZI,@OUJQ1=G03[F\%\E;'8;FEG*21E1SS6&0LC64A;^T;-9U+ M%P)!!"]A]M\W8;-6N"6ON9^NDS.4XH*H>B(&/(*3V&ZM,:HW>AL$FO1;K2TACT2G>AH[FJJ MG?A`I5`^X1B^SQJ,[O#R`:U"M$0>"./<-%*\%CA`'IWB)4O]#"+Y%IO[E/W& MD.U!>T//3?C49,VR/$@MU4YX5Q&*8ZO26L4T_@FV&)-\6)F&AZT?NDZQZ-4W!FG[ ME)UT&N[DVV*#HPYRKALPV6A'T_K;"+]]F MGS%!?,A_9B+X4!)!^\!N]@T#YHF#4[4[FQ3R-R$]=(/@5Q`D,JW.6SYS=K?8 MJ3P,M;8Y&DNEU=/S/J.CH>D'`S-"D7"!,'/`NP:(I.(^W^U__!E!0CE?[V[A M"PQL>46"E)TM%H,^DBC(U39Q>O*\";=)'*6#?[!W"NPBYWC#EM/L5G&U85@] M'NK)Z`Z"*"%9D=DFC_;<+#D&7/O.!@0I!K09BWJ>1"B$433S_IV@"-D,E_%( M'8/-Y,)8JMTANP`?*"*A\XMF<]>L6PJ\[/R<'QY]LD])^A]WGV((%S M\ZOQ@]TR4_7:A`:.ZFTLLQ\)M-B1N)^H\T1*`5%*0-A>/E>R"A"[';:U)QP& MG^S9O06G4A$89=CO4(@VR<:>,UPEX%SQ&VI6QK8&1OW20PU@\&H9X`J!D0-< M!<-(TX"4H#UXR\,[O4(GXD[E$`5Z^"KI"Q#%EPE,BT3UY8US3H$]0TSGLKQ5A'T` M#=X"_`&]QKM+L(L,B$YTK*F<25HE*`R8J\+VY8N#I%DYI_2%YLI=-SJ4W$M183;0N80Y>#9I39S0/=OR_9 M_07>YNV-&#]"]K9[A$E;V1YP#)0#5KNT0R$U";?H!5*?*Z9G4$1-??JLXRF" MRR2X14LKK^.$Z![#`A4#V$`Q8,/B+Y$8>J9F*I$9D1QB;M M%1J6D4:I8/6]H;A>IAP^HS`#W_?3:V807.`P0GY>3FO^I5ZNBG,.D!QRRGZB M+'H:=5^5B^9DE=%6%(@J0P2M*,O!_#E`JUPS%PD]XX`(5OY02.;:1"9M"/0A MUJ@?JWE-4DLLO411.O-[ZKH.D)Q;(7<EMH)UU5)'(E_WT!. MHZZHWHE_]D*99?'\:TQ8%YN#MV'%Q>-3F_*F+0*F1@%)$Y5CGT("08#^@OY' M@$)6<6\>VI5U#\4C6%YWX//4;<3_TYG?.1U("3/@O)05/D&P.QVK!$(7*R%//(E'$LQ"\3J!**0Z9/7/)4B%>$%5"?D"B)_S8/=*T M8PV":!52U(HJJ;I'+;'1BO%_)"",,H[.;#A,4O0G;;_5$"^40R$4U6A9)5E_ M,6$/)>;+3SB\A`%ZH>QEI_`O@/@LELH*#@J66A0;:NI67!2Q0J:#!Z8.QVG* M%*33O$BSOKW2ZWCHK^`E).@%L'LR*VW%J2PORT=^<%A2H%EJ@%1F3U8*"R:M7#Q*/ MG3J6F+"G7T)2YG\]\:VX`Y;B[8V#_+$%P1Z$?MHC+^?PZC7CSXH+UDEOZFZX M&*B%M#7SN`9N?O`=G=06DGBW"`#+8/6O_IV@])E#N=^!NA8>QIZ5QK;9^*"? MJ-+A500KN;8'@L/)&P&AP1N:KL_O84BG)1N$M:XH>2`J5R.%,_:UQ#]"O")@ MNZ8&R5IA2SXQE[NNW#HJ6^`.\#2;%LR3F$7,XC5\8J\[_)223*WOS@&9J[%2PRJJ['AQHQ>=;SS&[ MUPLPJQ=KTV/F4%)S/#NQD'.0!892=>4[AY9WC06';2$Q9?+)5=G0]I5UK=K7OZ3FJQ,TY8;A+T):30^,AI6+$7]^8<315AE]3_QS6\ MA5'$,H?8&Z>2S"K*]+A=Q5/6$N MJ,L:LA:#,GYA[9O1V\C&)-5K%NI8P04D9^_>O5L01,\'6Q!DM6]88K/<)9O( M...7B0@8ZL4%=>14L'PFTYBJ]LWH\6],4KTXGPFLWRM@_7YJ6+^O8:V0N6BB MP$+!SE,8;:&'E@CZ%@-H7&*C%YL`7N7B>.IW`.P1(A7LAEU-/-*_MQ4J:Z4S MOS,=FE?-8VB@8Z1+E5U^O9L$8?21/#G MX63D&I(->A-&,4GZ>]CKW;'7J#C-Y%"S/VU853M%RTKA)O2R9K@@8/'36PS" M:^"A`,4[J<[V?:,XS\#CJUG6[;X7!F/Y,;KRF:WH69[]2D]`]6'! M@JM@O_JJZ5HJ8Y5$S^K0CM%+8?_+XNX>ON#@A9I1!?P[/G=ZT]4M@:Y)&XNQ MRZZ"\_ERIB.*KN]'O1XZ)VXJ3BZ=7B<3TZN=!\8*=)OW;R)F;<)I91DM]LX. M7%ICWK'[@:KU<5:3PP65.XJ+=6?K\-!"98*'AS:L2@M)XVG(W@!625AL3]Q) MT.VZX*MDM7MG)V1FPALPCMD]8$;"GC1:Z;B.L8J)H1VB1B*B*5_HCW=FO*'Q M`MLS>6.I/":V"WM;=BN=::R(=HBJ(6Y5^'\%!+'=B97)L[57-VA,+!^WB5'- M45*K"@BB=$1[FT"-@ML]F*=HE;)]-4@,/!2XQ:&/P[1OP3,(/\^7U+Y!GQ&Y MO3F?WUO<@84(.SY(BPA%$$&]#;H@=I40[.,@`,2>9!HTG!ZQ14301,7((]XR M:7L;;PL5YPZ3".AMZ#3V7,7#&=MZ;.VVA\'=E7)5VV=+L)1RO72`SLN#V;,E M50+.];JA6&5X:V`8.<_F5?@L`EPA,'*`JV`8N8I/"5J,VI2&=[H-=@);`:&Z M]2F!^@G$"8'S9=[&RI8E;B,S-9O<"E4I.U3%.E_@S0:E[X*OH=2]2.N'KL_P M'1))98ZNBLNQZP+)-)&1[,0B*)=G M9W`W,&=D;EFI+6(Q[;F/INL$:`$ABN/77C-CU,94IA97[<6)@;P9"B/,7M_9 MSYLIT1JI<&Z[:O?Q@5,WW8>RUU*RK+*2>4?(6V0E3^C_]"![37D3(O;N-4W5 M;1$QQ\"KCCW:IT2M0E5&4'T34>\[T*Z!+`_8_J)-J8PWU4IBQ69XJ:<_J+7^ MJ2G:OC`1/:;F:@968O4@Q49RV!%$>Q7RP%'/J5:TKZ6[T+1!)./3TJ7Q8?Q) M2:X=(?5L:]/&\1Q$*'J@/`!_'I:O]JQT7!2F/:U-4AY:O$;Y05?N4NB MO.973K9\^C8R4[+QG7"5`Y`#]_.[S(EE$X+I9>!'@B-+M2IXQ*;JP7/!*T1J MH&F?M$QG&TQB]%>*WWRYGUW*G@VQ=M*;:)"K&\-"N@-7[N4XBH4'\8CSY,1S M3`C^PM@%6^"A>*?C@@N,/F%G3`K$0NQ:(3,C]TMPN.LE""M7$9.1@>>A"]"#>ZTB0Q89LN#V>A`7I1-N,:<`=8GAX(HEGH_W:SF(?7-]=S8\)O M'_WHY,X!L1"Y7I#,N,AOT;\3Y*>(_PJ"Q-Q2;PQ\=()N0E?(6"NB9EK&=.XH M6D/_(\:^6"-`V3&/3+(UP`JAZ@6[;"[<]+P8(<,R[B1Q9"+OAK-(-ADP7";F M8*3^Q4WX0O\G)CMKIKR7T,1.:F;`+;1BR(B;F/]!/L,X9=*&Z>\@,*V@JAZ6 MA?0'RT!K.V)67JGM[V/WW!_^64SXFB0FM2?HPEG(?\#0G#C+12,6>PK01F%" MUZ":4!;"'RZ2)\[PIX0]DV$,AQ'T$G:3>PEVIN7/HS*M+<``JH4JZ,3RC,5T MG\(D@GX1:*S,A)>E;"_`*\;,I#8-`]@7^J(3^3-@.:A7"\(XS^?(?%O1:SNI M`:<4S)=#JA"D9M*;/6'.?/J?%&L0'/3/E$N@2G%2J]TPV(7"#!@<%)A!EM#Y MB*_1*[5>:T!6,$K3.TUI!Y_`,?@*HE@6PM<)(@XF^CL(HH2DJ:-)UN/4NC*T MD)Q84,DTX,5K*;V@H[YO:=M=G-:>T(Y0(2N=4*#-"&9R\9;W`X0LD,;M'2ION+,"NF4UEJ$X^A]3$G*A> MY`IY:J7.&7ZSE#8A]NT&V"2H3]*LRZ!;Z(!""$VC&UC!Z8)@#T(_NJ:S+JFI MK7=(7>0F*>E._`K1Z@35#*SN$E_9CQ%%=4&0-T3=@2[B$]RQ)9`MI*\7(=-* MJ6CE3['``'^L*47%A?$II*?Y*-20]&Z6^?^`^RMBWNA+GH1-VOJ4KZJ>XBQ]SEU1!X)6JWL]&W096EBNXLQ211Z-'SI M."[K;O6%HQI'HQ@=.J`3R5-6@8.ONW>+2AV;4P?)VLE0B/:T[M+EH2VDK_=D M5M[C[.9NG_0A69A7;M2I>9>2F!6BU:PXIW.:R)V6C*-]OC>K#:WZD*9OQ&FM M5TFT"HD.%L7C.Q@X!D'I$8?F2;`^VH2<>0F("O$-7Q?N84UGG6[[-C;3TNC3 M6GYM\!1"&K($&U>'%@1?8[(!!\MO8+7Q!IW8(4@>M*+ZKHO,+Y&`8,KF37CU MZL$HXH95+9^`1/B9YBK7$T&A/"[JP.5]%Z+\#'\31A,S$V(8 M%M+5"JBI&P;;`FT2F6Y8HUUP@R6EU7G(NNU1T_&(;Q%X+IZZ;7&8>N_-](6N M[5IRW*FYR;*P%<(=OK!;41#T$;P6["$8M<[:SGH5)S]1>RR%<*$(KK/3GD*0 ME1.%_B6*O&$*-[81G:S0>]$L1*T5M5*RZ-`O%>IG+\QPF+H*4N:;.\BD-MQ^ M2`HQ#5AUK<5RS*((QA%SVC,LZ:;RA>TPEFTRE^Q4#T8"@!8"U\PA4UR915%? MG879/L8$?2@N'(6,M&)7#(U_?%L&@S+SN?B'^N\K*,'7F+4;W4^V@1/XC$GX M-P]O,J(,AA^N`&%O#*(%)/ED6#0NQ^%KU7V[-&HZWNR9[CK`L[)=Q;ZU>KT>0]WEN9[B8(DO02BB(H%!;4(N&YHW"=3MD;T$#31 MJ?2KP9?0C[?4%K3;D:\UWJHR`Q/97#0']%QEG%*K?H77I8VH1/-1WH7J7 M2$EI_0;(!M'C.20+&(;1+G@!(0+[NOOBXA(:R(GG+2,L,3C4.UYK/)J[`X0@ M&,?@(Z1C*LFH9X@IK*8^%-2;66LNI%\A"7'X,PJ"Z":@_X!1I""A_E&?QY_@EU_8#SL%(?6-,7HKUPN">M=J#0-7<$5M,%SC MA`[#IJ(@E]8!)K%NNB%PU$KZZI?\#`V"*W:^WA)$_7UZ?I803=\8HU\RO2"H M]WHV\)"^;0:7F)7R&.K\DU,;O1Q%$"NU8'86*I8YT(F''4K>D9ZJA?X]`R/( M6Z':T[(ZH3$*I/.FA8.7B;"CHORB",*6RW>?^LR9%\\,2`!.0NM8T0>`4PK7Z/AQZ3)F71']\D(O>RSGN\/?Y$L] MY?G`>.@S5?H$-A8CO%;X=',8$):\'=D86;&_4J5DGJTE.UH>WEGPQ)8%K6"G M$?_..?M(U2'-'F582ER`=7SNU""VJ%86V^#/UERNDI8`K@`)$"2_0T!DTLH$ MAG%KJ`0ETC9])WE)-;[M;4I5`L[O\SERXL!1M3S*#L0]VXQL[0.'P=W%[6QM M`R7@2E%9C0(->1\J>]YSE8!S=6]H7AG=&AAU;UD-8/!J&>`*@9$#7`7#S#F0 M$;1X^BL-[]3%Z02V`H*!](A'%`>0/43RT0OR$Q#8,M;MA([.?>?@6;J,4:Y% MB@CTZ#_;6P$U"F[=RD[%K#P-KN%2->:*ICP$V1G:IC6OT7!JC`T^!#"S$?R&XG4:TF<6O^!'EAY/>9B%/JM\ M#TL\,SH2=D]X,-?/H]KTC^$KCH:CR-ULDR8ML-$D9=/^I=.=G2<%SB1-A>1D M,7]Q,H M][Z)M\5=/2P6,F^PSRJ"VN>J'APM#M4$_<=S::5 ME=[HJ:MA;YX`+TT@GT&IS?JGQ%8TQ#R34XTLWO9V`3`K2R/UI)PH9GJU'-V$ M"T@0]C\2'%DYYMI@<\JY?U85M%6F!L\D`VMJMLCFR_1?HUD2KS%AM61'I:=< M)D\F5$R6)IZV.5+,0TNN2:AH![LG9965KY'7?FIJ6[2W@/YE0J@SDIG[C,4* MG*^0>"BRI(WR7+@LGFQ5SQ0$8N)]H1._\1J3)41QPI9#Z%^];A');F(*MV-4 MID^8Z>G>P%CU*`6D;>25I(8N/_?/[KD^N\-$+.NL$>:.^[QC1G[J!9GTWVLK M+[+T/_+4X6PB5EYT&^7OY"GV2K!446I@UW#?=*E]0A;K-PE2/EI3)HI\KAN: M33;.UI39D6H3! M=:YJU!K5%.!`\H(\V+X>/['^M!$%*5UZ4;K&RO_.RD)0V'^'\3WT\"JT%6.T MQ^QD;ZD[5=6B<`N%U2H(."Z-S3:0:TSR7[&_LW+B&7@&Q^H[#*T(A'GI?1/%Y#\K@&8>NE[*C\8UG>C].&#R?Z0K^U+HV&C926`QSW:+6. M67,VCTE^9>^L9YS18S70EL1:Z*E>]4NYIVR:Q]0[[*,E8J4RVNPL[Q&<::+' MIF?FI5*HEN9UD9QR%=TA.9-@#\H.S\M*#5=_3?V:F\T&^@C$,-@];7%8-+D7 MTC`[E(]-S2S)I]"U:5T*U3*E7BAJ+$^:.LNI.S$J![*/UZ,-4=F3;J&T.K=' M)M.*T@!O#:%T)O92AI48.5Y54Y-+H4<*-TT:Y<$.7N1\R73_-_I3Q.SW&@;L MO%_`D4=GA?90V3&/+)5'&M)"\L-?QBA;1584&2=AS#IVWP'R&<8+B@Z=$N6= ME56CF_NH]CT1?H],#8>1<9$,;J)!N_B+]3"D?F5M'=%E5R`G9*5Z!SDR?>@' MK9#E_/XD#S_";WX$:=V$@?LR=8C3N/3E6D+259^U..*DRJ@6HA>+Y`_ M\":4N>29IS7*<'TK@T=F5BQ)L5#(09LS&7\L=0_9XV^ZZNQ&-_O)'UL`RJ:D M"M5STDJJ\VD*%[PAC_6]K!R;KFF+IE"HH3M#=YOFX7;*M[7E'>2MW6RZ6$<# MMB,[>W<3TE_`1_`*B_YL7ZN&%_9#'7HHV>P>UD5.K656&QIR_;[X(T@?EGC# M-714B:G;VZDMR*#FTG;W:7S:&/*#, MB.&2CAW%R+M@`2FRLU@4NI60TY*&W2I8J0W=CE*C.Y:B9PIBUD+IEOY5\`MU M@"*?;I<4!GO"Z",Y$;'T(F=FC5QC`M$JM+Y$6NFXKIPG+HUVF.H-8`QM%O:* MX7%IN2V+)RX'/EBU>M#JUHJ=^A\\&`)Z3K.U;;<3XE:G;V#.*Z%WJE=J6_:BX*Y8L]R\KFA)\(E"E$, M;]$+]"FC$G+A?NS6Z/2*@S]I)SW9%I1%\H@IOC*+HOG5V%=!RSQ=]WTH6'T* MHRWTTEQ7BWU:N<1Y]*@$C:)\ZECP]2C50Q3WIQ-;J6>>J6>>J7VV8I'M*R,LE]"+Z>%_3^F>GH!8 M-8/00P'*((FO(:4$`G8Z2NA8N\H?V]`L$VR-[(;PMK-`A0DQ&.CAH!?>K_)[ ML68+[R8L'D6RD'84P3AB+WZR&04!_M)\@FKX(D"=JU%9B$[],2$"YZ>.^1:R M6JCAZA9'T04@9+?$),W*MJ$?'=2F(_ MUR#^#2>!?[/9`B_>6SV+.XDB)^,Z\'3J@"K6PQ?^9YR"($LK]I/TJO\F_(BQ M_P4%PW<,8D?16A>44EY)G576Q M5BGS,/XP^;0RY'66W"6[FV5)U*Q&[7/"R#$`61TZN\4SQ0@[OLQ04()*3J`8 MN$;ZXAD5?YZL3^Y`3-$)5Y5_SY[8#Z@3(MPXC[O9414A0:@?JO2W;'6^Y\OT M'\>E1P53KG,$G&G37BHF3G:R=<>Z>([:F#XTD\BK?LR6,22/7_#O$)!HOKR@ M/"/VK"BKR2KD]`_!A]N4+47E&D1`PQ\8#4Z+ZA4=CATE)[I\?'0_+]8-]` MLI<9/8,VCO`Z'!X&<^W+]&G2_B:R5VY&[JOWZ9S.&)UMS M99H6T]^YQ)QO!R+@"V`VBBP;"4,JOOFWSDQ.UXI2.]FFRUC)"5O9Y3JHC5$T MG5MM%&.R@A(>B&*+=5#:*8W]^6\?4(;JTIQ> M]"I)@_^B]TPGT?X6AZM'2#9%>;W#ZCW?75`65YCLYDMF_HN_\&U9,E56G(;% M=,R=,O9:%3\>_5^!Y]$]72)>5O_&]>K1U%HFA`8,3IX2/R3;;;";K0C<=V+Z M&4=;1("$='H'<;SS&)!6/T[FG@D8MJ.<&=K;]%19.8)%K2T-`W&T-U\C0V=+ M%*R9(=>U`L9H@P.UBAGA05>_/.G;>YRZ%3%8>Q5'&J'@RG8`H5H5[6J M@JQBMJ!)Z;';59("]0`"&-TE08RV`1*U&Y)CNGP5K!)93"V,+&X.L];SIA+1 M(\X72L$\C*PU6NRE.46ABP.J[I&_0/*,-;(0"E;H%)]1F$'J^ZF"LOZV)16= M?Q%\URPH*GT)2$TD.VL=&4IL[Z<<5QC=/UNU>8B086-Z.X$6 MZ.HO@9N;OG(@+FX-_=CK.-A+<\J.7C^@NIOOM"49P_V=B'A--W',"+ M6=A/R/CW#C)%H?4CDPOK!Q=GL**9[7.`5MG>D\";\('5!O+9`QLKA[!>HM/T MXR1`S46NT*E>U54O,B(7!+/*(=$]#*AWX3_BO%QCK;GQGG7!Q"7ET:>XI#6P MS`6OU:C>V%J_3N*$P)SI(GJ0]?'TV?RNJ1\*@N',@`0_DW3US4BB".+H5N\; M,D'V^Q;/E:4(;HO2-13&>;R&Y('NBS%<(>\F?(%1!O$A@];4226RF2[;24_E MT&T,0 MH=K9K(@V*G4XJWT\;O#Y>!G]`B]M8((6C]T;?'[!-`^6U.=1Z6`OT4^ M_3TUC`N"@NRG1[QE)40N"`0R[?[$1G(^M4 M3?FO4J#?`?(9QM!_8G?)L^=G`E\0RU?X!+]\[,_S/)]CWI7:?QZ=AKU_!F[,IG M3NVQD@#:OW0;0A?:?;C@*^2"&WEG?*HT9+K2T/5 M%BI'?&_8AFFM_;)L=2!(-K=8*JI2^\2MX\77LK3H3VUVCBLA5)G]!#86;P2Y MM,8LKWZ@C"0,72-60OT6O4#_ADX_7"&ZWK*.Q.>[._`G)AZA=,^+6(.)XK%,ZZ'4T"LQ+C'7+H*"_E=;A7)1-),;EJI4G3/+ M>7P<\:H M2L#Y/5Q#`_"6AW>ZA78"6P'!0+WI M![0*T1)Y((Q+A3A9VEEFRD!`W6)ZSJ3FS+/YF%6)CZ-]Y:HFE5+!#OE5]AN( M(QSF:8>E>4A7WU(6%N! M8=Q>SO+UD2$L@H)CBUJ=@#V+V4K']6[9+;UNB,R\KRW6]9MMA6+5LG'1+82G MNAU=O7HP>*%#2OF.S:]&4HJHHY]&RTR=M`&[#?#.GX5H`X*?(0ABE;>??6,X M/1$+R*(7`V?/0>)_5I,#Y=/Q;`F_.ZB7A-3:"?[(CC+=FK[&B6[1!,?0E9,#_VO5!3D`. M'5-7+_BN^03*0_!5)2S2^N$$9-`^8?7BZV:J-K0Q?NJV:*G;XD\Z62^U*H[G MU,D./?BPAC">A:7N3.R9=X"CA&)VOBNBTA\)3K81'2)(?!2NTJ?@K%!X`OWY M-F_38NT!PT"<'^UEX5"2+T[0BN4DKR[N<]<7TF,?]7\I`&R.*"TG+Q$I$AC' MM;T?=C&FL2@1=%T_6).9H.7W;(JLO#W%TA:>D=R?"U:9!!(*4+QC@UN[W6RC M<[PIT.VP%A+[H.*/W(31EOHV-6,D=:_9,8!SQZ]+$;-KS:[I&RS-J99"![=Y M/Y=2?Z_JA.S97''B3@-Y?1)6P-)$"?5;:@3FRV%R/+BTCC7=F@]N(3J5]SN_ M+.[H+*6J(=0^<1M&[5,YAF!]CJXM7!O/MZP)%+'X#*2/INL'(0)R%,=/QYCY M$/UQ"U<@N*(N8Y_]BJ#WMQ5^^99^E,F"_E`70=N`QV:D6D$KI/"=DEO-OXGZ MXYV!6S@7^'>H5O?=&YNQLY+I64XQ_1X3]J\(1G*WH5W?CU,0G3,VF*0A;9HZ_<:#W!:.*IT1T_SQ;.%<&;S MLD6(_L2WUI+H^/<7R45S,/H(\&1G38T?32G M?L'2J1W]B*OO72^0/&/E.M4=^ENZTZ/@<#M0-QO3[B"@L`_U2$4]F[.N2G+)@TU>BS+R]W3R\^7A M1JK"^?S+H2EW=X*A#H')W]NTZHD>YNIYIH'R(;?0['SG]#MJ*/T&T6I-+>2, MJB58P:<(+I/@%BVA#<.CQ<]Q*I<94:FGT):4S-26MB`X>Z,#@IMPBT- MG1<"P+!3]%R$U;.Q`R7W M>I][52E@?@T\.-LPPV4E,XY'ZYAC?WR`2ZG9RBM=2N8+`J]>4<34[B/&_A<4 M!*G5$3HN<3\^1N'QD2I7Z!CZW`R5V*F1..ZS2`/0"[N5W(-3E-PD#'S4[;@2HELZ7%R!:%\?H@>]C MFO2/647D!%%.;AY88R@`&ZJ^,?8^+P"9DS2-W_\5!`E&DZ#FF:PJO'SY6^`$!#&GW]->%XWSUNH4>71./X/42LKHY:9S7 MVB'3+(-''8DS9LT3!ZS_NQ\?HS_"1*H3F)-Y8 M>?C7_>XO/Z19"4O))S;0SM&A<04(J::-U?BNU3ENMVQ"U'EY8B3#=7E4ZB4=K5.98\B MNY5E)NJ:(L8I1,$"@/0@9$.?I.@?\TXA)XA"<08,P.:F,/-N]MD\>9(D=700 M%CN.BHQSG-N*$(*%9'4BJ$KIQR6WM6*ETIO#NR2(T39`HB5-)<<\RN"3-+"% MZ`=,^6SAL7!^KG$0X"]T(WMG=T<]HM7;[($:(PR-50EOR+'13*]BJ M^XI&8`:/!*U6=.<-5ZDU;KNL$7]4HTSO.-T=HQ(I%&JPM%%=[@M;/H@R[8D= MM2.E+XI"BP8,M9IB_F$+AM6EE.`11FW,"J1X,ZJ5)>O8!;O%7\;M@3$&C]*R M69)EH92#1ZK5YG&Q9C_>A-E>/U_VO=0>L(2+>=9/!PDS&E#HN%;2LNY.7L\V M4=V@&^.\F1-!$\%"L#JA;2FY=CS/IOI(8O07R._R$?:O,7D$KXN$4#"@F+QU MQC_&&P\MO`OM&+3V0@L2YR""'9>MXDN_.=#;\+E;`"QD.URN;PM?]Q!MGA,2 M91L35;\+L$4Q2!-"0S_M!*%LYH7&?C.F7PSI0BD&R[5M]6`VE*4HC\V3.Q30 M*6/Z1S.*(WQ1+\/3/_!1'GO4("XT02^!5U<7'F*PV5XF,8+1`B"V/]U2&&:A M?YY0%*G3JFP=!$8^TL.#(LR%0KC,Q*W8,P^O0O07=6M\.F.T1.#@V.39GG0" MQ2&&SHS^6[*!_F7..75T2O_X"8=>0IA`!CKNVN/_2-76C2X46C]<-866^14' M]19V=RQ3GN[J_FP%4!C%Q8L:5;.H0NK-^%!*>B^A>"]%+N52]GF:TC/LV0C+]\!9ZH)5V M;%L+SFRIP=F;.8T+0%RH@EX@UJPNL`F']+N=&0TX#/GL0^NFCJ!2!;.)4T6?T#/.21D=LJH\H M"T=I6Y3E4>C.X-FZK6_O*4A7KXQKZ`O62!!_R2))Y;BC#AKH%QJC$]64TIBT M8%GNTE+.PA(.\V5;*7".3HB,-J3 M[2DD$`3L)JNH96(E_5:!B^-4#!VQ%#JD5Q5`4XVHD_A0X=>JNC2I'6&L5@3C M0O8*\3A#I43XW%W8RV/H)WJDUSD2J!>JH1"\JZF&E%[D]%-/4*(^2,MG1RK" M-H`*6;EXU,]7);NY2$)TWZ19;\G[^)/13>'[X2GT*$@X0#XK&/X+1F'\*R61$)B#\[7J$TAV M0QWO[F"\QGX)\UE8H1+-GB,J&<^*[LJRH!X4;:4&.5;-.R0]1XY5=(%]384&+9:XS2 MTE15V'L4?6;0T_4/"1TM3-,<+:[%;H+2_HL*7H_":2CJH\N;$!5:C1W+^&P. M%)S:#"$U34N+J^M#J:V]3H.+,@'&]OGN'(;>>@/(Y]DKLG+0[J7I\N)+9W%6 M6YOT`5L3H(F>9G>0O7RU(;-V0DX7F:CJ=K0L*_`J[;I&UU+!SB7>4",PS%JJ MT72TEG2$U(]CP_89,WZ/]+,![=Z>W)&:O`.<19DD'6O7QA2C8\_L]5!T=5T@ MH<"5G(L>_.IFT,RB8AP-:`!+Y,9G^[JDTPD)5(2(E/J3;$)2@QNWW9$&QFHA:\"B=[\K_8NL8)D'=Y68MM@@$5RSY=DM0!*.;T&L[CG%65-\8HUQ"?#5E8NB%1=TA:NR1<4BG-Q-3V M!0VX2W%IG2CG@/&N]^\>6#$O>E*!%VM`5C#239V\AUD9J(2UM*#XY+@='O': MC7:)$I<-*%-M(`GT]VB=PQ`N41P]4O:CM>BCP/Y11N";2\J/K1D!=(SX4X/' M@]^?/<``>A2`?R5TY4,2[/8'^TL0@Z<0)#Z*67E%[?!PD\)-N,1DDT7E4>0% M.$H(M+E^9%E0"\C*@BH72U8;?9B9R$>:U2DXC=$HZG)Q*%;4$"/)=!2G]`CX MX,$0T".BK0AT.R%GT0NM15G)KFL'L"H;-=$4`_I_)EGVO,541QXM-^ZLD'96 MI,#%JIK?HR6(IS#:0@\M$=4*:P%,/C'7B5?2PFC!RX3):JF28LMH\4@Y/?\; M,UU<(+4"KS^C1^BM%_1XM0$>""ZPW.U8Q^=.M_@>K6.X=LW/X!5&5Z\Q`91K"@'9I?-D]P?T2\I44"I@:$,M;+([;5LQ MB$#5+X=>('G&)ES>]HXY9K2KUB+G&-2AV=C&Q89QSS@-H7\%2,C:D\T\+]DD MZ:7,)5PB#UFZ2>NE>B0^G@B^18DY@F&S(NDK@>-9O#;AQ1W-`S(6K4,/*V.Y:Y^P2!4E<+P!N M1\`%J>-9NUPPICY2A<_K'G]/7 M?>FMA,U$`3'"ZH]SGQX6=`,.XRAK/R)81I__M>NK(BE!E5_8M@#A+C.9[:/9 MJ6@%0V]W"39@Q6I-)ZMUW%*'VXRJ]1-U'C*7EJX$H.;RCP>R=)>8^L]9;N05 MG5F\*V5^?"WI`G>-U6[>.)9!:"!9!]V'Z(]LM'NX0FR0,/X$-AVK((+>WU;X MY5OZ9;8`Z`]UO>>.ZN:\)2,"IMI\4#3K];"!"V9840Q]E"NC.?&.5<"M8J!3 M48>-EB-2=8!!AP\M)XCRD).Q."UH ME`)B2F9G1GGP&1_7`3"@Y=7A'+U+4X&VAD,I1"7OI5?&NX211]"V^VV8-+SE M4:?CCK2#4HH8J;HCN3&"K!).<$.=Y-=_PITQFUT;UM415L-*UX$IQ6[4?>U\ M1[Z'6TS8P8EE828=<7%)U-M'GY!)Z48I%\%/RA8F&_Y7'"04`K*[1@$DQM"O M#SL]G6\`4YQZWJENE=FXZ7`7K`M$HPNU.MS502?H!]90*;#6.6)F`_\&@^"? M(?X2/D`0X1#Z-U&4=+TTD`.>-_P$1P/G_:Q6@[&C:?NP4S(V'&`* MS#^H&IMBW,-Y]YK^QH!]YPT\H8V5BTV!NL:!LSIV)E4KR)>'GHX'WP%/`?YW M!Z>2$^C^Q[=LS&<0P?1__O]02P,$%`````@`%H%Q1F%E$N'[+P```7,"`!$` M'`!A:W)X+3(P,30Q,C,Q+GAS9%54"0`#RXD(5`L``00E#@``!#D! M``#M?7MSVSBR[_^WZGX'GMRJ>^;4CM>6'>=U9Z9*?B7*V+'7DI/)G#JU!9.0 MQ`E%:OBPK?GT%PT^1$I``Z0H&\YP:VO*L0G@U^A&H]%H=/_T'SL[UGOJTY#$ MU+%N%Y9[_$,\^R]KQSH.9O.A[5H#/V9_M6/WCK+?^7&>-$FI=D-#JO6;_ M?W=X\.[EH74S.K;V]WJ':2/6XB%Z%]E3.B/6P\SSHW[\6).=]D7-'3M%U9,P@F-/Y$9C>;$ MII5FY%L0^D`-&Z7WLK=_T,L'>(@J']X?Y%AZN[]=G`\Y]@),X&O@"?R=`E/: MCGP+'S3A)-$.]+($-2;1+1\@_PMOLK/7VRG1X+G^-Q$9O;=OW^[RO^:?KGU9 MG7[X\RV)V/13C\ZH'Y\%X>R$CDGBQ3^_^#,AGCMVJ?.BQ$TG+OHK]W6XF_[Q M!9<#RP))(+X?Q"1V`_\7*_UM]OOYW/7'P2_Y[]AO`XOK=$S#^FCT\/&C)@$<'ZMD-4>HQPZ?G3" MV)BN[PK(:HLHFWB/3A0;TTX\(;.J9,'7(T:(!3_<7`\DBHEWRK:)*/!S_PM3LFS_&3(1X[J&[U7+OJRL M,XOW%OVTN]I?2_X7_O"K`60_9)WC;JHRLME0,O,*+E=8%.W8K_%A? M56UPZM]7)&1S,*6QRU!%6HQ;;:/!QWU]/EH_5+O_+P%C.ZZN*JK;!7-%"OVY89L[O2O-J^'4S95T\!S:!B=_IFX\0): M[@?A086WR&?J57NHQ4[@9GF8_[32@83ZMV/?^E(])M'TS`ONI8NR^$`P"16& MO:JQ_EB?%G3:6:\HHSX%,>T=)9'KTR@B/K-&(S<*QE>E*:CP3>=[%1M?,]:= MN)'M!5$24O8/Z-2"`TG>L<5ZMGC7P,MRYYW*1%FY/TQF,Q(N@O'0G?CNF.TS MS(BQ[2#Q8]>?7+'58K-S[AI+==N)=%R%MV^$O.6'E'0$KDZ78UC+0:Q\E&[% MJMA\D,U:=$UMZMZ16X\.B4=A0?8]IO3@T+?.9+U6ZGWSK9#'8`/G`UC+$7ZT M^!A\12]'Z39/!8=?#OP[1F\0BE9KY8]*?O7VA/P"8[;43\<1!4<.KU(WX>+* M8WJ+B3.8@?,UAX#B4\7>V.L)>066:M[GCQ;OE2^HHM]N6T1Y]^K,]9G>89M, M/PR)/TGMQ#6^23Y3K[!](=?`7"UZM,I==CN07&)M9A\KEU;%JR:JWPSBPOUW.8=SH=#;W@@6E_'=726A/241ABV$;S#6- MXM"UV?&:_W6-G8T[4FV#AT)^O^7G?];>RH;\T^B+IS@8HY^T,Z@>D:^.,@G$E<9J*/-/8]L3N%VYM9 MAU:IQV[?4[#J``PZ-^9&`ML**^T">&?ZWRA/7$7A)N>9;ZY7M4I>>. MB0HFOAPF\WD:(T>\_.Z@M`I1E17JS6 M#ZYO%8.)[@([MI?9?@@^Q8I3.@Q\]J,M.6HH&RB/]?MB9PPW3M.^*][K2N^= M5:/FZ*O\NH?IPUO7YP`B-M_S(.*DP,*XC*>&Y97OQX!IZ\]L!A*! M8PC]&#^Y[(N]0]QHKG9J\5ZMK-ON:(FS[\UQ$L7LW!?RS=&E(5L23&LZB1TS M"PCT:2BQGK5;*LX]^V(_$C>S\R%^M/)!^)+-AK$JXW2;M8+5;Z^I!PODBH3Q M8L38%<'S%[9RUGDK_U3%3+&3B!O>69\6[]0J]]JYWI4Q!'M#>@=+S*;'4WC9 M(P@76/]$H5+%SB!N01==65E?W5:HYE%O2#T*7LU_)01>DWF+[*:)>"9,$<5,_PN/3M$?KA_R7XN75\:Y^T-P(PID:A\YEK=4^WP.Q5ZE>")WU0SI> MIUQ;":63L+Y.6UP='XA=3;5BZE">=RP7Q]9)."OX1,%`L7=H)1!^1U^^6&@7D2'N)?JR[8 M#L0>'C1,#^-DQT<\7$_"1.13A8_@0.SVD<7M=;S;;OR>A+\;=J?>6<6>HC:B M^;K-MV%HGT041-\HM;0D2&DUT$_!JXY5>$R9C&/R3U7*61*A)`DNZY1S"T%F M,B9JM%%[CEY*XI&4(6<=:]L//9-QNGX7&HR7!"HU"D3KA.$QPI=DXM%&I_C9 M^.5VXYBZ7;Z5>":9?*B;J,RUEPVCFSI3>PNA3C(VUVRO/(*];"GPJ=L<6H[/ MD%TJUFRO%@"Q*ZU^M$9WA='NK?()C8GK-;Y6SILKSGHO)?%7-2^5L]&ZO1U/ M?C4%CR:SI-X'@7/O>AY?,=7T5^)/%):;).*J(1-!]:@\G++W.#\0!N&B[#<+PMC]BX]Y^C"G?D2#<=_^,W%# M2"^JDH0&S172<=A.O%A).LH8K0PD])'#U).93F`R@8'H]@D]C6)W!J?JFXB. M$^_MEM.K4T%*J MSH@;?B9>`LR/IQ32#1-_$17GMH$?Q6&R]`I61*EV8Y5]\&/-X=BQ^0F*FB)%)2/`_;.$BP7JJ6IZENE\_%0['RL&=U>8C)#9'%( MHO8=Y_',^KE?L>_\D627=G'P/@RBB,_[.O_U6BB4N]@!V5P$2NJA!,N*`XL# M2SOH=#AF#>03.P["_`[HA,*=#VR8@GU?XWO5657LP6PN!<6OK3&XLS)4UA)6 MY\+"1&#UE4N%WVM_5.MYL9MR[1%,B8&*#-0=H];7ZNF#G=9>N+R-V-]BFL_A M`E^SJG9*6TWLAL2X6UV>*8`T@"2#4+04EU/I^*_U)DIVAZAN@6_:K\2N18TG M4>7+'W6<=1VG52_?9`L7_UJEJ%_534?? M7>SK,?+CU<4UO0N\.S:!9\1V/3=>\-K>-(I'-)P)C"C-)DJ6BGUC.BQEGS`0 M5H'"RF'\:.5`+(ZD.S>WP'RL$&&S'I2B4?^M:VW1T*EAL=`=UWK_ M2B$3>_`TA0S<=3ED*\6<>]L+V%:!FYL6\+<"NE7";@%X*T??R:%<#K.;^\CU M>38\-G(<'`?LO,4FDO$<&"C8L/1;*=T!K\0^/TVAR8'`I4T.!=Q[)3"\O\[) MUXH08!M7XT[4(B)V"+8M(EK[5RWGCLA$M^P M5@.U-(C]AYK2L,0`FPN@V`$85@E'MUTT2NXA.Z8J/E='';T2NQ05"3ZPPVK' MS92;U]0.?##F^:C!N,2IE$VD]&GNSM2A]]1 M=S)E4T;2&.M2G.,X",N<%\3GU6NJUAEB]V.[H@!Q?1GNG0QX);@3;I+(.NJKYY8*@ MUT*Q8XA]@:U+!,.ZDX)=_ZX3D&:YXF0VAO`C#>4@*3ZZGB\.OY7N&%9$\65< MN`J#.S=RL[0@*\%\XF]4%S^OM9/[58+Z\C]8Q7"=EUZ'@]("32SMQKI;=W.5-7F5V_M5H! MOY'D"40E@`&QRDBL)139`[VTKTYYJZ(%3NB8AOSY=S7UZNJMO_0[?,&_D60' M1-D-5_;Y>.IR[1TS5][6W/@ATY`3'R(6V+0=49]1(O+9Z;50,%B2T0]E<.G] M3'EHKN+SP3NWG=).[EW3V`VY/Q0.*%)36?*=@K&25'T]?CV2]Y>>C'!CN>,9 MGEQ9RC?D6Z5K[(TDZ9XTP7)W(:)Q(;),4E#,W.TBFT[!G8CZ`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`'?:7BS# M;-[S22MQG6]#>'+T5@H?WKYG!%AE"JPE"9TLU;>VY]-[2<:\]SP<(S1J&"Q>6_X^;^W)W&F-Q<.UG")6O;"(BUU`+U! MO'XI6[Y>58Q.V$KJYBW/(,:.*B2,%R.F*R*2EA"0ZA=E"X5"D3C(W_+H;MXS MCY-96.6^NUR]-4HP[PTI9`M@"^QX2L()4FU9^J7RJ-';D]0PVN.QHEFO5M9M M%Z*PC2KJ4K;6[4"Q8MLKHMZ]UM")?]-CGB`.KDY#C14NJ9Z^`=_KMNP."TBJ MNVCI)K@*Z9T;)!&PW*-.,:'%05W@5&_4@4)32$JU;R8Q):!I_=0K5*WG9&@&[<0V+SL M:]]W3OV8I],OO/,I^]`O<#_BNF,H[\SJ0_$3WMW?\S[@I]V'Z!V9SUU&?/[; M]'>^'Z3D%+3_Q'[MSN9!&%L^F=%H3FQ:X>G#;>C],P@GN_M[>P>[KL]T'#.8 M7UB1/:4S^?#Y'S8O>71C"`\%L2U8:1MVL$ M8TRB6]Y?$NW$;,(CUG'OYC_4B!<)!E%M.")GSAKO4BZ.BKYUE7P6BFC/C MQ.$N]+7KLV40NK;>Y*RV@JEY"U/3>[4YD,#?:0@F\#\A>#00E;E_R/_EQ-KB MDC>`P0_7IX&FKR3XJ#^_8&='GYT=!W[^CK!_&\4AL=EP0,O/+Z`O]QVDN_(G M`[;QPVI]89'LJY]?Q&'"_IU^-6H5/O;'#*UD6*R6!2L/1/5N#:'6$VO"]YCU@G=L+D?J@G?F3,V6Z)+. M8UXN:U"4\1JME?$R9W9JH96KB&55J$M>F6I4K4QE#KVZ0.6D5I.R7@JK]YA# M;RVT3W,@;2 MJ@]5?K6RF@IO)$^%9Q#A35!C/%]]%*J7T;%GUWE9?"O=%"69,FLLG MH[TF1[)L-WW'__YFO"7:,`5>&?9L/2>-H1.$(<7(K953Q1S:F\%&_=22%;Z> MWZ/&>GXV"VL;A#:9[=4,$]_I7+=,IM1NT4J,8,YLU8.+J;4ZC[XOQZ8=+S=" MO^&TE-\U/ZL9$0+')F/Y[K%R:N=7N?WE:\V^Z+6F.3/3"A6HJM9\Y6+.E-0% MC!C8I:<0EQIO-LR9@Z;`L07#,]OD=T:F!=EAX!`&YRV,M!XP<(I38:XJV?I/ M]P>F)\`?$/C\ULL<&NN`Q=44?)K%C($63"!D[%E-Q<84R*^WH+N03ME&Z=Y1 MT\P=#!PBYMD!SY]DMT1&+5T,'$)3):@LOTZA0AD8!3RP(YKR*R6'&4`+HV=D M>Z0A8I_'FR^;YZA%[4YEJ9B=-\F`>_0UQ(T%!(H,LG648R[P9J`L844U?*0E/?0>"/VTZ MNZ7A06]_KW=@#JTJ@%+Q%C?<-YVR?35EJ?D`K^N*&`VFQ!,/I``6ACDD:B-% M[ZZRD!36W#1OA!P:'L&6!JS#=0!,"5P8F$,3B@XU#*Z+<)HT!@.>MSKLS^[8 M)MW6#W^I!?[SU5.4%J0-TC+V\(L:]]Q M$)FD\E0`I;M6>]/W[!8*3@RV50ANZXV1!`2;5`A*=]\K%]_&D*6&B*K^+#+L M&MXL&$25&!;VN+Q$L0$+;A40MFA*B^V"&]81I!8PZ2&$$F'S$YL!O%(BQ$/D MB[L/PT[=^G@6^3:)I[WR[]U>P$!D^"&KL.Z>^)ZU_Z1R2 M\HR9IE,MAJTZ(T)RWBB]P^,!/OP9M.]DN:(NQVQ-,75B,/7Z-&#W&.&$WA+[ M&VC,:_83$Y6KP'/MQ8@^Q$<>ZR^?`3_P_63V+LY_WW`.-M#T:JB(Z^N.^@G- MG$8PUC$;"BYKC216&RYZ:Q,DM_$X\?)P9#-)5:&4LC1/ZF8F63)TJ%:Z".[X M/]?3=IX^9`^O\C>U/&F]:40WQX]%ZC7*8&GD_+1""IZN5)[4L>15S873S$G: MA`34W,URG`Q\1;:]3!.9.3N;$8&LLRPK0S`N.A[G2>V((*F=D;.S&0UR,VDE ML8$PI9LJGYN1$[8-RE`%I9,%SLB9:@!F0'E1._F[*6H9W?\J.3).-&H`5*V>_L"&&+CM[CUT;S/'4 MFF*T\?.<6Y23S/S/[MJ!QT@!:94V;'=K<3##)*UUJN07A_6'0\Z70?5\25;/ ME\];5#!7?V/,6\.9D/_GL/VN!WXQ@^>$J@6#$I??V/?R7.BLS MQ-_6U7)GI,4B-[E)E@!#]67^<3$=+5P6%Y2T>U>\#A4-6,MN6HN+UNR%\A;I MVS0&!@&-7`JS\Z$?F4_<"E`YZXK:(;Y3>,"?`7TH;/R^R^$.V`AN:<-CA8!0&-NN(.UI.I\31KI"PJ^:95NO19OQ$STAIJ MFSRE?=_>@(;9-]L@#+$AB_(29T%8W">:'"0J!BS?2I;5RQPG=:_SY^++IV9& MA\1JH,?K,S-E%?4AGC"*GP5[99"ERE5>^W4ALRL"6+MR7ZL)Q"3$],HTPBVRMG_:IF7"0X:DS399:9NU^KB\6/C>J@!4]6QNBZ> MD?OXH]./&DV/B,8P*^!)*,<302\;9PTE52'-5:4U:,`O4U#NY`$V;A%@$XL# M;)[5VM>G:LM3]YP6:CUZT#,/#PC)^LM?Q40BAJ?]#O2YI1 M`E7G_PW'_A3P2%UI6>+O48KU:,9MOBU#^+X$7)]:=8#T7BF?ZM*[("C=:Z3D MUH6/!\MK=V:8.#4!7BM++OLA_UUF1R]O0?.<[^9Z?9J1HSE!I>0LQ5W%,*;S M9&[PG;T>?L3$$SC2MI!C9%ODZZ!7V0F]_:P4=*G.8!XKO^*:S5^*W^;5H\U4 MI1L3A._PF_1OFKYMA90M/Q[,`:V6$V6(8[TJU.GM035$LIK&E(AJ)ILIW<]Y M+K?Z1/+):#-M43_W693:M@*ZECFG:Z::SH"?NS:DY?,G:1)@'E,"%BKA)T868,3>D>]@`>&_#W846,^E,;"Z;&T>AO:SVU/G'?A0Q\]QO$-J?L"=U.%VP!?>LT MP%-.&WY5:CP1?Z.5W_:$/8II?^.3A-DVW*MV!IG)!%M'7BMZ2S=0E`$EB)[FW;2WZT-0\K#AS9A$2NV2S#!_$J![W+^]6\ M2QFJ5'H3EBWWN6MYT[2WXSS(/G*AP9/T<:DR=5E_XXI M5L`$#[6(1X?43D*^(0\#KPVQV5JQ0QPXIB[S>8/(D="A3E9(9^M2T?@9=!V\ M.H3G0;DKB&#$G.&#!SW4ZEGIT3(3_%42I; M_($N=4;!>>!/1C2<+1>(R5M!,X*447NI8P^^O:9W;K0,68+MZE>EV-6'>T/I54#3'9R:*)6 MW`XK>S',DU$#;_.,94;R6P/Q9HEE#..T)E9$OB%YVK)0PA5'Z-I9];BKU`R[ M'`^@WC'QS@/BIZ_!-C76-E;I37'K3T5(YVEO9Y1F'9+)QE9JVX1+4"+9R*OM MF1#Y,$77>:;=@7]$(C<:SD-*G$O_,PGY(X8V+/2V::^%7:KI-NCT]&@P.NGS M9)RC*;/RIFM^BB=))MHV1=IKAF=BI&.2>/RH-/"9O4(BT^1&AK+VFLE;CH+, M7#QBQ^;@/HW>);8;MY&<>'OOYIO2I"T.1=,CR`*2Z^13STUKKDDO!0R1D]KP M=05(W/$%DT6V$+VH[SM?!E>7_MG@[/)93(D8^6:S<>XRF]7A)E+%GV#T1*R! MWF0.F&GG1E/JP+/[Z!F07\7;&O3CVN>XKL)L]RE2B) MP-/5Z.BC\!N->5_/;1$AX&LGO<]+@;.306'+%<,L__STT[(A?/F2TN\X/1T* MI\5`VVTSNJ0G(?UN\^L#N.^C-L-[1R%D8N7LD[DX'OEJ8W,JZ@I46J8A)>EE$42Q_%<]!!3:G92(+2,_@H*-7]B)Y#G1(E?-3U MNDG/%^S$FH3\;)^(8B6,TD2-2<(,`!JS(UB4#W:9Q,!GA]D6J8[;_,IY<\E1 M0=2W^DH)[I:)^,L.2I53?HL\UT6J[40I=3$89_^@Q;Y^Q4BTW3GQ#+96FM&# M*@MIE\N]/?!+V_HH)"!IQM@HF^!73LQ2THKI78ZUW+NJ%SDF1B'5)T9[5643 MFC8K3A5,25,3S]$JM$V4R2B(B5[6S(2%%K MTBA*`-MQ$,50A=/.(OS6*DE=CN%S@R-QFU"#RPSK#'*3%S=G8.4'/D]1_@SF M00I=I3%XV_PNZ-&H;F5I(-"1%YL/MI=$W%\[8-8QVX1C_@PBS2U=1%F<4EZ18F M&>B+&T\'ON/>N4X"+_<*$^`SKS4SF,V8H<'L0F]QPVS!W&+<.'"_#[IG.G4!(ZJK[_N0<;G:@/6?KWDC MEI42I/S=53X[P^3V#VK'HX!/4^"!-V$4P-*+*FK-9..^/C$(XQNKJOS.D/\U MZB?Q-.`))XK"U`8HD2T2UZ@(EY%6D1RH(B.SH)UAY@L.$67AC<^.S5[*\\)Q MD!=^&8ROLS\:[![3I0"U+=ADI:\@W5L^()A[F;H-HPL2VU,(B"U]`/LO)`DI MMJ;^F!VW1_?!5TJ6EU[,3*3AG;NT-)YN$WT,(A]EBJ%`*.F''T2(YA^G)I_2!MS$%IK&^%F1U9OQ2NM1* M_@U(11)=)%[LSCUW-0;D2:*'ZB*N78Z(9VOX;G(/:="#&G."+LN9+"['&C/U M9#?@&X''KK<@LT>ZU?8G;%/-+E$Y/9#/Q(SX$!5(^2Z8'>'RJFQ%OI8LX&S% MF5`D;VDA*\G&+&^._5'R"INYD[9'V>-423!M,VZ7)D3Q7(7T],'EQGU^'.7Y M70W>DZ20$1?)RAH^<=/R[@:JEP(:MEMD0E:T<@V)+18"0U*1IA\M,UN-0N)' MRRCVM2ND)R)+!V`L M"$?D@1T%F)FVFJC^B>1A$_QUC_%'6\@-^YB5^];QURH`>4W=V6T21NF2.H,4 M=KQ:(H_U8EB3<+OE1[;BZ]$@J:Z8E*]_69<7+MO98C83S+B8NO2N%7_88TZ2 MFIZ:>G08D]G\)(%4S5"#BO5Y#O6D?.J6M)6Z?-Q*V9L M?8IJY8MJT%OO.YN=WF;KK,@N\ZRG94D%-AF9?7WNVFQS9#K^VIU,6\E?LK7Z M,F+`&JZ+DJ=C&2'Q*8@AH3%UJ',Y_AS`$2Q_[5+,Y-,'@VQ.`EIWAX?LI&7/-B78U&=M*?(2ZX#4DWD>C60IXNR+%?X4()NZV7IUO31*E24KG*-.H,\ MR`)8JN+/;XX3=HR8T7"8S'G@`3.9,Q7%#JFP0D/SXZ8:$='RS)AVM]<8OO)Z M/>^XJ&,,Y8@K?5Z[T3<3_')U$2NOTM]FU_)7A!G\_'J&V.FEJC%M`>CCE4I\JD-YI9_Q,+GE[RJ+F!0C-#Z.$-W#LMJ?0SCIPQ9Z1'TZ=N-( MDLW;J'LN-79U&=/>D/T2GB_^*V$20D-O411./2$Q*0I*F[RTFQ&A6.EU.S5L MX3>'K]SY;H97!'*%1^GIK8W(CO;*6:V#D]+3MUWZ4*B)"UI.D^8'/IP3G0"> M/3TR*4)<"!7%83)3]64?>?[VW2#B].$BA2*=/Q((W,G+.O'&!A&)P,-W(WCI MD;8V3":%P+!WM=`@#]3B'$)9RB[:]TI)8O;?D-ZY01)=WOL\%?9G M]E]R-27AS$1J-3'K<';9*$WU](&+AI$\QJ'J<7O9A^&K%0.JJ972S%,?7+;J MGP%O4:S2_?T8'GX%X:)G$E%52$KL^^9AW]?%?F`>]@,E]BG$_`_\4];MC)AT MYI,@P]<[1`9,Z"VQOT4\[^$M:VC2&L?P(3M4N2Z02>2(<,E%+?"3:$;##Y1X M\=0D*@2X$"JB8&[0$;""!U\<_,NK,].P%XA0JZ52GN8+@;=*L4E+`<.'5U.\ M(HM@/#:'E#5,:!;V(B"=1EE,DTF42-'ITO0I\&VCR5H#B!8H2N@)$U!(XD// MZ81XHY#<4:^?Y0Y8OF9"Z>4N7"E]('#%A3(-K2W']\!CL^-I(K;\Q#=C. MEW:>[2J0HLRH#0%!APENVBI[S6\<-55<4FT_N+K^]XDYX,MPD+GG!8W@W\PV MH^'L/""^@<%K&BBQ12-H;M[-O1JD?/L=^`ZD!':S/!&?+L]-HDN"#><8TY#$ M,S02#T&'+C7>BC^!,HZ6,BI,SJ*Y&]*50XU)Q"#X,++RO"H1/Y>:1)`0&6I# MP0-/#Z*T(:EE]H`^K2E$"1Q@H%`;.X0'<]-T?'W8R&K[>'5A<)@6@@ZG*0@G M)D5;KB#"5/JO9!X$H7F.8"$NJ97W*[#*GIZ$R20Z=V?PUL$@4J3@I/2MX3BDQ*`8&3V@ MJ/(_]X*%T_L4H%$5&`:4UFZMPPFS+L?Z+W(.I]>(-K&V8B:B*5 MVR35#FYO(5P*7.3K71G$VOJ@L1V#]1:Z-([)>\HV&9>8MXTK$$HUTH7]*XTB MH^2UB@AE"PWM;T;&)$N0H0HS+0Z9"J5YQ@F"#GMI>GE^^L`.0LRX/*(3U_=Y MVI?]O7V#@K64&)6OC`UB4QD.PI>L'NE[8",D8=K?Z[TTAP@$70V:3DD(&3%X M32ES:1.@Q%3>91+#S1@[@=^`(\L9QF:%J:'XD.SM-.SM[>TQ:].WW3GQ\JR% MAJTN'9CR/!.!!_FQ/,\UB*!53%AYAP`>GKLFO9E9A22?^Y#.TS*@X-$>N@^\ M6KI)DH4"Q'/CT<@.7:Y6C'6'JD%BE1W<(!P%;!,PR&A8!X5:">)\@":1@^"3 MLZ::T]D\HQ7%AY#ECLEL[AITGEA!A*80!,/"(.@5/'@>029\A`UMT".454C2 M#2;_T"`5M0I)CIWZ3)E=$)],#+MMER##I8CG@*/Q)WK_$7Y8F.>L44%$C+"\ M*=-E=!HD$>7)P,PC38A/KG'7L[KS7&YC2'FTFM_=(&+KHY8O0HCK3`^'$-4) M1U[6')*'F$2O`B.^,-.$+OW0#MCHQEU98?!PNI+;@#_=!_5^I1OSN2X!+*?;M;]1 M*#-AUL-W$2QT:[EG`L\.4NEQ@LO^BAEN$&VZ6.5,6_9P%B1A3*FY)`H`8HS\ M3$,&_`,;-QIXGNL';F2>Y:8&*3_#FYCK29C+28G?O$@U*39,XM@Q;P:YV6EX M17T_6GAWQ#:Q209% M%1"2[B6P$_@G/-7U6<>+@3\.PEEZ!LB`/GUI!BV47"W\M,M(C.PIG9%4L_]_ M4$L!`AX#%`````@`%H%Q1IYG.>ID@0,`NY-6`!$`&````````0```*2!```` M`&%K&UL550%``/+B0A5=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`%H%Q1M/^HLL4&```*DL!`!4`&````````0```*2!KX$#`&%K M`Q0````(`!:!<4;QRS4Q4*0``%H0"P`5`!@```````$```"D@1*:`P!A M:W)X+3(P,30Q,C,Q7V1E9BYX;6Q55`4``\N)"%5U>`L``00E#@``!#D!``!0 M2P$"'@,4````"``6@7%&H8:R"X\A`0#@)@\`%0`8```````!````I(&Q/@0` M86MR>"TR,#$T,3(S,5]L86(N>&UL550%``/+B0A5=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`%H%Q1IOX=U\GI0``QAX+`!4`&````````0```*2!CV`% M`&%K`Q0````(`!:!<49A91+A^R\```%S`@`1`!@```````$```"D@04& M!@!A:W)X+3(P,30Q,C,Q+GAS9%54!0`#RXD(575X"P`!!"4.```$.0$``%!+ 4!08`````!@`&`!H"``!+-@8````` ` end XML 64 R53.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) - Fair Values of the Company’s Financial Instruments (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Note 2 - Summary of Significant Accounting Policies (Details) - Fair Values of the Company’s Financial Instruments [Line Items]    
Cash and cash equivalents $ 70,680us-gaap_CashAndCashEquivalentsFairValueDisclosure $ 34,178us-gaap_CashAndCashEquivalentsFairValueDisclosure
Foreign currency forward contracts   208us-gaap_ForeignCurrencyContractAssetFairValueDisclosure
Available-for-sale securities 8,391us-gaap_AvailableForSaleSecurities  
Total assets 79,071us-gaap_AssetsFairValueDisclosure 34,386us-gaap_AssetsFairValueDisclosure
Purchase consideration payable 7,613us-gaap_CommitmentsFairValueDisclosure 14,728us-gaap_CommitmentsFairValueDisclosure
Total liabilities 7,613us-gaap_LiabilitiesFairValueDisclosure 14,728us-gaap_LiabilitiesFairValueDisclosure
Fair Value, Inputs, Level 1 [Member] | Fair Value, Measurements, Recurring [Member]    
Note 2 - Summary of Significant Accounting Policies (Details) - Fair Values of the Company’s Financial Instruments [Line Items]    
Cash and cash equivalents 70,680us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 34,178us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Total assets 70,680us-gaap_AssetsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 34,178us-gaap_AssetsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member]    
Note 2 - Summary of Significant Accounting Policies (Details) - Fair Values of the Company’s Financial Instruments [Line Items]    
Foreign currency forward contracts   208us-gaap_ForeignCurrencyContractAssetFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Total assets   208us-gaap_AssetsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member]    
Note 2 - Summary of Significant Accounting Policies (Details) - Fair Values of the Company’s Financial Instruments [Line Items]    
Available-for-sale securities 8,391us-gaap_AvailableForSaleSecurities
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		  
Total assets 8,391us-gaap_AssetsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		  
Purchase consideration payable 7,613us-gaap_CommitmentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 14,728us-gaap_CommitmentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember
Total liabilities $ 7,613us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember		 $ 14,728us-gaap_LiabilitiesFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
/ us-gaap_FairValueByMeasurementFrequencyAxis
= us-gaap_FairValueMeasurementsRecurringMember

XML 65 R72.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 8 - Leasing Arrangements (Details) (USD $)
 12 Months Ended 0 Months Ended 1 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Mar. 03, 2010
Jul. 31, 2012
Note 8 - Leasing Arrangements (Details) [Line Items]          
Operating Leases, Rent Expense $ 3,300,000us-gaap_LeaseAndRentalExpense $ 2,900,000us-gaap_LeaseAndRentalExpense $ 2,300,000us-gaap_LeaseAndRentalExpense    
Lake Forest and Gurnee Facilities [Member]          
Note 8 - Leasing Arrangements (Details) [Line Items]          
Lessee Leasing Arrangements, Operating Leases, Term of Contract 10 years        
Lessee Leasing Arrangements, Operating Leases, Renewal Term 5 years        
Warminster, Pennsylvania Facility [Member]          
Note 8 - Leasing Arrangements (Details) [Line Items]          
Lessee Leasing Arrangements, Operating Leases, Renewal Term 3 years        
Operating Lease, Rent Expense, Monthly 11,000akrx_OperatingLeaseRentExpenseMonthly
/ us-gaap_LeaseArrangementTypeAxis
= akrx_WarminsterPennsylvaniaFacilityMember		        
Area of Real Estate Property (in Square Feet) 12,000us-gaap_AreaOfRealEstateProperty
/ us-gaap_LeaseArrangementTypeAxis
= akrx_WarminsterPennsylvaniaFacilityMember		        
Marrietta, Georgia Facility [Member]          
Note 8 - Leasing Arrangements (Details) [Line Items]          
Operating Lease, Rent Expense, Monthly 10,000akrx_OperatingLeaseRentExpenseMonthly
/ us-gaap_LeaseArrangementTypeAxis
= akrx_MarriettaGeorgiaFacilityMember		        
Area of Real Estate Property (in Square Feet) 20,000us-gaap_AreaOfRealEstateProperty
/ us-gaap_LeaseArrangementTypeAxis
= akrx_MarriettaGeorgiaFacilityMember		        
Vernon Hills, Illinois Facility [Member]          
Note 8 - Leasing Arrangements (Details) [Line Items]          
Operating Lease, Rent Expense, Monthly 15,000akrx_OperatingLeaseRentExpenseMonthly
/ us-gaap_LeaseArrangementTypeAxis
= akrx_VernonHillsIllinoisFacilityMember		        
Somerset, New Jersey Facility [Member]          
Note 8 - Leasing Arrangements (Details) [Line Items]          
Lessee Leasing Arrangements, Operating Leases, Renewal Term 5 years        
Operating Lease, Rent Expense, Monthly 38,801akrx_OperatingLeaseRentExpenseMonthly
/ us-gaap_LeaseArrangementTypeAxis
= akrx_SomersetNewJerseyFacilityMember		        
Area of Real Estate Property (in Square Feet) 50,000us-gaap_AreaOfRealEstateProperty
/ us-gaap_LeaseArrangementTypeAxis
= akrx_SomersetNewJerseyFacilityMember		        
Somerset Warehouse Lease [Member]          
Note 8 - Leasing Arrangements (Details) [Line Items]          
Operating Lease, Rent Expense, Monthly 3,300akrx_OperatingLeaseRentExpenseMonthly
/ us-gaap_LeaseArrangementTypeAxis
= akrx_SomersetWarehouseLeaseMember		        
Area of Real Estate Property (in Square Feet) 6,600us-gaap_AreaOfRealEstateProperty
/ us-gaap_LeaseArrangementTypeAxis
= akrx_SomersetWarehouseLeaseMember		        
EJ Financial Enterprises Inc. [Member]          
Note 8 - Leasing Arrangements (Details) [Line Items]          
Lessee Leasing Arrangements, Operating Leases, Term of Contract       8 years  
Operating Leases, Rent Expense, Sublease Rentals         $ 240,000us-gaap_OperatingLeasesRentExpenseSubleaseRentals1
/ us-gaap_LeaseArrangementTypeAxis
= akrx_EJFinancialEnterprisesIncMember
XML 66 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
CURRENT ASSETS    
Cash and cash equivalents $ 70,680us-gaap_CashAndCashEquivalentsAtCarryingValue $ 34,178us-gaap_CashAndCashEquivalentsAtCarryingValue
Trade accounts receivable, net 220,716us-gaap_AccountsReceivableNetCurrent 64,998us-gaap_AccountsReceivableNetCurrent
Inventories, net 131,310us-gaap_InventoryNet 55,982us-gaap_InventoryNet
Deferred taxes, current 33,480us-gaap_DeferredTaxAssetsLiabilitiesNetCurrent 7,945us-gaap_DeferredTaxAssetsLiabilitiesNetCurrent
Available for sale security, current 7,268us-gaap_AvailableForSaleSecuritiesCurrent  
Prepaid expenses and other current assets 30,875us-gaap_PrepaidExpenseAndOtherAssetsCurrent 5,753us-gaap_PrepaidExpenseAndOtherAssetsCurrent
TOTAL CURRENT ASSETS 494,329us-gaap_AssetsCurrent 168,856us-gaap_AssetsCurrent
PROPERTY, PLANT AND EQUIPMENT, NET 143,788us-gaap_PropertyPlantAndEquipmentNet 82,108us-gaap_PropertyPlantAndEquipmentNet
OTHER LONG-TERM ASSETS    
Goodwill 278,774us-gaap_Goodwill 29,831us-gaap_Goodwill
Product licensing rights, net 704,218us-gaap_IntangibleAssetsNetExcludingGoodwill 115,900us-gaap_IntangibleAssetsNetExcludingGoodwill
Other intangibles, net 259,141us-gaap_OtherIntangibleAssetsNet 14,605us-gaap_OtherIntangibleAssetsNet
Deferred financing costs, net 21,560us-gaap_DeferredFinanceCostsNoncurrentNet 5,676us-gaap_DeferredFinanceCostsNoncurrentNet
Deferred taxes, non-current 3,020us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent 1,643us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent
Long-term investments 208us-gaap_CostMethodInvestments 10,006us-gaap_CostMethodInvestments
Other non-current assets 1,863us-gaap_OtherAssetsNoncurrent 3,180us-gaap_OtherAssetsNoncurrent
TOTAL OTHER LONG-TERM ASSETS 1,268,784us-gaap_AssetsNoncurrent 180,841us-gaap_AssetsNoncurrent
TOTAL ASSETS 1,906,901us-gaap_Assets 431,805us-gaap_Assets
CURRENT LIABILITIES    
Trade accounts payable 44,116us-gaap_AccountsPayableTradeCurrent 22,999us-gaap_AccountsPayableTradeCurrent
Purchase consideration payable, current 7,481us-gaap_CommitmentsAndContingencies 14,728us-gaap_CommitmentsAndContingencies
Income taxes payable 1us-gaap_TaxesPayableCurrent 1,459us-gaap_TaxesPayableCurrent
Accrued royalties 13,041us-gaap_AccruedRoyaltiesCurrent 6,004us-gaap_AccruedRoyaltiesCurrent
Accrued compensation 13,467us-gaap_EmployeeRelatedLiabilitiesCurrent 7,692us-gaap_EmployeeRelatedLiabilitiesCurrent
Current maturities of long-term debt 10,450us-gaap_LongTermDebtCurrent  
Accrued administrative fees 27,774us-gaap_OtherAccruedLiabilitiesCurrent 2,544us-gaap_OtherAccruedLiabilitiesCurrent
Accrued expenses and other liabilities 17,835us-gaap_AccruedLiabilitiesCurrent 5,819us-gaap_AccruedLiabilitiesCurrent
TOTAL CURRENT LIABILITIES 134,165us-gaap_LiabilitiesCurrent 61,245us-gaap_LiabilitiesCurrent
LONG-TERM LIABILITIES    
Long-term debt 1,114,481us-gaap_LongTermDebtNoncurrent 108,750us-gaap_LongTermDebtNoncurrent
Deferred tax liability, non-current 268,968us-gaap_DeferredTaxLiabilitiesGrossNoncurrent  
Lease incentive obligations and other long-term liabilities 2,536us-gaap_OtherLiabilitiesNoncurrent 1,630us-gaap_OtherLiabilitiesNoncurrent
TOTAL LONG-TERM LIABILITIES 1,385,985us-gaap_LiabilitiesNoncurrent 110,380us-gaap_LiabilitiesNoncurrent
TOTAL LIABILITIES 1,520,150us-gaap_Liabilities 171,625us-gaap_Liabilities
SHAREHOLDERS’ EQUITY    
Common stock, no par value — 150,000,000 shares authorized; 111,734,901 and 96,569,186 shares issued and outstanding at December 31, 2014 and 2013 351,235us-gaap_CommonStockValue 239,235us-gaap_CommonStockValue
Warrants to acquire common stock   17,946us-gaap_WarrantsAndRightsOutstanding
Retained earnings 50,711us-gaap_RetainedEarningsAccumulatedDeficit 15,366us-gaap_RetainedEarningsAccumulatedDeficit
Accumulated other comprehensive loss (15,195)us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax (12,367)us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
TOTAL SHAREHOLDERS’ EQUITY 386,751us-gaap_StockholdersEquity 260,180us-gaap_StockholdersEquity
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 1,906,901us-gaap_LiabilitiesAndStockholdersEquity $ 431,805us-gaap_LiabilitiesAndStockholdersEquity
XML 67 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 18 - Customer, Supplier and Product Concentration (Tables)
 12 Months Ended
Dec. 31, 2014
Risks and Uncertainties [Abstract]  
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
   
2014
   
2013
   
2012
 
 
 
 
 
 
Gross
Sales
   
 
Net
Revenue
   
Gross
 Accounts
Receivable
   
 
Gross
Sales
   
 
Net
Revenue
   
Gross
 Accounts
Receivable
   
 
Gross
Sales
   
 
Net
Revenue
   
Gross
 Accounts
Receivable
 
Amerisource
    38 %     28 %     46 %     19 %     14 %     25 %     19 %     14 %     29 %
Cardinal
    16 %     14 %     17 %     23 %     16 %     26 %     23 %     17 %     30 %
McKesson
    23 %     19 %     23 %     16 %     11 %     12 %     16 %     11 %     14 %
Total
    77 %     61 %     86 %     58 %     41 %     63 %     58 %     42 %     73 %
XML 68 R96.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Betimol Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities (Betimol Acquisition [Member], USD $)
In Millions, unless otherwise specified
 0 Months Ended 12 Months Ended
Jan. 02, 2014
Jan. 02, 2014
Dec. 31, 2014
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Betimol Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities [Line Items]      
Consideration paid in cash at closing $ 7.5us-gaap_PaymentsToAcquireBusinessesGross $ 7.5us-gaap_PaymentsToAcquireBusinessesGross $ 7.5us-gaap_PaymentsToAcquireBusinessesGross
Purchase consideration payable     4.0us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred
    11.5us-gaap_BusinessCombinationConsiderationTransferred1
Intangible assets     11.5us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
Licensing Agreements [Member]      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Betimol Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities [Line Items]      
Intangible assets     11.4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember
Other Intangible Assets [Member]      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Betimol Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities [Line Items]      
Intangible assets     $ 0.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember
XML 69 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statement of Shareholders' Equity (USD $)
In Thousands, except Share data
Warrant [Member]
Common Stock [Member]
Warrant [Member]
Warrant [Member]
Retained Earnings [Member]
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Warrant [Member]
Common Stock [Member]
Warrant [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
BALANCES AT at Dec. 31, 2011           $ 212,636us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ 17,946us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember		 $ (72,374)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		   $ 158,208us-gaap_StockholdersEquity
BALANCES AT (in Shares) at Dec. 31, 2011           94,938,000us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Consolidated net income               35,378us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		   35,378us-gaap_NetIncomeLoss
Excercise of stock options           1,511us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       1,511us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
Excercise of stock options (in Shares)           806,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Employee stock purchase plan issuance           368us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       368us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
Employee stock purchase plan issuance (in Shares)           71,000us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Restricted stock awards           351us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       351us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross
Restricted stock awards (in Shares)           29,000us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Stock-based compensation expense           6,681us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       6,681us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross
Foreign currency translation loss                 (5,904)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 (5,904)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
Excess tax benefit - stock compensation           4,488akrx_DeferredTaxAssetAdjustments
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       4,488akrx_DeferredTaxAssetAdjustments
BALANCES AT at Dec. 31, 2012           226,035us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 17,946us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember		 (36,996)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 (5,904)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 201,081us-gaap_StockholdersEquity
BALANCES AT (in Shares) at Dec. 31, 2012           95,844,000us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Consolidated net income               52,362us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		   52,362us-gaap_NetIncomeLoss
Excercise of stock options           2,634us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       2,634us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
Excercise of stock options (in Shares)           630,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Employee stock purchase plan issuance           588us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       588us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
Employee stock purchase plan issuance (in Shares)           61,000us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Restricted stock awards           579us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       579us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross
Restricted stock awards (in Shares)           34,000us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Stock-based compensation expense           6,471us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       6,471us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross
Foreign currency translation loss                 (6,463)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 (6,463)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
Excess tax benefit - stock compensation           2,928akrx_DeferredTaxAssetAdjustments
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       2,928akrx_DeferredTaxAssetAdjustments
BALANCES AT at Dec. 31, 2013           239,235us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 17,946us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember		 15,366us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 (12,367)us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 260,180us-gaap_StockholdersEquity
BALANCES AT (in Shares) at Dec. 31, 2013           96,569,000us-gaap_CommonStockSharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       96,569,186us-gaap_CommonStockSharesOutstanding
Consolidated net income               35,345us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		   35,345us-gaap_NetIncomeLoss
Excercise of stock options           8,013us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       8,013us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
Excercise of stock options (in Shares)           4,226,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Employee stock purchase plan issuance           829us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       829us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
Employee stock purchase plan issuance (in Shares)           73,000us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Restricted stock awards           1,188us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       1,188us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross
Restricted stock awards (in Shares)           16,000us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
Stock-based compensation expense           6,354us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       6,354us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross
Foreign currency translation loss                 (1,704)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 (1,704)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
Excess tax benefit - stock compensation           38,710akrx_DeferredTaxAssetAdjustments
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       38,710akrx_DeferredTaxAssetAdjustments
Unrealized holding loss on available-for-sale securities                 (1,124)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 (1,124)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
Convertible securities 26,117us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 (17,946)us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember		     8,171us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember		 30,789us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		       30,789us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
Convertible securities (in Shares) 7,192,000us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		         3,659,000us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		        
BALANCES AT at Dec. 31, 2014 $ 351,235us-gaap_StockholdersEquity
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   $ 50,711us-gaap_StockholdersEquity
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 $ (15,195)us-gaap_StockholdersEquity
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 $ 386,751us-gaap_StockholdersEquity
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember		         $ 386,751us-gaap_StockholdersEquity
BALANCES AT (in Shares) at Dec. 31, 2014 111,735,000us-gaap_CommonStockSharesOutstanding
/ us-gaap_FinancialInstrumentAxis
= us-gaap_WarrantMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		                 111,734,901us-gaap_CommonStockSharesOutstanding
XML 70 R94.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business (USD $)
 12 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Aug. 12, 2014
Apr. 17, 2014
Feb. 28, 2012
Aug. 12, 2014
Apr. 17, 2014
Feb. 28, 2012
Sep. 30, 2014
Jun. 30, 2014
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense $ 32,147,000us-gaap_BusinessCombinationAcquisitionRelatedCosts $ 2,912,000us-gaap_BusinessCombinationAcquisitionRelatedCosts $ 9,155,000us-gaap_BusinessCombinationAcquisitionRelatedCosts                
Goodwill 278,774,000us-gaap_Goodwill 29,831,000us-gaap_Goodwill 32,159,000us-gaap_Goodwill             285,080,000us-gaap_Goodwill 190,448,000us-gaap_Goodwill
Cash Paid To VersaPharm Stockholder [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       322,700,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToVersaPharmStockholderMember		              
Cash Paid To VersaPharm Stockholder [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       322,700,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToVersaPharmStockholderMember		              
Cash Paid To VersaPharm Option Holders [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       14,200,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToVersaPharmOptionHoldersMember		              
Cash Paid To VersaPharm Option Holders [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       14,200,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToVersaPharmOptionHoldersMember		              
Cash Paid To Escrow [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       10,300,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToEscrowMember		              
Cash Paid To Escrow [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       10,300,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToEscrowMember		              
Cash Paid To Paid To Previous Owners Of VersaPharm [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       3,400,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToPaidToPreviousOwnersOfVersaPharmMember		              
Cash Paid To Paid To Previous Owners Of VersaPharm [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       3,400,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToPaidToPreviousOwnersOfVersaPharmMember		              
Equity Consideration Paid At Closing [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       350,600,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_EquityConsiderationPaidAtClosingMember		              
Equity Consideration Paid At Closing [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       350,600,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_EquityConsiderationPaidAtClosingMember		              
Debt Payoff [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       82,400,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_DebtPayoffMember		              
Debt Payoff [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       82,400,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_DebtPayoffMember		              
Cash Paid to Hi-Tech Stockholders [Member] | Initial Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid         605,000,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToHiTechStockholderMember		            
Cash Paid to Hi-Tech Stockholders [Member] | Adjusted Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid         605,000,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToHiTechStockholderMember		            
Cash Paid to Vested Hi-Tech Option Holders [Member] | Initial Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid         40,500,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToVestedHiechOptionHoldersMember		            
Cash Paid to Vested Hi-Tech Option Holders [Member] | Adjusted Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid         40,500,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToVestedHiechOptionHoldersMember		            
Cash Paid to Key Executives [Member] | Initial Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid         4,100,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToKeyExecutivesMember		            
Cash Paid to Key Executives [Member] | Adjusted Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid         4,100,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_CashPaidToKeyExecutivesMember		            
Stamp Duties Paid for Transfer of Land and Buildings [Member] | Initial Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense           1,600,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_StampDutiesPaidForTransferOfLandAndBuildingsMember		          
Stamp Duties Paid for Transfer of Land and Buildings [Member] | Adjusted Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense           1,600,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_StampDutiesPaidForTransferOfLandAndBuildingsMember		          
Acquisition Related Compensation Expense [Member] | Initial Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense           6,700,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_AcquisitionRelatedCompensationExpenseMember		          
Acquisition Related Compensation Expense [Member] | Change In Estimate [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense           500,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_AcquisitionRelatedCompensationExpenseMember		          
Acquisition Related Compensation Expense [Member] | Adjusted Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense           7,200,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_AcquisitionRelatedCompensationExpenseMember		          
Due Diligence, Legal, Travel, and Other Acquistion Related Costs [Member] | Initial Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense           600,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_DueDiligenceLegalTravelAndOtherAcquistionRelatedCostsMember		          
Due Diligence, Legal, Travel, and Other Acquistion Related Costs [Member] | Change In Estimate [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense           100,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_DueDiligenceLegalTravelAndOtherAcquistionRelatedCostsMember		          
Due Diligence, Legal, Travel, and Other Acquistion Related Costs [Member] | Adjusted Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Acquisition related expense           700,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_DueDiligenceLegalTravelAndOtherAcquistionRelatedCostsMember		          
Trademarks [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets       1,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		     1,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		        
Trademarks [Member] | Initial Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets         5,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		     5,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		      
Trademarks [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets       1,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		     1,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		        
Trademarks [Member] | Adjusted Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets         5,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		     5,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		      
Product Licensing Rights [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets       250,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		     250,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		        
Product Licensing Rights [Member] | Initial Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets         343,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		     343,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		      
Product Licensing Rights [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets       250,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		     250,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		        
Product Licensing Rights [Member] | Adjusted Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets         343,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		     343,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		      
Intangibles Other [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets       5,200,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IntangiblesOtherMember		     5,200,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IntangiblesOtherMember		        
Intangibles Other [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets       5,200,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IntangiblesOtherMember		     5,200,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IntangiblesOtherMember		        
IPR&D [Member] | Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets       215,900,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IPR_DMember		     215,900,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IPR_DMember		        
IPR&D [Member] | Initial Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets         9,400,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IPR_DMember		     9,400,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IPR_DMember		      
IPR&D [Member] | Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets       215,900,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IPR_DMember		     215,900,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IPR_DMember		        
IPR&D [Member] | Adjusted Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets         9,400,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IPR_DMember		     9,400,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IPR_DMember		      
Customer Relationships [Member] | Initial Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets         300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		     300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		      
Customer Relationships [Member] | Adjusted Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets         300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		     300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		      
Other Intangible Assets [Member] | Initial Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets           5,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		     5,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Other Intangible Assets [Member] | Change In Estimate [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets           100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		     100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Other Intangible Assets [Member] | Adjusted Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Intangible assets           5,900,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		     5,900,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Initial Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       433,000,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		              
Cash and cash equivalents       100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Accounts receivable       10,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     10,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Inventory       20,900,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     20,900,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Other current assets       2,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     2,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Property and equipment       1,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     1,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Goodwill       90,600,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     90,600,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Total assets acquired       598,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     598,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Assumed current liabilities       (18,300,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (18,300,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Assumed non-current liabilities       (76,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (76,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Deferred tax liabilities       (153,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (153,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Total liabilities assumed       (248,200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (248,200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Total       350,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     350,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		        
Initial Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid         649,600,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		            
Cash and cash equivalents         89,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     89,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Accounts receivable         57,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     57,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Inventory         53,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     53,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Other current assets         20,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     20,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Property and equipment         45,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     45,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Goodwill         171,500,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     171,500,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Other non-current assets         600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Total assets acquired         797,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     797,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Assumed current liabilities         (23,500,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (23,500,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Assumed non-current liabilities         (2,800,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (2,800,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Deferred tax liabilities         (121,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (121,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Total liabilities assumed         (148,200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (148,200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Total         649,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     649,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		      
Initial Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid           55,200,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		          
Less working capital shortfall refunded by sellers           (900,000)akrx_BusinessCombinationLessWorkingCapitalShortfallRefundedBySellers
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (900,000)akrx_BusinessCombinationLessWorkingCapitalShortfallRefundedBySellers
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
          54,300,000us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		          
Acquisition related expense           8,900,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		          
Accounts receivable           2,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     2,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Inventory           1,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     1,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Land           3,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     3,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Other current assets           100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Property and equipment           8,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     8,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Construction in progress           14,200,000akrx_BusinessCombinationAssetsAcquiredConstructionInProgress
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		          
Goodwill           21,600,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     21,600,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Deferred tax liabilities           (1,400,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (1,400,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Total liabilities assumed           (2,100,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     (2,100,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Total           54,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		     54,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_InitialFairValuationMember		    
Change In Estimate [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Accounts receivable       1,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     1,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		        
Inventory       (200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		        
Other current assets       4,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     4,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		        
Goodwill       800,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     800,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		        
Total assets acquired       6,400,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     6,400,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		        
Assumed current liabilities       (600,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (600,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		        
Deferred tax liabilities       (5,800,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (5,800,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		        
Total liabilities assumed       (6,400,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (6,400,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		        
Change In Estimate [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Accounts receivable         (5,700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (5,700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Inventory         (700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Other current assets         13,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     13,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Property and equipment         (2,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (2,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Goodwill         (2,000,000)us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (2,000,000)us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Total assets acquired         2,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     2,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Assumed current liabilities         1,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     1,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Assumed non-current liabilities         (200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Deferred tax liabilities         (4,200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (4,200,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Total liabilities assumed         (2,700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (2,700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		      
Change In Estimate [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Less working capital shortfall refunded by sellers           (100,000)akrx_BusinessCombinationLessWorkingCapitalShortfallRefundedBySellers
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (100,000)akrx_BusinessCombinationLessWorkingCapitalShortfallRefundedBySellers
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		    
          (100,000)us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		          
Acquisition related expense           600,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		          
Land           (1,100,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (1,100,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		    
Goodwill           1,000,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     1,000,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		    
Deferred tax liabilities           700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		    
Total liabilities assumed           (800,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (800,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		    
Total           (100,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		     (100,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_ChangeInEstimateMember		    
Adjusted Fair Valuation [Member] | VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid       433,000,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		              
Cash and cash equivalents       100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Accounts receivable       11,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     11,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Inventory       20,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     20,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Other current assets       7,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     7,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Property and equipment       1,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     1,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Goodwill       91,400,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     91,400,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Total assets acquired       605,200,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     605,200,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Assumed current liabilities       (18,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (18,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Assumed non-current liabilities       (76,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (76,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Deferred tax liabilities       (159,700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (159,700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Total liabilities assumed       (254,600,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (254,600,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Total       350,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     350,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		        
Adjusted Fair Valuation [Member] | Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid         649,600,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		            
Cash and cash equivalents         89,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     89,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Accounts receivable         51,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     51,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Inventory         53,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     53,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Other current assets         33,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     33,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Property and equipment         43,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     43,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Goodwill         169,500,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     169,500,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Other non-current assets         600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Total assets acquired         800,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     800,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Assumed current liabilities         (21,800,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (21,800,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Assumed non-current liabilities         (3,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (3,000,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Deferred tax liabilities         (126,100,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (126,100,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Total liabilities assumed         (150,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (150,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Total         649,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     649,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		      
Adjusted Fair Valuation [Member] | Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid           55,200,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		          
Less working capital shortfall refunded by sellers           (1,000,000)akrx_BusinessCombinationLessWorkingCapitalShortfallRefundedBySellers
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (1,000,000)akrx_BusinessCombinationLessWorkingCapitalShortfallRefundedBySellers
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
          54,200,000us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		          
Acquisition related expense           9,500,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		          
Accounts receivable           2,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     2,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
Inventory           1,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     1,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
Land           2,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     2,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
Other current assets           100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
Property and equipment           8,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     8,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
Construction in progress           14,200,000akrx_BusinessCombinationAssetsAcquiredConstructionInProgress
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		          
Goodwill           22,600,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     22,600,000us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
Deferred tax liabilities           (700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (700,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
Total liabilities assumed           (2,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     (2,900,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
Total           54,200,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		     54,200,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_ChangeInAccountingEstimateByTypeAxis
= akrx_AdjustedFairValuationMember		    
VersaPharm [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid             440,000,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		        
Acquisition related expense 8,100,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		                    
Hi-Tech Pharmacal Co., Inc [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
              44,600,000us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		      
Acquisition related expense 21,300,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		 1,600,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		                  
Kilitch Drugs Limited [Member]                      
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business [Line Items]                      
Amount of cash paid                 60,100,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		    
Construction in progress     $ 14,200,000akrx_BusinessCombinationAssetsAcquiredConstructionInProgress
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		                
XML 71 R59.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 4 - Inventories (Details) - Inventories (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Inventories [Abstract]    
Finished goods $ 64,442us-gaap_InventoryFinishedGoods $ 22,886us-gaap_InventoryFinishedGoods
Work in process 4,335us-gaap_InventoryWorkInProcess 3,883us-gaap_InventoryWorkInProcess
Raw materials and supplies 62,533us-gaap_InventoryRawMaterialsAndSupplies 29,213us-gaap_InventoryRawMaterialsAndSupplies
$ 131,310us-gaap_InventoryNet $ 55,982us-gaap_InventoryNet
XML 72 R99.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 17 - Unconsolidated Joint Venture (Details)
Dec. 31, 2014
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investment, Ownership Percentage 50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
XML 73 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements (Tables)
 12 Months Ended
Dec. 31, 2014
Debt Disclosure [Abstract]  
Schedule of Guarantor Obligations [Table Text Block]
Fixed Charge
Coverage Ratio
Revolver ABR
Spread
Revolver
Eurodollar
Spread
Category 1
> 1.50 to 1.0
0.50%
1.50%
Category 2
> 1.25 to 1.00 but
< 1.50 to 1.00
0.75%
1.75%
Category 3
< 1.25 to 1.00
1.00%
2.00%
Carrying Amount of Liability Component and Remaining Unamortized Debt Discount [Table Text Block]
   
December 31,
 
   
2014
   
2013
 
Carrying amount of equity component
  $
14,930
    $ 20,470  
Carrying amount of the liability component
    82,543       108,750  
Unamortized discount of the liability component
   
4,982
      11,250  
Unamortized debt financing costs
    901       2,034  
Expenses in Relation to Convertible Notes [Table Text Block]
   
2014
   
2013
   
2012
 
Interest expense at 3.50% coupon rate
  $
4,105
    $ 4,200     $ 4,200  
Debt discount amortization
    4,317       4,113       3,828  
Deferred financing cost amortization
    780       744       692  
Loss on conversion
    990       —       —  
    $
10,192
    $ 9,057     $ 8,720  
Schedule of Maturities of Long-term Debt [Table Text Block]
(In thousands)
 
2015
   
2016
   
2017
   
2018
   
Thereafter
 
Maturities
  $ 10,450     $
97,975
    $ 10,450     $ 10,450     $ 1,000,588  
XML 74 R65.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements (Details) - JPM Revolving Facility, Interest Terms (Parentheticals) (JPM Revolving Facility [Member], Revolving Credit Facility [Member])
Apr. 17, 2014
Category 1 [Member] | Base Rate [Member] | Minimum [Member]  
Guarantor Obligations [Line Items]  
Fixed charge coverage ratio 1.50akrx_LineOfCreditFacilityCovenantFixedChargeCoverageRatio
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_StatementScenarioAxis
= akrx_Category1Member
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
Category 1 [Member] | Eurodollar [Member] | Minimum [Member]  
Guarantor Obligations [Line Items]  
Fixed charge coverage ratio 1.50akrx_LineOfCreditFacilityCovenantFixedChargeCoverageRatio
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_StatementScenarioAxis
= akrx_Category1Member
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember
Category 2 [Member] | Base Rate [Member] | Minimum [Member]  
Guarantor Obligations [Line Items]  
Fixed charge coverage ratio 1.25akrx_LineOfCreditFacilityCovenantFixedChargeCoverageRatio
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_StatementScenarioAxis
= akrx_Category2Member
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
Category 2 [Member] | Base Rate [Member] | Maximum [Member]  
Guarantor Obligations [Line Items]  
Fixed charge coverage ratio 1.50akrx_LineOfCreditFacilityCovenantFixedChargeCoverageRatio
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_StatementScenarioAxis
= akrx_Category2Member
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
Category 2 [Member] | Eurodollar [Member] | Minimum [Member]  
Guarantor Obligations [Line Items]  
Fixed charge coverage ratio 1.25akrx_LineOfCreditFacilityCovenantFixedChargeCoverageRatio
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_StatementScenarioAxis
= akrx_Category2Member
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember
Category 2 [Member] | Eurodollar [Member] | Maximum [Member]  
Guarantor Obligations [Line Items]  
Fixed charge coverage ratio 1.50akrx_LineOfCreditFacilityCovenantFixedChargeCoverageRatio
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_StatementScenarioAxis
= akrx_Category2Member
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember
Category 3 [Member] | Base Rate [Member] | Maximum [Member]  
Guarantor Obligations [Line Items]  
Fixed charge coverage ratio 1.25akrx_LineOfCreditFacilityCovenantFixedChargeCoverageRatio
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_StatementScenarioAxis
= akrx_Category3Member
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
Category 3 [Member] | Eurodollar [Member] | Maximum [Member]  
Guarantor Obligations [Line Items]  
Fixed charge coverage ratio 1.25akrx_LineOfCreditFacilityCovenantFixedChargeCoverageRatio
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_StatementScenarioAxis
= akrx_Category3Member
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember
XML 75 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 15 - Recent Accounting Pronouncements
 12 Months Ended
Dec. 31, 2014
Disclosure Text Block [Abstract]  
Description of New Accounting Pronouncements Not yet Adopted [Text Block]
Note 15 – Recent Accounting Pronouncements

In August 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-15 “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”), to provide guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for us in our fourth quarter of fiscal 2016 with early adoption permitted. The adoption of ASU 2014-15 is not expected to have a material effect on the Company’s consolidated financial statements or disclosures.

In May 2014, FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which provides guidance for revenue recognition. ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. This ASU also supersedes some cost guidance included in Subtopic 605-35, “Revenue Recognition-Construction-Type and Production-Type Contracts.” The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which a company expects to be entitled in exchange for those goods or services. In doing so, companies will be required to use more judgment and make more estimates than under previous guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for the Company for the fiscal year beginning January 1, 2017 and, at that time the Company may adopt the new standard under the full retrospective approach or the modified retrospective approach, as permitted under the standard. Early adoption of the standard is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company’s consolidated financial statements and disclosures.

In April 2014, the FASB issued ASU No. 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity” (“ASU 2014-08”), which changes the criteria for reporting discontinued operations while enhancing disclosures in this area. Pursuant to ASU 2014-08, only disposals representing a strategic shift, such as a major line of business, a major geographical area or a major equity investment, which were not expected to have continuing cash flows should be presented as a discontinued operation. If the disposal does qualify as a discontinued operation under ASU 2014-08, the entity will be required to provide expanded disclosures. ASU 2014-08 is effective for the Company beginning January 1, 2015. The adoption of ASU 2014-08 is not expected to have a material effect on the Company’s consolidated financial statements or disclosures.

In July 2013, the FASB issued Accounting Standards Update (“ASU”) 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.   ASU 2013-11 was issued to eliminate the diversity in practice in presentation of unrecognized tax benefits, and amends ASC 740, “Income Taxes,” to provide clarification of the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. According to the new guidance, unrecognized tax benefits will be netted against all available same-jurisdiction loss or other tax carryforward that would be utilized, rather than only being netted against carryforwards that are created by the unrecognized tax benefits. The revised guidance is effective for interim and annual periods beginning after December 15, 2013, with early adoption permitted.  Adoption of this guidance did not have a material impact on our financial statements or financial reporting.

XML 76 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 7 - Earnings Per Common Share (Tables)
 12 Months Ended
Dec. 31, 2014
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
2014
   
2013
   
2012
 
Income from continuing operations used for basic earnings per share
  $
35,848
    $ 52,362     $ 35,378  
Convertible debt income adjustments, net of tax
    5,825       —       —  
Income from continuing operations adjusted for convertible debt as used for diluted earnings per share
  $
41,673
    $ 52,362     $ 35,378  
Income from continuing operations per share:
                       
   Basic
  $
0.35
    $ 0.54     $ 0.37  
   Diluted (1)
  $
0.34
    $ 0.46     $ 0.32  
Loss from discontinued operations, net of tax
  $ (503 )   $ —     $ —  
Loss from discontinued operations, net of tax per share:
                       
   Basic
  $
(0.01
)   $ —     $ —  
   Diluted
  $
(0.01
)   $ —     $ —  
                         
Shares used in computing income (loss) per share:
                       
Weighted average basic shares outstanding
    103,480       96,181       95,189  
Dilutive securities:
                       
   Stock options and unvested RSAs
    4,234       4,516       4,289  
   Stock warrants
    1,874       6,702       6,564  
   Shares issuable on conversion of the Notes (2)
    13,522       6,499       4,468  
Total dilutive securities
    19,630       17,717       15,321  
                         
Weighted average diluted shares outstanding
    123,110       113,898       110,510  
XML 77 R98.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Unaudited Pro Forma Financial Information (Hi-Tech Acquisition, Watson Product Disposition and ECR Divestiture [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Hi-Tech Acquisition, Watson Product Disposition and ECR Divestiture [Member]
    
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Unaudited Pro Forma Financial Information [Line Items]    
Revenue $ 733,012us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_HiTechAcquisitionWatsonProductDispositionAndECRDivestitureMember		 $ 623,922us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_HiTechAcquisitionWatsonProductDispositionAndECRDivestitureMember
Net income from continuing operations $ 71,722us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_HiTechAcquisitionWatsonProductDispositionAndECRDivestitureMember		 $ 4,891us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_HiTechAcquisitionWatsonProductDispositionAndECRDivestitureMember
Net income from continuing operations per share (in Dollars per share) $ 0.58us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_HiTechAcquisitionWatsonProductDispositionAndECRDivestitureMember		 $ 0.04us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_HiTechAcquisitionWatsonProductDispositionAndECRDivestitureMember
XML 78 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 17 - Unconsolidated Joint Venture
 12 Months Ended
Dec. 31, 2014
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments and Joint Ventures Disclosure [Text Block]
 Note 17 — Unconsolidated Joint Venture

The Company was a 50% partner in a joint venture agreement with an Indian drug development company since September 2004.  This joint venture launched its first product in 2008 and generated revenue from 2008 until its business assets were sold and transferred.  While the joint venture still exists legally, it ceased operations upon the completion of the sale and transfer of its operating assets to Pfizer, Inc. in the second quarter of 2011. No operations have occurred since the sale, but the net income recorded in the year ended December 31, 2013 was primarily related to adjustments to the joint venture Company’s reserves for product returns upon expiration of the period for which product returns could be made.

The following tables sets forth condensed statements of income for the three years ended December 31, 2014, 2013 and 2012 and the condensed balance sheets as of December 31, 2014 and 2013 for Akorn-Strides, LLC, along with information regarding the amount of earnings allocated to each member-partner of the LLC (in thousands):

CONDENSED STATEMENTS OF INCOME (Unaudited)
 
       
   
Year ended December 31,
 
   
2014
   
2013
   
2012
 
REVENUES
  $ —     $ 163     $ —  
Cost of sales
    —       (1 )     —  
GROSS PROFIT
    —       164       —  
Operating expenses
    —       3       —  
OPERATING INCOME
    —       161       —  
Gain from Pfizer ANDA Sale
    —       —       —  
INCOME BEFORE INCOME TAXES
    —       161       —  
Income tax (benefit) / provision
    —       —       —  
NET INCOME
  $ —     $ 161     $ —  

CONDENSED BALANCE SHEETS (Unaudited)
 
       
   
December 31,
 
 
 
2014
   
2013
 
ASSETS
           
Cash
  $ 25     $ 25  
Other current assets
    1       1  
TOTAL ASSETS
  $ 26     $ 26  
                 
LIABILITIES & MEMBERS’ EQUITY
               
Trade accounts payable & other accrued liabilities
  $ —     $ —  
    TOTAL LIABILITIES
    —       —  
                 
Members’ equity
    26       26  
TOTAL LIABILITIES & MEMBERS’ EQUITY
  $ 26     $ 26  

As of December 31, 2014, no future product returns are expected.

XML 79 R68.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes (Parentheticals) (Convertible Debt [Member])
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Convertible Debt [Member]
      
Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes (Parentheticals) [Line Items]      
Coupon Rate 3.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 3.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 3.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
XML 80 R108.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) - Restatement of Previously Filed Financial Statements (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Jun. 30, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Prepaid expenses and other current assets $ 30,875us-gaap_PrepaidExpenseAndOtherAssetsCurrent $ 33,075us-gaap_PrepaidExpenseAndOtherAssetsCurrent $ 17,013us-gaap_PrepaidExpenseAndOtherAssetsCurrent   $ 5,753us-gaap_PrepaidExpenseAndOtherAssetsCurrent       $ 17,013us-gaap_PrepaidExpenseAndOtherAssetsCurrent $ 33,075us-gaap_PrepaidExpenseAndOtherAssetsCurrent $ 30,875us-gaap_PrepaidExpenseAndOtherAssetsCurrent $ 5,753us-gaap_PrepaidExpenseAndOtherAssetsCurrent    
TOTAL CURRENT ASSETS 494,329us-gaap_AssetsCurrent 494,095us-gaap_AssetsCurrent 397,073us-gaap_AssetsCurrent   168,856us-gaap_AssetsCurrent       397,073us-gaap_AssetsCurrent 494,095us-gaap_AssetsCurrent 494,329us-gaap_AssetsCurrent 168,856us-gaap_AssetsCurrent    
Goodwill 278,774us-gaap_Goodwill 285,080us-gaap_Goodwill 190,448us-gaap_Goodwill   29,831us-gaap_Goodwill       190,448us-gaap_Goodwill 285,080us-gaap_Goodwill 278,774us-gaap_Goodwill 29,831us-gaap_Goodwill 32,159us-gaap_Goodwill  
TOTAL OTHER LONG-TERM ASSETS 1,268,784us-gaap_AssetsNoncurrent 1,237,795us-gaap_AssetsNoncurrent 685,330us-gaap_AssetsNoncurrent   180,841us-gaap_AssetsNoncurrent       685,330us-gaap_AssetsNoncurrent 1,237,795us-gaap_AssetsNoncurrent 1,268,784us-gaap_AssetsNoncurrent 180,841us-gaap_AssetsNoncurrent    
TOTAL ASSETS 1,906,901us-gaap_Assets 1,871,262us-gaap_Assets 1,218,098us-gaap_Assets   431,805us-gaap_Assets       1,218,098us-gaap_Assets 1,871,262us-gaap_Assets 1,906,901us-gaap_Assets 431,805us-gaap_Assets    
Income taxes payable 1us-gaap_TaxesPayableCurrent   571us-gaap_TaxesPayableCurrent   1,459us-gaap_TaxesPayableCurrent       571us-gaap_TaxesPayableCurrent   1us-gaap_TaxesPayableCurrent 1,459us-gaap_TaxesPayableCurrent    
TOTAL CURRENT LIABILITIES 134,165us-gaap_LiabilitiesCurrent   103,673us-gaap_LiabilitiesCurrent   61,245us-gaap_LiabilitiesCurrent       103,673us-gaap_LiabilitiesCurrent   134,165us-gaap_LiabilitiesCurrent 61,245us-gaap_LiabilitiesCurrent    
TOTAL LIABILITIES 1,520,150us-gaap_Liabilities   929,200us-gaap_Liabilities   171,625us-gaap_Liabilities       929,200us-gaap_Liabilities   1,520,150us-gaap_Liabilities 171,625us-gaap_Liabilities    
Retained earnings 50,711us-gaap_RetainedEarningsAccumulatedDeficit 16,480us-gaap_RetainedEarningsAccumulatedDeficit 28,129us-gaap_RetainedEarningsAccumulatedDeficit   15,366us-gaap_RetainedEarningsAccumulatedDeficit       28,129us-gaap_RetainedEarningsAccumulatedDeficit 16,480us-gaap_RetainedEarningsAccumulatedDeficit 50,711us-gaap_RetainedEarningsAccumulatedDeficit 15,366us-gaap_RetainedEarningsAccumulatedDeficit    
TOTAL SHAREHOLDERS’ EQUITY 386,751us-gaap_StockholdersEquity 314,751us-gaap_StockholdersEquity 288,898us-gaap_StockholdersEquity   260,180us-gaap_StockholdersEquity       288,898us-gaap_StockholdersEquity 314,751us-gaap_StockholdersEquity 386,751us-gaap_StockholdersEquity 260,180us-gaap_StockholdersEquity 201,081us-gaap_StockholdersEquity 158,208us-gaap_StockholdersEquity
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 1,906,901us-gaap_LiabilitiesAndStockholdersEquity 1,871,262us-gaap_LiabilitiesAndStockholdersEquity 1,218,098us-gaap_LiabilitiesAndStockholdersEquity   431,805us-gaap_LiabilitiesAndStockholdersEquity       1,218,098us-gaap_LiabilitiesAndStockholdersEquity 1,871,262us-gaap_LiabilitiesAndStockholdersEquity 1,906,901us-gaap_LiabilitiesAndStockholdersEquity 431,805us-gaap_LiabilitiesAndStockholdersEquity    
Revenues 227,828us-gaap_SalesRevenueNet 132,732us-gaap_SalesRevenueNet 141,896us-gaap_SalesRevenueNet 90,622us-gaap_SalesRevenueNet 84,953us-gaap_SalesRevenueNet 81,892us-gaap_SalesRevenueNet 77,012us-gaap_SalesRevenueNet 73,854us-gaap_SalesRevenueNet 232,518us-gaap_SalesRevenueNet 365,250us-gaap_SalesRevenueNet 593,078us-gaap_SalesRevenueNet 317,711us-gaap_SalesRevenueNet 256,158us-gaap_SalesRevenueNet  
GROSS PROFIT 128,382us-gaap_GrossProfit 51,734us-gaap_GrossProfit 67,818us-gaap_GrossProfit 49,656us-gaap_GrossProfit 46,970us-gaap_GrossProfit 43,697us-gaap_GrossProfit 42,092us-gaap_GrossProfit 39,145us-gaap_GrossProfit 117,474us-gaap_GrossProfit 169,208us-gaap_GrossProfit 297,590us-gaap_GrossProfit 171,904us-gaap_GrossProfit 148,692us-gaap_GrossProfit  
OPERATING INCOME 71,907us-gaap_OperatingIncomeLoss (6,042)us-gaap_OperatingIncomeLoss 7,410us-gaap_OperatingIncomeLoss 23,440us-gaap_OperatingIncomeLoss 25,176us-gaap_OperatingIncomeLoss 22,188us-gaap_OperatingIncomeLoss 22,251us-gaap_OperatingIncomeLoss 18,589us-gaap_OperatingIncomeLoss 30,850us-gaap_OperatingIncomeLoss 24,808us-gaap_OperatingIncomeLoss 96,715us-gaap_OperatingIncomeLoss 88,204us-gaap_OperatingIncomeLoss 68,756us-gaap_OperatingIncomeLoss  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES     5,459us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest           21,151us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 2,612us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 59,136us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 82,895us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 57,500us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest  
Income tax provision     2,021us-gaap_IncomeTaxExpenseBenefit           7,885us-gaap_IncomeTaxExpenseBenefit 996us-gaap_IncomeTaxExpenseBenefit 23,288us-gaap_IncomeTaxExpenseBenefit 30,533us-gaap_IncomeTaxExpenseBenefit 22,122us-gaap_IncomeTaxExpenseBenefit  
INCOME FROM CONTINUING OPERATIONS 34,232us-gaap_IncomeLossFromContinuingOperations (11,650)us-gaap_IncomeLossFromContinuingOperations 3,438us-gaap_IncomeLossFromContinuingOperations 9,828us-gaap_IncomeLossFromContinuingOperations 16,678us-gaap_IncomeLossFromContinuingOperations 12,205us-gaap_IncomeLossFromContinuingOperations 12,637us-gaap_IncomeLossFromContinuingOperations 10,842us-gaap_IncomeLossFromContinuingOperations 13,266us-gaap_IncomeLossFromContinuingOperations 1,616us-gaap_IncomeLossFromContinuingOperations 35,848us-gaap_IncomeLossFromContinuingOperations 52,362us-gaap_IncomeLossFromContinuingOperations 35,378us-gaap_IncomeLossFromContinuingOperations  
CONSOLIDATED NET INCOME 34,232us-gaap_NetIncomeLoss (11,650)us-gaap_NetIncomeLoss 2,935us-gaap_NetIncomeLoss 9,828us-gaap_NetIncomeLoss 16,678us-gaap_NetIncomeLoss 12,205us-gaap_NetIncomeLoss 12,637us-gaap_NetIncomeLoss 10,842us-gaap_NetIncomeLoss 12,763us-gaap_NetIncomeLoss 1,113us-gaap_NetIncomeLoss 35,345us-gaap_NetIncomeLoss 52,362us-gaap_NetIncomeLoss 35,378us-gaap_NetIncomeLoss  
NET INCOME PER SHARE:                            
Income from continuing operations, basic (in Dollars per share) $ 0.32us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ (0.11)us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.03us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.10us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.17us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.02us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.35us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.54us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.37us-gaap_IncomeLossFromContinuingOperationsPerBasicShare  
NET INCOME, BASIC (in Dollars per share) $ 0.32us-gaap_EarningsPerShareBasic $ (0.11)us-gaap_EarningsPerShareBasic $ 0.03us-gaap_EarningsPerShareBasic $ 0.10us-gaap_EarningsPerShareBasic $ 0.17us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.11us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.01us-gaap_EarningsPerShareBasic $ 0.34us-gaap_EarningsPerShareBasic $ 0.54us-gaap_EarningsPerShareBasic $ 0.37us-gaap_EarningsPerShareBasic  
Income from continuing operations, diluted (in Dollars per share) $ 0.29us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ (0.11)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.03us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.08us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.14us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.10us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.01us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.34us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1] $ 0.46us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1] $ 0.32us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1]  
NET INCOME, DILUTED (in Dollars per share) $ 0.29us-gaap_EarningsPerShareDiluted $ (0.11)us-gaap_EarningsPerShareDiluted $ 0.02us-gaap_EarningsPerShareDiluted $ 0.08us-gaap_EarningsPerShareDiluted $ 0.14us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.10us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.01us-gaap_EarningsPerShareDiluted $ 0.33us-gaap_EarningsPerShareDiluted $ 0.46us-gaap_EarningsPerShareDiluted $ 0.32us-gaap_EarningsPerShareDiluted  
COMPREHENSIVE INCOME:                            
Consolidated net income 34,232us-gaap_NetIncomeLoss (11,650)us-gaap_NetIncomeLoss 2,935us-gaap_NetIncomeLoss 9,828us-gaap_NetIncomeLoss 16,678us-gaap_NetIncomeLoss 12,205us-gaap_NetIncomeLoss 12,637us-gaap_NetIncomeLoss 10,842us-gaap_NetIncomeLoss 12,763us-gaap_NetIncomeLoss 1,113us-gaap_NetIncomeLoss 35,345us-gaap_NetIncomeLoss 52,362us-gaap_NetIncomeLoss 35,378us-gaap_NetIncomeLoss  
COMPREHENSIVE INCOME     2,782us-gaap_ComprehensiveIncomeNetOfTax           14,315us-gaap_ComprehensiveIncomeNetOfTax 2,269us-gaap_ComprehensiveIncomeNetOfTax 32,517us-gaap_ComprehensiveIncomeNetOfTax 45,899us-gaap_ComprehensiveIncomeNetOfTax 29,474us-gaap_ComprehensiveIncomeNetOfTax  
Changes in operating assets and liabilities:                            
Trade accounts receivable                 (19,138)us-gaap_IncreaseDecreaseInAccountsReceivable (15,340)us-gaap_IncreaseDecreaseInAccountsReceivable (95,470)us-gaap_IncreaseDecreaseInAccountsReceivable (14,277)us-gaap_IncreaseDecreaseInAccountsReceivable (23,856)us-gaap_IncreaseDecreaseInAccountsReceivable  
Prepaid expenses and other current assets                 1,151us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (14,491)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (13,180)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (648)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (5,689)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets  
Accrued expenses and other liabilities                 8,695us-gaap_IncreaseDecreaseInAccruedLiabilities   26,249us-gaap_IncreaseDecreaseInAccruedLiabilities 2,537us-gaap_IncreaseDecreaseInAccruedLiabilities 10,720us-gaap_IncreaseDecreaseInAccruedLiabilities  
Scenario, Previously Reported [Member]                            
Prepaid expenses and other current assets   33,078us-gaap_PrepaidExpenseAndOtherAssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 17,120us-gaap_PrepaidExpenseAndOtherAssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           17,120us-gaap_PrepaidExpenseAndOtherAssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 33,078us-gaap_PrepaidExpenseAndOtherAssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
TOTAL CURRENT ASSETS   494,098us-gaap_AssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 397,180us-gaap_AssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           397,180us-gaap_AssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 494,098us-gaap_AssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
Goodwill   290,648us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 196,016us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           196,016us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 290,648us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
TOTAL OTHER LONG-TERM ASSETS   1,243,363us-gaap_AssetsNoncurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 690,898us-gaap_AssetsNoncurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           690,898us-gaap_AssetsNoncurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 1,243,363us-gaap_AssetsNoncurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
TOTAL ASSETS   1,876,833us-gaap_Assets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 1,223,773us-gaap_Assets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           1,223,773us-gaap_Assets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 1,876,833us-gaap_Assets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
Income taxes payable     675us-gaap_TaxesPayableCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           675us-gaap_TaxesPayableCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		          
TOTAL CURRENT LIABILITIES     103,777us-gaap_LiabilitiesCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           103,777us-gaap_LiabilitiesCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		          
TOTAL LIABILITIES     929,304us-gaap_Liabilities
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           929,304us-gaap_Liabilities
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		          
Retained earnings   22,051us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 33,700us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           33,700us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 22,051us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
TOTAL SHAREHOLDERS’ EQUITY   320,322us-gaap_StockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 294,469us-gaap_StockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           294,469us-gaap_StockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 320,322us-gaap_StockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   1,876,833us-gaap_LiabilitiesAndStockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 1,223,773us-gaap_LiabilitiesAndStockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           1,223,773us-gaap_LiabilitiesAndStockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 1,876,833us-gaap_LiabilitiesAndStockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
Revenues     150,749us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           241,371us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 374,103us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
GROSS PROFIT     76,671us-gaap_GrossProfit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           126,327us-gaap_GrossProfit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 178,061us-gaap_GrossProfit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
OPERATING INCOME     16,263us-gaap_OperatingIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           39,703us-gaap_OperatingIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 33,661us-gaap_OperatingIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES     14,312us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           30,004us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 11,465us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
Income tax provision     5,303us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           11,167us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 4,278us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
INCOME FROM CONTINUING OPERATIONS     9,009us-gaap_IncomeLossFromContinuingOperations
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           18,837us-gaap_IncomeLossFromContinuingOperations
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 7,187us-gaap_IncomeLossFromContinuingOperations
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
CONSOLIDATED NET INCOME     8,506us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           18,334us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 6,684us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
NET INCOME PER SHARE:                            
Income from continuing operations, basic (in Dollars per share)     $ 0.09us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           $ 0.19us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 $ 0.07us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
NET INCOME, BASIC (in Dollars per share)     $ 0.08us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           $ 0.18us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 $ 0.07us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
Income from continuing operations, diluted (in Dollars per share)     $ 0.08us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           $ 0.16us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 $ 0.06us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
NET INCOME, DILUTED (in Dollars per share)     $ 0.07us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           $ 0.16us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 $ 0.06us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
COMPREHENSIVE INCOME:                            
Consolidated net income     8,506us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           18,334us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 6,684us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
COMPREHENSIVE INCOME     8,353us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		           19,886us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 7,840us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
Changes in operating assets and liabilities:                            
Trade accounts receivable                 (27,991)us-gaap_IncreaseDecreaseInAccountsReceivable
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 (24,193)us-gaap_IncreaseDecreaseInAccountsReceivable
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
Prepaid expenses and other current assets                 4,329us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		 (11,209)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		        
Accrued expenses and other liabilities                 8,799us-gaap_IncreaseDecreaseInAccruedLiabilities
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioPreviouslyReportedMember		          
Scenario, Adjustment [Member]                            
Prepaid expenses and other current assets   (3)us-gaap_PrepaidExpenseAndOtherAssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (107)us-gaap_PrepaidExpenseAndOtherAssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (107)us-gaap_PrepaidExpenseAndOtherAssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (3)us-gaap_PrepaidExpenseAndOtherAssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
TOTAL CURRENT ASSETS   (3)us-gaap_AssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (107)us-gaap_AssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (107)us-gaap_AssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (3)us-gaap_AssetsCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Goodwill   (5,568)us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,568)us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,568)us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,568)us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
TOTAL OTHER LONG-TERM ASSETS   (5,568)us-gaap_AssetsNoncurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,568)us-gaap_AssetsNoncurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,568)us-gaap_AssetsNoncurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,568)us-gaap_AssetsNoncurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
TOTAL ASSETS   (5,571)us-gaap_Assets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,675)us-gaap_Assets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,675)us-gaap_Assets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_Assets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Income taxes payable     (104)us-gaap_TaxesPayableCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (104)us-gaap_TaxesPayableCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		          
TOTAL CURRENT LIABILITIES     (104)us-gaap_LiabilitiesCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (104)us-gaap_LiabilitiesCurrent
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		          
TOTAL LIABILITIES     (104)us-gaap_Liabilities
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (104)us-gaap_Liabilities
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		          
Retained earnings   (5,571)us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,571)us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
TOTAL SHAREHOLDERS’ EQUITY   (5,571)us-gaap_StockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_StockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,571)us-gaap_StockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_StockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   (5,571)us-gaap_LiabilitiesAndStockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,675)us-gaap_LiabilitiesAndStockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,675)us-gaap_LiabilitiesAndStockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_LiabilitiesAndStockholdersEquity
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Revenues     (8,853)us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (8,853)us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (8,853)us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
GROSS PROFIT     (8,853)us-gaap_GrossProfit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (8,853)us-gaap_GrossProfit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (8,853)us-gaap_GrossProfit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
OPERATING INCOME     (8,853)us-gaap_OperatingIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (8,853)us-gaap_OperatingIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (8,853)us-gaap_OperatingIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES     (8,853)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (8,853)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (8,853)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Income tax provision     (3,282)us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (3,282)us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (3,282)us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
INCOME FROM CONTINUING OPERATIONS     (5,571)us-gaap_IncomeLossFromContinuingOperations
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,571)us-gaap_IncomeLossFromContinuingOperations
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_IncomeLossFromContinuingOperations
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
CONSOLIDATED NET INCOME     (5,571)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,571)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
NET INCOME PER SHARE:                            
Income from continuing operations, basic (in Dollars per share)     $ (0.06)us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           $ (0.06)us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 $ (0.05)us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
NET INCOME, BASIC (in Dollars per share)     $ (0.05)us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           $ (0.05)us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 $ (0.06)us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Income from continuing operations, diluted (in Dollars per share)     $ (0.05)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           $ (0.05)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 $ (0.05)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
NET INCOME, DILUTED (in Dollars per share)     $ (0.05)us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           $ (0.05)us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 $ (0.05)us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
COMPREHENSIVE INCOME:                            
Consolidated net income     (5,571)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,571)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
COMPREHENSIVE INCOME     (5,571)us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,571)us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571)us-gaap_ComprehensiveIncomeNetOfTax
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Changes in operating assets and liabilities:                            
Trade accounts receivable                 8,853us-gaap_IncreaseDecreaseInAccountsReceivable
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 8,853us-gaap_IncreaseDecreaseInAccountsReceivable
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Prepaid expenses and other current assets                 (3,178)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (3,282)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Accrued expenses and other liabilities                 $ (104)us-gaap_IncreaseDecreaseInAccruedLiabilities
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		          
[1] Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $5.8 million, after-taxfor the year ended December 31, 2014.
XML 81 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 82 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
OPERATING ACTIVITIES:      
Consolidated net income $ 35,345us-gaap_NetIncomeLoss $ 52,362us-gaap_NetIncomeLoss $ 35,378us-gaap_NetIncomeLoss
Loss from discontinued operations, net of tax 503us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity    
Adjustments to reconcile consolidated net income to net cash provided by operating activities:      
Depreciation and amortization 58,538us-gaap_DepreciationDepletionAndAmortization 14,476us-gaap_DepreciationDepletionAndAmortization 11,455us-gaap_DepreciationDepletionAndAmortization
Amortization of deferred financing fees 12,129us-gaap_AmortizationOfFinancingCostsAndDiscounts 842us-gaap_AmortizationOfFinancingCostsAndDiscounts 782us-gaap_AmortizationOfFinancingCostsAndDiscounts
Amortization of favorable (unfavorable) contracts 72akrx_AmortizationOfFavorableUnfavorableContracts (1,905)akrx_AmortizationOfFavorableUnfavorableContracts (635)akrx_AmortizationOfFavorableUnfavorableContracts
Amortization of inventory step-up 20,798us-gaap_OtherDepreciationAndAmortization    
Non-cash stock compensation expense 7,542us-gaap_ShareBasedCompensation 7,050us-gaap_ShareBasedCompensation 7,032us-gaap_ShareBasedCompensation
Non-cash interest expense 4,871akrx_NoncashInterestOnConvertibleNotes 4,634akrx_NoncashInterestOnConvertibleNotes 6,436akrx_NoncashInterestOnConvertibleNotes
Non-cash gain on bargain purchase   (3,707)akrx_NoncashGainOnBargainPurchase  
Gain from product divestiture (9,807)us-gaap_GainLossOnDispositionOfAssets1    
Deferred income taxes, net 25,293us-gaap_IncreaseDecreaseInDeferredIncomeTaxes 2,091us-gaap_IncreaseDecreaseInDeferredIncomeTaxes 67us-gaap_IncreaseDecreaseInDeferredIncomeTaxes
Excess tax benefit from stock compensation (38,710)us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities (2,928)us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities (4,488)us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
Non-cash settlement of product warranty liability   (1,299)us-gaap_OtherNoncashExpense  
Equity in earnings of unconsolidated joint venture   (80)us-gaap_IncomeLossFromEquityMethodInvestments  
Loss on extinguishment of debt 990us-gaap_GainsLossesOnExtinguishmentOfDebt    
Gain on sale of available for sale security (7)us-gaap_GainLossOnSaleOfSecuritiesNet    
Changes in operating assets and liabilities:      
Trade accounts receivable, net (95,470)us-gaap_IncreaseDecreaseInAccountsReceivable (14,277)us-gaap_IncreaseDecreaseInAccountsReceivable (23,856)us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories, net (15,262)us-gaap_IncreaseDecreaseInInventories (3,797)us-gaap_IncreaseDecreaseInInventories (15,447)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other current assets (13,180)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (648)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (5,689)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Trade accounts payable 11,024us-gaap_IncreaseDecreaseInAccountsPayableTrade 1,975us-gaap_IncreaseDecreaseInAccountsPayableTrade 4,489us-gaap_IncreaseDecreaseInAccountsPayableTrade
Accrued expenses and other liabilities 26,249us-gaap_IncreaseDecreaseInAccruedLiabilities 2,537us-gaap_IncreaseDecreaseInAccruedLiabilities 10,720us-gaap_IncreaseDecreaseInAccruedLiabilities
NET CASH PROVIDED BY OPERATING ACTIVITIES 30,918us-gaap_NetCashProvidedByUsedInOperatingActivities 57,326us-gaap_NetCashProvidedByUsedInOperatingActivities 26,244us-gaap_NetCashProvidedByUsedInOperatingActivities
INVESTING ACTIVITIES:      
Payments for acquisitions and equity investments, net of cash acquired (987,802)us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates (55,482)us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates (55,047)us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates
Proceeds from disposal of assets 59,361us-gaap_ProceedsFromSaleOfProductiveAssets    
Payments for other intangible assets (8,532)us-gaap_PaymentsToAcquireIntangibleAssets    
Purchases of property, plant and equipment (29,568)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (11,642)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (20,454)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Distributions from unconsolidated joint venture   250us-gaap_EquityMethodInvestmentDividendsOrDistributions  
NET CASH USED IN INVESTING ACTIVITIES (966,541)us-gaap_NetCashProvidedByUsedInInvestingActivities (66,874)us-gaap_NetCashProvidedByUsedInInvestingActivities (75,501)us-gaap_NetCashProvidedByUsedInInvestingActivities
FINANCING ACTIVITIES:      
Proceeds from issuances of debt 1,045,000us-gaap_ProceedsFromIssuanceOfDebt    
Proceeds under stock option and stock purchase plans 8,842us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions 3,222us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions 1,878us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
Payments of contingent acquisition liabilities (15,000)us-gaap_ProceedsFromPaymentsForOtherFinancingActivities    
Debt financing costs (28,366)us-gaap_PaymentsOfDebtIssuanceCosts (3,032)us-gaap_PaymentsOfDebtIssuanceCosts  
Proceeds from warrant exercises 8,171akrx_ProceedsFromCommonStockAndWarrantOffering    
Excess tax benefits from stock compensation 38,710us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities 2,928us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities 4,488us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
Debt repayment (85,049)us-gaap_RepaymentsOfDebt    
NET CASH PROVIDED BY FINANCING ACTIVITIES 972,308us-gaap_NetCashProvidedByUsedInFinancingActivities 3,118us-gaap_NetCashProvidedByUsedInFinancingActivities 6,366us-gaap_NetCashProvidedByUsedInFinancingActivities
Effect of changes in exchange rates on cash and cash equivalents (183)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents (173)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents (290)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 36,502us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (6,603)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (43,181)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 34,178us-gaap_CashAndCashEquivalentsAtCarryingValue 40,781us-gaap_CashAndCashEquivalentsAtCarryingValue 83,962us-gaap_CashAndCashEquivalentsAtCarryingValue
CASH AND CASH EQUIVALENTS AT END OF YEAR $ 70,680us-gaap_CashAndCashEquivalentsAtCarryingValue $ 34,178us-gaap_CashAndCashEquivalentsAtCarryingValue $ 40,781us-gaap_CashAndCashEquivalentsAtCarryingValue
XML 83 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Balance Sheets (Parentheticals) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Common stock, no par value (in Dollars per share) $ 0us-gaap_CommonStockNoParValue $ 0us-gaap_CommonStockNoParValue
Common stock, authorized 150,000,000us-gaap_CommonStockSharesAuthorized 150,000,000us-gaap_CommonStockSharesAuthorized
Common stock, issued 111,734,901us-gaap_CommonStockSharesIssued 96,569,186us-gaap_CommonStockSharesIssued
Common stock, outstanding 111,734,901us-gaap_CommonStockSharesOutstanding 96,569,186us-gaap_CommonStockSharesOutstanding
XML 84 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Income Taxes
 12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
Note 10 — Income Taxes from Continuing Operations

The income tax provision (benefit) from continuing operations consisted of the following (in thousands):

 
 
Current
   
Deferred
   
Total
 
Year ended December 31, 2014
                 
Federal
  $ 34,799     $ (11,674 )   $ 23,125  
State
    4,991       (2,698 )     2,293  
Foreign
    4       (2,134 )     (2,130 )
    $ 39,794     $ (16,506 )   $ 23,288  
Year ended December 31, 2013
                       
Federal
  $ 27,985     $ (3,050 )   $ 24,935  
State
    4,145       2,051       6,196  
Foreign
    —       (598 )     (598 )
    $ 32,130     $ (1,597 )   $ 30,533  
Year ended December 31, 2012
                       
Federal
  $ 20,843     $ (504 )   $ 20,339  
State
    4,232       (911 )     3,321  
Foreign
    —       (1,538 )      (1,538 )
    $ 25,075     $ (2,953 )   $ 22,122  

Income tax expense differs from the “expected” tax expense computed by applying the U.S. Federal corporate income tax rates of 35% to income from continuing operations before income taxes, as follows (in thousands):

 
 
Years Ended December 31,
 
 
 
2014
   
2013
   
2012
 
Computed “expected” tax expense
  $ 20,698     $ 29,013     $ 20,125  
Change in income taxes resulting from:
                       
State income taxes, net of Federal income tax
    1,490       4,027       2,159  
Foreign income tax expense (benefit)
    (454 )     622       1,468  
Deduction for domestic production activities
    (1,444 )     (1,361 )     (1,277 )
R&D tax credits
    (447 )     (1,652 )     (508 )
Other expense (benefit), net
    2,329       (116 )     155  
Valuation allowance change
    1,116       —       —  
Income tax expense
  $ 23,288     $ 30,533     $ 22,122  

The geographical allocation of the Company’s income from continuing operations before income taxes between U.S. and foreign operations was as follows (in thousands):

   
2014
   
2013
   
2012
 
Pre-tax income from continuing U.S. operations
  $
67,114
    $ 86,382     $ 66,087  
Pre-tax loss from continuing foreign operations
    (7,978 )     (3,487 )     (8,587 )
Total pre-tax income from continuing operations
  $
59,136
    $ 82,895     $ 57,500  

Net deferred income taxes at December 31, 2014 and 2013 include (in thousands):

   
December 31, 2014
   
December 31, 2013
 
   
Current
   
Noncurrent
   
Current
   
Noncurrent
 
Deferred tax assets:
                       
   Net operating loss carry-forward
  $ 4,277     $ 16,190     $ 439     $ 14,061  
   Stock-based compensation
    —       6,408       —       6,630  
Chargeback reserves
    5,391       —       —       —  
   Reserve for product returns
    12,255       —       3,189       —  
   Inventory valuation reserve
    5,764       —       2,193       —  
   Other
    8,570      
192
      3,325       1,751  
      Total deferred tax assets
  $ 36,257     $
22,790
    $ 9,146     $ 22,442  
      Valuation allowance
    —       (1,116 )     —       —  
            Net deferred tax assets
  $ 36,257     $
21,674
    $ —     $ —  
                                 
Deferred tax liabilities:
                               
   Prepaid expenses
  $ (1,982 )   $ —     $ (1,120 )   $ —  
   Inventory step-up
    (1,619 )     —                  
   Unamortized discount – convertible notes
    —       (1,776 )     —       (4,223 )
   Depreciation & amortization – tax over book
    —       (285,022 )     —       (16,576 )
   Other
    —       —       (81 )     —  
      Total deferred tax liabilities
  $ (3,601 )   $ (286,798 )   $ (1,201 )   $ (20,799 )
                                 
Net deferred income tax asset (liability)
  $ 32,656     $ (265,124 )   $ 7,945     $ 1,643  

The Company records a valuation allowance to reduce net deferred income tax assets to the amount that is more likely than not to be realized. In performing its analysis of whether a valuation allowance to reduce the deferred income tax asset was necessary, the Company evaluated the data and determined that as of December 31, 2014 it could not conclude that it was more likely than not that certain of the net operating losses of its Indian subsidiary would be realized.  Accordingly, the Company established a valuation allowance of $1.1 million against its deferred tax assets as of December 31, 2014.  The Company had concluded that all of its deferred tax assets were more likely than not to be realized as of December 31, 2013; accordingly, no valuation allowance was in place as of that date.

The deferred tax balances have been reflected gross on the balance sheet, and are netted only if they are in the same jurisdiction.

The Company’s net operating loss (“NOL”) carry-forwards as of December 31, 2014 consist of three component pieces: (i) U.S. Federal NOL carry-forwards valued at $11.3 million, (ii) Illinois NOL carry-forwards valued at $2.2 million, and (iii) foreign (Indian) NOLs of $7.1 million.  The U.S. Federal NOL carry-forwards were obtained through the Merck Acquisition completed in the fourth quarter of 2013, ($7.5 million) and the acquisition of VersaPharm in the third quarter of 2014 ($3.8 million).  The Illinois NOL carry-forwards relate to the Company’s tax losses in the decade of the 2000s and have not yet been fully utilized due to the State of Illinois’s suspension of the use of NOLs for the years 2011, 2012 and 2013.  These NOLs would be due to expire from 2021 to 2025, and are expected to be utilized well before their expiration dates.  The foreign NOL carry-forwards relate to operating losses by the Company’s subsidiary in India, which was acquired in 2012.  Of the $7.1 million foreign NOL, $1.1 million expire beginning in 2022; the Company has established a valuation allowance against this entire amount.  The remaining $6.0 million of the foreign NOLs can be carried forward indefinitely, and the Company has concluded that they are more likely than not to be utilized and therefore has not established a valuation allowance against them.  The Company previously had valued NOL carry-forwards in the State of New Jersey.  However, due to changes in the tax law, the Company determined that these NOLs would never be utilized and wrote them off during 2013.

In late 2014, the Company was notified that its Federal income tax return for the year ended December 31, 2013 would be examined by the Internal Revenue Service beginning in early 2015.  The Company’s Hi-Tech Pharmacal subsidiary is currently undergoing an examination by the Internal Revenue Service for its tax year ended April 30, 2013.  The Company’s VersaPharm subsidiary has also been notified that its Federal income tax return for the year ended December 31, 2012 will be examined beginning in 2015.  Additionally, the Company is undergoing examinations by Illinois and Massachusetts for various tax years.  The Company’s U.S. Federal income tax returns filed for years 2011 through 2013 are open for examination by the Internal Revenue Service.  The majority of the Company’s state and local income tax returns filed for years 2010 through 2013 remain open for examination as well.

In accordance with ASC 740-10-25, Income Taxes – Recognition, the Company performs reviews of its tax positions to determine whether it is “more likely than not” that its tax positions will be sustained upon examination, and if any tax positions are deemed to fall short of that standard, the Company reserves based on the financial exposure and the likelihood of its tax positions not being sustained.  Based on its review as of December 31, 2014, the Company determined that it would not recognize tax benefits as follows (in thousands):

Balance at December 31, 2011
  $ —  
Additions relating to current year
    1,265  
Additions relating to prior years
    220  
Balance at December 31, 2012
  $ 1,485  
Additions relating to current year
    589  
Terminations of exposures relating to prior years
    (1,229 )
Balance at December 31, 2013
  $ 845  
Additions relating to current year
    408  
Additions relating to acquired entities
    456  
Terminations of exposures relating to prior years
    —  
Balance at December 31, 2014
  $ 1,709  

If recognized, $1.2 million of the above positions will impact the Company’s effective rate, while the remaining $0.5 million will result in a reduction of the Company’s goodwill.  Due to the uncertainty of both timing and resolution of potential income tax examinations, the Company is unable to determine whether any amounts included in the December 31, 2014 balance of unrecognized tax benefits represent tax positions that could significantly change during the next twelve months.  The Company accounts for interest and penalties as income tax expense.  There were no uncertain tax positions prior to 2012.

XML 85 R103.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 18 - Customer, Supplier and Product Concentration (Details) - Percentage of the Company’s Gross and Net Sales and Accounts Receivable (Customer Concentration Risk [Member])
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Amerisource [Member] | Gross Sales [Member]      
Concentration Risk [Line Items]      
Customer concentration 38.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember		 19.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember		 19.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember
Amerisource [Member] | Sales Revenue, Net [Member]      
Concentration Risk [Line Items]      
Customer concentration 28.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember		 14.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember		 14.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember
Amerisource [Member] | Accounts Receivable [Member]      
Concentration Risk [Line Items]      
Customer concentration 46.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember		 25.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember		 29.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_AmerisourceMember
Cardinal [Member] | Gross Sales [Member]      
Concentration Risk [Line Items]      
Customer concentration 16.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember		 23.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember		 23.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember
Cardinal [Member] | Sales Revenue, Net [Member]      
Concentration Risk [Line Items]      
Customer concentration 14.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember		 16.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember		 17.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember
Cardinal [Member] | Accounts Receivable [Member]      
Concentration Risk [Line Items]      
Customer concentration 17.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember		 26.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember		 30.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_CardinalMember
McKesson [Member] | Gross Sales [Member]      
Concentration Risk [Line Items]      
Customer concentration 23.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember		 16.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember		 16.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember
McKesson [Member] | Sales Revenue, Net [Member]      
Concentration Risk [Line Items]      
Customer concentration 19.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember		 11.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember		 11.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember
McKesson [Member] | Accounts Receivable [Member]      
Concentration Risk [Line Items]      
Customer concentration 23.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember		 12.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember		 14.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= akrx_McKessonMember
Gross Sales [Member]      
Concentration Risk [Line Items]      
Customer concentration 77.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		 58.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		 58.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= akrx_GrossSalesMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
Sales Revenue, Net [Member]      
Concentration Risk [Line Items]      
Customer concentration 61.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		 41.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		 42.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
Accounts Receivable [Member]      
Concentration Risk [Line Items]      
Customer concentration 86.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		 63.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		 73.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember
XML 86 R93.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for Xopenex adn the Fair Value of the Acquired Assets and Assumed Liabilities (Xopenex Acquisition [Member], USD $)
In Millions, unless otherwise specified
 0 Months Ended
Oct. 02, 2014
Xopenex Acquisition [Member]
  
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for Xopenex adn the Fair Value of the Acquired Assets and Assumed Liabilities [Line Items]  
Amount of cash paid $ 41.5us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexAcquisitionMember
Product returns and reserves assumed 3.5us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexAcquisitionMember
Total consideration at closing 45.0us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexAcquisitionMember
Accounts Receivable, net (product returns and reserves assumed) (3.5)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexAcquisitionMember
Inventory 6.3us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexAcquisitionMember
Product licensing rights 38.7akrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLicensingRights
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexAcquisitionMember
Fair value of net assets acquired $ 41.5us-gaap_FairValueOfAssetsAcquired
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexAcquisitionMember
XML 87 R91.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
 0 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended 0 Months Ended 1 Months Ended
Jun. 27, 2014
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Jun. 30, 2014
Dec. 31, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Apr. 17, 2014
Jan. 02, 2015
Jul. 22, 2014
Oct. 02, 2014
Oct. 01, 2014
Aug. 12, 2014
Jan. 02, 2014
Jan. 02, 2014
Nov. 15, 2013
Feb. 28, 2012
Sep. 30, 2011
Aug. 31, 2011
Oct. 22, 2014
Jun. 20, 2014
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Acquisition Related Costs                         $ 32,147,000us-gaap_BusinessCombinationAcquisitionRelatedCosts $ 2,912,000us-gaap_BusinessCombinationAcquisitionRelatedCosts $ 9,155,000us-gaap_BusinessCombinationAcquisitionRelatedCosts                            
Revenue, Net   227,828,000us-gaap_SalesRevenueNet 132,732,000us-gaap_SalesRevenueNet 141,896,000us-gaap_SalesRevenueNet 90,622,000us-gaap_SalesRevenueNet 84,953,000us-gaap_SalesRevenueNet 81,892,000us-gaap_SalesRevenueNet 77,012,000us-gaap_SalesRevenueNet 73,854,000us-gaap_SalesRevenueNet 232,518,000us-gaap_SalesRevenueNet   365,250,000us-gaap_SalesRevenueNet 593,078,000us-gaap_SalesRevenueNet 317,711,000us-gaap_SalesRevenueNet 256,158,000us-gaap_SalesRevenueNet                            
Number of Products Divested                               1akrx_NumberOfProductsDivested                          
Gain (Loss) on Disposition of Business                     9,000,000us-gaap_GainLossOnSaleOfBusiness                                    
Business Combination Amount of Deferred Tax Liability Reversed Against Goodwill                             700,000akrx_BusinessCombinationAmountOfDeferredTaxLiabilityReversedAgainstGoodwill                            
Business Acquisition Percentage Not Exceeded Of Voting Interests Acquired 20.00%akrx_BusinessAcquisitionPercentageNotExceededOfVotingInterestsAcquired                                                        
Available-for-sale Securities   8,391,000us-gaap_AvailableForSaleSecurities                 8,391,000us-gaap_AvailableForSaleSecurities   8,391,000us-gaap_AvailableForSaleSecurities                                
Available-for-sale Securities, Current   7,268,000us-gaap_AvailableForSaleSecuritiesCurrent                 7,268,000us-gaap_AvailableForSaleSecuritiesCurrent   7,268,000us-gaap_AvailableForSaleSecuritiesCurrent                                
Other Nonoperating Income (Expense) [Member] | Watson Product Disposition [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Gain (Loss) on Disposition of Business                               16,800,000us-gaap_GainLossOnSaleOfBusiness
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_OtherNonoperatingIncomeExpenseMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= akrx_WatsonProductDispositionMember		                          
Subsequent Event [Member] | Excelvision [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Payments to Acquire Businesses, Gross                                 25,900,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_ExcelvisionMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember		                        
Rifampin [Member] | VersaPharm [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Gain (Loss) on Disposition of Other Assets                         1,000,000us-gaap_GainLossOnSaleOfOtherAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ProductOrServiceAxis
= akrx_RifampinMember		                                
Other Nonoperating Income                         800,000us-gaap_OtherNonoperatingIncome
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ProductOrServiceAxis
= akrx_RifampinMember		                                
VersaPharm Products [Member] | VersaPharm [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Revenue, Net                         21,700,000us-gaap_SalesRevenueNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_ProductOrServiceAxis
= akrx_VersaPharmProductsMember		                                
Hi-Tech Products [Member] | Hi-Tech Pharmacal Co., Inc [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Revenue, Net                         176,900,000us-gaap_SalesRevenueNet
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_ProductOrServiceAxis
= akrx_HiTechProductsMember		                                
Lidocaine/Prilocaine Topical Cream [Member] | Watson Laboratories, Inc. [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Disposal Group, Including Discontinued Operation, Revenue                         1,500,000us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
/ dei_LegalEntityAxis
= akrx_WatsonLaboratoriesIncMember
/ us-gaap_ProductOrServiceAxis
= akrx_LidocainePrilocaineTopicalCreamMember		 6,800,000us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
/ dei_LegalEntityAxis
= akrx_WatsonLaboratoriesIncMember
/ us-gaap_ProductOrServiceAxis
= akrx_LidocainePrilocaineTopicalCreamMember		                              
Zioptan [Member] | Licensing Agreements [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred                         11,200,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember
/ us-gaap_ProductOrServiceAxis
= akrx_ZioptanMember		                                
Zioptan [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         10 years                                
Product Acquisition Transitional Period                         2 years                                
Before Discount [Member] | Lloyd Animal Health Products [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Contingent Consideration, Liability                                     2,000,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember
/ us-gaap_StatementScenarioAxis
= akrx_BeforeDiscountMember		                    
Before Discount [Member] | Betimol Acquisition [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Contingent Consideration, Liability   4,500,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember
/ us-gaap_StatementScenarioAxis
= akrx_BeforeDiscountMember		                 4,500,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember
/ us-gaap_StatementScenarioAxis
= akrx_BeforeDiscountMember		   4,500,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember
/ us-gaap_StatementScenarioAxis
= akrx_BeforeDiscountMember		                                
After Discount [Member] | Lloyd Animal Health Products [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Contingent Consideration, Liability                                     1,900,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember
/ us-gaap_StatementScenarioAxis
= akrx_AfterDiscountMember		                    
After Discount [Member] | Betimol Acquisition [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Contingent Consideration, Liability   4,000,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember
/ us-gaap_StatementScenarioAxis
= akrx_AfterDiscountMember		                 4,000,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember
/ us-gaap_StatementScenarioAxis
= akrx_AfterDiscountMember		   4,000,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember
/ us-gaap_StatementScenarioAxis
= akrx_AfterDiscountMember		                                
Marketed Under Abbreviated New Drug Applications [Member] | Watson Laboratories, Inc. [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Number of Products Divested                               3akrx_NumberOfProductsDivested
/ dei_LegalEntityAxis
= akrx_WatsonLaboratoriesIncMember
/ us-gaap_StatementScenarioAxis
= akrx_MarketedUnderAbbreviatedNewDrugApplicationsMember		                          
Marketed Under a New Drug Application [Member] | Watson Laboratories, Inc. [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Number of Products Divested                               1akrx_NumberOfProductsDivested
/ dei_LegalEntityAxis
= akrx_WatsonLaboratoriesIncMember
/ us-gaap_StatementScenarioAxis
= akrx_MarketedUnderANewDrugApplicationMember		                          
Before Adjustment [Member] | Kilitch Drugs Limited [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent                             1,400,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_StatementScenarioAxis
= akrx_BeforeAdjustmentMember		                            
After Adjustment [Member] | Kilitch Drugs Limited [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent                             700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember
/ us-gaap_StatementScenarioAxis
= akrx_AfterAdjustmentMember		                            
Term Loan [Member] | Hi-Tech Pharmacal Co., Inc [Member] | JPMorgan [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Debt Instrument, Face Amount                               600,000,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                          
Licensing Agreements [Member] | VersaPharm [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         11 years 146 days                                
Licensing Agreements [Member] | Hi-Tech Pharmacal Co., Inc [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         15 years 255 days                                
Other Intangible Assets [Member] | VersaPharm [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         11 years                                
Trademarks [Member] | VersaPharm [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         3 years                                
Trademarks [Member] | Hi-Tech Pharmacal Co., Inc [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         9 years                                
Customer Relationships [Member] | Hi-Tech Pharmacal Co., Inc [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         1 year                                
Convertible Debt [Member] | Aciex Agreement [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Payments for (Proceeds from) Other Investing Activities 400,000us-gaap_PaymentsForProceedsFromOtherInvestingActivities
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		                             400,000us-gaap_PaymentsForProceedsFromOtherInvestingActivities
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		                          
Minimum [Member] | Kilitch Drugs Limited [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                             4 years                            
Maximum [Member] | Kilitch Drugs Limited [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                             5 years                            
Watson Product Disposition [Member] | Hi-Tech Pharmacal Co., Inc [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Duration of Production                     2 years                                    
Incremental Term Loan Agreement [Member] | VersaPharm [Member] | JPMorgan [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Debt Instrument, Face Amount                                         445,000,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember
/ us-gaap_CreditFacilityAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Excelvision [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred                                   21,700,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_ExcelvisionMember		                      
Business Combination, Acquisition Related Costs                         300,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_ExcelvisionMember		                                
Lloyd Animal Health Products [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred                                     18,000,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		                    
Payments to Acquire Businesses, Gross                                     16,100,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		                    
Business Combination, Contingent Consideration, Liability                                     1,900,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		                    
Business Combination Discount Rate of Additional Consideration Owed                                     4.50%akrx_BusinessCombinationDiscountRateOfAdditionalConsiderationOwed
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		                    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         10 years 255 days                                
Xopenex Inhalation Solutions [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred                         45,000,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexInhalationSolutionsMember		                                
Payments to Acquire Businesses, Gross                                       41,500,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexInhalationSolutionsMember		                  
Business Combination, Acquisition Related Costs                         700,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_XopenexInhalationSolutionsMember		                                
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                                       10 years                  
VersaPharm [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred                                         433,000,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		                
Payments to Acquire Businesses, Gross                                         440,000,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		                
Business Combination, Acquisition Related Costs                         8,100,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		                                
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         11 years 146 days                                
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred                                         7,000,000us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		                
Pre Existing Goodwill Asset   43,200,000akrx_PreExistingGoodwillAsset
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		                 43,200,000akrx_PreExistingGoodwillAsset
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		   43,200,000akrx_PreExistingGoodwillAsset
/ us-gaap_BusinessAcquisitionAxis
= akrx_VersaPharmMember		                                
Hi-Tech Pharmacal Co., Inc [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred                               650,000,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		                          
Business Combination, Acquisition Related Costs                         21,300,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		 1,600,000us-gaap_BusinessCombinationAcquisitionRelatedCosts
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		                              
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         15 years 219 days                                
Business Acquisition, Share Price (in Dollars per share)                               $ 43.50us-gaap_BusinessAcquisitionSharePrice
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		                          
Payments to Acquire Businesses, Net of Cash Acquired                               44,600,000us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		                          
Business Acquisition, Goodwill, Expected Tax Deductible Amount   18,900,000us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		                 18,900,000us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		   18,900,000us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		                                
Business Acquisition, Percentage of Voting Interests Acquired                               50.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember		                          
Betimol Acquisition [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred                         11,500,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		                                
Payments to Acquire Businesses, Gross                         7,500,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		                 7,500,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		 7,500,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		            
Business Combination, Contingent Consideration, Liability   4,300,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		                 4,300,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		   4,300,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		                                
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                         15 years                                
Duration of Production                                           2 years              
Business Acquisition, Consideration, Sales Multiplier                                           1.5akrx_BusinessAcquisitionConsiderationSalesMultiplier
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		 1.5akrx_BusinessAcquisitionConsiderationSalesMultiplier
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		            
Business Acquisition, Duration Following the First Year Post-Acquisition                                           60 days              
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High                                           2,000,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		 2,000,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		            
Business Combination, Contingent Consideration Arrangements, Triggering Sales Amount                                           14,000,000akrx_BusinessCombinationContingentConsiderationArrangementsTriggeringSalesAmount
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		 14,000,000akrx_BusinessCombinationContingentConsiderationArrangementsTriggeringSalesAmount
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		            
Business Combination, Contingent Consideration Arrangements, Triggering Duration                                           1 year              
Business Combination, Contingent Consideration Arrangements, Triggering Duration Span                                           5 years              
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low                                           0us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		 0us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		            
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability                         300,000us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		                                
Merck Acquisition [Member] | Inspire Pharmaceuticals [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Number of Products                                               3akrx_BusinessCombinationNumberOfProducts
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember
/ us-gaap_CounterpartyNameAxis
= akrx_InspirePharmaceuticalsMember		          
Merck Acquisition [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred           52,800,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember		                                   52,800,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember		          
Business Combination, Number of Products                                               2akrx_BusinessCombinationNumberOfProducts
/ us-gaap_BusinessAcquisitionAxis
= akrx_MerckAcquisitionMember		          
Finite-lived Intangible Assets, Amortization Period for Tax Purposes                         15 years                                
Kilitch Drugs Limited [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred                                                 55,200,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		        
Payments to Acquire Businesses, Gross                                                 60,100,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		        
Business Combination, Contingent Consideration, Liability                                                 500,000us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		        
Business Combination, Base Consideration                                                 51,200,000akrx_BusinessCombinationBaseConsideration
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		        
Business Combination, Reimbursements for Capital Expenditures                                                 4,000,000akrx_BusinessCombinationReimbursementsForCapitalExpenditures
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		        
Business Combination, Compensation for Milestones Achieved                                                 7,300,000akrx_BusinessCombinationCompensationForMilestonesAchieved
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		        
Business Combination, Stamp Duties Paid for Land and Buildings                                                 1,600,000akrx_BusinessCombinationStampDutiesPaidForLandAndBuildings
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		        
Business Combination, Assets Acquired Construction in Progress                             14,200,000akrx_BusinessCombinationAssetsAcquiredConstructionInProgress
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		                            
Business Combination Assets Acquired Plant and Equipment                             8,500,000akrx_BusinessCombinationAssetsAcquiredPropertyPlantAndEquipment
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		                            
Business Combination, Assets Acquired Property                             2,600,000akrx_BusinessCombinationAssetsAcquiredAccountsReceivable
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		                            
Business Combination, Assets Acquired, Accounts Receivable                             2,100,000akrx_BusinessCombinationAssetsAcquiredAccountsReceivable1
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		                            
Business Combination, Assets Acquired, Inventory                             1,800,000akrx_BusinessCombinationAssetsAcquiredInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		                            
Product Licensing Rights                         2,800,000akrx_ProductLicensingRights
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		 2,700,000akrx_ProductLicensingRights
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		 800,000akrx_ProductLicensingRights
/ us-gaap_BusinessAcquisitionAxis
= akrx_KilitchDrugsLimitedMember		                            
Aciex Agreement [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Business Combination, Consideration Transferred 10,800,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                                                        
Payments to Acquire Additional Interest in Subsidiaries                                                   2,000,000us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		 8,000,000us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		    
Shares Received on Disposition of Assets (in Shares)                                                       4.3akrx_SharesReceivedOnDispositionOfAssets
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		  
Shares Sold (in Shares)                         0.2akrx_SharesSold
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                                
Shares Sold Value                         600,000akrx_SharesSoldValue
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                                
Available-for-sale Securities, Gross Unrealized Gain (Loss)                         1,100,000us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                                
Available-for-sale Securities   8,400,000us-gaap_AvailableForSaleSecurities
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                 8,400,000us-gaap_AvailableForSaleSecurities
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		   8,400,000us-gaap_AvailableForSaleSecurities
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                                
Available-for-sale Securities, Current   7,200,000us-gaap_AvailableForSaleSecuritiesCurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                 7,200,000us-gaap_AvailableForSaleSecuritiesCurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		   7,200,000us-gaap_AvailableForSaleSecuritiesCurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                                
Current Asset Period                         1 year                                
Available-for-sale Securities, Noncurrent   1,200,000us-gaap_AvailableForSaleSecuritiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                 1,200,000us-gaap_AvailableForSaleSecuritiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		   1,200,000us-gaap_AvailableForSaleSecuritiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= akrx_AciexAgreementMember		                                
ECR Pharmaceuticals Divestiture [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Number of Products Divested                                                         3akrx_NumberOfProductsDivested
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember
Disposal Group, Including Discontinued Operation, Revenue                         3,400,000us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		                                
Gain (Loss) on Disposition of Business                         900,000us-gaap_GainLossOnSaleOfBusiness
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		                                
Disposal Group, Including Discontinued Operation, Consideration   41,000,000us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		                 41,000,000us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		   41,000,000us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		                               41,000,000us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest                         $ (500,000)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		                                
Hi-Tech Pharmacal Co., Inc [Member]                                                          
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) [Line Items]                                                          
Common Stock, Par or Stated Value Per Share (in Dollars per share)                               $ 0.01us-gaap_CommonStockParOrStatedValuePerShare
/ dei_LegalEntityAxis
= akrx_HiTechPharmacalCoIncMember		                          
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)                               $ 43.50us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
/ dei_LegalEntityAxis
= akrx_HiTechPharmacalCoIncMember		                          
XML 88 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9
Document And Entity Information (USD $)
 12 Months Ended
Dec. 31, 2014
Feb. 27, 2015
Jun. 30, 2014
Document and Entity Information [Abstract]      
Entity Registrant Name AKORN INC    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   113,924,711dei_EntityCommonStockSharesOutstanding  
Entity Public Float     $ 1,701,738,000dei_EntityPublicFloat
Amendment Flag false    
Entity Central Index Key 0000003116    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Large Accelerated Filer    
Entity Well-known Seasoned Issuer Yes    
Document Period End Date Dec. 31, 2014    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
XML 89 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 11 - Retirement Plan
 12 Months Ended
Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]  
Pension and Other Postretirement Benefits Disclosure [Text Block]
Note 11 — Retirement Plan

All full-time Akorn employees are eligible to participate in the Company’s 401(k) Plan. During the years ended December 31, 2014, 2013 and 2012, plan-related expense totaled approximately $1.3 million, $0.8 million and $0.8 million, respectively. The Company provides a matching contribution based on a percentage of the amount contributed by each employee, which is funded on a current basis.  The Company suspended its match on 401(k) contributions during 2009 and did not match 401(k) contributions through March 31, 2010.  Effective April 1, 2010, the Company reinstituted a matching contribution at a rate of 25% of the first 6% contributed by employees.  On January 1, 2011, the Company increased its matching contribution to 50% of the first 6% contributed, and has maintained this match rate through December 31, 2014.  Company matching contributions vest 50% after two years of credited service and 100% after three years of credited service.

XML 90 R80.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Income Taxes (Details) - Income Tax Rate Reconciliation (USD $)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2014
Jun. 30, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income Tax Rate Reconciliation [Abstract]            
Computed “expected” tax expense       $ 20,698,000us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate $ 29,013,000us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate $ 20,125,000us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
Change in income taxes resulting from:            
State income taxes, net of Federal income tax       1,490,000us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes 4,027,000us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes 2,159,000us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes
Foreign income tax expense (benefit)       (454,000)us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential 622,000us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential 1,468,000us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential
Deduction for domestic production activities       (1,444,000)us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities (1,361,000)us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities (1,277,000)us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities
R&D tax credits       (447,000)us-gaap_IncomeTaxReconciliationTaxCreditsResearch (1,652,000)us-gaap_IncomeTaxReconciliationTaxCreditsResearch (508,000)us-gaap_IncomeTaxReconciliationTaxCreditsResearch
Other expense (benefit), net       2,329,000us-gaap_IncomeTaxReconciliationOtherReconcilingItems (116,000)us-gaap_IncomeTaxReconciliationOtherReconcilingItems 155,000us-gaap_IncomeTaxReconciliationOtherReconcilingItems
Valuation allowance change       1,116,000us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance 0us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance  
Income tax expense $ 2,021,000us-gaap_IncomeTaxExpenseBenefit $ 7,885,000us-gaap_IncomeTaxExpenseBenefit $ 996,000us-gaap_IncomeTaxExpenseBenefit $ 23,288,000us-gaap_IncomeTaxExpenseBenefit $ 30,533,000us-gaap_IncomeTaxExpenseBenefit $ 22,122,000us-gaap_IncomeTaxExpenseBenefit
XML 91 R90.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 14 - Supplemental Cash Flow Information (in thousands) (Details) - Supplemental Cash Flow Information (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Interest and taxes paid:      
Interest paid $ 31,413us-gaap_InterestPaid $ 4,320us-gaap_InterestPaid $ 4,200us-gaap_InterestPaid
Income taxes paid $ 6,294us-gaap_IncomeTaxesPaid $ 27,450us-gaap_IncomeTaxesPaid $ 21,455us-gaap_IncomeTaxesPaid
XML 92 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Comprehensive Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
REVENUES $ 593,078us-gaap_SalesRevenueNet $ 317,711us-gaap_SalesRevenueNet $ 256,158us-gaap_SalesRevenueNet
Cost of sales (exclusive of amortization of intangibles, included within operating expenses below) 295,488us-gaap_CostOfGoodsAndServicesSold 145,807us-gaap_CostOfGoodsAndServicesSold 107,466us-gaap_CostOfGoodsAndServicesSold
GROSS PROFIT 297,590us-gaap_GrossProfit 171,904us-gaap_GrossProfit 148,692us-gaap_GrossProfit
Selling, general and administrative expenses 95,463us-gaap_SellingGeneralAndAdministrativeExpense 53,508us-gaap_SellingGeneralAndAdministrativeExpense 48,053us-gaap_SellingGeneralAndAdministrativeExpense
Acquisition-related costs 32,147us-gaap_BusinessCombinationAcquisitionRelatedCosts 2,912us-gaap_BusinessCombinationAcquisitionRelatedCosts 9,155us-gaap_BusinessCombinationAcquisitionRelatedCosts
Research and development expenses 29,199us-gaap_ResearchAndDevelopmentExpense 19,858us-gaap_ResearchAndDevelopmentExpense 15,858us-gaap_ResearchAndDevelopmentExpense
Amortization of intangibles 44,066us-gaap_AmortizationOfIntangibleAssets 7,422us-gaap_AmortizationOfIntangibleAssets 6,870us-gaap_AmortizationOfIntangibleAssets
TOTAL OPERATING EXPENSES 200,875us-gaap_OperatingExpenses 83,700us-gaap_OperatingExpenses 79,936us-gaap_OperatingExpenses
OPERATING INCOME 96,715us-gaap_OperatingIncomeLoss 88,204us-gaap_OperatingIncomeLoss 68,756us-gaap_OperatingIncomeLoss
Amortization of deferred financing costs (12,129)us-gaap_AmortizationOfFinancingCosts (842)us-gaap_AmortizationOfFinancingCosts (782)us-gaap_AmortizationOfFinancingCosts
Interest expense, net (35,657)us-gaap_InterestIncomeExpenseNonoperatingNet (8,649)us-gaap_InterestIncomeExpenseNonoperatingNet (10,474)us-gaap_InterestIncomeExpenseNonoperatingNet
Equity in earnings of unconsolidated joint venture   80us-gaap_IncomeLossFromEquityMethodInvestments  
Bargain purchase gain   3,707us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount  
Gain from product divestiture 9,807us-gaap_GainLossOnDispositionOfAssets1    
Other non-operating income, net 400us-gaap_OtherNonoperatingIncomeExpense 395us-gaap_OtherNonoperatingIncomeExpense  
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 59,136us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 82,895us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 57,500us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax provision 23,288us-gaap_IncomeTaxExpenseBenefit 30,533us-gaap_IncomeTaxExpenseBenefit 22,122us-gaap_IncomeTaxExpenseBenefit
INCOME FROM CONTINUING OPERATIONS 35,848us-gaap_IncomeLossFromContinuingOperations 52,362us-gaap_IncomeLossFromContinuingOperations 35,378us-gaap_IncomeLossFromContinuingOperations
Loss from discontinued operations, net of tax (503)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity    
CONSOLIDATED NET INCOME 35,345us-gaap_NetIncomeLoss 52,362us-gaap_NetIncomeLoss 35,378us-gaap_NetIncomeLoss
CONSOLIDATED NET INCOME PER COMMON SHARE:      
Income from continuing operations, basic (in Dollars per share) $ 0.35us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.54us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.37us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
Loss from discontinued operations, basic (in Dollars per share) $ (0.01)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare    
CONSOLIDATED NET INCOME, BASIC (in Dollars per share) $ 0.34us-gaap_EarningsPerShareBasic $ 0.54us-gaap_EarningsPerShareBasic $ 0.37us-gaap_EarningsPerShareBasic
Income from continuing operations, diluted (in Dollars per share) $ 0.34us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1] $ 0.46us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1] $ 0.32us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1]
Loss from discontinued operations, diluted (in Dollars per share) $ (0.01)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare    
CONSOLIDATED NET INCOME, DILUTED (in Dollars per share) $ 0.33us-gaap_EarningsPerShareDiluted $ 0.46us-gaap_EarningsPerShareDiluted $ 0.32us-gaap_EarningsPerShareDiluted
SHARES USED IN COMPUTING CONSOLIDATED NET INCOME PER COMMON SHARE:      
BASIC (in Shares) 103,480us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 96,181us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 95,189us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
DILUTED (in Shares) 123,110us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 113,898us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 110,510us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
COMPREHENSIVE INCOME:      
Consolidated net income 35,345us-gaap_NetIncomeLoss 52,362us-gaap_NetIncomeLoss 35,378us-gaap_NetIncomeLoss
Unrealized holding loss on available-for-sale securities, net of tax of $663 (1,124)us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent    
Foreign currency translation loss, net of tax of $877, $3,328 and $3,040 for the years ended December 31, 2014, 2013 and 2012, respectively (1,704)us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent (6,463)us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent (5,904)us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
COMPREHENSIVE INCOME $ 32,517us-gaap_ComprehensiveIncomeNetOfTax $ 45,899us-gaap_ComprehensiveIncomeNetOfTax $ 29,474us-gaap_ComprehensiveIncomeNetOfTax
[1] Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $5.8 million, after-taxfor the year ended December 31, 2014.
XML 93 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 5 - Property, Plant and Equipment
 12 Months Ended
Dec. 31, 2014
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block]
Note 5 – Property, Plant and Equipment

Property, plant and equipment consist of the following (in thousands):

   
December 31,
 
 
 
2014
   
2013
 
Land
  $ 9,323     $ 2,606  
Buildings and leasehold improvements
    63,846       46,281  
Furniture and equipment
    112,708       76,536  
      185,877       125,423  
Accumulated depreciation
    (68,093 )     (54,470 )
      117,784       70,953  
Construction in progress
   
26,004
      11,155  
    $
143,788
    $ 82,108  

At December 31, 2014 and 2013, property plant and equipment carrying a net book value of $25.6 million and $21.1 million, respectively, was located outside the United States.

XML 94 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 4 - Inventories
 12 Months Ended
Dec. 31, 2014
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
Note 4 — Inventories

The components of inventories, net of allowances, are as follows (in thousands):

   
December 31,
 
 
 
2014
   
2013
 
Finished goods
  $
64,442
    $ 22,886  
Work in process
   
4,335
      3,883  
Raw materials and supplies
   
62,533
      29,213  
    $ 131,310     $ 55,982  

The Company maintains an allowance for excess and obsolete inventory, as well as inventory where its cost is in excess of its net realizable value.  The activity in the allowance for excess, obsolete, and net realizable value inventory account for the two years ended December 31, 2014 was as follows (in thousands):

   
Years Ended December 31,
 
 
 
2014
   
2013
 
Balance at beginning of year
  $ 5,700     $ 6,819  
Provision
    12,275       2,089  
Additions from acquisitions
    8,220       —  
Charges
    (5,016 )      (3,208 )
Balance at end of year
  $ 21,179     $ 5,700  

XML 95 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments
 12 Months Ended
Dec. 31, 2014
Business Combinations [Abstract]  
Business Combination Disclosure [Text Block]
Note 16 – Business Combinations, Dispositions and Other Strategic Investments

Excelvision AG

On July 22, 2014, our Luxembourg subsidiary, Akorn International S.à r.l., entered into a share purchase agreement with Fareva SA to acquire all of the issued and outstanding shares of capital stock of its wholly owned subsidiary, Excelvision AG, a Swiss Company (“Excelvision”) for 21.7 million Swiss Francs (“CHF”), net of certain working capital amounts. Excelvision is a contract manufacturer located in Hettlingen, Switzerland specializing in ophthalmic products.

On January 2, 2015, the Company acquired all of the outstanding shares of capital stock of Excelvision for $25.9 million U.S. dollars funded through available cash on hand. The consideration remains subject to a net working capital adjustment payable by the Company. The Company’s acquisition of Excelvision AG is being accounted for as a business combination in accordance with ASC 805 – Business Combinations.  The purpose of the acquisition is to expand the Company’s manufacturing capacity and reduce production costs. The Company will include information about the fair value of acquired assets and assumed liabilities of the Excelvision acquisition in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2015. During the year ended December 31, 2014, the Company recorded approximately $0.3 million in acquisition related expenses in connection with the Excelvision acquisition.

Lloyd Animal Health Products

On October 2, 2014, Akorn Animal Health, Inc., a wholly owned subsidiary of the Company entered into a definitive Product acquisition agreement with Lloyd, Inc., to acquire certain rights and inventory related to a suite of animal health injectable products (the “Lloyd Products”) used in pain management and anesthesia. The Company acquired the products for $16.1 million, funded through available cash paid at closing, and a contingent payment of $2.0 million, discounted to $1.9 million using a 4.5% discount rate and other unobservable inputs, which becomes payable upon FDA approval of a supplement related to one of the acquired products. The Company’s acquisition of the Lloyd Products is being accounted for as a business combination in accordance with ASC 805 – Business Combinations.  The purpose of the acquisition is to expand the Company’s animal health product portfolio.

The following table sets forth the consideration paid for the Lloyd Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with generally accepted accounting principles (“GAAP”).  The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of the Lloyd Products.

Consideration:
     
Amount of cash paid
 
$
16.1
 
Fair value of contingent payment
   
1.9
 
Total consideration at closing
 
$
18.0
 
         
Recognized amounts of identifiable assets acquired:
       
Accounts receivable
   
0.1
 
Inventory
   
2.5
 
Product licensing rights
   
10.0
 
IPR&D
   
5.5
 
Accounts payable assumed
   
(0.1)
 
Fair value of assets acquired
 
$
18.0
 

IPR&D assets represent ongoing in-process research and development projects obtained through the acquisition. Weighted average remaining amortization period of intangible assets acquired through the Lloyd acquisition as of the closing date was 10.7 years. The rights to Lloyd products are included within product licensing rights, net on the Company’s condensed consolidated balance sheet as of December 31, 2014.

The Company has not provided pro forma revenue and earnings of the Company as if the Lloyd Products Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Lloyd Product rights were not managed as a discrete business by the previous owner. Accordingly, determining the pro forma revenue and earnings of the Company including the Lloyd Products Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.

Xopenex Inhalation Solutions

On October 1, 2014, the Company entered into a definitive product acquisition agreement with Sunovion Pharmaceuticals Inc., a Delaware corporation to acquire certain rights and inventory related to the branded product, Xopenex® Inhalation Solution (levalbuterol hydrochloride) (the “Xopenex Product”) for $45 million, funded through available cash paid at closing, net of certain liabilities for product return reserves, rebates, and chargeback reserves, which were assumed by Oak Pharmaceuticals, Inc. (“Oak”), a subsidiary of Akorn, subject to a cap. The total cash paid at closing was $41.5 million, which was net of certain liabilities for product return reserves, rebates, and chargeback reserves assumed by the Company.

Xopenex® is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. The Company’s acquisition of Xopenex® (the “Xopenex Acquisition”) is being accounted for as a business combination in accordance with ASC 805 – Business Combinations.  The purpose of the Xopenex Acquisition is to expand the Company’s product portfolio of prescription pharmaceuticals.

Pursuant to the purchase agreement, certain trademarks and patents related to the Xopenex Product will be licensed to Oak by Sunovion. Further, in connection with closing the Purchase Agreement, the Company and Sunovion entered into a customary transition services agreement. Additionally, the Company assumed a distribution agreement for authorized generic of the product and assumed certain open purchase orders placed in ordinary course for active pharmaceutical ingredients.

The following table sets forth the consideration paid for the Xopenex Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.  The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of the Xopenex Product.

Consideration:
     
Amount of cash paid
 
$
41.5
 
Product returns and reserves assumed
   
3.5
 
Total consideration at closing
 
$
45.0
 
         
Recognized amounts of identifiable assets acquired:
       
Accounts Receivable, net (product returns and reserves assumed)
   
(3.5)
 
Inventory
   
6.3
 
Product licensing rights
   
38.7
 
Fair value of net assets acquired
 
$
41.5
 

Weighted average remaining amortization period of the intangible asset acquired as of the closing date was 10 years. The rights to Xopenex® are included within product licensing rights, net on the Company’s condensed consolidated balance sheet as of December 31, 2014.  During the year ended December 31, 2014, the Company recorded approximately $0.7 million in acquisition related expenses in connection with the Xopenex acquisition.

VPI Holdings Corp. Inc.

On August 12, 2014, the Company completed its acquisition of VersaPharm, a Georgia corporation for a total purchase price of approximately $433.0 million, subject to net working capital adjustments. This purchase price was based on acquiring all outstanding equity interests of VPI Holdings Corp. (“VPI”), the parent company of VersaPharm and was equal to $440.0 million, net of various post-closing adjustments related to working capital, cash, and transaction expenses of approximately $7.0 million.

On May 9, 2014, the Company entered into an Agreement and Plan of Merger (the “VP Merger Agreement”) to acquire VPI. Upon consummation of the merger, each share of VPI’s common stock and preferred stock issued and outstanding immediately prior to such time, other than those shares held in treasury by VersaPharm, owned by Akorn, Akorn Enterprises II, Inc., or VPI or any other subsidiary of VPI (each of which were cancelled) and to which dissenters’ rights have been properly exercised, were cancelled and converted into the right to receive its per share right to the aggregate merger consideration, subject to various post-closing adjustments related to working capital, cash, transaction expenses and funded indebtedness. In addition, all stock options of VPI held immediately prior to the consummation of the merger became fully vested and were cancelled upon consummation of the merger with the right to receive payment on the terms set forth in the VP Merger Agreement.

The acquisition was approved by the Federal Trade Commission (“FTC”) on August 4, 2014 following review pursuant to provisions of Hart-Scott Rodino Act (“HSR”). In connection with the VersaPharm Acquisition, the Company entered into an agreement (the “Rifampin Divestment Agreement”) with Watson, a wholly owned subsidiary of Actavis plc, to divest certain rights and assets to the Company’s Rifampin injectable product. Under the terms of the disposition the Company received $1.0 million for the pending product rights and recorded a gain of $0.8 million in Other non-operating income, net in the year ended December 31, 2014 related to the divestment.

VersaPharm is a developer and marketer of multi-source prescription pharmaceuticals. VersaPharm markets its products to drug wholesalers, retail drug chains, pharmaceutical distributors, group purchasing organizations, hospitals, clinics and government agencies.

The VersaPharm Acquisition complements and expands the Company’s product portfolio by diversifying its offering to niche dermatology markets.  VersaPharm’s product portfolio, pipeline and development capabilities are complementary to our acquisition of Hi-Tech Pharmacal Co, Inc. (“HiTech”) acquisition which brought with it the manufacturing capabilities needed for many of VersaPharm’s current and pipeline products. The VersaPharm Acquisition also enhances the Company’s new product pipeline as VersaPharm has significant research and development experience and knowledge and numerous IPR&D products are under active development.

The VersaPharm Acquisition was principally funded through a $445.0 million Incremental Term Loan Facility entered into concurrent with completing the acquisition, and through available Akorn cash. For further details on the term loan financing, please refer to the description in Note 6 – Financing Arrangements.

During the year ended December 31, 2014, the Company recorded approximately $8.1 million, in acquisition-related expenses in connection with the VersaPharm Acquisition. These expenses principally consisted of various legal fees and other acquisition costs which have been recorded within “acquisition related costs” as part of operating expenses in the Company’s consolidated statement of comprehensive income in the applicable periods.

The following table sets forth the consideration paid for the VersaPharm Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.  The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of VersaPharm.

Consideration:
 
Initial Fair
Valuation
   
Measurement
Period
Adjustments
   
Adjusted
 Fair
Valuation
 
Amount of cash paid to VersaPharm stockholders
  $ 322.7     $ —     $ 322.7  
Amount of cash paid to vested VersaPharm option holders
    14.2       —       14.2  
Amounts paid to escrow accounts
    10.3       —       10.3  
Transaction expenses paid for previous owners of VersaPharm
    3.4       —       3.4  
Total consideration paid at closing
    350.6       —       350.6  
VersaPharm debt paid off through closing cash
    82.4       —       82.4  
Total cash paid at closing
  $ 433.0     $ —     $ 433.0  
                         
Recognized amounts of identifiable assets acquired and liabilities assumed:
                       
Cash and cash equivalents
  $ 0.1     $ —     $ 0.1  
Accounts receivable
    10.0       1.0       11.0  
Inventory
    20.9       (0.2 )     20.7  
Other current assets
    2.8      
4.8
     
7.6
 
Property and equipment
    1.5       —       1.5  
Trademarks
    1.0       —       1.0  
Product licensing rights
    250.8       —       250.8  
Intangibles, other
    5.2       —       5.2  
IPR&D
    215.9       —       215.9  
Goodwill
    90.6       0.8       91.4  
Total assets acquired
  $ 598.8     $
6.4
    $
605.2
 
Assumed current liabilities
    (18.3 )     (0.6 )     (18.9 )
Assumed non-current liabilities
    (76.0 )             (76.0 )
Deferred tax liabilities
    (153.9 )      (5.8 )      (159.7 )
Total liabilities assumed
  $ (248.2 )   $
(6.4
)   $ (254.6 )
    $ 350.6     $ —     $ 350.6  

The changes in estimates recorded subsequent to the initial accounting estimate was related to refining the calculated fair value of acquired accounts receivable and assumed tax amounts, due to the acquisition.

Goodwill represents expected synergies resulting from the combination of the entities and other intangible assets that do not qualify for separate recognition, while IPR&D assets represent ongoing in-process research and development projects obtained through the acquisition. The Company does not anticipate being able to deduct any of the associated incremental value of goodwill and other intangible assets for income tax purposes, but expects to be able to deduct approximately $43.2 million of value associated with pre-existing VersaPharm goodwill and other intangible assets for income tax purposes in future periods.

During the year ended December 31, 2014, the Company recorded net revenue of approximately $21.7 million related to sales of the VersaPharm products subsequent to acquisition.

Weighted average remaining amortization period of intangible assets acquired other than goodwill and IPR&D through the VersaPharm acquisition as of the closing date was 11.4 years in aggregate, 11.4 years for product licensing rights, 11.0 years for other intangibles, and 3 years for trademarks.

Hi-Tech Pharmacal Co., Inc.

On April 17, 2014, the Company completed its acquisition of Hi-Tech for a total purchase price of approximately $650.0 million. This purchase price was based on acquiring all outstanding shares of Hi-Tech common stock for $43.50 per share, buying out the intrinsic value of Hi-Tech’s stock options, and paying the single-trigger separation payments to various Hi-Tech executives due upon change in control. The total consideration paid is net of Hi-Tech’s cash acquired subsequent to Hi-Tech’s payment of $44.6 million of stock options and single trigger separation payments as of April 17, 2014.

On August 27, 2013, the Company entered into an Agreement and Plan of Merger (the “HT Merger Agreement”) to acquire Hi-Tech. Subject to the terms and conditions of the HT Merger Agreement, upon completion of the merger on April 17, 2014, each share of Hi-Tech’s common stock, par value $0.01 per share, issued and outstanding and held by non-interested parties at the time of the merger (the “Hi-Tech Shares”), was cancelled and converted into the right to receive $43.50 in cash, without interest, less any applicable withholding taxes, upon surrender of the outstanding Hi-Tech Shares.

In connection with the Hi-Tech Acquisition, the Company entered into an agreement (the “Divestment Agreement”) with Watson Laboratories, Inc., a wholly owned subsidiary of Actavis plc, to divest certain rights and assets - see below for further consideration.

Hi-Tech is a specialty pharmaceutical company which develops, manufactures and markets generic and branded prescription and OTC products. Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gel products. Hi-Tech’s Health Care Products division is a developer and marketer of OTC products, and their ECR Pharmaceuticals subsidiary markets branded prescription products. Hi-Tech operates a manufacturing facility and corporate offices in Amityville, New York, and ECR maintains its corporate offices in Richmond, Virginia.

The Hi-Tech Acquisition is expected to complement and expand the Company’s product portfolio by diversifying its offering to its retail customers beyond ophthalmics to other niche dosage forms such as oral liquids, topical creams and ointments, nasal sprays and otics. The Hi-Tech Acquisition is also expected to enhance the Company’s new product pipeline. Further, the Hi-Tech Acquisition will add branded OTC products in the categories of cough and cold, nasals, and topicals to the Company’s existing TheraTears® brand of eye care products, and will provide additional domestic manufacturing capacity for the Company.

The Hi-Tech Acquisition was principally funded through a $600.0 million term loan entered into concurrent with completing the acquisition, and through Hi-Tech cash assumed through the acquisition.

During the year ended December 31, 2014,and 2013 the Company recorded approximately $21.3 million and $1.6 million, respectively, in acquisition-related expenses in connection with the Hi-Tech Acquisition. These expenses principally consisted of various legal fees and other acquisition costs which have been recorded within “acquisition related costs” as part of operating expenses in the Company’s consolidated statement of comprehensive income in the applicable periods.

The following table sets forth the consideration paid for the Hi-Tech Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.  The figures below are preliminary and subject to review of the facts and assumptions used to determine the fair values of the acquired assets developed utilizing an income approach and may differ from historical financial results of Hi-Tech.

Consideration:
 
Initial Fair
Valuation
   
Measurement
Period
Adjustments
   
Adjusted Fair
Valuation
 
Amount of cash paid to Hi-Tech shareholders
  $ 605.0     $ —     $ 605.0  
Amount of cash paid to vested Hi-Tech option holders
    40.5       —       40.5  
Amount of cash paid to key executives under single-trigger separation payments upon change-in-control
    4.1       —       4.1  
    $ 649.6     $ —     $ 649.6  

Recognized amounts of identifiable assets acquired and liabilities assumed:
 
Initial Fair Valuation
   
Measurement Period Adjustments
   
Adjusted Fair Valuation
 
Cash and cash equivalents
  $ 89.7     $ —     $ 89.7  
Accounts receivable
    57.3       (5.7 )     51.6  
Inventory
    53.7       (0.7 )     53.0  
Other current assets
    20.6       13.1       33.7  
Property and equipment
    45.5       (2.0 )     43.5  
Product licensing rights
    343.5       —       343.5  
IPR&D
    9.4       —       9.4  
Customer Relationships
    0.3       —       0.3  
Trademarks
    5.5       —       5.5  
Goodwill
    171.5       (2.0 )     169.5  
Other non-current assets
    0.6       —       0.6  
Total assets acquired
  $ 797.8     $ 2.7     $ 800.5  
Assumed current liabilities
    (23.5 )     1.7       (21.8 )
Assumed non-current liabilities
    (2.8 )     (0.2 )     (3.0 )
Deferred tax liabilities
    (121.9 )     (4.2 )     (126.1 )
Total liabilities assumed
  $ (148.2 )   $ (2.7 )   $ (150.9 )
    $ 649.6     $ —     $ 649.6  

The changes in estimates recorded subsequent to the initial accounting estimate was related to refining the calculated fair value of acquired accounts receivable and assumed tax amounts, due to the merger.

Goodwill represents expected synergies resulting from the combination of the entities and other intangible assets that do not qualify for separate recognition, while IPR&D assets represent ongoing in-process research and development projects obtained through the acquisition. The Company does not anticipate being able to deduct any of the associated incremental value of goodwill and other intangible assets for income tax purposes, but expects to be able to deduct approximately $18.9 million of value associated with pre-existing Hi-Tech goodwill and other intangible assets for income tax purposes in future periods.

During the year ended December 31, 2014, the Company recorded net revenue of approximately $176.9 million related to sales of the Hi-Tech products subsequent to acquisition.

Weighted average amortization period of intangible assets acquired other than goodwill and IPR&D through the Hi-Tech acquisitions as of the closing date was 15.6 years in aggregate, 15.7 years for product licensing rights, 1 year for customer relationships and 9 years for trademarks.

Watson Product Disposition

In connection with the Hi-Tech Merger, Akorn entered into an agreement (the “Disposition Agreement”) with Watson to dispose of certain rights and assets related to three Hi-Tech products marketed under Abbreviated New Drug Applications — Ciprofloxacin Hydrochloride Ophthalmic Solution, Levofloxacin Ophthalmic Solution and Lidocaine Hydrochloride Jelly — and one Akorn product marketed under a New Drug Application: Lidocaine/Prilocaine Topical Cream, collectively “the products”. The Divestment Agreement further included one product under development. Net revenues for the Akorn products marketed under a New Drug Application: Lidocaine/Prilocaine Topical Cream were approximately $1.5 million and $6.8 million in the years ended December 31, 2014 and 2013, respectively. This disposition was required pursuant to a proposed consent order accepted by vote of the FTC on April 11, 2014. The closing of the disposition agreement, which was contingent upon the consummation of the Company’s acquisition of 50% or more of the voting securities of Hi-Tech, took place on April 17, 2014. Under the terms of the disposition the Company received $16.8 million for the intangible product rights, associated goodwill, and saleable inventory of the products denoted above. The Company recorded a gain of $9.0 million in Other (expense) income, net in the year ended December 31, 2014, resulting from the difference of the consideration received and assets disposed, see below.

Calculation of gain from Watson product disposition (in millions)
       
Consideration received
  $
16.8
 
Intangible assets disposed
   
(5.9
)
Goodwill disposed
   
(1.1
)
Other assets disposed
   
(0.8
)
Pre-Tax gain recognized
  $
9.0
 

Upon completing the Watson product disposition, the Company entered into a master supply agreement with Watson whereby the Company will continue manufacturing the products for a transitional period not to exceed two years. The parties also entered into a transition services agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to Watson.

ECR Divestiture

On June 20, 2014, the Company divested its subsidiary, ECR Pharmaceuticals, net of three branded products (specifically Cormax®, VoSol® HC, and Zolvit® Oral Solution otherwise known as “Lortab”) to Valeant Pharmaceuticals (“Valeant”) for $41.0 million in cash and assumption of certain liabilities. Through the divestiture, the Company recognized a nominal gain on the sale of the intangible product rights, associated goodwill, saleable inventory and other assets of ECR. ECR, which promotes certain branded pharmaceuticals through its sales force, was acquired through the acquisition of Hi-Tech. As the Company has divested a component of the combined entity and does not expect material continuing cash flows, ECR results which included net revenues of $3.4 million and a net loss from discontinued operations of ($0.5) million for the period from acquisition to disposition (which both occurred during the year ended December 31, 2014) have been included within discontinued operations in the consolidated statements of comprehensive income, see below.

Calculation of gain/from ECR Divestiture (in millions)
     
Consideration received
  $
41.0
 
Intangible assets divested
   
(33.6
)
Goodwill divested
   
(10.4
)
Other assets divested
   
(1.2
)
Assumed liabilities divested
   
5.1
 
Pre-Tax Gain recognized
  $
0.9
 

Zioptan Acquisition

On April 1, 2014, the Company acquired the U.S. NDA rights to Zioptan®, a prescription ophthalmic eye drop indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, from Merck, Sharp and Dohme Corp. (“Merck”). The Company’s acquisition of U.S. NDA rights to Zioptan® (the “Zioptan Acquisition”) is being accounted for as a business combination in accordance with ASC 805 – Business Combinations. The purpose of the Zioptan Acquisition is to expand the Company’s product portfolio of prescription pharmaceuticals. The total consideration at closing was $11.2 million, all of which was recognized as product licensing rights as of the acquisition date and has an amortization period of 10 years.

Upon completing the Zioptan Acquisition, the Company entered into a master supply agreement with Merck whereby Merck will continue manufacturing Zioptan® for a transitional period not to exceed two years, during which time the Company will work to transfer manufacturing. The transfer price, per the terms of the supply agreement, will equal Merck’s historical product cost. The parties also entered into a Transition Services Agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to the Company.

The U.S. NDA rights to Zioptan® are included within product licensing rights, net on the Company’s consolidated balance sheet as of December 31, 2014.

The Company has not provided pro forma revenue and earnings of the Company as if the Zioptan Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Zioptan® rights were not managed as a discrete business by Merck. Accordingly, determining the pro forma revenue and earnings of the Company including the Zioptan Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.

Betimol Acquisition

On January 2, 2014, the Company acquired the NDA rights to Betimol®, a prescription ophthalmic eye drop for the reduction of eye pressure in glaucoma patients, from Santen. The Company’s acquisition of U.S. NDA rights to Betimol® (the “Betimol Acquisition”) is being accounted for as a business combination in accordance with ASC 805 – Business Combinations. The purpose of the Betimol Acquisition is to expand the Company’s product portfolio of prescription pharmaceuticals. The total consideration will be equal to 1.5 times the Company’s net sales of Betimol® in the first year following acquisition, such year starting upon the Company’s first sale of the product. The Company paid $7.5 million upon completing the acquisition and will pay any remaining amount 60 days following the first year post-acquisition. There is also a provision for a $2.0 million increase to the total consideration should net sales of Betimol® exceed $14.0 million in any one of the first five years following acquisition, the Company has valued this at $0. There is no provision for reducing the purchase price below the initial $7.5 million paid.

Upon completing the Betimol Acquisition, the Company entered into a supply agreement with Santen whereby Santen will continue manufacturing Betimol® for a transitional period not to exceed two years, during which time the Company will work to site transfer manufacturing to one of its facilities. The transfer price, per the terms of the supply agreement, will equal Santen’s cost of API plus actual cost of manufacturing the product, making this a favorable contract pursuant to ASC 805. The parties also entered into a transition services agreement, the purpose of which is to affect a smooth transfer of all intellectual property and necessary historical data to complete the ownership transfer to the Company.

The following table sets forth the consideration paid for the Betimol Acquisition and the fair values of the acquired assets and assumed liabilities (in millions) as of the acquisition date adjusted in accordance with GAAP.

Betimol Acquisition:
     
Consideration paid in cash at closing
  $
7.5
 
Purchase consideration payable
   
4.0
 
    $
11.5
 
         
Fair value of acquired assets:
       
U.S. NDA rights to Betimol®
  $
11.4
 
Favorable supply agreement
   
0.1
 
    $
11.5
 

The U.S. NDA rights to Betimol® are included within product licensing rights, net on the Company’s consolidated balance sheet as of December 31, 2014 and has an amortization period of 15 years. The favorable supply agreement is included within other long-term assets on the Company’s consolidated balance sheet as of December 31, 2014.

The Company estimated that it would owe additional consideration to Santen of approximately $4.5 million. Since this is a performance-based earn-out payment, this additional consideration was discounted to approximately $4.0 million. As of the year ended December 31, 2014, the Company revised the additional consideration calculation to $4.3 million and recorded $0.3 million of other operating expense reflecting a fair value adjustment to increase the estimated additional consideration obligation as a result of revised operating expectations.

The Company has not provided pro forma revenue and earnings of the Company as if the Betimol Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The acquired Betimol® rights were not managed as a discrete business by Santen. Accordingly, determining the pro forma revenue and earnings of the Company including the Betimol Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.

Merck Products Acquisition

On November 15, 2013, the Company acquired from Merck the U.S. rights to three branded ophthalmic products for $52.8 million in cash (the “Merck Acquisition”). The acquired assets met the definition of a business, and accordingly, have been accounted for as a business combination in accordance with ASC 805 – Business Combinations. Through the Merck Acquisition, the Company purchased Inspire Pharmaceuticals, Inc. (“Inspire”), a wholly owned subsidiary of Merck. This legal entity owns the U.S. rights to AzaSite®, a prescription eye drop used to treat bacterial conjunctivitis. The U.S. rights to the other two products involved in the acquisition, Cosopt® and Cosopt® PF (preservative free), were purchased directly from Merck. The Cosopt® products are prescription sterile eye drop solutions used to lower the pressure in the eye in people with open-angle glaucoma or ocular hypertension. The acquisition of these products expands the Company’s ophthalmic product portfolio to include branded, prescription eye drops, and is complementary to the Company’s existing portfolio of products. The Company believes that this acquisition leverages its existing sales force and ophthalmic and optometric physician relationships.

The following table sets forth the consideration paid for the Merck Acquisition and the fair values of the assets acquired and the liabilities assumed (in millions):

Product rights:
     
AzaSite®
  $
13.8
 
Cosopt®
   
21.6
 
Cosopt® PF
   
20.3
 
Product rights total
  $
55.7
 
Prepaid expenses
   
0.1
 
Deferred tax assets, net
   
0.7
 
Total fair value of acquired assets
  $
56.5
 
Consideration paid
  $
52.8
 
Gain from bargain purchase
  $
3.7
 

Through its acquisition of Inspire Pharmaceuticals, Inc. the Company assumed that entity’s net operating loss carry-forwards (“NOLs”) and unamortized start-up costs. The “deferred tax assets, net” listed above represents the difference between the acquired deferred tax assets, the NOLs, and unamortized start-up costs, and the acquired deferred tax liabilities, which represent the book versus tax basis differences in the product rights. The bargain purchase amount was largely derived from the difference between the fair value and the economic value, as calculated through discounted cash flow analysis, of the deferred tax assets, net. In particular, due to the long-term nature of the NOLs acquired, the book value of the resulting deferred tax asset significantly exceeded its discounted cash flow value.

The Company anticipates amortizing the acquired products on a straight-line basis from the Merck Acquisition date through December 31, 2019. The Merck Acquisition agreement specified the tax values assigned to each product. The tax value of AzaSite® product rights will not be amortizable for tax purposes, as these rights were obtained through the stock acquisition of Inspire Pharmaceuticals, Inc. That Company anticipates that the assigned tax values of Cosopt® and Cosopt® PF will be amortizable for tax purposes over a 15-year period.

The Company has not provided pro forma revenue and earnings of the Company as if the Merck Acquisition was completed as of January 1, 2013 because to do so would be impracticable. The products acquired from Merck were not managed as a discrete business by Merck. Accordingly, determining the pro forma revenue and earnings of the Company including the Merck Acquisition would require significant estimates of amounts, and it is impossible to distinguish objectively information about such estimates that provides evidence of circumstances that existed on the dates at which those amounts would be recognized and measured, and would have been available when the financial statements for that prior period were issued.

Kilitch Acquisition

On February 28, 2012, Akorn India Private Limited, a wholly owned subsidiary of the Company completed and closed on its acquisition of selected assets of Kilitch Drugs (India) Limited (“KDIL”).  This acquisition (the “Kilitch Acquisition”) was pursuant to the terms of the Business Transfer Agreement (the “BTA”) entered into among the Company, KDIL and the members of the promoter group of KDIL on October 5, 2011.  In accordance with terms contained in the BTA, the Company also closed on a related product transfer agreement between the Company and NBZ Pharma Limited (“NBZ”), a company associated with KDIL.  The primary asset transferred in the Kilitch Acquisition was KDIL’s manufacturing facility in Paonta Sahib, Himachal Pradesh, India, along with its existing contract manufacturing business.  KDIL was engaged in the manufacture and sale of pharmaceutical products for contract customers in India and for export to various unregulated world markets.  While the Paonta Sahib manufacturing facility is not currently certified by the FDA for the exporting of drugs to the U.S., the facility was designed with future FDA certification in mind.  Accordingly, the Kilitch Acquisition provided the Company with the potential for future expansion of its manufacturing capacity for products to be sold in the U.S., as well as the opportunity to expand the Company’s footprint into markets outside the U.S.  The Company has determined that the assets acquired through the Kilitch Acquisition constitute a “business” as defined by Rule 11-01(d) of Regulation S-X and ASC 805, Business Combinations.  Accordingly, the Company has accounted for the Kilitch Acquisition as a business combination.

AIPL paid the equivalent of approximately USD $60.1 million at closing.  Total purchase consideration was approximately $55.2 million which consisted of approximately $51.2 million in base consideration and $4.0 million in reimbursement for capital expenditures made by KDIL from April 1, 2011 to the closing date.  AIPL also paid $7.3 million related to compensation earned from the achievement of acquisition-related milestones, and $1.6 million in stamp duties paid to transfer title to the land and buildings at Paonta Sahib from Kilitch to AIPL.  In addition, the Company expects to pay up to an additional $0.5 million for future services that would be expensed as the services are provided.  The compensation for acquisition-related milestones and other acquisition costs have been recorded within “acquisition related costs” as part of operating expenses in the Company’s consolidated statement of comprehensive income.  The BTA also contains a working capital guarantee that calls for KDIL or AIPL to reimburse the other party for any shortfall or excess, respectively, in the actual acquired working capital compared to the target working capital as established in the BTA.

The following table sets forth the consideration paid for the Kilitch Acquisition, the acquisition-related costs incurred, and the fair values of the assets acquired and the liabilities assumed (U.S. dollar amounts in millions):

Consideration:
Initial Fair
Valuation
   
Measurement Period Adjustments
   
Adjusted Fair
Valuation
 
Cash paid
  $ 55.2     $ —     $ 55.2  
Less working capital shortfall refunded by sellers
    (0.9 )     (0.1 )     (1.0 )
    $ 54.3     $ (0.1 )   $ 54.2  
                         
Acquisition-related costs:
                       
Stamp duties paid for transfer of land and buildings
  $ 1.6     $ —     $ 1.6  
Acquisition-related compensation expense
    6.7       0.5       7.2  
Due diligence, legal, travel and other acquisition-related costs
    0.6       0.1       0.7  
    $ 8.9     $ 0.6     $ 9.5  
                         
Recognized amounts of identifiable assets acquired and liabilities assumed:
                 
Accounts receivable
  $ 2.1     $ —     $ 2.1  
Inventory
    1.8       —       1.8  
Land
    3.7       (1.1 )     2.6  
Buildings, plant and equipment
    8.5       —       8.5  
Construction in progress
    14.2       —       14.2  
Goodwill, deductible
    21.6       1.0       22.6  
Other intangible assets, deductible
    5.8       0.1       5.9  
Other assets
    0.1       —       0.1  
Assumed liabilities
    (2.1 )     (0.8 )     (2.9 )
Deferred tax liabilities
    (1.4 )     0.7       (0.7 )
    $ 54.3     $ (0.1 )   $ 54.2  

The Adjusted Fair Valuation presented above is final.  The changes in estimate recorded subsequent to the initial accounting estimate were primarily related to refining the calculated fair value of certain acquired assets, adjustments to the working capital settlement amount due from the sellers to the Company, and final determination regarding the tax-deductibility of the acquired intangible assets.  The acquisition-related compensation expense during 2012 was primarily related to pre-negotiated compensation paid to members of the sellers’ family based on achievement of various operational milestones.

Goodwill represents expected synergies and intangible assets that do not qualify for separate recognition.  Based on an Indian Supreme Court ruling in 2012 upholding the deductibility of goodwill for India tax purposes, the Company anticipates being able to deduct the value of goodwill for income tax purposes in India.  A later Indian Supreme Court ruling raised doubt as to the tax deductibility of the cost of the non-compete agreement entered into between AIPL and the sellers.  Accordingly, the Company amended its acquisition accounting to establish a deferred tax liability related to this intangible asset. The Company had initially recorded a deferred tax liability valued at $1.4 million and subsequently adjusted to $0.7 million related to intangible assets and other accrued liabilities that it does not believe will be amortizable for Indian tax purposes.  This remaining deferred tax liability of $0.7 million was reversed against goodwill during 2012.  

For book purposes, the other intangible assets acquired are being amortized over lives of four to five years. Goodwill is not amortized for book purposes but is subject to impairment testing.  The tangible assets acquired consist primarily of construction in progress fair valued at $14.2 million, buildings, plant and equipment fair valued at a combined $8.5 million, land fair valued at $2.6 million, accounts receivable fair valued at $2.1 million and inventory fair valued at $1.8 million as of the acquisition date.

During 2014, 2013 and 2012, the Company paid $2.8 million, $2.7 million and $0.8 million, respectively, for the acquisition of drug product licensing rights (NDA and ANDA rights) which were not individually significant. No assets were acquired other than the drug rights, and no liabilities assumed.

The unaudited pro forma results presented below reflect the consolidated results of operations inclusive of the Xopenex acquisition, VersaPharm acquisition and Akorn Rifampin product divestiture (“VersaPharm transactions”), and the Hi-Tech acquisition, Watson product disposition and ECR divestiture (“Hi-Tech transactions”) which occurred during the year ended December 31, 2014, as if the transactions had taken place at the beginning of the earliest period presented below. The pro forma results include amortization associated with the acquired tangible and intangible assets, interest on debt incurred for the transactions, amortization of inventory step-up, acquisition related expenses and income tax expense affected for the pro forma results. The unaudited pro forma financial information presented below does not reflect the impact of any actual or anticipated synergies expected to result from the acquisitions. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations as they would have been had the transactions been effected on the assumed date (amounts in thousands, except per share data):

   
For the Year Ended
December 31,
 
   
2014
   
2013
 
Revenue
  $
733,012
    $ 623,922  
Net income from continuing operations
   
71,722
      4,891  
Net income from continuing operations per share
  $
0.58
    $ 0.04  

Other Strategic Investments

On August 1, 2011, the Company entered into a Series A-2 Preferred Stock Purchase Agreement to acquire a minority ownership interest in Aciex Therapeutics Inc. (“Aciex”), a private ophthalmic development pharmaceutical company based in Westborough, MA, for $8.0 million in cash. Subsequently, on September 30, 2011, the Company entered into Amendment No. 1 to Series A-2 Preferred Stock Purchase Agreement to acquire additional shares of Series A-2 Preferred Stock in Aciex for approximately $2.0 million in cash. On April 17, 2014, the Company entered into a secured note and warrant purchase agreement to acquire secured, convertible promissory notes of Aciex for approximately $0.4 million in cash. On June 27, 2014, the Company entered into a second secured note and warrant purchase agreement to acquire additional secured, convertible promissory notes of Aciex for an additional amount of approximately $0.4 million. The Company’s aggregate investment in Aciex was $10.8 million at cost. Aciex was an ophthalmic drug development company focused on developing novel therapeutics to treat ocular diseases. Aciex’s pipeline consisted of both clinical stage assets and pre-Investigational new drug stage assets. The investments detailed above had provided the Company with an ownership interest in Aciex of below 20%. The Aciex Agreement and Aciex Amendment contained certain customary rights and preferences over the common stock of Aciex and further provided that the Company shall have had the right to a seat on the Aciex board of directors.

On July 2, 2014 Nicox S.A., (“Nicox”) an international Company entered into an arrangement to acquire all of the outstanding equity of Aciex (the “Aciex Acquisition”).

On October 22, 2014 Nicox shareholders voted at the Nicox General Meeting, to approve the Aciex Acquisition. The transaction was consummated on October 24, 2014, following the completion of certain legal conditions and formalities. As consideration for its carried investment in Aciex, the Company received from the Aciex Acquisition pro-rata shares of Nicox which are publically traded on the Euronext Paris exchange. Through the closing the Company received approximately 4.3 million shares of Nicox which were subject to certain lockup provisions preventing immediate sale of underlying shares received for the Company’s investment in an available for sale security.

Through the year ended December 31, 2014 the Company sold 0.2 million unrestricted shares for approximately $0.6 million realizing an immaterial gain on the sale of shares.

In accordance with ASC Topic 820, the Company records unrealized holding gains and losses on the remaining available for sale securities in the “Accumulated other comprehensive income” caption in the consolidated Balance Sheet. For the year ended December 31, 2014 the Company recognized an unrealized holding loss, net of tax of $1.1 million as calculated based on the discounted value of the investment given the contractual lockup provisions. The Company has determined that of the remaining $8.4 million of unrealized fair value associated with the investment, $7.2 million is expected to be converted to cash within 1 year from the balance sheet date and has been classified as a current asset, while $1.2 million is expected to be converted beyond one year and has been classified as a non-current asset.

XML 96 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 12 - Segment Information
 12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 12 — Segment Information

During the year ended December 31, 2014, the Company acquired Hi-Tech and as a result, underwent a change in the organizational and reporting structure of the Company's reportable segments, establishing two reporting segments that each report to the Chief Operating Decision Maker (CODM), as defined in ASC Topic 280, Segment Reporting, and Chief Executive Officer (CEO), Raj Rai. Our performance will be assessed and resources will be allocated by the CODM based on the following two reportable segments:

- Prescription Pharmaceuticals

- Consumer Health

Prior to the realignment the Company managed the business as three distinct reporting segments; Ophthalmics, Hospital Drugs and Injectables, and Contract Services.

The changes combine operations that have a similar product type, serve comparable customers and address similar business issues and industry dynamics. The new segment reporting structure provides shareholders and other users of our financial statements with more useful information about our segments.

     
Current Segments
     
Prescription Pharmaceuticals
Consumer Health
Former Segments
Akorn
Ophthalmics
X
X (a)
Hospital Drugs and Injectables
X
 
Contract Services
X
 
Hi-Tech
Generic Pharmaceuticals (“Hi-Tech Generic”)
X
 
OTC Branded Pharmaceuticals (“HCP”)
 
X (b)
Prescription Brands (“ECR”)
     X (c)
 

(a)
Represents the previous acquisition of Advanced Vision Research, Inc./TheraTears®
(b)
Represents the previous Hi-Tech reportable segment HCP (“Health Care Products”)

(c)
Represents the previous Hi-Tech reportable segment ECR which was divested during the year ended December 31, 2014 and whose results have been included within discontinued operations.

The Company’s Prescription Pharmaceutical segment principally consists of generic and branded Prescription Pharmaceuticals products which span a broad range of indications as well as a variety of dosage forms including: sterile ophthalmics, injectables and inhalants, and non-sterile oral liquids, topicals, nasal sprays. In addition, the Company, through Akorn India Private Limited (“AIPL”), manufactures pharmaceuticals for various markets outside the US. The Company’s Consumer Health segment principally consists of animal health and over-the-counter products, both branded and private label.  OTC products includes a suite of products for the treatment of dry eye sold under the TheraTears® brand name.

Financial information about the Company’s reportable segments is based upon internal financial reports that aggregate certain operating information. The Company’s CEO oversees operational assessments and resource allocations based upon the results of the Company’s reportable segments, which have available and discrete financial information.

Selected financial info by reporting segment is presented below (in thousands). The Company has restated prior periods including the years ended December 31, 2013 and 2012 to reflect the strategic realignment described above.

 
 
Years ended December 31,
 
 
 
2014
   
2013
   
2012
 
REVENUES
                 
Prescription Pharmaceuticals
  $ 542,846     $ 279,911     $ 223,881  
Consumer Health
    50,232       37,800       32,277  
Total revenues
  $ 593,078     $ 317,711     $ 256,158  
                         
GROSS PROFIT
                       
Prescription Pharmaceuticals
  $ 270,197     $ 151,182     $ 129,884  
Consumer Health
    27,393       20,722       18,808  
Total gross profit
  $ 297,590     $ 171,904     $ 148,692  

The Company manages its business segments to the gross profit level and manages its operating and other costs on a company-wide basis. Inter-segment activity at the gross profit level is minimal. The Company does not have discrete assets by segment, as certain manufacturing and warehouse facilities support more than one segment, and therefore does not report assets by segment.

During 2014, 2013 and 2012, approximately $16.6 million, $27.3 million and $29.4 million of the Company’s net revenue, respectively, was from customers located in foreign countries.  Sales generated by Akorn India Private Limited, the Company’s wholly owned subsidiary in India, accounted for $7.2 million, $15.8 million and $16.7 million of the foreign sales amounts for 2014, 2013 and 2012, respectively.  In these years, AIPL sold product exclusively to contract customers in India and to export customers in unregulated world markets, outside the United States, which has declined in the current year due to a reduction in the customer base.

Goodwill from the Company’s acquisition of Advanced Vision Research, Inc. in May 2011, the acquisition of selected assets of Kilitch Drugs (India) Limited in February 2012, the merger with Hi-Tech and subsequent disposal of the Watson assets on April 17, 2014, the disposal of the ECR component June 20, 2014 and the acquisition of VersaPharm on August 12, 2014 have been allocated to the appropriate reporting segment and reporting unit.  The carrying amounts of goodwill as restated by segment were as follows (in thousands):

   
Prescription Pharmaceuticals
   
Consumer Health
   
Total
 
December 31, 2012
  $ 20,296     $ 11,863     $ 32,159  
Acquisitions
 
─
   
─
   
─
 
Impairments
 
─
   
─
   
─
 
Foreign currency Translation
    (2,328 )  
─
      (2,328 )
December 31, 2013
  $ 17,968     $ 11,863     $ 29,831  
Acquisitions
    256,057       4,854       260,911  
Impairments
 
─
   
─
   
─
 
Dispositions
    (11,454 )  
─
      (11,454 )
Foreign currency translations
    (514 )  
─
      (514 )
December 31, 2014
  $ 262,057     $ 16,717     $ 278,774  

XML 97 R84.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 11 - Retirement Plan (Details) (USD $)
In Millions, unless otherwise specified
 9 Months Ended 12 Months Ended
Dec. 31, 2010
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Compensation and Retirement Disclosure [Abstract]        
Defined Contribution Plan, Cost Recognized (in Dollars)   $ 1.3us-gaap_DefinedContributionPlanCostRecognized $ 0.8us-gaap_DefinedContributionPlanCostRecognized $ 0.8us-gaap_DefinedContributionPlanCostRecognized
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 25.00%us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent 50.00%us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent    
Defined Contribution Plan, Employer Matching Contribution, Percent of Match 6.00%us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch 6.00%us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch    
Defined Contribution Plan Employers Matching Contribution Vesting Percentage After Two Years of Credited Service   50.00%akrx_DefinedContributionPlanEmployersMatchingContributionVestingPercentageAfterTwoYearsOfCreditedService    
Defined Contribution Plan Employers Matching Contribution Vesting Percentage After Three Years of Credited Service   100.00%akrx_DefinedContributionPlanEmployersMatchingContributionVestingPercentageAfterThreeYearsOfCreditedService    
XML 98 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 8 - Leasing Arrangements
 12 Months Ended
Dec. 31, 2014
Leases [Abstract]  
Leases of Lessee Disclosure [Text Block]
Note 8 — Leasing Arrangements

The Company leases real and personal property in the normal course of business under various operating leases, including non-cancelable and month-to-month agreements. Rental expense under these leases was $3.3 million, $2.9 million and $2.3 million for the years ended December 31, 2014, 2013 and 2012, respectively.

Landlord incentives are recorded as deferred rent and amortized on a straight-line basis over the lease term.  Rent escalations are recorded on a straight-line basis over the lease term.  The Company’s main operating leases for its Lake Forest and Gurnee facilities have original terms of ten years.  The Lake Forest facility lease allows for a five-year renewal at the option of the Company.

The following is a schedule, by year, of future minimum rental payments required under non-cancelable operating and capital leases in place as of December 31, 2014 (in thousands):

Year ending December 31,
     
2015
  $
2,569
 
2016
   
2,532
 
2017
   
2,230
 
2018
   
769
 
2019
    466  
2020 and thereafter
   
3,182
 
Total
  $
11,748
 

Through the acquisition of VersaPharm during 2014, our wholly owned subsidiary Clover Pharmaceuticals Corp. leased a research and development facility in Warminster, Pennsylvania for an initial term ending December 31, 2017 , with option to renew for an additional 3 years. Monthly rent at the Warminster facility is approximately $11,000 for 12,000 square feet and is used for drug research and development and administrative activities related to our Prescription Pharmaceuticals segment. As part of the VersaPharm acquisition, the Company also took over a lease of a warehouse and office space in Marietta, Georgia consisting of approximately 20,000 square feet and terminated effective August, 2016 with monthly rent of approximately $10,000. All other leases maintained by VersaPharm and its subsidiaries prior to the acquisition have been terminated.

On December 1, 2012, the Company entered into a lease for a new R&D center in Vernon Hills, Illinois which was expanded during the year ended December 31, 2014.  This lease extends through April 30, 2020, and obligates the Company to pay monthly rent of approximately $15,000, plus proportionate real estate taxes and common area maintenance.  Prior to moving its R&D activities to Vernon Hills, Illinois, the Company had leased space for its R&D activities within the Illinois Science & Technology Park in Skokie, Illinois.  This lease commenced on February 1, 2010, and extended through its early termination date of February 1, 2014.  Upon vacating the Skokie space shortly after moving R&D operations to Vernon Hills, Illinois, the Company accrued to expense its remaining obligations under the Skokie lease.

On July 27, 2010, the Company, through its wholly owned subsidiary, Akorn (New Jersey), Inc., an Illinois corporation, entered into a seven-year building lease agreement (the “Original Somerset Lease”) with Veronica Development Associates, a New Jersey general partnership, extending the Company’s occupancy of its 50,000 square foot manufacturing facility located at 72-6 Veronica Avenue, Somerset, New Jersey. This lease commenced on August 1, 2010 and continues through July 31, 2017. Under terms of the new lease, base rent was initially set at $38,801 per month, subject to periodic cost of living adjustments. In addition to base rent, the Company is obligated to pay its proportionate share of estimated property taxes, assessments and maintenance costs. The lease agreement contains a renewal provision allowing the Company the option to renew for up to four additional five-year periods upon providing written notice of its intention to renew at least six months prior to termination of the original lease or any renewal period. Furthermore, on January 24, 2011 the Company entered into an additional lease in Somerset for approximately 6,600 square feet of warehousing space to store various pharmaceutical products (the “Somerset Warehouse Lease”). The monthly lease was set at $3,300 per month, subject to similar period cost of living adjustments and other proportionate costs as the Original Somerset Lease. The lease agreement is set for annual renewal at the option of the Company and has been renewed until at least January 31, 2016.

On March 3, 2010, the Company entered into an eight-year sub-lease agreement with a related party, EJ Financial Enterprises, Inc. (“EJ Financial”), for their sub-lease of a portion of the Company’s corporate offices in Lake Forest, Illinois.  John N. Kapoor, Ph.D., Chairman of the Company’s Board of Directors, is the President of EJ Financial.  This sub-lease commenced on April 1, 2010.  Per the terms of the sub-lease agreement, EJ Financial will pay monthly base rent plus a proportionate share of common area maintenance costs.   The Company and EJ Financial agreed to early terminate this agreement, and the sub-lease was terminated in July 2012 at which time the space was retrofitted for corporate purposes.  EJ Financial paid the Company approximately $240,000 in rent and common area maintenance fees during the shortened term of this sub-lease.

XML 99 R60.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 4 - Inventories (Details) - Allowance for Excess and Obsolete Inventory (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Allowance for Excess and Obsolete Inventory [Abstract]    
Balance at beginning of year $ 5,700us-gaap_InventoryValuationReserves $ 6,819us-gaap_InventoryValuationReserves
Provision 12,275akrx_ProvisionForInventory 2,089akrx_ProvisionForInventory
Additions from acquisitions 8,220akrx_InventoryAdditionsFromAcquisitions  
Charges (5,016)akrx_ChargesAgainstInventory (3,208)akrx_ChargesAgainstInventory
Balance at end of year $ 21,179us-gaap_InventoryValuationReserves $ 5,700us-gaap_InventoryValuationReserves
XML 100 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements
 12 Months Ended
Dec. 31, 2014
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
Note 6 — Financing Arrangements

Incremental Term Loan

Concurrent with the closing of its acquisition of VersaPharm Incorporated (“VersaPharm”), Akorn, Inc. and its wholly owned domestic subsidiaries (the “Akorn Loan Parties”) entered into a $445.0 million Incremental Facility Joinder Agreement (the “Incremental Term Loan Facility”) pursuant to a Loan Agreement (the “Incremental Term Loan Agreement”) dated August 12, 2014 between the Akorn Loan Parties as borrowers, certain other lenders, with JPMorgan Chase Bank, N.A. (“JPMorgan”), acting as administrative agent. The proceeds received pursuant to the Incremental Term Loan Agreement were used to finance the acquisition of VersaPharm, a Georgia corporation (“VersaPharm Acquisition”).

The Incremental Term Loan Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement.

The Incremental Term Loan Facility requires quarterly principal repayment equal to 0.25% of the initial loan amount of $445.0 million beginning with the first full quarter following the closing date of the Incremental Term Loan Agreement, with a final payment of the remaining principal balance due at maturity seven (7) years from the date of closing of the Existing Term Loan Agreement. The Company may prepay all or a portion of the remaining outstanding principal amount under the Incremental Term Loan Agreement at any time, or from time to time, subject to prior notice requirement to the lenders and payment of applicable fees. Prepayment of principal will be required should the Company incur any indebtedness not permitted under the Incremental Term Loan Agreement, or effect the sale, transfer or disposition of any property or asset, other than in the ordinary course of business. To the extent the Incremental Term Loan Facility is refinanced within the first six (6) months of closing, a 1.00% prepayment fee will be due. As of December 31, 2014 outstanding debt under the Incremental Term Loan Facility was $443.9 million and the Company was in full compliance with all applicable covenants which included customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities.

Interest accrues based, at the Company’s election, on an adjusted prime/federal funds rate (“ABR Loan”) or an adjusted LIBOR (“Eurodollar Loan”) rate, plus a margin of 2.50% for ABR Loans, and 3.50% for Eurodollar Loans. Each such margin will decrease by 0.25% in the event the Company’s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. During an event of default, as defined in the Existing Term Loan Agreement, any interest rate will be increased by 2.00% per annum. Per the Existing Term Loan Agreement, the interest rate on LIBOR loans cannot fall below 4.50%.

For the year ended December 31, 2014, the Company recorded interest expense of $7.8 million in relation to the Incremental Term Loan Agreement.

As of December 31, 2014, in connection with entering into the $445.0 million Incremental Term Loan Agreement, the Company capitalized $10.9 million in deferred financing fees. Approximately $1.8 million of this total represented loan commitment fees which were amortized to expense during the year ended December 31, 2014. The $1.8 million of loan commitment fees amortized in the year ended December 31, 2014 consisted of $1.7 million in commitment fee amortization and $0.1 million in ticking fees. The Company will amortize the remaining deferred financing fees using the effective interest method over the term of the Incremental Term Loan Agreement.

Existing Term Loan

Concurrent with the closing of its acquisition of Hi-Tech (the “Hi-Tech Acquisition”) Akorn Loan Parties entered into a $600.0 million Term Facility (the “Existing Term Facility”) pursuant to a Loan Agreement dated April 17, 2014 (the “Existing Term Loan Agreement”) between the Akorn Loan Parties as borrowers, certain other lenders, with JPMorgan, acting as administrative agent. The Company may increase the loan amount up to an additional $150.0 million, or more, provided certain financial covenants and other conditions are satisfied. The proceeds received pursuant to the Existing Term Loan Agreement were used to finance the Hi-Tech Acquisition.

The Existing Term Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement.

The Existing Term Loan Agreement requires quarterly principal repayment equal to 0.25% of the initial loan amount of $600.0 million beginning with the second full quarter following the closing date of the Existing Term Loan Agreement, with a final payment of the remaining principal balance due at maturity seven (7) years from the date of closing of the Existing Term Loan Agreement. The Company may prepay all or a portion of the remaining outstanding principal amount under the Existing Term Loan Agreement at any time, or from time to time, subject to prior notice requirement to the lenders and payment of applicable fees. Prepayment of principal will be required should the Company incur any indebtedness not permitted under the Existing Term Loan Agreement, or effect the sale, transfer or disposition of any property or asset, other than in the ordinary course of business. As of December 31, 2014 outstanding debt under the term loan facility was $598.5 million and the Company was in full compliance with all applicable covenants which included customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities.

Interest accrues based, at the Company’s election, on an adjusted prime/federal funds rate or an adjusted LIBOR rate, plus a margin of 2.50% for ABR Loans, and 3.50% for Eurodollar Loans. Each such margin will decrease by 0.25% in the event Akorn’s senior debt to EBITDA ratio for any quarter falls to 2.25:1.00 or below. During an event of default, as defined in the Existing Term Loan Agreement, any interest rate will be increased by 2.00% per annum. Per the Existing Term Loan Agreement, the interest rate on LIBOR loans cannot fall below 4.50%.

For the year ended December 31, 2014, the Company recorded interest expense of $19.4 million in relation to the Existing Term Loan.

As of December 31, 2014, in connection with entering into the $600.0 million Existing Term Loan, the Company capitalized $20.3 million in deferred financing fees. Approximately $7.4 million of this total represented loan commitment fees, of which $7.4 million was amortized to expense during the year ended December 31, 2014. The $7.4 million of loan commitment fees amortized in the year ended December 31, 2014 consisted of $5.0 million in ticking fees and $2.4 million in commitment fee amortization. The Company will amortize the remaining deferred financing fees using the effective interest method over the term of the Existing Term Loan Agreement.

JPMorgan Credit Facility

On April 17, 2014, the Akorn Loan Parties entered into a Credit Agreement (the “JPM Credit Agreement”) with JPMorgan acting as administrative agent, and Bank of America, N.A., as syndication agent for certain other lenders (at closing, Bank of America, N.A. and Wells Fargo Bank, N. A.) for a $150.0 million revolving credit facility (the “JPM Revolving Facility”). Upon entering into the JPM Credit Agreement, the Company terminated its prior $60.0 million revolving credit facility with Bank of America, N.A., as further described below.

Subject to other conditions in the JPM Credit Agreement, advances under the JPM Revolving Facility will be made in accordance with a borrowing base consisting of the sum of the following:

  (a)
85% of eligible accounts receivable;
  (b)
The lesser of:

 
a.
65% of the lower of cost or market value of eligible raw materials and work in process inventory, valued on a first in first out basis, and
 
b.
85% of the orderly liquidation value of eligible raw materials and work in process inventory, valued on a first in first out basis;

                              (c)
The lesser of:
 
a.
75% of the lower of cost or market value of eligible finished goods inventory, valued on a first in first out basis, and

 
b.
85% of the orderly liquidation value of eligible finished goods inventory, valued on a first in first out basis up to 85% of the liquidation value of eligible inventory (or 75% of market value finished goods inventory); and
 (d)
Less any reserves deemed necessary by the administrative agent, and allowed in its permitted discretion.

The total amount available under the JPM Revolving Facility includes a $10.0 million letter of credit facility.

Under the terms of the JPM Credit Agreement, if availability under the JPM Revolving Facility falls below 12.5% of commitments or $15.0 million for more than 30 consecutive days, the Company may be subject to cash dominion, additional reporting requirements, and additional covenants and restrictions. The Company may seek additional commitments to increase the maximum amount of the JPM Revolving Facility to $200.0 million.

Unless cash dominion is exercised by the lenders in connection with the JPM Revolving Facility, the Company will be required to repay the JPM Revolving Facility upon its expiration five (5) years from issuance, subject to permitted extension, and will pay interest on the outstanding balance monthly based, at the Company’s election, on an adjusted prime/federal funds rate (“ABR”) or an adjusted LIBOR (“Eurodollar”), plus a margin determined in accordance with the Company’s consolidated fixed charge coverage ratio (EBITDA to fixed charges) as follows:

Fixed Charge
Coverage Ratio
Revolver ABR
Spread
Revolver
Eurodollar
Spread
Category 1
> 1.50 to 1.0
0.50%
1.50%
Category 2
> 1.25 to 1.00 but
< 1.50 to 1.00
0.75%
1.75%
Category 3
< 1.25 to 1.00
1.00%
2.00%

In addition to interest on borrowings, the Company will pay an unused line fee of 0.25% per annum on the unused portion of the JPM Revolving Facility.

During an event of default, as defined in the JPM Credit Agreement, any interest rate will be increased by 2.0% per annum.

The JPM Revolving Facility is secured by all of the assets of the Akorn Loan Parties, including springing control of the Company’s primary deposit account pursuant to a deposit account control agreement. The financial covenants require the Akorn Loan Parties to maintain the following on a consolidated basis:

 
(a)
Minimum Liquidity, as defined in the JPM Credit Agreement, of not less than (a) $120.0 million plus (b) 25% of the JPM Revolving Facility commitments during the three month period preceding the June 1, 2016 maturity date of the Company’s senior convertible notes.
 
(b)
Ratio of EBITDA to fixed charges of no less than 1.00 to 1.00 (measured quarterly for the trailing 4 quarters).

As of December 31, 2014 the Company was in full compliance with all covenants applicable to the JPM Revolving Facility.

The Company may use any proceeds from borrowings under the JPM Revolving Facility for working capital needs and for the general corporate purposes of the Company and its subsidiaries, and to otherwise replace letters of credit that were outstanding upon the termination of the Company’s prior revolving credit facility with Bank of America, N.A. At December 31, 2014, there were no outstanding borrowings and one outstanding letter of credit in the amount of approximately $1.2 million under the JPM Revolving Facility. Availability under the facility as of December 31, 2014 was approximately $148.8 million.

The JPM Credit Agreement places customary limitations on indebtedness, distributions, liens, acquisitions, investments, and other activities of the Akorn Loan Parties in a manner designed to protect the collateral while providing flexibility for growth and the historic business activities of the Company and its subsidiaries.

Convertible Notes

On June 1, 2011, the Company closed on an offering of $120.0 million aggregate principal amount of 3.50% Convertible Senior Notes due 2016 (the “Notes”) which included $20.0 million in aggregate principal amount of the Notes issued in connection with the full exercise by the initial purchasers of their over-allotment option. The Notes are governed by the Company’s indenture with Wells Fargo Bank, National Association, as trustee (the “Indenture”).  The Notes were offered and sold only to qualified institutional buyers.  The net proceeds from the sale of the Notes were approximately $115.3 million, after deducting underwriting fees and other related expenses.

The Notes have a maturity date of June 1, 2016 and pay interest at an annual rate of 3.50% semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2011.  The Notes are convertible into the Company’s common stock, cash or a combination thereof at an initial conversion price of $8.76 per share, which is equivalent to an initial conversion rate of approximately 114.1553 shares per $1,000 principal amount of Notes.  The conversion price is subject to adjustment for certain events described in the Indenture, including certain corporate transactions which will increase the conversion rate and decrease the conversion price for a holder that elects to convert its Notes in connection with such corporate transaction.

The Notes may be converted at any time prior to the close of business on the business day immediately preceding December 1, 2015 only under the following circumstances:  (1) during any calendar quarter commencing after September 30, 2011, if the closing sale price of the Company’s common stock, for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the calendar quarter immediately preceding the calendar quarter in which the conversion occurs, is more than 130% of the conversion price in effect on each applicable trading day; (2) during the five consecutive trading-day period following any five consecutive trading-day period in which the trading price for the Notes per $1,000 principal amount of Notes for each such trading day was less than 98% of the closing sale price of the Company’s common stock on such date multiplied by the then-current conversion rate; or (3) upon the occurrence of specified corporate events.  On or after December 1, 2015 until the close of business on the business day immediately preceding the stated maturity date, holders may surrender all or any portion of their Notes for conversion at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, at the Company’s option, cash, shares of the Company’s common stock, or a combination thereof.  If a fundamental change (as defined in the Indenture) occurs prior to the stated maturity date, holders may require the Company to purchase for cash all or a portion of their Notes.

The Notes became convertible for the quarter ending on June 30, 2012 as a result of the Company’s stock trading at or above the required price of $11.39 per share for 20 of the last 30 trading days in the quarter ended March 31, 2012.  The Notes have remained convertible for each successive quarter as a result of meeting the trading price requirement at the end of each prior quarter. During the year ended December 31, 2014, approximately $32.5 million of this convertible debt was converted at the holder’s request which resulted in an additional $1.0 million of expense recognized due to the conversions.

The Notes are not listed on any securities exchange or on any automated dealer quotation system, but are traded on a secondary market made by the initial purchasers.  The initial purchasers of the Notes advised the Company of their intent to make a market in the Notes following the offering, though they are not obligated to do so and may discontinue any market making at any time.

As of December 31, 2014, the Notes were trading at approximately 412.4% of their face value, resulting in a total market value of $360.9 million compared to their face value of $87.5 million.  The actual conversion value of the Notes is based on the product of the conversion rate and the market price of the Company's common stock at conversion, as defined in the Indenture.  As of December 31, 2014, the Company's common stock closed at $36.20 per share, resulting in a pro forma conversion value for the Notes of approximately $361.7 million.  Increases in the market value of the Company’s common stock increase the Company’s obligation accordingly.  There is no upper limit placed on the possible conversion value of the Notes.

The Notes are accounted for in accordance with ASC 470-20, Debt with Conversion and Other Options.  Under ASC 470-20, issuers of convertible debt instruments that may be settled in cash upon conversion, including partial cash settlement, are required to separately account for the liability (debt) and equity (conversion option) components.  The application of ASC 470-20 resulted in the recognition of $21.3 million as the value for the equity component.  This amount was offset by $0.8 million of equity issuance costs, as described below, and both were affected by the conversion of $32.5 million notes as documented above.  At the dates indicated, the net carrying amount of the liability component and the remaining unamortized debt discount were as follows (in thousands):

   
December 31,
 
   
2014
   
2013
 
Carrying amount of equity component
  $
14,930
    $ 20,470  
Carrying amount of the liability component
    82,543       108,750  
Unamortized discount of the liability component
   
4,982
      11,250  
Unamortized debt financing costs
    901       2,034  

The Company incurred debt issuance costs of $4.7 million related to its issuance of the Notes.  In accordance with ASC 470-20, the Company allocated this debt issuance cost ratably between the liability and equity components of the Notes, resulting in $3.9 million of debt issuance costs allocated to the liability component and $0.8 million allocated to the equity component.  The portion allocated to the liability component was classified as deferred financing costs and is being amortized by the effective interest method through the earlier of the maturity date of the Notes or the date of conversion, while the portion allocated to the equity component was recorded as an offset to additional paid-in capital upon issuance of the Notes.

During the years ended December 31, 2014, 2013 and 2012, the Company recorded the following expenses in relation to the Notes (in thousands):

   
2014
   
2013
   
2012
 
Interest expense at 3.50% coupon rate
  $
4,105
    $ 4,200     $ 4,200  
Debt discount amortization
    4,317       4,113       3,828  
Deferred financing cost amortization
    780       744       692  
Loss on conversion
    990       —       —  
    $
10,192
    $ 9,057     $ 8,720  

Upon issuing the Notes, the Company established a deferred tax liability of $8.6 million related to the debt discount of $21.3 million, with an offsetting debit of $8.6 million to common stock.  The deferred tax liability was established because the amortization of the debt discount generates non-cash interest expense that is not deductible for income tax purposes.  Since the Company’s net deferred tax assets were fully reserved by valuation allowance at the time the Notes were issued, the Company reduced its valuation allowance by $8.6 million upon recording the deferred tax liability related to the debt discount with an offsetting credit of $8.6 million to common stock.  As a result, the net impact of these entries was a debit of $8.6 million to the valuation reserve against the Company’s deferred tax assets and a credit of $8.6 million to deferred tax liability.  The deferred tax liability is being amortized monthly as the Company records non-cash interest from its amortization of the debt discount on the Notes.

Aggregate cumulative maturities of long-term obligations commencing in 2015 are:

(In thousands)
 
2015
   
2016
   
2017
   
2018
   
Thereafter
 
Maturities
  $ 10,450     $
97,975
    $ 10,450     $ 10,450     $ 1,000,588  

Bank of America Credit Facility

On October 7, 2011, the Company and its domestic subsidiaries (the “Borrowers”) entered into a Loan and Security Agreement (the “BoA Credit Agreement”) with Bank of America, N.A. (the “Agent”) and other financial institutions (collectively with the Agent, the “BoA Lenders”) through which it obtained a $20.0 million revolving line of credit, which included a $2.0 million letter of credit facility. On April 17, 2014, concurrent with the Company entering into the JPM Credit Agreement, the Company and the Agent agreed to early terminate the BoA Credit Agreement, without penalty.

XML 101 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 7 - Earnings Per Common Share
 12 Months Ended
Dec. 31, 2014
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 7 — Earnings per Common Share

Basic net income per common share is based upon the weighted average common shares outstanding during the period. Diluted net income per common share is based upon the weighted average number of common shares outstanding, including the dilutive effect, if any, of stock options, warrants and the conversion feature of convertible notes using the treasury stock method.

Diluted net income per share assumed the principal amount of the convertible Notes would be cash settled and any conversion spread would be settled using common shares, as the Company has the choice of settling either in cash or shares. The Company had demonstrated a past practice and intent of cash settlement for the principal and stock settlement of the conversion spread. As a result, earnings per share calculations for periods ended prior to and including September 30, 2014 only included the assumption of conversion to common shares for the convertible spread. During the quarter ended December 31, 2014, the Company changed its practice of cash settlement and settled redemptions using common shares for both the principal and conversion spread and accordingly, earnings per share amounts were calculated using the if-converted method. For the year ended December 31, 2014, the earnings per share amounts were calculated using the if-converted method.

The Company’s potentially dilutive shares consist of: (i) vested and unvested stock options that are in-the-money, (ii) unvested RSAs, (iii) warrants that are in-the-money, and (iv) shares potentially issuable upon conversion of the Notes.  

A reconciliation of the earnings per share data from a basic to a fully diluted basis is detailed below (amounts in thousands, except per share data):

   
2014
   
2013
   
2012
 
Income from continuing operations used for basic earnings per share
  $
35,848
    $ 52,362     $ 35,378  
Convertible debt income adjustments, net of tax
    5,825       —       —  
Income from continuing operations adjusted for convertible debt as used for diluted earnings per share
  $
41,673
    $ 52,362     $ 35,378  
Income from continuing operations per share:
                       
   Basic
  $
0.35
    $ 0.54     $ 0.37  
   Diluted (1)
  $
0.34
    $ 0.46     $ 0.32  
Loss from discontinued operations, net of tax
  $ (503 )   $ —     $ —  
Loss from discontinued operations, net of tax per share:
                       
   Basic
  $
(0.01
)   $ —     $ —  
   Diluted
  $
(0.01
)   $ —     $ —  
                         
Shares used in computing income (loss) per share:
                       
Weighted average basic shares outstanding
    103,480       96,181       95,189  
Dilutive securities:
                       
   Stock options and unvested RSAs
    4,234       4,516       4,289  
   Stock warrants
    1,874       6,702       6,564  
   Shares issuable on conversion of the Notes (2)
    13,522       6,499       4,468  
Total dilutive securities
    19,630       17,717       15,321  
                         
Weighted average diluted shares outstanding
    123,110       113,898       110,510  

 
(1)
Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $5.8 million, after-tax for the year ended December 31, 2014.

 
(2)
Shares issuable on conversion of the Notes for the year ended December 31, 2014 have increased in comparison to the fiscal years ended December 31, 2013 and 2012 due to stock appreciation which underlies the shares issuable on conversion of the notes and the Company’s change in practice on October 1, 2014 to more likely than not settle future note conversions solely through shares as we are now utilizing the if-converted method for convertible debt conversion obligations.

XML 102 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock
 12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note 9 — Stock Options, Employee Stock Purchase Plan and Restricted Stock

Stock Option Plan

The Company maintains equity compensation plans that allow the Company’s Board of Directors to grant stock options to eligible employees, officers and directors.  Under the 2003 Stock Option Plan, 2,519,000 options were granted, none of which remained outstanding as of December 31, 2011.  On March 29, 2005, the Company’s Board of Directors approved the Amended and Restated Akorn, Inc. 2003 Stock Option Plan (the “Amended 2003 Plan”), effective as of April 1, 2005, and this was subsequently approved by its stockholders on May 27, 2005. The Amended 2003 Plan was an amendment and restatement of the 2003 Stock Option Plan and provides the Company with the ability to grant other types of equity awards to eligible participants besides stock options. Starting on May 27, 2005, all new awards were granted under the Amended 2003 Plan.  The aggregate number of shares of the Company’s common stock initially approved for issuance pursuant to awards granted under the Amended 2003 Plan was 5,000,000.  On August 7, 2009, the Company’s stockholders voted to increase this figure to 11,000,000 at the recommendation of the Company’s Board of Directors, and on December 31, 2011 voted to increase the available shares by another 8,000,000, to a final total of 19,000,000 shares. Under the Amended 2003 Plan, 15,828,000 options have been granted to employees and directors, 6,529,000 options have been exercised, 4,331,000 options have been canceled, and 4,968,000 remain outstanding as of December 31, 2014.  Options granted under the Amended 2003 Plan have exercise prices equivalent to the market value of the Company’s common stock on the date of grant and expire five years from date of issuance.  All options granted during 2013 vest one quarter per year on each of the first four anniversaries of their grant dates.  Options granted in earlier years generally had a three-year vesting schedule.

The Amended 2003 Plan reached its scheduled expiration date on November 6, 2013.  Accordingly, no additional awards may be issued under the Amended 2003 Plan beyond that date.  However, any awards outstanding as of November 6, 2013 issued under the Amended 2003 Plan will remain outstanding in accordance with their terms.

At the Company’s 2014 Annual Meeting of Shareholders, the Company’s shareholders approved the adoption of the Akorn, Inc. 2014 Stock Option Plan (the “2014 Plan”). The 2014 Plan reserves 7.5 million shares for issuance upon the grant of stock options, restricted shares, or various other instruments to directors, employers and consultants.

Under the 2014 Plan, 1,475,000 options have been granted to employees and directors, no options have been exercised, 57,000 options have been canceled, and 1,419,000 remain outstanding as of December 31, 2014.  Options granted under the 2014 Stock Option Plan have exercise prices equivalent to the market value of the Company’s common stock on the date of grant and expire from five to ten years from date of issuance depending on the option grant date.  All options granted to employees during the year ended December 31, 2014 vest one quarter per year on each of the first four anniversaries of their grant dates while all options granted to non-employee directors fully vest on the first anniversary date of their grant.

The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation – Stock Compensation (formerly SFAS No. 123 (revised 2004), Share Based Payment (SFAS 123(R))).  Accordingly, stock-based compensation cost is estimated at the grant date based on the fair value of the award, and the cost is recognized as expense ratably over the vesting period. The Company uses the Black-Scholes model for estimating the grant date fair value of stock options. Determining the assumptions that enter into the model is highly subjective and requires judgment. The Company uses an expected volatility that is based on the historical volatility of its stock. The expected life assumption is based on historical employee exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the average market rate on U.S. Treasury securities in effect during the quarter in which the options were granted. The dividend yield reflects historical experience as well as future expectations over the expected term of the option. The Company estimates forfeitures at the time of grant and revises in subsequent periods, if necessary, if actual forfeitures differ from those estimates.

The Company recorded stock option compensation expense of approximately $6.0 million, $6.2 million and $6.4 million during the years ended December 31, 2014, 2013 and 2012, respectively.  The Company uses the single-award method for allocating the compensation cost to each period.

The assumptions used in estimating the fair value of the stock options granted during the period, along with the weighted-average grant date fair values, were as follows:

 
2014
 
2013
 
2012
           
Expected volatility
46%
-
71%
  49% -
68%
  77% -
85%
Expected life (in years)
 
5.4
       4.0
  
   
4.0
 
Risk-free interest rate
0.9% -
2.2%
  0.7% -
1.4%
  0.7% -
0.8%
Dividend yield
 
—
     
—
     
—
 
Fair value per stock option
 
$16.08
 
   
$6.95
 
   
$7.76
 

     A summary of stock option activity within the Company’s stock-based compensation plans for the years ended December 31, 2014, 2013 and 2012 is as follows:

 
 
 
 
 
 
Number of
Shares
(in thousands)
   
 
Weighted
Average
Exercise Price
   
Weighted Average
Remaining
Contractual Term
(Years)
   
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding at December 31, 2011
    9,399     $ 2.89                  
Granted
    1,221       12.96                  
Exercised
    (806 )     1.87                  
Forfeited or expired
    (87 )     4.42                  
Outstanding at December 31, 2012
    9,727     $ 4.22                  
Granted
    321       15.76                  
Exercised
    (630 )     4.18                  
Forfeited or expired
    (190 )     13.10                  
Outstanding at December 31, 2013
    9,228     $ 4.45                  
Granted
    1,475       28.59                  
Exercised
    (4,226 )     1.91                  
Forfeited or expired
    (91 )     22.56                  
Outstanding at December 31, 2014
    6,386     $
11.44
      2.48     $ 158,097  
Exercisable at December 31, 2014
    4,316     $ 5.43       1.01     $ 132,813  

The aggregate intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company’s common stock at the end of the period and the exercise price of the in-the-money stock options. The total intrinsic value of stock options exercised during the years ended December 31, 2014, 2013 and 2012 was approximately $141.7 million, $8.9 million and $9.1 million, respectively. As a result of the stock options exercised, the Company received cash and recorded additional paid-in-capital of approximately $8.0 million, $2.6 million and $1.5 million during the years ended December 31, 2014, 2013 and 2012, respectively.

As of December 31, 2014, the total amount of unrecognized compensation cost related to non-vested stock options was approximately $20.7 million which is expected to be recognized as expense over a weighted-average period of 3.1 years.

From time to time the Company grants restricted stock awards to certain employees and members of its Board of Directors (“Directors”). Restricted share awards are valued at the closing market price of the Company’s common stock on the day of grant and the total value of the award is recognized as expense ratably over the vesting period of the grants.

On May 2, 2014, the Company granted a total of 71,582 restricted shares to senior management which vest at 25% per year on the anniversary date of the grant ending May 2, 2018. Also on May 2, 2014, the Company modified approximately 2.3 million options to extend the option term for grants to certain individuals in Senior Management. On September 5, 2014, the Company granted a total of 257,416 restricted shares to senior management and 8,034 shares to a Director to make the individuals who received extended option terms on May 2, 2014 whole given increased tax liabilities. The shares each vest at 25% per year on the anniversary date of the grant ending September 5, 2018. On May 3, 2013, the Company granted a total of 31,899 restricted shares to its Directors, of which 15,946 shares vested immediately upon issuance and the remaining 15,953 shares vested on May 3, 2014.  During 2012, the Company granted 35,000 shares of restricted shares valued at approximately $0.5 million to members of its Board of Directors, of which half vested immediately and half vested on the one year anniversary of grant.  The Company recognized compensation expense of approximately $1.2 million, $0.6 million and $0.4 million during the years ended December 31, 2014, 2013 and 2012, respectively, related to restricted stock awards.

The following is a summary of non-vested restricted stock activity:

   
Number of Shares
(in thousands)
   
Weighted Average
Grant Date Fair Value
 
Nonvested at December 31, 2011
    13     $ 1.34  
Granted
    35       14.63  
Vested
    (30 )     9.09  
Canceled
    —       —  
Nonvested at December 31, 2012
    18     $ 14.63  
Granted
    32       15.36  
Vested
    (34 )     14.98  
Canceled
    —       —  
Nonvested at December 31, 2013
    16     $ 15.36  
Granted
    337       35.31  
Vested
    (16 )     15.36  
Canceled
    —       —  
Nonvested at December 31, 2014
    337     $ 35.31  

As of December 31, 2014, the total amount of unrecognized compensation cost related to restricted stock awards was approximately $10.8 million which is expected to be recognized as expense over a weighted-average period of 3.6 years.

Employee Stock Purchase Plan

     The Akorn, Inc. Employee Stock Purchase Plan (the “ESPP”) permits eligible employees to acquire shares of the Company’s common stock through payroll deductions.  The ESPP has been structured to qualify under Section 423 of the Internal Revenue Code (“IRC”).  Employees who elect to participate in the ESPP may withhold from 1% to 15% of base wages toward the purchase of stock.  Shares are purchased at a 15% discount off the lesser of the market price at the beginning or the ending of the applicable offering period.  The ESPP has two offering periods each year, one running from January 1st to December 31st and the other running from July 1st to December 31st.  In a given year, employees may enroll in either plan, but not both.  Per IRC rules, annual purchases per employee are limited to $25,000 worth of stock, valued as of the beginning of the offering period.  Accordingly, with the 15% discount, employees may withhold no more than $21,250 per year toward the purchase of stock under the ESPP.

     A maximum of 2 million shares of the Company’s common stock may be issued under the ESPP.  Including shares issues in early 2015 related to employee participation in the ESPP during 2014, a total of 1,420,438 shares have been issued thus far under the ESPP, leaving 579,562 shares available for future issuance.  The Company issued approximately 67,000, 73,000 and 61,000 shares of its common stock related to employee participation in the ESPP during 2014, 2013 and 2012, respectively.  For the years ended December 31, 2014, 2013 and 2012, the Company recorded compensation expense of approximately $0.4, $0.2 and $0.2 million, respectively in each period related to the ESPP.

XML 103 R64.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements (Details) - JPM Revolving Facility, Interest Terms (JPM Revolving Facility [Member], Revolving Credit Facility [Member])
 0 Months Ended
Apr. 17, 2014
Category 1 [Member] | Base Rate [Member]  
Guarantor Obligations [Line Items]  
Basis spread on variable rate 0.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_StatementScenarioAxis
= akrx_Category1Member
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
Category 1 [Member] | Eurodollar [Member]  
Guarantor Obligations [Line Items]  
Basis spread on variable rate 1.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_StatementScenarioAxis
= akrx_Category1Member
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember
Category 2 [Member] | Base Rate [Member]  
Guarantor Obligations [Line Items]  
Basis spread on variable rate 0.75%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_StatementScenarioAxis
= akrx_Category2Member
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
Category 2 [Member] | Eurodollar [Member]  
Guarantor Obligations [Line Items]  
Basis spread on variable rate 1.75%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_StatementScenarioAxis
= akrx_Category2Member
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember
Category 3 [Member] | Base Rate [Member]  
Guarantor Obligations [Line Items]  
Basis spread on variable rate 1.00%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_StatementScenarioAxis
= akrx_Category3Member
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
Category 3 [Member] | Eurodollar [Member]  
Guarantor Obligations [Line Items]  
Basis spread on variable rate 2.00%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_StatementScenarioAxis
= akrx_Category3Member
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember
XML 104 R85.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 12 - Segment Information (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 12 - Segment Information (Details) [Line Items]      
Number of Reportable Segments 2us-gaap_NumberOfReportableSegments    
Outside the United States [Member]      
Note 12 - Segment Information (Details) [Line Items]      
Revenues $ 16.6us-gaap_Revenues
/ us-gaap_StatementGeographicalAxis
= akrx_OutsidetheUnitedStatesMember		 $ 27.3us-gaap_Revenues
/ us-gaap_StatementGeographicalAxis
= akrx_OutsidetheUnitedStatesMember		 $ 29.4us-gaap_Revenues
/ us-gaap_StatementGeographicalAxis
= akrx_OutsidetheUnitedStatesMember
INDIA      
Note 12 - Segment Information (Details) [Line Items]      
Revenues $ 7.2us-gaap_Revenues
/ us-gaap_StatementGeographicalAxis
= country_IN		 $ 15.8us-gaap_Revenues
/ us-gaap_StatementGeographicalAxis
= country_IN		 $ 16.7us-gaap_Revenues
/ us-gaap_StatementGeographicalAxis
= country_IN
XML 105 R66.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements (Details) - Net Carrying Amount of the Liability Component and the Remaining Unamortized Debt Discount (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Note 6 - Financing Arrangements (Details) - Net Carrying Amount of the Liability Component and the Remaining Unamortized Debt Discount [Line Items]    
Carrying amount of the liability component $ 1,114,481us-gaap_LongTermDebtNoncurrent $ 108,750us-gaap_LongTermDebtNoncurrent
Convertible Debt [Member]    
Note 6 - Financing Arrangements (Details) - Net Carrying Amount of the Liability Component and the Remaining Unamortized Debt Discount [Line Items]    
Carrying amount of equity component 14,930us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 20,470us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
Carrying amount of the liability component 82,543us-gaap_LongTermDebtNoncurrent
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 108,750us-gaap_LongTermDebtNoncurrent
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
Unamortized discount of the liability component 4,982akrx_UnamortizedDiscountOfTheLiabilityComponent
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 11,250akrx_UnamortizedDiscountOfTheLiabilityComponent
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
Unamortized debt financing costs $ 901us-gaap_DeferredFinanceCostsNet
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember		 $ 2,034us-gaap_DeferredFinanceCostsNet
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_ConvertibleDebtMember
XML 106 R102.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 18 - Customer, Supplier and Product Concentration (Details)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 18 - Customer, Supplier and Product Concentration (Details) [Line Items]      
Number of Customers Considered as Concentration Risks 3akrx_NumberOfCustomersConsideredAsConcentrationRisks 3akrx_NumberOfCustomersConsideredAsConcentrationRisks 3akrx_NumberOfCustomersConsideredAsConcentrationRisks
Sales Revenue, Net [Member] | Product Concentration Risk [Member]      
Note 18 - Customer, Supplier and Product Concentration (Details) [Line Items]      
Concentration Risk, Percentage 12.50%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember		 11.80%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember		  
XML 107 R63.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements (Details) (USD $)
 0 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 0 Months Ended 1 Months Ended 9 Months Ended
Jun. 01, 2011
Jun. 02, 2011
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Jun. 30, 2011
Mar. 31, 2012
Aug. 12, 2014
Apr. 17, 2014
Sep. 30, 2014
Oct. 07, 2011
Note 6 - Financing Arrangements (Details) [Line Items]                      
Amortization of Financing Costs     $ 12,129,000us-gaap_AmortizationOfFinancingCosts $ 842,000us-gaap_AmortizationOfFinancingCosts $ 782,000us-gaap_AmortizationOfFinancingCosts            
Deferred Tax Liabilities, Financing Arrangements   8,600,000us-gaap_DeferredTaxLiabilitiesFinancingArrangements                  
Debt Instrument, Unamortized Discount   21,300,000us-gaap_DebtInstrumentUnamortizedDiscount                  
Debt Issued Reduction in Common Stock   8,600,000akrx_DebtIssuedReductionInCommonStock                  
Deferred Tax Assets, Valuation Allowance   8,600,000us-gaap_DeferredTaxAssetsValuationAllowance                  
Debt Issued Increase in Common Stock 8,600,000akrx_DebtIssuedIncreaseInCommonStock                    
Over-Allotment Option [Member] | Senior Notes [Member] | Notes [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Convertible Notes Payable           20,000,000us-gaap_ConvertibleNotesPayable
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_OverAllotmentOptionMember		          
Prepayment Term Six Months [Member] | Incremental Term Loan Agreement [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Prepayment Fee Percentage               1.00%akrx_DebtInstrumentPrepaymentFeePercentage
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_StatementScenarioAxis
= akrx_PrepaymentTermSixMonthsMember		      
Terminated [Member] | B of A Revolving Facility [Member] | Revolving Credit Facility [Member] | B of A [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Line of Credit Facility, Maximum Borrowing Capacity                 60,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_BOfARevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_BOfAMember
/ us-gaap_StatementScenarioAxis
= akrx_TerminatedMember		    
The Lesser Of For Scenario Two Consideration A [Member] | JPM Revolving Facility [Member] | Revolving Credit Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument Borrowing Base Percent Of Materials And WIP On FIFO                 65.00%akrx_DebtInstrumentBorrowingBasePercentOfMaterialsAndWIPOnFIFO
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_StatementScenarioAxis
= akrx_TheLesserOfForScenarioTwoConsiderationAMember		    
The Lesser Of For Scenario Two Consideration B [Member] | JPM Revolving Facility [Member] | Revolving Credit Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument Borrowing Base Percent Of Liquidation Value                 85.00%akrx_DebtInstrumentBorrowingBasePercentOfLiquidationValue
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_StatementScenarioAxis
= akrx_TheLesserOfForScenarioTwoConsiderationBMember		    
The Lesser Of For Scenario Three Consideration A [Member] | JPM Revolving Facility [Member] | Revolving Credit Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument Borrowing Base Percent Finished Goods                 75.00%akrx_DebtInstrumentBorrowingBasePercentFinishedGoods
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_StatementScenarioAxis
= akrx_TheLesserOfForScenarioThreeConsiderationAMember		    
The Lesser Of For Scenario Three Consideration B [Member] | JPM Revolving Facility [Member] | Revolving Credit Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument Borrowing Base Percent Of Liquidation Of Finsihed Goods                 85.00%akrx_DebtInstrumentBorrowingBasePercentOfLiquidationOfFinsihedGoods
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_StatementScenarioAxis
= akrx_TheLesserOfForScenarioThreeConsiderationBMember		    
Debt Instrument Borrowing Base Percent Of Elgible Inventory Liquidation Value                 85.00%akrx_DebtInstrumentBorrowingBasePercentOfElgibleInventoryLiquidationValue
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_StatementScenarioAxis
= akrx_TheLesserOfForScenarioThreeConsiderationBMember		    
Debt Instrument Borrowing Base Percent Of Market Value Finished Goods                 75.00%akrx_DebtInstrumentBorrowingBasePercentOfMarketValueFinishedGoods
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_StatementScenarioAxis
= akrx_TheLesserOfForScenarioThreeConsiderationBMember		    
Potential [Member] | JPM Revolving Facility [Member] | Revolving Credit Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Line of Credit Facility, Maximum Borrowing Capacity                 200,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_StatementScenarioAxis
= akrx_PotentialMember		    
Per $1,000 Principal Amount of Notes [Member] | Senior Notes [Member] | Notes [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Convertible, Conversion Rate     114.1553                
Scenario #1 [Member] | Senior Notes [Member] | Notes [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Convertible, Threshold Non-Consecutive Trading Days     20 days                
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger     130.00%us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember
/ us-gaap_StatementScenarioAxis
= akrx_Scenario1Member		                
Scenario #2 [Member] | Senior Notes [Member] | Notes [Member] | Minimum [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Convertible, Threshold Consecutive Trading Days     5 days                
Scenario #2 [Member] | Senior Notes [Member] | Notes [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Convertible, If-converted Amount of Principal     1,000akrx_DebtInstrumentConvertibleIfConvertedAmountOfPrincipal
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember
/ us-gaap_StatementScenarioAxis
= akrx_Scenario2Member		                
Debt Instrument, Convertible, Threshold Consecutive Trading Days     5 days                
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger     98.00%us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember
/ us-gaap_StatementScenarioAxis
= akrx_Scenario2Member		                
Senior Notes [Member] | Notes [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Face Amount     87,500,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Convertible Notes Payable           120,000,000us-gaap_ConvertibleNotesPayable
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		          
Debt Instrument, Interest Rate, Stated Percentage           3.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		          
Proceeds from Convertible Debt           115,300,000us-gaap_ProceedsFromConvertibleDebt
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		          
Debt Instrument, Convertible, Conversion Price (in Dollars per share)     $ 8.76us-gaap_DebtInstrumentConvertibleConversionPrice1
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Instrument, Convertible, If-converted Amount of Principal     1,000akrx_DebtInstrumentConvertibleIfConvertedAmountOfPrincipal
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Instrument, Convertible, Threshold Non-Consecutive Trading Days             20 days        
Debt Instrument, Convertible, Threshold Consecutive Trading Days     30 days       30 days        
Debt Instrument, Convertible, Stock Price Trigger (in Dollars per share)             $ 11.39us-gaap_DebtInstrumentConvertibleStockPriceTrigger
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		        
Debt Conversion, Converted Instrument, Amount     32,500,000us-gaap_DebtConversionConvertedInstrumentAmount1
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Conversion, Converted Instrument, Additional Amount     1,000,000akrx_DebtConversionConvertedInstrumentAdditionalAmount
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Instrument, Trading Amount, Percent of Face Value     412.40%akrx_DebtInstrumentTradingAmountPercentOfFaceValue
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Instrument, Convertible, Total Market Value     360,900,000akrx_DebtInstrumentConvertibleTotalMarketValue
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Share Price (in Dollars per share)     $ 36.20us-gaap_SharePrice
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Instrument, Convertible, Pro Forma Conversion Value     361,700,000akrx_DebtInstrumentConvertibleProFormaConversionValue
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Instrument, Convertible, If-converted Value in Excess of Principal     21,300,000us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Payments of Stock Issuance Costs     800,000us-gaap_PaymentsOfStockIssuanceCosts
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Issuance Cost     4,700,000us-gaap_DebtIssuanceCosts
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Debt Issuance Cost Allocated to Liability Component of Debt     3,900,000akrx_DebtIssuanceCostAllocatedToLiabilityComponentOfDebt
/ us-gaap_DebtInstrumentAxis
= akrx_NotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SeniorNotesMember		                
Incremental Term Loan Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Face Amount               445,000,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		      
Incremental Term Loan Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Basis Spread on Variable Rate               3.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember		      
Debt Instrument, Interest Rate, Effective Percentage Rate Range, Minimum               4.50%us-gaap_DebtInstrumentInterestRateEffectivePercentageRateRangeMinimum
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember		      
Incremental Term Loan Agreement [Member] | Commitment Fees [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Amortization of Financing Costs     1,700,000us-gaap_AmortizationOfFinancingCosts
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_NatureOfExpenseAxis
= akrx_CommitmentFeesMember		                
Incremental Term Loan Agreement [Member] | Ticketing Fees [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Amortization of Financing Costs     100,000us-gaap_AmortizationOfFinancingCosts
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_NatureOfExpenseAxis
= akrx_TicketingFeesMember		                
Incremental Term Loan Agreement [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Periodic Payment, Percent of Initial Loan Amount                 0.25%akrx_DebtInstrumentPeriodicPaymentPercentOfInitialLoanAmount
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Debt Instrument, Term               7 years      
Long-term Debt     443,900,000us-gaap_LongTermDebt
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Debt Instrument, Potential Reduction in Basis Spread on Variable Rate               0.25%akrx_DebtInstrumentPotentialReductionInBasisSpreadOnVariableRate
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		      
Debt Instrument, Potential Reduction in Basis Spread on Variable Rate, EBITDA Ratio Threshold               2.25akrx_DebtInstrumentPotentialReductionInBasisSpreadOnVariableRateEBITDARatioThreshold
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		      
Debt Instrument, Debt Default, Rate Increase               2.00%akrx_DebtInstrumentDebtDefaultRateIncrease
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		      
Interest Expense, Debt     7,800,000us-gaap_InterestExpenseDebt
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Deferred Finance Costs, Gross     10,900,000us-gaap_DeferredFinanceCostsGross
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Amortization of Financing Costs     1,800,000us-gaap_AmortizationOfFinancingCosts
/ us-gaap_DebtInstrumentAxis
= akrx_IncrementalTermLoanAgreementMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Term Loan Facility [Member] | Base Rate [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Basis Spread on Variable Rate               2.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember		 2.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember		    
Term Loan Facility [Member] | Eurodollar [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Basis Spread on Variable Rate                 3.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember		    
Debt Instrument, Interest Rate, Effective Percentage Rate Range, Minimum                 4.50%us-gaap_DebtInstrumentInterestRateEffectivePercentageRateRangeMinimum
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_VariableRateAxis
= us-gaap_EurodollarMember		    
Term Loan Facility [Member] | Maximum [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Potential Reduction in Basis Spread on Variable Rate, EBITDA Ratio Threshold                 2.25akrx_DebtInstrumentPotentialReductionInBasisSpreadOnVariableRateEBITDARatioThreshold
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		    
Term Loan Facility [Member] | Commitment Fees [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Amortization of Financing Costs                   2,400,000us-gaap_AmortizationOfFinancingCosts
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_NatureOfExpenseAxis
= akrx_CommitmentFeesMember		  
Term Loan Facility [Member] | Ticketing Fees [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Amortization of Financing Costs                   5,000,000us-gaap_AmortizationOfFinancingCosts
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember
/ us-gaap_NatureOfExpenseAxis
= akrx_TicketingFeesMember		  
Term Loan Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Face Amount                 600,000,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Debt Instrument, Periodic Payment, Percent of Initial Loan Amount           0.25%akrx_DebtInstrumentPeriodicPaymentPercentOfInitialLoanAmount
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		          
Debt Instrument, Term                 7 years    
Long-term Debt     598,500,000us-gaap_LongTermDebt
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Debt Instrument, Potential Reduction in Basis Spread on Variable Rate                 0.25%akrx_DebtInstrumentPotentialReductionInBasisSpreadOnVariableRate
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Debt Instrument, Debt Default, Rate Increase                 2.00%akrx_DebtInstrumentDebtDefaultRateIncrease
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Interest Expense, Debt                 19,400,000us-gaap_InterestExpenseDebt
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Deferred Finance Costs, Gross     20,300,000us-gaap_DeferredFinanceCostsGross
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Amortization of Financing Costs     7,400,000us-gaap_AmortizationOfFinancingCosts
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Debt Instrument, Potential Increase to Maximum Borrowing Capacity                 150,000,000akrx_DebtInstrumentPotentialIncreaseToMaximumBorrowingCapacity
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Debt Instrument, Fee Amount     7,400,000us-gaap_DebtInstrumentFeeAmount
/ us-gaap_DebtInstrumentAxis
= akrx_TermLoanFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
JPM Revolving Facility [Member] | Revolving Credit Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Term                 5 years    
Line of Credit Facility, Maximum Borrowing Capacity                 150,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Debt Instrument, Borrowing Base, Percent of Eligible Accounts Receivable                 85.00%akrx_DebtInstrumentBorrowingBasePercentOfEligibleAccountsReceivable
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Line of Credit Facility, Commitment Fee, Threshold, Percent of Commitments                 12.50%akrx_LineOfCreditFacilityCommitmentFeeThresholdPercentOfCommitments
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Line of Credit Facility, Commitment Fee, Threshold, Amount of Commitments                 15,000,000akrx_LineOfCreditFacilityCommitmentFeeThresholdAmountOfCommitments
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Line of Credit Facility, Commitment Fee, Threshold, Number of Consecutive Days                 30 days    
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage                 0.25%us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Long-term Line of Credit     0us-gaap_LineOfCredit
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Line of Credit Facility, Remaining Borrowing Capacity     148,800,000us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
JPM Revolving Facility [Member] | Letter of Credit [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Line of Credit Facility, Maximum Borrowing Capacity                 10,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_LetterOfCreditMember
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
JPM Revolving Facility [Member] | JPMorgan [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Debt Instrument, Debt Default, Rate Increase                 2.00%akrx_DebtInstrumentDebtDefaultRateIncrease
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Line of Credit Facility, Covenant, Minimum Liquidity                 120,000,000akrx_LineOfCreditFacilityCovenantMinimumLiquidity
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Line of Credit Facility, Covenant, Minimum Liquidity, Additional Percentage of Commitments                 25.00%akrx_LineOfCreditFacilityCovenantMinimumLiquidityAdditionalPercentageOfCommitments
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Line of Credit Facility, Covenant, Minimum EBITDA to Fixed Charges Ratio                 1.00akrx_LineOfCreditFacilityCovenantMinimumEBITDAToFixedChargesRatio
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		    
Line of Credit Facility, Covenant, Minimum EBITDA to Fixed Charges Ratio, Measurment Duration                 12 months    
Letters of Credit Outstanding, Number     1akrx_LettersOfCreditOutstandingNumber
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Letters of Credit Outstanding, Amount     1,200,000us-gaap_LettersOfCreditOutstandingAmount
/ us-gaap_DebtInstrumentAxis
= akrx_JPMRevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_JPMorganMember		                
Letter of Credit [Member] | B of A [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Line of Credit Facility, Maximum Borrowing Capacity                     2,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_LetterOfCreditMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_BOfAMember
B of A Revolving Facility [Member] | B of A [Member]                      
Note 6 - Financing Arrangements (Details) [Line Items]                      
Line of Credit Facility, Maximum Borrowing Capacity                     $ 20,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= akrx_BOfARevolvingFacilityMember
/ us-gaap_LineOfCreditFacilityAxis
= akrx_BOfAMember
XML 108 R92.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Lloyd Animal Health Products Acquisition and the Fair Value of the Acquired Assets and Assumed Liabilities (Lloyd Animal Health Products [Member], USD $)
In Millions, unless otherwise specified
 0 Months Ended
Oct. 02, 2014
Oct. 02, 2014
Lloyd Animal Health Products [Member]
    
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Lloyd Animal Health Products Acquisition and the Fair Value of the Acquired Assets and Assumed Liabilities [Line Items]    
Amount of cash paid $ 16.1us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		  
Fair value of contingent payment 1.9us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		 1.9us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember
Total consideration at closing 18.0us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		  
Accounts receivable 0.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		 0.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember
Inventory 2.5us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		 2.5us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember
Product licensing rights 10.0akrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLicensingRights
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		 10.0akrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLicensingRights
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember
IPR&D 5.5akrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInntelectualPropertyResearchAndDevelopment
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		 5.5akrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInntelectualPropertyResearchAndDevelopment
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember
Accounts payable assumed (0.1)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		 (0.1)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember
Fair value of assets acquired $ 18.0us-gaap_FairValueOfAssetsAcquired
/ us-gaap_BusinessAcquisitionAxis
= akrx_LloydAnimalHealthProductsMember		  
XML 109 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 5 - Property, Plant and Equipment (Tables)
 12 Months Ended
Dec. 31, 2014
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment [Table Text Block]
   
December 31,
 
 
 
2014
   
2013
 
Land
  $ 9,323     $ 2,606  
Buildings and leasehold improvements
    63,846       46,281  
Furniture and equipment
    112,708       76,536  
      185,877       125,423  
Accumulated depreciation
    (68,093 )     (54,470 )
      117,784       70,953  
Construction in progress
   
26,004
      11,155  
    $
143,788
    $ 82,108  
XML 110 R51.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) - Amortization Expense of Acquired Intangible Assets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Amortization Expense of Acquired Intangible Assets [Abstract]  
2015 $ 65,966us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2016 65,739us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2017 65,312us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2018 65,108us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2019 $ 62,244us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
XML 111 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 14 - Supplemental Cash Flow Information (in thousands)
 12 Months Ended
Dec. 31, 2014
Supplemental Cash Flow Elements [Abstract]  
Cash Flow, Supplemental Disclosures [Text Block]
Note 14 — Supplemental Cash Flow Information (in thousands)

   
Year ended December 31,
 
   
2014
   
2013
   
2012
 
Interest and taxes paid:
                 
   Interest paid
   
31,413
      4,320       4,200  
   Income taxes paid
    6,294       27,450       21,455  

XML 112 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 19 - Related Party Transactions
 12 Months Ended
Dec. 31, 2014
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
Note 19 — Related Party Transactions

In the recent past, the Company engaged in various related party transactions with John N. Kapoor, Ph.D., Chairman of the Company’s Board of Directors and a significant holder of the Company’s common stock.

On March 3, 2010, the Company entered into an 8-year agreement with EJ Financial for their sub-lease of a portion of the Company’s corporate offices in Lake Forest, Illinois.  This sub-lease commenced on April 1, 2010.  Subsequently, the Company and EJ Financial agreed to early terminate this agreement, and accordingly the sub-lease was terminated in July 2012.  EJ Financial paid the Company a total of approximately $240,000 in rent and common area maintenance fees over the shortened term of this sub-lease.

In connection with the various modifications agreed to during 2009 to the EJ Funds credit facility and the Subordinated Note, the Company issued various stock warrants to Dr. Kapoor.  See Note 2, Summary of Significant Accounting Policies, for information about the Kapoor Warrants.

During the years ended December 31, 2014, 2013 and 2012 the Company obtained legal services totaling $1.9 million, $0.7 million and $0.5 million, respectively, of which $0.2 million was payable as of December 31, 2014 and 2013 from Polsinelli PC (formerly Polsinelli Shughart PC), a law firm for which the spouse of the Company’s Senior Vice President, General Counsel and Secretary is an attorney and shareholder.

XML 113 R95.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Disposal Groups, Including Discontinued Operations (USD $)
In Millions, unless otherwise specified
 9 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2014
Jun. 20, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Pre-Tax gain recognized $ 9.0us-gaap_GainLossOnSaleOfBusiness    
Watson Product [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Consideration received 16.8us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		 16.8us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		  
Intangible assets divested (5.9)us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		 (5.9)us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		  
Goodwill divested (1.1)us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		 (1.1)us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		  
Other assets divested (0.8)us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		 (0.8)us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		  
Pre-Tax gain recognized   9.0us-gaap_GainLossOnSaleOfBusiness
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_WatsonProductMember		  
ECR Pharmaceuticals Divestiture [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Consideration received 41.0us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		 41.0us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		 41.0us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember
Intangible assets divested (33.6)us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		 (33.6)us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		  
Goodwill divested (10.4)us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		 (10.4)us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		  
Other assets divested (1.2)us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		 (1.2)us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		  
Assumed liabilities divested 5.1us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		 5.1us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		  
Pre-Tax gain recognized   $ 0.9us-gaap_GainLossOnSaleOfBusiness
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= akrx_ECRPharmaceuticalsDivestitureMember		  
XML 114 R49.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Summary of Significant Accounting Policies (Details) - Major Categories of Intangible Assets (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 1,045,592us-gaap_FiniteLivedIntangibleAssetsGross    
Accumulated Amortization (82,233)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization (39,100)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization  
Net Carrying amount 963,359us-gaap_FiniteLivedIntangibleAssetsNet    
Intellectual Property and Research and Development [Member]      
Finite-Lived Intangible Assets [Line Items]      
Weighted Average Remaining Amortization Period       
In-process research and development (“IPR&D”) 230,788us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_IntellectualPropertyandResearchandDevelopmentMember		    
In-process research and development (“IPR&D”)       
Product Licensing Rights [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 778,734us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		    
Accumulated Amortization (74,516)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		    
Net Carrying amount 704,218us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		 115,900us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember		 63,654us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= akrx_ProductLicensingRightsMember
Weighted Average Remaining Amortization Period 12 years 146 days    
In-process research and development (“IPR&D”) 12 years 146 days    
Trademarks [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 16,000us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		    
Accumulated Amortization (1,721)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		    
Net Carrying amount 14,279us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		 8,656us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember		 8,972us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksMember
Weighted Average Remaining Amortization Period 18 years 219 days    
In-process research and development (“IPR&D”) 18 years 219 days    
Customer Relationships [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 6,427us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		    
Accumulated Amortization (3,392)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		    
Net Carrying amount 3,035us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		 4,638us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		 5,588us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember
Weighted Average Remaining Amortization Period 11 years    
In-process research and development (“IPR&D”) 11 years    
Other Intangible Assets [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 11,234us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Accumulated Amortization (879)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Net Carrying amount 10,355us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_OtherIntangibleAssetsMember		    
Weighted Average Remaining Amortization Period 7 years 6 months    
In-process research and development (“IPR&D”) 7 years 6 months    
Noncompete Agreements [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 2,409us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		    
Accumulated Amortization (1,725)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		    
Net Carrying amount $ 684us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		 $ 1,311us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember		 $ 2,171us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_NoncompeteAgreementsMember
Weighted Average Remaining Amortization Period 1 year 146 days    
In-process research and development (“IPR&D”) 1 year 146 days    
XML 115 R105.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 20 - Severance Charges (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2014
Restructuring and Related Activities [Abstract]  
Accrued Severance Benefits Threshold $ 0.1akrx_AccruedSeveranceBenefitsThreshold
XML 116 R41.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 13 - Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]  
Commitment Payment to Strategic Business Partners [Table Text Block]
Year ending December 31,
 
Milestone Payments
 
2015
  $ 12,916  
2016
    3,250  
2017
    3,202  
2018
    21  
Total
  $ 19,389  
XML 117 R107.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) - Selected Quarterly Financial Data (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Jun. 30, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Selected Quarterly Financial Data (Unaudited) [Abstract]                          
Revenue $ 227,828us-gaap_SalesRevenueNet $ 132,732us-gaap_SalesRevenueNet $ 141,896us-gaap_SalesRevenueNet $ 90,622us-gaap_SalesRevenueNet $ 84,953us-gaap_SalesRevenueNet $ 81,892us-gaap_SalesRevenueNet $ 77,012us-gaap_SalesRevenueNet $ 73,854us-gaap_SalesRevenueNet $ 232,518us-gaap_SalesRevenueNet $ 365,250us-gaap_SalesRevenueNet $ 593,078us-gaap_SalesRevenueNet $ 317,711us-gaap_SalesRevenueNet $ 256,158us-gaap_SalesRevenueNet
Gross Profit 128,382us-gaap_GrossProfit 51,734us-gaap_GrossProfit 67,818us-gaap_GrossProfit 49,656us-gaap_GrossProfit 46,970us-gaap_GrossProfit 43,697us-gaap_GrossProfit 42,092us-gaap_GrossProfit 39,145us-gaap_GrossProfit 117,474us-gaap_GrossProfit 169,208us-gaap_GrossProfit 297,590us-gaap_GrossProfit 171,904us-gaap_GrossProfit 148,692us-gaap_GrossProfit
Operating Income (Loss) 71,907us-gaap_OperatingIncomeLoss (6,042)us-gaap_OperatingIncomeLoss 7,410us-gaap_OperatingIncomeLoss 23,440us-gaap_OperatingIncomeLoss 25,176us-gaap_OperatingIncomeLoss 22,188us-gaap_OperatingIncomeLoss 22,251us-gaap_OperatingIncomeLoss 18,589us-gaap_OperatingIncomeLoss 30,850us-gaap_OperatingIncomeLoss 24,808us-gaap_OperatingIncomeLoss 96,715us-gaap_OperatingIncomeLoss 88,204us-gaap_OperatingIncomeLoss 68,756us-gaap_OperatingIncomeLoss
Net Income (loss) From Continuing Operations, Amount 34,232us-gaap_IncomeLossFromContinuingOperations (11,650)us-gaap_IncomeLossFromContinuingOperations 3,438us-gaap_IncomeLossFromContinuingOperations 9,828us-gaap_IncomeLossFromContinuingOperations 16,678us-gaap_IncomeLossFromContinuingOperations 12,205us-gaap_IncomeLossFromContinuingOperations 12,637us-gaap_IncomeLossFromContinuingOperations 10,842us-gaap_IncomeLossFromContinuingOperations 13,266us-gaap_IncomeLossFromContinuingOperations 1,616us-gaap_IncomeLossFromContinuingOperations 35,848us-gaap_IncomeLossFromContinuingOperations 52,362us-gaap_IncomeLossFromContinuingOperations 35,378us-gaap_IncomeLossFromContinuingOperations
Net Income (loss) From Continuing Operations, Per Basic Share (in Dollars per share) $ 0.32us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ (0.11)us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.03us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.10us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.17us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.13us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.02us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.35us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.54us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.37us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
Net Income (loss) From Continuing Operations, Per Diluted Share (in Dollars per share) $ 0.29us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ (0.11)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.03us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.08us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.14us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.10us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.11us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.01us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.34us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1] $ 0.46us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1] $ 0.32us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare [1]
Net Income (Loss), Amount $ 34,232us-gaap_NetIncomeLoss $ (11,650)us-gaap_NetIncomeLoss $ 2,935us-gaap_NetIncomeLoss $ 9,828us-gaap_NetIncomeLoss $ 16,678us-gaap_NetIncomeLoss $ 12,205us-gaap_NetIncomeLoss $ 12,637us-gaap_NetIncomeLoss $ 10,842us-gaap_NetIncomeLoss $ 12,763us-gaap_NetIncomeLoss $ 1,113us-gaap_NetIncomeLoss $ 35,345us-gaap_NetIncomeLoss $ 52,362us-gaap_NetIncomeLoss $ 35,378us-gaap_NetIncomeLoss
Net Income (Loss), Per Basic Share (in Dollars per share) $ 0.32us-gaap_EarningsPerShareBasic $ (0.11)us-gaap_EarningsPerShareBasic $ 0.03us-gaap_EarningsPerShareBasic $ 0.10us-gaap_EarningsPerShareBasic $ 0.17us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.11us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.01us-gaap_EarningsPerShareBasic $ 0.34us-gaap_EarningsPerShareBasic $ 0.54us-gaap_EarningsPerShareBasic $ 0.37us-gaap_EarningsPerShareBasic
Net Income (Loss), Per Diluted Share (in Dollars per share) $ 0.29us-gaap_EarningsPerShareDiluted $ (0.11)us-gaap_EarningsPerShareDiluted $ 0.02us-gaap_EarningsPerShareDiluted $ 0.08us-gaap_EarningsPerShareDiluted $ 0.14us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.10us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.01us-gaap_EarningsPerShareDiluted $ 0.33us-gaap_EarningsPerShareDiluted $ 0.46us-gaap_EarningsPerShareDiluted $ 0.32us-gaap_EarningsPerShareDiluted
[1] Due to a change in the expectation that management may settle all future note conversions solely through shares in the year and quarter ended December 31, 2014, the diluted income from continuing operations per share calculation includes the dilutive effect of convertible debt and is offset by the exclusion of interest expense and deferred financing fees related to the convertible debt of $5.8 million, after-taxfor the year ended December 31, 2014.
XML 118 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Comprehensive Income (Parentheticals) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Foreign currency translation loss, tax $ 877us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $ 3,328us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax $ 3,040us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
XML 119 R88.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 13 - Commitments and Contingencies (Details) (USD $)
In Millions, unless otherwise specified
 1 Months Ended 0 Months Ended 12 Months Ended
Jul. 31, 2014
Oct. 17, 2012
Jan. 02, 2014
Jan. 02, 2014
Dec. 31, 2014
Dec. 31, 2015
Mar. 31, 2015
Dec. 31, 2011
Scenario, Forecast [Member] | Supply Agreement with Hospira [Member]                
Note 13 - Commitments and Contingencies (Details) [Line Items]                
Purchase Obligation, Future Minimum Payments, Remainder of Fiscal Year           $ 1.9us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis
= akrx_SupplyAgreementWithHospiraMember
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioForecastMember		    
Scenario, Forecast [Member]                
Note 13 - Commitments and Contingencies (Details) [Line Items]                
Business Combination, Revised Additional Consideration Owed             4.0akrx_BusinessCombinationRevisedAdditionalConsiderationOwed
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioForecastMember		  
Business Combination Discount Rate of Additional Consideration Owed             12.60%akrx_BusinessCombinationDiscountRateOfAdditionalConsiderationOwed
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioForecastMember		  
Td Vaccine [Member]                
Note 13 - Commitments and Contingencies (Details) [Line Items]                
Long-term Purchase Commitment, Period   2 years            
Distribution Agreement Contract Term 1 year              
Purchase Obligation, Due in Second Year 4.8us-gaap_PurchaseObligationDueInSecondYear
/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis
= akrx_TdVaccineMember		              
Supply Agreement with Hospira [Member]                
Note 13 - Commitments and Contingencies (Details) [Line Items]                
Number of Products Related to Minimum Annual Purchase Obligations               2akrx_NumberOfProductsRelatedToMinimumAnnualPurchaseObligations
/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis
= akrx_SupplyAgreementWithHospiraMember
Betimol Acquisition [Member]                
Note 13 - Commitments and Contingencies (Details) [Line Items]                
Business Acquisition, Consideration, Sales Multiplier     1.5akrx_BusinessAcquisitionConsiderationSalesMultiplier
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		 1.5akrx_BusinessAcquisitionConsiderationSalesMultiplier
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		        
Payments to Acquire Businesses, Gross     7.5us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		 7.5us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		 7.5us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		      
Business Combination, Original Additional Consideration Owed         4.5akrx_BusinessCombinationAdditionalConsiderationOwed
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		      
Business Combination, Contingent Consideration, Liability         $ 4.3us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= akrx_BetimolAcquisitionMember		      
XML 120 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 3 - Accounts Receivable, Sales and Allowances
 12 Months Ended
Dec. 31, 2014
Receivables [Abstract]  
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]
Note 3 — Accounts Receivable, Sales and Allowances

The nature of the Company’s business inherently involves, in the ordinary course, significant amounts and substantial volumes of transactions and estimates relating to allowances for product returns, chargebacks, rebates, doubtful accounts and discounts given to customers. This is a natural circumstance of the pharmaceutical industry and is not specific to the Company. Depending on the product, the end-user customer, the specific terms of national supply contracts and the particular arrangements with the Company’s wholesaler customers, certain rebates, chargebacks and other credits are deducted from the Company’s accounts receivable. The process of claiming these deductions depends on wholesalers reporting to the Company the amount of deductions that were earned under the terms of the respective agreement with the end-user customer (which in turn depends on the specific end-user customer, each having its own pricing arrangement, which entitles it to a particular deduction). This process can lead to partial payments against outstanding invoices as the wholesalers take the claimed deductions at the time of payment.

With the exception of the provision for doubtful accounts, which is reflected as part of selling, general and administrative expense, the provisions for the following customer reserves are reflected as a reduction of revenues in the accompanying consolidated statements of comprehensive income. The ending reserve balances are included in trade accounts receivable, net in the Company’s consolidated balance sheets.

Net trade accounts receivable consists of the following (in thousands):

   
December 31,
 
 
 
2014
   
2013
 
Gross accounts receivable
  $
445,027
    $ 88,165  
Less reserves for:
               
Chargebacks and rebates
    (155,297 )     (12,882 )
Product returns
    (44,644 )     (8,164 )
Discounts and allowances
    (22,691 )     (1,644 )
Advertising and promotions
    (1,217 )     (452 )
Doubtful accounts
    (462 )     (25 )
Trade accounts receivable, net
  $ 220,716     $ 64,998  

For the years ended December 31, 2014, 2013 and 2012, the Company recorded the following adjustments to gross sales (in thousands):

   
Year ended December 31,
 
   
2014
   
2013
   
2012
 
Gross sales
  $ 1,442,537     $ 528,574     $ 386,582  
Less adjustments for:
                       
Chargebacks and rebates
    (739,760 )     (183,403 )     (112,244 )
Product returns
    (20,006 )     (5,001 )     (3,783 )
Discounts and allowances
    (31,178 )     (8,464 )     (6,074 )
Administrative fees
    (50,786 )     (9,471 )     (5,293 )
Advertising, promotions, and other
    (7,729 )     (4,524 )     (3,030 )
Revenues, net
  $
593,078
    $ 317,711     $ 256,158  

The annual activity in the Company’s allowance for customer deductions accounts for the three years ended December 31, 2014 is as follows (in thousands):

   
Returns
   
Chargebacks & Rebates
   
Discounts
   
Doubtful Accounts
   
Advert. & Promotions
   
TOTAL
 
Balance at December 31, 2011
    6,846       5,949       743       99       386       14,023  
Provision
    3,783       112,243       6,074       (82 )     2,063       124,081  
Charges processed
    (2,220 )     (104,740 )     (5,455 )     13       (1,864 )     (114,266 )
Balance at December 31, 2012
  $ 8,409     $ 13,452     $ 1,362     $ 30     $ 585     $ 23,838  
Provision
    5,001       183,403       8,464       (5 )     4,524       201,387  
Charges processed
    (5,246 )     (183,973 )     (8,182 )     —       (4,657 )     (202,058 )
Balance at December 31, 2013
  $ 8,164     $ 12,882     $ 1,644     $ 25     $ 452     $ 23,167  
Provision
    20,006      
739,760
      31,178       346       7,729      
799,019
 
Additions from acquisitions
    29,172      
29,593
     
5,161
      88       311      
64,325
 
Charges processed
    (12,698 )     (626,938 )     (15,292 )     3       (7,275 )     (662,200 )
Balance at December 31, 2014
  $ 44,644     $
155,297
    $
22,691
    $ 462     $ 1,217     $
224,311
 

XML 121 R58.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions [Line Items]      
Balance $ 23,167us-gaap_ValuationAllowancesAndReservesBalance $ 23,838us-gaap_ValuationAllowancesAndReservesBalance $ 14,023us-gaap_ValuationAllowancesAndReservesBalance
Provision 799,019us-gaap_ValuationAllowancesAndReservesRecoveries 201,387us-gaap_ValuationAllowancesAndReservesRecoveries 124,081us-gaap_ValuationAllowancesAndReservesRecoveries
Additions from acquisitions 64,325us-gaap_ValuationAllowancesAndReservesAdjustments    
Charges Processed (662,200)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense (202,058)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense (114,266)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
Balance 224,311us-gaap_ValuationAllowancesAndReservesBalance 23,167us-gaap_ValuationAllowancesAndReservesBalance 23,838us-gaap_ValuationAllowancesAndReservesBalance
Allowance for Sales Returns [Member]      
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions [Line Items]      
Balance 8,164us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		 8,409us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		 6,846us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember
Provision 20,006us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		 5,001us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		 3,783us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember
Additions from acquisitions 29,172us-gaap_ValuationAllowancesAndReservesAdjustments
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		    
Charges Processed (12,698)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		 (5,246)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		 (2,220)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember
Balance 44,644us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		 8,164us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember		 8,409us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForSalesReturnsMember
Charegebacks and Rebates [Member]      
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions [Line Items]      
Balance 12,882us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		 13,452us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		 5,949us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember
Provision 739,760us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		 183,403us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		 112,243us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember
Additions from acquisitions 29,593us-gaap_ValuationAllowancesAndReservesAdjustments
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		    
Charges Processed (626,938)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		 (183,973)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		 (104,740)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember
Balance 155,297us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		 12,882us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember		 13,452us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= akrx_CharegebacksandRebatesMember
Reserve for Cash Discount [Member]      
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions [Line Items]      
Balance 1,644us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		 1,362us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		 743us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember
Provision 31,178us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		 8,464us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		 6,074us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember
Additions from acquisitions 5,161us-gaap_ValuationAllowancesAndReservesAdjustments
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		    
Charges Processed (15,292)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		 (8,182)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		 (5,455)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember
Balance 22,691us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		 1,644us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember		 1,362us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_ReserveForCashDiscountMember
Allowance for Doubtful Accounts [Member]      
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions [Line Items]      
Balance 25us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 30us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 99us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember
Provision 346us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 (5)us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 (82)us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember
Additions from acquisitions 88us-gaap_ValuationAllowancesAndReservesAdjustments
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		    
Charges Processed 3us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		   13us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember
Balance 462us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 25us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember		 30us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForDoubtfulAccountsMember
Allowance for Promotions [Member]      
Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions [Line Items]      
Balance 452us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		 585us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		 386us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember
Provision 7,729us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		 4,524us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		 2,063us-gaap_ValuationAllowancesAndReservesRecoveries
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember
Additions from acquisitions 311us-gaap_ValuationAllowancesAndReservesAdjustments
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		    
Charges Processed (7,275)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		 (4,657)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		 (1,864)us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember
Balance $ 1,217us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		 $ 452us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember		 $ 585us-gaap_ValuationAllowancesAndReservesBalance
/ us-gaap_ValuationAllowancesAndReservesTypeAxis
= us-gaap_AllowanceForPromotionsMember
XML 122 R82.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 10 - Income Taxes (Details) - Net Deferred Income Taxes (USD $)
In Thousands, unless otherwise specified
Jun. 02, 2011
Dec. 31, 2014
Dec. 31, 2013
Deferred tax assets:      
Valuation allowance $ (8,600)us-gaap_DeferredTaxAssetsValuationAllowance    
Deferred Taxes Current [Member]      
Deferred tax assets:      
Net operating loss carry-forward   4,277us-gaap_DeferredTaxAssetsOperatingLossCarryforwards
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		 439us-gaap_DeferredTaxAssetsOperatingLossCarryforwards
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Chargeback reserves   5,391akrx_DeferredTaxAssetsTaxDeferredExpenseChargebackReserves
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		  
Reserve for product returns   12,255us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		 3,189us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Inventory valuation reserve   5,764us-gaap_DeferredTaxAssetsInventory
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		 2,193us-gaap_DeferredTaxAssetsInventory
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Other   8,570us-gaap_DeferredTaxAssetsOther
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		 3,325us-gaap_DeferredTaxAssetsOther
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Total deferred tax assets   36,257us-gaap_DeferredTaxAssetsGross
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		 9,146us-gaap_DeferredTaxAssetsGross
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Net deferred tax assets   36,257us-gaap_DeferredTaxAssetsNet
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		  
Deferred tax liabilities:      
Prepaid expenses   (1,982)us-gaap_DeferredTaxLiabilitiesPrepaidExpenses
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		 (1,120)us-gaap_DeferredTaxLiabilitiesPrepaidExpenses
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Inventory step-up   (1,619)akrx_DeferredTaxLiabilitiesInventoryStepup
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		  
Other     (81)us-gaap_DeferredTaxLiabilitiesOther
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Total deferred tax liabilities   (3,601)us-gaap_DeferredIncomeTaxLiabilities
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		 (1,201)us-gaap_DeferredIncomeTaxLiabilities
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Net deferred income tax asset (liability)   32,656us-gaap_DeferredTaxAssetsLiabilitiesNet
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember		 7,945us-gaap_DeferredTaxAssetsLiabilitiesNet
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesCurrentMember
Deferred Taxes Noncurrent [Member]      
Deferred tax assets:      
Net operating loss carry-forward   16,190us-gaap_DeferredTaxAssetsOperatingLossCarryforwards
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		 14,061us-gaap_DeferredTaxAssetsOperatingLossCarryforwards
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember
Stock-based compensation   6,408us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		 6,630us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember
Other   192us-gaap_DeferredTaxAssetsOther
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		 1,751us-gaap_DeferredTaxAssetsOther
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember
Total deferred tax assets   22,790us-gaap_DeferredTaxAssetsGross
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		 22,442us-gaap_DeferredTaxAssetsGross
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember
Valuation allowance   (1,116)us-gaap_DeferredTaxAssetsValuationAllowance
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		  
Net deferred tax assets   21,674us-gaap_DeferredTaxAssetsNet
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		  
Deferred tax liabilities:      
Unamortized discount – convertible notes   (1,776)akrx_UnamortizedDiscountConvertibleNotes
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		 (4,223)akrx_UnamortizedDiscountConvertibleNotes
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember
Depreciation & amortization – tax over book   (285,022)us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		 (16,576)us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember
Total deferred tax liabilities   (286,798)us-gaap_DeferredIncomeTaxLiabilities
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		 (20,799)us-gaap_DeferredIncomeTaxLiabilities
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember
Net deferred income tax asset (liability)   $ (265,124)us-gaap_DeferredTaxAssetsLiabilitiesNet
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember		 $ 1,643us-gaap_DeferredTaxAssetsLiabilitiesNet
/ us-gaap_BalanceSheetLocationAxis
= akrx_DeferredTaxesNoncurrentMember
XML 123 R106.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) (USD $)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended 0 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Jun. 30, 2014
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Apr. 17, 2014
Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) [Line Items]                            
Chargeback and Rebate Reserve $ 155,297,000akrx_ChargebackAndRebateReserve       $ 12,882,000akrx_ChargebackAndRebateReserve           $ 155,297,000akrx_ChargebackAndRebateReserve $ 12,882,000akrx_ChargebackAndRebateReserve    
Revenue, Net 227,828,000us-gaap_SalesRevenueNet 132,732,000us-gaap_SalesRevenueNet 141,896,000us-gaap_SalesRevenueNet 90,622,000us-gaap_SalesRevenueNet 84,953,000us-gaap_SalesRevenueNet 81,892,000us-gaap_SalesRevenueNet 77,012,000us-gaap_SalesRevenueNet 73,854,000us-gaap_SalesRevenueNet 232,518,000us-gaap_SalesRevenueNet 365,250,000us-gaap_SalesRevenueNet 593,078,000us-gaap_SalesRevenueNet 317,711,000us-gaap_SalesRevenueNet 256,158,000us-gaap_SalesRevenueNet  
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest     5,459,000us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest           21,151,000us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 2,612,000us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 59,136,000us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 82,895,000us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 57,500,000us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest  
Goodwill 278,774,000us-gaap_Goodwill 285,080,000us-gaap_Goodwill 190,448,000us-gaap_Goodwill   29,831,000us-gaap_Goodwill       190,448,000us-gaap_Goodwill 285,080,000us-gaap_Goodwill 278,774,000us-gaap_Goodwill 29,831,000us-gaap_Goodwill 32,159,000us-gaap_Goodwill  
Retained Earnings (Accumulated Deficit) 50,711,000us-gaap_RetainedEarningsAccumulatedDeficit 16,480,000us-gaap_RetainedEarningsAccumulatedDeficit 28,129,000us-gaap_RetainedEarningsAccumulatedDeficit   15,366,000us-gaap_RetainedEarningsAccumulatedDeficit       28,129,000us-gaap_RetainedEarningsAccumulatedDeficit 16,480,000us-gaap_RetainedEarningsAccumulatedDeficit 50,711,000us-gaap_RetainedEarningsAccumulatedDeficit 15,366,000us-gaap_RetainedEarningsAccumulatedDeficit    
CONSOLIDATED NET INCOME 34,232,000us-gaap_NetIncomeLoss (11,650,000)us-gaap_NetIncomeLoss 2,935,000us-gaap_NetIncomeLoss 9,828,000us-gaap_NetIncomeLoss 16,678,000us-gaap_NetIncomeLoss 12,205,000us-gaap_NetIncomeLoss 12,637,000us-gaap_NetIncomeLoss 10,842,000us-gaap_NetIncomeLoss 12,763,000us-gaap_NetIncomeLoss 1,113,000us-gaap_NetIncomeLoss 35,345,000us-gaap_NetIncomeLoss 52,362,000us-gaap_NetIncomeLoss 35,378,000us-gaap_NetIncomeLoss  
Earnings Per Share, Basic (in Dollars per share) $ 0.32us-gaap_EarningsPerShareBasic $ (0.11)us-gaap_EarningsPerShareBasic $ 0.03us-gaap_EarningsPerShareBasic $ 0.10us-gaap_EarningsPerShareBasic $ 0.17us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.11us-gaap_EarningsPerShareBasic $ 0.13us-gaap_EarningsPerShareBasic $ 0.01us-gaap_EarningsPerShareBasic $ 0.34us-gaap_EarningsPerShareBasic $ 0.54us-gaap_EarningsPerShareBasic $ 0.37us-gaap_EarningsPerShareBasic  
Earnings Per Share, Diluted (in Dollars per share) $ 0.29us-gaap_EarningsPerShareDiluted $ (0.11)us-gaap_EarningsPerShareDiluted $ 0.02us-gaap_EarningsPerShareDiluted $ 0.08us-gaap_EarningsPerShareDiluted $ 0.14us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.10us-gaap_EarningsPerShareDiluted $ 0.11us-gaap_EarningsPerShareDiluted $ 0.01us-gaap_EarningsPerShareDiluted $ 0.33us-gaap_EarningsPerShareDiluted $ 0.46us-gaap_EarningsPerShareDiluted $ 0.32us-gaap_EarningsPerShareDiluted  
Scenario, Adjustment [Member]                            
Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) [Line Items]                            
Chargeback and Rebate Reserve     (8,900,000)akrx_ChargebackAndRebateReserve
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (8,900,000)akrx_ChargebackAndRebateReserve
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		          
Revenue, Net     (8,853,000)us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (8,853,000)us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (8,853,000)us-gaap_SalesRevenueNet
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest     (8,853,000)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (8,853,000)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (8,853,000)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Goodwill   (5,568,000)us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,568,000)us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,568,000)us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,568,000)us-gaap_Goodwill
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Retained Earnings (Accumulated Deficit)   (5,571,000)us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571,000)us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,571,000)us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571,000)us-gaap_RetainedEarningsAccumulatedDeficit
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
CONSOLIDATED NET INCOME     (5,571,000)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           (5,571,000)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 (5,571,000)us-gaap_NetIncomeLoss
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Earnings Per Share, Basic (in Dollars per share)     $ (0.05)us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           $ (0.05)us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 $ (0.06)us-gaap_EarningsPerShareBasic
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Earnings Per Share, Diluted (in Dollars per share)     $ (0.05)us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		           $ (0.05)us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		 $ (0.05)us-gaap_EarningsPerShareDiluted
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioAdjustmentMember		        
Hi-Tech Pharmacal Co., Inc [Member]                            
Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) [Line Items]                            
Business Combination, Consideration Transferred                           $ 650,000,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= akrx_HiTechPharmacalCoIncMember
XML 124 R69.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 6 - Financing Arrangements (Details) - Maturities of Long-term Obligations (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Maturities of Long-term Obligations [Abstract]  
Maturities $ 10,450us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
Maturities 97,975us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
Maturities 10,450us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
Maturities 10,450us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
Maturities $ 1,000,588us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
XML 125 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 20 - Severance Charges
 12 Months Ended
Dec. 31, 2014
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure [Text Block]
Note 20 — Severance Charges

Subsequent to the closing of the various mergers and acquisitions transacted through the years ended December 31, 2014 and 2013, the Company entered into severance agreements promising associated payments; and as such, severance expense was recognized related to these agreements. As of December 31, 2014 and 2013, the accrued severance balances were insignificant, equaling less than $0.1 million in each year.

XML 126 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 525 602 1 true 172 0 false 5 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://www.akorn.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.akorn.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.akorn.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) false false R4.htm 003 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.akorn.com/role/ConsolidatedIncomeStatement Consolidated Statements of Comprehensive Income false false R5.htm 004 - Statement - Consolidated Statements of Comprehensive Income (Parentheticals) Sheet http://www.akorn.com/role/ConsolidatedIncomeStatement_Parentheticals Consolidated Statements of Comprehensive Income (Parentheticals) false false R6.htm 005 - Statement - Consolidated Statement of Shareholders' Equity Sheet http://www.akorn.com/role/ShareholdersEquityType2or3 Consolidated Statement of Shareholders' Equity false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.akorn.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows false false R8.htm 007 - Disclosure - Note 1 - Business and Basis of Presentation Sheet http://www.akorn.com/role/Note1BusinessandBasisofPresentation Note 1 - Business and Basis of Presentation false false R9.htm 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.akorn.com/role/Note2SummaryofSignificantAccountingPolicies Note 2 - Summary of Significant Accounting Policies false false R10.htm 009 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances Sheet http://www.akorn.com/role/Note3AccountsReceivableSalesandAllowances Note 3 - Accounts Receivable, Sales and Allowances false false R11.htm 010 - Disclosure - Note 4 - Inventories Sheet http://www.akorn.com/role/Note4Inventories Note 4 - Inventories false false R12.htm 011 - Disclosure - Note 5 - Property, Plant and Equipment Sheet http://www.akorn.com/role/Note5PropertyPlantandEquipment Note 5 - Property, Plant and Equipment false false R13.htm 012 - Disclosure - Note 6 - Financing Arrangements Sheet http://www.akorn.com/role/Note6FinancingArrangements Note 6 - Financing Arrangements false false R14.htm 013 - Disclosure - Note 7 - Earnings Per Common Share Sheet http://www.akorn.com/role/Note7EarningsPerCommonShare Note 7 - Earnings Per Common Share false false R15.htm 014 - Disclosure - Note 8 - Leasing Arrangements Sheet http://www.akorn.com/role/Note8LeasingArrangements Note 8 - Leasing Arrangements false false R16.htm 015 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock Sheet http://www.akorn.com/role/Note9StockOptionsEmployeeStockPurchasePlanandRestrictedStock Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock false false R17.htm 016 - Disclosure - Note 10 - Income Taxes Sheet http://www.akorn.com/role/Note10IncomeTaxes Note 10 - Income Taxes false false R18.htm 017 - Disclosure - Note 11 - Retirement Plan Sheet http://www.akorn.com/role/Note11RetirementPlan Note 11 - Retirement Plan false false R19.htm 018 - Disclosure - Note 12 - Segment Information Sheet http://www.akorn.com/role/Note12SegmentInformation Note 12 - Segment Information false false R20.htm 019 - Disclosure - Note 13 - Commitments and Contingencies Sheet http://www.akorn.com/role/Note13CommitmentsandContingencies Note 13 - Commitments and Contingencies false false R21.htm 020 - Disclosure - Note 14 - Supplemental Cash Flow Information (in thousands) Sheet http://www.akorn.com/role/Note14SupplementalCashFlowInformationinthousands Note 14 - Supplemental Cash Flow Information (in thousands) false false R22.htm 021 - Disclosure - Note 15 - Recent Accounting Pronouncements Sheet http://www.akorn.com/role/Note15RecentAccountingPronouncements Note 15 - Recent Accounting Pronouncements false false R23.htm 022 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments Sheet http://www.akorn.com/role/Note16BusinessCombinationsDispositionsandOtherStrategicInvestments Note 16 - Business Combinations, Dispositions and Other Strategic Investments false false R24.htm 023 - Disclosure - Note 17 - Unconsolidated Joint Venture Sheet http://www.akorn.com/role/Note17UnconsolidatedJointVenture Note 17 - Unconsolidated Joint Venture false false R25.htm 024 - Disclosure - Note 18 - Customer, Supplier and Product Concentration Sheet http://www.akorn.com/role/Note18CustomerSupplierandProductConcentration Note 18 - Customer, Supplier and Product Concentration false false R26.htm 025 - Disclosure - Note 19 - Related Party Transactions Sheet http://www.akorn.com/role/Note19RelatedPartyTransactions Note 19 - Related Party Transactions false false R27.htm 026 - Disclosure - Note 20 - Severance Charges Sheet http://www.akorn.com/role/Note20SeveranceCharges Note 20 - Severance Charges false false R28.htm 027 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) Sheet http://www.akorn.com/role/Note21SelectedQuarterlyFinancialDataUnaudited Note 21 - Selected Quarterly Financial Data (Unaudited) false false R29.htm 028 - Disclosure - Note 22 - Legal Proceedings Sheet http://www.akorn.com/role/Note22LegalProceedings Note 22 - Legal Proceedings false false R30.htm 029 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.akorn.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) false false R31.htm 030 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.akorn.com/role/Note2SummaryofSignificantAccountingPoliciesTables Note 2 - Summary of Significant Accounting Policies (Tables) false false R32.htm 031 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances (Tables) Sheet http://www.akorn.com/role/Note3AccountsReceivableSalesandAllowancesTables Note 3 - Accounts Receivable, Sales and Allowances (Tables) false false R33.htm 032 - Disclosure - Note 4 - Inventories (Tables) Sheet http://www.akorn.com/role/Note4InventoriesTables Note 4 - Inventories (Tables) false false R34.htm 033 - Disclosure - Note 5 - Property, Plant and Equipment (Tables) Sheet http://www.akorn.com/role/Note5PropertyPlantandEquipmentTables Note 5 - Property, Plant and Equipment (Tables) false false R35.htm 034 - Disclosure - Note 6 - Financing Arrangements (Tables) Sheet http://www.akorn.com/role/Note6FinancingArrangementsTables Note 6 - Financing Arrangements (Tables) false false R36.htm 035 - Disclosure - Note 7 - Earnings Per Common Share (Tables) Sheet http://www.akorn.com/role/Note7EarningsPerCommonShareTables Note 7 - Earnings Per Common Share (Tables) false false R37.htm 036 - Disclosure - Note 8 - Leasing Arrangements (Tables) Sheet http://www.akorn.com/role/Note8LeasingArrangementsTables Note 8 - Leasing Arrangements (Tables) false false R38.htm 037 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Tables) Sheet http://www.akorn.com/role/Note9StockOptionsEmployeeStockPurchasePlanandRestrictedStockTables Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Tables) false false R39.htm 038 - Disclosure - Note 10 - Income Taxes (Tables) Sheet http://www.akorn.com/role/Note10IncomeTaxesTables Note 10 - Income Taxes (Tables) false false R40.htm 039 - Disclosure - Note 12 - Segment Information (Tables) Sheet http://www.akorn.com/role/Note12SegmentInformationTables Note 12 - Segment Information (Tables) false false R41.htm 040 - Disclosure - Note 13 - Commitments and Contingencies (Tables) Sheet http://www.akorn.com/role/Note13CommitmentsandContingenciesTables Note 13 - Commitments and Contingencies (Tables) false false R42.htm 041 - Disclosure - Note 14 - Supplemental Cash Flow Information (in thousands) (Tables) Sheet http://www.akorn.com/role/Note14SupplementalCashFlowInformationinthousandsTables Note 14 - Supplemental Cash Flow Information (in thousands) (Tables) false false R43.htm 042 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables) Sheet http://www.akorn.com/role/Note16BusinessCombinationsDispositionsandOtherStrategicInvestmentsTables Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Tables) false false R44.htm 043 - Disclosure - Note 17 - Unconsolidated Joint Venture (Tables) Sheet http://www.akorn.com/role/Note17UnconsolidatedJointVentureTables Note 17 - Unconsolidated Joint Venture (Tables) false false R45.htm 044 - Disclosure - Note 18 - Customer, Supplier and Product Concentration (Tables) Sheet http://www.akorn.com/role/Note18CustomerSupplierandProductConcentrationTables Note 18 - Customer, Supplier and Product Concentration (Tables) false false R46.htm 045 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.akorn.com/role/Note21SelectedQuarterlyFinancialDataUnauditedTables Note 21 - Selected Quarterly Financial Data (Unaudited) (Tables) false false R47.htm 046 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) Sheet http://www.akorn.com/role/Note2SummaryofSignificantAccountingPoliciesDetails Note 2 - Summary of Significant Accounting Policies (Details) false false R48.htm 047 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Goodwill Sheet http://www.akorn.com/role/ChangesinGoodwillTable Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Goodwill false false R49.htm 048 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Major Categories of Intangible Assets Sheet http://www.akorn.com/role/MajorCategoriesofIntangibleAssetsTable Note 2 - Summary of Significant Accounting Policies (Details) - Major Categories of Intangible Assets false false R50.htm 049 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets Sheet http://www.akorn.com/role/ChangesinIntangibleAssetsTable Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Intangible Assets false false R51.htm 050 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Amortization Expense of Acquired Intangible Assets Sheet http://www.akorn.com/role/AmortizationExpenseofAcquiredIntangibleAssetsTable Note 2 - Summary of Significant Accounting Policies (Details) - Amortization Expense of Acquired Intangible Assets false false R52.htm 051 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment Sheet http://www.akorn.com/role/AverageEstimatedUsefulLivesofPropertyPlantandEquipmentTable Note 2 - Summary of Significant Accounting Policies (Details) - Average Estimated Useful Lives of Property, Plant and Equipment false false R53.htm 052 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Fair Values of the Company’s Financial Instruments Sheet http://www.akorn.com/role/FairValuesoftheCompanysFinancialInstrumentsTable Note 2 - Summary of Significant Accounting Policies (Details) - Fair Values of the Company’s Financial Instruments false false R54.htm 053 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Assumptions Used in Estimating the Fair Value of the Warrants Sheet http://www.akorn.com/role/AssumptionsUsedinEstimatingtheFairValueoftheWarrantsTable Note 2 - Summary of Significant Accounting Policies (Details) - Assumptions Used in Estimating the Fair Value of the Warrants false false R55.htm 054 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Warrants Sheet http://www.akorn.com/role/WarrantsTable Note 2 - Summary of Significant Accounting Policies (Details) - Warrants false false R56.htm 055 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances (Details) - Net Trade Accounts Receivable Sheet http://www.akorn.com/role/NetTradeAccountsReceivableTable Note 3 - Accounts Receivable, Sales and Allowances (Details) - Net Trade Accounts Receivable false false R57.htm 056 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances (Details) - Summary of Adjustments to Gross Sales Sheet http://www.akorn.com/role/SummaryofAdjustmentstoGrossSalesTable Note 3 - Accounts Receivable, Sales and Allowances (Details) - Summary of Adjustments to Gross Sales false false R58.htm 057 - Disclosure - Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions Sheet http://www.akorn.com/role/AllowanceforCustomerDeductionsTable Note 3 - Accounts Receivable, Sales and Allowances (Details) - Allowance for Customer Deductions false false R59.htm 058 - Disclosure - Note 4 - Inventories (Details) - Inventories Sheet http://www.akorn.com/role/InventoriesTable Note 4 - Inventories (Details) - Inventories false false R60.htm 059 - Disclosure - Note 4 - Inventories (Details) - Allowance for Excess and Obsolete Inventory Sheet http://www.akorn.com/role/AllowanceforExcessandObsoleteInventoryTable Note 4 - Inventories (Details) - Allowance for Excess and Obsolete Inventory false false R61.htm 060 - Disclosure - Note 5 - Property, Plant and Equipment (Details) Sheet http://www.akorn.com/role/Note5PropertyPlantandEquipmentDetails Note 5 - Property, Plant and Equipment (Details) false false R62.htm 061 - Disclosure - Note 5 - Property, Plant and Equipment (Details) - Property, Plant, and Equipment Sheet http://www.akorn.com/role/PropertyPlantandEquipmentTable Note 5 - Property, Plant and Equipment (Details) - Property, Plant, and Equipment false false R63.htm 062 - Disclosure - Note 6 - Financing Arrangements (Details) Sheet http://www.akorn.com/role/Note6FinancingArrangementsDetails Note 6 - Financing Arrangements (Details) false false R64.htm 063 - Disclosure - Note 6 - Financing Arrangements (Details) - JPM Revolving Facility, Interest Terms Sheet http://www.akorn.com/role/JPMRevolvingFacilityInterestTermsTable Note 6 - Financing Arrangements (Details) - JPM Revolving Facility, Interest Terms false false R65.htm 064 - Disclosure - Note 6 - Financing Arrangements (Details) - JPM Revolving Facility, Interest Terms (Parentheticals) Sheet http://www.akorn.com/role/JPMRevolvingFacilityInterestTermsTable_Parentheticals Note 6 - Financing Arrangements (Details) - JPM Revolving Facility, Interest Terms (Parentheticals) false false R66.htm 065 - Disclosure - Note 6 - Financing Arrangements (Details) - Net Carrying Amount of the Liability Component and the Remaining Unamortized Debt Discount Sheet http://www.akorn.com/role/NetCarryingAmountoftheLiabilityComponentandtheRemainingUnamortizedDebtDiscountTable Note 6 - Financing Arrangements (Details) - Net Carrying Amount of the Liability Component and the Remaining Unamortized Debt Discount false false R67.htm 066 - Disclosure - Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes Notes http://www.akorn.com/role/ExpensesinRelationtoConvertibleNotesTable Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes false false R68.htm 067 - Disclosure - Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes (Parentheticals) Notes http://www.akorn.com/role/ExpensesinRelationtoConvertibleNotesTable_Parentheticals Note 6 - Financing Arrangements (Details) - Expenses in Relation to Convertible Notes (Parentheticals) false false R69.htm 068 - Disclosure - Note 6 - Financing Arrangements (Details) - Maturities of Long-term Obligations Sheet http://www.akorn.com/role/MaturitiesofLongtermObligationsTable Note 6 - Financing Arrangements (Details) - Maturities of Long-term Obligations false false R70.htm 069 - Disclosure - Note 7 - Earnings Per Common Share (Details) Sheet http://www.akorn.com/role/Note7EarningsPerCommonShareDetails Note 7 - Earnings Per Common Share (Details) false false R71.htm 070 - Disclosure - Note 7 - Earnings Per Common Share (Details) - Reconciliation of Earnings Per Share Data Sheet http://www.akorn.com/role/ReconciliationofEarningsPerShareDataTable Note 7 - Earnings Per Common Share (Details) - Reconciliation of Earnings Per Share Data false false R72.htm 071 - Disclosure - Note 8 - Leasing Arrangements (Details) Sheet http://www.akorn.com/role/Note8LeasingArrangementsDetails Note 8 - Leasing Arrangements (Details) false false R73.htm 072 - Disclosure - Note 8 - Leasing Arrangements (Details) - Future Minimum Lease Payments Sheet http://www.akorn.com/role/FutureMinimumLeasePaymentsTable Note 8 - Leasing Arrangements (Details) - Future Minimum Lease Payments false false R74.htm 073 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) Sheet http://www.akorn.com/role/Note9StockOptionsEmployeeStockPurchasePlanandRestrictedStockDetails Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) false false R75.htm 074 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Weighted-average Assumptions for Stock Options Sheet http://www.akorn.com/role/WeightedaverageAssumptionsforStockOptionsTable Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Weighted-average Assumptions for Stock Options false false R76.htm 075 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Stock Option Activity Sheet http://www.akorn.com/role/StockOptionActivityTable Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Stock Option Activity false false R77.htm 076 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Non-vested Restricted Stock Activity Sheet http://www.akorn.com/role/NonvestedRestrictedStockActivityTable Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Non-vested Restricted Stock Activity false false R78.htm 077 - Disclosure - Note 10 - Income Taxes (Details) Sheet http://www.akorn.com/role/Note10IncomeTaxesDetails Note 10 - Income Taxes (Details) false false R79.htm 078 - Disclosure - Note 10 - Income Taxes (Details) - Income Tax Provision Sheet http://www.akorn.com/role/IncomeTaxProvisionTable Note 10 - Income Taxes (Details) - Income Tax Provision false false R80.htm 079 - Disclosure - Note 10 - Income Taxes (Details) - Income Tax Rate Reconciliation Sheet http://www.akorn.com/role/IncomeTaxRateReconciliationTable Note 10 - Income Taxes (Details) - Income Tax Rate Reconciliation false false R81.htm 080 - Disclosure - Note 10 - Income Taxes (Details) - The Geographical Allocation of the Company’s Income Sheet http://www.akorn.com/role/TheGeographicalAllocationoftheCompanysIncomeTable Note 10 - Income Taxes (Details) - The Geographical Allocation of the Company’s Income false false R82.htm 081 - Disclosure - Note 10 - Income Taxes (Details) - Net Deferred Income Taxes Sheet http://www.akorn.com/role/NetDeferredIncomeTaxesTable Note 10 - Income Taxes (Details) - Net Deferred Income Taxes false false R83.htm 082 - Disclosure - Note 10 - Income Taxes (Details) - Summary of Unrecognized Tax Benefits Sheet http://www.akorn.com/role/SummaryofUnrecognizedTaxBenefitsTable Note 10 - Income Taxes (Details) - Summary of Unrecognized Tax Benefits false false R84.htm 083 - Disclosure - Note 11 - Retirement Plan (Details) Sheet http://www.akorn.com/role/Note11RetirementPlanDetails Note 11 - Retirement Plan (Details) false false R85.htm 084 - Disclosure - Note 12 - Segment Information (Details) Sheet http://www.akorn.com/role/Note12SegmentInformationDetails Note 12 - Segment Information (Details) false false R86.htm 085 - Disclosure - Note 12 - Segment Information (Details) - Financial Information by Segment Sheet http://www.akorn.com/role/FinancialInformationbySegmentTable Note 12 - Segment Information (Details) - Financial Information by Segment false false R87.htm 086 - Disclosure - Note 12 - Segment Information (Details) - Carrying Amount of Goodwill by Segment Sheet http://www.akorn.com/role/CarryingAmountofGoodwillbySegmentTable Note 12 - Segment Information (Details) - Carrying Amount of Goodwill by Segment false false R88.htm 087 - Disclosure - Note 13 - Commitments and Contingencies (Details) Sheet http://www.akorn.com/role/Note13CommitmentsandContingenciesDetails Note 13 - Commitments and Contingencies (Details) false false R89.htm 088 - Disclosure - Note 13 - Commitments and Contingencies (Details) - Commitment Payment to Strategic Business Partners Sheet http://www.akorn.com/role/CommitmentPaymenttoStrategicBusinessPartnersTable Note 13 - Commitments and Contingencies (Details) - Commitment Payment to Strategic Business Partners false false R90.htm 089 - Disclosure - Note 14 - Supplemental Cash Flow Information (in thousands) (Details) - Supplemental Cash Flow Information Sheet http://www.akorn.com/role/SupplementalCashFlowInformationTable Note 14 - Supplemental Cash Flow Information (in thousands) (Details) - Supplemental Cash Flow Information false false R91.htm 090 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) Sheet http://www.akorn.com/role/Note16BusinessCombinationsDispositionsandOtherStrategicInvestmentsDetails Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) false false R92.htm 091 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Lloyd Animal Health Products Acquisition and the Fair Value of the Acquired Assets and Assumed Liabilities Sheet http://www.akorn.com/role/ConsiderationPaidfortheLloydAnimalHealthProductsAcquisitionandtheFairValueoftheAcquiredAssetsandAssumedLiabilitiesTable Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Lloyd Animal Health Products Acquisition and the Fair Value of the Acquired Assets and Assumed Liabilities false false R93.htm 092 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for Xopenex adn the Fair Value of the Acquired Assets and Assumed Liabilities Sheet http://www.akorn.com/role/ConsiderationPaidforXopenexadntheFairValueoftheAcquiredAssetsandAssumedLiabilitiesTable Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for Xopenex adn the Fair Value of the Acquired Assets and Assumed Liabilities false false R94.htm 093 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business Sheet http://www.akorn.com/role/ConsiderationforAcquiredBusinessTable Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business false false R95.htm 094 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Disposal Groups, Including Discontinued Operations Sheet http://www.akorn.com/role/DisposalGroupsIncludingDiscontinuedOperationsTable Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Disposal Groups, Including Discontinued Operations false false R96.htm 095 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Betimol Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities Sheet http://www.akorn.com/role/ConsiderationPaidfortheBetimolAcquisitionandtheFairValueoftheAcquiredAssetsandAssumeLiabilitiesTable Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Betimol Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities false false R97.htm 096 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities Sheet http://www.akorn.com/role/ConsiderationPaidfortheMerckAcquisitionandtheFairValueoftheAcquiredAssetsandAssumeLiabilitiesTable Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities false false R98.htm 097 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Unaudited Pro Forma Financial Information Sheet http://www.akorn.com/role/UnauditedProFormaFinancialInformationTable Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Unaudited Pro Forma Financial Information false false R99.htm 098 - Disclosure - Note 17 - Unconsolidated Joint Venture (Details) Sheet http://www.akorn.com/role/Note17UnconsolidatedJointVentureDetails Note 17 - Unconsolidated Joint Venture (Details) false false R100.htm 099 - Disclosure - Note 17 - Unconsolidated Joint Venture (Details) - Unconsolidated Joint Venture Condensed Statement of Income Sheet http://www.akorn.com/role/UnconsolidatedJointVentureCondensedStatementofIncomeTable Note 17 - Unconsolidated Joint Venture (Details) - Unconsolidated Joint Venture Condensed Statement of Income false false R101.htm 100 - Disclosure - Note 17 - Unconsolidated Joint Venture (Details) - Unconsolidated Joint Venture Condensed Balance Sheet Sheet http://www.akorn.com/role/UnconsolidatedJointVentureCondensedBalanceSheetTable Note 17 - Unconsolidated Joint Venture (Details) - Unconsolidated Joint Venture Condensed Balance Sheet false false R102.htm 101 - Disclosure - Note 18 - Customer, Supplier and Product Concentration (Details) Sheet http://www.akorn.com/role/Note18CustomerSupplierandProductConcentrationDetails Note 18 - Customer, Supplier and Product Concentration (Details) false false R103.htm 102 - Disclosure - Note 18 - Customer, Supplier and Product Concentration (Details) - Percentage of the Company’s Gross and Net Sales and Accounts Receivable Sheet http://www.akorn.com/role/PercentageoftheCompanysGrossandNetSalesandAccountsReceivableTable Note 18 - Customer, Supplier and Product Concentration (Details) - Percentage of the Company’s Gross and Net Sales and Accounts Receivable false false R104.htm 103 - Disclosure - Note 19 - Related Party Transactions (Details) Sheet http://www.akorn.com/role/Note19RelatedPartyTransactionsDetails Note 19 - Related Party Transactions (Details) false false R105.htm 104 - Disclosure - Note 20 - Severance Charges (Details) Sheet http://www.akorn.com/role/Note20SeveranceChargesDetails Note 20 - Severance Charges (Details) false false R106.htm 105 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) Sheet http://www.akorn.com/role/Note21SelectedQuarterlyFinancialDataUnauditedDetails Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) false false R107.htm 106 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) - Selected Quarterly Financial Data (Unaudited) Sheet http://www.akorn.com/role/SelectedQuarterlyFinancialDataUnauditedTable Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) - Selected Quarterly Financial Data (Unaudited) false false R108.htm 107 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) - Restatement of Previously Filed Financial Statements Sheet http://www.akorn.com/role/RestatementofPreviouslyFiledFinancialStatementsTable Note 21 - Selected Quarterly Financial Data (Unaudited) (Details) - Restatement of Previously Filed Financial Statements false false R109.htm 108 - Disclosure - Note 22 - Legal Proceedings (Details) Sheet http://www.akorn.com/role/Note22LegalProceedingsDetails Note 22 - Legal Proceedings (Details) false false All Reports Book All Reports Element akrx_ChargebackAndRebateReserve had a mix of decimals attribute values: -5 -3. Element akrx_DebtInstrumentDebtDefaultRateIncrease had a mix of decimals attribute values: 3 4. Element us-gaap_AvailableForSaleSecurities had a mix of decimals attribute values: -5 -3. Element us-gaap_AvailableForSaleSecuritiesCurrent had a mix of decimals attribute values: -5 -3. Element us-gaap_BusinessCombinationAcquisitionRelatedCosts had a mix of decimals attribute values: -5 -3. Element us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount had a mix of decimals attribute values: -5 -3. Element us-gaap_CommonStockSharesOutstanding had a mix of decimals attribute values: -3 0. Element us-gaap_ConcentrationRiskPercentage1 had a mix of decimals attribute values: 2 3. Element us-gaap_DeferredTaxAssetsValuationAllowance had a mix of decimals attribute values: -5 -3. Element us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization had a mix of decimals attribute values: -5 -3. Element us-gaap_Goodwill had a mix of decimals attribute values: -5 -3. Element us-gaap_PropertyPlantAndEquipmentNet had a mix of decimals attribute values: -5 -3. Element us-gaap_ShareBasedCompensation had a mix of decimals attribute values: -5 -3. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod had a mix of decimals attribute values: -3 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod had a mix of decimals attribute values: -3 0. Element us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised had a mix of decimals attribute values: -3 0. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '1/1/2014 - 9/30/2014' is shorter (272 days) and has only 4 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '1/1/2014 - 6/30/2014' is shorter (180 days) and has only 5 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '1/1/2013 - 3/31/2013' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '4/1/2013 - 6/30/2013' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '7/1/2013 - 9/30/2013' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '10/1/2013 - 12/31/2013' is shorter (91 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '1/1/2014 - 3/31/2014' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '4/1/2014 - 6/30/2014' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '7/1/2014 - 9/30/2014' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '10/1/2014 - 12/31/2014' is shorter (91 days) and has only 2 values, so it is being removed. 'Monetary' elements on report '046 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '062 - Disclosure - Note 6 - Financing Arrangements (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '071 - Disclosure - Note 8 - Leasing Arrangements (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '073 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details)' had a mix of different decimal attribute values. 'Shares' elements on report '076 - Disclosure - Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) - Non-vested Restricted Stock Activity' had a mix of different decimal attribute values. 'Monetary' elements on report '079 - Disclosure - Note 10 - Income Taxes (Details) - Income Tax Rate Reconciliation' had a mix of different decimal attribute values. 'Monetary' elements on report '090 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '093 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration for Acquired Business' had a mix of different decimal attribute values. 'Monetary' elements on report '096 - Disclosure - Note 16 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the Merck Acquisition and the Fair Value of the Acquired Assets and Assume Liabilities' had a mix of different decimal attribute values. 'Monetary' elements on report '105 - Disclosure - Note 21 - Selected Quarterly Financial Data (Unaudited) (Details)' had a mix of different decimal attribute values. Process Flow-Through: 001 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2014' Process Flow-Through: Removing column 'Jun. 30, 2014' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 002 - Statement - Consolidated Balance Sheets (Parentheticals) Process Flow-Through: 003 - Statement - Consolidated Statements of Comprehensive Income Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '6 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '9 Months Ended Sep. 30, 2014' Process Flow-Through: 004 - Statement - Consolidated Statements of Comprehensive Income (Parentheticals) Process Flow-Through: 006 - Statement - Consolidated Statements of Cash Flows akrx-20141231.xml akrx-20141231.xsd akrx-20141231_cal.xml akrx-20141231_def.xml akrx-20141231_lab.xml akrx-20141231_pre.xml true true XML 127 R74.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) (USD $)
 12 Months Ended 0 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Sep. 05, 2014
May 02, 2014
May 03, 2013
Jul. 08, 2004
Dec. 31, 2011
May 03, 2014
Aug. 07, 2009
May 27, 2005
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Allocated Share-based Compensation Expense (in Dollars) $ 6,000,000us-gaap_AllocatedShareBasedCompensationExpense $ 6,200,000us-gaap_AllocatedShareBasedCompensationExpense $ 6,400,000us-gaap_AllocatedShareBasedCompensationExpense                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value (in Dollars) 141,700,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue 8,900,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue 9,100,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue                
Adjustments to Additional Paid in Capital, Share-based Compensation and Exercise of Stock Options (in Dollars) 8,000,000us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions 2,600,000us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions 1,500,000us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions                
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars) 20,700,000us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized                    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 3 years 36 days                    
Stock Issued During Period, Value, Restricted Stock Award, Gross (in Dollars) 1,188,000us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross 579,000us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross 351,000us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross                
Share-based Compensation (in Dollars) 7,542,000us-gaap_ShareBasedCompensation 7,050,000us-gaap_ShareBasedCompensation 7,032,000us-gaap_ShareBasedCompensation                
Restricted Stock [Member] | Director [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     35,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_DirectorMember		 8,034us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_DirectorMember		 71,582us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_DirectorMember		 31,899us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_DirectorMember		          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage       25.00%us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_DirectorMember		              
Deferred Compensation Arrangement With Individual Common Stock Vested Immediately Upon Issuance           15,946akrx_DeferredCompensationArrangementWithIndividualCommonStockVestedImmediatelyUponIssuance
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_DirectorMember		          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                 15,953us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_DirectorMember		    
Stock Issued During Period, Value, Restricted Stock Award, Gross (in Dollars)     500,000us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_DirectorMember		                
Restricted Stock [Member] | Management [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage         25.00%us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= us-gaap_ManagementMember		            
Restricted Stock [Member] | Senior Management [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period       257,416us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember
/ us-gaap_TitleOfIndividualAxis
= akrx_SeniorManagementMember		              
Restricted Stock [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Allocated Share-based Compensation Expense (in Dollars) 1,200,000us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 600,000us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 400,000us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		                
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars) 10,800,000us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		                    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 3 years 219 days                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 337,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 32,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		 35,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_RestrictedStockMember		                
Options Granted in 2014 [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years                    
Options Granted in Earlier Years [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 3 years                    
Minimum [Member] | 2014 Plan [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 5 years                    
Minimum [Member] | Employee Stock Purchase Plan (ESPP) [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Percentage of Base Wages Withheld for Purchase of Stock 1.00%akrx_PercentageOfBaseWagesWithheldForPurchaseOfStock
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember		                    
Maximum [Member] | 2014 Plan [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years                    
Maximum [Member] | Employee Stock Purchase Plan (ESPP) [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Percentage of Base Wages Withheld for Purchase of Stock 15.00%akrx_PercentageOfBaseWagesWithheldForPurchaseOfStock
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		                    
Annual Purchase of Stock Per Employee (in Dollars) 25,000akrx_AnnualPurchaseOfStockPerEmployee
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		                    
Base Wages Subject To Withholding Towards Stock Purchase (in Dollars) 21,250akrx_BaseWagesSubjectToWithholdingTowardsStockPurchase
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember		                    
Senior Management [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Modified in Period (in Dollars)         2,300,000akrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsModifiedInPeriod
/ us-gaap_TitleOfIndividualAxis
= akrx_SeniorManagementMember		            
2003 Stock Option Plan [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number             0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_PlanNameAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember		        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             2,519,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
/ us-gaap_PlanNameAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember		        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                   11,000,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
/ us-gaap_PlanNameAxis
= akrx_TwoThousandAndThreeStockOptionPlanMember		  
Amended 2003 Plan [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 4,968,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_PlanNameAxis
= akrx_Amended2003PlanMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 15,828,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
/ us-gaap_PlanNameAxis
= akrx_Amended2003PlanMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized               19,000,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
/ us-gaap_PlanNameAxis
= akrx_Amended2003PlanMember		     5,000,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
/ us-gaap_PlanNameAxis
= akrx_Amended2003PlanMember
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized               8,000,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
/ us-gaap_PlanNameAxis
= akrx_Amended2003PlanMember		      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 6,529,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_PlanNameAxis
= akrx_Amended2003PlanMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 4,331,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
/ us-gaap_PlanNameAxis
= akrx_Amended2003PlanMember		                    
The 2003 Plan and Amended 2003 Plan [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 5 years                    
2014 Plan [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1,419,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
/ us-gaap_PlanNameAxis
= akrx_TwoThousandFourteenPlanMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1,475,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
/ us-gaap_PlanNameAxis
= akrx_TwoThousandFourteenPlanMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized         7,500,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
/ us-gaap_PlanNameAxis
= akrx_TwoThousandFourteenPlanMember		            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 0us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_PlanNameAxis
= akrx_TwoThousandFourteenPlanMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 57,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
/ us-gaap_PlanNameAxis
= akrx_TwoThousandFourteenPlanMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years                    
Employee Stock Purchase Plan (ESPP) [Member]                      
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Details) [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2,000,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date 15.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		                    
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 1,420,438us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		                    
Share Based Compensation Arrangement By Share Based Payment Award Number of Shares Authorized Remaining 579,562akrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedRemaining
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		                    
Stock Issued During Period, Shares, Employee Stock Purchase Plans 67,000us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		 73,000us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		 61,000us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		                
Share-based Compensation (in Dollars)   $ 400,000us-gaap_ShareBasedCompensation
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		 $ 200,000us-gaap_ShareBasedCompensation
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		         200,000us-gaap_ShareBasedCompensation
/ us-gaap_PlanNameAxis
= akrx_EmployeeStockPurchasePlanESPPMember		      
XML 128 R38.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 9 - Stock Options, Employee Stock Purchase Plan and Restricted Stock (Tables)
 12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
 
2014
 
2013
 
2012
           
Expected volatility
46%
-
71%
  49% -
68%
  77% -
85%
Expected life (in years)
 
5.4
       4.0
  
   
4.0
 
Risk-free interest rate
0.9% -
2.2%
  0.7% -
1.4%
  0.7% -
0.8%
Dividend yield
 
—
     
—
     
—
 
Fair value per stock option
 
$16.08
 
   
$6.95
 
   
$7.76
 
Schedule of Share-based Compensation, Activity [Table Text Block]
 
 
 
 
 
 
Number of
Shares
(in thousands)
   
 
Weighted
Average
Exercise Price
   
Weighted Average
Remaining
Contractual Term
(Years)
   
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding at December 31, 2011
    9,399     $ 2.89                  
Granted
    1,221       12.96                  
Exercised
    (806 )     1.87                  
Forfeited or expired
    (87 )     4.42                  
Outstanding at December 31, 2012
    9,727     $ 4.22                  
Granted
    321       15.76                  
Exercised
    (630 )     4.18                  
Forfeited or expired
    (190 )     13.10                  
Outstanding at December 31, 2013
    9,228     $ 4.45                  
Granted
    1,475       28.59                  
Exercised
    (4,226 )     1.91                  
Forfeited or expired
    (91 )     22.56                  
Outstanding at December 31, 2014
    6,386     $
11.44
      2.48     $ 158,097  
Exercisable at December 31, 2014
    4,316     $ 5.43       1.01     $ 132,813  
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
   
Number of Shares
(in thousands)
   
Weighted Average
Grant Date Fair Value
 
Nonvested at December 31, 2011
    13     $ 1.34  
Granted
    35       14.63  
Vested
    (30 )     9.09  
Canceled
    —       —  
Nonvested at December 31, 2012
    18     $ 14.63  
Granted
    32       15.36  
Vested
    (34 )     14.98  
Canceled
    —       —  
Nonvested at December 31, 2013
    16     $ 15.36  
Granted
    337       35.31  
Vested
    (16 )     15.36  
Canceled
    —       —  
Nonvested at December 31, 2014
    337     $ 35.31  
XML 129 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 13 - Commitments and Contingencies
 12 Months Ended
Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
Note 13 — Commitments and Contingencies

On January 2, 2014 the Company acquired the U.S. NDA rights to Betimol® from Santen. The total consideration payable will equal 1.5 times the Company’s net sales of Betimol® in the first year following acquisition. The Company paid consideration of $7.5 million upon closing this transaction and expects to owe additional consideration, which will become payable in the first quarter of 2015. The additional consideration contingently payable to Santen was initially estimated at $4.5 million discounted to $4.0 million based on a discount rate of 12.6%. The Company performed evaluations of the fair value of this liability at December 31, 2014 based on utilizing significant unobservable inputs and determined the fair value of this liability to be $4.3 million.

The Company has entered into strategic business agreements for the development and marketing of finished dosage form pharmaceutical products with various pharmaceutical development companies.

Each strategic business agreement includes a future payment schedule for contingent milestone payments and in certain strategic business agreements, minimum royalty payments.  The Company will be responsible for contingent milestone payments and minimum royalty payments to these strategic business partners based upon the occurrence of future events.  Each strategic business agreement defines the triggering event of its future payment schedule, such as meeting product development progress timelines, successful product testing and validation, successful clinical studies, various FDA and other regulatory approvals and other factors as negotiated in each agreement.  None of the contingent milestone payments or minimum royalty payments is individually material to the Company.  

On October 17, 2012, the Company entered into an exclusive distribution agreement with the Massachusetts Biological Laboratory of the University of Massachusetts (“MBL”) for the Company’s marketing of MBL-manufactured tetanus-diphtheria vaccine (“Td vaccine”) over an initial contract term of two (2) years. On July 1, 2014, the Company terminated the agreement and renegotiated a new distribution agreement for an additional contract term of (1) year. The new agreement commits the Company to acquire $4.8 million of Td vaccine in the first six months of the fiscal year ended December 31, 2015.

The Company is party to a supply agreement with a third party for the provision of two of the injectable pharmaceuticals acquired by the Company from Lundbeck on December 21, 2011. This agreement requires the Company to acquire product with an estimated total cost of approximately $1.9 million in 2015.

The table below summarizes contingent potential milestone payments due to strategic partners in the years 2015 and beyond, assuming all such contingencies occur (in thousands):

Year ending December 31,
 
Milestone Payments
 
2015
  $ 12,916  
2016
    3,250  
2017
    3,202  
2018
    21  
Total
  $ 19,389  

The Company is a party in legal proceedings and potential claims arising in the ordinary course of its business. The amount, if any, of ultimate liability with respect to such matters cannot be determined. Despite the inherent uncertainties of litigation, management of the Company believes that the ultimate disposition of such proceedings and exposures will not have a material adverse impact on the financial condition, results of operations, or cash flows of the Company.

XML 130 R101.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 17 - Unconsolidated Joint Venture (Details) - Unconsolidated Joint Venture Condensed Balance Sheet (Akorn-Strides [Member], USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Akorn-Strides [Member]
    
Condensed Balance Sheet Statements, Captions [Line Items]    
Cash $ 25akrx_EquityMethodInvestmentSummarizedFinancialInformationCash
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		 $ 25akrx_EquityMethodInvestmentSummarizedFinancialInformationCash
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember
Other current assets 1akrx_EquityMethodInvestmentSummarizedFinancialInformationOtherCurrentAssets
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		 1akrx_EquityMethodInvestmentSummarizedFinancialInformationOtherCurrentAssets
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember
TOTAL ASSETS 26us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		 26us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember
Members’ equity 26akrx_EquityMethodInvestmentSummarizedFinancialInformationAccountsPayableAndOtherAccruedLiabilities
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		 26akrx_EquityMethodInvestmentSummarizedFinancialInformationAccountsPayableAndOtherAccruedLiabilities
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember
TOTAL LIABILITIES & MEMBERS’ EQUITY $ 26us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember		 $ 26us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_TypeOfArrangementAxis
= akrx_AkornStridesMember

W&8B.NM-E8/Z_56'LZBE6Y@U!:44>[ M?:R,#-[E(`J:AE5IJ:_=(ZH%H>Q=.H65$>&LC]]!%;C4SE^]RA,P`(B)H3"L M3Z[@!HQ]4#1C.I%C0:5>NVD]VV3A#UW\4;)8\.49?;GY_.T7A<'N6EL!#027 M[5"U#?U/$%9K@HBOE#B>35D<9?N8[4%1[([:NK5#[Z2#(M9(^Z_GN#Q*5]V6 M`"H@5$"H@!J-$+OMC!\4P98,G^4*(=W0&6JT+FI$8M09-N.>9C;C5EQ+^9W: M#KF;$7L.;X6IS2Q#@Z]D30GIK5A*2>6DC+2O))2LL$CVEBY4"04R4W^B%$CF MUNR7!H-^/R,QMVK5LQN+-%!:$"L0*QJ/%8(;SON]?IH=$#(0,A`R$#+0O)#( M:44_M`8_](FRN&+4';46O`EWID.*_B@JC%HH(;GBZ)UT^DDJH-I`$Q,1`Q$# MO=/Z60:A`Z&C-="!Q@9NK*)#ZSNT3NC)4D>UK6>%^(UQ<2<5E8D,E)!=F733 MS0-1F:#YB8B!B(&>:_TL@]"!T-$:Z$!CH\6[JX75+\F#;@[6:^4M?(C*MUCI MRX*:#O5=V(EE*PN;/NF6YRC6LTEM?B#8V6-M*X=3NS`.2"E<9"FGSHH5# MT-U;]BTNUFG[3!GJG!1$FFI1:+LQ6@,Y#;$+L0NQJVV>/,(8PAC"&,(8FF#R M6++;0;@J4.6V,73??] MR6#0Z6*XNADF,&(%8@7NBB-D(&0@9#0#,M"\D'0W?"O_LD&DV1)(FA:E:!-> MUA\;E`G&J_%$>(=MR?+#&]IA<[?;LQXEF%9DL?3AXG3N8:MH,^Z^F[ M-0C40`KM10NVDW2(0XA#B$.(0W63#G$(<0AQ"'%(TEA!Y>Y_7BI(NUWYY1LO M678P\\1YFC`%UQP(2%.G3V&&L'Q*)L8VF,*S5QIT.[T$%:33$TTW-Q`G$"<: MCQ.8'8R0@9"!D(&FA022TJR-Z4/W3$?^,W)4T?>L>/EN MS"=JNI;]BAXGZ@-)*"&Y/NAW.Q>H#]""K%U.$#$:@ACONIT^(D8>=7[:;2L, MD0*1HC5(`;;%&2(%;HJB8WKKSJBMJ)YM@W_J5]3&5QW]4]0AJ$,R=$CG'/,&=;2VH[;[R$E]6W;N84UC!@E@:Q@Q05S9, M5U:8$SG$F`'&#.J6$L2+AN`%5OLB=,@E,`@=#8$.-#5P@QL=5IB7330Z)_8/ MW-9&O2$#):37&UBVAW9F[5*">-$0O$`7%:%#+H%!Z&@(=*"I@=ND+?4Z[VQ+ M\U17,725FHYN3H6H.<4J$OU05`ZH'/STZF$WE6"-"@(-2L0,Q`ST165@&80. MA([60`>:&[AEBLZK>..-Z1)SJH\-ZAPI%BL0+EQS]%I1C:`:$:\;ICK0H`I! MLQ/Q`O$"/=;Z60:A`Z&C-="!I@;NGK;5`;V[YRO(_KU"WQ,5@AR4D%PA]'O# M=,=D5`IH1")F(&:@_RD!RR!T('2T!CK0W,`=TV[6"MR-KJYNOGT^_GC[^'C[ M]1>EOW@I="8/R;/];%G:LVX8\CNU.R^II()5ACKZ>'M_=7T?4F-L@/PIO4YO M`1.V#%WS6^GEH%!;296IKS8C55JC[9%8%]U$E[\-J52).MN-U1K(:XA>B%Z( M7IL3*YV^B-B%V"4EF1"[$+OBEE>OR!(\>+1<8OAG-"E$_'AIPD' MHY@O=C2<$,81QA'&$<8S^0EA?!<8[R:K'JIS?Q'%#R9])8]W#B6P-'(<;TZU M\!AP0R=CW=!=G:8:UDD77VIW9!^S(1N2#?FN=]X9R!?\D28;\J?=3#C$"L2* M]F"%C(EFB!2(%(@4LB$%6!588U$V5M2>\8#^IO`W3NV MYB0#[=65W@"AVBIRB$X'@TYQ8E4'@L-$;9)\IGZ3X#"?P]&D0]"4GE1-!\UW ME3Z]-[SHG!6`)2)EVS?H,1"R44N"2`2$M2=@>_OY$H-1$'GT0+-59IO*PJI3 ME?V3\]1),1M2"I48&OF(6(A8L?%@(:NT#DQAMX,$"Y9HFJ&:0#6!:@+5Q'Z( M5"V$]HC4/"J5+;G]SAG0 M1-$L;VS0%;)[P*JH@$P9Z9/[)-1@F%'5*ZF:V(C9#DLX5T/Z09$#L:J-6"7W MJ8\'"5EH=2&2(9*AU=4\",MSU,7W!.8:1$_X'XI*#6-!-$TWI_X\NCX%V2_. M@JCI7V($[V;ZXAO-/>^+G/M7+DTX_:P=BFVR4HIPO+LJRA"\N+XDE/1X*F%A M_XL_KL7HQI:A+<=Q:9F.KE&;N+IE_I+D[&R*1;<^LI8R8/^<92YG/;.'5H/T M;T$!U6(2')"@OQ&?KXIHRL3R*C5=:AA#D(=U!9(H%J658^(BF9]LP$E M$2G,"J-MD]535LPMOU7K@8;7(K@TAU5P%6NBJ,29*0NB:XIK*;_JQX]4G2G. MC-AT9AD:M5<<&!*RP6Z25V+GM0;*41G;8>MGNE9.DO1F5V6DV*('VYZ)P4ZX M2K5AVY-N*K-O7[,$"?$$\60;4LB/)T6I/@@K""L(*P@K:*;(+4AK^,WH"N]K M07-37.2?=SG"%)*'&00L6444BDLB/ M*N@@([S430:$ERU)(C^\H-$BDYLLW?;R9NUZT/G.=KY_T%>%OE#5 M(=XAWB'>H6'7<*`K"!6(GUK8;C23J;+.14EPW4X]1S=IVY*7!5)37DK6<"IA M;?^+[.ZC]U2UIJ;^-X6%X$DK#LM:T35JNOI$YYQ)'(?"UT3]R]-M=IVI99VD MFVA=FD?M,$TD)XLD:-R;SS!E=:/=>U900?_B[:FQIZ9'=0M/JFE/]OI5O(+1 M9J;*)EU\RN+]6EOYM$5D$$"BU$``V>,*1IIW*J(;I9+;7A%A1&[!01B)4@-A M9(\K&.N_6&"(((1(*331\$"VV[Q-`4B9/G9^8X4M_>C>>74%'C4(X"4KZV". M,*_OH.`9`RWWJL)++$ELN#25$23?-`*YWQAXQ139HCJQ!IJ<7W3.UO"T*U1? M.W)12Z0,@2=%$@2>[2C2#.#)32=`\$'PJ9\D"#[;4:09X(-6C^2>.CK?Z0%5 M'?U25;%3;5.5@N/-,^B=%DO;HGQK)TPQE-#SK#%`9U<]3B$(IDB`* M'0P*O1NB2;PAR7XJR;-"X$F1!('G8(!GV$NGV2/P2.2+XZZYW([[C?E$3=>R M7]%=EQR045^U05\-T%"6@:<0A5(D010Z&!1ZUT440G>]69*%P-,"X`'S)W7T M'P*/1.XZ>N#I`56\P+?NC-J*ZMDVJT`3E=V)I49O7#J\1774`G74[V+T6`:> M0A1*D011Z&!0J#=(]I/>A3*(0HA"B$(RD:<9*#3`G0FY77/<29?;C[^SK06U MW5=>@\[*SQ>L@+,E"X&D!\)P,T/R1VGU'CSP]H.H]4,4+?.DY0"QJ*_?4X,<>.C-]D:QB1_=<0L1% MA=0"A=1-]X!'A81&OD(D2I$$D>A@D`BM(:G=<]QBE]N7 M?[2)1N?$_H%=Z*0'9-17+=!7&87KJ*_09JZ?)(A!!X-!Z+W+PU>(1"F2(!(= M#!*A-22U]XX.>7I`%2_P9\O2GG7#6&=YT2-''20S>9JA@WIG/2S4DH*K$(=2 M)$$<.A@FQ0=Z.KJYMOGX\_WCX^ MWGX%:D6)M9UGWZW,L:_!KQ<'OYF6>5QT^)OL/GX)2]X(B2Q##7Z\O;^ZO@^I M,S9`;)5>!ZBD.):A:^^50DP[)/IEZLG-Z)>A26O(14L=,">7$MV1)5O"DPB% M6Y$-H7`?]&L)%#8DQ0`!$0$1`5%J^K4$$-$VE)DG,15B1<2DCI#)H^42PP^3 M*$3]R]-MJJT6HBHB)ANO9WQ/H-&RT<(M@;]V,;U!;N=:RO2&73SQ5J4NC!S' MFU--"1(7#)V,=4-W=8I-_U!O-9T\S5!B[_IXF@RF!S=-MA!Z6@`]/73:)>`H MQ*`421"##@:#WO5[N#FQ9_.G'7OBK?3$HV4$!=XX.N/2P2UJHU9HHPQEA+H( M77&))0N!IPW`T^WT$7@0>)HD60@\;0">`?8FD\Y/OQLGOQ6/>%=5\5T*\E=5_O>OU>YZ(D(Q0+O^0SZ1'^$/XJH%];X.]$ M^H@%XA_BWR9D0_S;!_W:@G^]_FFGA^:?//`G3UH#QDHV;@80"9*PQ@`L&2*! M3/N)EFQ=-K?!FF=S8'L1OQ4:4X("O"8JR9/SI)N`2E(*'Z$Z=$-H0V@[`&C+ M:'F`V"8'MJ%!AZB'J%>-03?LXJ:73*"W]W22,F,A_4Y_V,)`G*1;KG;"-M[?69LAS`C#B(.(@Y6 MRW?-/(GAD)&PHHR,#"AL"?$0"RLD6SNP$&U"R84Y/TPA?B$P>_Y.1G_VAZ)2 MPU@03=/-J3^OKD]3]HNS(&KZE]@2=#-#$!O1(N^+G/LS%RN>>A*=^[9686I,LS-6JSIT<8 M?HVQ+*^^M$Q'AV<05[?,7V(B4H3@L9R5+)8(A2B#5U2+<7Y`WL%&K+(J,BH- MUZC4=*D='F&;YNAM3=W5B*)^(;B>!;X.E/"B:_4X,C\O!*DVQ$_=OHY7+ MVQM(3Z0.S;L)O4I2(!PF^PB3%2S55THX[)O M"BM=$0,0`Q`#VH`!0N"IEFDKH;&$QI+\>!$-3,1OV2%[8B,<7ITVD22T3_J8 M9`0(GA8%\9`KEB((4BNL8H]BR,E\29*0NBI\Z?+%48RVPRU1C1 M*B.`OT'.X#Z#\M508)N647NDP7"8+OFN6B.5VG"L";*"2(%(T7BDR$U-V)0: M"!D(&0@9AP`9:%S4Y^/NS6W-##-6XLT>I"_[A3J.\FS9/W1SJJADH;/."L[, MLMT),0S%IA.VZ:TIXU?%H89![>K"]'M(>&M!C+JV.J>VDJJ2,KL]$NM=JKI. M`BU8:F5GI>3[:3=#"D$+00M!:QO0ZB%H(6@U7Q(1M`X'M'KI@R\0M"H&K29L MMB?![V3QTFQYWH."2-!HOZPHJ8;8J,KL((+-NU:5[9E0PY/.H!D:8I>"QB:( M)B(8(A@B6)L=F.SCH&'-O4(*SA@FHYKE/4="QK-;;.YBZS36DL7-D8<:Q"DZ7K(?K) M6&Y;Z;.>?EN#0`VDT%ZT7CM)ASB$.(0XA#A4-^D0AQ"'$(<0AR2-#8@@9"!D(&6A:2"`I![!+ MW2*W-7LC>;Z@IL/[T2OTA7VF<4Y`1Q6U22V4D%RKG';.4*N@]5FWE"!>-`0O MNITAX@7B1=U2@GC1$+PX2Y7`(E[LQVNMW!$MS`A9H]M>H<-ZW#M?Z;+VS[;V M6??JL5YY5-%T&`XU57H$/#M=P9M162ER%='/R2PIO=E1B2 M;K?B4*!K7YOD908A>DD(;!"]]ZDJ4G1J'I6P^6*)9&I#\\7SU!E4 M1/A"^$+X:G]\$>$+X0OA"^$K0:@+^=*$#@F^=L@-P,;7V+0RFI#1^,!5N_*I MFM2NHNE$0H1`A$"$0(1`A$"$0(1`A)!PMS0GDQL>XRQ(\,/)JF7)"SMAX^L2 M&E_?4]6:FOK?%%9K#HOL.JRUEJY1T]4G.AD;5"&.0^%KG@!N4]%RRX"?=$/G MS;G@=V].M<).V26FA&\CV/)@?L:RKB/5I6B!]L5OUUW70YASK:E/-2IM>61[ M?TQP.%R-DMQ,UD5)7G[=M"ZRJVWG"[EMY^4;1ZHJC%J;JE1_8O9L\2;ICL8I M5L-`0OT#M%Z)!+8!`Z&@(= M:&K@AFA+'<\OQ-30YT1%(`DE)%<$`_DZ>K5$$2!>(%ZT#R_>]5+[&X@8X>M^ MVLT/1Z1`I&@-4O3EZZ`D#4[@1NCA^*,?/=W0='/J'"D+@\!+6'49_@+LEJ)BI=.ZN6Z!+$"\2+]N$%[HPB=,@E,`@=#8$.-#5P9[2E MGNBE93JN[:GLA$MXEK*PK:E-G2:<;XG*`96#!,JA=Y(Z3AG5`YJ3B!B(&.B) M2L`R"!T(':V!#C0V<`L5'5?VQL^6I3WKAG&D:%1C_FNJR1$ZK*A#4(=D).'T M4EDXJ$/0ZD3$0,3(K0SKXOX'XD7=4H)XT1"\Z*?S?!$Q]N2EHN-9\?+=NC-J MPT-<8D[UY4D1Z(=*@HVH)1JB)8;8;P"MROJE!/&B(7C1Q2Z:B!?U2PGB14/P M8MBY0+S`G5)T6+G#*KS4HJ@,^J:H.U!WH*V)MJ8T4H)XT1"\P)1>A`ZY!`:A MHR'0@::&A%NE&[J8A=3S#["/>99WHZNKFV^??5>R&W$E5SN7N>*:Z="N&,C6 M+FX]ONS(<;PYU11#)V/=T%V=8J5JW?B*FJ8AFN9=^APRU#7AZ[!/)R(%(H6/ M%-U4;@8B!2(%(@4B1=JF2.ZR(E+LB!3[VEXMU\D-7-J/MX^/MU_!4^P,%]7X MO@?I^5[1";5M<'U=\M(P]S=&CTPV.5B5]O'V_NKZ/B3&V`!I5GJ=W@(F;!FZ MYC-N#I:UE529.F\S4J6UXCZ58J]S(IU2W(W5Y->:"%H(6@A:N^Q#27?J5W,@ M2ZJ-;80NA*Z#@JYW:>Q"\*H[2E%1X"&)9[TDGC513/>`^RDZ-8]*90MCOW,& M-%$TRQL;=(4X[I-<;W?S?\K&_`(R9<2>]TFHX4EGT`SL"17\],^?/>=X2LCB MEP=U1C7/H+>3>ZI:4U/_FVHW&C5=?:)3;<2+@T?J7YYNPU^F]F6YP>RG7#^R M9S[2%_M-_MG3Q:O;[_\?OOU';(W8S8\Z]T/J;V M]QMXCDZ,3T2W?R>&1]BQ1?Y/E\29W1%=>[26=SVX,-:996C4%E>]432JZG-B M./]Z`W"7-_F3]V8^T_WJ.2[7:IU_F_(>5K?[M M@EWP*Y^_DTV`WDF_[OF?5K?^%1&@Q,F?E;SXUXYJ6\\Y4^T.MECK$B=[7O9* MES_;,J=[4?+:^O^UZ9-N><[MLPE/N9TDGY6"N)-:%_VB6_:B[Y$,9=*A5PHW M7,.+W5=V:*$.F,9_8?08N9>&!8.9YDQ^V#VM&>8O^N7PP1X)4.+DR['PKNC8 MA7%8DTGV+,_[6S!YB;,LR9*K9)IESK,4BRTYJY.!T%=UL6@Y9E@ILXI/*_CY MTIJ/=9._*^W",>=L#2>.:1'X@8$(^-EL%,5$.?L^`MU2ROKV$F2H=EHR$?%\ M%1$WX*>]4[%",GJV#3>(*^$I%-X*=^Z;(RNC9L[T/LA&T8M5%+V<$7-*;\QK MQP7JN;20F@=.S%)EO2:25D?3&_,)KK?LU[W)>+][42$-P_E4R(=KTJPD*3Y. M1H-:2JXRY;3?3<90*R+:GL!.]`O=FX2>[POD^+SV9]*L0<:2A/9D_R24AX9E M2O)9,DC29$+>V=:"VN[KG4'@K<*N7S#/=MC59K@*^>=$826B.Z] M';A:>L++2O3^#LP.TLU.*/NBJ]1D>P7W+(FEI?[H+U]_=?[_*@9K>L-I0 M67,IOM(E*N1VJ4D>I_DZY"C50[Q(I27DL<-Z0RLIH)+4N3F`O-Z8RG3^+GK) MK?_^.*X<5YE5:/N*1"Y;H.N4KBU-,D/U1!J$IMP'6(5:8(G78K MM2Q"FE4=((W\L+^`WGDRI[3:B>TETKPV(I( M^KH[,=5BJ_9/S*JW\F%U0 M/^&:X$SNSY2JQ1SM#T^J-.SCU"N#=$'@*-NBH/O3WQFU215-J1Q1W8UP9?+< M/BE77JG-23>H@UW8?JG-F?_Q^Z_Z(U5GG!Q$)<:E=6.JFY2(BOM7EKV?=H=) M>WS/]8`GW8MMB+!>A6B55"B/`KUN96SP.V5$^E6'AZQ1`G_23:94[94,O>H8 MH7HZE$F(?F7\\!_Z>OU"5<_5GVC>Y).55?NMCS[I#:IC@\JF7^;\3\I=_;1M M>U%C!?1);UCR\I8R/UEJ)$]Z?E)#N6M^7JE3G5TN*0])S]8GZ09\5@M-Y:KR MJXA;AV=[V%Q+352R"LJ3WOGZM%VSI&U8*1%*>ZE%1$/EGJ!BN2WWY9`3DI*@@W)6GI0MT;5-KO M))N<\M"S&ED?5*IC]D[4K4HR*Q+_DV'[BC.WI&_Y"KY?I8HJI*UTQ*T&&$X& MM7&OK*4?O8LR8&*CDK]!M>DB[(+U2Y*.@1NJBRIR4AA._ M7XXT2$Q]62D_*(7M+V%)K#FU[ZG!OW9F^B(/A5`*\M;BI!PI:,YBR+H0PU*$ M8E5CD$I=K(:+P@9.[2Z]6>I>@HV+<"MR]WMGJ69,.Y56[\5KWG&$U;B>O=.+ M(DI6)W"/,.58:,]J"JM7P52UDK;-6NB+V/+LX:WE% M?@78FSI:JPJ2U[^VA>['L=?Q5R7^5I%U1T"\=AZ9T)+2N>*XDK]TRHSR!K15Z$JR#B@#@M-"PY(UVNA,OD> M5GJ^DUQ=%ZH*/:8WR9E$]M-4,R0_+!?LKCD"_SY MAV7_T,WI)5GH+C$>9I;M3HAAP+0\4Z/:Q]<':AC47C%[D;Q8[IH>!WA;QO`_ M[(\8@^[:Q%@W&%@V(?9%B=[:E-A`%([#`UO*H<>Z(`"0>#OA9<,^@-8*>"?) MU*!-1K[)*=V;37O0WV+:&XJ!7#.N'/E3;ORF\UYI"_&+'5T8#@8L@'9I.2MV MXP:#4OG[^X-+YHLKCYD@K)7()\M^M(GI@-=[._E"3&8U?_1T0P.9SCO':0V[ M*&>FU5'II%SFD(!,U=!I6"XW98UAOJ"FPR^Z?F$?\UH3KN$NY].G$N*/=-E&Q5;)%P[$.=LC0A5@5150IYM%%.!3%UY]`KNFU)3I5_HE!B` M/$^4N8]\*T,,,3G"K9.E]LQ*%^6)6(ET6B.BO&>F.NF6+',E4FLGX*Z$6A4[ M`>N<2[!OT*G._M_-;JED>2LV_5.9RB5;M/MM"U1)D*B_M[8-\9Y`LA&WFE!+ M?=2MN_M-)2KAAWW2+\*]S'!2]\_ZU7:B85-J>($A%5$JR#H M7B7V"8K52*YJU$6EYQ($3"9;CY1*Y/6\I@8IDM&V&CZMB[C%VV[Q9U]:IN/: MGLI^N3'AH5.;UKO'W@LW(G:9P>J-V-WI4+%;5B(AMJB+K?,AEJZ, MPQW?4D97C>Y+*3_YCQL_69\2!7%A_L[D0'*V$*HUX)O<4>&DOZ/,;+(.59JV M#5^&01G@L)%,5)E66F>/EPU[D%83<=E7_*KJ,U`W)&9%\9<]4[/^9/+FQ:P3 M"?FU4[!T6[!*$T(ZXE5CJNZOD$'6(K!JE$V5+0S7*@"3E-KE!V?K/<)84BI7 M`A:U'Q9=?R5/)6"13N"N:&JEH?!.-*RN*.(PR%>);*=3RZLD8IR*#^J,:IY! M;R=7NK.P'&)\MBUOX=R8JN&Q]&7XFM%`-SVJW2ZHS0?#?K;F],$%OF`Q]8_$ M(*9*'V:4LEC[2--X)@PQV-V&Y7@V=1Z!C!\-2_T1IZF?J/1O8HIC$@>]*ZJR MCV\^_'^&^]YELU14:A@+HK'Q_.O_^\NSW/==\3_^B[,@:OJ79UUS9_YWP*3_ M\+]VW%>#^E]_NOWV>/QI]/7FRY^_*,#E8`::]%F!\1#SO<)_?;CY?]>_*+WN MPLW[(N=^\8;_;PJ7<8J+?_B4;/%M]'O_%TTAACXU_>$9=.+ZHWZ*?C^V7->: M9TSS(IAE\K7!"S3]*4:`Q^O_>SR^^79U_>WQ%X5/Z>KFX>[+"*8S9DOU7ODZ MNO]\\^WXR_6GX`K_F_N;S[^*K_R!9(\\F&IB,&(X$V"$V'C"M^NF`0)03.&\ M!?GC6@QM;!G:>X5/\>KZ\O9^]'AS^^T7A=4=V>SIRP&N,Y;EU9?$4#W1,EBQ M)LJ4Z*8R@1$I?Q#7@>\6HM>\HG&!XH*@O(-KYB"93'9^8J_[F;TO>'?X1]:: M_0R+EDE%_J.KI>_S66D]GNEE"<;=Z.KJYMOGXX^WCX^W7W]1^HN7R'*FQUCR M0D96ALP7[_^G=]I-T@E)42DISI`4A\`5XFL[`UZ$HHH->4S4'U,P#DSM6+4, MR_Y%^9_+R^OK3Y_>QZ&^:5KM0FZM%E$\H#QTS3?!%)NG:E(MN>ZU:9#<]TO* M_(V9YMO4[#::7G1V-COW9B/I.Y/$I(R,/`-C*UZ!WFGGO'@14-(*IKE*S:#F MJ'CYEOO/"A$=GH5SDM(>R-(X350BU:S$NV'GHE(ELA-6QCCTT")'RS?^5#H@ MHH_5)$T99J?E*$C4D*@A44-6I2%[G1YJ2,D1I+M*ZC]NL(3-4RT[D.+C[?W5]7U(B;$!!J8",+N`"5N&KN6;E#7[J.)[EBG+WV&T)&U6 M21L+!?H_EUOJ-NE8'K@^>2U0-Y4P77W9L#_S;-CKRWOE2G^B,'G7L^G:*;![ M`9#U<_F2[Y0:(,*9@_$,XAU,O;_2%MZ`'LTCQL&Q0;-TD2J M)OJ$J/36GR8JO3(*&?J5!A91[S51[\GE%NZ\^WDHC.(WT%.,2+O@/%=2DORG MEO0GJBP5#"L@$NH:*R`V7+UA1JFB'++?4H:OW:DL!MA.?W5*^8[%`8U1F$%Q MP.=&%@=D+&5SI*0R`)$@>5J*A)GM*97-1P>A++L9G6_D$'Y9>7T?A0++?N,U M=`%/'BL4>W'Q>^,)DX7'B)WP?NUA3_'OHD7SG>C0G'-\R&GR:)MMAY;N6;_! MDY)'AJUY^L0V,TX=?5;*,'>:?;!E6^&L4P=+[S2\U#E%&SR-1^L%^4J?Y0Z\ M'!E6:G;,LOMB.T"C,B:>//AD>WA*3#AR_DG"J"E^ZAY7?9A40+N/.0U]VP#U8-C+ M!>HMYIFT+M;'[:59FC[]AFIKG&SUR$S=G(-G!L-\=?21@J5N&?S9X@0/?VKM M.9.FROB9!.ZN-"?0+`?A,Y42X:I?*MTDWK@B6E)O-IS0AE6M+0S>-6SEFK4A M7G?*2MUA^[COLR"Z!D]45.+,%.(J+((#&BW)!IA&UK9I2A%FKUL6:PV7GW6& M\H3+FR9GDN\38U[5450 MW)@357[K/'24;U,;/!:\>"S[C_>*[]?WS_>7(Z^!`=.L,RG M8]=:I!CF["3.,+C#VW:DP-B(!+&1D^)%0$DKF&:SG(RZ-X0;HP(_D2?+YLFU MCK=8&*\*F=J4EY8EF$2.'2'<#6[[YACN!M==-XQ--J12K.5M.A0BZ4E[CQS: M6*N5RN*4FK^$G7`=^25N1/.H^4_(R@^I,YG MVUI5%KE%P6"B%O)LF"B&7#6@C-+6X(I+:S[6S70I^*--3&=";2!0A#HWHD94 MJWJ&)\F*]MV&N]O\>U7/MM=++N@FHUMOZ$D)*OC><7TXXR$)>/% M)=T38[PCD[XG6 MD)#2U``$ELHW;.6:F7_1.Z\,:_:*,Z._R8/NTG(S+0J[@6#RA13Q1DR^6%_8 M6Q,$''3.)0H"-DW2FI5\<=!J[=)RK(4KG59#4<-IHG*K9B7ZO>1IU,E%0(DK MF&;M;EBUR8*HV,I5;,K=)XF$#;,3#RI9"[,3:U:UW49&MK;CDQ6^,=`0W)DN2 MZY24#=:R,=)471!D\9(.@32/+'N+^660ZV"U8]JODD/F6\CHZ(;5K/<>6;1. MF10U",187KL=,XSEU:URAJ=2U2LW3=):Y)+AP4'+-Z8/JI/4+L,<#/DWI*50 M\^Y5"W.ZB[?Y"L].VO1=\D M08?#L]82])+UOC-=<:6?#WCX6\5L5A*VR<=C:$ZL2:H.,CD?R(J[^ M9HEN@V!05$#/*MFT8"H?E"HYM#KV&YY6V6@MY*[5M-FJJ>3)<"#ZIMVJ+IOT MLF_:VO/OKV'C%+:47#6QCR(H<.?'!%BT8$G/T=SR5LG!KE,S:TEA+F@FM4U^<,<=-IACO M^G:Z*LJ2'P_85VA$!?"F=OXR['\A`"X4,$.4/RFQE6M3HZF]Q0VB)X=.3(!0 MK@"40>^HNM"S:3W;9.'/1ORQ,KZ86@^_&4`J=-]@6-AAPV8]PB4#]]W.<.'N M%5/W&+MO^<0W;!BZPX;GH2'D\G7,G*QTTWI7)%RUD.^5(JQL'M.CM*.T5RGM MU;8'06EO3Q+H^4YE!\=K]/42EVR5OK)7L;FG3]3TDIDJ9IO_^DEE3[\;#`XZO;Z ML=6N,IEE&X6ZF]`T$#\0/1$]]X6>E='@M#\XNNC'D06A8D\&-]K05:_?-^K" M(U1K3D4:.-OIU$U/-Z>*M?!WC9-]E=#"1AU1#R5:96G7,(PTN#39Z*_6H^@= MG?4+'(I\@R"-B>AXH.,A&Y2B4FF(`W)R='Y1W&L/,0-#_NBN+-T5!3XISHS8 MN#6`.J8-P2U)')9F&O+=SC#>_Z'(AS*[VVGO$P.N-865?9 M,S[M#R[ZUV0;3CDUA,P[?8/;[6_63\XO>]I-? M-??@QFMBF^`Y.G?4?F#>XI5N>"[58D2`W[@GZ=3$"_TW'Y@!NQ;&I1J6`X/8K@ZTKA9B47VY MH8I_Y"K^&ZCX^XU4_)JOR2Y<^F:Y5.F=*>*1Y_U>_[WR&\BSR3.+">._?ULZ MO.!W6!4O$=/),3"B;AS[/+9_#C[6?>AMI2:.0I1A]Q_* M@MBN26UX.'SQ7T[+)T%+A4QM2AF[@WGISA1B*C>FIL/_--N;@M0]4<-:\-]5 M_[$@;"I5'NC"%?5ZH*1..A%V"#\]SG0G\3:#>"9K8J3HKJ-,=-MQE85_\!^, M#9YT#B/0E"DU62@/KK-]8X3'^OCOGNGJ!K]_[,N]WV%<>:;P!N`9C3_#75:Z M9X[NCYEN4%Z^&1\BX(YA*/1%=^"1!IT2PW@]@O[3`Z\`=0$`!-^66E MJY25KBK1`DSVL@%GH(4-L&OKQBO<:O`E@0$3[;^>#Y+LSS01?18,)?KLO0/W M.]0&<%7`)`]7W:9P?4!*^K+0_4:]/AEAIKJE\3N>9[HZ2]VG6AZL]Y@J[,X`( MSBE.#JN<^`S#&!X^]`7G<\$(WC`F!F',' MU]8UZAPI7[Y<'@%-+9@+QRI]Z=P!/TR)K?%IPFN):$P!;Z"^`0#WP>H%_$L) ML-**^]^,XFGZ<#Q/R48&,O* MVEEOW[J0>%,GE$##[BJ1R!2]9DRUV?TTJHY8[R+-;2\K;\K$]]Z*:35>H/6T M^\K]F>WX5I@OA+:21+:29""#Z+HO=,7^)7M:O,P&1@BG$@D&8@1B1.T8D6Y[ MA!@AD6`@1B!&U(X1?<0("05CE5LF1>'4V6$?T5ZX^O?7OU]_^^WZH<*8!^;Z M8ZY_XW/](WEINU$#D_X1,A`R#@$R>J=)OQ9Q`G$"<0)Q`DV+)F5GE.-[[AHK M:[>/NGSCI>7PI%V6O9YJ.2B?6RI9"%0F'2-Y4*PF4JU_.'TNJ=+J"K55*3S7 M0*9#%$,40Q3;F%CO$KWT$+C6)EVRD@0!"P%+?E(U';#0[)*!Z7"[6_Y00N%V M]^?[VX<'Y>[^]M/-8T%P7HK00KL!6>JP=/VJ"(%X@7J"I(:T/BSOADNR$WX9=XNC+@C70PNWPAL`LQF4Q+KLIN3`N M*X\YC"B&*'90*)8NP$;L0NR2DDJ(78A=:(%)QW2X,RY_:*%P9_SV[OI^]`C* MPN\='&<"Z0(-[<9DC%ACQ!HCUCL*3\LE`S&B(1C1.TT>W([`(*7KC#8%XH4$ M>($VA03^*NZ"2[(+_IGHICCY39R0IHR^78V4!V+0`J4JA8N*D=A<:F`D%B.Q M&(EMA%&,*(8HABB&*(8H)C.5$,40Q1#%I&,ZW!67/]10N"ONGZ/[\?K3[?UU M<*KNX^C_D@W3I0L^M!N=,9:-L6R,92-T('2T%SIPVQSQ0@(I0;QH"%Z@J2&! M0XO;YI)LF]^8JC6GBDM>E'=C:M*)[OZD_*PL;.M)=W3+3"Z^=`XL1FQSJ8$1 M6XS88L2V$;8QHABB&*(8HABBF,Q40A1#%$,4DX[IFK5[7@B2O4./3!3NLG^[ M?LRL.D^/3?;`Q!KK+*FP5:8,^YTSH(FB6=[8H"N@:9_DJN_HT4W)E!%71V58 M'L\U4$81R1#)$,G:D%*`\(7PA?"%\(6&6).0+"\R(;XG,%?^#OAK;/\6V[\!NO`6S$3WVP3W5Z89M<60'S9HV:S))F&EEQ1[A M/[8S>/UN+WG>+>H$J00#,0(QHG:,2!^VA1A1OV"LLAOK2C;<5HJ.+U:*T45: MC(:=[G!-`[)N21H]/%P_5M>&I^51R)6`CU'(9D#C3]8;XU6@76'TK3F7+P/`82 MS9L[8@1B!&)$X\(WV29E8;BYOWB)#^.P;<];=T9M1?5LF\(;B.-0UZDLZK.' MRH1UEE=2(2M#&4D>8*Z)5$UOF)"LJ]J02-@F01KS>#/L:AZ1$+H0NA"Z)&&U MVF.[E39M6<,.[YWO9(C7O@G[>/LX^J)D;<4VS"K'>F&L%VY;O7#_5+)8TR&5 M"._1*D]B5_-HA-"%T(70)8M8[BN6OE4>1H/HN"6\-OWUX_7]0]BG[>R]>>O9I:%J\9Q:N,#VJ*88.AGKAN[JU"GDHQ)W M\3$]K7PUUICT-,EVP>1,2VM@L^\6)J@A>"%X(7@A>#42O#!V7+\I'EG!XD_K M#Z(H$S<2EXYQ3)Q]9#/J$F&<(6PA;"%L)6PV!K7^%0 M;+.5)$Q%C+'9YOX616?-,O&QIPWVM,&>-C7HRI;VM$'H0NA"Z$+H:B!TY9GZ MXGM6V<7?`7^-[9^#CX46LS"'*S]9?@N:/G*:?@.:WJ^@ZWU8& MO2.%G;]]!/RF3#S7LZFRL"W-4UW%IO"GZ2@$OJ,O"ZJZ5.LD5D*,.6H41PCZ MSY\]YWA*R.*7:QXZ_TK=F:7=F$_4<>?4=)TKW5$-RX&7/M(7]R.CYP?^R'\6 MWWC[;%+;F>F+.VJSLXK)E"J>J;OW=/*O-PMXW!M%A2'",_DW:O?[R+F=#'HP M;3;9-XI&57U.#.=?;_IO/G0[P^ZJH6:\\8._9.%8']09U3R#WDXN+5.CID/A M`:HUIP\N<2E[RB/CNG"J\3&>#$^_?P*)Z/V;F&R0CU8XWN^7EKVP;'C(ORW= M='^')\$G/M=T?K[_"C!^4VT_* MS;?+VZ_7RKO?3.)I.L#$3YDP$4-F/*E;LI.Z"V2M=6?AMFY""33LKA*)YIES MI0'`802RMY'F7=-#)"55XR9>G0[8&B_0>MI]Y?ZDQ%8H>`9:S/^J<+\!;26) M;"7)0`;1=5_H6IEKFERA0P=8%BLI9&&$TYH%`S$",:)VC!@@1L@L&(@1B!&U M8T0?,4)"P5CEEDF1O7FV4QNG$@5+PH3,^^O?K[_]=IT\\[2J',OM#SUMGQ/> MF*+<^K*+9"O&Q=8H^\]M1,A`R&@D9/1.DWXMX@3B!.($X@2:%DW*SBC']ZRT MTT?C?=3E&R\MQV4)T0XQ]G>*Q_:Z0[(0J$PZ1O*@6$VD:GJAO-S:ZE"JYA'% M$,40Q;8GUKM>G$@(7&N3+EE)@H"%@"4_J9H.6&AVR:Q(#@O16BAW8`L=5BZ?M6$X>D2.*:!+(/0@=#1&NCHG2:K/Q`O M$"\0+Q`OT-20UH?%G7!)=L)O%]0FKFY.>:\OT\'M\*;`+,9E,2Z[*;DP+BN/ M.8PHABAV4"B6+L!&[$+LDI)*B%V(76B!2<=TN#,N?VBA<&?\]N[Z?O0(RL+O M'1QG`ND"#>W&9(Q88\0:(]8["D_+)0,QHB$8T3M-))LC,,CI.J--@7@A`5Z@ M32&!OXJ[X)+L@G\FNJE,X"KE;J+_36UE].UJI#P0@Q8H52E<5(S$YE(#([$8 MB<5(;".,8D0Q1#%$,40Q1#&9J80HABB&*"8=T^&NN/RAAL)=LW?-"D.P=>F2B<)?] MV_5C9M5Y>FRR!R;66&=)A:TR9=COG`%-%,WRQ@9=`4W[)%=]1X]N2J:,N#HJ MP_)XKH$RBDB&2(9(UH:4`H0OA"^$+X0O-,2:A&1YD0GQ/8&YLI_^^;/G'$\) M6?SRH,ZHYAGT=G)IF1KKY:Z)#?H'E[AT3DWWD=WT2%_TR=J>E3Q M3-V]IY-_O?$<[8VBPESA1?P+]61X]OT3$*OW;V+VN[W!HS7H75&5??P^^F'9 MYH-KZQIUOM+YF-IO%(VJ^IP8SK_>'`_>?.B=#KK=[G*>.PSR0PGS96?'WTY8 M;P"GNCD?]W:>:;JN^RQQW2-YH4[ZL=\LDY'(M@Q0/M,;()8-$]D? M$2NKJ^O<5^<19$3?\2 M,\^ZF7L2V\3K4U_DW)_M::W,"54M-IW`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``I#B"%HGFI-*^:&ZV4U:^4&K1C MUHR"UQ9NDB%L(6PA;"%L-0RV]A4.Q39;2<)4Q!B;;>YO4736+!,?>]I@3QOL M:5.#KFQI3QN$+H0NA"Z$K@9"5YZI+[YGE5WLIW_^[#G'4T(6OSRH,ZIY!KV= M7%JF1DV':A^)04R5/LPH=1_9'8_TQ?W(#.4/XGG_)#_LEU^N>6#X*W5GEG9C M/E''G5/3??#FT\G_WKC.=H; M187YP?/Y%^K)\/S[R+F=#'I75&4G9'\?_;!L\\&U=8TZ(CK]1M&HJL^)X?SK MS?'@S8?^L-OM_O/GG<;T(2!5E5.[B$UMT)RI\4,U+L69&B-^I$;9:]C;;9[I M`7[8\Y0W7]NJIAP(]C8/K69Q^Z=\JKL/;,G*54]R"U$M?Y);\\;(K^6]$Z6\ M(U/CW#(2%;Q?E@6\%:UT]0/_(`N-MF:4/=)H%YZ,/`_>))X@(3YD#?-#+=.O M!3G6F3Z8=RH\R.8WW.O.CRO=40W+\>RE?1>?3/_[)[!5>_\F)EO(1RMR MG2/^L+QQ9%5&Y@TM;&]B4Y7J3[S#"7'89`#3."PK@]Y1%AW$P#6/*A-`0S9W MIW#,[+'/U#`ZR@@83W!!.]FP-_BMD8`&+:6DPI8Q@V*%"S2/0 M:F(9AO6LFU.%AZ,4[HT!(=T9)R60C2$U$4RR"=2PO_SOLZ3=%>S!_W"M&"O% MN#Q84W_]EFO[2_8>:<%:BI>I(`X+HH%\3GUR=OWE8+\X"Z*F?XG%-+N9.^/; M;!BGOLBY/WN#?66^;GZ,=L<47$F#K3AQU6(,;(:&VV+XL7`9& MU,Y?I:HW4\`B*=YXVC$[8YL=%TS50U%'4:]`U`9Z[Q).\?Z!*.>?.;5Z[F!;"#!D$JP:PV&=ON22XFB.Y="ORG!` M#FZ4R-=L;7UF06$DU5JLM<;#EU<_L+C[6EO5:U$:C5H9_%=40ZB&4`U50*]O MU"UD:J35MGKH7FS5%VDB5$/-*:+;+5(B.SFJU$UQUDG+\/J0$GN$_]AR8*9- M#D"KJ!3)N/+S9RI25^VBVH::*DA(0K=)5H!&MPG=)G2;I'$%,'J'T3M40ZB& M4`VA&L+H72-HA=&[]J@AC-[%R('1N_8X`*VB$D;O,'J'^@K=)G2;T&V2R!7` MZ!U&[PY1#:';%",'NDTU.@3H.ZV+O+H6S''TL7=\?I'!C;%Y##IGR>>$A*XN M8-A.VF.L$)4>*CU4>G*Z&ZVB$L8*,59XP/I*?"WY<6B]BW\4$[>"8XG[G8OU M@FY[E;MH6\S*3#T\OAZ/K\^@Q*GL6'J!<)-N88U;^-!'K):TAH/)7/NJ_H,]W0R[2M3<;EPJOQY$4$-00U`K%=02 MQ:((:@AJC9%4!#4$-;34$-1:):D(:@AJV9;:*8(:@EHS)15!#4$M&]1Z"&H( M:LV45`0U!+5L4.LCJ"&H-5-2$=00U-#]1%!KE:0BJ"&HH?N)H-8J24500U#+ M!K43!#6Y\[7S.!U[@I:U;H^6FVP(6EM.=0UX4;L>DD5^ZU$`X0#A(.XL]!$.$`X0#A`.1-X!.@M[ MR2X3WY.Q03D'PE]C^^?@8V'F5^]\9>97-YWY%4ZE..\K/L`-:?G(:?D-:'F_ M@I8W$\4A!ESL6LIH3FW=L3Q;I4=*<#RT8ME*T'!3>:8V95=J^EPW=6?&?E0I M<>!Z=T:52VN^(.:K,J:&3I_80V?$Y;]04U,\A]J.8DT4W764A6UIG@H?GBW/ MT)2)#A<8NNL:%!X^F>BJ9[BOBC5V";S(G$8?+T#BO-\[>Q]Y#M7A$AMNMJGJ M&J_*!+@H-B@8*O^.F)9_I>/:^MAS+;N3QU#\>S_=;1/.Z-;'&&*E'__\`DNM MN_`D-3*2K9C%_^*/:S',L65HRP$]>(L%++8-9#95:KHV#!'XW2;/RIRX((;$@"M`)E2XS3*!L%Q" MX37>A*BN!V+(?ET0]0>94F4Q(_:9[HZ@XN5&7'@K6PE59=J'84-?F'KIJHOX-&1\<"X5THE M80-57?U)O!L`1?R1&#!(N$TUG3^6SYK:3/#]^3'Y#ZG24;YR:>8OARE%!L1? M]D1T@X&Y$';+!`(#I>$1\)7`-O:&(W@E'[T*X,4>-E\^-'-&HV]7(S$V]N%( M/!C>*Q:1"0#<'%\^1L@QI::B:S`\?:(S:GZD*F$K\>EJI)`%T.F)0>Q$T6QO MZBR9([+0-E]Y9T%5??+*QJ?;C+X+RZ%:^':^&CYM-R"F3P5X(F'/4;GPPNR2 MHV/$89HYG*Q`[3$-1@Q+F_E^X#7'`[[*>C=7)J:E&)8YA4Y7AGT$#Y%XG#@,,6DX0C M9>4@J*/:^H*#79XI%AM@KW/^#_Y\D+/A/XJ>[;**G/@4X#&@%YFJ!1-$S`>T MJ'!JUJ%'WJLB+^E$`C'AIZ@52UR7SA>^40H>VES_FPJEICL_0,$X%N@`]FYN M6_JC8BIA*1"@-5ZYH:F;'N<%"PP(KO4X97S]S!5[."MVC<:5(E=HH)TGEJ%; M::PJE*Y__NPYQU-"%K_$)/0>AGZE.ZIA.:`R'^F+^Y&)U8<07_Y)?M@OOWSS M&)O<3BX]Q[7`8W;@(0Z8>*"M1T[J@,R]$,1OU/W*8>F[ MKU12;Q0_1Z/.AV^GUS@O8/#+,#TIY<^I%YW2RG--)27/J#[>Y56H8"\`G0#-?779] M=;(:NNW$_8I'(]P_Q11U%O3)1[Z.HU\_Q>=D?:_@Z&_<66K_)6A8! M)0BBU[J>&\@&$@P)5BW!JC$JF..ND97A]2(D]PG]L.3#3)@>@551:\O=(52W/=)V*U%6[J+:AIE*I M_L3+"M%MDA2@T6U"MPG=)FE<`8S>8?0.U1"J(51#J(8P>M<(6F'TKCUJ"*-W M,7)@]*X]#D"KJ(31.XS>H;Y"MPG=)G2;)'(%,'J'T;M#5$/H-L7(@6Y3C0X! M^D[K(J^N!7,P=GU]D<&-L'H/.6?(Y(:&K"QBVD_88*T2EATH/E9Z<[D:K MJ(2Q0HP5'K"^$E_G5_W'ACP&&DQM$!+M&/#.+E=)UD9:N?N=BO:#;7N4N<@!%=:8>G@:$IP%E4$+RTX`& M>%9@#F7P<#"$@X.#@S["`<(!P@'"@7C=R2G"`<(!P@'"`7]=[P+A`.$`X0#A M0,#!"<(!P@'"`<*!B!T,$0X0#A`.$`[064`X0#A`.$!G`>$`X0#A(,M90.N@ M5#@07^_G'!I,,LM:MTMB:[I)C$+9QARS\J>)6"\YUO=P%QE-/X0#A`/T!!$. M$`X0#N)P<(9P@'"`<(!P(`)#`X0#A`.$`X0#C!T@'"`<(!S$K`.$`X0#A`.$ M`W06$`X0#A`.,)2(<(!P@'"0V=NFBW"PSQRSV%!K[WH6&\TVIS4<3.;:5_4_ MU'$LLQ`Q]IJYML':M15;,TEQ(.T5RU!#FY$JK:CV2:PU'I[K\^YFV%6BYG;C M4OGU(((:@AJ"6JF@EB@615!#4&N,I"*H(:BAI8:@UBI)15!#4,NVU$X1U!#4 MFBFI"&H(:MF@UD-00U!KIJ0BJ"&H98-:'T$-0:V9DHJ@AJ"&[B>"6JLD%4$- M00W=3P2U5DDJ@AJ"6C:HG2"HR9VOGP@'"`<(!P@%_W3DV^$$X0#A`.!"O M&YXC'"`<(!P@'/#7G:"S@'"`<(!PX,<.L/T?P@'"`<(!.@L(!P@'"`=Q9Z&/ M<(!P@'"`<"#R#M!9V$MVF?B>C`W*?OKGSYYS/"5D\3NYUY\?'5_;?3T1U+?N1OK@?6=K7!_^Q_PR>$;N1W7!';?8%F=*> MXIFZ>T\G_WJS\&SZ1E%A/O`@_HUZA=495]_/[9 MMASG@<#(OM+YF-K?+ST'EI':J;?YOX_@-]VQ/'BU^.:-HE%5GQ/#^=>;_IL/ MW<[@?#GOHC%_*&UZ@]SI\9G=TR=J>O0;=4N;8W_O-(52W/=&&:*M6? M&.^5-LV3TW6G62*S#J,S'2QG.JB"67L7^U[(T]SI5<6LO9-]S_$L=XX5,FM_ M6`.SGD=GVE_.M-\.9KW(G5YKF/6LFSO'*IEU[:4LCUG/>N69`9?$UG23&'FK MN('B*&MV^4;.=KRZ:HIK,VIY4\PW=+9FU56S/-NW.)Z4I_Y7S*T_V/\*YALW MU3!I#7*8;^!4Q:3]M6=9UAS/RE/[$C)IOE%3#9.NC3'E33'?L*F*20?=/3/I M>;<\=1^F**:YO>Y9;-%4Q::^_;R8]+4_=2\BD^<9,:Y@TWZ*IC$GW'<Y-LLV[)A:EKG^_:%+OJE:?#49(9K;[.4 MMT;Y!DDY?'=2`]_EFR&E\=WIOBW'BV%I2ED*OLNW,4KBN[6MIO+FE&]9E,9W M9]OQW3TUB$NU.V*[KX\V,1VBLIN<*]U1#_W^N\5G[@*IZX2)6\RV4*,FG_K-X)AG\?VS\''0GKVSBLC:(7D7+[E MQE3<&55LRIA461#'/>)?7%KS!3%?%6I.@74U>(WR1&S=\ARX5I!VP4GK1DBK M/.ON3/FW-3.5;QWE/V1A6?:14KL=69,CA2`#.ZR>5VJ"S+^0'53Y9 M-F6\>&/`;"W=Z412Z<)/CS/=B;R5+3L%^`4.,I71PM8-I2 MS,IXC5.!\5QLCGS^F@(T`6H8P/34GL./,&Z7#2$DSY%@5U`L+`X[95?"8Y+&SK!9222^%Y;_LGW:-N MM\M>8+-58Z/RA8+8E"AS`@M,V8.I,J%`=NN)VF*L,U@U:K+)PCC%VD6)C.*4 MPD_0S2;E`"BD@Y$QP,JYI7'8$O"X9"/-LX$_8.&[%^Q/=@M;:\_40"A``'57 MF1!5-W17<".[`/B5LQ5G':;SXDRK.XY'M?#-'/R`X6S`9]=A+[FR`TS.%@=* M^5.5_E$VR00-'O_\`D30@>]T-;)PR>Z##]Y\3NQ7QD`/$>SV;2XV]SL+GJ#3 MN#X^XG"BF_#?.2>:0L:6Y_*)BK$K?_A32G+B8?/AE6`H1B>&V`X@N0;<`(8A MMUF5@4#"$_[?`>"B<439?`*?/`\TT'MP$7]\"Z&APORRFQO!3XR MQ9\<<##4@3(!HY=QC0-CA-N5NTOE'>,3RA`Y\OW#S)O.P#:!"WX"0%8,\JQ, MP/3@K"4&P9%N`6)"B[33`S5UN.5W(()R!]/1-0[QGP$>;:#/)7"R0PT^P`<* M4NLRAF?J`,CA@O%B4B&\#HR&"JME(Z9=>A4;N`H??->)_+!??@'G0[>T1T#R MVPG`QQ>&X*-0ER<\)1&@'(!UP%0FN!7^I^_7_PZ5T#6S#T"S.M2Y,57?'_IP M=_[G/W]>_<(/":_N=D&9GV1.^67@AYGN] MU@./.'+=-Q]`:<(_2Z*O/[QTAE3.@HWFW..\G42^*YY;?D1UR?'IV1P/WWSH M773C\]E@3)5-:-CMYL:!5DWH;+?Y5#.=7FYX8=5TAB5.)PAEW`DLC3P*%.RE M9S,C<&1JWRQ3%7\43ZK_?00O7)_5^HFI;#R<#TJ*X4J>TB`VI=7,5L64[L&C ML3W5Y:H:+O8?,F)*4F?/:6KDI];`3[\;"_P\4'!EN&-S"6IW2E/QG@,W%)=> M;^!X,)9CUIUO"86N"P7J!0$8]2]/=W3AQ001'^;)S&P+C*W59F=HQ16$&YQP MY4)_&JQ#X'>=#X\XC@6:7$2>7OFO[\7@F'NJSHXB#Z!"3W/[TJ:J!0[(WW!? M$+D2$W>B+^HHHQ7VIQ@Y^/8V<[.6[QH3@_W?49YA*C"32*CJ2`%*"]/9H`Y0 M;@:F(1C`O=``!@>=$C!(&?$V=*VCFF-S7/D0L1)'8DZAY'P$`W>BN\[C#(Q> M9K<606LWKBM25HB/H^N]**78_M<#A&4&?FC(W2Q]PV:!9,THV5NB9(^AI$&Y M!(<$C@2:KHA+E'>_F<33=+CFITT=;5Y\J*B@7!=$8W$P?XY=GTKL%V=!U/0O ML9K-;C>K:G.C&LN\+W+NS])IP5S]2LMT6>@VW?K7/[8D6MD9?6O=JCX^FI)+ M8PO9.;>F.HM,R][^Z84+:VJS?JQG5:6@8R8]MB26:C%)-T.1+I6&*!>UR,4V MQ?A%=??OE4U.;I*(L%L)2BFLWRZ2[`02JPX1D@8Q5.[L%#69D&HE-T$-)*2[ MX>%<-Z9JS:GR[HOE.#\IS%\!GYCMBWG,6?0CS\EDE?S^*:L6:!^PON-I7BW# M-(3Y%$D0YFM"7>Q3Y(!4(#&I_=$,0?EH)/[PFKC%&C9PTW`S"[VQKHKM%`([P+3-6(7RG M2(+P7=AD8P[;12@)=Y!^:2-!2L$+]3)$'\KFL=&7Y?Z8;G4FV7 MO5,D)6(X8CAB.&)X'>N([C]"#T(/0@^Z_PTE(YJ.B-^(WXC?Z/XWEY2(X:W' MX2?.KBE>_[#=C MIRF6PFHIVZ])L+)LK:$T:6&GCBK(A&*#8H-B@V*#8H-B@V*#8H-B(R&94&Q0 M;%!L4&Q0;%!L4&Q0;%!L)"03B@V*#8H-B@V*#8I-961:L:E>WCYY_#B2BW^L MYJU=]\_%X5+;;:#O9P=]^<(3=Q:<'E/CQG9LB1(KU#"^WG*VA9)?)T'>)MBB M*D*OWSH\%Y M'Z%"2N%!J$"HD`8JSGI'%]VSG4F!0(%`L>-L$2BD!HK!R5%_D#0I$"BD$!T$ M"@0*:8"BVTG!1.9T$2D0*1`I#ALI^A>(%)+*#B(%(H4T2('.A[RB@T"!0"$- M4*#S(;'L(%(@4DB$%.A\U)YB5U/?&LS'*S2V;0WS\5"!R$,0N15);]`_.DM; MG:A)I!"BPY`0A(Q&0<:P!XAQ@N$LF3@&`0,!0UK`>'=ZU#W!^'*7N_H=-A%9P2A`J&B;H)(#A7=3J^W*R$0)A`F$"9V(PC"!,($P@3" M1+-A`AT/A`J$"CD((CE4H$6!,($P43]!$"8.%";$3ULTOMLPHZZ0:OX1:K%3 M&M<^E3&7V)F)>BO>NO79D%ED+QS(^J_-.``O^TC*U0<>5LZ'E3Z\;X;9B,H[ MXB@V=5SB4BW._$4X$7)\F*>(>8RH;YNJ;XL`CM]?`<+M.P.YTH?W3GI'YQ>G M&\#'KN#0:B,$\[000Q%##PQ#3\^.SGOG!1":QX<(HY+($<(HPBC":,TP>G9T MTNL6HRB"J,12A""*((H@6C.(#HY.!BM,4011B:4(011!%$&T9A#M=KJ#0@Q% M")58AA!"$4(10A%"$4(SR+1;G"!@R<0P"!@*&M(#1'QR=G"2; M-B%@2"%"AR$?"!B-`HR+H_/^^:Z$0+A`N-AQM@@7C8"+;J>7:@F)!H8D,G08 M`H*(T3#$Z)XC8DC&,H@8B!C2(@:Z)++Q"\(%PH6T<($NB80L@XB!B"$Q8J!+ M4GL^7\[#&I&BE]'+>=T,O;TDZ/F9OU?7E[?WH\>;6V`ES]2HS1X56>$U7KR\ M^D]*;.4:GJ(I5U2E\S&UE4'O2.EW>X-?8BR2$JUZ,P%CT[L;75W=?/M\_/'V M\?'VZR]*?_$28Y=FB5@5:NJ]4DRC5E-H/;VUBD1-I=%>]%E;B8>@5")%$)00 ME!"4$)2DH@B"$H(2@A*"DE0405!"4$)00E"2BB((2@A*"$H(2E)1!$$)00E! M"4%)*HH@*"$H(2@A*$E%$00E!"4$)00EJ2B"H(2@A*"$W34/J+OFB3O#[IJR MZZ$Z"?(VP1;UJINZE._YR='%<+`S*;":`X%BQ]DB4/S_[;UMR9"+6M[M;\NRVOI-ZS^VH#0\EF!H,6D+M[/_U=!9(LH6`V``&,("HV9IC59QX@E@"!%":L0'@"$5,$Q3 M,VP(VD)Y#(`!8`@+#,/43+T.8(CD,0`&@"$L,/1KH_B@X-K3!3%`#!`#Q,B( M88`8@KD,B`%B"$L,3$K$\Q@``\`0%AB8E`CH,B`&B"$R,3`IN72;WM*@L63> MRBFL*WS/?M'-$#U]2"0"&43L1-)L:KJ!GCZA/`;``#"$!4;-U'0T`8OE,0`& M@"$L,$Q3,^O%R2J`(40(J1$?`(94P#!,K6'AJ0&A/`;``#"$!09NGPGH,B`& MB"$R,7#[3#27`3%`#&&)@4F)>!X#8``8P@(#DQ(!70;$`#%$)@8F)9?NZ=NP M,[3IG;J>3E*TZ2$WB&,0L7-#T]+L>G%A5J0&(4)(C?@`,*0"AM72C!J>017* M8P`,`$-88!BV5K=;`(9('@-@`!CB`D/7[!H>!!#*8P`,`$-88,QW[GNSH;7? M&^]:^II!+^F:]>)>YI9<)YD#04($I1H1!P15`D'&40C2@2"A?!`(`H*$11"F M3>)Y#(`!8`@+#+0%">@R(`:((3(Q5J8D(,8;-1+F'SL/`9U-%1_BGV=_;NWP MR]OWMG;XZ:L-?O.3VKN[KX19AYE9[YA9^_O.L,^Q\UY(OCBQ^T2,ID9,W:AK M)'VBY"9Z'COA#^(GR81ZQ"'CF"8)B6E`G802)PRC2>CZX2/[M9-FF[0GGI_R M#9_]-*641*/%/>6^89M&\]>$O(^)&H1M,/#:F^8'9T%[\:)($\^&._-!AHW,"9C(GS;9, M^):IPTSE,9-M'-FT?Y+MJD_'4^$D&/MLR.^D'ZCJ3)#.8 M$Q(:Q^P@TR&N/1$GR7_JS8>3/L649I\D_G?RS$[T:><05_<2,N,L;3S==O5D MM&R[Z06(D@WC_):=<':RV:=LBXA=RS]I?C3J,H]RXA_$<5WF3"EW)L?[8Y*D MV>;72PQ986^!#M-65E'8L(9KTN*A/8[]8(:'VC(>6*2.`\HOK<\=T_W/Q$_\ M6=A^\M\-*2,+]R^'7?N4N<=XPEC#"<)VZN8N/Q['T7?_F3D(B[J_-.KZM4Z> M_2!@>[DFMY,XAPS-/?<'=>)WE+MO1ANV*?/' M/,-.6)0$[$+/T>(D"9V-/.:@8[L.?.?!#]AI4!YKR>0YWP_C!_/9;,-O/HL1 MOM_U9ZR1;T\^.W'F]Y,@S;=F`XQ>:#P-!&:#^)'R]6WYCVC\0J?QN&SL:S)D M!\E.;+;/POE%ZPCU-\DU+FK+;O*-'C6N`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`+']L0N>88.QA4G\=UL8\\/)LO(X'MA"<2)Z9KDPRKM^NL/RHU\_TGC MZ0;=R+8K##]+3F/N&2_L=]MH)1&IW@@E;$;&?)]G_3S-+DR<)BS9\$G7^BG^ M/!!HD-"LN,LW9)>Z'68E82ZCK*VHNBP%>EY6=N6S2N>!E1&L[,OF=FRG"0WR MP?QGKLJ\CB*K)]<,G+D8Y5@,V2!?H;6QI)O-9)T@81M^YPZ4N2GG#2MAF#/G M9[HH`_WD*Y^:_>47=%"2Y8N+'\[/)BK@L,+*H&/%SS8O9>:V3Y#4" MFU'%'DOPO`+;J`IE=N=:S,(0-FM.?(;&-I\PO')]E^1EW]P:W*Y3XJ;)XHG/ M3HL?:`JHZXW:C)#A]4;!M=_.L].^[=ST^NUAMW?W"[LN'O-S]MWKGCJC4>:4 MS%OZ=&&*$9+[5^_[D%VL1?4R2U?;:C9)KI(0U^D(PF;W+3BE@NA;IJ+SBY=Q M*;NNL^G,FIA>5$-Y\#H+E5Z\X`F>G["),9^+YP#=(KROFU\(JC%COB&,"R][ M:KP,H<(=F#QK\(Q'PR3_*XD"W\N<=UG1R+UCI;#EJ2<*6+0DVC2I31+F0LDO M^\!LJS=DH4A<&@1C7GB$CU-;S;KE^3<)*WI7OUFZ!:OKZV["'G3/=-,'&[;? M<$,W.Z#E9%,=SY@O*ROC^-/UON;&Z<%F/6"FH3,?+89>]V/YRB"-(&TE`$I!4*22] MSG6`)#DC"4@"DBJ%I&0FN"E8)@=YO;Y.8SB6 MG8O7[.#@?C.]]PU=L,G3&A^GR7B74G$G<1Q)KYFG8%G#_Q%JRP\ MX7#,XP#G]A)Q`_L4S^`<3M+M2>JL%OO+1AGTQ)8RCS?591\1;FJ&67R"1Y#' M=X[U.%F#%.@#^H"^LQOJRM"++UE::Q&P;Z.:%V>N'WT`Q[P_9G&=*` MH&H0A,X"G07H`_I*6$QV]#7LNF99U>EU5EAG0:N+$J+,^D>.\-"1T*&K7"+& MP[S[WNC03-/2FJO=IA(G88@P`."180T`J@+`J[K6:-8AOD!\`?*`/"60QVH^ MP];TU=MN$H-/8>%%'2VE2H\-=?.W<:;.=[;!V/G!7Y^T70:%IB)45"J77W%S MX]";&ROS"HD3+$05$/#(>`8!52/@E:'7*C3)@+H"]I6,9+!/-?;5FT9UJC^% MY17TM2C1US);4O=SM_V^^[D[[':PKJY,48R$C(2\X[:'SAM=5E:5E#8G0Y$! M!(\,:4!0-0A"D8$B`_:!?64L)CO[>`'8P+JZ4O@F>EXJJK-LT5>@L`@=DDBP M2+#;#=8R6YJU.K^0-L%"80$$CPQI0%`U"$)A@<("]H%]92PF._MX`6CJ6,Y% M!M]$VXOJCR#U:>JP[3U"G3CTP\<$@HQ4$8Q\C'R\XTV"EM9<2]\ MZGUF]AKD7F*;1O-7TOG[U^[P7RMZ"^06@8,4"1<)=T?";=6T6J.8<>5-N1!< M`,$C0QH05`V"$%P@N`!]0%\)B\F./M.V*_4V2X4E%[2_**'/+#R-1-IWMX?J M-1!L1`YQY1(V5L#'6X\@U@"`9<,:`%0%@'CK$40:(`_(4PAY>.N17)&\0:#) M/\[>EL./PO[U$/\\^_-BC^X4!WZ@68>96>^86?N[S'K.G0^?**&C$753$HU( MROX5TR1U4OI,V1&C,/MH'-,7/YHDP0\R\@/J$3<*/1HF^5^9U[$M/#:6[`5' MK]N/HCC;0?H44TJ>V4D\)82R;3WR^R2DQ-(U8NI&C?@)<1+V\R"(OB4:VQ'; MA!W0"3WV^^\N98,A3&]*->(#-+&GNS*>ES%O2?&\EBKL,E#3>7DZ>^8*V$]*GXRAF#%^I ME$XM=YWA"-)&$I`$)%4*2=X?DR3E1>3J(^I`DA21!"0!295"$J^2 MLKFM@E62@K(3^H(46A;GA883FFQS('3Z"!6TN.N#NSX;[OK4=:U9PR-98H4I MX`?X`7YG-]25K=GU8H\CT(8##=9L:`VL[""6ZP&!0*!$%I,=@5!4 MH*@`?4!?"8O)CKY&4[.-XL-3TJ)/85T%+2P5%V%Z]YU^>]B]^TBZ=S>]+YVS M-Z@A$R,32V0QV3.QT=#,!B8A0KD>$`@$2F0QV1$('08Z#-`'])6PF.SH:VHU M0S_65H*`3V$5!L**?,)*+J>0#_W>%W+#?M2]^\I5EJG>TKL;D/>=#[U^9ZJ[ MD&'[GYW!-O>!]")4R"+Y(OGN:B_5+,/$O$,DUP,"@4")+"8[`B&]0'H!^H"^ M$A:3'7UUK59O'6LK0<"GL/2"!IC*K^'2S11)CR52[181FU/0[4T7:_*G0Z(*P#?D>$,\*D"OJNZ5L<: M5Q!5@#P@3Q'D65K-LBM2ZRDLIJ"KI>+*RUUGN&%!%X@L`H`3Q7P062!R`+D`7D*(<_46E:](K6>PB(+=!.9=1-RW^F3 MP:=VO_-+44(YN88B2/Z4+/R42Z!H_;R8P03)IM503H`[<R6*@H&`45%A"09^**JNOC-COB,L.XH<3/WPDT9C&3NI'8:*1!R?Q7?2Q M2!36RF5IW-O8TU#Z=?%9H?46D20W8X8"]AT9T6"?*NR[8O!##Q\:60`\`$\) MX#'>%1?_7FL129BGL!"CCK92Q5X6C;QO#[HWNT(1(HI0(8F\BKRZ,:_:%*H`#R**-$&,;A9TL^SL9O'\8))2 M#V*,5*&-_(S\##%&FB@%^\`^L._LAH(8`S$&P`/PE`$>Q!AI@A@=+97N:+GM M?OXZ[-QN!10IK*&AHJ;C@[$-1]P!]P!=_+$*W`'W)6T&'`G&.X4%E;4T4JJ]/#/311F!G%2 MRH*(IFQ__&F@;2Z"#A6APE*Y+(N;%GC_LJ0A"O`!?`#?V0V%]R^C007(`_(4 M0A[>ORQ'!*,[!=TIQ>Z48G,*Y!:!`Q@I&"EXD]QBU:V*I&#(+0#?D>$,\*D" M/L@MD%N`/"!/(>296M,V*U+K*2BWY!\[#P'-CL+^]1#_//OS8KT?Q8$?:-9A M9M8[9M;^+K.><^?#)TKH:$3=E$0CDK)_Q31)G90^4W;$*,P^&L?TQ8\F2?"# MC/R`>GSA68^&2?[7:T=*WHU"7KG)@2YSF:A&FR_)!0 M490I>L]4CRGX3N93Q*5!,'8\SP\?I\;5IY>??Y.,'7?UFZ7`UO5UH7U0$&WZ M8,/V&T!Z\M:N4Q86\^^'O?OMV)(+6GLDT\N843;ZSPWI1CSJ9I8TS^.E)D+#29`Z/<1 M*FAQ#PCW@#;<`ZH9FK5RWUO>^T#5F`T`?H`?X'=V0UW9FEWL=@3ZT/,#Y`%Y M%46>:9E:W5AY;Z:TT%-8:E%'/:G.DU,?^[W!@-SW>Q^ZPQ5=%!J*R-&H7$[% M0G`'&LPP&YIEKKQ/2=K<"BT%$#PRI`%!U2`(306:"M`'])6PF.SH,XRF5FO6 M*E/_*:RMH(VEXD),[[[3;P^[=Q\W+%\#+4;DZ$4N1B[>;C"KI35U3$.$E70I[`.`VE%/FDE%U3(AW[O"[EA M/^K>?>4ZRU1QZ=T-R/O.AUY_MG`P&;;_V1EL?:6A&O3(KJ2LLOJ`)IO)KN73S MI8E3YSL9Q]&+G_A1N+U_#6*,4"&,=(QTO*LK53,:Q8>2I$W'$&.`P",#&@A4 M#8%7EF86WW0"!$*,`?J`OHJCKZG9-EZI+;Y?H@]&O3X8]+Q($Y[*)5HLJ+:O MO&)KM@5Y1:@@!?J`/J#O[(;"*[,AJP!Y0)Y"R#,LS6PTJH(\A045]+947'VY MZPPW+.T"H47@L$7J1>K=*+18%AXJ$BI(@3Z@#^@[NZ$@M$!H`?*`/(609YA: MLU&9YR<5%EJ@G!.,-PIK)6@*465!5=&['?$90?QPXD? M/I)H3&,G]:,PT!!1)$FB-'-@FZ6G=TLGA],4NI!C)$JM)&?D9\WYN?B^F=K+2))?H88`_8= M&=%@GRKL@Q@#,0;``_"4`1XK]HK+3JVUB"3,4UB,44=?J69'RVWW\]=AYW8K MN*"A"!612*M(J]!0I(E2L`_L`_O.;BAH*-!0`#P`3QG@04.1)HC1T**VX'+3 M^W+?[WSJW`VZ_^A,I1>L>RMFK"J7<+$RFNHKHU5#9P'NQ#4?<`?<`7?RQ"MP M!]R5M!AP)QCN%!96U-%*JO3PSTT49@9Q4LJ"B*9L?_QIH&TN@@X5H<)2N2R+ MFQ9XV;*T00KT`7U`W]D-A97K8L2PRC0P4=*L4.E6*#"B07 M@0,821A)>$,2;FFV77PL2-HD#,D%Z#LRH($^5=`'R062"Y`'Y"F$/*.F64:] M*LA34'+)/W8>`IH=A?WK(?YY]N?%>D"*`S_0K,/,K'?,K/U=9CWGSH=/E-#1 MB+HIB48D9?^*:9(Z*7VF[(A1F'TTCNF+'TV2X`<9^0'U^`*T'@V3_*_7SI2% M#4?$=9(G,@JB;PD917&VG\3_3I[9F3PEA+(=>.3W24B)I6O$U(T:\1/B\!\' M?".-G1G;B!W5";UD^=&@3>ZU*+\4W"1S'^+2(!@[GN>'CU,[ZM,KS;])QHZ[ M^LU2#.OZNB@^*%XV?;!A^PW4W-7-M9E)IRP7YM\/>_?50A$,>6I#NA$/L)DE MS9VYLY1Y2YKOK21ME[&1QMN+QC-?T'9"^G0L6"C^UG%VF9#I1=;2'(T@; M24`2D%0I)'E_3)*4UXT)D"1G)`%)0%*ED,2KI&PZJV"5I*#$A*X>/$N%9ZDD MB6'-/4`>D*<0\O`LE2PQO$-U44=(J=#C M44].^,A^ZX>S=U"'C\1)$IHFQ`D]$OC.@Q_XJ4^3XKJ^IQ97!$FKDL6D"X4YA`05M*Y5O6QG&CD>) MX[KLPJ8)B:E+_9?LF;A"?QI:5P2.8Z1EI.4=]W'-IM9JK;S&4-JL?,E)".[D M2AW*@)]J\+,UNVX=:RN`#]U[@EL5`#R3Q60'X)71T@S+KDSU)[`F4[HX1#-+ M!>65^YB.'=\C]/N8+VR3][!$Z1.-B3N)8[ZF3=[<4@Q-Z"U5RA_(N*IEW)IF MF2U,.01R/``0`)3(8K(#\,K2C&9QQ@$$0FX&^H"^:J//T(RZ49':3V"E!=TO MD&>.78_)=>,)72O/+#QHM,V](,P(%=)(SDC.N^X%-UL09D1R/``0`)3(8K(# M\,K0BTM9K;4(&`AEIMJ1#/:IQCY;:[3J%2G^%%1F\H_QQJ9S['SH_$E#DD:/ ME,L?&G^Q4D*)\[J&/G^#TR3@Z]JR""#^\]AQYV]RNHG8/\,?^76W3:/Y:Y*M M@9N]K&D<1R\^?RW3PX_%-5W/@.S#56>T-;PVKE'H+ M<`%YJXD45>QK*LC0= MC]B(%:1`']`'])W=4%?%]_.`>VA@`^_`NXKR+BOUZE4I]1368=215JJCF0Y[ MP_9GWGQ5U17Y(6?PO(*VEPJW^;R,8J\;WX0;',@Z"]" M!2U2,%+P=H.9+5UKU*"_B.5\@"`@*)'%9(?@55VK-]#/!PD&Z`/ZU$*?:=UG2[0602.3.19Y-E=KZ8P M:Y9F-5;N]$J<:Z&U`(1'AC5`J!H(H;5`:P'Z@+X2%I,=?:P&M)I:<[7A16(` M*JRWH.5%"7%F_6-'>/!(Z-!5+AGC@=Z]D[#=;&BV!2%&M%`%``%``/#LAN(" M3-,XVEI`'P08(`_(DP%YO.8S-+-A5JCF4UAX44=+J=+C0WV:.FQ[CU`G#OWP M<74U7$@J(@>E9!(6O0I+*^@KT6)OI;!IW:_\ZGWF=EKL/!.=]+Y^]?N\%\KX@RT M&8$C&MD9V7G'.O:FKEGFR@T0:?,SU!E`\,B0!@15@R#4&:@S0!_05\)BLJ// M,FI:<^7FG+SP4UB?@>0BJ^3RN=M^W_W<'78[`]*^NSU4@H$&(W+4*I>#T7Z* M1XZ@OP"`9<,:`%0%@-!=H+L`>4">0LC#(T=R1?(&S27_V'D(:'84]J^'^.?9 MGQ=[=*L?,VM]EUG/N?/A$"1V-J)N2:$12]J^8)JF3TF?*CAB% MV4?CF+[XT20)?I"1'U"/N%'HT3#)_\J\CFWAL;&XT3,EK]N/HCC;0(J1LUXB?$2=@F01!]2S2V,[8I.Z@3>FRC[R[; M@(S9[Y,G)Z;$>8XF89K\LN1IV\)\4:8IN%#F6L2E03!V/,\/'ZP+]) MQHZ[^LU2?.OZN@@_*)8V?;!A^PUZKV,?:ME M73?BP3C[PCR/S4O95!$9O9V0/AU',2/^"G!/+8Z7*;I.5%_M@2V`"^#:W[H` MUZ7!Y?TQ25)>F*X^]@YPR1Q:`!?`565P\8HKFU4K6'$I*'CA(3"%%N1YH>&$ M)ML<"#U&0@4M[C?A?M.&_MYF33/TE0XC:>\U56_.`/@!?H#?>?J+;,VN%]D' M]*&_",@#\JJ)/*M1U\PZWMLM0Q3OD%K444^J(XM^[/<&`W+?[WWH#G=U^$%# M$2H:E%;ZT-[=IJWIC>H\*PTM!1`\,J0!0=4@"$T%F@K0!_25L)CLZ#,: M+BRU+ M:ZQ(,=)F8B@Q0."1`0T$JH9`*#%08H`^H*^$Q61'GUG3[!4A1EKT*:S#0%J1 M3UK)!17RH=_[0F[8C[IW7[G.,E5<>G<#\K[SH=?O3)47,FS_LS/8YCX07X0* M6:1?I-\=-T(,K=:H5R7]0GP!`H\,:"!0-01"?('X`O0!?24L)COZ3*UAF,?: M2A#P*2R]H`6F\BNY=//%CU/G.QG'T8N?^%&XO7L-4HQ0(8QDC&2\W6`US6S: M%4G&$&(`P"/#&0!4#8!7EF;:Q;>I`($08H`^H*_:Z&NU&L79G+SD4UB)44=< M4:@)!@TOTH2G MH36,1D5J/87%%+2U5%QYN>L,-ZSI`I%%X+!%XD7B76^HAM:P:Q5)O!!9`+XC MPQG@4P5\$%D@L@!Y0)Y"R#,TP[`J4NLI++)`-Y%9-R'WG3X9?&KW.[_LZ!\[ M7D,1)']*%G[*)5#T?E[,8()DTVHH)\"=N.8#[H`[X$Z>>`7N@+N2%@/N!,.= MPEH)&E)466=EQ'Y'7'80/YSXX2.)QC1V4C\*$XT\.(GOHF%%HK!6+DOC)L:> MAM*O]68QE''C%CTK8!_85W7V73'XU8_U*H`/'2L`'H`G`_`8[XJK2ZVUB"3, M4UB(44=;J6+3BD;>MP?=FUVA"!%%J)!$7D5>A8@B392"?6`?V'=V0W$1I2I+ M#4!$`?!*AC&`IPKP&.^*SSFNM8@DS%-81$$W"[I9-.+YP22EWOG%&$'RL&0Q MC$2,1+PQ$:^N&2]O(H;J@DG(D1$-]JG"/K2N0'4!\``\98`'U46:($;K2J5; M5VZ[G[\..[=;P87.%:$B$FD5:14:BC11"O:!?6#?V0T%#04:"H`'X"D#/&@H MT@0Q.E?4%EQN>E_N^YU/G;M!]Q^=J?2"!6[%C%7E$BZ60%-]";1JZ"S`G;CF M`^Z`.^!.GG@%[H"[DA8#[@3#G<+"BCI:296>\KF)PLP@3DI9$-&4[8\_]K/- M1="A(E18*I=E<=,";U26-$0!/H`/X#N[H?!&932H`'E`GD+(PQN5Y8A@=*>@ M.Z78G5)L3H'<(G``(P4C!:\W5%.S:WI%4C#D%H#OR'`&^%0!'^06R"U`'I"G M$/),S6RT*E+K*2BWY!\[#P'-CL+^]1#_//OS8KT?Q8$?:-9A9M8[9M;^+K.> M<^?#)TKH:$3=E$0CDK)_Q31)G90^4W;$*,P^&L?TQ8\F2?"#C/R`>GR%68^& M2?[7:T?*PH8CXCK)$QD%T;>$C*(XVT_(1DJ>V:D\)82R/7AD0,=LBP<:$TO7 MB*D;->(GQ.&;!'Q3C9T?VY0=VPF]9/G!H(WT6U1@"MZ2>1%Q:1",'<_SP\>I M.?7I!>??)&/'7?UF*91U?5TP'Q0VFS[8L/T&=.YJYMJ,IE/6#//OA[W[:A&I MO$9[&?M6R[INQ(-Q]H5Y'IN7LJDB^G<[(7TZCN)URX:?6O$N2&,8=)MQAPL-;0HA#P]OR1'!.Q07=424 MZJBC-T].^,A^ZX>S-UN'C\1)$IHFQ`D]$OC.@Q_XJ4^3XB+"IQ96!$FJDL6D M04X$Y<\P%WP!UP)T^\`G?`74F+`7>"X4YA`04M*Y5O61G& MCD>)X[KLPJ8)B:E+_9?L0;Q";QK:5@2.8Z1EI.4==W'-FF:TK.U1+5%6ON0D M!/=QI0YEP$\U^-F:7:_*_=QJJ"\`(``HD<5D!^"54=>LXF*($E=_`FLRI8M# M-+-44%ZYC^G8\3U"OX_Y:CIY#TN4/M&8N),XY@OIY,TMQ="$WE*E_(&,JU[& M-313;U4FXT)O`?Q*AC+@IQS\+,VTS:.C%N@#^N0.9*!/.?09-:W6*CXN*2_\ M%%):\H^5781XZ/Q)0Y)&CY3+$QI?SC>AQ'E=9HVO&SP)^*(FS#F)_SQVW/GZ MP3<1^V?X(\>%;1K-7Y-L`91LB>!Q'+WX?"W@AQ^+#_6XJ?^2/+$*8V#'Q_\D!W"=X)NR,[GF9UD%`[I]_0]]X;?LEW^S?DS_O[+S9,3 M/U+>3M4.O3[[(Z5]9NKXA9))Z*=].OK?GR:)]Q-?>3EE.\@^<.MZ[=_MI#>R M]-\G(1_ROP.$[-+\IC>U8?B.[AGSK!Q.^&H\8@YZ.YJ2&KN=C_MT))3+TN0=] M#D,W5\;,.'+HF!MO;.B3#+J$H0?N$_4F`>V-M@.2I]LY)9<';Q:';MQ2E__Y MTV]9C52!A=[7528GO=6S>$[W[=O;[MW'>?5GCK_O,;6M]'/'TP_^KS,M;J-@ MH9[=-/EG4ZZ^[V0JTY.ISE"1_);R@ M)C=L8S^<<`VFEZLQ4;C^1685\+UB$N#[4M>Q-^L1+*]# MPXQ'W2A`)2XOMX#R%9,`Y1>[C@48'CE&9Y_)=J+_$H&Y+O6SHALK49D_5JO M[_/0R!O%8W9&MYV;7K\][/:8YS%[TW@YU`X+S']1)R:=;%FT6^I.UR\S\O7+ M?GG;CAU9*H7=4?:V)<'.Q]8DM4D%5^HXAYD0-@@;A`W"!F&#L$'8(&P0-@*: M"6&#L$'8(&P0-@@;A`W"!F$CH)D0-@@;A`W"!F&#L#F;F7;<5#_=??+E-Y*T M_F>W;QU[_SQ_8UFY&^AO`!*H`*85!AF+9FK;R@ M&Z@0(WB`"J!"&%0T#:VE-X\V!4`!4!QYM@"%T*"P:III%4L*@$*(T`$H``IA M0*%?KV!B[>F"%"`%2*$V*-80P`3P`0P<9Q!@`E@`I@`)N3&!"8>0`50(89!!$<% M*@I@`IBXO$&`"44QD7]58N&[`SOJMEIM^@JUI;R_V'7O`!O_2LI=[_P\.Q^>-:=F^&\&Y%<.0F):9(Z*?66G7\;)^8> M/^]31!\C\JVL^78;X++MST"XM^Y`/NO.C9JAV:W&`?@X%@Z5+D+0IP6&@J&* M,;31U&S#WH+037X(C`H21\`H,`J,7ABC3:UFZ-LI"H@*'$6`*"`*B%X8HI96 MLW:4HH"HP%$$B`*B@.B%(:I?Z]96A@*A`L<0$`J$`J%`*!"ZQDS'+0[U/UO] M51(3@*NE#`*NBL!54VM9=`*""*XA0(+1U#0"@0"H1>'J$F$"I, M#.5?865IF5:6-I(4*TLCLXIC$+&?@&SI6L/$JH]">0R``6`("XQ:2VO4&P"& M2!X#8``8P@+#M+1:K;AH$X`A1`BI$1\`AE3`:&FV:1]K".`"N#CR;($+*7"A M7QLK2T*BP!`DAM0($!!#,F+H-H@AF,N`&""&L,3`E$0T?P$N@`MA<8$IB8`N M`V*`&`(3`U.2B_?S;=B9%"UZ:]9RWK=#[TT:]*:=O[>=FUZ_/>SVF"M-0H_& M?%<+5WB/`[_^^E_4B4F'[<4CM]2ESP\T)I:A$5,WK%^67&0EM"[;";AT>O?M MV]ONW<=W[WO#8>_++\0RW4:5MM!^>6N7B62UT9ODLZH: M#U`ZH44`)4`)4`*4A+((H`0H`4J`DE`6`90`)4`)4!+*(H`2H`0H`4I"6010 M`I0`)4!)*(L`2H`2H`0H"6410`E0`I0`):$L`B@!2H`25M=4:'7-6OJ$U35% MST.7-,A?"FYQV71SJ>1KU[16W3K:%'B:`Z`X\FP!"J%!46MHK286QQ,R=``* M@$(84)AUS6ABV5TA0P>@`"B$`871T!K-XK/D`(40H0-0`!3"@$*_-IHK&AY( M(4;L@!0@A4BDJ($4@L8.2`%2"$,*3#[$#1V``J`0!A28?`@<.R`%2"$2*3#Y MN'0OWH:=H;WNQ-?1BCVTUR$GB&,0L7.#;6AV"R^O%LIC``P`0UA@U"RMT2I. M/`$,(4)(C?@`,*0"AFEJA@U!6RB/`3``#&&!89B:J=_9+[H9HJ4QP`8 M`(:PP*B9FHXF8+$\!L``,(0%AFEJ9KTX604PA`@A->(#P)`*&(:I-2P\-2"4 MQP`8`(:PP,#M,P%=!L0`,40F!FZ?B>8R(`:((2PQ,"D1SV,`#`!#6&!@4B*@ MRX`8((;(Q,"DY-(]?1MVAC:]4]?328HV/>0&<0PB=FYH6II=+R[,BM0@1`BI M$1\`AE3`L%J:4<,SJ$)Y#(`!8`@+#,/6ZG8+P!#)8P`,`$-<8.B:7<.#`$)Y M#(`!8`@+C/G.?6\VM/9[XUU+7S/H)5VS7MS+W)+K)',@2(B@5"/B@*!*(,@X M"D$Z$"24#P)!0)"P",*T23R/`3``#&&!@;8@`5T&Q``Q1";&RI0$Q'BC1L+\ M8^G2>+]1%QV#FS+ M[`.WKMO__L",8/3[C:.2?:A"&:5NVN32(A8/\-G?A^1!Z8QHSDX6/W="- MGNEG]ML3#:5IM/3FTDC6'&O-B%Z_Y`>Z84?WPPG;:+IU%)YJ@%;-M)9-M?O0 MI<9[3^/W3N*[@RP-):R9W/K!Y.4>N+.<4TM M>=9+NN&81S&ZE8_D]TDP'8D^H..U>+3,9N'*G8S1>P^B;C2MVE9$'T?HO0?R MKJ'7S`L0>O\!&D:CKA^,Z#?`\UZGP'S_'9]W'L'G-V'S.4]F![QRR\D2W)*B@SWD^IZJ@]_<; MLV75MQ+Z5'PN:;8WJ)\/&=F6ROX$];-A3/.$$\XJ^2].O.ZRM?2&N:M\+D?F MO8=0:S7JC3.2>>^!F%:MMA^:3\OF_2]648X2A\U[G4/F^L9!X[\4F_<_']V^ M%)O+^\W9V%S.#=Z"S>4NZ#G8;"ZJ+-:KRF(5+YM=:]6ML[!Y[R'4&JVF?D8V M[ST0LVXT&Q=@\]X#-!ILAB&H]KS?6>1AV92!S@><3^U2=#["<\ZF/9=TA+?@ M<[E+>@X^6XL:B_6JL:SRV;!;YZF=]QY"S=SM/Q,[Y^%S.$=Z"S^4NZ3GX7%M46:Q7E67E MPC6;NG$>/N\]A)JIM[8W;QS'Y[T'8IJL@KX`G_<>H&$VK*:H?-[K+"3B\P'G MPB?#[@?`Y5TT_&YR,\YWQ\+N<(;\'G M[XNW0NX_]*&8[\".O[?TQ2=)G&J;)O)=Z>:#F MBDP^:P'\+>M^YVW8Q*5!,'8\CXULVGT^6ZN`?Y.,'7?UFZ4&>%U?UP)_4,?Z MI@\V;+_X%$:Q6WW;ZK:;._H71_Z^U[_M]-^][PV'O2]\$5J'V=6X-L8I2:+` M]WXETU_D3TUO_G[8NU_S]=(C)'(]#0!#GMJ0;L0C;&9)<^>3)Z7,6])\6U=J MUGTG9`^'4JSL@2HH627-OYY> MI2H%VH:GO&<3ZJ5!/[#3?HRC2>B]8V$9Q;^0_^_FIM/Y\.'7C0^Y3R_I4>^6 MJ=?7B0S'LG.3D+!7<.=OHCE-=*^L+?'&H7T?T['C>X1^'],P81LYH4>B](G& MQ)W$,6,/<9*$OD$MLFB5A04FCEF-X=Q>(FY@GV()E,-)NCU)G=5B?SEZS;$] M+64>;ZK+KM#6U`RSN(#*VZ3ILWNOO*I;6N0IK,6H(Z^<4#N]\&N`A[UA^S.Y^=KOLQ,C M[<&@,QP4"Q#(*`+'I')Y]&7),*""IB6Q40/)/%9(<@ MA!4(*V`?V%?&8K*SCQ>`>K.HL,@+/X4E%K2[5+[=Y6,4>=_\(-CF0-!@A`I: MI&"DX!WW.%H-33<:E4G!T&``P2-#&A!4#8)7=:W>L*MRHQ<2#-!7,I"!/M70 M9[1TK58KLD]>^"DLP:BCJE2MRZ4W_-3ID\^]NX_OAIW^E[7=+M!9!(Y,Y%GD MV>T&:[`\:[>JDV>ALP""1X8T(*@:!*&S0&(\3#OOC`#:RK M*X5OHN>EHCK+%GT%"HO0(8D$BP2[W6`MLZ59J_,+:1,L%!9`\,B0!@15@R`4 M%B@L8!_85\9BLK./%X"FCN5<9/!-M+VH_@A2GZ8.V]XCU(E#/WQ,(,A(%<'( MQ\C'.]XD:&G-E70L;3:&'`,$'AG00*!J".2+ZZYTX@.!4&.`/J"OVN@S;E`O!!1`\,J0!0=4@",$%@@O0!_25L)CLZ#-MNU)O MLU18R17)&P2:_./L;3G\*/QR\'\0EP;!V/$\/WRR4.6#^_;!W7RW/@B%/;4@W MXA$VLZ2Y$X6ES%O2?&^E9[HT3&F\O1(X\P5M)Z1/QU&<4N_LK65E,N")DMT> MCB!M)`%)0%*ED.3],4G29S:0U:>+@20I(@E(`I(JA21>)26IHV25I*!B@)8. MA58T>:'AA";;'`A-&D(%+01["/8;!/NZKC5K>)I&K#`%_``_P._LAKJR-;M> M;$\#^M"@`>0!>=5$GE$S-+O5J$R]I[#4HHYZ4IT'8C[V>X,!N>_W/G2'NUJD MH*$(%8W*Y50\F7J@P9H-K8&'\L5R/2`0")3(8K(C$(H*%!6@#^@K83'9T==H M:K91?.Y%6O0IK*N@A:7B(DSOOM-O#[MW'TGW[J;WI7/V!C5D8F1BB2PF>R8V M&IK9P"1$*-<#`H%`B2PF.P*APT"'`?J`OA(6DQU]3:UFZ,?:2A#P*:S"0%B1 M3UC)Y13RH=_[0F[8C[IW7[G*,M5;>G<#\K[SH=?O3'47,FS_LS/8YCZ07H0* M621?)-]=[:6:99B8=XCD>D`@$"B1Q61'(*072"]`']!7PF*RHZ^NU>JM8VTE M"/@4EE[0`%/Y-5RZH1L]4Y(ZW\DXCE[\Q(_"8AL,I!B!0QC)&,EX5S*V=*LB MR1A"#`!X9#@#@*H!\,K23!M:-(08H`_H4PM]IJ:;1D5J/X6%&'6T%85Z8-#O M(DUX*I=HL8S:GH9J:;I>E3L=$%<`OB/#&>!3!7Q7=:V.-:X@J@!Y0)XBR+.T MFF57I-936$Q!5TO%E9>[SG##@BX0600.6R1>)-[UAK*UNMZH2.*%R`+P'1G. M`)\JX(/(`I$%R`/R%$*>J;6L>D5J/85%%N@F,NLFY+[3)X-/[7[GEZ*$A M].OBLT+K+2));L8,!>P[,J+!/E78=\7@AQX^-+(`>`">$L!CO"LN_KW6(I(P M3V$A1AUMI8J]+!IYWQYT;W:%(D04H4(2>15Y=6->M2N45R&B@'U'1C38IPK[ MN(A2E>9XB"@`7LDP!O!4`1Y$%&F"&-TLZ&;9V6F]^6^W_G4N1MT_]&92B]8#E?,6%4NX6)E--571JN&S@+!3!7R06R"W`'E`GD+( M,[6F;5:DUE-0;LD_=AX"FAV%7P[^#^+2(!@[GN>'C],ST:O*FG%.FA/GWP][]=H>3R]WVP.!ES"A;W,X-Z48\ M[&:6-,_CI27-]U:2I4O#E,;;RX(S7]!V0OIT',7K%H$^M5Q9)BV>*`/NX0C2 M1A*0!"15"DG>'Y,D?68#28`D.2,)2`*2*H4D7B4EJ:-DE:2@C("N#66>D^G3 M%QI.:++-@="I(5300KV'>K]!O:\9FK5RQU)>!;\:LP'`#_`#_,YNJ"M;LXM] M:D`?NC6`/""OHL@S+5.K&RMO/)06>@I++>JH)]5YYN5COS<8D/M^[T-WN**+ M0D,1.1J5RZE8PNM`@QEF0[/,E3?A2)M;H:4`@D>&-""H&@2AJ4!3`?J`OA(6 MDQU]AM'4:LU:9>H_A;45M+%47(CIW7?Z[6'W[N.&A4>@Q8@=_YT.O/EGPEP_8_.X-M[@/Q1:B01?I% M^MV9?G6]>!]$VO0+\04(/#*@@4#5$`CQ!>(+T`?TE;"8[.@S#_,2/PNW]:Q!CA`IAI&.DXUU=J9K1*#Z4)&TZ MAA@#!!X9T$"@:@B\LC2S^(X*(!!B#-`']%4EXNK+76>X86D7""T"ARU2+U+O1J'%LO!0D5!!"O0!?4#?V0T%H05" M"Y`'Y"F$/,/4FHW*/#^IL-`"[41F[83<=_ID\*G=[_Q2E%%.KJ,(DD$E"S_E M4BA:0"]F,$&R:36T$^!.7/,!=\`=<"=/O`)WP%U)BP%W@N%.8:T$32FJ++@R M8K\C+CN('T[\\)%$8QH[J1^%B48>G,1WT;0B45@KEZ5Q&V-/0^G71FM%.)4W M-U=C*@+V@7U@W]D-=:5?ZXUCO0K@0\\*@`?@R0`\5NP5.U;66D02YBDLQ*BC MK52Q:44C[]N#[LVN4(2((E1((J\BKV[,JW:%\BI$%+#OR(@&^U1A'Q=1JK)^ M(T04`*]D&`-XJ@`/(HHT08QN%G2S[.QF\?Q@DE(/8HQ4H8W\C/R\,3\7US]; M:Q%)\C/$&+#OR(@&^U1A'\08B#$`'H"G#/!8L5=<=FJM121AGL)BC#KZ2C4[ M6FZ[G[\..[=;P04-1:B(1%I%6H6&(DV4@GU@']AW=D-!0X&&`N`!>,H`#QJ* M-$&,AA:U!9>;WI?[?N=3YV[0_4=G*KU@W5LQ8U6YA(N5T51?&:T:.@MP)Z[Y M@#O@#KB3)UZ!.^"NI,6`.\%PI["PHHY64J6'?VZB,#.(DU(61#1E^^-/`VUS M$72H"!66RF59W+3`RY:E#5*@#^@#^LYN*+QL&2TJ0!Z0IQ#R\+)E66(8'2KH M4"EVJ!0;5""Y"!S`2,)(PAN2<$NS[>)C0=(F84@N0-^1`0WTJ8(^2"Z07(`\ M($\AY!DUS3+J54&>@I)+_K'S$-#L*/QR\'\0EP;!V/$\/WRR4])]_/^S=5\NS8,A3&]*->(3- M+&GN1&$I\Y8TWULIE"X-4QIOKP'.?$';">G3<12O6_?YU.IDF0QXHF2WAR-( M&TE`$I!4*21Y?TR2])D-)`&2Y(PD(`E(JA22>)64I(Z259*"B@&:-/!H#!Z- MD22&H=Q#N<>C,;($*=`']`%]9S<4^C30IP'D`7D*(0^/QL@2PSM4%W6$E`H] M[?+DA(_LMWXX>Z5P^$B<)*%I0IS0(X'O//B!G_HT*2[3>FIQ19"T*EE,*I=7 ML8R7ZLMX54-0`>[$-1]P!]P!=_+$*W`'W)6T&'`G&.X4%E#0ME+YMI5A['B4 M.*[++FR:D)BZU'_)'G$J]*>A=47@.$9:1EK><1_7;&JMULI;Z:3-RI>N8_IV/$]0K^/:9C0O(``@`"B1Q60'X)6E&67C0:)M[09@1*J21G)&<=]T+;K8@S(CD>``@`"B1Q60' MX)6A%Y>R6FL1,!#*3+4C&>Q3C7VVUFC5*U+\*:C,Y!_C!3Q8$?VTLXZ]9+G+ MV+=:UA5C&?J#)<_J+*^$U_142BX!N``N1<"%E_D`7``7P"4=N/#*'Z4T"G2/ M*-,]@H=[4')!2A8E*Y MO(I.S$/71VG5-+U5G17)(*8`@D>&-""H&@0AJD!4`??`/=6XEQ=_175%7O@I M+*^@S:7R;2X?H\C[Y@?!-@>"_B)4T"(%(P5O-YC9TK5&#?J+6,X'"`*"$EE, M=@A>U;5Z`_U\D&"`/J!/+?29=EW3;;TR]9_"$HPZJDK5.EQZPT^=/OG#(1)Y%GMVU%KQ9LS2KL7*G5^)<"ZT%(#PRK`%"U4`(K05: M"]`'])6PF.SH8S6@U=2:JPTO$@-08;T%+2]*B#/K'SO"@T="AZYRR1@/].Z= MA.UF0[,M"#&BA2H`"``"@&4">#,CC-9^AF0VS0C6? MPL*+.EI*E1X?ZM/48=M[A#IQZ(>/JZOA0E(1.2B52Z^XOW%H+ZFIZ77,+(1R M/2`0")3(8K(C$.(*Q!6@#^@K83'9T605]+4KTM0P^M?N= M3[W/S%Z#W*5LTVC^2CI__]H=_FM%G($V(W!$(SLC.^]8Q][4-0?.P\!S8["+P?_!W%I$(P=S_/#Q^F9Z%,3\V^2L>.N?K-T M171]W34YZ.PW?;!A^TV4W24J;7:Q4^:`^??#WGVU/*N\.G<9^U;+NF[$HW'V MA7D>FY>RJ2+*9SLA?3J.XI1Z9^\I*Y,G3Y02]\`6P`5P[6]=@.O2X/+^F"3I M,PW3U2>5`2Z90PO@`KBJ#"Y><26IHV3%I:!&@>=V%%I#Y86&$YIL:0J2]/5"].0/@!_@!?N=I";$UNUYD']"'EA`@#\BK M)O*L1ETSZWC5L@Q1O$-J44<]J8XL^K'?&PS(?;_WH3OJ\W@KM!1`\,B0!@15@R`T%6@J0!_05\)BLJ//:+0T4R^^5EY> M^"FLK:"-I>)"3.^^TV\/NWE<_8F->1BY&*)+"9[+K8LK;$BQ4B; MB:'$`(%'!C00J!H"H<1`B0'Z@+X2%I,=?69-LU>$&&G1I[`.`VE%/FDE%U3( MAW[O"[EA/^K>?>4ZRU1QZ=T-R/O.AUZ_,U5>R+#]S\Y@F_M`?!$J9)%^D7YW MW`@QM%JC7I7T"_$%"#PRH(%`U1`(\07B"]`'])6PF.SH,[6&81YK*T'`I[#T M@A:8RJ_DT@W=Z)F2U/E.QG'TXB=^%&[O7H,4(U0((QDC&6\W6$TSFW9%DC&$ M&`#PR'`&`%4#X)6EF7;Q!1A`((08H`_HJS;Z6JU&<38G+_D45F+4$5<4:H)! MPXLTX:EQ:11(O1!:`[\AP!OA4 M`1]$%H@L0!Z0IQ#R#,TPK(K4>@J++-!-9-9-R'VG3P:?VOW.+SOZQX[74`3) MGY*%GW()%+V?%S.8(-FT&LH)<">N^8`[X`ZXDR=>@3O@KJ3%@#O!<*>P5H*& M%%7661FQWQ&7'<0/)W[X2*(QC9W4C\)$(P].XKMH6)$HK)7+TKB)L:>A]&N] M60QEW+A%SPK8!_95G7U7#'[U8[T*X$/'"H`'X,D`/,:[XNI2:RTB"?,4%F+4 MT5:JV+2BD??M0?=F5RA"1!$J))%7D5'XP2:EW?C%&D#PL60PC$2,1 M;TS$JVO&RYN(H;I@$G)D1(-]JK`/K2M070`\`$\9X$%UD2:(T;I2Z=:5V^[G MK\/.[59PH7-%J(A$6D5:A88B392"?6`?V'=V0T%#@88"X`%XR@`/&HHT08S. M%;4%EYO>E_M^YU/G;M#]1VA.*7:G M%)M3(+<(',!(P4C!ZPW5U.R:7I$4#+D%X#LRG`$^5<`'N05R"Y`'Y"F$/%,S M&ZV*U'H*RBWYQ\Y#0+.C\,O!_T%<&@1CQ_/\\'%Z)OK4Q/R;9.RXJ]\L71%= M7W=-#CK[31]LV'X377 MQ^:E;*J(CME.2)^.HWC=\L^GUB_+Y,D3I<0]L`5P`5S[6Q?@NC2XO#\F2?I, MPS0!N"H56@`7P%5EX4X"$<.4(4 MX`/X`+ZS&PI=(>@*`?*`/(60AX=PY(C@'8J+.B)*==31FR"7SGP0_\U*=)<3'84PLK@B15R6)2N:R*Q<)47RRL&G(*<">N M^8`[X`ZXDR=>@3O@KJ3%@#O!<*>P@(*6EPQ*E3S0F[B2.*3MLWMQ2#$WH+57*'\BXZF5<0S/U5F4R+O06P*]D*`-^ MRL'/TDS;/#IJ@3Z@3^Y`!OJ40Y]1TVJMXN.2\L)/(:4E_WBVF.S??IXD[QX= M9_S+P'VBWB2@O5$GCJ/X)F+S=C?UHS!IA]Y][$?Q/67_ZRVL2#:DW]/W7+?X M;7;LO\WV-E4$.KD@P/;0XVI`.Q,!;J:2P"3TTSX=_>]/D\3[B;CL#-G^L@_< MNM'X=SOIC2S]]TEHZD;MWP.7A@X[/MOQBQ]-DN#';$''+_3Y@<8_$8^Z_K,3 M)/_[TSOKI]^,IF'J[+_7$]QC2-EYG/9$]-J&$WFUX_H3>&?HSL(X?XAAYAM9J&O>P2Q8M?MK0=>/O+'*/*^ M^4%PYI!M-726@Q>'-3MPT11[#:C\9:G7&_:F<1P^D)UQU-)KM3V/EU^GNRAT MWR)D&BW=;MEK'.5U`,>-\(27:-W`RH]LUS5KV'7+6@>3W0,X8U@:P>?7QZ/?IIC464PM9^K5(1PYR--=Q%,/;6?XZ5:C M0)RU0]@XAO->O);9LC9;J/2XSG*]RHYFUR5B-LAF0YN/NGS8/DT=-FGU.DX< M^N%CTG;=R?,DX"L^WM*1[_KGKM6M9F&XNT>T8KLC3^*8VJ2`M/T&?]+A[_(( MTS;,5IE!+HUQD++9_U,4>#1..O^9^.F/\_J%V:K5&LO#7AU"D78'#O*$UWWM MV(X9W.ZK:A<+]CW&L(`"-F=_ZVNZKF+=-:+?3G@")RQQWW#896KBW<,K^*83 MT*1/7V@XH7=T!_*;__X01\]&>QSSX0RC(QRBKC=KA2!?'LEOY<>I-W:.<^=U MM]GD;_OP"B)!'"7)?1R-=J7-T]FPV6@46+0PB++C.XOMEL=5&%EOMCA2-UMB M^C/[Z9MY8<-L+(]TS6!64'KH@,]BT@T#+0SU]4L^@ALV+#^Q$L>>S@?WHIO0YDSO8EG$4!-GQ4AK3Y.U(4;,RE?_UU,]X M4L6HN93]SN(RY[6;()8S]$V66]$D:O766]IGC7G8/J;W4=[3D+YAZF">LVXM,W33V'-:!\?%6OL""X-`X./')G,(] M5N9E>YU%T5=88??V58C-#+`T]*51'#7*LUAV97@'^L(]C=\[B>\.GIR8+@V? M?9/P#Y,S6=O\Z3?]6F\=XB1+@WV;DSWRHK&3?,?.LG'$62Z=XTPK8K_)OLY^ M>('+9K^>T-HA_5;BTMSZP80=\E*>:!]XC1:'>SB#2YWO:9RQ?MR)%L.N>/VG M/[_`%6QN=LKIH-8,_R9Z'L?TB54'_LNTFF1,[8U8T?!F.<F7' M?Y9LM'7@IS'[_L5@LU"C[K#J,5JW3:7'UG>,\N19W MD!U;F\:W8B;+K!OVCG&4%`5/=S$-LV&9S6WJ6SE9\!R7<:LLN+?M]KZ`AM&L M-6M;1W"D,GFZR\C;]]Y`F3S'5=U/F3S8MGM?9DNWZ[I,6ND)O8:==DTYK?0< M3JR&5KI_[C.,^J'RRLD-=*"$=\*<:AB-YGXBW_%2Z0F\^6VETKV=J&G;]4M( MI2=T!-NVUCG"+I7QI&+I"1SD-&+IL==E_\+-,AN--Q5W3^DREE7;)I^657;/ MX0;;E=T#[+?_I36;A3OPEU"73W.Y,T7($%Y=/LYQ3JTNG^>"[N5_^?6RCKI> M.X3)0[3R4SKA@5KY,<,N9^H-HWH;3?NDICXT$BZAX9\DY$^LX9_KVA[@C\:Q M9W3"FQ)G@MS?^_&[:G+W_HS]_]\&;W4)JMULJ4:N?HUO#_N#,ZEQ:V MSYF<^EP.<**68=EG&?)TL8-;.J)Q3-O!6+O:N9IDKC5HEQKNNRCKU:9_` M#RVCN>N:[GNVY[_*>[OJNW5":MG3VB/@X@GU]GX*\W2^:C,<[@[(PN#VP?LA MYW,*&!:?X]SO/$Y^9?;V+[O16M%8#Q_PL0OBF/KTP:4!'9>[D67IA>B_S,H^ MIK'A1'9K\*5&?]K!F\N#7V?D>HEAEEQ!YVBGJ+5JZU>`.'YH)[K,N]SQ=-M->R^D6'EJ\8!'K)]S M]#4QS)IE-=9YZJE6TCGE93KUR'9<-X,_F+PVDA:'<.B2.L=?,[O9L*V3+?%S MS/4IJ`?'C&+7M;";AMDPUQ[NE*L^'$\Y4Z^76?WAI"=QNDMZ@:4K=OM"GD:. M'>6!ZP0<7[B:NF4N>_#)%Z\XX94_^>(5NXM.H]:L[S.($Z[^\ MXF\Z[!*\WV/]BO+-WJ:U,H\N'>C-FJ'OZ$HOWS3?W#G.BS;-F[5-XULQ4Z-N M%KIQ3]4T?\*+R:7&QK:E-$HVS9_C,IZD:7[_"V@T6J9N;QW!<8W=IXQ)JU&X MBF=IFC_'53U/T_S^E]EDU99=8D27:ET^9?`;M<:ZOM1J-\V?PXF5:)H_(*8: M;[IPS?&MW"<,JIJY>O?NG`N,G,"=W[1K?G\O:K76M3[O]^A!Z=[L$WI"DU7Y M%UY>Y`3.(43'_"%5FU&J8;YDO_<)W:71L+>VRQ^S&,HY_.!4+?,'7%O#V-XQ M?_[^ZA-=[Y4E%,1LF#_.;4IVS[YMP_Q^WI=?+U.0AOES.>&9&^8/,?665MDW M;9@_J:EE:)B_2,A?IF&^I#]>NF'^7"[Y1@WS)Z+`B1OF3UGV9V7<6R\P=(X* M[_SM\@=("F9A9?S#%A@ZNB?[A`YBUHQ6J3[S$W?,GTD(NT3'_`%SB+I5"$]A M.N9/JNR:JTN;BMHQ?[P?KA.P1.V8/\!5:[6=3]:4[)C_3!^=X(N3IBQ+LQ_G M1WG;OA+T0?I[^2 M^2MC'_C.?R5?VOV/W;OI^Z6S7TP_F;ZE=OZ>V*777Q??IH/R_CO_O\[T';M1L/!:W;LHI<0T2?XJ9MLTC%])=@W(?1RYE'J\ MM+E>>A=N\>W#TS/-/F;&GOWD(?YY]N?62V#89[L&;W()_H\27MB/G3C]0=*( M!)GUQJ_6(T[HD3&S,W-E]HT;./XS^S#V$_8M.SIA`4%F]Q.8:T_BA/U[1-@? MY&'"?D23Y)H,)N[3FGW[H1M,/$K:?T9Q.+^(S5\30'K,1^8"?_%+&1K^Z6GR.KM\=L`D*O%][Y/?]KR/;I//.=:L0? ML=/:VJ'#/.83:F8 M4=A`GOPD>[7TTC&]B+]J.CMJX-,7_B7[;<*OX^*`LS;G)X=][Q!^MC%W$L=[ MH=P-?+8K=J91F'G#B+D((R%WHBCT_/SXS!K,4-FPHOE$C]DO9B>=/)%1$'WC M[D-3,F)Y^8F/)OI&V(`==AH)IRO?=.Z?P8_74:Q:E_URX12UJ?OQ?60.J)%/ M_KLA=9]R7_D'.P?GGDV*GKD+T._L<(SD[$3G._+XY65_,Q_*+QD;UX>(_=[0 MW_V_Z[6OX%:5,[V07<1QFI49Q#`TPE*$R@ESB/S]R1=OJ#AY)G&K,J;$F3, M+ZWCTDGJNYE3\\S.@IF#_V#"KMX/ M'MS\`U8F.4&:&=&97M8E*XPHS3.*&R4I"VSF%CTWC3*GJ"\ZQ=RJ"1OZCVX)K8FN_3SXK,'@2XQ/:C$RL(O59COA, M^1P@C]PO/P(G)/=+M$GXCMUK``XQ_H6?V<`'K%SRD-L[/#\FK"4Z_)Y4!8:DSR0>19F'TR] MM1<[K$PC[Z/HSVP<[?\Z"2M(#KA<^05IZO_S*_E'IS_LWK0_OVM_[GZ\^X7P M2=.[-!IOG1),BZ%F;;G27ULN,?K\/@DI,6K:Z]5FP]48#V/WS_G%ST[T?N3_ ME\;S%,331<"+JGGLYM>9_]1A'I$]1D!X5<(*O^6TP0SEQUF)&G%;3CG/S#"* M_;S(Y7&?VW5J^8V%)R_<>5G'BF4Z119SO2#'U',V$WTM?&>$8YQZ]I,DSQQY MPF05//MEQ#T_9DDM-TA]Q]1IJ700#$1O-(5=KFO,S&SL?S^PK+H:\I\_WRQ% M//_5NH`GKO_B!VM<;+%`S[)H7MBSDV!F]KT)ST&OB7,:DX/)F*4T.DV/++;Y M>?TKBO]R[NQP>1&6+"7>S$YSS#FL M`.*)=W[B>09=L$-6T_#BXCGBE7]6Q[&RFQ7W&GF(LWJ,'?%U_I:!,2LWPA$K MM;(Y0A:0/%QXN<6V&\7.Q'M-Y2P6\T*,;\?").,J(^42&O/Q^*/14G63QH[' MZR4WIEM"=J^"@!TDF=9P^9QH(\#8N;(DM.Y;#C0>Q=J2W[P"+)L&9]7&W,&R MZ['H68M1[HSX1(>O?^EZ<^T>=^_[]2\VK.T_6#X)\HGEJ=Q3V;[_JO%YY#?*ZCWV__#R'23L*G$7?_&C8-KNQ38=4#?_V\BV-><3*A8M MS[R:<'/G9O5YFLUPN"?&(ZX6L-(E*S-FRDV>R#;ZWW"U%GZM@=G\*J'3F1>C M1S8GSV;,[',VCZVYDTI6E]@S),]QP](S,_(W\LEA M_I`P'F71O-8[^3R"74`G\X79-$(C-UEJ:>>?WD77+&F],^U64YM=P&USJH[# MBI+->)]"Y/^<'VSPW&49X6]_A*PJ)9^=AXA5EU& M:!X8&ML\X'1F_GO#AL?=9SJ+S_(5K\R-QJIA;AV6`,DM#6+ZBKC]+5`S6^)8 M8.F<.SRI[9D"%\K+@1^RR'X_X<,];?F]L]9^52ZXM.P_\_Q)XTR:XY,5ZFGL M8CS0/.E[?#KB<0@^1<\T8O7N$YNBS/8P4VWSTUK.B*R4&/.;=;,),Q?B>"KG M^@V_K\6*;W:%GG@N7RP.V#PGYF3C.V9C"[B@\8V%DY/KHUG]GDLG!:PNZT'\ M=S/UY#5%YH((3:YGUX_]+N&"S4QZGE[&Z7$R@/."AS\`]6ZFK2\4>U.M>U[3 MS20%[I*LIF&F\[ULHI%;)_T693S.D!ZQN:X'-=Y1/$@>'#"/^/).'5_3(LSCG_^DS#Z-J5Z-@')YA8S(V0Y M91ZK"?^J/:O`2'X"MVP.G1?1>7!;\VE+?K9SL2N3U[)#9%L_\$J8S3OY]"7? MTQW[6;XG/=M333;MY-SB1IM5LP&WC/$ZPUTK3VP1/5:T=,?]S\3/_9Q5LH_, M\5^+".;V#WXX+:##A0LTE_Q6%90@5U!&ZXM:M?Y"/PDF;`=_#'Q'C-0L7&.G!=V M"=G0%G6E5\PO`'+$9_3 MG6(&YRU&77NZT]]SUK/0H$Z0!3NK_'E[!;^P)6>\63L$U[[#US'E,QN>>!=R M_^P,DZ=HPDJ&[*YCEG%&;"KK9;W3R0/E2EJ0_C>K=P)&ROA5=IIK M7NRKYPR2>79@OMZ>//):C^?YU3"?;YB7?VR'W%_SP^8:S[P*F9:#LU(UO\V> M!<67^'HVLB6UYW4W:QU_83,R8D#@$3XMWO/Q/673YGEAQDZ5@X^E@SQJIW&< M9:'O>2=!WF7``_XO]6N3//M!L$_8,32.>5$Z#:-9F9GQX#`):K,:+(42+',< M]0K2/)O[3MAD@U<42]//I+D@Q+ MT].GHQ$7]5YH5D^S#_UT*MN%>3\-?WR;<-UMX?SBK)93+,N83HQ6 MY/4D6F;4:F/6_@?EMP^8Q\]&GNOIL^:<;]3Y,],WDVEGS;0(*5X[9I)P-EMW M7'<2.VXV]\A:&((?F2_QBY9U7LQ*03JC][3V3A@;_!&;V+!S9)5&!M.$+(%A MNG_.UVP(K.Q.G*F,^GKLZ;Q_>LU>3W5Z01:MD+$,? MVF+VR?/,NOM3T[RT*2V=("OMO$.YL$S4/JV[\[YMY\_X^R]W$VZU=FP>$?XTOI:NPX[ZY/^V\_?'^+I8JG_/U!+`P04```` M"``6@7%&T_ZBRQ08```J2P$`%0`<`&%K`L``00E#@``!#D!``#M7?USVS;2_OV=N?]!E_OEO>FX MCN(X7Y-T1K9LUZX=.9*=_K\__W?GH'/JS1'CX^./%OTHL1"&Q`NP!0G[1>?@X*<.^^\? M__>>@9QBR"#>=<8![-P`W.F^IO^_.SYZ]_*X'KXXOGSH\/X@\_"3[Y[8K](??[QB'^Z^_;MVT/^ MK^N/$I3U0=IL]_#7F^N1-8-S<(!>!7SDN1)R=82?8'\[ MB#]VP'YUT'UQ<-3]\8G8SWX*-=?IO,>>`X=PTN&BO_-7"_CA&4'SA<,DXK^; M83CY\`Q\Q4^TE>[+[HNPC7^QW_R.?Z><$<]!-M/^"7!87T8S"/UG'=;TW?`R MU0OPU<,NX^^0_>NA\,N'/^F0[]*ER'#DTY_GT"TOXO;WF90:Q#P%9';N>(^E MY5M_\5`AP><`X<_`">CLF_@SR.8M<%?D'+F4+@2<2SJ"<<#T0<;@@34K(77I M1@_CV:ZB2Q^A/\;`ACW+\@(*,8061$N&(]^#HC:HP&J$'07S.<`K;]*S_PB( MSW7B>Q?8(V0$'%A"Z7(M*1S4EW0Y=WT/HS)2[GQ)F29OL;>@V\OJEBXT=-&U MS_X,T()I05ZX@B94SCLZH#PZ%QS$]P)O<@:PB]PIN85X-`,8]H$/Y`67;TV9 MNL\#/\#P!KEH'LRO(=V&;L&J[#I1T(8R8<.E?0R>*,-+1*B.RHS8[.\J7;/& M,W@!O2D&BQFR@--SG,A*2"V@L2BRHI=O5=W.3%?0/IQ`C..-E6JPS$*1]WVE M._-\COAB&0T]WQOYS)Z=(NLD(,B%A-P"[%,CMX3PY5M5I_@[JJV-T7#E(=?_ M3"6@$XT:$S9T2=H8D^]4I88W5-$!:`4.'W[7M!NI#L(G'](F[+B+#*^291DN M&!2-CO04`A_Y'HX!'/``G0_/`G(P!6#Q>X\0Z)/3@(XV9C@F]1P)PMGS M3P'&*[KF<[M+1Q?D@-=\IQGOX70?`;9B&>F/.W2G#SO1)PX)LW!8:P>(FNCQ M]R?8FQ=A&^(/S[K/.H\036<^^_&PZNC:,2+IXJ9SL.7AI7E*4 MKZ^(F1=;S%2C)C9'5Q^A%BI2[>_]W$AK(U+TD8HI$&_E=!,/I;A&X(':JSX] M!^B=#)+(+9@6LCJ,>'NI9(+TE@`Y;`J>>Y@=(T?0"C"'U+F`%8*V@"X)S45, M'2MAZA;#!4#VV=."F6)TBQM0&Q]KMVQD8#<'YWTE2TIY$5VOMNFJ.K5XZQ_I MP5VWW9G`J+J`7WB>_8@<1X>0Z[;W95;OO5$>?/^7OA**%!F=%=U1=)3< M0'_FV>SP&%T[:7$_90+M/S,"!0EMR>J[4!/V9#;0_K,@4%#$PFLU+(3MZS/C M]T+/F4?=S'.2,K,X=2W;2US+:MK0<_'V92_//L7F*4IH^.YI;X33==M4K#BL M$END1O](!DJ=N1#[QF_!BD>CL""5!JX2LN!,N[/%_&5=)F0J3.4MS^;.E[#[ M)<_UZ;$3NA853X\])(9K!S.Y"A,L5I68X9$#$?\:YTH6C.&3N1P1F?I1N];2 M68@#:`^]%7!T7QX(H,QO==(+5K:JE-[KG,T7CK>"<`@=%D31S%Y8#-H6DB34 MI_1RY]ISIV.(YWWXH/.R-`NF%4M8IGYTG+'#R=G,="E`-'ZK)D=-D=Z$9_!: M.TTS#+6>G&)>WBCB)>F0U.JBR@:J:CLF%Q;-V60 M$(VG.31V79`#W!JZ)/4H=AI5WT0;6PIRT,RZ4J59RM.7-F^8YE5Y?W2?N8R) MM\(V29BWV5_I&#P9*+5"Z+WYW'-YH_JBY;W#6UZ,X]3,'<<$.S5F,ZG$BDP76R\$?H#R;4&M1T3E8N9EMFKQ:* ME/J"$Y8"76*:V=(+,??H()6K%('))7'N;4NOLCZ5'W%GL3/;MR6$(E]`-H*;HEVT(XV,V@Y;4\-Q6B6CB58YO M'$Q8]#B?,!`OD07)B,X&74&.`C2SYX<"#O*TM+M4'-1S(2U8O2EJ7D7).EK< M%;L@-<[(T'%8!@(OE.50_?3L.7(1804!J`D0(6B9RG+(YBTI(:>IB2ZI1Y5! M/7&Q!FJT/2`W5(I%]T""V(_1[2^/E-?!7PETT^:2%(-EM%D_3S<+Q>&"DQLF7#VCX/"M%5X'*1"?9:@?9N8=]](W+/9AL)PII.9/F(QHW M>Z0H*E*;,&&GWM:[.;9JW7P3,/LR7W9[GDH-39I)^?O0'O2H&W3?PZI)VD=]JT&_2WCN\2S[$ MD&BJXJ%/7+,CH@$B,D=6<@"JM-=B\+#]:/Q2^;P86%N=%PGJ)/*DIBV-)I>)!4I4M@V%;S^U($UN&!VT=DX86GT<$DM*&[6ES!^8C& MSQX-#X(B`I2&TO-+N.1&E-JAM(6AB1'_:FP7$2`*VU?@5X@JD+M3;2Z[7#SS MCM:&J<[7_F[D_T$=R[^H9V9.AON_GQ?;;HK'B=H#7R1`M'R<0!=JNK\50;5A M5HLYSE"=ZAL[>M+3ZS!,`YCG([/#Y:973OR(@N61FEE6"`KM#68<7M3S?8P> M`I_GRWM#N&"+N#L]HU_0$PRD3KC6<5^+":6AG]MO1IP`@BP=;&<#Z=OW*0Z' MX&!FC("T"*;]0+E,EUNFMG2K.->KS%1IF.4RPK24[U+Z5IPGEA$DJS,^.0_. M-'L2JDARN+7_J+2U1>'+ZTK7]$1`4I6N=T.7;]D.1K67VMAN@=8,0(TB&_?= ME!P=VBG44%TW0]RL8'GVRB25RK5S0^?W9/SIZ8!A5X.BL:B)W+QPI:9CUM=/ M.58UUME[#[0-_B09E>%D=4=8)/SZ?KW'GES5ELQ;`KWZW/\K>@U*F@_.F_+5"P]##;`>_<2?PC.\&SU[BWN!4\)5BFO;:NGN45ISBB MEME`R66@@66U$-/TB;?>W"M6J;`"?M4$G\BIPG(7YNPJ11MU`J1V$R92G_BY MI0J+([N+I"+&EY`#ET[I):2#@KTNZ/G;=K)@22QNI=4+H822U%3,3Z*QX)_! M=M!7&3:R&_@>B!"H1EB9KU8\%`-L(`@J"6/87Z%@G]G66T3-6T6/DUJ8/8K> MA^&?EVY6,7--=QTRR&V=8V45'!^FG^NC=:L*9V.D;N.V^3@MI]B83(6O]OT= M6M&.T:$X[J*K*AWN[P!TM51+QI-WCS(BW%2MZ7%]U42$9#.+>A9PNP^(DLJ- M67VYPVJU>*@G"Q)"VX[B(MFJD7U4;>C6I9Y`;=[8:U(1#XQC#8'F?R<9:MRD MBW(&NZ_43'6V7Q`&"NF6U!>>#MMWBDE!K3.1.#DAM M2XJ5!1M,-G$LFA*_\P%;[>`HT&5,W1M5:0+BT_@06A`MF3'>K+,C@=OF[5-. ML3&?;U7MDEN8;`%WZ1<:\VXD`5L]$0MT&<<'/-<$D)]M*: MD&2WK+(5AZ_=@A4_!(X]7CH2P[B""*]HO:DZU)M,D(/`SLV^HBE<7HI]]:G* M3NH*>M\-;JNW(^W(T$2=R&+0O3VG5Z56IHYD'7_+#J#PX?I&"!6C[ZDSK2JO M.6K>C8F+#W_O_WEPT/G/EYO/+__[GU^M1?!T[QZ_M;^]7D[O5^Y=/WB\>(W? MOO[EQ1]WXQ5Q7B^M;\^=*__-W>GUK7W_FW-T[/[Z,#CM7ZXNQG]V[[]UO>G) M'_T?!O>79[]]6W9_P%]^>W'C!X-S.!S?OWJZ/OUA.?[E\JI_/I@$Z%/W],W- MSY_N'^Y.WKPZ^_;;(0Q^^'CW^O[K!3R^.KY\O7Q.KBYFP8NOOST>WY\&^'/_ M^KK_XL^SR\>KGP>__'QR='EBWZ.CT:O>U>+ME^[\\KHWL4;'D_'5[=&;CU>O MO#>?5JN71S>GQ\,C]`OJ_OSITRMX9CG=R\WR*OPPR6&BSJO4*O+?;=JV1HXS.G"=>:HV\>%LAM,)A#O//DG"/.5;ZV-^T!9 MA:DL?"E_K][0)*TG4!OI5T2%.*6EU@$M-$3BS45;T<0\N):OPWF*W$UPJ7'A M-H2+%)8.GG8PVCSC=A4FJD=9>1HQZ>@:SOY@1^TELT?T?U[!MPI M'`(?#MSL[FBQF,K@MYSDO)@1!]P5B08E<"Y= MXN,@=-'R&)P:6TWHJ%\CLO0&QR.!GE)X8K`Z)=\R>6RH1_+@9DV>0II3KW+* M:U3I=?RZF-BYAT>I8F):!J,8K45E,:9G7K>I:<64++FQ#DZVL"*:/@*6( M+*U?-15@8OA$JF-#;!8@UBL".D=AR']3VT`^HO$0#CEVTR\SY^LPITY8$R82 MM=MYCO5N0/+&(JJV!^TTR(X(?%)J<8WDXM7Q(>PVS!^9;+0K*43CDT"&VM36 M6J!!1;>LW)%_.@-X"A\`]]T/Z0\^9*_HXJ5<19.CW$Y.E8HRW&\1^:B+J75W`;,7[.74G.^ M,H1Q<)4&<,_FU94( M_$G@[(JKNQ%3`UYYDTUM:>)[W%Q@A_*DFZY:I4#6 MR!`NH1O`"\^S=66E9N+4.(GMM,=5THCD(9)I%T`><:E:A@)%J7G,261=999M MDS;:LUJCG9A>72..`3X"T;*PGU:,ZX8-#K*LE1U@IRTPO M+Q+0AH\0IR526X5),9AQTTF6I1Q]J;5] M;P#^"OW0SDY8W1K9*4!L#45%FA.:L4W9L(G:`#5]J'%+*TU6:JK].D];1LV< ML[DS@[:V/4&`9'K#SN(I75$@6T%BQV=-(KYX^"LK6^"QF%:M1*216D/$EH+$ M*=(UB1B"QQMJ(F,$'+;9CX+%PM%6?Z4`LS7D")56D"/1Q.*>RN`$B0S.]5)? M*5LC.RNT-_'3+RF$;WZSAZQ\'/`7N?@@GN*=:2Y.Y5`!52\'+EL";1Z-`D1C MAH\&[K(+4KA29K M.!?/_"6:C#J2^6Q*!HO*5^RR,;0M^WEPIDTA62ZE5)>3)]R$132$EN=:O.0, M;YHB0@NUJ_91["^\ M#6CW*!B8PH_!_('NJ:&`8?6'0>`3=CID7LKU1;8.DJN*4K&Z`=Z'G"5A*YLIDD" M:`S(+BF!68N]Y%!(/5U;4M,JW;"2V)?N^-&[AP!K,:[*"V'8\-9/=E+ABDNV MRTM`.89[0/I&C.]]BJ=U+K"2]9)^[@78/.<;*8S;CTVPGE"ZN$Z.;N+1<@\F M^T:*OP;Q&Z6+:T9J)7X\@Q@"=@]LD/>$$-_]SIY4^&YTO4/`E;/H>4)^`TV1DAI%D;2([<5+1"D0J5 M7BY$:",?^*S.^C7]<*.T%0";=@-5IJ](H6KO5.,Q$Q9O:G3:B2#;.NV$*E1: M=W/G!7C]A!5!5CTIQ>U&"Y:!'A4@F[]*DF0[.1QEM:HZ"2;&3:U?!CB5PC=L M^]:@54Z]*M\P60^H<($S,4WSD=L]30NTJNI]DG087B/TR?%5LHIG[JK65,AF M!2F,.UE*C,TJ2E86>M/TAND.MA MY*_BF&C^,G"RE>S'HPWE$Z@3OT[Q@M)2]ND/Q-<3:E5'',.'"0/#M5Q>1PZ1 MJL.=RTH2K81[,J)B:9?/1G60Y4JM M5&NY#5._CN+4/K8B(40,S8I86!8.@)-9?-'0S)>5[GN:[]*,B`+CU`R5=;FI M1JC?H)EUQM5@,J$PQ:\=[]H0[)GT9JPPCF0Z2*..N16J2AQ7INAZ/_'R42-W M^TD\%1U)-WF+X0*@>$72O?KG`._+R,OC63#^\M2IPM#?-C,2>.NE:.3#1;`H M:X_EM-06/LHH1TVD%D>\W`?1^\I2VE;=M5C>&:@--4I;`('#0E(NO)3(_ M$ZA&W='=UG@NWD>JZO$C=);PAGYFIJL,J2RZZ9F1R^]6.5)IC2I>QL70(U:' MU&:IE"O/.3ZGZDQ$?#BX#;SZ]DGP&&& MW6@&H5\WDB0["B=\_Y,Y4>#AD([37=(RW&M)4?GRX"N8I(#,I M!UOEQLU.JOJC8NV0JZY>)<&`E67@;HHHES-KP"LD/`/*^&9H>`1D:5]E$EL5 MF1*GS&EI<)))"^!^=@> MU:.OUE0K05UN?`L``00E#@``!#D!``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`9YG^`/2DP+/B=,VI?SN9>N MKJ+D15NBNP^9["QQ]BG)T+NS/`UCE*9>3)9'&J;)XHY8=P(7LWM*C*J,8YOO M]P_Y>NWA;;)X")=QN"":%6_;:JNS-9$/)9'T M'ODH?/:>(O3@18C*<181Q*G!4I^&VFC6=)N2_.LU\13B+,$ZXFY\9)6=[^]P MLB&>R_:.V'JRGP=T76^4C:]D"-MJ_,-5&!-,B(;-,/;B);.7ZF+D?&Y5H#]> M>C@F%-([A(FGN$YB9C65>>1];W$7H&1^ND'$[!C*L?-C>QX!)?'S0Y;X7^8; M:@W32_)QLD6(_>R.>-(KXAE2;2/*=H_2#(<^,?KLM\IS,"9@?4OYKMC_'[U7 M#8O0_,JRO^`EG3TZWB1X+7FIMOUL5VU??>! MKMDP8TN"*`]Q2NA^B&*MW54\BO4]]=U?'_(-^822\Z+*=ZH)*23>:))33C3F MH#.H_2E]3W?TADN"DYC\T][WZH_$*B`$]DLV+6Z2),-TD:LG\3 M<:D^I&Q.^4?/Q-#MG?=?TV(8OQ&Z.0:FZ9P$-O& M\:?S/,V(Z<5,P4-$]L"`*$60^QE9J%19L*9=4A[1NCG]^1Y%5&#DR$D.X!/5/A^.B<^$1+G?-*^U/+:O'^W0.*$'43_IE[-!(8 M;4MOTXLNO,S[''MY$))?J_.L/*)U0;^_04LO(BKH(Q109U2=Z?:G%@7=/F&> M;=F_MDH,"CZW:M,43\>/]+QI_I*QZ\_6#^::\^CZUO[1J.,4K,LG?PCK'JKH**S+ML)8EL,!&H=@WMZJ9R9=WUMS7'O7H2NZ M1Q/5_Y@DP4L818R`VH5H]Z<65\&M]V>"S^ER8^YPLKBF;N8R)&1F:8K*A:?$ MK.)05E?!3D#F;$N&L+D;SM8)SL+_L*5S^;I!<8J2Q*,+/CC;'VNT>/ M&EI::3RZ1?.FSW8'*]:V;)0]8B]`[:").GNR,:SM6KM(U2SX,R^=L"SYB),T M92$>=9;51K(98JQ"3\21KAR9"T2=%ZJ,&AJL,(Y-0WH8EE)BLO61-0VH3__R MU2\RG>9/Q,-%&:K(;LW$*1O/ZKJSL`/2?1,S&45YX?1F&V M97G*Y"CTB/!:0S<4A[(J;#6:)OF69B/;MN#G9'_8TM#;FMI?MGO=A-X3XX;N MWTF,F(:0G]^CM1?2P"(Y6A0N&@HNT%-&SKS,>&M9?>MTK0JF=#N)%\VN$HE] MS)(RH9ZZGO3\I:&WZJ-9,W;*)$TTUWAP:].[];(L-:<][W0\]H\][:)Z[ MNL/*^]AF])6%-M'A=88^LVHC6?2N=_<;Q"=Z#M,J"JCHK'9_:W4OVA&Y]S+4 M7/,&G/(&L2C1QQ7ZB)(E]C8K:O:IG^R7)JH6%*@X4IV!_J@6U1ME%VB!,*Y> MQNROPU3]'>[W-M_25"?3SS$F$"]CZBD14F(Y/I11_T5!K+ZOBP,4'$%=>>%`2%$CT-1L@UFQ$ORHE^0%V6K\L8J9:'P MXHZQ."`U@X]5I+R(C]/4)>JEH*`Z7FF%8USQ9OO,9Q%6\!/5B%P!#1:%>Q>L].;?+VSA_GHPTZQ7A[!ZNS:`UN< MV!U9&=356J+&48[=J)$U0`Y/NR3L'C>-_:G8M%4ZN3MJ+JO.@/:\*QJEV2G^ M'4;/89*GE'B$@AT'N[6A846-!K;]@$;M><,%RKQ0,71N,*SM_%5^#K[N1.0C M60:D.Q=?EVWQ*-:S&CGI^+I<2X:QFTG;E9"OR[!H#*L9EJ:Y]KH3ZDO'=K)O M/35?=RZ='UO.QCYX>:_-(N=[VV+L>#F@S:I@#+M/.43O!;2Y5AG,^NN)7FGS MVE.T0LU^HKL@N5Y[B@IC65[8JNGTVE/1'=BV*>`^'->>B70DVZYJZS6YME?* M'<&N]BB_6]">@.[`MB%HO3/7G@%W!`L07"0^R[R>$3>=V'F::Z97KT8XP%Z6 M'O95F>34VZS*9=)"F]\SWH.0$*;7Z]\$:.'E4?;U5R69.L^[,8@!_)9\\FWY M-]^V/Z\V96!F$YJX9LQK\75M`X;@=D6&P'[^A+[94=9CN&N`^H8)(F(FFF_6 M:/V$L*9\&Y_"JJT717K,T0_V+!%E#6/FI=P0X@VVT&N&XH!6[BA^2K\V*OFZ M!XH0C!*_085E6"2X(A)Y3RCZ^]=Y^LW2\S;_V@5?"'?HFOPS[103F^S"2Y_8 MC,N/OZ6FZ5L496GU$V:LOOGN75E5]_\24/G6!M-E)`J0X6:HK8'G##=Y)OA7 MK)2JH*8KY3<+G*Q5<,D2OB`2'"#\]Z^_(W_+M/B_Z6474;/+XAZ'<>#I/9:PBK1PU"Y3Y@'9Q.JRH$JZ&/G4`U)=3& MZQ`/4T1*,I_C=(/\@U#<-X$1,+36[\ MC)#:O3W]A$"0:8P_C973%(G4QAF)O"[YJ:5NP2T61\E06C:H@2Q@_ M6%X^LVJ3OU&F!"%%X@7-3*?K>J2H)I%GDC*^KRM7R'`XF'$ET'D1T3G-1D MJ!!_,T*0,=O!`@1J7%HNPJ$F4/&%!7M2+=)CT'F2$G))[!.H^0Y6FF+0%=5-:"*@<*0D/Z3V"1'`XC%5*+@H_`B#`ISLIW)YJF)\C`1< MVX)FKAT"DF>=F5LX\@`P7VR]2+H*VP.*<>7.=K6K5M> M0,D&U3/R\KE@FUD(I.1$)X69@@R!,@ZJPQFM1@Z(5Q>9Z=B[3B'!1FV*13S, M8I)0='M*TD-*)CR%J$ZO76H8P(X#*SE,HK"/K=/L,*?8:6U'`DA^LK3_L/!@ M95?K,0Z=7!#1]V//!1'.72YLXP50V\I@@]`<2DYP4=4VWJ;?$9*V_VRQ=HU7 M8Y%5]QOL0E1`>#+`*R=R"(SO#)*8D89[6WI( MPRD4,G4\O!MH2@@]+3D6HZ`J-SOS_7R=L\@J\0U#/P2Q;PI4W18WT,%-182`%SX5+>8:TCKG M&*UH.8UG5-1\O2&^_%6"4;B,BP"%7U0H+%HY[KL:?T+9?$'.`4!!..ML3FIM M@^`$=$G5GMDP+LZT$.V2$M2]DR2M"?@`T$USQ#%#=;E5FZHTL/&W;YOE^6H5 M#P>HVW?86/=4Q@^,X5,9OU,9OU,9/PDJIS)^-B$ZE?$;51F_6K#D4T(VWB'B M235"HX_O<>0#%)^H46,-<-)9GJT23!L4`V/2(C(A7(K`L5@AO6EBU!6#%98=<7-:+$)(NSE^;;R83^?#T_GP M=#X\G0]/Y\/3^?!T/NS$B?8-OD?/*,X14/&<0Q)3>'O=$@O,FT-:%F2^H!6M M6$P?X>?01^E#$@&=-[C47)[3NS7PL'H*3TQ@FPQ+&[W#R0(F::`^O$/IRS6P M43^O+A.XK)L'%$6TTAN*$?8BPM7*<9!*# MJI@W)^=NC]:S*%4"!)PV$;?-+I2TL_$VI"TE.(=C1VR?O`8*2HV,2V/6`Y6Z MH(`NRYKV0XR68VR"D-WZ/3RPN:.J1GCL?KFB^%2J&5@[89UY>$FF=I<3W]-+ MT4?R[WOD)\N87I@3ZY##O',TY&3D3KRI?"T72]@%7@@QJFWS^"),-TEQ_)LO MBHWZ'4A\2DQQ]-Z]3&+REY4]WH#7[7C#P(-XE6**HT=*)C&59Y8V-L&BRF!. M&"B]W"1.S]`BP>63%E;[[O(UPQ[AB-@$O&77!_1]-/F2""1BO!?;.OS6:9?= MT2?J@6(%U#AVQTNIRV9(5$%+_G#YC%79$D*0T6)4(0#O)N2JO%M/*#E24\DH@;/8%V&4D^FX MM=D-)ER>JH2*K6VAF[)5L-%#6.AA`==C9X+0:\H;JION(?"GU/Z`(^6=,HSEC]@]_33FXC;4FK2\U!_(0+57?H=T3)\ M*)@]$U.P1)]R.LWYHO4P%,QCTF/`S;65U770*(>H)WVP5PT1S5^CLTR@!^3DNBKRU:B3>T7`HD64C2EH44P/+*P!DV:&%5U@`K0P%2/"`KB=Y?'<5 MYB13I^S%@;!,YTA4$&8"+CQ+F^H(!"O4T]<6_Y`U>T7D1KQE*4E+L6&]\SHN M784_3V5=3F5=3F5=3F5=&+U361>Y9I[*NIS*NIA[_JIE^8&\,!ML3J-)3$E#7[,[R0( MMH]#G/>[10;T'.*`&)S)[R;DUG8K:6DC'ZA;6C";>"M8;2#C^I9 MOV]9_-O&R16H%GY)Q.DQ7&@S.!7P*^'`+)6RW2D<`DT"CM\%*9-0.)S4B3LL?*`,G(8H5;JO.)LP1%!`;FVLWX&\ MV8ZR:H%!?F-22-_GU!+(7DL@^P^^WM:;=S4HNA^OV^^;Q<`NNG-=Y)C@?(=P MF`2LTQW[W7S#7@9=OB+LARG,TQQ])L;[SJ.'8%5Z;EE%N5CDKF$6<3&)=B`& MPH6IN"K2N3!Y,\8,3()PVPH8[!:K4+MXS($%.0V8V7R MBUPD9FF55^LK_1Z1TU#HTP=#]*]F+QX.6&^6H5K$0_GGYWI\V>5G3:GHL4\S)4A>Q,F'S+A>S0OU9ZSF:(WMO MII\0>K#8.<]R1=^/.&M6/O=* MX)9O*'B*\#G&R(MH5?=?DH@&QO:UQ&LO/'&8DE_530GD^S4P7B>]9/LC5:F6 MTH6)O7W]/(F?$4Y92?KBWQEMO+-G>NC=7<[0Z"N$]Y1WI0G6^WT)/2VS)O%(&824(-X]JS[UT=14E+U\;QQ5.[RY.[RY.CV=/CV=/CV=/CV=/ MCV0Y)`>?LVU?.PM'W5D9,$4- M@1:^0A*@D8VY0!M,=G&FNN3?$2HKD]4;%T.8#R6ZK@KW@R^BNDU10P!NEQ&U MJ"9L,".7`_4=5J;ML"SEH,J@#H;U].UBLDWZWG."Z?[U.5Y4_Z2]"RCW:K=? M.N.Y]`,&`5E?PF"IW^SNIFYY!C#Y4IKN:DH/NL;ELH?IR-6=3P$2Y.BF]$;P MY1NF64&:*K7(C6&D]^3S MPX[V.@AV#_"FP./($"P-7-;1WKYQE5!\*YZR3/#2_.\>43F,B%)=H.+_7L=5 MFE2M62Y0Q$V!\!O99!51D":%FY5@>?51FA(291=M&@SLWO4[9@6A&OT8>A-A MEIZ8P66:L^-`N7N5S=G!3E\'9)P%58<_;QT*6"%_W,JM3?':_A9EJX18IF?4 MF3H,<2/#(_QV]@<5%!2RQHW=PI121\1!N7RE?.=ANJ)4YXL+]`3R4$!.].B/ M`AKRE^>O]SX2/'@1FB_V*8QD5K`G@BZ";\/(2X2NE%%NT+-MY<5+E%[7?`9V M_IC%P4WH/861_A6JYI!'[;L9R1@L9;Q]Y)CYQ6T,F3\*GZ&28)7HNM(#LQ4@ M/LEUB14H^Z]-G+H',?D`Z*0F)NBNV1D`C`U)PB6JM0G?8;3QPJ`*")0^/YD* M.PD4$QL&6R5.C@IT-=FKW&O:-M)WWI:E8F$O&-A,-RB[=,$AC753O&!ULSH9 M(&/6)S`8NH=TCVP3;HD5J`EZRSTLFCL/%#O5H#[B5'$36=K.*62Z6(17S%-( M1=^/6/[RN>L4@=5;/\3TE@>QF?_O/,3H+$\)CS3X02Q`=9U-EO1B09:RUTH+ ML+..#+AP>%>IH*;U964B8J`C"UG:/D(!BVL6L0[RDR"GTT!POJT"56=^K"Z6 M"@*$::_)$;\B^FFUIR;F,V`%Z MS;!9`Y4!TJ#N[HZG+YP"B8(=*;HOARY"ZD#%03K'%V%:/.6ASWM`KN_U.'!U MS-`$5U>N"F5X;1XO.F8SX/&BB_J(W5L36=K&D^G@[DF$X?%"]/V(Y2^?NTIF M:G^'DU9O(3P@N$ML`357=D]!YWC^Y:&\%)YQ6<2HJ*SS.28TK\D/8N;AQD%W MVA.KFTO^+,IIS:YZ_>SA8+;%L$N/UHJV6$,.[MZESGCEQUTEF,7Y.V0`K40J M++CSBWLHA9)LP1Z*5=0+`U8I*'N/"'G(Z2(W'?1$,K-^C&$RG?T8&CGNEJ2NX%,;MD;<-$P$ M!+XM&A.!K"T;A;=;-N,"`ZT_#>HC/I>:R!(*STMBQGUBS,FB9_?A]X3Q>4S9 M(J:>_A\:D'KV(JC\>RWZ+GLRZ"M^PZ9JB1FLM&(WP:*B[&$V`P3:6O3'WX%# M3YPJCRMMPCHC"HOQEN@F*QP]')Z'A"=@BA4EJ-`N9[A2RO1U_;OJ2MV+`^*> MA6FRN,,H)\(0\: M#0J7<;@(?7I55F3AT9K:213ZQ'3OR$/,LA<_;OO2*.A#?37UD[QRU:[AEMG[ MAWR]]O`V60@G\;7YSMP>#'+!":@9%\IQMJZT5I"S)20'N%$.Q]I:&7:A?&@_ M0Z'90G1[FD51\D)C>FR9&(8`JD%!5T<7&>/,LYO$BU-6"(=E>5=)_34:'<85 M8E9FC#A>-0+$Z\O%4,@CW&G^6G\`9/Y`JQACNY\UY'H1D>OS M+<3@-6\:GB<$10 M-><3F`\HF)^5V3CSQ0U](X:& M.A=+B3HVY]WX-8Z_;G>1,D6(?:SJ@0M]<;(<>"@EWW_2PW: M+'.?Q7*/(M:-DJ::,=OP1/-X]C#CJX2.I$CZK$X;UI7JRY-KGLJ)< M#=^L+T:C\^'>?5IY(EN M?%K_[AYE(69^'-W03+>ON@V8T4VQ&G289:!#OE>*1B:FIK!55IY,+A)";_]/O>3I_0"T]*1))_ MH&P6))ML+WZ[]Z$FC(PF4VVPH[/&%)7ZHG@Z0'?GWB%!T##^0,*E)VO*Q4@&Z\&5"4YP@WIQ\_ MQWZMA\.O"1'7;V25Y+WR$[J[[Q"?N#X^Z-K19:''*]1N2@,M*`WJ3I^R&:J$ MO+S<1`)Z/YWG:9:LR8Y$7=@08;)#E55(R3F1^H>XUZNW^S#]0J5)EC/"&4&# M7RC-TD,#(4'C6%]#&)3&8%$*!;H.8Q-*^#9C$2J"')]K]W-Y1WSGX6S[2)9) M2B;(2EN9K@S.>+"O<"0T^Y02Z1YZH'6B0][Y^QLUX)O%2#2D.[K%\_Z[!_1, MMQ8?G:\\O.R3J<`2E\CNE--"2>PRCDE&5H73EI:I$C<-UDDI#+:>#/APZLEI M*T9S?9F(7;K0!EYF[QY0A&A.WS]S8B@0CK;E"P8ONO`R[W/LY4%(0R>&RMD> MMA:!'^:"2I<%\PU-2`ET[2E2=KR-&2I#?=6IBGA\&]K[&[3THK*@'\V!-]_0 M.BS+_CIAX,!Y!V'S!<1$=.ME!.'6M2-P]KD*8:>;E1;HS;1T):&.*<[0+K9P MMF7_VAI'O"=?V6/?GY9(N!`&=!B!3V]253S$D@-J=?0Y1?/%99J%:ZBF50<4 M7#[VUG0`<"H1GA","I*4EKSV_BTR`KU@0W64(>7E.0;F2GDK"/EP::`BZ9X2GA^MFC?+I+\ M*5OD4;4WFD`B&V,:5DTJB>JT;;V/VRQX1C@+:-!$J_4^<`F!EQKA"<6:%"5906DK MOL'.(&5O2J-3&._;2?@;XME7LA;&)0Q?H7'F;5;AEM%)FQ, M9MLRDG&%N3C8,;H6.H^L6T.?.CV3S[=Y\%4G3_7IMX03D7I=Y?1=[6Q-BW[]A^V]EZ]T&T;# MK6TK_$UNT=M!12%9R,0:S.@KL26JT@F#SRE:Y!%EE;4^Y(2*#`R#%4+3.<78 MD:LTL:BOQ2`;4G70+?21<',3>D]AQ-Y@W2*/9LP'\_@>^3FF3[585\Q!W0$+ M#$Y@;P%"QFY.4Z'::9JOBWKW1??P4LD)"[6H276,-S$5?0A,(11O08QVDYS: MRL=Z%*R2B%!)BW(;]/A;<3/']S2O%;@CJC$SDUSNVA*7IE8-&QI1:II:"XP8 MYGU-KW?J'N)*0JS')^OV27/$JY9G>Z(#+2M]=ES>OB@V4>TE;>@(RQW9I_UP MXT7UBA)EYM=`H*NQX+BN@";2BF)5":@8N$-%Q8+M=;PSRND256Z;I6;W=/=ANQ2X2?/E*7#Q6&T&X:X!'VPG:3TS@.+]]NWVL3.^BZVW5?CV'"3:]KM]^Y M1\,>",V?HG!9//0;*G]`2-KEVE#OB*TL2-4ZU)K/)3V,MU2MU]1=GR^JN/66 M9OXD,6*+]![1"9._^AQ[Q?47"JH9TL\,7`8(NJ[K^DLQAY,X4`)"><&97A=- M0&GAL>0\B=D+'L(`"]<8@&\PK%N77Q%:$W$!U139FY5;CQ9NI!=11->2>/F( M\)K.9\CSG"(/HU_`YM)5+"`RG$?S8^UM`FV!E<1%F_I:.J25YR*@_0)XM"PL MF\.QZ96M3RSS11CE&0J&7#UZK+BUE#+XNU>1IK#'5,"/KJ6?;I"7\LX&AN4A MO13VWNR`@H454^1'W1+!KO/U/6OW534)OTIP604D7A:$!TU+Z<&8RT-$MQ)P M,E#Z"']DI9I_9O?KQ7.#]'*]B9(M0NQG=SGV5V0&-'K@42^9B":D-9W9;WO& MK?9;_WQ1?_=0EKMFK]69=7JB+R,JZ0Y3A-:((QNG^_U3D'+XV8N'@SI`-/NE M:/Z\SY(9DLAAA,[)4@'??[9Z!-U\%]GN! M/U0R`)^<#>.\BTVF]!J[I%6&N\Y03)`8-)ZDSXY+,ZV@"]W+RD#JUF\).@[K MBP6B2QKM6+HG!H160XO],`J+N.>0X1%]?EPGD!CJ@XGD[=\,="6V4';.:$+$ MGK4+\G_2C(5QR`D4A]PNKE>/=H0^_4XR6D2\ZE92'4?CAV34!GV_*70P5+ MM%AQ:U9E\',B(7K"!NJR4]_LF^_2B8E7J0)AW\-29<-AT,,,<0T)CRZM]]T' M>IL?%FW6O<,F:+V+'=4&/^RP-DRD0X\!X[2X'94R$/:8/-"VW&@9^F=Y&L8H M36F_X1AADP2H'L,[]D>,\-_GOO40Z^CZ7+[[Z[XKH1?1QC-74?)2VQV(>%=) M3A>AA8771>NR^`'H':02W?[/+:NAZ^3V"C7H05&/%<<>C896<&*,>H)7C2\. MN`Q_J"P'L2Y/85PD3I,I;)*446'/R`%=9VB= M*FT>]JD:U1:QQ0;[WT$G7E"$>VKK15%SM<(JRVYWM8Q(>ZF3W9ZLT-*^_/WK MM'"N+1]T*OYG_K_SL.!Y]AJ"-`KBD8+TL5;D2^SG3^@;\E,4IV180&5I+*[Z M!L"5,DQ=A2YR])\8H0NVRPT%;Y,HJ#-=P?M-T)AAI)3_ M]9T[_*#!0PLOCS)X]*@,@9[Q_$:.4][=RL/KVX8O*=QM6Q\Y#.,HFX_=7MB> M,LS[N?])-BA&KS7&-$3,_=AEMH*^K/DRD.NSOL3/4!:ND\A,XMR/IR5QO@PL M/RE0H9QY M$:V1\K!"B#YHG@4!DV,SN#10YL=@TW`3#'2AQ0.JAE*>L(TSS1U.KFCLOIYN M`*FANBPXV36'4RYM1$;WIOK=CY^)IL=I$H4!S:G_-2&"_HU,/^_QL'H/@'1T M@SBRQICZ^8`:9#2CP(KC0<9W!%%>?:":,5Q5:?6/T&H"&J#P7S=HZ467Q,9G M6W%<-D7^7Y;),UE]86$3R3\.36'7@&".H$;H54]?*7J=HK%?T8^2*2C(XJ:J MXF^,!A;C$09#!6I5B;8Y9WBYBB*:II)U$ZO4%*YB&-(P>0AO$NH;U-=35S3! M5JH0GYP37XJW>.M>D%!&\*]PSQ/B],2LR4'#9Q_V=9<2#XXRH?IN\^8R'^+( MO^.E?DAS`KZ``=?';.O`BX2M%M$=\)#S4U7MFZ4,A>20'P?DH$8K?Y,)T=:@ MN)FJ;]@_(DR_T!Q#(FN$,P)*!MQ94TRP=^)VRO#>BV>^H`3/MO1_KPB%!`^R MPG38<'CCIX1^UZK2$O/HSA#.-KN>EI?>)GW.?;R(*Q* M8IDOKO;HM1#+,(G%@#PWNXEQ@DF'C=& M9=<*NI.%";Y#Y'^#6?!G7H4O!WK*KL^/V_QCJ\IA@H:R3SR,#3]?T0*`:1@W MW@L9IA>7@UWO!NLVQ[PW)MRO>U2!J,:"6`:[L5T>[*0RKZON7AI0IFK'17DU M?)'3]I'%@H#$H)/>Y'#IEAI4=*NB^CL.,V(UYHM%65KI,:'=]>:+ZH*+5D6" M!$^-`8>':",P%<6J4-.B)[ZL;J9(@A[CK<"13752HMO_*9^`3,Y*(79S=[8MEE/DI2G4,QY=%N`T0'K#;+Y:ZGJA+7,H]U3" MR)Z-3]X:\*&/"1MN;KI[KAH-)>B6/5AY0`-N8!X-&>J"VW=$;M1![:K?MHLS MQ(Z@0][I8T\[^X&6M,%*-0NX&&HCT&5AD(4OV`8,EHDB[H;F?PC@8>R^$?1N MK?ZPZ*N^+]6/4Y>7_S>A3V<=+^_#Y8KPH/Y*3#B`X^LO0ZNV2^@5"\=^(F/% M]R/V`K3V\)=.(.RLN18-APD#/7#BBTRZ7LS2(,O\F:I)8+H*-X`HB<@Y?8AI M`3*A*(%:*[(W+BV&P>`3D9LZ?$)1RL/"1O!]2FB6Y09E:+;$J"B5!8>>@-JT MC:5(C-)*POH^!F$3130S*O>BJH=XT0$,>;0G6!Q)4P`P<\6M-WZX!?5V5B@R: M=P,#*V3EZ!`7"UZA1P/(_7\G')^1G4]>LKYF09.IYR?R4)VROF9 M-'RGG)_)0G?*^3GE_("&$MY2UL`@UQ>:*0;V`P2G>^61:H3Q);1MUZI0S:@[ MHZFHWP*8<2*AZ\#L.[`+,N'#]3G::Z&0!UBK(";MM"_1L)9`@H%"\I&1$M0S MG>:M:BL0V$LHO@&'0"9S><;1J4K6D:B"68&M'X:\2QJNY)8^$T>_/QC@4NK( MCY*=8IB$Q;JINWS=T(+KR:+:U>PE,7:0F7/):%7R-!NYCULF>F709N830>3Q M!47/Z#:)L]70ZU*%(W>MTWJIA>K+#Q5,X*Z=]#C[`WGX\25QKR05(RY/^XZT M8X?!\&_".,P0-0`I#&C*BD._SZ5.%#`H/!@;2"^NDASDBL:0$V>^GD.=*"`` MNI@S8(?\[4@T@G+R)C6"02"/!@WHXC\C["W199J%:WIR_9RB11[1.:7)HKKO MNHL\.K_@DLAHL^NO];6!XV-X_#+CLG4VL_RBIR]7)I[CH*Q"/H?JPQ&8Z;#U M4LJ2OO9X1M4+\-YOK(QVM`97LQI79]M'\CE4@KP*64"?%BHOWL**K^]U2N#` M'92YY"EQN`QY%;*0YQVEM'B-=:.$:%VD,"GP"J1ATMX5\729Y@Z')DA*>T7_ M+`\CFO0`EQMX0,'%\<'`&M4Q.I014);8#?)2M$JBX'J]PU'FRWN09PCO>`)^*<$@Y?H-EB!)7<';STZ5<5@>5!4BP4H7L MI#)7+(8:M*!1[`4X3!3SR@OQ;UZ4TSEG*T15V8NWZ=6^M6I*V"HZH!JV(#.$ M1X,SZ'"E$2OZ5U;PW$&&);79@#3VML*1?92P1PQ2'U(+Q9T,O>^*U;/M[I^_ MA,2R8G^UO:$/?,#JG%5T;PEIT)RKF#,MAD!K-&A MQ8#S6*3>.NH$6DW28-6;M/@`*LZAB[G3LAS#(`Y9H&D_@QHG5QC].T>QOQW` M\'/)3O#>R;+1YR,"5YFI0R]WM(>U](=DQV3?96M%MM1;(@4JMR0G/9P5[\!S M)+;;,IJ@=TT[^M?Q)B='%KK)O`.,E0O(N2TI8N*<=@+9)4C`K/<.LN^'Q>_] MT>+W?H"KJ@ZR'X;%[\/1XO=!Y^;*XA'G'ODYQJ`W^$IT7=;Y47?\I.>8ECC! M#JSG7KJ:Q0']/S10_^Q%#36\"%-*B?`%<@6F3'PZ]2#Z1DL-@%&\3-%?Z0E& M9,;G1!6I#I\G,4MF9SGJ`VF(+@ONWANZTQ1MF."R&I[)O.BQG+!$G[`_4#-& M$$`PQ23XU-Z>N1")7B%=P@QN]EAE($O`)^:V%958@=[C MI6F^WK#BO)\)$V%<)O80M2:ZN^.?:?+O'L9>(Z5ED*=D!ARVUI7MQV2]>#(J ML3H,DZ`O\(SY@?/1K3W`LZ&D?9[?F6/=/P?&:)NYIP6.H.XZ]X.#/=L`>T?7 M=]76MZ*:D($25A@%N!!>?7BW;<-:^MJ2LW+DK:^@8>X/#T3MMOF*JK1![_UN MR;S7^1I.NYL$'*?Q=ZSDNM`/A`%D3FZ]5V"1-PB,7.1-84"G(]5V'EI"Q,]0 M\%M"2P:2L\SVWLM@PK7JU*<4J;7F#YJ@!!;=%_#PB/!Z:/U@-$]:(40$K$!8 M!^7[,/URA1&B+2PP2K,A;48G[4F%#0=1CFZ(I.'^X>)1[1B380B;MEF9+\KA MYI@U=N.$A2R%L,44^X3CNT;NB-0`SF,7AQDF"J.'8B-H+I"5FS)#G1Q!!3[X MQ%RF=JLKLA1*Z,(_G43ADK!%Y%RWOY4JKA0LC<(_"]5..TR)'T$#F MP@$<1T]T)"\6A/W494;T'!,W/KOR?'8V-Y"^<(`)25\L"/N)QXSH0_Y$1@YC M6J2"GL8,Y"\9PG%B@@8`,ED`U8SN8C'-+@@75V0JOZ]"?U5Q4O*?7KX25S), MASS<:'#D-/W?SF%(1_Y`=O%33B>YXRO]2/_WL'4<+^V`\^T8K6$G-F()0(7K M.ODKL49W./31GIE*%4!Z.9HQ,AET>\I;*1"GM]@J*KMHH-(R:W\U$=/'F_.8 M:N!_0MDC]@)4AH+IVQT4/E.3NXMZ&AA5[J!:':P4AC%V!]IC?L1)FA;/$$`Z M"$HHNKP?4(:KD0PND:#UC'#&ZPU*4]I_'#^C]"K!6OK$^]9IXV8MV8M%8#WY MI#@PK3R\1$^>_V5&6[\_$8^MI*YV;N1_[NJ=BT2']D=%PT^! M=&^T&!@WEH9"!>MTWB))O(9!/=4:O>DX2VKBDQO#X0YCNQR=6EOD+&%N-7V< MV>NQ4SGVO#[V8VUL+4]:>;`>F29LH'OTC.(0M\YE-QE\^EB5==V MGM@L)TGO3&F-19/S&.=S5T<#$\E+16$[!Y9W."F;+9H>RZK/71[+Q-HD.IGM M)@_V$KU<6>P$PU86H"VJ$7%GAM0`$8@'*OF;D:K..!7-QED'%A\%TDZ/XIJ@ MJ4@2KB+7+%@3\5`6L_`972&4=MHQ2ZXMEYCC$XDZ9`)YV;VRV3_]P5]05AQI M:P=<0)0D%"<#E4QR,-UE6AX@.>X,XC93.@ZQL>HU,YDI&[V!ZF-41GF1X',R MPV2-\`4*APCYN-&N=P%!NT?O%GOLZ%6P ML$W737<60$5JU*2PCI*S_BLT*X"EX>[Y9J>:(D1)&Y=!O=!0I#R._BM`R[*^ M"Z@B`?3@7$P>[N&'$EVW%2_TUH@ZICHM5>!`A7D@H@JKVW56 M#WX`MD054W2;`ZYCO7B7;%UBA,DCHA%$5(00Z0Y2Q!"UWD.(!G"<(ZH+A8)$ MP`K;E%P1\&FQZ"H4!5C%241O8KBIR5#MAM-JQL$P)I!#U47HU:81Y`D3K!!R MC?8N964@"%OT)KH"Q3($JHXK9O;,B^B/AOT4OV%0K`,DDXE-QY30+YUU66)R&84L,[:K\G^,MU3'QKLD1@\6A2 MF@X>!Q*R6S2G1>W>>[GU,N+0>!$U60_Y9A,!^9E2FM/!B"LUJ4O8#RV@%)#& M^--!H9[<,89"DW4'XO*5+E_B9LR?4O*[#.VX-BU#6;Q,J@4H"A*S#A):^Z[F MD+UU>.X1J$:WJ;DZMYA!UZGX'2*$>!=`]J#GD%[]$8YWM)5TJOO+Z4E> M)`:81Z][=H*`"2BE=75F_K]SP@+[;RUG6C",L]3FGG"H2,AR9*;V6"&=+]AN:,#&*,FR,L.-46>U M45LA`IL[F@)5X]/R@T_.?WF$Y@LN%;#:T,JT`://W&+1ZE`WLI"5Q>DL69'+ MV-D6,E-1A>P8JDKK+H@Z^DJB!7O=QN>7?`R7>ZA"%O+Z2"G[4$/IE0"MBQ0F M;*9`&B;I4!%/EQF'<&B"=@"[(7X(7%)&;72W:80:=JC1Z+8F':@2[V=Y&`7% M:Z[JG]?K#3GD%96,-L1.)3N7EG-V-#:PZB(3B2*VE\)PA$R)0=[^9[^?K/**%OR_0!B,_ M9+%(\N\(,9G%P6R=X"S\#_LYETL(E*WQ-DXK+%0'>[A87_95'+6;X&R1T4R+ M//2?1,W'BJ_XJ M56]'V@"T=Q_%C[G'>A.@^5,4+CU1M0$["B4F:"%JWD5@@(`YGZR+6+D2K-UA MSA,H&+BW82@SI$&(7"I=C=`[18;W,/LBL[G.-T0 MYV81$N\7+,S-)^8\N"W4U^:RXPH,J"`"ER),[%H(DLN(=7^(5"/39CA=H*?L MFGF8[,@`9.\ZJ#BM3-+3X'4)#2CPTB3UR5L#7NAQ:<&E#2F9.;Z.\D&I2PKJ M4H%'$<;$"=%Q6PBD'T#VV\3NSLZ-AI%@S;+;5*9LW+J$!O3JL4D*L#UV%QWG MWAM?._EPZ!0]L@8)4!-L#B@N#9DY)&I>FN%S4!S2Q7I//$FX1!,42QMD-J4*79.N%P6X?-!`S(^FKW7KP$ MLU7[P<$$#VVE:O*!ZCS$2`#6XJH-[[:^9$O76H)63B[K*V@8BW,@:K>V1E7: M(/F4[+Z[ZZY*H_B?X'.'>5RR,,_NME\T>[C-=4>RZ?I"EOH3$719)DYT9FT6 M]A.*#"CL?N:E;(L'3&AM4G!;L8_G?S?R5`]$`K=*+G.1A._"T:#HV6 MFOS;4K%\3BZ>)A(>E@G>OM.I`WOPC=O4+^FEYOX9YN%<[:MT@\Y[`YF^GZA, MWZLK:2^9?C"0Z8>)RO3#@4R%.:9FIO>6R&"=K^'L;I.`XXRTCK-=HW=14QA` MKL:M]PHL\@:!D8N\*8Q!+H.)8Q.F#QN,O&`>U_?B=_#7CP+:;JV3=D::NDS5 M0!U3PN:_[CS:*7F%LM#WHO24OWG*WSSE;Y[R-UN@GO(W3_F;I_Q-((A.^9NC M,WBG_,U3_N8I?_.4O\FE,F7C=LK?',BLG?(W3_F;I_S-4_ZF!C2G_,U3_J8M M,$[YFZ?\S5/^YBE_\Y2_>)\]D,<;95?B*@J*[$OT1]I9T4PX3 M)?-B-+#32JC*:6<]!*=T(SE,LN8GE)U[&&]IL?PU[4R=++(5NB&^5SF7]2:) M$>M617Y^CZC\R-]^CKVB=#.M[?R4780I:VO=JY6>>W"B!C1Q;,[_A M)HF7&<)KRA3M,@%U3=!)!]!UEMX9.%_RC:8YG2@`N8J'Q.`N2SF4!@F;"^XH M1#HO0@4Z@ZV;'LPUA@@:MW<:_=`!3%]+8N*29B%9PI0DW$FKFY##R*+88!RT M-^B2$G'#P8(/J$U_DK>6-*UYZ8TO%-8[BWC;6V\,&:'%V@ M!2(*%A0"0>=)FJ5`O7)XI!Q%6$>C#%(H%%.UA@D*7KYNB&^+TC"^1Q$+@69) M;0>C`MUWW0$(3:G0MQR^TR-I?$5GA0^+L39U= M0EWV0UW:Z\A&`,MNJ.04PSK%L$XQK%,,:SHQK*K*3VE\*<'+5S_*@\*SWK7Z MA`XFG@0%H7 M<*PIVB<* MJD)C=,C9CSQ?5/E0M9%G3T1(.AT29 M-EYT'7\B0GY\0=$SNB5ZLP+S#LT9:O,V!_(PX\OB7.- MJ/AP9X*'4H6=Q&&\'WU>".8@&Z\A)\Z2M0=5@$+H"B'?893@*LE!7&0S1EPF M9PZI!874U<+*D#HP6Q`OBC$4/KLV!4U>CMLO.)"[0LKMD)[V/?*3F%808'-. M%I<>IEG&*3D;/*S(4>/"R[P>[G9S^'GG\%H^M]:`QLOJ.B8"0C=)FEX1=2%' ML"R,ZB=U%1#XA^B[">X6\ M*.43=;D!]H=3*E*@VN&$P%Z79L]>&%'K])B<)^MU$C]DB?]EE42$='H11GFV MMX0VP=5G8K(+UT#>MAU>-H^""9[QJ&:CM9=H#NG*33%%T$AL0'ZJW/P35FBK M29_QXV9W;;+@+DAAINIZN^V!N.&V7@5&2L/A%OD&$\ZL]4#0-R4.UXNMR0Q+ M(&7\H&#/3N4QS+(,AT]Y5FPOY"A%D[?BY27Y(-O"JT4?YJ;MR5F#2'ZT-:@1 MJ,28T?9O./3D/+E>CD1$$;:[S".@QV&73G3O1;0HT+9;N0`24B M]&<2VB&QS:(SDS0JU=)V:O1W(S9V^IF,@PX?#C8 MU[74E'0)^(^R%"2#'8$8AO`9/2"_O*CI7J"VC#N7VM0B2"H"+%'[">3PB%EZ MG!>5P4:F.,U#"/L9;8@2W!57;_6T.J!38U^N7'9EDBZ%@[-A;P3@4J"4N#OW MHFB^*>YSX^!WC_+F4#$X[+A\00>@$CRA0[W^5F-J]PJS>,Z\GZ\[;>"SY/CA M,812".0/U(V[TP&I'Q/J7L@L^#-/LS5084I35H[-_5.1?JD-/UMW!#D.*8^G M`9U_+@O3.^T9"[O:'22UVH?)B[K*LQRCLN_0#2+N3>G=]'E\P!]4*V*@,(RQ MR2P#*_&2C9LV2%54+G)T#E?"5Y,#5VLR(GU_'C2T*S%T&\ M)'TFG(4Z0?&N2QG*259GA::MCP#R/1M'N<:;@H9K)*C,#DU4=P_[G@N'KB\P M\#5)@Y7?5F>&'/-&`/N.BR.&?2]IE5<`D+`_KA!&'GV9X!#U&A,N`V#F*\5` M"^J"!^I-ILQYU MQX9B5J\@V;!)NU(=M M2AW(&=G?#M.D'R(1KQ#U_HKX;-N^0::L[?F+`RJ*3]X:L#@:")]P;HY29;7. M=557`1APH-Z20'`+4\X-3)G3N*5=06\Y^<#`C,*&]IB9JJ/`V M(P%7!K`^/%@X6LFJM]2V)6C80G\U$C#6\T#4;FV>JK25S)312?#Q)7E<)7E* MEB26^\56.0-`B,7>5,80"4[I*N9MYBOO!#_YD5YW>6@-5*I@_); M0BNDTDZIM*"I$R_>`MM.FY8[C7(-JAPP!PC&UY.<]2<=UFE5L7=@Z@S#K>/F M9N/18R!E`$J/MKKT[L/TRQ5QH>IEID=OE3N9=EL@?#S*#*L98(DO(!O*1?@< M!H@(?0I:W_O"`3V$UT5#IN M.`576:/3UW=3G5$H%C-%%$A"^OUWWWW0N(Z5#N+DU#[H+:QF=M,3OA0K.K6`B(,>(]DA]�_KE*_$<0R)7(LU1QG1467=987G:JBO6 M"*C>9,:W8=()W".*%ODY+6U.GV3F7D2OR=Z/ZLZTQS2F?9EJI.E#*XK*W9-S M4WY-N`Z)4^V/-B#/9W;*:2T.;?4AY*.]3?J-2`[1K,E=HD)"?U1N+C1F-%Z? M6)GWDQ)#*(1*0X&1ZO34G.N>,SH=%0?3'6FM'@ MBJ)2[MVYWC<]LK&K]R&W)RVV!3ME1:SK^X<^*,7B5X@4): M"C$M@B%AV0JPFM4875,YTZ<=WJX.5-HKNH`;I_Z.SFB#3NADPP=4GFI1\&_[ MAGL[\XGV:J(A[0/)MA_2.'DJ(F.O!3/TVQ%UADQ"14-Q.>AS&S5FP.Y@P1[? M:.NFS9I(ST),WJ=;7O*^> MUM(XX'W*">TCU?Y#[9"_+!JU>A_9UF!0,>RT0EPKF,JCI[&MHB+_?YJ;Q`'O MITT"7#OD3Z!&IMZUF\TCVR&T9G9:&HXU2_I,:L`K\NN8_!,]>J]W.'D.:72U M5EU2_WJW/=QARVGAA:S@<]/XZ7F.,8'L"A&9>Q$9FKYMBU-TAF(BQ0QBGGOEJD@@/J;'*!%HA0#DK".Z;A<5.D[/*]AQZ$JJ*TWO&I8D!,F#ZF M"^,\C)=E&VIB22%P->#"8?19#V(3"4OC5WT,[4-&-KM9'-R0/Q[4W$H(NSL4 M&YE=F1@5:K_TLKX-^@YLL!)]9YZLF1E6DRE@X$"!_E`VV9B7:3A/YJ(&.E57 MWER"R?DD'M0-YI%TF5K0QYP,N>0G%X\%9)EJPEE^5B7%@QP6H'@.D M4LG".=T#@OD&=F$9@+;<9N;R_X$\?$F#Z1?(9_/[\(Y(_H-61%LVQKB/,VIB MD-]GV)/^>PO2?S]]Z;]O25]8@,S!?1)M)'B/_"3VPRAD"[K/:TO!L&873()Q M>NS@^^$;0W.LUJRZ7*$6,B>C;AOL@6X15A@<04Q5K@^=VX<=?"S?@+&9G:_H M;?3UGB>4WJ,TC\CVN+PB`M!2=^7!QG#?H0:EII"`CN,<1>IV=1#(65R7!7>+ M55>E%58L7]!`M](U&X"%%`_+OR9V6&4CBH,5#EZ*AL@S(,\N"<3>T@/SC'*`@S M.D'BU/NK`16A@[BKLP\`XEVBE4;I;&++\@%W/XJ7'55;0.'MIN_L>AP`8HZ$ MP5J+<-BH9E8%%,D?S-(492E-[2Q\UBA*7KP8IHZ6!:Z.:-EK@2$-$)ZBN\,? MPSE17%D?MV%"68\K]!$E2^QM5B$Y95!=\MG4D@4Q1C2%W(NW:3677=*TP9F? M2VF^>-Q1>B@H:9W_C08V3QXK!KI)TI2NZ*Z8_AE:$+^]9@,NR#_2+/3A5HP9 M.\[VSCZZT%YCAEC`]*HU8*D\Y8U$.RIN7)I*#:*<&I+ ML'<]36.S?^9%])3VL$(HNRF-"51Y32XM,)=/OUJ^HC M9X\3?.XPF5-N)79;EVC^$`D7#7J?DMCO)_+6""XB"7W%WA:#_2/?(=4B=*L5 MWN)_[;AZI`T73B`:H*26%L7R(!8OZ>GJW,-X2XYCM"`&B&.F0]YE!$:JLUV9 MYTHRA2HYVV*"_*/Z61F"/Z]71(F#,B*?=I=,.4]2T-<(5OET%LGMIR=6(`+W M4+B\$J:6Z,GSO]`;>?Q\F/6B:M"51G;\O@%R=?%W`S69`]=H$7!3\4"F._-] MG'M1>H^R',?L)]6][#`;B3EW1V,\E.$`>['88I*&9V.:53V(#NRINGITA9SDJ4AV8`'KCA]Q1&+&N[ M.SYD':DNBM..*:F*%:ZY03?E.XPV7EBYJ=`;FX#P6/8Y@;++<6Q)TW[QH4./ MJ49]YZ,^9&B3;W2/_(*1)@*.CFPL!W$9Z<^QMTYP%OX'!1=AZB=Y3"LK/"/R MHZ<(42NB%H=1&6?:YE!=7$"],'CK-]D0\EM:!)LF-]%TIDV92QX+:O M!.C^)Y`[_+FNQL<09^X6N1$:5^DZD$/:/)9#G?]V:E>C#(E?)[WQ!,!YJBPL MQM00W6!W8#6J0YW\#DBZ"D3"6--NJ2H]NQHFY_8A7Z\]O$T6GV.,_&09TWV? M,%[=QO3)OBW'GO/&UDIK4!ZL1S2>,S3$,N"1>YHH,R71R"9(UB MY*4'[RC+C*FB20_YZ[LD#1OEU`:`5IGP= MF;6B@+U[6 MB+0.-E;[6ZC0-;7F#_X*!7F$Y@L!F;.F#"'F:,#&8,_I3!2@T<'#1,;]7]"9 M-W9A#0SSE,PI34NN4J@W=&*"[A[265@@K2XN?+FJW*WU,5IPS^B:!$`W0Z77 M##,Q3N384+A_']0-"Z5& MT=(#J<8K+?DHKNOD=ZWZW5VE@A#LOATMJG8E<9ZN$?X%>5&VTI!VYX>.>X0( MY=L]4X70C)%AN4?/*,YATYE:-%PV\S#TPMIR@@N6/7@1/4`Q@D`W0HX<36G@=<%5TD7'Y1-=T972*2[%^7A]L@#%Q::0$&LB1 MO++G.4PHA3TG)3HT6]-4IF3Q,4F"ES"*NL(IAE5YWIJQ0,TYR[,N"9F&BWI3`S)B@5I%-?6A6+^HO^-[1F%,PQDY5(UMKZ!2;.<5F M3K&94VQF;+VSFF&(SU1X$NDMT/Q;__G-]]\]?_\?OO;7__?_^=__$W^^D?\_<_!?WY\7OZQC3]? MY"\??\0___B/]W]^?MRFT8_/_G^^BW[-?OI\?G,7_/&_T8?OX_]YFI]?7&\_ M/O[[W1__>97__N?YW?_A7__W_>W63Z_0O>/?_SP>G/^7\^/ M_[C^]>)JOLC#?[X[_^GVEW_^\?3Y[*_?G_] MX_-WZ:\?5_G[+__[\OT?YSG^[>+FYN+]OR^O7W[]9?Z/7\X^7)\%?X0?'GZ8 M_;KY^?=WZ^N;V<)_^'[Q^.O=AY\^_?I#\M,_M]O_^OR"_OS\\3?\^$MR]^+9"MU$R3:8Q>':BXI[F[()>UI[[NK%`?G+*R_$ MM`(A8HU5JW!K44^"_`7Y1[Y&0:VR1+^H!HLD_5!MP&23?@KCHMW<19ANJE=R MA#"K8++;L6O=Y*J8T^`3;P6QY%E%4Y^HT=7HA&>NF30VY4G";8."A+5I"JPS M>CWU2;E]-%F)K#8/L):#'%*0#KI&>MZDM:?M+7&!!>JMUT&NX!X!]D&4$G6? M."A98#+(#F0(=.Z34@9JD*B$G\ML0YOHJ39+-/#TN`9&(Q].-H;+OHFJQF7G M#T@%`G;K5@8YT\>D9+%B'L'UK)#2=%RS=II;JS!70@XSU-U?ARR+IO%+Q`HW M[Z54S06DM9`)&TY+?1ZA$AJI`M#%93PY84E%1)O7=^LH=G;TD0> M^@HWK"9>T/VN*%B1_Y;.%]U'I&A]`)9> M$=LR>'O^!&S%];F6LR_+HA9_249!X3/]$C0,`\JWZQ39(]+\8?5-J5*YT[4" MVC`3AM'3:ACU:F@W%?W!COHS!&QR6@KW)O1I\"I>WH?+U>$3"(X+,P`;)W_' MLK\SA.J4&O_C2#7^.HXS%"&6]E>UPZ%=G(E>K,@'%^@914E';Z@!5H$&:Z>5 M,>*5H:-BY6KY:;SN4>G:U7_ALYYNZ9VWA:J!/.P$3M&;$3M3"OI7+J*?[2=0 M[L0R7S19A5!Z/K&3OV]=107(5AD'<+\US9!F`_:8U MHB1.6Q,Q>_TPXJF-)`O3QB0`3;*#-$O+2V^8-$HKNM@_3?*4)SG./$F+ILI. M'J1-53FE0IY2(4^ID$.D0I9FI$9:(P>2^['+VNCZV8]\&0`MFE/2XU3V2>BD MQE-*XTG%'*0LVDVF/64M'K.R]R3KE M'1Y[WN&P1M)%7N$8EL,IM?"D\'"I@T;^PRE[\*3*8\X./&5JO!6=4\_$X&?' M?>4L%8/(I.*S$OGX$BLZF!Q#FH20K3$E/7!!'I7LCBHA045E@=,+^*B[2A9X M",DFO`A]CQR%]G9EFX9I8.K+_D>^A=@HENE#I-5/9'M3`@>I%Q"5.2<-M!4IT MP1*OE*R_SJ)1P[,N4JBCI`IU&!.O"JE;JPZ)JOW.\Z>G*:,RU;*')L)J=Z>' M)J>')J>')E-Y:%*1?\1>@-8>_M)99]L.7BT:#NMP&X8)ZHBU16;W8,LV@^YL M!HUW0,(!'#>4ZP&"@G"`7F7M.4W9!JR!!>=3)Z][;&'`$X?*0P<#X=_=_^M" M1^*UOY^FM6E/&ZRI:YYFR1KA>Q05[N8JW`#N!B)R4UT12J*4Y],;P<=67XMA M,/A$Y*8.GU"4\O1O?;-&NZG2=+?'Y#>$4^]NY>'U0Y;X7U9)%&AM,6HC.06H M3Q;`SB(J2LQZ900N\?F&,_`5ZRNZ\;;)8:,#3^LCA4C^)!YZ\U%3M]= M4<)7":[*4LP7-_1Y5AR#88]@=9D(4UZ.6A_4V@Q8.`L%Y\EZ M@PCW]$>7K_2?2`--G?&.86/3DI^\`+2!RY>CBS`*ERCVT0U:>A'A^1E%LS*! MH."OP5ZJ=PJW0%EQ1F=Q/D7EX4?6VE6F9UAT5]W.'7K]._E[M M:HHO"=)]>QKR%DP>>3$K=(#-:? M$3"*_Z"%(_S5!2N^.J,J!.B@` M]W4=D[XA__E[@K^0O?#M`I@](;(^CVC@L9^0ME\0>-BD"6:M.@?60E3B]:E`RN0LK9=\1ER1M_W M7#>,:=7'.*[2VEIV0BI>H'2XCDES6(&P`1K4W[J#H0.4W9;N!E61NPH.0I:Z M%M,[NI)_6I;%*G(`W=+M\3>P8KU5I\0Z:BHE1]V7BF8^5AS0Q*1G+Z)"'&A' MM,GQ&U79H?1!H1RJ>ST^=0`X:;5Y/7]A#V_GRGVJY_^VU;==G5_4)'P,&DMS ME,:NK(S'DYY:1UTAL64,*MK8$YB(QZZP'1R?/%]0?:A4V?X]A4W.[W"R03C; MWD4TFZUPWC=E/?!1*S2?\;<9,Q]8.2KMYE^I6+F\;3))!4.&9VF5US'A;HG1 MX>V^^J6MTMAO=H_OATBE'@-_#%)@I=PWT!BK"90/H'3 M%C^DME1*;[_!'Z1&-I3E;=JZMI@K*$5/!IT;,":+3TGLU[W/L1NM;J9/=]G@ M:E&IM*VWE!"L3T.%3SH+!GREI(+[(N=*6A[V:[\8N\)V<'SR#$'UH=+C<=\- M[3>)VN\F$,@$4Q.O,B+_;1PPHA>O\V"P(V(2^BI(D\RTX;2ZS(=DWWVOA MN>SHN#X5`=<[LP_4FMVA\M=MV6!J8:$E^V@U'ZKKUD"<.VS\[L@Z#;L"E-O$ MF^FW%B^PO7Q-68%,.%%J'#:LC:BKGS%Z4+TB#1F":5K60Z%<=C*;G#K9;U+) MSFN_>UF:Q&7C*8W"0%W?N2Q^V-/$[E++.N4!4Q+K\OR^+`2%\BSTO8@DI M.,R(MND4FU<8QVVU)EO@*$D,KJ=@8QKB632B%^!F5X<7A^72'!^DS.&#:0ZL MP<]AEA_L59$=QESN!M/1-!&R8!6E-/BK0J*CT;@.ADXFS1!(:?TI:.TJ:DJ# M9=<9H+'0H,[6'ME@:NW:[1L0&JW<-8NT9Y([B9)TWG\ MX$5HOJBN$4'>-_!HO6'KPY>_2JNDX2Y>6]W.%@DFUO`,9>$ZB6K5WKPX(#^O M"IBC9$'^:Y<@P4PG;7S"[I=KJ\+HJA;P]MW^##FWO9P`Q_1F95BZ!]+YYBDK5]F2T MT+;!!U'C^(&TKI,%P+Q%I4MF@T6JB'JWQ*7(#P$\S+VP$?3PX(ONA(=% M7^E"MV_>?KT_"M#.PB-UVD5Z[R)<%.5Z8TUK.KOJ0.M/D^A`ID&P+TB6DPRS M`QD"[?=2RC"&7@T_EW;=)GJJ5MLTVNW3"<7+V9)09":H*Q'$5A";1\QMMHBA MW]H,,7/EJ)++8P8>VT5:'(/!)R+GM-FC!?R$HK2\^145Q5I;N48"%O=CEZ%\ MY;U\7U6-*P.(YK)M:EK=(02?'U>AQ2%C>2),X#:]4YO$XU$C=4S!DILZ)->0 M!.N!7CRHK\WFNKA;'JK"MPY')U7LI8I]]4&A21^XHKYSK);OCJTPTWAU\)U" M,I6^M[6;S7S1G(J6TR4?Y?@*OPSI?RF@)$U\P!SU@A]=8('=.=;$DN);U22 M2^%NZOG$G%<'$:V8#G"ZY`63B\4E"',9+X3(Y1U\;X!.Z5(GNPN5+&53;4[Y M4J=\J5.^%'"^%+-7L_]X#V&F4RFG^86C6+6RZ[8[-1U,U'99,4;C/$F3C4X! MJ,8'3O.-U`79G"1$'E%!X>Y*6Y"[3USF#.E*-+NUW&&T(()>O&^*IHUF))5R))#<3.=Z4MHFM(0W=D^?!.5])M49)0]1) M'(KU8TZJFMAZ$6J80A$TYTMD&CO):9L8E]H?[`$#9!^>,J'?B$[*\Z"E1=]L MZ-N9AY=$^GBF@ENOUJF:V3?#`70H63DPY:U4$E\$MM%/2I'[($X>?8 MRX,P0\$=3JX2O/:NR%QB/_2B:]HM;UTLIUU&J,.D0B5.6X@-DR"HR9O9G<"P MW#I(L]3@"S!1"#ACTDR-[6<^ZBB!A0S&4S^W(^OGYMHDC;2QVZFOVZFOVZFO MVZFOV['T=?LE?$3^JG:2:C0VJUEY(I7+\WNSSF.]B1Q#Q[C^D@;K.]J1<))6 M&_4]>D9DC@-E.+;(NBDQ-I8C@19`0V:][ZA_0EEA2F^`*O"H$Y]\%A&LGAP@ MI9+R8$U=*AXN/1P3VYG>$3FL/(PNPBC/8(OI:'!QLC6F\*G6OADJYDEVYC2) MPH!(*?@U(6#\1D1$=M+SA(P3$\YVCE^R*!:%80BT$MINX`._,CWW-@PZ3N#2 MCJYK4#<_=?"(=`0286>UCQ`.$Q\TQ[B^K"3BZQV",\+TD?S-?#'#V(N7C`Y4 MO*R;$-2.+0UN:>ET'46.P,`\\QHEFFW_B1Q)]S]AMZ">SW0/KGZL+@NN>S,( M=;J.I;9LQX(R3"#'"&>W#]"@H%9[C&;P$HWZ*<1Y"P/4N6!YS]':GSE^DV9H MEO8OU3H$`5=P^Y(XLMGV%F6K)-A[S`_Y>NUA>G/?Y2(#ACWZL.,R$-;/_^D% M`EAHPX2K\R3-Y@O:>1+$5>K+DF/3,+R6-/!0"&L,IBBL@C$Y.R_"#"HZ9H,M MIV\=AU>7%BJ6'RRP#OF)3S'8+Z?91SGV$]HK( MZ+RX8"*\[F^8SA#Y8W3YFF&/L$V&P%NPN-+`,W#;3F9X2]0';'F&?;^D+#E7 M5=ST%:5M!NES%_(ED3TAL;R.,X2)2.`RL6#8=7"C9$<;03%4JI,[B+4$OWSL MS]1;LVG=MXS"9/AQW0S5,X%L70K5QW1U-:3*0Y^M0TP,_J)(0';(A/*^^'=> M&XE$ZBI_^W1]I*SOEBZ13K=(IUNDTRW2Z1;I=(LTV"U20:K17N<[-8$??#.2 MHX"!,](M`MMEQHPC>N=>N@*+E;+!QQ`(,,7-7*(PQ1J-8K8TZ[%1@P@N-MXF M-?&%:TO@"DF>@T5^X,K3].!F+#>O/8Z;?;!0*&MD8"YJY1J*/3XM>-0J.RH= M9!QWH*8K7"XC^]<%QJ9EYONT4$9ZYVU95:&J?)SO$U;J-87`3+PZ!Q->T4/@ M,YZ;@'HIJC@H1AC+[M#)VV0-CGV4%.X(AKLAN$/8)_/PED4-H?-DO?'B;=&, MW"-G5"(GFFA$JPF5Z^0>^2A\IDNENBXPC9U3PL7UW'V8?H&^%N!1,UVVK2$A MX_U=E."6E"C"+P'M();?*2%7X?M;[\^$./EIEJR)RP`5N^^@XK2'D9J^UG'K MDA-8%)>^()\O&B3AJH'PB3FO]\%7SCHT`FD-CQ!,1%V(D4^$`,+CW*5] MMCU#L;\BKLD7*#,GI>FPEI.^R9-+$*K)1)MR11?.#$IINKZ-5%5H,82'@H2[ M<);1AK&4:C"ZO6R$0%*Q=YHM4TKO2P>THCMR4S>@>[E!/5)ILT<^&M!LULB- MT&(>ZJWX:%:3W(!V31IAZ[%5,I-.K MM?F)2[U5%^?A/*T_NB]:E?K_0&FJUZ.U^T MD;:/0`T/4B8\J4&QX_?OKQU!&A<)Z;E/9B;Y`<4(3]#P3]S M#V<(1]O=C?B%EWF[.HW[-V8FUE21B%:RE.Z8UOS]`3Q]ES4^#;$2N/S6_9V* M3JU&!@0H]>%=5>VU@$9#2E`!V%VY"MB7SEUDG'4/LX!-I]BD/AA0P00(P!2H M3AD_%:%*$]*!X"0NQYF7ACZK@>P&VR8+[OJ?#H+T@;RMYYEK<5+6O':+?8.) MXU[F+9%+4]G-DGJ@2XETE069+&S=53Z$#5@-<\$/*LXS.P`!3S>A"3NG',DI M)EOW!@JPLX.X?ZN+L?P'\O`E#6A<()]-Z\,[(O`/>F^XP>@Z3/*53CFHO,?8O/'H6-KK$.,'G"<:H M>)\_BX,['":8J&Z8!+/@S[QL2E)CJQ75LVH2>C%DZC,\^"L4Y!&:+U3IU\B# MO8ZPP!74ML=]1V%%H1J!,@O0]'^68:95%1L//HH]PB14KETW(>=%E>RMJH9" M=$L5YGJGHO$Y3C?(#QNVX(YU9U1)TF`M3L`1 M[<+N>,#KADF0QF5VX9XDP4NX/QY9O6VOQG9=[J]+$1OWZ3LAP-7(9#S0RN;0 MZZ%&PV$Z'-!RJ`M0I?=K'[#@(#I"8-1N1PVK/=,V`655(,#MI(N,2R^NJ86- M.LY=`H%Z&U.KG0,H_`XJQ[:A=PE27AZM+V;`8!V5*=.K,69LS^YIQ_08!=7% MV\SW\W4>TQI9\5(=MO$TS_8&^/9>`8$92O&S MH'>66WF<7E3J(R[2=3M/)ZU'YM_NXZ_!UNGA:[!WUE[P%;6_DO4&HQ7-&'XN MCTEZ#\&$`QP+.`JBJN"Q^%JOFD8'8;*;SQ?D(`JQTD3DCNL&12C8"E!!4-Y@ MN:UHF]OT.MY%+"TJ9?8L=K>6NSJ74/ M'.C9NRU8]U%74X&Z:CU8>-F[QZNHO(.6PK8V,QM$-"'*D"^D9= M1.$>O(L)PGDZ2D_>%11;`3'@Q^]"JC`/X.6@N>T\8Q,WV!?QYY&7IO/%[Q[& MQ$C,\7VX7&5@_;BXQ``A&]QN"D0*V`P5V,P`\@1F/5>)2TZ,EO7`YKAZNIT6#6A!G9*'*Q=-8>2R&19D;H;XV0J M>,`NU%=>B'_SHAR=;7?__"5$F,QHM;U!SRB"\MH4*4/N)8/[<*K25BE7T`_N M6^2E.2X*;;99@?/R]!AP7AQ.;WET0JTF:;!B(EI\P+B*VIB[=!P'0AS0I)_E M:1BC-)WY_\[#-(0,6?)('971YLH3K,=#%T7Z3XP`&V7+B0YTK!.88XEJRU`[ MD"%0X%)*&<;*JN'GTK3:1`\V?'E/;XJAC.9^\.F?S3L$)B]3TPL5N/*<]>'= M',RYZM<2-6SGSQH)&%MU(&JW9DE5VJHFQ_"VJWC*6:8)P6EY-R&'KT>4KF:; MUUJ=HK(=66)DEP&1A.-=I!=W[H]@V=PGW.+E>C>]Y`#M/NC'0=;_(L M98>L#W`K0$3.:;ZQ47"F\P3:)4BX&MJW1$SK?`V'6).`XX<:'5Y('8,#80`M MF5OO%5CD#0(C%WE3&);#*LP>7M/Y>E&Y.I5W@8[/'(E2N9G&PM[C`%=T5*3O:?R#`5Y6UY78(;"IW7II=Y(@5WY,] MGN-87LD0;@Z+UK/^98*RVQ^]V&W#UVQ[X6U3"R"ICN7L[9I-K)0%!U>_GR[A MF/QZ^SLQZV3+?P'*SF]1.2*[V"5#H.+Q.U+TP,#B=L0H(_P,];R02\W5HT(H MZ#KD:;_(/)L!)4#C2F3_O*`!HV13MJND9)5LI'B$H[",$B$I-"PWC8U2@:&; M\!D1[R;SXF5(##![M_HY18L\N@D7($_UE>@>R:)3D[']#N=R^O76!;-U@K/P M/\PH#(LXEXOINZA](``KA%XG,U\<\@.!O83B\>`L$ZV\?KHQJA=H@Y$?@JW? MQOA'$^!I2DVA5+K9BB-\!;1X&3$`#\C/,:OD'-8] M(UJ5`[7IL\+8U%TPRS#)2YP;.=)5Z)KP\!3&QBAI_ MJ(1N;R)37]>61"TOI&TC+>4B3-G<[HDG.$!:2H/8E>(P@_QQAY M4?@?%'PD,Z6%G^S$F6B!:CJRZ:QTZ+%H18]))&:'RL98OH8*0G* M=I7>MF(,N]ZZUMJ40521I[PHK_X"JUS=>^33X0/F(/4Y6&@->!2'"#T15B!: MROUI<%!W:3^GBN=\[L='!4Y;-!40_$B,R=&]*M@]7\R)STHX/?,B+_;1/6)1 M_,?D)HF7CPBO]V=+Q?.ZR@WK* M.9WL?/$IB2]0%#X3VL7)],7#`0T"TJK;BL6@U88Z%LNK*KD*.(#(S/[$2<@B M,IMSEESKUVJDH&")+A`.GSUZ/0-R]##@8OI'RSX05!IA,3&)36U'<-*V< M//9CI54L'>0XMERYK"J4A($;*R!]3JG7%GG^EP=_1021[M(,;Y,`1>7;15/T M%$<_6EA5I5OA;2]SR)2CXN$D%-[EZ&\6[TJZU1,'>\7=&$<5&Y>O/L(^=>(7 M":8O893PY'\]_2U3)IX*$-MI1'(-PMKV+/)IB&%R2TS;+&-^WV#%M22,=NR5):2<:C2&-(G)*-/2: MYR@.![?U\-OEZ`/4Z)"C*JC^37&,3-RN3L]'E"RQMUF190U6(IA/;!2-'?1T MNF[0!%*$:A#P4*A#G2!<+4D^,><5?:4*W,")+S28RFM<@C!UV(0XN:S)9@J#?U3X<#Z+K7B M<(;9Z5(*>LZTPE"06LYWI?5`:;C1*N*QT%?2<)?/GXC9#,GAF*:)S1)_ M`7.BN<1&X42KZW%CR^=+$*R30HW2)V]-_LFN33V_7:W4*GQRJD/4]19YU#)M M;@"G($2X2I5RZD!^MAJ(;NL@6\91T?GN%X5X\%'LX3`!CT`T"$$=CL"M9K?8 MX,KE570^Q^D&^>$B1`&@I>02&T_0H4M?&PCQ!094299+$<@2BD`:1<3!&"+8 MEA0TMS)#>'V!GK)'\O=0%J^3SH0]Q6ZY66\>R2,'9^XXE`9IIR`P=2(]%>$" MW2"WFQZ,D1-!X];'ZX>._6:X^S(?3]EUG)(QY!UQ^Y1(:5$91Z*2T-F M#@E@6]G?R*&7+E;Z0@S*AK5H3#72UA867%O$.BTXX]5!9:#SC,!V\722!P7\ M#4.;&HS9XL#ATFJ9@0%Y3?!VVKB:6:EVUU;1TT%S"$X]6T\]6^W:FE'T;/WD M93E&\T59&@W*T'21F:S)Z9290OE\\\)_X?J._$\2G"A#'A1.MHW21>7'&@U758-HKC!R:RV\1:-V*I/"PO)1[9V1(C]J-^.!P. MXZ+"E`T46N*P'<)AA'NL`9'BCU[@$EVW62WQU[O;>_2<1,_$+3$0L^!S!\5@ MM04MFKT\D\)(I\_FBUD?B8N^GX9V"R4@O>(U>RVE\S2S_O=34.+&_.Q?,Y7% M/]?KD'56OD):PNS\T$V%&9.H4*WZ:9<`[`8^"ML?^E\0+9"B*>BN[UQZ%T92 M[IP\7$[US@HUG7W`ZPHA09=PB7)@FCW7A2*#.MBB+*,5,`NB@1-CI8E'# M2E&"4&E9ESE.@B2*/`R'58N&PY.\&BAMJ5CV;RI"\V>$Z4&,G6;G&U:O%@P' M/C&WN[MZ,8\Z1@+10=Q#W&&T\;:4%HT(/X2OMTF&U^$2L]5"O'!`DHPX'Z$7Z3A>!]],Q:*UYJKP M,,1(I@B_^^Z[[^YP&/OAQHMF:]H7@/:XTKNL51EG,K)7D8E"KKP)'A67[S1D M?_C-5.3.G-W`=&PWNT;?NMW&D@2KYM?D MB`;*X)(#"CN<:`ONS#Q%4*EMGA+M2KX:B,Y.3-;7E0\(=G- MNZW?W3^6=_=`-[+[\:<&3[>05!)X+=BR,R\-TX<-1EXPC^L7E"!=UY5I3V[C MTI>N/*#2VQ)6,9Q[%.3L1O,ZYG)D8A^UQI^8#]E?GK:K&?3EZ/+L^O%B=D_C MI#1PFJZ2*(!&O9/F&].$;KG;?K7=P27]KXOB-2SE@SW?\U*3E,_K@(0G0U9(?8DG49`L_`^['9XO=JPSVA"P">E--YPC%F.%'C^R8\W3K3;HQZ2\ M\CA+,$Y>*"_>QO/#;-O'IU48_0A\'BUA5MC:KK9]$)Q'P]UK(-0(CT\)3*GP M*K3X<2-K%874UA]<;2'A"IT@IGHRKH`&C!_MJ-(W/;M[E\LH7(;D:#OS?:IR MZ3WR4?BLW&BV)XDCL+[Z8JVP%H228+"^]>CC?2]*9W'P^_7=/+ZZOII;@[E[ M]*-%F"/,"EQ!)`@&W)OPWWD8,(_N-R_*[2W?UL!'"VE;A!6:@GPG"#3)%,-T MA8*/21*H=2?7'?-(,3P07)5!8/7YEJ8FL>-5&EI&4TCB2,$5B[7"VE:42&.K M9SO]=?Q,_C/!6S!#+"4TO0.012%7^%L+.6EX`O@+RA@;$(9;0&!RH4,+,JUP MMIUVU'5>:Y0'V]WV[9C<_UH-ZYXD)FG6^XJU@MOJ4RUUIJK'&G!0=U&8UCV< M#9%6,%L*=&FR]"FG`J$LQ2GR.%M;2/-HS)-*VY!NA7H%E^AB:)OG^.< M#%[%W!J\\A)+X<*=:LQ,S>1;$'^E%+:?PG7K*W$GO3@K(E2EKAG2P_X!(YI3U>5:?4>Q&)QN-Y0G&A@ MQK;@*P6Q7GJNSBBT`ST2G2R.HKG)W!!Q, M*Y1E*N8*J>EY+U+A57CQ(T^6GX,\ M9+02(VR828/Z5&VOCH`KC"T&DBHV[G#B(Q2D5V1>-1V#>N`A(C=5)(4BK*"S M6+JI6X-JE(M_TIZ3=SCTAW@P+2(^S6U30[@5Q,)*4GWOZSLY,'P>S1]KBK%= M93E5%20L%V+FTK]>E/^!=A>%N\IY_5`3CCP]'Z>/&"M0[?;UY#*SOPE,XMHE MX"/VZ*E)^::US_A'M495Y%E!#%T]J8LM%8R!-U09+T>VOTI%7ZF#,&L*2!WJ M]T*L-0/S`1YQN%S"E!WLR]+T-@-K8%1Z8KEB%)YFM=34Q5NA9J@K54"EHP-I$)GW0[P;&8KK1 MWOK72-$6J3Z]97],;D+OJ7KQLTEBYOVV;[]%NZ?FN%/U/W7%5V%IN>!35:KO MT7NM:(',/DNL>XP)^RUMR0A;$:W89L;_^^][*2VR1I6S<["T&B5U,#,5-BR5<=SZ9'+3L7]'K2(4NVN'T?W=P^LP3HD?>(?B.-U&SUX<>KO: M[NIH*`WDX.1H@(6:3"PWTV:4;SV,0Y1EWD=$IFF$@V2(R2P(F2BDC93UI?\; MPG$2_Q)&47H=D=\F86H`@'P41X%C`Q`4)*+2,%D?B@=RV,0IRCZAEU_I/[8& M0,C&F(8QDDI"V@ZYA_B))42K)$\18]A`]IT#3$?_Q7*PWO^XB,_\6L9@O.B2 MQFAW[&N*7C3$-U9=*PG)_XB:+<7!/WY1$9=L^N%/$(2&7X77=:(M$ M9%(?R1"?-$6H@]/Y!M&R7/&2L9/23N6L0BM8?-N0$Z>Y_N80FTE=ZJB9!]'4 M&"(ZB5Z\B/+E4@?J;$QSB1N(6^H=ZN^/37+4X)3FYI:HW"I2JW,K'<1M%H%1 MT%LN&+FK:-K!%"-OOKA'Q/2GM&;-'4X(,S"UNKBT)FE5^9*S[EU6)-OKM5*4 MA_PIJG3'BU*0%XT:U*>U!DW$J^;`#G>7^C/+AIAOZ(#IY7H3)5M4OK;-L;^B MS4PBC[CDQ,]+,QSZ&0K8;^MI"697F#TIMQ"17G5:(VBTB5G@0.]FUPHQN`7) MO_^UK1B-.V([$/2_1S;;=%\\'$#>'#<)0$9MU&^,;2Z:QC[<%";,+25+S*$M MH0*:(T_F6>0$UC:8L^W^;\J7*XRS/7MQ0"?XR5L#7D*#\`GGGBG=7W>NEM:S M3>O@*.1+C4:58*[*P93)[2V[$WU2NI0WTJ??B+FDSB[05E(?'BKXX7X3:0C1 M>O+$`14X\]\D`'I;HV2Z.W2S0^H:%M>&X&&,95OT+FV((UGI.$9?>[V&VND<1<\W3 M5;AY3"[C+,RV<,Z5+@N#K$"!N1/JOA!+F6Q5GQ)!HPQC18UP=FMKH:!6L\UF M17+*XS&406Z,#[<4W5OBIB!5+HK[`09G8,<5=NQ2T"ZYJQM%"V*'L7BC"]'I MR5[5@S0LLQ!BY)-?PYV0#BBXR(;HZ68U2B@IUR@."?Q"='C)Y]V?.DDGL2!VH3C`LBL/_`?`R$XG(8C2F,,VJ55Q*$ M]2SX,ON>>7(?B9?`RB51Z6J(7O"Y0\/>F6I0>W#`GS+,GGE(\=+#48CP'\C# M.I4C%(9Q:6'TI-XE`Z!HZRV1PSI?`QZ4&P0RA#_E4+#99]+EFT2()']`.$>J>&Q+ M2*_C.X3#)/B(DQ3D3@R"3=>UM,>L@)VP@L7]C+DM%L=\P7Z;SO)LE6!:4WQ4 M*LAE\F3]E.&4'V'=*-Z^V>`D5%#`[DD9#2"V7`=IQW/5-0@%%SDF3D!AA@OZ M#5F](NR'*9"VZ7/AN'H^J!X98")]3N_$9;M*\`*%64YU.0XN7S_DJ:F`6.J:[=9%N^9SW=P"%NY3I'S,IDA5^"7VHBY' M;ERORC?<[;RLA?9U3`01IZ'?T3AY'-Z7$M_'[/P/@GL5XK5]GS,+_LS3C&61 M/2;[X^R=%P;7\;FW";/R;-O>Y:F[6+!>]K(M)P1BX`#8/&IK"`%KI8,`Z>B[ MZ2/\'/JH>TU]HMVO4R(&MGQ2MD[JOZ<-8(E@_T#9/?*390P5:H-CUFG)0$A] M!,2WTDK^U<.X-+(P\N3<7?Z(_AW(P6+@&1SQ%C^T+E0J/9HKC?9"N''E1=WW@F.RDW5Y?UH;?!PZ%?ZR[_[ @6`\"W(?+54:[4OJTZND2 M[DAEG=$C-K!`R%9Z**A9;/`0K.=Y[S8)PD5(,R6[C"7O"9EMHD>H3$#H5$HD MNO\P4*.JP2V'3?H<;_\XK]8:^C?F8UROUR@(O0Q%V\^;)*9WC^W.Z-QVVA"4 MCU6A@'"JM&I$]QT'&3;/1"ZT.@/Q3MG^/BJG3L;K,<=VX`"NE%)P,6*LE=TI M$BRZ>2`#QBMM3V;05,HBO$DQV!CW#MQ\057X=_*OE)K9%8KH4;F: MP$LC"J62C9&^D@QP?Z(K"JU"S M%*UG5'>F["%_^A/YV6/";%H2T3GY4``K)2.,MOZ*T_5KE'5.QDW<`&_>3DCS5:`XE8I63V M.^`)WP]PQ3/D\5C*RA$J5&]T*H6QW0^Z6\F'V\[>W+ZTAU(:KAVN-^*[[ZYC M\@/TZ+VBJA'DUZ9!%]Z`+6%)&_N)1S&."O&&UNLZR!\!S'?G=Q)4DG>C/:!` M`+U[_AE9HAT[Y8:9;:$*7W,HC:$$ME0MZP:&)S&@\%BNI M&!S@,M@\@C`%L84`N2V-W1\CV'+9#[07-K6?#SZ*/>+^0=FY;D+N.ZYH&3F. MM&`Z!58T/L?I!ODL>0.P$RF7V#!K2&#FA"K:0(J7%T==:R=ERI*=1$L@83_2=&@&U,Y$3= M-^:4Z*\,M`,9`AE#*648HZB>OK:!,]6#OY=OI_:AG"=E-/^QWS3FT]6U(X MM?4\DK:>Q'31EPS^.I%D3KO!C0N2HH]_MKR:BT!W3M6Q$*IY. M_1Y._1Z.M]\#6TRWY&#^I1;6T#`@G$^=6A'E4.7.FO`$H-+`QT#>OR&<>GJ.$?2K8\<>N3Z$FY/&>Q$>[E8(.+R/Z.=7WI/S@2TV$GLAU%8)&=F5XB0 M]R)Z7LC)6-O&'T/8'!MLN>QAO%PEF MKT\@H!=0FQ2D(JF!!>D_QWA7XHIP>H9B(J@L?5QYV>])'@77ZXWG9SN3!&CI M#3EQ^I)+&V-3<5ON4,$F0'GQHN+E1)"S<-]U_#%)@I>*3M(4S7YDWH/1'#GFVO$OR96&Q,.(X)\W=)X3RFGXCESXF9AZGXH4/> M==$%[86H)5MI6X6!GQ.\NT<9.370]"3Z?J+^HL!(T0Z*RNY'IZ^[R51SC&9/ M:8:):8)0-!WR?3S7"PH#?2Y""S8_Y90<%1^M]@A;A5:-L-/3OX$*-&[ZU$0+ M=?/'(5^^.,*W7N:OB&/5^'U18&-`N%6X<1Q4@]$")1C@KNJ-F9HOV"_'I2(5 M4VXO+YTIR@X3Z>'5J,Z?B*NTBZU]OY*R7,]LD2'\^)*PIMKSQ3DYA(?T66-1 MCUC)F1Z"#Y?7@8;*,QQ&EMM4VF:<*`\:AWH).'$89Q^)?HE@DI_G!W^C_/ZA M>'9Z'2\2O&;"JQTL#)\!\P=MG<[D+X)5!C--!)`0T'R[+!L(:G$(7C!K(-%\ MR"P52N_WS,:NW>Z1SD>4++&W686^%X$_]VL1`W3%--*_%96W\_%?6WY0S\L* M'NOT`%\`I6&` MLA7Z'#/W@O*;:F1'"`=P'(N0FHK=-B46@^V8DU\DX?[K^A-_+:3(_\LR>?ZV M_%NZ%#Y4_T%A^%!;!;7QG.9HJHB[/G>X#(.JP-<]VB0XHYM7R1S(OBZ@YO3Z M6--A4Q$>S*O^>_2,XAS!O+"KQG9^P60(QUXXBD^,!SSQ?:`]$,*B]:`7LS,O M.<:BV`_K5:H,SU(*@QL<`;5&-7P!H4A'\TBH/"*@;RHX'IK`U3PGJHO,PH'Q M5!G&Z(RHJ];JE6(&JT,"@M>I5(Q-B$ZE8D95*N8FB9>/"*^KDIM[&W"V/2>L M+Q.\G2^H9:_^(H`RC*:LC"/"UL=Z&H,`X[/SV>$P`V=\35EQ;II[KBLU[9#` M`1/_,V0'QN[WT`^7NX)[[0`M@'&J/V9C5^A3C^Q4D.Q4D*Q%^520;*P%R9C! M>`Q^\WR?D->XHSG\QFWB7T_'<1"ZF56Y\+\T`RS5U4QI_]0Z9J(!6SQG*PG42F14Y MX'[L\II3_PT^7P80Q7\Z^",>);W>QNS.Z<&+4'I+]L%P$X6J0&B.Z?B]?*^K M"&WY054V*SM6I8])J5\59R@%:Y@LI3E19-5E"O`JH*)!>'\*XR*I.`B8X&@7 M^9INS5\47\MJ#NDT#<'*:E25'43B?0=9PU1"M]$M\K^E'C:3>IK,'%[G4W9#1$AXU) MFO!>^F>]UGYEUGG?AF@5+:4[Y%;>844S.-1Y_RXNPA MTRKH((S765JW5WF68U3R5)V@BU[9`67_BKAU7C3M!TP*B617T(- MF#/^0XA?Q\\H+638:'ULF)EM@X$6:/+T M;;MD]?=ENYQHYJ[;(PFY?PNRVT&4IIG^;A$6&P^J>Y1VW>6STFX@D(D](G)P MCH%&:H_UI=:NX,H1-DQ>'X<)\!+UED"D;CAMPP3T/DD$E-/W219@4K.39A&+(GPRQV5Q+"@+V4EG'`^+ M0*UCMWS!$LRK:-@LKJJ=I7#&D4_,N7$4J74'/%WR@CD$<`G"F$4A1"[-8F^` M0-_7G-ZJP[J,PL?LPC8;I_?LI_?LI_?L4H'!G:HOT%-V':=D',HDE%WLH/(6 MSM)=PK7GPD^C[PTA;*..N3?@MG4@D/>,,JV2NPY M@#6SNBP`IO\HF5^#5:2(>K?$84[TFFS`V'`CZ-W:]F'1!PT75/F[="."O&;J MI/,&@JC=\E7)<;<")VSUI0Y*K@VS2)]%N$#[Q=WTX`H?\:!Q:SC[H0/G%-_3 MYL=0IF\_.-B9<2S6KB9'Z;,/PX7$2,`5>J@//T`X36#)6CK9$K1R.8&^@H8Q M4P>B=FN95*4->W<3+N-P$?I>G-7*$-`+I&*!>A'Q+Q^Q1Q:I#YE?:<3'\2=> MFL$C?6@%I2HU3@!OC$SX<.TD]EEGF@K1`8+]DCM]^`&ZHS)6"[?;@$O-4-Q: MC#2CZ"-XY?GLD374OM%!Y2W$<+N$:_DM9C2<=Y#@!?B_EP@&>+=I&# M,:H\4%P:3'-(`#-#NVJUO!-U MYD5>[*.'%4(9\6WWI9WV#;.)OURYO!]QDF]2,D24!V&\9&6AZ,/X'`7S35D( M""SQ8"#.CS\*,I0**%0Q,,M0TF$%.+G,D!7GCOBP9J"1,&6*'EC"FQE#0/EP MY@HUHH>YXU&-A[,MI0<6JNFB\P;R,;KE6V$I?-5F>(V&-F4Q MGUHAMB8/K;WL ME%X%$O\]G39"Q?`R.Z@*3V,T-QZE0.TJN3;G;#\;XY"&R$J92M:-]=$4+D1" M0]$##N'U3>+I])0Z^,1E)RG9\]5]J[N#:4*%L)AU^I3$21'IB)=%/.;R=4.4 M`3#75HFN@P8(G+!4=]7#^DZK)DC;,#)=^=W+TB0N2X[4=A^-)2(9PFW[R#[Y MCKL%)1,22%\VM$@PJEJ@:'7!Z_C0,0@J'0<%LP9J-CA;9,27U9=PUW*+1J&FD^EV,`O^S(L3H/:&T/K422<, MTQVA/7'+-6+VYM%(QMU?.O1!-?<$KGPM=U0K&U'`G0V:!!S;EHXWAW6W_T`8 M0,'06^\56.0-`B,7>5,8EO.(V7JZ/+^_6WEX[?DHS\C6$*47(8W;A:P1B[I) M41G'K5O?,R-J9X&4)`9T!KA\]5'T'*9ZKDW[*Z>[J7)Z\U[D[6D#"?@F2K;! MC!@Z+_H%>5&VJLJ;:HA;-H;#?59?]%*!P)S'_B?9H!B]7L=UE^.F&9K@^G)NWNV4/U8;X)?7J5'R]W%#L=1%LI4SQB;D$RK&S:S)[B MRA&ND`>[2&YQ#'L1SR'G=">Q@)]0E$#OSQ^Q%Z"UA[\`8M:BX="KM0!36V32 M$YO9^YH\S9(UPJSG-CT@KL(-($HB5G3)2 M!62PF?&RW74";9;7;)&.>.,])9C^28A2O1"GZ'LGSH54QL(9VW^#PFC>APMO MO0EU+./!)RXMH[0KYDZVA_.$T=E]]-_@_H_[\30DS)\[S%5?:9'TY=SYH=M( MC+J4NV<-=']W$P;DE\3[N,-A5/SK,=G0W`7BC'@ZEWIJ(SD]\ZECH"@6RX<\ M1OI_PV23:?FQS2\29'LW038G20E:-U*!,,X#I%3+>R1NV8 M)A(+6*70CH>BQ'M.PZ#,K6(/6!8(DV/0.XA3AA9]%UNRW4>U]%!YG:&UL(Z> M&A8PM7[NO"WC]S$I;XXJIE#Z$2703+A"$^>C%S]%JD!VTY-EOMC8>E,X?W(^/%".)Q!1:'ICFS1'CG=ZC9Q3GZ-,A.)8RY@Y('+USWY*I2A5Q M6XUS'E8>IK=S/LBF*"9XI(M34=H*A8IMWP80[9HOSKUT59TG![X9:-,_E]4T_7"])KJ7)?Z7.P_/,:M$&/SF13FZ(W.C.@FA""IDC]ZX*\F^`EX4 MYC-#GF;?SQ>_>YBS0[I=I^=L4Y,K8C)'C/SL9`E0I M##^D9\L_N"M3(Q@OLR@J:Y=6#BH3A7[T7B\035AA`4FPLYA=!H\]YF(9 MSDKIA'$X@Y/?IYQ*:;ZH4IZ*8C^*-T_0XQY.1([49? M?*ID)MO5"`_O!2K^AKA_V=$Z#-O\G+<>6/F$%5Z8S_)L+C2HT;DBHB#4]&31K3( MR0%"5;3H'[DYU\.BT@FKA;%+8U4X$;M\C3*-C?@38:)V>E,9Y[@W`"5)5A@* MTP![Y(76G,&&16$W4[=YE(6;*%0MW*/QT7E=UPE492\ MD.WE<86N0IQF?R`/WR5IO3F.*>Q:-(XWU&L'@DHQK!72T\]2G]$P]+(H7<;* MJL\7\SRC>U'*[C-^"9>K@;(U^W!XO)H&!6FE>_R@HI4G"0H\/N)PN22;8KQD MEK/KHD']A8(QO>/V2*PB4ZF.Q1Q`*TQ6QG<0W=D1>Q.^3G](JJ=R=OOG66+O M8>,-JS6,X'%&/`"`J73'\A-K>UOJ3?(R;B>),GBLA@H(SDKI`.*U9IR>K^@_ MK^-B&YXO9.].!RP389_UDT-O30DJ1>8'D*ULO(?Y"Z;[:6N<-^>9MR5902AL MYF$`H^#I*5$PG(7_\Y9A,'*G!VV?\(PWX]Y=[I0SVWH_S M%/',2Y'@PE!]3;<'>EN^;X<@*Q0M97OR*-^CPW9[W5)%[!;SOOLM.K6!/*:1F7QK=A1*:7D#^:^:L0/9M7`Y$/ M?*Q'CAZBKH`7)'-:0?TA\]:;BSP+47KGA703N2&SG<7!61Y&-/?`>-DKC'R\ MWGL?<5?0@^5G-JR0GRSC\#_$P0C(G,(%.1#L7(PR`9!P5YT3"-OD=_D:!1>H MJ-!`7([:+S\EL9^3'\.^`!B$_^/533?J4!6WLE1>G[?`J@-O!T-;F@%--MQ@ MMB323[/JX8.I@3,A]>;<'",\*EVQ7<:]B[^&;E/GFY!@J9C7M*#-$K?RD344 M1&7LMZ<12A*O5,!VL6XI0X2%#<+9]B[RXHS8NDORX\VZM:.9:@%_^./=<'H+ MOE(&46XK@"J4-:M2LBNB\)GNA'9TH&/ M!5%7H%OMBRQEA!^OA"'GTZ/& MBR>N"AM!@-%.)9I]J=OJA>%U3%L,AD'HT29.$`$#?2:.]#:I!RJ5@M@*1!ZR M#,R=*HF]#QV?%"Q!54!8CU-]%\98!-;E&B^U;-;DEP3'?_&3];=,=$PT/WZ. M?2*`)`H#6N+WUX0(^#?";8Y1.?&O>SB']"8TV]ZB;)4$-9'.X@:A=/:4$L'[ M(-JIRX+Y^NNF-'^)$4Y7X68?@1ANFEW$':S$GNI07VD:0I9V,AYXJ?UTGJ=9 MLB96)M^PPBG$ZI27&^?$2A"VB]3Y^KHSJ$MK0*IEV\3%:WM1,'(X3$@^*J<] MF(\.%U?W]ME]A[M97W#W!7G-I=I>6TF?NX?*/54BL;B:%;^ METE8I4&\+70KRLU.]K#H'M`$O#JK,/TF:$RON6>JJKP8Q$-!N@/Q7]^Y@Q$> M2+3P\B@;#DDJS:HJMNWS9`>_C^2S`>WLCMRQF]B]7!7`M`4G)3J@8:V1&Z%- M/=1L(6!UR0UH2?=D!S*BAY"-SGX:H@9I-0_ZXMTVCL.`'0=+0@Y/]ZKNFZ"+ M8"4MI:.[?N)6A[&F?,)A)*'HY@I28T-HY%A)I&??$!9;;UDKI-I\TZK,``IF M:8L9Q0B&YIB.T^?L'?AU93F@-[*/W,&TS+2LD[OG%#4W_0*AL;(/(I_J0YJ%.&0W-V*;:<$Z"F=H`-:.7BH)R M%*[D,7>VK?\&ZD"M07T4YVLMI:];/!TQPQW7ZK3@CM4=5`8ZF@G.T_IZSH-/ M^51M"2*8@S0'))>'9]L0*1ZA#3;`RU^OPMB+_="++FE>_@:'*4JO8[_KF,;9 M]61C.#PE\\W$;F>32D#%B!F\2TPBFB431:&&I%L?C5NT[3G"*'&1[/6(\'J^ M>,B?;I"7HMD2(Z1,GKI/:'%BM6EB/`0 MT9_1'WD13&ZZ!G7'@08C7$V$K'`*M>EP%Z5\TOFB]K,!/>Y.\LYC#KW`UA)T M51;.FHG=I5V6M1CNO"T]&]28VF=`S^(`./U5FXD)&N\>$J^>VDI/7,.%G-Y_ M]T`+>!$7"YVO/+Q$J85TF!'7:5@_;]EH$C52`;DE:CW7LZ)5D/L?I M!OGA(B0L@H5M^<0@8'"2[$,&$;84@N0S>]H=(-5S;KSQW MK=X*E!GDD8+T'!T80ZY$I2!:`[`HA0.8(2HGZOYF2Z+9,L@.9`AD)J6487:3@+C?:#/%XI=%??X!NT%RZ#N- MZUHYA)N)W;Y9+(IGL-#LD^=_8:&X)^(#WZ,4X6>U&(K@QLORCI;F_="J M8*CXNT?O%:67KQGV"#=D:GC+^*>7..1+(JBH5B,3`G%(=B>_U@?!5'Y)9Z2' MW8V*["C-06>B(T&YU4K(?K6V>\I&C()+#\>T;]O,]_-USFZZ+HCP_!#HAE)* M]7C\)Q41E_@*6@N8`DPVEKVQ@,"R2>"HUM^![$J0A$U,S8I%E9IQAS"KUGKF MI:$/@54WH:/9%3ER+'&S7?K_D-I%&.798=%V&-PJ4D>UVKCR+/$3ENE'97H`R;2%GZ"),Z<1RC!X)3V?DC[^P%X#LL@>' M.[+CQ5E:]&Y1;&[`_]KMNXG2P1+&_O?#6WI(6`\^7 MJZRC8+H=?9(3=9S:I8V>AC@52TD,8ZLN$N)J%EF8EX3K;'L=DU/AFIT0O];W M5P(4_JL:LC92RZJWE2E%_E^6R3.9=%CH$?G'H?I(1]>W0'3(8N+W:!E27./L MD[<6:+TJHYVCNCBSJ&)"U9@O#H68O;&FT$H2]C2#C>;`8]65 M9VGFQ=0]M&5OA#0F`HV*M.2/1`Q!NLN?HM"_BA)/X$GK85(?<@)VJ4,.RH\R MM`0^(QP%E*NKR+.P`)K#.7D;IROJ`PE(8[CF(KY`J8_#C?@IF[:DZZ-.P;7I M%H=":-74XK/*.M$U\?A.$1RT<:#C7$X[,-/"@VNC"IK?-75)BP=BKN'G8:!HDCDDK\PN0PQ+W.E4J%@\\#;)%;`#@)"?>@I'!,$@JEP$!Z%1>'[OWU+23UY*6*" M^/\#4$L#!!0````(`!:!<4:AAK(+CR$!`.`F#P`5`!P`86MR>"TR,#$T,3(S M,5]L86(N>&UL550)``/+B0A5RXD(575X"P`!!"4.```$.0$``.S]?7/DN)$O MC/Y_(^YWP+/[7,=,'+6G7]9OZW-.1.FM1UZU2I;4,SOKV-B@BBB);A99)EEJ MR9_^(@&0!*L`$`!)@&K[Q)ZQ6B(2">0/B40B,_&__Y\W;]!'G.$BJG",[E]0 MO4$G^69[NTK015:1OZZJY`F3WV5/N"#_)G]_K*KMO__PP]>O7W^] M(I^6JZ3`9;XK5KB$7Z`W;_XO@O_W__W__&_HY*3`T,6_H[L=1I^B`KW['?F_ M?__-AW__M]^@SW47\*\W]6=OX%=OWKU_\^'= MKY_+^%_^+YLYA/YWD:?X!J\19?W?JY4E8Z#"'GRNK#M$4%F!>U#1IS__G7W;EFX),H MO<[+!);LXKZL0)M)9XNRLH[*>\H/)T?X>O=O/^"T*NO?O('?O'G[CB_6?[7J METQ7/2C@NC.L6H%:S163FO-$_$]ZGU*-2!IG#T1>V9O/M__R?YNF*%^CIC&J M6Z._U.W_^W\S%OZO("WX]Z+HBBPJ5C67Y,>>D?$O?ECE1/-NJS>=0:Z+?.,F M["IWF)L?W(%X$I6/BRR&_SG[VRYYBE+27[FH3J*B>$FRAY^B="=?MP.1:-;Q M#_LRFQ2,1CPIT`B-4)3%:`4_X+9Y"[X0V+.2KP@^\[D86UUL<9'D,0%_4>O[ M8<)Z*Y/6XO9'M+@Z1?2'LS]_OOAI<7EV=7>+%G?H^.SCQ=75Q=5'M#Q'OYPM M;@3]\:U*\6VS28XLQ[,L'D6*[VRE>$9^?R"_;U-X[SK"L]+_B]4JWQ&J-WB% M20_W*;["U^7^M- M[%JQ>NM/$ES.8;W*A"$BX6!$8YM:O:MQGP/9ZGMED_C6?;,\Q6M,EF%\%STO MRA)7Y642W2W!)S\!:32:-=3&FR]7;JW6[KXTB!N*8=6N<%*DE+ M5+*F+X?P"V4MF(JX8S(83<@$UIS@XW:7E&Q3:1J^(:)Z0T75MCU")_O"^K9$ M-@)%E$S0WW9W6UH%T$?..0P\+BW[_X^M/!$)'Z.KL+JPQ M82+/KA+OF8(`OKL^GGJ\!]_$O.\O:C]V=A]7LMN3N@U9$="*FCA-.[(B@KO' MQA;-NR'Z]F.>QU^3-)U"MS:T?>O1NF.%SJS_'-3(W9]X4>(=_L=7>(8WT2(7 M,A5W'*40GA=V?S&=QDGTE]%5L,B%3%\=3&,@M60ZDX/4S456D;$G]REF9B-1 M86?/JW07)]G#E*K(J%^?`6(F#"D/\7F\6U4H35;DH$N^1T7R\%@=7/V$NK

(4SD1[N3GAMQ MM2M$?INN$/E!+6]^N5PU!38X7UIWS]Q1%2F1WT'QANU#RZRB3(Z$W(E-`Q?A M%(QH"L9D*1C!$HQ@"4:L!",P@D$_P1A$!$X,] M-=B1P8X-]HO!GAGLQ&"G!CLSV'.#O3#82X.],MAK@[TQV%N#O3/8>X.=&^S" M8)<&@TX:3.AD0)<*T,EHNF2`3D;3I0-T,IHN(:"3T70I`9TJS89.426X+!*,%@ ME&`P2C`8)1B,$@Q&"0:C!(-1@L$HP6"48#!*,!@E&(P2#$8)%HQ2$$8I"*,4 M=+G`7E:CZ;*!O:Q&T^4#>UF-ILL(]K(:S28G&D9%-?86,=:L:&BO0X%K';>C2!.GCTJM^^:\6TVR4?QRAR';P=P]MH!UQ;%:4\3?3 M*U;PMEC!V:7!R0K.+N#<"C]@:QZY8>6D6,Q`RP3=SKN=J(7>0JRRI#I_/.^; MCM=0U-RF".C:N^A5*[`$8]P>KY53M@G>8'?#"\C2T-0S(ED*P--GLXGD`&ZV M"&U2K8Z$KL"*'KZ?;J#]T1WAUJX0[FVZ0K`'M0TO(,?6S0HLPG(;D<^*ZN1? M1KO$ZJJ+G.\]ZLUHQ@`X7$QAH60P84ZL+R$,1WP7;/:ZD,"FX5F#!%8:)(K2 M(&S,BZ'1!@F/-$@LI$%X5RXVE8^=J$;>`N^RJ%EY/[$P/Z8>9=EFL&#^ M*171B0:X?P"AP&!L9I(Q5&J0`,>K-'=!3DL!F]V9V":S8);#.[KUU MXWDHF0UNM$O$U2X1%[M$W-GEANM$)N*EP;ECYC?<1#Q*G/.(WU#,BO#)6B&Q MZ2D$@@I&&`5C>!2,)QC!B(]@A$V.PMP9CK2#7OC?8N<$N#'9IL%@KB)%8?2OH4B%6WZKIDB%6 MWZKITB%6WZKI$B)6WZKI4B)6WW/-ACI1(_X>ZH1^6\P:L*:8U6Z?Q8>C7IDL M<*%@>%`P'"@8_A,,]PF&]P3#>8+A.\%PG6#023#H)!AT$@PZ"0:=!(-.@D$G MP:"38-!),.@D&'02##H)!IT$@TZ"!9T4A$X*NE0(.JFF2X:@DVJZ=`@ZJ:9+ MB*"3:KJ4"#K--1LZQ2N"[Z%3OE*H'C(2JV8BP7"78'A+,)PE&+X2#%<)AJ<$ MPU&"X2?!<)-@4$[<"^&P@E+AHA?VY%+A7B_LE[XJ7/?"?C&IPKY#W+/IT/Z*"_GZ MA1.%00[*=Z(PQWGA3A3&.#;9B-AACBR.JG7"12_DJ`DC7(6]E;6W"GLK:V\O M6MRS#:[CWOCXKK&U#EM\I].)PA;?)32BG?N(6%4[T6Z(^G5T&YJ=\#X+"G/5 M_;!UW]K:C?O:M?>U&QFT:Q-H&??%:W=CJ\]8WBH:49^O/EUWPA;U7W?5,D3] MQ"&WO!.B_L?1K6@95[$9US2XC*O8F^E$X7EV]SE1>)[=7TX4GF?CD1-%;@Q+ MX::'C&7+CK'+=9$Q:=DQ!CD9A%]V3#!.]A`O.OR@'PML_Z)[3M![U@@>XJ$8 M\LR]AN^LZ\)SSG&<`KC`!1P#K*UQ3-0"%U@9M%_@`BOCIWP[M,F/P%V;R/A5 MCY/Q0YP=VK0R?MW4.Y"S-K11A)%J<4*`"A_M<8-[[K(C),=6H'DV$I. MD)Q:R:-=6+#K?'>$Y-A*3I"<6LG!,H8S?FRCG3M81@R9957$=V2Y63>:\<$+ M)"[;&;MISDG(ZDAJ8X>VDE;Y!PG+RYYAS)A96PZL=! MG.=GKN(KOAT?%G&2QT@>6\D3)$^MYY[@N:?VFB.N.;*28R3'3O)^W;UW^/FZ MNW#6S_>["Z=_N>XN'<[7CSL^-.'N_0#)H9.\6''/UMW-H-)X%-G]V2?`<-XXFS=G3G\^;I[[O#+ M57?I1HF'#YDN'UK)`9)G5G(24ZR3'*X[&QV2V68L"?O$]?;INK/92K(>.R\= M[3/@&B]Q"P>VGZONT.&/5@SVIIVS57?F\.>K[KG#7ZRZ"_<$\F*ON^CU[X[/ M'U\?_/SGAT]7IQ^^?/KMCZ]W/E]]9/UQ[Q^\%KWSY;=/L2ME^,^WZS]9E_QT MYU_7W[Y=_][_\]>K#_^Y^A(**'^\OOY6_L.@>O>OZR__[=&PO=V]R:W-H965T46,>[DK>Z@X(^@:57FX\?U@=M[FT#X`@R=+:@C7-]SI@5#2AN(]U#AW\J M;11W^&EJ9GL#O!P6J9:E<7S.%)<=#0RY.85#5Y44<*/%7D'G`HF!ECOLWS:R MMR]L2IQ"I[BYW_=G0JL>*7:RE>YI(*5$B?RN[K3ANQ9]/R89%R_CB/%JNXD6"<+(# MZVZEIZ1$[*W3ZD\`)4-3@6MH[88[OED;?2"XW8BV/??#D^1(_'8OV(3';CVX MH#B.*&,QOX=-$F?)FCV@:_$,N@X@?+Z"1@1#U5$:Y4Z7]F`O[6/QO5R'PE0F M?5MF,9?QJ2]P[]YWZA4>=S5#:B9L'B-)P>K`7;=E9SW??C]."Y5JA,[(0#&DZ!`E/#)VA;2X3>^\.7XER/U?%>V*9^E_^M M9_EVN"_8^`//:\]K^,9-+3M+6JB0,HY6Z-2$$Q\^G.ZQ2SRUVN%)'5X;O)@! M)SN.$%QI[5X^4)B-5_WF+P```/__`P!02P,$%``&``@````A`,[18"SI`@`` MG`@``!D```!X;"]W;W)K&ULE%;);MLP$+T7Z#\( MO,?:O,2"Y-K0.J>5K%E*GIDF-^N/'U8' MJ1YTR9CQ@*'6*2F-:1+?UUG)!-43V;`:?BFD$M3`I]KYNE&,YG:1J/PH".:^ MH+PFCB%1EW#(HN`9NY/97K#:.!+%*FI@_[KDC3ZQB>P2.D'5P[ZYRJ1H@&++ M*VZ>+2GQ1)9\W=52T6T%OI_"*\V.O:\])<^,*U7 M.0<'F'9/L2(EFS"Y#6/BKU?BL>/Z-UPRR#>>$)["5\@&A M7W,,P6)_M/K>GL`/Y>6LH/O*_)2'+XSO2@/'/0-':"S)G^^8SB"C0#.)9LB4 MR0HV`$]/<"P-R`A]2DD$PCPW94KB^62V".(0X-Z6:7//D9)XV5X;*?XZ4&@W MY;CLUNZHH>N5D@7'>S:(O^WIE(KBOY2)C-]A-.P5O+^$< M[M%;;G!=7^$8&;BY/N]FV9=]W0V"^UHN,G830A<:VEE"['5^NZHO<`H-W"S/ MNPGQDG>R^(;:Z]B!7`&DP6X56ZZN`\C&SAKF!#2P%2PKR7\"V#010.L^T)*<_K` M^=7^KUC_`P``__\#`%!+`P04``8`"````"$`89H_*G\"```G!@``&0```'AL M+W=OXZOO;EY5@UY`F.E;G,: M1S-*H!6ZD&V5TS^_[Z^N*;&.MP5O=`LY?0%+;[:?/VV.VCS:&L`19&AM3FOG MNHPQ*VI0W$:Z@Q;_E-HH[O#35,QV!GC1+U(-2V:S%5-ZT?/?2A\"5"3*.DG`P/ASSE-4%@6 MKL[I?!4MT]D\1CC9@W7WTE-2(@[6:?4O@.*^J<#5MW;''=]NC#X2W&Y$VX[[ MX8DS)/ZX%VS"8W<>G%,<1Y2QF-_3-HV7&_:$IL4KYC9@\#E@X@'!4'101K7+ ME3W8*_M4?"NWH3"623Z6F4]E?.ASW+KS1OTBQ(U,I/%JX`\=!,RB3W?L:S$5 M/"_DP1@]NAGB2N/TG=(K:#4!70^@2:HX"9>GZL&]^A!KJ)R:0NTQK4\Q66-? MY]WY55/^UPK*C/RN/[:23C7/2WGP5"I41E;"P0S3K\!4\`6:QA*A#_[0)3C/ M0W6X#W:)W]_W]46VZ^\)-OS`<]KQ"GYP4\G6D@9*I)Q%*1HUX:2'#Z<[[!)/ MJW9X0OO7&B]DP)&>10@NM79O'RC,ABM^^Q\``/__`P!02P,$%``&``@````A M`!L;7X&2'@``M:0``!D```!X;"]W;W)K&ULK)U; M7HU?7EQ=WW]X_?+C_ M]NG-Y?_\*_W'\O+BZ?GVVX?;+P_?[MY<_N?NZ?*?;__[OU[_^?#XV]/GN[OG M"^/AV].;R\_/S]]OKJZ>WG^^^WK[].KA^]TW<^7CP^/7VV?S?Q\_73U]?[R[ M_=`9??UR-;Z^GE]]O;W_=ND\W#R>XN/AX\?[]W>;A_>_?[W[]NR' MQ]M?OYAV_WLTO7T/W]W_(?=?[]\_/CP]?'Q^9=Q=N8IRFU=7JROCZ>WK#_>F M!?:V7SS>?7QS^F^[AKDCM__N_OWS_L/SYS>7 MD_&KT?1Z;M07O]X]/:?WUN/EQ?O?GYX?OOZ?TXR\)^=C['V8?^%C_FJVN)Z, MSG`R\4[,OSU.!DJ?>D/SKS=(_04^Q^GM1%=Q&;4 MF6U$9QE);SFQ7X[0;^Q_H(VKT\*(GC.2KM,;QBLW#'2CRN;V^?;MZ\>'/R_, M4&V"^?3]U@[\HQOK!..)"^=QA/G1`&-&%NOE%^OFS:6Q-X/'DQD5_W@['U^_ MOOK#C&3OO>8=:T:Q8@V%';:LVXT&B0:I!ID&N0:%!J4&E0:U!HT&K09;#78: M[#4X!.#*A.<8(Y,U?T>,K!L;(]S==P`2M+$*"!0PV6B0:)!JD&F0:U!H4&I0 M:5!KT&C0:K#58*?!7H-#`**`F+$H"DC_Y(O9F"@A$$Y491Q$"MB&2$$F)9$1R(@61DDA%I";2$&F);(GLB.R)'$(2 MA'!3WWD2Y`61#9&$2$HD(Y(3*8B41"HB-9&&2$MD2V1'9$_D M$)+HQIM5R!DWWJKC&^_(U/P3),%4)<%1A'AMB"1$4B(9D9Q(0:0D4A&IB31$ M6B);(CLB>R*'D$2Q,"NR,V)AU7$L/`F2@,B&2$(D)9(1R8D41$HB%9&:2$.D M);(ELB.R)W((273CS7HTNO%N/]^__^W=@^G<9M75,W]/S"+6+6VM MDS@>GLQELO9DM#JB#Q]T)4 M\%Z2]XJ]UV(GWD=CE?V-J."]#;U'D3`;U"@2/7?D>GZP=U6Q/PN(FMU!T M38X#:O=]X1Y\.#GL08S*CB.*%K83M0%?>]E8)I(-T/@8XP3(CH!_O)VN5FJO MDD(0I`N0>,Z!Q',!%'6[B7)?0A4.G&..E+L+05MJ&$J)#9!KRWB\4LOX%H*N M+7%4[.8OC,I/31YVJZ&#Y5`W"2&'YA/5$]?>,$H^9V@.+9&/"51+%ZNXRZ4H M7&:E#`;2P7,@<5L`F>'\F"SSB;IWI;@754^@?*VEQ!KNI<0&*"Y1S3CM2R7& M`;1[QK\>0+_SE$[USAY%FI@&T\S:HZ`W;J`RS3_>PYZATOMR'72R6JQ4FU/X M";/-&06EY5`-EE9`%0[?\XD:J4JH7DA`JD0-P\%*-%#YG)R,EVKB::'H24J[ MT1R*Z;\>OO]H11>L+^R!L,Y*(-.L8[SF$S6UK6$I77<#)!T\\2A(WA0HG/%\ MD>(K9U\%#,5]"22^*AB*KQI(#!L8"FJ!>J8EN[<,[_4+TY*5JW4&4-@AYF,5 M[K4];#>607?>`(6&/$5"WGS5C+J:;=_;91A?C^![0 M.L/)@NZ_@:7TO,2CL5LR34=3"IYW(]T\@XVXR=ES`95?C%W/:(E!GBO8B.>: M/3=0.<_ST4J-#RT$/>ED=ZGAW?^Y]83?ZX9!`0I[3L^"PLFB+'-H(ONEQ#Z" M,A&>A`$>3U3&IE!)+3*/`O&%A=[E_/9)NKQREET MZ=U`"C]A>E%I.52#I15>-0M5\PGMP7R=3/8-C8U4B?JD2C10^29?S_2*M86B M)SOM=GLHIB2!2BI1GU2)!H9H M\D1G;PL%)X\9]./D&5XI=G(54.O!HG``GNLA:^TM@TEF`R2=,0%R:Z3I6.^M M4PBDFV=`TH%S(/%<`$7=;JJV[B54X6#(TQ=44F(-)"4V0*XM$S..QWO\%H*> M-#/W2Z;,`"MW/=3*7XCZH!)TXP9>46`-)B0U07*+:U+/X(,,CTZNPZ-]`%:8F[\6@\AN3V?5"+^>A"+..SA!RJ`9+*Z`* MA_&YWD"44+V0B%2)&H:#E6B@\DT>F]%+)Z=S/>U)3E.GP9B>MMXPCRPH.SV2 M"*ZA$K1AE#!*&66,=W:2'>??"M.;V M]%&".10_19^J/>/:#)$VB$8E.4-R>/PJ/1Y(7ZS&A#:.$4JWAD>3&&BI!&X_F9K@]KB*F(W4TEX@*>98R MRACEC`I&):.*4M%[4$]TANZWKLD=G*X8YMP$P- M[<'"^'JDUC9)H(!5ZEGX4@-D@?,<3)RK?5<1*."\9.<59('S&DRF![K[2YWAP'2[)J+0[G*8+SJTUFJN]M[ M&#!5IXEK;QGF!9!LH!,@UU%&TY4Z>$LAD%Z9`4FOS('$EB96KNP\4'7+,U&U;>\N@VV[@ M3'I,(BJ9F.?Z<4P*E5E[':=O.C#)H!+W.9=8B,K]"$6-\26NA_G@6APTI6;' M#0S=`=G(_-Q,;?8@Z,D.NPT,9XK3L\-M(,-)8P)D:GV\6_.9:N?:RZ+L<);F M[`$C32*JT)<:N%.H!O?1&532MW,@*;$`BGN76D.44`V66$$E)=9`4F(#%)>H M3B=:J'Y48CSB'+CK[@/N<2"_@RPWO0!U5&E%`-EEA!)0VJN<1&5&&)-##ZVO^HQ#B* M=I-]1A3=GCS*1:`H%^23]-S*.Z+M9^U)_H5QA3"&0^R8`D`W(@ M\5P`17UMKDZ22ZC,+3S&E$;A"BHIL0:2$AN@4;=)&,THVWQ;>R8P$[HH*#^U MDYQ8+RKC@.*[0..FDT49YY&LEQ+O?^K;-])/D%)40'9.F4>!YQQ(/!=`9NLE M4=`'XB6[KV`8IA%5O(%JT'T;N8]SYF_9Z$]XH^]1O!>:JYEH[551)CE?TS`% M>2_D#:?'Y-(OG:50A-GE7`>EY5`-EE9`Y4J;\)/H$@HIK?(H**V&:K"T!BK? MMIYS:"AZTLUN\<,Q4*?;:>?0$W]2($/`.R`9*-:,-HP21BFCC%'.J&!4,JH8 MU8P:1BVC+:,=HSVC0X3BG+-;\C!&+ZPVW`X^FJ</IR:@(%48;1@E MC%)&&:.<4<&H9%0QJADUC%I&6T8[1GM&APC%L3"3>Y0J>C@[Z5&IF=;UZ@%( M9NHUT.2X$-]X9,ZA?W`V*@*D6`HD[ZQE[#F'ZNA9S8R%"."Y!!+/%7NNH3IZ M5BNB1@3PW`+Q\;2=ABD`)QT$=98J+ZRS[OFTK(7F<[667'O#8-[<``W.FPE4 MKN7SQ4@?9:=0R"R=`4FNYD"#I150N=*6YJU'=:-+**2T"DA*JX$&2VN@\FV; M7R_5=K"%@M<$9I'4$T.S%CK]-Y.="Q5,?VYA_1Q_]C+7&UYO&"R2-T"2>@E0 MN(J=SU4+4U3"3&O'$FE#D\&7K)MS("FQ`(I+U!O>DTJLX$M*K(&DQ`8H+E%O M>%\J,1X=[>XX7$ATYU#G!=9ML,/%A7F[@;-TH??`7A5EJ3<<[,D)W+N>/%N- M]&\R4B@D;S(N+8=JL+0"*I^EX^5*#3T8[1D=(A0GG-V`AS$:7KG;];DZM?`H7KDOU-'-6E28HC>,$D8IHXQ1 MSJA@5#*J&-6,&D8MHRVC':,]HT.$XO#8_?T9X;%R-:EY)'FQGA+:,$H8I8PR M1CFC@E')J&)4,VH8M8RVC':,]HP.$8IC84\0PEC\W,K=>E$A\DBFUO64T`;( M/.ZW2_>I^:JEVAXG@019EO:PK(?E/:SH8268'!M60%+_&@B5'=%/+9I`@LJV M/6S;PW8];-_##F!=9>-@VI.$OQY,=QX134T>RP;!L>%Y7RAEO-%($,!I6?F12J@"C(IH/9HN/Z-J."KA2^I M_Q9(W._$<*#Z>U'!_0&^.."S\\Y`.GFCW1R%29_-&(FN2!,:JA<>\-P%P=?9FUY-.1C>ABZA^S3\4+OZ2"0&YH! M2<3RDPHK8.B?Z)M??2AT@Z#S'`=;'.R\$V)_;2.'O9GU'.0M]E.-5T2#@#:5#)U"Y MKCJ;T-=F()"\R(#$3>Y1\%9$(:J!KE-")>XK('%?L_M&5`/N6ZC$_19(W._8 M_5Y4`^X/4/6DL3[K>2'*?*YC?\QK,ENEL1J0UUX5I;$S#-\S@LIU5_-#&?U& M0`J%9$(&))F0`TEG+(`&$ZV$2MQ70.*^!A+W#9"K^62TU"=P$(CG+9!XW@&) MYSW08,4/4/7DL3X`>B'"?-`S\RB>S-40N/:J*(^]H73A!"J?QPO]=#&%0#(A M`Q(WN4=1'KO"3/D#F5#"E[BO@,1]S>X;J%S%QR/Z1!0$XGD+))YW['DOJH&* M'Z#J26%]>O136^(9'RIYI#);=>RU5T69[7R9]X"QADZ\:C[N]LU+\U<`XM^@$L_[V/-HH=]T/<"F\QS/RO;8*-PROY#-_I1)JOANYE&4S4L5CK571=GL M#:,$TV\T)3!T>3(Q?R]"304I%)(H&9`D2NZ1_4R-K.AT:04,?5:.%[PV=[4. MM](PDM+JDTIK8.A*6YF7>^-.W$(@3=L"26&[DPK;PQ!-F^H?D!^@Z!D2_I93 MLAF?DGD4#PE+?<[L5=&0X'Q%0X)'@Q-;ZGU%XX(S#-SG4$F2%4"A^SD]3(7* M;`.DF^D?Z%9>%918PU!*;(#"$NFC."U4DI);=K^#2MSO@0;='Z#J&3KL"5@X M=/S[-NZ)V1]P[HG@_ MDG:9-PI*R^%GL+0"*E>:.7I8J%.+$@HIK>+2:J@&2VN\RJ[>Y`[H?6L+7U+B MEDO<017YTG=S?U*)!_CBH<7\-F^X%YWV/+%S$Y\'>&3&%JP`UHPV'H6[!B!9 M1Z=`LMK.V%<.E?3E`DA\E4#BJV)?-53BJP$27RV0^-JRKQU4XFL/)+X.0+SD MGYLA(LKTX45")U>QL!X,BA<)*A/6,)1#XPV03'>)1T$JID#2H3,8BJ\<2'P5 M,!14`HFO"H;BJP82PP:&@EH@\;6%H?C:`8GA'H:"#D`]*63/G,*!^(7PN".J M\/F&69/RGEM_U7#M5<&LM0&*ICL]1B10A3/-?*D6.RE4T7BCI\X,*NFX.=!@ M)0JHPDK0;%I")0E5`4F)-=!@B0U488GFKX6I-1Y4@\W>0B65V`$-5F(/55@) M:O8!JI[T;](Q:0B6)7L&7)'H-)`UJ8"BH!1)?6QB*KQV0&.YA*.@` MU#-HF/YVSJ!AY6I,=RA>N^O]TGKN5-&@X9%,1XFH@HCINYQ")Y$#B MO@`*DV"NCWQ+J$SU?MQM*JBDQ!I(2FR`PA(I[5JHI$%;('&_`Q+W>Z#0_5P? M51R@^E&#HI,`^X>'SND05JXZA$=1HNMSK7573OS;0H^"T[=$5$$LN$.X$H/- M>":&6/7E[+X0E;B?ZV]@EU`-CB,55))V-9?8B$I*[.D0U*"M&*)!.W:_%Y6X MG^N7"`]0_:A!<8>PIV[ALN*G]G=SZT7U$X?B@6.ASP&]831P.,-PT^]5]I?I MDK/<3[RA9%#&[G/XD@U#`33HOH1*W%?LOH9*W#=`H?LY?=P7JFBBU]/9EDO< MP5!*W`.%)5(W/$#5-2CN%/;XZZ]W"NM%=0J/XL%#+9;6BAN%@)9J^2BSH M!6#X&JS$EBNQ@^%@)?;]E5#G?@?X^E$EXIYI3_&&>N:)!PGN,##:'3D4'200 MVLP=B@X2/)*Y/(5*9OS,H\!]#I4,*`60^"J!Q%?%OFJHQ%<#)+Y:(/&U95\[ MJ,37'DA\'8`Z7W&,[,':4(Q.^IW4W!W/12'R*!P]%M?JT%X/J/-J_MXWUC"UX^2H_N#4A57HH;A M8"4:J-RYI?G[(/II%032XBT7MH-JL+`]5*ZP$7TJ]0`![V,6?\_Y8>O&6T8)8Q21AFCG%'!J&14,:H9-8Q:1EM&.T9[1H<(16F_,*L-2OOQ[)59 M[)[Y]YX[3RI,UKGY^\)F-W^JU-S0JK*(WC!)&*:.,4:1210WL:U%)JCA?0?8DK$H9 M98QR1@6CDE'%J&;4,&H9;1GM&.T9'2(4A\=,<>>DBI6KDXRBUYGVW>-SIQMW'!.N-.W' M%WFZ4T:'",5Q,XO9 M*&XO3#=6KG+(HS"'"&T6A!)&*:.,4*&!?@<=C`6= M!]/_S"KS6(/%M7JVL/:J\`14#(]C`53N5>&1.>Z,SQY3"/@XSHY%44-^ZJ%A MYT4ED]N"1@%*R\IKG>W-^Z(YVWREKS)`PKC M-*&'Y%X5QDTMV<1^VHYMRS5+R].](+?W^(,POCTRQDE\C M]<1J[0VCN#E#\^F?53X$L]K4A1"3-7'U7A=Z3BCFF7RF&C7QA`W,HZ M&B$=BH(WU<\%UTNO"H/78]C3,8^&-IY+_3@AA>.>>-IEYAE-\ZO2,'8>1;'C M?NE44>R.AA*[H\JV@WZYFR[]]9[\LHNN,]KAUFA1B!R*0K30?^]BO?2J,$1' M0VG'4=6U@QYHP0O'8Z471N?G5^7&3TUBG1?5R)Y5R/1:;WN]83B)>60_GBV^JF]9.=)=\;`0*L\BK!&U8E3!*&66,/_S^S8RI MYO?0`;YXO/OXYM(@/1=F9DKW=NHY&UNKG0K$[JR,%>Z*92N+,V5 M95\Y4U..^0AA3PVFIASS_;N^*Z8<\S6VGBL+!-?,1]FNK$?8N(KOXQN?NF]*^9&]MY'^*^839C?U`&=N8KX^9&/_%B+;F#\Z>&/_K"!?,7\Q\,;^34"^ M8O[SC&Q.ROI)S$[`^7IMP=?SJ6*&GMZ^_ MWWZZ:VX?/]U_>[KX=E'^\_V56I^S_/#]_-`N;RXM>'Y^>'K]U_ M?KZ[_7#W:`5F$_'QX>$9_\?&ULK)U;<]LXDX;OMVK_@\OW(^LL697DJU@\G\GZ=O?:XRB):V(K97DF,_]^ M&R1:#>#%2I9KYV+D/&B\(-%H@`U2U(=__?WTX^JOWG[]]O/ZO?T>_K:^O#J_WSU_N?^R?=Q^O_]D=KO_UZ3__X\.O_L5*3P?/EY_?WW]N;FY.3Q\WSW='T;[G[MG*OFZ?WFZ?Z5_OGR[.?Q\V=U_ MZ2L]_;B9CL?+FZ?[Q^?K06'S\A:-_=>OCP^[8/_PY]/N^740>=G]N'^EXS]\ M?_QY8+6GA[?(/=V__/'GS]\>]D\_2>+WQQ^/K__THM=73P^;]-OS_N7^]Q]T MWG]/YO]H?]U]<1R=T,!XKG?'MS>T-*GSY\>:0S4-U^];+[ M^O'Z\V33K>?7-Y\^]!WTWX^[7P?C[ZO#]_VO^.7Q2_'XO*/>)C\I#_R^W_^A M3-,O"E'E&Z@=]1YH7JZ^[+[>__GCM=O_2G:/W[Z_DKL7=$;JQ#9?_@EVAP?J M49(931=*Z6'_@PZ`_G_U]*B&!O7(_=_]YZ_'+Z_?/U[/EJ/%:CR;D/G5[[O# M:_2H)*^O'OX\O.Z?_FC3(W*BXDQ7I$]=<4H:)RK,=07ZY`KS MT72]F"R6ZGA/U*32_D3IDVN>;FJI*]"GKK`<3>;C<^VL=#7Z?%L[%(G]@=$G M5QB/UHO%?+E>G3ZE6UV3/KGFZ5.:T/`:O*W&V='=;SBKR7&5G_P<9+*B7$X87^K M/]YRG#=#Q/830'#_>O_IP\O^UQ7-JN2)P\][-4=/-DJ,0W]H_#@9_%]S`4T" M2N6SDOEX3?4IS`\T@?WU:;$WP+)``2`HF`Q$`2("F0#$@.I`!2`JF` MU$`:("V0SB262VCBMEQRVA7*FF8\\J\Q7SF#_VXP6I)?#:.9$R%'(W98`"0$ M$@&)@21`4B`9D!Q(`:0$4@&I@31`6B"=22SW4"=>X!YEW;N'._5.$R,N@`1` M0B`1D!A(`B0%D@')@11`2B`5D!I(`Z0%TIG$ZGBZCKB@XY6UW?&:C*D!(PKF M3A2(%7LL0!0BBA#%B!)$*:(,48ZH0%0BJA#5B!I$+:+.0I9SZ'KO`NJJ=T&7 M7Q=>]2H9VR,#6=,R943+PHF6H]$Q6("$0"(@,9`$2`HD`Y(#*8"40"H@-9`& M2`ND,XGE),I(+2>=7M*5M>T+38SH`!(`"8%$0&(@"9`42`8D!U(`*8%40&H@ M#9`62&<2J^-5AG]!S_?F=M=KY,3!THD#L3H&`J(0480H1I0@2A%EB')$!:(2 M486H1M0@:A%U%K+=H_)$,V<_'1AJU\6)#$9&:"`*$(6((D0QH@11BBA#E",J M$)6(*D0UH@91BZBSD.T+E2)>X(LAHZ3$@T?\G4I"R#U.J*S<4#E:<<5`*C(* M$46(8D0)HA11ABA'5"`J$56(:D0-HA919R';/2I?O,`].KTTW6-FG/VFU%9M M)ZJ`DN@)$(6((D0QH@11BBA#E",J$)6(*D0UH@91BZBSD.T+E1R:OE`77=/% MB#*+"R^[)D.:26[GD7^GD1-%:S>*AHIDQ14#J<@H1!0ABA$EB%)$&:(<48&H M1%0AJA$UB%I$G85LSZGLTO3S22D-FJ'78WB@"%:!4ABA$EB%)$ M&:(<48&H1%0AJA$UB%I$G85L7ZALTO2%BJ+96MV7NSB,=&)J^FE`3AC=NF%T MM.*8"=1=CV$58Q0BBA#%B!)$*:(,48ZH0%0BJA#5B!I$+:+.0K;K5#IJNNY, M&.GLU72/F=#JQ0A0H&XCV9$5(HH0Q8@21"FB#%&.J$!4(JH0U8@:1"VBSD*V M+U36>8$OAB356G&.>:N1ZJ^<>UY;=4O-CHL`48@H0A0C2A"EB#)$.:("48FH M0E0C:A"UB#H+V>Y1N>D%[M&IK!DJ9G:K0P50,`$4(HH0Q8@21"FB#%&.J$!4 M(JH0U8@:1"VBSD*6+Z:7[0;TYO9N@$;VJK)R;GUMQ8J7D`!1B"A"%"-*$*6( M,D0YH@)1B:A"5"-J$+6(.@O9[KEL-V"*NP&,C(LS1`&B$%&$*$:4($H198AR M1`6B$E&%J$;4(&H1=1:R?>'N!@Q/4XS4(SBOWQ\?_KC;T]4:><"S\L_HJ8E^ MGOJLGEY2Z[.+B9BP,HIH@R5<['2RLX]UT(,6+FTD-W=EV7W4\SN&;&;.*,C:VV MFHQ7_;@U'H).FNYA60[567,;[].4DFB.[,,J)^A^-&MF3N5 M;+FBG&L@J'_::^3,/J&4"WI_R)&M>7U`3D@Y@V8[U5;#3+\>W=K_S<+?G/,. MN,:9$+-TIZ.)K7L;_N;T>J1U)V,9"#&W-1S=:C2V_YO`T25Y2H=/R"4:*S=W/U'Y`3H\Z$ MM)WJBN*:0)"$TG3F5`S%BB,BTLB*5)!/I.()^52L6#Y#^1RM"D$GY$NV\H3G M93G^%'-\C:SP7*R<"6++5OT#^OTE7,!:X]M^$9PL1^.5&5S@@J'ME4A$1PGQ M9XPM)4>SH:7EZ%:6BOY84JR4'2N)=HYFQ=%LT%Z-5LY27FJ+^?#U`NN95959 M7S#J=2)NCGK(S;=30`&B$%&$*$:4($H198AR1`6B$E&%J$;4(&H1=1:R9J#9 M91E\;V[G'QK-:<$X7K(M5LY(VXH51WJ`*$04(8H1)8A21!FB'%&!J$14(:H1 M-8A:1)V%;/=4ZXHKLX8B7S. M2#J^8&3)KYTMV%*L^.@K1B)?,Q+YAI$M[ZP/K5BQ?,?(XU>Z'+_@`F*FS!V_ M#LCR*Z!`5W3\ZJ1@H5CQH4>,I&=B1J9?=8MVSSBWB5*N:/I55Q3YG*VDXPM& MMKR3MI5BQ4=?,1+YFI'(-XPL>7>KIA4KEN\8>?SJ;EF\:X]TACL9C.@&+!_& MUL,"S6C?U+R6<:_(Q8K%(D9RT1Q[]!,V,_5G4V<*3<6*]3-&HI\?]<5-!9N9 M^HNUHU^*%>M7C$2_]N@WFBWD(9D646>)V4LH#99+`E>9.X$[(#OM6CNYQW8V M6`VYQY!V:40[QGS2(:,A;;^=W3I3:L0&$K,Q*B=L9>Y]3B?.(:5L-1FVY$=K MI[&,#:2Q'!LKV$I.HV0D5W@5(]&J4:MA*]%J&8E6QZC7LKVITOZWYW$SO4L@ MS=UI9.U>+-;.!+OEBC+0`T8R'X4:4:JC=NHFTZFS@D5L('-`S#*BG#`2Y90K MJAUPI3RZ=9R;L85(YZPCT@4CD2ZYHJ"*D6C57%&T&D92L>6*@CI&O9;MN\LV M0&:X`:*1$XG.7+G55E8D#EI6)&I$Z8ODD&Z$1%I+[8`?K:939T&+L<6$*\K( M2QD-X3@9N8,N8P,)H1R5"[82Y9*1A%#%2+1JU&K82K1:1J+5,?*$H[NM\K[5 M$W=;9KRU8KGGUKE0V6JSA8R_0"/:AY-)=Q!3NT-')RYN(59UD_1QM/*X>K`R M6DRPQ931N@_?^6CNC)A,&]!C#GR4.2,Y\(*1G%[)RH(J1F;TZG,1K0:U6JXH M6ATCC%X*ITMFWM[<7DAGI=70U=2;PB`UD_,<: MT0AUEJR%PZ=T7ISQYO#OL^9=90KRD`,&,FH"S6B6UMJM9O!,LKE,L)C M5A'AA)$(IUQ1+Z,+V#+.V$*D<]81Z8*12)=<45#%2+1JKBA:#2.IV')%01TC M3R!>MBQ`7+O+J+8R1EV@D16(@[QZ".4X:RYNG7D:QQ80K MRCA/&7$T3IP#S]A`(BA'Y8*M1+ED)!%4,1*M&K4:MA*MEI%H=8P\T:AV6\RK MVGAG%%A.6EU!) M&0W+Z&0VC?0R.ITZL11I&;K^Y0Z.43EA MJS/+J&Z,`W?N;,AE+".-Y=A8P582;"4C";:*D6C5J-6PE6BUC$2K8^0)7'?W MZ(PW<9M(O:>%@O;<,JHKRD`,=$7Z:@9[)M2(T]&Y>TL(](%(Y$NN:*@BI%HU5Q1M!I&4K'EBH(Z1IY(O&QC M2-UL=&=7[\:0$T);7=&*Q*&B%8D:V1.UD_1'6NM,.HHM)EQ1!GK*B--1-R'* MV$!"*$?E@JU$N60D(50Q$JT:M1JV$JV6D6AUC#SAZ.X.O6\=Q4VCN4;GUM'! MS%I'!V2MHQK9ZR@D,+K),^LHM)CH8S5:3!D-Z^AT.EHX`ROC$S3R48V,DRE8 M1Z*P9"2[N!5JU:C5<$71:AF)5F=I6;M)<[5_8RZD[_.U4G&NF32B-=>\9H*P M'LSHHH[GWZ`_I(_7!@H9#0OL,9#YN&)T\D9:MAFZ;+-;C M6R<^.C;QS`)J\P-&!KT!E/RIGGK_]_XG>5S_XTV/P,_U=HITQQTC]355X\K: M61:W1S/I@D`SNB?%[@T9#9T[G[E;^1$;R)(8>Z03-C,/RC-,AM-9S/MT>S&: M.^E:QC+26NYIK6`S.9%2(RU-[^AUKM@KKB/2M=3A_FC8ZN1YM&REA_MLNG8? M_^[8!)?_A;N?YPPL-*#ZL\K/:PQL-:#^ML9DWZZJ5($-KO^M)^K^3X38D[K[Y8CMU<65!V`2A`%"**$,6($D0IH@Q1CJA`5"*J$-6(&D0MHLY"MB_<[:8SOL!]);H; M[PD59Z[?BA7/@P&B$%&$*$:4($H198AR1`6B$E&%J$;4(&H1=1:RW:/V29.J&ADA@J@@!;IOJ)8A8@B1#&B!%&**$.4(RH0E8@J1#6B!E&+J+.0 M[0NU\7*!+_0^C7&A2/F3)U2<.TA;L9)0.59D%*)5A"A&E"!*$66(3WYNJ_'!#=4>`@V&ID/*8?,*)+A>-6WW+LW+T,Q8JU(D:RQQTSDCVSA)$I M#U]R2<6*Y3-&O;S=,VZV[6YNO6G;[K#+4F+UM+Z3V,NYT!XA"C?@9,BPNRQ5Z`>,IVX'#NW7K;:RAI5@Y:! M0K:B.>\X()9CYXY%Q%;DFJ,5/@:KK:SQ!BVFK#4,KMN1VUC&!I[!I?(RZTEGN&PTB;64\[!MK1)DM MSWT):\EP3!F=E,\L>3M"5:)C=N*9"!WR(FN!')`]_B;N1M]RL#(&6X`H9*2G M&F<01UQLSFJ#KC7*CDT9/>[>+DM92S?E"UJMXQEY*F^YH--TFF,.L0&=F]9T M11D"P1)0J!%/:\Z^4<3%YK2F160<):B;&9:&ZRL`0C6&(HXF)C7M/('&9L92[T M>+7&5KHI3]2RA6?DJ:OFM\]KJFN<2UR-SLQK7%'\'3"2J2[4B.>UF7.A''&Y M,;&QB@@GC$0XY8K#Q#:C+G)6JXPM<&);798%].;.N!H2`]7$,7#P>DU7-/P? M:&0,M9"1=;WFO@LM8JO3$QNVF'!%6;A21B>&UW!^P_/`=DRJ:WES>+UO8E,J M3I=J=&YB&\R,F2>@]Q\EEA&L'(V,5#%"`*$46(8D0)HA11ABA'5"`J M$56(:D0-HA919R';1^I*W)PX3BEGE8[F&%AY4>5GE8[6&-A[4>UMG,\M?:3?9.3VV] MN1T[C(S8010@"A%%B&)$":(4488H1U0@*A%5B&I$#:(646@0A0BBA#%B!)$*:(,48ZH0%0BJA#5B!I$+:+. M0K;G+DM'[[O=:W#_>O_IP]/NY=MNN_OQXW#UL/_SF5:C M]9*^D'/$5R^[KQ^O[U:W&W6)00/;+5F/-VJ]\Y5,J*1W$]294DGO4RB944F? M]D/)G$KZ5-XM6:PWZDDFSQ$LZ*CI(1I/R9*.FA[I\)2LEG2F_::BO35 MH:.F9^X\)5/R#]VO\)50O]'WMSTE,^HW>FFOKX34Z!6RGI(%U:%OT_A*J`Y] M6<-3,J$S'6ZUNV\>::MYC?T>->^VI:=_(_#S??/:'(!V1[X#NU'CU-4P^]`Y6%6$^>_*?+[SH M#;ATI/X6)IL[>M`&.XD>K=ILO27TA-5&/3^%=8+EE$I\:O1PU48]+X1UZ!FK MC7IL"$OH4:N->I#*5S*E$E\=>LIJHQXHLEEM"[AC?J99980J\< MWJ@7"OM*9E3BK_R1KW!$]NAURQOU(L\L83>MKQ1 M[U+VEEVVKV1&);YC MH_?\4HGOV.B%L%3B:X=^8FNC?C(+VZ&?R-JDWA+ZB:N-^LDJK$._+$5JOF.C MWXDB-5\)_>H3J?4E-\>Y\?#IP\_[;[OR_N7;X_/AZL?N*UW*C/L?&7MY_*;R M@^$?K_IKU[_O7U_W3[3-<7WU?7?_94?O^1ZK[V9_W>]?^1]TN#>_]B]_])=+ MG_Y7`````/__`P!02P,$%``&``@````A`*KN2N.O`@``%`<``!@```!X;"]W M;W)K]('PX_B[GV(?UY;VNR)VT3IDZI>-H1(FL MA`4+N4EMXW"6-. ME%)S%YE&UO`E-U9S#TM;,-=8R;-VDZY8/!K-F>:JI@$AL>_!,'FNA+PV8J]E M[0.(E17WH-^5JG$G-"W>`Z>YO=TW%\+H!B!VJE+^H06E1(OD:U$;RW<5^+X? M3[DX8;>+,WBMA#7.Y#X".!:$GGM>L14#I,TZ4^``RTZLS%.Z'2=7*\HVZ[8^ M?Y0\N-X[<:4Y?+8J^Z9J"<6&-F$#=L;<8NK7#$.PF9WMOFD;\,.23.9\7_F? MYO!%JJ+TT.T9&$)?2?9P+9V`@@),%,\029@*!,"3:(4G`PK"[U,:`['*?)G2 MR3R:+4:3,:23G73^1B$D)6+OO-%_0]*X%16P6FG7W//-VIH#@79#MFLX'IYQ M`L`G30&A4_F22%"'(%M$22F<4^!W4-B[S7@9K]D=5$,<U?9$#GW M-Q_"AB,TB19O&L2-0XIC!$SU+,^?=[,8TKY^3#!Y2!4BYVYPV#ZY$/&DO9%O MM`LW#BF.$:A#S\WB>3>K(>WK;C!Y2!4B/3=A"H6KKJ4MY"=958X(L\<)$\,= M[:+=\-O&>':?QJ?)MAV*K/L`0ZGAA?S.;:%J1RJ9`^2H;;@-8RTLO&E`)8PF MXV$5?UE M>ZCW,'/?=KMJ@(_=PZH_='6U&1?MMBL91>EJ5S7[)5JXZN;8:._OFW5MVO73 MKMX/:*2KM]4`_/O'YM`?K>W6<\SMJN[KT^%BW>X.8.*NV3;#C]'H@?V^=?NF;S>[.O(=J0)YN!N[;]:J&_ M;>P0+%Y-5G\9,_!GM]C4]]73=OBK??ZU;AX>!TAW`AY9QZXV/TS=KR&B8.92 M)M;2NMT"`?AWL6ML:4!$JN_C_\_-9GB\6:KT,LDB)0"^N*O[X4MC32X7ZZ=^ M:'?_(4@X4VA$.B,QL'?S\E+FB4C2MZVLD-'HH*F&ZO:Z:Y\74#7PG?VALC4H MKL#RT3/DLC/MUL1)]>K;Q#3M<.4B($MX3$4H8\( M&T!KU@0#*^![(@VAX*05)/5\.HX<[2+*46:40'D&0A'Z#"*G$#.%9!Y"W%#4 MC=?I6S#431B^.*5?72(F'LO&!E#S`1,,$"J0^C"BKU.QX)LE^.DS*02C@IAT MK`65*%X-.IQ/I$HE76_">5C_4@AA^X2\;?F^70EV$>5?\$I`2#S23R)%R>GC M[*E0@P$2UG1*+P;LZ^&UBWBF.3_$!)GF`R88()0R2NEU*A9,(R5B7\SC)BT1 MDV"H\D2Q>1W.BSC.6-$:,@]MP_<-PMMJ*6M4;V?:+N+\"YK,$C'(7T@AV;S& M>2R%/.9U&LYFN9\EW(N/<+>+&/,DX@"]O$XY0>E8C@KIX@QXJ"FE= M"8M;*1"$]+*$IUS3^8@GQ;!YY>U3YE8HYC-'6:',65\J!8*0>9QG+/":SJ,(Y2=U8KY[%!90G8BZ)".'H*0GDQDP>I" MV[,J]!('B`I6%\;-8Q])?:`I<:LH`?%Y6BM0AZ@#OJZ<`P@ZYAH*ES4Z["-QDQX0CEPS1NYFX\HW4I M.Y25$D%N,Q5YED>,NJ:0)(F#!TP75V(D2:*7VHI]5I[?TTDB]2G#RG8@ ME_1"\;+1#N!%R(0C),Z*2>'K>1_1G![;\:4#N?C"Q02/K@.$]`+5I/28(LXK M`S551I&RG5$ZD*,I"^BJM`%HBA"0".:)H0@9Q8G/%?6#2>-,/Z82*8*G!%<- M"/+1U.HX8M5$3AZ33]/\7*D^I(#C*EX3+)2E`QWW7)HF,>MUFD+2-,]\+''/ M440&F\[;H-%^EPPJE#@(6G"N\S+EHHR@,,I\Q#A#(X;R>9>XJ:FX"7YL*QT( M`RJ@\*+(R]-(63N(IVS"$4KP0Q*FSD@8O_HH'0B)YI-[/$WFE923+18*F(!F M?=JDU`.F7S,W&$H4M`N?>GZ=5RH$N=H5YR+-EG:&_WVC)YE7,\4 MD2*9*][J-$6HB'=DXP!3NO&[U&M$LU;`=W'I0*X@!"\8[>:#L@U'2-)C)E[S MDCZNXBRYB#D0LE1G+D8(X,R]")E_^5HD9@+W>CV,:$Z="YL#N7K-X6C"FIEV MB##$J)AG"L!J27#7,#/$J$!T7['S=1DC"'D6F521W]O8P0A""7[Z-60^#>N> MELF'="W&9S+J`V-8.I"[DA`YVYN:S?.]:^B\#"Y>J`=,T&9F`16*>L!JH;0_ MBYVN*%6:3,["!'"1IOQ'.4,!,3S>OB#+,9/!F5Z);SA,;X. ML3I-P`L6A^JA_J/J'II]O]C6][`TNLR@D#I\10,_#.UA_-G_KAW@U8KQST=X ME::&W\>C2P#?M^UP_&"/HJ>7P*RC;E4DE/'6)(O,U534W-Y)L1)J`:<`KK3_>^/9`DC[65HR$O3 M^5C:MI=U60+\\,?/S;KWH]KM5_7VL<_NA_U>M5W6+ZOMVV/_O_\1=Y-^;W]8 M;%\6ZWI;/?9_5?O^'T]__]O#9[W[MG^OJD-/5=CN'_OOA\/';##8+]^KS6)_ M7W]46_7.:[W;+`[JS]W;8/^QJQ8O3:/->A`,A_%@LUAM^Z;";'=-C?KU=;6L MTGKY?5-M#Z;(KEHO#NK\]^^KC_VQVF9Y3;G-8O?M^\?=LMY\J!+/J_7J\*LI MVN]MEK/\;5OO%L]K==T_6;18'FLW?T#YS6JYJ_?UZ^%>E1N8$\5KG@ZF`U7I MZ>%EI:Y`V][;5:^/_3_9K(S"_N#IH3'H?ZOJ<^_\O[=_KS_E;O7RC]6V4FZK M^Z3OP'-=?]/2_$4CU7@`K45S!_ZUZ[U4KXOOZ\._Z\^L6KV]']3M'JDKTA_F55ONEU[O)5$\V'4MWZ2_W+-;V3_6?XY6P*_O%P/3U9NBDB\/BZ6%7 M?_;4?*1J[3\6>G9C,WV$XZ`Q7;P=1N=&D1H^NLJ?NDQ33`V0O1KZ/YX8FSP, M?JCANK2:I$,3#'W-W&C4K3K5H9KTBCK\"HVXXEBR2\/\<\ZZ-.2Z\BY-X-#H\W4K>B-W+:'J"YV4F')B"FS(UF MTLR-NH>D78V(`[Q+0QP0M+"D(*,@IZ"@H'2`YZ&:@3T/+WNGU8]]5XYJ-8?ST$]O_R^%^I6U$ERSHG1.$Y2D%+`*1`42`-&C9/3 M:!I.AD,RE#/:)J>@H*!T@&>.6E\]O:H#'*#/5I-[2$W*C$:QQX*4@HX!8(":8"Q9S*, M<4C1%CD%!06E`SQ+]&;.S3.7AY164TOH:FR MX[MZCZ(7SYR"@H+R"&A!SQP57SUSKIN,=2MB4D@FQ<1H'),H2"G@%`@*I`&F MWXP9=AO:(*>@H*!T@.>,SNB>-9?[32.GGM"YV(H<4X"D0#@0`42VI+G;(W+@ MK'V[[3]`"B!E2VA1WRB=0*\?8'I+`9V'Q+[$BERC3+,324'#@0@@TA+3A8(I M=B%HD@,I@)0N\=W10?(&=TSN]!)C2`)OPHSHY,4<2`J$`Q%`I"7&G3B>0#^B M1\ZA1@&D/%_5MTHGR!NL,H'3MXJDU(31F#H'D@+A0`00"20#D@,I+#$&WXVF M0W+"Y06!;Y9.D*Y9U\W;59?U+0<"`"B+3$7'X43>@R M!RUR(`60\GQ5WS(=,5W+?C.CFT3J6T6W'/K31#6;N591DH*&`Q%`I"5VH@KB M84AN4^8INO9PGN`NC*=3=/1)(HZ%@1Z]!SJ%$!*E_A&Z9SJ&O6;7FABK6<0 MW4XDS,F^S?"<`TF!<"`"B`22`3VS M8+_'CL'XF(7F0%(@'(@`(BVQ@R4.R=R>08L<2`&D/%_5MTH'V1NL,KG7MXI, MQPESPK'M5Y2DH.%`!!!IB;$J#M6H(_N'#-KD0`H@I4L\>X+;XGPC)W$^H/M` M*W(F?R`I$`Y$`)$MTL.I'?0<"`"B+3$ M#K)H3#IP!BUR(`60\GQ5WRJ=1*]?W_27ZS#BR(*<6)%K%:1WT'`@`H@$D@') M@126&(/OXB@F][:\(/#-^EH:#[K2.-EV)%;DFD83<@H:#D0`D9:8RP^F`8DC M&;3(@11`RO-5?2`N%` M!!!IB3%Y&H_BCH\+H54.I`!28F4V.=GO6W=;K@\Z0ZT'#@0@@ M$D@&)+?$V*J^&XS(#%-`D_)"$\\L_3WR#8M$(R>Q#/:+5N28!20%PH$((-(2 M8\1DR,ALGT&+'$@!I#Q?U;>*YOS+T2/LR/=T@DZLR+4*\CUH.!`!1%IBK(H" M-=?`AA$:Y4`*(*5+?']N2_AA1\*'#:,5N?[0H)V"A@,10&1+=!B?T`-G[=MM MP@=2`"E;0HOZ1M&$?]W<'G8E_=/RT7S,5N1:!4D?-!R(`"(ML59US4OT0#D4*8"4+O'= MH='^-_-V5Z0G"TT2T@`_!Y("X4`$$&F)<2<.1V0'ED&+'$@!I#Q?U;?JMD@? M=D5Z4'@F1;=%M(;.0GI$5T*KB(,/KJ-R&236)'I*TR- M]W`$O65N1:[1=/O`02.`2"`9D!Q(`40_ZZ:OS#GI:#H\367&//,TFWDD9U/M MWJIYM5[O>\OZNWY2;:Q^B-Y2\Q1=J9ZB"_3C`X3/V6S>Q06;J6E67,KP? MJVB\,X_EF3\.]4?SJ,ES?5"/TS7_?5>/3U;J%Z_#>R5^K>O#\0]]@/:!S*>_ M````__\#`%!+`P04``8`"````"$`NY94_VP"``"3!0``&````'AL+W=O]$FJ86DPZ'+4@I8:;%5T+I`8J#A M#O7;6G;VP*;$>^@4-YMM=R6TZI!B+1OI7GI22I28/5:M-GS=H._GY)J+`W=_ M.*-74AAM=>DBI&-!Z+GG&W;#D&DQ+R0Z\&4G!LJ$G7WU M3&RM=Y^,++[(%K#8V";?@+76&P]]+/P5)K.S[(>^`=\,*:#DV\9]U[O/(*O: M8;=':,C[FA4O*[`""XHT43KR3$(W*`!_B9)^,K`@_+G_W\G"U3G-QM%H$F<) MPLD:K'N0GI(2L;5.J]\!E.RI`DFZ)[E&]?MX&J7343(:_Y^%!46]P15W?#$W M>D=P:/"=MN-^!),9,A^KD=!XT^::@QG0P%W%^`#!'+ M"XCI$+(ZATQ.D(&-;&CCW_(].*=(?BI?\E9_P(S[!DPG;Z++U]$L2T^B0K$' MX?@Z/MH*FL-RA-E18"I80M-8(O36#WZ"[SS>AIV\QYWL)Y@=`[@3':_@*S>5 M;"UIH,34.)K@$IBP5>'@=-=W:JT=;D/_6./'#W`FX@C!I=;N_R<+OX` M``#__P,`4$L#!!0`!@`(````(0"?@L)4@4,``(F8`0`8````>&PO=V]R:W-H M965T&ULK-U9DQLWFK;A\R_B^P\*G8]49.T.VQ,MDLE]2>[D MF5J6VXJV+(;=?$_#R]??/GZ]K>?WO[ZZ;?W M/[S\[_LO+__WQ____[[_]Z?/__SRR_OW7U^HA=^^_/#REZ]??__N]>LO[WYY M__'MEU>??G__FW[R\Z?/']]^U?_\_(_77W[__/[M3Z>#/O[ZNGUU=??ZX]L/ MO[VL6OCN\W/:^/3SSQ_>O>]^>O?'Q_>_?:T:^?S^U[=?]?B__/+A]R_6VL=W MSVGNX]O/__SC]_]Y]^GC[VKB[Q]^_?#UOZ=&7[[X^.Z[X3]^^_3Y[=]_U7G_ MIW7S]IVU??H?:/[CAW>?/WWY]//75VKN=?5`>TO M/K__^8>7?VM]=VP]7KU\_>/WIV=H^^']O[]$_W[QY9=/_^Y__O#3Y,-O[_5T M:Z#<$/S]TZ=_NM+A3XYT\&L<79R&8/'YQ4_O?W[[QZ]?EY_^/7C_X1^_?-5X MW^J4W)E]]]-_N^^_O--3JF9>M6]=2^\^_:H'H/__XN,'EPT])6__\\/+MCK^ M\-/77WYX>7WWZO;^ZKJE\A=_?__E:_'!-?GRQ;L_OGS]]'%7%;5\4U4CU[X1 M_;>AD3,'WO@#]=^&`Y_9NQ[GZ13NZD;:BO>97N_]`?JO]=I^==.^O7\XG?29 M(]7NJ2O]UQ]Y][P#'_V!^J\_L'W]JOUPV[J]<\_SF2Y;BL2I3_/BTZV;8ER__!'/OMD+5'MD*CGGJP%REVBOMO6,U/1 MMD"Y?SSG9%]7$_-IGN^^_?KVQ^\_?_KW"[UZZHG^\OM;]UK<^LXU9C-\=>'7 M<_Z?3?F:ZUTK?W/-_/!2,=-L_D4O5/_ZL?7P\/WK?^FUY9VO>=-0DU9TK,*] MD+AFNSGTQR MV.=PR.$8P6O%I,Z*+JR_(BNN&9<5&^4W!B$\[2P85F&'='/HY5#DT,]AD,,P MAU$.XQPF.4QSF.4PSV&10YG#,H=5#NL<-CEL<]CEL,_AD,,Q@B08FC>38#0O M#VVN<-5:""9SQ6,ZX&^J&JTL;,0[D"ZD!RD@?<@`,H2,(&/(!#*%S"!SR`)2 M0I:0%60-V4"VD!UD#SE`CK$DT=#+X@71<-5Z)5+.PNO(XU66C:KH3O^)BEII M4:E#!I`A9`090R:0*60&F4,6D!*RA*P@:\@&LH7L('O(`7*, M)8F+ED(7Q,55G^)B@_S&2S1O0+J0'J2`]"$#R!`R@HPA$\@4,H/,(0M("5E" M5I`U9`/90G:0/>0`.<:2!$%+T0N"X*K3(%3RD,XD^;*B+K+\="$]2`'I0P:0 M(60$&4,FD"ED!IE#%I`2LH2L(&O(!K*%["![R`%RC"7)ANZ$+\B&JTZSX26: M)"!=2`]20/J0`60(&4'&D`ED"IE!YI`%I(0L(2O(&K*!;"$[R!YR@!QC28*@ M^\TD".[FM:T=#MOR>O;MJVLHS4@E#UK71(N,ZVR141?5\P>D!RD@?<@`,H2, M(&/(!#*%S"!SR`)20I:0%60-V4"VD!UD#SE`CK$DL=&>5A*;\[E#!I`A9`090R:0*60&F4,6D!*RA*P@:\@&LH7L('O(`7*,)0F" MV_2^(`FG\C0*GK)UQDTV3X2J>J(@]4@%J4\:D(:D$6E,FI"FI!EI3EJ02M*2 MM"*M21O2EK0C[4D'TC&A-#9N@RS>-#T_@;CW1[(9Q"B:0DA=4H]4D/JD`6E( M&I'&I`EI2IJ1YJ0%J20M22O2FK0A;4D[TIYT(!T32C/B]LHNR$BUM::=#YLA MWKA=$,4F6X+J3!J0A:40:DR:D*6E&FI,6I)*T)*U( M:]*&M"7M2'O2@71,*(V-VTB[(#9^WRV.3;P5=WH7I>/>*7434)AMNJ0>J2#U M20/2D#0BC4D3TI0T(\U)"U))6I)6I#5I0]J2=J0]Z4`Z)I1FQ.V>79"1:K-- MF;/IX(U[^]M-+9H[HKN;NWQJJ:OLP&XXT*A'*DA]TH`T)(U(8]*$-"7-2'/2 M@E22EJ05:4W:D+:D'6E/.I".":6Q<7MM%\3&;\W%L8EWZ_S4`NJZST>DLTV/ M5)#ZI`%I2!J1QJ0):4J:D>:D!:DD+4DKTIJT(6U).]*>="`=$THSXO;<+LA( MM4673"U^UTXO.='4G%E#7?08JGUI`!:OZ MI`%I2!J1QJ0):4J:D>:D!:DD+4DKTIJT(6U).]*>="`=$THSXK;C+LA(M7N7 M3"U^0R]=M62?,NJXS[I5:YLPM8!ZK"I(?=*`-"2-2&/2A#0ES4ASTH)4DI:D M%6E-VI"VI!UI3SJ0C@FEL7&;=Q?$QN_UQ5-+O/WGIQ90UWW0,9]:0`6K^J0! M:4@:D<:D"6E*FI'FI`6I)"U)*]*:M"%M23O2GG0@Z8/NT0@E&7$?-+T@(Z?R M=!O74W9#E'THJ1.JZJF%U",5I#YI0!J21J0Q:4*:DF:D.6E!*DE+THJT)FU( M6]*.M"<=2,>$TMA>__+C/GN<9J2B96O0UINR& MR!^HJC"UU`<:]5A5D/JD`6E(&I'&I`EI2IJ1YJ0%J20M22O2FK0A;4D[TIYT M(!T32F/C=EPOB(W?H`VC_\9]%R%=CW1(75*/5)#ZI`%I2!J1QJ0):4J:D>:D M!:DD+4DKTIJT(6U).]*>="`=$THS*^E?95_$M8?J/>1 M;![IDGJD@M0G#4A#TH@T)DU(4]*,-"J2"U"<-2$/2B#0F34A3THPT)RU()6E) M6I'6I`UI2]J1]J0#Z9A0FA&WEQIGY)L_&.>^$I;/.GZC5LN3>H>W?95_M-8? MF"QHZ@-M(NJQJB#U20/2D#0BC4D3TI0T(\U)"U))6I)6I#5I0]J2=J0]Z4`Z M)I0FRFVSQHDZ_Y&7MM^5C6<=;-1VK"KU(>]*!=$PHS8C;9HTS\NVS3K5AF]QJ^SW<=*V3?R#7 M?35?TU6RU@'U6%60^J0!:4@:D<:D"6E*FI'FI`6I)"U)*]*:M"%M23O2GG0@ M'1-*$^6V_.)$/3'K^!W">-:)-PVKS=\VJ$OJD0I2GS0@#4DCTI@T(4U),]*< MM""5I"5I15J3-J0M:4?:DPZD8T))1J[SS=]OGG5.+:4;?)Z2S^"UK_*/]X8J M6]AT23U20>J3!J0A:40:DR:D*6E&FI,6I)*T)*U(:]*&M"7M2'O2@71,*$W4 M9?O"U]P7-@H+FPZI2^J1"E*?-"`-22/2F#0A34DSTIRT()6D)6E%6I,VI"UI M1]J3#J1C0FE&W.9L_,KT[;-.MJ2#U20/2D#0B MC4D3TI0T(\U)"U))6I)6I#5I0]J2=J0]Z4`Z)I0FZK+=Y&ON)AN%*:9#ZI)Z MI(+4)PU(0]*(-"9-2%/2C#0G+4@E:4E:D=:D#6E+VI'VI`/IF%":D7PW^8E7 M)FX97]<[O_'4DG\H.%2%J:4^T*C'JH+4)PU(0]*(-"9-2%/2C#0G+4@E:4E: MD=:D#6E+VI'VI`/IF%`:F\NVC*^Y96P43RW81>ZRJDNZRJ:8+JE'*DA]TH`T)(U(8]*$-"7-2'/2@E22EJ05:4W:D+:D'6E/ M.I".":6)NFS+^)I;QD;QK,,M8U;U2`6I3QJ0AJ01:4R:D*:D&6E.6I!*TI*T M(JU)&]*6M"/M20?2,:$D(S=_V9;QJ:5TR]A3]GF__*/$H:J>=4@]4D'JDP:D M(6E$&I,FI"EI1IJ3%J22M"2M2&O2AK0E[4A[TH%T3"A-U&5;QC?<,C:*9AU2 ME]0C%:0^:4`:DD:D,6E"FI)FI#EI02I)2]**M"9M2%O2CK0G'4C'A-*,N,W9 MOV2M-;AEC&K>J2"U"<-2$/2B#0F M34A3THPT)RU()6E)6I'6I`UI2]J1]J0#Z9A0FI%\R_C\YLT-]X4]I>^!M_)/ M&8>J,+7X#>7PP>,>JPI2GS0@#4DCTI@T(4U),]*0?)0Y586KQ^\+QU`(J>&"? M-"`-22/2F#0A34DSTIRT()6D)6E%6I,VI"UI1]J3#J1C0FEL+ML7ON&^L%&8 M1SJD+JE'*DA]TH`T)(U(8]*$-"7-2'/2@E22EJ05:4W:D+:D'6E/.I".":49 M^%/66S3OY1XE!5 MSSJD'JD@]4D#TI`T(HU)$]*4-"/-20M225J25J0U:4/:DG:D/>E`.B:4)NJR M?>%;[@L;1;,.J4OJD0I2GS0@#4DCTI@T(4U),]*_?/-)P>-?]SS6G_%\_2%N;_=3^_A/_8GB MZ^R=\%XHLFFIL*8>7>OI"5VV+7G+;4E/^JU0[H^4WK3:]UB"50?I=P+9`^K: M09HNZQ-IM[*/1O>LRCUS__KQNMVZSVFWW$LS6V[Q>'*_82=Z4-GS MV;&J>*BJMMR'/Z(#<39U53B;BO2+-T1IZ)HV(RZ_BK@1<>LI&;)V_J:MKTJ& MK#I07\6VA]^S*OTDG'<[>Y>FL!Z39Z<=-ES3\W9WM_$;UD\L3/S-O1YR?NSI5G9^,I&9AVOK?G#TP&IC[0'FCG7+];+QJ?C#TK&VA^D_X2' MCI=S?Z"^%^&:;M\_W.=+A<)*&JY+!3!)E`.B:4QL8M8"]X\:S6N_&'".\\A7FD0^J2 M>J2"U"<-2$/2B#0F34A3THPT)RU()6E)6I'6I`UI2]J1]J0#Z9A0FA%WXW!! M1OP-2K2DOZM(;^_;I-$A=8T4J/`*V\YN1GNARMHJC$ZW_J?MA[Y1Z'%@E#1_ MG=TX#4.5-3\R"LV/C4+S$Z.T^;"T.3VN::BRYF=&H?FY46A^XXN$F=8W2385L%Z87JNR, M"D]Z8\RH;U7A"1M857B]&9)&1J&M,=N:&)U]J--098]KQN;G5A4>ZL*JPEJI M)"V-3@\UF7CO+[M//Y5G(]9TGWZ=W95U_('Q'9Y1,MW@;L>JJANI>]WM7&?) M+:SD=-]>S[&UI5-]7E.[^W&3KH8Y5A>ND M:Q2"VS.J+HK6W57^MPH*JPC71-\H-#TP"DT/C9*+_B;;MQU9U1,7O3_ET./$ M#@P]3HW\R=RT[[,7KYE5A).9>THN\/H)MO$L[4!_@3^\8[]G=M-KW>W>73#8KCP;[(JR:SU[=>FX=WAU M8+(.J`^T(>E9E;\\6FV^YON#PN71MX/"E3T"B]UK/ERLBJ]`R'5R>^ MP.-D)G9@Z'%JY$]&HYWU-K.*<#)S3\FUCN>IM`.K:_W^5=;PTG[><''G>WG? MMH"O]O.2*=^3'FQXYFZR!53GOJJ*KI.N40AXSY.^NGK:Z;ZYRB;)PA?H+W!9 M=/K63+C`!T:AY:%1LBJ_R::446@^.A>F`.9#CU.CA].YW#UD%\8L]&6G M,C<*K2R,PMF5UK"_Y+F>\P^OX9K7_69RS7];!EPKV510413>SGU%R77OJ\ZN MA7O^0'V1T&6@=75S>_N8O8(45A.NGS[[&UC5V?Z&5I7F%^L]_]B?F!]PTA-K M_NR#F%I5==*/=]?7^4`JS=<>J`G5)/5)!ZI,&I"%I1!J3)J0I:4::DQ:DDK0DK4AK MTH:T)>U(>]*!=$PH75)3JU&(5Y MI$/JDGJD@M0G#4A#TH@T)DU(4]*,-"PI*K8U6!NIZ2SX^V\YNX7JBR>:FPMJ+UJE%H?A`. MC):=M]FNR3!46?,C:RLT/S8*S4_"@5'S^:;,-%19\S-K*S0_-PK-+\*!AE:5W'Q?YXMKJPH]CHU"CQ.CLSU.K:HZ MOX?'^RR(,RL(GZ&R/!ZNJ3D^?X<[V$H]6<.HLO0;/]YE:\K"*L(&7-\HW'H/V/0P5$57'1/N MMVU#\^-PH#W,"9N?AJHSS<^L*C0_-PJ/?L'FRU!UIOFE587F5T:A^36;WX2J M,\UOK2HTOS,*S>_9_"%4G6G^:%6GYM.0NOW4"T+JMU_#O?6;AXK2/=#\8/1DGS^2OVT:K^[(32T+M=Y3CT^0[/\Y;2 MKI5LT>(IF;#QR>^'JBJ9L#V%55G/JI+MVOQI+7Q5O!ML!X:)8V`4FA\:G6U^ MQ.;'=F!H?F(4FI\:G6U^QN;G=F!H?F$4FB^-DN;S]QB6H?DSU]7*V@H]KHU" MCQNCI,=\.+:A1[M&=W9@:'YO%)H_&"7-WV9K\&-HOOF$TI2[3?`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`:DD:D,6E" MFI)FI#EI02I)2]**M"9M2%O2CK0G'4C'A-+L7/;.WR/?^?/DWK<)D^!=MHO? M"56VINR2>J2"U"<-2$/2B#0F34A3THPT)RU()6E)6I'6I`UI2]J1]J0#Z9A0 M&AO-98Q3-.]L&8 MCJ]JA7]+M$^O M^^VK5O9X.J-=]B9-8>UP,_K1[0A?<%Y^`SG< M([PYM:!KWJ]#K_*'U_$%R8*:^]!69?NY]_F7)@NK:%@8N9W`"TZBVCA,!L?O M)=:#D^V!=QY]03QGU<=8?GI692-QW'KGU9%2/1+;!V/$% MR4APU\FJ;"1:5UD[A55P)%I7^2;$^>NDJD]?,Q1U"4O:\+UFTP/7K4Z>'" M^@TV:+!A@XT:;-Q@DP:;-MBLP>8-MFBPLL&6#;9JL'6#;1ILVV"[!MLWV*'! MCJDE+XNMJ_QV[:GX\+ZL:N.'E^X3?=&B.YO>E:CJ4)795*1$P90HF!(%4Z)@ M2A1,B8(I43`E"J9$P90HF!(%4Z)@2A1,B8(I43`E"J9$P90HF!(%4Z)@2A1, MB8(I4;%EB;KL)JYUQ;NXVL+DH_CXNF"*#TSQ@2D^,,4'IOC`%!^8X@-3?&"* M#TSQ@2D^,,4'IOC`%!^8X@-3?&"*#TSQ@2D^,,4'IOC`%!^8XA-;%I_\9NZ; M%NKZ[J=66_E+=F7N%UA'\U2^B*H/C=;J9MEB/5MR*'M5#RJS*4[9\X^$R_76 M57Y3\M3DR]N/J@W]-BLM::*3XF*D.C3ZFJVNGLJTA+%'JS/PYG?WL_A>8"?VAXGG4VWL+[5SJ;RK26K!9IV:^!J'_> MM$:\[)ZC=<6;#K-T;/)/PNMLJD/3L:DL'1MO_AO\.!G_XZ:A<7KQIEY"T/*O2.ADZC(+E8;&6S(TE?FAR6XSE3/_XZ:1N>P>I'7%FQ"S;&3R M?<*H+#J9JKET9+Q5(\.3\3]N&)G6A;_)EJ)JLO"M4!3HE"G1,&4*)@2!5.B8$H43(F" M*5$P)0JF1,&4*)@2!2L;3(E"G1(%4Z)@2A1,B8(I43`E"J9$P92HV+)$N97] M!2\5VJ#"0LLLF9!\73!-2##%!Z;XP!0?F.(#4WQ@B@],\8$I/C#%!Z;XP!0? MF.(#*QM,\4&=X@-3?&"*#TSQ@2D^,,4'IOC`%)_8LOBXE?TE\?%W`F$-^J;5 MJBR;D+)754U(=5DT(<&4*)@2!5.B8$H43(F"*5$P)0JF1,&4*)@2!5.B8$H4 M3(F"*5$P)0JF1,&4*)@2!5.B8$H43(F"*5&Q98ER]T^7),K?;R6)\A8F'\4' MI@D)IOC`%!^8X@-3?&"*#TSQ@2D^,,4'IOC`%!^8X@-3?&"*#TSQ@2D^,,4' MIOC`%!^8X@-3?&"*#TSQB2V+C[MAC>/C]A/:MZ_$[_[X\O73Q\'[#_\X[3$\ M]8M)]66;AI>ZRK*Y"GN?_M!D[Y.FL-7-V9RFL,$4-IC"!E/88`H;3&&#*6PP MA0VFL,$4-IC"!E/88`H;3&&#*6PPA0VFL,$4-IC"!E/88`I;;%G8W'Y#'+8G M-G1:?L\BF:N\)7,53',53/&!*3XPQ0>F^,`4'YCB`U-\8(H/3/&!*3XPQ0>F M^,`4'YCB`U-\8(H/3/&!*3XPQ0>F^,`4'YCB$UL6'[>#[*D^VQ0S MBT-/Z[9HO08K&JS?8(,&&S;8J,''IL&F#S1ILWF"+!BL;;-E@JP9;-]BF MP;8-MFNP?8,=&NR86A8?MSF&T-]-O%[3T2[6P&^8MR;W9$[FWLB3W#^'M ML.R!NVV9^($_E7N_C1-/]GI;XW0"2>YARCU,N8[#=TJS!^[N_N,'_E3N_6Y!DOMX M!^'TI>Q.2W]&.;L6E'N8<@]3[F'*/4RYARGW,.4>IMS#E'N8<@]3[F'*/4RY MARGW,.4>IMS#E'N8<@]3[F'*/4RYARGW,.4^MBP^[G[^DOA4]_]IUOV>@'(; M%B@/V>=JE:BZS)9`2A1,B8(I43`E"J9$P90HF!(%4Z)@2A1,B8(I43`E"J9$ MP90HF!(%4Z)@2A1,B8(I43`E"J9$P90HF!(56Y8H=XM_2:+\ED`R(<7;!#8A MP10?F.(#4WQ@B@],\8$I/C#%!Z;XP!0?F.(#4WQ@B@],\8$I/C#%!Z;XP!0? MF.(#4WQ@B@],\8$I/C#%)[8L/NY^/H[/Z:[K]I7["QU??_GP[I_/^C5K+?>5 ME/PC<&;A@U.:E'Q=,*6JLNA/ZRE5,*6J,IV,36A*E6\O_)DYI:HR]_>VH_DQ M^[R-@E:767,*&DQ!@REH,`4-IJ#!%#28@@93T&`*FK?3=\VS@71WUO%`/K4P M[NS;*%E`-,IUA;6D4?:6C#):URC7QT;/ST.VIZQ1KLNL"XTRNM`HHPN- M- M\JD^N\:]):-L%H^R'1LNCUZ+5ICI3RC;*?1K"^T-:DLGB&SW;1B567.CVD(7 MX]I"%Y/:DBX>LXE_&I59%[/:0A?SVD(7B]K2+K(+H(S*K(ME;: MF+NO&W9^O*7C6M7=A3/HMNS89%Q]>\$TKO[8\(QH7-&>QM5;\HP\A.W2TY2I M<:W+[!G1N*(+C2NZT+C6Q\874_:D:USK,NM"XXHN-*[H0N-:'QMWDZ MS+K0N,9=9./J-D#B6?G;%E?7?A\E7K)[2X>[JDN'N[+;L$#290S3&NCXW'(EM*:+CK,NM"PXTN--SH M0L-=6?2L:&QA&MNXO6QLW;91/+9/7;.N/I^+*W/[9/6*)O^K[)V6?C6/.U+[ MLW:BNHH;CFSG7S362/NRZNN>]U=WT7[N::0T\+XDO.KK.D>/&OCG]*CK_*D> ME0/TJ!R@1^7@.3TJ!_6AX4ELY[]`2]%`KXI&?:@]LXK&U%5@JHR[2+8>2I!]:%FBHNOJ[[H M_'"=KWR5%E\1WX.9A=:5%K2N:/ACDP>;#Y3B@2X4C_I0>["*![I0%NJZZ/G( MNU`6T(6R4!]J72@+Z$(#[^O^[#G2F,>M9V/N]G'B,?_&%P373#Z75);,)>W' M['584?!ER612F5O=A10U3"95V5WU+?3[QZO\VT6*AV\I9%23"7I4/)[3HQ*3 M]LCI2VE!CTH+>E1:GM.C`N3+])H>GHJ&`*%7!0B]*D#/Z569JLK\,\OK3IF* M.\PRI957DJFG7HA;V&QIZ3`-&EX"Y>Z)HW*HLE%.?"63!-H3SE`>QIT MM*=11GL:9;2G449[&E*TIPD`[6G\T)[&#^UIL-">AB=N+QL>MV7S%USRUE9_Z4%L`*#_/Z57YJ0\]TZOR@UZ5G_I0 MZU7Y>4ZORH\_],^>7.4G[C#+C]MENB0_U:Y4FA]O86)16&`*"TRO&C#-)3"M M'F#*`DP##],HPS3*,(TR3$,*T_C!-'XPC1],@P73\,!6#;9NL$V#;1MLUV#[ M!CLTV#&U-#[NR\R7Q.=4GRTZO&D+([IJ\M_^V6E965AS=&O3RVX]<[4?LBV" M7E1F%U=16UCJ]&L+70QJ2[O(=G"'49EU,:HM=#&N+70QJ2WI(K_GFD9EUL6L MMM#%O+;0Q:*VLUV449EUL:SMU$4V^F[+ZX+)XZ;:(DLF#V_)!I99.`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`92;IV2R3)-\UK$NQ:9HQXMFF_JYA*#9,[-51E:M1*)!8?4"XK#MU`8: MJ#[&7/4QR*J/02[;3O4QR*J/$55]S';5QR"J/F:[ZF/$5!]3NZZO&9Y83ZJ' MYQMS?%F6FHU:SV8S7B^"9"!+L=F,[]EM7S643:IAUCQJM% MAOHN+3+ZI1A7P./G5O99H%810JTBQ%U:Q9&[M(HV:A5MU"K:W*553.J+?;EW M$:MN<2[6P9ZK?;ORS5G"P.9G"?JRH12KIOAIEVV:G'X.F_;KX:E!0Y$Z60QL M2C3G=VOQ8BC&SG[5H*&%J=7'U:9#'K\<6#SS8Q*R_6R\&HI]O=4G8[&IU:F!?;_794(R[4^/3*NG=YV.178N-0;',5*>F?W_]^N6@7Y::G74,;$HN M]SLS="G;3N7.$O8@80\3A@RJCY$7>Y0PAEGE&&8QQE2,`11C`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`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`ZO4EL]/.#'WJ==9=,D,? M,?010Q\Q]!%#'S'T$4,?,?010Q\Q]!%#'S'T$4,?,?010Q\Q]!%#'S'T$4,? M,?010Y^:-?K$RN4^^O0KG;,SI$W/XC_3@G?[>+3[72G&,VRJA%0V[7]IN/A^ ML]TLZG_-;9[H5C9(?M:[B56T?0ZEK+K-9D+/=F]\&!XBNNJ:O>!0^F*SGYVL MNN8^+^9+:8'3B:ICFCLL.*92[&#W5B,O15CU\3( MPV+D83'RL!AY6(P\+$8>%B,/BY&'Q5CER,-BY&$Q\K`8>;AFC3YQ$;N//N6B=^9_SYH30ZWE;\9B51X6PR@QC!+# M*#&,$L,H,8P2PR@QC!+#*#&,$L,H,8P2PR@QC!+#*#&,$L,H,8P2PR@QC!+# M*#&,JEEC5%S$UD;%-T?=WF\SVO37PO,\5=@L3XF1I\2P2@RKQ+!*#*O$L$H, MJ\2P2@RKQ+!*#*O$L$H,J\2P2@RKQ+!*#*O$L$H,J\2P2@RKQ+!*#*MJUE@5 MU[;_`:O*)?(L??4LDN1TMK34RO^F%,/\JEBS'H=[I=CT6"7#JQZ M\]GYP'@?^W"H%P.KZGN4L,<#J^J['%A5W]7`JOJ>).SIP/KZFBZ.R[!Z[MS6 MQ>6RK9XDM!_?>\T?/K%LKCSH];Y8G'!7ID]7$KL+=0:B+U:=US,08PM#9S(0 MA95S_>UJ>[AJSBL8F5)H>@@-(Z,&&)FQ@6G?ENU/^QFL4JSK?V3_?=?5%X;M MHYD92#7/0(YU#,?"0-ZE><:V%.L/>7VT;(Z7D:X;;$8ZKE+W&>G^JG;V(7M4 M&)<S8\VN!@T6U73?9BI$NAZ7$* MC+0:8*3'!J9]RT:Z5-=?_W:WC[2:9Z3'.H9C8:3'Y@?&L)9R_:,;5IMU\_G" ML-:U-\,:%^K[#&NYL)]-X)[=.H'[8LT$;JYEF.\-:U]X,:RQ+U,/Z;6?*1_WJQGP2%W;;)"[%YI/8HUV*S29Q MSW@;YM`;C';/>)YM_S0M^GW5?$0PVJ6R^HQF8%-EC'8I5Q]"-HG+?HR3^+;1 M+N6G',)HCW4,Q\)H%S;M$J/=LW)\!\L#3^*^1/]ZDVW7:[:957&L12:S5HUP#CVC,0S="Z?L85- M)UU,P\*F^A@8E6-@>A8/UQT_>.0%8U6*E[3MBSA#U/V(N$O4S8JX2]3MB;A+U-V+N$O9^S1JM8 M-JFUNDV??IEEGMK'I9?)_U5[ELC\'XL-TPZCQ#!*#*/$,$H,H\0P2@RCQ#!* M#*/$,$H,H\0P2@RCQ#!*#*/$,$H,H\0P2@RCQ#!*#*/$,$H,HVK6&!5+)OL8 M59989@FIL"D;HX\8^HBACQCZB*&/&/J(H8\8^HBACQCZB*&/&/J(H8\8^HBA MCQCZB*&/&/J(H8\8^HBACQCZB*&/&/K4K-$G%F9J?;[])TE'_1K//%>5M:#Z MLWKEMVN63;D"JG+5N.G`D$T,V<2030S9Q)!-#-G$D$T,V<2030S9Q)!-#-G$ MD$T,V<2030S9Q)!-#-G$D$T,V<2030S9:C:7;;OG4M^N?'.J.[`Z5YF==F9G M"7N0L(<).T_81<(>)>QQPBX3=I6P)PE[FK#KA#U+V/.$O4C8RX2]2MCKA+U) MV-N$O4O8^SGK]?GA][_>W'P^_?#YPT\__N/FTZ\W]V]^^^WW[W[^^#_QS/UE M%U>;(__NT\TO__6G$W+>\2[QD3PYI26.'$=M= M5*K.S29BNPM)QV(_^=XCJ_,HZN1,.8U%G9P79+'#`V+\7"*-19W<^)[&HD[N M:DYCL9_=!4%NMBC+I\C);1G\N\/Y>QG_WUN8Y]&?NRS/=E&?O2/R78 MVX5G_9<1BG717G^>X%CT2Y?W2Q?[TN7[TL6^\/SAKGD:?1>CK5=K7*_IZE?;UDFV6Z3:1VO+,MJ2O MEVE?1\K+,UXDO#S?+>GK+V0[MOE"7F*;+V0E^CK/2;L4G_9U1U_WR\X:'_HZ MS_QLDHY.QQ9=.CH=/CDY'3W\AH]/3:3Z_UQW?R^MB@ZSU&.:, MQX1*^+WU\;TOG.7%Y$RV.&$8TUG&(*9SC"%,9QB3)1L_GOV_..9/UG;<0'*\ MNSW$_1YW?AP_BALL'(M;-HYW-V0XQL7T@CK33S$NC!?4F<:XR%U09QH[X:&$ MC`]/)G1[Q.B1>.Q<&J-7XB%ACO$6AF@O[1?>QK`XYD_69[R587',.Q+\%5R%KN. MV#/^)/./V#9B67[A+13[PFNCL_U\'#%>'YW% M+B-VE1\#L6W$LF/@S=,Q_])C(!;S+ST&8C'_TGUY$/O"J[2S_7P8,5ZIG<7. M(W:1'P.Q;<2R8^!MW#%OTV,@%O,V/09B,6_3?3F)?3G)8_I2LXSZGM>1JYWC#!^7&/>_Z4 MGC]+>_Z0AD8=IY)S(1;K7Y^SU1;K7Y^SU15K;(VI[ ME$9.#]`_794ZY;3O+#WK.^6D[RP]YSL]Q(-\#8\].$GWX#Z1^VGDE,A9V@>G M],%9V@>G],%97]L/XR73[S_]^*\/O]Y_?JO<_N'Q_8D"` ML2O)J3%(2'Q_?]UY')*X)C8IVS.9^?>G6]V+K=X+$Y.:F^`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`W M[F5YGP_FCQ.C(@O*YH_3]K1L$L>]X9,SJ(P4LG^3MQ7I%%9\NB- MF5M&(MD_?-2R.<1'4J^,%+)_G+B/2"(;XK1]K""+[!^^Z1OWL8(LLG_XII7C M^UA!]M@_3MO'"K+'_G'B/B)[*I(];]U'9(^M&R=&1?94)'N.C\\+5[7SDT#K M]N7VX_NGW8\SI\O7U@WEWV73_H3PVOG`G`BLRV_6YL.YR2Y3 MZI_-2>ROCU%4?G_QESGQW'G-#6N4H@F%/58XCT1A,;AQHKIY*8BJH:BY%R&!6D1B(@F1-I&4 M2$:D0Z1+I$>D3V1`9$AD1&1,9$)D2F1&9$YD061)9$5D3613)$&ZF*G0">EB MU7FZX"#?>%*H&T1:1&(B"9$VD91(1J1#I$ND1Z1/9$!D2&1$9$QD0F1*9$9D M3F1!9$ED161-9%,D02*8J6B0"'9>6JF],_H39Z;6*,P11QJF9!7J1TW5C[T( MJ=4B$A-)B+2)I$0R(ATB72(](GTB`R)#(B,B8R(3(E,B,R)S(@LB2R(K(FLB MFR()TL9<$@=ID3V1`9$AD M1&1,9$)D2F1&9$YD061)9$5D3613)$$BF$O1$Q+!JL-$<$05B;HJ$GO1OD@0 MB8DD1-I$4B(9D0Z1+I$>D3Z1`9$AD1&1,9$)D2F1&9$YD061)9$5D36139$$ MN6$6DD[(#:L.<\.30I$@TB(2$TF(M(FD1#(B'2)=(CTB?2(#(D,B(R)C(A,B M4R(S(G,B"R)+(BLB:R*;(@D2P:YSGY`)N3Q,!8]4G;A4=4)4^T+!*&:4,&HS M2AEEC#J,NHQZC/J,!HR&C$:,QHPFC*:,9HSFC!:,EHQ6C-:,-@$*T\8ND!47 M38_/,NPM$55!@`HEA%&+4O,@Q=RG#NA2+"O8)HS:CE%'& MJ`/D;D`75Y+M_;I_H7?\JE.Q=SRJ[[NBF<Q;Z- M$4C'N#;U?&?RH]-FYU0:VGL@QEDM7F4B@'/'(^<<)I%=)RDFT8%D,7>/]MGB MEE5,M\/[QM[4--G2,"^%B]U&F`=-KZI(.6H!%9?B*F4U`8ZALAG[U\=JM5:J MJ'-?`DEU_Z;:0!(N!3H:+H/*A6LTRG65T1TH\FAA7]JEAA/ZTJ],%/O2H88= MP7*7ZTKWI6\HX[-E;P_;(>L>G[`WMF*/S,'#H4J`)'7;W#!EE*&A>'6`I>2ETJ2H= M3:\JY$S+(W.XD4:QJ(I>JL`E4)D.VD<\T*7N?14BIAPQ@UZ[6<\><, MBIC"7B)F0&%$5;8[4+T6,>Q2>Q5T0I?ZBR9Y4S?V"1#.4JI_3E7(F99O&&3I M7B7Y%]54$4E\0_MA2^UQ+T*6_-,?+ M7KI&C:TY.M$E)E6QY%P="CZ1%4=HIF M9H.5TJ66))`4SOH<+H7J:+@,*A>N7KVZTA4#"IX7V*>FCO;P;/?==-W!ZQ73 M,9B"YC:JBZVS07)>;D(EJ,4H9I0P:C-*&66,.HRZC'J,^HP&C(:,1HS&C":, MIHQFC.:,%HR6C%:,UHPV`0I'I[TT>ONIQ3YEIX>AOR`S+_M"']74%*+I&YK% M-A3Z%J.84<*HS2AEE#'J,.HRZC'J,QHP&C(:,1HSFC":,IHQFC-:,%HR6C%: M,]H$*$P;4\U.21LK5Z7%(ZDC3?L<9EAM6HQB1@FC-J.44<:HPZC+J,>HSVC` M:,AHQ&C,:,)HRFC&:,YHP6C):,5HS6@3H#!'[*5SL;3\VA3+7X`7IU@>R65Z MTYS&\M0IEA>'@F6TJ*:N(F+?T*A0EQ)&;48IHXQ1AU&748]1G]$`B)?D["3[ M7^AIZZ(&J4VKFL8Q*.JSET>M+C@G.7 MG7O2T#NK&7I?!'`>!,YAJML+Y&*J'U_LJ[CKZ>"RP:%PL:^FKE.;OJ&9"N)- MM8""N;B>JL90N=6W/2!IV$=#00.@ M`U0/5:Q*"H MF96(4PYB+@]/'Q[]9&W4JPH9WX*7)%LLJF*7JE&>0&7.+ON.YX,(E=BG'#$3 ME7A%=;7ZTH'J:,0N5!*QQQ'[HBI&5(5S`-5K$<.#:-<_WCX2(RM7!]$A-1+5 M/*KI&Q9'(I!D:0P49JFZ5DR@>BU+W6HL5#(N4B")F`&%$=6[[T!U-&(7*HG8 M`Y*(?:`PHCK9#J!Z+6)X$.TRS`D'T1(J:^86'%.8.7F='O1W5TJIQQ+ZHBA%U.87J MM8CA0=0K+;]T.13Q`HQ'=HVGT#NJ,C:ADN1M>63J":8:,5"0O)>JYB50%2,> MJ++NK19*0HJ&$C$#"B.JFM>!ZFC$KE<5(O;04"+V@<*(J@@-H'HM8GALS3`. M!NBO'5OKHL:M0^',\E*5KZ9=RK;3(,GIED<_6>2&RJTZUZZBTJ6J"0DD,F%L M>U0(ET)EWL@^!^F1@PPJ%RXJ7UZ6U9#J0"+ANARN!]71<'VH7+A*K5[6<_(! M)#R%C>SR0;'FZD/ZMD7UW$8=4[]6(2.Q"96@%J.84<*HS2AEE#'J,.HRZC'J M,QHP&C(:,1HSFC":,IHQFC-:,%HR6C%:,]H$*"P'YH00Y,[QY8#(RE6..!0^ MFWJI)A%-W["XJ,XH9I0P:C-*&66,.HRZC'J,^HP&C(:,1HS&C":,IHQFC.:, M%HR6C%:,UHPV`0K3YK15I(A7D8"DCC09M1C%C!)&;48IHXQ1AU&748]1G]&` MT9#1B-&8T831E-&,T9S1@M&2T8K1FM$F0&&.Z,4J?5IZT[.I$:]A`B@OV"[9=LOY*& M17LU]5^+"O:;P#Y,5KL65YQ#_>0\Z);NBLN`D4-5LQ0E^=905P=-KRK,^UM` M`[E%XGI#/U&60"`KTFT@*:@ID#AG0'ZU^ZJJ,K8#@3AW@<2Y!R3.?:!R M_A3*954=C@&VB_$02(Q'0&(\!G+&5^H-3[!9?*=`XCL#$M\YD/,U*_'ALZ4+ M;!?C)9`8KX#$>`WD^KA<+5547VR@R*V#/+3IYO)P/@84U#W]3'[3JXH% M$PWETBR&ZBH_IJ9ZJAU)()!KH#:0V*3LG$'EG,OE2D4G3`<2\>X"B7>/O?M0 M.>]Z2=_/&4`@SD,@<1ZQ\UA4Q3&N$F<"U6MK+?EZTA0JB3CCB'.HW+Y42GI1 M=P&![,L22)Q7[+R&RA^!2K744/5_`TGN'::I69$(TO27SNU5ZZ*RUR$;N5!% M]=6$;UBLHAX55XB`@M63AEXU@.JUU1.W^L<14S24]9H,*(RH*E8'JJ,1NQRQ MAX82L0\41+Q2\X0!5$Z)2 M<@'5T3U9[KNP8_R7V^ M/5!U2!5_M=S=]*J@^/OU>RDZ,51^HELJJ4J20"#3NS:03.]2(''.@/STKA%5 M2VIX=B`1[RZ0>/>`Q+L/Y+S-O%]=/PP@$.K\V=;$NJG)[%%1N_<::5:<**K='LIX10V46/_;U-;I2(R'Q*OMIDKV* M;V[!2XI!"B01,Z`PHIK:=MX4L0LOB=@#DHA]H#"B.I"#-T4'OIGTDRKN[Q#)Z+RI.A14\6I)G2&;7A54<=`U3?-KTJ.`=X+QGO,51^ M+E8R/U@05JH$"IGYM8'$)_6H^)0*5,[Z,KJZI"?^(!'O+I!X]]B[#Y7SCLIE MO>8^@$*LAT!B/6+KL:CR2;=>%9U@NQA/@<1XQL9SJ'Q_7%94"5U`(,Y+('%> ML?,:*N]\=54J*^\-)+EWF(\FC8*IRD]JL96K.8E#04FMZJEPL^I5,MA:0%+7 M8R`_LJ[*E^H"*X%"QG$;2*Q3(+'.@&!M'N\(4[T#A5AW@<2Z!R36?2!G72O7 MU77```)Q'@*)\PA(G,=`KJKI=:4)-HOO%$A\9T#B.P=ROF8`A5VQP'8Q7@*) M\0I(C-=`KBOJU4@7_0T4N768BF:*$:3BK\V:K8O*4(],"N[/PS2=;U:=*JB8 M'LET*(;*;-E[F=7WL/\2K_K9K)DBIK"7B!E0&)&2UWD=C]B%EQ24'I!$[`.% M$6FB\):(0WA)Q!&01!P#N:^Q4?LV\5O-OLELV04O'*P9/,1V#A3NB#I5+L1> M#BE=XBSA)3NR`I*(:Z`PHCJI;GX6,1P6^K;AKPT+OIM8/7`WL5I24YFF5P63 M:-_PZ"PIAKTK!56SSJ`R*(%"JDR;HZ50'8V60>6BE6NURI7:DPXD$J[+X7I0 M'0W7A\J%JU3J5ZJ$#J"0:$..-H+J:+0Q5.[1O:I>=9Q@N\2:Z'8QZV3U^VS>VW;\]G=[L_[2^#F<>S M93=1[=H^W6C./;2E;K;DU4JU_9K#@ZTJ41F2_YQ56I3-5OR8::VF!]N^^V@EPU_,(8Q M.L1-Z$.1?ZM>_V8.U8$W:][1H3=T8X[(P0-BCL?!PV&.QL&#T;@VWZW+<8I[)NK9/7/$6\SC5M7U8BK>8)Z&N[7-.O,4\Q'1M'U'B+>;YHVO[ M=!%O,5^(>&V_HO#0ENC:?M\?;S%?YF?:'-K2JM2N[:>KN8WY'/-U;#[CRUO, MYY"OLX-;S.>(C9N[R-SGD/F)O>^W7[;]VZ?%?RW+[[L7\^-ZIB";GW`R/Z:X-5\R5[+?EO]YMWO!?\R;NMC_/./'_PD` M``#__P,`4$L#!!0`!@`(````(0`ED[0]Z@<``&TA```9````>&PO=V]R:W-H M965T547Y>5^ MR$:3X2"_[,I]<7FZ'_[].?RT&`[J)KOLLU-YR>^'W_)Z^-OZUU_N7LOJ2WW, M\V8`'B[U_?#8--?5>%SOCODYJT?E-;_`G4-9G;,&?E9/X_I:Y=E>-#J?QLYD M,AN?L^(RE!Y6U??X*`^'8I?[Y>[YG%\:Z:3*3UD#SU\?BVN-WLZ[[W%WSJHO MS]=/N_)\!1>/Q:EHO@FGP\%YMTJ>+F65/9X@[J_,RW;H6_P@[L_%KBKK\M", MP-U8/BB->3E>CL'3^FY?0`0\[8,J/]P/']@J=;SA>'TG$O1/D;_6VK\'];%\ MC:IB_WMQR2';,$Y\!![+\@LW3?8<0>,Q:1V*$?BS&NSS0_9\:OXJ7^.\>#HV M,-Q3B(@'MMI_\_-Z!QD%-R-GRCWMRA,\`/P].!=<&I"1[*NXOA;[YG@_=">C M.9LLW3EX>'KE9#::SB?*'JZW!0332G0$UUL" M6JIF<,6`W)&SF++I1ZE@H!@Y@%PZ,OF]L8WEP`L=^5F3K>^J\G4`DQ.&MKYF M?*JS%?>&"I+CW6KJ+4F!EKB7!^[F?@AQ@UIJF`&A<30PM(,<"-MF%Q(^%!O M"?$)"0@)"8D(B0E)"$EU8H0.:],-H7-KF$F0QVX>L(D5NS2:P?*E&=E3H35J M)4!(0$A(2$1(3$A"2*H3(QWPT#>D@UN+=&`0&T6T<2?$)R0@)"0D(B0F)"$D MU8D1**RB-P3*K1E,-[\1KWV:8['[LBEA\&!WZ%GO M7-CDY-;'G9CQ*S)O5_RM(FY+?$EFL.ZT^H`=WUPI@M8(]1$2$A$2$Y(0DBHB MJTM]SX,:Y/^GA#LQ4Z+(K$W`5A$M)9(L%J)\<";,L[+1WF^S( MX[85+TK`JVMZ3=K[Z#75O1IRX?61D9P>74#MBL(0YF8:%'+,#<)ZI"U:=1/( M1Z0W=-C,C"5`*R[.E_7,\SQKQ0G10KR3R)0AZGJ+$;W;6X)6LC?'62RLYTG1 M0O1FII+77/K4^R"5LD2#C15':0.U@Q`9GZMMS6EK9JNL8%2PH=\U1!2@U5+D MS7-=:R*&:-#I-T+4>8ZIYP2MI&=WL;#&.D4#X=E,$63?2)$LS6]SU_DM_\0##<$*\^A3%%`44A11%%.44)0:R,P0KRSU#'VPN,M"U%"% M0KHJ"/(900%%(44113%%"46I@9&IQ_QC*XXJ5?4)HI"^XD@T76K#+Y%1 M3WIL;M<'K17J)F0$113%%"44I8AH5&K(SZ#*@:N%.:Q'U''<-WZ@C.P/TG"(2GDVU\!KSAGS(DM3(AT1S MO43SF/7);!C+MF9E(%>2"K4B3?^KLX2M%)E MZX)97XM2-*!UI'-;22[,S157(?'.AW6D:[^);;%A-PM]1%T!&"CD2/DQQYE; M556(%IUF(^HGIBC!AJCLA9TC-*";MW-;K2W,K1S)6ML4V\3^9*4:ZF)3",2& MDR)`)`=[X3BVLM!`4Q;U'*-5YSE!!`_;[IV.:TV)%*UZM/13"FX^L:Q-72%# M8IXM\BTVU"4F?3D="I25`XM6&Z1'`F9D:^4X5KT788^=@F-TW_68(#)[ MM`8_15]O]6@L?["LF,O?#VV6PHLE5%DT M'GLV7_%JL>_.8A5`D43O0+D%;?KN;!@$#J\>M,V&0>BR&!RWCP:'W=?L*?\C MJYZ*2STXY0<8>CCBAA>H2AZ7RQ^->G]]+!LXY@9UP$DH_+>&'$ZF)OS-[E"6 M#?Z`KL?M?Y18_P<``/__`P!02P,$%``&``@````A`$"\IO.B!@``CQL``!D` M``!X;"]W;W)K&ULK%EMCZ-&#/Y>J?\!\?U"()`W M)3EM`M-6:J6JNK:?64(2M"%$P-[>_?O:\P(S8RYEK_UR7)ZQO;8?CST,FX]? MRJOS.:^;HKIM77\R=9W\EE7'XG;>NG]^8A^6KM.TZ>V87JM;OG6_YHW[.F#AUFS=2]O>UY[79)>\3)M)=<]OL'*JZC)MX6=]]II[G:=' MKE1>O6`ZG7ME6MQ<86%=C[%1G4Y%EL=5]EKFMU88J?-KVH+_S:6X-\I:F8TQ M5Z;UR^O]0U:5=S#Q7%R+]BLWZCIEMO[E?*OJ]/D*<7_QPS13MOD/8KXLLKIJ MJE,[`7.><)3&O/)6'EC:;8X%1(!I=^K\M'6?_#4+EJZWV_`$_57D;XWV?Z>Y M5&\_U<7QU^*60[:!)V3@N:I>4/27(T*@[!%MQAGXO7:.^2E]O;9_5&\_Y\7Y MT@+=$42$@:V/7^.\R2"C8&821&@IJZ[@`/SKE`66!F0D_<*?;\6QO6S=V7P2 M+:8S'\2=Y[QI68$F72=[;=JJ_%L(^=*4,!)((_`<,/)`<285X2D5@V@2!M%B MR?_\`\U0:L)3:D83/YS.T>L':K#*PX6G5/.CR3**POER\5AS+C7A.G;;K;U-6;`[L!(EF6"Q`1)",)TQ/`/MJGN'V[9V1(;JNPUHWJLLXA1(*,0,R@\(YI171XZQ#A[;3KB`M M[Q2**910B!F0Z2:.HO%NBL$%'5SE:8_='`H&3R]=`PGF),%2<=$IQE(QG'=0 M0B$FH8!+F9[C3!KON9Q@NN<"6@3\]!),_=#0,`'GLD@*LNY@R\$8'@HG5A"<&Y7 M4**D5C*$F342F!(8(`;'V/@04-K:LP+JB5F8^3W@"P;H&,1(J,]$HJ0D"\', M.FDP)3#``HZN\2&(06>P(*">!>MH?/"%@,&"-*.ST$DAF0M:1W)]@`0<;N,C MD*.PS][>%U!/@E7#!RE@D"!T@MY,TDMA!.'4R:\T5R* M[&5?P0Z$MCG06)%Q^98BAJ)!C8",AA5%9.\+*8,?"?4]+/$%%/I\E\S\)=DE M0L!?T8V.X_`_AR=G:I_P/?PIWH_U#N4'I!\+*8,\`86Z8F!WCT2:#\6F\OV% M_=+'E`1E-!B8\_#ZVS'ZJ;I_BU'@05'*K9@-0T%]HSY0**900B%F0$9KAF01 MQI:K[SF%ZF$0LR`3#=Q\&IN8C=8P$W1N]^``C'!]8X@(2OW]M#II?K< M"UL:'0F58@9D!O6N81_08:^@/JL'"L442BC$#,AT$V>KE7L_@MC?>64$=42* M1T!6ZNUA*16U/,<42BC$#,B,"2>G%M._E+T]REM]P\```#__P,`4$L#!!0`!@`(````(0#3SQU5\@P``&X^```9```` M>&PO=V]R:W-H965T#4O@R3G[O_DEO=LB3PW1\_ M=V^#[YO#<;M_OQ]Z-^/A8/.^WC]MWU_NA__Z,_DT'PZ.I]7[T^IM_[ZY'_[: M'(=_//S];W<_]H>OQ]?-YC0`A??C_?#U=/JX'8V.Z]?-;G6\V7]LWN'*\_ZP M6YW@S\/+Z/AQV*R>6J?=V\@?CZ>CW6K[/M0*MX=+-/;/S]OU)MJOO^TV[R'KMX]/Z_WN`R2^;-^VIU^MZ'"P6]_F+^_[ MP^K+&]SW3V^R6J-V^X>0WVW7A_UQ_WRZ`;F1[JB\Y\5H,0*EA[NG+=R!"OO@ ML'F^'W[V;IM@,1P]W+4!^O=V\^-H_7]P?-W_2`_;IVK[OH%HPSBI$?BRWW]5 MIOF30N`\$MY).P+_.`R>-L^K;V^G?^Y_9)OMR^L)ACN$.U(W=OOT*]H[X?!9#CXLCF>DJV2&@[6WXZG M_>X_^J)G)+2S;YSA$YVG-^%L''C0UJ4B@1&!3R,RO?'GH1=.E/HV]/Z%8G7&$2FU[ M")_8T,T\#"?3^6]ZN#".\'G=K7F0A3HI8/BOZZR'*:'^'T!_?C;Y#):^-S:.T\5R+)5JHLE6R$0-!480VBZ^D!;_C_@J&15?C,PC`@JXSX*)%N@2<1!SD'"0 M/I:5ZEW%*0 M2)!8D$205)!,D%R00I!2D$J06I#&)DX(H<2O"*&RAID!QL.J:Y9HC]IH"A^6 M4<"RL3/JTE&06)!$D%203)!458E74;5@S&HR%6 M'@H2"1(+D@B2"I()D@M2"%(*4@E2"]+8Q`D8+".<@*GGCA_>@/V53QXEY,92 MDSF4@)6/$Y:/G1$.021(+$@B2"I()D@N2"%(*4@E2"U(8Q,GO+#J-@L2")(*D@F2"Y((4@I2"5(+4@C0V<8(+*W(GN.>S45F[ M,33$RD9!(D%B01)!4D$R07)!"D%*02I!:D$:FS@!4SN2*R+6FKLA,XCEW93E M'5EUB2=1+%$B42I1)E$N42%1*5$E42U1XR`WI&J%;E?X^22$)2'/0D16&DH4 M211+E$B42I1)E$M42%1*5$E42]0XR(V?6I1?$3^]AH>E(V;6HUI&0F&SE)SQ ME.RLT#$B1T2Q1(E$J4291+E$A42E1)5$M42-@]R0JE7Z%2$UBWH[I/8ZO]TR M+]5I@IH^*4LCB6*)$HE2B3*) MM^NOCWM8`4(A]Y1Z`(<4YNA"+^IAF#"['M5!B(KAK$-+1$&'(H.F2NK[@S_V MV!HS)@-43A"UAYQM^ZE4SM"J4V:[J9P,4+E`1,JE5*[0JE-FF[F:#%"Y0:0/ M9NW##77P*@;`A^-,X#TQ!]P%77FR)Y9&/M2_M6Z?\^G!6-GIW>/H>^Q1%[=] MA3V&OO,@G$^8=((6DVZ(4T346H;([J9H+4&_!C-U;@Q9M:VX1J3T$+R(?ULE75)#>AC@59!`,C368"SZ8V@KR`I,M M\@RBTHL-FGCZ7''NL]5S8@R\]FL'4U1".9/*.2)8N':]]`,6NT+*E^A(':\0 M4<=K1&?E&T?>'1JU6^%#`U^N_*ZVS";'GM`TT2YCO5%'ZE'\1HK/Y M%Z.5SK^)-YVQ"2M!"\KV%!&UEB$ZVUJ.5F=JR]P(M5:B$[56(3K;6HU69VK+ M;LT=0+4CL@?P-Y.BWD`Y=6204TL:*&LQ'1$@U4DUT"1L&+&&7QA&&&1,V0F0[]DQU1MY.GS!@ M4U""6K^IFDX+.Y&AX]E.Y&AE=Z*G:HR\736BQ0JUSK98H]79%ANTZJD:=29P M^<+#-T<(UL(#D5LJ8C;4CE811'V./>/:.=II(\;56,'^J$NNGMFPTZ)QU4AM M),F1[[)STU7HO64E=E1H95>B:+&ZZ+9KU#K;8H-6/?4*CM>,JS)G#SF-)G3R MLE3W#U86B@R"JL:0QHBHA!-$E/&IU,K0BK1R1*15("*M4FI5:$5:-2+2:A#U MU(7::=MUV.;Q"$KTNRD*?/$JUHUHX0T10=&P0]QX`GB"CO4G0D MK0P1.>;H2*A`1%HE.I)6A8@<:W0DU"#JR4ZUM[2C>WX'J'::W:D].X8! M/XDQCL[3I'/$^,5HI??"WCB8S-D90H(FE'0I(DJG#!$E78Y(:R^FWISM<@NT M(.D2$4E7B$BZ1F2D0V_.;K]!BY[TOFX+[\LM/"(GIR: MZ-FOAA.6+TO?6%%R1(@H.6)$.CDFOMP_&!E*NQ1]2#E#1,HY(J,<\H=E@0:D M7"(BY0H1*=>(L,\RG^T^.SOQX+J=>&ON/NX0N?G,EZ?&RLK4B!PQ4V.T6K1' MN]Y\QC=O:$`9F2*B7,NDL; M$"F=(2+IW""4GLT\MA\II'2).G:=B%[73!IVL&R";AQI=UC4+N_R1T2@-X7V M(\(@:P6^E"@RR%Z4(Z(9.$%$\W0JM3*THO3-$9%6@8BT2JE5H15IU8A(JT'4 M:KGQ4[LI.WY_8:(Q^SWJPJ-Z4T:EN9O3_*S'6#DYK1WA"N6T0>HKX>\/GA]X M'EL2)48HH!DZE=H96I%VCLAH>\%\P6:$`DU(NY3:%5J1=HT(M<#)CWS M/T1.#(L]V_RY_X#X_NX+OD#)L.G&(,J.)5H1BB2*)4HD2B7*),HE*B0J):HD MJB5J'.2F>]\>U)NTKX#]YLM2R"X12XU"RHVEL0*DLO43F\@B;+1PCX\$&FQZ;;F?50OR*P=;K=F>P#:*1 M7:J?`*CZ)Q1)%$N42)1*E$F42U1(5$I4251+I%X8I1O2\=,O@.I7U7:;P\MF MN7E[.P[6^V_JY4Y8Q3[<=5B_>0J_+[Q5/[:#1XRX$L"5]I=;_$H0PNNJ[3I& M7)G!E7:E)*XL\!57?F5Z"[_([VD?I'J5YK?PF^D>>VB@7.U6YP.[`K]2NU4_1).M9'!%_9!,7H%?B=VJ'X+)*_!V[^?^"$/S/?:/,"2] M]C`@?>/Q>7+[&9)!-OPXN867;WHXC%\[?*/NON%MWX_5RZ9>'5ZV[\?!V^89 M$F;=6^* M/_P7``#__P,`4$L#!!0`!@`(````(0`K#BV(<",``,_J```9````>&PO=V]R M:W-H965TZW82N(:VTI92C+S[=\'!$"@^]^Q1%?F8I+\T&B`6*L!]`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`K MD.,JS]W+U13=_E].V\_5%-/^7Z8]?>9A74UA[;/YU%V>8K+2OYRXRPKC<*3F M>#XW$U930%=S8)Y[E-=3A/I_.6V7U],8[O]E.LK7KU;G9T\EX'H*;?\OSSO& MKX?SQ^%TM+M]O'W[P]?[OU[H)*]M/_Q^VU\R5F_Z[J83T9"5QU/3WYV9=$KJ M>_FI[^;'ESJ0.ND\Z'SZY]OSS?:'UW_J%/A^;/..;59FBYNI17^^Z[O=V;"W MP;/!MR&P(;0ALB&V(;$AM2&S(;>AL*&TH;*AMJ&QH;6A6\!KA?@89X7VGXAS MWTT?YRE"[R:8`[^V@CJUF%;9V;"WP;/!MR&P(;0ALB&V(;$AM2&S(;>AL*&T MH;*AMJ&QH;6A6X`15)V>C:"Z[QZF,=JWUGV",48OS&"]&]JLAON$?@C>0':0 M/<2#^)``$D(B2`Q)("DD@^20`E)"*D@-:2`MI%N*$5)=/D\(:=]:9V[EQ^*\ M>VG%=&ATH>OQHM&5V>CFV.@X3"%[B`?Q(0$DA$20&))`4D@&R2$%I(14D!K2 M0%I(MQ0CS`K&"6'N6Q_"/`7GW2B+<0K90?80#^)#`D@(B2`Q)(&DD`R20PI( M":D@-:2!M)!N*48`=8=Z0@#[UF8`1SG3!A:C\MH:E7.K*?([TI[DD7Q20`I) M$2DF):24E)%R4D$J216I)C6DEM099`1:\XD3`MVW-@,]RF*D0G:0/<2#^)`` M$D(B2`Q)("DD@^20`E)"*D@-:2`MI%N*$4!-2HP`]C.<]?:5!MZ)<5IK.Y)'LDG!:20 M%)%B4D)*21DI)Q6DDE21:E)#:DF=06:H^VK%LOKT[<&J::D]6B=:#%?2CK0G M>22?%)!"4D2*20DI)66DG%202E)%JDD-J25U!IEQ[0L6R[CVU]S-5?\HX]2+ M;C^WM<[0(UG#VRX[S:VFL;PC[4D>R2<%I)`4D6)20DI)&2DG%:225)%J4D-J M27I.=HC07P!NW8:D_R2#XI((6D MB!23$E)*RD@YJ2"5I(I4DQI22^H,,N/:ES66R1O?&NJD> M5S0NWL<5IP&_9RN/Y),"4DB*2#$I(:6DC)23"E))JD@UJ2&UI,X@,POZVL@R M"YX8W7USZSYMI.7H!NWZ!XGF.6!/\D@^*2"%I(@4DQ)22LI(.:D@E:2*5),: M4DOJ##+CVM="3HCK6#I9GK4'LH;PN3V$CZVF\;KKG_LJU(M1O2=Y))\4D$)2 M1(I)"2DE9:2<5)!*4D6J20VI)74&F:'NBR8GA'JLL2Q#O2R[')[9WJQ`.]*> MY)%\4D`*21$I)B6DE)21[QI MD+[K7Y<8!NFRZF4][+^96TTK[DA[DD?R20$I)$6DF)204E)&RDD%J215I)K4 MD%I29Y"9!7V)99D%3UR@QXK,,M3+(LTXND&[_K49^P(-\MC*)P6DD!218E)" M2DD9*2<5I))4D6I20VI)G4%&7/M7C4Z(ZZ&Y>>,UD?GTZ=QZ&>!FT>PXB!VV M=YCG,-]A@<-"AT4.BQV6."QU6.:PW&&%PTJ'50ZK'=8XK'589YH9_].J9OWK M9?WP7(SKB18WWJ0=:4_R2#XI((6DB!23$E)*RD@YJ2"5I(I4DQI22^H,,N/J MJII]UY.J_D4^.^3'*LWRJFV]*G(SKKBX`=^1]B2/Y),"4DB*2#$I(:6DC)23 M"E))JD@UJ2&UI,X@,PM.*YJM632;:#FZ631CJSW)(_FD@!22(E),2D@I*2/E MI()4DBI236I(+:DSR(RK733[]MW8FI6QD:QIM?TBU]QJOF:S,L96'LDG!:20 M%)%B4D)*21DI)Q6DDE21:E)#:DF=06:H^XK5\V^\^ZD M/.*QA7ZN.(TXO=LY9%\4D`*21$I)B6DE)21VJ^5S:VF M\;HC[4D>R2<%I)`4D6)20DI)&2DG%:225)%J4D-J29U!9JA/*Y!M6"";:'&! M)NU(>Y)'\DD!*21%I)B4D%)21LI)!:DD5:2:U)!:4F>0&==_K$"V88%L)&MT MVV^5S:WFT7VLK$VT9RN/Y),"4DB*2#$I(:6DC)23"E))JD@UJ2&UI,X@,PM. M*Y!M6"";:#FZ62!CJSW)(_FD@!22(E),2D@I*2/EI()4DBI236I(+:DSR(SK M:06R#0MD$YF/M;;VNV.+9M.(W3EL[S#/8;[#`H>%#HL<%CLL<5CJL,QAN<,* MAY4.JQQ6.ZQQ6.NPSC0S_J=5S3:LFDVT'-7R[9#*6K9=U[)&L( MV^^3S:WF(8PRV)ZM/))/"D@A*2+%I(24DC)23BI():DBU:2&U)(Z@\Q0GU89 MV[`R-M$\7F](.]*>Y)%\4D`*21$I)B6DE)21BM_3K9V.I:FUNTFE]!,7?JM!K..6LX(UD[93\N'UM9 M.S4_=3-WRBY`?+LV?,XJPT2+$4#:D?8DC^23`E)(BD@Q*2&EI(R4DPI22:I( M-:DAM:3.(#.N=DFA?["[54H]$5^6%LX'VEX^&2!KEZU:V&YR2<%I)`4D6)20DI)&2DG%:225)%J4D-J29U!9ESMV=T3^<)YG[:\X_G#QE.1$=]/I"1B0-9F8B3M[/5?,MF[/'6OD/L]_B[ M2CB'GLR;QY&L\3_?%@[?.QE;F>/_PKJ;V\VM[/'?7\U/F*<>FEO[.=YBSB/G M9FHUTXZT)WDDGQ200E)$BDD)*25EI)Q4D$I21:I)#:DE=0:9J7G:+?F6M^0C MF?6'"^O*22?%)!"4D2*20DI)66DG%202E)%JDD-J25U M!IEQM6UZG-M[NOO)K3]['>9J4_<<@R3Y>53R^TX?]9-YF)S<_%S/"DY6\WU MGD.KW=27SF"+ON89L''4+UQS\9,'V:$7)'8DTS#W9_)[H\K7Q?:HSWLW.`W_5_O$'71#,UKN8$']O?,2WW]MLGP8OA!FMY$AS)2@UKJ-U,*XYQ/GMU9AWF'5O,'\W?PJ#]W-?4RB/YI(`4DB)23$I(*2DC MY:2"5)(J4DUJ2"VI,\@,]6GSO4O.]R9:#N&QU4P[MMJ3/))/"D@A*2+%I(24 MDC)23BI():DBU:2&U)(Z@\RXNN;+5]>'OQ/QQ%F:<^2^RJPYLLK3TPB\&;*JA[MW*WFNHNYR_:DN9_BCW_:XHE=YOSY]+\Q'YR=GPYTCQ4;D@[TI[DD7Q20`I)$2DF):24E)%R4D$J216I)C6D MEM099,;UM/+")`(<5C0L@:#_W-0T_C^23`E)(BD@Q*2&E MI(R4DPI22:I(-:DAM:3.(#/4_;3_^16'RZ%*L*PX3+0U(>Y)'\DD!*21%I)B4D%)21LI)!:DD5:2:U)!:4F>0&=?3*@]7 MK#R,9`UA^['$W&H>PD-?BVOVGJT\DD\*2"$I(L6DA)22,E).*D@EJ2+5I(;4 MDCJ#S%"?5HSH`VJ]XS+1<@B/K6;:L=6>Y)%\4D`*21$I)B6DE)21^Y\Q;+$1/,@OB'M M2'N21_))`2DD1:28E)!24D;*206I)%6DFM206E)GD!E75QGG^VZ\6=:Y&J@_ MJ\PO\ES;CX;F5M/@WI'V)(_DDP)22(I(,2DAI:2,E),*4DFJ2#6I(;6DSB`S M"TZKC%VQ,C;1Y)%\4D`*21$I)B6DE)21Z+%V";M2'N21_))`2DD1:28E)!24D;*206I)%6DFM20 M6E)GD!E7NV3VW5?N_DLE=LB/1;'EE7M^T#L\[AI7U#E@'MW'%2?:LY5'\DD! M*21%I)B4D%)21LI)!:DD5:2:U)!:4F>0F06G5=.N64V;:#FZ64UCJSW)(_FD M@!22(E),2D@I*2/EI()4DBI236I(+:DSR(SK:=4T?14)0W@@XP*M;XU8?UI\ M7-$8PL<5YR$,\KBB3PI((2DBQ:2$E)(R4DXJ2"6I(M6DAM22.H/,4)]6.+MF MX6RBY1`>6\VT8ZL]R2/YI(`4DB)23$I(*2DCY:2"5)(J4DUJ2"VI,\B,ZS]6 M.+MFX6PD:W3/KS6-%^AC>6T:RKMYQ8GV)(_DDP)22(I(,2DAI:2,E),*4DFJ M2#6I(;6DSB`S"TXKG%VS<#;1/)1O2#O2GN21?%)`"DD1*28EI)24D7)202I) M%:DF-:26U!EDQO4?*YSUWPFT;[^/]:_Y]GM[9K]M-JYH7+N/*\ZC&^1Q19\4 MD$)21(I)"2DE9:2<5)!*4D6J20VI)74&F5EP6N&L_]*D'6I4R6ZF5O.`WY'V M)(_DDP)22(I(,2DAI:2,E),*4DFJ2#6I(;6DSB`CKJO^V\ZHG)W\VP%#-V;A M[&B7QUGSC<-VD_4_*']\-K:VO_FX7S2;AKSG,-]A@<-"AT63K:[[7;8.E%U> M.A043_TEDY6^\6R/C*/-S_1UH,9V\\'3@1I,;XV]_>'/M^NSE?76CX[1L<7B M&(T]'3[3X79)QPB]ZQ@=UQU[MUX+U!$[MIAZUQ%;]FX=,;MP\^W::_\==1Z: MP?J_C7[,C>V9M6E'(S,M)^=^?8S,C(H3NM.AU/';O1AF0XO[9_P4&';FQA9-]H<^\Z=.A=A\[H M?;5:.X[Y[NILM#FL M.C(P#4*8$@FF@P'3J(/I8,!T,&#Z^+#888G#4H=E#LL=5CBL=%CEL-IAC<-: MAW6F6>&VI[O?_51B=<:I\&16V<-^HV#1;,IL) M360/>?LU@T6PQX(?NS`$/ M4P;`E`$P90!,&0!3!L"4`3!E`$P9`%,&P)0!,&4`3!D`4P;`E`$P90!,&0!3 M!BS-S("5/8M^8L`?VEO3Y+>:;)[WWSA,63"L MJZ+)W]4"YA;3J4(YL9RMC[6`R>8M*B?LWJT)G3+DV&+J71F"WI4AH\V]*T.. MZX[[;A5\E2_'%E/ORI=E[U8\^NGR,AY/#;]A>FU<;_4?_>3%FM?9;X)H"C4T MFT>I8N%8%?-^#=*QV3C5TV3"G,4J/&.+Y51OLGF#"L]S-J@8F1M-U=KZUY"L5CV;L6B+PJ<$HNAB*#H3@=/9[*QL*"(+V)A M/[D]-IO33;$XKCIUIUB,-OR>ZZ7]:Z,*Q=C`&#S'E::.%`ITKE`:49ZA9F M?$8SQXIU*M98&9H9E9G)YI.ZXC.VNSIO0TTIS,BL^8T=S MYXK/L?,YE]8;*Z,U7K`)16E<==Z$HH1-*$K/V81BM=R$%:N^.O(/Q&HLLAAC M:3#]N\06%:WG;%$! M-+9X?;:USJ2*'3:HV&&#BMUS-JAP&AN\NEQ;%P%%;#=)L/*QVFVWRTJQW6.*QU6&>:E0;]E-].@^_Z1N!J-58/C$$]F#GEMV\" ME!S'9M/85W+`E!PP)0=,R0%3&K.,50/S'/!:,:Y`*9PPQ1NF,(-4[AA M"C=,X88IW#"%&Z9PPQ1NF,(-4[AA"C=,X88IW#"%&Z9PPQ1NF,*]-#/:-ZNYV3S@:7M'.\]AOL,"AX4.BQP6.RQQ6.JPS&&YPPJ' ME0ZK'%8[K'%8Z[#.-"L#^OK#"0->-V9X&CK9E?6H'=E#7I7UAS7'7NW)@'*H6.+J7?E M$'I7#J%WY=!QW;%W:WJHC#JVF'I71J%W911Z5T8=UUV&S#H\2K)CLVD32K+E M)JPDZTLPRR1[XB9B/19ZEK>1H_6_BKQ()NO0*IG&:L]\^M!I9K3EJH[IXM1L MFBZ>VV^1*,'&GI;3Q7UI97F2CIL44DWVKQ%)=US MMJC,,[:H%V?LSZA$Q!:5B-BB$O$Y6U0V/K5%)2>VJ.3$%I6\Z]'F$"DU84I-F,YL,"4>3&'N2UVGA'LL MC1DGI\'Z7TE;G)RL,[,RX-AL.FTJ`V#*`)@R`*8,@"D#8,H`F#(`I@R`*0-@ MR@"8,@"F#(`I`V#*`)@R`*8,@"D#8,H`F#)@:58&]"6R4S)@**F9`WXT8\## M%&Z8P@U3N&$*-TSAABG<,(4;IG##%&Z8P@U3N&$*-TSAABG<,(4;IG##%&Z8 MP@U3N)=FA;LOK2W#_?WOM*W'*IUQ+AC,FO[B">NXZN)U%B7'<=7I_*#D@"DY M8$H.F)(#IN2`*3E@2@Z8D@.FY(`I.6!*#IB2`Z;D@"DY8$H.F)(#IN2`*3F6 M9B5'7PI;)L=3MZI#Z[N\?=[>/MVQ\^WWW] M]>[F[M.GAQ?O[__XH@MX__AKX2^^WOWRX\MWNHEXH\X.]_['=8[+MOVRP],W M+KOHEQV>G7/99;_L\!"0RZ[Z95?]!!?+SOIE>EG/N>RZ7W9X`(GU5F=:IG>K M7.NM^GW1@P?GLGY[JA,[E_7;4U'1L>Q:'UU?IG4MT<;T=4S7$FU*7]%S+=&& M]"4OQQ*]PZQ]T(O;SF7]Y])[K(YEUSH<^JT=UY*5EAQ&L'T,K]=:+H2^>.)5=:1S_0Z5JB=?0+CZXE.@SZU3_7$AT$_6Z< M:XF.MWY+S+5$QUN_1N58D74MT MK'57[5JB8SUZV_A.99<:J_UU]1<2[37 M^N-;KB7::Q4J'$LVVL[&N9USK7/N7.=M=9Q MGR776L=]CESK6*^=QWJCF&Z<,=WHN&VUUE&%U?%YUEI'93'7 M$AUKE2!<2W2LW=>8M8ZU^PJSUK'^F^N+UM'%S+&=57_"=,;GE8_TW MUP`=:_<58*UCK<K@'L\\&*QUIO0+F M6D='6N\D<EOKNO:)=<>O5,8G5%4 M$)TQU'!Q1E`!=(TO/=MGTWWJ^HUN3%V?4/>ZR70MT_WC6GTZ ME^E>,FI;U\7&.1/TEYC?]WS#F6OH+ MS&]V[B7ZFK0^F[XY[EA+7PC6,=&W@KE,WRQ8]>NYEND9=[^>\SCK>76_GG/9 MNTNEDOY*'+?V[E(IH[\SYEK2)X'K,]^'A[0^_W_YZE]Y^_?7CEX<7G^Y^T2W_F?X&^\L77XCE_'QZ_MDV3U\ER/__DQTS! MJQ_1J`Z',B_\*G^Y%->6B=3%.6OA_IM3>6N$VB5_1.Z2U<\OMP]Y=;F!Q%-Y M+MNO5'0\NN1>,S+Z7(* M2IO5OH01D+2/ZN*P'G\RO=0RQM/-BB;HW[)X:Z3_CYI3]1;5Y?Z/\EI`MF&> MR`P\5=4S"4WV!$'C*6H=TAGXJQ[MBT/V6ICN.8R(#,S;?_6+ M)H>,@LS$FA.EO#K##<"_HTM)K`$9R;[0ZUNY;T_KL;V8S!W#-B%\]%0T;5@2 MR?$H?VG:ZO(?"S*Y%!.QN`A\'5Q%AX^-S`3/ M,0L0\W$/#(UMRJQ#G>AG;;99U=7;")8WF*.Y962S,#VB)CS(YJ]SY?=,"6XD M*I^(S'H,XP:_-;"27C)IND0@]AR(LT[(CXB`2(A(A$B,2()(JE,E('"F?&.@9)H M=:",S.`B3;*C37(7)/+C(Q(@$B(2(1(CDB"2RD09.YQ_[Q@[B5;'SHDTR8CX MB`2(A(A$B,2()(BD,E$&2@IJ?`A.''!%>RKSYVT%DP>GQ,"BM^&P8T<@$5'' MSXG3[?P[3NR.^(PL8-_I_&&YVDX1=$'"'R$B$2(Q(@DB*2>L3I7//BA%?CTE M1$1-"2>++@$[1N;+COB,N"XM(RS#U,Z,H/N]RP8C"SH*.AD14HV[5J0X`56M M.DFZWX5J*JLJ=B%UDI*<`5]`!2Z,0$JVT+/,KJ%Y`OD-S0,K5# M(Q!1Q)ROFZ6MEV*A")AU68\$ZCN+!;K;62*B6&?6PM#N)A4!M#,UD:3RDA?> M#Q+)"C4X5L4<;:%R(!:C*[6O/)=Z(ED4?XABE2778L]5!`5U81/7:B:KM M+.:V-B^I:$2EU>21@NX=#N/U7W^/6Y,C:1?G2+$3C^KG/!!1;,Y-=^XZVKD? MBA#93TQ(TH[%'?3:B6C(M:TY>MI*11^N=U8\YLQT4G`0^1C8>ZB\U'NDM$%.O.M4S] MW$E%Q(`72?5[+Y^?JQNLJL&Z'Q+3U7>LB%;,R%%?3.U,A'R,`HQ"C"*,8HP2 MC%(%J5L5J7;U7%CS"6P([WT5R.IF)1T,J4_!MK:F=F87)4X4'Z,`HQ"C"*,8 MHP2C5$%*AN!+@)JA^YLY#5>K?H$D5V#D8Q1@%&(4811CE&!$OG'0XX/>%QLS M^V;!WA1?BOI8[(KSN1GEU0OY'@';^V;58?:Q9+OPX$T"S)S.'0\>O`>XZ7K$ MCT._+.$7^D"H:UF&^"*C_>*['CS=8BU_Z<'S(N;QTH,G/LSAD\\GNC%J^EOX M%$33HW,+;FA`9VM[\"YQ0'\&^K3HT(5F'KQMPPVV3@&?=@W@$]`M.Q9_ M9O6QO#:CSU5+7S\H1O9"3[V%?"L8Y!U?:BJ5OQ! M.N@^'VZ^`0``__\#`%!+`P04``8`"````"$`1%M.B-4"``!I!P``&0```'AL M+W=O^K&Z?N]9YHD(RWA689#5Q4C M])Z3?4=[94D$;;$"_;)A@WQEZ\A[Z#HL'O?##>'=`!0[UC+U8DB1TY'\2]US M@7N,*U7)0,'.G9'T*I`=T&^ M72!OO3+Y_&;T("?_'=GPPR?!RJ^LIQ`VE$D78,?YHX9^*?40+/8N5C^8`GP7 M3DDKO&_5#W[X3%G=**AV`H:TK[Q\N:>20*!`XX:)9B*\!0'P[71,GPP(!#^; MWP,K55.@*'63A1\%`'=V5*H'IBF10_92\>Z/!05'*DL2'DDB4'^<#]TP2X(D M_3^+9Q49@_=8X?5*\(,#AP;VE`/61S#(@5D[BR"?MYV!);WF3B\R2P$MH1I/ MZR`*%ROO"3(D1]#&@N`&C*!PCMB^@M%DS.3X<:"XM/6DX'9UO$U6VMP@<#%&'H<1&.F M=F>+24W=TCB.S\LRG0_#+$O']3-=<'+?'XD&G^N*1UZKRV(2HRN.HF0^O9U. M1UEV3N?#93A)>Z9K<8TN#=:Z="?1 MQW)C!VS)@@@^_EDX4T"2++-33:T*V]KLS>^HJ.F6MJUT"-_KMA5"YN.H[:B; M(-\8`6?C6^BT9MP;)Z#3#;BFW["H62^=EE9`Z;L+*)BPO=(^*#Z8Z[CC"GJ< M^=O`*XV"0=\%<,6Y>GW0W7A\2:[_`@``__\#`%!+`P04``8`"````"$`]3F> M\#L^``!U;`$`&0```'AL+W=O==QI9'BO&DAR29OOWYRVB$K4\$)OL,W,Q MDA]E90+(MQ)5"9#\Z7___?&/5_]\_^7KA\^??G[=^.'J]:OWG]Y]_O7#I[_] M_'J]*O[GX?6KK]_>?OKU[1^?/[W_^?5_WG]]_;^__-__\]._/G_Y^]??W[__ M]DH>/GW]^?7OW[[]^>.;-U_?_?[^X]NO/WS^\_TG_75U]^;CVP^?7I<>?OQRCH_/O_WVX=W[]N=W__CX_M.W MTLF7]W^\_:;C__K[AS^_FK>/[\YQ]_'ME[__X\__>??YXY]R\=O/K[[L?^W3Y^_O/WK'SKO?S=NWKXSW\?_@/N/']Y]^?SU\V_??I"[-^6! M\IP?WSR^D:=??OKU@\[`7?977][_]O/KOS1^/#3NKUZ_^>6GXQ7:?'C_KZ_1 MWU]]_?WSO[I?/OPZ^O#IO2ZW$N52\-?/G__N3/N_.J3!;S"Z.*9@]N75K^]_ M>_N//[XM/O^K]_[#WW[_IGS?ZI3/V]*HX5V53JZ]$_U9X^3$P!L_4'_6##PSNH[S>`IWE9.FY'TBZKT? MH#\M:O.'F^;M_72\_6%-$(DFA* MNF==*1."T_^EIROQE*<;5'1_9EB34R/H2*F2=;-,4Y?[B1YY]LJ:H9E#4N2=K M@G)3U(=MG*F*I@G*_>6&JMU/;_ZIF\L[;_14 M8Y1:M,S"W4F#'`QS,,K!.`>3'$QS,,O!/`>+'"QSL,K!.@>;'&QSL,O! M/@>'""3"4.%,A%&_/K1BX:RU$HR+Q<-CFO"GTD9+"\MX"Z0-T@$I0+H@/9`^ MR`!D"#("&8-,0*8@,Y`YR`)D";("68-L0+8@.Y`]R"$FB31T7[Q`&LY:MR+I M++Z1W&7B**T>$JO'O&141J:@-D@'I`#I@O1`^B`#D"'("&0,,@&9@LQ`YB`+ MD"7("F0-L@'9@NQ`]B"'F"1ZT6+H`KTXZZ->+,E/GD2%`Z0-T@$I0+H@/9`^ MR`!D"#("&8-,0*8@,Y`YR`)D";("68-L0+8@.Y`]R"$FB1"T&$V$X%:F36U? M;#][]MK4.4HU4I('U:Q091ZOTR+3JHQ,6FV0#D@!T@7I@?1!!B!#D!'(&&0" M,@69@Q!#C%)9*-MM&>]0*]..NTEG@2W6]`VB`=D`*D"](#Z8,,0(8@(Y`QR`1D"C(# MF8,L0)8@*Y`UR`9D"[(#V8,<8I((09VN"X3@K%,AE"2[J60MD%9E5!4)D`Y( M`=(%Z8'T008@0Y`1R!AD`C(%F8',018@2Y`5R!ID`[(%V8'L00XQ2;3ANN,7 MB.-HSMO*0WK'>/)FV7TEV^RT@E6E&:(.44'4)>H1]8D&1$.B$=&8:$(T)9H1 MS8D61$NB%=&::$.T)=H1[8D."4JEY)IK<49]H0#0D&A&-B29$4Z(9T9QH0;0D6A&MB39$6Z(=T9[HD*!4(Z[/=H%& MRK:Y&V;JV%:QL8)NH0U00=8EZ1'VB`=&0:$0T)IH038EF M1'.B!=&2:$6T)MH0;8EV1'NB0X)2V;@F7"P;MV6^OOKA7GOF9ZI,V;Y+&FJ- M9MZ3=4]Z)"@5%2N4_NK?!%4=0+C9DPFO99[ M8%]*SQ34)NH0%41=HAY1GVA`-"0:$8V))D13HAG1G&A!M"1:$:V)-D1;HAW1 MGNB0H%14KNL7B^J9\N2;A)F4&KF42K.D/NF-L=2JY=[?R*4$U*%50=0EZA'U MB09$0Z(1T9AH0C0EFA'-B19$2Z(5T9IH0[0EVA'MB0X)2J7D.H$72*EL'.HF M:H7DJ>%1O)X&:M.J0U00=8EZ1'VB`=&0:$0T)IH038EF1'.B!=&2:$6T)MH0 M;8EV1'NB0X)2C;CNWP4:*9N%B49\_U`+F>J10?,J*T`M]XY6N>HV<;6).D0% M49>H1]0G&A`-B49$8Z()T91H1C0G6A`MB59$:Z(-T99H1[0GT@NT4=)2V;A> M82R;\]?3993-LE51IL56L#+]M(DZ1`51EZA'U"<:$`V)1D1CH@G1E&A&-"=: M$"V)5D1KH@W1EFA'M"(%=":7)V^5+:#S-SN" ME2FH3=0A*HBZ1#VB/M&`:$@T(AH338BF1#.B.=&":$FT(EH3;8BV1#NB/=$A M0:FH7$LX+U-G/4MS'^>BJ#*Y/'FK3%3YNQ_!*HB*O6I:%41=HAY1GVA`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`51%VB'E&?:$`T)!H1C8DF M1%.B&=&<:$&T)%H1K8DV1%NB'=&>Z)"@5"-YQ_GEVW0VHZ]+E-WQK6!E MNFL3=8@*HBY1CZA/-"`:$HV(QD03HBG1C&A.M"!:$JV(UD0;HBW1CFA/=$A0 MJBC7";Y@W5PVCI,UD4>AQ+2N@=I$':*"J$O4(^H3#8B&1".B,=&$:$HT(YH3 M+8B61"NB-=&&:$NT(]H3'1*4:B3O.#^S;BX;R(E&?$]9^ZGJ+8]F(WL>W[JN MK$)I`>K0JB#J$O6(^D0#HB'1B&A,-"&:$LV(YD0+HB71BFA-M"':$NV(]D2' M!"6RNG??TA%P/\?S[Z4W9 M)2EKYHV(F](J29E'8?IUS"K)8C-KRQ?>RGVJ)ER=9NBP MI9/MLBWS#;?,'E63[2Z?_2VSB#-8^LE2C\GFKHN:A.;[O&=N MG=S,W7B49(Z3K;1*,E<--.%UO"\]/79EHWEW]9@_32G,I&:FN;U`K,UG3L5O M'>*Z4:+L:LX3R5Z;J955G;"Q8WW59,8MQZ]X&S*Y6LRI3Q*$M/,/Y1S M4UHEB:D&VG%V@E4\6;+;16%64MOS4^HV7[2]J)0Y-M%3B>/M7-^%D>6GY0?% MN?;(]:3#">)V;E:WY;R\?[C/EPJ%F7!>WKJ51ZSD/-&KSW]^;^6E0[6EU]%- M=L;.LU#(8#3/-%*N!=->8S.[A;;\0%G9U&\3=8@*HBY1CZA/ M-"`:$HV(QD03HBG1C&A.M"!:$JV(UD0;HBW1CFA/=$A0*ANW@(U+SNFEP&VY MWHUOGH9"'6D1M8DZ1`51EZA'U"<:$`V)1D1CH@G1E&A&-"=:$"V)5D1KH@W1 MEFA'M"M7ZP,O<#0\']T%!P/S*4N@^[I.-QC8.5N9\8"NZG MAH+[F4?N!A`N3OZE%O-@9>X7YHM]D5NWU[D@K^76*,EKB9*\`K6/<7Y^[?8C MX=";^>XZ6-FA%X;"E>D:"E>F9RAQGV_L^L'*W`\,!?=#0\']R%#B/C_Z<;`R M]Q-#P?W44'`_\RC+:[8>G0LP@7KF56XW_2)!H:"KR%]C0R=/-1QL++C MFM#]U*S"H<[,*JR5YD0+0^5/CL:_*W;K]KP73-!RBYQ,T!*E.[SK;%?6.L;1 MYWW#)6T;2LH-=SO>?;F1NM=NYSI3;F&.COMV7YO]J!"N9U8GP_7-*MEC7F1!CL_+G?'73;&2E;&(FX9RG'JGK;AJ:F55H MJ\P--8Z[QX9^63+]DL:%&;`+7<\TA?>6B^^\$J/L[, M_<"L@ONAH>!K1/=CL_K^H4_,)/B>FJ/09YUYE-X!\[;F/%C9"2X2]\FB["YO M"IU>N!_-TR1[E-8&O-%F5F&>M`T%X78,E9.B<7>5?[UH819A3G0-!=<]0\%U MWU`RZ6^RONW`K$Y/>K,*$4>&0L2Q(7\R-\W[[.8U,8MP,E./X@EN5L'UW)"? MX`\_N"L5_I>=U<+,.=WO\M[8,^DO.U[QK>'H08I0?0BWZ9MLO=KR5O$<#P-- MIAVS*B?*G:Y86K<*,PC3I&LH3,$>/?>#57R466MV8%9:>X9S04`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`51%VB'E&?:$`T)!H1C8DF1%.B&=&<:$&T)%H1 MK8DV1%NB'=&>Z)"@5".NO1>7EI>M7LLF85)Q/`I+KM8=4-NCY/W19KZ)ZP0K MJTN%^8K7JW#?"P.CA=%M]OI=/UB9^P'=#PV%$QJ%@9'[O"DS#E;F?F*^PM%/ M#07WLS`P=I]M^N?!RMPOS%=POS04W*_"P-A]MII>!RMSOS%?P?W64'"_"P-C M]]GV91^LS/W!?!W=IV+-VZ;/%#3?WPQ+MJ>[$E6O*_+=8+,():]MZ.1*LV-6 MY4KS[OKN-KN4A5F$A6;74(C6,W0R6M^LDLWW-1;7_G1#Q&$8:!=\9.ADQ+%9 ME>?W\'B?"7%B!B'8U%`XO9FAD\'F9E4&N[W-N]`+,PC!EH9"L)6AD\'69G7R M6F[,*D3<&@H1=X9.1MR;57EZ>H<[ZR4>S.`8+)D#]Y>UDH_FZ7[!4+(OPYNM MWBKN*X2!)IV.697]M]O[Q[ML35F816C`=0V%K7>/KOO!*JH?4+A9!?=#0\'] MB.['P>J$^XE9!?=30\']C.[GP>J$^X59!?=+0\']BN[7P>J$^XU9!?=;0\'] MCN[WP>J$^X-9'=VG(G4=['A5<;I0WSOS3*0E2GN@^7L"+3\P:@NT#86BWS&4 MS._;;,H59G6R$=$UJS#E>X9"Q+ZA)"*UZ\\Q5)1A&&A3;&0HN!\;2MS?YO78 MK$Z>T-2LP@G-#(6(>RUZ:KQ!Q92A$7!M*(N;IV(2(5A6V-C"X MWQD*[O>&$O>WV1K\$-S7GU"J\OQQQS.EG<\U[GV7WSZ?QX\,F468PFU#4G30 M+5K<9E6NJQKZ>!X>;9M)J!A=0R%9F50:[N+.T,F(>[/R8KG.G_$>S.`8+)T$NB$DI?Z92>#,LYKN45+3N0@O MK9*:7@VT6M"Y]U;^@;Z>B-UFS]\*,PDKP:ZA4$%Z'L4O[9A5Z;M9\T+0P$R" M[Z&AX'M$WV.S\L=]F\_5B1D$SU-#P?.,GN?!ZO@YW=SQPOX].%X:"HY7=+PV MJ_*0&WRT?4^6$45+I]R![,ZND\UZ1X#7;#F=N:9)DOTW)K; M6X7YUG8?-I>OZ-E8QU`RG2E+/U`"#E4]OY5V@R^3?,]06-'U#241\^LW,*M0 M0(:&P@F-#`7W8T.)^]NLX3(QJY,G-#6K$'%F*$2<&THC9OOKA5F=C+@TJQ!Q M92A$7!M*(MYDKT)LS.IDQ*U9A8@[0R'BWE`2\2YKT![,ZGL1TWEPV<.R>SXL M,R1Q1JK,-CLM;Y749N\K3/1.L(I\W6'O60YTOY001]D6D@_R[DN4EG9N(;U5F+-M M/S#^\+"A9,[F`BO,*DSVKAU$<-\SJ_"B1=_02?<#LPKNAW0_,JO@?FSHI/N) M607W4[J?F55P/S=4OFB5-ZP6]L_![Y)^5V85_*X-G3SLC5D%]UNZWYE5<+\W ME+B_RPK0P:R2=75TNT[KL#:=R7KD95IV7K)E2HE.?"#\OK1(2K,?E-Q"N'_T M5N4;8/V^E#V&Z[07>0#R8EV.L=%+D3S#S27'>6V#W?+)I*!37%E&;J$-4 M$'6)>D1]H@'1D&A$-"::$$V)9D1SH@71DFA%M";:$&V)=D1[HD."$NT\7/;D M[VB>5DZ/TK?`[O*%;;"R"MZ)"@5#:ZIR?WX=.]J@=GGLG&HZBTF%5`;:(.44'4)>H1 M]8D&1$.B$=&8:$(T)9H1S8D61$NB%=&::$.T)=H1[8D."4HUHA5=HI'\MG36 MAY#=]ZWGTBF1^WFWL+&]RUZ,:=G`\.2B[5'Z8MA=UHKH!"LK587YXMM#KNPE M)_G,1."3BZ.'8Y_K^"F**WP!JQG$T\(_[4C6S%AXVL"R%WUW^WB7/:0IS(+- MZ`>37"/_#KT*C^\UC&$3CSL?ML>1:V!CEE9/_<^_]!D819<&#VX M3N#YW78251/2)R?K@;?\F/AE`4-AO]0Q9)FX;F2[H,(L:C+AFBH7G(1O MWH3H3P]5/\>?1-9@;'F#)!/5&)L$';.R3#3RWS0LS*(F$ZX)<,%)E#V#^-7/ M!]]&:)8?-KIJ9#W+EAG$TZ0:$T["(Y^)9O,FJQN%^:G)A-LV77`2Y2Y+)Q'* ME'XP(FO3/3V49J[$1-4LFZFM8&6GTB;J$!5$7:(>49]H0#0D&A&-B29$4Z(9 MT9QH0;0D6A&MB39$6Z(=T9[HD*#TWIAOV9ZY;7!K]N!1D'N+J$W4(2J(ND0] MHC[1@&A(-"(:$TV(ID0SHCG1@FA)M"):$VV(MD0[HCW1(4&)1A[SK=F+UD]' M+^E-S2/WM4!1QQ0_8#3D&ZW9(Z/"_IFWAD>W)#W_UG`TST[#>1#2_2DD MY3X[@I8-C)/B!X9E5,=;Z7Y>WO"SC^+;/_,V_7C9:O9HGIU&N3)-LY&_B=SR M`Y-L5$M:4TW'6VEMY4XCTV=A_UJ3C,O6KH] M)R/;;!1^@![2R411EHN\,Q.LPEE4JUY#'6_E$6\7&UC>Z,IQ=2 MCW[Y'Q59B2J;$D_>*A-5)OI6L`JB*MUKH*$.K0JB+E&/J$\T(!H2C8C&1!.B M*=&,:$ZT(%H2K8C61!NB+=&.:$]T2%`JJGQWYT3UHA\4?*S?^&4;S2=OEJDL MW_@%*Y-4FZA#5!!UB7I$?:(!T9!H1#0FFA!-B69$Z)#@E*57;;Q>^3&SU"T\2-J$W6("J(N48^H3S0@&A*-B,9$$Z(IT8QH3K0@ M6A*MB-9$&Z(MT8YH3W1(4**1QE6^\SM]4ROMTW6X,=?AC?83V2*Z%9E5Y:6& M=6I84<.Z-:Q7P_HU;%##AC5L5,/&-6Q2PZ8U;%;#YC5L4<.6-6Q5P]8U;%/# MMC5L5\/V->R0LDQ1EVVS&U?^Z5Q8R#Q5+"H\-:Q=PR0?[R^,E7S`)!\PR0=, M\@&3?,`D'S#)!TSR`9-\P"0?,,D'3/(!DWS`)!\PR0=,\@&3?,`D'S#)!TSR M`9-\8I;))V]O'!?<5Z+/52;?G$AT5#)]>[&5')4AS](-=]99DK2\F19845$+ MO9[LJ"_K9C2NRA9$O(6N6!"N#M;;!:8C`Y/HP21Z,(D>3*('D^C!)'HPB1Y, MH@>3Z,$D>C")'DRB!Y/HP21Z,(D>3*('D^C!)'HPB1Y,H@>3Z,$D^IAE\LG; M2$?1WUR=\86ZC2OVE(RENB_MW!=`1X*F[KU9HON'T!S,#ORRSE'CBJVCB@6- M2_?>+C#I'DRZ!Y/NP:1[,.D>3+H'D^[!I'LPZ1Y,N@>3[L&D>S#I'DRZ!Y/N MP:1[,.D>3+H'D^[!I'LPZ1Y,N@>3[F.6R:>N9=>\:9ZE>__8.*GW)4MU[]ES MNO=FJ>[#$]3LP%WW)6X+/7=S3+H'D^[! MI'LPZ1Y,N@>3[L&D>S#I'DRZ!Y/NP:1[,.D>3+H'D^[!I'LPZ1Y,N@>3[L&D M^YAE\G%MFTODX^QS^90LW74]9$UK*:HRLR60%`4F18%)46!2%)@4!29%@4E1 M8%(4F!0%)D6!25%@4A28%`4F18%)46!2%)@4!29%@4E18%(4F!0%)D6!25$Q MRQ1U6;.G<<5N3\62@N3M`I-\P"0?,,D'3/(!DWS`)!\PR0=,\@&3?,`D'S#) M!TSR`9-\P"0?,,D'3/(!DWS`)!\PR0=,\@&3?,`D'S#))V:I?!IY&RAZS''^ MSS`WCFZR.F4L/$=N57:!M8U%O_?2J6&%L?(Q9OD;'\8:X;=/>L;Y# M]ORE'YE9?1S4L&$-&]6P<0V;U+!I#9O5L'D-6U3L^`&H+)%N9WW!G44_TH@[ MBV?NNX"C*Y<]4U`2RZ'ZVE>[\5F.C$(]A+5C^NE9D9NZ4:H10 MJA%"J3XGQ#PRLQ#*?APBR[YK6ER2_;+)D;0AW$N$6FLH^Q92J?8LY$&I]NS. MWI+,!*(L5Q;F25GV+,DRO"O+U=@H!0]93UE9KLPLA+*,$,HR0BC+U=@H1/Z- MXIK0E9F%4)810EE&"&6Y&AN'R+2J+%=F%D)9CD-D67:-A$NR[!L/\4Y)I9)9 M]BS)LA\;IH?R"J:\^K%)7N%/>?4L+1!9%T)YK:W,+(3R&H?(\NI:+Y?DM6S52"GF_DEO M&-3DU;,DKWYLDE0[OT6#*5U\K,#EEY10CE%2&4UVKL MB8NNO%9F%D)Y10CE%2&4UVIL'"*K.LIK968AE-N;13G]IE& M4,/9YRODDB5?;I#_5*CNP=XJS%C=@VM&-O-/ORC3WJS\),+]U5W4SSUF2HGW M)N&NK\0CHA)_3D3-\^(*!T@HG1P3D3IH!H:R27_5@=)`U$EC6JH24C2 M.">JU%(-/1%5`HJC9@)R7:)+!.2[2DD5\$PRC69C=E.5@DJS^+,WQJ1P.W?) MQ=N5G[YYN,Y7OE*+MPC/U:06>)=:2A9YES0JN^A@\T1)'@@A>51#[6`E#X20 M%BJ[$R&D!820%JJA%D):0`@EWMM][QHIY['W+.>NCQ/G_(4WA+(=E-[_2Y;4 MDN9C=A^6%+Q94DQ*IJ]*B:Y:33$IS?2#4L=7I1^O\E>N)0_O*6A4\D!$R>.< MB%),&I'E2VI!1*D%$:66):4"?B3 M#N!/28<_91G^E&7X4Y;A3RF%/^4/_I0_^%/^X$_)@C^E)_:7ID??V)^FYV53 M_N@F6SYXEDSYZ_PK`UL-,XNGO&?/37EO9E/^KI%MI@IS?AW4U#46?5ZU9^QT MP'YE=G+^#2JS$'5H+(HZ,G8ZZK@R.QEU4IF%J%-C4=29L=-1YV;VW8N[,(OR MXF:RG''__)@-)/=:S1<>7U6_I!5.FG&FH+`.GGG*C23S7T1%3I!U&E MGVJH195^SHDJ_?BAW[NXTD\<,-./ZS)=HI^R*Y4L.5SA<5N:4%@D%C")!:Q3 MPU1+8*=:`B8M@"GQ8,HRF+(,IBR#*:5@RA^8\@>F_($I66!*#]BRAJUJV+J& M;6K8MH;M:MB^AAU2ELG'-;,ND4_9_$KEXQMBZI^$&I+_**84Y2%"LS"R$I(H2DB!"28C7V1`BILS*S$%)G'"++OFMY79+]LD669M^WS4+? M0:GV+$FU9]73AFP)HBQ7%G;PRK)G29;A75FNQD;7AT\;@IF%4)810EE&"&6Y M+@2?-@0S"Z$L(X2RC!#*SU8T,.E5$4)YK<;&(?"T(9A9".4U#I'EU?6=XKR^ M<*?IFUYAE_/4<%^#Y:9L4JP]"]=.]^6217UUI1M,Z?9CXZ<-QH(_I=O;Z584 MTLVG#<',+I32C1!*MV=I@9N73ANN; MQGU6<)5X[RD(2:LOST)$)?ZB=%`-#1>QF6\P M)0U$E32JH79E)8USHDHMU=`3426@.&HF(->AB@7TPN+@&V))E[9&'R25B>A9JL>N'9@W^]A!KR\:+?>*H&!>?2$)Q+,)7S<*Q(GT2#$!*- M'QI"2#0((854(M&(AWJQB)^/-*S,U MA:IY"NTO*K-CU$P[KI\4%Y'GM%/VGY*[T+5G8S-?#>\ M<7/?S`JG4NT]A9N/4EVR:+FB5)\34=GW9KJ@X<#R6[D$@:@2!*)*$.=$E4;. MB2K9(*ID@ZB2S3E1I:32[/M75\**(V;"KR!ODA0+1)2"SHDH!55#3RL(4:6@:JB5*"GHG*A2 M4#7T1%0I"%&EH&JH196"SHDJ!?FAW[VZ4E`<,5.0:S-=HJ"R+94JR+-07'3G M`)--Q;6*K-T@Z]2PHH9U:UBOAO5K MV*"O8J(:-:]BDADUKV*R&S6O8HH8M:]BJAJUKV*:&;6O8KH;M:]@A99E\ M7'O!7KWCZ_?/G_LO?_PMV-?\]GOA;LI.Z7);="SK%AESQ9:^@$5 M'<;/KV46BA69U`8[J0U,:@.3VL"D-C"I#4QJ`Y/:P*0V,*D-3&H#D]K`I#8P MJ0U,:@.3VL"D-C"I#4QJ`Y/:P*0V,*DM9IG:7,LS5MN_&S=OW_WXZW_:[[^^ M>_])/8;C%[']\M/QLW)_T3?#'V61*LJSI%B!J5B!23Y@D@^8Y`,F^8!)/F"2 M#YCD`R;Y@$D^8)(/F.0#)OF`23Y@D@^8Y`,F^8!)/F"2#YCD`R;Y@$D^8))/ MS#+YN'YG+)^7+ZQN?!,V7EAYEM6J["TAU:IR:%JKP"0V,(GM_[%V;LUMW&88 M_BN9WM?A-#.D)5NR)5NVY9/NW%0Y3-(J8[O3_/P^'P'N`GA?VZ$GODBG MSX?%`O@>@+L0N2L,V80AFS!D$X9LPI!-&+()0S9AR"8,V80AFS!D$X9LPI!- M&+()0S9AR"8,V80AFS!D$X9L)6MDB]W;OTBVO!&,V<,?OKINUERR[[I9*E<] M/+YO_TR-@$.QXL-2&`(*0T!A""@,`84AH#`$%(:`PA!0&`(*0T!A""@,`84A MH#`$%(:`PA!0&`(*0T!A""@,`84AH#`$+%DC8.R8E@+^\84/R[3#6G]89E9] M6`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`.K%R0E)UT MRM`GUS<>BS["T$<8^@A#'V'H(PQ]A*&/,/01AC["T$<8^@A#'V'H(PQ]A*&/ M,/01AC["T$<8^@A#'V'H4[)&G]@6/4:?O(U:7B'-$VL6)/GAT%BL6)"&0P\, MHX1AE#",$H91PC!*&$8)PRAA&"4,HX1AE#",$H91PC!*&$8)PRAA&"4,HX1A ME#",$H91PC!*&$:5K#$J]CZ/,2KME=8+4F;CHG*_XV>7^Y\SC(P%21CZ"$,? M8>@C#'V$H8\P]!&&/L+01QCZ"$,?8>@C#'V$H8\P]!&&/L+01QCZ"$,?8>@C M#'V$H8\P]"E9HT_L7!ZC3]KIK/5);(FDP\9XWS[S"J-2,;Y^<%A\,"H?FGX^ M-KFW7"\GY;_FNWOHE@\P/[.:QR[:,5W)NV[5VIK8DO\INM*T@JZD8O&T@*)8 M\Y<`>I>*Q5/HBF+-G\WI4RZ6W@D_NS=95__&\DWJ8A_GF/ZF?9\Z=8DUJ9,_ MEO&"H%@,ZM3E0U/J.E)7_SO]>_.11$?+:IK.Q*[",9W)NQ!5\A)KDM?\'HKD MY4/'GZ61JPQ'4@WO74V,AO77%HKC-8*HVG"6(>% ML0X+8QT6QCHLC'58&.NP,-9A8:S#PEB'A;$."V,=%L8Z+(QU6-@+PZX->VD8 MZ[#4QSHLC'58&.NP,-;ADC7ZQ$WL,?KDF][*_\2:"T/9RY\/Q8IU6!A&"<,H M81@E#*.$890PC!*&4<(P2AA&"<,H81@E#*.$890PC!*&4<(P2AA&"<,H81@E M#*.$890PC"I9;=2BW?O8?_UK?F^_//[\RP^_[N[X4.)6Y0_=XX\U/7]Y9U]- MLR5R8.4ZI>RD4W9JV`/#'AIV9MBY88\,>VS8A6&7ACTQ[*EA5X8],^RY82\, MNS;LI6&O#'MMV!O#WAIV4[/&JKBW+=>IK[0JWR*7R]/5TE1V_@_% M^"@NBC7[<;B7:QN?E8-[B:W*WU3WT^8R!1V'8H<%$AUS=>/3,]!13H&.P[%E MZYK?Q&'H4.QP"@R54V"HG`)#AV/+4S37J$@[%#N<`FG+4S2)C5O,,K%F6>!Z M=UP7TBUI=?W"[Z3W]XSCE=7]3AFYD7+D)K'5N*:0"&$D(K'BP04D0NHC$7(L MHRZ,49?Z&'6ICU&78QEB80QQ65\SQ'$;=LP0Y]NV:I(D5C]18-K<>3#JJ=B2 MNZ5BDHQW$OO%G42D8L5U/8D8SG#PAD1DEJ_UU_UZT3?7%60F%QJ?NT%FY`1D M9CC!V#;Y73K)RL72[S%J_S73'@2*:G*;BZ4NSU;3 MIK]DNCQAD^FX2STFT^FNMIY,F57WF%.Y->/A8OLYQZ7E9S.=BXU3DTP/9SB, M#IE.C"?AQ&-XV`GOUGVS>I'I7&A\'@"9EA.0Z>$$8]M@(/9SATF[1FEB?P8CY939K5@+3F0M4$EA.0UN$$GT]K+C9,X'F] M05#_3IP)+*QL&L=RG8O5DUBSG8M5DS@Q'H)W&`VRG1A?X4_/TF+<^^8C@FSG MRJHK&CD!V,>MR;5OSH?9#N7']<0LCW4<>@+VAG][]NK1(P: MBAVF'48)PRAA&"4,HX1AE#",$H91PC!*&$8)PRAA&"4,HX1AE#",$H91PC!* M&$8)PRAA&"4,HX1AE#",$H91):N-XAVYM5%Q#3%+NVU?D&M_*,_E*=;1CB_I MUA^8NRX7JW]6H@^B'8N-OBD[+:H[E'M@V$/#S@P[-^R188\-NS#LTK`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`/3>-;/O)9NNG(I$;'@^KQ^QZ,L<#;UV$5O/$4A>AU3R)TD5H MM6_!E`AO0C''3,D<]U\:V4X7FRT/7-?(CLA-VM9OQWI*3M,&AT3(J:^M(\(7 M;_0\VVY-"VQ/B=RD+0,Y#V/-6_VTMMV4L4Z/T95C&&N_P$X9ZT^T@`AO/#?G MZ6)-=F.][9@_Z9G-;0N(L/[;VF*EMFM(QUC;VK9+)KVKBP/L["4!;OQW#+*K M9]MA>KK#DGXP^IT=_8[13V^_D6,8?5O;MB/]KA]1E>.11L=CPAB^Y<+!CBP) M=/G;D22;HUCF3?T\IK[?[-]ZH99P&]EMN&]T_>"6L-L\\C%N[[H-]W/N..J< M1IUN#*AS&G6Z&'5.HTX7B\=?,=I^S>5!-\3\JLMC22+FVLD;`GK.9]<)WA30 M;_9O&=$QXXT!_897!+A<$IM%S.6-V#QB+G?$%A%S^2.VC)B;,[PNH=_L7[BB M[>2U"?V&]R2X=A*;1@WO!;"M878+&*N M+<3F$7-M(;:(F&L+L67$7%MX[42/@S;&*V8[YLHGUD".V_GCXO5Y&_[CSA>O MT=OPO@W7=V*SB+F^$YM'S/6=V")BKN_$EA%S;>'-,#UST\;B_7P;_N..XU6^ M,=_MN/!*WXZY8F.\VK?#7;OB$IM&S,UW8C''["<;L9AC]K.-6,PQVQ9>;QSK MF8WQFN..>61CO.ZXPVO;!V+3B+D^$(OY9_M`+.:?[0.QF'^V+;SR.=9K&^,5 MX!WYLS%>`=TQ'VP?B$TCYOI`+.:M[0.QF+>V#\1BWMJV[*(M_,=YS>NP.^:1 MC?%:[`ZO;1^(32/F^D`LYI_M`[&8?[8/Q&+^V;9H4V$.(_YBC&>+)YYF.[-1<#:[ MVL@#(@]LY"&1AS9R1N3V0C)UQFG=JKK),9D\_N MQYRP*W9J-\5.9GC@MZ]HP4M;$)+VOI1T>6DM6]K:VK*=?/K[G^>GHY^+]6:Y>OE\')P4CH\6+W>K M^^7+M\_'DW'\5_7X:+.=O]S/GU8OB\_'_RXVQW^?_?<_GWZMUM\WCXO%]H@4 M7C:?CQ^WV]?ZZ>GF[G'Q/-^KK?316#P_+NT5S=??C>?&RU2+KQ=-\2^>_>5R^;J#V?+>/ MW/-\_?W'ZU]WJ^=7DOBZ?%IN_\U$CX^>[^KIMY?5>O[UB:[[GZ`XOX-V]A]/ M_GEYMUYM5@_;$Y([U2?J7W/MM'9*2F>?[I=T!:K;C]:+A\_'7X+Z;50Z/CW[ ME'70=+GXM;$^'VT>5[_:Z^5];_FRH-ZF<5(C\'6U^JZHZ;V"J/&IUSK.1F"X M/KI?/,Q_/&U'JU_)8OGM<4O#7:(K4A=6O_^WN=C<48^2S$F8G<;=ZHE.@/X] M>EZJT*`>F?^3_?VUO-\^?CZ.RB>E2B$*B'[T=;'9QDLE>7QT]V.S73W/-"E0 M)Y6+A$:$_D*D"D6BH5R]7*_B="S.QJZ*\1J1PN4C8B M]#<_DT-[A*97=B+TUVC0=>WHP9KATU]XED[":BDH97VXHV5`(:-'4,6.&9V# M1S#`$*H/N^N#@X0@QJ.J#.8,BJ^SP#S&AU0><>[1?*(4(`O4! M;=EUWV2`X0OMX3LXE%3JR.):?3`G'0*SK5J3++O,WY=G[V:;WZ M=43+&?7LYG6N%L>@KH21<_6PY%GXO21,B5.I?%$RGX\I3"B_;FCE^'D6T'3_ M=/J3TOV=(9V_07(9#3!40E:Z30FT)!!+H"V!1`*I!#H2Z$J@)X&^!`82N)#` M4`*7$AA)X$H"8PE,)#"5P$P"UQ*XD<"M!9Q2G.3!0E/I_Q$L2D8%"T;Y'`!' M3R@"`PPT:4J@)8%8`FT))!)()="10%<"/0GT)3"0P(4$AA*XE,!(`E<2&$M@ M(H&I!&82N);`C01N+<`)#%HAG,O*0*P\9>\C$0Z8> M,O.0:P^Y\9!;&W%"@Q9.)S3T`G.B"N'MX_+N^_E*E^1OA$Q$"XE>7I0(K5`4 M?O;Z4G&3Q+EA5?+$TC!(E"--C93I=',E*DU=H59.0KJ)/:3M(8F'I![2,8C> M!]FIE;KCS[M)B63=A/,^-T@Y[X"&0:PNT4BUFBW;82$HBM[(CT,UUD@YNXIL M@-J>:I*W4L4`J4:N:IH?AVK'5G5"B,H2IV_>"!4JK!`KBNUV@D:JU/?YF$=1 MU3V?AB91I8GS:1K$#KHP$#5-RY!4J/X\*Q9+A5!$96P8Q5RX[5DE^UBECE6U M&I1%V'9L)Z<#J?0_H`,5V^U`C51I@*P.K(D.-,UX]C4-HK?J*H>W-$*#A4Z. M#<(!VO9:)1Z2>CH=6\>Y=JI)#[AVQ7:O72-5ZEN^]F)!7+LFV<%CD#"_TE;. ML84"5R@V)#M4PU"LC>U<";V8>&YISK'=A%#G`S>G'VDW?T`_*K;;CQJITCA9 M_2B20D.3K/AH&B&.F%;.L85$SHH-R1XUOQ]SI;P?/;QNQ<(*BIETK/ADEM6E)9$Q8K!V1RA8 M+)_XCBFS;$>16CI@O>?H=JFJ].TN_:VR315L(@T8R`W>DDA,#<-R@E=K15QT MM`PKTY`>!V3U75BH2$H,BK6V^W8)6#OM4K"T M7;E8JWD9PYQVYN;V,$G[/4Q/!BCGJ1W(>/5*"=;\9Z_MB+J9J^.:)QS=[Q*G M=`X:ET0-0%;Y;2!G2Q+)>VTP M`XH5$6J;+/!"@/'&5W*E#R=P;@@Y52T45/:\C=3)5$P=!0SRFH MH9._#>0D19DS6FBH]U-!D9Y31$(\!L?:40&R2X]]_%(TU'XENA50\;*Y$6*[ M+EJQ70_0SLOK@Z7MHFJY5!7C.0`ELW,'3^UQ[)7B@\'36R):C!`8YX&&W"5! MIJV&8=$?-&P"XOG5,I"U%K-X68E*H@J-P7(63+^> M\1P3-&3'%)!3SY1%K=H!:Z=C%RQ[4GC7V&>6=8UE498,P'K/T9T7:OMUP"": M31YWPWF@(5'^BT*R85A6Q#<-1`D74Z7%+/L"Q2R/P:+CA\P"!F='=E,I"8B7); M;%CVR@2(`Z(%R)T78ML?@_5>E.I;HV#QO$@`L6,*R'449]\!:Z=C%RQV[`%B MQSX@UU$LM@.PWG-T!Y&T#AE$11>#J"%W)I9%8=V@T`Y>%21Z12LG8Y=L/@:>[YCGUFVHTRG8+WGZ`XB ME3#.(/[6UE^]=B''5D/JB-4[(C,V3$,Z9:34IH'LK3\@&A9+2^2\&"S;T<^R MOF."AM;6'Y#K*')>!ZR=CEW?L8>&[-@'Y#J*)#0`ZSU'=VS5)ME>*G]O;/56 MVRZ#0@VYE65%I*^&8=DKJ($^N-L`EM[^EVI1H2)R0@P*%XQMWRX!RTEG2 M@J7MHJ!2"<24ZH#"=EW?K@?63KL^6.9>2JGLW4H8@.*7L.K-)'](_^3N1J:8 MI66>6W1W0R3.<]"X'&\8R!E?=7HD)B)#C%X+8D3#M(^!U7*H[1LD8`D#<;:I M18-!!Q@;='V#'EBN055D];Y%@\$`&!M<^`9#`T6T5>)<5A4!=\DLR(]\^2M? M?LP-;7F1=B?,@OS4EY_Y\M?3=+"5O$^W>Z%*X>4N-AHI4 M5%I=*I)UPS1TEAK=D)(JSK,%EMZSEZM%D=5B$/@&01L0+V()(%9.`9F;#[6B M"-H."*S"7@%%CN.?<<)6/I:PH+<8T]!X&N9`6+E:U_Y!BPS`F&Q(//_ M+2B9MANFZA[;GQ=UYDX=SYWS4$,BBXH=8L.PG"RJ&SH%NX&<8K8JRH#8:$7O M%;-F,Z:U+,<$#;E\3@&YCB)C=<#:Z=@U+,NQAX;LV`?D.-9$H3``:Z?CA>\X M1$-VO`2DTZ9\QVJ$PSRF5[[N&"S6G0!RKT24)%.P=E[)S'>\1D-VO`'D.HHJ MY1:L]QS=>:'N/MKSXH/TK6]6.KL:`U&\YXDT#J04/_ MW3$TU+.^6BR(X(Q!X'S2!L1FR5YF*1J:%!,5Y4/W#ACLU@7$;KV]W/IH"+>R M&,D!"&QV`8C-AGN977)#]8PL$A-NA,-L=06(K<9[64VXH;(JR3='ISC.7C-` M['6]E]<-&NH^#*.J?&?Q%HS,S8W]P^Z)A_X]<0.)Y.^5+KJAE1B;IJ%30AN6 M*70+!9%)8K3A\JX-B,N[!!"GLQ20*>^J4;$@IF<'%-;N`F+M'B#6[@/2VE3W MB_W#``16O@#$RD-`K'P)R$UV0GX$EG/S0#[HN0*+'<>`V'$"2%\+S7UA-@6! MKV4&B)6O`;'R#2"MK%[TK8H*X1:43-L)4ZH0W!3]6_>C,A6W\`;D9&YY8@W# ML@MO0'Q7HP6(TGR>S*.:F`DQ'"G455@5,<9Z\9(/:Z!K33ZP8LLS9$05EDE%LP,C4]Q\,9!]\P4L4XL5Z(\*SK"<1:^`L3"8U]X M`I;ICTHH4N@4!%:>`6+E:U_Y!BRC7*L5`J%]"TJF[<:C?'2V>S<9^<_(#*0> MV.450E&6P@VP>+(U`7'5U0)D9E8MJ(@-5@P&S^,V()9.`+%T"@C2]+3-#?4. M&"S=!<32/4`LW0>DI4N!]]X/"*Q\`8B5AX!8^1*0SFKROM((AUGW"A#KC@&Q M[@20UJ4)Y';%%,=9>`:(A:\!L?`-(-T5Y6(DD_XM&)FT&XIO/O([]#5:]A4S;HAW9Y!F=8"RRZ'Z.Z[VW\Q3N*#JMG(\_1.(,^.*2#7 MT0M>(';L`W(=O4)A'\<+:+'C$!`[7@+27]84US8R1^G%*PS# M%1JP[!@0RTX`N1@5`IKXDHZH+!=U[?K@;73K@^6M@O#F)H7]I2__>R_-B_6W16#P];8[N5C_4KVC1JWUGGW+8_,17 M6*Q_(27*'_)(4/^2K5\"/ZZ-RG5Z2OQ;^C0U:LOV;QUA*3T'D5T/7T= MI9Z^>82^3D)JF<]IWHA^0NUU_FW1GZ^_+5\V1T^+!PJ.0O:EG+7^$3;]GZWY MGM37U99^/(WV6O1K0?1C>0OZ8G=!?9GJ8;7:XC]TNJ?YS^^=_4\`````__\# M`%!+`P04``8`"````"$`1/K9(9@&``!^'0``&0```'AL+W=O[E,TM( M@AI"!&RW_?=G>QSPV'2!+^UFYO'D\7AF'HB?/GRO+MZWHFG+^KKWR6KC>\4U MKP_E];3W__G[T\/6]]HNNQZR2WTM]OZ/HO4_//_ZR]-;W7QMST71>2+"M=W[ MYZZ[/:[7;7XNJJQ=U;?B*CS'NJFR3GQL3NOVUA3902VJ+FNZV43K*BNO/D1X M;.;$J(_',B]XG;]6Q;6#($UQR3K!OSV7M_8>K MRNZ'"NI[5?[X^72MF^SE(O;]G019?H^M/CCAJS)OZK8^=BL1;@U$W3WOUKNU MB/3\="C%#F3:O:8X[OV/Y)$'Q%\_/ZD$_5L6;ZWQM]>>Z[??FO+P1WDM1+;% M.*GKKQ+Z^2!-8O':6?U)G<"?C7([VULF:Y`\BLCWG0&/?J\_VZK8HPSR4491L<0N6G$^WYX)W6Z>UM]$4G,- M2@`D>F(`841Z1\@,RKC<,*P%X9ZUR(7-FHE3'3^/.TFY").D,2:0C$`P(AU! M;#&$NY!X@*!M,'<;P4_+ZKX-N4@4D)E&NB680P*@0-6BS&1J&[AA0)Q$$9BI M?3^E$KSWQ8;[(Z7,I@*82%5%$&RB"%--37\<4(K=W'1'VW@H*L1:9&T^:PFV M6%.&OS8!3*A8/Q`2A`$&I``8,LP-`Z(6+:$FP9B::"0K)0F`@-LN8BS<6=P` M8'`S#(A;C+G)[I_N([G(YAC9G02@@4)J&[AA0)RD:%H3:;HIY*+)I@"0P;0H+M_&SM^@(0G"%EFW@[C`@U^E(`#&2Y84#)Z?0 MD^PTZAUZ&F'P,RV8H)SBQHE.$(29;\X40HVV5]E)"*"&KT\="S;:[QXK720P"CU-%@0&R$:A,S1U%$4& MVL2TX%R*"C(/^?VI3B4:TW.GC@8%\'BZC>T1B?V,6*GFO5^^]:(7JT4*1&IPC@%@;7_IZ0_=$Q_8NNY/M&HX6!3Q\)-"TZ?)3#S^EF^ MOD\_O6J420S6#19N8C"Q15)"72D9&=4:!><:1,P>U,@?AO83+M?^D6-=I"MT MEJYH%'0,<]L9@IBI-"PXE8M$A+HB,M+.`(),/I`=LXHRU5%TO\>!]0C'>[_3 MSW+`&P(S,7M`#K#B;2TR";V+AOR=QW[=3Y'W@1*'ZGVU356^>,ZGJM!X3(Z4 MJ$9!8MF&A=:+,O*[)%TA:,K>LE(]A;I"AO3 M%?L-)-&HX?!2Q\)-"TZ8I1TS^P"&O:B1_H=,,4VL-[F$&9(`3]2.A9L63&R1 M;#!7-L;&FZD;A!&+<*JCP$E3$EM^KOTCQ[I(-I@K&R--<9_[4C4>(N(4'?8' MU@]F7'^)RS58I!L*;8]B1^(T2G<1'QSM%; MX?HM$==OZJYJW3O$[=NXN?_\ MKI>0Z>EA6\(.5-FM MNM@]VA_=^RR([.730U>@?\OBK2$_6\V^>ONM+K=_E*<"J@WGI$[@N:J^*NCG MK0K!XJ6Q^E-W`G_6UK;8Y:^']J_J[?>B?-FW<-PA[$AM['[[(RN:#504TBR\ M4&7:5`<@`%^M8ZE:`RJ2?^^^OY7;=O]H^]$BC!W?!;CU7#3MIU*EM*W-:]-6 MQ_\0Y.I4F,332>"[3N)&B\`+X]4M67R=)1BS>`MO%;IA=)W+$O?5E2G+V_SI MH:[>+.@]8-Z<<]7)[CUD5O4)?EH?*(Q:\U$MZI8"NH%#_?;D>I'WL/P&)['1 MH&0"Q!%ICU!E5WDS$E@"OX$D%$Z2]*$5I@^Q)ZD6<9)>S`DD$Q".2"<0*P[) M3$@\0M@VX`1OWX9:!%UG6[36/N>0("CHNDY5,I6!C`08)SASRNER217XT88- M4RZ!X(*@"-O""<)P+3HC1<3(-B,!1@X:<3XY!3;(A8(<@L*.W-W*\WQ1R90! M_+7K.#Q#AH"./.,:W<)5@0VN$?]-"8*0ZSKR_7#-`2D"2!U)@'&+.336F34:52` M3MD2!$&?#Y,3QK+U>LP@AR3`:+J@?;?7KEME$!4]E6@4=IWG._%*;"75B+&^ M&8UPHDK0;SYD%VU`R(Q!%%&72ZI34:[],G770#W&53I.N%Y6P@XMBQD+K4@T M:OSUJ1'):(034I)-",V;6A>%'KX.G0;>+%HMT2A*C!B$-F,2X<247!-B5RJ% MXBY.4YJ&BRALNSA>Q;Y`I!HQ4LYHA!-4&CV?("JZ("B-0]TTPIAKYXB#T!5R MG6H$)?@SKW"54,\GB+(N"(I?GW0Y>X*Q$WBN,;B8![?@NN':\#:6(_*C<#P$ M7F`EZH3_S-9$*Q#[$"P3MS<,VL"Q*ZQO0`UB22./$ MI$8DHQ%.3'C+Y4IYDYXRMC>ZM$;I"8D<.2"I!HR,,QKA_.!4YI^DI]#23R(I M0AJE1(NPODI>9_=:1Z:`>^T2&J01NGZ!5XLYB5E@%44B@09 MO[XFK:IS_>I!-)_=$HP!(#->[5!M0PTC3"R0HWFDEVTI5$/1/UX`]M MY,S>5/.%!M3A:BQ*5.];HQD-,()O1VP#;])HA-.[R4B\*2,QY0=1 M6GY\WWBPUVG&@F8TPOBI9[WYY>O0ACP*]4@T"OGYCB_D,V77@\@7HY^QZV%( MGGPX=>$\\P;:GW0@02'1*#'0QD8P%ZGSL`Y&G)-5^D_:="99=`W1KE)]?$1= M(]NC!O49UAED;_(D?\J38J,I$#76*M7KQDA&([QZL+=W5$^MNGKWXR-JI)$: MD8Q&.#$EX.18+]_]^"CWXCBE^FB4=F_7,Q[!-&!DG-$(YW>3C_A3/F+(CT8% M^H]WQLW%<'UL-.(\G)YPE2OE0S<1Y3,:#5&Z?*`^QM0B@):/1#@_82XSIW;2 M9`R)Z4V$>F,LK<;O46,Q2823%58SD^RDY1@2@R@A,0;9'C62)1%&-KC)=SJT M]!WRYWU\;-"H\6!3(Y+1""?T+C<)T`&NW.!H%"5F.`?%<&)*MV=+3(`J+V9$ M2HQ&X8QX@2...]771\(9C7!Z-WE%,.45AL)H%-*[@^^'\A'5< MEI@`S4"43TJ,1N&[E6@EJINRRZ[OBJ?#C%WW7/)'%,N\>59O#OY2GQCH4.WA`<18Q;*_&M]/XH:W.W;O+YZJ%M\K=CWOX+X("WNTY"P#O MJJKM/\#O70[_E_#T/P```/__`P!02P,$%``&``@````A`/7B#6I(`P``MPD` M`!D```!X;"]W;W)K&ULE%;;CILP%'ROU']`O`